<SEC-DOCUMENT>0001501134-21-000012.txt : 20210226
<SEC-HEADER>0001501134-21-000012.hdr.sgml : 20210226
<ACCEPTANCE-DATETIME>20210226160759
ACCESSION NUMBER:		0001501134-21-000012
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		118
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210226
DATE AS OF CHANGE:		20210226

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Invitae Corp
		CENTRAL INDEX KEY:			0001501134
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				271701898
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36847
		FILM NUMBER:		21688779

	BUSINESS ADDRESS:	
		STREET 1:		1400 16TH STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103
		BUSINESS PHONE:		(415) 374-7782

	MAIL ADDRESS:	
		STREET 1:		1400 16TH STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	InVitae Corp
		DATE OF NAME CHANGE:	20121105

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Locus Development Inc
		DATE OF NAME CHANGE:	20100910
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>nvta-20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:1a5642af-41c4-4761-89fa-6771b997ee20,g:0d35037d-3d4c-4753-897e-12e6bc13039e,d:e13029cdd7d64c5bac971f0e86e8f19a--><html xmlns:nvta="http://www.invitae.com/20201231" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>nvta-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV80L2ZyYWc6NWM2MjVjODRlOTU5NGRiMDlkOWZlNTg0NDJiNzU3YWYvdGFibGU6MmI3NTdlYjBjYjFhNDE4Njk4MjI5YjY3YTUxYWE2MTcvdGFibGVyYW5nZToyYjc1N2ViMGNiMWE0MTg2OTgyMjliNjdhNTFhYTYxN18zLTEtMS0xLTA_d8f5204f-cabc-413d-bff1-1dea2e5318ac">0001501134</ix:nonNumeric><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV80L2ZyYWc6NWM2MjVjODRlOTU5NGRiMDlkOWZlNTg0NDJiNzU3YWYvdGFibGU6MmI3NTdlYjBjYjFhNDE4Njk4MjI5YjY3YTUxYWE2MTcvdGFibGVyYW5nZToyYjc1N2ViMGNiMWE0MTg2OTgyMjliNjdhNTFhYTYxN180LTEtMS0xLTA_26fc2223-1f28-4ab9-8941-a887109a62b6">false</ix:nonNumeric><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV80L2ZyYWc6NWM2MjVjODRlOTU5NGRiMDlkOWZlNTg0NDJiNzU3YWYvdGFibGU6MmI3NTdlYjBjYjFhNDE4Njk4MjI5YjY3YTUxYWE2MTcvdGFibGVyYW5nZToyYjc1N2ViMGNiMWE0MTg2OTgyMjliNjdhNTFhYTYxN182LTEtMS0xLTA_63f7a23b-7555-47ee-a0b9-b9a3fe79301f">2020</ix:nonNumeric><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV80L2ZyYWc6NWM2MjVjODRlOTU5NGRiMDlkOWZlNTg0NDJiNzU3YWYvdGFibGU6MmI3NTdlYjBjYjFhNDE4Njk4MjI5YjY3YTUxYWE2MTcvdGFibGVyYW5nZToyYjc1N2ViMGNiMWE0MTg2OTgyMjliNjdhNTFhYTYxN183LTEtMS0xLTA_5dbdade9-bafc-4a4d-b84c-e242e0320b58">FY</ix:nonNumeric><ix:nonNumeric contextRef="i34f5ec56f0f64fb1a6076e5b2da4e8bb_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzY4NQ_d2037801-faba-4d7d-9a9d-b880ce2dc05c">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i317a0d3674754e8eadf2100b8122a12e_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzgzOQ_4c24a27f-0da2-4313-a3a1-cf19d3484ec4">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="i317a0d3674754e8eadf2100b8122a12e_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMTE2Mjg_1217d9ea-71ec-462e-9a23-2257607bd016">P3Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="ieaa221a30dbd47088197aad0397a06dd_D20190601-20190630" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84OC9mcmFnOjYxOTViYzE2NmMxMzQwMjFhZTc2ZTNhNzAzMzFmZGZjL3RhYmxlOjRlZjY2Y2QxZjRhZjRmNGZhOTMxMjllZTFmMzE2ZDA4L3RhYmxlcmFuZ2U6NGVmNjZjZDFmNGFmNGY0ZmE5MzEyOWVlMWYzMTZkMDhfMi0xLTEtMS0w_e47ba71b-bfaf-4556-a0f8-0c385bdb2dc9">0.3333</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i12c1cc42834c4cf6a61f40ac2f7ef3ce_D20190601-20190630" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84OC9mcmFnOjYxOTViYzE2NmMxMzQwMjFhZTc2ZTNhNzAzMzFmZGZjL3RhYmxlOjRlZjY2Y2QxZjRhZjRmNGZhOTMxMjllZTFmMzE2ZDA4L3RhYmxlcmFuZ2U6NGVmNjZjZDFmNGFmNGY0ZmE5MzEyOWVlMWYzMTZkMDhfMy0xLTEtMS0w_4227a5d7-388d-4c4d-b402-cba6b6213cbd">0.3333</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i047bbad9f41248d784dfd314328495e2_D20190601-20190630" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84OC9mcmFnOjYxOTViYzE2NmMxMzQwMjFhZTc2ZTNhNzAzMzFmZGZjL3RhYmxlOjRlZjY2Y2QxZjRhZjRmNGZhOTMxMjllZTFmMzE2ZDA4L3RhYmxlcmFuZ2U6NGVmNjZjZDFmNGFmNGY0ZmE5MzEyOWVlMWYzMTZkMDhfNC0xLTEtMS0w_5594858e-7c39-4b08-b70a-3ffc6a5a5906">0.3333</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ia8407226615949bfb9526b70f7a7df3e_D20200601-20200630" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84OC9mcmFnOjYxOTViYzE2NmMxMzQwMjFhZTc2ZTNhNzAzMzFmZGZjL3RhYmxlOmNkZjJlNzBjOTMyNDQ0MzM4NjMzOGM5ZTY4OTljNmU4L3RhYmxlcmFuZ2U6Y2RmMmU3MGM5MzI0NDQzMzg2MzM4YzllNjg5OWM2ZThfMS0xLTEtMS01MTIz_73ced9e6-f198-412f-9303-a63711b5523a">0.5</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ib8a01b84d4884fd689e8d6d16e307111_D20200601-20200630" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84OC9mcmFnOjYxOTViYzE2NmMxMzQwMjFhZTc2ZTNhNzAzMzFmZGZjL3RhYmxlOmNkZjJlNzBjOTMyNDQ0MzM4NjMzOGM5ZTY4OTljNmU4L3RhYmxlcmFuZ2U6Y2RmMmU3MGM5MzI0NDQzMzg2MzM4YzllNjg5OWM2ZThfMi0xLTEtMS01MTIz_d1849a64-3a02-4460-99d1-09a3e03a973f">0.5</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="id0de66aa513b490fa2a83655afd401b3_D20201201-20201231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xNjg3L2ZyYWc6YzJhYzVkMjBmYjk0NDhjYjgzODJlM2NjNWQxMzk3ZWUvdGFibGU6M2ZmOWQxOWUxZmEwNDNmYjhhM2MwODA5ZWYwZjUyZDYvdGFibGVyYW5nZTozZmY5ZDE5ZTFmYTA0M2ZiOGEzYzA4MDllZjBmNTJkNl8xLTEtMS0xLTY0NjA_68aff98d-78a8-4b63-845d-d4ed396f8992">0.5</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i82a2c1c8bfbc441895243a5d3091ba15_D20201201-20201231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xNjg3L2ZyYWc6YzJhYzVkMjBmYjk0NDhjYjgzODJlM2NjNWQxMzk3ZWUvdGFibGU6M2ZmOWQxOWUxZmEwNDNmYjhhM2MwODA5ZWYwZjUyZDYvdGFibGVyYW5nZTozZmY5ZDE5ZTFmYTA0M2ZiOGEzYzA4MDllZjBmNTJkNl8yLTEtMS0xLTY0NjA_c1d95f59-eb72-4017-bc41-3860257aabff">0.5</ix:nonFraction><ix:nonNumeric contextRef="i317a0d3674754e8eadf2100b8122a12e_D20200101-20201231" name="nvta:DebtSecuritiesAvailableForSaleMaturityPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfNzY5NjU4MTQxMDEzMQ_d4b367b6-e09c-49d9-900c-330dab11d098">P1M</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xNjk5L2ZyYWc6MzdhZGYyY2JlZTBmNGU0ZGE0MmE5MGE1NmE0MThkM2IvdGFibGU6ODM2ZDc5NzUyZTY4NGFhZThlYzMyZDM1NDA4OGI5YmQvdGFibGVyYW5nZTo4MzZkNzk3NTJlNjg0YWFlOGVjMzJkMzU0MDg4YjliZF8wLTItMS0xLTY0OTg_7c136f8e-6d53-429e-99e8-42d73a57b798">0.0336293</ix:nonFraction><ix:nonNumeric contextRef="i5411d1bf0e774eac8fe3c0f582fa2af1_D20201201-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzIyNTM5OTg4Mzg2Njgy_3f341498-9f73-4766-bb53-9c8f75c67d63">P2Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTUvZnJhZzo0OWI4Y2M4NjFjMTA0OGZjYmM5OGJmMzM0MTQwOTc1Mi90YWJsZTpiZDJkOTkyMDA5N2Q0NmE3OWY4MzNhMjBmMzdlZGFlZS90YWJsZXJhbmdlOmJkMmQ5OTIwMDk3ZDQ2YTc5ZjgzM2EyMGYzN2VkYWVlXzUtMS0xLTEtMA_870ddb50-1a1c-4fe7-88bb-a47f1e8cb217">25</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" decimals="INF" name="nvta:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTUvZnJhZzo0OWI4Y2M4NjFjMTA0OGZjYmM5OGJmMzM0MTQwOTc1Mi90YWJsZTpiZDJkOTkyMDA5N2Q0NmE3OWY4MzNhMjBmMzdlZGFlZS90YWJsZXJhbmdlOmJkMmQ5OTIwMDk3ZDQ2YTc5ZjgzM2EyMGYzN2VkYWVlXzYtMS0xLTEtMA_33502561-954c-4f4a-81b6-dc67a89abe6b">2.08</ix:nonFraction><ix:nonNumeric contextRef="i29d2feec4499443ba9d3aee65162bf6d_D20200101-20201231" name="nvta:IncomeTaxExaminationNumberOfPeriodUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzQ5NTQ_150b999c-d788-453b-aa59-382e59e7d0d3">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="nvta-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ifc8bfb591e99451c9a0fcc043f9c90de_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i3580f7eb63464181853f57b89cae8eeb_I20210219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-02-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica8df88fbc13471181f2a555e9880399_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fe154ccb77e426d92286dae5aeff26e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="id9b882f2b7c04e7297a6e4005b4ccdd9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i437a19f6fb264a83b0e5e51fec25eb41_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58cad0e4115a408fb292a43a94deba31_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8d899ddc8834e689efc87de396289f8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4f2ead9ac6540068a6b97873f3f9752_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i616089384d754359aaf3b67545a021a0_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f3778e5a29f4a89b8566f4904cf689f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2809c9d3c7ed495ea105d1d0909333c7_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie554d3df8b1f425f9be76437e8b27488_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8214f3614960469ea38d28cf9303f211_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id753156daf9b430195e021dca2c527bb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23abde67124a40d590374be251a1dee1_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37dd50d3619f4aff904889d2b15d5117_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4e2421641034f4f9c940f901e1fbdef_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c3a7b53ff0f4c5ba0b9fc100703d37d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82869c0962ef4cf1bddc91ff73996c6e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ec2e6bbc47e4933af77c2c3a21ca309_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bfa576bed044795b85e3c7f95992d6a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbef3252651e4df5be4e543eeb29b46a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65fbe0254a9a4420a86969e2d6309651_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c6a38f48b1244e19aff28ddf6d53576_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">nvta:ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia370e5ff06d5431fa9bca439bb1b889b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia58ce6bc9aca49d9aa127557c52c11a9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8594685f80541b1b4777011ea3b8353_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2ce8df417b84195a8e55c791ce044b8_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfbbd53bd90042b58ef516ba23872688_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34b06356d84b48aabb5a47a229bf0277_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a108a141584487ca8dbd201dfd46516_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24ea52a8309a4413a699941e900a6c44_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6cd188a85204aaf8d02aeae0c5dfe1a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i133819ff76b24d47a6fe9cf8b026d64f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1dffb2fad8b40ca9e2827b034550280_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="business"><xbrli:measure>nvta:business</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>nvta:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i70c89bb06a7246a1bb3d4f7eec32e812_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:ConvertibleSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e1175abf83148d8836d04d1ecf72a47_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:CustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id09edfceda314a48a3bae75a5376813e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:CustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i654d4e6d51c24784b92cf81e78d322ef_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:CustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34f5ec56f0f64fb1a6076e5b2da4e8bb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd5dd2727548445bba930982eb5e164a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i317a0d3674754e8eadf2100b8122a12e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23413efbba8a4bce99ca014f751cd629_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife1d8cfb66ed44aebe09b9526f251933_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i479bb752e9834ff889d964d04d4fd5f8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cc8be4a617648da91ede3d8cd832c3b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ef676364d144f13b1b75fad36a56028_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7aecb12307a4028a550cb1bdd7c0949_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f632804fdba4dc8928d0db037568eff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">nvta:ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16fc5f68786d447999f8e4e68164aebb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">nvta:ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i799d7ced2b4d4f649c58a173693d0e85_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">nvta:ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8c91c8e1cbc46d49aa79331ab90dcd2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9c67b77700048fab0585b6066fa04c5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6871dfde02ea4071998e693ce797f046_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbcb07071f07445fafa80ea82f6b1aa1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b8929e13ba7497294e5422447cdf72c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07eda2ee4f144ad196ef401a7db1bffe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueDecentralizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8e9734305bb4650bd1c5a51bad8c420_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueDecentralizedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48186d64febd4653a8f230b2dee4ce39_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueDecentralizedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6be0b9df48b4580a4f57239b6c93c95_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueDecentralizedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b1d5edf779f44dc9cb12c8fa50f37f7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueDecentralizedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0883ec36ca8f4b61abb4136ad60dfd6c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54c647460d3a4f2ca2462ceef18be368_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9bff46bd60c485b87b8b76a524b891b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd3bd1b58fce419091528683f64e06f4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f2c32a0a92c4d75956a7049d4a3d2ea_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ac952c0d68641358df70ac8ca6a5650_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie754d8f483fb4e51858045ccc2f3ce90_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74e133af2bf04b16807d4769bdb0cb72_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0865c1b494ba451ab270138139c94f26_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e1ebc0d9c8f4fa49f8160f97e726c28_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5822641e200b480e91f0f00410faaa4f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i930f6e9c37794d87a77e92a1acdd9d20_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9ceb9d1a9ba4fefab7b0de9a46a08f5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id351fd76aed144bd8c8d86224002492a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3e33012667e4e30a31dc4fd2506de06_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04c0ca3a9d3842ebb3e2454a419f73db_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id48ae029801d40a797835dbbc0b21225_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i569b0aa5a6f34fb192244d9b4ba6eda3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58747813981d448b9d05d26c6c6d5246_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f82f2edd74c43e996978b02294c3f96_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6829414e2ffa46ec8834efbb42474a0a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i491dfe25cfb649818908611d2258015f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ba34653ed3d4026b109adcc85e47692_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7194b23e865e4e6985412838b83facfa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4a31b78347c4b40b403d983d215552b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7296e71c4e804c2c81cdefbc5ff88c20_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i969948f32a3e419e836b2483a8c32d1b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied3c3598292b417c808a16a8f89056d5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if00851ed8e674d059de41cc8a623702e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fd4026968274daa9db97163c9bf7adb_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddcdbd12b8c7475aba56d81dda39e665_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d4f784ba21340fca1b9b756750631dc_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63d5268d5fcc418f821908f9c967fc66_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3b56aad901d4542b70fef47b9e041b7_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c178e50df2e482c954755b5678ede25_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fd6d6acd7ce4ad4bca9f6796da9e37a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1e9baa6d9c74475a1b214d6a20dd9a3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeca44f7c289448bba37ead51a718ccb_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie19147196bf74f8a98a96a08aa4ff4ef_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d25782f3f414458ad4852af49306b8a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82f3fed101ff476eac77b5bae97ef149_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f15ba33a7ce4679b90a0c0de0249127_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98f5fa2ae5e04ed4892542827e4eda04_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf399717bf28435a89aca26b773c0386_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31abe8effbe949ff872826205878e9e6_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35a9b0c466f0496cad68a4ecd841c041_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if46861699db14e22b253710d388c79d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForChangeInAccountingPrincipleAxis">nvta:ChangeInEstimateOfRevenueRecognitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcf84e334a474c329adf523e6663178a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForChangeInAccountingPrincipleAxis">nvta:ChangeInEstimateOfRevenueRecognitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3516e7ca9c34c0eb58ee7744a7f3850_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForChangeInAccountingPrincipleAxis">nvta:ChangeInEstimateOfRevenueRecognitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1f0935550d444fa90ce07c61f19769c_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffa172b7ed5b4b2d868c2ae82bbc52a8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cfd56d90ca84309ab029f02e8df5f24_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7780db32fd364ad99995fb2cdcbfc4fc_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">nvta:CARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05128bf9cc8243f2bc27b6e1f8a3f4b1_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">nvta:CARESActMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i088f81f066a440d084e5a4dba897c8f8_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if97a189b033643b79b8524895f6a78c7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i175aab7c76c643de95548d9a1cb45a8e_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8c530faa72844268e7ba46c4a287907_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7db43ef787b49d99180bd32eb0c2d09_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icefe8e19fd8546d5821a526b27974ab7_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvta:RestrictedStockUnitsPeriodofTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbe2c42636474f38911d7bec038c9f4a_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="tradingday"><xbrli:measure>nvta:tradingDay</xbrli:measure></xbrli:unit><xbrli:context id="i664d8f88777d401d939dcc07f67fa240_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76b34857279b4a77ad109619d8a570f6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvta:RestrictedStockUnitsPeriodofTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8beb45e3e6464392a4fe1aeb393268c9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvta:RestrictedStockUnitsPeriodofTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iece04e5008c1410393b57b628e274295_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4451a9390a774709818e6fbfd6084973_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d36b97f4bad4698aa59cb3ac9774f0a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvta:RestrictedStockUnitsPeriodofTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34ac12069b86446385fba11d5714dfa1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20988f3b4f3842aca296183226b1191c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabffd0b7435a46ab8001e51bc9e0f884_I20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:JunglaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5c0b15b91a8498db2213d6c5cd2acbd_D20190701-20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:JunglaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id813b06cc8204234a74cd25abe6470b0_I20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:JunglaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34ca71f207834945b160a2a860186500_D20190701-20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:JunglaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3849bfee08db4045a8d579e08dc78573_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:JunglaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedca751c89a74c22904be3c69b76ea13_D20190701-20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:JunglaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:IndemnificationObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icad31fda692c44d6b3ebd405fc1f5bfb_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ClearGeneticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b7028fd67c14ce39c1a361bf67387ac_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ClearGeneticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c0220e1f83a4ee1a04a467bc49d5677_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:IndemnificationObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ClearGeneticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id28b9a63ced0431fa69e448208ef5a4b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61df02f3966840fc94c9ac82e9b14a0a_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:IndemnificationObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21aa382eb1b9450d946befd8e9d905ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if78d990dbf00451cac45ceb3bfbb2548_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf11c41e83954282a4bbb12523482153_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fa43003f790492f944ab337f15b503e_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:YouScriptMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i920e93e600db4f87ad9b6f58a894b7ed_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:IndemnificationObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:YouScriptMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id10eb65b4a854730b97cac8b3b292344_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:YouScriptMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:IndemnificationObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0be3804e02eb472fa855c077d75a96ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexandYouScriptMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4a51d4bcba64524baa8cc419ee0d7bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i604983240be1439382d7e6de61b44b46_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaee9d8368b47462ebefed8a888e444ac_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexandYouScriptMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49c0120db25348e6a3ad6bfc5753b6e0_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexandYouScriptMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i376851875deb457fb8f3344dfc678b71_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexandYouScriptMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i098aab9e153f4c929328dfcb7cfaab20_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76b9ebec35b749d1bea22642506ec50a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96044be6fb014778a5e4a8af9e0dfbbb_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd1c00bbb2f5471097e760d29754a813_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">nvta:AccelerationofVestedEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bf4bd068321410598134af3a04bf469_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:MilestoneAchievementAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4c5e282814b430c8949b3e79a822850_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:MilestoneAchievementAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19caca01816142a3b5b28f51ca27894b_D20201101-20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:MilestoneAchievementAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2020-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i911717b1170c40cf972400c897d04ea0_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">nvta:AccelerationofVestedEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c4c49beaa8748e88bf241eeb61857e2_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22c6518824a44e32968c6279d316dbfe_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ba4d5c315834206a2dfed011b842a81_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4faeb825368e4fbebb63eb99ebd16fe1_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50a8e75f54fb41df880dd13c66ec40f7_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1faba8c669949feb0448beb8f5f7f73_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7afe4132b22c414b94a24036e21c8d41_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id04b1d5d7d6f42a7972c2a960edf12fa_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cba339628964b39a0875938b2811685_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43a9b372cb9d4068a0c794bfc92b1120_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaa221a30dbd47088197aad0397a06dd_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12c1cc42834c4cf6a61f40ac2f7ef3ce_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i047bbad9f41248d784dfd314328495e2_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8407226615949bfb9526b70f7a7df3e_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8a01b84d4884fd689e8d6d16e307111_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic716b0d977014b47953f608abb21ee07_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46f04de7671548948145a3408339daf3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1859f563a61401391afb23698e3d1f0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:YouScriptMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i185c1e74a04443a291a72f01a6c8a9f5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i214eccad6a7f4c09b2611b0dd7b962db_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5869dcd08fba40eaad37b756d9760bb6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a9ae61cda6d4c61b9b7cbc0b7d88e7d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44f6002ca8f94affa0c1cb580edec0ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9b892712a0a4fdc91399aedf309b228_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad65ac656fd04a3d9861477f940eb9ec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20ab20c5638141578c0fa5ed16421662_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b08ae6f22a34f9ca4efcdd7622c90b6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">nvta:PatentLicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1145d52e94e041bc8011849883eb468c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">nvta:PatentLicensingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83741d505a5c43ce85ad0ffbef5d30fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id489f9ef13794b19800824a2e713d3e3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76054c8277e34b278fb7cb28ef0095cc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bfd608ebc2f4679bbacfd7c6509b051_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92c98fa4920d4181bdc4e4ebafa5d57d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if61da7ae894b44d3a17390db3eb337f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67b31cc1f5c4428988fc99230afca7da_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae69da4291404d09846bdd7eea1b3df7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0de66aa513b490fa2a83655afd401b3_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82a2c1c8bfbc441895243a5d3091ba15_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide3fcab1d351422aa89b205d3c4e9817_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i109c3eeeb37142eeaff5dbcd7fb30a51_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d6c19c668184c16ab5abb3b2f56e025_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia86d7ba53b5946f4a663cf20df932e8c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fa0c386cddc4e38a421e7ec46fd9828_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie41b32eea41a4075bd7d4ef22299e442_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaed14ac220d841b784c269f25af4118e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e9a07f9f51544b588b193d821061957_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i950327dbdb864aa59bae2e677d3cc59e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f1d4c48e1794eef98c5bba9a22a83d2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbb2e86c476945ceb7204aa84003647f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f5901d15dd341af989b63f1e1be596d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i221de2cc80ed4f658ae2b575f1e37709_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99c28c17201b43acb7779bcb565aff06_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9f5a000cae84d829d333a825f105334_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i130e2d48b5004c6e9a3aeb316acff2f7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27addbbb2eb641a0b57afd4322937765_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54333500eabc422aa4fb7b50ec024580_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28fae00650bb4a91b726c9ae7389e05c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08aad59bfa6646eb872d92df4fe25c56_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i188d8124d1e9488595a24ed023c83ec0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c5de93de50148019914bf27c7db6355_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia032f7f120de4f9c8d66f9fc7b25aca0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i473285deb1174f398238bf9d728acff8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if082e3e8efba43fc80a4f205e0fe9272_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ec63a96541542f6a5bd94b8d12a174b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e46526580a74ee5aa03b64dbd08a141_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3b0d2fd70ee437db964f0f6171b13e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5b55a4267c44c95b43de4a61c59e2f8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62eb3a1e610e4f46ac59f207fd5c2df3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3372e8a93caa498bb1f1a10e5af5a318_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2590f9ee0bf41149e7cf8182ba63d51_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cceadd9383544c5a008badc36969778_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i858f7fb75312498eac5fbdd977be8915_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b9ca881766247fdba01b8fa00874e5d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d4614b08b464e53b288d71792d75a12_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia093c7d811d143d4ae900c0461f04e11_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac515eea33b64659b00dd874246c95ae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bcaa1c58b304863a4d0704739b31457_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied2ebd117b5349d18d84166bce5ec784_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i360a34815adf46b48fc3bc240b973154_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieef125570a5d410a9ae17d5d2ed6cb95_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f3a2163cfa940a4aa419fae83424ede_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06993cb5d1c6406493c955e36efe376c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d1e92459dfa4c3c86e03c46590cf11e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib528de6cd5d94b218ca6a72049368aa7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea18a70d0f8f4bc58647fa548740fb30_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c59cd454de14e7b98c76fd5c5755dd8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d259a569c8740668939cd2c6f008b27_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6db56f1860564b5c948005ffd0e54da2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib787a31ca31242e590f07fd32f7f3247_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43b1dc051d8642cd979ce95901f997a3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic93726820e244b3e870907dd6bf88b60_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i038907853f764077b79a59ffd5d636f8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09a2305fa55f403db2e53d3b4c66fdf4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i862cbc61396149b4a904c89b1e7af8f4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib57776d437354dc2ac23cfa698397058_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i820b4148e0c34bafbdd13e8562a3b4f7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i205c8b0c236749ab8849be640e1c99ba_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec01bbe55f3a4c9eb2bb920d009b727d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7df43ef9d55e4c67ac7eb55388c00aca_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie763bd4d168247b5a8706e65eafef728_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c5983241a3e4da6ba46a2a2e89d89fe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib13c4fca32874b758541909197f604c5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i763bfe6fa0b547ce82fc98bd8524a4fe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d2ff72b9ebd43228f6d29da67e34f55_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id715584d8ddc40bbbff675871872b46e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i595e483b9f0344c4aca995e6a572302d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9192e09ee4e24faaa76e6fc28d55f441_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73e6634d1bca4bdc955007d68d05ebaf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i531f978b6c494fe5962f9f63ddfd8712_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icecfd6fced1c453ba8fe7e4e77e3c937_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d0f0692653f4d25aaef40c6c24a8aac_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id23b32f856364b628d82e533acbde8ae_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nvta:OfficeFacilityInSanFranciscoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nvta:NewLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fe976692891413ba81c58b02db5d00d_I20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">nvta:NotePurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f703415354e4db28b8eb792013da139_D20181101-20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">nvta:NotePurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id859a147fbaa47b580a323a7f9e4189d_I20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">nvta:NotePurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5fd4ad3c7b6406383062accfcffbe19_D20181101-20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">nvta:NotePurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63443cb782824ffab2f81095d44a8e69_D20181101-20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3449298aceb411e8995fb489e02c922_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">nvta:NotePurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69711d9dc55a46288486cf518a43bbe2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">nvta:NotePurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i117de729dbf54fc8b1c7825fc2b3e06d_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:SeniorSecuredTermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4f48e652c334267bca5c0f3175f3e6d_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:SeniorSecuredTermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bf76301d2c04d1fa068a5ac5c9c4e49_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:ConvertibleSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibccee1e9674b4a1394120efaba533158_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:SeniorSecuredTermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f033130abcd435b987c4fb6e75bdba0_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:SeniorSecuredTermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89b10cf6330f40a29dfcad173848efc4_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:SeniorSecuredTermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02d506f5f7744c309e1d6654a886c893_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:DebtFinancingContingencyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8beb7cf99ebe46ce83c4c7ac46d96be8_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad8e118b6e0b43acac375dbb27f97699_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id14582e54d2c40feb9322c61bbb86ebe_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bbfab5b3a264c389f363d3c5993ae97_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:ConvertibleSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74cd37df131042188edd2e1114ee7668_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:ConvertibleSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i272e3fbf659b47e08751fee97f870e59_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:ConvertibleSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i190b1aad115641d5b928506daad609a7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i266c72c2a75741499dc45fa4f1f47af3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:ConvertibleSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8065d0a2eaf64cef95166d99a6cbe527_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:ConvertibleSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f47c08fe00946e393ea1524efcfa65c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis">nvta:ServiceAgreementsAndLaboratorySuppliesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36aab3b4c6bf4533beccf6b9244c271d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nvta:OfficeFacilityInSanFranciscoTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i468f27e028dd4eabbd6a49ffcfef1827_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81554310853b4484b5d45f21ba86a785_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i226038a1ff7c4ae9a815cea5810f19b6_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbede5a1c6e74525ab5e6cb2315db66f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd21f307a6594587965e4a37c05d759c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9861d9436174ce2b7457414cdf1a8a5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i586e2494307941b4b023e85dc64835bc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id86f15571c184f4ab4dc89850a302590_D20180801-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-01</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65858024a6ee4670bd95a107e05b518c_D20180801-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-01</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7be9af2688664a66b2e3f803d85e8307_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic85e5a44169e47ba9cd182e29953f08a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91467e89bd9d48e69c729af397fac23a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0937db87178b4e798b350becedc51ccc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb647a44d30c450faf1555b120835483_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d8cf03a0e974c96bbcca6588d723e4b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50983d9ab9d24b97a4405cc2c8508678_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fc482b9b4e6420fa7de24243abc75c8_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic835049fa580444680cccf150af3d6d5_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i743deb0ca96048c0ad0d0d994c7de3bc_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia72cba2cf21e4e85808615721f1799df_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16d33aaa9e224dbeb56cab5c37d2117e_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5a08f2fb5df43589f4951124966ba71_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab0062e9ec3943238240137781cd0e8e_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2395cc0a9644defb0e33c2083cde3e1_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i407b882e58514927b4d6e234330fb0af_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d039501b157438480d3f00c8b7489fc_D20170801-20170831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-08-01</xbrli:startDate><xbrli:endDate>2017-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32e8155326254dfdbe5fdaa570c6e110_I20170831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42987b8252bd433a93091bf2d1686bc0_D20170801-20170831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-08-01</xbrli:startDate><xbrli:endDate>2017-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2efecf6d7544e109ede0602218829c7_I20170831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82a6b8eccfb740329aeaa15bd047f71b_D20170801-20170831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-08-01</xbrli:startDate><xbrli:endDate>2017-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib58041aa8f654c0bbf3e16262383a5bd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">nvta:SeriesAConvertiblePreferredStockConvertedtoCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7027e57e0c047a4b6418f097ab58a3e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">nvta:SeriesAConvertiblePreferredStockConvertedtoCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2455da1e7a143d7851eb9d50d083334_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebaff4dc5d934f078872f079f91ec08d_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id57225c75bc24501b26be0327fa8bcbb_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2406ee2925e4cdfa9b0c5c418c48d97_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nvta:SeriesFWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:CombiMatrixCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf0c262e5e494ba1a0b9dd846e947808_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if94fe272d7e54bc5a7c51daac714d62e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief4a6302d24a4af294e7028833fe7fb2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a98899500704f17a6fcfb0d3cdf1f52_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb3a6b1e9224415e90b51c05440aa312_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5411d1bf0e774eac8fe3c0f582fa2af1_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie879d74e4a2947429031c4d39f6c60f1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:A2019IncentiveCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f83a392f53641de82f099c66bcd8add_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:A2019IncentiveCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b24e569ebe043d1bcd9a86c0d20cfa2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:A2019IncentiveCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79688bef1f2243f8af291580e680c142_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a15e9739bdb4dd3ba91eff47a68dee8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc2ccdad682745929752c4bdbabe6ad4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a23a8c0acc9467b8816b6d8750a8e4e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvta:RSUsAndPRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22b5947ce6b3433694f42047bef22a47_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i043b18d384cc4cbbbd4ea576bf1e0ee8_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8df5ce0c23374e0f96f0da2ab94af033_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d14ed300bd94484b318f56f0730a43a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvta:TimebasedRSUsandPRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97e8d6d759574ef190efeec1fa288be0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib230a508963e4077bf9c329a3d9e10af_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1bf01002c574012aeba2a32221405d2_D20150101-20150131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2015-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i842c32fb0e4d4001b6d4b09acb1051bc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice92feeec65b4c99bf48cdc4f7ae3064_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9687cb514ee64df88920c8e6d2c79f5b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i212150697d1b4df0b9d350151ba23788_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39d9c671420c4cbfb753905344bfe23e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5f75e5a153a43f58048be8074c30cd4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaca634719b854efb84813c2dc3f0fd0e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3381401fa094fc08b04b11cc3984e08_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nvta:CostOfTestRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8599a661d45463f82a2aba708062fcf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nvta:CostOfTestRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18c7b5a94cb34e1680e560d7a9eaae4c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nvta:CostOfTestRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ea80e59e1504ea393646ffa29e23426_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nvta:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i513eed0ba1b74e578f8b16b9d3528e41_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nvta:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida02d0b10c2a4069bcefe8098bf63928_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nvta:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cf68f6fddea486e8c354682f35dc67a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7bbe3658f5441e29fe16218b50948b6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74963f7211644269a32529bd0993cd1f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85ac1d76e52246da9b9419a6cfe9a0bc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c65f7d592aa4164a8822f00359cee73_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cecaa430d444086b81cce9a00a27278_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief55ba984c4f4d3db6d80102c5abb216_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i859858a3113c4e09b4edddb15541a2ca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61559c3568b9476ea2715a4b590e704a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i865f60d02fe3450983596a2fbd237a90_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">nvta:SubjectToExpirationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54c826b980cc42e1988fb3773b439e74_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">nvta:ExpirationTaxYearUnknownMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56b9662e01b744d1affd87e3dbdd024d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92d0ca5609ab4791a50bc6f0f888d703_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29d2feec4499443ba9d3aee65162bf6d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i627cf3443eb34249aeaac7655a38320d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8b8eff0cc4e4594a303839728013b12_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42aa1ffe56be41719edfa03ee1a676ad_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdc9926f8d9440acbfcda346d7729365_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50d11234658f4896a2cb7ac1ea474e67_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60b5dacd6ae24b4eace690f79d47b5c8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cc357735b2e4b579432134168aed0ea_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74957556027a49b782337f801d6e878f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11b22b79bd2d4bc687f04292330d55b3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied097690f5dc477a99c5073e45f85740_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idffc47e14f9e48b0a7c357f2a1edd12b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:PerformanceRestrictedStockUnitsRsusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i056d7c98eb70405abd4b0748fbcab7e9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:PerformanceRestrictedStockUnitsRsusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7824b6f46524c12b4e8ecb3fee953ff_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:PerformanceRestrictedStockUnitsRsusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec867c6aa9fe4723b6c30bd3d93f4b55_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia20172a5e2204ead90215591879a2beb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3995f1e95bed45a6aeef8542e96511ae_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a2c42a62e2e4aefb13cd19623905faf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5615bcaf3cb24df28897143410b35483_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ee3478f49dc43bdb576001358749eff_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20c6e963b50d4140ad7de3d98e256dab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb07f61948004d04843b243732524e95_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72ab58f3157e4792a29e684275f6f509_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdb77ef12cba40759cb6e357bad02f51_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90fd9f70a9fd4afa806aa085235719e1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd3c433db9754198990763fc88d3b083_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5f0bb9d47b64539b838c7aa19d3033f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i916d5790c5474c6cb3f18a4b6f227ba6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied08cb30dbfd48dcb62017c3f188ee2a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i515b20f3a9db410289d47edad55e5a77_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nvta:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0264e9789ee44e2ab9f703d1a70e7335_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nvta:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84d0c14c0a5d4355a536eea3dc700eca_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nvta:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if177aa5c31294d399a4f1b9ea9366117_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaba7a2a4e309410f8a88976be58969ff_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c5bd43459294503984672c6404ac8b8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i272dd1562cfd41dbab6bd49a206984bc_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb8a205c97a741eabfc5c124772fda7e_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa9952ab3c9045afa4ce575e3df76321_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16a3b4edc4c5441aa3a7b118f61cc1ed_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c5ed2de4b2b4acc8e01d44e041365bc_I20210226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:OneCodexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99d734e257e9441f812ed6b0c9affac9_D20210201-20210226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501134</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:OneCodexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-26</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_1"></div><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:48.275%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6NGMxMjlmNjM4MDU2NDg3NmEyYWJiZTJlYmUzZWY1M2YvdGFibGVyYW5nZTo0YzEyOWY2MzgwNTY0ODc2YTJhYmJlMmViZTNlZjUzZl8wLTEtMS0xLTA_8c6ce993-7b5f-4e24-a97a-e20c2db2a5bd">10-K</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.988%"><tr><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6MmM3YjdhOGQ1MDQ2NDg1NWIwOWVjZTY1MDZkODVmOTAvdGFibGVyYW5nZToyYzdiN2E4ZDUwNDY0ODU1YjA5ZWNlNjUwNmQ4NWY5MF8wLTAtMS0xLTA_5c087ac5-31ed-4d83-a7b5-7e8822f541f5">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div style="margin-top:4pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8xMDg_c4002d46-7338-4848-99f6-1078ba020d2c"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8xMDg_51dae979-cbca-4847-90dd-02f03bf3dd03">December 31</ix:nonNumeric>, 2020</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.988%"><tr><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6ZGYxOTBjZjk2YmIyNGExMGFjODMxZTQyMTBiY2MwYzEvdGFibGVyYW5nZTpkZjE5MGNmOTZiYjI0YTEwYWM4MzFlNDIxMGJjYzBjMV8wLTAtMS0xLTA_de260400-64e4-497b-9c2c-56b8637aaddb">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div style="margin-top:4pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:4pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File No.&#160;<ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODA5_39800881-b1ef-427b-a725-3bba5cdb60c0">001-36847</ix:nonNumeric> </span></div><div style="margin-top:9pt;text-align:center;text-indent:31.5pt"><img src="nvta-20201231_g1.jpg" alt="nvta-20201231_g1.jpg" style="height:57px;margin-bottom:5pt;vertical-align:text-bottom;width:204px"/></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:48.419%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6ZTIwMjczYmQ1OWNjNGRmNWJkNGExODNkMjc4YjkyMTkvdGFibGVyYW5nZTplMjAyNzNiZDU5Y2M0ZGY1YmQ0YTE4M2QyNzhiOTIxOV8wLTAtMS0xLTA_55618fba-f1ac-43a1-847a-15bef67bc15a">Invitae Corporation</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Exact name of the registrant as specified in its charter)</span></td></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.988%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6ZWMwYjhmZDgwYmM1NGEzZWJhMjRlMzY2YzExYzE4MTEvdGFibGVyYW5nZTplYzBiOGZkODBiYzU0YTNlYmEyNGUzNjZjMTFjMTgxMV8wLTAtMS0xLTA_10f10676-9bcf-4902-a76e-7a60e130e451">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6ZWMwYjhmZDgwYmM1NGEzZWJhMjRlMzY2YzExYzE4MTEvdGFibGVyYW5nZTplYzBiOGZkODBiYzU0YTNlYmEyNGUzNjZjMTFjMTgxMV8wLTEtMS0xLTA_30405424-8e4e-4f8f-a9b0-fdb72a75af33">27-1701898</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:4pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODE5_6f29e329-b34e-44af-8601-5bfffc0bd27a">1400 16th Street</ix:nonNumeric>, <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODE2_40063011-f9aa-4780-82ca-b33682088fd4">San Francisco</ix:nonNumeric>, <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODEz_99687434-9ac0-4716-874a-33bafec66ee8">California</ix:nonNumeric> <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODE3_b9018a43-3e8c-4d45-8197-5102360d02bb">94103</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, Zip Code)</span></div><div style="margin-top:4pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODIw_d4921f56-dd8f-4661-8f31-32779c81dfcf">415</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODIx_86e0c860-2d92-4d0a-9ef9-56d1e95fab9c">374-7782</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:4pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.988%"><tr><td style="width:1.0%"></td><td style="width:39.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6ZjU0NmQ3MGEzZGRiNGNiN2E1ZmQwOWU2MTg3M2RhNTUvdGFibGVyYW5nZTpmNTQ2ZDcwYTNkZGI0Y2I3YTVmZDA5ZTYxODczZGE1NV8xLTAtMS0xLTA_df04b984-7573-46b8-a5ff-9fbc06a0d38d">Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6ZjU0NmQ3MGEzZGRiNGNiN2E1ZmQwOWU2MTg3M2RhNTUvdGFibGVyYW5nZTpmNTQ2ZDcwYTNkZGI0Y2I3YTVmZDA5ZTYxODczZGE1NV8xLTItMS0xLTA_2c95a5c1-0459-4c75-b980-7c6f7c96f4d9">NVTA</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6ZjU0NmQ3MGEzZGRiNGNiN2E1ZmQwOWU2MTg3M2RhNTUvdGFibGVyYW5nZTpmNTQ2ZDcwYTNkZGI0Y2I3YTVmZDA5ZTYxODczZGE1NV8xLTQtMS0xLTA_e2d9c021-a1d7-4a95-8c65-dd513b3028c3">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:31.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:48.419%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities registered pursuant to Section&#160;12(g) of the Act:&#160;None</span></div></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160;<ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODEw_c46557da-09c4-4e65-9149-06200f2a5bb3">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act.&#160;Yes&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODEx_e7759ee6-f3f1-4825-b9ba-6f702f69df1b">No</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;<ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODEy_99a94153-a708-43ed-8f34-522242f051fa">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit and post such files).&#160;<ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODE0_229fabb9-ee3c-4f52-a317-b6153ec8cf75">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.118%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.440%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.921%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6MWEyZDgzZDg4MDgwNDM5Njg5MGJhNTMwNDc2YzY2YjQvdGFibGVyYW5nZToxYTJkODNkODgwODA0Mzk2ODkwYmE1MzA0NzZjNjZiNF8wLTAtMS0xLTA_7beefae4-53ea-4ea6-9a3b-14e5f5602e6e">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6MWEyZDgzZDg4MDgwNDM5Njg5MGJhNTMwNDc2YzY2YjQvdGFibGVyYW5nZToxYTJkODNkODgwODA0Mzk2ODkwYmE1MzA0NzZjNjZiNF8wLTctMS0xLTA_96fd6835-13a5-4290-b1e8-3dcb3c489f63">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6MWEyZDgzZDg4MDgwNDM5Njg5MGJhNTMwNDc2YzY2YjQvdGFibGVyYW5nZToxYTJkODNkODgwODA0Mzk2ODkwYmE1MzA0NzZjNjZiNF8wLTktMS0xLTA_e4fc84f1-79cc-4077-a15d-5ec7752b3f3c">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; &#9744; </span></div><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report.  </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yMjUzOTk4ODM3NDU3MA_d75f1410-0cae-422f-9fb2-580cf088a2d1">&#9746;</ix:nonNumeric></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Act).&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODE1_045057e8-b06c-4818-86f1-6e502b78f699">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:3pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of June&#160;30, 2020, the aggregate market value of common stock held by non-affiliates of the Registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="ifc8bfb591e99451c9a0fcc043f9c90de_I20200630" decimals="-8" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yMjI5_6ae7ed63-1e17-4044-a54e-114354ceda10">4.0</ix:nonFraction> billion, based on the closing price of the common stock as reported on The New York Stock Exchange for that date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s Common Stock outstanding as of February&#160;19, 2021 was <ix:nonFraction unitRef="shares" contextRef="i3580f7eb63464181853f57b89cae8eeb_I20210219" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yNDE3_fac790ad-d8b2-4b76-a677-6f8f6a8c7c0a">196,654,925</ix:nonFraction>.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-indent:31.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:3pt;text-indent:31.5pt"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODIy_4eec0eb2-b043-4e3d-ac50-07ab084ca11d" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Items&#160;10 (as to directors and Section&#160;16(a) Beneficial Ownership Reporting Compliance), 11, 12, 13 and 14 of Part&#160;III incorporate by reference information from the registrant&#8217;s proxy statement to be filed with the Securities and Exchange Commission in connection with the solicitation of proxies for the registrant&#8217;s 2021 Annual Meeting of Stockholders</span><span style="color:#1f497d;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></ix:nonNumeric></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span><br/></span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.568%"><tr><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.300%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page No.</span></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_1711">Forward-</a><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_1711">L</a><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_1711">ooking </a><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_1711">S</a><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_1711">tatements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_1711">1</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_1716">Summary of </a><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_1716">R</a><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_1716">isk </a><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_1716">F</a><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_1716">actors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_1716">2</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ie13029cdd7d64c5bac971f0e86e8f19a_10">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_13">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_13">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_16">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_16">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_16">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_19">Item&#160;1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_19">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_22">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_22">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_22">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_25">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_25">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_25">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_28">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_28">Mine Safety Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_28">59</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ie13029cdd7d64c5bac971f0e86e8f19a_31">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_34">Item&#160;5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_34">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases&#160;of&#160;Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_34">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_37">Item&#160;6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_37">Selected Financial Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_37">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_40">Item&#160;7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_40">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_40">63</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_43">Item&#160;7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_43">Qualitative and Quantitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_43">77</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_46">Item&#160;8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_46">Consolidated Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_46">78</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_136">Item&#160;9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_136">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_136">121</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_139">Item&#160;9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_139">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_139">121</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_142">Item&#160;9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_142">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_142">124</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ie13029cdd7d64c5bac971f0e86e8f19a_145">PART III</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_148">Item&#160;10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_148">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_148">125</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_151">Item&#160;11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_151">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_151">125</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_154">Item&#160;12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_154">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder&#160;Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_154">125</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_157">Item&#160;13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_157">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_157">125</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_160">Item&#160;14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_160">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_160">126</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ie13029cdd7d64c5bac971f0e86e8f19a_163">PART IV</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_166">Item&#160;15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_166">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_166">127</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_169">Item 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_169">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_169">130</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_172">SIGNATURES</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-indent:31.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span><br/></span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_1711"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this report other than statements of historical fact, including statements identified by words such as &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;expect&#8221; and similar expressions, are forward-looking statements. Forward-looking statements include, but are not limited to, statements about:</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our views regarding the future of genetic testing and its role in mainstream medical practice;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of COVID-19 on our business and the actions we may take in response thereto;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our mission and strategy for our business, products and technology, including our ability to expand our content and develop new content while maintaining attractive pricing, further enhance our genetic testing service and the related user experience, build interest in and demand for our tests and attract potential partners;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the implementation of our business model;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expected benefits from and our ability to integrate our acquisitions;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rate and degree of market acceptance of our tests and genetic testing generally;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to scale our infrastructure and operations in a cost-effective manner;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of and our ability to introduce improvements to our genetic testing platform and to expand our assays to include additional genes;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and results of studies with respect to our tests;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments and projections relating to our competitors and our industry;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our competitive strengths;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the degree to which individuals will share genetic information generally, as well as share any related potential economic opportunities with us;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our commercial plans, including our sales and marketing expectations as well as our ability to expand internationally;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain and maintain adequate reimbursement for our tests;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory developments in the United States and foreign countries;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract and retain key scientific or management personnel;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our ability to obtain and maintain intellectual property protection and not infringe on the rights of others;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain funding for our operations and the growth of our business, including potential acquisitions;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our financial performance;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of accounting pronouncements and our critical accounting policies, judgments, estimates and assumptions on our financial results;</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our future revenue, cost of revenue, operating expenses and capital expenditures, and our future capital requirements; and</span></div><div style="margin-top:3pt;padding-left:42.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of tax laws on our business.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those expected. These risks and uncertainties include, but are not limited to, those risks discussed in Item&#160;1A of this report. Although we believe that the expectations and assumptions reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. In addition, neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Any forward-looking statements in this report speak only as of the date of this report. We expressly disclaim any obligation or undertaking to update any forward-looking statements.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report contains statistical data and estimates that we obtained from industry publications and reports. These publications typically indicate that they have obtained their information from sources they believe to be reliable, but do not guarantee the accuracy and completeness of their information. Some data contained in this report is also based on our internal estimates. Although we have not independently verified the third-party data, we believe it to be reasonable.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this report, all references to &#8220;Invitae,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or &#8220;the Company&#8221; mean Invitae Corporation.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Invitae and the Invitae logo are trademarks of Invitae Corporation. We also refer to trademarks of other companies and organizations in this report.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_1716"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Risk Factors.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to numerous risks and uncertainties that could affect our ability to successfully implement our business strategy and affect our financial results. You should carefully consider all of the information in this report and, in particular, the following principal risks and all of the other specific factors described in Item 1A. of this report, &#8220;Risk Factors,&#8221; before deciding whether to invest in our company. </span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face risks related to health epidemics, including the recent COVID-19 pandemic, which could have a material adverse effect on our business and results of operations. </span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We expect to continue incurring significant losses, and we may not successfully execute our plan to achieve or sustain profitability. </span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to raise additional capital on acceptable terms in the future may limit our ability to develop and commercialize new tests and expand our operations. </span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have acquired and may continue to acquire businesses or assets, form joint ventures or make investments in other companies or technologies that could harm our operating results, dilute our stockholders&#8217; ownership, or cause us to incur debt or significant expense. </span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If third-party payers, including managed care organizations, private health insurers and government health plans do not provide adequate reimbursement for our tests or we are unable to comply with their requirements for reimbursement, our commercial success could be negatively affected. </span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face intense competition, which is likely to intensify further as existing competitors devote additional resources to, and new participants enter, the market. If we cannot compete successfully, we may be unable to increase our revenue or achieve and sustain profitability. </span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to manage our future growth effectively, which could make it difficult to execute our business strategy. </span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Security breaches, loss of data and other disruptions could compromise sensitive information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and our reputation. </span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Litigation or other proceedings or third-party claims of intellectual property infringement or misappropriation, including ongoing litigation with respect to alleged intellectual property infringement against ArcherDX, Inc., or ArcherDX, will require us to spend significant time and money, could, in the future, prevent us from selling certain of our tests, and could have a material adverse effect on our business, financial condition and stock price. </span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely on highly skilled personnel in a broad array of disciplines and, if we are unable to hire, retain or motivate these individuals, or maintain our corporate culture, we may not be able to maintain the quality of our services or grow effectively. </span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We need to scale our infrastructure in advance of demand for our tests, and our failure to generate sufficient demand for our tests would have a negative impact on our business and our ability to attain profitability. </span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are not able to continue to generate substantial demand of our tests, our commercial success will be negatively affected. </span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If ArcherDX&#8217;s products and services do not perform as expected, we may not realize the expected benefits of our recent acquisition of ArcherDX. </span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The future growth of our distributed products business is partially dependent upon regulatory approval and market acceptance of our in vitro diagnostic, or IVD products, including STRATAFIDE and Personalized Cancer Monitoring, or PCM. </span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our success will depend on our ability to use rapidly changing genetic data to interpret test results accurately and consistently, and our failure to do so would have an adverse effect on our operating results and business, harm our reputation and could result in substantial liabilities that exceed our resources. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_13"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;  Business</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Invitae is in the business of delivering genetic testing services that support a lifetime of patient care &#8211; from inherited disease diagnoses, to family planning, to proactive health screening to personalized diagnosis, treatment and monitoring of cancer. Those tests are delivered via a unique, rapidly expanding platform that serves patients, healthcare providers, biopharma companies and other partners, thereby capturing the broad potential of genetics and helping to expand its use across the healthcare continuum. Invitae applies proprietary design, process automation, robotics and bioinformatics software solutions to achieve efficiencies in sample processing and complex variant interpretation, allowing medical interpretation at scale. The result is a new and simplified process for obtaining and using affordable, high-quality genetic information to inform critical healthcare decisions. That access and scale also enable genomic information to speed the discovery and development of new personalized medical therapies &#8212; all while making clinical genetic testing available to billions of people. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By pioneering new ways of sharing, understanding and applying genetic information, Invitae is transforming the field of genetics from a series of one-time, one-dimensional queries to a lifelong clinical dialogue with our genes using complex analyses and information management to improve medical decisions and optimize health interventions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mission and strategy</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Invitae&#8217;s mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Our goal is to aggregate a majority of the world&#8217;s genetic information into a comprehensive network that enables sharing of data among network participants to improve healthcare and clinical outcomes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were founded on four core principles:</span></div><div style="margin-top:3pt;padding-left:49.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Patients should own and control their own genetic information;</span></div><div style="margin-top:3pt;padding-left:49.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Healthcare professionals are fundamental in ordering and interpreting genetic information;</span></div><div style="margin-top:3pt;padding-left:49.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Driving down the price of genetic information will increase its clinical and personal utility; and</span></div><div style="margin-top:3pt;padding-left:49.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Genetic information is more valuable when shared.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategy for long-term growth centers on five key drivers of our business, which we believe work in conjunction to create a flywheel effect extending our leadership position in the new market we are building:</span></div><div style="margin-top:6pt;text-align:center;text-indent:24.75pt"><img src="nvta-20201231_g2.jpg" alt="nvta-20201231_g2.jpg" style="height:260px;margin-bottom:5pt;vertical-align:text-bottom;width:368px"/></div><div style="margin-top:6pt;text-align:center;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Expanding our content offering.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;We intend to continue steadily adding additional testing and analysis content to the Invitae platform, ultimately leading to affordable and ongoing access to the molecular information that enables personalized medicine. The breadth and depth of our offering is a core and central contribution to an improved user experience.&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Creating a unique user experience.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;A state-of-the-art interactive platform will enhance our service offering, leverage the uniquely empowering characteristics of online sharing of genetic information and, we believe, enable a superior economic offering to clients. We intend to continue to expend substantial efforts developing, acquiring and implementing technology-driven improvements to our customers&#8217; experience. We believe that an enhanced user experience and the resulting benefits to our brand and reputation will help draw customers to us over and above our direct efforts to do so.</span></div><div style="margin-top:6pt;padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Driving volume.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;We intend to increase our brand equity and visibility through a commitment to precision testing results, excellent service and a variety of marketing and promotional techniques, including scientific publications and presentations, sales, marketing, public relations, social media and web technology vehicles. We believe that rapidly increasing the number of customers using our platform helps us to attract partners.&#160;</span></div><div style="margin-top:6pt;padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Attracting partners.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;As we add more customers to our platform, we believe our business becomes particularly attractive to potential partners that can help the patients in our network further benefit from their genetic information or that provide us access to new customers who may wish to join our network. We believe the cumulative effect of the increased volume brought by these strategic components will allow us to lower the cost of our service and expand patient access globally.</span></div><div style="margin-top:6pt;padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Lowering the cost and price of genetic information.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Our goal is to provide customers with a broad menu of genetic content at a reasonable price and rapid turn-around times in order to grow volume and, in turn, achieve greater economies of scale. As our customers and our business benefit from further cost savings, we expect that those cost savings will allow us to deliver still more comprehensive information at decreasing prices and further improve the customer experience, allowing us to reap the cumulative benefits from all of the efforts outlined above.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We&#160;seek to differentiate our service in the market by establishing an exceptional experience for our customers. To that end, we believe that elevating the needs of the customer over those of our other stakeholders is essential to our success. Thus, in our decision-making processes, we strive to prioritize, in order:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">The needs of our customers;</span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Motivating our employees to serve our customers; and</span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Our long-term stockholder value.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are certain that focusing on customers as our top priority rather than short-term financial goals is the best way to build and operate an organization for maximum long-term value creation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business overview</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are focused on making comprehensive, high-quality genetic information more accessible by lowering the cost of genetic testing, by utilizing a testing delivery platform that is accessible to patients throughout their lives, by enabling a growing network of partners to increase the utility of genetic information across the healthcare continuum, and, ultimately, by managing that information on behalf of our customers, enabling improved health and the advancement of molecular medicine around the globe.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As our market share grows, we expect that our business will grow in three stages:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:9.11pt">Genetic</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">testing:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> making genetic testing more affordable and more accessible with fast turnaround time. We believe that there is a significant market opportunity for high-volume, low-cost genetic testing that allows us to serve a large number of customers. We launched our first commercial offering in November 2013 with an offering of approximately 200 genes, growing the test menu over time to include more than 20,000 genes to help diagnose disease, inform family planning, and serve healthy individuals. In 2020, we processed billable volume of approximately 659,000 units and generated revenue of $279.6 million reflecting an approximate 41% and 29% increase over 2019 billable volume and revenue, respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:9.11pt">Genome</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">network:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> sharing genetic information on a global scale to advance science and medicine. We are focusing our efforts on partnering with patients, family members, healthcare professionals, payers, industry professionals, researchers, and clinical trial sponsors to advance the development of our genome network. Our goal is to enable and build a network through which individuals and organizations can access, aggregate, and customize genetic information in order to participate in research, clinical trials, treatment planning, or other related purposes that may benefit the individual and/or their clinician. Individuals can also share information if they feel it will benefit them or will contribute more broadly to furthering knowledge about their conditions.</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to investing in informatics solutions and infrastructure to support network development, we have been expanding our partnerships, which now number more than 100 of the world's leading biopharmaceutical companies supporting improved patient diagnosis, clinical trial recruitment and other research-related initiatives. Our biopharmaceutical industry partnerships are complemented by partnerships with leading health systems, executive health programs and leading research institutions, including The Christ Hospital Health Network, the Cleveland Clinic, the Geisinger Health System, the Mayo Clinic, Memorial Sloan Kettering Cancer Center, MedCan, and Stanford Health Care, among others. </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our recent acquisition of ArcherDX, we partner with global biopharmaceutical companies such as AstraZeneca AB (Publ), Illumina and Merck KGaA, Darmstadt, Germany through collaboration agreements to bring new treatment options for patients to market faster by enabling clinical research and trials.</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:9.11pt">Genome</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">management:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> building a secure and trusted genome management infrastructure. By generating and storing large amounts of individualized genetic information for every patient sample and enabling the analysis of that cumulative data for broad health research applications, we believe we can create value for all the constituents of our testing platform and partner network. Broad access to centralized, standardized genomic data can benefit patients and their families with information that will improve therapy and outcomes, while it is also expected to aid in the compression of drug development timelines and the greater application of fact-based healthcare decisions throughout life.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors include companies that offer molecular genetic testing and consulting services, including specialty and reference laboratories that offer traditional single- and multi-gene tests and biopharmaceutical companies. Principal competitors include companies such as Ambry Genetics, a subsidiary of Konica Minolta Inc.; Athena Diagnostics and Blueprint Genetics, subsidiaries of Quest Diagnostics Incorporated; Baylor-Miraca Genetics Laboratories; Caris Life Sciences, Inc.; Centogene AG; Color Genomics, Inc.; Connective Tissue Gene Test LLC, a subsidiary of Health Network Laboratories, L.P.; Cooper Surgical, Inc.; Emory Genetics Laboratory, a subsidiary of Eurofins Scientific; Foundation Medicine, a subsidiary of Roche Holding AG; Fulgent Genetics, Inc.; GeneDx, a subsidiary of OPKO Health, Inc.; Guardant Health, Inc.; Integrated Genetics, Sequenom Inc., Correlagen Diagnostics, Inc., and MNG Laboratories, subsidiaries of Laboratory Corporation of America Holdings; Myriad Genetics, Inc.; Natera, Inc.; Perkin Elmer, Inc.; PreventionGenetics, LLC; Progenity, Inc.; and Sema4 Genomics; as well as other commercial and academic labs. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there are a large number of new entrants into the market for genetic information ranging from informatics and analysis pipeline developers to focused, integrated providers of genetic tools and services for health and wellness, including Illumina, Inc. which is also one of our suppliers. In addition to the companies that currently offer traditional genetic testing services and research centers, other established and emerging healthcare, information technology and service companies may commercialize competitive products including informatics, analysis, integrated genetic tools and services for health and wellness.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the principal competitive factors in our market are:</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">breadth and depth of content;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">quality;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reliability;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accessibility of results;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">turnaround time of testing results;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">price and quality of tests;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">coverage and reimbursement arrangements with third-party payers;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">convenience of testing;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">brand recognition of test provider;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additional value-added services and informatics tools;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">client service; and</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">quality of website content.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we compare favorably with our competitors on the basis of these factors. However, certain competitors and potential competitors have longer operating histories, larger customer bases, greater brand recognition and market penetration, substantially greater financial, technological and research and development resources and selling and marketing capabilities, and more experience dealing with third-party payers. As a result, they may be able to respond more quickly to changes in customer requirements, devote greater resources to the development, promotion and sale of their tests, or sell their tests at prices designed to win significant levels of market share. We may not be able to compete effectively against these organizations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reimbursement</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2014, Congress passed the Protecting Access to Medicare Act of 2014, or PAMA, which included substantial changes to the way in which clinical laboratory services are paid under Medicare. Under PAMA (as amended by the Further Consolidated Appropriations Act, 2020 and the Coronavirus Aid, Relief, and Economic Security (CARES) Act) and its implementing regulations, laboratories that realize at least $12,500 in Medicare Clinical Laboratory Fee Schedule, or CLFS, revenues during the six month reporting period and that receive the majority of their Medicare revenue from payments made under the CLFS or the Physician Fee Schedule must report, beginning in 2017, and then in 2022 and every three years thereafter (or annually for &#8220;advanced diagnostic laboratory tests&#8221;), private payer payment rates and volumes for their tests. We do not believe that our tests meet the current definition of advanced diagnostic laboratory tests, and therefore believe we are required to report private payer rates for our tests on an every three years basis starting next in 2022. CMS uses the rates and volumes reported by laboratories to develop Medicare payment rates for the tests equal to the volume&#8209;weighted median of the private payer payment rates for the tests. Laboratories that fail to report the required payment information may be subject to substantial civil money penalties.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As set forth under the regulations implementing PAMA, for tests furnished on or after January 1, 2018, Medicare payments for clinical diagnostic laboratory tests are paid based upon these reported private payer rates. For clinical diagnostic laboratory tests that are assigned a new or substantially revised code, initial payment rates for clinical diagnostic laboratory tests that are not advanced diagnostic laboratory tests will be assigned by the cross&#8209;walk or gap&#8209;fill methodology, as under prior law. Initial payment rates for new advanced diagnostic laboratory tests will be based on the actual list charge for the laboratory test.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payment rates calculated under PAMA went into effect starting January 1, 2018. Where applicable, reductions to payment rates resulting from the new methodology are limited to 10% per test per year in each of the years 2018 through 2020. Rates will be held at 2020 levels during 2021, and then, where applicable based upon median private payer rates reported in 2017 or 2022, reduced by up to 15% per test per year in each of 2022 through 2024 (with a second round of private payer rate reporting in 2022 to establish rates for 2023 through 2025).</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PAMA codified Medicare coverage rules for laboratory tests by requiring any local coverage determination to be made following the local coverage determination process. PAMA also authorizes CMS to consolidate coverage policies for clinical laboratory tests among one to four laboratory-specific MACs. These same contractors may also be designated to process claims if CMS determines that such a model is appropriate. It is unclear whether CMS will proceed with contractor consolidation under this authorization.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PAMA also authorized the adoption of new, temporary billing codes and/or unique test identifiers for FDA-cleared or approved tests as well as advanced diagnostic laboratory tests. The American Medical Association has created a new section of billing codes, Proprietary Laboratory Analyses (PLA), to facilitate implementation of this section of PAMA. These codes may apply to one or more of our tests if we apply for PLA coding.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, CMS published a national coverage determination, or NCD, for next generation sequencing, or NGS tests for somatic (acquired) cancer testing. CMS subsequently updated this NCD in January 2020 to address coverage for NGS tests for germline (inherited) cancer testing and to clarify certain aspects of Medicare&#8217;s coverage of NGS for somatic cancer testing. For somatic cancer testing, the updated NCD establishes full coverage for FDA-approved or FDA-cleared NGS-based companion diagnostic assays that report results using report templates that specify treatment options when offered for their FDA-approved or FDA-cleared use(s), ordered by the patient&#8217;s treating physician for Medicare beneficiaries with advanced cancer (recurrent, relapsed, refractory, metastatic, or advanced stage III or IV cancer) who have not have previously been tested with the same test using NGS for the same cancer genetic content, and have decided to seek further cancer treatment (e.g., therapeutic chemotherapy.) The NCD also gives MACs the authority to establish local coverage for NGS-based somatic cancer assays that are not FDA-approved or FDA-cleared companion diagnostics when offered to patients meeting the above-referenced criteria. It appears that NGS-based somatic cancer tests provided for patients with cancer that do not meet the above-referenced criteria - e.g., patients with earlier stage cancers - are currently nationally non-covered under the NCD.   </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 27, 2020, the NCD also establishes full coverage for FDA-approved or FDA-cleared NGS-based germline tests that report results using report templates that specify treatment options when ordered by the patient&#8217;s treating physician for patients with ovarian or breast cancer, a clinical indication for germline testing for hereditary breast or ovarian cancer, and a risk factor for germline breast or ovarian cancer, provided the patient has not previously been tested with the same germline test using NGS for the same germline genetic content. The NCD also gives MACs the authority to establish local coverage for NGS-based germline tests for ovarian or breast cancer that are not FDA-approved or FDA-cleared, as well as for NGS-based tests for any other cancer diagnosis (regardless of the test&#8217;s FDA regulatory status) when offered to patients meeting the above-referenced criteria for germline testing. Since we already have local coverage for our germline tests for ovarian and breast cancer, we believe that the NCD will not have a material impact on which of our tests will be reimbursable by CMS for Medicare patients.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical Laboratory Improvement Amendments of 1988, or CLIA</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our clinical reference laboratories in California and Colorado are required to hold certain federal certificates to conduct our business. Under CLIA, we are required to hold certificates applicable to the type of laboratory examinations we perform and to comply with standards covering personnel, facilities administration, inspections, quality control, quality assurance and proficiency testing.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have current certifications under CLIA to perform testing at our laboratory locations in San Francisco and Irvine, California and Golden, Colorado. To renew our CLIA certifications, we are subject to survey and inspection every two years to assess compliance with program standards. Moreover, CLIA inspectors may make random inspections of our clinical reference laboratories. The regulatory and compliance standards applicable to the testing we perform may change over time, and any such changes could have a material effect on our business.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our clinical reference laboratories are out of compliance with CLIA requirements, we may be subject to sanctions such as suspension, limitation or revocation of our CLIA certificates, as well as directed plan of correction, state on&#8209;site monitoring, significant civil money penalties, civil injunctive suit or criminal penalties. We must maintain CLIA compliance and certifications to be eligible to bill for diagnostic services provided to Medicare and Medicaid beneficiaries. If we were to be found out of compliance with CLIA requirements and subjected to sanction, our business could be harmed.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laboratory licensure requirements</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to maintain in-state licenses to conduct testing in California and Washington. California and Washington laws establish standards for day&#8209;to&#8209;day operations of our laboratories in San Francisco and Irvine, and Seattle, respectively. Such laws mandate proficiency testing, which involves testing of specimens that have been specifically prepared for the laboratories. If our clinical reference laboratories are out of compliance with applicable standards, the appropriate state agency may suspend, restrict or revoke our licenses to operate our clinical reference laboratories, assess substantial civil money penalties, or impose specific corrective action plans. Any such actions could materially affect our business. We maintain current licenses in good standing. However, we cannot provide assurance that state regulators will at all times in the future find us to be in compliance with all such laws.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several states require the licensure of out&#8209;of&#8209;state laboratories that accept specimens from those states. Our California laboratories hold the required out&#8209;of&#8209;state laboratory licenses for Maryland, New York, Pennsylvania, and Rhode Island. Our Seattle laboratory holds the required out-of-state laboratory licenses in Maryland, New York, Pennsylvania, and Rhode Island (but not California). Our laboratory in Golden, Colorado holds the required out&#8209;of&#8209;state laboratory licenses for California, Maryland, Pennsylvania and Rhode Island (but not New York).</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to having laboratory licenses in New York, our clinical reference laboratories are also required to obtain approval on a test&#8209;specific basis for the tests they run as LDTs by the New York State Department of Health, or NYDOH, before specific testing is performed on samples from New York.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other states may adopt similar licensure requirements in the future, which may require us to modify, delay or stop our operations in such jurisdictions. Complying with licensure requirements in new jurisdictions may be expensive, time&#8209;consuming, and subject us to significant and unanticipated delays. If we identify any other state with such requirements, or if we are contacted by any other state advising us of such requirements, we intend to follow instructions from the state regulators as to how we should comply with such requirements.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also be subject to regulation in foreign jurisdictions as we seek to expand international utilization of our tests or such jurisdictions adopt new licensure requirements, which may require review of our tests in order to offer them or may have other limitations such as restrictions on the transport of human blood or saliva necessary for us to perform our tests that may limit our ability to make our tests available outside of the United States.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal oversight of laboratory developed tests</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide many of our tests as laboratory&#8209;developed tests, or LDTs. CMS and certain state agencies regulate the performance of LDTs (as authorized by CLIA and state law, respectively).</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, the U.S. Food and Drug Administration, or FDA, has exercised enforcement discretion with respect to most LDTs and has not required laboratories that furnish LDTs to comply with the agency&#8217;s requirements for medical devices (e.g., establishment registration, device listing, quality systems regulations, premarket clearance or premarket approval, and post&#8209; market controls). In recent years, however, the FDA has stated it intends to end its policy of general enforcement discretion and regulate certain LDTs as medical devices. To this end, on October 3, 2014, the FDA issued two draft guidance documents, entitled &#8220;Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs)&#8221; and &#8220;FDA Notification and Medical Device Reporting for Laboratory Developed Tests (LDTs),&#8221; respectively, that set forth a proposed risk&#8209;based regulatory framework that would apply varying levels of FDA oversight to LDTs. The FDA has indicated that it does not intend to modify its policy of enforcement discretion until the draft guidance documents are finalized. Subsequently, on January 13, 2017, the FDA published a &#8220;discussion paper&#8221; in which the agency outlined a substantially revised &#8220;possible approach&#8221; to the oversight of LDTs. The discussion paper explicitly states that it is not a final version of the 2014 draft guidance and that it does not represent the agency&#8217;s &#8220;formal position;&#8221; rather, the discussion paper describes the evolution of the agency&#8217;s thinking on LDTs, which the agency posted to &#8220;spur further dialogue.&#8221; Notably, in the discussion paper, the agency expressed its willingness to consider &#8220;grandfathering&#8221; currently marketed LDTs from most or all FDA regulatory requirements. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the U.S. Department of Health and Human Services &#8211; the parent agency for FDA &#8211; announced that the FDA &#8220;will not require premarket review of [LDTs] absent notice-and-comment rulemaking, as opposed to through guidance documents, compliance manuals, website statements, or other informal issuances.&#8221; It is unclear at this time whether the Biden Administration will rescind or reverse this policy.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is unclear at this time when, or if, the FDA will finalize its plans to end enforcement discretion (e.g., via notice and comment rulemaking or otherwise), and even then, the new regulatory requirements are expected to be phased&#8209;in over time. Nevertheless, the FDA may attempt to regulate certain LDTs on a case&#8209;by&#8209;case basis at any time.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative proposals addressing the FDA&#8217;s oversight of LDTs have been introduced in previous Congresses, and we expect that new legislative proposals will be introduced from time&#8209;to&#8209;time. The likelihood that Congress will pass such legislation and the extent to which such legislation may affect the FDA&#8217;s plans to regulate certain LDTs as medical devices is difficult to predict at this time.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA ultimately regulates certain LDTs, whether via final guidance, final regulation, or as instructed by Congress, our tests may be subject to certain additional regulatory requirements. Complying with the FDA&#8217;s requirements can be expensive, time&#8209;consuming, and subject us to significant or unanticipated delays. Insofar as we may be required to obtain premarket clearance or approval to perform or continue performing an LDT, we cannot assure you that we will be able to obtain such authorization. Even if we obtain regulatory clearance or approval where required, such authorization may not be for the intended uses that we believe are commercially attractive or are critical to the commercial success of our tests. As a result, the application of the FDA&#8217;s requirements to our tests could materially and adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the FDA&#8217;s current position with respect to oversight of our tests, we may voluntarily decide to pursue FDA pre&#8209;market review for our current tests and/or tests we may offer in the future if we determine that doing so would be appropriate from a strategic perspective &#8211; e.g., if CMS indicated that it no longer intended to cover tests offered as LDTs.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with applicable FDA regulatory requirements may trigger a range of enforcement actions by the FDA including warning letters, civil monetary penalties, injunctions, criminal prosecution, recall or seizure, operating restrictions, partial suspension or total shutdown of operations, and denial of or challenges to applications for clearance or approval, as well as significant adverse publicity.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in November 2013, the FDA issued final guidance regarding the distribution of products labeled for research use only. Certain of the reagents and other products we use in our tests are labeled as research use only products. Certain of our suppliers may cease selling research use only products to us and any failure to obtain an acceptable substitute could significantly and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical device regulatory framework</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to its authority under the Federal Food, Drug, and Cosmetic Act, or FDCA, the FDA has jurisdiction over medical devices, which are defined to include, among other things, in vitro diagnostics, or IVDs. The FDA regulates the research, design, development, pre-clinical and clinical testing, manufacturing, safety, effectiveness, packaging, labeling, storage, recordkeeping, pre-market clearance or approval, adverse event reporting, marketing, promotion, sales, distribution and import and export of medical devices. Specifically, for the test we offer that FDA currently regulates as a device, and if the FDA begins to actively regulate LDTs, then for those tests as well, each new or significantly modified test we seek to commercially distribute in the United States could require either a premarket notification to the FDA requesting permission for commercial distribution under Section 510(k) of the FDCA, also referred to as a 510(k) clearance, or approval from the FDA of a premarket approval, or PMA, application, unless an exemption applies. Both the 510(k) clearance and PMA processes can be resource intensive, expensive, and lengthy, and require payment of significant user fees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Device classification</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the FDCA, medical devices are classified into one of three classes (Class I, Class II or Class III) depending on the degree of risk associated with each medical device and the extent of control needed to provide reasonable assurances with respect to safety and effectiveness.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class I includes devices with the lowest risk to the patient and are those for which safety and effectiveness can be reasonably assured by adherence to General Controls for Medical Devices, which require compliance with the applicable portions of the FDA&#8217;s Quality System Regulation, facility registration and product listing, reporting of adverse events and malfunctions, and appropriate, truthful and non-misleading labeling and promotional materials. While some Class I devices also require premarket clearance by the FDA through the 510(k) premarket notification process described below, most Class I products are exempt from the premarket notification requirements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class II devices are those that are subject to the General Controls, as well as Special Controls as deemed necessary by the FDA to ensure the safety and effectiveness of the device. These Special Controls can include performance standards, patient registries, FDA guidance documents and postmarket surveillance. Most Class II devices are subject to premarket review and clearance by the FDA. Premarket review and clearance by the FDA for Class II devices is accomplished through the 510(k) premarket notification process.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class III devices include devices deemed by the FDA to pose the greatest risk, such as life-supporting, life-sustaining devices, or implantable devices, in addition to those deemed novel and not substantially equivalent to a legally-marketed predicate device. The safety and effectiveness of Class III devices cannot be reasonably assured solely by the General Controls and Special Controls described above. Therefore, these devices are subject to the PMA process, which is generally more costly and time-consuming than the 510(k) process. Through the PMA process, the applicant must submit data and information demonstrating reasonable assurance of the safety and effectiveness of the device for its intended use to the FDA&#8217;s satisfaction. Accordingly, a PMA typically includes, but is not limited to, extensive technical information regarding device design and development, pre-clinical and clinical trial data, manufacturing information, labeling and financial disclosure information for the clinical investigators in device studies. The PMA application must provide valid scientific evidence that demonstrates to the FDA&#8217;s satisfaction a reasonable assurance of the safety and effectiveness of the device for its intended use.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The 510(k) clearance process</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 510(k) clearance process, the manufacturer must submit to the FDA a premarket notification, demonstrating that the device is &#8220;substantially equivalent&#8221; to a legally marketed predicate device. A predicate device is a legally marketed device that is not subject to a PMA, i.e., a device that was legally marketed prior to May 28, 1976 (pre-amendments device) and for which a PMA is not required, a device that has been reclassified from Class III to Class II or I, or a device that was previously found substantially equivalent through the 510(k) process. To be &#8220;substantially equivalent,&#8221; the proposed device must have the same intended use as the predicate device, and either have the same technological characteristics as the predicate device or have different technological characteristics, but the information submitted demonstrates that the device is as safe and effective and does not raise different questions of safety or effectiveness than the predicate device. Clinical data is sometimes required to support substantial equivalence.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a 510(k) premarket notification is submitted, the FDA determines whether to accept it for substantive review. If it lacks necessary information for substantive review, the FDA will refuse to accept the 510(k) premarket notification. If it is accepted for filing, the FDA begins a substantive review. By statute, the FDA is required to complete its review of a 510(k) notification within 90 days of receiving the 510(k) notification. As a practical matter, clearance often takes longer, and clearance is never assured. Although many 510(k) premarket notifications are cleared without clinical data, the FDA may require further information, including data from samples collected in a clinical setting, to make a determination regarding substantial equivalence, which may significantly prolong the review process. If the FDA agrees that the device is substantially equivalent, it will grant clearance to commercially market the device.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA determines that the device is not &#8220;substantially equivalent&#8221; to a predicate device, or if the device is automatically classified into Class III because there is no available predicate device, the device sponsor must then fulfill the much more rigorous premarketing requirements of the PMA approval process, or seek reclassification of the device through the De Novo classification process. The De Novo classification process is an alternate pathway to classify medical devices that are automatically classified into Class III but which are low to moderate risk. A manufacturer can submit a petition for direct de novo review if the manufacturer is unable to identify an appropriate predicate device and the new device or new use of the device presents moderate or low risk. De Novo classification may also be available after receipt of a &#8220;not substantially equivalent&#8221; letter following submission of a 510(k) to FDA.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a device receives 510(k) clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a new or major change in its intended use, will require a new 510(k) clearance or, depending on the modification, could require a PMA application. The FDA requires each manufacturer to determine whether the proposed change requires a new submission in the first instance, but the FDA can review any such decision and disagree with a manufacturer&#8217;s determination. Many minor modifications are accomplished by an internal letter-to-file in which the manufacturer documents its reasoning for why a change does not require premarket submission to the FDA. The letter-to-file is in lieu of submitting a new 510(k) to obtain clearance for such change. The FDA can always review these letters to file in an inspection. If the FDA disagrees with a manufacturer&#8217;s determination regarding whether a new premarket submission is required for the modification of an existing 510(k)-cleared device, the FDA can require the manufacturer to cease marketing and/or recall the modified device until 510(k) clearance or approval of a PMA application is obtained. In addition, in these circumstances, the FDA can impose significant regulatory fines or penalties for failure to submit the requisite application(s).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The PMA approval process</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following receipt of a PMA application, the FDA conducts an administrative review to determine whether the application is sufficiently complete to permit a substantive review. If it is not, the agency will refuse to file the PMA. If it is, the FDA will accept the application for filing and begin the review. The FDA has 180 days to review a filed PMA application, although the review of an application more often occurs over a significantly longer period of time. During this review period, the FDA may request additional information or clarification of information already provided, and the FDA may issue a major deficiency letter to the applicant, requesting the applicant&#8217;s response to deficiencies communicated by the FDA.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before approving or denying a PMA, an FDA advisory committee may review the PMA at a public meeting and provide the FDA with the committee&#8217;s recommendation on whether the FDA should approve the submission, approve it with specific conditions, or not approve it. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to approval of a PMA, the FDA may conduct inspections of the clinical trial data and clinical trial sites, as well as inspections of the manufacturing facility and processes. Overall, the FDA review of a PMA application generally takes between one and three years, but may take significantly longer. The FDA can delay, limit or deny approval of a PMA application for many reasons, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the device may not be shown safe or effective to the FDA&#8217;s satisfaction;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the data from pre-clinical studies and/or clinical trials may be found unreliable or insufficient to support approval;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the manufacturing process or facilities may not meet applicable requirements; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in FDA clearance or approval policies or adoption of new regulations may require additional data.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA evaluation of a PMA is favorable, the FDA will issue either an approval letter, or an approvable letter, the latter of which usually contains a number of conditions that must be met in order to secure final approval of the PMA. When and if those conditions have been fulfilled to the satisfaction of the FDA, the agency will issue a PMA approval letter authorizing commercial marketing of the device, subject to the conditions of approval and the limitations established in the approval letter. If the FDA&#8217;s evaluation of a PMA application or manufacturing facility is not favorable, the FDA will deny approval of the PMA or issue a not approvable letter. The FDA also may determine that additional tests or clinical trials are necessary, in which case the PMA approval may be delayed for several months or years while the trials are conducted and data is submitted in an amendment to the PMA, or the PMA is withdrawn and resubmitted when the data are available. The PMA process can be expensive, uncertain and lengthy and a number of devices for which the FDA approval has been sought by other companies have never been approved by the FDA for marketing.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New PMA applications or PMA supplements are required for modification to the manufacturing process, equipment or facility, quality control procedures, sterilization, packaging, expiration date, labeling, device specifications, ingredients, materials or design of a device that has been approved through the PMA process. PMA supplements often require submission of the same type of information as an initial PMA application, except that the supplement is limited to information needed to support any changes from the device covered by the approved PMA application and may or may not require as extensive technical or clinical data or the convening of an advisory panel, depending on the nature of the proposed change.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In approving a PMA application, as a condition of approval, the FDA may also require some form of post- approval study or post-market surveillance, whereby the applicant conducts a follow-up study or follows certain patient groups for a number of years and makes periodic reports to the FDA on the clinical status of those patients when necessary to protect the public health or to provide additional or longer term safety and effectiveness data for the device. The FDA may also approve a PMA application with other post-approval conditions intended to ensure the safety and effectiveness of the device, such as, among other things, restrictions on labeling, promotion, sale, distribution and use. New PMA applications or PMA supplements may also be required for modifications to any approved diagnostic tests, including modifications to manufacturing processes, device labeling and device design, based on the findings of post-approval studies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The investigational device process</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, absent certain exceptions, human clinical trials intended to support medical device clearance or approval require an investigational device exemption, or IDE, application. Investigations that meet certain requirements &#8211; i.e., involve tests that are labeled investigational use only (IUO), are noninvasive, do not require an invasive sampling procedure that presents significant risk, do not by design or intention introduce energy into a subject, and are not used as a diagnostic procedure without confirmation of the diagnosis by another, medically established product or procedure &#8212;are exempt from the IDE requirement. Some types of studies deemed to present &#8220;non-significant risk&#8221; are deemed to have an approved IDE &#8212; without affirmative submission of an IDE application to the FDA &#8212; once certain requirements are addressed and Institutional Review Board, or IRB, approval is obtained. If the device presents a &#8220;significant risk&#8221; to human health, as defined by the FDA, the sponsor must submit an IDE application to the FDA and obtain IDE approval prior to commencing the human clinical trials. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where applicable, the IDE application must be supported by appropriate data, such as animal and laboratory testing results, showing that it is safe to test the device in humans and that the testing protocol is scientifically sound. Generally, clinical trials for a significant risk device may begin once the IDE application is approved by the FDA and the study protocol and informed consent are approved by appropriate IRBs at the clinical trial sites. Submission of an IDE will not necessarily result in the ability to commence clinical trials, and although the FDA&#8217;s approval of an IDE allows clinical testing to go forward for a specified number of subjects, it does not bind the FDA to accept the results of the trial as sufficient to prove the product&#8217;s safety and efficacy, even if the trial meets its intended success criteria.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such clinical trials must be conducted in accordance with the FDA&#8217;s IDE regulations that govern investigational device labeling, prohibit promotion and specify an array of recordkeeping, reporting and monitoring responsibilities of study sponsors and study investigators. Clinical trials must further comply with good clinical practice regulations for IRB approval and for informed consent and other human subject protections. Required records and reports are subject to inspection by the FDA for any clinical trials subject to FDA oversight. The results of clinical testing may be unfavorable, or, even if the intended safety and efficacy success criteria are achieved, may not be considered sufficient for the FDA to grant marketing approval or clearance of a product. The commencement or completion of any clinical trial may be delayed or halted, or be inadequate to support approval of a PMA application or clearance of a 510(k) premarket notification, for numerous reasons.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Breakthrough Devices Program is a voluntary program intended to expedite the review, development, assessment and review of certain medical devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human diseases or conditions, provided the device also represents breakthrough technology, is one for which no approved or cleared treatment exists, offers significant advantages over existing approved or cleared alternatives, or is one whose availability is in the best interest of patients. All submissions for devices designated as Breakthrough Devices will receive priority review, meaning that the review of the submission is placed at the top of the appropriate review queue and receives additional review resources, as needed. Although Breakthrough Device designation or access to any other expedited program may expedite the development or approval process, it does not change the standards for approval. Access to an expedited program may also be withdrawn by the FDA if it believes that the designation is no longer supported by data from our clinical development program. Additionally, qualification for any expedited review procedure does not ensure that we will ultimately obtain regulatory clearance or approval for such product.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research use only, or RUO</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, products labeled and sold for research use only, and not for the diagnosis or treatment of disease, are sold to a variety of parties, including biopharmaceutical companies, academic institutions and molecular labs. Because such products are not intended for use in clinical practice in diagnostics, and the products cannot include clinical or diagnostic claims, they are exempt from many regulatory requirements otherwise applicable to medical devices. In particular, while the FDA regulations require that RUO products be labeled, &#8220;For Research Use Only. Not for use in diagnostic procedures,&#8221; the regulations do not otherwise subject such products to the FDA&#8217;s pre- and post-market controls for medical devices.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant change in the laws governing RUO products or how they are enforced may require a change to our RUO products business model in order to maintain compliance. For instance, in November 2013 the FDA issued a guidance document entitled &#8220;Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only&#8221;, or the RUO Guidance, which highlights the FDA&#8217;s interpretation that distribution of RUO products with any labeling, advertising or promotion that suggests that clinical laboratories can validate the test through their own procedures and subsequently offer it for clinical diagnostic use as a laboratory developed test is in conflict with RUO status. The RUO Guidance further articulates the FDA&#8217;s position that any assistance offered in performing clinical validation or verification, or similar specialized technical support, to clinical laboratories, conflicts with RUO status. If we engage in any activities that the FDA deems to be in conflict with the RUO labeling on the products that we sell, we may be subject to immediate, severe and broad FDA enforcement action that would adversely affect our ability to continue operations selling these products. Accordingly, if the FDA finds that we are distributing RUO products in a manner that is inconsistent with its regulations or guidance, we may be forced to stop distribution of our RUO products until we are in compliance, which would reduce our revenues, increase our costs and adversely affect our business, prospects, results of operations and financial condition. In addition, the FDA&#8217;s proposed implementation for a new framework for the regulation of LDTs may negatively impact the LDT market and thereby reduce demand for RUO products. If the FDA requires marketing authorization of our RUO products in the future, there can be no assurance that the FDA will ultimately grant any clearance or approval we request in a timely manner, or at all.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Post-market regulation</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a device is cleared or approved for marketing, numerous and pervasive regulatory requirements continue to apply. These include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishment registration and device listing with the FDA;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">QSR requirements, which require manufacturers, including third-party manufacturers, to follow stringent design, testing, control, documentation and other quality assurance procedures during all aspects of the design and manufacturing process;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">labeling regulations and FDA prohibitions against the promotion of investigational products, or the promotion of &#8220;off-label&#8221; uses of cleared or approved products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requirements related to promotional activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clearance or approval of product modifications to 510(k)-cleared devices that could significantly affect safety or effectiveness or that would constitute a major change in intended use of one of our cleared devices, or approval of certain modifications to PMA-approved devices;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">medical device reporting regulations, which require that a manufacturer report to the FDA if a device it markets may have caused or contributed to a death or serious injury, or has malfunctioned and the device or a similar device that it markets would be likely to cause or contribute to a death or serious injury, if the malfunction were to recur;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">correction, removal and recall reporting regulations, which require that manufacturers report to the FDA field corrections and product recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDCA that may present a risk to health;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA&#8217;s recall authority, whereby the agency can order device manufacturers to recall from the market a product that is in violation of governing laws and regulations; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">post-market surveillance activities and regulations, which apply when deemed by the FDA to be necessary to protect the public health or to provide additional safety and effectiveness data for the device.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Device manufacturing processes are required to comply with the applicable portions of the QSR, which cover the methods and the facilities and controls for the design, manufacture, testing, production, processes, controls, quality assurance, labeling, packaging, distribution, installation and servicing of finished devices intended for human use. The QSR also requires, among other things, maintenance of a device master file, device history file, and complaint files. Manufacturers are subject to periodic scheduled or unscheduled inspections by the FDA. A failure to maintain compliance with the QSR requirements could result in the shut-down of, or restrictions on, manufacturing operations and the recall or seizure of products. The discovery of previously unknown problems with products, including unanticipated adverse events or adverse events of increasing severity or frequency, whether resulting from the use of the device within the scope of its clearance or approval or off-label by a physician in the practice of medicine, could result in restrictions on the device, including the removal of the product from the market or voluntary or mandatory device recalls.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has broad regulatory compliance and enforcement powers. If the FDA determines that a manufacturer has failed to comply with applicable regulatory requirements, it can take a variety of compliance or enforcement actions, including the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issuance of warning letters, untitled letters, fines, injunctions, consent decrees and civil penalties;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requesting or requiring recalls, withdrawals, or administrative detention or seizure of our products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">imposing operating restrictions or partial suspension or total shutdown of production;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusing or delaying requests for 510(k) marketing clearance or PMA approvals of new products or modified products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdrawing 510(k) clearances or PMA approvals that have already been granted;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal to grant export approvals for our products; or</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">criminal prosecution.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HIPAA and state privacy, security and breach notification laws</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the administrative simplification provisions of the Health Insurance Portability and Accountability Act of 1996, or HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, the U.S. Department of Health and Human Services issued regulations that establish uniform standards governing the conduct of certain electronic healthcare transactions and requirements for protecting the privacy and security of protected health information (PHI) used or disclosed by covered entities, including most health care providers and their respective business associates, as well as the business associates&#8217; subcontractors. Four principal regulations with which we are required to comply have been issued in final form under HIPAA and HITECH: privacy regulations, security regulations, breach notification regulations, and standards for electronic transactions, which establish standards for common healthcare transactions.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The privacy regulations cover the use and disclosure of PHI by covered entities as well as business associates, which are persons or entities that perform certain functions for or on behalf of a covered entity that involve the creation, receipt, maintenance, or transmittal of PHI. Business associates are defined to include a subcontractor to whom a business associate delegates a function, activity, or service, other than in the capacity of the business associate&#8217;s workforce. As a general rule, a covered entity or business associate may not use or disclose PHI except as permitted or required under the privacy regulations. The privacy regulations also set forth certain rights that an individual has with respect to his or her PHI maintained by a covered entity or business associate, including the right to access or amend certain records containing his or her PHI, request restrictions on the use or disclosure of his or her PHI, or request an accounting of disclosures of his or her PHI.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Covered entities and business associates also must comply with the security regulations, which establish requirements for safeguarding the confidentiality, integrity, and availability of PHI that is electronically transmitted or electronically stored. In addition, HITECH established, among other things, certain breach notification requirements with which covered entities and business associates must comply. In particular, a covered entity must notify any individual whose unsecured PHI is breached according to the specifications set forth in the breach notification rule. A covered entity must also notify the Secretary of the U.S. Department of Health and Human Services and, under certain circumstances, the media of a breach of unsecured PHI.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are significant civil and criminal penalties that may be imposed on a covered entity or business associate for violating HIPAA. A covered entity or business associate may also be liable for civil money penalties for a violation that is based on an act or omission of any of its agents, including a downstream business associate, as determined according to the federal common law of agency. Additionally, to the extent that we submit electronic healthcare claims and payment transactions that do not comply with the electronic data transmission standards established under HIPAA and HITECH, payments to us may be delayed or denied.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The HIPAA privacy, security, and breach notification regulations establish a uniform federal &#8220;floor&#8221; and do not supersede state laws that are more stringent or provide individuals with greater rights with respect to the privacy or security of, and access to, their records containing PHI or insofar as such state laws apply to personal information that is broader in scope than PHI as defined under HIPAA. Massachusetts, for example, has a state law that protects the privacy and security of personal information of Massachusetts residents. In addition, every U.S. state has a data breach notification law that requires entities to report certain security breaches to affected consumers and, in some instances, state regulators and consumer reporting agencies. Many states also have laws or regulations that specifically apply to genetic testing and genetic information and are more stringent than the standards under HIPAA. These state genetic information privacy laws include specific informed consent requirements for the conduct of genetic testing and restrict the collection, use, disclosure, or retention of genetic information. Failure to comply with applicable state laws that impose privacy, security, or breach notification requirements for genetic or other personal information could result in significant civil or criminal penalties, administrative actions, or private causes of action by patients, and adversely affect our business, results of operations and reputation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal and state consumer protection laws </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Federal Trade Commission, or FTC, is an independent U.S. law enforcement agency charged with protecting consumers and enhancing competition across broad sectors of the economy. The FTC&#8217;s primary legal authority with respect to data privacy and security comes from Section 5 of the FTC Act, which prohibits unfair or deceptive acts or practices in the marketplace. The FTC has increasingly used this broad authority to police data privacy and security, using its powers to investigate and bring lawsuits. Where appropriate, the FTC can seek a variety of remedies, such as but not limited to requiring the implementation of comprehensive privacy and security programs, biennial assessments by independent experts, monetary redress to consumers, and provision of robust notice and choice mechanisms to consumers. In addition to its enforcement mechanisms, the FTC uses a variety of tools to protect consumers&#8217; privacy and personal information, including pursuing enforcement actions to stop violations of law, conducting studies and issuing reports, hosting public workshops, developing educational materials, and testifying before the U.S. Congress on issues that affect consumer privacy.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vast majority of data privacy cases brought by the FTC fall under the &#8220;deceptive&#8221; acts prong of Section 5. These cases often involve a failure on the part of a company to adhere to its own privacy and data protection principles set forth in its policies. To avoid Section 5 violations, the FTC encourages companies to build privacy protections and safeguards into relevant portions of their business, and to consider privacy and data protection as the company grows and evolves. In addition, privacy notices should clearly and accurately disclose the type(s) of personal information the company collects, how the company uses and shares that information, and the security measures used by the company to protect that information.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, the FTC&#8217;s enforcement under Section 5 related to data security has included alleged violations of the &#8220;unfairness&#8221; prong. Many of these cases have alleged that companies were unfair to consumers because they failed to take reasonable and necessary measures to protect consumer data. The FTC has not provided bright line rules defining what constitutes &#8220;reasonable and necessary measures&#8221; for implementing a cybersecurity program, but it has provided guidance, tips and advice for companies. The FTC has also published past complaints and consent orders, which it urges companies use as guidance to help avoid an FTC enforcement action, even if a data breach or loss occurs.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the FTC Act, most U.S. states have unfair and deceptive acts and practices statutes, known as UDAP statutes, that substantially mirror the FTC Act and have been applied in the privacy and data security context. These vary in substance and strength from state to state. Many have broad prohibitions against unfair and deceptive acts and practices. These statutes generally allow for private rights of action and are enforced by the states&#8217; Attorneys General.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">California Consumer Privacy Act</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Consumer Privacy Act, or CCPA, is a comprehensive consumer privacy law that took effect on January 1, 2020, and regulates how certain for-profit businesses that meet one or more CCPA applicability thresholds collect, use, and disclose the personal information of consumers who reside in California. Among other things, the CCPA confers to California consumers the right to receive notice of the categories of personal information that will be collected by a business, how the business will use and share the personal information, and the third parties who will receive the personal information; the CCPA also confers rights to access, delete, or transfer personal information; and the right to receive equal service and pricing from a business after exercising a consumer right granted by the CCPA. In addition, the CCPA allows California consumers the right to opt out of the &#8220;sale&#8221; of their personal information, which the CCPA defines broadly as any disclosure of personal information to a third party in exchange for monetary or other valuable consideration. The CCPA also requires a business to implement reasonable security procedures to safeguard personal information against unauthorized access, use, or disclosure.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CCPA does not apply to personal information that is PHI under HIPAA. The CCPA also does not apply to a HIPAA-regulated entity to the extent that the entity maintains patient information in the same manner as PHI. In addition, California amended the law in September 2020 to clarify that de-identified data as defined under HIPAA will also be exempt from the CCPA. Accordingly, we do not have CCPA compliance obligations with respect to most genetic testing and patient information we collect and process. However, we are required to comply with the CCPA insofar as we collect other categories of California consumers&#8217; personal information, such as information about California employees, contractors, and business-to-business contacts. The CCPA provides partial exemptions for employee and business-to-business information that are set to expire on January 1, 2023. In addition, to the extent that we sell or license de-identified information that is derived from California patients&#8217; information, the contracts for the sale or license of such de-identified information will need to include certain provisions required under the CCPA beginning January 1, 2021. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Attorney General has had authority to enforce the CCPA and its implementing regulations against covered businesses since July 1, 2020. The CCPA provides for civil penalties for violations, as well as private right of action for data breaches that result from a business&#8217; failure to implement and maintain reasonable data security procedures. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2020, California passed the California Privacy Rights Act (CPRA) through a ballot initiative. The CPRA will create a new California Privacy Protection Agency, an &#8220;independent watchdog&#8221; whose mission is both to &#8220;vigorously enforce&#8221; the CPRA and &#8220;ensure that businesses and consumers are well&#8208;informed about their rights and obligations.&#8221; Among other things, the CPRA will create a new category of &#8220;sensitive personal information&#8221; and offer consumers the right to limit processing of such information, impose purpose limitation, data minimization, data retention, and security compliance obligations on regulated businesses, and add or modify the rights available to consumers, including by providing a right to correct the information a business holds about them. The CPRA&#8217;s amendments to the CCPA will take effect on January 1, 2023, and will generally apply to personal information collected by businesses on or after January 1, 2022. The California Attorney General will have authority to begin enforcing the CPRA&#8217;s amendments to the CCPA beginning on July 1, 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Privacy and data protection laws</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a growing number of jurisdictions around the globe that have privacy and data protection laws that may apply to Invitae as it enters or expands its business in jurisdictions outside of the United States. These laws are typically triggered by a company&#8217;s establishment or physical location in the jurisdiction, data processing activities that take place in the jurisdiction, and/or the processing of personal information about individuals located in that jurisdiction. Certain international privacy and data protection laws, such as those in the European Union (EU), are more restrictive and prescriptive than those in the U.S., while other jurisdictions may have laws less restrictive or prescriptive than those in the U.S. Enforcement of these laws varies from jurisdiction to jurisdiction, with a variety of consequences, including civil or criminal penalties, litigation, private rights of action or damage to our reputation.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Europe</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The EU&#8217;s General Data Protection Regulation, or GDPR, took effect on May 25, 2018. The GDPR applies to any entity established in the EU as well as extraterritorially to any entity outside the EU that offers goods or services to, or monitors the behavior of, individuals who are located in the EU. The GDPR imposes strict requirements on controllers and processors of personal data, including enhanced protections for &#8220;special categories&#8221; of personal data, which includes sensitive information such as health and genetic information of data subjects. The GDPR also grants individuals various rights in relation to their personal data, including the rights of access, rectification, objection to certain processing and deletion. The GDPR provides an individual with an express right to seek legal remedies if the individual believes his or her rights have been violated. Failure to comply with the requirements of the GDPR or the related national data protection laws of the member states of the EU, which may deviate from or be more restrictive than the GDPR, may result in significant administrative fines issued by EU regulators. Maximum penalties for violations of the EU GDPR are capped at 20 million Euros or 4% of an organization's annual global revenue, whichever is greater.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Australia</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Australia&#8217;s federal Privacy Act 1988, or the Privacy Act, and the 13 Australian Privacy Principles, or the APPs, contained in the Privacy Act, apply to government agencies and private sector organizations with annual turnover exceeding AU $3 million. The Privacy Act extends to all of Australia's external territories, but also applies to an act done, or practice engaged in, or outside Australia (and Australia's external territories) by an organization, or small business operator, that has a link to Australia, such as a continued presence, partnership, incorporation, central management and control, or citizenship in Australia. An organization may also have a link to Australia if the organization conducts business in Australia and collects or stores personal information in Australia. The Privacy Act applies to any collection, holding, use or disclosure of personal information by a regulated entity, with enhanced protections for sensitive information such as genetic information. The Privacy Act prescribes certain rights for individuals, including rights to know why the information is collected, how it is used, and to whom it is disclosed, the right of the individual not to identify themself in certain circumstances, the right of access, the right to stop receiving unwanted direct marketing, the right to correct information, and the right to make a complaint.  Australia&#8217;s Privacy Commissioner enforces the Privacy Act and any acts that may violate an individual&#8217;s privacy. The Privacy Commissioner can levy significant fines on individuals and corporations that violate the Privacy Act.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canada</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Canada has several federal, provincial and territorial privacy statutes that govern the protection of personal information. The Personal Information Protection and Electronic Documents Act 2000, or PIPEDA, applies to the collection, use, and disclosure of personal information in the course of commercial activities in Canada. Although PIPEDA is silent with respect to its extraterritorial application, the Federal Court of Canada has concluded that PIPEDA applies to businesses established in other jurisdictions if there is a &#8220;real and substantial connection&#8221; between the organization&#8217;s activities and Canada. PIPEDA and provincial data protection laws require specific notices regarding openness and transparency and require regulated organizations to obtain consent in order to process such information. Canadian individuals enjoy rights or access and to correct inaccuracies. Violations of Canadian data protection laws can result in significant fines. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">India</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Indian Constitution was recently interpreted to include a fundamental right to privacy. In addition, India&#8217;s laws and regulations address specific sectoral data protection concerns. The Information Technology Act 2000, as amended, or the IT Act, is the primary national law regulating the collection and use of personal information that is sensitive. The IT Act applies to corporations and other &#8220;body corporates&#8221; that possess, maintain, or otherwise process personal information, including body corporates that act on behalf of other body corporates. Certain provisions of the IT Act provide liability for negligent handling of personal information. For example, the IT Act provides that any corporation or other body corporate that handles sensitive personal data is liable to pay damages for any loss caused by its negligence in implementing and maintaining reasonable security practices and procedures. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Information Technology (Reasonable Security Practices and Procedures and Sensitive Personal Data or Information) Rules 2011, or the Data Privacy Rules, issued under the IT Act regulate the use of personal information and sensitive personal data. The Data Privacy Rules mandate that businesses have a privacy policy, obtain consent when collecting or transferring personal information, and inform the data subject about any recipients of that data. The IT Act includes a private right of action for individuals, and authorizes criminal punishment (with a fine, three years in prison, or both) for disclosing personal information without the consent of the data subject or in breach of any relevant contract. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Israel</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Israel&#8217;s data protection regime is governed primarily by the Protection of Privacy Law and the regulations promulgated under it, or the PPL, and the guidelines of the Israeli regulator, the Privacy Protection Authority, or the PPA. The PPL applies to: (1) database owners, database holders, and database managers based in Israel; and (2) data processing operations that take place in Israel, regardless of whether the individuals about whom the data relates are residents or citizens of Israel. The PPL could also be interpreted to apply to non-Israeli database owners, database holders, or database managers that process personal information about Israeli residents or citizens when such processing takes place outside of Israel. Various regulations promulgated under the PPL by the PPA set out rules and procedures for data security, data retention, data subject rights, and cross border transfers of data. These regulations also do not clearly state their jurisdictional scope, such that there is a risk they could be interpreted as applying to foreign-based entities that process data about Israeli citizens.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PPA is required to maintain a registry of databases and is empowered to supervise compliance with and investigate alleged violations of the PPL and related regulations. The PPA may impose administrative fines for violations of the PPL and related regulations, and willful violations may result in criminal liability and up to five years in prison. A breach of privacy is also actionable, and an individual claimant may obtain monetary compensation or injunctive relief. A court may award statutory damages without proof of damages for breach of privacy rights. If the breach was intentional, the damages may be doubled. The PPL also specifies that an act or omission in breach of certain of its provisions, such as failure to ensure data security, may give rise to a tort claim.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Japan</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japan&#8217;s primary data protection law, the Act on the Protection of Personal Information, or APPI, was recently amended to include GDPR-like requirements, including additional transparency requirements, data transfer obligations, enhanced data breach notification requirements, additional data subject rights and stronger penalties for violations, including significant fines. The amendment clarifies that its provisions, obligations and penalties apply to entities outside of Japan that supply goods or services in Japan and handle personal information from an individual in Japan.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Information Blocking Prohibition</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 1, 2020, the Office of the National Coordinator for Health Information Technology promulgated final regulations under the authority of the 21st Century Cures Act to impose new conditions to obtain and maintain certification of certified health information technology and prohibit certain covered actors, including developers of certified health information technology, health information networks / health information exchanges, and health care providers,  from engaging in activities that are likely to interfere with the access, exchange, or use of electronic health information (information blocking). The final regulations further defined exceptions for activities that are permissible, even though they may have the effect of interfering with the access, exchange, or use of electronic health information. The information blocking effective date is April 5, 2021. Under the 21st Century Cures Act, health care providers that violate the information blocking prohibition will be subject to appropriate disincentives, which the U.S. Department of Health and Human services has yet to establish through required rulemaking. Developers of certified information technology and health information networks / health information exchanges, however, may be subject to civil monetary penalties of up to $1 million per violation. The U.S. Department of Health and Human Services Office of Inspector General has the authority to impose such penalties and on April 24, 2020 published a proposed rule to codify new authority in regulation, which the agency proposed would be effective 60 days after it issues a final rule, but in no event before November 2, 2020. The U.S. Department of Health and Human Services Office of Inspector General has not yet issued a final rule.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal, state and foreign fraud and abuse laws</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, there are various fraud and abuse laws with which we must comply, and we are potentially subject to regulation by various federal, state and local authorities, including CMS, other divisions of the U.S. Department of Health and Human Services (e.g.,&#160;the Office of Inspector General), the U.S. Department of Justice, and individual U.S. Attorney offices within the Department of Justice, and state and local governments. We also may be subject to foreign fraud and abuse laws.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the federal Anti-Kickback Statute prohibits knowingly and willfully offering, paying, soliciting or receiving remuneration, directly or indirectly, overtly or covertly, in cash or in kind, to induce or in return for the referral of an individual for the furnishing of or arranging for the furnishing of any item or service for which payment may be made in whole or in part by a federal healthcare program, or the purchasing, leasing, ordering or arranging for or recommending purchasing, leasing or ordering of any good, facility, service or item for which payment may be made in whole or in part by a federal healthcare program. Many courts have held that the Anti-Kickback Statute may be violated if any one purpose of the remuneration is to induce or reward patient referrals or other federal healthcare program business, regardless of whether there are other legitimate purposes for the arrangement. The definition of &#8220;remuneration&#8221; has been broadly interpreted to include anything of value, including gifts, discounts, credit arrangements, payments of cash, consulting fees, waivers of co-payments, ownership interests, and providing anything at less than its fair market value. The Anti-Kickback Statute is broad and may technically prohibit many innocuous or beneficial arrangements within the healthcare industry. The Anti-Kickback Statute includes several statutory exceptions, and the U.S. Department of Health and Human Services has issued a series of regulatory &#8220;safe harbors.&#8221; These exceptions and safe harbor regulations set forth certain requirements for various types of arrangements, which, if met, will protect the arrangement from potential liability under the Anti-Kickback Statute. Although full compliance with the statutory exceptions or regulatory safe harbors ensures against liability under the federal Anti-Kickback Statute, the failure of a transaction or arrangement to fit within a specific statutory exception or regulatory safe harbor does not necessarily mean that the transaction or arrangement is illegal or that prosecution under the federal Anti-Kickback Statute will be pursued. Penalties for violations of the Anti-Kickback Statute are severe, and include imprisonment, criminal fines, civil money penalties, and exclusion from participation in federal healthcare programs. Many states also have anti- kickback statutes, some of which may apply to items or services reimbursed by any third-party payer, including commercial insurers.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are also federal laws related to healthcare fraud and false statements, among others, that apply to healthcare matters. The healthcare fraud statute prohibits, among other things, knowingly and willfully executing a scheme to defraud any healthcare benefit program, including private payers. A violation of this statute is a felony and may result in fines, imprisonment, or exclusion from governmental payer programs such as the Medicare and Medicaid programs. The false statements statute prohibits, among other things, knowingly and willfully falsifying, concealing or covering up a material fact, or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items, or services. A violation of this statute is a felony and may result in fines, imprisonment, or exclusion from governmental payer programs.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another development affecting the healthcare industry is the increased enforcement of the federal False Claims Act and, in particular, actions brought pursuant to the False Claims Act&#8217;s &#8220;whistleblower&#8221; or &#8220;qui tam&#8221; provisions. The False Claims Act imposes liability on any person or entity that, among other things, knowingly presents, or causes to be presented, a false or fraudulent claim for payment by a federal governmental payer program. The qui tam provisions of the False Claims Act allow a private individual to bring actions on behalf of the federal government alleging that the defendant has defrauded the federal government by presenting or causing to be presented a false claim to the federal government and permit such individuals to share in any amounts paid by the entity to the government in fines or settlement. When an entity is determined to have violated the False Claims Act, it may be required to pay up to three times the actual damages sustained by the government, plus civil penalties for each false claim. For penalties assessed after June 19, 2020, whose associated violations occurred after November 2, 2015, the penalties range from $11,665 to $23,331 for each false claim. The minimum and maximum per claim penalty amounts are subject to annual increases for inflation.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, various states have enacted false claim laws analogous to the federal False Claims Act, and some of these state laws apply where a claim is submitted to any third-party payer and not only a governmental payer program.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the civil monetary penalties statute imposes penalties against any person or entity that, among other things, is determined to have knowingly presented or caused to be presented a claim to a federal health program that the person knows or should know is for an item or service that was not provided as claimed or for a claim that is false or fraudulent. This law also prohibits the offering or transfer of remuneration to a Medicare or state healthcare program beneficiary if the person knows or should know it is likely to influence the beneficiary&#8217;s selection of a particular provider, practitioner, or supplier for items or services reimbursable by Medicare or a state healthcare program. There are several exceptions to the prohibition on beneficiary inducement.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Eliminating Kickbacks in Recovery Act of 2018, or EKRA, prohibits payments for referrals to recovery homes, clinical treatment facilities, and laboratories. EKRA&#8217;s reach extends beyond federal health care programs, to include private insurance (i.e., it is an &#8220;all payer&#8221; statute). For purposes of EKRA, the term &#8220;laboratory&#8221; is defined broadly and without reference to any connection to substance use disorder treatment. EKRA is a criminal statute and violations can result in fines of up to $200,000, up to 10 years in prison, or both, per violation. The law includes a limited number of exceptions, some of which closely align with corresponding federal Anti-Kickback Statute exceptions and safe harbors and others that materially differ.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to the U.S. Foreign Corrupt Practices Act, or FCPA, which prohibits companies and their intermediaries from making payments in violation of law to non-U.S. government officials for the purpose of obtaining or retaining business or securing any other improper advantage. In Europe various countries have adopted anti-bribery laws providing for severe consequences, in the form of criminal penalties and/or significant fines, for individuals and/or companies committing a bribery offence. Violations of these anti-bribery laws, or allegations of such violations, could have a negative impact on our business, results of operations and reputation. For instance, in the United Kingdom, under the Bribery Act 2010, which went into effect in July 2011, a bribery occurs when a person offers, gives or promises to give a financial or other advantage to induce or reward another individual to improperly perform certain functions or activities, including any function of a public nature. Bribery of foreign public officials also falls within the scope of the Bribery Act 2010. Under the new regime, an individual found in violation of the Bribery Act 2010, faces imprisonment of up to ten&#160;years. In addition, the individual can be subject to an unlimited fine, as can commercial organizations for failure to prevent bribery.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Physician Payments Sunshine Act, enacted as part of the Affordable Care Act, also imposed annual reporting requirements on entities including manufacturers of certain devices, medical supplies, drugs and biologics for certain payments and transfers of value that the manufacturer provides, directly or indirectly, to or on behalf of certain types of health care providers, including physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as defined by such law as well as ownership and investment interests held by physicians and their immediate family members. Beginning in 2022, applicable manufacturers also will be required to report such information regarding its relationships with physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and certified nurse midwives during the previous year. The Physician Payments Sunshine Act also requires entities including applicable manufacturers to report certain ownership and investment interests held by such physicians and their immediate family members in such manufacturers. In addition, certain states, such as Vermont and Massachusetts, have enacted laws that impose certain reporting requirements for payments and transfers of value provided to covered healthcare providers. These state laws are not preempted by the federal Physician Payments Sunshine Act to the extent the state law requires the reporting of information that is not required to be reported under the federal Physician Payments Sunshine Act. Finally, certain states such as Massachusetts, Nevada, and Vermont have enacted laws that limit or prohibit the provision of payments or other transfers of value to covered recipients, such as certain health care providers, hospitals, and health benefit plan administrators.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Physician referral prohibitions</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A federal law directed at &#8220;self-referrals,&#8221; commonly known as the &#8220;Stark Law,&#8221; prohibits a physician from referring a patient to an entity for certain Medicare-covered designated health services, including laboratory services, if the physician, or an immediate family member, has a financial relationship with the entity, unless an exception applies. The Stark Law also prohibits an entity from billing for services furnished pursuant to a prohibited referral. A physician or entity that engages in a scheme to circumvent the Stark Law&#8217;s referral prohibition may be fined up to $172,137 for each such arrangement or scheme. In addition, any person who presents or causes to be presented a claim to the Medicare program in violation of the Stark Law is subject to civil monetary penalties of up to $25,820 per service, an assessment of up to three times the amount claimed and possible exclusion from participation in federal healthcare programs. Bills submitted in violation of the Stark Law may not be paid by Medicare, and any person collecting any amounts with respect to any such prohibited bill is obligated to refund such amounts. Many states have comparable laws that apply to services covered by other third-party payers. The Stark Law also prohibits state receipt of federal Medicaid matching funds for services furnished pursuant to a prohibited referral. This provision of the Stark Law has not been implemented by regulations, but some courts have held that the submission of claims to Medicaid that would be prohibited as self-referrals under the Stark Law for Medicare could implicate the False Claims Act.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate practice of medicine</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous states have enacted laws prohibiting business corporations, such as us, from practicing medicine and employing or engaging clinicians to practice medicine, generally referred to as the prohibition against the corporate practice of medicine. These laws are designed to prevent interference in the medical decision-making process by anyone who is not a licensed physician. For example, California&#8217;s Medical Board has indicated that determining what diagnostic tests are appropriate for a particular condition and taking responsibility for the ultimate overall care of the patient, including providing treatment options available to the patient, would constitute the unlicensed practice of medicine if performed by an unlicensed person. Violation of these corporate practice of medicine laws may result in civil or criminal fines, as well as sanctions imposed against us and/or the professional through licensure proceedings.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual property</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on a combination of intellectual property rights, including trade secrets, copyrights, trademarks, customary contractual protections and, to a lesser extent, patents, to protect our core technology and intellectual property. With respect to patents, we believe that the practice of patenting individual genes, along with patenting tools and methods specific to individual genes, has impeded the progress of the genetic testing industry beyond single gene tests and is antithetical to our core principle that patients should own and control their own genomic information. The U.S. Supreme Court has issued a series of unanimous (9-0) decisions setting forth limits on the patentability of natural phenomena, natural laws, abstract ideas and their applications &#8212; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mayo Collaborative v. Prometheus Laboratories (2012)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mayo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Association for Molecular Pathology v. Myriad Genetics (2013)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Myriad</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alice Corporation v. CLS Bank (2014)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alice.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As discussed below, we believe the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mayo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Myriad</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alice</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decisions bring clarity to the limits to which patents may cover specific genes, mutations of such genes, or gene-specific technology for determining a patient&#8217;s genomic information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patents</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Supreme Court cases have clarified that naturally occurring DNA sequences are natural phenomena, which should not be patentable. On June&#160;13, 2013, the U.S. Supreme Court decided </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Myriad</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a case challenging the validity of patent claims held by Myriad relating to the cancer genes BRCA1 and BRCA2. The </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Myriad</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Court held that genomic DNAs that have been isolated from, or have the same sequence as, naturally occurring samples, such as the DNA constituting the BRCA1 and BRCA2 genes or fragments thereof, are not eligible for patent protection. Instead, the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Myriad</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Court held that only those complementary DNAs (cDNAs) which have a sequence that differs from a naturally occurring fragment of genomic DNA may be patent eligible. Because it will be applied by other courts to all gene patents, the holding in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Myriad</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> also invalidates patent claims to other genes and gene variants. Prior to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Myriad</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on August&#160;16, 2012, the U.S. Court of Appeals for the Federal Circuit had held that certain patent claims of Myriad directed to methods of comparing or analyzing BRCA1 and BRCA2 sequences to determine whether or not a person has a variant or mutation are unpatentable abstract processes, and Myriad did not appeal such ruling.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently have any patents or patent applications directed to the sequences of specific genes or variants of such genes, nor do we rely on any such in-licensed patent rights of any third party. We believe that correlations between specific gene variants and a person&#8217;s susceptibility to certain conditions or diseases are natural laws that are not patentable under the U.S. Supreme Court&#8217;s decision in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mayo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mayo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case involved patent claims directed to optimizing, on a patient-specific basis, the dosage of a certain drug by measuring its metabolites in a patient. The </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mayo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Court determined that patent claims directed at detection of natural correlations, such as the correlation between drug metabolite levels in a patient and that drug&#8217;s optimal dosage for such patient, are not eligible for patent protection. The </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mayo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Court held that claims based on this type of comparison between an observed fact and an understanding of that fact&#8217;s implications represent attempts to patent a natural law and, moreover, when the processes for making the comparison are not themselves sufficiently inventive, claims to such processes are similarly patent-ineligible. On June&#160;19, 2014, the U.S. Supreme Court decided </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alice</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, where it amplified its </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mayo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Myriad</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decisions and clarified the analytical framework for distinguishing between patents that claim laws of nature, natural phenomena and abstract ideas and those that claim patent-eligible applications of such concepts. According to the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alice</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Court, the analysis depends on whether a patent claim directed to a law of nature, a natural phenomenon or an abstract idea contains additional elements, an &#8220;inventive concept,&#8221; that &#8220;is sufficient to ensure that the patent in practice amounts to significantly more than a patent upon the [ineligible concept] itself;&#8221; (citing </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mayo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mayo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Myriad</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alice</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> not only render as unpatentable genes, gene fragments and the detection of a person&#8217;s sequence for a gene, but also have the same effect on generic applications of conventional technology to specific gene sequences. For example, we believe that generic claims to primers or probes directed to specific gene sequences and uses of such primers and probes in determining a person&#8217;s genetic information are not patentable. We do not currently have any patents or patent applications directed to such subject matter nor have we in-licensed such patents rights of any third party.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unlike patents directed to specific genes, we do rely upon, in part, patent protection to protect technology that is not gene-specific and that provides us with a potential competitive advantage as we focus on making comprehensive genetic information less expensive and more broadly available to our customers. In this regard, we have issued U.S. patents, pending U.S. patent applications and corresponding non-U.S. patents and patent applications directed to various aspects of our laboratory, analytic and business practices. We intend to pursue further patent protection where appropriate.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding legal actions that pertain to intellectual property rights, see Note 8, &#8220;Commitments and contingencies&#8221; in Notes to Consolidated Financial Statements in Part II, Item 8 of this report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade secrets</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to seeking patent protection for some of our laboratory, analytic and business practices, we also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain and develop our competitive position. We have developed proprietary procedures for both the laboratory processing of patient samples and the analysis of the resulting data to generate clinical reports. For example, we have automated aspects of our processes for curating information about known variants, identifying variants in an individual&#8217;s sequence information, associating those variants with known information about their potential effects on disease, and presenting that information for review by personnel responsible for its interpretation and for the delivery of test reports to clinicians and patients. We try to protect these trade secrets, in part, by taking reasonable steps to keep them confidential. This includes entering into nondisclosure and confidentiality agreements with parties who have access to them, such as our employees and certain third parties. We also enter into invention or patent assignment agreements with our employees and consultants that obligate them to assign to us any inventions developed in the course of their work for us. However, we may not enter into such agreements with all relevant parties, and these parties may not abide by the terms of their agreements. Despite measures taken to protect our intellectual property, unauthorized parties might copy or independently develop and commercially exploit aspects of our technology or obtain and use information that we regard as proprietary.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trademarks</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We work hard to achieve a high level of quality in our operations and to provide our customers with a superior experience when interacting with us. As a consequence, our brand is very important to us, as it is a symbol of our reputation and representative of the goodwill we seek to generate with our customers. As a consequence, we have invested significant resources in protection of our trademarks.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental matters</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations require the use of hazardous materials (including biological materials) that subject us to a variety of federal, state and local environmental and safety laws and regulations. Some of these regulations provide for strict liability, holding a party potentially liable without regard to fault or negligence. We could be held liable for damages and fines as a result of our, or others&#8217;, business operations should contamination of the environment or individual exposure to hazardous substances occur. We cannot predict how changes in laws or new regulations will affect our business, operations or the cost of compliance.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Raw materials and suppliers</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on a limited number of suppliers, or, in some cases, sole suppliers, including Agena Bioscience, Inc., Illumina,&#160;Inc., Integrated DNA Technologies Incorporated, Roche Holdings&#160;Ltd., QIAGEN, Inc. and Twist Bioscience Corporation for certain laboratory reagents, as well as sequencers and other equipment and materials which we use in our laboratory operations. We are in active litigation with affiliates of QIAGEN, Inc. as described in Note 8, "Commitments and contingencies" in Notes to Consolidated Financial Statements in Part II, Item 8 of this report. We rely on Illumina as the sole supplier of next generation sequencers and associated reagents and as the sole provider of maintenance and repair services for these sequencers and QIAGEN, Inc. to provide the enzymes that we use in our products. Our operations could be interrupted if we encounter delays or difficulties in securing these reagents and enzymes, sequencers or other equipment or materials, and if we cannot obtain an acceptable substitute. Any such interruption could significantly affect our business, financial condition, results of operations and reputation. We believe that there are only a few other manufacturers that are currently capable of supplying and servicing the equipment necessary for our operations, including sequencers and various associated reagents and enzymes. The use of equipment or materials provided by these replacement suppliers would require us to alter our operations. Transitioning to a new supplier would be time consuming and expensive, may result in interruptions in operations, could affect the performance specifications of our laboratory operations or could require that we revalidate our tests. We cannot be certain that we will be able to secure alternative equipment, reagents and other materials, or bring such equipment, reagents and materials on line and revalidate them without experiencing interruptions in our workflow. If we encounter delays or difficulties in securing, reconfiguring or revalidating equipment and materials, our business and reputation could be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer concentration and seasonality</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive payment for our products and services from patients, biopharmaceutical partners, third-party payers and other business-to-business customers. As of December&#160;31, 2020, our revenue has been primarily derived from test reports generated from our assays. See information regarding our customer concentration in Note 2, &#8220;Summary of significant accounting policies&#8221; in Notes to Consolidated Financial Statements in Part II, Item 8 of this Annual Report.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically experienced higher revenue in our fourth quarter compared to other quarters in our fiscal year due in part to seasonal demand of our tests from patients who have met their annual insurance deductible. However, changes in our product and payer mix might cause these historical seasonal patterns to be different than future patterns of revenue or financial performance.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human capital resources</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our mission</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The strength of our team and the culture in which we work is essential to our ability to achieve our broader mission. Attracting, developing and retaining exceptional employees is vitally important to us, but we also invest in creating a differentiated culture for our team that enables continuous innovation at scale. We want Invitae to be a force for good, a team that is helping make genetics and healthcare equally accessible to all. We had approximately 2,100 employees as of December&#160;31, 2020, of which approximately 55% are women and 45% men. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our employee engagement and culture</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our hiring process has been designed to provide an equitable candidate experience, facilitate the inclusion of new perspectives, foster innovation and creativity, and leverage technology and data analytics to address gaps in representation. In 2020 we established a Diversity, Equity and Inclusion, or DEI, roadmap. Our vision is to cultivate a place where we all belong. Our DEI mission is to engage, develop and retain talent from diverse backgrounds by fostering community, providing education and support, and advancing inclusive research and health equity globally. As of December 2020, excluding employees who joined us through our acquisition of ArcherDX in October 2020, approximately 59% of our workforce was White, 20% Asian, 8% Hispanic, 5% two or more races (not Hispanic or Latino), and 4% Black or African American.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to maintaining and improving the health and safety of our employees. As per our Code of Business Conduct and Ethics, all employees have responsibility for maintaining a safe and healthy workplace for all other employees by following our safety and health rules, policies and practices and reporting accidents, injuries and unsafe equipment, practices or conditions. In addition, we established a Crisis Management Team that, along with the Employee Health and Safety Administrator, comprise the Steering Committee for pandemic response. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We empower our employees to own their career path and seek out training programs to take them to the next level. We are currently in the process of developing a structure of growth opportunities and ways to understand and communicate pathways. We have also invested in our training and development programs and infrastructure for our employees.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our commitment to data-driven decision making, we conduct an ongoing monthly survey that asks our teammates three key questions: how they feel about the company direction, what&#8217;s going well and what&#8217;s not going well. We&#8217;ve been asking these questions consistently for several years so we can quickly identify trends as they emerge. We believe this combination of ongoing pulse surveys to help detect timely changes in team morale and engagement, and occasional deep dives for a more complete picture, allows our management and Talent Operations to better understand team dynamics and make changes to policies, benefits and organizational structure to respond to current challenges. It allows us to quickly gather feedback on what&#8217;s working and what&#8217;s not.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information about our Executive Officers</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The names of our executive officers and other corporate officers, and their ages as of February&#160;26, 2021, are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.039%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.513%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sean E. George, Ph.D.</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, Chief Executive Officer, Director and Co-Founder</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas R. Brida</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Counsel and Secretary</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shelly D. Guyer</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kenneth D. Knight</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert L. Nussbaum, M.D.</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Medical Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Katherine A. Stueland</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Commercial Officer</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert F. Werner</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Accounting Officer</span></td></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sean E. George, Ph.D. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is one of our co-founders and has been our President and Chief Executive Officer since January 2017, a position he also held from January 2010 through August 2012. Dr. George also served as our President since August 2012 and he served as our Chief Operating Officer from August 2012 until January 2017. He has also served as a director since January 2010. Prior to co-founding Invitae, Dr.&#160;George served as Chief Operating Officer from 2007 to November 2009 at Navigenics,&#160;Inc., a personalized medicine company. Previously, he served as Senior Vice President of Marketing and Senior Vice President, Life Science Business at Affymetrix,&#160;Inc., a provider of life science and molecular diagnostic products, as well as Vice President, Labeling and Detection Business at Invitrogen Corporation, a provider of tools to the life sciences industry, during his tenure there from 2002 to 2007. Dr. George currently serves as a director of CM Life Sciences, Inc., a publicly traded special purpose acquisition company. Dr.&#160;George holds a B.S. in Microbiology and Molecular Genetics from the University of California Los Angeles, an M.S. in Molecular and Cellular Biology from the University of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California Santa Barbara, and a Ph.D. in Molecular Genetics from the University of California Santa Cruz.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thomas R. Brida </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our General Counsel since January 2017. Mr. Brida also served as our Deputy General Counsel from January 2016 to January 2017.&#160;Prior to joining Invitae, he was Associate General Counsel at Bio-Rad Laboratories, a life science research and clinical diagnostics manufacturer, from January 2004 to January 2016. He holds a B.A. from Stanford University and a J.D. from the U.C. Berkeley School of Law.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shelly D. Guyer</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Financial Officer since June 2017. On November 5, 2020, we announced that Ms. Guyer will be transitioning to a new role leading our sustainability efforts, including our ESG (environmental, social and governance) initiatives. She will continue to serve as Chief Financial Officer while the Company conducts a search for her successor.  Ms. Guyer served as Chief Financial Officer of Veracyte, Inc., a genomic diagnostics company, from April 2013 to December 2016 and served as Veracyte&#8217;s Secretary from April 2013 to March 2014. Previously, she served as Chief Financial Officer and Executive Vice President of Finance and Administration of iRhythm Technologies, Inc., a digital healthcare company, from April 2008 to December 2012. From March 2006 to August 2007, Ms. Guyer served as Vice President of Business Development and Investor Relations of Nuvelo, Inc., a biopharmaceutical company. Prior to joining Nuvelo, Ms. Guyer worked at J.P. Morgan Securities and its predecessor companies for over 17 years, serving in a variety of roles including in healthcare investment banking and four years with the H&amp;Q Environmental Technology Fund. Ms. Guyer currently serves as a director and chair of the audit committee of NGM Biopharmaceuticals, Inc., a publicly held biopharmaceutical company. Ms. Guyer holds an A.B. in Politics from Princeton University and an M.B.A. from the Haas School of Business at the University of California Berkeley. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kenneth D. Knight </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our Chief Operating Officer since June 2020. Prior to that, he most recently served as Vice President of transportation services at Amazon.com, Inc., a multinational and diversified technology company, from December 2019 to June 2020, and as Vice President of Amazon&#8217;s global delivery services, fulfillment operations and human resources from April 2016 to December 2019. Prior to his time at Amazon, from 2012 to March 2016, Mr. Knight served as general manager of material handling and underground business division at Caterpillar Inc., a manufacturer of machinery and equipment. Prior to that, Mr. Knight served in various capacities at General Motors Company, a vehicle manufacturer, for 27 years, including as executive director of global manufacturing engineering and as manufacturing general manager. Mr. Knight holds a B.S. in Electrical Engineering from the Georgia Institute of Technology and a Master of Business Administration from the Massachusetts Institute of Technology.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Robert L. Nussbaum, M.D. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our Chief Medical Officer since August 2015. From April 2006 to August 2015, he was chief of the Division of Genomic Medicine at UCSF Health where he also held leadership roles in the Cancer Genetics and Prevention Program beginning in January 2009 and the Program in Cardiovascular Genetics beginning in July 2007. From April 2006 to August 2015, he served as a member of the UCSF Institute for Human Genetics. Prior to joining UCSF Health, Dr.&#160;Nussbaum was chief of the Genetic Disease Research Branch of the National Human Genome Research Institute, one of the National Institutes of Health, from 1994 to 2006. He is a member of the National Academy of Medicine and a fellow at the American Academy of Arts and Sciences. Dr.&#160;Nussbaum is a board-certified internist and medical geneticist who holds a B.S. in Applied Mathematics from Harvard College and an M.D. from Harvard Medical School in the Harvard-MIT joint program in Health Sciences and Technology. He completed his residency in internal medicine at Barnes-Jewish Hospital and a fellowship in medical genetics at the Baylor College of Medicine.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Katherine A. Stueland </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our Chief Commercial Officer since October 2016.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From January 2014 to October 2016, she served as our head of communications and investor relations. Prior to joining Invitae, Ms. Stueland was a Principal at Vivo Communications, a healthcare communications company, from&#160;January 2013 to December 2013. Previously, she served as Vice President, Communications and Investor Relations at Dendreon Corporation, a biotechnology company. Ms. Stueland holds a&#160;B.S&#160;in&#160;English Literature&#160;from Miami University in Ohio.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Robert F. Werner</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Accounting and Principal Accounting Officer since May 2020. Prior to that, Mr. Werner served as our Corporate Controller from September 2017. Prior to joining Invitae, from February 2015 to September 2017, Mr. Werner served as Vice President of Finance and Corporate Controller of Proteus Digital Health, Inc., a digital medicine pharmaceuticals company. Prior to that, Mr. Werner served as Corporate Controller and Principal Accounting Officer of CardioDx, Inc., a molecular diagnostics company, from March 2012 to February 2015. Mr. Werner is a Certified Public Accountant and started his career at Ernst &amp; Young LLP. Mr. Werner holds a Bachelor of Science in Accounting and a Master of Accountancy in Professional Accounting from Brigham Young University&#8217;s Marriott School of Management.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Information</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were incorporated in the State of Delaware on January&#160;13, 2010 under the name Locus Development,&#160;Inc. and changed our name to Invitae Corporation in 2012. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are located at 1400 16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Street, San Francisco, California 94103, and our telephone number is (415)&#160;374-7782. Our website address is www.invitae.com. The information contained on, or that can be accessed through, our website is not part of this annual report on Form&#160;10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make available free of charge on our website our annual reports on Form&#160;10-K, quarterly reports on Form&#160;10-Q, current reports on Form&#160;8-K and amendments to those reports, as soon as reasonably practicable after we electronically file or furnish such materials to the Securities and Exchange Commission, or SEC. You may obtain a free copy of these reports in the Investor Relations section of our website, www.invitae.com. All reports that we file are also available at www.sec.gov.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;Risk Factors.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks related to our business and strategy</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face risks related to health epidemics, including the recent COVID-19 pandemic, which could have a material adverse effect on our business and results of operations.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business has been and could continue to be adversely affected by a widespread outbreak of contagious disease, including the recent pandemic of respiratory illness caused by a novel coronavirus known as COVID-19. Global health concerns relating to COVID-19 have negatively affected the macroeconomic environment, and the pandemic has significantly increased economic volatility and uncertainty.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic has resulted in government authorities implementing numerous measures to try to contain the virus, such as travel bans and restrictions, quarantines, shelter-in-place or stay-at-home orders, and business shutdowns. For example, some of our personnel located at our headquarters and other offices in California, elsewhere in the United States and in other countries, have been subject to shelter-in-place or stay-at-home orders from state and local governments. These measures have adversely impacted and may further impact our employees and operations and the operations of our customers, suppliers and business partners, and may continue to negatively impact spending patterns, payment cycles and insurance coverage levels. These measures have adversely affected and may continue to adversely affect demand for our tests. Earlier this year, many of our customers, including hospitals and clinics, suspended non-emergency appointments and services, which resulted in a significant decrease in our test volume. Travel bans, restrictions and border closures have also impacted our ability to ship tests to and receive samples from our customers. Some of these measures by government authorities have and may continue to remain in place for a significant period of time. Even if these measures are lifted, they may be implemented again if COVID-19 is not contained or returns, as has been the case recently. These measures have adversely affected and may continue to adversely affect our test volume, sales activities and results of operations.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of COVID-19 has caused us to modify our business practices (including employee travel, mandating that all non-essential personnel work from home, temporary closures of our offices, cancellation of physical participation in sales activities, meetings, events and conferences and increasing inventories of certain supplies because, although we have not experienced significant disruption in our supply chain, over the past several months, we have experienced supply delays as a result of the COVID-19 pandemic and have also had to obtain supplies from new suppliers), and we may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, customers and business partners. Such actions could also impact our ability to fully integrate businesses we have acquired and those we may acquire in the future. There is no certainty that such actions will be sufficient to mitigate the risks posed by the virus or otherwise be satisfactory to government authorities. If significant portions of our workforce are unable to work effectively, including due to illness, quarantines, social distancing, government actions or other restrictions in connection with COVID-19, our operations will be impacted. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which COVID-19  continues to impact our business, results of operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to, the duration and spread of the pandemic, the actions to contain the virus and treat its impact, and how quickly and to what extent normal economic and operating activities can resume. COVID-19 could limit the ability of our customers, suppliers and business partners to perform, including third-party payers&#8217; ability to make timely payments to us during and following the pandemic. We have also experienced and may continue to experience a shortage of, or delays in, laboratory supplies and equipment, or a suspension of services from other laboratories or third parties. Even after COVID-19  has subsided, we may continue to experience an adverse impact to our business as a result of its global economic impact, including any recession that has occurred or may occur in the future, and loss of health insurance coverage resulting from pandemic-related job losses. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, difficult macroeconomic conditions, such as decreases in per capita income and level of disposable income, increased and prolonged unemployment or a decline in consumer confidence as a result of COVID-19, as well as limited or significantly reduced points of access of our tests, could have a material adverse effect on the demand for our tests. Under difficult economic conditions, consumers may seek to reduce discretionary spending by forgoing our tests. Decreased demand for our tests, particularly in the United States, has negatively affected and could continue to negatively affect our overall financial performance. Because a significant portion of our revenue is concentrated in the United States, where the impact of  COVID-19  has been significant, COVID-19  has had and could continue to have a disproportionately negative impact on our business and financial results. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no comparable recent events which may provide guidance as to the effect of the spread of  COVID-19  and a pandemic, and, as a result, the ultimate impact of COVID-19  or a similar health epidemic is highly uncertain and subject to change. We do not yet know the full extent of  COVID-19&#8217;s  impact on our business, our operations, or the global economy as a whole. However, the effects could have a material impact on our results of operations, and we continue to monitor the situation closely. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent the COVID-19 pandemic continues to adversely affect our business and financial results, it may also have the effect of heightening many of the other risks described in this section. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We expect to continue incurring significant losses, and we may not successfully execute our plan to achieve or sustain profitability.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred substantial losses since our inception. For the years ended December 31, 2020, 2019 and 2018, our net losses were $602.2 million, $242.0 million and $129.4 million, respectively. At December 31, 2020, our accumulated deficit was $1.4 billion. While our revenue has increased over time, we expect to continue to incur significant losses as we invest in our business. We incurred research and development expenses of $240.6 million, $141.5 million and $63.5 million in 2020, 2019 and 2018, respectively, and selling and marketing expenses of $168.3 million, $122.2 million and $74.4 million in 2020, 2019 and 2018, respectively. We expect these losses may increase as we focus on scaling our business and operations and expanding our testing capabilities, which may also increase our operating expenses, and we have experienced and may continue to experience decreases in test volume due to the impact of COVID-19. In addition, as a result of the integration of acquired businesses, we may be subject to unforeseen or additional expenditures, costs or liabilities, including costs and potential liabilities associated with litigation. Our prior losses and expected future losses have had and may continue to have an adverse effect on our stockholders&#8217; equity, working capital and stock price. Our failure to achieve and sustain profitability in the future would negatively affect our business, financial condition, results of operations and cash flows, and could cause the market price of our common stock to decline.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We began operations in January 2010 and commercially launched our initial assay in late November 2013; accordingly, we have a relatively limited operating history upon which you can evaluate our business and prospects. Our limited commercial history makes it difficult to evaluate our current business and makes predictions about our future results, prospects or viability subject to significant uncertainty. Our prospects must be considered in light of the risks and difficulties frequently encountered by companies in their early stage of development, particularly companies in new and rapidly evolving markets such as ours. These risks include an evolving and unpredictable business model and the management of growth. To address these risks, we must, among other things, increase our customer base; continue to implement and successfully execute our business and marketing strategy;  identify, acquire and successfully integrate companies, assets or technologies in areas that are complementary to our business strategy; successfully enter into other strategic collaborations or relationships; obtain access to capital on acceptable terms and effectively utilize that capital; identify, attract, hire, retain, motivate and successfully integrate additional employees; continue to expand, automate and upgrade our laboratory, technology and data systems; obtain, maintain and expand coverage and reimbursement by healthcare payers; provide rapid test turnaround times with accurate results at low prices; provide superior customer service; and respond to competitive developments. We cannot assure you that we will be successful in addressing these risks, and the failure to do so could have a material adverse effect on our business, prospects, financial condition and results of operations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our inability to raise additional capital on acceptable terms in the future may limit our ability to develop and commercialize new tests and expand our operations.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect capital expenditures and operating expenses to increase over the next several years as we expand our infrastructure, commercial operations, research and development and selling and marketing activities and pursue and integrate acquisitions. We believe our existing cash and cash equivalents as of December 31, 2020, including the net proceeds from our recent public offering and revenue from sales of our tests will be sufficient to meet our anticipated cash requirements for our currently-planned operations for the foreseeable future. We may raise additional capital to finance operations prior to achieving profitability, or should we make additional acquisitions. We may seek to raise additional capital through equity offerings, debt financings, collaborations or licensing arrangements. Additional funding may not be available to us on acceptable terms, or at all. In addition, the terms of our credit agreement restrict our ability to incur certain indebtedness and issue certain equity securities. If we raise funds by issuing equity securities, dilution to our stockholders would result. Any equity securities issued also may provide for rights, preferences or privileges senior to those of holders of our common stock. The terms of debt securities issued or borrowings, if available, could impose significant restrictions on our operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The incurrence of additional indebtedness or the issuance of certain equity securities could result in increased fixed payment obligations and could also result in restrictive covenants, such as limitations on our ability to incur additional debt or issue additional equity, limitations on our ability to acquire or license intellectual property rights, and other operating restrictions that could adversely affect our ability to conduct our business. In addition, the issuance of additional equity securities by us, or the possibility of such issuance, may cause the market price of our common stock to decline. In the event we enter into collaborations or licensing arrangements to raise capital, we may be required to accept unfavorable terms. These agreements may require that we relinquish or license to a third party on unfavorable terms our rights to tests we otherwise would seek to develop or commercialize ourselves, or reserve certain opportunities for future potential arrangements when we might be able to achieve more favorable terms. If we are not able to secure additional funding when needed, we may have to delay, reduce the scope of or eliminate one or more research and development programs, selling and marketing initiatives, or potential acquisitions. In addition, we may have to work with a partner on one or more aspects of our tests or market development programs, which could lower the economic value of those tests or programs to our company.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have acquired and may continue to acquire businesses or assets, form joint ventures or make investments in other companies or technologies that could harm our operating results, dilute our stockholders&#8217; ownership, or cause us to incur debt or significant expense.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our business strategy, we have pursued and expect to continue to pursue acquisitions of complementary businesses or assets, as well as technology licensing arrangements. We also may pursue strategic alliances that leverage our core technology and industry experience to expand our offerings or distribution, or make investments in other companies. Since 2017, we have acquired several companies, including companies in family health genetic information services, the patient data collection industry, the non-invasive prenatal screen offering industry, the genetic information industry and the use of artificial intelligence in such industry, the pharmacogenetic testing industry, and the oncology industry. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to our acquired businesses and any acquisitions we may make in the future, we may not be able to integrate these acquisitions successfully into our existing business, and we could assume unknown or contingent liabilities. For example, if we are unable to integrate ArcherDX's technology, people and distributed products business model into our existing business, we will not realize the expected benefits of that acquisition. Any acquisitions by us also could result in significant write-offs or the incurrence of debt and contingent liabilities, any of which could harm our operating results. Furthermore, as we experienced in the past, the loss of customers, payers, partners or suppliers following the completion of any acquisitions by us could harm our business. Changes in services, sources of revenue, and branding or rebranding initiatives may involve substantial costs and may not be favorably received by customers, resulting in an adverse impact on our financial results, financial condition and stock price. Integration of an acquired company or business also may require management&#8217;s time and resources that otherwise would be available for ongoing development of our existing business. We may also need to divert cash from other uses to fund these integration activities and these new businesses. Ultimately, we may not realize the anticipated benefits of any acquisition, technology license, strategic alliance, joint venture or investment, or these benefits may take longer to realize than we expected.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain of our completed acquisitions, we have agreed to pay cash and/or stock consideration that is contingent upon the achievement of specified objectives, such as development objectives, regulatory submissions, regulatory approvals and revenue recognized related to certain products. As of the date of the applicable acquisition, we record a contingent liability representing the estimated fair value of the contingent consideration we expect to pay. On a quarterly basis, we reassess these obligations and, in the event our estimate of the fair value of the contingent consideration changes, we recorded increases or decreases in the fair value as an adjustment to operating expense, which could have a material impact on our results of operations. As of December 31, 2020, we accrued $796.6&#160;million of contingent consideration, most of which related to potential milestone payments in the form of our common stock in connection with our acquisition of ArcherDX. In addition, our actual payments may differ materially from the amount of the contingent liability, which could have a material impact on our results of operations. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To finance any acquisitions or investments, we may raise additional funds, which could adversely affect our existing stockholders and our business, as discussed in the preceding risk factor. If the price of our common stock is low or volatile, we may not be able to acquire other companies for stock. In addition, our stockholders may experience substantial dilution as a result of additional securities we may issue for acquisitions. Open market sales of substantial amounts of our common stock issued to stockholders of companies we acquire could also depress our stock price. Additional funds may not be available on terms that are favorable to us, or at all.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If third-party payers, including managed care organizations, private health insurers and government health plans do not provide adequate reimbursement for our tests or we are unable to comply with their requirements for reimbursement, our commercial success could be negatively affected.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to increase the number of billable tests and our revenue will depend on our success achieving reimbursement for our tests from third-party payers. Reimbursement by a payer may depend on a number of factors, including a payer&#8217;s determination that a test is appropriate, medically necessary, cost-effective and has received prior authorization. The commercial success of our distributed products, including STRATAFIDE, a pan-solid tumor in vitro diagnostic, or IVD, and our Personalized Cancer Monitoring product, or PCM, if approved, will depend on the extent to which our customers receive coverage and adequate reimbursement from third-party payers, including as managed care organizations and government payers (e.g., Medicare and Medicaid). </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since each payer makes its own decision as to whether to establish a policy or enter into a contract to cover our tests, as well as the amount it will reimburse for a test, seeking these approvals is a time-consuming and costly process. In addition, the determination by a payer to cover and the amount it will reimburse for our tests will likely be made on an indication by indication basis. To date, we have obtained policy-level reimbursement approval or contractual reimbursement for some indications for our tests from most of the large commercial third-party payers in the United States, and the Centers for Medicare &amp; Medicaid Services, or CMS, provides reimbursement for our multi-gene tests for hereditary breast and ovarian cancer-related disorders as well as colon cancer. We believe that establishing adequate reimbursement from Medicare is an important factor in gaining adoption from healthcare providers. Our claims for reimbursement from third-party payers may be denied upon submission, and we must appeal the claims. The appeals process is time consuming and expensive and may not result in payment. In cases where there is not a contracted rate for reimbursement, there is typically a greater coinsurance or copayment requirement from the patient, which may result in further delay or decreased likelihood of collection.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In cases where we have established reimbursement rates with third-party payers, we face additional challenges in complying with their procedural requirements for reimbursement. These requirements often vary from payer to payer, and we have needed additional time and resources to comply with them. We have also experienced, and may continue to experience, delays in or denials of coverage if we do not adequately comply with these requirements. Our third-party payers have also requested, and in the future may request, audits of the amounts paid to us. We have been required to repay certain amounts to payers as a result of such audits, and we could be adversely affected if we are required to repay other payers for alleged overpayments due to lack of compliance with their reimbursement policies. In addition, we have experienced, and may continue to experience, delays in reimbursement when we transition to being an in-network provider with a payer.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to focus our resources on increasing adoption of, and expanding coverage and reimbursement for, our current tests and any future tests we may develop or acquire. If we fail to expand and maintain broad adoption of, and coverage and reimbursement for, our tests, our ability to generate revenue could be harmed and our future prospects and our business could suffer.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face intense competition, which is likely to intensify further as existing competitors devote additional resources to, and new participants enter, the market. If we cannot compete successfully, we may be unable to increase our revenue or achieve and sustain profitability.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the development of next generation sequencing, the clinical genetics market is becoming increasingly competitive, and we expect this competition to intensify in the future. We face competition from a variety of sources, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">dozens of relatively specialized competitors focused on genetics applied to healthcare, such as Ambry Genetics, a subsidiary of Konica Minolta Inc.; Athena Diagnostics and Blueprint Genetics, subsidiaries of Quest Diagnostics Incorporated; Baylor-Miraca Genetics Laboratories; Caris Life Sciences, Inc.; Centogene AG; Connective Tissue Gene Test LLC, a subsidiary of Health Network Laboratories, L.P.; Cooper Surgical, Inc.; Emory Genetics Laboratory, a subsidiary of Eurofins Scientific; Foundation Medicine, a subsidiary of Roche Holding AG; Fulgent Genetics, Inc., GeneDx, a subsidiary of OPKO Health, Inc.; Guardant Health, Inc.; Integrated Genetics, Sequenom Inc., Correlagen Diagnostics, Inc., and MNG Laboratories, subsidiaries of Laboratory Corporation of America Holdings; Myriad Genetics, Inc.; Natera, Inc.; Perkin Elmer, Inc.; PreventionGenetics, LLC; Progenity, Inc.; and Sema4 Genomics;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a few large, established general testing companies with large market share and significant channel power, such as Laboratory Corporation of America Holdings and Quest Diagnostics Incorporated;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a large number of clinical laboratories in an academic or healthcare provider setting that perform clinical genetic testing on behalf of their affiliated institutions and often sell and market more broadly; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a large number of new entrants into the market for genetic information ranging from informatics and analysis pipeline developers to focused, integrated providers of genetic tools and services for health and wellness including Illumina, Inc., which is also one of our suppliers.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hospitals, academic medical centers and eventually physician practice groups and individual clinicians may also seek to perform at their own facilities the type of genetic testing we would otherwise perform for them. In this regard, continued development of equipment, reagents, and other materials as well as databases and interpretation services may enable broader direct participation in genetic testing and analysis.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participants in closely related markets such as clinical trial or companion diagnostic testing could converge on offerings that are competitive with the type of tests we perform. Instances where potential competitors are aligned with key suppliers or are themselves suppliers could provide such potential competitors with significant advantages.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the biotechnology and genetic testing fields are intensely competitive both in terms of service and price, and continue to undergo significant consolidation, permitting larger clinical laboratory service providers to increase cost efficiencies and service levels, resulting in more intense competition.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also face competition as a result of our recently completed acquisition of ArcherDX. In particular, ArcherDX competes with numerous companies in the life sciences research, clinical diagnostics and drug development spaces, including, among others, Natera, QIAGEN N.V., Guardant Health, Inc., Thermo Fisher, Inc., Foundation Medicine, Caris Life Sciences, Inc., Tempus, Laboratory Corporation of America, Quest Diagnostics, Inc., NeoGenomics, Inc., BioReference Laboratories, Inc. and Illumina, Inc.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the principal competitive factors in our market are:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">breadth and depth of content;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">quality;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reliability;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accessibility of results;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">turnaround time of testing results;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">price and quality of tests;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">coverage and reimbursement arrangements with third-party payers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">convenience of testing;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">brand recognition of test provider;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additional value-added services and informatics tools;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">client service; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">quality of website content.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our competitors and potential competitors have longer operating histories, larger customer bases, greater brand recognition and market penetration, higher margins on their tests, substantially greater financial, technological and research and development resources, selling and marketing capabilities, lobbying efforts, and more experience dealing with third-party payers. As a result, they may be able to respond more quickly to changes in customer requirements, devote greater resources to the development, promotion and sale of their tests than we do, sell their tests at prices designed to win significant levels of market share, or obtain reimbursement from more third-party payers and at higher prices than we do. We may not be able to compete effectively against these organizations. Increased competition and cost-saving initiatives on the part of governmental entities and other third-party payers are likely to result in pricing pressures, which could harm our sales, profitability or ability to gain market share. In addition, competitors may be acquired by, receive investments from or enter into other commercial relationships with larger, well-established and well-financed companies as use of next generation sequencing for clinical diagnosis and preventative care increases. Certain of our competitors may be able to secure key inputs from vendors on more favorable terms, devote greater resources to marketing and promotional campaigns, adopt more aggressive pricing policies and devote substantially more resources to website and systems development than we can. In addition, companies or governments that control access to genetic testing through umbrella contracts or regional preferences could promote our competitors or prevent us from performing certain services. In addition, some of our competitors have obtained approval or clearance for certain of their tests from the U.S. Food and Drug Administration, or FDA. If payers decide to reimburse only for tests that are FDA-approved or FDA-cleared, or if they are more likely to reimburse for such tests, we may not be able to compete effectively unless we obtain similar approval or clearance for our tests. If we are unable to compete successfully against current and future competitors, we may be unable to increase market acceptance and sales of our tests, which could prevent us from increasing our revenue or achieving profitability and could cause our stock price to decline.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to manage our future growth effectively, which could make it difficult to execute our business strategy.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our expected future growth could create a strain on our organizational, administrative and operational infrastructure, including laboratory operations, quality control, customer service, marketing and sales, and management. We may not be able to maintain the quality of or expected turnaround times for our tests, or satisfy customer demand as it grows. We may need to continue expanding our sales force to facilitate our growth, and we may have difficulties locating, recruiting, training and retaining sales personnel. Our ability to manage our growth effectively will require us to continue to improve our operational, financial and management controls, as well as our reporting systems and procedures. As we grow, any failure of our controls or interruption of our production facilities or systems could have a negative impact on our business and financial operations. We plan to implement new enterprise software systems in a number of areas affecting a broad range of business processes and functional areas. The time and resources required to implement these new systems is uncertain, and failure to complete these activities in a timely and efficient manner could adversely affect our operations. Future growth in our business could also make it difficult for us to maintain our corporate culture. If we are unable to manage our growth effectively, it may be difficult for us to execute our business strategy and our business could be harmed.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security breaches, privacy issues, loss of data and other incidents could compromise sensitive or personal information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and our reputation.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect and store sensitive data, including protected health information, or PHI, personally identifiable information, genetic information, credit card information, intellectual property and proprietary business information owned or controlled by ourselves or our customers, payers and other parties. We manage and maintain our applications and data utilizing a combination of on-site systems, managed data center systems and cloud-based systems. We also communicate PHI and other sensitive patient data through our various customer tools and platforms. In addition to storing and transmitting sensitive data that is subject to multiple legal protections, these applications and data encompass a wide variety of business-critical information including research and development information, commercial information, and business and financial information. We face a number of risks relative to protecting this critical information, including loss of access risk, inappropriate disclosure, inappropriate modification, and the risk of our being unable to adequately monitor and modify our controls over our critical information. Any technical problems that may arise in connection with our data and systems, including those that are hosted by third-party providers, could result in interruptions to our business and operations or exposure to security vulnerabilities. These types of problems may be caused by a variety of factors, including infrastructure changes, intentional or accidental human actions or omissions, software errors, malware, viruses, security attacks, fraud, spikes in customer usage and denial of service issues. From time to time, large third-party web hosting providers have experienced outages or other problems that have resulted in their systems being offline and inaccessible. Such outages could materially impact our business and operations.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The secure processing, storage, maintenance and transmission of this critical information are vital to our operations and business strategy, and we devote significant resources to protecting such information. Although we take what we believe to be reasonable and appropriate measures, including a formal, dedicated enterprise security program, to protect sensitive information from various compromises (including unauthorized access, disclosure, or modification or lack of availability), our information technology and infrastructure may be vulnerable to attacks by hackers or viruses or breached due to employee error, malfeasance or other disruptions. For example, ArcherDX has been subject to phishing incidents and we may experience additional incidents in the future. Any such breach or interruption could compromise our networks and the information stored therein could be accessed by unauthorized parties, altered, publicly disclosed, lost or stolen. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, our various customer tools and platforms are currently accessible through our online portal and/or through our mobile applications, and there is no guarantee we can protect our them from a security breach. Unauthorized access, loss or dissemination could also disrupt our operations (including our ability to conduct our analyses, provide test results, bill payers or patients, process claims and appeals, provide customer assistance, conduct research and development activities, collect, process and prepare company financial information, provide information about our tests and other patient and physician education and outreach efforts through our website, and manage the administrative aspects of our business) and damage our reputation, any of which could adversely affect our business.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to data security risks, we also face privacy risks. Should we actually violate, or be perceived to have violated, any privacy promises we make to patients or consumers, we could be subject to a complaint from an affected individual or interested privacy regulator, such as the FTC, a state Attorney General, an EU Member State Data Protection Authority, or a data protection authority in another international jurisdiction. This risk is heightened given the sensitivity of the data we collect.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any security compromise that causes an apparent privacy violation could also result in legal claims or proceedings; liability under federal, state, foreign, or multinational laws that regulate the privacy, security, or breach of personal information, such as but not limited to the HIPAA, HITECH, state data security and data breach notification laws, the European Union&#8217;s General Data Protection Regulation, or GDPR, the UK Data Protection Act of 2018; and related regulatory penalties. Penalties for failure to comply with a requirement of HIPAA or HITECH vary significantly, and, depending on the knowledge and culpability of the HIPAA-regulated entity, may include civil monetary penalties of up to $1.5 million per calendar year for each provision of HIPAA that is violated. A person who knowingly obtains or discloses individually identifiable health information in violation of HIPAA may face a criminal penalty of up to $50,000 and up to one-year imprisonment. The criminal penalties increase if the wrongful conduct involves false pretenses or the intent to sell, transfer or use identifiable health information for commercial advantage, personal gain or malicious harm. Penalties for unfair or deceptive acts or practices under the FTC Act or state Unfair and Deceptive Acts and Practices, or UDAP, statutes may also vary significantly.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been unprecedented activity in the development of data protection regulation around the world. As a result, the interpretation and application of consumer, health-related and data protection laws in the United States, Europe and elsewhere are often uncertain, contradictory and in flux. The GDPR took effect on May 25, 2018. The GDPR applies to any entity established in the EU as well as extraterritorially to any entity outside the EU that offers goods or services to, or monitors the behavior of, individuals who are located in the EU. The GDPR imposes strict requirements on controllers and processors of personal data, including enhanced protections for &#8220;special categories&#8221; of personal data, which includes sensitive information such as health and genetic information of data subjects. The GDPR also grants individuals various rights in relation to their personal data, including the rights of access, rectification, objection to certain processing and deletion. The GDPR provides an individual with an express right to seek legal remedies if the individual believes his or her rights have been violated. Failure to comply with the requirements of the GDPR or the related national data protection laws of the member states of the EU, which may deviate from or be more restrictive than the GDPR, may result in significant administrative fines issued by EU regulators. Maximum penalties for violations of the GDPR are capped at 20M euros or 4% of an organization&#8217;s annual global revenue, whichever is greater. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the United Kingdom&#8217;s decision to leave the European Union, often referred to as Brexit, has created uncertainty with regard to data protection regulation in the United Kingdom. In particular, it is still unclear whether the transfer of personal information from the EU to the United Kingdom will in the future remain lawful under the GDPR. The United Kingdom-EU post-Brexit trade deal provides that transfers of personal information to the United Kingdom will not be treated as restricted transfers to a non-EU country for a period of up to six months from January 1, 2021. However, unless the EU Commission makes an &#8220;adequacy finding&#8221; with respect to the United Kingdom before the end of that transition period, from that date the United Kingdom will be a &#8220;third country&#8221; under the GDPR and transfers of personal information from the EU to the United Kingdom will require an &#8220;adequacy mechanism,&#8221; such as the SCCs. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the implementation of GDPR has led other jurisdictions to either amend or propose legislation to amend their existing data privacy and cybersecurity laws to resemble the requirements of GDPR. For example, on June 28, 2018, California adopted the CCPA. The CCPA regulates how certain for-profit businesses that meet one or more CCPA applicability thresholds collect, use, and disclose the personal information of consumers who reside in California. Among other things, the CCPA confers to California consumers the right to receive notice of the categories of personal information that will be collected by a business, how the business will use and share the personal information, and the third parties who will receive the personal information; the CCPA also confers rights to access, delete, or transfer personal information; and the right to receive equal service and pricing from a business after exercising a consumer right granted by the CCPA. In addition, the CCPA allows California consumers the right to opt out of the &#8220;sale&#8221; of their personal information, which the CCPA defines broadly as any disclosure of personal information to a third party in exchange for monetary or other valuable consideration. The CCPA also requires a business to implement reasonable security procedures to safeguard personal information against unauthorized access, use, or disclosure. California amended the law in September 2018 to exempt all PHI collected by certain parties subject to HIPAA, and further amended the law in September 2020 to clarify that de-identified data as defined under HIPAA will also be exempt from the CCPA. The California Attorney General&#8217;s final regulations implementing the CCPA took effect on August 14, 2020. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches resulting from a business&#8217;s failure to implement and maintain reasonable data security procedures that is expected to increase data breach litigation. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, California voters recently approved the California Privacy Rights Act of 2020, or CPRA, that is scheduled to go into effect on January 1, 2023. The CPRA would, among other things, amend the CCPA to give California residents the ability to limit the use of their sensitive information, provide for penalties for CPRA violations concerning California residents under the age of 16, and establish a new California Privacy Protection Agency to implement and enforce the law. Other jurisdictions in the United States are beginning to propose laws similar to the CCPA. Some observers have noted that the CCPA could mark the beginning of a trend toward more stringent privacy legislation in the United States, which could increase our potential liability and adversely affect our business, results of operations, and financial condition. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible the GDPR, CCPA and other emerging United States and international data protection laws may be interpreted and applied in a manner that is inconsistent with our practices. If so, this could result in government-imposed fines or orders requiring that we change our practices, which could adversely affect our business. In addition, these privacy laws and regulations may differ from country to country and state to state, and our obligations under these laws and regulations vary based on the nature of our activities in the particular jurisdiction, such as whether we collect samples from individuals in the local jurisdiction, perform testing in the local jurisdiction, or process personal information regarding employees or other individuals in the local jurisdiction. Complying with these various laws and regulations could cause us to incur substantial costs or require us to change our business practices and compliance procedures in a manner adverse to our business. We can provide no assurance that we are or will remain in compliance with diverse privacy and data security requirements in all of the jurisdictions in which we do business. Failure to comply with privacy and data security requirements could result in a variety of consequences, including civil or criminal penalties, litigation, or damage to our reputation, any of which could have a material adverse effect on our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on highly skilled personnel in a broad array of disciplines and, if we are unable to hire, retain or motivate these individuals, or maintain our corporate culture, we may not be able to maintain the quality of our services or grow effectively.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance, including our research and development programs and laboratory operations, largely depend on our continuing ability to identify, hire, develop, motivate and retain highly skilled personnel for all areas of our organization, including software developers, geneticists, biostatisticians, certified laboratory scientists and other scientific and technical personnel to process and interpret our genetic tests. In addition, we may need to continue to expand our sales force with qualified and experienced personnel. Competition in our industry for qualified employees is intense, and we may not be able to attract or retain qualified personnel in the future due to the competition for qualified personnel among life science and technology businesses as well as universities and public and private research institutions, particularly in the San Francisco Bay Area. In addition, our compensation arrangements, such as our equity award programs, may not always be successful in attracting new employees and retaining and motivating our existing employees. If we are not able to attract and retain the necessary personnel to accomplish our business objectives, we may experience constraints that could adversely affect our ability to scale our business, support our research and development efforts and our clinical laboratory. We believe that our corporate culture fosters innovation, creativity and teamwork. However, as our organization grows, we may find it increasingly difficult to maintain the beneficial aspects of our corporate culture. This could negatively impact our ability to retain and attract employees and our future success.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We need to scale our infrastructure in advance of demand for our tests, and our failure to generate sufficient demand for our tests would have a negative impact on our business and our ability to attain profitability.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in large part on our ability to extend our market position, to provide customers with high-quality test reports quickly and at a lower price than our competitors, and to achieve sufficient test volume to realize economies of scale. In order to execute our business model, we intend to continue to invest heavily in order to significantly scale our infrastructure, including our testing capacity and information systems, expand our commercial operations, customer service, billing and systems processes and enhance our internal quality assurance program. We expect that much of this growth will be in advance of demand for our tests. Our current and future expense levels are to a large extent fixed and are largely based on our investment plans and our estimates of future revenue. Because the timing and amount of revenue from our tests is difficult to forecast, when revenue does not meet our expectations, we may not be able to adjust our spending promptly or reduce our spending to levels commensurate with our revenue. Even if we are able to successfully scale our infrastructure and operations, we cannot assure you that demand for our tests will increase at levels consistent with the growth of our infrastructure. If we fail to generate demand commensurate with this growth or if we fail to scale our infrastructure sufficiently in advance of demand to successfully meet such demand, our business, prospects, financial condition and results of operations could be adversely affected.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to continue to generate substantial demand of our tests, our commercial success will be negatively affected.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model assumes that we will be able to generate significant test volume, and we may not succeed in continuing to drive adoption of our tests to achieve sufficient volumes. Inasmuch as detailed genetic data from broad-based testing panels such as our tests have only recently become available at relatively affordable prices, the continued pace and degree of clinical acceptance of the utility of such testing is uncertain. Specifically, it is uncertain how much genetic data will be accepted as necessary or useful, as well as how detailed that data should be, particularly since medical practitioners may have become accustomed to genetic testing that is specific to one or a few genes. Given the substantial amount of additional information available from a broad-based testing panel such as ours, there may be distrust as to the reliability of such information when compared with more limited and focused genetic tests. To generate further demand for our tests, we will need to continue to make clinicians aware of the benefits of our tests, including the price, the breadth of our testing options, and the benefits of having additional genetic data available from which to make treatment decisions. A lack of or delay in clinical acceptance of broad-based panels such as our tests would negatively impact sales and market acceptance of our tests and limit our revenue growth and potential profitability. Genetic testing is expensive and many potential customers may be sensitive to pricing. In addition, potential customers may not adopt our tests if adequate reimbursement is not available, or if we are not able to maintain low prices relative to our competitors. Also, we may not be successful in increasing demand for our tests through our direct channel, in which we facilitate the ordering of our genetic tests by consumers through an online network of physicians.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are not able to generate demand for our tests at sufficient volume, or if it takes significantly more time to generate this demand than we anticipate, our business, prospects, financial condition and results of operations could be materially harmed.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have devoted a portion of our resources to the development and commercialization of STRATAFIDE, and to research and development activities related to our PCM product for cancer monitoring, including clinical and regulatory initiatives to obtain diagnostic clearance and marketing approval. The demand for these regulated products is unproven, and we may not be successful in achieving market awareness and demand for these products through our sales and marketing operations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If ArcherDX&#8217;s products and services do not perform as expected, we may not realize the expected benefits of our recent acquisition of ArcherDX. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of ArcherDX&#8217;s products depends on the market&#8217;s confidence that it can provide reliable products that enable high quality diagnostic testing with high sensitivity and specificity and short turnaround times. There is no guarantee that the accuracy and reproducibility ArcherDX has demonstrated to date will continue as its product deliveries increase and its product portfolio expands. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ArcherDX&#8217;s products and services use a number of complex and sophisticated biochemical and bioinformatics processes, many of which are highly sensitive to external factors. An operational, technological or other failure in one of these complex processes or fluctuations in external variables may result in sensitivity or specificity rates that are lower than ArcherDX anticipates or result in longer than expected turnaround times. In addition, labs are required to validate their processes before using ArcherDX products for clinical purposes. These validations are outside of our control. If our products do not perform, or are perceived to not have performed, as expected or favorably to competitive products, our consolidated operating results, reputation, and business will suffer, and ArcherDX may also be subject to legal claims arising from product limitations, errors, or inaccuracies. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we plan to match our test reports for STRATAFIDE to identified mutations with FDA-approved targeted therapies or relevant clinical trials of targeted therapies. If a patient or physician who orders a test using one of our products is unable to obtain, or be reimbursed for the use of, targeted therapies because they are not indicated in the FDA-approved label for treatment, the patient is unable to enroll in an identified clinical trial due to the enrollment criteria of the trial, or some other reason, the ordering physician may conclude the test report does not contain actionable information. If physicians do not believe our products consistently generate actionable information about their patients&#8217; disease or condition, they may be less likely to use our products. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, we cannot provide assurance that customers will always use these products in the manner in which intended. Any intentional or unintentional misuse of these products by customers could lead to substantial civil and criminal monetary and non-monetary penalties, and could result in significant legal and investigatory fees. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The future growth of our distributed products business is partially dependent upon regulatory approval and market acceptance of our IVD products, including STRATAFIDE and PCM. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that the future success of our distributed products business will depend in large part on our ability to effectively introduce enhanced or new offerings of IVD products, such as STRATAFIDE. The development and launch of enhanced or new products and services, whether research use only, or RUO, or IVD, require the completion of certain clinical development and commercialization activities that are complex, costly, time-intensive and uncertain, and require us to accurately anticipate patients&#8217;, providers&#8217; and, if applicable, payers&#8217; attitudes and needs and emerging technology and industry trends. This process is conducted in various stages, and each stage presents the risk that ArcherDX will not achieve its goals on a timely basis, or at all. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have limited experience commercializing IVD products. We may experience research and development, regulatory, marketing and other difficulties that could delay or prevent our introduction of enhanced or new products or new services and result in increased costs and the diversion of management&#8217;s attention and resources from other business matters. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An important factor in our ability to commercialize our distributed products is collecting data that supports their value proposition. The data collected from any studies we complete may not be favorable or consistent with its existing data or may not be statistically significant or compelling to the medical community or to third-party payers seeking such data for purposes of determining coverage for these products. This is particularly true with respect to service defects and errors. Any of the foregoing could have a negative impact on our ability to commercialize our future products, which could have a material adverse effect on our ability to realize the intended benefits of our recent acquisition of ArcherDX. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success will depend on our ability to use rapidly changing genetic data to interpret test results accurately and consistently, and our failure to do so would have an adverse effect on our operating results and business, harm our reputation and could result in substantial liabilities that exceed our resources.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on our ability to provide reliable, high-quality tests that incorporate rapidly evolving information about the role of genes and gene variants in disease and clinically relevant outcomes associated with those variants. Errors, such as failure to detect genomic variants with high accuracy, or mistakes, such as failure to identify, or incompletely or incorrectly identifying, gene variants or their significance, could have a significant adverse impact on our business.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hundreds of genes can be implicated in some disorders, and overlapping networks of genes and symptoms can be implicated in multiple conditions. As a result, a substantial amount of judgment is required in order to interpret testing results for an individual patient and to develop an appropriate patient report. We classify variants in accordance with published guidelines as benign, likely benign, variants of uncertain significance, likely pathogenic or pathogenic, and these guidelines are subject to change. In addition, it is our practice to offer support to clinicians and geneticists ordering our tests regarding which genes or panels to order as well as interpretation of genetic variants. We also rely on clinicians to interpret what we report and to incorporate specific information about an individual patient into the physician&#8217;s treatment decision.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The marketing, sale and use of our genetic tests could subject us to liability for errors in, misunderstandings of, or inappropriate reliance on, information we provide to clinicians, geneticists or patients, and lead to claims against us if someone were to allege that a test failed to perform as it was designed, if we failed to correctly interpret the test results, if we failed to update the test results due to a reclassification of the variants according to new published guidelines, or if the ordering physician were to misinterpret test results or improperly rely on them when making a clinical decision. In addition, our entry into the reproductive health and pharmacogenetic testing markets expose us to increased liability. A product liability or professional liability claim could result in substantial damages and be costly and time-consuming for us to defend. Although we maintain liability insurance, including for errors and omissions, we cannot assure you that such insurance would fully protect us from the financial impact of defending against these types of claims or any judgments, fines or settlement costs arising out of any such claims. Any liability claim, including an errors and omissions liability claim, brought against us, with or without merit, could increase our insurance rates or prevent us from securing insurance coverage in the future. Additionally, any liability lawsuit could cause injury to our reputation or cause us to suspend sales of our tests. The occurrence of any of these events could have an adverse effect on our reputation and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our industry is subject to rapidly changing technology and new and increasing amounts of scientific data related to genes and genetic variants and their role in disease. Our failure to develop tests to keep pace with these changes could make us obsolete.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, there have been numerous advances in methods used to analyze very large amounts of genomic information and the role of genetics and gene variants in disease and treatment therapies. Our industry has and will continue to be characterized by rapid technological change, increasingly larger amounts of data, frequent new testing service introductions and evolving industry standards, all of which could make our tests obsolete. Our future success will also depend on our ability to keep pace with the evolving needs of our customers on a timely and cost-effective basis and to pursue new market opportunities that develop as a result of technological and scientific advances. Our tests could become obsolete and our business adversely affected unless we continually update our offerings to reflect new scientific knowledge about genes and genetic variations and their role in diseases and treatment therapies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success will depend in part on our ability to generate sales using our internal sales team and through alternative marketing strategies.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to market or sell our current tests and any future tests we may develop or acquire effectively enough to drive demand sufficient to support our planned growth. We currently sell our tests primarily through our internal sales force. Historically, our sales efforts have been focused primarily on hereditary cancer and more recently on reproductive health. Our efforts to sell our tests to clinicians and patients outside of oncology may not be successful, or may be difficult to do successfully without significant additional selling and marketing efforts and expense. In addition, following the acquisition of ArcherDX, our sales efforts have expanded to include distributed products sold to laboratories. In the past, we have increased our sales force each year in order to drive our growth, and in October 2020, we increased our sales force through the acquisition of ArcherDX. In addition to the efforts of our sales force, future sales will depend in large part on our ability to develop and substantially expand awareness of our company and our tests through alternative strategies including through education of key opinion leaders, through social media-related and online outreach, education and marketing efforts, and through focused channel partner strategies designed to drive demand for our tests. We also plan to continue to spend on consumer advertising in connection with our direct channel to consumers, which could be costly. We have limited experience implementing these types of marketing efforts. We may not be able to drive sufficient levels of revenue using these sales and marketing methods and strategies necessary to support our planned growth, and our failure to do so could limit our revenue and potential profitability.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use a limited number of distributors to assist internationally with sales, logistics, education and customer support. Sales practices utilized by our distributors that are locally acceptable may not comply with sales practices standards required under U.S. laws that apply to us, which could create additional compliance risk. If our sales and marketing efforts are not successful outside the United States, we may not achieve significant market acceptance for our tests outside the United States, which could adversely impact our business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment in the value of our goodwill or other intangible assets could have a material adverse effect on our operating results and financial condition.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record goodwill and intangible assets at fair value upon the acquisition of a business. Goodwill represents the excess of amounts paid for acquiring businesses over the fair value of the net assets acquired. Goodwill and indefinite-lived intangible assets are evaluated for impairment annually, or more frequently if conditions warrant, by comparing the carrying value of a reporting unit to its estimated fair value. Intangible assets with definite lives are reviewed for impairment when events or circumstances indicate that their carrying value may not be recoverable. Declines in operating results, divestitures, sustained market declines and other factors that impact the fair value of a reporting unit could result in an impairment of goodwill or intangible assets and, in turn, a charge to net income. Any such charges could have a material adverse effect on our results of operations or financial condition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on a limited number of suppliers or, in some cases, sole suppliers, for some of our laboratory instruments, materials and services, and we may not be able to find replacements or immediately transition to alternative suppliers.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on a limited number of suppliers, or, in some cases, sole suppliers, including Illumina, Inc., Integrated DNA Technologies Incorporated, Qiagen N.V., Roche Holdings Ltd. and Twist Bioscience Corporation for certain laboratory substances used in the chemical reactions incorporated into our processes, which we refer to as reagents, as well as sequencers and other equipment and materials which we use in our laboratory operations. We do not have short- or long-term agreements with most of our suppliers, and our suppliers could cease supplying these materials and equipment at any time, or fail to provide us with sufficient quantities of materials or materials that meet our specifications. Our laboratory operations could be interrupted if we encounter delays or difficulties in securing these reagents, sequencers or other equipment or materials, and if we cannot obtain an acceptable substitute. Any such interruption could significantly affect our business, financial condition, results of operations and reputation. We rely on Illumina as the sole supplier of next generation sequencers and associated reagents and as the sole provider of maintenance and repair services for these sequencers. Any disruption in Illumina&#8217;s operations could impact our supply chain and laboratory operations as well as our ability to conduct our tests, and it could take a substantial amount of time to integrate replacement equipment into our laboratory operations.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that there are only a few other manufacturers that are currently capable of supplying and servicing the equipment necessary for our laboratory operations, including sequencers and various associated reagents. The use of equipment or materials provided by these replacement suppliers would require us to alter our laboratory operations. Transitioning to a new supplier would be time consuming and expensive, may result in interruptions in our laboratory operations, could affect the performance specifications of our laboratory operations or could require that we revalidate our tests. We cannot assure you that we will be able to secure alternative equipment, reagents and other materials, and bring such equipment, reagents and materials on line and revalidate them without experiencing interruptions in our workflow. In the case of an alternative supplier for Illumina, we cannot assure you that replacement sequencers and associated reagents will be available or will meet our quality control and performance requirements for our laboratory operations. If we encounter delays or difficulties in securing, reconfiguring or revalidating the equipment and reagents we require for our tests, our business, financial condition, results of operations and reputation could be adversely affected.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our planned STRATAFIDE and PCM products are currently being developed to use only Illumina&#8217;s sequencing platform. Without access to these sequencers, we would be unable commercialize these products. In addition, any efforts to validate these distributed products on additional sequencing platforms would require significant resources, expenditures and time and attention of our management, and there is no guarantee that we will be successful in implementing any such sequencing platforms in a commercially sustainable way. We also cannot guarantee that it will appropriately prioritize or select alternative sequencing platforms on which to focus our efforts. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our laboratories become inoperable due to disasters, health epidemics or for any other reasons, we will be unable to perform our tests and our business will be harmed.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform all of our tests at our production facilities in San Francisco and Irvine, California, in Golden, Colorado and in Seattle, Washington. Our laboratories and the equipment we use to perform our tests would be costly to replace and could require substantial lead time to replace and qualify for use. Our laboratories may be harmed or rendered inoperable by natural or man-made disasters, including earthquakes, flooding, fire and power outages, or by health epidemics, such as the COVID-19 pandemic, which may render it difficult or impossible for us to perform our tests for some period of time. This risk of natural disaster is especially high for us since we perform the substantial majority of our tests at our San Francisco laboratory, which is located in an active seismic region, and we do not have a redundant facility to perform the same tests in the event our San Francisco laboratory is inoperable. The inability to perform our tests or the backlog that could develop if our laboratories are inoperable for even a short period of time may result in the loss of customers or harm our reputation. Although we maintain insurance for damage to our property and the disruption of our business, this insurance may not be sufficient to cover all of our potential losses and may not continue to be available to us on acceptable terms, if at all.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ArcherDX relies on third-party laboratories to perform portions of its service offerings.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A large portion of ArcherDX&#8217;s biopharmaceutical testing services is performed by third-party laboratories while the remaining portion is performed by third-party laboratories certified under the CLIA, or our CLIA-certified laboratory in Colorado. The third-party laboratories are subject to contractual obligations to perform these services for us, but are not otherwise under our control. We therefore do not control the capacity and quality control efforts of these third-party laboratories other than through our ability to enforce contractual obligations on volume and quality systems, and have no control over such laboratories&#8217; compliance with applicable legal and regulatory requirements. We also have no control over the timeliness of such laboratories&#8217; performance of their obligations to us, and the third-party laboratories that we have contracted with have in the past had, and occasionally continue to have, issues with delivering results to us or resolving issues with us within the time frames we expected or established in our contracts with them, which sometimes results in longer than expected turnaround times for, or negatively impacts the performance of, these tests and services. In the event of any adverse developments with these third-party laboratories or their ability to perform their obligations in a timely manner and in accordance with the standards that we and our customers expect, our ability to service customers may be delayed, interrupted or otherwise adversely affected, which could result in a loss of customers and harm to our reputation. Furthermore, when these issues arise, we have had to expend time, management&#8217;s attention and other resources to address and remedy such issues. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not have sufficient alternative backup if one or more of the third-party laboratories that we contract with are unable to satisfy their obligations to us with sufficient performance, quality and timeliness. Any natural or other disaster, acts of war or terrorism, shipping embargoes, labor unrest or political instability or similar events at one or more of these third-party laboratories&#8217; facilities that causes a loss of capacity would heighten the risks that we face. Changes to or termination of agreements or inability to renew agreements with these third-party laboratories or enter into new agreements with other laboratories that are able to perform such portions of our service offerings could impair, delay or suspend our efforts to market and sell these services. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The loss of any member or change in structure of our senior management team could adversely affect our business.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in large part upon the skills, experience and performance of members of our executive management team and others in key leadership positions. The efforts of these persons will be critical to us as we continue to develop our technologies and test processes and focus on scaling our business. If we were to lose one or more key executives, we may experience difficulties in competing effectively, developing our technologies and implementing our business strategy. All of our executives and employees are at-will, which means that either we or the executive or employee may terminate their employment at any time. We do not carry key person insurance for any of our executives or employees. In addition, we do not have a long-term retention agreement in place with our president and chief executive officer.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Development of new tests is a complex process, and we may be unable to commercialize new tests on a timely basis, or at all.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure you that we will be able to develop and commercialize new tests on a timely basis. Before we can commercialize any new tests, we will need to expend significant funds in order to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conduct research and development;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">further develop and scale our laboratory processes; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">further develop and scale our infrastructure to be able to analyze increasingly larger and more diverse amounts of data.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our testing service development process involves risk, and development efforts may fail for many reasons, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of any test to perform as expected;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of validation or reference data; or</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to demonstrate utility of a test.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we develop tests, we will have to make significant investments in development, marketing and selling resources. In addition, competitors may develop and commercialize competing tests faster than we are able to do so.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our research and development efforts to add additional indications to our IVD products, if approved, will be hindered if we are not able to contract with third parties for access to tissue samples.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under standard clinical practice, tumor biopsies removed from patients are preserved and stored in formalin-fixed paraffin embedded, or FFPE, format, and liquid biopsies are taken with a blood draw and stored in blood collection tubes. In order to add additional indications to our IVD products, if approved, we will need to secure access to these FFPE tumor biopsy and liquid biopsy samples, as well as information pertaining to the clinical outcomes of the patients from which they were derived for its IVD development activities. Others compete with us for access to these samples. Additionally, the process of negotiating access to samples is lengthy because it typically involves numerous parties and approval levels to resolve complex issues such as usage rights, institutional review board approval, privacy rights, publication rights, intellectual property ownership and research parameters. If we are unable to negotiate access to tissue samples on a timely basis or on commercially reasonable terms, or at all, or if other laboratories or competitors secure access to these samples before us, our ability to research, develop and commercialize future IVD products will be limited or delayed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on our information technology systems, and any failure of these systems could harm our business.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on information technology and telecommunications systems for significant elements of our operations, including our laboratory information management system, our bioinformatics analytical software systems, our database of information relating to genetic variations and their role in disease process and drug metabolism, our clinical report optimization systems, our customer-facing web-based software, our customer reporting, and our various customer tools and platforms. We have installed, and expect to expand, a number of enterprise software systems that affect a broad range of business processes and functional areas, including for example, systems handling human resources, financial controls and reporting, customer relationship management, regulatory compliance and other infrastructure operations. In addition, we intend to extend the capabilities of both our preventative and detective security controls by augmenting the monitoring and alerting functions, the network design, and the automatic countermeasure operations of our technical systems. These information technology and telecommunications systems support a variety of functions, including laboratory operations, test validation, sample tracking, quality control, customer service support, billing and reimbursement, research and development activities, scientific and medical curation, and general administrative activities, including financial reporting.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information technology and telecommunications systems are vulnerable to damage from a variety of sources, including telecommunications or network failures, malicious human acts and natural disasters. Moreover, despite network security and back-up measures, some of our servers are potentially vulnerable to physical or electronic break-ins, computer viruses and similar disruptive problems. Despite the precautionary measures we have taken to prevent unanticipated problems that could affect our information technology and telecommunications systems, failures or significant downtime of our information technology or telecommunications systems or those used by our third-party service providers could prevent us from conducting tests, preparing and providing reports to clinicians, billing payers, processing reimbursement appeals, handling physician or patient inquiries, conducting research and development activities, and managing the administrative and financial aspects of our business. Any disruption or loss of information technology or telecommunications systems on which critical aspects of our operations depend could have an adverse effect on our business and results of operations.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Technical problems have arisen, and may arise in the future, in connection with our data and systems, including those that are hosted by third-party providers, which have in the past and may in the future result in interruptions in our business and operations. These types of problems may be caused by a variety of factors, including infrastructure changes, human or software errors, viruses, security attacks, fraud, spikes in customer usage and denial of service issues. From time to time, large third-party web hosting providers have experienced outages or other problems that have resulted in their systems being offline and inaccessible. Such outages could materially impact our business and operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ethical, legal and social concerns related to the use of genetic information could reduce demand for our tests.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Genetic testing has raised ethical, legal and social issues regarding privacy rights and the appropriate uses of the resulting information. Governmental authorities could, for social or other purposes, limit or regulate the use of genetic information or genetic testing or prohibit testing for genetic predisposition to certain conditions, particularly for those that have no known cure. Similarly, these concerns may lead patients to refuse to use, or clinicians to be reluctant to order, genomic tests even if permissible. These and other ethical, legal and social concerns may limit market acceptance of our tests or reduce the potential markets for our tests, either of which could have an adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our international business exposes us to business, regulatory, political, operational, financial and economic risks associated with doing business outside of the United States.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Doing business internationally involves a number of risks, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">multiple, conflicting and changing laws and regulations such as privacy regulations, tax laws, export and import restrictions, employment laws, regulatory requirements, and other governmental approvals, permits and licenses;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure by us or our distributors to obtain regulatory approvals for the use of our tests in various countries;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">complexities and difficulties in obtaining protection and enforcing our intellectual property;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in staffing and managing foreign operations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">complexities associated with managing multiple payer reimbursement regimes, government payers or patient self-pay systems;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">logistics and regulations associated with shipping samples, including infrastructure conditions, customs and transportation delays;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limits on our ability to penetrate international markets if we do not to conduct our tests locally;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">natural disasters, including the recent and ongoing outbreak and spreading of Coronavirus, political and economic instability, including wars, terrorism and political unrest, outbreak of disease, boycotts, curtailment of trade and other business restrictions; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory and compliance risks that relate to maintaining accurate information and control over activities that may fall within the purview of the U.S. Foreign Corrupt Practices Act, or FCPA, its books and records provisions, or its anti-bribery provisions.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these factors could significantly harm our international operations and, consequently, our revenue and results of operations.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, applicable export or import laws and regulations such as prohibitions on the export of samples imposed by countries outside of the United States, or international privacy or data restrictions that are different or more stringent than those of the United States, may require that we build additional laboratories or engage in joint ventures or other business partnerships in order to offer our tests internationally in the future. Any such restrictions would impair our ability to offer our tests in such countries and could have an adverse effect on our business, financial condition and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, our total gross deferred tax assets were $418.9 million. Due to our lack of earnings history and uncertainties surrounding our ability to generate future taxable income, our net deferred tax assets have been fully offset by a valuation allowance. The deferred tax assets are primarily comprised of federal and state tax net operating losses and tax credit carryforwards. Furthermore, under Section 382 of the Internal Revenue Code of 1986, as amended, or the Internal Revenue Code, if a corporation undergoes an &#8220;ownership change,&#8221; the corporation&#8217;s ability to use its pre-change net operating loss carryforwards, or NOLs, and other pre-change tax attributes (such as research tax credits) to offset its future taxable income may be limited. In general, an &#8220;ownership change&#8221; occurs if there is a cumulative change in our ownership by &#8220;5% shareholders&#8221; that exceeds 50 percentage points over a rolling three-year period. Some of our prior acquisitions have resulted in an ownership change, and we may experience ownership changes in the future. Our existing NOLs and tax credit carryovers may be subject to limitations arising from previous ownership changes, and if we undergo one or more ownership changes in connection with completed acquisitions, or other future transactions in our stock, our ability to utilize NOLs and tax credit carryovers could be further limited by Section 382 of the Internal Revenue Code. As a result, if we earn net taxable income, our ability to use our pre-change net operating loss and tax credit carryforwards to offset U.S. federal taxable income may be subject to limitations, which could potentially result in increased future tax liability to us. The annual limitation may result in the expiration of certain net operating loss and tax credit carryforwards before their utilization. In addition, the Tax Cuts and Jobs Act limits the deduction for NOLs to 80% of current year taxable income and eliminates NOL carrybacks. Also, at the state level, there may be periods during which the use of NOLs is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks related to government regulation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the FDA regulates the tests we currently offer as LDTs as medical devices, we could incur substantial costs and our business, financial condition and results of operations could be adversely affected.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide many of our tests as laboratory-developed tests, or LDTs. CMS and certain state agencies regulate the performance of LDTs (as authorized by CLIA, and state law, respectively).</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, the FDA has exercised enforcement discretion with respect to most LDTs and has not required laboratories that furnish LDTs to comply with the agency&#8217;s requirements for medical devices (e.g., establishment registration, device listing, quality systems regulations, premarket clearance or premarket approval, and post-market controls). In recent years, however, the FDA has stated it intends to end its policy of general enforcement discretion and regulate certain LDTs as medical devices. To this end, on October 3, 2014, the FDA issued two draft guidance documents, entitled &#8220;Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs)&#8221; and &#8220;FDA Notification and Medical Device Reporting for Laboratory Developed Tests (LDTs),&#8221; respectively, that set forth a proposed risk-based regulatory framework that would apply varying levels of FDA oversight to LDTs. Subsequently, on January 13, 2017, the FDA published a &#8220;discussion paper&#8221; in which it outlined a substantially revised &#8220;possible approach&#8221; to the oversight of LDTs.  </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, a bill titled the &#8220;Verifying Accurate Leading-edge IVCT Development Act of 2020,&#8221; or VALID Act, was officially introduced in Congress. The bill proposes a risk-based approach to regulate LDTs and creates a new in vitro clinical test, or IVCT, category of regulated products, which includes LDTs, and a regulatory structure under the FDA. As proposed, the bill grandfathers many existing tests from the proposed premarket approval, quality systems, and labeling requirements, respectively, but would require such tests to comply with other regulatory requirements (e.g., registration and listing, adverse event reporting). Later that month, Senator Paul introduced the Verified Innovative Testing in American Laboratories Act of 2020, or VITAL Act, which proposes that all aspects of &#8220;laboratory-developed testing procedures&#8221; be subject to regulation under CLIA, and that no aspects of such procedures be subject to regulation by the FDA. We cannot predict if either of these bills will be enacted in their current (or any other) form and cannot quantify the effect of these bills on our business.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the U.S. Department of Health and Human Services, the parent agency for FDA, announced that the FDA &#8220;will not require premarket review of LDTs absent notice-and-comment rulemaking, as opposed to through guidance documents, compliance manuals, website statements, or other informal issuances.&#8221; It is unclear at this time whether this policy will be retained by the Biden Administration, and if so, when the FDA might seek to begin the notice and comment rulemaking process.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative proposals addressing the FDA&#8217;s oversight of LDTs have been introduced in previous Congresses, and we expect that new legislative proposals may be introduced from time-to-time. The likelihood that Congress will pass such legislation and the extent to which such legislation may affect the FDA&#8217;s plans to regulate certain LDTs as medical devices is difficult to predict at this time.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, we completed our acquisition of Genelex Solutions, LLC, which offers certain pharmacogenetic, or PGx, tests as LDTs. Recently the FDA has taken a more active role in the oversight of PGx tests offered as LDTs. In 2019, the FDA contacted several clinical laboratories, including Genelex, to demand changes to PGx test reports and marketing materials. In February 2020, the FDA issued a statement indicating that it continues to have concerns about the claims that certain clinical laboratories make with respect to their PGx tests, and published tables that list PGx associations for which FDA has determined that the data support therapeutic management recommendations, a potential impact on safety or response, or a potential impact on pharmacokinetic properties only, respectively. To date, however, the FDA has not provided any general guidance on the type(s) of claims or other characteristics that will cause a PGx test to fall outside FDA&#8217;s enforcement discretion. As such, the extent to which the FDA will allow any laboratory, including Genelex or Invitae, to offer PGx tests in their current form without meeting FDA regulatory requirements for medical devices is unclear at this time.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA ultimately regulates certain LDTs (either as medical devices or as part of a new stand-alone regulatory category for IVCTs), whether via individualized enforcement action, or more generally, as outlined in final guidance or final regulation, or as instructed by Congress, our tests may be subject to certain additional regulatory requirements. Complying with the FDA&#8217;s requirements can be expensive, time-consuming and subject us to significant or unanticipated delays. Insofar as we may be required to obtain premarket clearance or approval to perform or continue performing an LDT, we cannot assure you that we will be able to obtain such authorization. Even if we obtain regulatory clearance or approval where required, such authorization may not be for the intended uses that we believe are commercially attractive or are critical to the commercial success of our tests. As a result, the application of the FDA&#8217;s requirements to our tests could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with applicable FDA regulatory requirements may trigger a range of enforcement actions by the FDA including warning letters, civil monetary penalties, injunctions, criminal prosecution, recall or seizure, operating restrictions, partial suspension or total shutdown of operations, and denial of or challenges to applications for clearance or approval, as well as significant adverse publicity.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in November 2013, the FDA issued final guidance regarding the distribution of products labeled for research use only. Certain of the reagents and other products we use in our tests are labeled as research use only products. Certain of our suppliers may cease selling research use only products to us and any failure to obtain an acceptable substitute could significantly and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with federal, state and foreign laboratory licensing requirements, we could lose the ability to perform our tests or experience disruptions to our business.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to CLIA, a federal law that regulates clinical laboratories that perform testing on specimens derived from humans for the purpose of providing information for the diagnosis, prevention or treatment of disease. CLIA regulations establish specific standards with respect to personnel qualifications, facility administration, proficiency testing, quality control, quality assurance and inspections. CLIA certification is also required in order for us to be eligible to bill state and federal healthcare programs, as well as many private third-party payers, for our tests. We have current CLIA certifications to conduct our tests at our laboratories in San Francisco and Irvine, California, Golden, Colorado, and Seattle, Washington. To renew these certifications, we are subject to survey and inspection every two years. Moreover, CLIA inspectors may make random inspections of our clinical reference laboratories.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also required to maintain in-state licenses to conduct testing in California and Washington. California and Washington laws establish standards for day-to-day operation of our clinical reference laboratories in San Francisco and Irvine, and in Seattle, respectively, which include the training and skills required of personnel and quality control. (Our Colorado laboratory is not required to maintain a state clinical laboratory license.)</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several states require the licensure of out&#8209;of&#8209;state laboratories that accept specimens from those states. Our California laboratories hold the required out&#8209;of&#8209;state laboratory licenses for Maryland, New York, Pennsylvania, and Rhode Island. Our Washington laboratory holds the required out-of-state laboratory licenses in Maryland, New York, Pennsylvania, and Rhode Island (but not California).  Our laboratory in Colorado holds the required out&#8209;of&#8209;state laboratory licenses for California, Maryland, Pennsylvania and Rhode Island (but not New York).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to having laboratory licenses in New York, our clinical reference laboratories are approved on test-specific bases for the tests they run as LDTs by the New York State Department of Health, or NYDOH, for tests offered to patients in New York. Other states may adopt similar licensure requirements in the future, which may require us to modify, delay or stop our operations in such jurisdictions. We may also be subject to regulation in foreign jurisdictions as we seek to expand international utilization of our tests or such jurisdictions adopt new licensure requirements, which may require review of our tests in order to offer them or may have other limitations such as restrictions on the transport of samples necessary for us to perform our tests that may limit our ability to make our tests available outside of the United States. Complying with licensure requirements in new jurisdictions may be expensive, time-consuming, and subject us to significant and unanticipated delays.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to eventually market certain of our current or future products and services in any particular foreign jurisdiction, we must establish and comply with numerous and varying regulatory requirements on a jurisdiction-by-jurisdiction basis regarding quality, safety, performance and efficacy. In addition, clinical trials or clinical investigations conducted in one country may not be accepted by regulatory authorities in other countries, and regulatory clearance, authorization or approval in one country does not guarantee regulatory clearance, authorization or approval in any other country. For example, the performance characteristics of certain of our products and services may need to be validated separately in specific ethnic and genetic populations. Approval processes vary among countries and can involve additional product testing and validation and additional administrative review periods.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seeking foreign regulatory clearance, authorization or approval could result in difficulties and costs for us and our collaborators and require additional preclinical studies, clinical trials or clinical investigations which could be costly and time-consuming. Regulatory requirements and ethical approval obligations can vary widely from country to country and could delay or prevent the introduction of certain of our products and services in those countries. The foreign regulatory clearance, authorization or approval process involves all of the risks and uncertainties associated with FDA clearance, authorization or approval. ArcherDX currently sells its RUO products outside the United States but has no experience in obtaining regulatory clearance, authorization or approval in international markets other than Japan. If we or our collaborators fail to comply with regulatory requirements in international markets or to obtain and maintain required regulatory clearances, authorizations or approvals in international markets, or if those approvals are delayed, our target market will be reduced and our ability to realize the full market potential of our products and services will be unrealized.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with applicable clinical laboratory licensure requirements may result in a range of enforcement actions, including license suspension, limitation, or revocation, directed plan of action, onsite monitoring, civil monetary penalties, criminal sanctions, and cancellation of the laboratory&#8217;s approval to receive Medicare and Medicaid payment for its services, as well as significant adverse publicity. Any sanction imposed under CLIA, its implementing regulations, or state or foreign laws or regulations governing clinical laboratory licensure, or our failure to renew our CLIA certifications, a state or foreign license, or accreditation, could have a material adverse effect on our business, financial condition and results of operations. Even if we were able to bring our laboratory back into compliance, we could incur significant expenses and potentially lose revenue in doing so.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The College of American Pathologists, or CAP, maintains a clinical laboratory accreditation program. CAP asserts that its program is &#8220;designed to go well beyond regulatory compliance&#8221; and helps laboratories achieve the highest standards of excellence to positively impact patient care. While not required to operate a CLIA-certified laboratory, many private insurers require CAP accreditation as a condition to contracting with clinical laboratories to cover their tests. In addition, some countries outside the United States require CAP accreditation as a condition to permitting clinical laboratories to test samples taken from their citizens. We have CAP accreditations for our laboratories. Failure to maintain CAP accreditation could have a material adverse effect on the sales of our tests and the results of our operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to obtain regulatory clearance or approval of our IVD products, or even if approved, such products may not be approved for guideline inclusion, which could adversely our ability to realize the intended benefits of our recently completed acquisition of ArcherDX.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of ArcherDX&#8217;s commercial strategy, including for STRATAFIDE and PCM, relies on receiving regulatory approvals with guideline inclusion to strengthen its position in establishing coverage and reimbursement of its IVD products with both public and private payers. If we do not receive such regulatory approvals in a timely manner or at all, or we are not successful in obtaining such guideline inclusion, it may not be able to commercialize our IVD products. Additionally, third-party payers may be unwilling to provide sufficient coverage and reimbursement for these products necessary for hospitals and other healthcare providers to adopt our solutions as part of their oncological treatment strategy. ArcherDX has also focused its efforts on the development of PCM for FDA clearance and approval as a prognostic device for predicting recurrence of a primary cancer after initial treatment, which can include surgery alone or surgery plus adjuvant therapy. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, development of the data necessary to obtain regulatory clearance and/or approval of an IVD, such as STRATAFIDE, is time-consuming and carries with it the risk of not yielding the desired results. The performance achieved in published studies may not be repeated in later studies that may be required to obtain FDA clearance and/or approval or regulatory approvals in foreign jurisdictions. Limited results from earlier-stage verification studies may not predict results from studies in larger numbers of subjects drawn from more diverse populations over longer periods of time. Unfavorable results from ongoing preclinical and clinical studies could result in delays, modifications or abandonment of ongoing analytical or future clinical studies, or abandonment of a product development program, or may delay, limit or prevent regulatory approvals or clearances or commercialization of our product candidates, any of which may materially impact our ability to realize the expected benefits of our recently completed acquisition of ArcherDX. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Complying with numerous statutes and regulations pertaining to our business is an expensive and time-consuming process, and any failure to comply could result in substantial penalties.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are subject to other extensive federal, state, local and foreign laws and regulations, all of which are subject to change. These laws and regulations currently include, among others:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, which establishes comprehensive federal standards with respect to the privacy and security of protected health information and requirements for the use of certain standardized electronic transactions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">amendments to HIPAA under HITECH, which strengthen and expand HIPAA privacy and security compliance requirements, increase penalties for violators and expand vicarious liability, extend enforcement authority to state attorneys general, and impose requirements for breach notification;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the GDPR, which imposes strict privacy and security requirements on controllers and processors of personal data, including enhanced protections for &#8220;special categories&#8221; of personal data, including sensitive information such as health and genetic information of data subjects; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the CCPA, which, among other things, regulates how subject businesses may collect, use, and disclose the personal information of consumers who reside in California, affords rights to consumers that they may exercise against businesses that collect their information, and requires implementation of reasonable security measures to safeguard personal information of California consumers; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Anti-Kickback Statute, which prohibits knowingly and willfully offering, paying, soliciting or receiving remuneration, directly or indirectly, overtly or covertly, in cash or in kind, to induce or in return for the referral of an individual, for the furnishing of or arrangement for the furnishing of any item or service for which payment may be made in whole or in part by a federal healthcare program, or the purchasing, leasing, ordering, arranging for, or recommend purchasing, leasing or ordering, any good, facility, item or service for which payment may be made, in whole or in part, under a federal healthcare program; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">EKRA, which prohibits payments for referrals to recovery homes, clinical treatment facilities, and laboratories and reaches beyond federal health care programs, to include private insurance;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal physician self-referral law, known as the Stark Law, which prohibits a physician from making a referral to an entity for certain designated health services covered by the Medicare program, including laboratory and pathology services, if the physician or an immediate family member has a financial relationship with the entity unless an exception applies, and prohibits an entity from billing for designated health services furnished pursuant to a prohibited referral;   </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal false claims law, which imposes liability on any person or entity that, among other things, knowingly presents, or causes to be presented, a false or fraudulent claim for payment to the federal government;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Civil Monetary Penalties Law, which prohibits, among other things, the offering or transfer of remuneration to a Medicare or state healthcare program beneficiary if the person knows or should know it is likely to influence the beneficiary&#8217;s selection of a particular provider, practitioner or supplier of services reimbursable by Medicare or a state healthcare program, unless an exception applies; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the HIPAA fraud and abuse provisions, which create new federal criminal statutes that prohibit, among other things, defrauding health care benefit programs, willfully obstructing a criminal investigation of a healthcare offense and falsifying or concealing a material fact or making any materially false statements in connection with the payment for healthcare benefits, items or services;  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other federal and state fraud and abuse laws, such as anti-kickback laws, prohibitions on self-referral, fee-splitting restrictions, insurance fraud laws, anti-markup laws, prohibitions on the provision of tests at no or discounted cost to induce physician or patient adoption, and false claims acts, which may extend to services reimbursable by any third-party payer, including private insurers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the 21st Century Cures Act information blocking prohibition, which prohibits covered actors from engaging in certain practices that are likely to interfere with the access, exchange, or use of electronic health information;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Physician Payments Sunshine Act and similar state laws that require reporting of certain payments and other transfers of value made by applicable manufacturers, directly or indirectly, to or on behalf of covered recipients including physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals as well as ownership and investment interests held by physicians and their immediate family members. Beginning in 2022, applicable manufacturers also will be required to report such information regarding its relationships with physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and certified nurse midwives during the previous year; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state laws that limit or prohibit the provision of certain payments and other transfers of value to certain covered healthcare providers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prohibition on reassignment of Medicare claims, which, subject to certain exceptions, precludes the reassignment of Medicare claims to any other party; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state laws that prohibit other specified practices, such as billing clinicians for testing that they order; waiving coinsurance, copayments, deductibles and other amounts owed by patients; billing a state Medicaid program at a price that is higher than what is charged to one or more other payers; and  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">similar foreign laws and regulations that apply to us in the countries in which we operate or may operate in the future.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted policies and procedures designed to comply with these laws and regulations. In the ordinary course of our business, we conduct internal reviews of our compliance with these laws. Our compliance may also be subject to governmental review. The growth of our business and our expansion outside of the United States may increase the potential of violating these laws or our internal policies and procedures. The risk of our being found in violation of these or other laws and regulations is further increased by the fact that many have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Any action brought against us for violation of these or other laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business. If our operations are found to be in violation of any of these laws and regulations, we may be subject to any applicable penalty associated with the violation, including significant administrative, civil and criminal penalties, damages, fines, imprisonment, exclusion from participation in Federal healthcare programs, refunding of payments received by us, and curtailment or cessation of our operations. Any of the foregoing consequences could seriously harm our business and our financial results.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare policy changes, including legislation reforming the U.S. healthcare system, may have a material adverse effect on our financial condition, results of operations and cash flows.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, collectively referred to as the Affordable Care Act, was enacted in the United States, which made a number of substantial changes in the way healthcare is financed by both governmental and private insurers. Policy changes or implementation of new health care legislation could result in significant changes to health care systems. In the United States, this could include potential modification or repeal of all or parts of the Affordable Care Act.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2014, Congress passed the Protecting Access to Medicare Act of 2014, or PAMA, which included substantial changes to the way in which clinical laboratory services are paid under Medicare. Under PAMA (as amended by the Further Consolidated Appropriations Act, 2020 and the Coronavirus Aid, Relief, and Economic Security Act, respectively) and its implementing regulations, clinical laboratories must report to CMS private payer rates beginning in 2017, and then in 2022 and every three years thereafter for clinical diagnostic laboratory tests that are not advanced diagnostic laboratory tests and every year for advanced diagnostic laboratory tests.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that our tests meet the definition of advanced diagnostic laboratory tests, but in the event that we seek designation for one or more of our tests as an advanced diagnostic laboratory test and the tests are determined by CMS to meet these criteria or new criteria developed by CMS, we would be required to report private payer data for those tests annually. Otherwise, we will be required to report private payer rates for our tests on an every three years basis starting in 2022. Laboratories that fail to timely report the required payment information may be subject to substantial civil money penalties.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As set forth in the PAMA final rule, for tests furnished on or after January 1, 2018, Medicare payments for clinical diagnostic laboratory tests are paid based upon these reported private payer rates. For clinical diagnostic laboratory tests that are assigned a new or substantially revised code, initial payment rates for clinical diagnostic laboratory tests that are not advanced diagnostic laboratory tests will be assigned by the cross-walk or gap-fill methodology. Initial payment rates for new advanced diagnostic laboratory tests will be based on the actual list charge for the laboratory test. The payment rates calculated under PAMA went into effect starting January 1, 2018. Where applicable, reductions to payment rates resulting from the new methodology are limited to 10% per test per year in each of the years 2018 through 2020. Rates will be held at 2020 levels during 2021, and then, where applicable based upon median private payer rates reported in 2017 or 2022, reduced by up to 15% per test per year in each of 2022 through 2024 (with a second round of private payer rate reporting in 2022 to establish rates for 2023 through 2025).</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PAMA also authorized the adoption of new, temporary billing codes and/or unique test identifiers for FDA-cleared or approved tests as well as advanced diagnostic laboratory tests. The CPT&#174; Editorial Panel approved a proposal to create a new section of billing codes to facilitate implementation of this section of PAMA, but these codes would apply to our tests only if we apply for such codes.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, CMS published a national coverage determination, or NCD, for next generation sequencing, or NGS tests for somatic (acquired) cancer testing.  CMS subsequently updated this NCD in January 2020 to address coverage for NGS tests for germline (inherited) cancer testing and to clarify certain aspects of Medicare&#8217;s coverage of NGS for somatic cancer testing. For somatic cancer testing, the updated NCD establishes full coverage for FDA-approved or FDA-cleared NGS-based companion diagnostic assays that report results using report templates that specify treatment options when offered for their FDA-approved or FDA-cleared use(s), ordered by the patient&#8217;s treating physician for Medicare beneficiaries with advanced cancer (recurrent, relapsed, refractory, metastatic, or advanced stage III or IV cancer) who have not have previously been tested with the same test using NGS for the same cancer genetic content, and have decided to seek further cancer treatment (e.g., therapeutic chemotherapy). The NCD also gives MACs the authority to establish local coverage for NGS-based somatic cancer assays that are not FDA-approved or FDA-cleared companion diagnostics when offered to patients meeting the above-referenced criteria. It appears that NGS-based somatic cancer tests provided for patients with cancer that do not meet the above-referenced criteria, e.g., patients with earlier stage cancers, are currently nationally non-covered under the NCD.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 27, 2020, the NCD also established full coverage for FDA-approved or FDA-cleared NGS-based germline tests that report results using report templates that specify treatment options when ordered by the patient&#8217;s treating physician for patients with ovarian or breast cancer, a clinical indication for germline testing for hereditary breast or ovarian cancer, and a risk factor for germline breast or ovarian cancer, provided the patient has not previously been tested with the same germline test using NGS for the same germline genetic content. The NCD also gives MACs the authority to establish local coverage for NGS-based germline tests for ovarian or breast cancer that are not FDA-approved or FDA-cleared, as well as for NGS-based tests for any other cancer diagnosis (regardless of the test&#8217;s FDA regulatory status) when offered to patients meeting the above-referenced criteria for germline testing. Since we already have local coverage for our germline tests for ovarian and breast cancer, we believe that the NCD will not have a material impact on which of our tests will be reimbursable by CMS for Medicare patients.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict whether future healthcare initiatives will be implemented at the federal or state level, or how any future legislation or regulation may affect us. For instance, the payment reductions imposed by the Affordable Care Act and the expansion of the federal and state governments&#8217; role in the U.S. healthcare industry as well as changes to the reimbursement amounts paid by payers for our tests and future tests or our medical procedure volumes may reduce our profits and have a materially adverse effect on our business, financial condition, results of operations and cash flows. Notably, Congress enacted legislation in 2017 that eliminated the Affordable Care Act&#8217;s &#8220;individual mandate&#8221; beginning in 2019, which may significantly impact the number of covered lives participating in exchange plans. The U.S. Supreme Court is currently reviewing the constitutionality of the Affordable Care Act, although it is unclear when a decision will be made. Moreover, Congress has proposed on several occasions to impose a 20% coinsurance on patients for clinical laboratory tests reimbursed under the clinical laboratory fee schedule, which would increase our billing and collecting costs and decrease our revenue. Further, it is possible that additional governmental action be taken in response to the COVID-19 pandemic.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we use hazardous materials in a manner that causes injury, we could be liable for resulting damages.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our activities currently require the use of hazardous chemicals and biological material. We cannot eliminate the risk of accidental contamination or injury to employees or third parties from the use, storage, handling or disposal of these materials. In the event of contamination or injury, we could be held liable for any resulting damages, and any liability could exceed our resources or any applicable insurance coverage we may have. In 2018, we decommissioned our laboratory in Massachusetts; however, we could be held liable for any damages resulting from our prior use of hazardous chemicals and biological materials at this facility. Additionally, we are subject on an ongoing basis to federal, state and local laws and regulations governing the use, storage, handling and disposal of these materials and specified waste products. The cost of compliance with these laws and regulations may become significant, and our failure to comply may result in substantial fines or other consequences, and either could negatively affect our operating results.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could be adversely affected by violations of the FCPA and other worldwide anti-bribery laws.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the FCPA, which prohibits companies and their intermediaries from making payments in violation of law to non-U.S. government officials for the purpose of obtaining or retaining business or securing any other improper advantage. We are increasing our direct sales and operations personnel outside the United States, in which we have limited experience. We use a limited number of independent distributors to sell our tests internationally, which requires a high degree of vigilance in maintaining our policy against participation in corrupt activity, because these distributors could be deemed to be our agents, and we could be held responsible for their actions. Other U.S. companies in the medical device and pharmaceutical fields have faced criminal penalties under the FCPA for allowing their agents to deviate from appropriate practices in doing business with these individuals. We are also subject to similar anti-bribery laws in the jurisdictions in which we operate, including the United Kingdom&#8217;s Bribery Act of 2010, which also prohibits commercial bribery and makes it a crime for companies to fail to prevent bribery. These laws are complex and far-reaching in nature, and, as a result, we cannot assure you that we would not be required in the future to alter one or more of our practices to be in compliance with these laws or any changes in these laws or the interpretation thereof. Any violations of these laws, or allegations of such violations, could disrupt our operations, involve significant management distraction, involve significant costs and expenses, including legal fees, and could result in a material adverse effect on our business, prospects, financial condition or results of operations. We could also incur severe penalties, including criminal and civil penalties, disgorgement and other remedial measures.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks related to our intellectual property</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">One of ArcherDX&#8217;s competitors has alleged that its Anchored Multiplex PCR, or AMP, chemistry and products using AMP are infringing on its intellectual property, and ArcherDX may be required to redesign the technology, obtain a license, cease using the AMP chemistry altogether and/or pay significant damages, among other consequences, any of which would have a material adverse effect on ArcherDX&#8217;s business as well as our financial condition and results of operations, and the intended benefits of our recently completed acquisition of ArcherDX.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ArcherDX&#8217;s AMP chemistry underlies all of its RUO products and is also the foundation of STRATAFIDE and Personalized Cancer Monitoring, or PCM. On January 27, 2020, one of ArcherDX&#8217;s competitors, Natera, Inc., or Natera, filed a complaint against ArcherDX in the United States District Court for the District of Delaware, alleging that ArcherDX&#8217;s products using AMP chemistry, and the manufacture, use, sale, and offer for sale of such products, infringe U.S. Patent No. 10,538,814. On April 15, 2020, Natera amended its complaint to allege that ArcherDX&#8217;s products using AMP chemistry and the manufacture, use, sale, and offer for sale of such products, infringe U.S. Patent No. 10,538,814, U.S. Patent No. 10,557,172, U.S. Patent No. 10,590,482, and U.S. Patent No. 10,597,708, each of which are held by Natera. On August 6, 2020, Natera filed another complaint against ArcherDX in the United States District Court for the District of Delaware alleging that ArcherDX&#8217;s products using AMP chemistry, and the manufacture, use, sale, and offer for sale of such products, infringe U.S. Patent No. 10,731,220 (together with U.S. Patent Nos. 10,538,814, 10,557,172, 10,590,482, and 10,597,708, the &#8220;Natera Asserted Patents.&#8221;) Natera seeks, among other things, damages and other monetary relief, costs and attorneys&#8217; fees, and an order enjoining ArcherDX from further infringement of The Natera Asserted Patents. On October 13, 2020, the court issued an order denying ArcherDX's motion for dismissal of Natera&#8217;s infringement claims against STRATAFIDE, PCM, and ArcherMET, and declined to enter judgment that U.S. Patent No. 10,538,814, U.S. Patent No. 10,557,172, and U.S. Patent No. 10,590,482 are invalid. On January 12, 2021, the court issued an order granting Natera leave to amend its complaint to add Invitae as a co-defendant and plead allegations that ArcherDX and Invitae induce end-users to infringe the patents-in-suit. Natera filed its Second Amended Complaint on the same day and served Invitae on January 15, 2021. The litigations have now been consolidated for all purposes, are ongoing, and trial has been scheduled for May 2022.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of ArcherDX&#8217;s products or ArcherDX&#8217;s use of AMP chemistry is found to infringe any of the Natera Asserted Patents, it could be required to redesign its technology or obtain a license from Natera to continue developing, manufacturing, marketing, selling and commercializing AMP and its products. However, ArcherDX may not be successful in the redesign of its technology or able to obtain any such license on commercially reasonable terms or at all. Even if ArcherDX were able to obtain a license, it could be non-exclusive, thereby giving Natera and other third parties the right to use the same technologies licensed to ArcherDX, and it could require ArcherDX to make substantial licensing, royalty and other payments. ArcherDX also could be forced, including by court order, to permanently cease developing, manufacturing, marketing and commercializing ArcherDX&#8217;s products that are found to be infringing. In addition, ArcherDX could be found liable for significant monetary damages, including treble damages and attorneys&#8217; fees, if ArcherDX is found to have willfully infringed any of the Natera Asserted Patents. Even if ArcherDX were ultimately to prevail, litigation with Natera could require us to divert substantial financial and management resources that we would otherwise be able to devote to our business.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot reasonably estimate the final outcome, including any potential liability or any range of potential future charges associated with these litigations. However, any finding of infringement by ArcherDX of any of the Natera Asserted Patents could have a material adverse effect on the business of ArcherDX and the benefits we expected to achieve through our acquisition of ArcherDX, as well as our financial condition and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation or other proceedings or third-party claims of intellectual property infringement or misappropriation will require us to spend significant time and money, and could in the future prevent us from selling our tests or impact our stock price.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success will depend in part on our avoiding infringement of patents and proprietary rights of third parties, including for example the intellectual property rights of competitors. As we continue to commercialize our tests in their current or an updated form, launch different and expanded tests, and enter new markets, competitors might claim that our tests infringe or misappropriate their intellectual property rights as part of business strategies designed to impede our successful commercialization and entry into new markets. Our activities may be subject to claims that we infringe or otherwise violate patents or other intellectual property rights owned or controlled by third parties. For example, as discussed in the preceding risk factor, we are currently engaged in litigation with a competitor of ArcherDX alleging infringement. We cannot assure you that our operations do not, or will not in the future, infringe existing or future patents. We may be unaware of patents that a third party, including for example a competitor in the genetic testing market, might assert are infringed by our business. There may also be patent applications that, if issued as patents, could be asserted against us. Third parties making claims against us for infringement or misappropriation of their intellectual property rights may seek and obtain injunctive or other equitable relief, which could effectively block our ability to perform our tests. Further, if a patent infringement suit were brought against us, we could be forced to stop or delay our development or sales of any tests or other activities that are the subject of such suit. Defense of these claims, regardless of merit, could cause us to incur substantial expenses and be a substantial diversion of our employee resources. Any adverse ruling or perception of an adverse ruling in defending ourselves could have a material adverse impact on our business and stock price. In the event of a successful claim of infringement against us by a third party, we may have to (1) pay substantial damages, possibly including treble damages and attorneys&#8217; fees if we are found to have willfully infringed patents; (2) obtain one or more licenses, which may not be available on commercially reasonable terms (if at all); (3) pay royalties; and/or (4) redesign any infringing tests or other activities, which may be impossible or require substantial time and monetary expenditure, all of which could have a material adverse impact on our cash position and business and financial condition.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If licenses to third-party intellectual property rights are or become required for us to engage in our business, we may be unable to obtain them at a reasonable cost, if at all. Even if such licenses are available, we could incur substantial costs related to royalty payments for licenses obtained from third parties, which could negatively affect our gross margins. Moreover, we could encounter delays in the introduction of tests while we attempt to develop alternatives. Defense of any lawsuit or failure to obtain any of these licenses on favorable terms could prevent us from commercializing tests, which could materially affect our ability to grow and thus adversely affect our business and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Developments in patent law could have a negative impact on our business.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we view current U.S. Supreme Court precedent to be aligned with our belief that naturally occurring DNA sequences and detection of natural correlations between observed facts (such as patient genetic data) and an understanding of that fact&#8217;s implications (such as a patient&#8217;s risk of disease associated with certain genetic variations) should not be patentable, it is possible that subsequent determinations by the U.S. Supreme Court or other federal courts could limit, alter or potentially overrule current law. Moreover, from time to time the U.S. Supreme Court, other federal courts, the U.S. Congress or the U.S. Patent and Trademark Office, or USPTO, may change the standards of patentability, and any such changes could run contrary to, or otherwise be inconsistent with, our belief that naturally occurring DNA sequences and detection of natural correlations between observed facts and an understanding of that fact&#8217;s implications should not be patentable, which could result in third parties newly claiming that our business practices infringe patents drawn from categories of patents which we currently view to be invalid as directed to unpatentable subject matter. For example, the U.S. Senate Judiciary Committee, Subcommittee on Intellectual Property held hearings in 2019 regarding a legislative proposal that would overrule current U.S. Supreme Court precedent concerning the scope of patentable subject matter. Our President and Chief Executive Officer, Sean George, appeared before this subcommittee. If such proposal were to be formulated as a bill and enacted into law, there could be an increase in third-party claims to patent rights over correlations between patient genetic data and its interpretation and such third parties may assert that our business practices infringe some of those resulting patent rights.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our inability to effectively protect our proprietary technologies, including the confidentiality of our trade secrets, could harm our competitive position.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently rely upon trade secret protection and copyright, as well as non-disclosure agreements and invention assignment agreements with our employees, consultants and third parties, and to a limited extent patent protection, to protect our confidential and proprietary information. Although our competitors have utilized and are expected to continue utilizing similar methods and have aggregated and are expected to continue to aggregate similar databases of genetic testing information, our success will depend upon our ability to develop proprietary methods and databases and to defend any advantages afforded to us by such methods and databases relative to our competitors. If we do not protect our intellectual property adequately, competitors may be able to use our methods and databases and thereby erode any competitive advantages we may have.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be able to protect our proprietary rights from unauthorized use by third parties only to the extent that our proprietary technologies are covered by valid and enforceable patents or are effectively maintained as trade secrets. In this regard, we have applied, and we intend to continue applying, for patents covering such aspects of our technologies as we deem appropriate. However, we expect that potential patent coverage we may obtain will not be sufficient to prevent substantial competition. In this regard, we believe it is probable that others will independently develop similar or alternative technologies or design around those technologies for which we may obtain patent protection. In addition, any patent applications we file may be challenged and may not result in issued patents or may be invalidated or narrowed in scope after they are issued. Questions as to inventorship or ownership may also arise. Any finding that our patents or applications are unenforceable could harm our ability to prevent others from practicing the related technology, and a finding that others have inventorship or ownership rights to our patents and applications could require us to obtain certain rights to practice related technologies, which may not be available on favorable terms, if at all. If we initiate lawsuits to protect or enforce our patents, or litigate against third-party claims, which would be expensive, and, if we lose, we may lose some of our intellectual property rights. Furthermore, these lawsuits may divert the attention of our management and technical personnel.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to rely primarily upon trade secrets and proprietary know-how protection for our confidential and proprietary information, and we have taken security measures to protect this information. These measures, however, may not provide adequate protection for our trade secrets, know-how or other confidential information. Among other things, we seek to protect our trade secrets and confidential information by entering into confidentiality agreements with employees and consultants. There can be no assurance that any confidentiality agreements that we have with our employees and consultants will provide meaningful protection for our trade secrets and confidential information or will provide adequate remedies in the event of unauthorized use or disclosure of such information. Accordingly, there also can be no assurance that our trade secrets will not otherwise become known or be independently developed by competitors. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret can be difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, trade secrets may be independently developed by others in a manner that could prevent legal recourse by us. If any of our confidential or proprietary information, such as our trade secrets, were to be disclosed or misappropriated, or if any such information was independently developed by a competitor, our competitive position could be harmed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to enforce our intellectual property rights throughout the world.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws of some foreign countries do not protect proprietary rights to the same extent as the laws of the United States, and many companies have encountered significant challenges in establishing and enforcing their proprietary rights outside of the United States. These challenges can be caused by the absence of rules and methods for the establishment and enforcement of intellectual property rights outside of the United States. In addition, the legal systems of some countries, particularly developing countries, do not favor the enforcement of patents and other intellectual property protection, especially those relating to healthcare. This could make it difficult for us to stop the infringement of our patents, if obtained, or the misappropriation of our other intellectual property rights. For example, many foreign countries have compulsory licensing laws under which a patent owner must grant licenses to third parties. In addition, many countries limit the enforceability of patents against third parties, including government agencies or government contractors. In these countries, patents may provide limited or no benefit. Patent protection must ultimately be sought on a country-by-country basis, which is an expensive and time-consuming process with uncertain outcomes. Accordingly, we may choose not to seek patent protection in certain countries, and we will not have the benefit of patent protection in such countries. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business. Accordingly, our efforts to protect our intellectual property rights in such countries may be inadequate. In addition, changes in the law and legal decisions by courts in the United States and foreign countries may affect our ability to obtain adequate protection for our technology and the enforcement of intellectual property.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third parties may assert that our employees or consultants have wrongfully used or disclosed confidential information or misappropriated trade secrets.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ individuals who were previously employed at universities or genetic testing, diagnostic or other healthcare companies, including our competitors or potential competitors. Although we try to ensure that our employees and consultants do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or our employees or consultants have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of a former employer or other third parties. Further, we may be subject to ownership disputes in the future arising, for example, from conflicting obligations of consultants or others who are involved in developing our intellectual property. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks related to being a public company</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We incur increased costs and demands on management as a result of compliance with laws and regulations applicable to public companies, which could harm our operating results.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we incur significant legal, accounting and other expenses, including costs associated with public company reporting requirements. In addition, the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, as well as rules implemented by the SEC and the New York Stock Exchange, or NYSE, impose a number of requirements on public companies, including with respect to corporate governance practices. The SEC and other regulators have continued to adopt new rules and regulations and make additional changes to existing regulations that require our compliance. In addition, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, enacted in 2010, includes significant corporate governance and executive-compensation-related provisions. Our management and other personnel need to devote a substantial amount of time to these compliance and disclosure obligations. If these requirements divert the attention of our management and personnel from other aspects of our business concerns, they could have a material adverse effect on our business, financial condition and results of operations. Moreover, these rules and regulations applicable to public companies substantially increase our legal, accounting and financial compliance costs, require that we hire additional personnel and make some activities more time consuming and costly. It may also be more expensive for us to obtain director and officer liability insurance.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to maintain effective internal control over financial reporting, investors may lose confidence in the accuracy and completeness of our reported financial information and the market price of our common stock may be negatively affected.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to maintain internal control over financial reporting and to report any material weaknesses in such internal controls. Section 404 of the Sarbanes-Oxley Act requires that we evaluate and determine the effectiveness of our internal control over financial reporting and provide a management report on our internal control over financial reporting. If we have a material weakness in our internal control over financial reporting, we may not detect errors on a timely basis and our financial statements may be materially misstated. We have compiled the system and process documentation necessary to perform the evaluation needed to comply with Section 404 of the Sarbanes-Oxley Act. We need to maintain and enhance these processes and controls as we grow and we have required, and may continue to require, additional personnel and resources to do so.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the evaluation and testing process, if we identify one or more material weaknesses in our internal controls, our management will be unable to conclude that our internal control over financial reporting is effective. Our independent registered public accounting firm is required to issue an attestation report on the effectiveness of our internal control over financial reporting every fiscal year. Even if our management concludes that our internal control over financial reporting is effective, our independent registered public accounting firm may conclude that there are material weaknesses with respect to our internal controls or the level at which our internal controls are documented, designed, implemented or reviewed.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to conclude that our internal control over financial reporting is effective, or if our auditors were to express an adverse opinion on the effectiveness of our internal control over financial reporting because we had one or more material weaknesses, investors could lose confidence in the accuracy and completeness of our financial disclosures, which could cause the price of our common stock to decline. Internal control deficiencies could also result in the restatement of our financial results in the future.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks related to our indebtedness</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The terms of our credit agreement require us to meet certain operating and financial covenants and place restrictions on our operating and financial flexibility. If we raise additional capital through debt financing, the terms of any new debt could further restrict our ability to operate our business. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we entered into a credit agreement with Perceptive Credit Holdings II, LP, pursuant to which we borrowed an aggregate principal amount of $135.0 million, or the 2020 Term Loan. The 2020 Term Loan is secured by a first priority lien on all of our and our subsidiaries&#8217; assets (including our intellectual property) and is guaranteed by our subsidiaries, in each case, excluding certain excluded assets and immaterial subsidiaries. If the 2020 Term Loan is prepaid, we may be required to pay a prepayment fee of up to 6% and a make-whole fee, in each case depending on when the prepayment is made. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit agreement restricts our ability to pursue certain mergers, acquisitions, amalgamations or consolidations, other than permitted acquisitions, that we may believe to be in our best interest. In addition, the credit agreement contains financial covenants that require us to maintain a minimum cash balance and minimum quarterly revenue levels. If we default under the credit agreement, the lender will be able to declare all obligations immediately due and payable, including prepayment fees and other obligations. The lender could declare an event of default under the credit agreement upon the occurrence of any event that it interprets as a material adverse change or material adverse effect, each as defined under the credit agreement. Any declaration by the lender of an event of default could significantly harm our business and prospects and could cause the price of our common stock to decline. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we raise any additional debt financing, the terms of such additional debt could further restrict our operating and financial flexibility. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Servicing our debt requires a significant amount of cash, and we may not have sufficient cash flow from our business to pay our substantial debt.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, we issued $350.0 million aggregate principal amount of our Convertible Senior Notes in a private placement and in October 2020 we entered into our credit agreement and borrowed $135.0 million through the 2020 Term Loan. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to make scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the notes, depends on our future performance, which is subject to economic, financial, competitive and other factors beyond our control. Our business may not continue to generate cash flow from operations in the future sufficient to service our debt and make necessary capital expenditures. If we are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as selling assets, restructuring debt or obtaining additional equity capital on terms that may be onerous or highly dilutive. Our ability to refinance our indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities or engage in these activities on desirable terms, which could result in a default on our debt obligations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not have the ability to raise the funds necessary to settle conversions of the Convertible Senior Notes in cash or to repurchase the notes upon a fundamental change, and our current credit agreement contains and our future debt may contain limitations on our ability to pay cash upon conversion or repurchase of the notes.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the notes have the right to require us to repurchase all or any portion of their notes upon the occurrence of a fundamental change at a fundamental change repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest, if any. In addition, upon conversion of the notes, unless we elect to deliver solely shares of our common stock to settle such conversion (other than paying cash in lieu of delivering any fractional share), we will be required to make cash payments in respect of the notes being converted. However, we only have limited ability to make those cash payments under our credit agreement and, even if the credit agreement limitations are no longer in effect, we may not have enough available cash or be able to obtain financing at the time we are required to make repurchases of notes surrendered therefor or notes being converted. In addition, our ability to repurchase the notes or to pay cash upon conversions of the notes may be limited by law, by regulatory authority or by agreements governing our future indebtedness. Our failure to repurchase notes at a time when the repurchase is required by the indenture or to pay any cash payable on future conversions of the notes as required by the indenture would constitute a default under the indenture. A default under the indenture or the occurrence of the fundamental change itself could also lead to a default under our credit agreement and any agreements governing our future indebtedness. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness and to repay or repurchase the notes. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The conditional conversion feature of the Convertible Senior Notes, if triggered, may adversely affect our financial condition and operating results. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event the conditional conversion feature of the notes is triggered, such as was the case for the quarter ending March 31, 2021, holders of notes will be entitled to convert the notes at any time during specified periods at their option. If one or more holders elect to convert their notes, unless we elect to satisfy our conversion obligation by delivering solely shares of our common stock (other than paying cash in lieu of delivering any fractional share), we would be required to settle a portion or all of our conversion obligation through the payment of cash, which could adversely affect our liquidity. In addition, even if holders do not elect to convert their notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The accounting method for convertible debt securities that may be settled in cash, such as the notes, could have a material effect on our reported financial results.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2008, the Financial Accounting Standards Board, or FASB, issued FASB Staff Position No. APB 14-1, Accounting for Convertible Debt Instruments That May Be Settled in Cash Upon Conversion (Including Partial Cash Settlement), which has subsequently been codified as Accounting Standards Codification 470-20, Debt with Conversion and Other Options, or ASC 470-20. Under ASC 470-20, an entity must separately account for the liability and equity components of the convertible debt instruments (such as the notes) that may be settled entirely or partially in cash upon conversion in a manner that reflects the issuer&#8217;s economic interest cost. The effect of ASC 470-20 on the accounting for the notes is that the equity component is required to be included in the additional paid-in capital section of stockholders&#8217; equity on our consolidated balance sheet at issuance, and the value of the equity component would be treated as original issue discount for purposes of accounting for the debt component of the notes. As a result, we are required to record a greater amount of non-cash interest expense in current periods presented as a result of the amortization of the discounted carrying value of the notes to their face amount over the term of the notes. We will report larger net losses or lower net income in our financial results because ASC 470-20 will require interest to include both the current period&#8217;s amortization of the debt discount and the instrument&#8217;s non-convertible coupon interest rate, which could adversely affect our reported or future financial results, the trading price of our common stock and the trading price of the notes.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under certain circumstances, convertible debt instruments (such as the notes) that may be settled entirely or partly in cash are currently accounted for utilizing the treasury stock method, the effect of which is that the shares issuable upon conversion of the notes are not included in the calculation of diluted net income (loss) per share except to the extent that the conversion value of the notes exceeds their principal amount. Under the treasury stock method, for diluted earnings per share purposes, the transaction is accounted for as if the number of shares of common stock that would be necessary to settle such excess, if we elected to settle such excess in shares, are issued. In August 2020, the FASB amended these accounting standards, effective for fiscal years beginning after December 15, 2021, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020, to eliminate the treasury stock method for convertible instruments and instead require application of the &#8216;&#8216;if-converted&#8217;&#8217; method. Under that method, diluted net income (loss) per share would generally be calculated assuming that all the notes were converted solely into shares of common stock at the beginning of the reporting period, unless the result would be anti-dilutive. The application of the &#8216;&#8216;if-converted&#8217;&#8217; method may reduce our reported diluted net income (or further increase our diluted net loss, as the case may be) per share.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General risk factors</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price is volatile, and you may not be able to sell shares of our common stock at or above the price you paid.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our common stock is volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control. These factors include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated fluctuations in our operating results;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition from existing tests or new tests that may emerge;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, collaborations or capital commitments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to meet or exceed financial estimates and projections of the investment community or that we provide to the public;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issuance of new or updated research or reports by securities analysts or changed recommendations for our stock;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our focus on long-term goals over short-term results;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of short interest in our stock, and the effect of short sellers on the price of our stock;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and magnitude of our investments in the growth of our business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated changes in regulatory oversight of our business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additions or departures of key management or other personnel;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes or other developments related to our intellectual property or other proprietary rights, including litigation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in reimbursement by current or potential payers; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic and market conditions; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issuances of significant amounts of our common stock.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the stock market in general, and the market for stock of life sciences companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. Broad market and industry factors, including COVID-19, may seriously affect the market price of our common stock, regardless of our actual operating performance. In addition, in the past, following periods of volatility in the overall market and the market price of a particular company&#8217;s securities, securities class action litigation has often been instituted against these companies. This litigation, if instituted against us, could result in substantial costs and a diversion of our management&#8217;s attention and resources.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts issue an adverse opinion regarding our stock or do not publish research or reports about our company, our stock price and trading volume could decline.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our common stock will depend in part on the research and reports that equity research analysts publish about us and our business. We do not control these analysts or the content and opinions included in their reports. Securities analysts may elect not to provide research coverage of our company and such lack of research coverage may adversely affect the market price of our common stock. The price of our common stock could also decline if one or more equity research analysts downgrade our common stock, change their price targets, issue other unfavorable commentary or cease publishing reports about us or our business. If one or more equity research analysts cease coverage of our company, we could lose visibility in the market, which in turn could cause our stock price to decline.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have never paid dividends on our capital stock, and we do not anticipate paying dividends in the foreseeable future.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never paid dividends on any of our capital stock and currently intend to retain any future earnings to fund the growth of our business. In addition, the terms of our credit agreement restrict our ability to pay dividends. Any determination to pay dividends in the future will be at the discretion of our board of directors and will depend on our financial condition, operating results, capital requirements, general business conditions and other factors that our board of directors may deem relevant. As a result, capital appreciation, if any, of our common stock will be the sole source of gain for the foreseeable future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover provisions in our charter documents and under Delaware law could discourage, delay or prevent a change in control and may affect the trading price of our common stock.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions in our restated certificate of incorporation and our amended and restated bylaws may have the effect of delaying or preventing a change of control or changes in our management. Our restated certificate of incorporation and amended and restated bylaws include provisions that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorize our board of directors to issue, without further action by the stockholders, up to 20,000,000 shares of undesignated preferred stock;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require that any action to be taken by our stockholders be effected at a duly called annual or special meeting and not by written consent;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">specify that special meetings of our stockholders can be called only by our board of directors, our chairman of the board or our chief executive officer;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish an advance notice procedure for stockholder approvals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board of directors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish that our board of directors is divided into three classes, Class I, Class II and Class III, with each class serving staggered terms;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that our directors may be removed only for cause;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that vacancies on our board of directors may, except as otherwise required by law, be filled only by a majority of directors then in office, even if less than a quorum; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require a super-majority of votes to amend certain of the above-mentioned provisions as well as to amend our bylaws generally.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are subject to the provisions of Section 203 of the Delaware General Corporation Law regulating corporate takeovers. Section 203 generally prohibits us from engaging in a business combination with an interested stockholder subject to certain exceptions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our certificate of incorporation designates the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or other employees.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any derivative action or proceeding brought on our behalf;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, or other employees to us or our stockholders;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law; or</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim against us governed by the internal affairs doctrine.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision in our certificate of incorporation will not apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. As a result, the exclusive forum provision in our certificate of incorporation will not apply to suits brought to enforce any duty or liability created by the Securities Act or any other claim for which the federal and state courts have concurrent jurisdiction.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock shall be deemed to have notice of and consented to the provisions of our certificate of incorporation described above. This choice of forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers and other employees. Alternatively, if a court were to find these provisions of our certificate of incorporation inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect our business, financial condition or results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales of a substantial number of shares of our common stock in the public market could cause our stock price to fall. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of a substantial number of shares of our common stock in the public market or the perception that these sales might occur could depress the market price of our common stock and could impair our ability to raise capital through the sale of additional equity securities. As of December 31, 2020, we had outstanding 185.9 million shares of our common stock, options to purchase 4.8 million shares of our common stock (of which 4.4 million were exercisable as of that date), outstanding restricted stock units, or RSUs, representing 6.6 million shares of our common stock (which includes an estimated number of RSUs, subject to certain employee&#8217;s continued service with us, or Time-based RSUs, and RSUs that are performance based RSUs, or PRSUs, granted in connection with an acquisition), outstanding Series A convertible preferred stock convertible into 0.1 million shares of our common stock and warrants to purchase 0.2 million shares of our common stock. The foregoing does not include shares that may be issuable in connection with indemnification hold-backs and contingent consideration related to our acquisitions other than ArcherDX, and up to 22.0 million shares which may be issuable upon the achievement of certain milestones related to our acquisition of ArcherDX, inducement awards issued in connection with an acquisition, or shares that may be issuable in the future in connection with the convertible senior notes. Also not included are the shares issued or issuable in connection with acquisitions after December 31, 2020, including approximately 1.4 million shares of our common stock that we will register for resale following the filing of this Report. The sale or the availability for sale of a large number of shares of our common stock in the public market could cause the price of our common stock to decline. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_19"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B.&#160;&#160;&#160;&#160;Unresolved Staff Comments.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_22"></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;Properties.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our headquarters and main production facility is located in San Francisco, California, where we currently lease and occupy approximately 103,000 square feet of laboratory and office space. The lease for this facility expires in July 2026 and we may renew the lease for an additional ten years.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also lease approximately 330,000 square feet of additional office and laboratory space domestically in California, Colorado, Massachusetts, New York and Washington, and internationally in Australia and Israel.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our facilities are adequate for our current needs and that additional space will be available on commercially reasonable terms if required.</span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_25"></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;Legal Proceedings.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of legal matters as of December 31, 2020, see Note 8, &#8220;Commitments and contingencies&#8221; in Notes to Consolidated Financial Statements in Part II, Item 8 of this report, which is incorporated into this item by reference. </span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_28"></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;Mine Safety Disclosure.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_31"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_34"></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;&#160;&#160;Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock has been publicly traded on the New York Stock Exchange under the symbol &#8220;NVTA&#8221; since February&#160;12, 2015. Prior to that time, there was no public market for our common stock.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;19, 2021, there were 247 stockholders of record of our common stock. The actual number of stockholders is greater than this number of record holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid any cash dividends on our capital stock. We currently intend to retain any future earnings and do not expect to pay any dividends in the foreseeable future. In addition, the terms of the credit agreement restrict our ability to pay dividends. Any determination to pay dividends in the future will be at the discretion of our board of directors and will depend on our financial condition, operating results, capital requirements and general business conditions and other factors that our board of directors may deem relevant.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock performance graph</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information shall not be deemed to be soliciting material or to be filed with the SEC, or subject to Regulations&#160;14A or 14C under the Securities Exchange Act of 1934, or Exchange Act, or to the liabilities of Section&#160;18 of the Exchange Act nor shall such information be incorporated by reference into any future filing under the Securities Act or the Exchange Act, except to the extent that we specifically incorporate it by reference into such filing.</span></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><img src="nvta-20201231_g3.jpg" alt="nvta-20201231_g3.jpg" style="height:435px;margin-bottom:5pt;vertical-align:text-bottom;width:690px"/></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(*)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.45pt">The above graph shows the cumulative total stockholder return of an investment of $100 in cash on December 31, 2015 through December&#160;31, 2020 for: (i)&#160;our common stock; (ii)&#160;the S&amp;P&#160;500 Index; and (iii)&#160;the S&amp;P&#160;500 Healthcare Index. All values assume reinvestment of the full amount of all dividends. The comparisons in the table are not intended to be forecasts or indicative of future stockholder returns.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:38.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.540%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.540%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.540%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2015</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Invitae Corporation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.71&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.60&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.71&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.47&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509.26&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.07&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Healthcare Index</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.64&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.77&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.16&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.60&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.90&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_37"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160; Selected Financial Data.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information set forth below should be read together with &#8220;Item&#160;7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our audited consolidated financial statements and related notes included elsewhere in this report. The selected consolidated balance sheet data at December&#160;31, 2020 and 2019 and the selected consolidated statements of operations data for each of the years ended December&#160;31, 2020, 2019, and 2018 have been derived from our audited consolidated financial statements that are included elsewhere in this report. The selected consolidated balance sheet data at December 31, 2018, 2017 and 2016 and the selected consolidated statement of operations data for the years ended December 31, 2017 and 2016 have been derived from our audited consolidated financial statements not included in this report. Historical results are not necessarily indicative of results to be expected in any future period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Statements of Operations Data:</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Test revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,288&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,351&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,139&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,052&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,598&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,824&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,699&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,048&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,275&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,103&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,105&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,142&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,878&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,317&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,237&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,428&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,417&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,638&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(652,172)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244,112)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,557)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121,279)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100,183)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,568)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,766)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,412)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,030)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,654)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(714,270)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260,415)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132,155)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125,236)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100,256)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,100)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,450)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,800)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,856)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(602,170)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241,965)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,355)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,380)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100,256)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.47)</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.66)</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.94)</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.65)</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.02)</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,587&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,859&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,747&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,512&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,176&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:32.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1,2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Balance Sheet Data:</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,186&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,436&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,727&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,607&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,798&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,430,485&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781,601&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,959&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,078&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,651&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes, net</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,724&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,755&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,454,192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,360,847)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(758,677)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(516,712)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398,598)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(275,218)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379,640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">___________________________________________________________________&#160;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15.37pt">In 2020 we completed the acquisition of four businesses, including ArcherDX, in 2019 we completed the acquisition of three businesses, and in 2017 we completed the acquisition of four businesses, all of which are included in our selected consolidated financial data as of the applicable acquisition date.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15.37pt">On January 1, 2019, we adopted Accounting Standards Codification, or ASC, Topic 842</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">using the modified retrospective transition method as of the adoption date which required the recognition of operating lease right-of-use assets and operating lease liabilities to be recognized on our consolidated balance sheets. Prior period amounts are presented as originally reported based upon the accounting standards in effect for those periods.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15.37pt">On January 1, 2018, we adopted ASC Topic 606 using the modified retrospective transition method. Prior period amounts are presented as originally reported based upon the accounting standards in effect for those periods.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15.37pt">Includes employee stock-based compensation as follows (in thousands):</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:49.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.936%"><tr><td style="width:1.0%"></td><td style="width:37.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.531%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.531%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.531%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.531%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,713&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,563&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,960&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,093&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,353&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,762&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,017&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,158&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,976&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,418&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,641&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,956&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,709&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,854&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,986&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,014&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,661&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,747&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,948&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,850&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,221&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,699&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Note 4, "Business combinations," and Note 10, "Stock incentive plans," in our audited consolidated financial statements included elsewhere in this report for further information regarding our stock-based compensation.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15.37pt">See Note&#160;2, "Summary of significant accounting policies," and Note 12, "Net loss per share," in our audited consolidated financial statements included elsewhere in this report for an explanation of the calculations of our basic and diluted net loss per share.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7.&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes included in Item&#160;8 of this report. Historic results are not necessarily indicative of future results.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business overview</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer high-quality, comprehensive, affordable genetic testing across multiple clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, personalized oncology, metabolic conditions and rare diseases. To augment our offering and realize our mission, we have acquired multiple assets including four businesses in 2020, which expanded our suite of genome management offerings and established a broader entry into oncology therapy selection and personalized cancer monitoring.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we completed the acquisition of ArcherDX, Inc. (&#8220;ArcherDX&#8221;), a genomics company democratizing precision oncology by offering a suite of products and services that are accurate, personal, actionable and easy to use in local settings, thereby empowering clinicians to control the sample, data, patient care and economics. ArcherDX&#8217;s development platform, including its proprietary Anchored Multiplex PCR, or AMP, chemistry at the core, is enabling clinical tests and services that allow for therapy selection and cancer monitoring in community locations for the first time at scale. In addition, applying these assets via biopharma partnerships may enable more efficient development of new cancer therapies, companion diagnostics and result in more productive clinical trial processes. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced rapid growth. For the years ended December&#160;31, 2020, 2019 and 2018, our revenue was $279.6 million, $216.8 million and $147.7 million, respectively and we incurred net losses of $602.2 million, $242.0 million and $129.4 million, respectively. At December&#160;31, 2020, our accumulated deficit was $1.4 billion. To meet the demands of scaling our business, we increased our number of employees to approximately 2,100 at December&#160;31, 2020 from approximately 1,300 at December 31, 2019. Our sales force grew to approximately 300 at December&#160;31, 2020 from approximately 230 at December 31, 2019. We expect headcount will continue to increase as we add staff to support anticipated growth.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of our tests have grown significantly. In 2020, 2019 and 2018, we generated 659,000, 469,000 and 292,000 billable units, respectively. We calculate volume using billable units, which are billable events that include individual test reports released and individual reactions shipped. We refer to the set of reagents needed to perform an NGS test as a "reaction." Through December&#160;31, 2020, 46% of the billable units we performed have been billable to patients, biopharma partners and other business-to-business customers (e.g., hospitals, clinics, medical centers), and the remainder have been billable to third-party payers. Many of the gene tests on our assays are tests for which insurers reimburse. However, when we do not have reimbursement policies or contracts with private insurers, our claims for reimbursement may be denied upon submission, and we must appeal the claims. The appeals process is time consuming and expensive, and may not result in payment. Even if we are successful in achieving reimbursement, we may be paid at lower rates than if we were under contract with the third-party payer. When there is not a contracted rate for reimbursement, there is typically a greater payment requirement from the patient that may result in further delay in payment for these tests.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to incur operating losses for the near term as we continue to invest in our business to achieve our revenue growth objectives, including expansion of our platform to capture the broad potential of genetics across healthcare, and may need to raise additional capital in order to fund our operations. If we are unable to achieve these objectives and successfully manage our costs, we may not be able to achieve profitability in the near term or at all.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the keys to our future growth will be to increase billable volume, achieve broad reimbursement coverage for our tests from third-party payers, drive down the price for genetic analysis and interpretation, steadily increase the amount of genetic content we offer, consistently improve the client experience, drive physician and patient utilization of our website for ordering and delivery of results and increase the number of strategic partners working with us to add value for our clients. We also believe that providing a unique genetic testing platform that is agnostic to stage of life or disease category will deliver unique benefits to customers, payers and other institutions that are seeking to make genetic information a standard element of healthcare decisions in the future.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our test volumes decreased significantly in the second half of March 2020 as compared to the first few months of 2020 as a result of COVID-19 and related limitations and priorities across the healthcare system. Our daily volumes have consistently increased from the low in March 2020, although we are currently still experiencing changes in product mix due to the impact of COVID-19. COVID-19 could have a material impact on our financial results for the foreseeable future, particularly on product mix and as a result, the revenue we recognize. We have reviewed and adjusted for the impact of COVID-19 on our estimates related to revenue recognition and expected credit losses. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the pandemic we have implemented measures to protect the health of all of our employees during this time with additional measures in place to better protect our on-site lab production and support teams. Our production facilities currently remain fully operational. While we have not experienced significant disruption in our supply chain, over the past several months, we have experienced supply delays as a result of the COVID-19 pandemic and have also had to obtain supplies from new suppliers. Although we do not yet know the full impact COVID-19 will have on our supply chain, we have increased our inventory on hand to respond to potential future disruptions that may occur. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many announced healthcare guidelines call for a shift of regular physician visits and healthcare delivery activities to remote/telehealth formats. This is particularly important for patients who, despite the fall-out from COVID-19, continue to be diagnosed with critical diseases, like cancer, and for women who are pregnant or are trying to conceive. We believe our investments in new access platforms and technologies will position us well to provide a range of testing to clinicians and patients using a &#8220;clinical care from afar&#8221; model. An example is our rollout in April 2020 of our Gia telehealth platform, which expands access to remote interaction between patients and clinicians as well as direct ordering of genetic tests. Such access helped to counteract some of the adverse in-office impacts of COVID-19, allowing continuation of key testing categories in a safe environment.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the unknown duration and extent of COVID-19&#8217;s impact on our business, and the healthcare system in general, we are adapting our spending and investment levels to evolving market conditions, including focusing commercial execution on workflows that support remote ordering, online support and telehealth.&#160;Approximately 8% of our workforce as of March 2020 was impacted by a reduction in force in April 2020 in an initiative to manage costs and cash burn, which resulted in one-time costs in the second quarter of 2020 of $3.8 million. In addition, effective May 2020, we reduced the salaries of our named executive officers by approximately 20%, which reductions ceased as of January 2021.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, was signed into law which was a stimulus bill intended to bolster the economy, among other things, and provide assistance to qualifying businesses and individuals. The CARES Act included an infusion of funds into the healthcare system, and in April 2020, we received $3.8&#160;million as a part of this initiative. This payment was recognized as other income (expense), net in our consolidated statement of operations during the year ended December 31, 2020. We also received $2.3&#160;million during January 2021 which we recognized as other income (expense), net during the three months ended March 31, 2021. At this time, we are not certain of the availability, extent or impact of any future relief provided under the CARES Act.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Factors affecting our performance</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Number of billable units</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our centralized test revenue is tied to the number of tests which we bill third-party payers, biopharmaceutical partners, other business-to-business customers (e.g., hospitals, clinics, medical centers), or patients. Our decentralized product revenue is tied to the number of individual reactions we ship biopharma partners and other business-to-business customers. We refer to the set of reagents needed to perform an NGS test as a "reaction," and we refer to billable events that include individual test reports released and individual reactions shipped as billable units. We typically bill for our services following delivery of the billable report derived from testing samples and interpreting the results. For units manufactured for use by customers in distributed facilities, we typically bill customers upon shipment of those units. Test orders are placed under signed requisitions or contractual agreements, as we often enter into contracts with biopharmaceutical partners, other business-to-business customers (e.g., hospitals, clinics, medical centers) and insurance companies that include pricing provisions under which such tests are billed. We incur the expenses associated with a unit in the period in which the unit is processed regardless of when payment is received with respect to that unit. We believe the number of billable units in any period is an important indicator of the growth in our testing business, and with time, this will translate into the number of customers accessing our platform.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Number and size of research and commercial partnerships</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharma development services revenue, which we recognize within other revenue in our consolidated statements of operations, is generated primarily from services provided to biopharmaceutical companies and other partners and is related to companion diagnostic development, clinical research, and clinical trial services across the research, development, and commercialization phases of collaborations. The result of these relationships may include the development of new targeted companion diagnostics, which underscore and expand the need for genetic testing and in some cases may lead to intellectual property and/or revenue sharing opportunities with third-party partners.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to research partnerships, we also seek to grow the number of biopharmaceutical partners and other business-to-business customers (e.g., hospitals, clinics, medical centers) for whom we provide testing technologies, analysis, supplies and expertise to institutions that provide independent testing services to customers in their respective regions.      </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Success obtaining and maintaining reimbursement</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to increase volume and revenue will depend in part on our success achieving broad reimbursement coverage and laboratory service contracts for our tests from third-party payers and agreements with institutions and partners. Reimbursement may depend on a number of factors, including a payer&#8217;s determination that a test is appropriate, medically necessary and cost-effective, as well as whether we are in contract, where we get paid more consistently and at higher rates. Because each payer makes its own decision as to whether to establish a policy or enter into a contract to reimburse for our testing services and specific tests, seeking these approvals is a time-consuming and costly process. In addition, clinicians and patients may decide not to order our tests if the cost of the test is not covered by insurance. Because we require an ordering physician to requisition a test, our revenue growth also depends on our ability to successfully promote the adoption of our testing services and expand our base of ordering clinicians. We believe that establishing coverage and obtaining contracts from third-party payers is an important factor in gaining adoption by ordering clinicians. Our arrangements for laboratory services with payers cover approximately 315 million lives, comprised of Medicare, all national commercial health plans, and Medicaid in most states, including California (Medi-Cal), our home state.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ability to lower the costs associated with performing our tests</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reducing the costs associated with performing our genetic tests is both a focus and a strategic objective of ours. Over the long term, we will need to reduce the cost of raw materials by improving the output efficiency of our assays and laboratory processes, modifying our platform-agnostic assays and laboratory processes to use materials and technologies that provide equal or greater quality at lower cost, improve how we manage our materials, port some tests onto a next generation sequencing platform and negotiate favorable terms for our materials purchases. Our acquisition of Singular Bio, Inc. is a component of this objective and we expect the technology acquired in this transaction, once developed, to help decrease the costs associated with our NIPS offering. We also intend to continue to design and implement hardware and software tools that are designed to reduce personnel-related costs for both laboratory and clinical operations/medical interpretation by increasing personnel efficiency and thus lowering labor costs per test. Finally, we plan to reduce the cost of providing test equipment and software to laboratories and other facilities in the U.S. and internationally. Those efforts are designed to enable more rapid expansion of genetic testing and patient access, enlarging our geographic footprint outside the U.S. while achieving lower costs.   </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ability to expand our genetic content and create new pathways to test</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our focus on reducing the average cost per test will have a countervailing force &#8212; increasing the number of tests we offer, the content of each test and the means to connect our testing services with patients and physicians. We intend to continue to expand our test menus by steadily releasing additional genetic content for the same or lower prices per test, ultimately leading to affordable whole genome services. The breadth and flexibility of our offering will be a critical factor in our ability to address new markets, including internationally, for genetic testing services. Both of these, in conjunction with our continued focus on strategic partnerships, will be important to our ability to continue to grow the volume of billable tests we deliver.  We have and will continue to identify new ways to connect our testing services and information to patients.  These include direct patient outreach and ordering capacity, the use of automated assistants for physician customers to assist with the ease of ordering and processing genetic tests and programs designed to reach underserved patient populations with genetic testing.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment in our business and timing of expenses</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to continue to invest in our genetic testing and information management business. We deploy state-of-the-art technologies in our genetic testing services, and we intend to continue to scale our infrastructure, including our testing capacity and information systems. We also expect to incur software development costs as we seek to further automate our laboratory processes and our genetic interpretation and report sign-out procedures, scale our customer service capabilities to improve our customers' experience, and expand the functionality of our website. We also expect to incur costs as we seek to provide the testing equipment and software necessary to enable decentralized genetic and genomic testing in the U.S. and internationally. We will incur costs related to marketing and branding as we spread our initiatives beyond our current customer base and focus on providing access to customers through our website. We plan to hire additional personnel as necessary to support anticipated growth, including software engineers, sales and marketing personnel, billing personnel, research and development personnel, medical specialists, biostatisticians and geneticists. We will also incur additional costs related to the expansion of our production facilities to accommodate growth and as we expand internationally. In addition, we expect to incur ongoing expenses as a result of operating as a public company. The expenses we incur may vary significantly by quarter as we focus on building out different aspects of our business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">How we recognize revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally recognize revenue on an accrual basis, which is when a customer obtains control of the promised goods or services, typically a test report. Accrual amounts recognized are based on estimates of the consideration that we expect to receive, and such estimates are adjusted and subsequently recorded until fully settled. Changes to such estimates may increase or decrease revenue recognized in future periods. Revenue from our tests may not be equal to billed amounts due to a number of factors, including differences in reimbursement rates, the amounts of patient payments, the existence of secondary payers and claim denials. Some test orders are placed under signed requisitions or contractual agreements, and we often enter into contracts with biopharmaceutical partners, other business-to-business customers (e.g., hospitals, clinics, medical centers) and insurance companies that include pricing provisions under which such tests are billed.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharma development service revenues are generated primarily from custom assay design services, sample processing activities and consultative inputs, which is separate from revenue generated by any related or unrelated product component. Revenue is recognized as samples are processed or scope of work is completed based on contracted agreements with those biopharmaceutical customer companies.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these collaborations we also generate revenue from achievement of milestones, provision of on-going support, and related pass-through costs and fees. We generally have distinct performance obligations for development milestones related to our development of a companion diagnostic device. We use a cost plus a margin approach to estimate the standalone value of our companion diagnostic development service performance obligations. Revenue is recognized over time using input or output methods based on our assessments of performance completed to date toward each milestone.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial overview</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily generate revenue from testing services and sales of distributed precision oncology products. Customers are typically billed upon delivery of test results or shipment of products. We also generate revenue from development agreements with biopharmaceutical customers. Our ability to increase our revenue will depend on our ability to increase our market penetration, obtain FDA and other international regulatory authority approvals on future products and services offerings, obtain contracted reimbursement coverage from third-party payers, and grow our relationships with biopharmaceutical customers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue reflects the aggregate costs incurred in delivering our products and services and includes expenses for materials and supplies, personnel-related costs, freight, costs for lab services and clinical trial support, equipment and infrastructure expenses and allocated overhead including rent, information technology, equipment depreciation, amortization of acquired intangibles, and utilities. We expect cost of revenue to generally increase in line with the increase in billable volume, however, we expect a future increase in amortization of acquired intangible assets that is not dependent on billed volume. We anticipate our cost per unit for existing tests will generally decrease over time due to the efficiencies we expect to gain as volume increases and from automation and other cost reductions. These reductions in cost per unit will likely be offset by new offerings which often have a higher costs per unit during the introductory phases before we are able to gain efficiencies. The cost per unit may fluctuate significantly from quarter to quarter. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating expenses</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating expenses are classified into three categories: research and development, selling and marketing, and general and administrative. For each category, the largest component is generally personnel-related costs, which include salaries, employee benefit costs, bonuses, commissions, as applicable, and stock-based compensation expense.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses represent costs incurred to develop our technology and future offerings. These costs are principally for process development associated with our efforts to expand the number of genes we can evaluate, our efforts to lower the costs per unit and our development of new products to expand our platofrm. In addition, we incur process development costs to further develop the software we use to operate our laboratories, analyze generated data, process customer orders, validate clinical activities, enable ease of customer ordering, deliver reports and automate our business processes. These costs consist of personnel-related costs, including stock-based compensation, laboratory supplies and equipment expenses, consulting costs, amortization of acquired intangible assets, and allocated overhead including rent, information technology, equipment depreciation and utilities.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense all research and development costs in the periods in which they are incurred. We expect our research and development expenses to increase as we continue our efforts to develop additional offerings, make investments to reduce costs, streamline our technology to provide patients access to testing, scale our business domestically and internationally and acquire and integrate new technologies, including those acquired through our acquisition of ArcherDX.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During June 2019 through our acquisition of Singular Bio, we recognized $30.0&#160;million of in-process R&amp;D technology using an income approach. This technology is estimated to be developed in 2021 with significant development costs incurred during the second half of 2019 through 2020 and expected through development completion. If not completed timely, the ability to lower the cost of our NIPS offering may be delayed. During October 2020 through our acquisition of ArcherDX, we recognized $512.4&#160;million of in-process R&amp;D technology for two assets representing STRATAFIDE and Personalized Cancer Monitoring, or PCM, technologies, both using an income approach. We estimate these technologies to be developed in the next few years with significant development costs through completion. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and marketing</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling and marketing expenses consist of personnel-related costs, including commissions, client service expenses, advertising and marketing expenses, educational and promotional expenses, market research and analysis, and allocated overhead including rent, information technology, equipment depreciation, amortization of acquired intangibles, and utilities. We expect our selling and marketing expenses to increase as we continue to build our brand and focus on advertising our products and services.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses include executive, finance and accounting, billing and collections, legal and human resources functions as well as other administrative costs. These expenses include personnel-related costs; audit, accounting and legal expenses; consulting costs; allocated overhead including rent, information technology, equipment depreciation, and utilities; costs incurred in relation to our co-development agreements; changes in the fair value of contingent consideration related to our acquisitions; and post-combination expenses incurred in relation to companies we acquire. We expect our general and administrative expenses to increase as we support continued growth of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other expense, net</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net, primarily consists of adjustments to the fair value of our stock payable liabilities arising from business combinations, and we expect it to fluctuate significantly from period to period due to the volatility of our common stock. Other expense, net also includes income generated from our cash equivalents and marketable securities and amounts received under the CARES Act.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense is primarily attributable to interest incurred related to our debt financings and finance leases. See Note 8, &#8220;Commitments and contingencies&#8221; in Notes to Consolidated Financial Statements in Part II, Item 8 of this Annual Report for more details.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income tax benefit</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since we generally establish a full valuation allowance against our deferred tax balances, our income tax benefit primarily consists of tax impacts of our deferred income tax assessments resulting from our acquisitions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting policies and estimates</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles, or U.S.&#160;GAAP. The preparation of these financial statements requires us to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenue generated and expenses incurred during the reporting periods. We evaluate our estimates on an ongoing basis. Our estimates are based on current facts, our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions and any such differences may be material. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management&#8217;s judgments and estimates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. All revenues are generated from contracts with customers. We utilize the following practical expedients and exemptions:</span></div><div style="margin-top:3pt;padding-left:49.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Costs to obtain or fulfill a contract are expensed when incurred because the amortization period would have been one year or less, and</span></div><div style="margin-top:3pt;padding-left:49.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">No adjustments to promised consideration were made for financing as we expect, at contract inception, that the period between the transfer of a promised good or service and when the customer pays for that good or service will be one year or less.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Test revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Test revenue is comprised of testing services and sales of distributed precision oncology products. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our test revenue is generated from genetic testing, in addition to somatic testing for therapy selection and personalized cancer monitoring. These testing services provide analysis and associated interpretation of the sequencing of parts of the genome. Test orders are placed under signed requisitions or contractual agreements, and we often enter into contracts with biopharmaceutical partners, other business-to-business customers (e.g., hospitals, clinics, medical centers) and insurance companies that include pricing provisions under which such tests are billed. Billing terms are generally net 30 to 60 days.  </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the transaction price of diagnostic tests is originally established either via contract or pursuant to our standard list price, we often provide concessions for tests billed to insurance carriers, and therefore the transaction price for patient insurance-billed tests is considered to be variable and revenue is recognized based on an estimate of the consideration to which we will be entitled at an amount for which it is probable that a reversal of cumulative consideration will not occur. Making these estimates requires significant judgments based upon such factors as length of payer relationship, historical payment patterns, changes in contract provisions and insurance reimbursement policies. These judgments are reviewed each reporting period and updated as necessary.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We look to transfer of control in assessing timing of recognition of revenue in connection with each performance obligation. In general, revenue in connection with the service portion of our diagnostic tests is recognized upon delivery of the underlying clinical report or when the report is made available on our web portal. Outstanding performance obligations pertaining to orders received but for which the underlying report has not been issued are generally satisfied within a 30-day period. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also generate test revenue through the sale of our precision oncology products, which is comprised primarily of sales of our distributed RUO and IVD products for therapy selection. We recognize revenue on these sales once shipment has occurred. Product sales are recorded net of discounts and other deductions. Billing terms are generally net 30 days. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling fees billed to customers are classified on the consolidated statements of operations and comprehensive loss in revenue. The associated shipping and handling costs are classified in cost of revenue.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue is primarily generated from pharma development services provided to biopharmaceutical companies related to companion diagnostic development as well as through collaboration agreements and genome network contracts.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts for companion diagnostic development consist primarily of milestone-based payments along with annual fees and marked-up pass-through costs. The arrangements are treated as short-term contracts for revenue recognition purposes because they allow termination of the agreements by the customers with 30 to 120 days&#8217; written notice without a termination penalty. Upon termination, customers are required to pay for the proportion of services provided under milestones that were in progress. We recognize revenue in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. We recognize revenue over time based on the progress made toward achieving the performance obligation, utilizing both input or output methods, depending on the performance obligation, including labor hours expended, tests processed, or time elapsed, that measure our progress toward the achievement of the milestone.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We also enter into collaboration and genome network contracts. Collaboration agreements provide customers with diagnostic testing and related data aggregation reporting services that are provided over the contract term. Collaboration revenue is recognized as the data and reporting services are delivered to the customer. Genome network offerings consist of subscription services related to a proprietary software platform designed to connect patients, clinicians, advocacy organizations, researchers and therapeutic developers to accelerate the understanding, diagnosis and treatment of hereditary disease. Such services are recognized on a straight-line basis over the subscription periods. Amounts due under collaboration and genome network agreements are typically billable on net 30-day terms.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC 805,&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires recognition of assets acquired, liabilities assumed, and contingent consideration at their fair value on the acquisition date with subsequent changes recognized in earnings; requires acquisition-related expenses and restructuring costs to be recognized separately from the business combination and expensed as incurred; requires in-process research and development to be capitalized at fair value as an indefinite-lived intangible asset until completion or abandonment; and requires that changes in accounting for deferred tax asset valuation allowances and acquired income tax uncertainties after the measurement period be recognized as a component of provision for taxes.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for acquisitions of entities that include inputs and processes and have the ability to create outputs as business combinations. The tangible and identifiable intangible assets acquired and liabilities assumed in a business combination are recorded based on their estimated fair values as of the business combination date, including identifiable intangible assets which either arise from a contractual or legal right or are separable from goodwill. We base the estimated fair value of identifiable intangible assets acquired in a business combination on third-party valuations that use information and assumptions provided by our management, which consider our estimates of inputs and assumptions that a market participant would use. Any excess purchase price over the estimated fair value assigned to the net tangible and identifiable intangible assets acquired and liabilities assumed is recorded to goodwill. The use of alternative valuation assumptions, including estimated revenue projections, growth rates, estimated cost savings, cash flows, discount rates, estimated useful lives and probabilities surrounding the achievement of contingent milestones could result in different purchase price allocations and amortization expense in current and future periods.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In circumstances where an acquisition involves a contingent consideration arrangement that meets the definition of a liability under ASC Topic 480, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities from Equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We remeasure this liability each reporting period and record changes in the fair value as a component of operating expenses.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs associated with acquisitions are expensed as incurred in general and administrative expenses. Results of operations and cash flows of acquired companies are included in our operating results from the date of acquisition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 350,&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASC 350, we do not amortize goodwill or other intangible assets with indefinite lives but rather test them for impairment.&#160;ASC 350 requires us to perform an impairment review of our goodwill balance at least annually, which we do in the fourth quarter of each year for our single consolidated reporting unit, and whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. We did not incur any goodwill impairment losses in any of the periods presented.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incur stock-based compensation expense for awards granted to employees and directors and for inducement awards granted in connection with our business acquisitions. Stock-based compensation expense is measured at the date of grant and is based on the estimated fair value of the award. Compensation cost is recognized as expense on a straight-line basis over the vesting period for options and restricted stock unit, or RSU, awards and on an accelerated basis for performance-based restricted stock unit, or PRSU, awards. We recognize stock-based compensation expense associated with PRSU grants when we determine the achievement of performance conditions is probable. In determining the fair value of stock options and Employee Stock Purchase Plan, or ESPP, purchases, we estimate the grant date fair value, and the resulting stock-based compensation expense, using the Black-Scholes option-pricing model. We estimate the grant date fair value of RSU and PRSU awards based on the grant date share price.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option-pricing model requires the use of highly subjective assumptions, which determine the fair value of stock-based awards. These assumptions include:</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected term</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The expected term represents the period that stock-based awards are expected to be outstanding. We use the simplified method to determine the expected term, which is based on the mid-point between the vesting date and the end of the contractual term.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected volatility</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;We estimate expected volatility based on the historical volatility of our common stock over a period equal to the expected term of awards and over the expected six-month term ESPP purchase periods.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-free interest rate</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of an option.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend yield</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;We have never paid dividends on our common stock and have no plans to pay dividends on our common stock. Therefore, we used an expected dividend yield of zero.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Black-Scholes assumptions, we estimate our forfeiture rate based on an analysis of our actual forfeitures and will continue to evaluate the adequacy of the forfeiture rate based on actual forfeiture experience, analysis of employee turnover behavior and other factors. The impact from any forfeiture rate adjustment would be recognized in full in the period of adjustment and if the actual number of future forfeitures differs from our estimates, we might be required to record adjustments to stock-based compensation in future periods.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. Significant judgment is required in determining the net valuation allowance which includes our evaluation of all available evidence including past operating results, estimates on future taxable income and acquisition-related tax assets and liabilities. As of December&#160;31, 2020, we recorded a full valuation allowance on our net deferred tax assets because we expect that it is more likely than not that our deferred tax assets will not be realized in the foreseeable future. Should the actual amounts differ from our estimates, the amount of our valuation allowance could be materially impacted.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A discussion regarding our financial condition and results of operations for the year ended December&#160;31, 2020 compared to the year ended December 31, 2019 is presented below. A discussion regarding our financial condition and results of operations for the year ended December 31, 2019 compared to the year ended December 31, 2018 can be found under Part II, Item 7 in our Annual Report on Form 10-K for the year ended December 31, 2019.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Years Ended December&#160;31, 2020 and 2019 </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.844%"><tr><td style="width:1.0%"></td><td style="width:53.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.887%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dollar Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Test revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,598&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,824&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,774&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(652,172)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244,112)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408,060)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,441)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,766)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,354)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(714,270)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260,415)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(453,855)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,450)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,650)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(602,170)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241,965)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(360,205)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149%</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in revenue of $62.8 million for the year ended December&#160;31, 2020 compared to the same period in 2019 was due primarily to increased billable volume from growth in our business as well as the contribution from businesses acquired in 2020, including ArcherDX in the fourth quarter of 2020. Billable units increased to approximately 659,000 during the year ended December&#160;31, 2020 compared to 469,000 in the same period in 2019, an increase of 41%. Average revenue per unit decreased to $413 during the year ended December&#160;31, 2020 compared to $453 in the same period in 2019, primarily due to changes in payer and product mix, the impact of the businesses acquired during 2020, particularly ArcherDX, as well as reductions in pricing for some payers as we focus on providing cost effective genetic testing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the cost of revenue of $80.2 million for the year ended December&#160;31, 2020 compared to the same period in 2019 was primarily due to costs associated with increased billable volume and the added costs related to businesses acquired in 2020, partially offset by the effect of cost efficiencies. For the year ended December&#160;31, 2020, the number of units billed increased to approximately 659,000 from approximately 469,000 for the same period in 2019. Cost per billable unit was $299 in 2020 compared to $252 in 2019. The cost per unit increased primarily due to an increase in amortization of acquired intangible assets by $17.5 million as well as increased stock-based compensation by $4.2 million. The increase in the cost per unit was also due to changes in product mix, including the impact of the cost per unit of ArcherDX, as well as the influence of COVID-19. The increases were partially offset by production improvements that resulted in material efficiencies and automation and software improvements which reduced the medical interpretation time per report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in research and development expense of $99.1 million for the year ended December&#160;31, 2020 compared to the same period in 2019 was due to growth in the business and the effect of business acquisitions in 2020 and principally consisted of increases in personnel-related costs by $87.7 million, reflecting increased headcount as well as a $39.3 million increase in stock-based compensation; an increase in general lab expenses by $8.4 million; an increase in information technology costs by $4.8 million due to increased spending on networking equipment and software licenses; an increase by $4.7 million in professional fees; an increase by $2.4 million of depreciation and amortization; and an increase by $1.9 million in occupancy expenses. These cost increases were partially offset by a net increase of $9.6 million in allocations of resources from research and development to cost of revenue to support the increase in production volumes as well as a decrease in travel-related costs by $1.3 million due to a reduction in travel as a result of COVID-19.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and marketing</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in selling and marketing expenses of $46.1 million for the year ended December&#160;31, 2020 compared to the same period in 2019 was due to growth in the business and the effect of business acquisitions in 2020 and principally consisted of the following elements: an increase in personnel costs by $40.6 million due to increases in headcount; an increase by $3.7 million in allocations from other functional areas; an increase in marketing costs, principally for branding initiatives and advertising, by $2.0 million; an increase in information technology costs by $1.4 million; an increase in professional fees by $1.2 million; and an increase in depreciation and amortization by $1.2 million. These cost increases were partially offset by a decrease in travel expenses of $4.1 million due to a reduction in travel as a result of COVID-19.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in general and administrative expenses of $245.5 million for the year ended December&#160;31, 2020 compared to the same period in 2019 was primarily due to the growth of the business and the effect of business acquisitions in 2020 and principally consisted of the following elements: an increase in acquisition-related expense by $140.1 million, which includes $125.8 million of post-combination expense related to the acceleration of unvested equity from our acquisition of ArcherDX; an increase in fair value adjustments to contingent consideration by $54.4 million, primarily related to the development milestones for ArcherDX; an increase in personnel-related costs by $46.5 million primarily due to increases in headcount; an increase in legal and accounting costs by $5.2 million; an increase in information technology costs by $2.7 million due primarily to computer equipment and software purchases to support headcount growth; and an increase in depreciation and amortization by $0.9 million.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These cost increases were offset by increased allocations of technology and facilities-related expenses to other functional areas of $7.1&#160;million.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other expense, net</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in other expense, net of $28.4 million for the year ended December&#160;31, 2020 compared to the same period in 2019 was principally due to fair value adjustments related to our stock payable liabilities of $37.5 million due to the increase in the price of our common stock partially offset by a reduction of debt extinguishment costs of $8.9 million incurred in September 2019 with no similar expense in 2020, $3.8 million received under the CARES Act during 2020, and decreases in interest income from our cash equivalents and marketable securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in interest expense of $17.4 million for the year ended December&#160;31, 2020 compared to the same period in 2019 was due principally to increased borrowings under our debt facilities as compared to the prior year period.&#160;See Note 8, &#8220;Commitments and contingencies&#8221; in Notes to Consolidated Financial Statements in Part II, Item 8 of this Annual Report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax benefit</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in income tax benefit of $93.7 million for the year ended December&#160;31, 2020 compared to the same period in 2019 was due to net deferred tax liabilities assumed in connection with our acquisitions of YouScript Incorporated and ArcherDX which provided a future source of income to support the realization of our deferred tax assets and resulted in a partial release of our valuation allowance. As the short period tax returns for our 2020 acquisitions have not yet been filed, material changes to the tax returns may have a material impact on the net deferred tax liabilities assumed in connection with the acquisitions and the related income tax benefit. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and capital resources</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and capital expenditures</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred net losses since our inception. For the years ended December&#160;31, 2020, 2019 and 2018, our net losses were $602.2 million, $242.0 million and $129.4 million, respectively, and we expect to incur additional losses in the future. At December&#160;31, 2020, we had an accumulated deficit of $1.4 billion. While our revenue has increased over time, we may never achieve revenue sufficient to offset our expenses.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, our operations have been financed primarily by fees collected from our customers, net proceeds from sales of our capital stock as well as borrowing from debt facilities and the issuance of Convertible Senior Notes.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, we issued, in an underwritten public offering, an aggregate of 10.4 million shares of our common stock at a price of $19.00 per share, for gross proceeds of $196.7 million and net proceeds of $184.5 million. During 2019, we issued 0.8 million shares of common stock at an average price of $25.71 per share in "at the market" offerings for aggregate proceeds of $20.2 million and net proceeds of $19.5 million. In April 2020, we issued, in an underwritten public offering, an aggregate of 20.4 million shares of our common stock at a price of $9.00 per share, for gross proceeds of $184.0 million and net proceeds of approximately $173.0 million. In 2020, we issued approximately 3.6 million shares of common stock at an average price of $26.33 per share in an "at the market" offering for aggregate proceeds of $93.7 million and net proceeds of $90.7 million. In January 2021, we issued, in an underwritten public offering, an aggregate of 8.9 million shares of our common stock at a price of $51.50 per share, for gross proceeds of $460.0&#160;million and net proceeds of approximately $434.3&#160;million. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, we issued $350.0 million of aggregate principal amount of Convertible Senior Notes, which bear cash interest at a rate of 2.0% per year. Also in September 2019, we used the funds received through the issuance of our Convertible Senior Notes to settle our Note Purchase Agreement we entered into in November 2018.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020 in connection with our acquisition of ArcherDX, we issued $275.0 million of our common stock in a private placement at a price of $16.85 per share to a syndicate of life sciences investors. We also entered into a credit facility to borrow $135.0 million. The private placement and credit facility closed concurrently with the merger in October 2020. In connection with the credit facility, we issued warrants to purchase 1.0 million shares of our common stock at an exercise price of $16.85 per share which were exercised in October 2020 on a net exercise basis. The terms of this credit facility restrict our ability to incur certain indebtedness, pay dividends, make acquisitions and take other actions.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 and 2019, we had $360.7 million and $398.0 million, respectively, of cash, cash equivalents, restricted cash and marketable securities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary uses of cash are to fund our operations as we continue to grow our business, enter into partnerships and acquire businesses and technologies. Cash used to fund operating expenses is affected by the timing of when we pay expenses, as reflected in the change in our outstanding accounts payable and accrued expenses. We estimate our capital expenditures will be approximately $30.0 million for 2021.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We&#160;have incurred substantial losses since inception, and we expect to continue to incur losses in the future. We believe our existing cash, cash equivalents and marketable securities as of December&#160;31, 2020 and fees collected from the sale of our tests will be sufficient to meet our anticipated cash requirements&#160;for the foreseeable future.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may need additional funding to finance operations prior to achieving profitability or should we make additional acquisitions. We regularly consider fundraising opportunities and will determine the timing, nature and size of future financings based upon various factors, including market conditions and our operating plans.&#160;We may in the future elect to finance operations by selling equity or debt securities or borrowing money. We also may elect to finance future acquisitions. If we issue equity securities, dilution to stockholders may result. Any equity securities issued may also provide for rights, preferences or privileges senior to those of holders of our common stock. If we raise funds by issuing additional debt securities, these debt securities would have rights, preferences and privileges senior to those of holders of our common stock. In addition, the terms of additional debt securities or borrowings could impose significant restrictions on our operations. If additional funding is required, there can be no assurance that additional funds will be available to us on acceptable terms on a timely basis, if at all. If we are unable to obtain additional funding when needed, we may need to curtail planned activities to reduce costs. Doing so will likely have an unfavorable effect on our ability to execute on our business plan and have an adverse effect on our business, results of operations and future prospects.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.844%"><tr><td style="width:1.0%"></td><td style="width:63.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.210%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended&#160;December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used in operating activities</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298,502)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145,053)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92,220)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400,583)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280,310)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by financing activities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672,993&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464,771&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,152&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,092)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,705&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash flows from operating activities</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, cash used in operating activities was $298.5 million and principally resulted from our net loss of $602.2 million and $112.1 million related to our income tax benefit generated from business combinations completed in 2020 partially offset by non-cash charges of $158.7 million for stock-based compensation, $92.3 million in remeasurements of liabilities associated with business combinations such as contingent consideration, $91.0 million related to post-combination expense due to the acceleration of unvested equity in the acquisition of ArcherDX, $39.1 million for depreciation and amortization, $17.2 million of amortization of debt discount and issuance costs and $1.4 million of other adjustments. The net effect on cash for changes in net operating assets was an inflow of cash of $16.0 million due principally to increases in accounts payable and accrued liabilities partially offset by increases in inventory and accounts receivable due to timing of collections.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2019, cash used in operating activities of $145.1 million principally resulted from our net loss of $242.0 million and $18.5 million related to our income tax benefit generated from business combinations completed in 2019 offset by non-cash charges of $75.9 million for stock-based compensation, $16.2 million for depreciation and amortization, $8.9 million for debt extinguishment costs related to the settlement of our 2018 Note Purchase Agreement and $1.1 million of other adjustments. The net effect on cash for changes in net operating assets was a use of cash of $8.8 million due principally to increases in accrued liabilities which include acquisition-related liabilities for 2019 business acquisitions partially offset by increases in accounts receivable due to timing of collections and increases in prepaid expenses and other current assets.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2018, cash used in operating activities of $92.2 million principally resulted from our net loss of $129.4 million offset by non-cash charges of $20.9 million for stock-based compensation, $13.5 million for depreciation and amortization, $5.3 million related to debt extinguishment costs, $2.9 million of impairment losses related to a collaboration agreement, $0.8 million of other non-cash adjustments and $0.4 million for remeasurements of liabilities associated with business combinations, all partially offset by a $2.9 million benefit from income taxes resulting from the completion of our analysis of historical net operating losses for CombiMatrix Corporation. The net effect on cash of changes in net operating assets was a use of cash of $3.8 million due principally to the effect of increase in accounts receivable due to timing of collections partially offset by an increase in accrued and other liabilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash flows from investing activities</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, cash used in investing activities of $400.6 million was primarily related to net cash used to acquire Orbicule BV ("Diploid"), Genelex, YouScript and ArcherDX of $383.8 million, purchases of property and equipment of $22.9 million, and other cash outflows of $4.0 million, all partially offset by net sales and maturities of marketable securities of $10.1 million. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2019, cash used in investing activities of $280.3 million resulted primarily from purchases of marketable securities exceeding proceeds from maturities and sales of marketable securities by $226.4 million, net cash used to acquire Singular Bio, Jungla Inc., and Clear Genetics, Inc. of $33.8 million and purchases of property and equipment of $20.0 million.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2018, cash provided by investing activities of $35.8 million resulted primarily from proceeds from maturities and sales of marketable securities exceeding purchases of marketable securities by $42.7 million and purchases of property and equipment of $6.0 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash flows from financing activities</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, cash provided by financing activities of $673.0 million consisted of cash received from issuances of common stock totaling $284.2 million, including cash received from shares issued through a private placement in October 2020 upon the close of the ArcherDX acquisition, exercises of stock options and employee stock plan purchases; net proceeds from the public offerings of common stock of $263.7 million; and net proceeds from debt financings of $129.2 million. These cash inflows were partially offset by other cash outflows of $4.1 million.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2019, cash provided by financing activities of $464.8 million consisted of net proceeds from the issuance of Convertible Senior Notes of $339.9 million, net proceeds from the public offerings of common stock of $204.0 million and cash received from issuances of common stock totaling $9.5 million, including cash received from exercises of stock options of $3.5 million and employee stock plan purchases of $5.8 million. These cash inflows were partially offset by payments related to the settlement of our Note Purchase Agreement through repayment of loan obligations of $75.0 million and payment of debt extinguishment costs of $10.6 million, as well as finance lease payments of $2.1 million.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2018, cash provided by financing activities of $157.2 million consisted of net proceeds from the public offerings of common stock of $112.4 million, net proceeds of $93.9 million from the second term loan under the Amended 2017 Loan Agreement and from the 2018 Note Purchase Agreement, and cash received from issuances of common stock totaling $17.5 million (which includes $6.5 million received from exercises of warrants issued pursuant to the acquisition of CombiMatrix, $5.0 million received pursuant to the Securities Purchase Agreement entered into in connection with our 2018 Note Purchase Agreement, employee stock purchases of $3.2 million, and stock option exercises of $2.7 million). These cash inflows were partially offset by loan payments of $60.0 million to extinguish our 2017 Loan Agreement, payments of $4.6 million related to the extinguishment of our 2017 Loan Agreement and related amendments and capital lease payments of $2.1 million.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contractual obligations, including interest, as of December&#160;31, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.557%"><tr><td style="width:1.0%"></td><td style="width:29.091%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.864%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractual obligations:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 and 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024 and 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026 and beyond</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase commitments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,947&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523,855&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668,210&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8, &#8220;Commitments and contingencies&#8221; in Notes to Consolidated Financial Statements in Part II, Item 8 of this Annual Report for additional details regarding our leases, Convertible Senior Notes, 2020 Term Loan and purchase commitments. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-balance sheet arrangements</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not entered into any off-balance sheet arrangements. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent accounting pronouncements</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Recent accounting pronouncements&#8221; in Note&#160;2, &#8220;Summary of significant accounting policies&#8221; in the Notes to Consolidated Financial Statements for a discussion of recently adopted accounting pronouncements and accounting pronouncements not yet adopted, and their expected effect on our financial position and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_43"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A.  Quantitative and Qualitative Disclosures about Market Risk.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risks in the ordinary course of our business. These risks primarily relate to interest rates. Our cash, cash equivalents, restricted cash and marketable securities totaled $360.7 million at December&#160;31, 2020, and consisted primarily of money market funds, U.S. treasury notes, and U.S. government agency securities. Such interest-bearing instruments carry a degree of risk; however, because our investments are primarily high-quality credit instruments with short-term durations with high-quality institutions, we have not been exposed to, nor do we anticipate being exposed to, material risks due to changes in interest rates. At December&#160;31, 2020, a hypothetical 1.0% (100 basis points) increase or decrease in interest rates would not have resulted in a material change in the fair value of our cash equivalents and portfolio of marketable securities. Fluctuations in the value of our cash equivalents and portfolio of marketable securities caused by a change in interest rates (gains or losses on the carrying value) are recorded in other comprehensive gain (loss) and are realized only if we sell the underlying securities prior to maturity or declines in fair value are determined to be other-than-temporary.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2020 Term Loan bears interest at an annual rate equal to LIBOR, subject to a 2.00% LIBOR floor, plus a margin of 8.75% and is therefore sensitive to changes in interest rates. We currently do not use interest rate derivative instruments to manage our exposure to interest rate fluctuations. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although our Convertible Senior Notes are based on a fixed rate, changes in interest rates could impact their fair market value. As of&#160;December&#160;31, 2020, the fair market value of the Convertible Senior Notes was&#160;$586.0 million. For additional information about the Convertible Senior Notes, see Note 8, &#8220;Commitments and contingencies&#8221; in Notes to Consolidated Financial Statements in Part II, Item 8 of this Annual Report.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_46"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8.&#160;&#160;&#160;&#160;Consolidated Financial Statements and Supplementary Data.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:31.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Consolidated Financial Statements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:92.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_49">Report of independent registered public accounting firm</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_49">79</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_52">Consolidated balance sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_52">81</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_58">Consolidated statements of operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_58">82</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_61">Consolidated statements of comprehensive loss</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_61">83</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_64">Consolidated statements of stockholders&#8217; equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_64">84</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_67">Consolidated statements of cash flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_67">85</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_70">Notes to consolidated financial statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0888b2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie13029cdd7d64c5bac971f0e86e8f19a_70">86</a></span></div></td></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_49"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and Board of Directors of Invitae Corporation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Invitae Corporation (the Company) as of December 31, 2020 and 2019, the related consolidated statements of operations, comprehensive loss, stockholders&#8217; equity and cash flows for each of the three years in the period ended December 31, 2020, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February&#160;26, 2021 expressed an unqualified opinion thereon.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Measurement of test revenue</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">During the year ended December 31, 2020, the Company&#8217;s test revenue subject to estimation was $181.0 million. As discussed in Note 3 of the consolidated financial statements, test revenue is recognized when the performance obligation is complete, generally upon delivery of the underlying clinical report or when the report is made available to the customer on the Company&#8217;s website.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The amounts recognized are based on estimates of the consideration that the Company expects to receive, and such estimates are adjusted and subsequently recorded until fully settled. Auditing the measurement of the Company&#8217;s test revenue was complex and judgmental due to the significant estimation required in determining the amount expected to be collected for each test. In particular, the estimate of revenue for tests billed to insurance carriers is affected by assumptions in payer behavior such as changes in historical payment patterns, contract provisions and government and private insurance reimbursement policies. </span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s revenue recognition process. As part of our testing, we considered controls over management&#8217;s review of the significant assumptions and inputs used in the determination of the amount expected to be collected. We also tested controls used by management to compare the current and historical data used in making the estimates for completeness and accuracy.<br/><br/>Our audit procedures over the Company&#8217;s test revenue included, among others, assessing valuation methodologies and models and testing the significant assumptions above and the underlying data used by the Company in its analysis. We agreed a sample of transactions to the payer contract terms. We compared the significant assumptions above and inputs used by management to changes in the Company&#8217;s contracted rates, government and private insurance payer collection trends, and other relevant factors. We assessed the historical accuracy of the cash collections used in the Company&#8217;s revenue models and assessed the completeness of adjustments to estimates of future cash collections as a result of significant contract amendments and changes in collection trends.</span></td></tr></table></div><div style="text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Valuation of intangible assets associated with business acquisitions</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As described in Note 4 to the consolidated financial statements, the Company completed several business acquisitions during 2020. As a result of the acquisitions, the Company recorded goodwill of $1,736.8 million, and intangible assets of $880.4 million. The acquisitions were accounted for as business combinations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auditing the Company&#8217;s accounting for the acquisitions was challenging as the determination of the fair value of the intangible assets acquired required management to make subjective estimates and assumptions. The Company used an income approach to measure the acquired intangible assets. The valuation of the intangible assets is subject to higher estimation uncertainty due to management&#8217;s judgments in determining significant assumptions that included assumed revenue growth, estimated cost savings and discount rates. Changes in these significant assumptions could have a significant effect on the fair value of the intangible assets.</span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We tested the design and operating effectiveness of internal controls over the Company&#8217;s process for accounting for acquisitions. For example, we tested controls over management&#8217;s review of the valuation of intangible assets, including the review of the valuation model and significant assumptions used in the valuation.<br/><br/>Our audit procedures related to the valuation of intangible assets included, among others, utilizing a valuation specialist to assist in evaluating the appropriateness of the Company&#8217;s valuation models and evaluating the reasonableness of significant assumptions used such as the revenue growth, estimated cost savings and the discount rates as compared to industry and market data and historical results. We also evaluated whether the assumptions used were reasonable by comparing them to the past performance of prior acquisitions, current industry data and current market forecasts, and whether such assumptions were consistent with evidence obtained in other areas of the audit.</span></td></tr></table></div><div style="margin-top:18pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst&#160;&amp; Young&#160;LLP</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2013.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redwood City, California</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;26, 2021 </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_52"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INVITAE CORPORATION</span></div><div style="margin-top:12pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except par value data)</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNC0xLTEtMS0w_639bd98b-7b0a-494f-8740-df1e3d0447ea">124,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNC0zLTEtMS0w_6c9d622d-3fde-4450-9a9a-ac17843ca964">151,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNS0xLTEtMS0w_af890e2f-28d0-40e7-9727-359c2ad0c935">229,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNS0zLTEtMS0w_9f575b32-c1c0-405d-9627-cfefe5628508">240,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNi0xLTEtMS0w_e2e77a8a-80ae-4a3b-b8df-cb7f3cfa0393">47,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNi0zLTEtMS0w_26548c72-3c01-441a-acf2-429172521a75">32,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNy0xLTEtMS00NDU2_9166c7ad-2218-4c66-9278-493ba2719b89">32,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNy0zLTEtMS00NDU2_e9ceded1-d2e5-42c2-bb1e-407723c99a72">6,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNy0xLTEtMS0w_8cff570a-d355-4c2d-9530-ce6c1f00ac08">20,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNy0zLTEtMS0w_4d1dbbf6-8c3a-40ee-89c8-e48c6172f911">11,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfOC0xLTEtMS0w_8dd43390-364d-496a-a257-3432b57401ab">453,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfOC0zLTEtMS0w_ecf729bd-c47a-4cfb-8d99-9323c75b62a6">442,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfOS0xLTEtMS0w_c0620dfb-6f29-44a3-afce-c30bba504a0b">66,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfOS0zLTEtMS0w_55cd74c1-31e0-4cca-8d66-51ba402fd47a">37,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTAtMS0xLTEtMA_2199d02e-ee2d-4a32-a199-67b03d19a166">45,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTAtMy0xLTEtMA_eb50e9ff-843d-4247-a23d-9b239a56cd38">36,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTEtMS0xLTEtMA_920217f4-665b-4e6d-8e2e-165e669374bf">6,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTEtMy0xLTEtMA_01318495-d0d5-4bdd-ae46-b13ee8b8ba35">6,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTMtMS0xLTEtMA_fa3603cb-b28b-4bb5-96da-c6d4e7782343">981,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTMtMy0xLTEtMA_2fd1511a-0fe0-4321-9b27-7b7a5c1a13ac">125,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTQtMS0xLTEtMA_520c60bf-1a4b-419f-9d44-7a49edaee40c">1,863,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTQtMy0xLTEtMA_2fd659fa-dbef-4f47-8935-bd84c3881a8b">126,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTUtMS0xLTEtMA_a906c0d6-ab9f-4b35-baf9-9f1c7c2fe2ef">13,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTUtMy0xLTEtMA_62c26cc3-1607-47a3-86f8-042690711151">6,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTYtMS0xLTEtMA_e242c630-66bf-4900-83c0-d56443e97810">3,430,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTYtMy0xLTEtMA_d467886c-be3e-4046-bc83-e82b69bd1661">781,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTktMS0xLTEtMA_00b4a26d-53ee-43f1-9c87-78744bfd0c2c">25,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTktMy0xLTEtMA_3e80e798-d436-4559-b296-80653fc5e7c4">10,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjAtMS0xLTEtMA_73be4a2d-2990-49f3-80bc-72073c70690f">86,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjAtMy0xLTEtMA_7c11b114-558b-4ad6-bb85-4341e51a508f">64,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjEtMS0xLTEtMA_535f54b4-18bd-49bb-94ac-4c6694297d4c">8,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjEtMy0xLTEtMA_cb0a4878-c5bf-4bdb-a648-639f33b5ac14">4,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjItMS0xLTEtMA_2976766c-3fd4-46c4-be00-886220d7cc92">1,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjItMy0xLTEtMA_874457e4-a680-4c5f-9943-d9da6fdba57c">1,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjQtMS0xLTEtMA_888706b0-13a1-4eff-9df0-6361d17d7128">121,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjQtMy0xLTEtMA_bb1d397d-6cb5-4129-bbfe-1c3ef2c52843">81,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligation, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjUtMS0xLTEtMA_66f6b200-b216-4f48-8d33-d307251d513f">48,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjUtMy0xLTEtMA_c6623153-88fb-4086-90ae-5f20a5d43e9f">42,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjYtMS0xLTEtMA_a686c82a-f214-4b30-a41f-dad218839232">3,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjYtMy0xLTEtMA_8d21d9dd-34de-4fdf-ad11-44cf280d1b0e">1,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjctMS0xLTEtMA_40b3fc32-7925-4cea-8cb9-052aaabb6996">104,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherLongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjctMy0xLTEtMA_aa2b7825-46d8-4abf-87a3-a697f73caf3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjgtMS0xLTEtMA_9651d44f-3eb4-49b5-8c88-b14c6d552841">283,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjgtMy0xLTEtMA_255d1e19-9334-4da6-9c4c-9543ac20c82b">268,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjktMS0xLTEtNDkx_83cd5a62-2934-4301-b8cd-af8ad0d2cfc9">51,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjktMy0xLTEtNDg4_cf38b292-b71b-42a8-9521-ade78f3e05d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjktMS0xLTEtMA_1f254d08-657f-4f4b-82fd-112e34d23b33">841,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjktMy0xLTEtMA_aa5d1fcf-d3a6-45d1-886a-0e5ec5482a21">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzAtMS0xLTEtMA_e0a2f013-6cdc-4a1d-bcdd-5a6f58a57159">1,454,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzAtMy0xLTEtMA_59d967d8-e93a-4801-8624-00697c302bf9">401,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 8)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzEtMS0xLTEtMA_05f0d1a3-60d9-46a5-b59c-df8a9544ebc3"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzEtMy0xLTEtMA_4e1743d7-53c5-45a8-9c7a-58e65175621b"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTgx_4dcaa471-d14f-4310-b70f-b98479d6b8d0"><ix:nonFraction unitRef="usdPerShare" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTgx_fadb4449-0076-4825-ab36-2e9fe7fbe165">0.0001</ix:nonFraction></ix:nonFraction> par value: <ix:nonFraction unitRef="shares" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTkw_499cbd23-6138-45e7-bf9c-aa3397686e7c"><ix:nonFraction unitRef="shares" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTkw_aca949d9-edb0-4323-8192-479a1dcfc91e">20,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTk2_46f8b1ad-4db2-449b-97a2-c38cb97c7a71"><ix:nonFraction unitRef="shares" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTk2_6dd30187-5d5b-4884-a0ad-e40be6097e14"><ix:nonFraction unitRef="shares" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTk2_7e75b11e-6fae-4ff9-b1df-400bfcd46436"><ix:nonFraction unitRef="shares" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTk2_c5c5c1d8-d7af-4c9d-838a-df2efe1f6217">125</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December&#160;31, 2020 and 2019</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMS0xLTEtMA_220d7c7a-3d67-44b1-bbde-e6950f82d694">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMy0xLTEtMA_84cc6c0d-9e67-4ecd-9a02-62eb65347574">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjAy_a2dcdff8-b321-4244-9c6a-3d6e447ae560"><ix:nonFraction unitRef="usdPerShare" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjAy_ea85c2be-b02e-432f-8bcd-a0a063075197">0.0001</ix:nonFraction></ix:nonFraction> par value: <ix:nonFraction unitRef="shares" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjEy_2c1c6f32-521c-4def-a79f-fdda6dde8392"><ix:nonFraction unitRef="shares" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjEy_7f9cdd13-94a1-4f5f-89f3-d2fc1bb490ac">400,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjIx_09a4e71b-3bc3-48f3-a2a3-aa9c13bd8940"><ix:nonFraction unitRef="shares" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjIx_9cdd241c-f0e3-448d-a48c-e3280e261068">185,886</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjMw_49b69604-39ed-4fa6-82a3-3b1d73a0c04e"><ix:nonFraction unitRef="shares" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjMw_bdd6b44f-f62d-4eba-adfe-773e943bd830">98,796</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December&#160;31, 2020 and 2019, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMS0xLTEtMA_f5a1069f-40b6-4bb9-8444-bb43657f3795">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMy0xLTEtMA_5d4cff77-df0b-4125-847d-0e6f9611f39f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzUtMS0xLTEtMA_401dca7e-9b20-46c0-a511-429ca8a7d35e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzUtMy0xLTEtMA_d427fbc6-cc18-466b-ad9a-05c647e86681">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzYtMS0xLTEtMA_3a4bfa6c-2360-418e-9523-826ccbbc7acf">3,337,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzYtMy0xLTEtMA_7e5fdc41-3052-413c-acda-3f40304dc215">1,138,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzctMS0xLTEtMA_c80abc7c-bd40-4d54-8f31-683e849a56e2">1,360,847</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzctMy0xLTEtMA_da939a3f-76d1-49aa-8111-984b3ebc679f">758,677</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzgtMS0xLTEtMA_2947adf9-7c2d-4e4f-9e8b-3a3b8c94857e">1,976,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzgtMy0xLTEtMA_9f615702-b7e7-4889-8feb-beb77609b488">379,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzktMS0xLTEtMA_9dd5dcd7-823a-42b2-8a06-49f0280ff135">3,430,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzktMy0xLTEtMA_46913b3c-0af4-4204-92bb-b7a05f2b287b">781,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_58"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INVITAE CORPORATION</span></div><div style="margin-top:12pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except per share data)</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Test revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9b882f2b7c04e7297a6e4005b4ccdd9_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMy0xLTEtMS0w_6a687ece-6ebe-4837-afa6-002273337e5a">272,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437a19f6fb264a83b0e5e51fec25eb41_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMy0zLTEtMS0w_9a4a85de-ff5d-4ce7-8920-37b43703caa5">212,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58cad0e4115a408fb292a43a94deba31_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMy01LTEtMS0w_cbac4fdb-c5e4-49d6-939a-4a7d8f54dc59">144,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8d899ddc8834e689efc87de396289f8_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNC0xLTEtMS0w_c809ea67-d78a-407e-86e5-e8ca0295a62e">7,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f2ead9ac6540068a6b97873f3f9752_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNC0zLTEtMS0w_1a6a3af0-01db-4244-8d95-9be47e34462f">4,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616089384d754359aaf3b67545a021a0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNC01LTEtMS0w_26df5e48-3cca-4f14-950d-3a03eec62dba">3,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNS0xLTEtMS0w_908696e7-e855-4dc8-889e-768781cfa3de">279,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNS0zLTEtMS0w_2e0fe379-8b28-4a23-a1fa-9c9262ca7c22">216,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNS01LTEtMS0w_29ac02c1-e1e4-431e-a0ac-ae4859c38743">147,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNi0xLTEtMS0w_d5e24935-85e3-425b-85e5-b1da14c178fc">198,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNi0zLTEtMS0w_e1165101-4d1e-4ce4-9639-f7900c04dbf9">118,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNi01LTEtMS0w_df41025e-10e6-4826-8440-93740b517a82">80,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNy0xLTEtMS0w_fd33c6b1-dfe9-43bc-8522-647360feae2c">240,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNy0zLTEtMS0w_50e2f3b9-32e1-421d-a253-4ea202efd808">141,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNy01LTEtMS0w_8062c620-3fb5-49f5-9976-bda2fbdc5625">63,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfOC0xLTEtMS0w_4d76d6d3-f7c9-4293-8f53-28c520944308">168,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfOC0zLTEtMS0w_7a133902-a413-404d-b3a4-534afd307d47">122,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfOC01LTEtMS0w_2d857ae6-2d02-47e2-8ed3-faa904268aee">74,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfOS0xLTEtMS0w_3e74c002-af5a-45d1-bb04-5ab7243522d1">324,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfOS0zLTEtMS0w_96f3764d-e676-459a-a690-18c86ad74168">79,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfOS01LTEtMS0w_61f845a5-615a-4ff0-9e2b-dab8b001cecd">52,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTEtMS0xLTEtMA_01a0f6be-8ee0-4762-9c60-529cf77d976b">652,172</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTEtMy0xLTEtMA_06c81013-e16c-4bd8-9239-57aab96ec633">244,112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTEtNS0xLTEtMA_0674782d-0e56-467d-9c3a-392bbd50cfeb">122,557</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTItMS0xLTEtMA_c6abcddf-649f-4886-b440-48d4b1522cfe">32,332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTItMy0xLTEtMA_a5e14920-5e20-4021-98b3-0ec884d98bc3">3,891</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTItNS0xLTEtMA_031a3362-3165-45ef-b22a-bd7ca0199fb8">2,568</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTMtMS0xLTEtMA_10eba01b-7635-41e5-a2cb-78ac1a553719">29,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTMtMy0xLTEtMA_b1df317a-ffde-45ce-ab78-68ba3aa2ad56">12,412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTMtNS0xLTEtMA_a1d4b6b9-e703-416b-aa59-ffd981b2601c">7,030</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTQtMS0xLTEtMA_2884b55d-5afd-42b9-8b45-c7defbe7ef24">714,270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTQtMy0xLTEtMA_2e0271ce-e61b-41e9-9580-ea4b2989c9b8">260,415</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTQtNS0xLTEtMA_c0483419-785c-4177-953e-f918f6b6df86">132,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTUtMS0xLTEtMA_4886f6f2-06ca-43ab-9bbe-f6a74362f543">112,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTUtMy0xLTEtMA_190f8c80-e954-4bf7-bf57-69d0d17ec011">18,450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTUtNS0xLTEtMA_b56a443f-7723-4347-b5d1-f8cb9aac8063">2,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTYtMS0xLTEtMA_5c824880-f371-4a13-b1de-6349c1a5532c">602,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTYtMy0xLTEtMA_90986e80-940a-4ea5-b1d3-d0e8c3a54aef">241,965</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTYtNS0xLTEtMA_1d8362fe-5b0f-4b84-a23b-7c22f417a4ce">129,355</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTctMS0xLTEtMA_07af50dc-7549-436e-b570-2c15ec24719b">4.47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTctMy0xLTEtMA_0ebc3fed-b8ba-4de0-9d0e-f9fa8781cfff">2.66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTctNS0xLTEtMA_6b6f3d27-43bf-4a0a-a956-88d2049e6d4b">1.94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTgtMS0xLTEtMA_f2d847c2-3701-46b3-86fc-65ce7de0f069">134,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTgtMy0xLTEtMA_f0ac1199-0ee3-45c8-bb1a-37f507ac57ea">90,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTgtNS0xLTEtMA_f9ba42d2-8924-4108-ab90-beda528745f6">66,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_61"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INVITAE CORPORATION</span></div><div style="margin-top:12pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Loss</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands)</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfMy0xLTEtMS0w_18688fdf-cc02-4ab9-b7de-12b9d506c6f7">602,170</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfMy0zLTEtMS0w_fc207d5e-bd50-44d6-b8ab-c9ccb047e95c">241,965</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfMy01LTEtMS0w_5c7c7a21-950c-447d-912a-a10b2d3d0dd3">129,355</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized income (loss) on available-for-sale marketable securities, net of tax</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfNS0xLTEtMS0w_c4d61d70-e8d6-420a-b402-919efe86ac4d">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfNS0zLTEtMS0w_10ca26c0-c869-45e9-93ae-500ff2121b42">4</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfNS01LTEtMS0w_7fb083da-e3ed-4672-9c4a-f0b984614b53">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfNi0xLTEtMS0w_d27c67d5-3e74-4512-9842-d2cc00e12bbb">602,160</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfNi0zLTEtMS0w_a79a02ca-08e7-4830-b41b-d75f6a4fb128">241,969</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfNi01LTEtMS0w_dc51c5ab-9a1d-4e19-b30f-da4eec7e666d">129,189</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_64"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INVITAE CORPORATION</span></div><div style="margin-top:12pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders&#8217; Equity</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f3778e5a29f4a89b8566f4904cf689f_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMy0xLTEtMS0w_e329bd74-8248-4f5d-a6c4-2f4b42cead49">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2809c9d3c7ed495ea105d1d0909333c7_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMy0zLTEtMS0w_9ffe9155-6f27-4532-b47a-4009e79e581c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie554d3df8b1f425f9be76437e8b27488_I20171231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMy01LTEtMS0w_98ee50c4-8860-4239-a8ca-e6ef50168629">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfNC0xLTEtMS0w_21951b9f-1db9-400b-8577-d3864d46d980">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfNC0zLTEtMS0w_30827ff6-922d-4afa-b446-1c0f3028c5ec">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfNC01LTEtMS0w_4fd2845e-bd01-4be9-b048-9b1ad656ba61">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8214f3614960469ea38d28cf9303f211_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfNS0xLTEtMS0w_2b7ad58f-deed-4989-8d26-c6fc3994ba65">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f3778e5a29f4a89b8566f4904cf689f_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfNS0zLTEtMS0w_1149b126-3213-4ed8-820d-210bc049bb02">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2809c9d3c7ed495ea105d1d0909333c7_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfNS01LTEtMS0w_93c20447-2c95-4934-8ba3-e6bc26a59d27">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753156daf9b430195e021dca2c527bb_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfOC0xLTEtMS0w_ecf7bb66-6be8-4d8e-af68-70be800d5403">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23abde67124a40d590374be251a1dee1_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfOC0zLTEtMS0w_8ebbbed0-3402-4dc0-bbee-a8d3decb3063">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37dd50d3619f4aff904889d2b15d5117_I20171231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfOC01LTEtMS0w_409eff30-9570-44e6-91f6-902ee27a4fc5">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized income (loss) on available-for-sale marketable securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4e2421641034f4f9c940f901e1fbdef_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfOS0xLTEtMS0w_e482240c-33d1-4b40-9a82-e332becac91d">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c3a7b53ff0f4c5ba0b9fc100703d37d_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfOS0zLTEtMS0w_1be16f28-49c2-412e-ba36-46cdc5972490">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82869c0962ef4cf1bddc91ff73996c6e_D20180101-20181231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfOS01LTEtMS0w_e48e44e5-699f-4489-b647-4705e2f8fbdb">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ec2e6bbc47e4933af77c2c3a21ca309_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTAtMS0xLTEtMA_45ae10eb-2c8f-4e9c-a7a3-5e0c2ebf21ef">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753156daf9b430195e021dca2c527bb_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTAtMy0xLTEtMA_e1ee6cf8-4c1f-4d7d-8013-3cb34ae4914c">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23abde67124a40d590374be251a1dee1_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTAtNS0xLTEtMA_2d208425-39f8-47ee-bddf-b253e9806a02">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bfa576bed044795b85e3c7f95992d6a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTMtMS0xLTEtMA_6677887e-ca2b-48ec-aa58-6c91117f065f">1,138,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbef3252651e4df5be4e543eeb29b46a_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTMtMy0xLTEtMA_efdb61b5-db9d-4218-8f75-06088bdc03ed">678,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65fbe0254a9a4420a86969e2d6309651_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTMtNS0xLTEtMA_01b96a73-5343-4f62-8207-eddc99b68fe4">520,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued in private placement, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTQtMS0xLTEtMA_56898a6d-8bfc-4afc-a2af-13bf5809a9d1">263,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="nvta:StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTQtNS0xLTEtMA_2e9701fe-368f-4ec1-9308-956f4d70dd53">5,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued in connection with public offering, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTUtMS0xLTEtMA_9bfe1669-3437-428c-a135-823bd9132233">263,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTUtMy0xLTEtMA_0af0f952-9818-41b5-8e35-0f8b566cce78">204,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTUtNS0xLTEtMA_4f7656d2-cdd7-4039-b3d7-ebd1c285ce3d">112,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued on exercise of stock options, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTYtMS0xLTEtMA_2612313c-f442-4c03-82c4-59f19492b9bb">10,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTYtMy0xLTEtMA_59bd63e7-1906-4add-89e0-5ec36da0b502">3,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTYtNS0xLTEtMA_8dca1a43-bfb7-4ddb-b36f-f30463b8e415">2,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued pursuant to exercises of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231" decimals="-3" name="nvta:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTctMS0xLTEtMA_c5976f45-5681-4a66-af0d-5ec3e4a5fb8e">974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231" decimals="-3" name="nvta:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTctMy0xLTEtMA_44eefde3-79cb-4229-a3b9-d3672dfa4d89">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="nvta:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTctNS0xLTEtMA_230b8e83-a051-479b-923f-aa1eca4066c2">6,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued pursuant to employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTgtMS0xLTEtMA_833317d5-0e0d-4a26-89f1-6c8cfb9e7e35">8,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTgtMy0xLTEtMA_1dfec71c-cd30-4679-bc31-cb70371601cb">5,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTgtNS0xLTEtMA_34c1f18e-eee7-4fdd-b88b-933f7306b07e">3,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued or issuable pursuant to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTktMS0xLTEtMA_a037859f-06f5-48c2-8735-1ab1c37ce03c">1,524,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTktMy0xLTEtMA_48f99e15-4573-40db-a605-082c6775ad8e">133,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTktNS0xLTEtMA_24964612-0a9e-4538-9413-c77183010092">6,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component of convertible senior notes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjAtMy0xLTEtMA_646988d9-f023-406b-b490-8d750a6fcb9f">75,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warrants issued pursuant to loan agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjEtMS0xLTEtMA_3015f891-bebd-4f0a-b142-946bd0aaf0b4">27,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjEtNS0xLTEtMA_9b0eeb60-a742-4a10-a525-20becd740d9d">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjMtMS0xLTEtMA_528f78d6-3301-48fd-a285-f38860a601b7">110,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjMtMy0xLTEtMA_2d17dcdf-406b-45de-b72b-4f54a3672e4e">36,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjMtNS0xLTEtMA_4b1daa08-3439-4d86-9186-22aec7932812">20,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification of stock payable liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c6a38f48b1244e19aff28ddf6d53576_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjQtMS0xLTEtNTAw_6d4cae28-08c7-491d-bd25-fa2c097978c4">10,387</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia370e5ff06d5431fa9bca439bb1b889b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjUtMS0xLTEtMA_bf239802-adaf-4573-b736-980aeed346aa">3,337,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bfa576bed044795b85e3c7f95992d6a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjUtMy0xLTEtMA_28700b0a-e2d5-461b-b409-416f82db11ce">1,138,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbef3252651e4df5be4e543eeb29b46a_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjUtNS0xLTEtMA_c4a03567-6de8-41d7-8c67-970cead07689">678,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia58ce6bc9aca49d9aa127557c52c11a9_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjgtMS0xLTEtMA_14fe675f-bc67-45b5-8747-cf6c36dd5c88">758,677</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8594685f80541b1b4777011ea3b8353_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjgtMy0xLTEtMA_39e78635-9a4f-4413-8ad7-4b20bdbacd8e">516,712</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2ce8df417b84195a8e55c791ce044b8_I20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjgtNS0xLTEtMA_24328eab-27f7-4e8c-8e5a-f5492ebd001f">398,598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative effect of accounting change</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbbd53bd90042b58ef516ba23872688_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjktNS0xLTEtMA_968f6a0a-6b04-4238-87da-ed3e219ed140">11,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34b06356d84b48aabb5a47a229bf0277_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzAtMS0xLTEtMA_becc2d6e-14cc-46a1-ba93-7f27d79befe0">602,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a108a141584487ca8dbd201dfd46516_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzAtMy0xLTEtMA_e539d840-35d8-4b9f-8259-459f022ac785">241,965</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea52a8309a4413a699941e900a6c44_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzAtNS0xLTEtMA_4537d3b1-e3b3-4f59-89cb-68aa825a10c7">129,355</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6cd188a85204aaf8d02aeae0c5dfe1a_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzEtMS0xLTEtMA_ea9535ab-0575-45f9-9075-f45fa5ccf058">1,360,847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia58ce6bc9aca49d9aa127557c52c11a9_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzEtMy0xLTEtMA_53c2decb-4897-4021-97ab-f5dfc5684f43">758,677</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8594685f80541b1b4777011ea3b8353_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzEtNS0xLTEtMA_52beadc8-6648-43ad-9279-75f264f2dec5">516,712</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzItMS0xLTEtMA_28a797bf-17cb-4224-be97-8f83006a520a">1,976,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzItMy0xLTEtMA_6a9fbd2d-d4bf-4a95-9d25-47ae4fd8cd54">379,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i133819ff76b24d47a6fe9cf8b026d64f_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzItNS0xLTEtMA_21285f14-e261-41e8-8734-5093c71c30ad">161,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_67"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INVITAE CORPORATION</span></div><div style="margin-top:9pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-bottom:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands)</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMy0xLTEtMS0w_672777cc-0062-459e-b623-baf53152cfd1">602,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMy0zLTEtMS0w_3657667a-614b-4a80-a0aa-3ef722d38609">241,965</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMy01LTEtMS0w_35efa694-748b-462d-88ce-b1b0d75814f1">129,355</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNS0xLTEtMS0w_6222ed3a-e0ca-4267-96d5-b176ba0be083">39,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNS0zLTEtMS0w_196ad82d-b23e-4dfa-b06e-c837f54313fe">16,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNS01LTEtMS0w_9d4ef7aa-0aa9-42a9-afc8-ce6a3250341c">13,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNi0xLTEtMS0w_33b1a7fa-4e29-40e2-83dd-11478d4c6a93">158,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNi0zLTEtMS0w_1c95ff77-b6cd-49eb-91ff-02ea795a99f2">75,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNi01LTEtMS0w_89ae4333-a0c6-4654-a2b4-8ca64af52f4a">20,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt discount and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNy0xLTEtMS0w_d19da460-f390-4380-ba6f-d3053bc3e572">17,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNy0zLTEtMS0w_2ec4a84f-ed6c-4efe-9dc3-30efe3d95201">4,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNy01LTEtMS0w_d2894b59-3713-44c8-97d7-cd58284a09f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfOS0xLTEtMS0w_70ec6776-893c-466f-a431-c4d1a8445395">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfOS0zLTEtMS0w_95d792e6-2a46-4773-9e48-aaf370634249">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfOS01LTEtMS0w_b7a7aa8d-c30e-451f-be34-cac4df352b2a">2,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Remeasurements of liabilities associated with business combinations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:BusinessCombinationRemeasurementOfLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTItMS0xLTEtMA_13bd2850-6769-4d9e-b147-4ad3d16fbd21">92,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="nvta:BusinessCombinationRemeasurementOfLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTItMy0xLTEtMA_f4f47033-a67c-48e3-b688-400a2cac5056">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="nvta:BusinessCombinationRemeasurementOfLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTItNS0xLTEtMA_3d3eb64a-8668-47ce-9c1e-c3c96cdee0ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTMtMS0xLTEtMA_2cfc8538-7c19-4237-9b6d-706baf6715e3">112,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTMtMy0xLTEtMA_e8f4aedc-756f-42cc-be8d-25e71612c2db">18,450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTMtNS0xLTEtMA_2cd1837d-c78d-4bb0-a741-47d27ffdb09c">2,862</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt extinguishment costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTQtMS0xLTEtMA_003d7576-2638-49ba-8597-8196b018d099">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTQtMy0xLTEtMA_5c9f793e-e029-4782-9e02-af00ee2df256">8,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTQtNS0xLTEtMA_206af902-7eed-4718-abad-fd5f5809dd68">5,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Post-combination expense for acceleration of unvested equity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTUtMS0xLTEtOTE0Mw_756bd13d-95cf-4fa7-b748-a3f8cde4254e">91,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="nvta:BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTUtMy0xLTEtOTE0Mw_fa20c0f8-90a3-4e64-b8f7-5e7d0c8968ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="nvta:BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTUtNS0xLTEtOTE0Mw_980c5a1e-5a1c-439e-8eb9-fd191d313247">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTUtMS0xLTEtMA_d6725006-06be-4923-a957-397a486124e2">1,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTUtMy0xLTEtMA_e06a0567-4d5f-4fea-87ac-bf71f8658863">1,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTUtNS0xLTEtMA_c0424b79-8811-4c4a-a85b-d735abb62544">1,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of businesses acquired:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTctMS0xLTEtMA_2ee9c767-493a-4341-8312-79a99b883505">2,814</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTctMy0xLTEtMA_8b2caa55-dc4a-49c7-bc4e-11aa8683cacf">6,131</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTctNS0xLTEtMA_a1f87856-d52a-4a32-93a1-1b932e389014">5,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTgtMS0xLTEtOTEzNA_74b86b6d-1972-49d0-8b8e-a81aa4ca6344">7,832</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTgtMy0xLTEtOTEzNA_556e5a88-8880-470b-ac8c-2431f6279a18">1,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTgtNS0xLTEtOTEzNA_bdcd6587-f475-4cd0-a477-300b6d55d4b4">2,848</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTgtMS0xLTEtMA_71a786ad-65f5-4660-aada-3d52b4b39a87">2,010</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTgtMy0xLTEtMA_66690a7c-b143-43fa-b3ec-9e622c9bfd4f">6,624</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="nvta:IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTgtNS0xLTEtMA_c13b1280-5500-4ecd-999d-c734c524d4f2">1,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTktMS0xLTEtMA_2a4a8c2a-51bf-4c2d-a889-bf2bc2c62073">895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTktMy0xLTEtMA_287b7698-0437-44b1-9203-c8d2e926dc19">2,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTktNS0xLTEtMA_8fcd6226-9ec5-49f0-ac01-c65e9ece84b7">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjAtMS0xLTEtMA_33227387-767b-4584-acae-9fe8e567e2dd">10,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjAtMy0xLTEtMA_46ff83f7-17e6-4e5a-935b-dbc283aeef9a">1,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjAtNS0xLTEtMA_62cd47bb-b49f-43e2-b056-58308ecea55d">417</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued expenses and other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjEtMS0xLTEtMA_0e850ee9-10e1-44e2-8fe2-78e8a435f790">17,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjEtMy0xLTEtMA_9666ce54-0689-464d-bc7b-c80e4c4c4178">16,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjEtNS0xLTEtMA_ae7e250f-4cf4-4e0b-b7f9-bca1e9f75290">3,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjItMS0xLTEtMA_adc76f99-4c2c-4463-ab33-0f582d0133da">298,502</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjItMy0xLTEtMA_01c7dac8-8ebc-4333-a002-71d7677d09ee">145,053</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjItNS0xLTEtMA_17bea9c5-d458-4899-aea1-6e9aeef81037">92,220</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjQtMS0xLTEtMA_34cdb59b-2793-42ba-87ca-e2cbac5d1a57">280,258</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjQtMy0xLTEtMA_f5431784-723a-4580-8f1e-b96ff1523af3">260,917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjQtNS0xLTEtMA_38c66ddc-2051-44ab-b9e0-f9848e49a369">9,680</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sales of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjUtMS0xLTEtMA_d614a060-4770-4992-aab7-eb4c67306dd6">12,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjUtMy0xLTEtMA_81f4a375-c4c1-4691-b845-007ffbd86549">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjUtNS0xLTEtMA_bbbb2392-9c7c-4fd7-bd1a-bd4e2dc96b18">19,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from maturities of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjYtMS0xLTEtMA_3c3a8272-e22a-4151-8a88-dcfefede7a13">277,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjYtMy0xLTEtMA_a5b9af4f-6c43-455d-9fa4-0d957fc7c025">34,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjYtNS0xLTEtMA_96fd69c5-fdac-442d-96e3-c54a3076e522">32,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjctMS0xLTEtMA_4e67b977-c1ff-490d-93a0-f5418fb3040e">383,753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjctMy0xLTEtMA_ac515120-df6a-47a8-af73-16a196d0ab7a">33,846</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjctNS0xLTEtMA_8951c2c5-5c5d-4e99-b52b-73e5cb8df5b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjgtMS0xLTEtMA_c243407d-f3ca-4409-8056-44d4c7ff259e">22,865</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjgtMy0xLTEtMA_4346b470-4f0c-443f-84fa-46e0a4fa8b87">20,047</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjgtNS0xLTEtMA_f95cdfbf-c37c-4ce0-8082-5ebc89e052c5">5,970</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjktMS0xLTEtMA_4b5ccb65-cc3d-44e3-ac9f-0950b1a65f52">4,026</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjktMy0xLTEtMA_65ae1986-d797-4ad0-a0dc-d0a41d165a95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjktNS0xLTEtMA_2cfa91c9-1ff4-4e5c-a81a-24de69cccc64">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzAtMS0xLTEtMA_3c2f40bd-2846-4ded-acb7-75c7fe4db426">400,583</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzAtMy0xLTEtMA_80838da4-70ec-4856-b4e3-19547ccf0416">280,310</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzAtNS0xLTEtMA_160e1bac-abf4-4bf1-9162-782ec4d11daf">35,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from public offerings of common stock, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzItMS0xLTEtMA_7179c1a3-76f0-427e-9d93-e0c01c7aef4c">263,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzItMy0xLTEtMA_b4f598ff-e917-4302-b9b3-b8a0fd305855">204,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="nvta:ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzItNS0xLTEtMA_b06f7f06-d8fe-47a2-bc86-5d3a3ed8a721">112,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzMtMS0xLTEtMA_1cc70715-29fb-4670-98cb-03d3028d7387">284,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzMtMy0xLTEtMA_f55c815e-0cb9-4b82-a612-a55c6fd9c20e">9,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzMtNS0xLTEtMA_1a8190cb-b6ec-47af-9224-58c986153b1e">17,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of convertible senior notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzQtMS0xLTEtMA_c9caf7ba-f02a-4231-b2ee-ea247a35500d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzQtMy0xLTEtMA_4ab83343-974d-4ec5-971a-9bee18fac005">339,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzQtNS0xLTEtMA_9d9c9284-ab51-4feb-87bc-97ae1a770e65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of debt, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzUtMS0xLTEtMA_865a6895-c9da-4837-b539-2afe03626c67">129,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzUtMy0xLTEtMA_66766596-3af1-4508-8604-6646fd4e88e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzUtNS0xLTEtMA_b1918be6-6157-42ef-84e9-e78c32bc8e45">93,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments of debt extinguishment costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzYtMS0xLTEtMA_4c853606-7e30-47d6-aa60-1335592ed71e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzYtMy0xLTEtMA_f31ea82a-db28-4061-afab-14d3bcdc1738">10,638</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzYtNS0xLTEtMA_b5316422-fc47-473b-a175-7155264858e1">4,609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loan payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsOfLoanCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzctMS0xLTEtMA_eb1bd2e9-298a-41c1-b5a3-3790ade3c412">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfLoanCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzctMy0xLTEtMA_4659c1f8-ddec-46d2-a40d-f1eae8df38da">75,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfLoanCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzctNS0xLTEtMA_6301712c-3596-4908-9419-4ed8abb8e96a">60,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzktMS0xLTEtMA_c674ce62-e232-419a-8ed2-5300e954362d">4,112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzktMy0xLTEtMA_f8bd7b95-5c89-400a-b122-9b83b658b1af">2,985</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzktNS0xLTEtMA_8854bb02-62f4-4eaf-900e-f73d0d06922c">2,100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDAtMS0xLTEtMA_eee50c6e-a2c9-48b6-b679-e307c583718c">672,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDAtMy0xLTEtMA_ece3ced7-2022-4db1-82c2-ea321224779d">464,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDAtNS0xLTEtMA_0f5e7d5b-fbb6-4399-a554-3d06fbf19fd2">157,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDEtMS0xLTEtMA_0d741c96-a256-4a35-a23a-15291062598a">26,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDEtMy0xLTEtMA_e1c29f15-76ca-48e4-9a31-d8bad905d1e4">39,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDEtNS0xLTEtMA_b7d1c5c8-b7b9-4b9d-ac84-0f0677e556e0">100,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDItMS0xLTEtMA_ae49723d-6b66-407a-9105-281e65e611a9">157,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i133819ff76b24d47a6fe9cf8b026d64f_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDItMy0xLTEtMA_cca29dfe-b131-4330-89e8-6a3fddba409c">118,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1dffb2fad8b40ca9e2827b034550280_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDItNS0xLTEtMA_8b973a28-e8dd-46b7-8511-46ca1b9727ad">17,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDMtMS0xLTEtMA_bec4a623-e562-45e4-a8aa-35c5a65f393d">131,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDMtMy0xLTEtMA_2a702014-9aad-4034-9bc2-60ce9084d325">157,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i133819ff76b24d47a6fe9cf8b026d64f_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDMtNS0xLTEtMA_f1e7533c-c4c3-43b3-bea8-ab41132c2cfc">118,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDYtMS0xLTEtMA_504a94b0-a771-4f17-af45-9297f59e13ed">12,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDYtMy0xLTEtMA_573d978b-7cfe-4a72-a93b-87b13ff7c84c">4,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDYtNS0xLTEtMA_c3915866-ef6e-4940-9d07-c49e3714395c">6,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental cash flow information of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equipment acquired through finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CapitalLeaseObligationsIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDgtMS0xLTEtMA_a761ee3f-de77-45b6-bdc0-027c99b3d17d">4,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CapitalLeaseObligationsIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDgtMy0xLTEtMA_234ca3fd-977a-4407-8d98-ce329503da85">1,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:CapitalLeaseObligationsIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDgtNS0xLTEtMA_eede69b3-96d6-4cea-b1aa-6ed5b8fbcf95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment in accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTAtMS0xLTEtMA_008a9174-31c2-457c-a0a2-392464a77cb9">1,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTAtMy0xLTEtMA_d45a617a-167c-4d64-858d-34844c84b89c">2,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTAtNS0xLTEtMA_a25da844-40da-4c77-b4b2-a1e550b60af2">510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrants issued pursuant to debt agreement</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTItMS0xLTEtMA_4b5c4f33-17da-42fa-96da-4420da53ff42">27,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTItMy0xLTEtMA_cb195ec3-c74d-45ed-98a3-ab0d3bac8b71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTItNS0xLTEtMA_b359c567-8f9a-4ec7-9428-5dc360ac92a0">383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued for acquisitions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTMtMS0xLTEtMA_8d0c192c-06fe-4228-aa60-e449c4b68b75">1,157,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTMtMy0xLTEtMA_b61de2a2-9e19-4fcc-9086-d93cec99d9f0">108,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTMtNS0xLTEtMA_a7a5f982-c6b3-4f67-a6a2-07d48d070aef">6,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consideration payable for acquisitions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTQtMS0xLTEtMA_fb6fce4f-266e-4716-a62c-41ee2cc5b98d">940,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTQtMy0xLTEtMA_fd534a00-7090-4f2e-872d-e2c45eec6d48">21,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTQtNS0xLTEtMA_2ee17156-6ea4-4ccf-b699-9d1936757d8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease assets obtained in exchange for lease obligations, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTYtMS0xLTEtMA_07e70424-5b17-4e41-8e87-5fc1ec85b5fb">14,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTYtMy0xLTEtMA_0b567b2f-6eb5-40cb-81ac-6a00c5cbaad1">4,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_70"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INVITAE CORPORATION</span></div><div style="margin-top:12pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_73"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.  <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83My9mcmFnOjhiNTcwZmE1NGFlMDQ0ZDRhNjIzNjA5NzExNWE5M2MzL3RleHRyZWdpb246OGI1NzBmYTU0YWUwNDRkNGE2MjM2MDk3MTE1YTkzYzNfMTY1Mw_7caa9977-347f-4512-a614-046125098082" continuedAt="i74ed5cfa8448450088665646c7bee866" escape="true">Organization and description of business</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i74ed5cfa8448450088665646c7bee866" continuedAt="i1845de33063b4965a67df0133256cd36">Invitae Corporation ("Invitae," &#8220;the Company," "we," "us," and "our") was incorporated in the State of Delaware on January 13, 2010, as Locus Development, Inc. and we changed our name to Invitae Corporation in 2012. We offer high-quality, comprehensive, affordable genetic testing across multiple clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, personalized oncology, metabolic conditions and rare diseases. To augment our offering and realize our mission, we have acquired multiple assets including <ix:nonFraction unitRef="business" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83My9mcmFnOjhiNTcwZmE1NGFlMDQ0ZDRhNjIzNjA5NzExNWE5M2MzL3RleHRyZWdpb246OGI1NzBmYTU0YWUwNDRkNGE2MjM2MDk3MTE1YTkzYzNfNzY5NjU4MTQxODQ2NA_b581c30b-50d7-4241-b71a-b3acd4e1da3e">four</ix:nonFraction> businesses in 2020, which expanded our suite of genome management offerings and established a broader entry into oncology therapy selection and personalized cancer monitoring.</ix:continuation></span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1845de33063b4965a67df0133256cd36">In October 2020, we completed the acquisition of ArcherDX, Inc. (&#8220;ArcherDX&#8221;). ArcherDX is a genomics company democratizing precision oncology by offering a suite of products and services that are accurate, personal, actionable and easy to use in local settings, thereby empowering clinicians to control the sample, data, patient care and economics. ArcherDX&#8217;s development platform, including its proprietary Anchored Multiplex PCR, ("AMP"), chemistry at the core, is enabling clinical tests and services that allow for therapy selection and cancer monitoring in community locations for the first time at scale. Invitae operates in <ix:nonFraction unitRef="segment" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83My9mcmFnOjhiNTcwZmE1NGFlMDQ0ZDRhNjIzNjA5NzExNWE5M2MzL3RleHRyZWdpb246OGI1NzBmYTU0YWUwNDRkNGE2MjM2MDk3MTE1YTkzYzNfMTI2NDQzODM3MzgxNTI_11f4f6c7-b359-4620-bc30-f3a09e0b9737">one</ix:nonFraction> segment.</ix:continuation> </span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_76"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.  <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MjU_a383c9a0-af55-48b4-beeb-766dff8e603e" continuedAt="i9bf97818e745447b8652e5e9ab27d9d9" escape="true">Summary of significant accounting policies</ix:nonNumeric></span></div><ix:continuation id="i9bf97818e745447b8652e5e9ab27d9d9" continuedAt="idee890ceb9f344d4baebee4cce628b2f"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2ODY_3814ba61-a461-4218-80d9-38a00bbc64a2" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of consolidation</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include our accounts and the accounts of our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NTY_ea7a9567-2ac7-4e5f-b5b6-2c8b5b1b0fee" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We base these estimates on current facts, historical and anticipated results, trends and various other assumptions that we believe are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those judgments, estimates and assumptions. We evaluate our estimates on an ongoing basis.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates and assumptions made by management include the determination of:</span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">revenue recognition; </span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the fair value of assets and liabilities associated with business combinations; </span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the impairment assessment of goodwill and intangible assets; </span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the valuation of our <ix:nonFraction unitRef="number" contextRef="i70c89bb06a7246a1bb3d4f7eec32e812_I20190930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNjU5NzA2OTgxNDc5Mg_763211de-e8a0-4a80-90fc-48b0c126023a">2.00</ix:nonFraction>% convertible senior notes due 2024 issued in September 2019 ("Convertible Senior Notes");</span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the recoverability of long-lived assets; </span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our incremental borrowing rates used to calculate our lease balances;</span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">stock-based compensation expense and the fair value of awards and warrants issued; and</span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">income tax uncertainties.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="idee890ceb9f344d4baebee4cce628b2f" continuedAt="i3b1070cdc63d4cbab48e8718aefad093"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2OTk_41210f4c-1bc4-4267-9dbe-85af074cb8e0" continuedAt="i18b8e08e1eed4128983e58cef6ec5319" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of credit risk and other risks and uncertainties</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to a concentration of credit risk consist of cash, cash equivalents, marketable securities and accounts receivable. Our cash and cash equivalents are held by financial institutions in the United States. Such deposits may exceed federally insured limits.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i18b8e08e1eed4128983e58cef6ec5319">Significant customers are those that represent 10% or more of our total revenue for each year presented on the consolidated statements of operations.</ix:continuation> <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NjM_7a5a865b-c93b-4d3f-b4a4-073df8b0357b" continuedAt="i0b21f519c6ab4e9897c12447e6d93e89" escape="true">Our revenue from significant customers as a percentage of our total revenue was as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="i0b21f519c6ab4e9897c12447e6d93e89"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:26.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.878%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7e1175abf83148d8836d04d1ecf72a47_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOjA3MmVkODUxNDRjYTQzZTE5YThhMzVkODAxYzEwMmRmL3RhYmxlcmFuZ2U6MDcyZWQ4NTE0NGNhNDNlMTlhOGEzNWQ4MDFjMTAyZGZfMi0yLTEtMS0w_32990bf3-40c6-4407-9b2b-973875a7f07e">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id09edfceda314a48a3bae75a5376813e_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOjA3MmVkODUxNDRjYTQzZTE5YThhMzVkODAxYzEwMmRmL3RhYmxlcmFuZ2U6MDcyZWQ4NTE0NGNhNDNlMTlhOGEzNWQ4MDFjMTAyZGZfMi00LTEtMS0w_f292eefa-2de0-479e-a125-93ffcaf3481f">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i654d4e6d51c24784b92cf81e78d322ef_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOjA3MmVkODUxNDRjYTQzZTE5YThhMzVkODAxYzEwMmRmL3RhYmxlcmFuZ2U6MDcyZWQ4NTE0NGNhNDNlMTlhOGEzNWQ4MDFjMTAyZGZfMi02LTEtMS0w_1bc167e4-7e4b-4761-85b4-cc14150dd36a">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No customers represented more than 10% of accounts receivable as of December&#160;31, 2020 or 2019. </span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2ODE_0aeeac39-6f46-4c6e-82a7-39dce7071aaa" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, cash equivalents, and restricted cash</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all highly liquid investments with original maturities of three months or less from the date of purchase to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds, U.S. treasury notes and government agency securities.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash consists primarily of money market funds that secure irrevocable standby letters of credit that serve as collateral for security deposits for our facility leases.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NzU_943e06ba-53f9-4d5e-9403-8d796704aaaa" escape="true"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MTU_9d96493e-93d1-48ad-a17a-142ead8aaa5e" escape="true"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:70.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmIxMjdjYTljOTRmNTQ0ZGNhNTg4MDdjMjcxMDk4ZDg1L3RhYmxlcmFuZ2U6YjEyN2NhOWM5NGY1NDRkY2E1ODgwN2MyNzEwOThkODVfMi0xLTEtMS0w_639bd98b-7b0a-494f-8740-df1e3d0447ea">124,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmIxMjdjYTljOTRmNTQ0ZGNhNTg4MDdjMjcxMDk4ZDg1L3RhYmxlcmFuZ2U6YjEyN2NhOWM5NGY1NDRkY2E1ODgwN2MyNzEwOThkODVfMi0zLTEtMS0w_6c9d622d-3fde-4450-9a9a-ac17843ca964">151,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmIxMjdjYTljOTRmNTQ0ZGNhNTg4MDdjMjcxMDk4ZDg1L3RhYmxlcmFuZ2U6YjEyN2NhOWM5NGY1NDRkY2E1ODgwN2MyNzEwOThkODVfMy0xLTEtMS0w_920217f4-665b-4e6d-8e2e-165e669374bf">6,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmIxMjdjYTljOTRmNTQ0ZGNhNTg4MDdjMjcxMDk4ZDg1L3RhYmxlcmFuZ2U6YjEyN2NhOWM5NGY1NDRkY2E1ODgwN2MyNzEwOThkODVfMy0zLTEtMS0w_01318495-d0d5-4bdd-ae46-b13ee8b8ba35">6,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmIxMjdjYTljOTRmNTQ0ZGNhNTg4MDdjMjcxMDk4ZDg1L3RhYmxlcmFuZ2U6YjEyN2NhOWM5NGY1NDRkY2E1ODgwN2MyNzEwOThkODVfNC0xLTEtMS0w_195c8d72-db1a-4a16-b68d-023f815db0f6">131,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmIxMjdjYTljOTRmNTQ0ZGNhNTg4MDdjMjcxMDk4ZDg1L3RhYmxlcmFuZ2U6YjEyN2NhOWM5NGY1NDRkY2E1ODgwN2MyNzEwOThkODVfNC0zLTEtMS0w_21382b06-8ddd-4d9c-81d1-1c308e22888c">157,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NzM_33ee7940-8761-4269-a58f-c1cbba2c7e15" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable securities</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All marketable securities have been classified as &#8220;available-for-sale&#8221; and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its marketable debt securities at the time of purchase and reevaluates such designation at each balance sheet date. Short-term marketable securities have maturities one year or less at the balance sheet date. Unrealized gains and losses are excluded from earnings and are reported as a component of other comprehensive loss. Realized gains and losses and impairments, if any, on available-for-sale securities are included in other expense, net. The cost of securities sold is based on the specific-identification method. Interest on marketable securities is included in other income (expense), net. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For marketable securities in an unrealized loss position, we assess our intent to sell, or whether it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis. If either of these criteria are met, the security&#8217;s amortized cost basis is written down to fair value through other income (expense), net.</span></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MjI_ebc5b8cc-21d6-47eb-81c4-58894f94a9fa" continuedAt="i73d0cca33be04a99b2f98bc60cba26ee" escape="true">Accounts receivable</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i73d0cca33be04a99b2f98bc60cba26ee">We receive payment from patients, biopharmaceutical partners, third-party payers and other business-to-business customers.</ix:continuation> See Note 3, "Revenue, accounts receivable and deferred revenue" for further information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjI1Mzk5ODg0NTc1MDM_b9f63a7a-10e4-4156-9188-f3cb71586a7a" continuedAt="i8ee369eb2ca3499a84d545d0d03f2adf" escape="true">Deferred revenue</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8ee369eb2ca3499a84d545d0d03f2adf" continuedAt="i791273eeefaa43ab8009ee21f2bc5cb9">We record a contract liability when cash payments are received or due in advance of our performance related to one or more performance obligations.</ix:continuation> See Note 3, "Revenue, accounts receivable and deferred revenue" for further information. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i3b1070cdc63d4cbab48e8718aefad093" continuedAt="i8682b89f5ae04ddcaf388d0ff6a18f88"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NzY_9685175d-46fb-44ec-9943-b69a5e73a7a0" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our inventory consists of raw materials, work in progress, and finished goods, which are stated at the lower of cost or net realizable value on a first-in, first-out basis. We periodically analyze our inventory levels and expiration dates, and write down inventory that has become obsolete, inventory that has a cost basis in excess of its net realizable value, and inventory in excess of expected sales requirements as cost of revenue. We record an allowance for obsolete inventory using an estimate based on historical trends and evaluation of near-term expirations.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NjY_036a33af-f2cc-4fdc-a645-7fe65de19157" continuedAt="i3d6bae7f02894a3b892c3eafcdc47f4c" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply Financial Accounting Standards Board ("FASB"), Accounting Standards Codification ("ASC") 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires recognition of assets acquired, liabilities assumed, and contingent consideration at their fair value on the acquisition date with subsequent changes recognized in earnings; requires acquisition-related expenses and restructuring costs to be recognized separately from the business combination and expensed as incurred; requires in-process research and development to be capitalized at fair value as an indefinite-lived intangible asset until completion or abandonment; and requires that changes in accounting for deferred tax asset valuation allowances and acquired income tax uncertainties after the measurement period be recognized as a component of provision for taxes.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for acquisitions of entities that include inputs and processes and have the ability to create outputs as business combinations. The tangible and identifiable intangible assets acquired and liabilities assumed in a business combination are recorded based on their estimated fair values as of the business combination date, including identifiable intangible assets which either arise from a contractual or legal right or are separable from goodwill. We base the estimated fair value of identifiable intangible assets acquired in a business combination on independent third-party valuations that use information and assumptions provided by our management, which consider our estimates of inputs and assumptions that a market participant would use. Any excess purchase price over the estimated fair value assigned to the net tangible and identifiable intangible assets acquired and liabilities assumed is recorded to goodwill. The use of alternative valuation assumptions, including estimated revenue projections, growth rates, estimated cost savings, cash flows, discount rates, estimated useful lives and probabilities surrounding the achievement of contingent milestones could result in different purchase price allocations and amortization expense in current and future periods.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In circumstances where an acquisition involves a contingent consideration arrangement that meets the definition of a liability under ASC Topic 480, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities from Equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We remeasure this liability each reporting period and record changes in the fair value as general and administrative expense.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs associated with acquisitions are expensed as incurred in general and administrative expenses. Results of operations and cash flows of acquired companies are included in our operating results from the date of acquisition.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MTY_ed0ee8f6-934c-43b5-a1f7-62ed8cd34f31" continuedAt="ie7106921837b4471bbf43b8015ccdbea" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortizable intangible assets include trade names, non-compete agreements, patent licensing agreements, favorable leases, developed technology, customer relationships, and rights to develop new technology acquired as part of business combinations. Customer relationships acquired through our business combinations in 2017 are amortized on an accelerated basis, utilizing free cash flows, over periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzY4NQ_d2037801-faba-4d7d-9a9d-b880ce2dc05c">five</span> to <ix:nonNumeric contextRef="idd5dd2727548445bba930982eb5e164a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzY5MQ_6004539b-b80f-4e6b-a22e-ebc3091d8aa5">12</ix:nonNumeric> years. All other intangible assets subject to amortization are amortized using the straight-line method over their estimated useful lives ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzgzOQ_4c24a27f-0da2-4313-a3a1-cf19d3484ec4">two</span> to <ix:nonNumeric contextRef="i23413efbba8a4bce99ca014f751cd629_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzg0NQ_04a12535-3ac0-4aed-84c1-425c3b97b897">15</ix:nonNumeric> years. All intangible assets subject to amortization are reviewed for impairment in accordance with ASC 360, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment.</span></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2OTU_f13ae65e-e076-43ac-a7a9-c64b10b42bf7" continuedAt="iba2724ef3fb249c1a6ccfd218f7d6bfc" escape="true">Goodwill</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:31.5pt"><ix:continuation id="iba2724ef3fb249c1a6ccfd218f7d6bfc" continuedAt="id81271c7c7ff49abb2882a9f4621bcb4"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 350, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other</span></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id81271c7c7ff49abb2882a9f4621bcb4"> (&#8220;ASC 350&#8221;), our goodwill is not amortized but is tested for impairment on an annual basis or whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. Under ASC 350, we perform annual impairment reviews of our goodwill balance during the fourth fiscal quarter or more frequently if business factors indicate. In testing for impairment, we compare the fair value of our reporting unit to its carrying value including the goodwill of that unit. If the carrying value, including goodwill, exceeds the reporting unit&#8217;s fair value, we will recognize an impairment loss for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. The loss recognized cannot exceed the total amount of goodwill allocated to that reporting unit.</ix:continuation> We did <ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjMwODk3NDQyNTU1OTI_1d91f341-125a-4436-adea-6c6bc9e2cf84"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjMwODk3NDQyNTU1OTI_200628b0-26f3-49bc-b140-0d6e6b38a78e"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjMwODk3NDQyNTU1OTI_ea7abd07-fb4a-4b40-a19a-2aeffde1d6e9">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t incur any goodwill impairment losses in any of the periods presented.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i8682b89f5ae04ddcaf388d0ff6a18f88" continuedAt="i933e09b12fc14a4d8d13347aa38bc407"><ix:continuation id="ie7106921837b4471bbf43b8015ccdbea" continuedAt="i6dcd7cac3c2a4898a4f656b4eba7ad88"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In-process research and development </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets related to in-process research and development costs (&#8220;IPR&amp;D&#8221;) are considered to be indefinite-lived until the completion or abandonment of the associated research and development efforts. If and when development is complete, the associated assets would be deemed finite-lived and would then be amortized based on their respective estimated useful lives at that point in time. During this period, the assets will not be amortized but will be tested for impairment on an annual basis and between annual tests if we become aware of any events occurring or changes in circumstances that would indicate a reduction in the fair value of the IPR&amp;D projects below their respective carrying amounts. </span></div></ix:continuation><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6dcd7cac3c2a4898a4f656b4eba7ad88">During the fourth quarter and if business factors indicate more frequently, we perform an assessment of the qualitative factors affecting the fair value of our IPR&amp;D projects. If the fair value exceeds the carrying value, there is no impairment. Impairment losses on indefinite-lived intangible assets are recognized based solely on a comparison of the fair value of an asset to its carrying value, without consideration of any recoverability test. We have not identified any such impairment losses to date.</ix:continuation> </span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NTg_48ed0606-d70c-4b78-bc30-4f99a31bd456" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 842, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we determine if an arrangement is a lease at inception. Operating leases are included in operating lease assets and operating lease obligations in our consolidated balance sheets. Finance leases are included in other assets and finance lease obligations in our consolidated balance sheets. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at commencement based on the present value of lease payments over the lease term. We generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments. The operating lease asset also includes any lease payments made and is adjusted for lease incentives. Our lease terms may include options to extend or terminate the lease which are recognized when it is reasonably certain that we will exercise that option. Leases with terms of 12 months or less are not recorded on our balance sheet. Lease expense is recognized on a straight-line basis over the lease terms, or in some cases, the useful life of the underlying asset. We account for the lease and non-lease components as a single lease component.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MTI_8b83c11a-1f55-4ecb-b745-cbc1d8c9aa6c" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and equipment, net</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMTE2Mjg_1217d9ea-71ec-462e-9a23-2257607bd016">three</span> and <ix:nonNumeric contextRef="i23413efbba8a4bce99ca014f751cd629_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMTE2MzU_af6f9313-c9d3-4a4f-852c-b094283870d0">seven years</ix:nonNumeric>. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the term of the lease. Maintenance and repairs are charged to expense as incurred, and improvements and betterments are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in the consolidated statements of operations in the period realized.</span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MjY_f6d65ccb-245d-44c9-8700-6fb4ef0b35bf" continuedAt="i9920348e423a437686fb1ebc59d273b7" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated useful lives of property and equipment are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:50.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.000%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ife1d8cfb66ed44aebe09b9526f251933_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmRjMzhkMjQ3M2IwMzQwOWE5MGU5M2RjNmNhNGIzZTg2L3RhYmxlcmFuZ2U6ZGMzOGQyNDczYjAzNDA5YTkwZTkzZGM2Y2E0YjNlODZfMC0xLTEtMS0w_5df26b00-f942-4ba3-b1aa-feea97a0603d">7</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Automobiles</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i479bb752e9834ff889d964d04d4fd5f8_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmRjMzhkMjQ3M2IwMzQwOWE5MGU5M2RjNmNhNGIzZTg2L3RhYmxlcmFuZ2U6ZGMzOGQyNDczYjAzNDA5YTkwZTkzZGM2Y2E0YjNlODZfMS0xLTEtMS0w_c4c8b5f4-99c5-4224-ae1b-24609a26e60f">7</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing and Laboratory equipment</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9cc8be4a617648da91ede3d8cd832c3b_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmRjMzhkMjQ3M2IwMzQwOWE5MGU5M2RjNmNhNGIzZTg2L3RhYmxlcmFuZ2U6ZGMzOGQyNDczYjAzNDA5YTkwZTkzZGM2Y2E0YjNlODZfMi0xLTEtMS0w_908d70de-e243-491d-9c4d-c8b70c977db5">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8ef676364d144f13b1b75fad36a56028_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmRjMzhkMjQ3M2IwMzQwOWE5MGU5M2RjNmNhNGIzZTg2L3RhYmxlcmFuZ2U6ZGMzOGQyNDczYjAzNDA5YTkwZTkzZGM2Y2E0YjNlODZfMy0xLTEtMS0w_f89f7b7b-6ecb-443a-a370-93fb6ca37bd9">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic7aecb12307a4028a550cb1bdd7c0949_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmRjMzhkMjQ3M2IwMzQwOWE5MGU5M2RjNmNhNGIzZTg2L3RhYmxlcmFuZ2U6ZGMzOGQyNDczYjAzNDA5YTkwZTkzZGM2Y2E0YjNlODZfNC0xLTEtMS0w_b24c3b23-3418-46e4-ae7e-96c37e165dac">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of lease term or estimated useful life</span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2Nzc_a5baaf28-149e-4146-8120-7fbd1ff5478d" continuedAt="i39e68e54fa964bfca4a7f3a8b764e827" escape="true">Long-lived assets</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i39e68e54fa964bfca4a7f3a8b764e827">We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. An impairment loss is recognized when the total estimated future undiscounted cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount. Impairment, if any, is assessed using discounted cash flows or other appropriate measures of fair value.</ix:continuation> There were <ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMTI2ODc_80f7bfc6-b49d-4341-8cb6-29c61fb8cb10"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMTI2ODc_d02d52ee-fe6c-4b93-84ce-9726bf5fa0d2"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMTI2ODc_f18eaa59-ba19-416e-aae3-befc44f13fba">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> long-lived asset impairment losses recorded for any period presented.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i933e09b12fc14a4d8d13347aa38bc407" continuedAt="i1682869aeecc413aacabd972db8a26d6"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MTM_304fe499-01e2-44ae-b705-916ab01fae49" continuedAt="i0455d7fe4d1d4d42b33a6e5d93c31819" escape="true">Fair value of financial instruments</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0455d7fe4d1d4d42b33a6e5d93c31819">Our financial instruments consist principally of cash and cash equivalents, marketable securities, accounts payable, accrued liabilities, finance leases, and liabilities associated with business combinations. The carrying amounts of certain of these financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued and other current liabilities approximate their current fair value due to the relatively short-term nature of these accounts. Based on borrowing rates available to us, the carrying value of finance leases approximate their fair values. Liabilities associated with business combinations are recorded at their estimated fair value.</ix:continuation> </span></div><ix:continuation id="i791273eeefaa43ab8009ee21f2bc5cb9" continuedAt="i4214e26a013b44b5b1dd0eb1b78d4656"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration it expects to be entitled to in exchange for those goods or services. All revenues are generated from contracts with customers. We utilize the following practical expedients and exemptions:</span></div><div style="margin-top:3pt;padding-left:63pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Costs to obtain or fulfill a contract are expensed when incurred because the amortization period would have been one year or less, and</span></div><div style="margin-top:3pt;padding-left:63pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">No adjustments to promised consideration were made for financing as we expect, at contract inception, that the period between the transfer of a promised good or service and when the customer pays for that good or service will be one year or less.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Test revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Test revenue is comprised of testing services and sales of distributed precision oncology products. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our test revenue is generated from genetic testing, in addition to somatic testing for therapy selection and personalized cancer monitoring. These testing services provide analysis and associated interpretation of the sequencing of parts of the genome. Test orders are placed under signed requisitions or contractual agreements, and we often enter into contracts with biopharmaceutical partners, other business-to-business customers (e.g., hospitals, clinics, medical centers) and insurance companies that include pricing provisions under which such tests are billed. Billing terms are generally net 30 to 60 days.  </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the transaction price of diagnostic tests is originally established either via contract or pursuant to our standard list price, we often provide concessions for tests billed to insurance carriers, and therefore the transaction price for patient insurance-billed tests is considered to be variable and revenue is recognized based on an estimate of the consideration to which we will be entitled at an amount for which it is probable that a reversal of cumulative consideration will not occur. Making these estimates requires significant judgments based upon such factors as length of payer relationship, historical payment patterns, changes in contract provisions and insurance reimbursement policies. These judgments are reviewed each reporting period and updated as necessary.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We look to transfer of control in assessing timing of recognition of revenue in connection with each performance obligation. In general, revenue in connection with the service portion of our diagnostic tests is recognized upon delivery of the underlying clinical report or when the report is made available on our web portal. Outstanding performance obligations pertaining to orders received but for which the underlying report has not been issued are generally satisfied within a 30-day period. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also generate test revenue through the sale of our precision oncology products, which is comprised primarily of sales of our distributed research use only ("RUO ") and in vitro diagnostics ("IVD") products for therapy selection. We recognize revenue on these sales once shipment has occurred. Product sales are recorded net of discounts and other deductions. Billing terms are generally net 30 days. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling fees billed to customers are recorded as revenue on the consolidated statements of operations. The associated shipping and handling costs are recorded as cost of revenue.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue is primarily generated from pharma development services provided to biopharmaceutical companies related to companion diagnostic development as well as through collaboration agreements and genome network contracts.</span></div></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i1682869aeecc413aacabd972db8a26d6" continuedAt="iafaa789ce1ab4017be7dd9d6806081ff"><ix:continuation id="i4214e26a013b44b5b1dd0eb1b78d4656"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts for companion diagnostic development consist primarily of milestone-based payments along with annual fees and marked-up pass-through costs. The arrangements are treated as short-term contracts for revenue recognition purposes because they allow termination of the agreements by the customers with 30 to 120 days&#8217; written notice without a termination penalty. Upon termination, customers are required to pay for the proportion of services provided under milestones that were in progress. We recognize revenue in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. We recognize revenue over time based on the progress made toward achieving the performance obligation, utilizing both input or output methods, depending on the performance obligation, including labor hours expended, tests processed, or time elapsed, that measure our progress toward the achievement of the milestone.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We also enter into collaboration and genome network contracts. Collaboration agreements provide customers with diagnostic testing and related data aggregation reporting services that are provided over the contract term. Collaboration revenue is recognized as the data and reporting services are delivered to the customer. Genome network offerings consist of subscription services related to a proprietary software platform designed to connect patients, clinicians, advocacy organizations, researchers and therapeutic developers to accelerate the understanding, diagnosis and treatment of hereditary disease. Such services are recognized on a straight-line basis over the subscription periods. Amounts due under collaboration and genome network agreements are typically billable on net 30-day terms. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue reflects the aggregate costs incurred in delivering our genetic offerings and includes expenses for personnel-related costs including stock-based compensation, materials and supplies, royalties, regulatory fees, commercialization fees, equipment and infrastructure expenses associated with testing and allocated overhead including rent, equipment depreciation, information technology costs, amortization of acquired intangibles and utilities.</span></div></ix:continuation><ix:continuation id="i3d6bae7f02894a3b892c3eafcdc47f4c"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License Agreements</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered and may continue to enter into license agreements to access and utilize certain technology. We evaluate if the license agreement results in the acquisition of an asset or a business and then determine if the acquired asset has the ability to generate revenues or is subject to regulatory approval. When regulatory approval is not required, we record the license as an asset and amortize it over the estimated economic life. When regulatory approval is required, we record the amount paid as a research and development expense.</span></div></ix:continuation><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NDk_50a76219-550d-4980-bb6b-f00192490840" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. Significant judgment is required in determining the net valuation allowance which includes our evaluation of all available evidence including past operating results, estimates on future taxable income and acquisition-related tax assets and liabilities.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We historically established a full valuation allowance against our deferred tax assets due to the uncertainty surrounding realization of such assets. In 2020, we released approximately $<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzY5NjU4MTQ4NzEzNw_4c706089-b461-462b-af21-8ef93c796ff8">112.1</ix:nonFraction>&#160;million of our valuation allowance to account for acquired intangibles that support the future realization of some of our deferred tax assets. Due to the overall increase of deferred tax assets, our valuation allowance has also increased from the prior year.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2Nzg_2649a6ca-b3ac-4813-835b-fc56d7ad6aef" continuedAt="i9427e3f0dac0459a91a34edab0f0a560" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure stock-based payment awards made to employees and directors based on the estimated fair values of the awards and recognize the compensation expense over the requisite service period. We use the Black-Scholes option-pricing model to estimate the fair value of stock option awards and employee stock purchase plan (&#8220;ESPP&#8221;) purchases. The fair value of restricted stock unit (&#8220;RSU&#8221;) awards with time-based vesting terms is based on the grant date share price. We grant performance-based restricted stock unit (&#8220;PRSU&#8221;) awards to certain employees which vest upon the achievement of certain performance conditions, subject to the employees&#8217; continued service relationship with us. The probability of vesting is assessed at each reporting period and compensation cost is adjusted based on this probability assessment. We recognize such compensation expense on an accelerated vesting method.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="iafaa789ce1ab4017be7dd9d6806081ff" continuedAt="ifaa197da50634e2b860d9e3b734a0465"><ix:continuation id="i9427e3f0dac0459a91a34edab0f0a560"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense for awards without a performance condition is recognized using the straight-line method. Stock-based compensation expense is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. As such, our stock-based compensation is reduced for estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for stock issued in connection with business combinations based on the fair value on the date of issuance.</span></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3Mjk_4ee2c090-bd8a-4156-8d6b-7fb3f57ea2a6" continuedAt="ie7ca15b278e44c23935687ec90caa015" escape="true">Advertising</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie7ca15b278e44c23935687ec90caa015">Advertising expenses are expensed as incurred.</ix:continuation> We incurred advertising expenses of $<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjA2ODI_c01238d5-12bc-4133-ac38-02b4a7e45bf0">11.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjA2ODY_e963ddff-6f98-403d-ad0e-375913d2f9b9">9.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjA2OTM_8f1adece-a4ef-4ed8-8ef2-33b6ec6ce7e0">0.6</ix:nonFraction> million during the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NTQ_25a4f1ff-ef23-4d5f-8162-a649eb94d43e" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive loss</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss is composed of two components: net loss and other comprehensive income (loss). Other comprehensive income (loss) refers to gains and losses that under U.S. GAAP are recorded as an element of stockholders&#8217; equity, but are excluded from net loss. Our other comprehensive income (loss) consists of unrealized gains or losses on investments in available-for-sale securities.</span></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NjI_5fd9dac6-bc50-41ce-accc-7c1f0a73d5eb" continuedAt="i83327b1237ae456da46feafcbac7e873" escape="true">Net loss per share</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i83327b1237ae456da46feafcbac7e873">Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, without consideration of common stock equivalents. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common share equivalents outstanding for the period determined using the treasury stock method. Potentially dilutive securities, consisting of preferred stock, options to purchase common stock, common stock warrants, shares of common stock pursuant to ESPP, common stock issuable in connection with our Convertible Senior Notes, RSUs and PRSUs, are considered to be common stock equivalents and were excluded from the calculation of diluted net loss per share because their effect would be antidilutive for all periods presented.</ix:continuation> </span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MDE_8cfa9f32-fc38-4e1d-82f2-70bfd5d33d33" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prior period reclassifications</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts in prior periods to conform with current presentation.</span></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Immaterial correction of an error</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined the historical classification of certain acquisition-related obligations as equity and the subsequent measurement of such obligations was inappropriate and instead should have been classified as liabilities and subsequently measured at fair value with changes recognized in other expense, net during the year ended December 31, 2020. We determined that the impact of the error to previously issued consolidated financial statements was not material and have corrected the immaterial error in the current period financial statements.&#160;The impact of this correction was an increase to other long-term liabilities of $<ix:nonFraction unitRef="usd" contextRef="i0f632804fdba4dc8928d0db037568eff_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjMwODk3NDQyNTU1OTc_6a92f7a8-aa10-4028-baa4-48925f7034b7">10.1</ix:nonFraction>&#160;million, a corresponding decrease to additional paid-in capital of $<ix:nonFraction unitRef="usd" contextRef="i16fc5f68786d447999f8e4e68164aebb_I20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjMwODk3NDQyNTU2MTI_e24ec45e-37e9-431a-8851-0ce91e1dbd07">10.4</ix:nonFraction>&#160;million and an increase to other income, net of $<ix:nonFraction unitRef="usd" contextRef="i799d7ced2b4d4f649c58a173693d0e85_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjMwODk3NDQyNTU2Mjc_c1efb4e9-5a59-435d-a0e8-941296178ab6">0.3</ix:nonFraction>&#160;million.</span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MDI_490bbf53-5089-4161-9347-3010041399cd" continuedAt="i02f92db8abab4e58b8b37cffa55e3be2" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent accounting pronouncements</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate all Accounting Standards Updates (&#8220;ASUs&#8221;) issued by the Financial Accounting Standards Board ("FASB") for consideration of their applicability. ASUs not included in the disclosures in this report were assessed and determined to be either not applicable or are not expected to have a material impact on our consolidated financial statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently issued accounting pronouncements not yet adopted </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06,&#160;Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which simplifies the accounting for certain convertible instruments, amends the guidance on derivative scope exceptions for contracts in an entity's own equity, and modifies the guidance on diluted earnings per share calculations as a result of these changes. This new standard is effective for our interim and annual periods beginning January 1, 2022, and earlier adoption is permitted. We may elect to apply the amendments on a retrospective or modified retrospective basis. We are currently evaluating the impact of the adoption of this standard on our consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ifaa197da50634e2b860d9e3b734a0465"><ix:continuation id="i02f92db8abab4e58b8b37cffa55e3be2"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently adopted accounting pronouncements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016,&#160;FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires measurement and recognition of expected credit losses for financial assets. This guidance became effective for us beginning in the first quarter of 2020 and was adopted using a modified retrospective approach, with certain exceptions. The adoption of Topic 326 did not have a material impact on our consolidated financial statements as credit losses are not expected to be significant.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our adoption of Topic 326, we assess our accounts receivables for expected credit losses at each reporting period by disaggregating by payer type and further by portfolios of customers with similar characteristics, such as customer type and geographic location. We then review each portfolio for expected credit losses based on historical payment trends as well as forward looking data and current economic trends. If a credit loss is determined, we record a reduction to our accounts receivable balance with a corresponding general and administrative expense.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Topic 326, we no longer evaluate whether our available-for-sale debt securities in an unrealized loss position are other than temporarily impaired. Instead, we assess whether such unrealized loss positions are credit-related. Our expected loss allowance methodology for these securities is developed by reviewing the extent of the unrealized loss, the issuers&#8217; credit ratings and any changes in those ratings, as well as reviewing current and future economic market conditions and the issuers&#8217; current status and financial condition. The credit-related portion of unrealized losses, and any subsequent improvements, are recorded in other income (expense), net. Unrealized gains and losses that are not credit-related are included in accumulated other comprehensive income (loss). </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2019, we adopted the provisions of ASC Topic 842, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> using the modified retrospective approach in accordance with Topic 842. Adoption of Topic 842 had a material impact on our consolidated balance sheets, but did not have an impact on our consolidated statements of operations. We elected the package of practical expedients permitted under the transition guidance which, among other things, allowed us to carry forward the historical classification of leases in place as of January 1, 2019. We did not identify any material embedded leases with the adoption of Topic 842 and therefore the implementation of Topic 842 primarily focused on the treatment of our previously identified leases. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period amounts were not adjusted and continue to be reported in accordance with our historic accounting under previous lease guidance, ASC 840, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 840, we rented facilities under operating lease agreements and recognized related rent expense on a straight-line basis over the term of the applicable lease agreement. Some of the lease agreements contained rent holidays, scheduled rent increases, lease incentives, and renewal options. Rent holidays and scheduled rent increases were included in the determination of rent expense recorded over the lease term. Lease incentives were recognized as a reduction of rent expense on a straight-line basis over the term of the lease. Renewals were not assumed in the determination of the lease term unless they were deemed to be reasonably assured at the inception of the lease. We recognized rent expense beginning on the date we obtained the legal right to use and control the leased space.</span></div></ix:continuation></ix:continuation><div id="ie13029cdd7d64c5bac971f0e86e8f19a_82"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.  <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMjI1OA_af3af264-26e0-441e-853e-50262fd85275" continuedAt="idc90cd05f42949c4844554e44375aed5" escape="true">Revenue, accounts receivable and deferred revenue </ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:31.5pt"><ix:continuation id="idc90cd05f42949c4844554e44375aed5" continuedAt="ibebba5f3fb7c42aabb9460b40a7ce510"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Test revenue is generated from sales of diagnostic tests and precision oncology products to four groups of customers: biopharmaceutical partners; patients who pay directly; patients' insurance carriers; and other business-to-business customers (e.g., hospitals, clinics, medical centers). Test revenue is generated in two ways: through a centralized lab and decentralized through the shipment of reactions to biopharma partners and other business-to-business customers. We refer to the set of reagents needed to perform a next-generation sequencing test as a "reaction." Amounts billed and collected, and the timing of collections, vary based on the type of payer. Other revenue consists principally of revenue recognized under contracts for pharma development services and other collaboration and genome network agreements and is accounted for under the provisions provided in ASC 606, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></ix:continuation></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ibebba5f3fb7c42aabb9460b40a7ce510" continuedAt="i1cb73180cc6a403bb089b8b4cdecb51b"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMjI2Mg_6afeb905-1c7a-4ea3-9ac7-114c9dc996b2" escape="true"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue as disaggregated by payer category and revenue subtype is as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:29.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.289%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Patient</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biopharma partner</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other business-to-business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Direct</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Test revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centralized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8c91c8e1cbc46d49aa79331ab90dcd2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfMy0yLTEtMS03MzMz_e30d9dfc-ba06-41de-8908-e071e6ae2f73">181,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c67b77700048fab0585b6066fa04c5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfMy00LTEtMS03MzM4_1d100290-1a3c-42eb-acbb-512035fc89b2">23,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6871dfde02ea4071998e693ce797f046_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfMy02LTEtMS03MzQ1_99788ce8-6185-47cd-a8cf-0cbb1988b2b6">26,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbcb07071f07445fafa80ea82f6b1aa1_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfMy04LTEtMS03MzQ3_cb512675-f000-4954-afe0-81fbf5679b29">32,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b8929e13ba7497294e5422447cdf72c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfMy0xMC0xLTEtNzM1MQ_0f46346d-06fc-44d5-9113-61f07d160cd0">263,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decentralized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07eda2ee4f144ad196ef401a7db1bffe_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNC0yLTEtMS03MzMz_b9fbaa7a-9b7d-4fdf-ba0e-c65b30443461">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8e9734305bb4650bd1c5a51bad8c420_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNC00LTEtMS03MzM4_a1c4c1a4-17c0-43fc-8eb4-d2c15534a722">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48186d64febd4653a8f230b2dee4ce39_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNC02LTEtMS03MzQ1_e769c73d-f7b3-4d6c-b867-edadf7723d0f">837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6be0b9df48b4580a4f57239b6c93c95_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNC04LTEtMS03MzQ3_7bb678db-3f95-48d9-8ba7-baf5c0b6558f">7,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d5edf779f44dc9cb12c8fa50f37f7_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNC0xMC0xLTEtNzM1MQ_2c62f2c4-dc07-438c-ac63-77bc84765995">8,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total test revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0883ec36ca8f4b61abb4136ad60dfd6c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNS0yLTEtMS03MzMz_d0141b19-2f5c-4fce-a327-16a25ed02247">181,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54c647460d3a4f2ca2462ceef18be368_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNS00LTEtMS03MzM4_5ddff351-1c2f-4bf3-b06e-83e6e6ec9b74">23,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9bff46bd60c485b87b8b76a524b891b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNS02LTEtMS03MzQ1_da15a03f-a622-49b0-9baa-4dffa561a7df">27,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd3bd1b58fce419091528683f64e06f4_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNS04LTEtMS03MzQ3_e70537cb-708d-46c3-aac7-b944ea83ba29">40,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9b882f2b7c04e7297a6e4005b4ccdd9_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNS0xMC0xLTEtNzM1MQ_b3c68289-f37b-4716-984d-16778e06c1c2">272,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f2c32a0a92c4d75956a7049d4a3d2ea_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNi0yLTEtMS03MzMz_48073220-fe38-4949-9886-1ba49db5589a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ac952c0d68641358df70ac8ca6a5650_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNi00LTEtMS03MzM4_e8cb4205-b9b8-42c2-b96e-2b55c1ba4de4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie754d8f483fb4e51858045ccc2f3ce90_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNi02LTEtMS03MzQ1_c71e87f5-39d0-4d25-a12e-8c8665bae31e">4,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74e133af2bf04b16807d4769bdb0cb72_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNi04LTEtMS03MzQ3_bfa83d8f-eaff-429e-8c34-4a1831b5ba53">2,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8d899ddc8834e689efc87de396289f8_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNi0xMC0xLTEtNzM1MQ_073c09c7-5541-4305-9b96-23146ea98d13">7,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0865c1b494ba451ab270138139c94f26_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNy0yLTEtMS03MzMz_8840cd61-a50b-4fe3-91b6-b6d48fb1b01d">181,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e1ebc0d9c8f4fa49f8160f97e726c28_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNy00LTEtMS03MzM4_2bbfaff9-4b90-45ad-874c-1b41364d6a08">23,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5822641e200b480e91f0f00410faaa4f_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNy02LTEtMS03MzQ1_39477b14-d018-45ea-b86f-bca9cc65474b">31,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i930f6e9c37794d87a77e92a1acdd9d20_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNy04LTEtMS03MzQ3_43a04486-6128-46ee-a46e-2a6224b98404">43,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNy0xMC0xLTEtNzM1MQ_bf57cc46-78e5-421c-b438-58683dd6fb91">279,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:29.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.289%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Patient</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biopharma partner</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other business-to-business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Direct</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Test revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centralized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9ceb9d1a9ba4fefab7b0de9a46a08f5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfMy0yLTEtMS03MzUz_ba4991a5-19e6-4c47-81cf-9bac612ef326">153,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id351fd76aed144bd8c8d86224002492a_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfMy00LTEtMS03MzUz_c3866d5c-3f15-4034-aa70-0b70e389582c">17,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3e33012667e4e30a31dc4fd2506de06_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfMy02LTEtMS03MzUz_500f28a4-ff99-411c-a08d-685d6c07c4e1">10,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04c0ca3a9d3842ebb3e2454a419f73db_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfMy04LTEtMS03MzUz_e5b7df38-9860-4f14-bc41-617328387adc">30,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id48ae029801d40a797835dbbc0b21225_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfMy0xMC0xLTEtNzM1Mw_ffadfb1e-5aee-424d-b03a-0e481ef72d47">212,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total test revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i569b0aa5a6f34fb192244d9b4ba6eda3_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNS0yLTEtMS03MzUz_b1d6895d-8fd7-48ce-bedd-520ed261c254">153,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58747813981d448b9d05d26c6c6d5246_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNS00LTEtMS03MzUz_21c784cc-7cb5-4add-925e-c948e3fdf293">17,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f82f2edd74c43e996978b02294c3f96_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNS02LTEtMS03MzUz_66a78ab4-4c7a-4940-9cb1-8b7e8b1527c5">10,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6829414e2ffa46ec8834efbb42474a0a_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNS04LTEtMS03MzUz_1bffe88c-fdb0-459c-83b8-bc45f7b86dbc">30,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437a19f6fb264a83b0e5e51fec25eb41_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNS0xMC0xLTEtNzM1Mw_2ea8622f-a32f-4d9c-a376-6eceb6599c9f">212,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491dfe25cfb649818908611d2258015f_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNi0yLTEtMS03MzUz_3cededa7-50bb-4001-b33e-71fc868cfc25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba34653ed3d4026b109adcc85e47692_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNi00LTEtMS03MzUz_714e60a5-356b-4f82-bb02-a3a044ce2098">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7194b23e865e4e6985412838b83facfa_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNi02LTEtMS03MzUz_54b47a9d-6d08-4eef-aa43-cc31ac1ba132">2,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a31b78347c4b40b403d983d215552b_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNi04LTEtMS03MzUz_0b878510-79e4-484b-b3fd-bb0c694f2271">2,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f2ead9ac6540068a6b97873f3f9752_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNi0xMC0xLTEtNzM1Mw_1b43840c-ef79-450e-90a4-af05e70f63e8">4,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7296e71c4e804c2c81cdefbc5ff88c20_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNy0yLTEtMS03MzUz_d465f31c-2330-438f-bb05-cfccdf60b0ae">153,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969948f32a3e419e836b2483a8c32d1b_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNy00LTEtMS03MzUz_c86d0a12-b6a5-4812-a433-cfcc023ba3d9">17,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied3c3598292b417c808a16a8f89056d5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNy02LTEtMS03MzUz_57cec00a-175b-4719-820e-1db597b15b61">12,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if00851ed8e674d059de41cc8a623702e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNy04LTEtMS03MzUz_894b083d-6570-4912-af04-816aa834f19c">32,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNy0xMC0xLTEtNzM1Mw_abafaf11-af9e-485c-ada0-a9f68d3404c7">216,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:29.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.289%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Patient</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biopharma partner</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other business-to-business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Direct</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Test revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centralized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd4026968274daa9db97163c9bf7adb_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfMy0yLTEtMS03MzU1_2c92bab3-a93f-49e7-9cd2-3eaa4d7f939d">96,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddcdbd12b8c7475aba56d81dda39e665_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfMy00LTEtMS03MzU1_fe001b23-e7a1-4e2c-82b0-01f8d0f062c2">13,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d4f784ba21340fca1b9b756750631dc_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfMy02LTEtMS03MzU1_62b270f0-bbe3-4204-b592-617efe917ecb">6,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63d5268d5fcc418f821908f9c967fc66_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfMy04LTEtMS03MzU1_54a70a4e-0fa8-45b4-b971-fb27c535d654">28,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3b56aad901d4542b70fef47b9e041b7_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfMy0xMC0xLTEtNzM1NQ_5c2f172f-c37a-4143-9fe6-85a9db9bfc79">144,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total test revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c178e50df2e482c954755b5678ede25_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNS0yLTEtMS03MzU1_b770a942-09fe-4847-b03f-539b0ee508d5">96,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fd6d6acd7ce4ad4bca9f6796da9e37a_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNS00LTEtMS03MzU1_ee01d213-d284-4f4e-8b1e-7d110490e5b0">13,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1e9baa6d9c74475a1b214d6a20dd9a3_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNS02LTEtMS03MzU1_5694cc0c-3211-42a6-9939-bb6ddc146bdf">6,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeca44f7c289448bba37ead51a718ccb_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNS04LTEtMS03MzU1_adbe08d4-bb2b-42aa-afe6-7284eb8e100a">28,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58cad0e4115a408fb292a43a94deba31_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNS0xMC0xLTEtNzM1NQ_17e271a6-6b99-43c5-89dd-1c9cc6f1111d">144,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie19147196bf74f8a98a96a08aa4ff4ef_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNi0yLTEtMS03MzU1_a78ba177-8770-4419-9620-5afa45a13f9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d25782f3f414458ad4852af49306b8a_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNi00LTEtMS03MzU1_abd0d989-c8f3-45af-acdc-b6c9681cd71b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82f3fed101ff476eac77b5bae97ef149_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNi02LTEtMS03MzU1_399c2193-1456-4e08-b956-bdaff08628eb">1,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f15ba33a7ce4679b90a0c0de0249127_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNi04LTEtMS03MzU1_e9d8bfe4-880d-470e-a28f-49a724558b1e">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616089384d754359aaf3b67545a021a0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNi0xMC0xLTEtNzM1NQ_abd148f3-adb5-4e48-a3cf-6bc23acc2cc4">3,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98f5fa2ae5e04ed4892542827e4eda04_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNy0yLTEtMS03MzU1_fb4cbd25-7459-4353-8424-9935ddbb36e5">96,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf399717bf28435a89aca26b773c0386_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNy00LTEtMS03MzU1_87e11735-bedd-42ba-9ae5-731c87f6c6cc">13,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31abe8effbe949ff872826205878e9e6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNy02LTEtMS03MzU1_094f4d3d-bb39-411e-8ada-ccf6aee3edff">7,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a9b0c466f0496cad68a4ecd841c041_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNy04LTEtMS03MzU1_0423690d-2ed1-4975-8935-29f06a5fbf02">29,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNy0xMC0xLTEtNzM1NQ_3097dcc8-b9b0-4446-9efd-141041a474ee">147,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue related to billings based on estimates of the amount that will ultimately be realized. Cash collections for certain tests delivered may differ from rates originally estimated. <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfChangeInAccountingEstimateTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMjI2Mw_1278dee8-89c3-4ed2-a979-8eae0975b7be" continuedAt="i537eb08d00734f04b02525c24ff899ea" escape="true">As a result of new information, we update our estimate quarterly of the amounts to be recognized for previously delivered tests which resulted in the following increases to revenue and decreases to our loss from operations and basic and diluted net loss per share (in millions, except per share amounts):</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="i537eb08d00734f04b02525c24ff899ea"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46861699db14e22b253710d388c79d1_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfMi0xLTEtMS02MjMx_5383e11f-530a-4676-8dc7-ca10dc13a61d">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf84e334a474c329adf523e6663178a_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfMi0xLTEtMS0w_2c9b482b-606d-4ae4-9588-f290c73970fc">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3516e7ca9c34c0eb58ee7744a7f3850_D20180101-20181231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfMi0zLTEtMS0w_38cc6fba-dcbd-4a25-b2ac-80c1a1084b8a">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if46861699db14e22b253710d388c79d1_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfMy0xLTEtMS02MjMx_f4fa8913-19d3-4ef5-a808-a1ae32769a52">4.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idcf84e334a474c329adf523e6663178a_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfMy0xLTEtMS0w_fe460320-497a-476a-a52f-3490ed7c4076">4.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3516e7ca9c34c0eb58ee7744a7f3850_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfMy0zLTEtMS0w_9e3718fa-9963-416c-9159-1a9b2978901d">4.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if46861699db14e22b253710d388c79d1_D20200101-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfNC0xLTEtMS02MjMx_d72d9aca-0918-4f4b-8dcd-30745dbb8096">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="idcf84e334a474c329adf523e6663178a_D20190101-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfNC0xLTEtMS0w_d7603642-202c-44bb-aa27-cac7d1bf351c">0.05</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie3516e7ca9c34c0eb58ee7744a7f3850_D20180101-20181231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfNC0zLTEtMS0w_b1f7797e-3af9-4976-9037-ef050e1c96ec">0.07</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our billable volumes decreased significantly in the second half of March 2020 as compared to the first few months of 2020 as a result of COVID-19 and related limitations and priorities across the healthcare system. Our daily test volumes have consistently increased from the low in March 2020, although we are currently still experiencing changes in product mix due to the impact of COVID-19. COVID-19 could have a material impact on our financial results for the foreseeable future, particularly on product mix and as a result, the revenue we recognize. We have reviewed and adjusted for the impact of COVID-19 on our estimates related to revenue recognition and expected credit losses. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately <ix:nonFraction unitRef="number" contextRef="ic1f0935550d444fa90ce07c61f19769c_D20200401-20200430" decimals="2" name="nvta:RestructuringandRelatedCostNumberofPositionsEliminatedPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMTI2NDQzODM3MjU3MDA_1b596774-5500-465b-827b-4f2c8aea2ead">8</ix:nonFraction>% of our workforce as of March 31, 2020 was impacted by a reduction in force in April 2020 in an initiative to manage costs and cash burn that resulted in one-time costs in the second quarter of 2020 of $<ix:nonFraction unitRef="usd" contextRef="iffa172b7ed5b4b2d868c2ae82bbc52a8_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMTI2NDQzODM3MjU3MDQ_618082cd-d02a-4c1e-b2e3-dddaffdcb47b">3.8</ix:nonFraction>&#160;million. In addition, effective May 2020, we have reduced the salaries of our named executive officers by approximately <ix:nonFraction unitRef="number" contextRef="i2cfd56d90ca84309ab029f02e8df5f24_D20200501-20200531" decimals="2" name="nvta:RestructuringandRelatedCostReductioninOfficerSalaryPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMTI2NDQzODM3MjU3MTg_590b5c51-27cf-49cc-915b-42441bfa3b65">20</ix:nonFraction>%, which reductions ceased as of January 2021.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i1cb73180cc6a403bb089b8b4cdecb51b"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was signed into law which was a stimulus bill intended to bolster the economy, among other things, and provide assistance to qualifying businesses and individuals. The CARES Act included an infusion of funds into the healthcare system, and in April 2020, we received $<ix:nonFraction unitRef="usd" contextRef="i7780db32fd364ad99995fb2cdcbfc4fc_D20200401-20200430" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:UnusualOrInfrequentItemNetGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMTI2NDQzODM3MjU3MjM_8ab90933-3b0e-4b94-80f1-837853065aae">3.8</ix:nonFraction>&#160;million as a part of this initiative. This payment was recognized as other income (expense), net in our consolidated statement of operations during the year ended December 31, 2020. We also received $<ix:nonFraction unitRef="usd" contextRef="i05128bf9cc8243f2bc27b6e1f8a3f4b1_D20210101-20210131" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:UnusualOrInfrequentItemNetGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfNzY5NjU4MTQxMTY4OA_f3519f0b-d257-4445-b512-3e60ab439683">2.3</ix:nonFraction>&#160;million in January 2021 which we recognized as other income (expense), net during the three months ended March 31, 2021. At this time, we are not certain of the availability, extent or impact of any future relief provided under the CARES Act.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our accounts receivable represents amounts billed to pharmaceutical partners and other business-to-business customers for test and other revenue recognized, and estimated amounts to be collected from third-party insurance payers for genetic testing revenue recognized. Also included are amounts due under the terms of collaboration and genome network agreements for diagnostic testing and data aggregation reporting services provided and proprietary platform access rights transferred. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also record unbilled revenue for revenue recognized but yet to be billed for services provided to biopharmaceutical companies related to companion diagnostic development. The amount is a contract receivable and is included in accounts receivable on the consolidated balance sheets; unbilled revenue was $<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfODI0NjMzNzIyNDY4Ng_16fd651f-ce06-43df-9299-f2db301da947">4.3</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfODI0NjMzNzIyNDcwNA_b533c61b-a03f-4741-b5fb-b161f692c785">nil</ix:nonFraction> as of December&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a contract liability when cash payments are received or due in advance of our performance related to one or more performance obligations. The deferred revenue balance primarily consists of advanced billings for pharma development services, including billings at the initiation of a performance-based milestones, and recognized as revenue in the applicable future period when the revenue is earned. Also included are prepayments related to our consumer direct channel. We recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMjI1Mzk5ODgzODY0NDU_f35e75f4-ba0a-415c-97b7-e3392a517872">1.4</ix:nonFraction> million from deferred revenue for the year ended as of December&#160;31, 2020. In addition, we recognized deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="i088f81f066a440d084e5a4dba897c8f8_D20201001-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMjI1Mzk5ODgzODY0Mjg_f935dc77-e6d1-4c4e-8272-1e0e3eedc826">4.8</ix:nonFraction> million upon the acquisition of ArcherDX in October 2020, $<ix:nonFraction unitRef="usd" contextRef="if97a189b033643b79b8524895f6a78c7_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMjI1Mzk5ODgzODY0NjI_41b1949c-09fc-4395-802e-affac62eec9b">2.0</ix:nonFraction> million of which was recognized as revenue during the year ended December 31, 2020.</span></div></ix:continuation><div id="ie13029cdd7d64c5bac971f0e86e8f19a_85"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.  <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMTU5MDM_0d2e2a51-9a04-4dae-bd80-2d04138846d4" continuedAt="i3f73ad69035b44eaa9cc78e2e242a154" escape="true">Business combinations</ix:nonNumeric></span></div><ix:continuation id="i3f73ad69035b44eaa9cc78e2e242a154" continuedAt="ia627dc2c191b47db8c510025072dbbc3"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Singular Bio</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, we acquired <ix:nonFraction unitRef="number" contextRef="i175aab7c76c643de95548d9a1cb45a8e_I20190630" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTE5NTk_51df41b4-f11c-47ad-8132-1b2d1c25af83">100</ix:nonFraction>% of the fully diluted equity of Singular Bio, a privately held company developing single molecule detection technology, for approximately $<ix:nonFraction unitRef="usd" contextRef="ic8c530faa72844268e7ba46c4a287907_D20190601-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0MjgyNQ_88a08269-3a44-4809-b41a-ace595c0b343">57.3</ix:nonFraction>&#160;million, comprised of $<ix:nonFraction unitRef="usd" contextRef="i175aab7c76c643de95548d9a1cb45a8e_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0Mjg0MA_75546e7e-96d0-48af-a03a-3a70447cbdd7">53.9</ix:nonFraction>&#160;million in the form of <ix:nonFraction unitRef="shares" contextRef="ic8c530faa72844268e7ba46c4a287907_D20190601-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0Mjg1NQ_6dbd2450-15ce-4d68-ba75-c9ab2e43ee1d">2.5</ix:nonFraction>&#160;million shares of our common stock and the remainder in cash. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We granted approximately $<ix:nonFraction unitRef="usd" contextRef="ie7db43ef787b49d99180bd32eb0c2d09_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0Mjg2OA_a120197f-56fe-4ffc-86b0-351437c16c2d">90.0</ix:nonFraction>&#160;million of restricted stock units ("RSU") under our 2015 Stock Incentive Plan as inducement awards to new employees who joined Invitae in connection with our acquisition of Singular Bio. $<ix:nonFraction unitRef="usd" contextRef="icefe8e19fd8546d5821a526b27974ab7_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0Mjg4Mw_ba9c8e8c-5f65-4c10-bd7e-772ffaf0c89f">45.0</ix:nonFraction>&#160;million of the RSUs are time-based and vested in three equal installments in December 2019, June 2020, and December 2020, subject to the employee's continued service with us ("Time-based RSUs") and $<ix:nonFraction unitRef="usd" contextRef="idbe2c42636474f38911d7bec038c9f4a_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0Mjg5OA_176900aa-ccee-47a0-a9de-91339acface6">45.0</ix:nonFraction>&#160;million of the RSUs are performance-based RSUs ("PRSU") that vest upon the achievement of certain performance conditions. Since the number of awards granted is based on a <ix:nonFraction unitRef="tradingday" contextRef="i664d8f88777d401d939dcc07f67fa240_D20190601-20190630" decimals="INF" name="nvta:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTM3MDE_83d9ea59-e91b-4f5e-a517-91c860715481">30</ix:nonFraction>-day volume weighted-average share price with a fixed dollar value, these Time-based RSUs and PRSUs are liability-classified and the fair value is estimated at each reporting period based on the number of shares that are expected to be issued at each reporting date and our closing stock price, which combined are categorized as Level 3 inputs. Therefore, fair value of the RSUs and PRSUs and the number of shares to be issued will not be fixed until the awards vest.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2020 and 2019, we recorded research and development stock-based compensation expense of $<ix:nonFraction unitRef="usd" contextRef="i76b34857279b4a77ad109619d8a570f6_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTE5Njc_3853bdfa-74db-40e7-a893-e4bf67a8ec44">29.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i8beb45e3e6464392a4fe1aeb393268c9_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNzcyNA_a4af2551-1ab9-42c3-bef4-07b70ea4f9d5">14.7</ix:nonFraction>&#160;million, respectively, related to the Time-based RSUs, and $<ix:nonFraction unitRef="usd" contextRef="iece04e5008c1410393b57b628e274295_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIwMTA_5edc47ad-8c74-42e8-bb4d-2d173a319d84">19.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i4451a9390a774709818e6fbfd6084973_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNzc3MA_03913bcf-37a9-4019-9169-e6e7ca8b6926">24.4</ix:nonFraction>&#160;million, respectively, related to the PRSUs based on our evaluations of the probability of achieving performance conditions. As of December&#160;31, 2020, the Time-based RSUs and PRSUs had a total fair value of $<ix:nonFraction unitRef="usd" contextRef="i1d36b97f4bad4698aa59cb3ac9774f0a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIwODQ_f828244a-715e-45cd-aa4b-f091163dea78">43.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i34ac12069b86446385fba11d5714dfa1_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIwOTk_b80768a6-ec9c-4495-b13a-661298e64521">43.8</ix:nonFraction>&#160;million, respectively, based on a total estimated issuance of <ix:nonFraction unitRef="shares" contextRef="i20988f3b4f3842aca296183226b1191c_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIxMTQ_52dfcb23-b1d4-4b6c-8149-5e06f587dfae">3.5</ix:nonFraction>&#160;million shares and expectation of the achievement of the performance conditions. As of December&#160;31, 2020, <ix:nonFraction unitRef="shares" contextRef="i76b34857279b4a77ad109619d8a570f6_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIxMjc_2a631920-71e0-4a64-a0fe-4dd90ceee7dd">2.0</ix:nonFraction>&#160;million of the Time-based RSUs and <ix:nonFraction unitRef="shares" contextRef="iece04e5008c1410393b57b628e274295_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIxNDA_3ee6c425-1083-43a9-9a11-abc0d2c9bfa9">1.2</ix:nonFraction>&#160;million of the PRSUs had vested with a total fair value of $<ix:nonFraction unitRef="usd" contextRef="i20988f3b4f3842aca296183226b1191c_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIxNTc_585d9b8f-fafc-49d9-b218-f89fed6c6d59">75.0</ix:nonFraction>&#160;million which was recorded in common stock issued or issuable pursuant to acquisitions in the consolidated statements of stockholders' equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ia627dc2c191b47db8c510025072dbbc3" continuedAt="i2e1d57fb849e4be9856080637602965d"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Jungla</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, we acquired <ix:nonFraction unitRef="number" contextRef="iabffd0b7435a46ab8001e51bc9e0f884_I20190731" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIxNzI_a1949b60-0f23-40cb-9e08-4158dbd30836">100</ix:nonFraction>% of the equity interest of Jungla, a privately held company developing a platform for molecular evidence testing in genes, for approximately $<ix:nonFraction unitRef="usd" contextRef="if5c0b15b91a8498db2213d6c5cd2acbd_D20190701-20190731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0NDE4Nw_f8c4d5b0-d4ec-45c1-8525-84d7fab54b0d">59.0</ix:nonFraction>&#160;million, comprised of $<ix:nonFraction unitRef="usd" contextRef="iabffd0b7435a46ab8001e51bc9e0f884_I20190731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0NDIwMg_8dfd3f7d-2599-4cf6-a410-342d797213a8">44.9</ix:nonFraction>&#160;million in the form of shares of our common stock and the remainder in cash.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to pay contingent consideration based on achievement of post-closing development milestones. As of the acquisition date, the fair value of this contingent consideration was $<ix:nonFraction unitRef="usd" contextRef="id813b06cc8204234a74cd25abe6470b0_I20190731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0NDE3Mg_f4b258b8-1dfd-444d-b548-ca3a87f0ff45">10.7</ix:nonFraction>&#160;million including cash and common stock. These milestones are expected to be completed within <ix:nonNumeric contextRef="i34ca71f207834945b160a2a860186500_D20190701-20190731" format="ixt-sec:durwordsen" name="nvta:BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIxODE_16f66b93-60bc-4b30-a5aa-fae4f9b36048">two years</ix:nonNumeric> of the date of acquisition, two of which were completed during the year ended December&#160;31, 2020. The material factors that may impact the fair value of the contingent consideration, and therefore, this liability, are the probabilities and timing of achieving the related milestones and the discount rate we used to estimate the fair value, which are Level 3 inputs not supported by market activity. Significant changes in any of the probabilities of success would result in a significant change in the fair value, which will be estimated at each reporting date with changes reflected as a general and administrative expense. As of December&#160;31, 2020, the fair value of this contingent consideration was $<ix:nonFraction unitRef="usd" contextRef="i3849bfee08db4045a8d579e08dc78573_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxOTc1OA_09a573b9-a381-4a0f-9739-794ef9d50c8b">7.1</ix:nonFraction>&#160;million. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon acquisition, we had a stock payable liability related to our acquisition of Jungla which represents the hold-back obligation to issue <ix:nonFraction unitRef="shares" contextRef="iedca751c89a74c22904be3c69b76ea13_D20190701-20190731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0NDIxNw_206fe240-45e1-40fa-abe5-91af36109d83">0.2</ix:nonFraction>&#160;million shares subject to indemnification claims that may arise. This liability was adjusted at each reporting period based on the fair value of our common stock, which is a Level 3 input, with the change recorded in other income (expense), net. During July 2020, the hold-back shares were remitted in full to the former owners of Jungla. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clear Genetics</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we acquired <ix:nonFraction unitRef="number" contextRef="icad31fda692c44d6b3ebd405fc1f5bfb_I20191130" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIxOTY_f8adfd1c-6835-45d4-aaba-96163eb0e4d1">100</ix:nonFraction>% of the equity interest of Clear Genetics, a developer of software for providing genetic services at scale, for approximately $<ix:nonFraction unitRef="usd" contextRef="i1b7028fd67c14ce39c1a361bf67387ac_D20191101-20191130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIyMDI_c6160458-bf6e-43e8-92f7-94d7924252a3">50.1</ix:nonFraction>&#160;million. Of the cash and stock purchase price consideration issued, $<ix:nonFraction unitRef="usd" contextRef="i3c0220e1f83a4ee1a04a467bc49d5677_D20191101-20191130" decimals="-5" format="ixt:numdotdecimal" name="nvta:BusinessCombinationHoldbackConsiderationCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0NDIzMA_6d432aaa-9d46-43cc-a9b0-04605cd47f8f">0.2</ix:nonFraction>&#160;million of cash and approximately <ix:nonFraction unitRef="shares" contextRef="i3c0220e1f83a4ee1a04a467bc49d5677_D20191101-20191130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIyMTc_1395b1aa-ee84-4edf-add3-0099f07ed2d6">0.4</ix:nonFraction>&#160;million shares of our common stock were subject to a 12-month hold back to satisfy indemnification obligations that  were released during the year ended December 31, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diploid</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we acquired <ix:nonFraction unitRef="number" contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTQ5MzkxMA_1793b01f-2fb6-46f7-92f2-dca4a4a0c567">100</ix:nonFraction>% of the equity interest of Diploid, a developer of artificial intelligence software capable of diagnosing genetic disorders using sequencing data and patient information, for approximately $<ix:nonFraction unitRef="usd" contextRef="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNjU5NzA2OTc5NTIyMA_42e2db35-1811-4308-aa17-02d822fc31ce">82.3</ix:nonFraction>&#160;million in cash and shares of our common stock. Of the stock purchase price consideration issued, approximately <ix:nonFraction unitRef="shares" contextRef="i61df02f3966840fc94c9ac82e9b14a0a_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNjU5NzA2OTc5NTIzNQ_bf959264-4502-49fc-81c9-4238555fd444">0.4</ix:nonFraction>&#160;million shares are subject to a hold-back to satisfy indemnification obligations that may arise. We included the financial results of Diploid in our consolidated financial statements from the acquisition date, which were not material for the year ended December&#160;31, 2020.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i2e1d57fb849e4be9856080637602965d" continuedAt="i801a18b7231d424fa62dc5dd442d82e4"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0ODk0MDY_38619b72-2c80-42ee-bb92-3b702ca18264" continuedAt="i039265e3c9324bc2a20c90cbb6298337" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the purchase price recorded as a part of the acquisition of Diploid (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjY4ZGE2ZDA4MWE0YzQ2NDI4ZWFjZDAzZmQxOGU2ODRiL3RhYmxlcmFuZ2U6NjhkYTZkMDgxYTRjNDY0MjhlYWNkMDNmZDE4ZTY4NGJfMS0xLTEtMS01MTI1_8ac677be-59bc-4a25-a055-0f9b220f273d">32,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hold-back consideration - common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331" decimals="-3" format="ixt:numdotdecimal" name="nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjY4ZGE2ZDA4MWE0YzQ2NDI4ZWFjZDAzZmQxOGU2ODRiL3RhYmxlcmFuZ2U6NjhkYTZkMDgxYTRjNDY0MjhlYWNkMDNmZDE4ZTY4NGJfNS0xLTEtMS01MTI1_123eaf67-ae79-4e85-9f67-72821df48591">7,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjY4ZGE2ZDA4MWE0YzQ2NDI4ZWFjZDAzZmQxOGU2ODRiL3RhYmxlcmFuZ2U6NjhkYTZkMDgxYTRjNDY0MjhlYWNkMDNmZDE4ZTY4NGJfOC0xLTEtMS01MTI1_d7b59757-cc74-4916-8495-db9ffff04fcc">42,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjY4ZGE2ZDA4MWE0YzQ2NDI4ZWFjZDAzZmQxOGU2ODRiL3RhYmxlcmFuZ2U6NjhkYTZkMDgxYTRjNDY0MjhlYWNkMDNmZDE4ZTY4NGJfOS0xLTEtMS01MTI1_8f123c05-44e7-44b9-9b47-bb4a00957ded">82,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:31.5pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired and liabilities assumed are recorded based on valuations derived from estimated fair value assessments and assumptions used by us. While we believe that our estimates and assumptions underlying the valuations are reasonable, different estimates and assumptions could result in different valuations assigned to the individual assets acquired and liabilities assumed, and the resulting amount of goodwill. <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0ODk0MDc_af8b49e3-2974-43d2-9027-bdaaf5d5e8b8" continuedAt="i3d36643221944565b683cd94895ffc49" escape="true">The following table summarizes the fair values of assets acquired and liabilities assumed through our acquisition of Diploid at the date of acquisition (in thousands):</ix:nonNumeric></span></div><div style="margin-top:6pt"><ix:continuation id="i3d36643221944565b683cd94895ffc49" continuedAt="id4443823ee734ca8bfa22ec634a26ecc"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfMC0xLTEtMS01MTI3_f70f068a-299d-4991-8f71-4f2d90356a6f">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfMS0xLTEtMS01MTI3_a2e8982f-8cb8-4e7b-baba-65255994c810">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfMi0xLTEtMS01MTI3_88a21806-7865-45b5-8977-9f67330bb383">41,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfMy0xLTEtMS01MTI3_10dfa35e-6312-4613-abae-1a91b1dcfbf8">41,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfNC0xLTEtMS01MTI3_40c4f159-1876-4c6a-9d11-f62134c9b5c8">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfNy0xLTEtMS01MTI3_214d0aba-bd5a-48fe-93df-53da14896d80">10,250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identifiable assets acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfOC0xLTEtMS01MTI3_ffc10ea4-0209-4c02-8c67-c5d2c588b533">31,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfOS0xLTEtMS01MTI3_5e9caac7-377a-4cf1-850f-e2a547696ef3">50,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfMTAtMS0xLTEtNTEyNw_6d6dec94-b8c5-4260-ace9-5340ccbf60ad">82,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:31.5pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the guidance provided in ASC 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accounted for the acquisition of Diploid as a business combination and determined that 1) Diploid was a business which combines inputs and processes to create outputs, and 2) substantially all of the fair value of gross assets acquired was not concentrated in a single identifiable asset or group of similar identifiable assets. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchase price allocation for the acquisition is preliminary and subject to revision as additional information about fair value of assets and liabilities becomes available, primarily related to our deferred tax liability assumed in connection with the acquisition. Additional information that existed as of the acquisition date but at the time was unknown to us may become known to us during the remainder of the measurement period, a period not to exceed 12 months from the acquisition date. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measured the identifiable assets and liabilities assumed at their acquisition date fair values separately from goodwill. The intangible asset acquired is developed technology related to Diploid's artificial intelligence technology platform. The fair value of the developed technology was estimated using an income approach with an estimated useful life of <ix:nonNumeric contextRef="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331" format="ixt-sec:durwordsen" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIyNDY_5a404369-a821-4ec1-890e-cb778b2199f3">nine years</ix:nonNumeric>. As of the acquisition date, we recorded a stock payable liability of $<ix:nonFraction unitRef="usd" contextRef="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNjU5NzA2OTc5NTQwMw_68f04094-b9f3-4c98-a64f-57af858e59be">7.5</ix:nonFraction>&#160;million to represent the hold-back obligation to issue <ix:nonFraction unitRef="shares" contextRef="i61df02f3966840fc94c9ac82e9b14a0a_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNjU5NzA2OTc5NTQxNw_7b07fcaa-592b-424b-9dd3-e77c2f03eeb4">0.4</ix:nonFraction>&#160;million shares subject to indemnification claims that may arise. This liability is adjusted at each reporting period based on the fair value of our common stock, which is a Level 3 input. As of December&#160;31, 2020, the value of this liability was $<ix:nonFraction unitRef="usd" contextRef="i21aa382eb1b9450d946befd8e9d905ff_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNjU5NzA2OTc5NTQ0Ng_4b8b544b-7e94-4ae5-801f-d96b72342ae2">17.7</ix:nonFraction>&#160;million with the change recorded in other income (expense), net.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired. The acquisition of Diploid resulted in the recognition of $<ix:nonFraction unitRef="usd" contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNjU5NzA2OTc5NTQ4NA_62dd449a-db19-4778-b807-27b440b7d065">50.7</ix:nonFraction>&#160;million of goodwill which we believe relates primarily to expansion of the acquired technology to apply to new areas of genetic testing. The goodwill created as a result of the acquisition of Diploid is not deductible for the foreign local tax purposes.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we granted <ix:nonFraction unitRef="shares" contextRef="if78d990dbf00451cac45ceb3bfbb2548_D20200601-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDkzNA_9c72e8ee-2a0c-4227-bd16-2b1c1f2a65a4">0.2</ix:nonFraction>&#160;million RSUs with a fair value of $<ix:nonFraction unitRef="usd" contextRef="icf11c41e83954282a4bbb12523482153_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDk0Nw_21ee730e-cdb5-419a-a284-2cb256733881">3.6</ix:nonFraction>&#160;million under our 2015 Stock Incentive Plan as inducement awards in connection with our acquisition of Diploid. These RSUs vest in two equal installments, in April 2021 and April 2022. The value of the awards was recognized as research and development stock-based compensation upon grant in June 2020 as there were no ongoing obligations required by the award recipients. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Genelex and YouScript</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, we acquired <ix:nonFraction unitRef="number" contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDQzNw_6ae02ec5-87db-4b90-9264-033e4963b5f6"><ix:nonFraction unitRef="number" contextRef="i4fa43003f790492f944ab337f15b503e_I20200430" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDQzNw_700627ad-befd-46f1-bb1d-709d5e99ea67">100</ix:nonFraction></ix:nonFraction>% of the equity interest of Genelex and YouScript to bring pharmacogenetic testing and integrated clinical decision support to Invitae. We acquired Genelex for approximately $<ix:nonFraction unitRef="usd" contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDQ0Mw_c35c7f58-3c8c-4796-a168-aced0b05b285">13.2</ix:nonFraction>&#160;million, </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i801a18b7231d424fa62dc5dd442d82e4" continuedAt="if16ba3a6491b42deae3f8b1fb4d5918f"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily in shares of our common stock. Of the stock purchase price consideration issued, approximately <ix:nonFraction unitRef="shares" contextRef="i920e93e600db4f87ad9b6f58a894b7ed_D20200401-20200430" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDQ1OA_477bc556-fe18-4608-9877-b39642161b24">0.1</ix:nonFraction>&#160;million shares are subject to a hold-back to satisfy indemnification obligations that may arise. We acquired YouScript for approximately $<ix:nonFraction unitRef="usd" contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDQ3MQ_2ea8511a-d445-47c5-8ada-6471383bd931">52.7</ix:nonFraction>&#160;million, including cash consideration of $<ix:nonFraction unitRef="usd" contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDQ4Ng_304f06a4-7253-402a-aae4-6968b18f1285">24.5</ix:nonFraction>&#160;million and the remaining in shares of our common stock. Of the purchase price consideration for YouScript, approximately $<ix:nonFraction unitRef="usd" contextRef="id10eb65b4a854730b97cac8b3b292344_D20200401-20200430" decimals="-5" format="ixt:numdotdecimal" name="nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDUwMQ_1901d373-9f30-4be6-9d2d-2e91e47db843">1.4</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="id10eb65b4a854730b97cac8b3b292344_D20200401-20200430" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDUxNQ_59616dfe-f4e6-43af-93dd-b1fdb3febb54">0.5</ix:nonFraction>&#160;million shares of our common stock are subject to a hold-back to satisfy indemnification obligations that may arise. We included the financial results of Genelex and YouScript in our consolidated financial statements from the acquisition date, which were not material for the year ended December 31, 2020. We recorded $<ix:nonFraction unitRef="usd" contextRef="i0be3804e02eb472fa855c077d75a96ad_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDc2Mg_affbb7a7-6314-4496-b569-36f5f926c888">1.7</ix:nonFraction>&#160;million of transaction costs related to the acquisition of Genelex and YouScript as general and administrative expense during the year ended December 31, 2020.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to pay contingent consideration in the form of additional shares of our common stock in connection with the acquisition of Genelex if, within a specified period following the closing, we achieve a certain product milestone, in which case we would issue shares of our common stock with a value equal to a portion of the gross revenues actually received by us for a pharmacogenetic product reimbursed through certain payers during an earn-out period of up to <ix:nonNumeric contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430" format="ixt-sec:durwordsen" name="nvta:BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIyNjU_2fad3a18-4b8d-46c0-89f9-e2714a8a5564">four years</ix:nonNumeric>. As of the acquisition date, the fair value of this contingent consideration was $<ix:nonFraction unitRef="usd" contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDgxNA_61048bc4-0e4f-467e-85c8-2d9b39a29dc4">2.0</ix:nonFraction>&#160;million in the form of shares of our common stock. The material factors that may impact the fair value of the contingent consideration, and therefore, this liability, are the probabilities and timing of achieving the related milestone, the estimated revenues achieved for a pharmacogenetic product and the discount rate we used to estimate the fair value, which are Level 3 inputs not supported by market activity. Significant changes in any of the probabilities of success would result in a significant change in the fair value, which is estimated at each reporting date with changes reflected as general and administrative expense. As of December&#160;31, 2020, the fair value of this contingent consideration was $<ix:nonFraction unitRef="usd" contextRef="ia4a51d4bcba64524baa8cc419ee0d7bf_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTQ4MDU_453ec194-8e2e-4857-84b0-aee1e82bba53">1.2</ix:nonFraction>&#160;million. </span></div><ix:continuation id="i039265e3c9324bc2a20c90cbb6298337" continuedAt="i498899a684d944c58beb403c0d6ba8e4"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the purchase prices recorded as a part of the acquisition of Genelex and YouScript (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.290%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.290%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Genelex</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">YouScript</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash transferred</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMS0xLTEtMS01MTcy_f0697ffb-fe66-4f34-84fd-6f1157c8cf44">972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMS0zLTEtMS01MTcy_555049db-ead0-4d38-94b5-b61c43d8ffe3">24,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604983240be1439382d7e6de61b44b46_D20200401-20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMS01LTEtMS01MTcy_eb24617a-b236-4827-89bf-2bfaffc53c43">25,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Hold-back consideration - cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430" decimals="-3" format="ixt:zerodash" name="nvta:BusinessCombinationHoldbackConsiderationCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMi0xLTEtMS01MTcy_f4635147-ce1b-445b-9490-71c8038f7719">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430" decimals="-3" format="ixt:numdotdecimal" name="nvta:BusinessCombinationHoldbackConsiderationCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMi0zLTEtMS01MTcy_d7a1e22b-db7f-466a-b72a-3c3c99daa99b">1,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604983240be1439382d7e6de61b44b46_D20200401-20200430" decimals="-3" format="ixt:numdotdecimal" name="nvta:BusinessCombinationHoldbackConsiderationCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMi01LTEtMS01MTcy_78e68c35-eb58-43f5-8560-32b65e33e749">1,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Hold-back consideration - common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430" decimals="-3" name="nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMy0xLTEtMS01MTcy_cbef6272-18b4-44a2-8ec4-7dddaf7d358b">781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430" decimals="-3" format="ixt:numdotdecimal" name="nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMy0zLTEtMS01MTcy_e830fd79-5da1-4722-8896-a5523ffc3921">5,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604983240be1439382d7e6de61b44b46_D20200401-20200430" decimals="-3" format="ixt:numdotdecimal" name="nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMy01LTEtMS01MTcy_1d535a7e-9862-4908-b718-e46a165c1785">6,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNC0xLTEtMS01MTcy_bcc0eeca-6857-4388-9cc2-dab92b905737">1,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNC0zLTEtMS01MTcy_a59dca21-83c8-4a44-a877-099994b06465">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604983240be1439382d7e6de61b44b46_D20200401-20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNC01LTEtMS01MTcy_b4e19e29-4d85-42a3-8aee-298bf748d398">1,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Common stock transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNS0xLTEtMS01MTcy_8d22f773-615a-4dab-af21-5290b4d10fbd">9,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNS0zLTEtMS01MTcy_78e92042-c43c-42bb-9080-24c51da57f30">21,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604983240be1439382d7e6de61b44b46_D20200401-20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNS01LTEtMS01MTcy_506b7b67-737d-466f-a82b-ba9749c828ed">30,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNi0xLTEtMS01MTcy_ba8dbec1-93e6-4ca4-a857-d4cc1c04351f">13,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNi0zLTEtMS01MTcy_4f10011e-4e4b-4599-8dd3-a32a6cda7448">52,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i604983240be1439382d7e6de61b44b46_D20200401-20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNi01LTEtMS01MTcy_53f4df71-2adb-41c4-87c7-bdf1ec341568">65,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="if16ba3a6491b42deae3f8b1fb4d5918f" continuedAt="i5a0585b3af894014b79ecc5487d3a5bd"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired and liabilities assumed are recorded based on valuations derived from estimated fair value assessments and assumptions used by us. While we believe that our estimates and assumptions underlying the valuations are reasonable, different estimates and assumptions could result in different valuations assigned to the individual assets acquired and liabilities assumed, and the resulting amount of goodwill. <ix:continuation id="id4443823ee734ca8bfa22ec634a26ecc" continuedAt="i772242e259744aa3b83fe42fc7c24a4e">The following table summarizes the fair values of assets acquired and liabilities assumed through our acquisitions of Genelex and YouScript at the date of acquisition (in thousands):</ix:continuation></span></div><div style="margin-top:6pt"><ix:continuation id="i772242e259744aa3b83fe42fc7c24a4e" continuedAt="i317c35028ab0439eaf5e086e331b3f33"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:42.686%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.254%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Genelex</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">YouScript</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMS0xLTEtMS01MTg0_d6ec5e66-3508-480b-b7f1-d8690c27382f">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i4fa43003f790492f944ab337f15b503e_I20200430" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMS0zLTEtMS01MTg0_0cc7129c-c488-4826-a790-d41e5e0ee2d1">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMS01LTEtMS01MTg0_b91fd91b-c52b-439f-bb32-b3e3cf3034e2">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMi0xLTEtMS01MTg0_c749c45b-bc58-4983-9e0a-314706e140a8">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i4fa43003f790492f944ab337f15b503e_I20200430" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMi0zLTEtMS01MTg0_df4f8b8e-530d-48e1-8a4a-d00ba8af440e">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMi01LTEtMS01MTg0_1dc0cf75-be5a-4680-8850-02bc6ba5e0f1">277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMy0xLTEtMS01MTg0_5f770dd9-d58d-4021-87cb-49c4104eca02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i4fa43003f790492f944ab337f15b503e_I20200430" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMy0zLTEtMS01MTg0_0bbaa4ce-edb1-4b72-a1dd-bcea0b2663f2">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMy01LTEtMS01MTg0_5f5169ba-a56b-40b1-b227-375c5e6b5ad7">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430" decimals="-3" format="ixt:zerodash" name="nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNC0xLTEtMS01MTg0_1e3c15f1-8cec-4990-b601-d087d373810b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i4fa43003f790492f944ab337f15b503e_I20200430" decimals="-3" name="nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNC0zLTEtMS01MTg0_47b6c167-6e49-47e0-8375-5f73edeaa126">355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430" decimals="-3" name="nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNC01LTEtMS01MTg0_196c5f9c-0696-4742-a94f-80f02d0b0b19">355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNS0xLTEtMS01MTg0_56d36420-3775-4dcb-95ac-01c45dc358cb">9,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i4fa43003f790492f944ab337f15b503e_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNS0zLTEtMS01MTg0_4132ffaa-e84c-4006-8cd8-8328f5b031b9">25,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNS01LTEtMS01MTg0_b90b0bd2-9290-457d-bbc0-bf287d974f55">34,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total identifiable assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNi0xLTEtMS01MTg0_5a72454a-e3ed-42f9-a60e-f5aa7267506c">9,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i4fa43003f790492f944ab337f15b503e_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNi0zLTEtMS01MTg0_05ebe67c-81fc-4e20-a7e9-a6a329701d60">26,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNi01LTEtMS01MTg0_e5c4d625-a8a7-477b-a93d-a101fe53fc8d">35,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNy0xLTEtMS01MTg0_a1dc3ecb-c590-4a1c-a05b-f470c9a0b30e">320</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="i4fa43003f790492f944ab337f15b503e_I20200430" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNy0zLTEtMS01MTg0_1a8bc807-ec76-4f1f-a346-5b1236ed2de3">481</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNy01LTEtMS01MTg0_412ff45b-41d2-4d14-a849-95560ea94785">801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfOC0xLTEtMS01MTg0_2588f4fb-1b78-4584-8f25-b1e6ca026b88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="i4fa43003f790492f944ab337f15b503e_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfOC0zLTEtMS01MTg0_fa38c7f6-4ab4-498d-a6ae-763444eff31d">2,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfOC01LTEtMS01MTg0_6d3f0492-ee0f-45c4-8964-fde9ecefad19">2,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfOS0xLTEtMS01MTg0_06b3336c-f55a-4815-a7b6-9de72d7c54fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="i4fa43003f790492f944ab337f15b503e_I20200430" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfOS0zLTEtMS01MTg0_d8a22697-4c41-4d74-8b31-701d25c9aab3">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfOS01LTEtMS01MTg0_37b05ef0-4b61-4acb-8f92-26272ae49488">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net identifiable assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTAtMS0xLTEtNTE4NA_646457d4-b38a-4020-b53c-7577284885dc">9,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i4fa43003f790492f944ab337f15b503e_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTAtMy0xLTEtNTE4NA_56737638-75b1-4b56-bfe6-f142374bf9fa">22,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTAtNS0xLTEtNTE4NA_81cc4863-5896-47d8-8cc5-1d76e8beeaa4">32,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTEtMS0xLTEtNTE4NA_2f4732d5-bf8e-43cb-88b0-b84b2c2b9cdb">4,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i4fa43003f790492f944ab337f15b503e_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTEtMy0xLTEtNTE4NA_01dcd8ff-d82c-4444-bdf4-7fa8260a2526">29,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTEtNS0xLTEtNTE4NA_1e212163-9891-485d-a4fc-f9d8d0eac711">33,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTItMS0xLTEtNTE4NA_183269b6-b8ec-4041-b4d2-d2f75c1602f7">13,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i4fa43003f790492f944ab337f15b503e_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTItMy0xLTEtNTE4NA_83dcf327-9f0e-4cc7-8e3d-206c1e011954">52,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTItNS0xLTEtNTE4NA_b6edb8fe-dcfb-443a-8843-14e4d25633c6">65,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:continuation></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the guidance provided in ASC 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accounted for the acquisitions of Genelex and YouScript as business combinations and determined that 1) Genelex and YouScript were businesses which combine inputs and processes to create outputs, and 2) substantially all of the fair value of gross assets acquired were not concentrated in a single identifiable asset or group of similar identifiable assets. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchase price allocation for the acquisitions is preliminary and subject to revision as additional information about fair value of assets and liabilities becomes available, primarily related to our deferred tax liability assumed. Additional information that existed as of the acquisition date but at the time was unknown to us may become known to us during the remainder of the measurement period, a period not to exceed 12 months from the acquisition date. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measured the identifiable assets and liabilities assumed at their acquisition date fair values separately from goodwill. The intangible assets acquired are the developed technologies related to Genelex's and YouScript's technology platforms. The fair value of the developed technologies were estimated using an income approach with an estimated useful life of <ix:nonNumeric contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430" format="ixt-sec:durwordsen" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIyOTU_0c2fd3aa-2d9a-48c4-ba73-ae862b42494f"><ix:nonNumeric contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430" format="ixt-sec:durwordsen" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIyOTU_263b0ca8-61bd-482c-908d-84e2ba5b4d44">eight years</ix:nonNumeric></ix:nonNumeric>. As of the acquisition date, we recorded stock payable liabilities of $<ix:nonFraction unitRef="usd" contextRef="i49c0120db25348e6a3ad6bfc5753b6e0_D20200401-20200430" decimals="-5" format="ixt:numdotdecimal" name="nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDg0MA_e322bb55-423b-4de1-bce1-918e42585fd1">6.2</ix:nonFraction>&#160;million to represent the hold-back obligation to issue shares subject to indemnification claims that may arise. These liabilities are adjusted at each reporting period based on the fair value of our common stock, which is a Level 3 input. As of December&#160;31, 2020, the value of this liability was $<ix:nonFraction unitRef="usd" contextRef="i376851875deb457fb8f3344dfc678b71_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDg3NQ_541d1684-24be-46a7-9d06-b36aa562c113">21.6</ix:nonFraction>&#160;million with the change recorded in other income (expense), net.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired. The acquisitions of Genelex and YouScript resulted in the recognition of $<ix:nonFraction unitRef="usd" contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDg5MQ_1484c7e0-292d-42d5-9016-02989d2f7de1">33.8</ix:nonFraction>&#160;million of goodwill which we believe relates primarily to future functionality and expansion of the acquired technologies. Of the goodwill recognized, $<ix:nonFraction unitRef="usd" contextRef="i4fa43003f790492f944ab337f15b503e_I20200430" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDkwNg_245d7b85-0265-44ea-8ea3-61975678513c">29.7</ix:nonFraction>&#160;million related to the YouScript acquisition is not deductible for tax purposes.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ArcherDX</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we entered into a definitive agreement with ArcherDX, a genomics analysis company democratizing precision oncology, and in October 2020, the closing conditions were met and the transaction was consummated. Under the terms of the agreement, we acquired <ix:nonFraction unitRef="number" contextRef="i098aab9e153f4c929328dfcb7cfaab20_I20200630" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg1MDE1MTM_73590a08-1ff0-4ab2-bc10-3dbd32103aee">100</ix:nonFraction>% of the equity interest of ArcherDX&#160;for $<ix:nonFraction unitRef="usd" contextRef="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIzNDU_2f5eede4-a9d1-4ce1-b7a0-5c424694b721">2.3</ix:nonFraction>&#160;billion, comprised of $<ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIzNTk_dcf5c004-8850-4cc0-837f-79ac2eda9958">2.0</ix:nonFraction>&#160;billion in the form of our common stock, $<ix:nonFraction unitRef="usd" contextRef="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTk0NTQ_c6698012-1564-49a2-842d-776b15029f0c">2.0</ix:nonFraction>&#160;million in liabilities, and the remainder in cash. We incurred $<ix:nonFraction unitRef="usd" contextRef="i76b9ebec35b749d1bea22642506ec50a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIzNzM_d7439e10-0d9d-4d53-84d9-7e68da129056">20.9</ix:nonFraction>&#160;million of transaction costs related to the acquisition of ArcherDX which we recorded as general and administrative expense during the year ended December 31, 2020. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i5a0585b3af894014b79ecc5487d3a5bd" continuedAt="i217d8b29a2e84285a882c48aaac7392b"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to pay contingent consideration based on achievement of post-closing development and revenue milestones. As of the acquisition date, the total fair value of the contingent consideration was $<ix:nonFraction unitRef="usd" contextRef="i96044be6fb014778a5e4a8af9e0dfbbb_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIzODg_e44bc393-b71b-483b-8dc5-47402f33c7a9">945.2</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyNTQwOQ_8283acc9-d6c7-4e02-83c5-d1694f51ea3c">933.6</ix:nonFraction>&#160;million of which was included in the purchase price and $<ix:nonFraction unitRef="usd" contextRef="ifd1c00bbb2f5471097e760d29754a813_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyNTA5OA_85baadb8-8727-4adc-b2cd-0c8e92233376">11.6</ix:nonFraction>&#160;million recognized as non-recurring post-combination compensation expense. Of this $<ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyNTA4Mg_e890d1f0-d576-4bf9-bc5a-e483260466ed">933.6</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i0bf4bd068321410598134af3a04bf469_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjMwODk3NDQzMDYyOTI_7d979805-3eb9-4c96-a9f1-7d2fc9725eec">925.1</ix:nonFraction> million would be in the form of shares of our common stock which will be priced at the time of the milestone achievement, and the remainder in cash. The milestones are expected to be completed within approximately <ix:nonNumeric contextRef="ia4c5e282814b430c8949b3e79a822850_D20201001-20201031" format="ixt-sec:durwordsen" name="nvta:BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjMwODk3NDQzMDYzMDY_82ff7ebf-8a51-4ad3-992e-dc1ccae79163">two years</ix:nonNumeric> from the date of the acquisition, with one of them being achieved during November 2020 which resulted in the issuance of <ix:nonFraction unitRef="shares" contextRef="i19caca01816142a3b5b28f51ca27894b_D20201101-20201130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODI0NjMzNzMzNDQwOQ_2f4e881f-807a-45c6-8ccd-412cae29b2b5">5.0</ix:nonFraction>&#160;million shares of our common stock and a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i19caca01816142a3b5b28f51ca27894b_D20201101-20201130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyMTg2NQ_25c92ca2-3dba-41d1-ada9-c9586481f62a">1.9</ix:nonFraction>&#160;million. This milestone achievement subsequent to the acquisition date resulted in the recognition of $<ix:nonFraction unitRef="usd" contextRef="i19caca01816142a3b5b28f51ca27894b_D20201101-20201130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTk0Njg_88d72c77-a916-4ff7-b134-ae4122bd940c">40.6</ix:nonFraction>&#160;million general and administrative expense. The material factors that may impact the fair value of the contingent consideration, and therefore the liability, are (i) the estimated number of shares issued, (ii) the volatility assumptions of our common stock used in the Monte Carlo simulation, (iii) the probabilities and timing of achievement of milestones and (iv) discount rates, all of which are Level 3 inputs not supported by market activity. Significant changes in any of these inputs may result in a significant change in fair value, which is estimated at each reporting date with changes reflected as general and administrative expense. As of December&#160;31, 2020, the fair value of the contingent consideration representing the remaining milestones was $<ix:nonFraction unitRef="usd" contextRef="i76b9ebec35b749d1bea22642506ec50a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjMwODk3NDQzMDYzMjQ_e4daa41b-6069-4ff0-8d91-e37a3c21c499">788.3</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition, all of ArcherDX's equity awards outstanding and unvested prior to the acquisition became fully vested per the terms of the agreement. The acceleration of vesting required us to allocate the fair value of the equity attributable to the pre-combination service to the purchase price and the remaining amount of $<ix:nonFraction unitRef="usd" contextRef="i911717b1170c40cf972400c897d04ea0_D20201001-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjMwODk3NDQzMDYzMzk_7edcebee-1b2a-4f4c-a0e5-5825b6f212ca">125.8</ix:nonFraction>&#160;million, inclusive of $<ix:nonFraction unitRef="usd" contextRef="ifd1c00bbb2f5471097e760d29754a813_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyNTE4Mw_731a10ae-e44a-485d-b97a-bd7e78743712">11.6</ix:nonFraction>&#160;million in contingent consideration, to non-recurring post-combination expense which we recognized as general and administrative expense during the year ended December 31, 2020. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We included the financial results of ArcherDX in our consolidated financial statements from the acquisition date, which contributed $<ix:nonFraction unitRef="usd" contextRef="if97a189b033643b79b8524895f6a78c7_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODI0NjMzNzMzNDQzOA_76fa3f38-7c0b-4041-890b-4257edf01d71">16.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if97a189b033643b79b8524895f6a78c7_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODI0NjMzNzMzNDQ1Mw_809b6657-2ebc-4d13-a66f-a41bc55fd503">24.8</ix:nonFraction>&#160;million of revenue and net loss, respectively, during the year ended December 31, 2020.</span></div><ix:continuation id="i498899a684d944c58beb403c0d6ba8e4"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the purchase price and post-combination expense recorded as a part of the acquisition of ArcherDX (in millions):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.465%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Post-combination Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfMS0xLTEtMS01NjUz_2f4ab856-e350-470e-baff-c0dd416cf0c2">335.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i911717b1170c40cf972400c897d04ea0_D20201001-20201031" decimals="-5" name="nvta:BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfMS0zLTEtMS01NjM4_94c575a3-7520-4d4b-a72d-7067a47acb7b">22.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration and liabilities incurred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031" decimals="-5" name="nvta:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfNS0xLTEtMS01NjUz_301183a9-df56-4af5-b9b6-55598aa0a246">935.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i911717b1170c40cf972400c897d04ea0_D20201001-20201031" decimals="-5" name="nvta:BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfNS0zLTEtMS01NjQw_c09eb0fa-1f43-4ea6-9b01-c076eba48d46">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfOC0xLTEtMS01NjUz_bad7f46d-b6d8-46a7-b16d-550942af69fd">1,060.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i911717b1170c40cf972400c897d04ea0_D20201001-20201031" decimals="-5" name="nvta:BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfOC0zLTEtMS01NjQy_0d5f9925-b627-4ac3-9573-8401dcd9c7ce">91.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfOS0xLTEtMS01NjUz_d008ba40-87b1-4b82-a54a-f67861e091f4">2,331.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i911717b1170c40cf972400c897d04ea0_D20201001-20201031" decimals="-5" name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfOS0zLTEtMS01NjMz_3aa5f2c7-f8ba-48ee-a7c8-aa39b5a23640">125.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i217d8b29a2e84285a882c48aaac7392b" continuedAt="idf3c66e5aefa40869ba23ba0448acf52"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired and liabilities assumed are recorded based on valuations derived from estimated fair value assessments and assumptions used by us. While we believe that our estimates and assumptions underlying the valuations are reasonable, different estimates and assumptions could result in different valuations assigned to the individual assets acquired and liabilities assumed, and the resulting amount of goodwill. <ix:continuation id="i317c35028ab0439eaf5e086e331b3f33" continuedAt="i966989f719d049d7bb9183f8471acc3b">The following table summarizes the fair values of assets acquired and liabilities assumed through our acquisition of ArcherDX at the date of acquisition (in millions):</ix:continuation></span></div><div style="margin-top:6pt"><ix:continuation id="i966989f719d049d7bb9183f8471acc3b"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMC0xLTEtMS01NjYw_7c5625af-726b-4455-8af8-d973ec14f975">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMS0xLTEtMS01NjYy_df564a71-6db5-4cae-a417-763dbc7f3f80">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMi0xLTEtMS05NjUz_7284adee-5277-4aae-aa90-8039a371c457">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMi0xLTEtMS01NjYy_6053838a-3eeb-4783-99ce-de691ca60963">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMy0xLTEtMS01NjYy_df97445a-c203-4cb8-a813-66cfaf013bf7">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfNC0xLTEtMS01NjYy_e538d7f6-8801-4811-b57e-262f130a7651">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfNS0xLTEtMS01NjYy_a327810b-653a-42d2-a929-f3c7af5d90ee">803.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfNi0xLTEtMS01NjYy_ceed9a68-fe12-42cc-a1ae-ecf5c54c953f">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable assets acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfNy0xLTEtMS01NjYy_6573bb38-9087-41a0-ae7b-5cef4ec9ebc8">875.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfOC0xLTEtMS01NjYy_f223a566-6422-41fc-be91-2fac97e0bd1b">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfOS0xLTEtMS01NjYy_aee1c715-df19-4ceb-95c1-931d4aafa107">18.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMTAtMS0xLTEtNTY2Mg_a07bcdbe-52b6-4802-a781-c49aa9d75e98">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMTEtMS0xLTEtNTY2Mg_4daf6f09-bd7c-47d3-a0f2-ac16ae66bd28">7.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMTItMS0xLTEtNTY2Mg_2ad72c87-7d67-4d42-bcc4-c0b01efff641">151.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMTMtMS0xLTEtNTY2Mg_68975849-14bb-4d13-b9ec-0061b2e2bd7f">13.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identifiable assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMTQtMS0xLTEtNTY2Mg_baa7cb05-db8f-4f83-82a7-185079502819">679.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMTUtMS0xLTEtNTY2Mg_07565703-4e3c-4334-8a06-32e5180c349f">1,652.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMTYtMS0xLTEtNTY2Mg_6e20341c-b747-4676-9c3e-9f607dd34e2c">2,331.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the guidance provided in ASC 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accounted for the acquisition of ArcherDX as a business combination and determined that 1) ArcherDX was a business which combines inputs and processes to create outputs, and 2) substantially all of the fair value of gross assets acquired was not concentrated in a single identifiable asset or group of similar identifiable assets. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchase price allocation for the acquisition is preliminary and subject to revision as additional information about fair value of assets and liabilities becomes available, primarily related to our deferred tax liability assumed in connection with the acquisition. Additional information that existed as of the acquisition date but at the time was unknown to us may become known to us during the remainder of the measurement period, a period not to exceed 12 months from the acquisition date. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="idf3c66e5aefa40869ba23ba0448acf52" continuedAt="i9c467f1b17f84ee5a082aaecb043632a"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measured the identifiable assets and liabilities assumed at their acquisition date fair values separately from goodwill. The intangible assets acquired are the developed technology related to ArcherDX's artificial intelligence technology platform, IPR&amp;D for its STRATAFIDE and PCM products, ArcherDX's customer relationships in place at the time of acquisition, and the ArcherDX tradename. We also acquired the right to develop new technology through an existing agreement for the development and commercialization of sequencing-based companion diagnostics between ArcherDX and a vendor. <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjMwODk3NDQzMDYzNTQ_750e933a-a9f7-49ac-a721-17131ab4e9a6" continuedAt="i9a26ff3d0bc34d0ebb4f6e92cfb6f9d1" escape="true">The fair value of our intangible assets acquired as of the acquisition date and the method used to value these assets as well as the estimated economic lives for amortizable intangible assets were as follows (in millions, except estimated useful life which is in years):</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="i9a26ff3d0bc34d0ebb4f6e92cfb6f9d1"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.744%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated useful life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation method</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization expense</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c4c49beaa8748e88bf241eeb61857e2_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfMi0xLTEtMS01NzA3_38f35958-6ec2-472f-b478-4c25249906c4">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i22c6518824a44e32968c6279d316dbfe_D20201001-20201031" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfMi0zLTEtMS01NzI4_02578a7d-8af1-4532-835e-217413a802f4">12.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">With-and-without</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling and marketing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba4d5c315834206a2dfed011b842a81_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfMy0xLTEtMS01NzA3_6bed121e-a2b8-4a7f-a31a-6735dc3dcd67">21.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4faeb825368e4fbebb63eb99ebd16fe1_D20201001-20201031" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfMy0zLTEtMS01NzI4_8dda886f-722d-42ba-9a49-f0b6666c9928">12.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Relief from royalty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling and marketing</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50a8e75f54fb41df880dd13c66ec40f7_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfNS0xLTEtMS01NzA5_100c3d00-9740-47ed-a2a0-e46783d883e7">233.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic1faba8c669949feb0448beb8f5f7f73_D20201001-20201031" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfNS0zLTEtMS01NzMw_f8f8621e-620e-4b04-90e8-00be43eebddd">12.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Multi-period excess earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right to develop new technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7afe4132b22c414b94a24036e21c8d41_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfNi0xLTEtMS01NzA5_b5e434db-6b61-487f-92b3-088f1d7fbe36">19.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id04b1d5d7d6f42a7972c2a960edf12fa_D20201001-20201031" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfNi0zLTEtMS01NzMw_55bfed21-b344-407f-a5c7-29aba99c5812">15.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost approach</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cba339628964b39a0875938b2811685_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfOS0xLTEtMS05NjU3_1ae51fe6-eef6-487d-aa4e-0322e7d3463b">512.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Multi-period excess earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Not applicable</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfOS0xLTEtMS01NzE0_e064c51c-3663-4963-82b2-9cfe8fc9a5d2">803.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></ix:continuation></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired. The acquisition of ArcherDX resulted in the recognition of $<ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyNjU1Ng_d984cb6f-3b22-4b46-9e35-50e63e7b13d7">1.7</ix:nonFraction>&#160;billion of goodwill which we believe relates primarily to the anticipated benefits of synergies created through the acquisition and assembled workforce. The acquisition of ArcherDX advances our objectives to create a comprehensive offering that provides testing services for disease risk, therapy selection and personalized cancer monitoring to enable precision approaches to cancer treatment. Goodwill created as a result of the acquisition of ArcherDX is not deductible for tax purposes.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i43a9b372cb9d4068a0c794bfc92b1120_D20201001-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjMwODk3NDQzMDYzODU_18880448-7f0b-4378-820c-35931f829e1e">109.5</ix:nonFraction>&#160;million in the three months ended December 31, 2020 due to net deferred tax liabilities assumed in connection with our acquisition of ArcherDX which provided a future source of income to support the realization of our deferred tax assets and resulted in a partial release of our valuation allowance.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition, we granted inducement awards of Invitae common stock to new employees who joined Invitae in connection with our acquisition of ArcherDX with an estimated fair value of $<ix:nonFraction unitRef="usd" contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTM2ODU_cba5ed86-ca8d-4507-a73f-04460c117031">112.2</ix:nonFraction>&#160;million, net of estimated forfeitures. These awards vest upon the achievement of the contingent consideration milestones discussed above and are subject to the employee&#8217;s continued service with us, unless terminated without cause in which case vesting is only dependent on milestone achievement. As the number of shares that are expected to be issued are fixed, the awards are equity-classified. During the year ended December&#160;31, 2020, we recorded $<ix:nonFraction unitRef="usd" contextRef="if97a189b033643b79b8524895f6a78c7_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyMzgzOA_973cd8f6-6ae4-4d08-af83-08ad4cc7d0c4">41.2</ix:nonFraction>&#160;million in stock-based compensation expense based on our probability of milestone achievement. Included in the stock-based compensation expense is $<ix:nonFraction unitRef="usd" contextRef="if97a189b033643b79b8524895f6a78c7_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyMzg1Mw_6c70ba7a-2687-4736-9e06-97744f21e0b5">2.1</ix:nonFraction>&#160;million related to the acceleration of stock-based compensation expense due to the termination of an employee without cause whereby the employee's continued service is not required. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pro forma financial information (unaudited)</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audited pro forma financial information in the table below summarizes the combined results of operations for Invitae and ArcherDX as though the companies had been combined as of January 1, 2019. The pro forma amounts have been adjusted for:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">transaction expenses incurred by ArcherDX and us,</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">depreciation expense resulting from the fair value of the acquired property and equipment,</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">amortization expense resulting from the acquired intangible assets,</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the elimination of historical interest expense incurred by ArcherDX on its debt and debt-like items and the incurrence of interest expense related to the issuance of debt in connection with the acquisition,</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lease expense resulting from the step-up in the operating lease obligation and operating lease asset,</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">nonrecurring post-combination expense,</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">income tax benefits resulting from the deferred tax liabilities acquired, and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the <ix:nonFraction unitRef="shares" contextRef="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjMwODk3NDQzMDYzNTc_254b2516-c0b9-42cf-bf95-a4beddb60b7d">26.3</ix:nonFraction>&#160;million shares of our common stock issued upon the closing of the ArcherDX transaction.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i9c467f1b17f84ee5a082aaecb043632a"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTI0Njc_140ab068-6ce4-4221-ba98-4c8aa0a88a5c" escape="true"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma financial information is for informational purposes only and is not necessarily indicative of the results of operations that would have been achieved as if the acquisition had taken place as of January 1, 2019 (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.704%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjEzZmFmMTI3ZTE2YzQ2NDc4OWZmZTk0N2ZhNDQ2MWNiL3RhYmxlcmFuZ2U6MTNmYWYxMjdlMTZjNDY0Nzg5ZmZlOTQ3ZmE0NDYxY2JfMy02LTEtMS01NjE0_0cf3af81-39df-45d4-8bae-9e66c3fe4d23">327,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjEzZmFmMTI3ZTE2YzQ2NDc4OWZmZTk0N2ZhNDQ2MWNiL3RhYmxlcmFuZ2U6MTNmYWYxMjdlMTZjNDY0Nzg5ZmZlOTQ3ZmE0NDYxY2JfMy0xMi0xLTEtNTYwMA_6f469a6c-b3bc-4cac-95e1-49f7b379cf11">267,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjEzZmFmMTI3ZTE2YzQ2NDc4OWZmZTk0N2ZhNDQ2MWNiL3RhYmxlcmFuZ2U6MTNmYWYxMjdlMTZjNDY0Nzg5ZmZlOTQ3ZmE0NDYxY2JfNC02LTEtMS01NjE0_e4f46bf2-2b8b-4829-b65a-b15d137c8391">685,589</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjEzZmFmMTI3ZTE2YzQ2NDc4OWZmZTk0N2ZhNDQ2MWNiL3RhYmxlcmFuZ2U6MTNmYWYxMjdlMTZjNDY0Nzg5ZmZlOTQ3ZmE0NDYxY2JfNC0xMi0xLTEtNTYwMA_cd6db01f-28db-459c-82ee-6cd89bd58e68">355,818</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_91"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.  <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMTIzMQ_3e730e1d-0449-4cf5-9e4c-eba61c081c0e" continuedAt="i3f8e26246b7e451ea1c01b64fe1dfa61" escape="true">Goodwill and intangible assets</ix:nonNumeric></span></div><ix:continuation id="i3f8e26246b7e451ea1c01b64fe1dfa61" continuedAt="iaf2aa8a3ce474da4ae3a3d5d8c8bbdab"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMTIzOA_432750f5-7b7c-4e1f-bc5f-d56ebd9f1b88" escape="true"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amounts of goodwill were as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjllMDJjOTkwZmQzMTRkNzM5OWY1YTMxMjk1ZDgzM2E3L3RhYmxlcmFuZ2U6OWUwMmM5OTBmZDMxNGQ3Mzk5ZjVhMzEyOTVkODMzYTdfMC0yLTEtMS0w_d48f57a6-39cf-4def-a16c-c469cfb53b99">126,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired - Diploid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic716b0d977014b47953f608abb21ee07_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjllMDJjOTkwZmQzMTRkNzM5OWY1YTMxMjk1ZDgzM2E3L3RhYmxlcmFuZ2U6OWUwMmM5OTBmZDMxNGQ3Mzk5ZjVhMzEyOTVkODMzYTdfMS0yLTEtMS0w_e12d35b2-64dd-41f1-96ac-2ed5701039e9">50,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired - Genelex</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f04de7671548948145a3408339daf3_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjllMDJjOTkwZmQzMTRkNzM5OWY1YTMxMjk1ZDgzM2E3L3RhYmxlcmFuZ2U6OWUwMmM5OTBmZDMxNGQ3Mzk5ZjVhMzEyOTVkODMzYTdfMi0yLTEtMS0w_0f58342e-78c6-41ef-bd65-13c695f7fbf8">4,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired - YouScript</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1859f563a61401391afb23698e3d1f0_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjllMDJjOTkwZmQzMTRkNzM5OWY1YTMxMjk1ZDgzM2E3L3RhYmxlcmFuZ2U6OWUwMmM5OTBmZDMxNGQ3Mzk5ZjVhMzEyOTVkODMzYTdfMy0yLTEtMS0w_4013f279-5f0d-46a5-83e5-72aeeafa8180">29,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired - ArcherDX</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if97a189b033643b79b8524895f6a78c7_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjllMDJjOTkwZmQzMTRkNzM5OWY1YTMxMjk1ZDgzM2E3L3RhYmxlcmFuZ2U6OWUwMmM5OTBmZDMxNGQ3Mzk5ZjVhMzEyOTVkODMzYTdfNC0yLTEtMS02NDA4_6b951784-410c-4aec-825a-20438faafd66">1,652,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjllMDJjOTkwZmQzMTRkNzM5OWY1YTMxMjk1ZDgzM2E3L3RhYmxlcmFuZ2U6OWUwMmM5OTBmZDMxNGQ3Mzk5ZjVhMzEyOTVkODMzYTdfNC0yLTEtMS0w_c4a52ef3-584c-4f49-b054-bb84e2e94f4e">1,863,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMTIzMw_94991eff-b93d-4825-a365-fd74836a3e4b" escape="true"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMTIzNQ_1dabd06c-238b-4fc0-900f-ffcd07af49ad" escape="true"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents details of our acquired intangible assets as of December&#160;31, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:33.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Useful Life<br/>(in Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Estimated Remaining<br/>Useful Life<br/>(in Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i185c1e74a04443a291a72f01a6c8a9f5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMS0xLTEtMS0w_1b44e1f9-70b0-455f-95c1-7940a63b5bdb">41,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i185c1e74a04443a291a72f01a6c8a9f5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMS0zLTEtMS0w_bf14e2ae-c403-40e3-8bdb-de8efb964477">8,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i185c1e74a04443a291a72f01a6c8a9f5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMS01LTEtMS0w_0e1269c9-7150-4641-8a1c-01326f809cc8">32,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i214eccad6a7f4c09b2611b0dd7b962db_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMS03LTEtMS0w_e0b8c0ae-6771-4e90-8c02-fe3a133a71f7">10.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i214eccad6a7f4c09b2611b0dd7b962db_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMS05LTEtMS0w_d1b49730-6125-4893-abc4-d9cdc2348963">8.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5869dcd08fba40eaad37b756d9760bb6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMi0xLTEtMS0w_377d13f1-7173-4886-8a8a-6508f3300fa2">397,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5869dcd08fba40eaad37b756d9760bb6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMi0zLTEtMS0w_305a6c6d-e1d6-431c-aca4-9f90072d6fb5">31,013</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5869dcd08fba40eaad37b756d9760bb6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMi01LTEtMS0w_57c491e9-b764-498b-9b68-945811926436">366,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3a9ae61cda6d4c61b9b7cbc0b7d88e7d_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMi03LTEtMS0w_8ba9f34a-8954-4066-aa42-9c53c2559002">10.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3a9ae61cda6d4c61b9b7cbc0b7d88e7d_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMi05LTEtMS0w_d31df23a-cafc-43a4-983f-6f9d6d2dc4f3">10.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44f6002ca8f94affa0c1cb580edec0ab_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMy0xLTEtMS0w_a5889750-5f10-4299-b9cc-794c9e8b5a64">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44f6002ca8f94affa0c1cb580edec0ab_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMy0zLTEtMS0w_0da6e824-1842-448a-85b3-d37680f09df4">229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44f6002ca8f94affa0c1cb580edec0ab_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMy01LTEtMS0w_4f576856-c0de-4447-9fb6-fecf90d1db1b">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic9b892712a0a4fdc91399aedf309b228_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMy03LTEtMS0w_ab8d651a-be64-450c-bc2f-37a98fd056a5">5.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic9b892712a0a4fdc91399aedf309b228_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMy05LTEtMS0w_4e21d5db-7e43-4ea1-ac4e-a30cd97e2b7a">1.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad65ac656fd04a3d9861477f940eb9ec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNC0xLTEtMS0w_4cd92206-b064-4fca-a5e7-5f1d84f29eb8">21,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad65ac656fd04a3d9861477f940eb9ec_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNC0zLTEtMS0w_b953a89f-6a80-4a88-aff1-7637199171d5">447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad65ac656fd04a3d9861477f940eb9ec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNC01LTEtMS0w_967294e4-eb5f-4e45-843a-be1355425df8">20,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i20ab20c5638141578c0fa5ed16421662_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNC03LTEtMS0w_e03d9d76-1d91-41b2-928c-015e1ec6a059">12.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i20ab20c5638141578c0fa5ed16421662_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNC05LTEtMS0w_81d13129-98d1-4a3c-8e06-4d5063e1a46c">11.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patent licensing agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b08ae6f22a34f9ca4efcdd7622c90b6_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNS0xLTEtMS0w_7fdbfcbe-b2c7-4439-ad05-8b6d2400e79f">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b08ae6f22a34f9ca4efcdd7622c90b6_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNS0zLTEtMS0w_384cfc09-c907-4206-a0e0-9c56b3b1091f">103</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b08ae6f22a34f9ca4efcdd7622c90b6_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNS01LTEtMS0w_be899d2e-0de2-4c37-83c3-8bf2fcfd2eab">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1145d52e94e041bc8011849883eb468c_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNS03LTEtMS0w_06c785fb-5d79-4a58-bd87-9cdd92f02b65">15.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1145d52e94e041bc8011849883eb468c_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNS05LTEtMS0w_cffa7acc-aef2-4474-b061-f7c646959418">11.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right to develop new technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83741d505a5c43ce85ad0ffbef5d30fa_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNy0xLTEtMS02NDEw_0133fe5f-418e-48b9-a922-036c7a566b32">19,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83741d505a5c43ce85ad0ffbef5d30fa_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNy0zLTEtMS02NDEw_3d2a7758-7dac-4cb0-bbc5-0fca989b9784">323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83741d505a5c43ce85ad0ffbef5d30fa_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNy01LTEtMS02NDEw_6145e2b0-6883-4d3b-8fd1-e8c947d9c48b">19,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id489f9ef13794b19800824a2e713d3e3_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNy03LTEtMS02NDEw_89aade1e-a311-4e88-bfc2-9dbb407a0d2c">15.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id489f9ef13794b19800824a2e713d3e3_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNy05LTEtMS02NDEw_37aaa978-31d1-421b-90b6-3ba5f5c1e611">14.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76054c8277e34b278fb7cb28ef0095cc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNy0xLTEtMS0w_ced0d926-6aaa-466a-a31d-2e69f974313e">542,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76054c8277e34b278fb7cb28ef0095cc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNy01LTEtMS0w_38fa7032-f428-440c-81c4-f8bd6c1c5a79">542,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfOC0xLTEtMS0w_741de547-d5ba-4792-92a5-9963d9e1e6fc">1,022,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfOC0zLTEtMS0w_533b4c81-f873-4a92-abe3-b7db05f5fdc0">40,407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfOC01LTEtMS0w_97be604d-1128-43ab-8680-affe14cfb8a9">981,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfOC03LTEtMS0w_a640d668-e8e5-4abd-9537-c77150aef77d">10.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfOC05LTEtMS0w_a55c7041-5d97-4529-aa8f-5a2ab044b998">10.2</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition-related intangibles included in the above table are finite-lived, other than in-process research and development which has an indefinite life, and are carried at cost less accumulated amortization. Customer relationships related to our 2017 business combinations are being amortized on an accelerated basis, in proportion to estimated cash flows. All other finite-lived acquisition-related intangibles are being amortized on a straight-line basis over their estimated lives, which approximates the pattern in which the economic benefits of the intangible assets are expected to be realized. Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfODE4_4648543f-8935-495b-b0a4-c1a6bfba38ac">26.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfODIy_3d13393b-6632-43e2-b8aa-5d668055cff3">7.7</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfODMw_d6559bbd-c48f-4227-a8b2-ab1bb7006429">5.0</ix:nonFraction> million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. Intangible assets are carried at cost less accumulated amortization. Amortization expense is recorded to cost of revenue, research and development, sales and marketing and general and administrative expense.</span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMTIzNg_ef35588c-714f-4784-9285-8d596e2f0155" escape="true"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our estimated future amortization expense of intangible assets with finite lives as of December&#160;31, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:84.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOmVjMWUyZTRiZDFhODQ2YWJhODZmYWE3MzAyZDQ5MzI1L3RhYmxlcmFuZ2U6ZWMxZTJlNGJkMWE4NDZhYmE4NmZhYTczMDJkNDkzMjVfMS0xLTEtMS0w_1a6ca23c-6892-432a-864e-3bc515dafbf9">46,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOmVjMWUyZTRiZDFhODQ2YWJhODZmYWE3MzAyZDQ5MzI1L3RhYmxlcmFuZ2U6ZWMxZTJlNGJkMWE4NDZhYmE4NmZhYTczMDJkNDkzMjVfMi0xLTEtMS0w_30652820-0f92-4f86-8e81-92031204bdf7">45,401</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOmVjMWUyZTRiZDFhODQ2YWJhODZmYWE3MzAyZDQ5MzI1L3RhYmxlcmFuZ2U6ZWMxZTJlNGJkMWE4NDZhYmE4NmZhYTczMDJkNDkzMjVfMy0xLTEtMS0w_9adae2b2-b044-41e0-be7e-7691cba60d8c">44,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOmVjMWUyZTRiZDFhODQ2YWJhODZmYWE3MzAyZDQ5MzI1L3RhYmxlcmFuZ2U6ZWMxZTJlNGJkMWE4NDZhYmE4NmZhYTczMDJkNDkzMjVfNC0xLTEtMS0w_9361201a-2847-44cf-be11-a03389505090">44,110</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOmVjMWUyZTRiZDFhODQ2YWJhODZmYWE3MzAyZDQ5MzI1L3RhYmxlcmFuZ2U6ZWMxZTJlNGJkMWE4NDZhYmE4NmZhYTczMDJkNDkzMjVfNS0xLTEtMS0w_a2d5e751-176a-4b03-acd4-1b85e6a75658">42,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOmVjMWUyZTRiZDFhODQ2YWJhODZmYWE3MzAyZDQ5MzI1L3RhYmxlcmFuZ2U6ZWMxZTJlNGJkMWE4NDZhYmE4NmZhYTczMDJkNDkzMjVfNi0xLTEtMS0w_c33bbf56-63f3-4be8-b18d-031b2721ce7f">216,292</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated future amortization expense</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOmVjMWUyZTRiZDFhODQ2YWJhODZmYWE3MzAyZDQ5MzI1L3RhYmxlcmFuZ2U6ZWMxZTJlNGJkMWE4NDZhYmE4NmZhYTczMDJkNDkzMjVfNy0xLTEtMS0w_a30cce73-51dc-47ca-843b-75c2fc299a2d">439,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:3pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaf2aa8a3ce474da4ae3a3d5d8c8bbdab">In December 2020, we entered into an agreement to acquire technology focused on informing clinical decisions for $<ix:nonFraction unitRef="usd" contextRef="i8bfd608ebc2f4679bbacfd7c6509b051_D20201201-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMjI1Mzk5ODgzNzc2OTA_d5af08b9-883f-4b7f-9ca0-7dd645f59f2f">2.9</ix:nonFraction>&#160;million. We accounted for this transaction as an asset acquisition of developed technology which will be amortized over <ix:nonNumeric contextRef="i8bfd608ebc2f4679bbacfd7c6509b051_D20201201-20201231" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMjI1Mzk5ODgzNzc5NjI_25091855-4609-4516-b40b-aff4578d1510">eight years</ix:nonNumeric>, initially to research and development expense. In connection with this transaction, we granted approximately $<ix:nonFraction unitRef="usd" contextRef="i92c98fa4920d4181bdc4e4ebafa5d57d_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMjI1Mzk5ODgzNzc3MDQ_4fc418d1-9190-4fc3-b2db-d3e1bdecd5e7">6.2</ix:nonFraction>&#160;million of RSUs under our 2015 Stock Incentive Plan as inducement awards to new employees who joined Invitae. These RSUs are time-based and vest in two equal installments in December 2021 and December 2022, subject to the employee's continued service with us. For $<ix:nonFraction unitRef="usd" contextRef="if61da7ae894b44d3a17390db3eb337f9_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfNzY5NjU4MTQwMzA3OQ_67eab045-a679-496e-9aa0-2bb6a69eed06">5.4</ix:nonFraction>&#160;million of these awards, the number of awards granted are based on the lower of the <ix:nonFraction unitRef="tradingday" contextRef="i67b31cc1f5c4428988fc99230afca7da_D20201201-20201231" decimals="INF" name="nvta:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMjI1Mzk5ODgzNzc3MTg_bebd411f-09bf-435a-bb1e-4806d0fbb5f9">20</ix:nonFraction>-day volume weighted-average share price prior to the vesting date and the date of close, both with a fixed dollar value, and therefore, these RSUs are liability-classified and the fair value is estimated at each reporting period based on the number of shares that are expected to be issued at each reporting date and our closing stock price, which combined are categorized as Level 3 inputs. Therefore, fair value of these RSUs and the number of shares to be issued will not be fixed until the awards vest. During the year ended December&#160;31, 2020, we recorded research and development stock-based compensation expense of $<ix:nonFraction unitRef="usd" contextRef="iae69da4291404d09846bdd7eea1b3df7_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfNzY5NjU4MTQwMzA1Mg_68558529-6524-40e7-baa6-04e3a2799a5b">0.2</ix:nonFraction>&#160;million related to the RSUs based on an estimated issuance of <ix:nonFraction unitRef="shares" contextRef="iae69da4291404d09846bdd7eea1b3df7_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfNzY5NjU4MTQwMzA2Ng_37fa8a21-b215-4ba8-a546-a9c5d91208c2">0.1</ix:nonFraction>&#160;million shares</ix:continuation>.</span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_94"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.  <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RleHRyZWdpb246Y2Y4NjAzNzcyMWQyNDAzNmEwYjA0OTIyNjFiMjVkYTZfNDA1_65fec449-6771-47d7-a27e-dc534ffd8266" continuedAt="i69b67eb8ba4c47b2a1c9222e5611aa48" escape="true">Balance sheet components</ix:nonNumeric></span></div><ix:continuation id="i69b67eb8ba4c47b2a1c9222e5611aa48" continuedAt="ib76fd21f16254db2aecf616e2369af81"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RleHRyZWdpb246Y2Y4NjAzNzcyMWQyNDAzNmEwYjA0OTIyNjFiMjVkYTZfMjMwODk3NDQxODQ3ODQ_fbe88a79-7d36-42bf-82f0-86e83fb2d147" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfMi0xLTEtMS00NDY4_f5e331b5-ae72-4f6d-ace3-161c85b574d5">21,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfMi0zLTEtMS00NDY4_5a495880-1768-491b-a975-dbdc5ca43bc6">6,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfNi0xLTEtMS00NDY4_315cd9e9-d972-4e9e-ac31-a86e517593c2">8,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfNi0zLTEtMS00NDY4_c085c5c8-2b40-4c6d-89cb-5133d807e14a">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfOS0xLTEtMS00NDY4_28b327d0-45e0-40d7-a3af-bde168c11a55">1,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfOS0zLTEtMS00NDY4_aa40d945-3dc4-428e-8e8a-06031df0141a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfMTAtMS0xLTEtNDQ2OA_995497ea-534a-4f67-be97-f66ba2fe342c">32,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfMTAtMy0xLTEtNDQ2OA_1a9f6e85-32b8-4dba-bcd0-e0c362cbde93">6,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and equipment, net</span></div><ix:continuation id="i9920348e423a437686fb1ebc59d273b7"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide3fcab1d351422aa89b205d3c4e9817_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMi0xLTEtMS0w_f87c6078-7e9b-4e47-9a77-a37309f08645">26,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i109c3eeeb37142eeaff5dbcd7fb30a51_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMi0zLTEtMS0w_44d4266a-8331-4335-a538-126bbc353fad">18,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d6c19c668184c16ab5abb3b2f56e025_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMy0xLTEtMS0w_d0856a78-d495-4ee5-91ff-365491a6cad6">45,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia86d7ba53b5946f4a663cf20df932e8c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMy0zLTEtMS0w_cfcf3991-ff86-4246-aa1d-b5e8b64b0e11">24,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa0c386cddc4e38a421e7ec46fd9828_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfNS0xLTEtMS0w_2e38be90-4dcb-471c-93bf-18ca241e8e5d">10,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie41b32eea41a4075bd7d4ef22299e442_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfNS0zLTEtMS0w_cb24681e-eff3-484f-b146-69e251b13b77">5,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed14ac220d841b784c269f25af4118e_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfNi0xLTEtMS0w_ad51009d-75ff-4b98-a260-4155337b1614">566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e9a07f9f51544b588b193d821061957_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfNi0zLTEtMS0w_857c3194-689e-4848-b6af-41d4a9cef0f5">2,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950327dbdb864aa59bae2e677d3cc59e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfNy0xLTEtMS0w_69bcf1d3-5b51-4a21-9e6b-b41bc03abad0">1,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1d4c48e1794eef98c5bba9a22a83d2_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfNy0zLTEtMS0w_b2872520-ac81-4d57-8404-7517634dfacd">1,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Automobiles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb2e86c476945ceb7204aa84003647f_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfOC0xLTEtMS0w_dd19070b-5c41-4328-bf12-01f149c53bdd">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5901d15dd341af989b63f1e1be596d_I20191231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfOC0zLTEtMS0w_20c2347c-cd17-4c7e-840c-01453569d71d">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i221de2cc80ed4f658ae2b575f1e37709_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfOS0xLTEtMS0w_40f9f3ec-a478-49c6-9c9c-457c48cbbbdd">12,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99c28c17201b43acb7779bcb565aff06_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfOS0zLTEtMS0w_71e70616-d78d-4d7c-a11b-5a61d543a034">10,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMTAtMS0xLTEtMA_06973a27-dbd1-470b-92e5-c78315479097">97,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMTAtMy0xLTEtMA_8b111e25-b435-4f9e-9a53-57d9bde72168">63,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMTEtMS0xLTEtMA_d7d39e25-f64e-4f7d-849d-542feb52c3e5">31,347</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMTEtMy0xLTEtMA_f6e8354c-8daa-45fe-a212-ac83c42182e1">26,135</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMTItMS0xLTEtMA_265f141f-d34b-49ad-9fb5-28a105cf22bf">66,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMTItMy0xLTEtMA_10efd3a2-18cb-4351-aa84-6c8fb27f207c">37,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RleHRyZWdpb246Y2Y4NjAzNzcyMWQyNDAzNmEwYjA0OTIyNjFiMjVkYTZfMTU1_65e52a9e-b7c7-4eb4-a95e-33011dc4387b">10.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RleHRyZWdpb246Y2Y4NjAzNzcyMWQyNDAzNmEwYjA0OTIyNjFiMjVkYTZfMTU5_69b95628-5304-42b6-b093-ba847fec0dc6">7.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RleHRyZWdpb246Y2Y4NjAzNzcyMWQyNDAzNmEwYjA0OTIyNjFiMjVkYTZfMTY2_151ef656-da84-4e04-a80b-9bfd51b0ff8f">8.5</ix:nonFraction> million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ib76fd21f16254db2aecf616e2369af81"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued liabilities</span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RleHRyZWdpb246Y2Y4NjAzNzcyMWQyNDAzNmEwYjA0OTIyNjFiMjVkYTZfNDA3_790c1a4a-1979-46d0-ab05-823ad958e674" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfMi0xLTEtMS0w_ecf35581-7b4c-4b62-8d26-bea0166ba893">25,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfMi0zLTEtMS0w_f94a0685-03ea-44d9-a708-16c20dc34665">16,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfMy0xLTEtMS0w_a36c7050-311c-48c8-ac6f-88b92c163f35">6,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfMy0zLTEtMS0w_a06f3bd1-7172-4b50-9e2d-2d4d2c19db19">1,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and other liabilities associated with business combinations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:BusinessCombinationAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfNS0xLTEtMS0w_747fab45-e7d4-4fff-89dc-4aad0e9858f1">25,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:BusinessCombinationAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfNS0zLTEtMS0w_814d51c1-530b-423b-bf30-88a90aa2c942">30,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfNy0xLTEtMS0w_dd9e91eb-02af-4661-9ef4-fb233b9fc2a3">28,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfNy0zLTEtMS0w_5e5e6c61-fc7a-4c99-88e6-c358842368e9">16,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfOC0xLTEtMS0w_dbda6e7b-a04f-4b84-842a-5316d62ac8ce">86,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfOC0zLTEtMS0w_0d84d500-8de6-4bfd-8198-bccfb51eddd2">64,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term liabilities</span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RleHRyZWdpb246Y2Y4NjAzNzcyMWQyNDAzNmEwYjA0OTIyNjFiMjVkYTZfNDAz_3237ca2b-f0b7-4527-9fc9-f83656e72812" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, non-current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfMy0xLTEtMS0w_bdea6aea-4d9a-44f7-9603-b653d690d7c7">1,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfMy0zLTEtMS0w_6d35ae72-a384-4f8e-af03-6799a0c4b9a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and other liabilities associated with business combinations, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:BusinessCombinationAccruedLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfNC0xLTEtMS0w_05633de3-a1d0-44ba-b94b-deb82728f1f1">825,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:BusinessCombinationAccruedLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfNC0zLTEtMS0w_705d7f0b-f743-4b94-b76d-ea467155eed8">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfNS0xLTEtMS0w_11fb3fe4-bd01-42fb-80d9-b5491dcdec4c">13,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfNS0zLTEtMS0w_97283a85-03b3-4d05-aedf-5a42878f96f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfNi0xLTEtMS0w_634bc1bb-cc68-4652-acf7-181d899dc72c">841,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfNi0zLTEtMS0w_f8689a21-6452-4f50-9f42-02793da29353">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_97"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.  <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfNDY1MA_3d0ced15-cb01-4e02-9deb-9bbc051ca4ce" continuedAt="icecb1bbedd834ffbbe939f0a8c9df7aa" escape="true">Fair value measurements</ix:nonNumeric></span></div><ix:continuation id="icecb1bbedd834ffbbe939f0a8c9df7aa" continuedAt="iad34ecf7120a420781326dc53ae646c5"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities are recorded at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The authoritative guidance establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The three-level hierarchy for the inputs to valuation techniques is summarized as follows:</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Observable inputs such as quoted prices (unadjusted) for identical instruments in active markets.</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Observable inputs such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, or model-derived valuations whose significant inputs are observable.</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Unobservable inputs that reflect the reporting entity&#8217;s own assumptions.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="iad34ecf7120a420781326dc53ae646c5" continuedAt="i0e225e84b86847819e878db9265d7846"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfNDY1Mg_0af2220b-77f1-4307-ae8f-990f298cc0fd" continuedAt="i209bc21344da4c429b21fef79bf037df" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the fair value of our consolidated financial instruments that were measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:28.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.540%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.540%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.540%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f5a000cae84d829d333a825f105334_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMy0yLTEtMS0w_86b50de2-bd24-42f5-a5ad-138be0a40090">83,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f5a000cae84d829d333a825f105334_I20201231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMy00LTEtMS0w_88cb4b10-608a-4e8a-b999-a6f518e7da50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f5a000cae84d829d333a825f105334_I20201231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMy02LTEtMS0w_81f0ba5c-f1f5-4352-87b6-23868429f127">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i130e2d48b5004c6e9a3aeb316acff2f7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMy04LTEtMS0w_ad819c10-fd0c-409a-abda-d2f9e051de6f">83,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27addbbb2eb641a0b57afd4322937765_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMy0xMC0xLTEtMA_a3e535cb-862f-4e5a-80f6-d3c657912a13">83,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54333500eabc422aa4fb7b50ec024580_I20201231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMy0xMi0xLTEtMA_6fe0fc8a-1035-4497-8a06-f81f7e6b66e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28fae00650bb4a91b726c9ae7389e05c_I20201231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMy0xNC0xLTEtMA_65779608-a603-4725-9a7b-3afebd0b81e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08aad59bfa6646eb872d92df4fe25c56_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNi0yLTEtMS0w_1f08f5ed-c37b-4440-a986-63969e100b7f">164,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08aad59bfa6646eb872d92df4fe25c56_I20201231" decimals="-3" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNi00LTEtMS0w_a707c78a-a22b-4136-95da-d61609f0d7d7">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08aad59bfa6646eb872d92df4fe25c56_I20201231" decimals="-3" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNi02LTEtMS0w_034e92a0-24e0-441c-a80f-785268cb8b48">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i188d8124d1e9488595a24ed023c83ec0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNi04LTEtMS0w_0e7e9fac-f214-4018-8a00-86b0823b1685">164,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c5de93de50148019914bf27c7db6355_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNi0xMC0xLTEtMA_d0af874d-3873-476b-9940-2155f676050f">164,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia032f7f120de4f9c8d66f9fc7b25aca0_I20201231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNi0xMi0xLTEtMA_91fc42cc-f9a6-46d3-b890-546f440132b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473285deb1174f398238bf9d728acff8_I20201231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNi0xNC0xLTEtMA_f48ac347-58a0-4c33-9e90-4092fbe6365e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if082e3e8efba43fc80a4f205e0fe9272_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNy0yLTEtMS0w_be704931-c6e0-4c46-843e-4f59c5f3d131">64,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if082e3e8efba43fc80a4f205e0fe9272_I20201231" decimals="-3" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNy00LTEtMS0w_70d54804-5280-44fd-bbf2-78429e5e2e1e">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if082e3e8efba43fc80a4f205e0fe9272_I20201231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNy02LTEtMS0w_d27c7db8-c34b-4a7a-8a1c-d63b70270fb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec63a96541542f6a5bd94b8d12a174b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNy04LTEtMS0w_a3d0a8f4-c74e-4ada-8f50-360acf148e27">64,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e46526580a74ee5aa03b64dbd08a141_I20201231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNy0xMC0xLTEtMA_679b19cd-ceb7-4bc2-b615-e5fe976df621">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b0d2fd70ee437db964f0f6171b13e5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNy0xMi0xLTEtMA_51610b35-6f4e-4dfa-8d2a-7e986b63c5ac">64,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b55a4267c44c95b43de4a61c59e2f8_I20201231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNy0xNC0xLTEtMA_025292a3-86b7-4100-a15f-58ea70539001">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfOC0yLTEtMS0w_b469767c-c5d8-4094-9804-dd7f58923d74">312,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfOC00LTEtMS0w_6e8ba74e-9207-4d71-a6bd-599a9f5f15f8">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfOC02LTEtMS0w_a04a20c8-f03f-4cf3-b9ea-c4b2a278018c">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62eb3a1e610e4f46ac59f207fd5c2df3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfOC04LTEtMS0w_034764e9-5842-4c4e-a97b-87167637c883">312,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3372e8a93caa498bb1f1a10e5af5a318_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfOC0xMC0xLTEtMA_98fe1f75-77eb-4409-93b4-e09b99c81f07">247,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2590f9ee0bf41149e7cf8182ba63d51_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfOC0xMi0xLTEtMA_2c202956-7c49-440f-bb6c-e1958c9f58a3">64,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cceadd9383544c5a008badc36969778_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfOC0xNC0xLTEtMjc2NA_35759d8f-a4f7-4fa8-9691-9f859afe1cac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock payable liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858f7fb75312498eac5fbdd977be8915_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtOC0xLTEtNzUzMA_26a6f02a-68d9-4df8-a7be-6afa6ed4fb50">39,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b9ca881766247fdba01b8fa00874e5d_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtMTAtMS0xLTc1MzA_3a8b69df-580a-4a6b-b9a1-2a9aadff2cd0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4614b08b464e53b288d71792d75a12_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtMTItMS0xLTc1MzA_8ee6a0c5-bbb7-48bc-bb9f-dfb0de209010">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia093c7d811d143d4ae900c0461f04e11_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtMTQtMS0xLTc1MzA_6b7c1f7c-99d3-4776-97ce-f0a773553193">39,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac515eea33b64659b00dd874246c95ae_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtOC0xLTEtMA_c4de1ebb-c3fd-44f8-9ac3-0353fa21f1b4">796,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bcaa1c58b304863a4d0704739b31457_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtMTAtMS0xLTA_a7bebb48-0c49-4303-8cbe-401cb9d3f8a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied2ebd117b5349d18d84166bce5ec784_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtMTItMS0xLTA_77cab00f-a068-46be-a2e9-a9944254e23f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i360a34815adf46b48fc3bc240b973154_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtMTQtMS0xLTA_55c5255b-30c6-4420-a12a-0d8b8ce91b64">796,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62eb3a1e610e4f46ac59f207fd5c2df3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTItOC0xLTEtMA_47fe7bcf-0842-40b9-abba-30200467c112">835,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3372e8a93caa498bb1f1a10e5af5a318_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTItMTAtMS0xLTA_aeed5f78-9557-462e-bcbe-8c8142b496b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2590f9ee0bf41149e7cf8182ba63d51_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTItMTItMS0xLTA_c4c80e5b-1122-43d0-9b13-3631e77c5a77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cceadd9383544c5a008badc36969778_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTItMTQtMS0xLTA_e3cc2c88-041d-4d7d-bbe5-90b0a0ac4181">835,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTYtMTItMS0zLTI3NjY_71432769-efc5-4dd2-86bc-fc830f7c896c">76,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTctMTItMS0zLTI3NjY_927f7d09-ef83-4a97-b65c-3e863cde839f">6,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="8" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTgtMTItMS0zLTI3NjY_b9209e7f-265d-49cf-82d6-b083b813c32c">229,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents, restricted cash, and marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTktMTItMS0zLTI3NjY_165d8fe9-3b9d-4219-9004-5768f5785b7c">312,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef125570a5d410a9ae17d5d2ed6cb95_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMjEtMTItMS0zLTI3NTg_9b10203c-2253-4133-a75e-a56db45531df">10,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f3a2163cfa940a4aa419fae83424ede_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMjItMTItMS0zLTI3NTg_6abad499-ac53-43f0-a466-b2790e9a062f">825,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:31.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i0e225e84b86847819e878db9265d7846" continuedAt="ie6f7bec07bb24f06a5f307a8374aecf5"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><ix:continuation id="i209bc21344da4c429b21fef79bf037df"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:30.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.540%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.540%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.540%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06993cb5d1c6406493c955e36efe376c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMy0yLTEtMS0w_7b4eaa14-b17e-4cc7-99f9-490995219dbb">39,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06993cb5d1c6406493c955e36efe376c_I20191231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMy00LTEtMS0w_a699dd6a-aec3-42e1-8552-463d5b4f5e39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06993cb5d1c6406493c955e36efe376c_I20191231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMy02LTEtMS0w_bea5af4b-7098-446d-a4ce-b196febd88d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d1e92459dfa4c3c86e03c46590cf11e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMy04LTEtMS0w_d7c7d0b3-2203-40d0-b323-e0b06d10673a">39,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib528de6cd5d94b218ca6a72049368aa7_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMy0xMC0xLTEtMA_7f11c138-1746-4449-af91-e6e3fb9f68dd">39,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea18a70d0f8f4bc58647fa548740fb30_I20191231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMy0xMi0xLTEtMA_d6dc134b-47f8-40fe-b0b0-54f7d4785e75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c59cd454de14e7b98c76fd5c5755dd8_I20191231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMy0xNC0xLTEtMA_b2b37611-f25a-41af-9c49-2af24dac760f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d259a569c8740668939cd2c6f008b27_I20191231" decimals="-3" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNC0yLTEtMS0w_8f3b291d-00f3-4d15-a1d2-b71a22e58dd1">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d259a569c8740668939cd2c6f008b27_I20191231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNC00LTEtMS0w_7c82206a-7d9c-48c8-8b0e-dea0f3712887">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d259a569c8740668939cd2c6f008b27_I20191231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNC02LTEtMS0w_d1dddd30-5760-4cdb-b137-9e3ae9bf0d1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db56f1860564b5c948005ffd0e54da2_I20191231" decimals="-3" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNC04LTEtMS0w_37a67e00-b55c-4c61-b462-e566cdb045f3">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib787a31ca31242e590f07fd32f7f3247_I20191231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNC0xMC0xLTEtMA_60173ab9-1e23-4489-882b-c03cb88da232">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43b1dc051d8642cd979ce95901f997a3_I20191231" decimals="-3" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNC0xMi0xLTEtMA_052f34d9-60a2-43c0-afa6-2d680134b270">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic93726820e244b3e870907dd6bf88b60_I20191231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNC0xNC0xLTEtMA_2971b5af-124f-41c0-848f-4a07bbcb9d86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i038907853f764077b79a59ffd5d636f8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNi0yLTEtMS0w_d77eb74a-752d-4736-ada2-2a4d329b8851">150,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i038907853f764077b79a59ffd5d636f8_I20191231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNi00LTEtMS0w_708e7c7f-2198-45e5-b721-e492d30af21e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i038907853f764077b79a59ffd5d636f8_I20191231" decimals="-3" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNi02LTEtMS0w_820a1e1b-0d61-40be-9e77-7d1c32818db0">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09a2305fa55f403db2e53d3b4c66fdf4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNi04LTEtMS0w_f7436c36-022d-4de1-a342-3df70b67f827">150,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i862cbc61396149b4a904c89b1e7af8f4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNi0xMC0xLTEtMA_657ab8bf-87a0-4ee1-bd58-b746e6f02404">150,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib57776d437354dc2ac23cfa698397058_I20191231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNi0xMi0xLTEtMA_7fa8ffb0-32e1-473f-96f3-4fd1388df43d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820b4148e0c34bafbdd13e8562a3b4f7_I20191231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNi0xNC0xLTEtMA_863f410c-839d-4ea0-b6db-c8197d75c3f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205c8b0c236749ab8849be640e1c99ba_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNy0yLTEtMS0w_2a5e76ef-151e-4325-954b-5dd81ed6b2b5">193,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205c8b0c236749ab8849be640e1c99ba_I20191231" decimals="-3" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNy00LTEtMS0w_9b89d709-34da-4a39-9f57-53ee940f4f37">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205c8b0c236749ab8849be640e1c99ba_I20191231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNy02LTEtMS0w_0c2d35e7-104c-4757-a51d-3c4598ac089f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec01bbe55f3a4c9eb2bb920d009b727d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNy04LTEtMS0w_47487970-6a7a-4846-85b1-253acbb6799f">193,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7df43ef9d55e4c67ac7eb55388c00aca_I20191231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNy0xMC0xLTEtMA_52a03635-408e-43a9-9a76-219da338e67a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie763bd4d168247b5a8706e65eafef728_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNy0xMi0xLTEtMA_c0e485dd-5073-4da0-8a8b-ff1bcc5c5a66">193,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c5983241a3e4da6ba46a2a2e89d89fe_I20191231" decimals="-3" format="ixt:zerodash" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNy0xNC0xLTEtMA_c8f94539-12fd-415d-bea0-43c789f2052e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfOC0yLTEtMS0w_799a2e20-7e01-4fe5-8f8c-a7a8da3401d0">383,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfOC00LTEtMS0w_ca104aab-3668-4d20-8e57-cac19885e240">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfOC02LTEtMS0w_06e2f3aa-7fa8-4e0f-bc1f-f3b229beb16a">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13c4fca32874b758541909197f604c5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfOC04LTEtMS0w_af83b1c4-7f84-4b4a-9ea5-f2a62e44a53a">383,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i763bfe6fa0b547ce82fc98bd8524a4fe_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfOC0xMC0xLTEtMA_5a5db5b2-475a-45a0-a302-a2d493e8edcb">190,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d2ff72b9ebd43228f6d29da67e34f55_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfOC0xMi0xLTEtMA_58f2169e-23e4-4b9b-b592-bd3075fee693">193,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id715584d8ddc40bbbff675871872b46e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfOC0xNC0xLTEtMA_236336f4-d5bb-4709-917e-d610eff9b20e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i595e483b9f0344c4aca995e6a572302d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTEtOC0xLTEtMA_199f3a60-da7d-4f68-8e26-ce61df6cefa6">11,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9192e09ee4e24faaa76e6fc28d55f441_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTEtMTAtMS0xLTA_03d8dbdc-f47e-4a62-abf9-b2cdaba629d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e6634d1bca4bdc955007d68d05ebaf_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTEtMTItMS0xLTA_2d9e0692-208b-4d36-8222-f49a955998d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i531f978b6c494fe5962f9f63ddfd8712_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTEtMTQtMS0xLTA_4b7ffd1f-8044-4763-b818-e84bfeebaba3">11,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13c4fca32874b758541909197f604c5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTItOC0xLTEtMA_e457570d-48a5-404e-a8d6-329a02bb13b1">11,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i763bfe6fa0b547ce82fc98bd8524a4fe_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTItMTAtMS0xLTA_85558f22-3897-460e-9f43-7143bc4ff324">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d2ff72b9ebd43228f6d29da67e34f55_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTItMTItMS0xLTA_3a38fea4-e572-4c6d-9036-fba6a52063de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id715584d8ddc40bbbff675871872b46e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTItMTQtMS0xLTA_cf401629-521d-437c-8776-6ba3e5c2c498">11,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTYtMTItMS0xLTA_26accc9c-afbd-4954-8bbd-26da3c13bcd0">136,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTctMTItMS0zLTI3MzU_57c4412a-c1b6-41d4-8297-a165a48e41c2">6,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="8" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTgtMTItMS0xLTA_10716f5d-6908-4bbd-80e9-d1df711722fb">240,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents, restricted cash, and marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTktMTItMS0xLTA_f4e769f0-5cb2-4e2b-881f-d368f834a649">383,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icecfd6fced1c453ba8fe7e4e77e3c937_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMjEtMTItMS0zLTI3MzU_bad6a6a5-fc5b-493c-af7e-6cfd547e198c">3,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d0f0692653f4d25aaef40c6c24a8aac_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMjItMTItMS0zLTI3MzU_3e2b8d58-3790-4b6b-82e0-ea9b5103ea55">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:10pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="nvta:FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfMjMwODk3NDQxOTEwMTc_18f63146-84fb-4618-b31b-22675614ad11"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="nvta:FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfMjMwODk3NDQxOTEwMTc_eef34941-a723-4b39-a9ba-ed6e960a6897">no</ix:nonFraction></ix:nonFraction> transfers between Level&#160;1, Level 2 and Level&#160;3 during the periods presented. The total fair value of investments with unrealized losses at December&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfMTUwOQ_99ffdbf4-9adc-4779-900d-d83774f00371">109.3</ix:nonFraction> million. None of the available-for-sale securities held as of December&#160;31, 2020 have been in an unrealized loss position for more than one year. At December&#160;31, 2020, the remaining contractual maturities of available-for-sale securities ranged from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfNzY5NjU4MTQxMDEzMQ_d4b367b6-e09c-49d9-900c-330dab11d098">one</span> to <ix:nonNumeric contextRef="i23413efbba8a4bce99ca014f751cd629_D20200101-20201231" format="ixt-sec:durwordsen" name="nvta:DebtSecuritiesAvailableForSaleMaturityPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfNzY5NjU4MTQxMDEzMA_136c1bda-8154-4894-a846-acd54564706f">nine months</ix:nonNumeric>. Interest income generated from our investments was $<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfNzY5NjU4MTQwMTE5MQ_9b91abeb-cf07-41d2-9560-f47dbd2111ae">4.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfNzY5NjU4MTQwMTIxNQ_0571e4aa-dd00-4a5d-a2ea-28ab31814035">5.2</ix:nonFraction> million during the years ended December&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificates of deposit and debt securities of U.S. government agency entities are classified as Level&#160;2 as they are valued based upon quoted market prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs obtained from various third-party data providers, including but not limited to benchmark yields, interest rate curves, reported trades, broker/dealer quotes and reference data.</span></div></ix:continuation><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie6f7bec07bb24f06a5f307a8374aecf5">Stock payable liabilities relate to certain indemnification hold-backs resulting from business combinations that are settled in shares of our common stock. We elected to account for these liabilities using the fair value option due to the inherent nature of the liabilities and the changes in value of the underlying shares that will ultimately be issued to settle the liabilities. The estimated fair value of these liabilities is classified as Level 3 and determined based upon the number of shares that are issuable to the sellers and the quoted closing price of our common stock as of the reporting date. The number of shares that will ultimately be issued is subject to adjustment for indemnified claims that existed as of the closing date for each acquisition. Changes in the number of shares issued and share price can significantly affect the estimated fair value of the liabilities. During the year ended December&#160;31, 2020, the change in fair value related to stock payable liabilities recorded to other income (expense), net was expense of $<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfMjI1Mzk5ODgzNzk0MzQ_22c9d52f-285c-455f-9e6c-fd2d2ee442af">37.5</ix:nonFraction>&#160;million.</ix:continuation> </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_103"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.  <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzEwNzI3_8f69003f-b7b9-4960-bb0c-bcddea014890" continuedAt="i652699a7f2b44b818634797dc4180831" escape="true">Commitments and contingencies</ix:nonNumeric></span></div><ix:continuation id="i652699a7f2b44b818634797dc4180831" continuedAt="ib59eeebe5c3347779eb71ba31ac6f95f"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In&#160;2015, we entered into an operating lease agreement for our headquarters and main production facility in San Francisco, California which commenced in 2016. This lease expires in&#160;2026 and we may renew the lease for an additional <ix:nonNumeric contextRef="id23b32f856364b628d82e533acbde8ae_I20161231" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI4Mw_def2900d-fc89-4458-850f-a6995e03566c">ten years</ix:nonNumeric>. This optional period was not considered reasonably certain to be exercised and therefore we determined the lease term to be a <ix:nonNumeric contextRef="id23b32f856364b628d82e533acbde8ae_I20161231" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIzMDg5NzQ0MjA2MjU2_1ca7b8af-ced2-445c-93db-afd5b2e023cb">ten-year</ix:nonNumeric> period expiring in 2026. In connection with the execution of the lease, we provided a security deposit of approximately $<ix:nonFraction unitRef="usd" contextRef="id23b32f856364b628d82e533acbde8ae_I20161231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SecurityDeposit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzU0Mg_ea932d8b-34e7-42c8-90ff-7a74b313f5b0">4.6</ix:nonFraction> million which is included in restricted cash in our consolidated balance sheets. We also have other operating leases for office and laboratory space in California, Colorado, Massachusetts, New York and Washington and internationally in Australia and Israel. We expect to enter into new leases and modify existing leases as we support continued growth of our operations.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into various finance lease agreements to obtain laboratory equipment. The terms of our finance leases are generally <ix:nonNumeric contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" format="ixt-sec:durwordsen" name="us-gaap:LesseeFinanceLeaseTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzYwNDczMTM5ODk1MTk_0b64ff9d-030e-4c3b-9f5c-18f1eb9f6417">three years</ix:nonNumeric> and are typically secured by the underlying equipment. The portion of the future payments designated as principal repayment and related interest was classified as a finance lease obligation on our consolidated balance sheets. </span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzEwNzI4_77ff8ac8-21c8-49fb-9841-164d349e9497" escape="true"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information regarding our operating and finance leases were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzMtMi0xLTEtMTAyNTM_1bea22a9-bfe4-4edb-b8af-64c1895fdcf0">5.4</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzMtNC0xLTEtMTEyNjY_eddaaa50-85ef-45e9-bde4-cde0d0fc1138">6.5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzQtMi0xLTEtMTEyNjQ_d1aa5b58-0a7f-454f-b51f-f984f5307a0c">2.6</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzQtNC0xLTEtMTEyNjY_806cb5bf-05dd-419a-be28-cd28da921678">2.0</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzYtMi0xLTEtMTEyNjc_2c082708-7795-4a78-80c2-46d9538ea645">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzYtNC0xLTEtMTEyNzA_916482f3-c232-4cf1-a2ec-0af7870075c9">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzctMi0xLTEtMTEyNjc_cc44c09d-a0b9-4aea-8dd8-694050029caa">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzctNC0xLTEtMTEyNzA_a36fad12-08f1-4406-8e9f-faf836fff2ff">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments included in the measurement of lease liabilities (in millions):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzktMi0xLTEtMTEyNTE_3c57b52d-ccc9-4030-85f6-0e096535e518">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzktNC0xLTEtMTEyNTM_ab797803-83c1-4c88-b38e-12488bc77f87">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-5" name="nvta:FinanceLeasePrincipalPaymentsandOtherAncillaryPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzEwLTItMS0xLTExMjU1_5fef7ef2-202f-4bab-b405-7909056dd45c">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-5" name="nvta:FinanceLeasePrincipalPaymentsandOtherAncillaryPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzEwLTQtMS0xLTExMjU1_2a6ae205-8dd8-47f4-8457-80b1c5f8ae37">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease costs, which were included in cost of revenue, research and development, selling and marketing and general and administrative expenses on our consolidated statements of operations, were as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:63.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.691%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.982%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzItMi0xLTEtMA_feda3a57-149a-4cd8-bbee-8f867952df87">11,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzItNC0xLTEtMA_1860b33e-1504-4087-bd0e-c5873622ea72">10,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseAndRentalExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzItNi0xLTEtMA_f0620043-eff7-4e6e-9f16-f831e550ac65">9,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzMtMi0xLTEtMA_5f4e0967-4fe0-4b2e-8d11-e9a79edaed24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzMtNC0xLTEtMA_8f8cfd62-f275-4b9b-af54-1b9d32e056e3">173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" name="us-gaap:OperatingLeasesRentExpenseSubleaseRentals1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzMtNi0xLTEtMA_d458393b-7207-4af9-ac58-81e54afe9a62">156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzUtMi0xLTEtMA_1b7af447-d401-4fb9-a025-75d1901baad6">2,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzUtNC0xLTEtMA_85812419-e19b-476a-b41c-f50565358153">1,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CapitalLeasesIncomeStatementInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzUtNi0xLTEtMA_eaf7b64a-e6b7-406b-8cbc-a66ff75c3b13">1,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzYtMi0xLTEtMA_01c7a16e-8116-4aac-95e2-1392d146fb67">13,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzYtNC0xLTEtMA_1eab8bb4-3bcd-42cb-b790-8188f72b6c43">11,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="nvta:LeasesExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzYtNi0xLTEtMA_f30a4eb6-5c27-401b-8819-76b0754e401c">11,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIyNTM5OTg4NDA4Mjk2_0c2f4d3d-e3e0-4eac-a7b9-f4fec212b95f" escape="true"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIyNTM5OTg4NDA4Mjk2_69011b4f-8843-4cce-8022-1a050118a8ef" escape="true"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future payments under operating and finance leases as of December&#160;31, 2020 are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.850%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzAtMS0xLTEtOTgzNw_e488eb10-de21-49c1-8447-d078f964de84">14,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEtMy0xLTEtMTAwNDQ_b294021d-99e7-4302-97e1-85129f546bd6">2,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEtMS0xLTEtOTgzNw_fd25d500-7ab7-4b8e-b073-2bd1e1c4f4fb">13,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzItMy0xLTEtMTAwNDQ_d5adea08-0c2c-4f60-94d1-4bcf53dadb2c">1,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzItMS0xLTEtOTgzNw_886395bd-42c0-4b54-b37d-50b3ea0b8067">13,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzMtMy0xLTEtMTAwNDQ_ab9e8198-0019-4056-b182-5037316cd12e">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzMtMS0xLTEtOTgzNw_8fc9501f-ab03-4c89-be81-22bfd071d8f5">13,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzQtMy0xLTEtMTAwNDQ_9fe7bf37-625c-42e4-b6d3-359ffa93c61c">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzQtMS0xLTEtOTgzNw_2a908544-8218-42f8-b5f2-d509e2549c4e">11,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzUtMy0xLTEtMTEyODg_f89473b5-46cc-4300-8daa-24173d81fa46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzUtMS0xLTEtOTgzNw_5f16b483-c467-4f9c-bc51-23d139f47ee2">9,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzYtMy0xLTEtMTEyOTE_920f653b-397f-4b30-afea-cc606a1620c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Future non-cancelable minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzctMS0xLTEtMTEzMDU_04edbfcc-7733-4a59-b869-6723bde07e38">75,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzctMy0xLTEtMTEyOTU_60e211ac-c8ae-4e07-b354-ddc5cf473735">5,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEwLTEtMS0xLTExMzEx_8cfbb3f4-d9f1-402b-ac52-f3668d75be1e">18,787</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEwLTMtMS0xLTExMjk3_05b9bc8c-d77d-4510-a405-8b58181e4ae5">321</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzExLTEtMS0xLTExMzEz_2f9470da-a14a-4978-b45c-eb4ee45966ed">57,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzExLTMtMS0xLTExMjk5_d271586a-2c73-4f72-be3e-f4af38e77ede">4,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEyLTEtMS0xLTExMzA3_5e3ad0e1-f2a6-4bbd-b0d3-52169bae0751">8,789</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEyLTMtMS0xLTExMzAx_2a10c719-67b4-41d0-bc6f-e101b77af932">1,695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations, net of current portion</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEzLTEtMS0xLTExMzA5_63588fe4-313d-4add-b704-1492278f1760">48,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEzLTMtMS0xLTExMzAz_c18d4902-da12-463f-9788-ef0c035bfff6">3,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ib59eeebe5c3347779eb71ba31ac6f95f" continuedAt="i0392ce53893f4cebbe6ac0b34a14c8a5"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt financing</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we entered into a Note Purchase Agreement (the "2018 Note Purchase Agreement") pursuant to which we were eligible to borrow an aggregate principal amount up to $<ix:nonFraction unitRef="usd" contextRef="i4fe976692891413ba81c58b02db5d00d_I20181130" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIzNTY_6f0d743a-f324-4732-b112-8ca60db753ca">200.0</ix:nonFraction> million over a <ix:nonNumeric contextRef="i1f703415354e4db28b8eb792013da139_D20181101-20181130" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIzMDg5NzQ0MjA2Mjcx_07fb92ee-2d87-40aa-b66e-1424d5e70330">seven year</ix:nonNumeric> maturity term which included an initial borrowing of $<ix:nonFraction unitRef="usd" contextRef="id859a147fbaa47b580a323a7f9e4189d_I20181130" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI0MzA_d2adc316-cc59-4c7c-a0b5-4e721a59b7d2">75.0</ix:nonFraction> million in November 2018. We received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ie5fd4ad3c7b6406383062accfcffbe19_D20181101-20181130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI0Nzk_afaa9461-34c7-4bc2-bd57-1e34d25463c2">10.3</ix:nonFraction> million after terminating and repaying the balance of our obligations of approximately $<ix:nonFraction unitRef="usd" contextRef="i63443cb782824ffab2f81095d44a8e69_D20181101-20181130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI1NjE_d3af9261-5be5-47cf-a7d9-a9e74d3e72c8">64.7</ix:nonFraction> million with our previous lender. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, we settled our obligations under the 2018 Note Purchase Agreement in full for $<ix:nonFraction unitRef="usd" contextRef="ie3449298aceb411e8995fb489e02c922_D20190901-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI2ODg_198f708e-7fb4-44de-b7b6-a77357bbabf7">85.7</ix:nonFraction> million, which included repayment of principal of $<ix:nonFraction unitRef="usd" contextRef="ie3449298aceb411e8995fb489e02c922_D20190901-20190930" decimals="INF" format="ixt:numdotdecimal" name="nvta:RepaymentsofLinesofCreditPrincipal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI3MzM_dd6e82ef-d853-45ae-b3d4-d23d844a6aae">75.0</ix:nonFraction> million, accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ie3449298aceb411e8995fb489e02c922_D20190901-20190930" decimals="-5" format="ixt:numdotdecimal" name="nvta:RepaymentsofLinesofCreditAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI3NTc_0362dfbe-1467-48d0-9e9e-a1f01509e016">2.4</ix:nonFraction> million, and prepayment fees of $<ix:nonFraction unitRef="usd" contextRef="i69711d9dc55a46288486cf518a43bbe2_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI3ODQ_ae71f287-ab4e-4dfe-98d7-5cb0b5372c19">8.9</ix:nonFraction> million which were recorded as debt extinguishment costs in other expense, net in our consolidated statement of operations during the year ended December 31, 2019.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we entered into a credit agreement with a financial institution under which we borrowed $<ix:nonFraction unitRef="usd" contextRef="i117de729dbf54fc8b1c7825fc2b3e06d_I20201031" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg3OTYwOTMwNTM0MzY_e033f671-b9bc-4e42-ac3b-4a9cb86defcd">135.0</ix:nonFraction>&#160;million (the "2020 Term Loan") concurrent with the closing of the ArcherDX transaction (the "closing date"). The 2020 Term Loan is secured by a first priority lien on all of our and our subsidiaries' assets (including our intellectual property), and is guaranteed by our subsidiaries, in each case, excluding certain excluded assets and immaterial foreign subsidiaries. The 2020 Term Loan bears interest at an annual rate equal to LIBOR, subject to a <ix:nonFraction unitRef="number" contextRef="if4f48e652c334267bca5c0f3175f3e6d_D20201001-20201031" decimals="INF" name="nvta:DebtInstrumentInterestRateFloorRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIyNTM5OTg4NDAxNzY4_48debb49-e004-4cf5-8be0-825e0cc86fc6">2.00</ix:nonFraction>% LIBOR floor, plus a margin of <ix:nonFraction unitRef="number" contextRef="if4f48e652c334267bca5c0f3175f3e6d_D20201001-20201031" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg3OTYwOTMwNTM0Mjk_732e7fcf-06ff-4dc5-bcbc-610a578421cf">8.75</ix:nonFraction>%. The 2020 Term Loan will mature on (i) June 1, 2024 if at such time our Convertible Senior Notes are outstanding and are due to mature on September 1, 2024 (provided that if, prior to such date, the maturity date of at least <ix:nonFraction unitRef="number" contextRef="i9bf76301d2c04d1fa068a5ac5c9c4e49_D20201001-20201031" decimals="2" name="nvta:DebtInstrumentMaturityTermsPercentOfDebtExtended" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIyNTM5OTg4NDEwNTUy_c1b5eeb2-bd4b-4533-88ad-08e4445c7364">80</ix:nonFraction>% of the Convertible Senior Notes is extended to a date that is prior to September 1, 2025 the maturity date for the 2020 Term Loan will be automatically extended to a date that is <ix:nonNumeric contextRef="ibccee1e9674b4a1394120efaba533158_D20201001-20201031" format="ixt-sec:durday" name="nvta:DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIyNTM5OTg4NDEwNTU5_87c5fe90-91b3-4398-93c1-fa75c517dd6f">90</ix:nonNumeric> days prior to such Convertible Senior Notes maturity date as extended), or (ii) otherwise, on June 1, 2025. The full amount of the 2020 Term Loan is due upon maturity. If the 2020 Term Loan is prepaid (whether such prepayment is optional or mandatory), we must pay a prepayment fee of <ix:nonFraction unitRef="number" contextRef="i9f033130abcd435b987c4fb6e75bdba0_D20201001-20201031" decimals="2" name="nvta:DebtInstrumentPrepaymentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIyNTM5OTg4NDEwNTcx_c9315d2c-e7e0-4f86-923f-3e89dfeb0a56">6</ix:nonFraction>% if the prepayment occurs prior to the third anniversary of the closing date or <ix:nonFraction unitRef="number" contextRef="i89b10cf6330f40a29dfcad173848efc4_D20201001-20201031" decimals="2" name="nvta:DebtInstrumentPrepaymentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIyNTM5OTg4NDEwNTc1_f6f9d316-2c7a-4dd8-bc4c-87344aa3b06c">4</ix:nonFraction>% if the prepayment occurs after the third anniversary of the closing date and we must also pay a make-whole fee if the prepayment occurs prior to the second anniversary of the closing date. In connection with the 2020 Term Loan, we issued warrants to purchase <ix:nonFraction unitRef="shares" contextRef="i02d506f5f7744c309e1d6654a886c893_I20201031" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg3OTYwOTMwNTM0NTI_5a37136d-a808-49e2-bd2b-2118f9e2985b">1.0</ix:nonFraction>&#160;million shares of our common stock with an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i02d506f5f7744c309e1d6654a886c893_I20201031" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg3OTYwOTMwNTM0MjE_e18eda30-0def-4dbb-bb91-adbc3e50993f">16.85</ix:nonFraction> per share, exercisable through October 2027. The warrants, which were classified as equity, were recorded at an amount based on the allocated proceeds and do not require subsequent remeasurement. In October 2020, these warrants were exercised in full through net settlement resulting in the issuance of <ix:nonFraction unitRef="shares" contextRef="i8beb7cf99ebe46ce83c4c7ac46d96be8_D20201001-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg3OTYwOTMwNTM0MDg_70a9076e-826c-4020-8b1c-b63fd0bfecbc">0.7</ix:nonFraction>&#160;million shares.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit agreement contains customary events of default and covenants, including among others, covenants limiting our ability to incur debt, incur liens, undergo a change in control, merge with or acquire other entities, make investments, pay dividends or other distributions to holders of our equity securities, repurchase stock, and dispose of assets, in each case subject to certain customary exceptions. In addition, the credit agreement contains financial covenants that require us to maintain a minimum cash balance and minimum quarterly revenue levels. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt discounts, including debt issuance costs, related to the 2020 Term Loan of $<ix:nonFraction unitRef="usd" contextRef="i117de729dbf54fc8b1c7825fc2b3e06d_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzgyNDYzMzcyNDAxOTc_7fd31bab-642a-4315-bc90-bd8698a9cbfb">32.8</ix:nonFraction>&#160;million were recorded as a direct deduction from the debt liability and are being amortized to interest expense over the term of the 2020 Term Loan. Interest expense related to our debt financings, excluding the impact of our Convertible Senior Notes, was $<ix:nonFraction unitRef="usd" contextRef="iad8e118b6e0b43acac375dbb27f97699_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzMwMjI_7ea50d72-43ef-4e65-bb86-a54ffbab9eae">7.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="id14582e54d2c40feb9322c61bbb86ebe_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzMwMjY_b82793b0-999c-44b2-96a9-c3c681ea8e10">5.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3bbfab5b3a264c389f363d3c5993ae97_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzMwMzM_99893afb-1ebc-41ba-a82d-55214a158ab6">6.7</ix:nonFraction> million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-top:3pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, we issued, at par value, $<ix:nonFraction unitRef="usd" contextRef="i70c89bb06a7246a1bb3d4f7eec32e812_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzMxNTQ_4a117202-4fee-472a-9ce5-77783052a5ef">350.0</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i70c89bb06a7246a1bb3d4f7eec32e812_I20190930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzMxODc_763211de-e8a0-4a80-90fc-48b0c126023a">2.00</ix:nonFraction>% Convertible Senior Notes due 2024 in a private offering. The Convertible Senior Notes are our senior unsecured obligations and will mature on September 1, 2024, unless earlier converted, redeemed or repurchased. The Convertible Senior Notes bear cash interest at a rate of <ix:nonFraction unitRef="number" contextRef="i70c89bb06a7246a1bb3d4f7eec32e812_I20190930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzM0NjM_32bf2bb2-d69c-419d-b144-61c218453b14">2.0</ix:nonFraction>% per year, payable semi-annually in arrears on March 1 and September 1 of each year, beginning on March 1, 2020. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion, the Convertible Senior Notes will be convertible into cash, shares of our common stock or a combination of cash and shares of our common stock, at our election. Our current intent is to settle the principal amount of the Convertible Senior Notes in cash upon conversion, with any remaining conversion value being delivered in shares of our common stock. The initial conversion rate for the Convertible Senior Notes is 33.6293 shares of our common stock per $1,000 principal amount of the Convertible Senior Notes (equivalent to an initial conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i70c89bb06a7246a1bb3d4f7eec32e812_I20190930" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzU0ODA_d454dadc-7812-4fd4-bfc9-73618205fcfd">29.74</ix:nonFraction> per share of common stock). </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we undergo a fundamental change (as defined in the indenture governing the Convertible Senior Notes), the holders of the Convertible Senior Notes may require us to repurchase all or any portion of their Convertible Senior Notes for cash at a repurchase price equal to <ix:nonFraction unitRef="number" contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzYyNzM_edebdda0-1cb5-4831-a498-7abdc096a12f">100</ix:nonFraction>% of the principal amount of the Convertible Senior Notes to be repurchased plus accrued and unpaid interest to, but excluding, the redemption date.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i0392ce53893f4cebbe6ac0b34a14c8a5" continuedAt="i587344bd69744159a8f9bbe91d845b83"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Senior Notes will be convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding March 1, 2024, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on December 31, 2019 (and only during such calendar quarter), if the last reported sale price of our common stock for at least <ix:nonFraction unitRef="tradingday" contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzY4NDU_a39e6fcd-2c72-456e-be7c-62949bc99ae5">20</ix:nonFraction> trading days (whether or not consecutive) during a period of <ix:nonFraction unitRef="tradingday" contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzY5MDk_bfbc149f-9a24-4635-90b6-b88fecc8cf4f">30</ix:nonFraction> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzcwNTg_1761eca2-8850-4cab-a48f-d7a58df5efe9">130</ix:nonFraction>% of the conversion price for the Convertible Senior Notes on each applicable trading day; (2) during the <ix:nonFraction unitRef="tradingday" contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930" decimals="INF" format="ixt-sec:numwordsen" name="nvta:DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzcxNjU_00f3383e-39fb-4937-988d-6b80b0e2d3fa">five</ix:nonFraction> business day period after any five consecutive trading day period (the &#8220;measurement period&#8221;) in which the trading price per $1,000 principal amount of Convertible Senior Notes for each trading day of the measurement period was less than <ix:nonFraction unitRef="number" contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930" decimals="INF" name="nvta:DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzc0MDE_54538a7b-8cff-4a49-8c1e-669f9df054a8">98</ix:nonFraction>% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; (3) if we call any or all of the Convertible Senior Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On or after March 1, 2024 until the close of business on the business day immediately preceding the maturity date, holders may convert their Convertible Senior Notes at any time, regardless of the foregoing circumstances. As of December&#160;31, 2020, none of the above circumstances had occurred and therefore the Convertible Senior Notes could not have been converted. However, these notes were convertible at the option of the holders during the quarter beginning on January 1, 2021 due to the sale price of our common stock during the quarter ended December 31, 2020.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not redeem the Convertible Senior Notes prior to September 6, 2022. We may redeem for cash all or any portion of the Convertible Senior Notes, at our option, on or after September 6, 2022 and on or before the <ix:nonFraction unitRef="tradingday" contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930" decimals="INF" name="nvta:DebtInstrumentRedemptionPeriodThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzgzMzU_96afb33a-14b7-41e9-ac19-1a8617eb5409">30</ix:nonFraction>th scheduled trading day immediately before the maturity date if the last reported sale price of the Common Stock has been at least <ix:nonFraction unitRef="number" contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg0Njk_2c80edbf-dfe5-42d3-9c65-ab31209bfac1">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="tradingday" contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg1MjQ_3f4b3987-7bfc-4cf7-9ee0-453ae1440ea9">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="tradingday" contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg1ODA_76a43635-4f02-4e71-8e4e-d60c444ad455">30</ix:nonFraction> consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg4MDc_7ca59ce4-52ca-4383-b581-71d3733b5563">100</ix:nonFraction>% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzEwNzMx_147c6f7b-a548-4039-a61e-21f957550d6f" escape="true"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Senior Notes consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.319%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.321%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74cd37df131042188edd2e1114ee7668_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToyNmM4NDZjOTc5NjM0OTYyODVhMzUxMWIxMWI4YWY5OC90YWJsZXJhbmdlOjI2Yzg0NmM5Nzk2MzQ5NjI4NWEzNTExYjExYjhhZjk4XzAtMS0xLTEtMA_9fc76f81-016e-4c91-9cc5-5a02a7abf361">350,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i272e3fbf659b47e08751fee97f870e59_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToyNmM4NDZjOTc5NjM0OTYyODVhMzUxMWIxMWI4YWY5OC90YWJsZXJhbmdlOjI2Yzg0NmM5Nzk2MzQ5NjI4NWEzNTExYjExYjhhZjk4XzAtMy0xLTEtMTc2NQ_b370d4cc-fa0f-463e-8c9c-88404844e95d">350,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74cd37df131042188edd2e1114ee7668_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToyNmM4NDZjOTc5NjM0OTYyODVhMzUxMWIxMWI4YWY5OC90YWJsZXJhbmdlOjI2Yzg0NmM5Nzk2MzQ5NjI4NWEzNTExYjExYjhhZjk4XzEtMS0xLTEtMA_e4116203-7165-488b-81bf-7411b6b4232f">66,276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i272e3fbf659b47e08751fee97f870e59_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToyNmM4NDZjOTc5NjM0OTYyODVhMzUxMWIxMWI4YWY5OC90YWJsZXJhbmdlOjI2Yzg0NmM5Nzk2MzQ5NjI4NWEzNTExYjExYjhhZjk4XzEtMy0xLTEtMTc2NQ_5276b202-2b46-415c-b52b-bb8d167fcfb3">81,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount, liability component</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74cd37df131042188edd2e1114ee7668_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToyNmM4NDZjOTc5NjM0OTYyODVhMzUxMWIxMWI4YWY5OC90YWJsZXJhbmdlOjI2Yzg0NmM5Nzk2MzQ5NjI4NWEzNTExYjExYjhhZjk4XzItMS0xLTEtMA_8a497881-2bc3-4ab3-bc9c-fc257552e6f8">283,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i272e3fbf659b47e08751fee97f870e59_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToyNmM4NDZjOTc5NjM0OTYyODVhMzUxMWIxMWI4YWY5OC90YWJsZXJhbmdlOjI2Yzg0NmM5Nzk2MzQ5NjI4NWEzNTExYjExYjhhZjk4XzItMy0xLTEtMTc2NQ_09d0834b-8115-41ed-8790-5e135f898b16">268,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the fair value of the Convertible Senior Notes was $<ix:nonFraction unitRef="usd" contextRef="i190b1aad115641d5b928506daad609a7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzkwODA_c42f35a2-15dd-4ef5-baf3-ebc9750c2bdb">586.0</ix:nonFraction> million. The estimated fair value of the Convertible Senior Notes, which are classified as Level 2 financial instruments, was determined based on the estimated or actual bid prices of the Convertible Senior Notes in an over-the-counter market. We recognized $<ix:nonFraction unitRef="usd" contextRef="i266c72c2a75741499dc45fa4f1f47af3_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzgyNDYzMzcyNDA2NjM_15862270-03ae-4424-bf37-ad633e01caf5">22.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i8065d0a2eaf64cef95166d99a6cbe527_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzkzMzE_d4531b21-35a7-4303-ae59-4cabace3fd97">6.5</ix:nonFraction> million of interest expense related to the Convertible Senior Notes during the years ended December&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees and indemnifications</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As permitted under Delaware law and in accordance with our bylaws, we indemnify our directors and officers for certain events or occurrences while the officer or director is or was serving in such capacity. The maximum amount of potential future indemnification is unlimited; however, we maintain director and officer liability insurance. This insurance allows the transfer of the risk associated with our exposure and may enable us to recover a portion of any future amounts paid. We believe the fair value of these indemnification agreements is minimal. Accordingly, we did not record any liabilities associated with these indemnification agreements at December&#160;31, 2020 or 2019.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i587344bd69744159a8f9bbe91d845b83" continuedAt="i1bd4ba77cd53403db2450866852f1873"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other commitments</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we enter into various purchase commitments primarily related to service agreements and laboratory supplies. <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:RecordedUnconditionalPurchaseObligationsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzEwNzMy_7c45bf2b-d520-41e0-8c04-300eb06cd896" continuedAt="idc1f1a156f2240f3ab0459e7b39504f7" escape="true">At December&#160;31, 2020, our total future payments under noncancelable unconditional purchase commitments having a remaining term of over one year were as follows (in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><ix:continuation id="idc1f1a156f2240f3ab0459e7b39504f7"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f47c08fe00946e393ea1524efcfa65c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2YTE4MzVlN2IxNmM0YmFiODM3MmYwYjVjNmJiZjMwNy90YWJsZXJhbmdlOjZhMTgzNWU3YjE2YzRiYWI4MzcyZjBiNWM2YmJmMzA3XzEtMS0xLTEtMA_241191b9-89a6-4781-a433-75a0790945d6">23,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f47c08fe00946e393ea1524efcfa65c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2YTE4MzVlN2IxNmM0YmFiODM3MmYwYjVjNmJiZjMwNy90YWJsZXJhbmdlOjZhMTgzNWU3YjE2YzRiYWI4MzcyZjBiNWM2YmJmMzA3XzItMS0xLTEtMA_3bf195c5-422f-43d7-9861-465c33a93c71">20,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f47c08fe00946e393ea1524efcfa65c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInThirdYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2YTE4MzVlN2IxNmM0YmFiODM3MmYwYjVjNmJiZjMwNy90YWJsZXJhbmdlOjZhMTgzNWU3YjE2YzRiYWI4MzcyZjBiNWM2YmJmMzA3XzMtMS0xLTEtMA_f3b76fc5-2794-465a-9754-2d606e882129">19,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f47c08fe00946e393ea1524efcfa65c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInFourthYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2YTE4MzVlN2IxNmM0YmFiODM3MmYwYjVjNmJiZjMwNy90YWJsZXJhbmdlOjZhMTgzNWU3YjE2YzRiYWI4MzcyZjBiNWM2YmJmMzA3XzQtMS0xLTEtODkwMg_1f4ca474-264f-46ca-ab20-d5d6b6ffceb3">9,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f47c08fe00946e393ea1524efcfa65c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInFifthYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2YTE4MzVlN2IxNmM0YmFiODM3MmYwYjVjNmJiZjMwNy90YWJsZXJhbmdlOjZhMTgzNWU3YjE2YzRiYWI4MzcyZjBiNWM2YmJmMzA3XzUtMS0xLTEtODkwMg_2aa07cb8-2df4-4935-9774-93cc4e49406f">4,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f47c08fe00946e393ea1524efcfa65c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RecordedUnconditionalPurchaseObligationDueAfterFifthYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2YTE4MzVlN2IxNmM0YmFiODM3MmYwYjVjNmJiZjMwNy90YWJsZXJhbmdlOjZhMTgzNWU3YjE2YzRiYWI4MzcyZjBiNWM2YmJmMzA3XzYtMS0xLTEtODkwMg_2cb4a969-a16e-4398-85d8-99e7a38d78a6">25,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f47c08fe00946e393ea1524efcfa65c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RecordedUnconditionalPurchaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2YTE4MzVlN2IxNmM0YmFiODM3MmYwYjVjNmJiZjMwNy90YWJsZXJhbmdlOjZhMTgzNWU3YjE2YzRiYWI4MzcyZjBiNWM2YmJmMzA3XzQtMS0xLTEtMA_a1c17a0c-ede2-42bd-be0b-c480a607a1a0">102,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we entered into a lease agreement in San Francisco, California for additional office and lab space. We determined the lease commencement date to be in January 2021 when we took possession of the leased premises. Total lease payments over the course of this lease will be $<ix:nonFraction unitRef="usd" contextRef="i36aab3b4c6bf4533beccf6b9244c271d_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzgyNDYzMzcyNDI3MDQ_2d03d7ab-bd20-472d-89db-a5f040e6ccce">45.0</ix:nonFraction>&#160;million and are included in the purchase commitments above. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were not a party to any material legal proceedings at December&#160;31, 2020, or at the date of this report except for matters listed below which are related to ArcherDX which we acquired in October 2020. We cannot currently predict the outcome of these actions. The outcome of any such proceedings, regardless of the merits, is inherently uncertain. If we were unable to prevail in any such proceedings, our consolidated financial position, results of operations, and future cash flows may be materially impacted. In addition, we are and may from time to time become involved in various legal proceedings and claims arising in the ordinary course of business. While we believe any such claims are unsubstantiated, and we believe we are in compliance with applicable laws and regulations applicable to our business, the resolution of any such claims could be material.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i1bd4ba77cd53403db2450866852f1873"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Natera, Inc. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;27, 2020, Natera filed a lawsuit against ArcherDX (a subsidiary of Invitae effective October 2, 2020) in the United States District Court for the District of Delaware, alleging that ArcherDX&#8217;s products using AMP chemistry, and the manufacture, use, sale, and offer for sale of such products, infringe U.S. Patent No. 10,538,814. On March&#160;25, 2020, ArcherDX filed an answer denying Natera&#8217;s allegations and asserting certain affirmative defenses and counterclaims, including that U.S. Patent No. 10,538,814 is invalid and not infringed. On April&#160;15, 2020, Natera filed an answer denying ArcherDX&#8217;s counterclaims and filed an amended complaint alleging that ArcherDX&#8217;s products using AMP chemistry, including STRATAFIDE, PCM, LiquidPlex, ArcherMET, FusionPlex, and VariantPlex, and the manufacture, use, sale, and offer for sale of such products, infringe U.S. Patent No. 10,538,814, U.S. Patent No. 10,557,172, U.S. Patent No. 10,590,482, and U.S. Patent No. 10,597,708, each of which are held by Natera. Natera seeks, among other things, damages and other monetary relief, costs and attorneys&#8217; fees, and an order enjoining ArcherDX from further infringement of such patents. On May&#160;13, 2020, ArcherDX filed an answer to Natera&#8217;s amended complaint denying Natera&#8217;s allegations and asserting certain affirmative defenses and counterclaims, including that the asserted patents are invalid and not infringed. On June&#160;3, 2020, Natera filed an answer denying ArcherDX&#8217;s counterclaims. On June&#160;4, 2020, ArcherDX filed a motion seeking dismissal of Natera&#8217;s infringement claims against STRATAFIDE, PCM, and ArcherMET, and for a judgment that U.S. Patent No.&#160;10,538,814, U.S. Patent No. 10,557,172, and U.S. Patent No. 10,590,482 are invalid. On August 6, 2020, Natera filed another complaint against ArcherDX in the United States District Court for the District of Delaware alleging that ArcherDX&#8217;s products using AMP chemistry, including STRATAFIDE, PCM, LiquidPlex, ArcherMET, and VariantPlex, and the manufacture, use, sale, and offer for sale of such products, infringe U.S. Patent No. 10,731,220. Natera seeks, among other things, damages and other monetary relief, costs and attorneys&#8217; fees, and an order enjoining ArcherDX from further infringement of the patent. On October 13, 2020, the court issued an order denying ArcherDX's motion for dismissal of Natera&#8217;s infringement claims against STRATAFIDE, PCM, and ArcherMET, and declined to enter judgment that U.S.&#160;Patent No.&#160;10,538,814, U.S. Patent No. 10,557,172, and U.S. Patent No. 10,590,482 are invalid.&#160;On January 12, 2021, the court issued an order granting Natera leave to amend its complaint to add Invitae  as a co-defendant and plead allegations that ArcherDX and Invitae induce end-users to infringe the patents-in-suit. Natera filed its Second Amended Complaint on the same day, with service completed on January 15, 2021. ArcherDX and Invitae filed answers to the Second Amended Complaint on January 26, 2021 and February 5, 2021, respectively, denying Natera's allegations and restating certain affirmative defenses and counterclaims of non-infringement and invalidity. The litigations have now been consolidated for all purposes, are ongoing, and trial has been scheduled for May 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">QIAGEN Sciences </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;10, 2018, ArcherDX and the General Hospital Corporation d/b/a Massachusetts General Hospital, which we refer to as MGH, filed a lawsuit in the United States District Court for the District of Delaware against QIAGEN Sciences, LLC, QIAGEN LLC, QIAGEN Beverly, Inc., QIAGEN Gaithersburg, Inc., QIAGEN GmbH and QIAGEN N.V., which is collectively referred to herein as QIAGEN, and a named QIAGEN executive who was a former member of ArcherDX&#8217;s board of directors, alleging several causes of action, including infringement of the &#8217;810 Patent, trade secret misappropriation, breach of fiduciary duty, false advertising, tortious interference and deceptive trade practices. The &#8217;810 Patent relates to methods for preparing a nucleic acid for sequencing and aspects of ArcherDX&#8217;s AMP technology. On October&#160;30, 2019, with the permission of the Court, ArcherDX amended ArcherDX&#8217;s complaint to add a claim for infringement of the &#8217;597 Patent. The &#8217;597 Patent relates to methods of preparing and analyzing nucleic acids, such as by enriching target sequences prior to sequencing, and aspects of ArcherDX&#8217;s AMP technology. The QIAGEN products that ArcherDX alleges infringe the &#8217;810 Patent and the &#8217;597 Patent include, but are not limited to, QIAseq Targeted DNA Panels, QIAseq Targeted RNAscan Panels, QIAseq Index Kits and QIAseq Immune Repertoire RNA Library Kits. ArcherDX is seeking, among other things, damages for ArcherDX&#8217;s lost profits due to QIAGEN&#8217;s infringement and a permanent injunction enjoining QIAGEN from marketing and selling the infringing products and from using ArcherDX&#8217;s trade secrets. On December&#160;5, 2019, QIAGEN and the named QIAGEN executive submitted their answer denying the allegations in ArcherDX&#8217;s complaint and asserting affirmative defenses that, among other things, the &#8217;810 Patent and &#8217;597 Patent are not infringed by QIAGEN&#8217;s products, that both patents are invalid, and that the complaint fails to state any claim for which relief may be granted. This litigation is ongoing, and trial is currently scheduled for August 2021.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_109"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.  <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzI5ODY_6ecb3518-8c39-447a-8119-6ab00bd54bcf" continuedAt="i6951fc9b247d4e298b56a90407960fde" escape="true">Stockholders&#8217; equity</ix:nonNumeric></span></div><ix:continuation id="i6951fc9b247d4e298b56a90407960fde" continuedAt="i0b8d4e3a83b540dc82ee6715add0f220"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shares outstanding</span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzI5ODc_032d4e30-19ec-47de-ad04-bce42123a9fb" escape="true"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of convertible preferred and common stock were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, beginning of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i468f27e028dd4eabbd6a49ffcfef1827_I20191231" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzMtMi0xLTEtMA_938a17e8-329f-46cb-9c9c-342b0e5997cc">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i81554310853b4484b5d45f21ba86a785_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzMtNC0xLTEtMA_e6f552f9-79e6-473c-a32f-e9e0543bc63f">3,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i226038a1ff7c4ae9a815cea5810f19b6_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzMtNi0xLTEtMA_f274fa26-253a-456a-aeba-701e9dda4709">3,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion into common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifbede5a1c6e74525ab5e6cb2315db66f_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ConversionOfStockSharesConverted1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzUtMi0xLTEtMA_50aceaf0-0220-4b53-ab95-de652236983d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="icd21f307a6594587965e4a37c05d759c_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConversionOfStockSharesConverted1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzUtNC0xLTEtMA_6341f527-58ae-495f-aad2-64b22a345ea3">3,334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9861d9436174ce2b7457414cdf1a8a5_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ConversionOfStockSharesConverted1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzUtNi0xLTEtMA_35948e2b-03c3-43fe-bf15-748aa6574409">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i586e2494307941b4b023e85dc64835bc_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzYtMi0xLTEtMA_b68d729a-b909-4bb4-8a3f-c5c8c2d3d039">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i468f27e028dd4eabbd6a49ffcfef1827_I20191231" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzYtNC0xLTEtMA_a7a04e35-9621-402e-ab6e-dde223a78dbb">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i81554310853b4484b5d45f21ba86a785_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzYtNi0xLTEtMA_3f27a649-02d2-4493-81e6-4f92963e748e">3,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f3778e5a29f4a89b8566f4904cf689f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzktMi0xLTEtMA_31e4f582-d092-4f64-bc8f-49a8216b1461">98,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2809c9d3c7ed495ea105d1d0909333c7_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzktNC0xLTEtMA_caf1ee30-668b-4382-adb4-c71ec0015d51">75,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie554d3df8b1f425f9be76437e8b27488_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzktNi0xLTEtMA_e19f9198-0447-40f8-844f-807e2258ab1f">53,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued in private placement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEwLTItMS0xLTA_04c6d448-c578-496b-ba59-1a5860f21ca5">16,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="nvta:StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEwLTQtMS0xLTA_460f506a-bf77-46ef-bafa-c16eee38ebe5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231" decimals="-3" name="nvta:StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEwLTYtMS0xLTA_c3764b7f-9f6c-4113-99bd-d13b89a33aa2">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued in connection with public offering</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzExLTItMS0xLTA_1f296ebb-559a-474b-8a55-7fddecffde1a">24,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzExLTQtMS0xLTA_fd95ecf8-3943-46e9-865c-ed901492fc3a">11,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzExLTYtMS0xLTA_0423182f-43be-4a3f-940b-6860983041ad">17,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued on exercise of stock options, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEyLTItMS0xLTA_1bc4cc94-d47b-46cd-a62a-702f768ed7c4">2,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEyLTQtMS0xLTA_65083ef0-c756-4f80-800e-b667372a3ce5">468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEyLTYtMS0xLTA_93e1a237-1772-419f-a881-36ed4840b75d">351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued pursuant to vesting of RSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEzLTItMS0xLTA_7aa8f4da-405a-425d-9215-84ce04f5b804">5,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEzLTQtMS0xLTA_da881794-3b44-45b6-959f-747a6a0edc2a">2,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEzLTYtMS0xLTA_842d3207-1a11-4f6f-a00c-14db4a190283">1,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued pursuant to exercises of warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231" decimals="-3" name="nvta:StockIssuedDuringPeriodSharesWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE0LTItMS0xLTA_e3c84bb9-445f-4bbe-8852-ef9765275bb0">968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231" decimals="-3" name="nvta:StockIssuedDuringPeriodSharesWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE0LTQtMS0xLTA_72475f0c-0cb1-4ee1-ad09-5ee547ae2157">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="nvta:StockIssuedDuringPeriodSharesWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE0LTYtMS0xLTA_f4fd8aad-e217-41af-aff1-14055f0a7ffe">1,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued pursuant to employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE1LTItMS0xLTA_1fc9d208-5067-4f34-ab45-e162d166d6c7">671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE1LTQtMS0xLTA_2d2785bf-0e3e-44ad-8d61-6dd03a7e197b">455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE1LTYtMS0xLTA_d5cc60b5-7f06-4568-aba3-246f7bd0b887">566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued pursuant to acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE2LTItMS0xLTA_03ab9568-0730-4e81-9b30-b27cca055158">37,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE2LTQtMS0xLTA_fcdb05e6-d61b-4569-a0ea-34623f5be18f">5,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE2LTYtMS0xLTA_a3c941a9-964b-42d3-8d60-bccb6fb9acf4">1,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued upon conversion of preferred stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ConversionOfStockSharesConverted1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE4LTItMS0xLTA_a2a01aba-3c95-4190-a3e9-96b4529fa4c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConversionOfStockSharesConverted1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE4LTQtMS0xLTA_71ee8a11-bde1-496c-80eb-b0c59147b12f">3,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ConversionOfStockSharesConverted1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE4LTYtMS0xLTA_8e06dbbc-a569-4e3c-8b86-309b7f733101">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8214f3614960469ea38d28cf9303f211_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzIwLTItMS0xLTA_73d622ce-49ff-494d-85dd-a7781c040077">185,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f3778e5a29f4a89b8566f4904cf689f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzIwLTQtMS0xLTA_9997c16c-02f4-41fd-8332-7ce1a1acc8bb">98,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2809c9d3c7ed495ea105d1d0909333c7_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzIwLTYtMS0xLTA_a32c87fe-8fdd-45a2-90dc-10d4867ca5e4">75,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2018 Sales Agreement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, we entered into a Common Stock Sales Agreement (the &#8220;2018 Sales Agreement&#8221;) with Cowen and Company, LLC (&#8220;Cowen&#8221;), under which we could offer and sell from time to time at our sole discretion shares of our common stock through Cowen as our sales agent, in an aggregate amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="id86f15571c184f4ab4dc89850a302590_D20180801-20180831" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzQ1OQ_31f48be0-af32-445f-ac6e-943a9886f56e">75.0</ix:nonFraction> million. Cowen may sell the shares by any method permitted by law deemed to be an &#8220;at the market&#8221; offering as defined in Rule 415 of the Securities Act of 1933, including without limitation sales made directly on The New York Stock Exchange, and also may sell the shares in privately negotiated transactions, subject to our prior approval. Per the terms of the agreement, Cowen receives a commission equal to <ix:nonFraction unitRef="number" contextRef="i65858024a6ee4670bd95a107e05b518c_D20180801-20180831" decimals="2" name="nvta:PercentageOfCommissionPayableOnGrossProceeds" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzg2Mw_4a8494e5-f62f-4ced-ac07-e182ed8d10eb">3</ix:nonFraction>% of the gross proceeds of the sales price of all shares sold through it as sales agent under the 2018 Sales Agreement. In March 2019, we amended the 2018 Sales Agreement to increase the aggregate amount of our common stock to be sold under this agreement to an amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="i7be9af2688664a66b2e3f803d85e8307_D20190301-20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzExNDc_3ffe22df-9a53-43b7-8669-67bcd03addc6">175.0</ix:nonFraction> million. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, we sold a total of <ix:nonFraction unitRef="shares" contextRef="ic85e5a44169e47ba9cd182e29953f08a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDI4ODY_4cf10f10-189f-491e-88ee-0598bb2046a0">3.6</ix:nonFraction> million shares of common stock under the 2018 Sales Agreement at an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i91467e89bd9d48e69c729af397fac23a_I20201231" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDI5Njc_67aea6e8-d6c1-44dc-8555-a764c9a9043d">26.33</ix:nonFraction> per share, for gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="ic85e5a44169e47ba9cd182e29953f08a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDMwMDQ_02a129d1-4794-4e0b-b58b-b56f2b95900e">93.7</ix:nonFraction> million and net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ic85e5a44169e47ba9cd182e29953f08a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="nvta:NetProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDMwMjg_f26bc662-c2d6-48b1-97b4-426c47af66d0">90.7</ix:nonFraction> million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, we sold a total of <ix:nonFraction unitRef="shares" contextRef="i0937db87178b4e798b350becedc51ccc_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDMyODg_8246a3b7-8fa9-41c2-9331-18122a9efb35">0.8</ix:nonFraction>&#160;million shares of common stock under the 2018 Sales Agreement at an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="icb647a44d30c450faf1555b120835483_I20191231" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDMzNjk_198b05a0-a5c1-495e-b761-b6656de0309a">25.71</ix:nonFraction> per share, for gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i0937db87178b4e798b350becedc51ccc_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDM0MDY_f02310dd-3564-4da8-9448-a11a0229d271">20.2</ix:nonFraction>&#160;million and net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i0937db87178b4e798b350becedc51ccc_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="nvta:NetProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDM0MzA_aec57717-462c-44f3-bb91-a7e104cff841">19.5</ix:nonFraction>&#160;million. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2018, we sold a total of <ix:nonFraction unitRef="shares" contextRef="i9d8cf03a0e974c96bbcca6588d723e4b_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzExODM_6669c138-d8bc-42ab-badf-edc691452621">4.3</ix:nonFraction> million shares of common stock under the 2018 Sales Agreement at an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i50983d9ab9d24b97a4405cc2c8508678_I20181231" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzEyNjM_dd3e64fd-1900-4868-8c9e-ad7ad11b56b4">14.13</ix:nonFraction> per share, for aggregate gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i9d8cf03a0e974c96bbcca6588d723e4b_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzEzMDk_976ea088-6c6d-4dc3-a1f7-316895d0e8b7">61.1</ix:nonFraction> million and net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i9d8cf03a0e974c96bbcca6588d723e4b_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="nvta:NetProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzEzMzI_6fea1436-6b50-4b58-affa-9d54a061a011">58.9</ix:nonFraction> million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public offerings</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we issued, in an underwritten public offering, an aggregate of <ix:nonFraction unitRef="shares" contextRef="i3fc482b9b4e6420fa7de24243abc75c8_D20210101-20210131" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDEyNjA_b29abb68-cd7a-43a5-a6a8-2d1e4fd3970f">8.9</ix:nonFraction>&#160;million shares of our common stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic835049fa580444680cccf150af3d6d5_I20210131" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDEyNzM_39081ad1-0eb5-4dd2-b8bc-cc5d34a4418c">51.50</ix:nonFraction> per share, for gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i743deb0ca96048c0ad0d0d994c7de3bc_D20210101-20210131" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDEzMTE_abcf7d5d-ce95-4333-9a32-390b7d728496">460.0</ix:nonFraction>&#160;million and net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i743deb0ca96048c0ad0d0d994c7de3bc_D20210101-20210131" decimals="-5" format="ixt:numdotdecimal" name="nvta:ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDEzMjc_de88e79b-f815-4e6c-adfb-82a5585bcb32">434.3</ix:nonFraction>&#160;million. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, we issued, in an underwritten public offering, an aggregate of <ix:nonFraction unitRef="shares" contextRef="ia72cba2cf21e4e85808615721f1799df_D20200401-20200430" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzYwNDczMTM5NTYwOTE_aefac65f-1e7c-4f5b-bc35-1e1095924dd9">20.4</ix:nonFraction>&#160;million shares of our common stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i16d33aaa9e224dbeb56cab5c37d2117e_I20200430" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzYwNDczMTM5NTYwNzY_bfecc881-9ceb-4143-a1a7-6d6e72ba756c">9.00</ix:nonFraction> per share, for gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="ie5a08f2fb5df43589f4951124966ba71_D20200401-20200430" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzYwNDczMTM5NTYwODM_228f2ac8-5e81-47c0-8920-be3fdeda525f">184.0</ix:nonFraction> million and net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ie5a08f2fb5df43589f4951124966ba71_D20200401-20200430" decimals="-5" format="ixt:numdotdecimal" name="nvta:ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzYwNDczMTM5NTYxMDU_d03ca799-87ab-4cc7-97e9-7558681c0463">173.0</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i0b8d4e3a83b540dc82ee6715add0f220"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, we sold, in an underwritten public offering, an aggregate of <ix:nonFraction unitRef="shares" contextRef="iab0062e9ec3943238240137781cd0e8e_D20190301-20190331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzE2MTg_63d23903-9972-4b4a-a5eb-cf6fb901b158">10.4</ix:nonFraction> million shares of our common stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie2395cc0a9644defb0e33c2083cde3e1_I20190331" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzE2NjI_0220f5b8-d8e4-4508-b97b-3dff683bba6d">19.00</ix:nonFraction> per share, for gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i407b882e58514927b4d6e234330fb0af_D20190301-20190331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzE2OTg_bf2e56a4-7322-47bd-ada7-972c6d479f51">196.7</ix:nonFraction> million and net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i407b882e58514927b4d6e234330fb0af_D20190301-20190331" decimals="-5" format="ixt:numdotdecimal" name="nvta:ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzE3MjE_a6bed459-5959-4a62-b57b-d8dca8862993">184.5</ix:nonFraction> million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private placement</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2017, in a private placement to certain accredited investors, we issued <ix:nonFraction unitRef="shares" contextRef="i6d039501b157438480d3f00c8b7489fc_D20170801-20170831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIwMDg_481bfd94-c2ff-460a-9972-36eabaa9536f">5.2</ix:nonFraction> million shares of common stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i32e8155326254dfdbe5fdaa570c6e110_I20170831" decimals="INF" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIwNDg_9523b12d-9d64-4eb5-b92f-d763aa2abace">8.50</ix:nonFraction> per share, and <ix:nonFraction unitRef="shares" contextRef="i42987b8252bd433a93091bf2d1686bc0_D20170801-20170831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIwNjY_77ec03e3-793a-42a0-ac26-ac3a282d65ec">3.5</ix:nonFraction> million shares of our Series A convertible preferred stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="if2efecf6d7544e109ede0602218829c7_I20170831" decimals="INF" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIxMzQ_6f535837-86df-4f78-a91e-7501cef9fc9a">8.50</ix:nonFraction> per share, for gross proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i82a6b8eccfb740329aeaa15bd047f71b_D20170801-20170831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIxODQ_add14711-8006-4243-bdfd-49aff567c9bb">73.5</ix:nonFraction> million and net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i82a6b8eccfb740329aeaa15bd047f71b_D20170801-20170831" decimals="-5" format="ixt:numdotdecimal" name="nvta:NetProceedsFromIssuanceOfPrivatePlacement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIyMDc_bd4c5df0-9aaa-4157-85cb-27899d1822c3">68.9</ix:nonFraction> million. The Series A preferred stock is convertible into common stock on a <ix:nonFraction unitRef="number" contextRef="i82a6b8eccfb740329aeaa15bd047f71b_D20170801-20170831" decimals="INF" format="ixt-sec:numwordsen" name="nvta:PreferredStockToCommonStockConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIyNzg_d0154502-d27c-4f92-95a2-3843d407cea0">one</ix:nonFraction>-for-one basis, subject to adjustment for events such as stock splits, combinations and the like. During the year ended December 31, 2019, <ix:nonFraction unitRef="shares" contextRef="ib58041aa8f654c0bbf3e16262383a5bd_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConversionOfStockSharesConverted1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzI0MDQ_7f326999-c1a7-4834-bbc8-47597798e241">3.3</ix:nonFraction> million shares of Series A convertible preferred stock were converted to <ix:nonFraction unitRef="shares" contextRef="ib7027e57e0c047a4b6418f097ab58a3e_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzI0NzI_8d485541-8106-432d-a028-b548b6b75e4d">3.3</ix:nonFraction> million shares of common stock.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our acquisition of ArcherDX, in June 2020 we entered into a definitive agreement to sell $<ix:nonFraction unitRef="usd" contextRef="if2455da1e7a143d7851eb9d50d083334_D20201001-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIyNTM5OTg4Mzc1MDY3_ada9bfca-da9c-45d7-bf5e-118f3b636d5c">275.0</ix:nonFraction>&#160;million in common stock in a private placement at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="iebaff4dc5d934f078872f079f91ec08d_I20201031" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIyNTM5OTg4Mzc1MDgz_19deb0e9-7fa2-4451-8a4e-73f49d591b4c">16.85</ix:nonFraction> per share. The private placement closed in October 2020, concurrently with our acquisition of ArcherDX. We received proceeds of $<ix:nonFraction unitRef="usd" contextRef="id57225c75bc24501b26be0327fa8bcbb_D20200901-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIyNTM5OTg4Mzc1MDkx_48fbd32a-0446-4162-a636-95e77594ddfe">5.0</ix:nonFraction>&#160;million from the private placement during September 2020 and the remainder of the proceeds were received in October 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common stock warrants</span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzI5OTA_3bbb7e8b-64b9-40e2-80ec-caddfe79a53d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had outstanding warrants to purchase common stock as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.880%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrant</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise<br/>Price<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares of Common Stock Underlying Warrants</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants issued in exchange for CombiMatrix Series F warrants</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2017</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2021</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id2406ee2925e4cdfa9b0c5c418c48d97_I20201231" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTphMTY2M2I3NDcxM2Q0MGMxYTdmYjkxODc5NTdlMDQ5NC90YWJsZXJhbmdlOmExNjYzYjc0NzEzZDQwYzFhN2ZiOTE4Nzk1N2UwNDk0XzEtNi0xLTEtMA_ffc85173-ce7f-414b-93b4-5cc1e8d3f06c">5.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id2406ee2925e4cdfa9b0c5c418c48d97_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTphMTY2M2I3NDcxM2Q0MGMxYTdmYjkxODc5NTdlMDQ5NC90YWJsZXJhbmdlOmExNjYzYjc0NzEzZDQwYzFhN2ZiOTE4Nzk1N2UwNDk0XzEtOC0xLTEtMA_cfd20cc7-4ace-403c-baf0-74ed18c97d35">214,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exercise price of warrants issued in exchange for CombiMatrix Series F warrants was determined pursuant to the terms of the acquisition.</span></div></ix:continuation><div id="ie13029cdd7d64c5bac971f0e86e8f19a_112"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.  <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgyMzI_8799f795-8c14-4332-ade3-da48a1020d9c" continuedAt="i91c4273d4cc646e2b63fff18286ea969" escape="true">Stock incentive plans</ix:nonNumeric></span></div><ix:continuation id="i91c4273d4cc646e2b63fff18286ea969" continuedAt="i39aaf774a3844a6f8e0b50e32eba0e16"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock incentive plans</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2010, we adopted the 2010 Incentive Plan (the &#8220;2010 Plan&#8221;). The 2010 Plan provides for the granting of stock-based awards to employees, directors and consultants under terms and provisions established by our Board of Directors. Under the terms of the 2010 Plan, options may be granted at an exercise price not less than the fair market value of our common stock. For employees holding more than <ix:nonFraction unitRef="number" contextRef="ibf0c262e5e494ba1a0b9dd846e947808_D20200101-20201231" decimals="INF" name="nvta:ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQyOA_ae20b2c9-6159-4b3b-8a8b-5d2b50ec6f50">10</ix:nonFraction>% of the voting rights of all classes of stock, the exercise prices for incentive and nonstatutory stock options must be at least <ix:nonFraction unitRef="number" contextRef="ibf0c262e5e494ba1a0b9dd846e947808_D20200101-20201231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzU1OQ_6a5d1f8a-392e-4449-9ef2-b231c53d3de9">110</ix:nonFraction>% of fair market of our common stock on the grant date, as determined by our Board of Directors. The terms of options granted under the 2010 Plan may not exceed <ix:nonNumeric contextRef="if94fe272d7e54bc5a7c51daac714d62e_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzcyMQ_7743ed58-1453-4e03-adf3-da49127c7f75">ten years</ix:nonNumeric>.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January&#160;2015, we adopted the 2015 Stock Incentive Plan (the &#8220;2015 Plan&#8221;), which became effective upon the closing of our initial public offering (&#8220;IPO&#8221;). Shares outstanding under the 2010 Plan were transferred to the 2015 Plan upon effectiveness of the 2015 Plan. The 2015 Plan provides for automatic annual increases in shares available for grant, beginning on January&#160;1, 2016 through January&#160;1, 2025. In addition, shares subject to awards under the 2010 Plan that are forfeited or terminated will be added to the 2015 Plan. The 2015 Plan provides for the grant of incentive stock options, nonstatutory stock options, restricted stock awards, stock units, stock appreciation rights and other forms of equity compensation, all of which may be granted to employees, including officers, non-employee directors and consultants. Additionally, the 2015 Plan provides for the grant of cash-based awards.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted generally vest over a period of <ix:nonNumeric contextRef="ief4a6302d24a4af294e7028833fe7fb2_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzE4MTQ_394164ed-3231-4b01-b42b-a1a4ef091ad3">four years</ix:nonNumeric>. Typically, the vesting schedule for options granted to newly hired employees provides that 1/4 of the award vests upon the first anniversary of the employee&#8217;s date of hire, with the remainder of the award vesting monthly thereafter at a rate of 1/48 of the total shares subject to the option. All other options typically vest in equal monthly installments over the <ix:nonNumeric contextRef="ief4a6302d24a4af294e7028833fe7fb2_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzIzMDg5NzQ0MTk1MjM0_a0d8a68f-7981-4c79-b8e1-83e6b4d514f4">four-year</ix:nonNumeric> vesting schedule. Upon the acquisition of ArcherDX, any option that was outstanding was converted into a fully vested option to purchase a share of our common stock which resulted in the issuance of <ix:nonFraction unitRef="shares" contextRef="i5a98899500704f17a6fcfb0d3cdf1f52_D20201001-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzIyNTM5OTg4Mzg2NjYz_ed796af8-afad-4649-86b6-2ddfdef65b12">3.7</ix:nonFraction>&#160;million options.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs generally vest over a period of <ix:nonNumeric contextRef="iae69da4291404d09846bdd7eea1b3df7_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzIyNDg_b51a9b32-1b10-46dd-8692-fdd758a0018c">three years</ix:nonNumeric>. Typically, the vesting schedule for RSUs provides that 1/3 of the award vests upon each anniversary of the grant date, with certain awards that include a portion that vests immediately upon grant. In June 2019, we granted Time-based RSUs in connection with the acquisition of Singular Bio which vest in three equal installments over a period of <ix:nonNumeric contextRef="ibb3a6b1e9224415e90b51c05440aa312_D20190601-20190630" format="ixt-sec:durmonth" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzI1OTc_c4876f34-16fe-46c2-8a2e-10107a938fcb">18</ix:nonNumeric> months and PRSUs that vest based on the achievement of performance conditions. In December 2020, we granted RSUs in connection with an asset acquisition which vest in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzIyNTM5OTg4Mzg2Njgy_3f341498-9f73-4766-bb53-9c8f75c67d63">two</span> equal installments in December 2021 and December 2022, subject to the employee's continued service with us. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i39aaf774a3844a6f8e0b50e32eba0e16" continuedAt="icdd33b2029884e0498fa9481cef4fe35"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our management incentive compensation plan, in July 2019 we granted PRSUs to our executive officers as well as other specified senior level employees based on the level of achievement of a specified 2019 revenue goal. One-third of the <ix:nonFraction unitRef="shares" contextRef="ie879d74e4a2947429031c4d39f6c60f1_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzYwNDczMTM5NjMxNzI_b2e47714-b65f-46fb-b2f3-eb238e2734e7">0.8</ix:nonFraction>&#160;million shares that were ultimately awarded under this plan vested during the year ended December&#160;31, 2020 and the remaining shares will vest through March 2022. In June 2020, we granted <ix:nonFraction unitRef="shares" contextRef="i2f83a392f53641de82f099c66bcd8add_D20200601-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzYwNDczMTM5NjQ0MDM_aeed2325-c7bc-4e35-a6d2-f6248fb552e4">0.3</ix:nonFraction>&#160;million PRSUs under this plan which are based on the level of achievement of a specified 2020 cash burn goal. Upon achievement of the specified 2020 cash burn goal, <ix:nonFraction unitRef="shares" contextRef="i2f83a392f53641de82f099c66bcd8add_D20200601-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzIyNTM5OTg4Mzg3MTI0_9cd34f16-8a4a-4407-91f2-7b00623b8b10">0.3</ix:nonFraction>&#160;million shares were ultimately awarded and began vesting in 2021 over a <ix:nonNumeric contextRef="i2f83a392f53641de82f099c66bcd8add_D20200601-20200630" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzIyNTM5OTg4MzgyMTM5_7cc3cc77-0d98-49ed-828a-20bfb62bfb8c">one year</ix:nonNumeric> period. These PRSUs had a grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="i5b24e569ebe043d1bcd9a86c0d20cfa2_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzYwNDczMTM5NjQ0MzE_cc4ddfcf-3454-41af-90ca-b4d5788ece29">4.2</ix:nonFraction>&#160;million based on an estimated issuance of <ix:nonFraction unitRef="shares" contextRef="i5b24e569ebe043d1bcd9a86c0d20cfa2_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzYwNDczMTM5NjQ0NDY_7f5a0c5f-21c0-42f7-a1f5-4bfc88d02ae4">0.3</ix:nonFraction>&#160;million shares and expectation of the performance conditions. During the year ended December&#160;31, 2020, $<ix:nonFraction unitRef="usd" contextRef="ie879d74e4a2947429031c4d39f6c60f1_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzMyMzY_b2232656-f7b7-4c0c-894a-92f2195ee9a6">2.1</ix:nonFraction> million was recorded as stock-based compensation expense related to the awards. <ix:nonFraction unitRef="shares" contextRef="i79688bef1f2243f8af291580e680c142_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzMzMTQ_90020926-9ad4-4520-9149-f929d3cdf73e">No</ix:nonFraction> PRSUs were granted during the year ended December&#160;31, 2018.</span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgyNDY_9ae4667f-8bf9-45e0-a042-08c17b87d2af" continuedAt="ie5bd062c8a064686bc7ffec134c23486" escape="true"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the 2010 Plan and the 2015 Plan is set forth below (in thousands, except per share amounts and years):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.844%"><tr><td style="width:1.0%"></td><td style="width:39.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.212%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Available For Grant</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Life (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a15e9739bdb4dd3ba91eff47a68dee8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEtMS0xLTEtMA_bc4ff232-a2f4-441c-b81c-11b90e1ec12b">5,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a15e9739bdb4dd3ba91eff47a68dee8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEtMy0xLTEtMA_6488e5f6-2825-4084-8a41-272a7b5b1a17">3,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2a15e9739bdb4dd3ba91eff47a68dee8_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEtNS0xLTEtMA_479a5238-985f-43c7-b484-a88e94513a61">9.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifc2ccdad682745929752c4bdbabe6ad4_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEtNy0xLTEtMA_89db87a9-d91e-41b4-a096-704d9538d73d">6.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a15e9739bdb4dd3ba91eff47a68dee8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEtOS0xLTEtMA_363fbeea-589b-4450-8bb7-265329ec1f7c">24,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzItMS0xLTEtMA_7c0e0068-07a6-4722-bea7-0cff91d35b8e">9,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzMtMS0xLTEtMA_694fc3ca-b6e6-44d9-a2bf-793e81ddd0b2">4,005</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzMtMy0xLTEtMA_ca5fd034-c600-4c2f-9848-b1c08a5f4d62">4,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzMtNS0xLTEtMA_20b4d350-5a74-4099-8fa9-9e029f525c9c">3.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzQtMS0xLTEtMA_979aa475-09c1-4485-9b52-9b1524e0fc95">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzQtMy0xLTEtMA_443dd80b-15a8-44db-94c5-ec302defdcb8">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzQtNS0xLTEtMA_683af4e9-5b07-454c-b360-da8afad8d44f">7.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzUtMy0xLTEtMA_645a2199-c7b8-4d9b-a682-02f2ca63e2d0">2,659</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzUtNS0xLTEtMA_f146d981-adc3-4038-a9b5-e55e552c56a0">4.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs and PRSUs granted</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4a23a8c0acc9467b8816b6d8750a8e4e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzYtMS0xLTEtMA_8a6c35c1-eb02-4a40-aeeb-ef613f6633f3">3,502</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs and PRSUs cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a23a8c0acc9467b8816b6d8750a8e4e_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzctMS0xLTEtMA_801390f3-f8bc-416a-b620-1892488593fe">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzktMS0xLTEtMA_2584a532-bd85-429a-8ebd-7fee38cc9d5a">7,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzktMy0xLTEtMA_aecf82a2-f4ad-45af-9587-7672ce8fed64">4,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzktNS0xLTEtMA_040b6aea-87f5-498f-a9d3-cb0c7b3f4126">7.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzktNy0xLTEtMA_aa0a2863-3e82-47cd-b7a5-9ba69ffb6c4e">6.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzktOS0xLTEtMA_da6b68b1-9d7a-462a-98b0-e94e03f18b2f">166,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEwLTMtMS0xLTA_e1ddc342-3b89-455c-9cb2-8c76bbb45327">4,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEwLTUtMS0xLTA_43e95927-26ed-48da-bcce-13c6ce279add">6.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEwLTctMS0xLTA_6801f51f-3f6a-465a-b129-0553eac26736">6.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEwLTktMS0xLTA_46b2e6cf-6a6d-462d-b144-b81c7f6c8ec7">154,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzExLTMtMS0xLTA_36326ea1-773d-4392-81f7-e1a70f572640">4,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzExLTUtMS0xLTA_a0b9579f-854f-4f5a-84e6-3503e209797c">7.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzExLTctMS0xLTA_f884c486-ef08-4069-bcc8-44a51a877a5f">6.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzExLTktMS0xLTA_8ce76619-9069-48ab-a9a9-83363849eccf">164,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"><ix:continuation id="ie5bd062c8a064686bc7ffec134c23486" continuedAt="i0d33040ac8ef43b080c07d522436360e">(1)</ix:continuation></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i0d33040ac8ef43b080c07d522436360e"> Includes the changes in time-based RSUs and PRSUs&#160;granted as a part of the Singular Bio acquisition in June 2019 and shares granted in an asset acquisition in December 2020 which are based on a fixed dollar value. The number of shares issued will be variable until the awards vest.</ix:continuation> </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock options and the fair value of our common stock for stock options that were in-the-money.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair value of options to purchase common stock granted was $<ix:nonFraction unitRef="usdPerShare" contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQwNDQ_fcb62f62-b7c0-449f-a135-fd36f1a6ccc6">10.10</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="ifc2ccdad682745929752c4bdbabe6ad4_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQwNDg_98814611-e739-49da-80bc-2486f61ea2d2">14.52</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i043b18d384cc4cbbbd4ea576bf1e0ee8_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQwNTU_1806646c-183e-4620-911d-a79d4dcb45c6">4.87</ix:nonFraction> in the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total grant-date fair value of options to purchase common stock vested was $<ix:nonFraction unitRef="usd" contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQxODU_91c9bfca-89c0-405e-b008-5d777271deec">2.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ifc2ccdad682745929752c4bdbabe6ad4_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQxODk_7545b54b-d2b6-4209-a30b-55f5634e9ce1">4.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i043b18d384cc4cbbbd4ea576bf1e0ee8_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQxOTY_d1f9bf23-eef2-45c6-8362-db5d76b1bedc">5.9</ix:nonFraction> million in the year ended December&#160;31, 2020, 2019, and 2018, respectively.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intrinsic value of options to purchase common stock exercised was $<ix:nonFraction unitRef="usd" contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQzMTc_01a7773a-01f4-48f5-b809-922ea1b73248">104.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ifc2ccdad682745929752c4bdbabe6ad4_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQzMjE_d1cbc394-422b-48b4-b725-f13d2affc340">6.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i043b18d384cc4cbbbd4ea576bf1e0ee8_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQzMjg_35eef271-46de-43d8-99e1-cc5680fada80">1.7</ix:nonFraction> million in the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="icdd33b2029884e0498fa9481cef4fe35" continuedAt="i1135e68b61cc485d9f7cc4be21346bb4"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgyNDc_f94a26f0-3f8b-4ad1-8bae-258cf46bfa0d" continuedAt="i6eba686c9c044e75b63827d1b0078f8b" escape="true"><div style="margin-bottom:3pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes RSU, including PRSU, activity (in thousands, except per share data):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8df5ce0c23374e0f96f0da2ab94af033_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzEtMS0xLTEtMA_5ddae288-cb3b-40cf-822a-26e75925964a">8,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8df5ce0c23374e0f96f0da2ab94af033_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzEtMy0xLTEtMA_5c296a31-ad89-4fe7-b909-47b3121cb6d2">15.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzItMS0xLTEtMA_55c83930-c17b-422b-b3d0-c023db73c0e6">4,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzItMy0xLTEtMA_7652d759-ab7e-4996-9a16-f45678b374d6">20.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time-based RSUs and PRSUs granted - variable </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7d14ed300bd94484b318f56f0730a43a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="nvta:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzMtMS0xLTEtMA_4f61d27a-882c-4528-a6bf-0cb99aa5ed32">1,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7d14ed300bd94484b318f56f0730a43a_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzMtMy0xLTEtMA_d16ef60f-4fde-4318-9ee3-d27417280889">24.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97e8d6d759574ef190efeec1fa288be0_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzQtMS0xLTEtMA_e0ef83f1-790a-4045-b224-01a72d627002">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97e8d6d759574ef190efeec1fa288be0_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzQtMy0xLTEtMA_4d4a196b-5e61-4948-a825-e91b2e9784ed">16.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzUtMS0xLTEtMA_959d1905-3ffe-4d6c-a74a-03cdabf2a3db">5,305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzUtMy0xLTEtMA_7b213c9c-0a2f-4632-bd3e-6887f425d500">19.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzYtMS0xLTEtMA_973d6841-d194-49ff-b125-2ab91ed2e736">480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzYtMy0xLTEtMA_99859f79-0515-42b2-a926-2fd6fdb01893">18.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib230a508963e4077bf9c329a3d9e10af_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzctMS0xLTEtMA_83f39db9-d9d5-4264-afd6-0d76ffbfac45">6,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib230a508963e4077bf9c329a3d9e10af_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzctMy0xLTEtMA_6fc06be4-961d-4c70-b00f-bc2a848c5351">12.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"><ix:continuation id="i6eba686c9c044e75b63827d1b0078f8b" continuedAt="i3df5a9511b28441a80be65cc994037a8">&#160;(1)</ix:continuation></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i3df5a9511b28441a80be65cc994037a8"> Includes the changes in the Time-based RSUs and PRSUs&#160;granted as a part of the Singular Bio acquisition in June 2019 and the shares granted in an asset acquisition in December 2020 which are based on a fixed dollar value. The number of shares issued will be variable until the awards vest. The weighted-average grant date fair value per share reflects the fair value pricing of the full award.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2015 Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January&#160;2015, we adopted the 2015 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;), which became effective upon the closing of the IPO. Employees participating in the ESPP may purchase common stock at <ix:nonFraction unitRef="number" contextRef="ie1bf01002c574012aeba2a32221405d2_D20150101-20150131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzUxODI_d627287d-1993-4360-856e-fa452004e291">85</ix:nonFraction>% of the lesser of the fair market value of common stock on the purchase date or last trading day preceding the offering date. At December&#160;31, 2020, cash received from payroll deductions pursuant to the ESPP was $<ix:nonFraction unitRef="usd" contextRef="i842c32fb0e4d4001b6d4b09acb1051bc_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzUzODA_1d047794-5ff1-4095-bce9-4415a82d7231">1.8</ix:nonFraction> million.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP provides for automatic annual increases in shares available for grant, beginning on January&#160;1, 2016 and continuing through January&#160;1, 2025. At December&#160;31, 2020, a total of <ix:nonFraction unitRef="shares" contextRef="ice92feeec65b4c99bf48cdc4f7ae3064_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzYwNDczMTM5Njc2ODk_8c2b0944-3391-48eb-a593-891beb4b2d01">0.9</ix:nonFraction>&#160;million shares of common stock are reserved for issuance under the ESPP.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the grant date fair value of our common stock to value options when granted. In determining the fair value of stock options and ESPP purchases, we use the Black-Scholes option-pricing model and, for stock options, the assumptions discussed below. Each of these inputs is subjective and its determination generally requires significant judgment. The fair value of RSU and PRSU awards is based on the grant date share price. Compensation cost is recognized as expense on a straight-line basis over the vesting period for options and RSUs and on an accelerated basis for PRSUs.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected term</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The expected term represents the period that our stock-based awards are expected to be outstanding and is determined using the simplified method (based on the midpoint between the vesting date and the end of the contractual term).</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected volatility</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;We estimate expected volatility based on the historical volatility of our common stock over a period equal to the expected term of stock option grants and RSUs and over the expected six-month term ESPP purchase periods.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-free interest rate</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of the option.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend yield</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;We have never paid dividends on our common stock and have no plans to pay dividends on our common stock. Therefore, we used an expected dividend yield of zero.</span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgyNDM_d5b584d9-ff74-4920-ad8f-631465d2753b" continuedAt="ib42a9b970d98489fa9ff9569106575f8" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of share-based payments for stock options granted to employees and directors was estimated on the date of grant using the Black-Scholes option-pricing model based on the following assumptions:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:52.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9687cb514ee64df88920c8e6d2c79f5b_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzItMS0xLTEtMA_3f55b497-3873-4dfb-98ad-9893faa52148">6.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i212150697d1b4df0b9d350151ba23788_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzItMy0xLTEtMA_0e7241aa-868d-4a52-a452-5538f028d368">6.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i39d9c671420c4cbfb753905344bfe23e_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzItNS0xLTEtMA_edecdef5-e5f5-4510-99ab-196c1770ff3c">6.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9687cb514ee64df88920c8e6d2c79f5b_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzMtMS0xLTEtMA_75d76bf8-a7a5-416b-bdfc-7e59984a13f4">71.0</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i212150697d1b4df0b9d350151ba23788_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzMtMy0xLTEtMA_2bf14f45-7e5f-4652-a0d0-399c18a9d60c">64.2</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39d9c671420c4cbfb753905344bfe23e_D20180101-20181231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzMtNS0xLTEtMA_4385f481-01a8-4be8-81be-1d1cef341495">59.6</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9687cb514ee64df88920c8e6d2c79f5b_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzQtMS0xLTEtMA_643afa1c-b48e-41f4-bb5e-0ac40a5e99af">0.5</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i212150697d1b4df0b9d350151ba23788_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzQtMy0xLTEtMA_29abc82b-1759-49f5-8a82-ed735bd08fe7">2.6</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39d9c671420c4cbfb753905344bfe23e_D20180101-20181231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzQtNS0xLTEtMA_b421380d-46f8-4835-98ab-af345992e568">2.8</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of shares purchased pursuant to the ESPP is estimated using the Black-Scholes option pricing model. For the years ended December&#160;31, 2020, 2019 and 2018, the weighted-average grant date fair value per share for the ESPP was $<ix:nonFraction unitRef="usdPerShare" contextRef="i842c32fb0e4d4001b6d4b09acb1051bc_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1Xzc1MTE_e7136b7c-6a42-422b-b73f-28bee59f1a39">10.98</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="ie5f75e5a153a43f58048be8074c30cd4_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1Xzc1MTU_566e7727-df4e-4dcb-a9e4-f53d435141b4">6.05</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="iaca634719b854efb84813c2dc3f0fd0e_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1Xzc1MjI_054773fa-ebb8-411f-80d2-78ba3fd68ebf">3.26</ix:nonFraction>, respectively.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i1135e68b61cc485d9f7cc4be21346bb4"><ix:continuation id="ib42a9b970d98489fa9ff9569106575f8"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the shares purchased pursuant to the ESPP was estimated using the following assumptions:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:52.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i842c32fb0e4d4001b6d4b09acb1051bc_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzItMS0xLTEtMA_a6d10e35-0ff8-4fe4-9828-6889a2bf3f87">0.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie5f75e5a153a43f58048be8074c30cd4_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzItMy0xLTEtMA_86f20018-2948-4476-9fd4-01483754acb3">0.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaca634719b854efb84813c2dc3f0fd0e_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzItNS0xLTEtMA_1ceb2a4d-9b4a-424f-a37e-416d8a38b119">0.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i842c32fb0e4d4001b6d4b09acb1051bc_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzMtMS0xLTEtMA_e84dc4c9-74c8-44c6-a291-458f205f369a">105.7</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5f75e5a153a43f58048be8074c30cd4_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzMtMy0xLTEtMA_dba249cf-3f11-40a3-b585-86c2b57f3461">66.3</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaca634719b854efb84813c2dc3f0fd0e_D20180101-20181231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzMtNS0xLTEtMA_9a9b012a-d483-4fd9-8709-c89671b28632">71.7</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i842c32fb0e4d4001b6d4b09acb1051bc_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzQtMS0xLTEtMA_ee927dcf-8886-4f4e-a923-230657c4fcd1">0.1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5f75e5a153a43f58048be8074c30cd4_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzQtMy0xLTEtMA_b336843b-56cb-4694-96c8-a18c7d210a53">2.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaca634719b854efb84813c2dc3f0fd0e_D20180101-20181231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzQtNS0xLTEtMA_1e66dcd9-ff3e-4143-8944-2bc13366ffde">2.1</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgyNDA_952f4aff-9502-4264-aef3-501ade60c59c" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock-based compensation expense for the years ended December&#160;31, 2020, 2019 and 2018, included in the consolidated statements of operations (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:52.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3381401fa094fc08b04b11cc3984e08_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzItMS0xLTEtMA_19ac5b46-f39f-491b-ab2f-d0372dae7dd6">8,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8599a661d45463f82a2aba708062fcf_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzItMy0xLTEtMA_a46aa487-602a-4ccc-862f-e4f0f9eabd83">4,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c7b5a94cb34e1680e560d7a9eaae4c_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzItNS0xLTEtMA_c75d113a-e9bb-4871-9b4d-5eac97681769">2,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea80e59e1504ea393646ffa29e23426_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzMtMS0xLTEtMA_8a554917-28d6-4f25-a87c-4fae00f99b36">91,762</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513eed0ba1b74e578f8b16b9d3528e41_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzMtMy0xLTEtMA_41ab6e5e-41ca-4acf-971f-65a094900484">52,450</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida02d0b10c2a4069bcefe8098bf63928_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzMtNS0xLTEtMA_d828da10-f3ed-439d-954a-df1a05e7114d">7,017</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cf68f6fddea486e8c354682f35dc67a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzQtMS0xLTEtMA_ef5024e0-cc6d-40fd-985a-14b2f8eff50e">14,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7bbe3658f5441e29fe16218b50948b6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzQtMy0xLTEtMA_8b040f10-0164-4d61-8179-ca02d2e5e6f6">7,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74963f7211644269a32529bd0993cd1f_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzQtNS0xLTEtMA_adaab54e-1d6a-4b65-91f5-54f694a0262e">4,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85ac1d76e52246da9b9419a6cfe9a0bc_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzUtMS0xLTEtMA_668a45ba-b653-4416-84e6-54b770800527">43,854</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c65f7d592aa4164a8822f00359cee73_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzUtMy0xLTEtMA_ac33c35b-8e80-4e74-8597-017c9a2d46ef">11,294</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cecaa430d444086b81cce9a00a27278_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzUtNS0xLTEtMA_203c0ce5-26cc-4705-ae50-94683c0b0a3f">5,986</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzYtMS0xLTEtMA_f6fdacb2-f56c-4480-aa1b-8923c0a32f6c">158,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzYtMy0xLTEtMA_93180256-cf3f-4bcb-967e-6c352a83d7d1">75,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzYtNS0xLTEtMA_acabfbd7-ad7f-49e0-8028-1e66042c6113">20,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, unrecognized compensation expense related to unvested stock options, net of estimated forfeitures, was $<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1Xzc5MzA_cee5a8e5-1ed3-45d1-af58-173d4aa179cf">3.1</ix:nonFraction> million, which we expect to recognize on a straight-line basis over a weighted-average period of <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgwMjI_5084b8a6-6c9b-4330-814a-de661711e83e">2.4</ix:nonNumeric> years. Unrecognized compensation expense related to RSUs, including PRSUs, and awards that are contingently issuable upon the completion of certain milestones related to our acquisition of ArcherDX at December&#160;31, 2020, net of estimated forfeitures, was $<ix:nonFraction unitRef="usd" contextRef="ib230a508963e4077bf9c329a3d9e10af_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgxMzU_323a80d8-fd2f-4e42-816b-2bf06ac461b5">144.2</ix:nonFraction> million, which we expect to recognize on a straight-line basis over a weighted-average period of <ix:nonNumeric contextRef="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgyMjc_2d4d2999-5fdf-4f82-84b6-8b3f4526f03b">1.6</ix:nonNumeric> years.</span></div></ix:continuation><div id="ie13029cdd7d64c5bac971f0e86e8f19a_118"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.  <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzUxMTE_3f89e5d3-f861-46f4-9c07-616b0a8b70eb" continuedAt="i464624a683f94db6afe93b7af2b654bb" escape="true">Income taxes</ix:nonNumeric></span></div><ix:continuation id="i464624a683f94db6afe93b7af2b654bb" continuedAt="iaf0027c255b644ae802489cadb6a428b"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a benefit for income taxes in the years ended December&#160;31, 2020, 2019 and 2018. <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzUxMTQ_bf78f8be-05a9-4147-903f-518922bdcc25" continuedAt="ic8b3bb852705431e998e40d9ca083627" escape="true">The components of net loss before taxes by U.S. and foreign jurisdictions are as follows (in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="ic8b3bb852705431e998e40d9ca083627"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:52.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzItMS0xLTEtMA_52426acb-2022-40af-ad2e-d0c783e37f1f">712,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzItMy0xLTEtMA_47fa826e-a040-4f58-b700-ade40c54c8fb">260,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzItNS0xLTEtMA_5118052e-9364-454e-bb82-7d516c8df212">132,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzMtMS0xLTEtMA_783698ae-38ac-4ae8-94ea-ae29cbee5689">1,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzMtMy0xLTEtMA_3fb3a23c-bea8-4906-b053-ccc699be41fd">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzMtNS0xLTEtMA_67566231-27b7-457d-9b8a-928c8b4d173f">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzQtMS0xLTEtMA_b48f32a6-8f52-4599-b23b-bcdc881edcb9">714,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzQtMy0xLTEtMA_8afd7ad2-ad79-4fbf-833f-3c404c13a404">260,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzQtNS0xLTEtMA_71fc37c1-8858-4809-987f-f35643ac6864">132,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzUxMjA_c57b143c-7f9f-4796-89ca-666a4e26c2de" escape="true"><div style="margin-top:12pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the provision for income taxes are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:52.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzUtMS0xLTEtMA_a5e432f9-af97-46fe-a3ac-7d6997f70d51">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzUtMy0xLTEtMA_23f253e6-32cb-4adb-9a5c-24e0e09e9832">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzUtNS0xLTEtMA_aadc6757-7d8c-4bb5-b54a-6eafa403dc8d">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current benefit for income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzYtMS0xLTEtMA_9b68624f-aa08-4a1c-aa9b-832b744ee147">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzYtMy0xLTEtMA_b925e294-da2d-466d-9969-3266193a087b">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzYtNS0xLTEtMA_3e7e372d-a2b7-42fe-b6af-c41ae64bbc5d">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzgtMS0xLTEtMA_d55a3c27-4d99-4cd5-b559-af8fe770e415">94,279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzgtMy0xLTEtMA_6fbde43d-feb3-466d-ba0b-698f92d4f86d">16,011</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzgtNS0xLTEtMA_620fbb95-f480-48ba-9c02-75358b2b6204">2,862</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzktMS0xLTEtMA_c6f90cd4-2c1b-409b-9fd1-4312925a977d">17,730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzktMy0xLTEtMA_71b21f72-dd0f-4b88-8379-6d569609c9fb">2,524</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzktNS0xLTEtMA_58d1219e-0e1e-4e27-8c8c-1cd9717ec0cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzEwLTEtMS0xLTA_2c4428f3-659e-43f2-b0f7-f6b83a81eb62">262</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzEwLTMtMS0xLTA_c9bb07d7-18c8-440d-b2f7-49499e65e9a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzEwLTUtMS0xLTA_edc5f5bd-c965-42fb-9162-a9526295c101">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred benefit for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzExLTEtMS0xLTA_cd3ecd09-8948-4f00-94af-bdac7326395b">112,271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzExLTMtMS0xLTA_1462b56b-659b-4a7a-9827-2778126c6bd3">18,535</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzExLTUtMS0xLTA_777161f1-b529-4790-8084-5f0fb571c2c5">2,862</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzEyLTEtMS0xLTA_4352390e-daff-416b-86b8-8b9a5ccbb6e0">112,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzEyLTMtMS0xLTA_f805f6bf-d721-4850-aa49-588926857dd5">18,450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzEyLTUtMS0xLTA_c1bbd44e-0b0f-4bea-aae2-e1b3ec663e9a">2,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="iaf0027c255b644ae802489cadb6a428b" continuedAt="ieab43c9145194d2699a2dcba42aac990"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzUxMTU_3380c944-9fa6-49b5-972d-8c56639e25e9" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the tax expense computed at the statutory federal rate and our tax expense for the periods presented:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:52.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal taxes at statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzItMS0xLTEtMA_13bd4ea3-5b3a-482b-a990-e0da2ef6755f">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzItMy0xLTEtMA_439a30ae-61cf-4ad4-b101-5f16c451810d">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzItNS0xLTEtMA_aa2c96d7-1b1f-4c75-86e5-704d4b6986ae">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes (net of federal benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzMtMS0xLTEtMA_b648921d-78bb-4fe6-83e6-11f0d1e6a0e1">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzMtMy0xLTEtMA_acf40a7e-1d4b-4df1-a6f1-698ae2974a94">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzMtNS0xLTEtMA_dc9ce275-4eb7-4dd1-9ea8-bc7ac43e058b">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzQtMS0xLTEtMA_390a49d2-55fc-4c8f-b034-344bbf6cb6da">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzQtMy0xLTEtMA_1cc52676-dc5a-4c4f-87d3-f4262daea257">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzQtNS0xLTEtMA_e3d06c61-7782-464e-b20f-a30fae1871fe">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzUtMS0xLTEtMA_09bac28b-e899-462c-a52b-7c5edf60bef1">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzUtMy0xLTEtMA_97364a56-8155-424a-8d9c-68ac511f0034">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzUtNS0xLTEtMA_d33786a5-b4a1-4722-ac10-ae3d24174a57">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzYtMS0xLTEtMA_7a1a0736-8783-4920-af81-e66a9f4e5184">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzYtMy0xLTEtMA_7a522582-c3e2-4e39-8551-bb8d1421cb34">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzYtNS0xLTEtMA_b9b0001d-0ba2-4353-a13f-69d7a21e6b4a">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzktMS0xLTEtMA_59ffdeb9-b0d6-4131-a640-abfc6a59affd">6.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzktMy0xLTEtMA_5e73aeec-d96a-4250-be1d-8e442ee22c0f">17.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzktNS0xLTEtMA_f03912a1-59ed-4000-9a5a-d6e10e7bb351">25.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzEyLTEtMS0xLTA_0f5b0596-d049-46a0-8252-fcbdad6ee6a0">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzEyLTMtMS0xLTA_426a901a-be73-4f63-9dad-e8ace4cbd702">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzEyLTUtMS0xLTA_b6b25fb2-4d9f-4ece-8773-dc60f5050aa8">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzUxMDk_32d8668d-75a8-4134-880a-1cb0d5ba0fe3" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences and carryforwards that give rise to significant portions of the deferred tax assets are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzMtMS0xLTEtMA_c142f287-fb53-4877-833e-908fac2786e2">337,866</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzMtMy0xLTEtMA_99ae83c1-4dc6-49b5-af3f-457ec037e255">173,182</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzQtMS0xLTEtMA_36e122ee-eda7-49f8-82e1-19b1c9d6ac0e">19,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzQtMy0xLTEtMA_e96df17e-84b5-4055-954c-25bb2352378b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognition differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:DeferredTaxAssetsRevenueRecognitionReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzUtMS0xLTEtMA_fe829d83-2fe3-413a-8f13-ef20ccee1343">9,099</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:DeferredTaxAssetsRevenueRecognitionReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzUtMy0xLTEtMA_6fd9533c-9f8b-4397-ab53-5298a49cba87">5,138</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasing Liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:DeferredTaxAssetsLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzYtMS0xLTEtMA_d0d9a40b-e015-4c61-aa28-e2a22dfe4143">14,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:DeferredTaxAssetsLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzYtMy0xLTEtMA_b648bd3d-f8dd-4ceb-a4a4-7628f89d6126">11,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:DeferredTaxAssetsTaxAccruedLiabilitiesAndOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzctMS0xLTEtMA_e258a593-aea3-410b-8b28-2bd3409b7ac4">37,677</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:DeferredTaxAssetsTaxAccruedLiabilitiesAndOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzctMy0xLTEtMA_248386fb-a87c-47a9-8d10-7ee0f55f76f7">14,391</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzgtMS0xLTEtMA_469e9831-80f2-4f2d-9bf5-34c8e13cace6">418,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzgtMy0xLTEtMA_fed49bcf-d87f-4dc9-8ec5-812e964113dd">204,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzktMS0xLTEtMA_74155929-0106-40e6-b584-bfe47fa8d3b2">209,308</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzktMy0xLTEtMA_533d87da-9c4c-4738-9dec-1ad398277278">145,318</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzEwLTEtMS0xLTA_a96558b4-6075-467d-b960-6afd4358940a">209,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzEwLTMtMS0xLTA_524f3dab-cc01-4659-8379-62a98636bc89">59,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization and depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzEyLTEtMS0xLTA_d6874004-97ca-40dd-bdc0-646b2e979eb8">233,150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzEyLTMtMS0xLTA_df3b72b7-7a8c-4a20-8003-530b8d72c5b8">30,875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Senior Notes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesFinancingArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzEzLTEtMS0xLTA_6d5d613f-6f44-4377-ac54-1e6265db5efc">14,658</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesFinancingArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzEzLTMtMS0xLTA_c8d6e9eb-0b66-471b-91b4-1b805b3e85b1">17,720</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasing Assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="nvta:DeferredTaxLiabilitiesLeaseRightofUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzE0LTEtMS0xLTA_b166c3fa-de65-49ad-90df-343b877526f1">13,307</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="nvta:DeferredTaxLiabilitiesLeaseRightofUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzE0LTMtMS0xLTA_b47fe119-0ce1-4c2e-a3ab-afc8c6bd0398">10,424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzE1LTEtMS0xLTA_def21759-3f7b-44e6-8ce0-203bcc22aa13">261,115</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzE1LTMtMS0xLTA_419fc8fd-6cbb-40e5-b21c-a7867bae6fda">59,019</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzE2LTEtMS0xLTA_3ceba766-327d-44b3-9243-c289fec272bf">51,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzE2LTMtMS0xLTA_0e205ab8-9288-4f0c-bac2-609ec371e459">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the Tax Cuts and Jobs Act of 2017 (the &#8220;Tax Act&#8221;) was signed into law making significant changes to the Internal Revenue Code. Changes included among other items, a reduction of the corporate tax rate from a top marginal rate of 35% to a flat rate of 21%. Although the Tax Act was generally effective January 1, 2018, GAAP required recognition of the tax effects of new legislation during the reporting period that includes the enactment date, which was December 22, 2017. As a result of the lower corporate tax rate enacted as part of the Tax Act, during 2017, the Company recorded a provisional estimate to reduce deferred tax assets by $<ix:nonFraction unitRef="usd" contextRef="ief55ba984c4f4d3db6d80102c5abb216_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzIyNTM5OTg4MzkxMTM0_2e3dd76b-6973-419a-aaf7-13b1ec48031a">48.8</ix:nonFraction>&#160;million offset by a corresponding reduction in the valuation allowance resulting in no net impact to our income tax benefit or expense.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 ("SAB 118") to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the Tax Act. In accordance with SAB 118, during 2017, we recorded a provisional estimate which resulted in a $<ix:nonFraction unitRef="usd" contextRef="ief55ba984c4f4d3db6d80102c5abb216_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzIyNTM5OTg4MzkxMTQ5_3bfc7c05-2135-4344-9d85-9eac82c3d167">48.8</ix:nonFraction>&#160;million reduction in deferred tax assets and in the fourth quarter of 2018, we completed our analysis of the impact of the Tax Act and determined that no material adjustments were required to the provisional amounts previously recorded. &#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We historically established a full valuation allowance against our deferred tax assets due to the uncertainty surrounding realization of such assets. In 2020, we released approximately $<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI2MzE_dd00ea2c-f4d2-4d2f-becf-5ef48be44b66">112.1</ix:nonFraction>&#160;million of our valuation allowance to account for acquired intangibles that support the future realization of some of our deferred tax assets. Due to the overall increase of deferred tax assets, our valuation allowance also increased from the prior year. Our valuation allowance increased by $<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI2NDc_48e5fb17-aad4-48b6-a1ad-84bc244a4250">64.0</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI2NjI_e5809b8b-461f-45f4-9297-63faaa53a97c">23.4</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI2Nzc_5b79bf53-c649-446c-b488-6e83c12a06fa">26.3</ix:nonFraction>&#160;million during the years ended December 31, 2020, 2019, and 2018, respectively.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ieab43c9145194d2699a2dcba42aac990"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i859858a3113c4e09b4edddb15541a2ca_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI2OTY_1196933b-d77c-4b28-96ce-071fc573f04f">1.4</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i61559c3568b9476ea2715a4b590e704a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI3MTA_d62db9a8-3e9f-4cd9-b52a-cce3c7f815f2">890.6</ix:nonFraction>&#160;million available to reduce future taxable income, if any, for federal and state income tax purposes, respectively. Of the $<ix:nonFraction unitRef="usd" contextRef="i859858a3113c4e09b4edddb15541a2ca_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI3MjY_a3ac4122-2034-4ae5-b528-c8f381629354">1.4</ix:nonFraction>&#160;billion, $<ix:nonFraction unitRef="usd" contextRef="i865f60d02fe3450983596a2fbd237a90_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI3NDA_08ff3535-dc2d-4b6d-9eb3-4a701ae509a6">284.9</ix:nonFraction>&#160;million will begin to expire in 2030 while $<ix:nonFraction unitRef="usd" contextRef="i54c826b980cc42e1988fb3773b439e74_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI3NTY_157bace5-5528-494f-9cd8-1194601a5c00">1.1</ix:nonFraction>&#160;billion have no expiration date. The state net operating loss carryforwards will begin to expire in 2030.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had research and development credit carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i56b9662e01b744d1affd87e3dbdd024d_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI3NzA_34a2ed85-1d0e-4d6a-8e9a-04c5c643217d">26.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i92d0ca5609ab4791a50bc6f0f888d703_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI3ODU_5ff10fc8-287d-46a2-88be-42dd2f7979ae">17.6</ix:nonFraction>&#160;million available to reduce our future tax liability, if any, for federal and state income tax purposes, respectively. The federal credit carryforwards begin to expire in 2030. California credit carryforwards have no expiration date.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal Revenue Code ("IRC") section 382 places a limitation (the &#8220;Section 382 limitation&#8221; or &#8220;annual limitation&#8221;) on the amount of taxable income that can be offset by net operating loss carryforwards after a change in control (generally greater than 50% change in ownership) of a loss corporation. Similar provisions exist for states. In addition, and as a result of the acquisitions of Good Start Genetics and CombiMatrix in 2017, acquisitions of Singular Bio, Jungla, and Clear Genetics in 2019, and acquisitions of YouScript and ArcherDX in 2020, tax loss carryforwards from acquired entities are also subject to the Section 382 limitation due to the change in control in the acquired entities in the current year.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a result of equity issued in connection with various acquisitions, we also performed a section 382 analysis in 2020 with respect to our operating loss and credit carryforwards. We concluded while an ownership change occurred in 2019 as defined under IRC section 382, none of our net operating loss carryforwards would expire unused solely as a result of annual limitations imposed on the use of the carryforwards under IRC sections 382 and 383.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had unrecognized tax benefits of $<ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzQxMDc_ef429c0e-f184-4f6b-91f7-f02a267cccdd">22.0</ix:nonFraction> million, which primarily relates to research and development credits, none of which would currently affect our effective tax rate if recognized due to our valuation allowance against our deferred tax assets. During the year, we benchmarked the reserves of similar tax positions within the industry based on IRS and state audits of comparable companies. Based on our analysis, we decreased our unrecognized tax benefits to more closely align with other comparable companies within the industry. As these reserves relate primarily to research and development credits which have a full valuation allowance, such adjustments did not impact our income tax provision. Unrecognized tax benefits are not expected to materially change in the next 12 months.</span></div><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzUxMjQ_71ef1fed-defd-403e-aad8-07fa84b88696" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:52.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzItMS0xLTEtMA_ff26e662-850f-4ad0-b094-e926357bdfec">26,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i133819ff76b24d47a6fe9cf8b026d64f_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzItMy0xLTEtMA_d715ac75-74e5-4f1a-afe4-3a65e81988d6">16,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1dffb2fad8b40ca9e2827b034550280_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzItNS0xLTEtMA_65ce8188-6463-4085-a3be-9a8aa82a3f44">10,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases&#8212;current period tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzMtMS0xLTEtMA_24e7e080-e31c-439e-8989-fa717a39c837">8,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzMtMy0xLTEtMA_46794719-4a1a-4742-8eac-59f86c3253f7">10,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzMtNS0xLTEtMA_e2a68357-30c1-4c9d-992e-df3bdbccc330">5,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases&#8212;prior period tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzQtMS0xLTEtMA_e749829e-981f-4ac3-b276-bdc7054864f4">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzQtMy0xLTEtMA_49488d41-eea8-47b1-b839-9760934b6576">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzQtNS0xLTEtMA_600ba768-36fd-41e8-8cfe-c7e0f1fbc5a1">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases&#8212;prior period tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzUtMS0xLTEtMTIyMDI_3ec4ed3b-65c4-40db-bf38-30e47828e053">13,441</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzUtMy0xLTEtMTIyMDI_38e84d8a-68ed-4ddd-bd17-aff1e91c959c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzUtNS0xLTEtMTIyMDI_836dcade-2ff7-4096-bf99-4e4e1ce3f3c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8df88fbc13471181f2a555e9880399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzUtMS0xLTEtMA_66f6eb6e-5138-405f-8345-0087a54d01ff">21,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzUtMy0xLTEtMA_4c102a46-3f2a-4eee-8909-9f7f1b22b56b">26,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i133819ff76b24d47a6fe9cf8b026d64f_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzUtNS0xLTEtMA_33ddb0fb-07ae-4c78-895b-3b8727179a28">16,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our policy is to include penalties and interest expense related to income taxes as a component of tax expense. We have not accrued interest and penalties related to the unrecognized tax benefits reflected in the financial statements for the years ended December&#160;31, 2020, 2019 and 2018.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our major tax jurisdictions are the United States and California. All of our tax years will remain open for examination by the Federal and state tax authorities for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzQ5NTQ_150b999c-d788-453b-aa59-382e59e7d0d3">three</span> and <ix:nonNumeric contextRef="i627cf3443eb34249aeaac7655a38320d_D20200101-20201231" format="ixt-sec:durwordsen" name="nvta:IncomeTaxExaminationNumberOfPeriodUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzQ5NjE_ee5e3996-e4b5-4a39-8353-bf18b7898ae2">four years</ix:nonNumeric>, respectively, from the date of utilization of the net operating loss or research and development credit. We do not have any tax audits pending.</span></div></ix:continuation><div id="ie13029cdd7d64c5bac971f0e86e8f19a_124"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90ZXh0cmVnaW9uOjc5Zjg0ZjdlOGI5MjQzMTA4YzYyNWVmODE1ZjcwM2JjXzMxNg_ef67164b-3411-4035-bd28-e49746fcb262" continuedAt="i2487d608de02457c979a9b9fa82fe8a5" escape="true">Net loss per share</ix:nonNumeric></span></div><ix:continuation id="i2487d608de02457c979a9b9fa82fe8a5" continuedAt="i9005caad5d0f4ad5a28e12b8132ec4b4"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90ZXh0cmVnaW9uOjc5Zjg0ZjdlOGI5MjQzMTA4YzYyNWVmODE1ZjcwM2JjXzMxMg_48224f50-da0c-43b2-9705-c6234912c0e1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzItMS0xLTEtMA_52e78758-8449-4e01-b515-1a6de7ece342">602,170</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzItMy0xLTEtMA_80d29353-f4f4-4741-afed-79d5833b6dba">241,965</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzItNS0xLTEtMA_0458dfe4-3ed1-4da9-9a7f-7e10c859e1b4">129,355</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing net loss per share, basic and diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzMtMS0xLTEtMA_9a9a8939-e550-4e17-9aa8-9f24106b2b0f">134,587</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzMtMy0xLTEtMA_986f0c25-b914-4869-b074-f424df82787d">90,859</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzMtNS0xLTEtMA_ec88ff03-a966-42eb-a4a3-a967d724b5a3">66,747</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzQtMS0xLTEtMA_840dcded-2210-4078-9a64-acefe7ef89c5">4.47</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzQtMy0xLTEtMA_cb948ae6-ff35-4eac-b98d-747febaac0ea">2.66</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzQtNS0xLTEtMA_9de6c359-66e0-4ed1-9cfa-781d0bac5b8e">1.94</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i9005caad5d0f4ad5a28e12b8132ec4b4"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90ZXh0cmVnaW9uOjc5Zjg0ZjdlOGI5MjQzMTA4YzYyNWVmODE1ZjcwM2JjXzMxNA_50a60bc3-cf7b-4012-a3bb-31d1dd9de872" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents have been excluded from diluted net loss per share because their inclusion would be anti-dilutive (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock subject to outstanding options</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia8b8eff0cc4e4594a303839728013b12_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzItMS0xLTEtMA_8a21d6c3-1ea6-4682-a729-e54deec9d578">6,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42aa1ffe56be41719edfa03ee1a676ad_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzItMy0xLTEtMA_6d352558-fc2c-4efe-bd29-f47e395de968">3,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdc9926f8d9440acbfcda346d7729365_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzItNS0xLTEtMA_03018e43-05e8-4358-8ba5-3a32870197cf">4,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock subject to outstanding warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i50d11234658f4896a2cb7ac1ea474e67_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzMtMS0xLTEtMA_c2b3b788-9958-47dd-8e70-74196da0faf4">405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i60b5dacd6ae24b4eace690f79d47b5c8_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzMtMy0xLTEtMA_795da611-6fc0-469f-83dc-c151c490a656">592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cc357735b2e4b579432134168aed0ea_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzMtNS0xLTEtMA_070a0846-1037-4478-be1a-80fc12eb0e99">1,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock subject to outstanding RSUs</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74957556027a49b782337f801d6e878f_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzQtMS0xLTEtMA_e29aca7c-8a39-480b-813f-27cc0b7aca73">5,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i11b22b79bd2d4bc687f04292330d55b3_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzQtMy0xLTEtMA_b92cc1c3-0355-40ed-8d07-096af29a0a3f">5,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied097690f5dc477a99c5073e45f85740_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzQtNS0xLTEtMA_10c40d36-fd5e-4d78-bbd4-7f403dffac95">3,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock subject to outstanding PRSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idffc47e14f9e48b0a7c357f2a1edd12b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzUtMS0xLTEtMA_aa7c0fcf-6bea-4618-b7a1-27b1a07d495f">1,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i056d7c98eb70405abd4b0748fbcab7e9_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzUtMy0xLTEtMA_d2fed531-35b7-4335-b05d-3d2987684caa">1,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7824b6f46524c12b4e8ecb3fee953ff_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzUtNS0xLTEtMA_cbaa4a18-4ef5-44b5-99ea-6d1d7caff806">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock pursuant to ESPP</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec867c6aa9fe4723b6c30bd3d93f4b55_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzYtMS0xLTEtMA_9e77c17f-cb52-41eb-bfc7-398accfb679b">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia20172a5e2204ead90215591879a2beb_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzYtMy0xLTEtMA_94e2af60-3ef0-405d-8681-a19ab0c5a8b4">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3995f1e95bed45a6aeef8542e96511ae_D20180101-20181231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzYtNS0xLTEtMA_989c6ca9-7808-4cf2-9a83-bf3238ddb6ae">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock underlying Series A convertible preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a2c42a62e2e4aefb13cd19623905faf_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzctMS0xLTEtMA_f53f1bab-d6b6-4be5-9f2e-49186bd79dba">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5615bcaf3cb24df28897143410b35483_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzctMy0xLTEtMA_f86bdd8f-b474-4fb5-bdde-bdc2649ad2c4">702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4ee3478f49dc43bdb576001358749eff_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzctNS0xLTEtMA_0c2d6e6e-7b77-4eb9-a621-b07b4e267dfb">3,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock subject to Convertible Senior Notes conversion</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i20c6e963b50d4140ad7de3d98e256dab_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzgtMS0xLTEtMA_6dd41330-9f92-4331-8c9c-60c8a9c6e167">8,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb07f61948004d04843b243732524e95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzgtMy0xLTEtMA_a3679e5d-b394-42de-9535-0e210660dc80">3,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i72ab58f3157e4792a29e684275f6f509_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzgtNS0xLTEtMA_bd83c8b8-daeb-46d0-9aa0-e874be545d79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzktMS0xLTEtMA_7011c737-871d-455a-8375-4cd25dffa8ac">23,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzktMy0xLTEtMA_edd0474f-c514-4888-bb32-58c819fbc505">15,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzktNS0xLTEtMA_efa660e9-ad36-41d0-83aa-b6dfb6411f9d">12,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_127"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.  <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90ZXh0cmVnaW9uOjUyMzVjNWNmMTY5MDRhZTBhYzIzOWMxNGM3NDRmY2E1XzIzMg_c16b1805-e541-4b43-8722-c41a58494efc" continuedAt="i1614cad625cb4b248d5b45cf9655a06c" escape="true">Geographic information</ix:nonNumeric></span></div><ix:continuation id="i1614cad625cb4b248d5b45cf9655a06c"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90ZXh0cmVnaW9uOjUyMzVjNWNmMTY5MDRhZTBhYzIzOWMxNGM3NDRmY2E1XzIzNQ_5b9605c8-3175-463e-8772-b8f6826437f2" escape="true"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by country is determined based on the billing address of the customer and is summarized as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.330%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb77ef12cba40759cb6e357bad02f51_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzItMS0xLTEtMA_536b1270-efd0-4d50-95dd-13b58cd66908">255,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90fd9f70a9fd4afa806aa085235719e1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzItMy0xLTEtMA_0c2acee0-b064-463d-b90c-79566b7cba79">202,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd3c433db9754198990763fc88d3b083_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzItNS0xLTEtMA_fe995e0c-871a-4336-8a49-a19cd5f6e527">138,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5f0bb9d47b64539b838c7aa19d3033f_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzMtMS0xLTEtMA_0f07a90c-4155-4b5d-8526-77298b57f027">4,529</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i916d5790c5474c6cb3f18a4b6f227ba6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzMtMy0xLTEtMA_c37b4e17-b71b-4d2b-963e-7229d747d6ba">4,356</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied08cb30dbfd48dcb62017c3f188ee2a_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzMtNS0xLTEtMA_56e546bb-6650-41ad-8cfd-ad90624fd0cc">4,206</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i515b20f3a9db410289d47edad55e5a77_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzQtMS0xLTEtMA_ff9618d2-2202-4bac-aea1-03bdde5e4142">19,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0264e9789ee44e2ab9f703d1a70e7335_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzQtMy0xLTEtMA_4efc7dd9-8525-43e1-b015-b88cf515477c">9,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84d0c14c0a5d4355a536eea3dc700eca_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzQtNS0xLTEtMA_4b1ef1b2-564b-4e10-9dbd-0cc8d7b3d90b">5,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzUtMS0xLTEtMA_18b6f29a-22ff-4ec4-ac56-f8ce10deb7c3">279,598</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzUtMy0xLTEtMA_c7dc0aaa-50a2-4fe6-8737-a47c54ffe23d">216,824</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzUtNS0xLTEtMA_4c764fea-6de4-4e13-a96a-88ed34c9f4a4">147,699</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, 2019 and 2018, our long-lived assets were primarily located in the United States other than operating lease assets representing our right-of-use for leased facilities in Israel and Australia.</span></div></ix:continuation><div id="ie13029cdd7d64c5bac971f0e86e8f19a_130"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.  <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90ZXh0cmVnaW9uOjRkNzYwNmRmM2VkOTRiOTVhYzA5ZjM1N2VkNjJjY2FjXzYzNw_0057ed7a-5dbe-4d34-8965-6b1bca76f35d" continuedAt="i5aee625041ed4da8adaf039919fd3e99" escape="true">Selected quarterly data (unaudited)</ix:nonNumeric></span></div><ix:continuation id="i5aee625041ed4da8adaf039919fd3e99"><ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90ZXh0cmVnaW9uOjRkNzYwNmRmM2VkOTRiOTVhYzA5ZjM1N2VkNjJjY2FjXzY0MA_a5e35020-c79f-4ca8-8ff7-b2748c9a2b66" escape="true"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our quarterly financial information for 2020 and 2019 (in thousands, except per share amounts):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.550%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if177aa5c31294d399a4f1b9ea9366117_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzItMi0xLTEtMA_2b7f8ff6-b195-48a2-a277-e15c36cbd3e2">64,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba7a2a4e309410f8a88976be58969ff_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzItNC0xLTEtMA_139b31b4-c49e-4fe0-8171-7b0242cf0aaa">46,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c5bd43459294503984672c6404ac8b8_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzItNi0xLTEtMA_2b137c3d-284a-453d-9966-043909011500">68,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzItOC0xLTEtMA_346544b9-7c5b-427c-aba8-e0b8db276984">100,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if177aa5c31294d399a4f1b9ea9366117_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzMtMi0xLTEtMA_ed00743c-6ebd-4ed9-b079-960773ac976d">40,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba7a2a4e309410f8a88976be58969ff_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzMtNC0xLTEtMA_fd3853f3-3e67-4383-9aeb-30950b9fd1e5">42,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c5bd43459294503984672c6404ac8b8_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzMtNi0xLTEtMA_18a1bf31-b345-4e66-beba-8791e1e00e4e">46,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzMtOC0xLTEtMA_5f304afd-b027-4fb2-8a60-098b58631e91">68,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if177aa5c31294d399a4f1b9ea9366117_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzQtMi0xLTEtMA_9450da89-fd6e-409b-aae6-b5301d6b0170">97,784</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba7a2a4e309410f8a88976be58969ff_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzQtNC0xLTEtMA_855db237-7c2e-415d-8c66-75f67e57b58f">142,082</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c5bd43459294503984672c6404ac8b8_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzQtNi0xLTEtMA_fd91891f-7cbd-4459-8df0-3c7eed17b80b">80,823</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzQtOC0xLTEtMA_6e791690-6b03-46ac-bf5c-4cc8d4f82cf1">331,483</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if177aa5c31294d399a4f1b9ea9366117_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzUtMi0xLTEtMA_b1b1c0d7-8cd5-4eac-8ffa-39f326847318">98,527</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba7a2a4e309410f8a88976be58969ff_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzUtNC0xLTEtMA_870a4ec7-e912-4560-9c22-23fd9db05816">166,403</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c5bd43459294503984672c6404ac8b8_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzUtNi0xLTEtMA_e671fbfd-67af-4362-b7cc-c39a818d8022">102,902</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzUtOC0xLTEtMA_cd2ba223-6db1-4414-9988-0d4fdb471ac4">234,338</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if177aa5c31294d399a4f1b9ea9366117_D20200101-20200331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzYtMi0xLTEtMA_ab4d9cc9-d868-479f-83e4-930ca5fa4fdf">0.99</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaba7a2a4e309410f8a88976be58969ff_D20200401-20200630" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzYtNC0xLTEtMA_f0a212d0-9483-425d-a36d-d60e005a1675">1.29</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7c5bd43459294503984672c6404ac8b8_D20200701-20200930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzYtNi0xLTEtMA_ac344aa7-a56c-4443-b1ae-26fa7ae8554b">0.78</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzYtOC0xLTEtMA_093a0b30-4340-46cc-b89c-4249f2d7f0af">1.30</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i272dd1562cfd41dbab6bd49a206984bc_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEwLTItMS0xLTA_1b0f07e5-d0cf-4956-a1cc-1199c7b7b862">40,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb8a205c97a741eabfc5c124772fda7e_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEwLTQtMS0xLTA_17f4f934-9920-4e94-8db5-c3f0a6c9ba83">53,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa9952ab3c9045afa4ce575e3df76321_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEwLTYtMS0xLTA_b107551b-4ee7-4ef7-b9e0-0a1a3f75355b">56,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16a3b4edc4c5441aa3a7b118f61cc1ed_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEwLTgtMS0xLTA_41059e50-18b7-4fbe-b468-d84fdc9d9bb8">66,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i272dd1562cfd41dbab6bd49a206984bc_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzExLTItMS0xLTA_cd965e9f-3e5f-4f6e-8920-b38296da6bea">21,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb8a205c97a741eabfc5c124772fda7e_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzExLTQtMS0xLTA_353d0faf-54ed-4282-8d65-02524bec8bf0">28,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa9952ab3c9045afa4ce575e3df76321_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzExLTYtMS0xLTA_a8145fc0-f80d-4132-8c1d-fe5dcb11e40d">32,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16a3b4edc4c5441aa3a7b118f61cc1ed_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzExLTgtMS0xLTA_917efef6-402c-47c5-b425-7ea78e7b1124">36,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i272dd1562cfd41dbab6bd49a206984bc_D20190101-20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEyLTItMS0xLTA_97dcb805-9ae0-4a2f-9f5e-ce5996721145">36,207</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb8a205c97a741eabfc5c124772fda7e_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEyLTQtMS0xLTA_26b40c58-b53e-47bf-95f8-16fe1870a02b">51,886</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa9952ab3c9045afa4ce575e3df76321_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEyLTYtMS0xLTA_3825641a-9b66-43c2-b3f5-74c885f0227a">76,983</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16a3b4edc4c5441aa3a7b118f61cc1ed_D20191001-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEyLTgtMS0xLTA_3f91306d-40e5-4c27-a8aa-4607ae5f5db3">79,036</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i272dd1562cfd41dbab6bd49a206984bc_D20190101-20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEzLTItMS0xLTA_0302afe3-8bf8-471b-8e22-7d335540bb92">37,677</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb8a205c97a741eabfc5c124772fda7e_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEzLTQtMS0xLTA_6e8379d1-96b2-4b35-9319-e2255be315d1">48,676</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa9952ab3c9045afa4ce575e3df76321_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEzLTYtMS0xLTA_e536ea02-447d-4b48-b61c-d1701aa217f8">78,707</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16a3b4edc4c5441aa3a7b118f61cc1ed_D20191001-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEzLTgtMS0xLTA_f0817cb0-2c23-4aa6-a38e-f194614d3e77">76,905</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i272dd1562cfd41dbab6bd49a206984bc_D20190101-20190331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzE0LTItMS0xLTA_40042451-498d-4c17-a6c3-ebba4472f3c0">0.47</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="idb8a205c97a741eabfc5c124772fda7e_D20190401-20190630" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzE0LTQtMS0xLTA_9db34d6c-c0dc-45e7-a8e0-38f6d7ee5cfe">0.54</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaa9952ab3c9045afa4ce575e3df76321_D20190701-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzE0LTYtMS0xLTA_29024c71-e266-49ba-9873-b3ba66de213d">0.82</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i16a3b4edc4c5441aa3a7b118f61cc1ed_D20191001-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzE0LTgtMS0xLTA_be1c0ec2-9f7c-4575-9ea2-bef4d89fad44">0.79</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">___________________________________________________________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss per share is computed independently for each of the quarters presented. Therefore, the sum of quarterly net loss per share information may not equal annual net loss per share.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_133"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.  <ix:nonNumeric contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzMvZnJhZzplMzA1MTRmMDczYjI0ZmIwYjc0MWE1Mzc4Yzg3NGRiMi90ZXh0cmVnaW9uOmUzMDUxNGYwNzNiMjRmYjBiNzQxYTUzNzhjODc0ZGIyXzIyNTM5OTg4Mzc5MzAz_f1ff7c4e-abc9-42ee-a5d4-9e6a98e3385b" continuedAt="i8bc889f963d6432097a467f0a23df519" escape="true">Subsequent event</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8bc889f963d6432097a467f0a23df519">In February 2021, we acquired <ix:nonFraction unitRef="number" contextRef="i2c5ed2de4b2b4acc8e01d44e041365bc_I20210226" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzMvZnJhZzplMzA1MTRmMDczYjI0ZmIwYjc0MWE1Mzc4Yzg3NGRiMi90ZXh0cmVnaW9uOmUzMDUxNGYwNzNiMjRmYjBiNzQxYTUzNzhjODc0ZGIyXzIyNTM5OTg4Mzc5MzA1_43718725-ee25-4314-9b4e-53a893d88db7">100</ix:nonFraction>% of the equity interest of Reference Genomics, Inc. d/b/a One Codex "One Codex", a company developing and commercializing products and services relating to microbiome sequencing, analysis and reporting, for upfront consideration consisting of <ix:nonFraction unitRef="shares" contextRef="i99d734e257e9441f812ed6b0c9affac9_D20210201-20210226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzMvZnJhZzplMzA1MTRmMDczYjI0ZmIwYjc0MWE1Mzc4Yzg3NGRiMi90ZXh0cmVnaW9uOmUzMDUxNGYwNzNiMjRmYjBiNzQxYTUzNzhjODc0ZGIyXzc2OTY1ODE0MDY2NTI_fdce93b6-b50c-41e8-8c41-e43b764860d4">1.2</ix:nonFraction>&#160;million shares of our common stock and $<ix:nonFraction unitRef="usd" contextRef="i99d734e257e9441f812ed6b0c9affac9_D20210201-20210226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzMvZnJhZzplMzA1MTRmMDczYjI0ZmIwYjc0MWE1Mzc4Yzg3NGRiMi90ZXh0cmVnaW9uOmUzMDUxNGYwNzNiMjRmYjBiNzQxYTUzNzhjODc0ZGIyXzc2OTY1ODE0MDY2NjU_93bf8a96-a2a1-4a7b-b2ea-1e5586c09b89">17.0</ix:nonFraction>&#160;million in cash. Up to approximately $<ix:nonFraction unitRef="usd" contextRef="i99d734e257e9441f812ed6b0c9affac9_D20210201-20210226" decimals="-5" format="ixt:numdotdecimal" name="nvta:BusinessCombinationHoldbackConsiderationCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzMvZnJhZzplMzA1MTRmMDczYjI0ZmIwYjc0MWE1Mzc4Yzg3NGRiMi90ZXh0cmVnaW9uOmUzMDUxNGYwNzNiMjRmYjBiNzQxYTUzNzhjODc0ZGIyXzc2OTY1ODE0MDY2ODA_4b704d28-810e-46f1-9712-4f802c3270b9">0.1</ix:nonFraction>&#160;million in cash and <ix:nonFraction unitRef="usd" contextRef="i99d734e257e9441f812ed6b0c9affac9_D20210201-20210226" decimals="-5" format="ixt:numdotdecimal" name="nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzMvZnJhZzplMzA1MTRmMDczYjI0ZmIwYjc0MWE1Mzc4Yzg3NGRiMi90ZXh0cmVnaW9uOmUzMDUxNGYwNzNiMjRmYjBiNzQxYTUzNzhjODc0ZGIyXzc2OTY1ODE0MDY2OTQ_64c94767-8dee-453f-ad79-17c6aee55a5d">0.2</ix:nonFraction>&#160;million additional shares of our common stock are subject to a hold back to satisfy indemnification obligations that may arise following the closing. Given the timing of the closing of the transaction with One Codex, we are currently in the process of valuing the assets acquired and liabilities assumed. As a result, we are not yet able to provide the amounts to be recognized as of the acquisition date for the major classes of assets acquired and liabilities assumed and other related disclosures. We will disclose this and other related information in our Quarterly Report on Form 10-Q for the three months ending March 31, 2021.</ix:continuation></span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_136"></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9.&#160;&#160;&#160;&#160;Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_139"></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A.&#160;&#160;&#160;&#160;Controls and Procedures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of disclosure controls and procedures</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain &#8220;disclosure controls and procedures,&#8221; as such term is defined in Rule&#160;13a-15(e) under the Securities Exchange Act of 1934, or Exchange Act, that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial and accounting officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Our disclosure controls and procedures have been designed to meet reasonable assurance standards. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on their evaluation as of the end of the period covered by this Annual Report on Form&#160;10-K, our Chief Executive Officer (our principal executive officer) and Chief Financial Officer (our principal financial officer) have concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in internal control over financial reporting</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in our internal control over financial reporting (as defined in Rule&#160;13a-15(f) under the Exchange Act) identified in connection with the evaluation described in Item&#160;9A above that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s annual report on internal control over financial reporting</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining internal control over our financial reporting. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within an organization have been detected. Projections of any evaluation of the effectiveness of internal control to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may deteriorate. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scope of management&#8217;s assessment of the effectiveness of our internal control over financial reporting excludes the operations of ArcherDX, which we acquired in October 2020. This exclusion is in accordance with the SEC&#8217;s general guidance that an assessment of a recently acquired business may be omitted from the scope of our evaluation in the year of acquisition. ArcherDX constituted 3% of our consolidated total assets and 6% of our consolidated revenue as of and for the year ended December 31, 2020. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2020. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission, or COSO, in Internal Control&#8212;Integrated Framework (2013 Framework). Based on the assessment using those criteria, our management concluded that, as of December&#160;31, 2020, our internal control over financial reporting was effective. Our independent registered public accounting firm, Ernst&#160;&amp; Young LLP, has issued an audit report with respect to our internal control over financial reporting, which appears in Part II, Item&#160;8 of this Annual Report on Form&#160;10-K.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and Board of Directors of Invitae Corporation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Invitae Corporation&#8217;s internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Invitae Corporation (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on the COSO criteria.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As indicated in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting, management&#8217;s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of ArcherDX, Inc., which is included in the 2020 consolidated financial statements of the Company and constituted 3% and 1% of total and net assets, respectively, as of December 31, 2020 and 6% and 4% of revenues and net loss, respectively, for the year then ended. Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of ArcherDX, Inc. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of Invitae Corporation as of December 31, 2020 and 2019, the related consolidated statements of operations, comprehensive loss, stockholders&#8217; equity and cash flows for each of the three years in the period ended December 31, 2020, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;) and our report dated February&#160;26, 2021 expressed an unqualified opinion thereon.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:6pt;margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst&#160;&amp; Young&#160;LLP</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redwood City, California</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;26, 2021 </span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_142"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B.  Other Information.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_145"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_148"></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10.&#160;&#160;&#160;&#160;Directors, Executive Officers and Corporate Governance.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item with respect to directors is incorporated by reference from the information under the caption &#8220;Election of Directors,&#8221; contained in our proxy statement to be filed with the Securities and Exchange Commission no later than 120&#160;days from the end of our fiscal year ended December&#160;31, 2020 in connection with the solicitation of proxies for our 2021 Annual Meeting of Stockholders, or the Proxy Statement. Certain information required by this item concerning executive officers is set forth in Part&#160;I of this Report under the caption &#8220;Information About our Executive Officers&#8221; and is incorporated herein by reference.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the procedures by which stockholders may recommend nominees to our Board of Directors.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;405 of Regulation&#160;S-K calls for disclosure of any known late filing or failure by an insider to file&#160;a report required by Section&#160;16(a) of the Exchange Act. To the extent disclosure for delinquent reports is being made, it can be found under the caption &#8220;Delinquent Section&#160;16(a) Reports&#8221; in the Proxy Statement and is incorporated herein by reference.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors has adopted a code of business conduct and a code of ethics for senior financial officers applicable to our Chief Executive Officer and Chief Financial Officer as well as other key management employees addressing ethical issues. The code of business conduct and the code of ethics are each posted on our website www.invitae.com. The code of business conduct and the code of ethics can only be amended by the approval of a majority of our board of directors. Any waiver to the code of business conduct for an executive officer or director or any waiver of the code of ethics may only be granted by our board of directors or our nominating and corporate governance committee and must be timely disclosed as required by applicable law. We have implemented whistleblower procedures that establish formal protocols for receiving and handling complaints from employees. Any concerns regarding accounting or auditing matters reported under these procedures will be communicated promptly to our audit committee. Stockholders may request a free copy of our code of business conduct and code of ethics by contacting Invitae Corporation, Attention: Chief Financial Officer, 1400 16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Street, San Francisco, California 94103. None of the materials on, or accessible through, our website is part of this report or incorporated by reference herein.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, there have been no waivers under our code of business conduct or code of ethics. We intend to disclose future amendments to certain provisions of our code of business conduct or code of ethics or waivers of such codes granted to executive officers and directors on our website at http://www.invitae.com within four business days following the date of such amendment or waiver.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has appointed an Audit Committee, comprised of Geoffrey S. Crouse, Christine M. Gorjanc, and Kimber D. Lockhart. The Board of Directors has determined that each of the members of our Audit Committee qualifies as an Audit Committee Financial Expert under the definition outlined by the Securities and Exchange Commission. In addition, each of the members of the Audit Committee qualifies as an "independent director" under the current rules of the New York Stock Exchange and Securities and Exchange Commission rules and regulations.</span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_151"></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11.&#160;&#160;&#160;&#160;Executive Compensation.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference from the information under the captions &#8220;Election of Directors-Director Compensation&#8221; and &#8220;Executive Compensation&#8221; contained in the Proxy Statement.</span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_154"></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12.&#160;&#160;&#160;&#160;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the disclosure appearing under the headings &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; and &#8220;Equity Compensation Plan Information&#8221; contained in the Proxy Statement.</span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_157"></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13.&#160;&#160;&#160;&#160;Certain Relationships and Related Transactions, and Director Independence.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference from the information under the captions &#8220;Certain Relationships and Related Transactions,&#8221; "Corporate Governance" and &#8220;Director Independence&#8221; contained in the Proxy Statement.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_160"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14.&#160;&#160;&#160;&#160;Principal Accountant Fees and Services.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference from the information under the caption &#8220;Ratification of the Appointment of Independent Registered Public Accounting Firm&#8221; contained in the Proxy Statement.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_163"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_166"></div><div style="-sec-extract:summary;margin-bottom:9pt;margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15.&#160;&#160;&#160;&#160;Exhibits and Financial Statement Schedules.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Documents filed as part of this report</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Financial Statements:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Reference is made to the Index to Financial Statements of Invitae Corporation included in Item&#160;8 of Part&#160;II hereof.</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Financial Statement Schedules:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> All schedules have been omitted because they are not required, not applicable, or the required information is included in the financial statements or notes thereto.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Exhibits</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: See Item&#160;15(b) below. Each management contract or compensating plan or arrangement required to be filed has been identified.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Exhibits</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.981%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">@</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312520177763/d920891dex21.htm">Agreement and Plan of Merger and Plan of Reorganization, dated as of June 21, 2020, by and among Invitae Corporation, Apollo Merger Sub A Inc., Apollo Merger Sub B LLC, ArcherDX, Inc. and Kyle Lefkoff, solely in his capacity as holders&#8217; representative (incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s Current Report on Form 8-K filed June 24, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">@</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113419000041/nvta-exhibit22.htm">Stock Purchase and Merger Agreement, dated as of July 11, 2019, by and among Invitae Corporation, Jumanji, LLC, Jungla Inc., and Fortis Advisors LLC (incorporated by reference to Exhibit 2.2 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2019).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">@&#94;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113420000013/nvta-exhibit23.htm">Agreement and Plan of Merger, dated as of November 8, 2019, by and among Invitae Corporation, Catalina Merger Sub A Inc., Catalina Merger Sub B LLC, Clear Genetics, Inc. and Shareholder Representative Services LLC.</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113420000013/nvta-exhibit23.htm">(incor</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113420000013/nvta-exhibit23.htm">porated by reference to Exhibit 2.3 to the Registrant's Annual Report on Form 10-K for the year ended December 31, 2019)</a></span><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">@&#94;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113420000028/nvta-exhibit21.htm">Share Purchase Agreement, dated as of March 10, 2020, by and among Invitae Corporation, Invitae Netherlands, B.V. and Peter Schols (incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">@&#94;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113420000039/exhibit21-q22020.htm">Agreement and Plan of Merger, dated as of March 10, 2020, by and among Invitae Corporation, Yasawa Merger Sub A Inc., Yasawa Merger Sub B LLC, YouScript Incorporated, and Fortis Advisors LLC, as representative of YouScript Incorporated&#8217;s stockholders (incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">@&#94;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113420000039/exhibit22-q22020.htm">Unit Purchase Agreement, dated as of March 10, 2020, by and among Invitae Corporation, David Colaizzi, Chris Howlett, Anthony Muhlenkamp, Gerald Schneider, and Matt Lehrian (incorporated by reference to Exhibit 2.2 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">@</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312520177763/d920891dex21.htm">Agreement and Plan of Merger and Plan of Reorganization, dated as of June 21, 2020, by and among Invitae Corporation, Apollo Merger Sub A Inc., Apollo Merger Sub B LLC, ArcherDX, Inc. and Kyle Lefkoff, solely in his capacity as holders&#8217; representative (incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s Current Report on Form 8-K filed June 24, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000110465915013066/a15-5079_1ex3d1.htm">Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit&#160;3.1 to the Registrant&#8217;s Current Report on Form&#160;8</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000110465915013066/a15-5079_1ex3d1.htm">-</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000110465915013066/a15-5079_1ex3d1.htm">K filed February&#160;23, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517243106/d434356dex31.htm">Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock of Invitae Corporation (incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K filed August 1, 2017).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000110465915013066/a15-5079_1ex3d2.htm">Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit&#160;3.2 to the Registrant&#8217;s Current Report on Form&#160;8</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000110465915013066/a15-5079_1ex3d2.htm">-</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000110465915013066/a15-5079_1ex3d2.htm">K filed February&#160;23, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit41-invitaecorporati.htm">Form of Common Stock Certificate</a></span><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113420000013/nvta-exhibit42.htm">Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517243106/d434356dex104.htm">Amended and Restated Registration Rights Agreement, dated as of July 31, 2017 (incorporated by reference to Exhibit 10.4 to the Registrant&#8217;s Current Report on Form 8-K filed August 1, 2017).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517283915/d411703dex44.htm">Form of Invitae Corporation Series F Warrant (incorporated by reference to Exhibit 4.4 to the Registrant&#8217;s Registration Statement on Form S</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517283915/d411703dex44.htm">-</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517283915/d411703dex44.htm">4 (File No. 333</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517283915/d411703dex44.htm">-</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517283915/d411703dex44.htm">220447), as amended, filed September 13, 2017).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517283915/d411703dex45.htm">Form of Invitae Corporation Series F Warrant Agent Agreement (incorporated by reference to Exhibit 4.5 to the Registrant&#8217;s Registration Statement on Form S</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517283915/d411703dex45.htm">-</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517283915/d411703dex45.htm">4 (File No. 333</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517283915/d411703dex45.htm">-</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517283915/d411703dex45.htm">220447), as amended, filed September 13, 2017).</a></span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.981%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113419000041/nvta-exhibit104.htm">Form of Registration Rights Agreement by and among Invitae Corporation and certain stockholders of Singular Bio, Inc. (incorporated by reference to Exhibit 10.4 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2019).</a></span></div><div><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113419000041/nvta-exhibit105.htm">Form of Registration Rights Agreement by and among Invitae Corporation and certain stockholders of Jungla Inc. (incorporated by reference to Exhibit 10.5 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2019).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113420000013/nvta-exhibit48.htm">Form of Registration Rights Agreement by and among Invitae Corporation and certain stockholders of Clear Genetics, Inc. (incorporated by reference to Exhibit 4.8 to the Registrant's Annual Report on Form 10-K for the year ended December 31, 2019).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312519242950/d795184dex41.htm">Indenture dated as of September&#160;10, 2019, between Invitae Corporation and U.S. Bank National Association, as trustee (including form of Note) (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed September&#160;11, 2019).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113420000028/nvta-exhibit41.htm">Registration Rights Agreement, dated as of March 10, 2020, by and between Invitae Corporation and Peter Schols (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Quarterly Report for the quarter ended March 31, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113420000039/exhibit41-q22020.htm">Registration Rights Agreement, dated as of April 1, 2020, by and among Invitae Corporation and certain stockholders of YouScript Incorporated (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113420000039/exhibit42-q22020.htm">Registration Rights Agreement, dated as of April 1, 2020, by and among Invitae Corporation, CFH Management, L.P., as assignee of David Colaizzi, Chris Howlett, Anthony Muhlenkamp, Gerald Schneider, and Matt Lehrian (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312520263893/d17647dex102.htm">Registration Rights Agreement, dated as of October 2, 2020, by and among Invitae Corporation and the investors party thereto (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K filed October 5, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.14*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit414-invitaexintelli.htm">Registration Rights Agreement, dated as of December 8, 2020, by and between Invitae Corporation and IntelliGene Health Informatics, LLC.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312520177763/d920891dex101.htm">Securities Purchase Agreement, dated as of June 21, 2020, by and among Invitae Corporation and the investors identified therein (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed June 24, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312520263893/d17647dex102.htm">Registration Rights Agreement, dated as of October 2, 2020, by and among Invitae Corporation and the investors party thereto (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K filed October 5, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312520263893/d17647dex103.htm">Credit Agreement and Guaranty, dated as of October 2, 2020, by and among Invitae Corporation, the subsidiary guarantors from time to time party thereto, the lenders from time to time party thereto and Perceptive Credit Holdings III, LP, as the Administrative Agent (incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Current Report on Form 8-K filed October 5, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312520263893/d17647dex104.htm">Support Agreement, dated as of September 23, 2020, by and among Invitae Corporation and certain securityholders of ArcherDX, Inc. (incorporated by reference to Exhibit 10.4 to the Registrant&#8217;s Current Report on Form 8-K filed October 5, 2020). </a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">#*</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit105-invitae2015stoc.htm">Invitae Corporation 2015 Stock Incentive Plan, as amended and restated as of December 7, 2020.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">#</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000104746915000141/a2222622zex-10_6.htm">Form of Notice of Stock Option Grant and Non-Qualified Stock Option Agreement for awards granted under the 2015 Stock Incentive Plan (incorporated by reference to Exhibit 10.6 to the Registrant&#8217;s Registration Statement on Form S 1 (File No. 333 201433), as amended, declared effective on February 11, 2015).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">#</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000104746915000141/a2222622zex-10_7.htm">Form of Notice of Restricted Stock Award and Restricted Stock Agreement for awards granted under the 2015 Stock Incentive Plan (incorporated by reference to Exhibit 10.7 to the Registrant&#8217;s Registration Statement on Form S 1 (File No. 333 201433), as amended, declared effective on February 11, 2015).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">#</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000110465915057170/a15-17117_1ex10d1.htm">Form of Notice of Restricted Stock Unit Award and Restricted Stock Unit Agreement for Awards Granted under the 2015 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8 K filed August 6, 2015).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">#</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000104746915000141/a2222622zex-10_8.htm">Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.8 to the Registrant&#8217;s Registration Statement on Form S 1 (File No. 333 201433), as amended, declared effective on February 11, 2015).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">#</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113419000041/nvta-exhibit102.htm">Form of Notice of Time-Based Restricted Stock Unit Award and Time-Based Restricted Stock Unit Agreement for Awards Granted under the Invitae Corporation 2015 Stock Incentive Plan (Inducement) (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2019).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.981%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">#&#94;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113419000041/nvta-exhibit103.htm">Form of Notice of Performance-Based Restricted Stock Unit Award and Performance-Based Restricted Stock Unit Agreement for Awards under the Invitae Corporation 2015 Stock Inventive Plan (Inducement) (incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2019).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.12</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517189563/d514375dex101.htm">Offer Letter, dated as of May 19, 2017,</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517189563/d514375dex101.htm"> </a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517189563/d514375dex101.htm">by and </a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312517189563/d514375dex101.htm">between Invitae Corporation and Shelly Guyer (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed June 1, 2017).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000110465915063843/a15-19027_1ex10d1.htm">Lease Agreement dated as of September&#160;2, 2015 by and between Invitae Corporation and 1400 16th&#160;Street&#160;LLC (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form&#160;8</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000110465915063843/a15-19027_1ex10d1.htm">-</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000110465915063843/a15-19027_1ex10d1.htm">K filed September&#160;4, 2015).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000156459017004633/nvta-ex1014_613.htm">Form of Warrant to Purchase Common Stock between Oxford Capital, LLC and Invitae Corporation (incorporated by reference to Exhibit 10.14 to the Registrant&#8217;s Annual Report on Form 10-K for the year ended December 31, 2016).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000150113419000022/nvta-exhibit1019.htm">Sales Agreement dated as of August 9, 2018 between Invitae Corporation and Cowen and Company, LLC (incorporated by reference to Exhibit 10.19 to the Registrant's Annual Report on Form 10-K for the year ended December 31, 2018). </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312519058833/d714295dex12.htm">Amendment No. 1 to Sales Agreement dated as of February 28, 2019 </a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312519058833/d714295dex12.htm">by and </a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312519058833/d714295dex12.htm">between Invitae Corporation and Cowen and Company, LLC (incorporated by reference to Exhibit 1.2 to the Registrant&#8217;s Current Report on Form 8-K filed March 1, 2019).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">#</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312520180918/d942664dex101.htm">Offer Letter, dated as of June 1, 2020, by and between Invitae Corporation and Kenneth D. Knight (incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Current Report on Form 8-K filed June 26, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312520177763/d920891dex101.htm">Securities Purchase Agreement, dated as of June 21, 2020, by and among Invitae Corporation and the investors identified therein (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed June 24, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312520263893/d17647dex104.htm">Support Agreement, dated as of September 23, 2020, by and among Invitae Corporation and certain securityholders of ArcherDX, Inc. (incorporated by reference to Exhibit 10.4 to the Registrant&#8217;s Current Report on Form 8-K filed October 5, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#94;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1501134/000119312520263893/d17647dex103.htm">Credit Agreement and Guaranty, dated as of October 2, 2020, by and among Invitae Corporation, the subsidiary guarantors from time to time party thereto, the lenders from time to time party thereto and Perceptive Credit Holdings III, LP, as the Administrative Agent (incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Current Report on Form 8-K filed October 5, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.21</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">#</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1021toxarcherdxinc2.htm">ArcherDX, Inc. 2015 Equity Incentive Plan, as amended, and forms of agreements thereunder.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit211-listofsubsidiar.htm">List of Subsidiarie</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit211-listofsubsidiar.htm">s</a></span><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231-sx8consentx1231.htm">Consent of Independent Registered Public Accounting Firm.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Power of Attorney (contained on the signature page to this Form&#160;10-K).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-q42020.htm">Principal Executive Officer&#8217;s Certifications Pursuant to Section&#160;302 of the Sarbanes</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-q42020.htm">-</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-q42020.htm">Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-q42020.htm">Principal Financial and Accounting Officer&#8217;s Certifications Pursuant to Section&#160;302 of the Sarbanes</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-q42020.htm">-</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-q42020.htm">Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-q42020.htm">Certification Pursuant to 18 U.S.C. &#167;&#160;1350 (Section&#160;906 of Sarbanes</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-q42020.htm">-</a><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-q42020.htm">Oxley Act of 2002).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0888b2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-q42020.htm">Certification Pursuant to 18 U.S.C. &#167; 1350 (Section 906 of Sarbanes-Oxley Act of 2002).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document and included as Exhibit 101).</span></td></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">__________________________________________</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicates management contract or compensatory plan or arrangement.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">@</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The schedules and exhibits to this agreement have been omitted pursuant to Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#94;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Portions of this Exhibit have been redacted in accordance with Item 601 of Regulation S-K</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Copies of the above exhibits not contained herein are available to any stockholder, upon payment of a reasonable per page fee, upon written request to: Chief Financial Officer, Invitae Corporation, 1400 16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Street, San Francisco, California 94103.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Financial Statement Schedules: Reference is made to Item&#160;15(a) 2 above.</span></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_169"></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16.&#160;&#160;&#160;&#160;Form 10-K Summary.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><div id="ie13029cdd7d64c5bac971f0e86e8f19a_172"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INVITAE CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sean E. George, Ph.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sean E. George, Ph.D.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</span></div></td></tr></table></div><div style="margin-top:9pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: February&#160;26, 2021 </span></div><div style="margin-top:18pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</span></div><div style="margin-top:12pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Sean E. George and Shelly D. Guyer, and each of them, his true and lawful attorneys-in-fact, each with full power of substitution, for him or her in any and all capacities, to sign any amendments to this report on Form&#160;10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact or their substitute or substitutes may do or cause to be done by virtue hereof.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons, on behalf of the registrant on the dates and the capacities indicated.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.419%"><tr><td style="width:1.0%"></td><td style="width:22.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.195%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sean E. George, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer (Principal Executive Officer) and Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sean E. George, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Shelly D. Guyer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer<br/>(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shelly D. Guyer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Robert F. Werner</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Accounting Officer<br/>(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert F. Werner</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Eric Aguiar, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eric Aguiar, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Geoffrey S. Crouse</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geoffrey S. Crouse</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christine M. Gorjanc</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine M. Gorjanc</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kimber D. Lockhart</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kimber D. Lockhart</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jason W. Myers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason W. Myers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Chitra Nayak</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chitra Nayak</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>exhibit41-invitaecorporati.htm
<DESCRIPTION>EX-4.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i9622a14e9774463f8effc72b594d3102_1"></div><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 4.1</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt;text-align:center"><img alt="image2.jpg" src="image2.jpg" style="height:575px;margin-bottom:5pt;vertical-align:text-bottom;width:861px"></div><div style="margin-top:0.2pt;text-align:center"><font><br></font></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i9622a14e9774463f8effc72b594d3102_188"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.2pt;text-align:center"><img alt="image1.jpg" src="image1.jpg" style="height:825px;margin-bottom:5pt;vertical-align:text-bottom;width:657px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.14
<SEQUENCE>3
<FILENAME>exhibit414-invitaexintelli.htm
<DESCRIPTION>EX-4.14
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="if570712244174be4a7d66dbe2b624cc2_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.14</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">REGISTRATION RIGHTS AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Registration Rights Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is made and entered into as of December 8, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) by and between Invitae Corporation, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and IntelliGene Health Informatics, LLC, a California limited liability company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Seller</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RECITALS</font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, concurrently herewith, the Company and Seller are entering into an Asset Purchase Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Purchase Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), pursuant to which, on the Effective Date, the Company will acquire the Purchased Assets (as defined therein)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">from Seller (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Asset Purchase</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, in connection with the Asset Purchase and pursuant to the Purchase Agreement, the Company will issue to Seller at the Closing (as defined in the Purchase Agreement) shares of the Company&#8217;s common stock, par value $0.0001 per share, identified on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereto as Stock Consideration Shares (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) pursuant to the Purchase Agreement&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, in connection with the consummation of the transactions contemplated by the Purchase Agreement, the Company agreed to grant certain registration rights to Seller as set forth in this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, the parties agree as follows&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE I</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DEFINITIONS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 1.1&#160;&#160;&#160;&#160;Definitions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For purposes of this Agreement, the following terms and variations thereof have the meanings set forth below&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, with respect to any person, any other person that, directly or indirectly, controls, or is controlled by, or is under common control with, such person. For this purpose&#58; (a) &#8220;control&#8221; (including, with its correlative meanings, &#8220;controlled by&#8221; and &#8220;under common control with&#8221;) means the possession, directly or indirectly, of the power to direct or cause the direction of management or policies of a Person, whether through the ownership of securities or partnership or other ownership interests, by contract or otherwise&#59; and (b) &#8220;person&#8221; means any natural person, corporation, limited liability company, partnership, association, trust or other entity.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the preamble.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#34; means any day, other than a Saturday, Sunday or one on which banks are authorized by law to be closed in New York, New York.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Company Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section 4.1(b).</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the preamble.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Effectiveness Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section 3.1(b).</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Securities Exchange Act of 1934.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Grace Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section 3.2(h).</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) means Seller and any transferee permitted under Section 3.6, in each case to the extent holding Registrable Securities.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Holder Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section 4.1(a).</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Indemnified Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section 4.1(c).</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Indemnifying Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section 4.1(c).</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Purchase Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the recitals.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Registrable Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Shares issued to Seller pursuant to the Purchase Agreement and any securities issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to such securities&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that Registrable Securities shall cease to be Registrable Securities with respect to a particular Holder when (i) such securities have been disposed of in accordance with the Registration Statement or pursuant to Rule 144&#59; (ii) such securities may be sold pursuant to Rule 144 without any limitation as to manner-of-sale restrictions or volume limitations&#59; or (iii) such securities cease to be outstanding.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Registration Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means all expenses incurred by the Company in effecting the registration pursuant to this Agreement, including all registration and filing fees, printing expenses, fees and disbursements of counsel for the Company, &#8220;blue sky&#8221; fees and expenses, and expenses of the Company&#8217;s independent registered public accounting firm in connection with any regular or special reviews or audits incident to or required by any such registration, but shall not include Selling Expenses.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section 3.1.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Rule 144</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Rule 144 under the Securities Act or any successor or other similar rule, regulation or interpretation of the SEC that may at any time permit the sale of Registrable Securities to the public without registration.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Rule 405</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Rule 405 under the Securities Act or any successor or other similar rule.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Rule 415</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Rule 415 under the Securities Act or any successor or other similar rule providing for offering securities on a continuous or delayed basis.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Rule 424</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Rule 424 under the Securities Act or any successor or other similar rule.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the recitals.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Securities and Exchange Commission.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Securities Act of 1933.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Selling Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means all discounts, selling commissions, fees of selling brokers, dealer managers and similar securities industry professionals and stock transfer taxes applicable to the sale of Registrable Securities and fees and disbursements of counsel for any Holder (other than the fees and disbursements of counsel for the Company included in Registration Expenses).</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, directly or indirectly, to sell, transfer, assign, pledge, encumber, hypothecate or similarly dispose of (by merger, testamentary disposition, operation of law or otherwise), either voluntarily or involuntarily, or to enter into any contract, option or other arrangement or understanding with respect to the sale, transfer, assignment, pledge, encumbrance, hypothecation or similar disposition of (by merger, testamentary disposition, operation of law or otherwise) any Shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Violation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section 4.1(a).</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE II</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TRANSFER RESTRICTIONS</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 2.1&#160;&#160;&#160;&#160;General Transfer Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The right of Seller to Transfer any Shares held by Seller is subject to the restrictions set forth below.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Seller acknowledges that the Shares have not been registered under the Securities Act and may not be Transferred except pursuant to an effective registration statement under the Securities Act or pursuant to an exemption from registration under the Securities Act. Seller covenants that the Shares will only be disposed of pursuant to an effective registration statement under, and in compliance with the requirements of, the Securities Act or pursuant to an available exemption from the registration requirements of the Securities Act, and in compliance with any applicable state and foreign securities laws. In connection with any Transfer of the Shares other than a Transfer (i) pursuant to an effective registration statement, (ii) to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company or (iii) pursuant to Rule 144, the Company may require Seller to provide to the Company an opinion of counsel selected by Seller and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such Transfer does not require registration under the Securities Act.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Seller agrees to the affixing, so long as is required by this Section 2.1, of the following legend on any certificate or book-entry position evidencing any of the Shares&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;ACT&#8221;), OR ANY STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER THE ACT AND THE RULES AND REGULATIONS THEREUNDER AND APPLICABLE STATE SECURITIES LAWS.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Certificates or book-entry positions evidencing the Shares shall not be required to contain such legend or any other legend (i) following any sale of such Shares pursuant to an effective registration statement (including the Registration Statement described in Section 3.1) covering the resale of the Shares, (ii) following any sale of such Shares pursuant to Rule 144 or if the Shares are transferrable by a person who is not an Affiliate of the Company or Seller pursuant to Rule 144 without any volume or manner of sale restrictions thereunder, (iii) if Seller is not an Affiliate of the Company, six (6) months following the Closing, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in the case of (i), (ii) and (iii), above, Seller provides the Company with customary legal representation letters reasonably acceptable to the Company or (iv) if Seller provides the Company with a legal opinion reasonably acceptable to the Company to the effect that the legend is not required under applicable requirements of the Securities Act. Whenever such restrictions shall cease and terminate as to any Shares, the Holder of such securities shall be entitled to receive from the Company upon a written request in writing, without expense, new securities of like tenor not bearing the legend set forth herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE III</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">REGISTRATION AND PROCEDURES</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.1&#160;&#160;&#160;&#160;S-3 Registration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;In compliance with the terms of this Agreement, the Company shall prepare and file with the SEC a registration statement on Form S-3ASR (or such other form that the Company is then eligible to use if not eligible to use Form S-3ASR) covering the resale as a secondary offering to be made on a continuous basis pursuant to Rule 415 of all Registrable Securities.  The registration statement (or new registration statement) required to be filed pursuant to this Section 3.1, together with any amendments and supplements to such registration statement, including post-effective amendments, and all exhibits and all materials incorporated by reference in such registration statement other than a registration statement on Form S-4 or S-8, is referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company shall exercise commercially reasonable efforts to prepare and file the Registration Statement with the SEC no later than fifteen (15) Business Days after the Closing Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that no filing of such Registration Statement shall be required (i) during any period in which the Company&#8217;s insider trading policy would prohibit executive officers of the Company from trading in the Company&#8217;s securities or (ii) prior to the date which is two (2) days following the Company&#8217;s first filing with the SEC after the Closing Date of an Annual Report on Form 10-K or a Quarterly Report on Form 10-Q.  Subject to the terms of this Agreement, the Company shall use commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable after such filing if not otherwise effective upon filing and to keep the Registration Statement continuously effective as promptly as practical and in compliance with the Securities Act and usable for resale of Registrable Securities covered thereby from the date of its initial effectiveness until the earlier of (i) the date on which such Registrable Securities have been disposed of in accordance with the Registration Statement or pursuant to Rule 144 or (ii) such Registrable Securities may be sold pursuant to Rule 144 without any limitation as to manner-of-sale restrictions or volume limitations (such period, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Effectiveness Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that nothing in this Agreement shall require the Company to maintain any Registration Statement once the Shares cease to be Registrable Securities.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;It shall be a condition precedent to the obligations of the Company to take any action pursuant to Section 3.1 or Section 3.2 with respect to Registrable Securities of a Holder that the Holder shall furnish to the Company such information regarding such Holder as required under Section 3.4(a).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.2&#160;&#160;&#160;&#160;Registration Procedures&#59; Company Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company shall use commercially reasonable efforts to effect the registration of the Registrable Securities in accordance with Section 3.1, and in connection therewith shall have the following obligations&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;No later than the first Business Day after the Registration Statement becomes effective, the Company shall file with the SEC the final prospectus included therein pursuant to Rule 424.  The Registration Statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, shall comply as to form and content with the applicable requirements of the Securities Act and shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Subject to Section 3.2(h), the Company shall prepare and file with the SEC such amendments and supplements to the Registration Statement and the prospectus used in connection with the Registration Statement as may be necessary to keep the Registration Statement effective and usable for resale of the Registrable Securities covered thereby at all times during the Effectiveness Period.  The Company shall use commercially reasonable efforts to cause any post-effective amendment to the Registration Statement that is not effective upon filing to become effective as soon as practicable after such filing.  No later than the first Business Day after a post-effective amendment to the Registration Statement becomes effective, the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company shall file with the SEC the final prospectus or prospectus supplement included therein pursuant to Rule 424.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Company shall as promptly as practicable notify the Holders of the time when the Registration Statement becomes effective or an amendment or supplement to any prospectus forming a part of such Registration Statement has been filed. The Company shall furnish to the Holders, without charge, such documents, including copies of any preliminary prospectus or final prospectus contained in the Registration Statement or any amendments or supplements thereto, as such Holder may reasonably request from time to time in order to facilitate the disposition of the Registrable Securities covered by the Registration Statement.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The Company shall use commercially reasonable efforts to register or qualify, and cooperate with the Holders of Registrable Securities covered by the Registration Statement in connection with the registration or qualification of such Registrable Securities for offer and sale under the securities or &#8220;blue sky&#8221; laws of each state and other jurisdiction of the United States as any such Holder reasonably requests in writing, and do any and all other things reasonably necessary or advisable to keep such registration or qualification in effect&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified or take any action which would subject it to taxation or general service of process in any such jurisdiction where it is not then so subject.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;The Company shall promptly notify (which notice shall be accompanied by an instruction to suspend the use of the prospectus) the Holders when a prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which any prospectus included in, or relating to, the Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein, or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading (provided that in no event shall such notice contain any material, non-public information), and, subject to Section 3.2(h), promptly prepare and file with the SEC a supplement to the related prospectus or amendment to such Registration Statement or any other required document so that, as thereafter delivered to the Holders, the prospectus will not contain an untrue statement of a material fact or omit to state any material fact required to be stated therein, or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;The Company shall use commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness of the Registration Statement, or the suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is issued, to obtain the withdrawal of such order or suspension as soon as reasonably practicable and to notify the Holders of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding for such purpose.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;The Company shall use commercially reasonable efforts to cause the Registrable Securities covered by the Registration Statement to be (i) listed on the New York </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stock Exchange and (ii) reflected in the stock ledger maintained by the Company&#8217;s transfer agent.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;Notwithstanding anything in this Agreement to the contrary, at any time after the Registration Statement becomes effective the Company may delay the disclosure of material, non-public information concerning the Company or any of its subsidiaries if the Board of Directors of the Company has a valid business reason for determining that disclosure of such information is not in the best interests of the Company and such disclosure is not otherwise required (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Grace Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Company shall promptly (i) provide written notice to the Holders of the Grace Period (provided that in no event shall such notice contain any material, non-public information) and the date on which the Grace Period will begin, (ii) advise the Holders in writing to cease sales under the Registration Statement until the end of the Grace Period, (iii) use commercially reasonable efforts to terminate a Grace Period as promptly as possible, and (iv) provide written notice to the Holders of the date on which the Grace Period ends&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that no Grace Period shall exceed thirty (30) consecutive days and during any twelve (12) month period such Grace Periods shall not exceed an aggregate of sixty (60) days&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Company shall not register any securities for its own account or that of any other stockholder during such Grace Period.  The provisions of Section 3.2(e) shall not be applicable during any Grace Period.  Upon expiration of a Grace Period, the Company shall again be bound by the provisions of Section 3.2(e) with respect to the information giving rise thereto unless such material, non-public information is no longer applicable.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.3&#160;&#160;&#160;&#160;Current Public Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  During the Effectiveness Period, the Company shall use commercially reasonable efforts to (i) make and keep public information available, as those terms are defined in Rule 144, until all the Registrable Securities cease to be Registrable Securities, and so long as a Holder owns any Registrable Securities, furnish to such Holder upon request a written statement by the Company as to its satisfaction of the current public information requirements of Rule 144 and (ii) file with the SEC in a timely manner all reports and other documents required to be filed by the Company under the Securities Act and the Exchange Act.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.4&#160;&#160;&#160;&#160;Obligations of the Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Each Holder shall furnish in writing to the Company such information regarding such Holder, the Registrable Securities held by such Holder and the intended method of disposition of the Registrable Securities held by such Holder as shall be reasonably required to effect the registration of such Registrable Securities and shall execute, or shall cause to be executed, such customary documents in connection with such registration as the Company may reasonably request.  In connection therewith, upon the execution of this Agreement, each Holder shall complete, execute and deliver to the Company a selling securityholder notice and questionnaire in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  At least five (5) Business Days prior to the first anticipated filing date of the Registration Statement, the Company shall notify each Holder of any additional information the Company requires from such Holder, and such Holder </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall provide such information to the Company at least three (3) Business Days prior to the first anticipated filing date of the Registration Statement.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Each Holder agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of the Registration Statement.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Upon receipt of written notice from the Company of any event of the kind described in Section 3.2(e) or Section 3.2(f) or written notice of any Grace Period, each Holder shall forthwith discontinue disposition of Registrable Securities until such Holder has received copies of a supplemented or amended prospectus or until such Holder is advised in writing by the Company that the use of the prospectus may be resumed or that the Grace Period has ended.  If so directed by the Company, such Holder shall use its commercially reasonable efforts to return to the Company (at the Company's expense) all copies of the prospectus covering such Registrable Securities current at the time of receipt of such notice other than permanent file copies then in such Holder&#8217;s possession.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;No Holder shall use any free writing prospectus (as defined in Rule 405) in connection with the sale of Registrable Securities without the prior written consent of the Company. </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it or an exemption therefrom in connection with sales of Registrable Securities pursuant to any Registration Statement.  </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.5&#160;&#160;&#160;&#160;Expenses of Registration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All Registration Expenses incurred in connection with any registration, qualification or compliance hereunder shall be borne by the Company. All Selling Expenses incurred in connection with any registration hereunder shall be borne by the Holders of the Registrable Securities so registered in proportion the Registrable Securities owned by such Holders.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.6&#160;&#160;&#160;&#160;Transfer of Registration Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The rights contained in Section 3.1 hereof to cause the Company to register the Registrable Securities, and the other rights set forth in this Article&#160;III, may be assigned or otherwise conveyed by Seller to any transferee of the Registrable Securities if the Transfer was permitted under Article&#160;II and the transferee agrees with the Company in writing to be bound by this Agreement.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE IV</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">INDEMNIFICATION AND CONTRIBUTION</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 4.1&#160;&#160;&#160;&#160;Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event any Registrable Securities are included in the Registration Statement&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Company shall indemnify and hold harmless each Holder of Registrable Securities and such Holder&#8217;s officers, directors, employees, partners, members, agents (including brokers), representatives and Affiliates and each person, if any, who controls </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">such Holder within the meaning of the Securities Act or the Exchange Act (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Holder Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), against any losses, claims, damages, liabilities or expenses to which they may become subject under the Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Violation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#58; (i) an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto or any documents incorporated therein by reference, (ii) an omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, and (iii) a violation or alleged violation by the Company or its agents of any rule or regulation promulgated under the Securities Act or the Exchange Act applicable to the Company or its agents and relating to action or inaction required of the Company in connection with the Registration Statement, and the Company will pay to each such Holder Indemnitee, as accrued, any legal or other expenses reasonably incurred by he, she or it in connection with investigating or defending any such loss, claim, damage, liability, action or expense&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the indemnification contained in this Section 4.1(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability, action or expense if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld, conditioned or delayed), nor shall the Company be liable for any such loss, claim, damage, liability, action or expense to the extent that it arises out of or is based upon a Violation which occurs (A) in reliance upon and in conformity with written information furnished by a Holder, (B) in connection with any failure of such person to deliver or cause to be delivered a prospectus made available by the Company in a timely manner, (C) in connection with any offers or sales effected by or on behalf of any Holder Indemnitee in violation of Section 3.4(c) of this Agreement, or (D) as a result of offers or sales effected by or on behalf of any Holder Indemnitee by means of a free writing prospectus (as defined in Rule 405) that was not authorized in writing by the Company.  Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of any such Holder Indemnitee, and shall survive the transfer of such securities by such Holder, and any termination of this Agreement.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Each Holder, severally and not jointly, shall indemnify and hold harmless the Company and each of its officers, directors, employees, agents, representatives and Affiliates and persons, if any, who control the Company within the meaning of the Securities Act or the Exchange Act (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Company Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), against any losses, claims, damages, liabilities or expenses to which any of the Company Indemnitees may become subject under the Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any (i) untrue statement or alleged untrue statement of a material fact regarding such Holder and provided in writing by such Holder which is contained in the Registration Statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, in each case to the extent (and only to the extent) that such untrue statement or alleged untrue statement or omission or alleged omission was made in the Registration </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Statement, preliminary or final prospectus, amendment or supplement thereto, in reliance upon and in conformity with written information furnished by such Holder, (iii) a violation or alleged violation by a Holder of any rule or regulation promulgated under the Securities Act or the Exchange Act applicable to such Holder and relating to action or inaction required of such Holder in connection with the registration of such Holder&#8217;s Registrable Securities or (iv) in connection with any offer or sales effected by or on behalf of such Holder in violation of Section 3.4(c) of this Agreement, and each Holder will pay, as accrued, any legal or other expenses reasonably incurred by any Company Indemnitee pursuant to this Section 4.1(b), in connection with investigating or defending any such loss, claim, damage, liability, action or expense as a result of a Holder&#8217;s untrue statement or omission or violation&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the indemnification contained in this Section 4.1(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability, action or expense if such settlement is effected without the consent of such Holder (which consent shall not be unreasonably withheld, conditioned or delayed).  Notwithstanding the foregoing, the amount any Holder will be obligated to pay pursuant to this Section 4.1(b) and Section 4.2 will be limited to an amount equal to the gross proceeds actually received by such Holder for the sale of the Registrable Securities pursuant to the Registration Statement which gives rise to such obligation to indemnify and&#47;or contribute (net of all expenses paid by such Holder in connection with any claim relating to this Section 4.1(b) and Section 4.2 and the aggregate amount of any damages which such Holder has otherwise been required to pay in respect of such loss, liability, claim, damage, or expense or any substantially similar loss, liability, claim, damage, or expense arising from the sale of such Registrable Securities).  Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of any such Company Indemnitee, and shall survive the transfer of such securities by such Holder, and any termination of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Promptly after receipt by a party to this Agreement entitled to indemnity hereunder (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Indemnified Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) under this Section 4.1 of notice of the commencement of any action (including any governmental action), such Indemnified Party will, if a claim in respect thereof is to be made against any party to this Agreement from whom indemnification may be sought under this Section 4.1 (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Indemnifying Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), deliver to the Indemnifying Party a written notice of the commencement thereof and the Indemnifying Party shall have the right to participate in, and, to the extent the Indemnifying Party so desires, jointly with any other Indemnifying Party similarly noticed, to assume the defense thereof with counsel reasonably satisfactory to the Indemnifying Party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that an Indemnified Party (together with all other Indemnified Parties which may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the reasonable fees and expenses of such counsel to be paid by the Indemnifying Party, if (i) the Indemnifying Party shall have failed to assume the defense of such claim within seven (7) days after receipt of notice of the claim and to employ counsel reasonably satisfactory to such Indemnified Party, as the case may be&#59; or (ii) in the reasonable opinion of counsel retained by the Indemnified Party, representation of such Indemnified Party by such counsel would be inappropriate due to actual or potential differing interests (including the availability of differing legal defenses) between such Indemnified Party and any other party represented by such counsel in such proceeding. It is understood that the Indemnifying Party shall not, in connection with any proceeding in the same jurisdiction, be liable for fees or expenses of more than one separate counsel at any time for all such Indemnified </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parties. The Indemnified Party shall cooperate fully with the Indemnifying Party in connection with any negotiation or defense of any such action or claim by the Indemnifying Party and shall furnish to the Indemnifying Party all information reasonably available to the Indemnified Party which relates to such action or claim. The Indemnifying Party shall keep the Indemnified Party reasonably apprised of the status of the defense or any settlement negotiations with respect thereto. No Indemnifying Party will, except with the consent of the Indemnified Party, consent to entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect of such action or claim. No Indemnifying Party shall be liable for any settlement of any action, claim or proceeding effected without its prior written consent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Indemnifying Party shall not unreasonably withhold, delay or condition its consent. The failure to deliver written notice to the Indemnifying Party within a reasonable time of the commencement of any such action shall not relieve such Indemnifying Party of any liability to the Indemnified Party under this Section 4.1, except to the extent such failure to give notice has a material adverse effect on the ability of the Indemnifying Party to defend such action.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 4.2&#160;&#160;&#160;&#160;Contribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;&#160; If the indemnification provided for in Section 4.1 is held by a court of competent jurisdiction to be unavailable to an Indemnified Party with respect to any loss, liability, claim, damage, or expense referred to therein, then the Indemnifying Party, in lieu of indemnifying such Indemnified Party hereunder, shall contribute to the amount paid or payable by such Indemnified Party as a result of such loss, liability, claim, damage, or expense in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party on the one hand and of the Indemnified Party on the other in connection with the statements or omissions that resulted in such loss, liability, claim, damage, or expense as well as any other relevant equitable considerations. The relative fault of the Indemnifying Party and of the Indemnified Party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the Indemnifying Party or by the Indemnified Party and the parties&#8217; relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission. Notwithstanding the foregoing, the amount any Holder will be obligated to severally and not jointly contribute pursuant to this Section 4.2, together with Holder&#8217;s liability under Section 4.1(b), will be limited to an amount equal to the gross proceeds received by a Holder for the sale of the Registrable Securities pursuant to the Registration Statement which gives rise to such obligation to contribute and&#47;or indemnify (net of all expenses paid by such Holder in connection with any claim relating to Section 4.1(b) and this Section 4.2 and the aggregate amount of any damages which such Holder has otherwise been required to pay in respect of such loss, liability, claim, damage, or expense or any substantially similar loss, liability, claim, damage, or expense arising from the sale of such Registrable Securities). No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution hereunder from any person who was not guilty of such fraudulent misrepresentation.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE V</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GENERAL PROVISIONS</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 5.1&#160;&#160;&#160;&#160;Entire Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  This Agreement (including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereto) constitutes the entire understanding and agreement between the parties as to the matters covered herein and supersedes and replaces any prior understanding, agreement or statement of intent, in each case, written or oral, of any and every nature with respect thereto.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 5.2&#160;&#160;&#160;&#160;Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any notice or other communication required or permitted to be delivered to any party under this Agreement shall be in writing and shall be deemed properly delivered, given and received (a)&#160;upon receipt when delivered by hand, (b)&#160;upon transmission, if sent by facsimile or electronic transmission (in each case with receipt verified by electronic confirmation), or (c)&#160;one&#160;(1) Business Day after being sent by courier or express delivery service, specifying next day delivery, with proof of receipt. The addresses, email addresses and facsimile numbers for such notices and communications are those set forth on the signature pages hereof, or such other address, email address or facsimile numbers as may be designated in writing hereafter, in the same manner, by any such person.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 5.3&#160;&#160;&#160;&#160;Counterparts.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other parties, it being understood that all parties need not sign the same counterpart and such counterparts may be delivered by the parties hereto via facsimile or electronic transmission.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 5.4&#160;&#160;&#160;&#160;Amendment&#59; Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement may be amended or modified, and any provision hereof may be waived, in whole or in part, at any time pursuant to an agreement in writing executed by the Company and Holders holding a majority of the Registrable Securities at such time. Any failure by any party at any time to enforce any of the provisions of this Agreement shall not be construed a waiver of such provision or any other provisions hereof.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 5.5&#160;&#160;&#160;&#160;Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event that any provision of this Agreement or the application thereof becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other persons or circumstances will be interpreted so as reasonably to effect the intent of the parties hereto.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Governing Law&#59; Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement and all claims or causes of action (whether sounding in contract or tort) arising under or related to this Agreement, shall be governed by and construed in accordance with, the Laws of the State of California, without regard to any rule or principle that might refer the governance or construction of this Agreement to the Laws of another jurisdiction.  In any action or proceeding between any of the parties arising under or related to this Agreement, each of the parties (a) knowingly, voluntarily, irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the state or federal courts located in the City and County of San Francisco, California, and each of the Parties hereby irrevocably submits to the exclusive jurisdiction of the aforesaid courts, (b) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">agrees that all claims in respect of any such action or proceeding shall be heard and determined exclusively in accordance with clause (a) of this Section 5.6, (c)&#160;waives any objection to the laying of venue of any such action or proceeding in such courts, including any objection that any such action or proceeding has been brought in an inconvenient forum or that the court does not have jurisdiction over any party, and (d) agrees that service of process upon such party in any such action or proceeding shall be effective if such process is given as a notice in accordance with Section 5.2.  The parties agree that any party may commence a proceeding in a court other than the above-named courts solely for the purpose of enforcing an order or judgment issued by one of the above-named courts.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Specific Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each party acknowledges and agrees that the other parties hereto would be irreparably harmed and would not have any adequate remedy at law in the event that any of the provisions of this Agreement were not performed by such first party in accordance with their specific terms or were otherwise breached by such first party.  Accordingly, each party agrees that the other parties hereto shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement, this being in addition to any other remedy to which such parties are entitled at law or in equity.</font></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Next Page is Signature Page)</font></div><div style="margin-bottom:11pt;text-align:center;text-indent:36pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div><div id="if570712244174be4a7d66dbe2b624cc2_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, each of the parties has executed this Agreement as of the date first written above.</font></div><div style="margin-bottom:11pt;padding-left:234pt"><font><br></font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">COMPANY&#58;</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">INVITAE CORPORATION</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; Sean E. George Ph.D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Sean E. George, Ph. D.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; President and Chief Executive Officer</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.173%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Address for Notice&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1400 16th Street</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">San Francisco, California 94103</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attn&#58; General Counsel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Facsimile No.&#58; (415) 276-4164</font></td></tr></table></div><div style="text-indent:36pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, each of the parties has executed this Agreement as of the date first written above.</font></div><div style="margin-bottom:11pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SELLER&#58;</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">INTELLIGENE HEALTH INFORMATICS, LLC</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; Amit Kulkarni&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Amit Kulkarni</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; President </font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Address for Notice&#58;</font></div><div style="margin-bottom:11pt;padding-left:234pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attn&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Facsimile No.&#58;</font></td></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.147%"><tr><td style="width:1.0%"></td><td style="width:18.726%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.338%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:11pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>4
<FILENAME>exhibit105-invitae2015stoc.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i9acbc4f464704150a9f4d6f795fc7e9f_1"></div><div style="min-height:72pt;width:100%"><div style="margin-top:0.5pt;padding-right:3.6pt;text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:93%">Exhibit 10.5</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">INVITAE CORPORATION</font></div><div style="margin-top:12.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:93%">2015 STOCK INCENTIVE PLAN</font></div><div style="margin-bottom:16.45pt;margin-top:10.2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(As Amended and Restated by the Board of Directors on December 7, 2020)</font></div><div style="margin-bottom:16.45pt;margin-top:10.2pt;text-align:center"><font><br></font></div><div style="margin-bottom:16.45pt;margin-top:10.2pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div></div><div id="i9acbc4f464704150a9f4d6f795fc7e9f_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.9pt;padding-left:1.8pt;padding-right:1.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:93%">INVITAE CORPORATION</font></div><div style="margin-top:12.1pt;padding-left:1.8pt;padding-right:1.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:93%">2015 STOCK INCENTIVE PLAN</font></div><div style="margin-top:12.1pt;padding-left:1.8pt;padding-right:1.8pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:6.02pt">ESTABLISHMENT AND PURPOSE.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Plan was adopted by the Board of Directors on January 8, 2015 and became effective immediately prior to the closing of the initial offering of Stock to the public pursuant to a registration statement filed by the Company with the Securities and Exchange Commission (the &#8220;Effective Date&#8221;), was amended and restated on June 11, 2019, and was further amended and restated on March 6, 2020, June 12, 2020 and December 7, 2020.  The purpose of the Plan is to promote the long-term success of the Company and the creation of stockholder value by (a) encouraging Employees, Outside Directors and Consultants to focus on critical long-range objectives, (b) encouraging the attraction and retention of Employees, Outside Directors and Consultants with exceptional qualifications and (c) linking Employees, Outside Directors and Consultants directly to stockholder interests through increased stock ownership.  The Plan seeks to achieve this purpose by providing for Awards in the form of restricted shares, stock units, options (which may constitute incentive stock options or nonstatutory stock options), stock appreciation rights or cash-based awards.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:6.02pt">DEFINITIONS.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;Affiliate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean any entity other than a Subsidiary, if the Company and&#47;or one or more Subsidiaries own not less than 50% of such entity.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;Award&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean any award of an Option, a SAR, a Restricted Share or a Stock Unit or a Cash-Based Award under the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">&#8220;Award Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean the agreement between the Company and the recipient of an Award which contains the terms, conditions and restrictions pertaining to such Award.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;Board of Directors&#8221; or &#8220;Board&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean the Board of Directors of the Company, as constituted from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">&#8220;Cash-Based Award&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean an Award that entitles the Participant to receive a cash-denominated payment.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.69pt">&#8220;Change in Control&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean the occurrence of any of the following events&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-47.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">A change in the composition of the Board of Directors occurs, as a result of which fewer than one-half of the incumbent directors are directors who either&#58;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">Had been directors of the Company on the &#8220;look-back date&#8221; (as defined below) (the &#8220;original directors&#8221;)&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">Were elected, or nominated for election, to the Board of Directors with the affirmative votes of at least a majority of the aggregate of the original directors who were still in office at the time of the election or nomination and the directors whose election or nomination was previously so approved (the &#8220;continuing directors&#8221;)&#59;</font></div><div style="margin-bottom:6pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">provided, however, that for this purpose, the &#8220;original directors&#8221; and &#8220;continuing directors&#8221; shall not include any individual whose initial assumption of office occurred as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents, by or on behalf of a person other than the Board&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-50.64pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">Any &#8220;person&#8221; (as defined below) who by the acquisition or aggregation of securities, is or becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company&#8217;s then outstanding securities ordinarily (and apart from rights accruing under special circumstances) having the right to vote at elections of directors (the &#8220;Base Capital Stock&#8221;)&#59; except that any change in the relative beneficial ownership of the Company&#8217;s securities by any person resulting solely from a reduction in the aggregate number of outstanding shares of Base Capital Stock, and any decrease thereafter in such person&#8217;s ownership of securities, shall be disregarded until such person increases in any manner, directly or indirectly, such person&#8217;s beneficial ownership of any securities of the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-53.97pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">The consummation of a merger or consolidation of the Company or a Subsidiary of the Company with or into another entity or any other corporate reorganization, if persons who were not stockholders of the Company immediately prior to such merger, consolidation or other reorganization own immediately after such merger, consolidation or other reorganization 50% or more of the voting power of the outstanding securities of each of (A) the Company (or its successor) and (B) any direct or indirect parent corporation of the Company (or its successor)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-53.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">The sale, transfer or other disposition of all or substantially all of the Company&#8217;s assets.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of subsection (e)(i) above, the term &#8220;look-back&#8221; date shall mean the later of (1) the Effective Date or (2) the date 24 months prior to the date of the event that may constitute a Change in Control.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of subsection (e)(ii)) above, the term &#8220;person&#8221; shall have the same meaning as when used in Sections 13(d) and 14(d) of the Exchange Act but shall exclude (1) a trustee or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">other fiduciary holding securities under an employee benefit plan maintained by the Company or a Parent or Subsidiary and (2) a corporation owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the Stock.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any other provision of this Section 2(e) notwithstanding, a transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company&#8217;s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transaction, and a Change in Control shall not be deemed to occur if the Company files a registration statement with the United States Securities and Exchange Commission for the initial or secondary public offering of securities or debt of the Company to the public.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;Code&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;Committee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean the Compensation Committee as designated by the Board of Directors, which is authorized to administer the Plan, as described in Section 3 hereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.69pt">&#8220;Company&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean Invitae Corporation, a Delaware corporation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.69pt">&#8220;Consultant&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean a consultant or advisor who provides bona fide services to the Company, a Parent, a Subsidiary or an Affiliate as an independent contractor (not including service as a member of the Board of Directors) or a member of the board of directors of a Parent or a Subsidiary, in each case who is not an Employee.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">&#8220;Employee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean any individual who is a common-law employee of the Company, a Parent, a Subsidiary or an Affiliate.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.69pt">&#8220;Exchange Act&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:19.36pt">&#8220;Exercise Price&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean, in the case of an Option, the amount for which one Share may be purchased upon exercise of such Option, as specified in the applicable Stock Option Agreement.  &#8220;Exercise Price,&#8221; in the case of a SAR, shall mean an amount, as specified in the applicable SAR Agreement, which is subtracted from the Fair Market Value of one Share in determining the amount payable upon exercise of such SAR.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;Fair Market Value&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> with respect to a Share, shall mean the market price of one Share, determined by the Committee as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-47.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">If the Stock was traded over-the-counter on the date in question, then the Fair Market Value shall be equal to the last transaction price quoted for such date by the OTC Bulletin Board or, if not so quoted, shall be equal to the mean between the last reported representative bid and asked prices quoted for such date by the principal automated inter-dealer quotation system on which the Stock is quoted or, if the Stock is not quoted on any such system, by the Pink Quote system&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-50.64pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">If the Stock was traded on any established stock exchange (such as the New York Stock Exchange, The Nasdaq Global Market or The Nasdaq Global Select Market) or national market system on the date in question, then the Fair Market Value shall be equal to the closing price reported for such date by the applicable exchange or system&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-53.97pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">If none of the foregoing provisions is applicable, then the Fair Market Value shall be determined by the Committee in good faith on such basis as it deems appropriate.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In all cases, the determination of Fair Market Value by the Committee shall be conclusive and binding on all persons.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;ISO&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean an employee incentive stock option described in Section 422 of the Code.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;Nonstatutory Option&#8221; or &#8220;NSO&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean an employee stock option that is not an ISO.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;Option&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean an ISO or Nonstatutory Option granted under the Plan and entitling the holder to purchase Shares.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.36pt">&#8220;Outside Director&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean a member of the Board of Directors who is not a common-law employee of, or paid consultant to, the Company, a Parent or a Subsidiary.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.36pt">&#8220;Parent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean any corporation (other than the Company) in an unbroken chain of corporations ending with the Company, if each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.  A corporation that attains the status of a Parent on a date after the adoption of the Plan shall be a Parent commencing as of such date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.69pt">&#8220;Participant&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean a person who holds an Award.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(u)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;Performance Based Award&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean any Restricted Share Award, Stock Unit Award or Cash-Based Award granted to a Participant pursuant to the terms set forth in Section 20.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">&#8220;Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean this 2015 Stock Incentive Plan of Invitae Corporation, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:20.02pt">&#8220;Purchase Price&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean the consideration for which one Share may be acquired under the Plan (other than upon exercise of an Option), as specified by the Committee.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">&#8220;Restricted Share&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean a Share awarded under the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">&#8220;SAR&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean a stock appreciation right granted under the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.36pt">&#8220;Service&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean service as an Employee, Consultant or Outside Director, subject to such further limitations as may be set forth in the Plan or the applicable Award Agreement.  Service does not terminate when an Employee goes on a bona fide leave of absence, that was approved by the Company in writing, if the terms of the leave provide for continued Service crediting, or when continued Service crediting is required by applicable law.  However, for purposes of determining whether an Option is entitled to ISO status, an Employee&#8217;s employment will be treated as terminating three months after such Employee went on leave, unless such Employee&#8217;s right to return to active work is guaranteed by law or by a contract.  Service terminates in any event when the approved leave ends, unless such Employee immediately returns to active work.  The Company determines which leaves of absence count toward Service, and when Service terminates for all purposes under the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(aa)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:16.02pt">&#8220;Share&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean one share of Stock, as adjusted in accordance with Section 12 (if applicable).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(ab)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:16.02pt">&#8220;Stock&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean the Common Stock of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(ac)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:16.7pt">&#8220;Stock Unit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean a bookkeeping entry representing the Company&#8217;s obligation to deliver one Share (or distribute cash) on a future date in accordance with the provisions of a Stock Unit Award Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(ad)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:16.02pt">&#8220;Subsidiary&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean any corporation, if the Company and&#47;or one or more other Subsidiaries own not less than 50% of the total combined voting power of all classes of outstanding stock of such corporation.  A corporation that attains the status of a Subsidiary on a date after the adoption of the Plan shall be considered a Subsidiary commencing as of such date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(ae)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:16.7pt">&#8220;Total and Permanent Disability&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean any permanent and total disability as defined by Section 22(e)(3) of the Code.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:6.02pt">ADMINISTRATION.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Committee Composition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Plan shall be administered by a Committee appointed by the Board, or by the Board acting as the Committee.  The Committee shall consist of two or more directors of the Company.  In addition, to the extent required by the Board, the composition of the Committee shall satisfy (i) such requirements as the Securities and Exchange Commission may establish for administrators acting under plans intended to qualify for exemption under Rule 16b-3 (or its successor) under the Exchange Act&#59; and (ii) such requirements as the Internal Revenue Service may establish for outside directors acting under plans intended to qualify for exemption under Section 162(m)(4)(C) of the Code.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Committee for Non-Officer Grants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Board may also appoint one or more separate committees of the Board, each composed of one or more directors of the Company who need not satisfy the requirements of Section 3(a), who may administer the Plan with respect to Employees who are not considered officers or directors of the Company under Section 16 of the Exchange Act, may grant Awards under the Plan to such Employees and may determine all terms of such grants.  Within the limitations of the preceding sentence, any reference in the Plan to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Committee shall include such committee or committees appointed pursuant to the preceding sentence.  To the extent permitted by applicable laws, the Board of Directors may also authorize one or more officers of the Company to designate Employees, other than officers under Section 16 of the Exchange Act, to receive Awards and&#47;or to determine the number of such Awards to be received by such persons&#59; provided, however, that the Board of Directors shall specify the total number of Awards that such officers may so award.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Committee Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Board of Directors shall designate one of the members of the Committee as chairman.  The Committee may hold meetings at such times and places as it shall determine.  The acts of a majority of the Committee members present at meetings at which a quorum exists, or acts reduced to or approved in writing (including via email) by all Committee members, shall be valid acts of the Committee.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Committee Responsibilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to the provisions of the Plan, the Committee shall have full authority and discretion to take the following actions&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-47.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">To interpret the Plan and to apply its provisions&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-50.64pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">To adopt, amend or rescind rules, procedures and forms relating to the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-53.97pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">To adopt, amend or terminate sub-plans established for the purpose of satisfying applicable foreign laws including qualifying for preferred tax treatment under applicable foreign tax laws&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-53.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">To authorize any person to execute, on behalf of the Company, any instrument required to carry out the purposes of the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-49.98pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">To determine when Awards are to be granted under the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-53.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">To select the Participants to whom Awards are to be granted&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-56.64pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">To determine the type of Award and number of Shares or amount of cash to be made subject to each Award&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-59.97pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">To prescribe the terms and conditions of each Award, including (without limitation) the Exercise Price and Purchase Price, and the vesting or duration of the Award (including accelerating the vesting of Awards, either at the time of the Award or thereafter, without the consent of the Participant), to determine whether an Option is to be classified as an ISO or as a Nonstatutory Option, and to specify the provisions of the agreement relating to such Award&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-53.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">To amend any outstanding Award Agreement, subject to applicable legal restrictions and to the consent of the Participant if the Participant&#8217;s rights or obligations would be materially impaired&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-49.98pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">To prescribe the consideration for the grant of each Award or other right under the Plan and to determine the sufficiency of such consideration&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-53.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(xi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">To determine the disposition of each Award or other right under the Plan in the event of a Participant&#8217;s divorce or dissolution of marriage&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-56.64pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(xii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">To determine whether Awards under the Plan will be granted in replacement of other grants under an incentive or other compensation plan of an acquired business&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-59.97pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(xiii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">To correct any defect, supply any omission, or reconcile any inconsistency in the Plan or any Award Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-59.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(xiv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">To establish or verify the extent of satisfaction of any performance goals or other conditions applicable to the grant, issuance, exercisability, vesting and&#47;or ability to retain any Award&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-55.98pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(xv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">To take any other actions deemed necessary or advisable for the administration of the Plan.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Subject to the requirements of applicable law, the Committee may designate persons other than members of the Committee to carry out its responsibilities and may prescribe such conditions and limitations as it may deem appropriate, except that the Committee may not delegate its authority with regard to the selection for participation of or the granting of Awards under the Plan to persons subject to Section 16 of the Exchange Act.  All decisions, interpretations and other actions of the Committee shall be final and binding on all Participants and all persons deriving their rights from a Participant.  No member of the Committee shall be liable for any action that he has taken or has failed to take in good faith with respect to the Plan or any Award under the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:6.02pt">ELIGIBILITY.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">General Rule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Only Employees, Consultants and Outside Directors shall be eligible for the grant of Awards.  Only common-law employees of the Company, a Parent or a Subsidiary shall be eligible for the grant of ISOs.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Ten-Percent Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Employee who owns more than 10% of the total combined voting power of all classes of outstanding stock of the Company, a Parent or Subsidiary shall not be eligible for the grant of an ISO unless such grant satisfies the requirements of Section 422(c)(5) of the Code.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Attribution Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of Section 4(c) above, in determining stock ownership, an Employee shall be deemed to own the stock owned, directly or indirectly, by or for such Employee&#8217;s brothers, sisters, spouse, ancestors and lineal descendants.  Stock owned, directly or indirectly, by or for a corporation, partnership, estate or trust shall be deemed to be owned proportionately by or for its stockholders, partners or beneficiaries.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Outstanding Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of Section 4(c) above, &#8220;outstanding stock&#8221; shall include all stock actually issued and outstanding immediately after the grant. &#8220;Outstanding stock&#8221; shall not include shares authorized for issuance under outstanding options held by the Employee or by any other person.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:6.02pt">STOCK SUBJECT TO PLAN.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%;padding-left:22.7pt">Basic Limitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Shares offered under the Plan shall be authorized but unissued Shares or treasury Shares.  The aggregate number of Shares authorized for issuance as Awards under the Plan (other than Inducement Awards as set forth in Section 15) shall not exceed the sum of (x) 4,250,000 Shares, plus (y) the sum of the number of Shares subject to outstanding awards under the Company&#8217;s 2010 Stock Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Predecessor Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) on the Effective Date that are subsequently forfeited or terminated for any reason before being exercised or settled, plus the number of Shares subject to vesting restrictions under the Predecessor Plan on the Effective Date that are subsequently forfeited, plus the number of reserved Shares not issued or subject to outstanding grants under the Predecessor Plan on the Effective Date, plus (z) an annual increase on the first day of each fiscal year, for a period of not more than ten years, beginning on January 1, 2016, and ending on (and including) January 1, 2025, in an amount equal to the lesser of (i) four percent (4%) of the outstanding Shares on the last day of the immediately preceding fiscal or (ii) if the Board acts prior to the first day of the fiscal year, such lesser amount (including zero) that the Board determines for purposes of the annual increase for that fiscal year.  Notwithstanding the foregoing&#58;  (A) the number of Shares that may be delivered in the aggregate pursuant to the exercise of ISOs granted under the Plan shall not exceed 16,833,333 Shares plus, to the extent allowable under Section 422 of the Code and the Treasury Regulations promulgated thereunder, any Shares that become available for issuance under the Plan pursuant to Section 5(c)&#59; and (B) an additional 543,872 Shares are authorized for issuance as Awards under the Plan as a result of the Company&#8217;s assumption of the 2015 ArcherDX, Inc. Stock Incentive Plan, provided such Awards may not be issued (I) to persons who were Employees, Consultants or Outside Directors of the Company or its Subsidiaries prior to October 2, 2020 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, the date of the Company&#8217;s acquisition of ArcherDX, Inc.) or (II) following September 2, 2025 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, the end of the original term of the 2015 ArcherDX, Inc. Stock Incentive Plan). The limitations of this Section 5(a) shall be subject to adjustment pursuant to Section 12. The number of Shares that are subject to Awards outstanding at any time under the Plan shall not exceed the number of Shares which then remain available for issuance under the Plan. The Company shall at all times reserve and keep available sufficient Shares to satisfy the requirements of the Plan.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Award Limitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No Participant eligible for an Award may receive Options or SARs under the Plan, excluding Inducement Awards, in any calendar year that relate to an aggregate of more than 2,000,000 Shares, and no more than two times this amount in the first year of employment.  In applying the foregoing limitation with respect to a Participant, if any Option or SAR is canceled, the canceled Option or SAR shall continue to count against the maximum number of Shares with respect to which Options and SARs may be granted to the Participant.  For this purpose, the repricing of an Option or SAR shall be treated as the cancellation of the existing Option or SAR and the grant of a new Option or SAR.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Additional Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If Restricted Shares or Shares issued upon the exercise of Options are forfeited, then such Shares shall again become available for Awards under the Plan.  If Stock Units, Options or SARs are forfeited or terminate for any reason before being exercised or settled, or an Award is settled in cash without the delivery of Shares to the holder, then any Shares subject to the Award shall again become available for Awards under the Plan.  Only the number of Shares (if any) actually issued in settlement of Awards (and not forfeited) shall reduce the number available in Section 5(a) and the balance shall again become available for Awards under the Plan.  Any Shares withheld to satisfy the grant or exercise price or tax withholding obligation pursuant to any Award shall again become available for Awards under the Plan.  Notwithstanding the foregoing provisions of this Section 5(c), Shares that have actually been issued shall not again become available for Awards under the Plan, except for Shares that are forfeited and do not become vested.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Substitution and Assumption of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Committee may make Awards under the Plan by assumption, substitution or replacement of stock options, stock appreciation rights, stock units or similar awards granted by another entity (including a Parent or Subsidiary), if such assumption, substitution or replacement is in connection with an asset acquisition, stock acquisition, merger, consolidation or similar transaction involving the Company (and&#47;or its Parent or Subsidiary) and such other entity (and&#47;or its affiliate).  The terms of such assumed, substituted or replaced Awards shall be as the Committee, in its discretion, determines is appropriate.  Any such substitute or assumed Awards shall not count against the Share limitation set forth in Section 5(a).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:6.02pt">RESTRICTED SHARES.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Restricted Share Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each grant of Restricted Shares under the Plan shall be evidenced by a Restricted Share Award Agreement between the Participant and the Company.  Such Restricted Shares shall be subject to all applicable terms of the Plan and may be subject to any other terms that are not inconsistent with the Plan.  The provisions of the various Restricted Share Award Agreements entered into under the Plan need not be identical.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Payment for Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Restricted Shares may be sold or awarded under the Plan for such consideration as the Committee may determine, including (without limitation) cash, cash equivalents, full-recourse promissory notes, past services and future services.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Award of Restricted Shares may or may not be subject to vesting.  Vesting shall occur, in full or in installments, upon satisfaction of the conditions specified in the Restricted Share Award Agreement.  A Restricted Share Award Agreement may provide for accelerated vesting in the event of the Participant&#8217;s death, disability or retirement or other events.  The Committee may determine, at the time of granting Restricted Shares or thereafter, that all or part of such Restricted Shares shall become vested in the event that a Change in Control occurs with respect to the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Voting and Dividend Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The holders of Restricted Shares awarded under the Plan shall have the same voting, dividend and other rights as the Company&#8217;s other stockholders.  A Restricted Share Award Agreement, however, may require that the holders of Restricted </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Shares invest any cash dividends received in additional Restricted Shares.  Such additional Restricted Shares shall be subject to the same conditions and restrictions as the Award with respect to which the dividends were paid.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Restrictions on Transfer of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Restricted Shares shall be subject to such rights of repurchase, rights of first refusal or other restrictions as the Committee may determine.  Such restrictions shall be set forth in the applicable Restricted Share Award Agreement and shall apply in addition to any general restrictions that may apply to all holders of Shares.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:6.02pt">TERMS AND CONDITIONS OF OPTIONS.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Stock Option Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each grant of an Option under the Plan shall be evidenced by a Stock Option Award Agreement between the Participant and the Company.  Such Option shall be subject to all applicable terms and conditions of the Plan and may be subject to any other terms and conditions which are not inconsistent with the Plan and which the Committee deems appropriate for inclusion in a Stock Option Award Agreement.  The Stock Option Award Agreement shall specify whether the Option is an ISO or an NSO.  The provisions of the various Stock Option Award Agreements entered into under the Plan need not be identical.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Number of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Stock Option Award Agreement shall specify the number of Shares that are subject to the Option and shall provide for the adjustment of such number in accordance with Section 12.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Stock Option Award Agreement shall specify the Exercise Price.  The Exercise Price of an ISO shall not be less than 100% of the Fair Market Value of a Share on the date of grant, except as otherwise provided in 4(c), and the Exercise Price of an NSO shall not be less 100% of the Fair Market Value of a Share on the date of grant.  Notwithstanding the foregoing, Options may be granted with an Exercise Price of less than 100% of the Fair Market Value per Share on the date of grant pursuant to a transaction described in, and in a manner consistent with, Section 424(a) of the Code.  Subject to the foregoing in this Section 7(c), the Exercise Price under any Option shall be determined by the Committee in its sole discretion.  The Exercise Price shall be payable in one of the forms described in Section 8.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Withholding Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  As a condition to the exercise of an Option, the Participant shall make such arrangements as the Committee may require for the satisfaction of any federal, state, local or foreign withholding tax obligations that may arise in connection with such exercise.  The Participant shall also make such arrangements as the Committee may require for the satisfaction of any federal, state, local or foreign withholding tax obligations that may arise in connection with the disposition of Shares acquired by exercising an Option.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Exercisability and Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Stock Option Award Agreement shall specify the date when all or any installment of the Option is to become exercisable.  The Stock Option Award Agreement shall also specify the term of the Option&#59; provided that the term of an ISO shall in no event exceed 10 years from the date of grant (five years for ISOs granted to Employees described in Section 4(c)).  A Stock Option Award Agreement may provide for accelerated exercisability in the event of the Participant&#8217;s death, disability, or retirement or other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">events and may provide for expiration prior to the end of its term in the event of the termination of the Participant&#8217;s Service.  Options may be awarded in combination with SARs, and such an Award may provide that the Options will not be exercisable unless the related SARs are forfeited.  Subject to the foregoing in this Section 7(e), the Committee at its sole discretion shall determine when all or any installment of an Option is to become exercisable and when an Option is to expire.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.69pt">Exercise of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Stock Option Award Agreement shall set forth the extent to which the Participant shall have the right to exercise the Option following termination of the Participant&#8217;s Service with the Company and its Subsidiaries, and the right to exercise the Option of any executors or administrators of the Participant&#8217;s estate or any person who has acquired such Option(s) directly from the Participant by bequest or inheritance.  Such provisions shall be determined in the sole discretion of the Committee, need not be uniform among all Options issued pursuant to the Plan, and may reflect distinctions based on the reasons for termination of Service.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Effect of Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Committee may determine, at the time of granting an Option or thereafter, that such Option shall become exercisable as to all or part of the Shares subject to such Option in the event that a Change in Control occurs with respect to the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">No Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant shall have no rights as a stockholder with respect to any Shares covered by his Option until the date of the issuance of a stock certificate for such Shares.  No adjustments shall be made, except as provided in Section 12.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.69pt">Modification, Extension and Renewal of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Within the limitations of the Plan, the Committee may modify, extend or renew outstanding options or may accept the cancellation of outstanding options (to the extent not previously exercised), whether or not granted hereunder, in return for the grant of new Options for the same or a different number of Shares and at the same or a different Exercise Price, or in return for the grant of a different Award for the same or a different number of Shares, without stockholder approval.  The foregoing notwithstanding, no modification of an Option shall, without the consent of the Participant, materially impair his or her rights or obligations under such Option.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.69pt">Restrictions on Transfer of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any Shares issued upon exercise of an Option shall be subject to such special forfeiture conditions, rights of repurchase, rights of first refusal and other transfer restrictions as the Committee may determine.  Such restrictions shall be set forth in the applicable Stock Option Award Agreement and shall apply in addition to any general restrictions that may apply to all holders of Shares.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Buyout Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Committee may at any time (a) offer to buy out for a payment in cash or cash equivalents an Option previously granted or (b) authorize a Participant to elect to cash out an Option previously granted, in either case at such time and based upon such terms and conditions as the Committee shall establish.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:6.02pt">PAYMENT FOR SHARES.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">General Rule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The entire Exercise Price or Purchase Price of Shares issued under the Plan shall be payable in lawful money of the United States of America at the time when such Shares are purchased, except as provided in Section 8(b) through Section 8(h) below.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Surrender of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  To the extent that a Stock Option Award Agreement so provides, payment may be made all or in part by surrendering, or attesting to the ownership of, Shares which have already been owned by the Participant or his representative.  Such Shares shall be valued at their Fair Market Value on the date when the new Shares are purchased under the Plan.  The Participant shall not surrender, or attest to the ownership of, Shares in payment of the Exercise Price if such action would cause the Company to recognize compensation expense (or additional compensation expense) with respect to the Option for financial reporting purposes.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Services Rendered</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  At the discretion of the Committee, Shares may be awarded under the Plan in consideration of services rendered to the Company or a Subsidiary.  If Shares are awarded without the payment of a Purchase Price in cash, the Committee shall make a determination (at the time of the Award) of the value of the services rendered by the Participant and the sufficiency of the consideration to meet the requirements of Section 6(b).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Cashless Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  To the extent that a Stock Option Award Agreement so provides, payment may be made all or in part by delivery (on a form prescribed by the Committee) of an irrevocable direction to a securities broker to sell Shares and to deliver all or part of the sale proceeds to the Company in payment of the aggregate Exercise Price.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Exercise&#47;Pledge</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  To the extent that a Stock Option Award Agreement so provides, payment may be made all or in part by delivery (on a form prescribed by the Committee) of an irrevocable direction to a securities broker or lender to pledge Shares, as security for a loan, and to deliver all or part of the loan proceeds to the Company in payment of the aggregate Exercise Price.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.69pt">Net Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  To the extent that a Stock Option Award Agreement so provides, by a &#8220;net exercise&#8221; arrangement pursuant to which the number of Shares issuable upon exercise of the Option shall be reduced by the largest whole number of Shares having an aggregate Fair Market Value that does not exceed the aggregate exercise price (plus tax withholdings, if applicable) and any remaining balance of the aggregate exercise price (and&#47;or applicable tax withholdings) not satisfied by such reduction in the number of whole Shares to be issued shall be paid by the Optionee in cash other form of payment permitted under the Stock Option Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Promissory Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  To the extent that a Stock Option Award Agreement or Restricted Share Award Agreement so provides, payment may be made all or in part by delivering (on a form prescribed by the Company) a full-recourse promissory note.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Other Forms of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  To the extent that a Stock Option Award Agreement or Restricted Share Award Agreement so provides, payment may be made in any other form that is consistent with applicable laws, regulations and rules.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.69pt">Limitations under Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding anything herein or in a Stock Option Award Agreement or Restricted Share Award Agreement to the contrary, payment may not be made in any form that is unlawful, as determined by the Committee in its sole discretion.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:6.02pt">STOCK APPRECIATION RIGHTS.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">SAR Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each grant of a SAR under the Plan shall be evidenced by a SAR Award Agreement between the Participant and the Company.  Such SAR shall be subject to all applicable terms of the Plan and may be subject to any other terms that are not inconsistent with the Plan.  The provisions of the various SAR Award Agreements entered into under the Plan need not be identical.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Number of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each SAR Award Agreement shall specify the number of Shares to which the SAR pertains and shall provide for the adjustment of such number in accordance with Section 12.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each SAR Award Agreement shall specify the Exercise Price.  The Exercise Price of a SAR shall not be less than 100% of the Fair Market Value of a Share on the date of grant.  Notwithstanding the foregoing, SARs may be granted with an Exercise Price of less than 100% of the Fair Market Value per Share on the date of grant pursuant to a transaction described in, and in a manner consistent with, Section 424(a) of the Code.  Subject to the foregoing in this Section 9(c), the Exercise Price under any SAR shall be determined by the Committee in its sole discretion.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Exercisability and Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each SAR Award Agreement shall specify the date when all or any installment of the SAR is to become exercisable.  The SAR Award Agreement shall also specify the term of the SAR.  A SAR Award Agreement may provide for accelerated exercisability in the event of the Participant&#8217;s death, disability or retirement or other events and may provide for expiration prior to the end of its term in the event of the termination of the Participant&#8217;s service.  SARs may be awarded in combination with Options, and such an Award may provide that the SARs will not be exercisable unless the related Options are forfeited.  A SAR may be included in an ISO only at the time of grant but may be included in an NSO at the time of grant or thereafter.  A SAR granted under the Plan may provide that it will be exercisable only in the event of a Change in Control.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Effect of Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Committee may determine, at the time of granting a SAR or thereafter, that such SAR shall become fully exercisable as to all Common Shares subject to such SAR in the event that a Change in Control occurs with respect to the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.69pt">Exercise of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon exercise of a SAR, the Participant (or any person having the right to exercise the SAR after his or her death) shall receive from the Company (a) Shares, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) cash or (c) a combination of Shares and cash, as the Committee shall determine.  The amount of cash and&#47;or the Fair Market Value of Shares received upon exercise of SARs shall, in the aggregate, be equal to the amount by which the Fair Market Value (on the date of surrender) of the Shares subject to the SARs exceeds the Exercise Price.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Modification or Assumption of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Within the limitations of the Plan, the Committee may modify, extend or assume outstanding SARs or may accept the cancellation of outstanding SARs (whether granted by the Company or by another issuer) in return for the grant of new SARs for the same or a different number of shares and at the same or a different exercise price, or in return for the grant of a different Award for the same or a different number of Shares, without stockholder approval.  The foregoing notwithstanding, no modification of a SAR shall, without the consent of the holder, materially impair his or her rights or obligations under such SAR.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Buyout Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Committee may at any time (a) offer to buy out for a payment in cash or cash equivalents a SAR previously granted, or (b) authorize a Participant to elect to cash out a SAR previously granted, in either case at such time and based upon such terms and conditions as the Committee shall establish.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:0.02pt">STOCK UNITS.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Stock Unit Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each grant of Stock Units under the Plan shall be evidenced by a Stock Unit Award Agreement between the Participant and the Company.  Such Stock Units shall be subject to all applicable terms of the Plan and may be subject to any other terms that are not inconsistent with the Plan.  The provisions of the various Stock Unit Award Agreements entered into under the Plan need not be identical.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Payment for Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  To the extent that an Award is granted in the form of Stock Units, no cash consideration shall be required of the Award recipients.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Vesting Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Award of Stock Units may or may not be subject to vesting.  Vesting shall occur, in full or in installments, upon satisfaction of the conditions specified in the Stock Unit Award Agreement.  A Stock Unit Award Agreement may provide for accelerated vesting in the event of the Participant&#8217;s death, disability or retirement or other events.  The Committee may determine, at the time of granting Stock Units or thereafter, that all or part of such Stock Units shall become vested in the event that a Change in Control occurs with respect to the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Voting and Dividend Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The holders of Stock Units shall have no voting rights.  Prior to settlement or forfeiture, any Stock Unit awarded under the Plan may, at the Committee&#8217;s discretion, carry with it a right to dividend equivalents.  Such right entitles the holder to be credited with an amount equal to all cash dividends paid on one Share while the Stock Unit is outstanding.  Dividend equivalents may be converted into additional Stock Units.  Settlement of dividend equivalents may be made in the form of cash, in the form of Shares, or in a combination of both.  Prior to distribution, any dividend equivalents which are not paid shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">subject to the same conditions and restrictions (including without limitation, any forfeiture conditions) as the Stock Units to which they attach.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Form and Time of Settlement of Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Settlement of vested Stock Units may be made in the form of (a) cash, (b) Shares or (c) any combination of both, as determined by the Committee.  The actual number of Stock Units eligible for settlement may be larger or smaller than the number included in the original Award, based on predetermined performance factors.  Methods of converting Stock Units into cash may include (without limitation) a method based on the average Fair Market Value of Shares over a series of trading days.  A Stock Unit Award Agreement may provide that vested Stock Units may be settled in a lump sum or in installments.  A Stock Unit Award Agreement may provide that the distribution may occur or commence when all vesting conditions applicable to the Stock Units have been satisfied or have lapsed, or it may be deferred to any later date, subject to compliance with Section 409A of the Code.  The amount of a deferred distribution may be increased by an interest factor or by dividend equivalents.  Until an Award of Stock Units is settled, the number of such Stock Units shall be subject to adjustment pursuant to Section 12.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.69pt">Death of Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any Stock Unit Award that becomes payable after the Participant&#8217;s death shall be distributed to the Participant&#8217;s beneficiary or beneficiaries.  Each recipient of a Stock Unit Award under the Plan shall designate one or more beneficiaries for this purpose by filing the prescribed form with the Company.  A beneficiary designation may be changed by filing the prescribed form with the Company at any time before the Participant&#8217;s death.  If no beneficiary was designated or if no designated beneficiary survives the Participant, then any Stock Units Award that becomes payable after the Participant&#8217;s death shall be distributed to the Participant&#8217;s estate.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Creditors&#8217; Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A holder of Stock Units shall have no rights other than those of a general creditor of the Company.  Stock Units represent an unfunded and unsecured obligation of the Company, subject to the terms and conditions of the applicable Stock Unit Award Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:0.02pt">CASH-BASED AWARDS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Committee may, in its sole discretion, grant Cash-Based Awards to any Participant in such number or amount and upon such terms, and subject to such conditions, as the Committee shall determine at the time of grant and specify in an applicable Award Agreement.  The Committee shall determine the maximum duration of the Cash-Based Award, the amount of cash which may be payable pursuant to the Cash-Based Award, the conditions upon which the Cash-Based Award shall become vested or payable, and such other provisions as the Committee shall determine.  Each Cash-Based Award shall specify a cash-denominated payment amount, formula or payment ranges as determined by the Committee.  Payment, if any, with respect to a Cash-Based Award shall be made in accordance with the terms of the Award and may be made in cash or in shares of Stock, as the Committee determines.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:0.02pt">ADJUSTMENT OF SHARES.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event of a subdivision of the outstanding Stock, a declaration of a dividend payable in Shares, a declaration of a dividend payable in a form other than Shares in an amount that has a material effect on the price of Shares, a combination or consolidation of the outstanding Stock (by reclassification or otherwise) into a lesser number of Shares, a recapitalization, a spin-off or a similar occurrence, the Committee shall make appropriate and equitable adjustments in&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-47.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">The number of Shares available for future Awards under Section 5&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-50.64pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">The limitations set forth in Sections 5(a) and (b) and Section 19&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-53.97pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">The number of Shares covered by each outstanding Award&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-53.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">The Exercise Price under each outstanding Option and SAR.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Dissolution or Liquidation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  To the extent not previously exercised or settled, Options, SARs and Stock Units shall terminate immediately prior to the dissolution or liquidation of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Reorganizations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event that the Company is a party to a merger or other reorganization, outstanding Awards shall be subject to the agreement of merger or reorganization.  Subject to compliance with Section 409A of the Code, such agreement shall provide for&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-47.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">The continuation of the outstanding Awards by the Company, if the Company is a surviving corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-50.64pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">The assumption of the outstanding Awards by the surviving corporation or its parent or subsidiary&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-53.97pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">The substitution by the surviving corporation or its parent or subsidiary of its own awards for the outstanding Awards&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-53.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">Immediate vesting, exercisability and settlement of outstanding Awards followed by the cancellation of such Awards upon or immediately prior to the effectiveness of such transaction&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-49.98pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">Settlement of the intrinsic value of the outstanding Awards (whether or not then vested or exercisable) in cash or cash equivalents or equity (including cash or equity subject to deferred vesting and delivery consistent with the vesting restrictions applicable to such Awards or the underlying Shares) followed by the cancellation of such Awards (and, for the avoidance of doubt, if as of the date of the occurrence of the transaction the Committee determines in good faith that no amount would have been attained upon the exercise of such Award or realization of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Participant&#8217;s rights, then such Award may be terminated by the Company without payment)&#59; in each case without the Participant&#8217;s consent.  Any acceleration of payment of an amount that is subject to section 409A of the Code will be delayed, if necessary, until the earliest time that such payment would be permissible under Section 409A without triggering any additional taxes applicable under Section 409A.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company will have no obligation to treat all Awards, all Awards held by a Participant, or all Awards of the same type, similarly.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Reservation of Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as provided in this Section 12, a Participant shall have no rights by reason of any subdivision or consolidation of shares of stock of any class, the payment of any dividend or any other increase or decrease in the number of shares of stock of any class.  Any issue by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall not affect, and no adjustment by reason thereof shall be made with respect to, the number or Exercise Price of Shares subject to an Award.  The grant of an Award pursuant to the Plan shall not affect in any way the right or power of the Company to make adjustments, reclassifications, reorganizations or changes of its capital or business structure, to merge or consolidate or to dissolve, liquidate, sell or transfer all or any part of its business or assets.  In the event of any change affecting the Shares or the Exercise Price of Shares subject to an Award, including a merger or other reorganization, for reasons of administrative convenience, the Company in its sole discretion may refuse to permit the exercise of any Award during a period of up to thirty (30) days prior to the occurrence of such event.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:0.02pt">DEFERRAL OF AWARDS.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Committee Powers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to compliance with Section 409A of the Code, the Committee (in its sole discretion) may permit or require a Participant to&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-47.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">Have cash that otherwise would be paid to such Participant as a result of the exercise of a SAR or the settlement of Stock Units credited to a deferred compensation account established for such Participant by the Committee as an entry on the Company&#8217;s books&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-50.64pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">Have Shares that otherwise would be delivered to such Participant as a result of the exercise of an Option or SAR converted into an equal number of Stock Units&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-53.97pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">Have Shares that otherwise would be delivered to such Participant as a result of the exercise of an Option or SAR or the settlement of Stock Units converted into amounts credited to a deferred compensation account established for such Participant by the Committee as an entry on the Company&#8217;s books.  Such amounts shall be determined by reference to the Fair Market Value of such Shares as of the date when they otherwise would have been delivered to such Participant.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">General Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A deferred compensation account established under this Section 13 may be credited with interest or other forms of investment return, as determined by the Committee.  A Participant for whom such an account is established shall have no rights other than those of a general creditor of the Company.  Such an account shall represent an unfunded and unsecured obligation of the Company and shall be subject to the terms and conditions of the applicable agreement between such Participant and the Company.  If the deferral or conversion of Awards is permitted or required, the Committee (in its sole discretion) may establish rules, procedures and forms pertaining to such Awards, including (without limitation) the settlement of deferred compensation accounts established under this Section 13.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:0.02pt">AWARDS UNDER OTHER PLANS.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company may grant awards under other plans or programs.  Such awards may be settled in the form of Shares issued under this Plan.  Such Shares shall be treated for all purposes under the Plan like Shares issued in settlement of Stock Units and shall, when issued, reduce the number of Shares available under Section 5.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:0.02pt">INDUCEMENT AWARDS POOL.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Inducement Share Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An additional pool of Shares (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Inducement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) are reserved under this Plan to be used exclusively for the grant of Awards in compliance with New York Stock Exchange Rule 303A.08 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Inducement Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The pool of Inducement Shares shall not exceed in the aggregate (a) 475,000 Shares (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Share-based Inducement Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), plus (b) $101,225,000, with the specific number of Shares within such $101,225,000 limit based on (i) the Fair Market Value of a Share on the vesting date of the Inducement Shares or, if so provided in the Award Agreement, the volume-weighted average trading price of a Share for up to 60 days immediately preceding such vesting date, (ii) the Fair Market Value of a Share on the date of grant of an Inducement Award, or (iii) any other value of a Share in the applicable agreement setting forth an Inducement Award including but not limited to an asset acquisition agreement, a stock acquisition agreement, a merger agreement, or any similar agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Value-based Inducement Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The number of Inducement Shares shall be subject to adjustment pursuant to Section 12, as applicable. For purposes of clarity, the Inducement Shares that may be awarded are in addition to and shall not reduce the number of Shares reserved under Section 5(a) for Awards other than Inducement Awards. The Shares underlying any Inducement Awards that are forfeited, canceled, held back upon exercise of an Inducement Award or settlement of an Inducement Award to cover the exercise price or tax withholding, reacquired by the Company prior to vesting, settled without the issuance of Shares or otherwise terminated (other than by exercise) shall be added back to the number of Inducement Shares available for grant under this Section 15 based on the number of Shares forfeited, canceled, held back, reacquired, settled without the issuance of Shares or otherwise terminated (other than by exercise) for Share-based Inducement Awards and based on vesting date Fair Market Value of the Inducement Shares returning to the Plan or other valuation method set forth in the Award Agreement for Value-based Inducement Awards, but shall not affect the number of Shares available for Awards under Section 5(a).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Inducement Award Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding anything to the contrary in this Plan, an Inducement Award may be granted only to an Employee as an inducement material to the individual&#8217;s entering into employment with the Company or an Affiliate within the meaning of New York Stock Exchange Rule 303A.08 and only if such individual has not previously been an Employee or has experienced a bona fide period of interruption of employment with the Company and its Affiliates prior to grant of the Inducement Award. In addition, notwithstanding any other provision of the Plan to the contrary, all such Inducement Awards must be granted by the Committee. No Inducement Award may be an ISO. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:0.02pt">PAYMENT OF DIRECTOR&#8217;S FEES IN SECURITIES.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No provision of this Section 16 shall be effective unless and until the Board has determined to implement such provision.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Elections to Receive NSOs, SARs, Restricted Shares or Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Outside Director may elect to receive his or her annual retainer payments and&#47;or meeting fees from the Company in the form of cash, NSOs, SARs, Restricted Shares or Stock Units, or a combination thereof, as determined by the Board.  Alternatively, the Board may mandate payment in any of such alternative forms.  Such NSOs, SARs, Restricted Shares and Stock Units shall be issued under the Plan.  An election under this Section 16 shall be filed with the Company on the prescribed form.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Number and Terms of NSOs, SARs, Restricted Shares or Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The number of NSOs, SARs, Restricted Shares or Stock Units to be granted to Outside Directors in lieu of annual retainers and meeting fees that would otherwise be paid in cash shall be calculated in a manner determined by the Board.  The terms of such NSOs, SARs, Restricted Shares or Stock Units shall also be determined by the Board.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:0.02pt">LEGAL AND REGULATORY REQUIREMENTS.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Shares shall not be issued under the Plan unless the issuance and delivery of such Shares complies with (or is exempt from) all applicable requirements of law, including (without limitation) the Securities Act of 1933, as amended, the rules and regulations promulgated thereunder, state securities laws and regulations and the regulations of any stock exchange on which the Company&#8217;s securities may then be listed, and the Company has obtained the approval or favorable ruling from any governmental agency which the Company determines is necessary or advisable.  The Company shall not be liable to a Participant or other persons as to&#58; (a) the non-issuance or sale of Shares as to which the Company has not obtained from any regulatory body having jurisdiction the authority deemed by the Company&#8217;s counsel to be necessary to the lawful issuance and sale of any Shares under the Plan&#59; and (b) any tax consequences expected, but not realized, by any Participant or other person due to the receipt, exercise or settlement of any Award granted under the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:0.02pt">TAXES.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Withholding Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  To the extent required by applicable federal, state, local or foreign law, a Participant or his or her successor shall make arrangements satisfactory to the Company for the satisfaction of any withholding tax obligations that arise in connection with the Plan.  The Company shall not be required to issue any Shares or make any cash payment under the Plan until such obligations are satisfied.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Share Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Committee may permit a Participant to satisfy all or part of his or her withholding or income tax obligations by having the Company withhold all or a portion of any Shares that otherwise would be issued to him or her or by surrendering all or a portion of any Shares that he or she previously acquired.  Such Shares shall be valued at their Fair Market Value on the date when taxes otherwise would be withheld in cash.  In no event may a Participant have Shares withheld that would otherwise be issued to him or her in excess of the number necessary to satisfy the minimum legally required tax withholding.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Award that provides for &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A of the Code shall be subject to such additional rules and requirements as specified by the Committee from time to time in order to comply with Section 409A.  If any amount under such an Award is payable upon a &#8220;separation from service&#8221; (within the meaning of Section 409A) to a Participant who is then considered a &#8220;specified employee&#8221; (within the meaning of Section 409A), then no such payment shall be made prior to the date that is the earlier of (i) six months and one day after the Participant&#8217;s separation from service, or (ii) the Participant&#8217;s death, but only to the extent such delay is necessary to prevent such payment from being subject to interest, penalties and&#47;or additional tax imposed pursuant to Section 409A.  In addition, the settlement of any such Award may not be accelerated except to the extent permitted by Section 409A.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:0.02pt">TRANSFERABILITY.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Unless the agreement evidencing an Award (or an amendment thereto authorized by the Committee) expressly provides otherwise, no Award granted under this Plan, nor any interest in such Award, may be sold, assigned, conveyed, gifted, pledged, hypothecated or otherwise transferred in any manner (prior to the vesting and lapse of any and all restrictions applicable to Shares issued under such Award), other than by will or the laws of descent and distribution&#59; provided, however, that an ISO may be transferred or assigned only to the extent consistent with Section 422 of the Code.  Any purported assignment, transfer or encumbrance in violation of this Section 19 shall be void and unenforceable against the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:0.02pt">PERFORMANCE BASED AWARDS.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The number of Shares or other benefits granted, issued, retainable and&#47;or vested under an Award may be made subject to the attainment of performance goals.  The Committee may utilize any performance criteria selected by it in its sole discretion to establish performance goals&#59; provided, however, that in the case of any Performance Based Award, the following conditions shall apply&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-47.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">The amount potentially available under a Performance Based Award shall be subject to the attainment of pre-established, objective performance goals relating to a specified period of service including but not limited to any of the following performance criteria&#58; (a) cash flow, (b) earnings per share, (c)&#160;earnings before interest, taxes and amortization, (d) return on equity, (e) total stockholder return, (f) share price performance, (g) return on capital, (h) return on assets or net assets, (i) revenue, (j) income or net income, (k) operating income or net operating income, (l) operating profit or net operating profit, (m) operating margin or profit margin, (n) return on operating revenue, (o) return on invested capital, (p) market segment shares, (q) costs, (r) expenses, (s) initiation or completion of research activities, (t) initiation or completion of development programs, (u) other milestones with respect to research activities or development programs, (v) regulatory body approval, (w) implementation or completion of critical projects, (x) commercial milestones or (z) other milestones with respect to the growth of the Company&#8217;s business or the development or commercialization of any product or service (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Qualifying Performance Criteria</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), any of which may be measured either individually, alternatively or in any combination, applied to either the Company as a whole or to a business unit or Subsidiary, either individually, alternatively or in any combination, and measured either annually or cumulatively over a period of years, on an absolute basis or relative to a pre-established target, to previous years&#8217; results or to a designated comparison group or index, in each case as specified by the Committee in the Award&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-50.64pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">The Committee may appropriately adjust the method of evaluating performance under a Qualifying Performance Criteria for a performance period as follows&#58; (i) to exclude asset write-downs, (ii) to exclude litigation or claim judgments or settlements, (iii) to exclude the effect of changes in tax law, accounting principles or other such laws or provisions affecting reported results, (iv) to exclude accruals for reorganization and restructuring programs, (v) to exclude any extraordinary nonrecurring items as determined under generally accepted accounting principles and&#47;or described in managements&#8217; discussion and analysis of financial condition and results of operations appearing in the Company&#8217;s annual report to stockholders for the applicable year, (vi) to exclude the dilutive effects of acquisitions or joint ventures, (vii) to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a performance period following such divestiture, (viii) to exclude the effect of any change in the outstanding shares of common stock of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends, (ix) to exclude the effects of stock based compensation and the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">award of bonuses under the Company&#8217;s bonus plans&#59; and (x) to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-53.97pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">The Committee shall establish the applicable performance goals in writing and an objective method for determining the Award earned by a Participant if the goals are attained, while the outcome is substantially uncertain, and shall determine and certify in writing, for each Participant, the extent to which the performance goals have been met prior to payment or vesting of the Award&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-53.31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">The maximum aggregate number of Shares that may be subject to Performance Based Awards granted to a Participant in any calendar year (other than Inducement Awards) is 2,000,000 Shares, and no more than two times this amount in the first year of employment (subject to adjustment under Section 12), and the maximum aggregate amount of cash that may be payable to a Participant under Performance Based Awards granted to a Participant in any calendar year that are Cash-Based Awards is $10,000,000.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:0.02pt">NO EMPLOYMENT RIGHTS.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No provision of the Plan, nor any Award granted under the Plan, shall be construed to give any person any right to become, to be treated as, or to remain an Employee or Consultant.  The Company and its Subsidiaries reserve the right to terminate any person&#8217;s Service at any time and for any reason, with or without notice.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:0.02pt">DURATION AND AMENDMENTS.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Term of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Plan, as set forth herein, shall come into existence on the date of its adoption by the Board of Directors&#59; provided, however, that no Award may be granted hereunder prior to the Effective Date.  The Board of Directors may suspend or terminate the Plan at any time.  No ISOs may be granted after the tenth anniversary of the earlier of (i) the date the Plan is adopted by the Board of Directors, or (ii) the date the Plan is approved the stockholders of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Right to Amend the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Board of Directors may amend the Plan at any time and from time to time.  Rights and obligations under any Award granted before amendment of the Plan shall not be materially impaired by such amendment, except with consent of the Participant.  An amendment of the Plan shall be subject to the approval of the Company&#8217;s stockholders only to the extent required by applicable laws, regulations or rules.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">Effect of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No Awards shall be granted under the Plan after the termination thereof.  The termination of the Plan shall not affect Awards previously granted under the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:0.02pt">EXECUTION.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To record the amendment and restatement of the Plan by the Board of Directors, the Company has caused its authorized officer to execute the same.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="margin-top:12.3pt;padding-left:223.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:95%">INVITAE CORPORATION</font></div><div style="margin-top:12.3pt;padding-left:223.2pt"><font><br></font></div><div style="margin-top:12.3pt;padding-left:223.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:95%">By&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:95%;text-decoration:underline">&#47;s&#47; Thomas Brida&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:223.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#160;&#160;&#160;&#160;&#58;&#160;&#160;&#160;&#160;Thomas Brida</font></div><div style="padding-left:223.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;General Counsel and Secretary</font></div><div style="margin-top:12.3pt;padding-left:223.2pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23</font></div><div style="text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.21
<SEQUENCE>5
<FILENAME>exhibit1021toxarcherdxinc2.htm
<DESCRIPTION>EX-10.21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7ce91d331e2545b088dfba29ab1c092b_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.21</font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">ARCHERDX, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">2015 STOCK INCENTIVE PLAN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Purpose</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The purpose of this 2015 Stock Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;) of ArcherDx, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;), is to advance the interests of the Company&#8217;s stockholders by enhancing the Company&#8217;s ability to attract, retain and motivate persons who are expected to make important contributions to the Company and by providing such persons with equity ownership opportunities and performance-based incentives that are intended to better align the interests of such persons with those of the Company&#8217;s stockholders. Except where the context otherwise requires, the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; shall include any of the Company&#8217;s present or future parent or subsidiary corporations as defined in Sections 424(e) or (f) of the Internal Revenue Code of 1986, as amended, and any regulations thereunder (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;) and any other business venture (including, without limitation, joint venture or limited liability company) in which the Company has a controlling interest, as determined by the Board of Directors of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">, that such other business ventures shall be limited to entities that, where required by Section 409A of the Code, are eligible issuers of service recipient stock (as defined in Treas. Reg. Section 1.409A-1(b)(5)(iii)(E), or applicable successor regulation).</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Eligibility</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">All of the Company&#8217;s employees, officers and directors, as well as consultants and advisors to the Company (as such terms are defined and interpreted for purposes of Rule 701 under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;) (or any successor rule)) are eligible to be granted Awards under the Plan. Each person who is granted an Award under the Plan is deemed a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; means Options (as defined in Section 5), SARs (as defined in Section 6), Restricted Stock (as defined in Section 7), Restricted Stock Units (as defined in Section 7) and Other Stock-Based Awards (as defined in Section 8).</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Administration and Delegation</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Administration by Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Plan will be administered by the Board. The Board shall have authority to grant Awards and to adopt, amend and repeal such administrative rules, guidelines and practices relating to the Plan as it shall deem advisable. The Board may construe and interpret the terms of the Plan and any Award agreements entered into under the Plan. The Board may correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem expedient to carry the Plan into effect and it shall be the sole and final judge of such expediency. All decisions by the Board shall be made in the Board&#8217;s sole discretion and shall be final and binding on all persons having or claiming any interest in the Plan or in any Award.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">_____________________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> As amended by the Board on 12&#47;10&#47;2019 and approved by the stockholders on 12&#47;10&#47;2019.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Appointment of Committees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">To the extent permitted by applicable law, the Board may delegate any or all of its powers under the Plan to one or more committees or subcommittees of the Board (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;). All references in the Plan to the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; shall mean the Board or a Committee of the Board or the officers referred to in Section 3(c) to the extent that the Board&#8217;s powers or authority under the Plan have been delegated to such Committee or officers.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Delegation to Officers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">To the extent permitted by applicable law, the Board may delegate to one or more officers of the Company the power to grant Options and other Awards that constitute rights under Delaware law (subject to any limitations under the Plan) to employees or officers of the Company and to exercise such other powers under the Plan as the Board may determine, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">that the Board shall fix the terms of such Awards to be granted by such officers (including the exercise price of such Awards, which may include a formula by which the exercise price will be determined) and the maximum number of shares subject to such Awards that the officers may grant&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">further, however, that no officer shall be authorized to grant such Awards to any &#8220;executive officer&#8221; of the Company (as defined by Rule 3b-7 under the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;)) or to any &#8220;officer&#8221; of the Company (as defined by Rule 16a-1 under the Exchange Act). The Board may not delegate authority under this Section 3(c) to grant Restricted Stock, unless Delaware law then permits such delegation.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Stock Available for Awards</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Number of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Subject to adjustment under Section 9, Awards may be made under the Plan for up to 8,053,231 shares of common stock, $0.01 par value per share, of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;), any or all of which Awards may be in the form of Incentive Stock Options (as defined in Section 5(b)). If any Award expires or is terminated, surrendered or canceled without having been fully exercised, is forfeited in whole or in part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the original issuance price pursuant to a contractual repurchase right), or results in any Common Stock not being issued, the unused Common Stock covered by such Award shall again be available for the grant of Awards under the Plan. Further, shares of Common Stock tendered to the Company by a Participant to exercise an Award shall be added to the number of shares of Common Stock available for the grant of Awards under the Plan. However, in the case of Incentive Stock Options, the two immediately preceding sentences shall be subject to any limitations under the Code. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or treasury shares.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Substitute Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">In connection with a merger or consolidation of an entity with the Company or the acquisition by the Company of property or stock of an entity, the Board may grant Awards in substitution for any options or other stock or stock-based awards granted by such entity or an affiliate thereof. Substitute Awards may be granted on such terms as the Board deems appropriate in the circumstances, notwithstanding any limitations on Awards contained in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">the Plan. Substitute Awards shall not count against the overall share limit set forth in Section 4(a), except as may be required by reason of Section 422 and related provisions of the Code.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Stock Options</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Board may grant options to purchase Common Stock (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;) and determine the number of shares of Common Stock to be covered by each Option, the exercise price of each Option and the conditions and limitations applicable to the exercise of each Option, including conditions relating to applicable federal or state securities laws, as it considers necessary or advisable.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Incentive Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">An Option that the Board intends to be an &#8220;incentive stock option&#8221; as defined in Section 422 of the Code (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Incentive Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;) shall only be granted to employees of the Company, any of the Company&#8217;s present or future parent or subsidiary corporations as defined in Sections 424(e) or (f) of the Code, and any other entities the employees of which are eligible to receive Incentive Stock Options under the Code, and shall be subject to and shall be construed consistently with the requirements of Section 422 of the Code. An Option that is not intended to be an Incentive Stock Option shall be designated a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Nonstatutory Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.&#8221; The Company shall have no liability to a Participant, or any other party, if an Option (or any part thereof) that is intended to be an Incentive Stock Option is not an Incentive Stock Option or if the Company converts an Incentive Stock Option to a Nonstatutory Stock Option.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Board shall establish the exercise price of each Option and specify the exercise price in the applicable Option agreement. The exercise price shall be not less than 100%, or not less than 110% in the case of an Option intended to be an Incentive Stock Option granted to a Ten Percent Owner (as defined below), of the fair market value per share of Common Stock, as determined by (or in a manner approved by) the Board (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;), on the date the Option is granted. A &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Ten Percent Owner</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; means a person who owns, or is deemed within the meaning of Section 422(b)(6) of the Code to own, stock possessing more than 10% of the total combined voting power of all classes of stock of the Company (or any parent or subsidiary corporations of the Company, as defined in Sections 424(e) and (f), respectively, of the Code). Whether a person is a Ten Percent Owner shall be determined with respect to an Option based on the facts existing immediately prior to the grant date of the Option.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Duration of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Each Option shall be exercisable at such times and subject to such terms and conditions as the Board may specify in the applicable option agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">, that no Option will be granted with a term in excess of 10 years.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Exercise of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Options may be exercised by delivery to the Company of a notice of exercise in a form of notice (which may be electronic) approved by the Company, together with payment in full (in a manner specified in Section 5(f)) of the exercise price for the number of shares for which the Option is exercised. Shares of Common Stock subject to the Option will be delivered by the Company as soon as practicable following exercise.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Payment Upon Exercise.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Common Stock purchased upon the exercise of an Option granted under the Plan shall be paid for as follows&#58;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">in cash or by check, payable to the order of the Company&#59;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">when the Common Stock is registered under the Exchange Act, except as may otherwise be provided in the applicable Option agreement or approved by the Board, in its sole discretion, by (i) delivery of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price and any required tax withholding or (ii) delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price and any required tax withholding&#59;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">when the Common Stock is registered under the Exchange Act and to the extent provided for in the applicable Option agreement or approved by the Board, in its sole discretion, by delivery (either by actual delivery or attestation) of shares of Common Stock owned by the Participant valued at their Fair Market Value, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(i) such method of payment is then permitted under applicable law, (ii) such Common Stock, if acquired directly from the Company, was owned by the Participant for such minimum period of time, if any, as may be established by the Board in its discretion and (iii) such Common Stock is not subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements&#59;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">to the extent provided for in the applicable Nonstatutory Stock Option agreement or approved by the Board in its sole discretion, by delivery of a notice of &#8220;net exercise&#8221; to the Company, as a result of which the Participant would pay the exercise price for the portion of the Option being exercised by cancelling a portion of the Option for such number of shares as is equal to the exercise price divided by the excess of the Fair Market Value on the date of exercise over the Option exercise price per share.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">to the extent permitted by applicable law and provided for in the applicable Option agreement or approved by the Board, in its sole discretion, by (i) delivery of a promissory note of the Participant to the Company on terms determined by the Board, or (ii) payment of such other lawful consideration as the Board may determine&#59; or</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">by any combination of the above permitted forms of payment.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Stock Appreciation Rights</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Board may grant Awards consisting of stock appreciation rights (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;) entitling the holder, upon exercise, to receive an amount of Common Stock or cash or a combination thereof (such form to be determined by the Board) determined by reference to appreciation, from and after the date of grant, in the Fair Market Value of a share of Common Stock over the measurement price established pursuant to Section 6(b). The date as of which such appreciation is determined shall be the exercise date.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Measurement Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Board shall establish the measurement price of each SAR and specify it in the applicable SAR agreement. The measurement price shall not be less than 100%, of the Fair Market Value on the date the SAR is granted.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Duration of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Each SAR shall be exercisable at such times and subject to such terms and conditions as the Board may specify in the applicable SAR agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">, that no SAR will be granted with a term in excess of 10 years.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Exercise of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">SARs may be exercised by delivery to the Company of a notice of exercise in a form (which may be electronic) approved by the Company, together with any other documents required by the Board.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Restricted Stock&#59; Restricted Stock Units</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Board may grant Awards entitling recipients to acquire shares of Common Stock (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;), subject to the right of the Company to repurchase all or part of such shares at their issue price or other stated or formula price (or to require forfeiture of such shares if issued at no cost) from the recipient in the event that conditions specified by the Board in the applicable Award are not satisfied prior to the end of the applicable restriction period or periods established by the Board for such Award. The Board may also grant Awards entitling the recipient to receive shares of Common Stock or cash to be delivered at the time such Award vests (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;) (Restricted Stock and Restricted Stock Units are each referred to herein as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Restricted Stock Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;).</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Terms and Conditions for All Restricted Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Board shall determine the terms and conditions of a Restricted Stock Award, including the conditions for vesting and repurchase (or forfeiture) and the issue price, if any.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Additional Provisions Relating to Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Unless otherwise provided in the applicable Award agreement, any dividends (whether paid in cash, stock or property) declared and paid by the Company with respect to shares of Restricted Stock (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Accrued Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;) shall be paid to the Participant only if and when such shares become free from the restrictions on transferability and forfeitability that apply to such shares. Each payment of Accrued Dividends will be made no later than the end of the calendar year in which the dividends are paid to stockholders of that class of stock or, if later, the 15th day of the third month following the lapsing of the restrictions on transferability and the forfeitability provisions applicable to the underlying shares of Restricted Stock.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Stock Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Company may require that any stock certificates issued in respect of shares of Restricted Stock, as well as dividends or distributions paid on such Restricted Stock, shall be deposited in escrow by the Participant, together with a stock power endorsed in blank, with the Company (or its designee). At the expiration of the applicable restriction periods, the Company (or such designee) shall deliver the certificates no longer subject to such restrictions to the Participant or if the Participant has died, to his or her Designated Beneficiary. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Designated Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; means (i) the beneficiary designated, in a manner determined by the Board, by a Participant to receive amounts due or exercise rights of the Participant in the event of the Participant&#8217;s death or (ii) in the absence of an effective designation by a Participant, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Designated Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; the Participant&#8217;s estate.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Additional Provisions Relating to Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Upon the vesting of and&#47;or lapsing of any other restrictions (i.e., settlement) with respect to each Restricted Stock Unit, the Participant shall be entitled to receive from the Company one share of Common Stock or (if so provided in the applicable Award agreement) an amount of cash equal to the Fair Market Value of one share of Common Stock. The Board may, in its discretion, provide that settlement of Restricted Stock Units shall be deferred, on a mandatory basis or at the election of the Participant in a manner that complies with Section 409A of the Code.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">A Participant shall have no voting rights with respect to any Restricted Stock Units.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Award agreement for Restricted Stock Units may provide Participants with the right to receive an amount equal to any dividends or other distributions declared and paid on an equal number of outstanding shares of Common Stock (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;). Dividend Equivalents may be paid currently or credited to an account for the Participants, may be settled in cash and&#47;or shares of Common Stock and may be subject to the same restrictions on transfer and forfeitability as the Restricted Stock Units with respect to which paid, in each case to the extent provided in the applicable Award agreement.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Other Stock-Based Awards</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Other Awards of shares of Common Stock, and other Awards that are valued in whole or in part by reference to, or are otherwise based on, shares of Common Stock or other property, may be granted hereunder to Participants (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Other Stock-Based-Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;). Such Other Stock-Based Awards shall also be available as a form of payment in the settlement of other Awards granted under the Plan or as payment in lieu of compensation to which a Participant is otherwise entitled. Other Stock-Based Awards may be paid in shares of Common Stock or cash, as the Board shall determine.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Terms and Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Subject to the provisions of the Plan, the Board shall determine the terms and conditions of each Other Stock-Based Award, including any purchase price applicable thereto.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Adjustments for Changes in Common Stock and Certain Other Events</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Changes in Capitalization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any dividend or distribution to holders of Common Stock other than an ordinary cash dividend, (i) the number and class of securities available under the Plan, (ii) the number and class of securities and exercise price per share of each outstanding Option, (iii) the share and per-share provisions and the measurement price of each outstanding SAR, (iv) the number of shares subject to and the repurchase price per share subject to each outstanding Restricted Stock Award and (v) the share and per-share-related provisions and the purchase price, if any, of each outstanding Other Stock-Based Award, shall be equitably adjusted by the Company (or substituted Awards may be made, if applicable) in the manner determined by the Board. Without limiting the generality of the foregoing, in the event the Company effects </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">a split of the Common Stock by means of a stock dividend and the exercise price of and the number of shares subject to an outstanding Option are adjusted as of the date of the distribution of the dividend (rather than as of the record date for such dividend), then an optionee who exercises an Option between the record date and the distribution date for such stock dividend shall be entitled to receive, on the distribution date, the stock dividend with respect to the shares of Common Stock acquired upon such Option exercise, notwithstanding the fact that such shares were not outstanding as of the close of business on the record date for such stock dividend.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Reorganization Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Definition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">A &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Reorganization Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; shall mean&#58; (a) any merger or consolidation of the Company with or into another entity as a result of which all of the Common Stock of the Company is converted into or exchanged for the right to receive cash, securities or other property or is cancelled, (b) any transfer or disposition of all of the Common Stock of the Company for cash, securities or other property pursuant to a share exchange or other transaction or (c) any liquidation or dissolution of the Company.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Consequences of a Reorganization Event on Awards Other than Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">In connection with a Reorganization Event, the Board may take any one or more of the following actions as to all or any (or any portion of) outstanding Awards other than Restricted Stock on such terms as the Board determines (except to the extent specifically provided otherwise in an applicable Award agreement or another agreement between the Company and the Participant)&#58; (i) provide that such Awards shall be assumed, or substantially equivalent Awards shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof), (ii) upon written notice to a Participant, provide that all of the Participant&#8217;s unexercised Awards will terminate immediately prior to the consummation of such Reorganization Event unless exercised by the Participant (to the extent then exercisable) within a specified period following the date of such notice, (iii) provide that outstanding Awards shall become exercisable, realizable, or deliverable, or restrictions applicable to an Award shall lapse, in whole or in part prior to or upon such Reorganization Event, (iv) in the event of a Reorganization Event under the terms of which holders of Common Stock will receive upon consummation thereof a cash payment for each share surrendered in the Reorganization Event (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">Acquisition Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;), make or provide for a cash payment to Participants with respect to each Award held by a Participant equal to (A) the number of shares of Common Stock subject to the vested portion of the Award (after giving effect to any acceleration of vesting that occurs upon or immediately prior to such Reorganization Event) multiplied by (B) the excess, if any, of (I) the Acquisition Price over (II) the exercise, measurement or purchase price of such Award and any applicable tax withholdings, in exchange for the termination of such Award, (v) provide that, in connection with a liquidation or dissolution of the Company, Awards shall convert into the right to receive liquidation proceeds (if applicable, net of the exercise, measurement or purchase price thereof and any applicable tax withholdings) and (vi) any combination of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">foregoing. In taking any of the actions permitted under this Section 9(b)(2), the Board shall not be obligated by the Plan to treat all Awards, all Awards held by a Participant, or all Awards of the same type, identically.</font></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Notwithstanding the terms of Section 9(b)(2)(i), in the case of outstanding Restricted Stock Units that are subject to Section 409A of the Code&#58; (i) if the applicable Restricted Stock Unit agreement provides that the Restricted Stock Units shall be settled upon a &#8220;change in control event&#8221; within the meaning of Treasury Regulation Section 1.409A-3(i)(5)(i), and the Reorganization Event constitutes such a &#8220;change in control event&#8221;, then no assumption or substitution shall be permitted pursuant to Section 9(b)(2)(i) and the Restricted Stock Units shall instead be settled in accordance with the terms of the applicable Restricted Stock Unit agreement&#59; and (ii) the Board may only undertake the actions set forth in clauses (iii), (iv) or (v) of Section 9(b)(2)(i) if the Reorganization Event constitutes a &#8220;change in control event&#8221; as defined under Treasury Regulation Section 1.409A-3(i)(5)(i) and such action is permitted or required by Section 409A of the Code&#59; if the Reorganization Event is not a &#8220;change in control event&#8221; as so defined or such action is not permitted or required by Section 409A of the Code, and the acquiring or succeeding corporation does not assume or substitute the Restricted Stock Units pursuant to clause (i) of Section 9(b)(2)(i), then the unvested Restricted Stock Units shall terminate immediately prior to the consummation of the Reorganization Event without any payment in exchange therefor.</font></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">For purposes of Section 9(b)(2)(A)(i), an Award (other than Restricted Stock) shall be considered assumed if, following consummation of the Reorganization Event, such Award confers the right to purchase or receive pursuant to the terms of such Award, for each share of Common Stock subject to the Award immediately prior to the consummation of the Reorganization Event, the consideration (whether cash, securities or other property) received as a result of the Reorganization Event by holders of Common Stock for each share of Common Stock held immediately prior to the consummation of the Reorganization Event (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">, that if the consideration received as a result of the Reorganization Event is not solely common stock of the acquiring or succeeding corporation (or an affiliate thereof), the Company may, with the consent of the acquiring or succeeding corporation, provide for the consideration to be received upon the exercise or settlement of the Award to consist solely of such number of shares of common stock of the acquiring or succeeding corporation (or an affiliate thereof) that the Board determined to be equivalent in value (as of the date of such determination or another date specified by the Board) to the per share consideration received by holders of outstanding shares of Common Stock as a result of the Reorganization Event.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Consequences of a Reorganization Event on Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Upon the occurrence of a Reorganization Event other than a liquidation or dissolution of the Company, the repurchase and other rights of the Company with respect to outstanding Restricted Stock shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">inure to the benefit of the Company&#8217;s successor and shall, unless the Board determines otherwise, apply to the cash, securities or other property which the Common Stock was converted into or exchanged for pursuant to such Reorganization Event in the same manner and to the same extent as they applied to such Restricted Stock&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">, that the Board may provide for termination or deemed satisfaction of such repurchase or other rights under the instrument evidencing any Restricted Stock or any other agreement between a Participant and the Company, either initially or by amendment. Upon the occurrence of a Reorganization Event involving the liquidation or dissolution of the Company, except to the extent specifically provided to the contrary in the instrument evidencing any Restricted Stock or any other agreement between a Participant and the Company, all restrictions and conditions on all Restricted Stock then outstanding shall automatically be deemed terminated or satisfied.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">General Provisions Applicable to Awards</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Transferability of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Awards (or any interest in an Award, including, prior to exercise, any interest in shares of Common Stock issuable upon exercise of an Option or SAR) shall not be sold, assigned, transferred (including by establishing any short position, put equivalent position (as defined in Rule 16a-1 issued under the Exchange Act) or call equivalent position (as defined in Rule 16a-1 issued under the Exchange Act)), pledged, hypothecated or otherwise encumbered by the person to whom they are granted, either voluntarily or by operation of law, and, during the life of the Participant, shall be exercisable only by the Participant&#59; except that Awards may be transferred to family members (as defined in Rule 701(c)(3) under the Securities Act) through gifts or (other than Incentive Stock Options) domestic relations orders or to an executor or guardian upon the death or disability of the Participant. The Company shall not be required to recognize any such permitted transfer until such time as such permitted transferee shall deliver to the Company a written instrument, as a condition to such transfer, in form and substance satisfactory to the Company confirming that such transferee shall be bound by all of the terms and conditions of the Award. References to a Participant, to the extent relevant in the context, shall include references to authorized transferees. For the avoidance of doubt, nothing contained in this Section 10(a) shall be deemed to restrict a transfer to the Company.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Documentation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Each Award shall be evidenced in such form (written, electronic or otherwise) as the Board shall determine. Each Award may contain terms and conditions in addition to those set forth in the Plan.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Board Discretion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Except as otherwise provided by the Plan, each Award may be made alone or in addition or in relation to any other Award. The terms of each Award need not be identical, and the Board need not treat Participants uniformly.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Termination of Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Board shall determine the effect on an Award of the disability, death, termination or other cessation of employment, authorized leave of absence or other change in the employment or other status of a Participant and the extent to which, and the period during which, the Participant, or the Participant&#8217;s legal representative, conservator, guardian or Designated Beneficiary, may exercise rights under the Award.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Participant must satisfy all applicable federal, state, and local or other income and employment tax withholding obligations before the Company will deliver stock certificates or otherwise recognize ownership of Common Stock under an Award. The Company may decide to satisfy the withholding obligations through additional withholding on salary or wages. If the Company elects not to or cannot withhold from other compensation, the Participant must pay the Company the full amount, if any, required for withholding or have a broker tender to the Company cash equal to the withholding obligations. Payment of withholding obligations is due before the Company will issue any shares on exercise, vesting or release from forfeiture of an Award or at the same time as payment of the exercise or purchase price unless the Company determines otherwise. If provided for in an Award or approved by the Board in its sole discretion, a Participant may satisfy such tax obligations in whole or in part by delivery (either by actual delivery or attestation) of shares of Common Stock, including shares retained from the Award creating the tax obligation, valued at their Fair Market Value&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">, except as otherwise provided by the Board, that the total tax withholding where stock is being used to satisfy such tax obligations cannot exceed the Company&#8217;s minimum statutory withholding obligations (based on minimum statutory withholding rates for federal and state tax purposes, including payroll taxes, that are applicable to such supplemental taxable income). Shares used to satisfy tax withholding requirements cannot be subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Amendment of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Board may amend, modify or terminate any outstanding Award, including but not limited to, substituting therefor another Award of the same or a different type, changing the date of exercise or realization, and converting an Incentive Stock Option to a Nonstatutory Stock Option. The Participant&#8217;s consent to such action shall be required unless (i) the Board determines that the action, taking into account any related action, does not materially and adversely affect the Participant&#8217;s rights under the Plan or (ii) the change is permitted under Section 9.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Board may, without stockholder approval, amend any outstanding Award granted under the Plan to provide an exercise price per share that is lower than the then- current exercise price per share of such outstanding Award. The Board may also, without stockholder approval, cancel any outstanding award (whether or not granted under the Plan) and grant in substitution therefor new Awards under the Plan covering the same or a different number of shares of Common Stock and having an exercise price per share lower than the then- current exercise price per share of the cancelled award.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Conditions on Delivery of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Company will not be obligated to deliver any shares of Common Stock pursuant to the Plan or to remove restrictions from shares previously issued or delivered under the Plan until (i) all conditions of the Award have been met or removed to the satisfaction of the Company, (ii) in the opinion of the Company&#8217;s counsel, all other legal matters in connection with the issuance and delivery of such shares have been satisfied, including </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">any applicable securities laws and regulations and any applicable stock exchange or stock market rules and regulations, and (iii) the Participant has executed and delivered to the Company such representations or agreements as the Company may consider appropriate to satisfy the requirements of any applicable laws, rules or regulations.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Acceleration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Board may at any time provide that any Award shall become immediately exercisable in whole or in part, free of some or all restrictions or conditions, or otherwise realizable in whole or in part, as the case may be.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Miscellaneous</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">No Right To Employment or Other Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">No person shall have any claim or right to be granted an Award by virtue of the adoption of the Plan, and the grant of an Award shall not be construed as giving a Participant the right to continued employment or any other relationship with the Company. The Company expressly reserves the right at any time to dismiss or otherwise terminate its relationship with a Participant free from any liability or claim under the Plan, except as expressly provided in the applicable Award.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">No Rights As Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Subject to the provisions of the applicable Award, no Participant or Designated Beneficiary shall have any rights as a stockholder with respect to any shares of Common Stock to be distributed with respect to an Award until becoming the record holder of such shares.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Effective Date and Term of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Plan shall become effective on the date on which it is adopted by the Board. No Awards shall be granted under the Plan after the expiration of 10 years from the earlier of (i) the date on which the Plan was adopted by the Board or (ii) the date the Plan was approved by the Company&#8217;s stockholders, but Awards previously granted may extend beyond that date.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Amendment of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Board may amend, suspend or terminate the Plan or any portion thereof at any time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">that if at any time the approval of the Company&#8217;s stockholders is required as to any modification or amendment under Section 422 of the Code or any successor provision with respect to Incentive Stock Options, the Board may not effect such modification or amendment without such approval. Unless otherwise specified in the amendment, any amendment to the Plan adopted in accordance with this Section 11(d) shall apply to, and be binding on the holders of, all Awards outstanding under the Plan at the time the amendment is adopted, provided the Board determines that such amendment, taking into account any related action, does not materially and adversely affect the rights of Participants under the Plan.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Authorization of Sub-Plans (including Grants to non-U.S. Employees)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The Board may from time to time establish one or more sub-plans under the Plan for purposes of satisfying applicable securities, tax or other laws of various jurisdictions. The Board shall establish such sub-plans by adopting supplements to the Plan containing (i) such limitations on the Board&#8217;s discretion under the Plan as the Board deems necessary or desirable or (ii) such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">desirable. All supplements adopted by the Board shall be deemed to be part of the Plan, but each supplement shall apply only to Participants within the affected jurisdiction and the Company shall not be required to provide copies of any supplement to Participants in any jurisdiction which is not the subject of such supplement.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Compliance with Section 409A of the Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Except as provided in individual Award agreements initially or by amendment, if and to the extent (i) any portion of any payment, compensation or other benefit provided to a Participant pursuant to the Plan in connection with his or her employment termination constitutes &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A of the Code and (ii) the Participant is a specified employee as defined in Section 409A(a)(2)(B)(i) of the Code, in each case as determined by the Company in accordance with its procedures, by which determinations the Participant (through accepting the Award) agrees that he or she is bound, such portion of the payment, compensation or other benefit shall not be paid before the day that is six months plus one day after the date of &#8220;separation from service&#8221; (as determined under Section 409A of the Code) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">New Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221;), except as Section 409A of the Code may then permit. The aggregate of any payments that otherwise would have been paid to the Participant during the period between the date of separation from service and the New Payment Date shall be paid to the Participant in a lump sum on such New Payment Date, and any remaining payments will be paid on their original schedule. The Company makes no representations or warranty and shall have no liability to the Participant or any other person if any provisions of or payments, compensation or other benefits under the Plan are determined to constitute nonqualified deferred compensation subject to Section 409A of the Code but do not to satisfy the conditions of that section.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Limitations on Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Notwithstanding any other provisions of the Plan, no individual acting as a director, officer, other employee, or agent of the Company will be liable to any Participant, former Participant, spouse, beneficiary, or any other person for any claim, loss, liability, or expense incurred in connection with the Plan, nor will such individual be personally liable with respect to the Plan because of any contract or other instrument he or she executes in his or her capacity as a director, officer, other employee, or agent of the Company. The Company will indemnify and hold harmless each director, officer, other employee, or agent of the Company to whom any duty or power relating to the administration or interpretation of the Plan has been or will be delegated, against any cost or expense (including attorneys&#8217; fees) or liability (including any sum paid in settlement of a claim with the Board&#8217;s approval) arising out of any act or omission to act concerning the Plan unless arising out of such person&#8217;s own fraud or bad faith.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The provisions of the Plan and all Awards made hereunder shall be governed by and interpreted in accordance with the laws of the State of Delaware, excluding choice-of-law principles of the law of such state that would require the application of the laws of a jurisdiction other than the State of Delaware.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12</font></div><div style="text-align:right"><font><br></font></div></div></div><div id="i7ce91d331e2545b088dfba29ab1c092b_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ARCHERDX, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Incentive Stock Option Agreement </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Granted Under 2015 Stock Incentive Plan</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Grant of Option.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This agreement evidences the grant by ArcherDx, Inc., a Delaware corporation (the &#8220;Company&#8221;), on the grant date described in the Carta record reflecting this grant (the &#8220;Grant Date&#8221;) to the participant described in the Carta record reflecting this grant, an employee of the Company (the &#8220;Participant&#8221;), of an option to purchase, in whole or in part, on the terms provided herein and in the Company&#8217;s 2015 Stock Incentive Plan (the &#8220;Plan&#8221;), a total number of shares as described in the Carta record reflecting this grant (the &#8220;Shares&#8221;) of common stock, $0.01 par value per share, of the Company (&#8220;Common Stock&#8221;) at an exercise price described in the Carta record reflecting this grant (the &#8220;Exercise Price&#8221;). Unless earlier terminated, this option shall expire at 5&#58;00 p.m., Eastern time, on the date described in the Carta record reflecting this grant (the &#8220;Final Exercise Date&#8221;).</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">It is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the &#8220;Code&#8221;). Except as otherwise indicated by the context, the term &#8220;Participant&#8221;, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Vesting Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This option will become exercisable (&#8220;vest&#8221;) as described in the Carta record reflecting this grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The right of exercise shall be cumulative so that to the extent the option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of this option under Section 3 hereof or the Plan.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Exercise of Option.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Form of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;Each election to exercise this option shall be accompanied by a completed Notice of Stock Option Exercise in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, signed by the Participant, and received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the Plan. The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for any fractional share or for fewer than ten whole shares.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Continuous Relationship with the Company Required</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;Except as otherwise provided in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee or officer of, or consultant or advisor to, the Company or any parent or subsidiary of the Company as defined in Section 424(e) or (f) of the Code (an &#8220;Eligible Participant&#8221;).</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Termination of Relationship with the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;If the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after such cessation (but in no event after the Final Exercise Date), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Participant, prior to the Final Exercise Date, violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon such violation.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Exercise Period Upon Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;If the Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for &#8220;cause&#8221; as specified in paragraph (e) below, this option shall be exercisable, within the period of one year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> this option shall be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the Final Exercise Date.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Termination for Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;If, prior to the Final Exercise Date, the Participant&#8217;s employment is terminated by the Company for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment. If, prior to the Final Exercise Date, the Participant is given notice by the Company of the termination of his or her employment by the Company for Cause, and the effective date of such employment termination is subsequent to the date of delivery of such notice, the right to exercise this option shall be suspended from the time of the delivery of such notice until the earlier of (i) such time as it is determined or otherwise agreed that the Participant&#8217;s employment shall not be terminated for Cause as provided in such notice or (ii) the effective date of such termination of employment (in which case the right to exercise this option shall, pursuant to the preceding sentence, terminate upon the effective date of such termination of employment). If the Participant is party to an employment or severance agreement with the Company that contains a definition of &#8220;cause&#8221; for termination of employment, &#8220;Cause&#8221; shall have the meaning ascribed to such term in such agreement. Otherwise, &#8220;Cause&#8221; shall mean willful misconduct by the Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of any employment, consulting, advisory, nondisclosure, non-competition or other similar agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant&#8217;s employment shall be considered to have been terminated for Cause if the Company determines, within 30 days after the Participant&#8217;s resignation, that termination for Cause was warranted.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Company Right of First Refusal.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Notice of Proposed Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;If the Participant proposes to sell, assign, transfer, pledge, hypothecate or otherwise dispose of, by operation of law or otherwise (collectively, &#8220;transfer&#8221;) any Shares acquired upon exercise of this option, then the Participant shall first give written notice of the proposed transfer (the &#8220;Transfer Notice&#8221;) to the Company. The Transfer Notice shall name the proposed transferee and state the number of such Shares the Participant proposes to transfer (the &#8220;Offered Shares&#8221;), the price per share and all other material terms and conditions of the transfer.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Company Right to Purchase</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;For 30 days following its receipt of such Transfer Notice, the Company shall have the option to purchase all or part of the Offered Shares at the price and upon the terms set forth in the Transfer Notice. In the event the Company elects to purchase all or part of the Offered Shares, it shall give written notice of such election to the Participant within such 30-day period. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Within 10 days after his or her receipt of such notice, the Participant shall tender to the Company at its principal offices the certificate or certificates representing the Offered Shares to be purchased by the Company, duly endorsed in blank by the Participant or with duly endorsed stock powers attached thereto, all in a form suitable for transfer of the Offered Shares to the Company. Promptly following receipt of such certificate or certificates, the Company shall deliver or mail to the Participant a check in payment of the purchase price for such Offered Shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> if the terms of payment set forth in the Transfer Notice were other than cash against delivery, the Company may pay for the Offered Shares on the same terms and conditions as were set forth in the Transfer Notice&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> that any delay in making such payment shall not invalidate the Company&#8217;s exercise of its option to purchase the Offered Shares.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Shares Not Purchased By Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;If the Company does not elect to acquire all of the Offered Shares, the Participant may, within the 30-day period following the expiration of the option granted to the Company under subsection (b) above, transfer the Offered Shares which the Company has not elected to acquire to the proposed transferee, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> such transfer shall not be on terms and conditions more favorable to the transferee than those contained in the Transfer Notice. Notwithstanding any of the above, all Offered Shares transferred pursuant to this Section 4 shall remain subject to the right of first refusal set forth in this Section 4 and such transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of this Section 4.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Consequences of Non-Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;After the time at which the Offered Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection (b) above, the Company shall not pay any dividend to the Participant on account of such Offered Shares or permit the Participant to exercise any of the privileges or rights of a stockholder with respect to such Offered Shares, but shall, insofar as permitted by law, treat the Company as the owner of such Offered Shares.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Exempt Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;The following transactions shall be exempt from the provisions of this Section 4&#58;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">any transfer of Shares to or for the benefit of any spouse, child or grandchild of the Participant, or to a trust for their benefit&#59;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">any transfer pursuant to an effective registration statement filed by the Company under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;)&#59; and</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the sale of all or substantially all of the outstanding shares of capital stock of the Company (including pursuant to a merger or consolidation)&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, that in the case of a transfer pursuant to clause (1) above, such Shares shall remain subject to the right of first refusal set forth in this Section 4.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Assignment of Company Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;The Company may assign its rights to purchase Offered Shares in any particular transaction under this Section 4 to one or more persons or entities.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">. The provisions of this Section 4 shall terminate upon the earlier of the following events&#58;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the closing of the sale of shares of Common Stock in an underwritten public offering pursuant to an effective registration statement filed by the Company under the Securities Act&#59; or</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the sale of all or substantially all of the outstanding shares of capital stock, assets or business of the Company, by merger, consolidation, sale of assets or otherwise (other than a merger or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">consolidation in which all or substantially all of the individuals and entities who were beneficial owners of the Company&#8217;s voting securities immediately prior to such transaction beneficially own, directly or indirectly, more than 75% (determined on an as-converted basis) of the outstanding securities entitled to vote generally in the election of directors of the resulting, surviving or acquiring corporation in such transaction).</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">No Obligation to Recognize Invalid Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;The Company shall not be required (1) to transfer on its books any of the Shares which shall have been sold or transferred in violation of any of the provisions set forth in this Section 4, or (2) to treat as owner of such Shares or to pay dividends to any transferee to whom any such Shares shall have been so sold or transferred.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Legends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;The certificate representing Shares shall bear a legend substantially in the following form (in addition to, or in combination with, any legend required by applicable federal and state securities laws and agreements relating to the transfer of the Company securities)&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#34;The shares represented by this certificate are subject to a right of first refusal in favor of the Company, as provided in a certain stock option agreement with the Company.&#34;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Agreement in Connection with Initial Public Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant agrees, in connection with the initial underwritten public offering of the Common Stock pursuant to a registration statement under the Securities Act, (i) not to (a) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any other securities of the Company or (b) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of shares of Common Stock or other securities of the Company, whether any transaction described in clause (a) or (b) is to be settled by delivery of securities, in cash or otherwise, during the period beginning on the date of the filing of such registration statement with the Securities and Exchange Commission and ending 180 days after the date of the final prospectus relating to the offering (plus up to an additional 34 days to the extent requested by the managing underwriters for such offering in order to address FINRA Rule 2711(f)(4) or NYSE Rule 472(f)(4) or any similar successor provision), and (ii) to execute any agreement reflecting clause (i) above as may be requested by the Company or the managing underwriters at the time of such offering. The Company may impose stop-transfer instructions with respect to the shares of Common Stock or other securities subject to the foregoing restriction until the end of the &#8220;lock-up&#8221; period.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Tax Matters.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Disqualifying Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;If the Participant disposes of Shares acquired upon exercise of this option within two years from the Grant Date or one year after such Shares were acquired pursuant to exercise of this option, the Participant shall notify the Company in writing of such disposition.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Transfer Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant agrees that he or she will not transfer any Shares issued pursuant to the exercise of this option unless the transferee, as a condition to such transfer, delivers to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of Section 3(f), Section 4 and Section 5, as applicable&#59; provided that such a written confirmation shall not be required with respect to (1) Section 4 after such provision has terminated in accordance with Section 4(g) or (2) Section 5 after the completion of the lock-up period in connection with the Company&#8217;s initial underwritten public offering.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Provisions of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is furnished to the Participant with this option.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">- </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:139%">Signature Pages Follow -</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">IN WITNESS WHEREOF, the Company has caused this option to be executed under its corporate seal by its duly authorized officer. This option shall take effect as a sealed instrument.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.826%"><tr><td style="width:1.0%"></td><td style="width:10.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.866%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARCHERDX, INC.</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">PARTICIPANT&#8217;S ACCEPTANCE</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges receipt of a copy of the Company&#8217;s 2015 Stock Incentive Plan.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.051%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PARTICIPANT&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Address&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">NOTICE OF STOCK OPTION EXERCISE</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Date&#58;_______________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ArcherDx, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">______________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">______________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Attention&#58; Treasurer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Dear Sir or Madam&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">I am the holder of_______________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Stock Option granted to me under the ArcherDx, Inc. (the &#8220;Company&#8221;) 2015 Stock Incentive Plan on ________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">for the purchase of ________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">4 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">shares of Common Stock of the Company at a purchase price of $____________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">per share.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">I hereby exercise my option to purchase ________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> shares of Common Stock (the &#8220;Shares&#8221;), for which I have enclosed _______________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">in the amount of _________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">. Please register my stock certificate as follows&#58;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.480%"><tr><td style="width:1.0%"></td><td style="width:25.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.932%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name(s)&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Address&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">__________________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Enter the date of exercise.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Enter either &#8220;an Incentive&#8221; or &#8220;a Nonstatutory&#8221;.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Enter the date of grant.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:158%">4 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:158%">Enter the total number of shares of Common Stock for which the option was granted.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Enter the option exercise price per share of Common Stock.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">6 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Enter the number of shares of Common Stock to be purchased upon exercise of all or part of the option.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:142%">7 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:142%">Enter &#8220;cash&#8221;, &#8220;personal check&#8221; or if permitted by the option or Plan, &#8220;stock certificates No. XXXX and XXXX&#8221;.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:142%">8 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:142%">Enter the dollar amount (price per share of Common Stock times the number of shares of Common Stock to be purchased), or the number of shares tendered. Fair market value of shares tendered, together with cash or check, must cover the purchase price of the shares issued upon exercise.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:140%">9 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">Enter name(s) to appear on stock certificate&#58; (a) Your name only&#59; (b) Your name and other name (i.e., John Doe and Jane Doe, Joint Tenants With Right of Survivorship)&#59; or (c) In the case of a Nonstatutory option only, a Child&#8217;s name, with you as custodian (i.e., Jane Doe, Custodian for Tommy Doe). Note&#58; There may be income and&#47;or gift tax consequences of registering shares in a Child&#8217;s name.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">I represent, warrant and covenant as follows&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">1.&#160;&#160;&#160;&#160;I am purchasing the Shares for my own account for investment only, and not with a view to, or for sale in connection with, any distribution of the Shares in violation of the Securities Act of 1933 (the &#8220;Securities Act&#8221;), or any rule or regulation under the Securities Act.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">2.&#160;&#160;&#160;&#160;I have had such opportunity as I have deemed adequate to obtain from representatives of the Company such information as is necessary to permit me to evaluate the merits and risks of my investment in the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">3.&#160;&#160;&#160;&#160;I have sufficient experience in business, financial and investment matters to be able to evaluate the risks involved in the purchase of the Shares and to make an informed investment decision with respect to such purchase.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">4.&#160;&#160;&#160;&#160;I can afford a complete loss of the value of the Shares and am able to bear the economic risk of holding such Shares for an indefinite period.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">5.&#160;&#160;&#160;&#160;I understand that (i) the Shares have not been registered under the Securities Act and are &#8220;restricted securities&#8221; within the meaning of Rule 144 under the Securities Act, (ii) the Shares cannot be sold, transferred or otherwise disposed of unless they are subsequently registered under the Securities Act or an exemption from registration is then available&#59; (iii) in any event, the exemption from registration under Rule 144 will not be available for at least one year and even then will not be available unless a public market then exists for the Common Stock, adequate information concerning the Company is then available to the public, and other terms and conditions of Rule 144 are complied with&#59; and (iv) there is now no registration statement on file with the Securities and Exchange Commission with respect to any stock of the Company and the Company has no obligation or current intention to register the Shares under the Securities Act.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.057%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Very truly yours,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Signature)</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div><div style="text-align:right"><font><br></font></div></div></div><div id="i7ce91d331e2545b088dfba29ab1c092b_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ARCHERDX, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Nonstatutory Stock Option Agreement </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Granted Under 2015 Stock Incentive Plan</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:23.237%"><tr><td style="width:1.0%"></td><td style="width:32.003%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.797%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Grant of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div></td></tr></table></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This agreement evidences the grant by ArcherDx, Inc., a Delaware corporation (the &#8220;Company&#8221;), on the grant date described in the Carta record reflecting this grant (the &#8220;Grant Date&#8221;) to the participant described in the Carta record reflecting this grant, a service provider of the Company (the &#8220;Participant&#8221;), of an option to purchase, in whole or in part, on the terms provided herein and in the Company&#8217;s 2015 Stock Incentive Plan (the &#8220;Plan&#8221;), a total number of shares as described in the Carta record reflecting this grant (the &#8220;Shares&#8221;) of common stock, $0.01 par value per share, of the Company (&#8220;Common Stock&#8221;) at an exercise price described in the Carta record reflecting this grant (the &#8220;Exercise Price&#8221;). Unless earlier terminated, this option shall expire at 5&#58;00 p.m., Eastern time, on the date described in the Carta record reflecting this grant (the &#8220;Final Exercise Date&#8221;).</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the &#8220;Code&#8221;). Except as otherwise indicated by the context, the term &#8220;Participant&#8221;, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:24.839%"><tr><td style="width:1.0%"></td><td style="width:29.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.933%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Vesting Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div></td></tr></table></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This option will become exercisable (&#8220;vest&#8221;) as described in the Carta record reflecting this grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The right of exercise shall be cumulative so that to the extent the option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of this option under Section 3 hereof or the Plan.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.961%"><tr><td style="width:1.0%"></td><td style="width:28.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:69.271%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Exercise of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div></td></tr></table></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Form of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;Each election to exercise this option shall be accompanied by a completed Notice of Stock Option Exercise in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, signed by the Participant, and received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the Plan. The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for any fractional share or for fewer than ten whole shares.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Continuous Relationship with the Company Required</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;Except as otherwise provided in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee, officer or director of, or consultant </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or advisor to, the Company or any other entity the employees, officers, directors, consultants, or advisors of which are eligible to receive option grants under the Plan (an &#8220;Eligible Participant&#8221;).,</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(c)&#160;&#160;&#160;&#160;Termination of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Relationship with the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;If the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after such cessation (but in no event after the Final Exercise Date), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon such violation.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Exercise Period Upon Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;If the Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for &#8220;cause&#8221; as specified in paragraph (e) below, this option shall be exercisable, within the period of one year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> this option shall be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the Final Exercise Date.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Termination for Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;If, prior to the Final Exercise Date, the Participant&#8217;s employment or other relationship with the Company is terminated by the Company for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment or other relationship. If, prior to the Final Exercise Date, the Participant is given notice by the Company of the termination of his or her employment or other relationship by the Company for Cause, and the effective date of such employment or other termination is subsequent to the date of the delivery of such notice, the right to exercise this option shall be suspended from the time of the delivery of such notice until the earlier of (i) such time as it is determined or otherwise agreed that the Participant&#8217;s employment or other relationship shall not be terminated for Cause as provided in such notice or (ii) the effective date of such termination of employment or other relationship (in which case the right to exercise this option shall, pursuant to the preceding sentence, terminate immediately upon the effective date of such termination of employment or other relationship). If the Participant is party to an employment, consulting or severance agreement with the Company that contains a definition of &#8220;cause&#8221; for termination of employment or other relationship, &#8220;Cause&#8221; shall have the meaning ascribed to such term in such agreement. Otherwise, &#8220;Cause&#8221; shall mean willful misconduct by the Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of any employment, consulting, advisory, nondisclosure, non-competition or other similar agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant&#8217;s employment or other relationship shall be considered to have been terminated for &#8220;Cause&#8221; if the Company determines, within 30 days after the Participant&#8217;s resignation, that termination for Cause was warranted.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:38.461%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Company Right of First Refusal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Notice of Proposed Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;If the Participant proposes to sell, assign, transfer, pledge, hypothecate or otherwise dispose of, by operation of law or otherwise (collectively, &#8220;transfer&#8221;) any Shares acquired upon exercise of this option, then the Participant shall first give written notice of the proposed transfer (the &#8220;Transfer Notice&#8221;) to the Company. The Transfer Notice shall name the proposed transferee and state the number of such Shares the Participant proposes to transfer (the &#8220;Offered Shares&#8221;), the price per share and all other material terms and conditions of the transfer.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Company Right to Purchase</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;For 30 days following its receipt of such Transfer Notice, the Company shall have the option to purchase all or part of the Offered Shares at the price and upon the terms set forth in the Transfer Notice. In the event the Company elects to purchase all or part of the Offered Shares, it shall give written notice of such election to the Participant within such 30-day period. Within 10 days after his or her receipt of such notice, the Participant shall tender to the Company at its principal offices the certificate or certificates representing the Offered Shares to be purchased by the Company, duly endorsed in blank by the Participant or with duly endorsed stock powers attached thereto, all in a form suitable for transfer of the Offered Shares to the Company. Promptly following receipt of such certificate or certificates, the Company shall deliver or mail to the Participant a check in payment of the purchase price for such Offered Shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> if the terms of payment set forth in the Transfer Notice were other than cash against delivery, the Company may pay for the Offered Shares on the same terms and conditions as were set forth in the Transfer Notice&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> that any delay in making such payment shall not invalidate the Company&#8217;s exercise of its option to purchase the Offered Shares.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Shares Not Purchased By Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;If the Company does not elect to acquire all of the Offered Shares, the Participant may, within the 30-day period following the expiration of the option granted to the Company under subsection (b) above, transfer the Offered Shares which the Company has not elected to acquire to the proposed transferee, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> such transfer shall not be on terms and conditions more favorable to the transferee than those contained in the Transfer Notice. Notwithstanding any of the above, all Offered Shares transferred pursuant to this Section 4 shall remain subject to the right of first refusal set forth in this Section 4 and such transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of this Section 4.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Consequences of Non-Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;After the time at which the Offered Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection (b) above, the Company shall not pay any dividend to the Participant on account of such Offered Shares or permit the Participant to exercise any of the privileges or rights of a stockholder with respect to such Offered Shares, but shall, insofar as permitted by law, treat the Company as the owner of such Offered Shares.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Exempt Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;The following transactions shall be exempt from the provisions of this Section 4&#58;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">any transfer of Shares to or for the benefit of any spouse, child or grandchild of the Participant, or to a trust for their benefit&#59;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">any transfer pursuant to an effective registration statement filed by the Company under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;)&#59; and</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the sale of all or substantially all of the outstanding shares of capital stock of the Company (including pursuant to a merger or consolidation)&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, that in the case of a transfer pursuant to clause (1) above, such Shares shall remain subject to the right of first refusal set forth in this Section 4.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Assignment of Company Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;The Company may assign its rights to purchase Offered Shares in any particular transaction under this Section 4 to one or more persons or entities.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;The provisions of this Section 4 shall terminate upon the earlier of the following events&#58;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the closing of the sale of shares of Common Stock in an underwritten public offering pursuant to an effective registration statement filed by the Company under the Securities Act&#59; or</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the sale of all or substantially all of the outstanding shares of capital stock, assets or business of the Company, by merger, consolidation, sale of assets or otherwise (other than a merger or consolidation in which all or substantially all of the individuals and entities who were beneficial owners of the Company&#8217;s voting securities immediately prior to such transaction beneficially own, directly or indirectly, more than 75% (determined on an as-converted basis) of the outstanding securities entitled to vote generally in the election of directors of the resulting, surviving or acquiring corporation in such transaction).</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">No Obligation to Recognize Invalid Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;The Company shall not be required (1) to transfer on its books any of the Shares which shall have been sold or transferred in violation of any of the provisions set forth in this Section 4, or (2) to treat as owner of such Shares or to pay dividends to any transferee to whom any such Shares shall have been so sold or transferred.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Legends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;The certificate representing Shares shall bear a legend substantially in the following form (in addition to, or in combination with, any legend required by applicable federal and state securities laws and agreements relating to the transfer of the Company securities)&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#34;The shares represented by this certificate are subject to a right of first refusal in favor of the Company, as provided in a certain stock option agreement with the Company.&#34;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Agreement in Connection with Initial Public Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant agrees, in connection with the initial underwritten public offering of the Common Stock pursuant to a registration statement under the Securities Act, (i) not to (a) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any other securities of the Company or (b) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of shares of Common Stock or other securities of the Company, whether any transaction described in clause (a) or (b) is to be settled by delivery of securities, in cash or otherwise, during the period beginning on the date of the filing of such registration statement with the Securities and Exchange Commission and ending 180 days after the date of the final prospectus relating to the offering (plus up to an additional 34 days to the extent requested by the managing underwriters for such offering in order to address FINRA Rule 2711(f)(4) or NYSE Rule 472(f)(4) or any similar successor provision), and (ii) to execute any agreement reflecting clause (i) above as may be requested by the Company or the managing underwriters at the time of such offering. The Company may impose stop-transfer instructions with respect to the shares of Common Stock or other securities subject to the foregoing restriction until the end of the &#8220;lock-up&#8221; period.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Transfer Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;The Participant agrees that he or she will not transfer any Shares issued pursuant to the exercise of this option unless the transferee, as a condition to such transfer, delivers to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of Section 3(f), Section 4 and Section 5, as applicable&#59; provided that such a written confirmation shall not be required with respect to (1) Section 4 after such provision has terminated in accordance with Section 4(g) or (2) Section 5 after the completion of the lock-up period in connection with the Company&#8217;s initial underwritten public offering.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Provisions of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is furnished to the Participant with this option.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">- </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:139%">Signature Pages Follow -</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">IN WITNESS WHEREOF, the Company has caused this option to be executed under its corporate seal by its duly authorized officer. This option shall take effect as a sealed instrument.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.160%"><tr><td style="width:1.0%"></td><td style="width:9.762%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.903%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.035%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARCHERDX, INC.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">PARTICIPANT&#8217;S ACCEPTANCE</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges receipt of a copy of the Company&#8217;s 2015 Stock Incentive Plan.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:13.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.879%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PARTICIPANT&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Address&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">NOTICE OF STOCK OPTION EXERCISE</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Date&#58;___________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ArcherDx, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">______________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">______________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Attention&#58; Treasurer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Dear Sir or Madam&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">I am the holder of___________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Stock Option granted to me under the ArcherDx, Inc. (the &#8220;Company&#8221;) 2015 Stock Incentive Plan on ___________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">for the purchase of___________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">4 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">shares of Common Stock of the Company at a purchase price of $ ___________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> per share.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">I hereby exercise my option to purchase___________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> shares of Common Stock (the &#8220;Shares&#8221;), for which I have enclosed ___________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> in the amount of ___________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">. Please register my stock certificate as follows&#58;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.480%"><tr><td style="width:1.0%"></td><td style="width:25.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.932%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name(s)&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Address&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">__________________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Enter the date of exercise.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Enter either &#8220;an Incentive&#8221; or &#8220;a Nonstatutory&#8221;.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Enter the date of grant.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Enter the total number of shares of Common Stock for which the option was granted.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Enter the option exercise price per share of Common Stock.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Enter the number of shares of Common Stock to be purchased upon exercise of all or part of the option.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Enter &#8220;cash&#8221;, &#8220;personal check&#8221; or if permitted by the option or Plan, &#8220;stock certificates No. XXXX and XXXX&#8221;.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Enter the dollar amount (price per share of Common Stock times the number of shares of Common Stock to be purchased), or the number of shares tendered. Fair market value of shares tendered, together with cash or check, must cover the purchase price of the shares issued upon exercise.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Enter name(s) to appear on stock certificate&#58; (a) Your name only&#59; (b) Your name and other name (i.e., John Doe and Jane Doe, Joint Tenants With Right of Survivorship)&#59; or (c) In the case of a Nonstatutory option only, a Child&#8217;s name, with you as custodian (i.e., Jane Doe, Custodian for Tommy Doe). Note&#58; There may be income and&#47;or gift tax consequences of registering shares in a Child&#8217;s name.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">I represent, warrant and covenant as follows&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">1.I am purchasing the Shares for my own account for investment only, and not with a view to, or for sale in connection with, any distribution of the Shares in violation of the Securities Act of 1933 (the &#8220;Securities Act&#8221;), or any rule or regulation under the Securities Act.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">2.I have had such opportunity as I have deemed adequate to obtain from representatives of the Company such information as is necessary to permit me to evaluate the merits and risks of my investment in the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">3.I have sufficient experience in business, financial and investment matters to be able to evaluate the risks involved in the purchase of the Shares and to make an informed investment decision with respect to such purchase.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">4.I can afford a complete loss of the value of the Shares and am able to bear the economic risk of holding such Shares for an indefinite period.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">5.I understand that (i) the Shares have not been registered under the Securities Act and are &#8220;restricted securities&#8221; within the meaning of Rule 144 under the Securities Act, (ii) the Shares cannot be sold, transferred or otherwise disposed of unless they are subsequently registered under the Securities Act or an exemption from registration is then available&#59; (iii) in any event, the exemption from registration under Rule 144 will not be available for at least one year and even then will not be available unless a public market then exists for the Common Stock, adequate information concerning the Company is then available to the public, and other terms and conditions of Rule 144 are complied with&#59; and (iv) there is now no registration statement on file with the Securities and Exchange Commission with respect to any stock of the Company and the Company has no obligation or current intention to register the Shares under the Securities Act.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.057%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Very truly yours,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Signature)</font></td></tr></table></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div><div style="text-align:right"><font><br></font></div></div></div><div id="i7ce91d331e2545b088dfba29ab1c092b_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Form of Restricted Stock Agreement</font></div><div style="text-align:right"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">under 2015 Stock Incentive Plan</font></div><div style="text-align:center"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ARCHERDX </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">INC.</font></div><div style="text-align:center"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Restricted Stock Agreement</font></div><div style="text-align:center"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Granted Under 2015 Stock Incentive Plan</font></div><div style="text-indent:36pt"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">AGREEMENT made this &#91;&#160;&#160;&#160;&#93; day of &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;, 20&#91;&#160;&#160;&#160;&#93;</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">between ArcherDx</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Inc.</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">a Delaware corporation (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Company&#8221;), and &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Participant&#8221;).</font></div><div style="text-indent:36pt"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">For valuable consideration</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">receipt of which is acknowledged</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the parties hereto agree as follows&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">1.&#160;&#160;&#160;&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Purchase of Shares</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:36pt"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Company shall issue and sell to the Participant</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and the Participant shall purchase from the Company, subject to the terms and conditions set forth in this Agreement and in the Company</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">' </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s 2015 Stock Incentive Plan (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">)</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; shares (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">) of common stock</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">$0.01 par value</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">of the Company (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">)</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">at a purchase price of $&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; per share. The aggregate purchase price for the Shares shall be paid by the Participant by check payable to the order of the Company or such other method as may be acceptable to the Company. Upon receipt by the Company of payment for the Shares</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Company shall issue to the Participant one or more certificates in the name of the Participant for that number of Shares purchased by the Participant. The Participant agrees that the Shares shall be subject to the purchase options set forth in Sections 2 and 5 of this Agreement and the restrictions on transfer set forth in Section 4 of this Agreement.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">2.&#160;&#160;&#160;&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Purchase Option</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">In the event that the Participant (i) is terminated without Cause (as defined below) or resigns for Good Reason (as defined below) or (ii) is terminated for Cause (as defined below) or resigns for any reason other than Good Reason</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">prior to the fourth anniversary of the Vesting Commencement Date (as defined below)</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Company shall have the right and option (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Purchase Option&#8221;) to purchase from the Participant, for a sum of $&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; per share</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">1</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Unvested Option Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">)</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">some or all of the Unvested Shares (as defined below) and</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(x) in the case of clause (i)</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the additional right and option to purchase from the Participant</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">for a sum per share equal to the fair market value of the Company</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">' </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s Common Stock at the time of the Participant</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">' </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s termination of employment with the Company as determined by the Company</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">' </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s Board of Directors in its good faith judgment</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or (y) in the case of clause (ii)</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the additional right and option to purchase from the Participant, for a sum of $&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; per share</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">2</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> (in each case of clauses (x) and (y), the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Vested Option Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and together with the Unvested Option Price, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Option Price&#8221;)</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">some or all of the Shares that are not Unvested Shares.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Unvested Shares&#8221; means the total number of Shares multiplied by the Applicable Percentage at the time the Purchase Option becomes exercisable by the Company. The </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Applicable Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">shall be (i) 100% during the period ending on the first anniversary of the Vesting Commencement Date</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(ii) 75% on the first anniversary of the Vesting Commencement Date</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(iii) 75% less 2.0833% for each month of employment completed by the Participant with the Company from and after the first anniversary of the Vesting Commencement Date</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and (iv) zero on or after the fourth anniversary of the Vesting ________________________</font></div><div><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">1</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This should be the same as the purchase price</font></div><div><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">2</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This should be the same as the purchase price</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Commencement Date. For purposes of this Agreement</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Vesting Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">shall mean &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;, 20&#91;&#160;&#160;&#160;&#93;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">3</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">If the Participant is employed by a parent or subsidiary of the Company</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">,</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> any references in this Agreement to employment with the Company or termination of employment by or with the Company shall instead be deemed to refer to such parent or subsidiary. For purposes of this Agreement</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">employment with the Company shall include employment with a parent or subsidiary of the Company and service to the Company as an advisor</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">consultant or member of the Board of Directors of the Company.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">For purposes of Section 2(a)</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">shall exist upon (i) mutual written agreement by the Participant and the Board of Directors of the Company that Good Reason exists&#59; (ii) the relocation of the Company</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">' </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s offices such that Participant's daily commute is increased by at least 50 miles without the written consent of the Participant</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#59; </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(iii) material reduction of the Participant's annual base salary without the prior consent of the Participant (other than a reduction in annual base salary that is implemented in connection with a contemporaneous reduction in annual base salaries affecting other employees of the Company)</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#59;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> or (iv) demotion of the Participant to a position with responsibilities substantially less than the Participant's current position without the prior consent of the Participant.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">For purposes of Section 2(a)</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Participant's employment shall be considered terminated without &#8220;Cause&#8221; when such termination does not exist upon (i) a good faith finding by the Board of Directors of the Company (A) of repeated and willful failure of the Participant after written notice to perform her reasonably assigned duties for the Company</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or (B) that the Participant has engaged in dishonesty</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">gross negligence or misconduct&#59; (ii) the conviction of the Participant of</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or the entry of a pleading of guilty or nolo contendere by the Participant to</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">any crime involving moral turpitude or any felony</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#59; </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or (iii) a breach by the Participant of any material provision of any employment</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">consulting, advisory</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">nondisclosure</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">,</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> non-competition or other similar agreement between the Participant and the Company</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">which breach is not cured within ten days written notice thereof.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">3.&#160;&#160;&#160;&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Exercise of Purchase Option and Closing.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Company may exercise the Purchase Option by delivering or mailing to the Participant (or his or her estate), within 90 days after the termination of the employment of the Participant with the Company</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">a written notice of exercise of the Purchase Option. Such notice shall specify the number of Shares to be purchased</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">including the number of Unvested </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Shares and Shares that are not Unvested Shares, if applicable. If and to the extent the Purchase Option is not so exercised by the giving of such a notice within such 90-day period, the Purchase Option shall automatically expire and terminate effective upon the expiration of such 90-day period.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Within 10 days after delivery to the Participant of the Company's notice of the exercise of the Purchase Option pursuant to subsection (a) above, the Participant (or his or her estate) shall, pursuant to the provisions of the Joint Escrow Instructions referred to in Section 7 below, tender to the Company at its principal offices the certificate or certificates representing the Shares which the Company has elected to purchase in accordance with the terms of this Agreement, duly endorsed in blank or with duly endorsed stock powers attached thereto, all in form suitable for the transfer of such Shares to </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">__________________________________</font></div><div><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">3</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Vesting Commencement Date for new employees is typically the date of hire. The Vesting Commencement Date for existing employees (e.g.</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">who are receiving a subsequent grant of restricted stock) is typically the date the restricted stock is granted.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Company. Promptly following its receipt of such certificate or certificates, the Company shall pay to the Participant the aggregate Option Price for such Shares (provided that any delay in making such payment shall not invalidate the Company's exercise of the Purchase Option with respect to such Shares).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">After the time at which any Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection (b) above, the Company shall not pay any dividend to the Participant on account of such Shares or permit the Participant to exercise any of the privileges or rights of a stockholder with respect to such Shares, but shall, in so far as permitted by law, treat the Company as the owner of such Shares.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Option Price may be payable, at the option of the Company, (i) in cancellation of all or a portion of any outstanding indebtedness of the Participant to the Company (ii) in cash (by check) or (iii) by any combination of clauses (i)-(ii).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Company shall not purchase any fraction of a Share upon exercise of the Purchase Option, and any fraction of a Share resulting from a computation made pursuant to Section 2 of this Agreement shall be rounded to the nearest whole Share (with any one-half Share being rounded upward).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Option Price as so determined shall be reduced by any amounts owed by Participant to the Company as of the closing date and the amount of any claim by the Company for damages, costs, liability and expenses incurred by the Company and relating to any act or omission by Participant which would constitute termination for cause or material violation by Participant, whether before or after termination of Participant's employment with the Company, of any provision of any agreement between Participant and the Company.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Company may assign its Purchase Option to one or more persons or entities.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">4.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Restrictions on Transfer.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant shall not sell, assign, transfer, pledge, hypothecate or otherwise dispose of, by operation of law or otherwise (collectively &#8220;</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">transfer&#8221;) </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">any Shares, or any interest therein</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">that are subject to the Purchase Option</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">except that the Participant may transfer such Shares (i) to or for the benefit of any spouse</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">children, parents</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">uncles</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">aunts</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">siblings</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">grandchildren and any other relatives approved by the Board of Directors (collectively</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, &#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Approved Relatives&#8221;) or to a trust established solely for the benefit of the Participant and</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#47;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or Approved Relatives</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> that such Shares shall remain subject to this Agreement (including without limitation the restrictions on transfer set forth in this Section 4</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Purchase Option and the right of first refusal set forth in Section 5) and such permitted transferee shall</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">as a condition to such transfer</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">deli</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">v</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">er to the Company a written instrument confirming that such transferee shall be bound b</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">all of the terms and conditions of this Agreement or (ii) as part of the sale of all or substantially all of the shares of capital stock of the Company (including pursuant to a merger or consolidation), </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> that</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">in accordance with the Plan</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the securities or other property received by the Participant in connection with such transaction shall remain subject to this Agreement.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant shall not transfer any Shares</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or any interest therein</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">that are no long</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">e</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">r subject to the Purchase Option</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">except in accordance with Section 5 below.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">5.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Right of First Refusal.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">If the Participant proposes to transfer any Shares that are no longer subject to the Purchase Option (because the Purchase Option expired unexercised)</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">then the Participant shall first give written notice of the proposed transfer (the &#8220;Transfer Notice&#8221;) to the Company. The Transfer Notice shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">name the proposed transferee and state the number of such Shares the Participant proposes to transfer (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Offered Shares&#8221;)</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the price per share and all other material terms and conditions of the transfer.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">For 30 days following its receipt of such Transfer Notice</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Company shall have the option to purchase all or part of the Offered Shares at the price and upon the terms set forth in the Transfer Notice</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">. </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">In the event the Company elects to purchase all or part of the Offered Shares</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">it shall give written notice of such election to the Participant within such 30-day period. Within 10 days after his or her receipt of such notice</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Participant shall tender to the Company at its principal offices the certificate or certificates representing the Offered Shares to be purchased by the Company</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">duly endorsed in blank by the Participant or with duly endorsed stock powers attached thereto</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">all in a form suitable for transfer of the Offered Shares to the Company. Promptly following receipt of such certificate or certificates</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Company shall deliver or mail to the Participant a check in payment of the purchase price for such Offered Shares</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#59; </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided that</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> if the terms of payment set forth in the Transfer Notice were other than cash against delivery</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Company may pay for the Offered Shares on the same terms and conditions as were set forth in the Transfer Notice&#59; and </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided further</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> that any delay in making such payment shall not invalidate the Company</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">' </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s exercise of its option to purchase the Offered Shares.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">If the Company does not elect to acquire all of the Offered Shares</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Participant may</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">within the 30-day period following the expiration of the option granted to the Company under subsection (b) above</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">transfer the Offered Shares which the Company has not elected to acquire to the proposed transferee</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">. </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided that</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> such transfer shall not be on terms and conditions more favorable to the transferee than those contained in the Transfer Notice</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">. </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Notwithstanding any of the above</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">all Offered Shares transferred pursuant to this Section 5 shall remain subject to this Agreement (including without limitation the restrictions on transfer set forth in Section 4 and the right of first refusal set forth in this Section 5) and such transferee shall</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">as a condition to such transfer</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">deliver to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of this Agreement.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">After the time at which the Offered Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection (b) above</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Company shall not pay any dividend to the Participant on account of such Offered Shares or permit the Participant to exercise any of the privileges or rights of a stockholder with respect to such Offered Shares</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">but shall</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">insofar as permitted b</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">law</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">treat the Compan</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y a</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s the owner of such Offered Shares.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The following transactions shall be exempt from the provisions of this Section 5&#58;</font></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(1)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">a transfer of Shares to or for the benefit of any Approved Relatives</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or to a trust established solely for the benefit of the Participant and</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#47;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or Appro</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ve</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">d Relatives</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#59;</font></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(2)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">any transfer pursuant to an effective registration statement filed by the Company under the Securities Act of 1933</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">as amended (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Securities Act&#8221;)</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#59; </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and</font></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(3)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the sale of all or substantially all of the outstanding shares of capital stock of the Company (including pursuant to a merger or consolidation)&#59;</font></div><div><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">however</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">that in the case of a transfer pursuant to clause (1) above</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">such Shares shall remain subject to this Agreement (including without limitation the restrictions on transfer set forth in Section 4 and the right of first refusal set forth in this Section 5) and such transfere</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">e </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">shall</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">as a condition to such transfer</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">deliver to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Compan</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ma</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">assign its rights to purchase Offered Shares in any particular transaction under this Section 5 to one or more persons or entities.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The provisions of this Section 5 shall terminate upon the earlier of the following events&#58;</font></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(1)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the closing of the sale of shares of Common Stock in an underwritten public offering pursuant to an effective registration statement filed by the Company under the Securities Act</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#59; </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or</font></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(2)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the sale of all or substantially all of the outstanding shares of capital stock</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">assets or business of the Company, by merger, consolidation</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">sale of assets or otherwise (other than a merger or consolidation in which all or substantially all of the individuals and entities who were beneficial owners of the Company </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">' </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s voting securities immediately prior to such transaction beneficially own</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">directly or indirectl</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">more than 75% (determined on an as-converted basis) of the outstanding securities entitled to vote generally in the election of directors of the resulting</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">surviving or acquiring corporation in such transaction).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Company shall not be required (1) to transfer on its books any of the Shares which shall have been sold or transferred in violation of any of the provisions set forth in this Agreement </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or (2) to treat as owner of such Shares or to pay dividends to any transferee to whom any such Shares shall have been so sold or transferred.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">6.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Agreement in Connection with Initial Public Offering.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant agrees</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">in connection with the initial underwritten public offering of the Common Stock pursuant to a registration statement under the Securities Act</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(i) not to (a) offer</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">pledge</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">announce the intention to sell</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">sell</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">contract to sell, sell any option or contract to purchase</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">purchase any option or contract to sell, grant any option</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">right or warrant to purchase</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or otherwise transfer or dispose of</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">directly or indirectly</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">any shares of Common Stock or any securities convertible into or exercisable or exchangeable for shares of Common Stock or (b) enter into any swap or other agreement that transfers, in whole or in part</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">any of the economic consequences of ownership of shares of Common Stock</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">whether any transaction described in clause (a) or (b) is to be settled by delivery of shares of Common Stock or other securities</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">in cash or otherwise</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">during the period beginning on the date of the filing of such registration statement with the Securities and Exchange Commission and ending 180 days from the date of the final prospectus relating to the offering (plus up to an additional 34 days to the extent requested by the managing underwriters for such offering in order to address FINRA rules or any similar successor provision)</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and (ii) to execute any agreement reflecting clause (i) above as may be requested by the Company or the managing underwriters at the time of such offering. The Company may impose stop-transfer instructions with respect to the shares of Common Stock or other securities subject to the foregoing restriction until the end of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">lock-up&#8221; period.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">7.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Escrow.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant shall, upon the execution of this Agreement</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">execute Joint Escrow Instructions in the form attached to this Agreement as </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">E</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">xhibit A</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">. The Joint Escrow Instructions shall be delivered to the Secretary of the Company</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">as escrow agent thereunder. The Participant shall deliver to such escrow agent a stock assignment duly endorsed in blank, in the form attached to this Agreement as </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Exhibit B</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and hereby instructs the Compan</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">to deliver to such escrow agent</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">on behalf of the Participant</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the certificate(s) evidencing the Shares issued hereunder. Such materials shall be held by such escrow agent pursuant to the terms of such Joint Escrow Instructions</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">8.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Restrictive Legends.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">All certificates representing Shares shall have affixed thereto legends in substantially the following form</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">in addition to any other legends that may be required under federal or state securities laws&#58;</font></div><div style="padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The shares of stock represented by this certificate are subject to restrictions on transfer and an option to purchase set forth in a certain Restricted Stock Agreement between the corporation and the registered owner of these shares (or his or her predecessor in interest) </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and such Agreement is available for inspection without charge at the office of the Secretary of the corporation.&#8221;</font></div><div style="padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The shares represented by this certificate have not been registered under the Securities Act of 1933</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">as amended</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and may not be sold</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">transferred or otherwise disposed of in the ab</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ence of an effective registration statement under such Act or an opinion of counsel satisfactory to the corporation to the effect that such registration is not required.&#8221;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">9.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Provisions of the Plan.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This Agreement is subject to the provisions of the Plan</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">a copy of which is furnished to the Participant with this Agreement.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">As provided in the Plan</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">upon the occurrence of a Reorganization Event (as defined in the Plan)</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the repurchase and other rights of the Company hereunder shall inure to the benefit of the Company</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">' </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s successor and shall apply to the cash</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">securities or other property which the Shares were converted into or exchanged for pursuant to such Reorganization Event in the same manner and to the same extent as they applied to the Shares under this Agreement. If</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">,</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> in connection with a Reorganization Ev</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">e</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">nt</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">a portion of the cash, securities and</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#47;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or other property received upon the conversion or exchange of the Shares is to be placed into escrow to secure indemnification or similar obligations</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the mix between the </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">v</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ested and unvested portion of such cash</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">securities and</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#47;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or other property that is placed into escrow shall be the same as the mix between the vested and unvested portion of such cash</font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">securities and</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#47;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or other property that is not subject to escrow.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">10.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Investment Representations</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant represents</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">warrants and covenants as follows&#58;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant is purchasing the Shares for his or her own account for investment only, and not with a view to</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or for sale in connection with, any distribution of the Shares in violation of the Securities Act</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or any rule or regulation under the Securities Act.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant has had such opportunity as she has deemed adequate to obtain from representatives of the Company such information as is necessary to permit her to evaluate the merits and risks of his or her investment in the Company</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant has sufficient experience in business</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">financial and investment matters to be able to evaluate the risks involved in the purchase of the Shares and to make an informed investment decision with respect to such purchase</font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant can afford a complete loss of the value of the Shares and is able to bear the economic risk of holding such Shares for an indefinite period.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant understands that (i) the Shares have not been registered under the Securities Act and are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">restricted securities&#8221; within the meaning of Rule 144 under the Securities Act</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#59; </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(ii) the Shares cannot be sold</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">transferred or otherwise disposed of unless they are subsequently registered </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">under the Securities Act or an exemption from registration is then available </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#59; </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(iii) in any event</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the exemption from registration under Rule 144 will not be available for at least one year and even then will not be available unless a public market then exists for the Common Stock</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">adequate information concerning the Company is then available to the public</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">,</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> and other terms and conditions of Rule 144 are complied with&#59; and (iv) there is now no registration statement on file with the Securities and Exchange Commission with respect to any stock of the Company and the Company has no obligation or current intention to register the Shares under the Securities Act.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">11.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Withholding Taxes&#58; Section 83(b) Election.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant acknowledges and agrees that the Compan</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">has the right to deduct from payments of any kind otherwise due to the Participant any federal</font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">state or local taxes of any kind required by law to be withheld with respect to the purchase of the Shares by the Participant or the lapse of the Purchase Option.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant has reviewed with the Participant</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">' </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s own tax advisors the federal, state</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">local and foreign tax consequences of this investment and the transactions contemplated by this Agreement. The Participant is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. The Participant understands that the Participant (and not the Company) shall be responsible for the Participant's own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement. The Participant understands that it may be beneficial in many circumstances to elect to be taxed at the time the Shares are purchased rather than when and as the Compan</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y' </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s Purchase Option expires by filing an election under Section 83(b) of the Internal Revenue Code of 1986 with the I.R.S. within 30 days from the date of purchase.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">THE PARTICIPANT ACKNOWLEDGES THAT IT IS SOLELY THE PARTICIPANT'S RESPONSIBILITY AND NOT THE COMPANY'S TO FILE TIMELY THE ELECTION UNDER SECTION 83(b), EVEN IF THE PARTICIPANT REQUESTS </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">THE COMPANY OR ITS REPRESENTATIVES TO MAKE THIS FILING ON THE PARTICIPANT'S BEHALF.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">12.&#160;&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Miscellaneous</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">No Rights to </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Employment</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant acknowledges and agrees that the vesting of the Shares pursuant to Section 2 hereof is earned only by continuing service as an employee at the will of the Company (not through the act of being hired or purchasing shares hereunder). The Participant further acknowledges and agrees that the transactions contemplated hereunder and the </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">vesting </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">schedule set forth herein do not constitute an express or implied promise of continued engagement as an employee or consultant for the vesting period, for any period, or at all.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Severability</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Waiver</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board of Directors of the Company.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Binding </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Effect</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;This </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Agreement shall be binding upon and inure to the benefit of the Company and the Participant and their respective heirs, executors, administrators, legal representatives, successors and assigns, subject to the restrictions on transfer set forth in Sections 4 and 5 of this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Notice</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">All notices required or permitted hereunder shall be in writing and deemed effectively given upon personal delivery or five days after deposit in the United States Post Office, by registered or certified mail, postage prepaid, addressed to the other party hereto at the address shown beneath his</font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">her or its respective signature to this Agreement</font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or at such other address or addresses as either party shall designate to the other in accordance with this Section 12(e).</font></div><div style="text-indent:72pt"><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Pronouns</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Whenever the context may require, any pronouns used in this Agreement shall include the corresponding masculine</font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">feminine or neuter forms, and the singular form of nouns and pronouns shall include the plural</font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and vice versa.</font></div><div style="text-indent:72pt"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Entire </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Agreement</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This Agreement and the Plan constitute the entire agreement between the parties, and supersedes all prior agreements and understandings, relating to the subject matter of this Agreement.</font></div><div style="text-indent:72pt"><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Amendment</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;This </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Agreement may be amended or modified only by a written instrument executed by both the Company and the Participant.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Governing Law</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This Agreement shall be construed</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">interpreted and enforced in accordance with the internal laws of the State of Delaware without regard to any applicable conflicts of laws.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Participant</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">'</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">s Acknowledgments</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant acknowledges that she&#58; (i) has read this Agreement</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#59; </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(ii) has been represented in the preparation</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">negotiation</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and execution of this Agreement by legal counsel of the Participant</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">' </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s own choice or has voluntarily declined to seek such counsel&#59; (iii) understands the terms and consequences of this Agreement&#59; (iv) is fully aware of the legal and binding effect of this Agreement&#59; and (v) understands that the law firm of Latham &#38; Watkins LLP</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">is acting as counsel to the Company in connection with the transactions contemplated by the Agreement</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and is not acting as counsel for the Participant.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.917%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="21" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARCHERDX, INC.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Address&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2477 55th St</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Boulder</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CO 80301</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PARTICIPANT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Address&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Exhibit A</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Joint Escrow Instructions</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">20&#91;&#160;&#160;&#160;&#160;&#160;&#93;</font></div><div><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ArcherDx, Inc.</font></div><div><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">2477 55th St,</font></div><div><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Boulder, CO 80301</font></div><div><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Attn&#58; Secretary</font></div><div><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Dear Sir</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#47;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Madam&#58;</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">As Escrow Agent for ArcherDx</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Inc.</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">a Delaware corporation</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and its successors in interest under the Restricted Stock Agreement (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Agreement&#8221;) of even date herewith</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">to which a copy of these Joint Escrow Instructions is attached (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Company&#8221;)</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and the undersigned person (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Holder&#8221;)</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">you are hereby authorized and directed to hold the documents delivered to you pursuant to the terms of the Agreement in accordance with the following instructions&#58;</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Appointment.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;Holder irrevocably authorizes the Company to deposit with you any certificates evidencing Shares (as defined in the Agreement) to be held by you hereunder and any additions and substitutions to said Shares. For purposes of these Joint Escrow Instructions</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Shares&#8221;shall be deemed to include any additional or substitute property. Holder does hereby irrevocably constitute and appoint you as her attorne</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">-in-fact and agent for the term of this escrow to execute with respect to such Shares all documents necessary or appropriate to make such Shares negotiable and to complete any transaction herein contemplated. Subject to the provisions of this Section 1and the terms of the Agreement</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Holder shall exercise all rights and privileges of a stockholder of the Company while the Shares are held by you.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Closing of Purchase.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Upon any purchase by the Company of the Shares pursuant to the Agreement </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Company shall give to Holder and you a written notice specifying the number of Shares to be purchased </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the purchase price for the Shares</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">as determined pursuant to the Agreement</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and the time for a closing hereunder (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Closing&#8221;) at the principal office of the Company. Holder and the Company hereb</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">irrevocabl</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">authorize and direct </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ou to close the transaction contemplated by such notice in accordance with the terms of said notice.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">At the Closing</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">you are directed (i) to date the stock assignment form or forms necessary for the transfer of the Shares</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(ii) to fill in on such form or forms the number of Shares being transferred</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and (iii) to deliver the same</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">together with the certificate or certificates evidencing the Shares to be transferred</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">to the Company against the simultaneous delivery to you of the purchase price for the Shares being purchased pursuant to the Agreement.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Withdrawal.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;The Holder shall have the right to withdraw from this escrow any Shares as to which the Purchase Option (as defined in the Agreement) has terminated or expired.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Duties of Escrow Agent.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">a)&#160;&#160;&#160;&#160;Your duties hereunder may be altered , amended, modified or revoked only by a writing signed by all of the parties hereto.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;You shall be obligated only for the performance of such duties as are specifically set forth herein and may rely and shall be protected in relying or refraining from acting on any instrument reasonably believed by you to be genuine and to have been signed or presented by the proper party or parties. You shall not be personally liable for any act you may do or omit to do hereunder as Escrow </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Agent or as attorney-in-fact of Holder while acting in good faith and in the exercise of your own good judgment, and any act done or omitted by you pursuant to the advice of your own attorneys shall be conclusive evidence of such good faith.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(c)&#160;&#160;&#160;&#160;You are hereby expressly authorized to disregard any and all warnings given by any of the parties hereto or by any other person or entity, excepting only orders or process of courts of law, and are hereby expressly authorized to comply with and obey orders, judgments or decrees of any court. If you are uncertain of any actions to be taken or instructions to be followed, you may refuse to act in the absence of an order, judgment or decrees of a court. In case you obey or comply with any such order, judgment or decree of any court, you shall not be liable to any of the parties hereto or to any other person or entity, by reason of such compliance, notwithstanding any such order, judgment or decree being subsequently reversed, modified, annulled, set aside, vacated or found to have been entered without jurisdiction.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(d)&#160;&#160;&#160;&#160;You shall not be liable in any respect on account of the identity, authority or rights of the parties executing or delivering or purporting to execute or deliver the Agreement or any documents or papers deposited or called for hereunder.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(e)&#160;&#160;&#160;&#160;You shall be entitled to employ such legal counsel and other experts as you may deem necessary properly to advise you in connection with your obligations hereunder and may rely upon the advice of such counsel.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(f)&#160;&#160;&#160;&#160;Your rights and responsibilities as Escrow Agent hereunder shall terminate if (i) you cease to be Secretary of the Company or (ii) you resign by written notice to each party. In the event of a termination under clause (i), your successor as Secretary shall become Escrow Agent hereunder&#59; in the event of a termination under clause (ii), the Company shall appoint a successor Escrow Agent hereunder.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(g)&#160;&#160;&#160;&#160;If you reasonably require other or further instruments in connection with these Joint Escrow Instructions or obligations in respect hereto, the necessary parties hereto shall join in furnishing such instruments.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(h)&#160;&#160;&#160;&#160;It is understood and agreed that if you believe a dispute has arisen with respect to the delivery and&#47;or ownership or right of possession of the securities held by you hereunder, you are authorized and directed to retain in your possession without liability to anyone all or any part of said securities until such dispute shall have been settled either by mutual written agreement of the parties concerned or by a final order, decree or judgment of a court of competent jurisdiction after the time for appeal has expired and no appeal has been perfected, but you shall be under no duty whatsoever to institute or defend any such proceedings.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(i)&#160;&#160;&#160;&#160;These Joint Escrow Instructions set forth your sole duties with respect to any and all matters pertinent hereto and no implied duties or obligations shall be read into these Joint Escrow Instructions against you.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(j)&#160;&#160;&#160;&#160;The Company shall indemnify you and hold you harmless against any and all damages, losses, liabilities, costs, and expenses, including attorneys' fees and disbursements, (including without limitation the fees of counsel retained pursuant to Section 4(e) above, for anything done or omitted to be done by you as Escrow Agent in connection with this Agreement or the performance of your duties hereunder, except such as shall result from your gross negligence or willful misconduct.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Notice</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">. Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon personal deli</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">v</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ery or upon deposit in the United States Post Office</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">registered or certified mail with postage and fees prepaid</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">addressed to each of the other parties thereunto entitled at the following addresses</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or at such other addresses as a party may designate by ten days' advance written notice to each of the other parties hereto.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.173%"><tr><td style="width:1.0%"></td><td style="width:31.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.843%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">COMPANY&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notices to the Company shall be sent to </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the address set forth in the salutation </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">hereto, Attn&#58; President</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HOLDER&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notices to Holder shall be sent to the </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">address set forth below Holder's </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">signature below.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ESCROW </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AGENT&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notices to the Escrow Agent shall be </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sent to the address set forth in the </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">salutation hereto.</font></div></td></tr></table></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Miscellaneous</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;By signing these Joint Escrow Instructions, you become a party hereto only for the purpose of said Joint Escrow Instructions, and you do not become a party to the Agreement.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;This instrument shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns.</font></div><div style="text-indent:72pt"><font><br></font></div><div><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Very truly yours,</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.653%"><tr><td style="width:1.0%"></td><td style="width:4.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.942%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.998%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="15" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARCHERDX, INC.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HOLDER&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Signature)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.019%"><tr><td style="width:1.0%"></td><td style="width:14.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.839%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Address&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date Signed&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.102%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ESCROW AGENT&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;, Secretary</font></td></tr></table></div><div><font><br></font></div><div style="text-align:center"><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Exhibit B</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(STOCK ASSIGNMENT SEPARATE FROM CERTIFICATE)</font></div><div style="text-indent:36pt"><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">FOR VALUE RECEIVED</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">I hereby sell</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">assign and transfer unto ______________ (__________) shares of Common Stock</font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">$0.01 par value per share</font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">of ArcherDx</font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Inc. (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Corporation&#8221;) standing in my name on the books of the Corporation represented by Certificate(s) Number __________ herewith</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and do hereby irrevocably constitute and appoint Latham &#38; Watkins LLP attorney to transfer the said stock on the books of the Corporation with full power of substitution in the premises.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.115%"><tr><td style="width:1.0%"></td><td style="width:15.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.854%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14</font></div><div style="text-align:right"><font><br></font></div></div></div><div id="i7ce91d331e2545b088dfba29ab1c092b_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Form of Restricted Stock Agreement </font></div><div style="text-align:right"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">under 2015 Stock Incentive Plan</font></div><div style="text-align:center"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ARCHERDX </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">INC.</font></div><div style="text-align:center"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Restricted Stock Agreement </font></div><div style="text-align:center"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Granted Under 2015 Stock Incentive Plan</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">AGREEMENT made this &#91;&#160;&#160;&#160;&#93; day of &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;, 20&#91;&#160;&#160;&#160;&#93;</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">between ArcherDx</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Inc.</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">a Delaware corporation (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Company&#8221;), and &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Participant&#8221;).</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">For valuable consideration</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">receipt of which is acknowledged</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the parties hereto agree as follows&#58;</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">1.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Purchase of Shares</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Company shall issue and sell to the Participant</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and the Participant shall purchase from the Company, subject to the terms and conditions set forth in this Agreement and in the Company</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">'</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s 2015 Stock Incentive Plan (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Plan&#8221;)</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; shares (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Shares&#8221;) of common stock</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">$0.01 par value</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">of the Company (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Common Stock&#8221;)</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">at a purchase price of $&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; per share. The aggregate purchase price for the Shares shall be paid by the Participant by check payable to the order of the Company or such other method as may be acceptable to the Company. Upon receipt by the Company of payment for the Shares</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Company shall issue to the Participant one or more certificates in the name of the Participant for that number of Shares purchased by the Participant. The Participant agrees that the Shares shall be subject to the right of first refusal set forth in Section 2 of this Agreement.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">2.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Right of First Refusal.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">If the Participant proposes to sell</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">assign</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">transfer, pledge</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">hypothecate or otherwise dispose of</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">by operation of law or otherwise (collectively </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">transfer&#8221;) any Shares</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">then the Participant shall first give written notice of the proposed transfer (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Transfer Notice&#8221;) to the Company. The Transfer Notice shall name the proposed transferee and state the number of such Shares the Participant proposes to transfer (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Offered Shares&#8221;)</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the price per share and all other material terms and conditions of the transfer. For the avoidance of doubt</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Purchaser shall not transfer any Shares</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or any interest therein except in accordance with the terms of this Section 2.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">For 30 days following its receipt of such Transfer Notice</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Company shall have the option to purchase all or part of the Offered Shares at the price and upon the terms set forth in the Transfer Notice. In the event the Company elects to purchase all or part of the Offered Shares, it shall give written notice of such election to the Participant within such 30-day period. Within 10 days after his or her receipt of such notice</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Participant shall tender to the Company at its principal offices the certificate or certificates representing the Offered Shares to be purchased by the Company</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">duly endorsed in blank by the Participant or with duly endorsed stock powers attached thereto</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">all in a form suitable for transfer of the Offered Shares to the Company. Promptly following receipt of such certificate or certificates, the Company shall deliver or mail to the Participant a check in payment of the purchase price for such Offered Shares&#59; </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided that</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> if the terms of payment set forth in the Transfer Notice were other than cash against delivery</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Company may pay for the Offered Shares on the same terms and conditions as were set forth in the Transfer Notice</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#59; </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided further</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> that any delay in making such payment shall not invalidate the Company</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">' </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s exercise of its option to purchase the Offered Shares.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">If the Company does not elect to acquire all of the Offered Shares</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Participant may</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">within the 30-day period following the expiration of the option granted to the Company under subsection (b) above</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">transfer the Offered Shares which the Company has not elected to acquire to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">proposed transferee. </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided that</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> such transfer shall not be on terms and conditions more favorable to the transferee than those contained in the Transfer Notice. Notwithstanding any of the above</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">all Offered Shares transferred pursuant to this Section 2 shall remain subject to this Agreement (including without limitation the right of first refusal set forth in this Section 2) and such transferee shall</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">as a condition to such transfer</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">deliver to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of this Agreement.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">d)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">After the time at which the Offered Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection (b) above</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Company shall not pay any dividend to the Participant on account of such Offered Shares or permit the Participant to exercise any of the privileges or rights of a stockholder with respect to such Offered Shares</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">but shall</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">insofar as permitted b</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">law</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">treat the Company as the owner of such Offered Shares.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">e)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The following transactions shall be exempt from the provisions of this Section 2&#58;</font></div><div style="text-indent:108pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">a transfer of Shares to or for the benefit of any spouse</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">children</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">,</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> parents</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">uncles, aunts</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">siblings</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">grandchildren and any other relatives approved by the Board of Directors (collectively</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Approved Relatives&#8221;) or to a trust established solely for the benefit of the Participant and</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#47;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or Approved Relatives&#59;</font></div><div style="text-indent:108pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">any transfer pursuant to an effective registration statement filed by the Company under the Securities Act of 1933</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">as amended (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Securities Act&#8221;)&#59; and</font></div><div style="text-indent:108pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the sale of all or substantially all of the outstanding shares of capital stock of the Company (including pursuant to a merger or consolidation)&#59;</font></div><div><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">provided</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">however</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">that in the case of a transfer pursuant to clause (1) above</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">such Shares shall remain subject to this Agreement (including without limitation the right of first refusal set forth in this Section 2) and such transferee shall</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">as a condition to such transfer</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">deliver to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of this Agreement.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(f)&#160;&#160;&#160;&#160;The Company may assign its rights to purchase Offered Shares in any particular transaction under this Section 2 to one or more persons or entities.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(g)&#160;&#160;&#160;&#160;The provisions of this Section 2 shall terminate upon the earlier of the following events&#58;</font></div><div style="text-indent:108pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the closing of the sale of shares of Common Stock in an underwritten public offering pursuant to an effective registration statement filed by the Company under the Securities Act&#59; or</font></div><div style="text-indent:108pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the sale of all or substantially all of the outstanding shares of capital stock</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">assets or business of the Company</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">by merger </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">consolidation, sale of assets or otherwise (other than a merger or consolidation in which all or substantiall</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">all of the indi</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">v</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">iduals and entities who were beneficial owners of the Company's voting securities immediately prior to such transaction beneficially own</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">directly or indirectly</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">more than 75% (determined on an as-converted basis) of the outstanding securities entitled to vote generally in the election of directors of the resulting</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">surviving or acquiring corporation in such transaction)</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(h)&#160;&#160;&#160;&#160;The Company shall not be required (1) to transfer on its books any of the Shares which shall have been sold or transferred in violation of any of the provisions set forth in this Agreement</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or (2) to treat as owner of such Shares or to pay dividends to any transferee to whom any such Shares shall have been so sold or transferred.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">3.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Agreement in Connection with Initial Public Offering.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant agrees</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">in connection with the initial underwritten public offering of the Common Stock pursuant to a registration statement under the Securities Act</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(i) not to (a) offer</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">pledge</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">announce the intention to sell</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">sell</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">contract to sell</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">sell any option or contract to purchase</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">purchase any option or contract to sell</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">grant any option</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">right or warrant to purchase</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or otherwise transfer or dispose of</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">directly or indirectly</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">an</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">shares of Common Stock or any securities convertible into or exercisable or exchangeable for shares of Common Stock or (b) enter into any swap or other agreement that transfers</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">in whole or in part</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">any of the economic consequences of ownership of shares of Common Stock</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">whether any transaction described in clause (a) or (b) is to be settled by delivery of shares of Common Stock or other securities</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">in cash or otherwise</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">during the period beginning on the date of the filing of such registration statement with the Securities and Exchange Commission and ending 180 days from the date of the final prospectus relating to the offering (plus up to an additional 34 days to the extent requested by the managing underwriters for such offering in order to address FINRA rules or any similar successor provision)</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and (ii) to execute any agreement reflecting clause (i) above as may be requested by the Company or the managing underwriters at the time of such offering. The Company may impose stop-transfer instructions with respect to the shares of Common Stock or other securities subject to the foregoing restriction until the end of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">lock-up&#8221; period.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">4.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Escrow.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant shall</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">upon the execution of this Agreement</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">execute Joint Escrow Instructions in the form attached to this Agreement as </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Exhibit A</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">. The Joint Escrow Instructions shall be delivered to the Secretary of the Company</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">as escrow agent thereunder. The Participant shall deliver to such escrow agent a stock assignment duly endorsed in blank</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">in the form attached to this Agreement as </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Exhibit B</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and hereby instructs the Company to deliver to such escrow agent</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">on behalf of the Participant </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the certificate(s) evidencing the Shares issued hereunder. Such materials shall be held by such escrow agent pursuant to the terms of such Joint Escrow Instructions.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">5.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Restrictive Legends.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">All certificates representing Shares shall have affixed thereto legends in substantially the following form</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">in addition to any other legends that may be required under federal or state securities laws&#58;</font></div><div style="padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The shares of stock represented by this certificate are subject to a right of first refusal set forth in a certain Restricted Stock Agreement between the corporation and the registered owner of these shares (or his or her predecessor in interest)</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and such Agreement is available for inspection without charge at the office of the Secretary of the corporation.&#8221;</font></div><div style="padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The shares represented by this certificate have not been registered under the Securities Act of 1933</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">as amended</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and may not be sold</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">transferred or otherwise disposed of in the absence of an effective registration statement under such Act or an opinion of counsel satisfactory to the corporation to the effect that such registration is not required</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.&#8221;</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">6.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Provisions of the Plan.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This Agreement is subject to the provisions of the Plan</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">a copy of which is furnished to the Participant with this Agreement.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">As provided in the Plan</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">upon the occurrence of a Reorganization Event (as defined in the Plan), the rights of the Company hereunder shall inure to the benefit of the Company</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">' </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s successor and shall apply to the cash</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">securities or other property which the Shares were converted into or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">exchanged for pursuant to such Reorganization Event in the same manner and to the same extent as they applied to the Shares under this Agreement.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">7.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Investment Representations.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant represents, warrants and covenants as follows&#58;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;The Participant is purchasing the Shares for his or her own account for investment only, and not with a view to, or for sale in connection with, any distribution of the Shares in violation of the Securities Act, or any rule or regulation under the Securities Act.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;The Participant has had such opportunity as she has deemed adequate to obtain from representatives of the Company such information as is necessary to permit her to evaluate the merits and risks of his or her investment in the Company.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(c)&#160;&#160;&#160;&#160;The Participant has sufficient experience in business, financial and investment matters to be able to evaluate the risks involved in the purchase of the Shares and to make an informed investment decision with respect to such purchase.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(d)&#160;&#160;&#160;&#160;The Participant can afford a complete loss of the value of the Shares and is able to bear the economic risk of holding such Shares for an indefinite period.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(e)&#160;&#160;&#160;&#160;The Participant understands that (i) the Shares have not been registered under the Securities Act and are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">restricted securities&#8221; within the meaning of Rule 144 under the Securities Act&#59; (ii) the Shares cannot be sold , transferred or otherwise disposed of unless they are subsequently registered under the Securities Act or an exemption from registration is then available &#59; (iii) in any event, the exemption from registration under Rul</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">e 144 will not be available for at least one year and even then will not be available unless a public market then exists for the Common Stock</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">adequate information concerning the Company is then available to the public</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">,</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> and other terms and conditions of Rule 144 are complied with</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#59; </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and (iv) there is now no registration statement on file with the Securities and Exchange Commission with respect to any stock of the Company and the Company has no obligation or current intention to register the Shares under the Securities Act.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">8.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Withholding Taxes.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;The Participant acknowledges and agrees that the Company has the right to deduct from payments of any kind otherwise due to the Participant any federal, state or local taxes of any kind required by law to be withheld with respect to the purchase of the Shares by the Participant.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;The Participant has reviewed with the Participant's own tax advisors the federal, state , local and foreign tax consequences of this investment and the transactions contemplated by this Agreement. The Participant is rely</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ing solely on such advisors and not on any statements or representations of the Company or any of its agents. The Participant understands that the Participant (and not the Company) shall be responsible for the Participant</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">' </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">9.&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Miscellaneous.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">No Rights to Employment.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;The Participant acknowledges and agrees that the transactions contemplated hereunder do not constitute an express or implied promise of continued engagement as an employee or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">consultant</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> for any period or at all.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Severability.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;The invalidity or unenforceability of any provision of this Agreement shall not affect the </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">v</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">alidity or enforceability of an</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">other </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">provision</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> of this Agreement</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Waiver.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;Any provision for the benefit of the Company contained in this Agreement may be waived</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">either generally or in any </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">particular</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> instance</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">by the Board of Directors of the Company.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Binding Effect.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;This Agreement shall be binding upon and inure to the benefit of the Company and the Participant and their respective heirs</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">executors</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">administrators</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">,</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> legal representatives</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">successors and assigns</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">subject to the right of first refusal set forth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> in</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> Section 2 of this Agreement.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Notice.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;All notices required or permitted hereunder shall be in writing and deemed effectively given upon personal delivery or five days after deposit in the United States Post Office</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">by registered or certified mail</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">postage prepaid</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">addressed to the other party hereto at the address shown beneath his</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">her or its respective signature to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Agreement</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or at such other address or addresses as either party shall designate to the other in accordance with this Section 9(e).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Pronouns.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;Whenever the context ma</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">require</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">any pronouns used in this Agreement shall include the corresponding masculine </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">feminine</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> or</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> neuter forms</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and the singular form of nouns and pronouns shall include the plural</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and vice versa.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Entire Agreement.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Agreement</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> and the Plan constitute the entire agreement between the parti</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">e</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and supersedes all prior agreements and understandings</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">relating to the subject matter of this Agreement.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Amendment.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This Agreement may be amended or modified only by a written instrument executed by both the Company and the Participant.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This Agreement shall be construed, interpreted and enforced in accordance with the internal laws of the State of Delaware without regard to any applicable conflicts of laws.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Participant's Acknowledgments.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Participant acknowledges that she&#58;(i) has re</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ad this Agreement&#59; (ii) has been represented in the preparation</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">negotiation </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and execution of this Agreement b</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">legal counsel of the Participant</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">' </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">s own choice or has voluntarily declined to seek such counsel</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#59; </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(iii) understands the terms and consequences of this Agreement</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#59; (iv) </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">is fully aware of the legal and binding effect of this Agreement</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#59; </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and (v) understands that the law firm of Latham &#38; Watkins LLP</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">is acting as counsel to the Company in connection with the transactions contemplated by the Agreement</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and is not acting as counsel for the Participant.</font></div><div style="text-indent:36pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">IN WITNESS WHEREOF</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the parties hereto have executed this Agreement as of the day and year first above written</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.551%"><tr><td style="width:1.0%"></td><td style="width:4.890%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.959%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.793%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="18" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARCHERDX, INC.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Address&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2477 55th St</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Boulder</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CO 80301</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PARTICIPANT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Address&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Exhibit A</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Joint Escrow Instructions</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">20&#91;&#160;&#160;&#93;</font></div><div><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">ArcherDx, Inc.</font></div><div><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">2477 55th St,</font></div><div><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Boulder, CO 80301</font></div><div><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Attn&#58; Secretary</font></div><div><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Dear Sir</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#47;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Madam&#58;</font></div><div style="text-indent:36pt"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">As Escrow Agent for ArcherDx</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Inc.</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">a Delaware corporation</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and its successors in interest under the Restricted Stock Agreement (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Agreement&#8221;) of even date herewith, to which a copy of these Joint Escrow Instructions is attached (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Company&#8221;) </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and the undersigned person (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Holder&#8221;), you are hereby authorized and directed to hold the documents delivered to you pursuant to the terms of the Agreement in accordance with the following instructions&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Appointment.</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;Holder irrevocably authorizes the Company to deposit with you any certificates evidencing Shares (as defined in the Agreement) to be held by you hereunder and any additions and substitutions to said Shares. For purposes of these Joint Escrow Instructions</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Shares&#8221; shall be deemed to include any additional or substitute property. Holder does hereby irrevocably constitute and appoint you as her attorney-in-fact and agent for the term of this escrow to execute with respect to such Shares all documents necessary or appropriate to make such Shares negotiable and to complete any transaction herein contemplated. Subject to the provisions of this Section 1 and the terms of the Agreement</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Holder shall exercise all rights and privileges of a stockholder of the Company while the Shares are held by you.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Closing of Purchase.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Upon any purchase by the Company of the Shares pursuant to the Agreement </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the Company shall give to Holder and you a written notice specifying the number of Shares to be purchased </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the purchase price for the Shares</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">as determined pursuant to the Agreement</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and the time for a closing hereunder (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Closing&#8221;) at the principal office of the Company. Holder and the Company hereby irrevocably authorize and direct you to close the transaction contemplated by such notice in accordance with the terms of said notice.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">At the Closing, you are directed (i) to date the stock assignment form or forms necessary for the transfer of the Shares</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(ii) to fill in on such form or forms the number of Shares being transferred</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and (iii) to deliver the same, together with the certificate or certificates </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">evidencing the Shares to be transferred</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">to the Company against the simultaneous delivery to you of the purchase price for the Shares being purchased pursuant to the Agreement.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Duties of Escrow Agent.</font></div><div style="text-indent:72pt"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)Your duties hereunder may be altered, amended, modified or revoked only by a writing signed by all of the parties hereto.</font></div><div style="text-indent:72pt"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)You shall be obligated only for the performance of such duties as are specifically set forth herein and may rely and shall be protected in relying or refraining from acting on any instrument reasonably believed by you to be genuine and to have been signed or presented by the proper party or parties. You shall not be personally liable for any act you may do or omit to do hereunder as Escrow Agent or as attorney-in-fact of Holder while acting in good faith and in the exercise of your own good </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">judgment, and any act done or omitted by you pursuant to the advice of your own attorneys shall be conclusive evidence of such good faith .</font></div><div style="text-indent:72pt"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(c)You are hereby expressly authorized to disregard any and all warnings given by any of the parties hereto or by any </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">other person or entity</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">excepting only orders or process of courts of law</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and are hereby expressly authorized to comply with and obey orders</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">,</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> judgments or decrees of any court. If you are uncertain of any actions to be taken or instructions to be followed, you may refuse to act in the absence of an order</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">judgment or decrees of a court. In case you obey or comply with any such order</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">judgment or decree of any court</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">you shall not be liable to any of the parties hereto or to any other person or entit</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">y, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">by reason of such compliance</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">notwithstanding any such order</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">judgment or decree being subsequently reversed</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">modified</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">annulled</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">set aside</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, v</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">acated or found to have been entered without jurisdiction</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:72pt"><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(d)</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">You shall not be liable in any respect on account of the identity, authority or rights of the parties executing or delivering or purporting to execute or deliver the Agreement or any documents or papers deposited or called for hereunder.</font></div><div style="text-indent:72pt"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(e)You shall be entitled to employ such legal counsel and other experts as you may deem necessary properly to advise you in connection with your obligations hereunder and may rely upon the advice of such counsel.</font></div><div style="text-indent:72pt"><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(f)Your rights and responsibilities as Escrow Agent hereunder shall terminate if (i) you cease to be Secretary of the Company or (ii) you resign by written notice to each party. In the event of a termination under clause (i), your successor as Secretary shall become Escrow Agent hereunder&#59; in the event of a termination under clause (ii), th</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">e Company shall appoint a successor Escrow Agent hereunder.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(g)</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">If</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> you reasonably require other or further instruments in connection with these Joint </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">E</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">scrow Instructions or obligations in respect hereto</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">the necessary parties hereto shall join in furnishing such instruments.</font></div><div style="text-indent:72pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(h)</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">It is understood and agreed that if you believe a dispute has arisen with respect to the delivery and</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#47;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or ownership or right of possession of the securities held by you hereunder</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">you are authorized and directed to retain in your possession without liability to anyone all or any part of said securities until such dispute shall have been settled either by mutual written agreement of the parties concerned or by a final order, decree or judgment of a court of competent jurisdiction after the time for appeal has expired and no appeal has been perfected</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">but you shall be under no duty whatsoever to institute or defend any such proceedings.</font></div><div style="text-indent:72pt"><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(i)These Joint Escrow Instructions set forth your sole duties with respect to any and all matters pertinent hereto and no implied duties or obligations shall be read into these Joint </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Escrow </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Instructions against you.</font></div><div style="text-indent:72pt"><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(j)The Company shall indemnify </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">you </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and hold you harmless against any and all damages</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">losses </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">liabilities </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">costs</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and expenses</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">including attorneys </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">' </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">fees and disbursements, (including without limitation the fees of counsel retained pursuant to Section 3(e) above</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">for anything done or omitted to be done by you as Escrow Agent in connection with this Agreement or the performance of your duties hereunder</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">except such as shall result from your gross negligence or willful misconduct.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Notice</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">. Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon personal delivery or upon deposit in the United States Post Office, by registered or certified mail with postage and fees prepaid, addressed to each of the other parties thereunto </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">entitled at the following addresses</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">or at such other addresses as a party may designate by ten days' advance written notice to each of the other parties hereto.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.173%"><tr><td style="width:1.0%"></td><td style="width:31.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.843%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">COMPANY&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notices to the Company shall be sent to </font></div><div><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the address set forth in the salutation </font></div><div><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">hereto, Attn&#58; President</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HOLDER&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notices to Holder shall be sent to the </font></div><div><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">address set forth below Holder's </font></div><div><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">signature below.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ESCROW </font></div><div><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AGENT&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notices to the Escrow Agent shall be </font></div><div><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sent to the address set forth in the </font></div><div><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">salutation hereto.</font></div></td></tr></table></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Miscellaneous</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">By signing these Joint Escrow Instructions, </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">you </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">become a party hereto only for the purpose of said Joint Escrow Instructions</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and you do not become a party to the Agreement.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This instrument shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns.</font></div><div><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Very truly yours</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">,</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.198%"><tr><td style="width:1.0%"></td><td style="width:4.947%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.899%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="15" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARCHERDX </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">INC.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">HOLDER&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Signature)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.762%"><tr><td style="width:1.0%"></td><td style="width:18.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.941%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Address&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date Signed&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.974%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ESCROW AGENT&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;, Secretary</font></td></tr></table></div><div style="text-align:center"><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Exhibit B</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(STOCK ASSIGNMENT SEPARATE FROM CERTIFICATE)</font></div><div style="text-indent:36pt"><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">FOR VALUE RECEIVED</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">I hereby sell</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">assign and transfer unto ______________(__________) shares of Common Stock</font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">$0.01 par value per share</font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">of ArcherDx</font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Inc. (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Corporation&#8221;) standing in my name on the books of the Corporation represented by Certificate(s) Number __________herewith</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">and do hereby irrevocably constitute and appoint Latham &#38; Watkins LLP attorney to transfer the said stock on the books of the Corporation with full power of substitution in the premises.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.955%"><tr><td style="width:1.0%"></td><td style="width:14.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.801%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.959%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div><div style="text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>6
<FILENAME>exhibit211-listofsubsidiar.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i4411e8f69cc049c2a44df683e21c8b27_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;21.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">LIST OF SUBSIDIARIES OF INVITAE CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.720%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction</font></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ArcherDX, LLC</font></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Archer DX Clinical Services, Inc. </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clear Genetics, Inc.</font></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CombiMatrix Corporation</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CombiMatrix Molecular Diagnostics, Inc.</font></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genelex India Private Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genetic Solutions LLC, d&#47;b&#47;a Genelex</font></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Good Start Genetics, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jungla, LLC</font></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Invitae Australia PTY LTD</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Invitae Canada Inc.</font></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Colombia, Canada</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Invitae Israel, Inc. </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Invitae Japan, KK</font></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Invitae Latvia, SIA</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latvia</font></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Invitae Medical Genetics Brasil, Ltda.</font></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Invitae Netherlands, BV</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ommdom Inc.</font></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orbicule BVBA d&#47;b&#47;a Diploid</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PatientCrossroads, Inc.</font></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singular Bio, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YouScript LLC</font></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>exhibit231-sx8consentx1231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id040829c10e94dd983b0a4f64732785b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.630%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration Statements on Form S-3 (Nos. 333-220053,  333-220054 and 333-226756) of Invitae Corporation and the related prospectuses</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Registration Statements on Form S-3ASR (Nos. 333-230053, 333-233109, 333-233110, 333-234768 333-237268, 333-237758 and 333-237759)&#160;of Invitae Corporation and the related prospectuses</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration Statement on Form S-4 (No. 333-220447) of Invitae Corporation, including any post-effective amendments thereto on Form S-3 or Form S-8</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration Statement on Form S-4 (No. 333-240137) of Invitae Corporation, including any post-effective amendments thereto on Form S-8</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration Statement on Form S-8 (No. 333-202066) pertaining to the 2015 Stock Incentive Plan, the Employee Stock Purchase Plan, and the 2010 Stock Incentive Plan of Invitae Corporation</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration Statements on Form S-8 (Nos. 333-216761, 333-223455 ,333-229972 and 333-236799) pertaining to the 2015 Stock Incentive Plan and the Employee Stock Purchase Plan of Invitae Corporation</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Registration Statement on Form S-8 (Nos. 333-232208, 333-237073, 333-240360 and 333-249894) pertaining to the 2015 Stock Incentive Plan of Invitae Corporation</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our reports dated February&#160;26, 2021, with respect to the consolidated financial statements of Invitae Corporation and the effectiveness of internal control over financial reporting of Invitae Corporation included in this Annual Report (Form 10-K) of Invitae Corporation for the year ended December&#160;31, 2020.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redwood City, California</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;26, 2021 </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>8
<FILENAME>exhibit311-q42020.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i1a9caf4bf2bb45459c1b01e95f0cfffd_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRINCIPAL EXECUTIVE OFFICER&#8217;S CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;302 OF THE SARBANES&#8209;OXLEY ACT OF&#160;2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Sean E. George, certify that&#58;</font></div><div style="margin-top:12pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this annual report on Form&#160;10&#8209;K of Invitae Corporation&#59;</font></div><div style="margin-top:12pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a&#8209;15(e) and 15d&#8209;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:34.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; February 26, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sean E. George, Ph.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sean E. George, Ph.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer (Principal Executive Officer) and Director</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>9
<FILENAME>exhibit312-q42020.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ic5773daa814e4848813ad5a9ee709ffb_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER&#8217;S CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;302 OF THE SARBANES&#8209;OXLEY ACT OF&#160;2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Shelly D. Guyer, certify that&#58;</font></div><div style="margin-top:12pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this annual report on Form&#160;10&#8209;K of Invitae Corporation&#59;</font></div><div style="margin-top:12pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a&#8209;15(e) and 15d&#8209;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.419%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; February 26, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Shelly D. Guyer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shelly D. Guyer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer (Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>10
<FILENAME>exhibit321-q42020.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iccbd8d1cfab8441c9dc497c540dfed78_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES&#8209;OXLEY ACT OF&#160;2002</font></div><div style="margin-top:12pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the annual report of Invitae Corporation (the &#8220;Company&#8221;) on Form&#160;10&#8209;K for the year ended December&#160;31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes&#8209;Oxley Act of 2002, that, to such officer&#8217;s knowledge&#58;</font></div><div style="margin-top:12pt;text-indent:31.5pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;26, 2021 </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sean E. George, Ph.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sean E. George, Ph.D.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer (Principal Executive Officer) and Director</font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>11
<FILENAME>exhibit322-q42020.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="if7a17a34e5284af9842a29f23aa0bf2d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES&#8209;OXLEY ACT OF&#160;2002</font></div><div style="margin-top:12pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the annual report of Invitae Corporation (the &#8220;Company&#8221;) on Form&#160;10&#8209;K for the year ended December&#160;31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to such officer&#8217;s knowledge&#58;</font></div><div style="margin-top:12pt;text-indent:31.5pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;26, 2021 </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Shelly D. Guyer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shelly D. Guyer<br>Chief Financial Officer (Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>nvta-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:1a5642af-41c4-4761-89fa-6771b997ee20,g:0d35037d-3d4c-4753-897e-12e6bc13039e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nvta="http://www.invitae.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.invitae.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nvta-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nvta-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nvta-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nvta-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.invitae.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.invitae.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.invitae.com/role/ConsolidatedStatementsofOperations">
        <link:definition>1003004 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss">
        <link:definition>1004005 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>1005006 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.invitae.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1006007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Organizationanddescriptionofbusiness" roleURI="http://www.invitae.com/role/Organizationanddescriptionofbusiness">
        <link:definition>2101101 - Disclosure - Organization and description of business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationanddescriptionofbusinessDetails" roleURI="http://www.invitae.com/role/OrganizationanddescriptionofbusinessDetails">
        <link:definition>2402401 - Disclosure - Organization and description of business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Summaryofsignificantaccountingpolicies" roleURI="http://www.invitae.com/role/Summaryofsignificantaccountingpolicies">
        <link:definition>2103102 - Disclosure - Summary of significant accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesPolicies" roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies">
        <link:definition>2204201 - Disclosure - Summary of significant accounting policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesTables" roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesTables">
        <link:definition>2305301 - Disclosure - Summary of significant accounting policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesNarrativeDetails" roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails">
        <link:definition>2406402 - Disclosure - Summary of significant accounting policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails" roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails">
        <link:definition>2407403 - Disclosure - Summary of significant accounting policies - Schedule of significant customers, revenue as a percentage (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails" roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails">
        <link:definition>2408404 - Disclosure - Summary of significant accounting policies - Schedule of cash, cash equivalents and restricted cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails" roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails">
        <link:definition>2409405 - Disclosure - Summary of significant accounting policies - Schedule of useful lives of property and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenueaccountsreceivableanddeferredrevenue" roleURI="http://www.invitae.com/role/Revenueaccountsreceivableanddeferredrevenue">
        <link:definition>2110103 - Disclosure - Revenue, accounts receivable and deferred revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueaccountsreceivableanddeferredrevenueTables" roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueTables">
        <link:definition>2311302 - Disclosure - Revenue, accounts receivable and deferred revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails" roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails">
        <link:definition>2412406 - Disclosure - Revenue, accounts receivable and deferred revenue - Schedule of disaggregated revenue by payer category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails" roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails">
        <link:definition>2413407 - Disclosure - Revenue, accounts receivable and deferred revenue - Schedule of change in estimate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueaccountsreceivableanddeferredrevenueNarrativeDetails" roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails">
        <link:definition>2414408 - Disclosure - Revenue, accounts receivable and deferred revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Businesscombinations" roleURI="http://www.invitae.com/role/Businesscombinations">
        <link:definition>2115104 - Disclosure - Business combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsTables" roleURI="http://www.invitae.com/role/BusinesscombinationsTables">
        <link:definition>2316303 - Disclosure - Business combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsSingularBioDetails" roleURI="http://www.invitae.com/role/BusinesscombinationsSingularBioDetails">
        <link:definition>2417409 - Disclosure - Business combinations - Singular Bio (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsJunglaDetails" roleURI="http://www.invitae.com/role/BusinesscombinationsJunglaDetails">
        <link:definition>2418410 - Disclosure - Business combinations - Jungla (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsClearGeneticsDetails" roleURI="http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails">
        <link:definition>2419411 - Disclosure - Business combinations - Clear Genetics (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsDiploidDetails" roleURI="http://www.invitae.com/role/BusinesscombinationsDiploidDetails">
        <link:definition>2420412 - Disclosure - Business combinations - Diploid (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails" roleURI="http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails">
        <link:definition>2421413 - Disclosure - Business combinations - Summary of the purchase price and post-combination expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails" roleURI="http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails">
        <link:definition>2422414 - Disclosure - Business combinations - Summary of fair values of assets acquired and liabilities assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsGenelexandYouScriptDetails" roleURI="http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails">
        <link:definition>2423415 - Disclosure - Business combinations - Genelex and YouScript (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsArcherDXDetails" roleURI="http://www.invitae.com/role/BusinesscombinationsArcherDXDetails">
        <link:definition>2424416 - Disclosure - Business combinations - ArcherDX (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsSummaryofintangibleassetsacquiredDetails" roleURI="http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails">
        <link:definition>2425417 - Disclosure - Business combinations - Summary of intangible assets acquired (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsScheduleofproformafinancialinformationDetails" roleURI="http://www.invitae.com/role/BusinesscombinationsScheduleofproformafinancialinformationDetails">
        <link:definition>2426418 - Disclosure - Business combinations - Schedule of pro forma financial information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwillandintangibleassets" roleURI="http://www.invitae.com/role/Goodwillandintangibleassets">
        <link:definition>2127105 - Disclosure - Goodwill and intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandintangibleassetsTables" roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsTables">
        <link:definition>2328304 - Disclosure - Goodwill and intangible assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandintangibleassetsSummaryofgoodwillDetails" roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails">
        <link:definition>2429419 - Disclosure - Goodwill and intangible assets - Summary of goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandintangibleassetsScheduleofintangibleassetsDetails" roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails">
        <link:definition>2430420 - Disclosure - Goodwill and intangible assets - Schedule of intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandintangibleassetsScheduleofintangibleassetsDetails_1" roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails_1">
        <link:definition>2430420 - Disclosure - Goodwill and intangible assets - Schedule of intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandintangibleassetsNarrativeDetails" roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails">
        <link:definition>2431421 - Disclosure - Goodwill and intangible assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails" roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails">
        <link:definition>2432422 - Disclosure - Goodwill and intangible assets - Summary of estimated future amortization expense of intangible assets with finite lives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Balancesheetcomponents" roleURI="http://www.invitae.com/role/Balancesheetcomponents">
        <link:definition>2133106 - Disclosure - Balance sheet components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalancesheetcomponentsTables" roleURI="http://www.invitae.com/role/BalancesheetcomponentsTables">
        <link:definition>2334305 - Disclosure - Balance sheet components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalancesheetcomponentsScheduleofinventoryDetails" roleURI="http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails">
        <link:definition>2435423 - Disclosure - Balance sheet components - Schedule of inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalancesheetcomponentsPropertyandequipmentDetails" roleURI="http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails">
        <link:definition>2436424 - Disclosure - Balance sheet components - Property and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalancesheetcomponentsAccruedliabilitiesDetails" roleURI="http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails">
        <link:definition>2437425 - Disclosure - Balance sheet components - Accrued liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalancesheetcomponentsOtherlongtermliabilitiesDetails" roleURI="http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails">
        <link:definition>2438426 - Disclosure - Balance sheet components - Other long-term liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Fairvaluemeasurements" roleURI="http://www.invitae.com/role/Fairvaluemeasurements">
        <link:definition>2139107 - Disclosure - Fair value measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvaluemeasurementsTables" roleURI="http://www.invitae.com/role/FairvaluemeasurementsTables">
        <link:definition>2340306 - Disclosure - Fair value measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails" roleURI="http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails">
        <link:definition>2441427 - Disclosure - Fair value measurements - Financial instruments at fair value on a recurring basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvaluemeasurementsNarrativeDetails" roleURI="http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails">
        <link:definition>2442428 - Disclosure - Fair value measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Commitmentsandcontingencies" roleURI="http://www.invitae.com/role/Commitmentsandcontingencies">
        <link:definition>2143108 - Disclosure - Commitments and contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandcontingenciesTables" roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesTables">
        <link:definition>2344307 - Disclosure - Commitments and contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandcontingenciesLeaseadditionalinformationDetails" roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails">
        <link:definition>2445429 - Disclosure - Commitments and contingencies - Lease additional information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails" roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails">
        <link:definition>2446430 - Disclosure - Commitments and contingencies - Supplemental information regarding our operating and finance leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails" roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails">
        <link:definition>2447431 - Disclosure - Commitments and contingencies - Schedule of future payments under operating and finance leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails_1" roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails_1">
        <link:definition>2447431 - Disclosure - Commitments and contingencies - Schedule of future payments under operating and finance leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandcontingenciesDebtfinancingDetails" roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails">
        <link:definition>2448432 - Disclosure - Commitments and contingencies - Debt financing (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandcontingenciesConvertibleseniornotesDetails" roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails">
        <link:definition>2449433 - Disclosure - Commitments and contingencies - Convertible senior notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandcontingenciesComponentsofdebtDetails" roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails">
        <link:definition>2450434 - Disclosure - Commitments and contingencies - Components of debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandcontingenciesOthercommitmentsDetails" roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails">
        <link:definition>2451435 - Disclosure - Commitments and contingencies - Other commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Stockholdersequity" roleURI="http://www.invitae.com/role/Stockholdersequity">
        <link:definition>2152109 - Disclosure - Stockholders' equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersequityTables" roleURI="http://www.invitae.com/role/StockholdersequityTables">
        <link:definition>2353308 - Disclosure - Stockholders' equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails" roleURI="http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails">
        <link:definition>2454436 - Disclosure - Stockholders' equity - Schedule of convertible preferred and common stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersequityNarrativeDetails" roleURI="http://www.invitae.com/role/StockholdersequityNarrativeDetails">
        <link:definition>2455437 - Disclosure - Stockholders' equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails" roleURI="http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails">
        <link:definition>2456438 - Disclosure - Stockholders' equity - Schedule of outstanding warrants to purchase common stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Stockincentiveplans" roleURI="http://www.invitae.com/role/Stockincentiveplans">
        <link:definition>2157110 - Disclosure - Stock incentive plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockincentiveplansTables" roleURI="http://www.invitae.com/role/StockincentiveplansTables">
        <link:definition>2358309 - Disclosure - Stock incentive plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockincentiveplansAdditionalInformationDetails" roleURI="http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails">
        <link:definition>2459439 - Disclosure - Stock incentive plans - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockincentiveplansScheduleofactivityunderstockincentiveplansDetails" roleURI="http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails">
        <link:definition>2460440 - Disclosure - Stock incentive plans - Schedule of activity under stock incentive plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockincentiveplansSummaryofRSUactivityDetails" roleURI="http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails">
        <link:definition>2461441 - Disclosure - Stock incentive plans - Summary of RSU activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails" roleURI="http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails">
        <link:definition>2462442 - Disclosure - Stock incentive plans - Schedule of assumptions used in determination of fair value of options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockincentiveplansStockbasedcompensationexpenseDetails" roleURI="http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails">
        <link:definition>2463443 - Disclosure - Stock incentive plans - Stock-based compensation expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Incometaxes" roleURI="http://www.invitae.com/role/Incometaxes">
        <link:definition>2164111 - Disclosure - Income taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesTables" roleURI="http://www.invitae.com/role/IncometaxesTables">
        <link:definition>2365310 - Disclosure - Income taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails" roleURI="http://www.invitae.com/role/IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails">
        <link:definition>2466444 - Disclosure - Income taxes - Schedule of components of loss before income taxes by U.S. and foreign jurisdictions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails" roleURI="http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails">
        <link:definition>2467445 - Disclosure - Income taxes - Schedule of components of the provision for income taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails" roleURI="http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails">
        <link:definition>2468446 - Disclosure - Income taxes - Schedule of reconciliation of the tax expense computed at the statutory federal rate and Company's tax expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesScheduleofnetdeferredtaxassetsDetails" roleURI="http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails">
        <link:definition>2469447 - Disclosure - Income taxes - Schedule of net deferred tax assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesNarrativeDetails" roleURI="http://www.invitae.com/role/IncometaxesNarrativeDetails">
        <link:definition>2470448 - Disclosure - Income taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails" roleURI="http://www.invitae.com/role/IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails">
        <link:definition>2471449 - Disclosure - Income taxes - Schedule of reconciliation of unrecognized tax benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Netlosspershare" roleURI="http://www.invitae.com/role/Netlosspershare">
        <link:definition>2172112 - Disclosure - Net loss per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetlosspershareTables" roleURI="http://www.invitae.com/role/NetlosspershareTables">
        <link:definition>2373311 - Disclosure - Net loss per share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetlosspershareScheduleofearningspersharebasicanddilutedDetails" roleURI="http://www.invitae.com/role/NetlosspershareScheduleofearningspersharebasicanddilutedDetails">
        <link:definition>2474450 - Disclosure - Net loss per share - Schedule of earnings per share, basic and diluted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails" roleURI="http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails">
        <link:definition>2475451 - Disclosure - Net loss per share - Schedule of antidilutive securities excluded from computation of earnings per share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Geographicinformation" roleURI="http://www.invitae.com/role/Geographicinformation">
        <link:definition>2176113 - Disclosure - Geographic information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeographicinformationTables" roleURI="http://www.invitae.com/role/GeographicinformationTables">
        <link:definition>2377312 - Disclosure - Geographic information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeographicinformationDetails" roleURI="http://www.invitae.com/role/GeographicinformationDetails">
        <link:definition>2478452 - Disclosure - Geographic information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Selectedquarterlydataunaudited" roleURI="http://www.invitae.com/role/Selectedquarterlydataunaudited">
        <link:definition>2179114 - Disclosure - Selected quarterly data (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SelectedquarterlydataunauditedTables" roleURI="http://www.invitae.com/role/SelectedquarterlydataunauditedTables">
        <link:definition>2380313 - Disclosure - Selected quarterly data (unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SelectedquarterlydataunauditedDetails" roleURI="http://www.invitae.com/role/SelectedquarterlydataunauditedDetails">
        <link:definition>2481453 - Disclosure - Selected quarterly data (unaudited) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Subsequentevent" roleURI="http://www.invitae.com/role/Subsequentevent">
        <link:definition>2182115 - Disclosure - Subsequent event</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequenteventsDetails" roleURI="http://www.invitae.com/role/SubsequenteventsDetails">
        <link:definition>2483454 - Disclosure - Subsequent events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" abstract="false" name="CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_SubjectToExpirationMember" abstract="true" name="SubjectToExpirationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_ConvertibleSeniorNotesMember" abstract="true" name="ConvertibleSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_LeasesCashPaymentsIncludedInMeasurementAbstract" abstract="true" name="LeasesCashPaymentsIncludedInMeasurementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="nvta_DebtInstrumentPrepaymentFeePercentage" abstract="false" name="DebtInstrumentPrepaymentFeePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="nvta_ExpirationTaxYearUnknownMember" abstract="true" name="ExpirationTaxYearUnknownMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_CollaborationAndGenomeNetworkMember" abstract="true" name="CollaborationAndGenomeNetworkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_DiploidMember" abstract="true" name="DiploidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_LeasesWeightedAverageDiscountRateAbstract" abstract="true" name="LeasesWeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration" abstract="false" name="BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_CowenAndCompanyLimitedLiabilityCompanyMember" abstract="true" name="CowenAndCompanyLimitedLiabilityCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" abstract="false" name="BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_PatentLicensingAgreementMember" abstract="true" name="PatentLicensingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_RSUsAndPRSUsMember" abstract="true" name="RSUsAndPRSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent" abstract="false" name="RestructuringandRelatedCostNumberofPositionsEliminatedPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="nvta_A2019IncentiveCompensationPlanMember" abstract="true" name="A2019IncentiveCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_DebtSecuritiesAvailableForSaleMaturityPeriod" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="nvta_SeriesFWarrantsMember" abstract="true" name="SeriesFWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_TimebasedRSUsandPRSUsMember" abstract="true" name="TimebasedRSUsandPRSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_EmployeeStockPurchasePlan2015Member" abstract="true" name="EmployeeStockPurchasePlan2015Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_BusinessCombinationHoldbackConsiderationCash" abstract="false" name="BusinessCombinationHoldbackConsiderationCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_MilestoneAchievementAgreementMember" abstract="true" name="MilestoneAchievementAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_SeniorSecuredTermLoanFacilityMember" abstract="true" name="SeniorSecuredTermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_OfficeFacilityInSanFranciscoMember" abstract="true" name="OfficeFacilityInSanFranciscoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_NetProceedsFromIssuanceOfPrivatePlacement" abstract="false" name="NetProceedsFromIssuanceOfPrivatePlacement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_CommonStockSalesAgreementMember" abstract="true" name="CommonStockSalesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum" abstract="false" name="DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="nvta_BusinessCombinationAccruedLiabilitiesNoncurrent" abstract="false" name="BusinessCombinationAccruedLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_PercentageOfCommissionPayableOnGrossProceeds" abstract="false" name="PercentageOfCommissionPayableOnGrossProceeds" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="nvta_LoanAndSecurityAgreementMember" abstract="true" name="LoanAndSecurityAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_GenelexMember" abstract="true" name="GenelexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_DeferredTaxAssetsRevenueRecognitionReserves" abstract="false" name="DeferredTaxAssetsRevenueRecognitionReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_NotePurchaseAgreementMember" abstract="true" name="NotePurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_StockIncentivePlanMember" abstract="true" name="StockIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_StockIssuedDuringPeriodValueWarrantsExercised" abstract="false" name="StockIssuedDuringPeriodValueWarrantsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther" abstract="false" name="DeferredTaxAssetsTaxAccruedLiabilitiesAndOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_ChangeInEstimateOfRevenueRecognitionMember" abstract="true" name="ChangeInEstimateOfRevenueRecognitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred" abstract="false" name="BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_DiagnosticTestsMember" abstract="true" name="DiagnosticTestsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_LeasesExpense" abstract="false" name="LeasesExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts" abstract="false" name="StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_EarningsPerShareLineItems" abstract="true" name="EarningsPerShareLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate" abstract="false" name="DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="nvta_AccelerationofVestedEquityMember" abstract="true" name="AccelerationofVestedEquityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_JunglaMember" abstract="true" name="JunglaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_DebtInstrumentInterestRateFloorRate" abstract="false" name="DebtInstrumentInterestRateFloorRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="nvta_DebtFinancingContingencyMember" abstract="true" name="DebtFinancingContingencyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_PatientInsuranceMember" abstract="true" name="PatientInsuranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended" abstract="false" name="DebtInstrumentMaturityTermsPercentOfDebtExtended" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="nvta_RestrictedStockUnitsPeriodofTimeMember" abstract="true" name="RestrictedStockUnitsPeriodofTimeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_IndemnificationObligationsMember" abstract="true" name="IndemnificationObligationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_CustomerMember" abstract="true" name="CustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" abstract="false" name="CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments" abstract="false" name="FinanceLeasePrincipalPaymentsandOtherAncillaryPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_ServiceAgreementsAndLaboratorySuppliesMember" abstract="true" name="ServiceAgreementsAndLaboratorySuppliesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" abstract="false" name="CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_OneCodexMember" abstract="true" name="OneCodexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember" abstract="true" name="ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays" abstract="false" name="DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity" abstract="false" name="BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount" abstract="false" name="FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_RepaymentsofLinesofCreditPrincipal" abstract="false" name="RepaymentsofLinesofCreditPrincipal" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_StockIssuedDuringPeriodSharesWarrantsExercised" abstract="false" name="StockIssuedDuringPeriodSharesWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="nvta_StockIncentivePlan2010Member" abstract="true" name="StockIncentivePlan2010Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_SummaryOfSignificantAccountingPoliciesTable" abstract="true" name="SummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="nvta_LeasesWeightedAverageRemainingLeaseTermAbstract" abstract="true" name="LeasesWeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="nvta_SummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="SummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="nvta_RestOfWorldMember" abstract="true" name="RestOfWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts" abstract="false" name="ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember" abstract="true" name="SeriesAConvertiblePreferredStockConvertedtoCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays" abstract="false" name="DebtInstrumentRedemptionPeriodThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="nvta_PartnerMember" abstract="true" name="PartnerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_DeferredTaxAssetsLeaseLiability" abstract="false" name="DeferredTaxAssetsLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember" abstract="true" name="ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts" abstract="false" name="StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="nvta_UnderwrittenPublicOfferingMember" abstract="true" name="UnderwrittenPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred" abstract="false" name="BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" abstract="false" name="CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="nvta_EarningsPerShareTable" abstract="true" name="EarningsPerShareTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="nvta_TestRevenueCentralizedMember" abstract="true" name="TestRevenueCentralizedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_PreferredStockToCommonStockConversionRatio" abstract="false" name="PreferredStockToCommonStockConversionRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="nvta_ArcherDXInc.Member" abstract="true" name="ArcherDXInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_OfficeFacilityInSanFranciscoTwoMember" abstract="true" name="OfficeFacilityInSanFranciscoTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_PatientDirectMember" abstract="true" name="PatientDirectMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="nvta_NewLeasesMember" abstract="true" name="NewLeasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_NetProceedsFromIssuanceOfCommonStock" abstract="false" name="NetProceedsFromIssuanceOfCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_GenelexandYouScriptMember" abstract="true" name="GenelexandYouScriptMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts" abstract="false" name="ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_SingularBioMember" abstract="true" name="SingularBioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_TrancheOneMember" abstract="true" name="TrancheOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_BusinessCombinationRemeasurementOfLiabilities" abstract="false" name="BusinessCombinationRemeasurementOfLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_CostOfTestRevenueMember" abstract="true" name="CostOfTestRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_CombiMatrixCorporationMember" abstract="true" name="CombiMatrixCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred" abstract="false" name="BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_ClearGeneticsMember" abstract="true" name="ClearGeneticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_ResearchAndDevelopmentMember" abstract="true" name="ResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_BusinessCombinationAccruedLiabilitiesCurrent" abstract="false" name="BusinessCombinationAccruedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_OtherBusinessToBusinessMember" abstract="true" name="OtherBusinessToBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_TestRevenueDecentralizedMember" abstract="true" name="TestRevenueDecentralizedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset" abstract="false" name="DeferredTaxLiabilitiesLeaseRightofUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_PerformanceRestrictedStockUnitsRsusMember" abstract="true" name="PerformanceRestrictedStockUnitsRsusMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination" abstract="false" name="IncomeTaxExaminationNumberOfPeriodUnderExamination" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="nvta_CARESActMember" abstract="true" name="CARESActMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent" abstract="false" name="RestructuringandRelatedCostReductioninOfficerSalaryPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="nvta_RepaymentsofLinesofCreditAccruedInterest" abstract="false" name="RepaymentsofLinesofCreditAccruedInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_YouScriptMember" abstract="true" name="YouScriptMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets" abstract="false" name="IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nvta_SeriesAConvertiblePreferredStockMember" abstract="true" name="SeriesAConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>nvta-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:1a5642af-41c4-4761-89fa-6771b997ee20,g:0d35037d-3d4c-4753-897e-12e6bc13039e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.invitae.com/role/CoverPage" xlink:type="simple" xlink:href="nvta-20201231.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_aa7a8a97-c4ba-4bb5-b8d1-f0cd7887a0a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c8d9bb23-349f-48a3-a1bb-2689f0a00c94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_aa7a8a97-c4ba-4bb5-b8d1-f0cd7887a0a6" xlink:to="loc_us-gaap_Liabilities_c8d9bb23-349f-48a3-a1bb-2689f0a00c94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b976f56e-2b70-47fa-9229-e9d90ee327cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_aa7a8a97-c4ba-4bb5-b8d1-f0cd7887a0a6" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b976f56e-2b70-47fa-9229-e9d90ee327cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ea70fe9f-41e3-4c5d-a8dc-8373410ff4bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_aa7a8a97-c4ba-4bb5-b8d1-f0cd7887a0a6" xlink:to="loc_us-gaap_StockholdersEquity_ea70fe9f-41e3-4c5d-a8dc-8373410ff4bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_218621c8-50ce-42cf-be9c-d3d0c793b097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_7a582d1e-7893-422f-b62d-b36e3f6821ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_218621c8-50ce-42cf-be9c-d3d0c793b097" xlink:to="loc_us-gaap_PreferredStockValue_7a582d1e-7893-422f-b62d-b36e3f6821ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_beab80fb-da85-49ec-8dfe-ef439c344f9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_218621c8-50ce-42cf-be9c-d3d0c793b097" xlink:to="loc_us-gaap_CommonStockValue_beab80fb-da85-49ec-8dfe-ef439c344f9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_912a8fcb-ee45-467c-a04f-c8bdd4b9a0f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_218621c8-50ce-42cf-be9c-d3d0c793b097" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_912a8fcb-ee45-467c-a04f-c8bdd4b9a0f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_e482926a-d773-4fb3-b57e-b7940642b2ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_218621c8-50ce-42cf-be9c-d3d0c793b097" xlink:to="loc_us-gaap_AdditionalPaidInCapital_e482926a-d773-4fb3-b57e-b7940642b2ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8fa8b432-08c0-4ddb-9e7f-a0f8c0815fd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_218621c8-50ce-42cf-be9c-d3d0c793b097" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8fa8b432-08c0-4ddb-9e7f-a0f8c0815fd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_de585137-3a3e-4a8c-a9de-d7c4a9f56490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2797e393-e44b-4000-8c07-4b9dc5bde855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_de585137-3a3e-4a8c-a9de-d7c4a9f56490" xlink:to="loc_us-gaap_LiabilitiesCurrent_2797e393-e44b-4000-8c07-4b9dc5bde855" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0a03ac6c-ea8b-432e-93bf-95b1b40d47d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_de585137-3a3e-4a8c-a9de-d7c4a9f56490" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0a03ac6c-ea8b-432e-93bf-95b1b40d47d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5c27c1fa-d92f-4a5c-b496-48aaf9793bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_de585137-3a3e-4a8c-a9de-d7c4a9f56490" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5c27c1fa-d92f-4a5c-b496-48aaf9793bca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent_69997054-7eb7-45fc-8006-6c69f0ef6faa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_de585137-3a3e-4a8c-a9de-d7c4a9f56490" xlink:to="loc_us-gaap_OtherLongTermDebtNoncurrent_69997054-7eb7-45fc-8006-6c69f0ef6faa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_372ddb77-31f8-4fb9-bd34-1c0616ba1449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_de585137-3a3e-4a8c-a9de-d7c4a9f56490" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_372ddb77-31f8-4fb9-bd34-1c0616ba1449" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d7a7896c-de1b-427a-8088-83a51a56e01e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_de585137-3a3e-4a8c-a9de-d7c4a9f56490" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d7a7896c-de1b-427a-8088-83a51a56e01e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5b0026f0-0c97-43fb-8b44-6495d8d6d8a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_de585137-3a3e-4a8c-a9de-d7c4a9f56490" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5b0026f0-0c97-43fb-8b44-6495d8d6d8a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_73f118de-1feb-4848-addd-5668f66e017a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a0c21ec8-9d5e-441e-8f60-f316dca40b20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_73f118de-1feb-4848-addd-5668f66e017a" xlink:to="loc_us-gaap_AssetsCurrent_a0c21ec8-9d5e-441e-8f60-f316dca40b20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a47be303-414f-4352-a8cd-30b152d5a8e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_73f118de-1feb-4848-addd-5668f66e017a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a47be303-414f-4352-a8cd-30b152d5a8e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0fc72681-6a08-4c39-a1a5-71a6f7dd5a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_73f118de-1feb-4848-addd-5668f66e017a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0fc72681-6a08-4c39-a1a5-71a6f7dd5a8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_b517f255-5c5a-49d7-b4b9-735db6dd7c3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_73f118de-1feb-4848-addd-5668f66e017a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_b517f255-5c5a-49d7-b4b9-735db6dd7c3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0aa846b8-ea0a-4027-bebc-e4d2c2feec52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_73f118de-1feb-4848-addd-5668f66e017a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0aa846b8-ea0a-4027-bebc-e4d2c2feec52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cb90837e-5be7-4d39-a2df-ee14464b1bcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_73f118de-1feb-4848-addd-5668f66e017a" xlink:to="loc_us-gaap_Goodwill_cb90837e-5be7-4d39-a2df-ee14464b1bcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_eff234fd-d60e-4a83-b7a3-13fafaeb0585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_73f118de-1feb-4848-addd-5668f66e017a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_eff234fd-d60e-4a83-b7a3-13fafaeb0585" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fc453b37-95af-4365-a5d2-d4f28e979892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_373a55a5-d31a-453d-a090-7c26779d5b63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc453b37-95af-4365-a5d2-d4f28e979892" xlink:to="loc_us-gaap_AccountsPayableCurrent_373a55a5-d31a-453d-a090-7c26779d5b63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ffbe42c7-4f83-49af-b11d-3d5c9238361e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc453b37-95af-4365-a5d2-d4f28e979892" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ffbe42c7-4f83-49af-b11d-3d5c9238361e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_83a084c7-140c-42e9-8430-3abe07370766" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc453b37-95af-4365-a5d2-d4f28e979892" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_83a084c7-140c-42e9-8430-3abe07370766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_75fee52b-6866-4e54-a3ae-239ae0576cf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc453b37-95af-4365-a5d2-d4f28e979892" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_75fee52b-6866-4e54-a3ae-239ae0576cf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f4772dac-7468-4051-8c48-cedacb233cf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b52a9461-b757-41e5-a025-60dd38416412" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f4772dac-7468-4051-8c48-cedacb233cf1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b52a9461-b757-41e5-a025-60dd38416412" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d02fd44e-f310-4698-a479-d9ae4fdb864c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f4772dac-7468-4051-8c48-cedacb233cf1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d02fd44e-f310-4698-a479-d9ae4fdb864c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_65e5c2b2-295b-4373-afbe-333b4af4b831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f4772dac-7468-4051-8c48-cedacb233cf1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_65e5c2b2-295b-4373-afbe-333b4af4b831" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2cae212e-fc8e-4876-967f-b0c25f28fe88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f4772dac-7468-4051-8c48-cedacb233cf1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2cae212e-fc8e-4876-967f-b0c25f28fe88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_fccdb9ff-d1c1-4072-918d-543d8bd1b896" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f4772dac-7468-4051-8c48-cedacb233cf1" xlink:to="loc_us-gaap_InventoryNet_fccdb9ff-d1c1-4072-918d-543d8bd1b896" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_87ec78c2-a8a0-4b76-baac-5fe35028ee3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8f8658b3-7402-4d55-b8df-d90abb5abe19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_87ec78c2-a8a0-4b76-baac-5fe35028ee3f" xlink:to="loc_us-gaap_OperatingIncomeLoss_8f8658b3-7402-4d55-b8df-d90abb5abe19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3677de7f-a3d1-459f-8b44-dafb9e05e6bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_87ec78c2-a8a0-4b76-baac-5fe35028ee3f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3677de7f-a3d1-459f-8b44-dafb9e05e6bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e7c3e130-3734-4abb-847e-20328d10954f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_87ec78c2-a8a0-4b76-baac-5fe35028ee3f" xlink:to="loc_us-gaap_InterestExpense_e7c3e130-3734-4abb-847e-20328d10954f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_42bda8a3-78a5-4167-8987-6af8fb83fd56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_883984ac-3f22-4414-85b0-f482c232af1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_42bda8a3-78a5-4167-8987-6af8fb83fd56" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_883984ac-3f22-4414-85b0-f482c232af1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9a263632-87e8-4ea3-9ebe-0295924c368c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_42bda8a3-78a5-4167-8987-6af8fb83fd56" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9a263632-87e8-4ea3-9ebe-0295924c368c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_29e083d2-63e9-4f71-9222-2d6cbcb244e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ffd9385e-b8ad-4da8-86b0-cc2387fe6e6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_29e083d2-63e9-4f71-9222-2d6cbcb244e4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ffd9385e-b8ad-4da8-86b0-cc2387fe6e6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_fd0c800d-3699-4f99-bd55-c640e58a9b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_29e083d2-63e9-4f71-9222-2d6cbcb244e4" xlink:to="loc_us-gaap_CostOfRevenue_fd0c800d-3699-4f99-bd55-c640e58a9b0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_527b9e60-e6c1-42d6-abab-4434f3f8cb99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_29e083d2-63e9-4f71-9222-2d6cbcb244e4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_527b9e60-e6c1-42d6-abab-4434f3f8cb99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_f64adecb-079c-4e1e-878c-b155ab2abb63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_29e083d2-63e9-4f71-9222-2d6cbcb244e4" xlink:to="loc_us-gaap_SellingAndMarketingExpense_f64adecb-079c-4e1e-878c-b155ab2abb63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_a69264be-8f77-4ea8-bbd5-1368a26fa670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_29e083d2-63e9-4f71-9222-2d6cbcb244e4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_a69264be-8f77-4ea8-bbd5-1368a26fa670" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_2464e188-c645-4a2b-af9b-6ee13f6bcbca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b67e89c5-9843-4bf2-a7dd-85901d11b624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_2464e188-c645-4a2b-af9b-6ee13f6bcbca" xlink:to="loc_us-gaap_NetIncomeLoss_b67e89c5-9843-4bf2-a7dd-85901d11b624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a394500f-54c2-4577-88a4-d61a4d728f38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_2464e188-c645-4a2b-af9b-6ee13f6bcbca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a394500f-54c2-4577-88a4-d61a4d728f38" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_094ee330-f27d-419a-89e4-666208bcb195" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_fe609e8c-6095-4896-abbe-b011a592bf19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_094ee330-f27d-419a-89e4-666208bcb195" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_fe609e8c-6095-4896-abbe-b011a592bf19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_246a4dea-7572-4e10-ab2c-919ebb8db89e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_094ee330-f27d-419a-89e4-666208bcb195" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_246a4dea-7572-4e10-ab2c-919ebb8db89e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_a86992ac-84a8-4e0a-8130-1f2d61f195ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_094ee330-f27d-419a-89e4-666208bcb195" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_a86992ac-84a8-4e0a-8130-1f2d61f195ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2ae70f33-eda6-4389-bf36-39f469fbad3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_094ee330-f27d-419a-89e4-666208bcb195" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2ae70f33-eda6-4389-bf36-39f469fbad3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_23335b7f-b138-4493-b6f0-b01c1b3f7078" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_094ee330-f27d-419a-89e4-666208bcb195" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_23335b7f-b138-4493-b6f0-b01c1b3f7078" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ea62a180-842a-4fc3-9728-22c7d41d96a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_094ee330-f27d-419a-89e4-666208bcb195" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ea62a180-842a-4fc3-9728-22c7d41d96a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_21d5f31f-1d11-4c0b-8e0b-bdcf8b105c58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_b1e673f5-3110-4892-b1ec-7ae82b8fc6d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_21d5f31f-1d11-4c0b-8e0b-bdcf8b105c58" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_b1e673f5-3110-4892-b1ec-7ae82b8fc6d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_22498095-3d35-4d1b-860d-87aa394d70db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_21d5f31f-1d11-4c0b-8e0b-bdcf8b105c58" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_22498095-3d35-4d1b-860d-87aa394d70db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts_ecb00cfa-af57-4249-92f7-823317ff31da" xlink:href="nvta-20201231.xsd#nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_21d5f31f-1d11-4c0b-8e0b-bdcf8b105c58" xlink:to="loc_nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts_ecb00cfa-af57-4249-92f7-823317ff31da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfLoanCosts_ecfdf821-98dc-482a-bc9f-a908fc87eaa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfLoanCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_21d5f31f-1d11-4c0b-8e0b-bdcf8b105c58" xlink:to="loc_us-gaap_PaymentsOfLoanCosts_ecfdf821-98dc-482a-bc9f-a908fc87eaa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_0b15cdf6-1d0b-4a6f-b98f-424d3e781ea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_21d5f31f-1d11-4c0b-8e0b-bdcf8b105c58" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_0b15cdf6-1d0b-4a6f-b98f-424d3e781ea2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_b85c1703-ace2-4ff0-8965-5827d803c56b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_21d5f31f-1d11-4c0b-8e0b-bdcf8b105c58" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_b85c1703-ace2-4ff0-8965-5827d803c56b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_38b7dea9-39fc-4f8e-97bc-f7c9c5e974e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_21d5f31f-1d11-4c0b-8e0b-bdcf8b105c58" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_38b7dea9-39fc-4f8e-97bc-f7c9c5e974e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_c70249a1-041b-40c5-8a3c-332ef91458cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_c70249a1-041b-40c5-8a3c-332ef91458cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets_33328bb5-2cda-4499-9881-8b6fb1a53922" xlink:href="nvta-20201231.xsd#nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets_33328bb5-2cda-4499-9881-8b6fb1a53922" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_e017343f-68b3-4c21-8086-9a6159e4ed18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_e017343f-68b3-4c21-8086-9a6159e4ed18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_81350441-8a74-4427-8767-68cd002589cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_81350441-8a74-4427-8767-68cd002589cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationRemeasurementOfLiabilities_9b81b962-3301-490b-96db-0c0610182df2" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationRemeasurementOfLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_nvta_BusinessCombinationRemeasurementOfLiabilities_9b81b962-3301-490b-96db-0c0610182df2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_24fae70f-d280-446c-8502-3011f89a2bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_24fae70f-d280-446c-8502-3011f89a2bb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0a38b1d6-aedd-403f-a353-ab7abe35ecca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0a38b1d6-aedd-403f-a353-ab7abe35ecca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_c340cd49-8487-43aa-a915-ac15d1d4d6b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_us-gaap_AssetImpairmentCharges_c340cd49-8487-43aa-a915-ac15d1d4d6b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f5a9e2c3-e549-497d-aef1-3f1b2ae80bfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_us-gaap_ShareBasedCompensation_f5a9e2c3-e549-497d-aef1-3f1b2ae80bfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1119f94f-8933-4d68-ad88-8b2f29aa5653" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1119f94f-8933-4d68-ad88-8b2f29aa5653" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_e36aad70-4a74-4526-8fc7-99288045b5fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_e36aad70-4a74-4526-8fc7-99288045b5fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_cf4b5349-3c05-466c-88ce-f3580c84076a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_cf4b5349-3c05-466c-88ce-f3580c84076a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4022ab7d-71b7-4d77-b0f8-ce5f310e43b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_us-gaap_NetIncomeLoss_4022ab7d-71b7-4d77-b0f8-ce5f310e43b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3904158c-3c35-4810-b996-cd88d23a7ec5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3904158c-3c35-4810-b996-cd88d23a7ec5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_19ad162d-4787-4468-98ab-07d00623146b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_19ad162d-4787-4468-98ab-07d00623146b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity_0c3d40e4-e352-4315-90b5-799a33a0987c" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd97ffc-0e90-4ea8-9077-fefa3098bc31" xlink:to="loc_nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity_0c3d40e4-e352-4315-90b5-799a33a0987c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_429a5e5e-ff44-426e-bbb0-90e196d4ba6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_28e000be-6c7a-4018-a3dc-c6ca17f7af46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_429a5e5e-ff44-426e-bbb0-90e196d4ba6c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_28e000be-6c7a-4018-a3dc-c6ca17f7af46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_efe47fd9-d30a-4484-8a14-aa2a8bd2917b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_429a5e5e-ff44-426e-bbb0-90e196d4ba6c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_efe47fd9-d30a-4484-8a14-aa2a8bd2917b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1fd6db44-5f0a-481d-8f7b-69abdda46d28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_429a5e5e-ff44-426e-bbb0-90e196d4ba6c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1fd6db44-5f0a-481d-8f7b-69abdda46d28" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Organizationanddescriptionofbusiness" xlink:type="simple" xlink:href="nvta-20201231.xsd#Organizationanddescriptionofbusiness"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/Organizationanddescriptionofbusiness" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/OrganizationanddescriptionofbusinessDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#OrganizationanddescriptionofbusinessDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/OrganizationanddescriptionofbusinessDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Summaryofsignificantaccountingpolicies" xlink:type="simple" xlink:href="nvta-20201231.xsd#Summaryofsignificantaccountingpolicies"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/Summaryofsignificantaccountingpolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesTables"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fd276f0b-9140-4763-8041-7bd680b08034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9ce298fa-993d-458b-9aa7-7dfa9fa3334e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fd276f0b-9140-4763-8041-7bd680b08034" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9ce298fa-993d-458b-9aa7-7dfa9fa3334e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_14932495-cea3-463f-9ea7-1fef3d37ed54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fd276f0b-9140-4763-8041-7bd680b08034" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_14932495-cea3-463f-9ea7-1fef3d37ed54" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Revenueaccountsreceivableanddeferredrevenue" xlink:type="simple" xlink:href="nvta-20201231.xsd#Revenueaccountsreceivableanddeferredrevenue"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/Revenueaccountsreceivableanddeferredrevenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#RevenueaccountsreceivableanddeferredrevenueTables"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Businesscombinations" xlink:type="simple" xlink:href="nvta-20201231.xsd#Businesscombinations"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/Businesscombinations" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsTables"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsSingularBioDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsSingularBioDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsSingularBioDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsJunglaDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsJunglaDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsJunglaDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsClearGeneticsDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsDiploidDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsDiploidDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsDiploidDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_d2bf0125-907b-4adc-a7b9-f1d013514ae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred_c87d8222-3957-4d47-a14b-9bba9bbeb429" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_d2bf0125-907b-4adc-a7b9-f1d013514ae9" xlink:to="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred_c87d8222-3957-4d47-a14b-9bba9bbeb429" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration_a05603ec-b7be-4917-9c66-20b663272860" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_d2bf0125-907b-4adc-a7b9-f1d013514ae9" xlink:to="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration_a05603ec-b7be-4917-9c66-20b663272860" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred_894e7a2c-f101-439d-b563-2079a8f1d0c2" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_d2bf0125-907b-4adc-a7b9-f1d013514ae9" xlink:to="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred_894e7a2c-f101-439d-b563-2079a8f1d0c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bfdf26c9-8b49-4b0f-90ca-7347a4660b6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_f213e022-5d3c-47a2-b53e-98a43ae4e3dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bfdf26c9-8b49-4b0f-90ca-7347a4660b6d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_f213e022-5d3c-47a2-b53e-98a43ae4e3dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCash_7ee1c3e9-878d-460d-ab0e-b38f4cfd3e6c" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bfdf26c9-8b49-4b0f-90ca-7347a4660b6d" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCash_7ee1c3e9-878d-460d-ab0e-b38f4cfd3e6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_ada56a71-42c1-4b93-8e88-ff94229528b5" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bfdf26c9-8b49-4b0f-90ca-7347a4660b6d" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_ada56a71-42c1-4b93-8e88-ff94229528b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred_0cd16b1f-e82a-4b9c-a1e8-46d519238dd6" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bfdf26c9-8b49-4b0f-90ca-7347a4660b6d" xlink:to="loc_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred_0cd16b1f-e82a-4b9c-a1e8-46d519238dd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_fa40bd10-1c5a-43dc-89b6-99b6484916b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bfdf26c9-8b49-4b0f-90ca-7347a4660b6d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_fa40bd10-1c5a-43dc-89b6-99b6484916b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b0aed4b8-9193-4e2c-8e60-036f59c2336e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bfdf26c9-8b49-4b0f-90ca-7347a4660b6d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b0aed4b8-9193-4e2c-8e60-036f59c2336e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b93aa080-8512-49d2-affb-1cc00b015c7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3efa5113-18ab-4362-85f0-534db6db7128" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b93aa080-8512-49d2-affb-1cc00b015c7e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3efa5113-18ab-4362-85f0-534db6db7128" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2f095165-5a9b-426f-9bab-a3dc65b6d338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b93aa080-8512-49d2-affb-1cc00b015c7e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2f095165-5a9b-426f-9bab-a3dc65b6d338" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0242cd54-ca39-49f0-9adf-2569449237e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b93aa080-8512-49d2-affb-1cc00b015c7e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0242cd54-ca39-49f0-9adf-2569449237e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset_d93d523f-c0ac-49af-bc84-75d58c658db8" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b93aa080-8512-49d2-affb-1cc00b015c7e" xlink:to="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset_d93d523f-c0ac-49af-bc84-75d58c658db8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_4f814a37-5045-4007-9d40-57c98af1e1c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b93aa080-8512-49d2-affb-1cc00b015c7e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_4f814a37-5045-4007-9d40-57c98af1e1c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f2a1a10c-fbd2-4340-ad58-8c0b894e2556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b93aa080-8512-49d2-affb-1cc00b015c7e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f2a1a10c-fbd2-4340-ad58-8c0b894e2556" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_2e09aff7-7445-4674-b39f-30a53dbbba30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b93aa080-8512-49d2-affb-1cc00b015c7e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_2e09aff7-7445-4674-b39f-30a53dbbba30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_58dd91fa-030c-4853-8ed9-ea45fb2bf50a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b93aa080-8512-49d2-affb-1cc00b015c7e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_58dd91fa-030c-4853-8ed9-ea45fb2bf50a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_af289344-718f-4eb2-aace-03ee358e1a44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_eaf35eea-bfe5-4f98-a6e3-69fe4c2ad6ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_af289344-718f-4eb2-aace-03ee358e1a44" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_eaf35eea-bfe5-4f98-a6e3-69fe4c2ad6ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b1b1a332-0d44-410e-afbf-861088cf46c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_af289344-718f-4eb2-aace-03ee358e1a44" xlink:to="loc_us-gaap_Goodwill_b1b1a332-0d44-410e-afbf-861088cf46c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6e38a47a-2737-47ea-be2d-774616a4a64f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b48254e5-5cab-4bca-913d-0c670f430155" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6e38a47a-2737-47ea-be2d-774616a4a64f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b48254e5-5cab-4bca-913d-0c670f430155" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_ea4137c2-426f-4a45-8137-3b3d06e2348b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6e38a47a-2737-47ea-be2d-774616a4a64f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_ea4137c2-426f-4a45-8137-3b3d06e2348b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f2db7db5-d8fc-4a4b-b12d-e4a59f631e60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6e38a47a-2737-47ea-be2d-774616a4a64f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f2db7db5-d8fc-4a4b-b12d-e4a59f631e60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_01c59da6-8413-4eff-b207-86d1433fef15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6e38a47a-2737-47ea-be2d-774616a4a64f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_01c59da6-8413-4eff-b207-86d1433fef15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_4cddf734-3370-45a9-84f0-c053e00b0562" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6e38a47a-2737-47ea-be2d-774616a4a64f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_4cddf734-3370-45a9-84f0-c053e00b0562" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease_647a8e7c-0403-4f00-8028-772669afd630" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6e38a47a-2737-47ea-be2d-774616a4a64f" xlink:to="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease_647a8e7c-0403-4f00-8028-772669afd630" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease_f7df1c29-bcb9-4518-a712-eb1fc29fcc7c" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6e38a47a-2737-47ea-be2d-774616a4a64f" xlink:to="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease_f7df1c29-bcb9-4518-a712-eb1fc29fcc7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_5cc6f0e2-7ced-42a4-968c-238021237378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6e38a47a-2737-47ea-be2d-774616a4a64f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_5cc6f0e2-7ced-42a4-968c-238021237378" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsGenelexandYouScriptDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsArcherDXDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsArcherDXDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsArcherDXDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsSummaryofintangibleassetsacquiredDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_62414e79-5716-43ce-a4d1-0cd9cf3b2422" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_7bf5062b-ae61-46cb-98ce-ab247b86ff73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_62414e79-5716-43ce-a4d1-0cd9cf3b2422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_7bf5062b-ae61-46cb-98ce-ab247b86ff73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_53d1f854-35e6-4b22-8a74-7af6fd7ec934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_62414e79-5716-43ce-a4d1-0cd9cf3b2422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_53d1f854-35e6-4b22-8a74-7af6fd7ec934" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsScheduleofproformafinancialinformationDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsScheduleofproformafinancialinformationDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsScheduleofproformafinancialinformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Goodwillandintangibleassets" xlink:type="simple" xlink:href="nvta-20201231.xsd#Goodwillandintangibleassets"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/Goodwillandintangibleassets" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsTables"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsSummaryofgoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsScheduleofintangibleassetsDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_20e4bfd8-5af9-464a-90d8-6bb948c0cbdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0526ad17-1d58-418b-a80e-5496566e1f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_20e4bfd8-5af9-464a-90d8-6bb948c0cbdc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0526ad17-1d58-418b-a80e-5496566e1f25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_dee27009-7ae5-44d6-84fa-b1957fff6a1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_20e4bfd8-5af9-464a-90d8-6bb948c0cbdc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_dee27009-7ae5-44d6-84fa-b1957fff6a1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a5208c43-9fed-498e-a81e-3d5aef17aed2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_6503efe1-59fd-42b7-93aa-eb20b9928ca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a5208c43-9fed-498e-a81e-3d5aef17aed2" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_6503efe1-59fd-42b7-93aa-eb20b9928ca2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fca4d0e8-2bd2-4793-b670-2169b8c1a2b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a5208c43-9fed-498e-a81e-3d5aef17aed2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fca4d0e8-2bd2-4793-b670-2169b8c1a2b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_53ded3eb-fc57-4845-89a4-3cd56c9d79ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_824dd043-cb68-4ceb-bf99-7e2927dce696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_53ded3eb-fc57-4845-89a4-3cd56c9d79ea" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_824dd043-cb68-4ceb-bf99-7e2927dce696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_612ec081-f13d-4889-abba-2268d1d1d304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_53ded3eb-fc57-4845-89a4-3cd56c9d79ea" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_612ec081-f13d-4889-abba-2268d1d1d304" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails_1" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsScheduleofintangibleassetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bfdd373b-c769-418e-955a-adf2729fe6d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8e4f29c5-5cbb-4c80-9455-cfe5aafbe01b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bfdd373b-c769-418e-955a-adf2729fe6d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8e4f29c5-5cbb-4c80-9455-cfe5aafbe01b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_6b58c606-73ca-47a1-899b-198cbd97e97f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bfdd373b-c769-418e-955a-adf2729fe6d0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_6b58c606-73ca-47a1-899b-198cbd97e97f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_44ddfccf-1bfe-4194-ba50-65391533d77b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_3b96cd65-5dd9-440e-bac7-7cfd8dd21126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_44ddfccf-1bfe-4194-ba50-65391533d77b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_3b96cd65-5dd9-440e-bac7-7cfd8dd21126" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_b1565378-bd8a-44f1-a23e-7613d6042b93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_44ddfccf-1bfe-4194-ba50-65391533d77b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_b1565378-bd8a-44f1-a23e-7613d6042b93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_99138f76-7006-483a-9095-85e059983f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_44ddfccf-1bfe-4194-ba50-65391533d77b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_99138f76-7006-483a-9095-85e059983f91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e42baf22-ef66-44a2-8f5c-2862ce3a569c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_44ddfccf-1bfe-4194-ba50-65391533d77b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e42baf22-ef66-44a2-8f5c-2862ce3a569c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c9ff364b-e1df-43b2-9248-86690a510dab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_44ddfccf-1bfe-4194-ba50-65391533d77b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c9ff364b-e1df-43b2-9248-86690a510dab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f90eab3c-787f-4805-81f4-d8eba24fa1fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_44ddfccf-1bfe-4194-ba50-65391533d77b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f90eab3c-787f-4805-81f4-d8eba24fa1fd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Balancesheetcomponents" xlink:type="simple" xlink:href="nvta-20201231.xsd#Balancesheetcomponents"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/Balancesheetcomponents" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BalancesheetcomponentsTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#BalancesheetcomponentsTables"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BalancesheetcomponentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BalancesheetcomponentsScheduleofinventoryDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3b2285af-58eb-4b6a-ae74-a1b4573c69dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_4aea3acf-172a-482f-bd00-78c5339dd22c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3b2285af-58eb-4b6a-ae74-a1b4573c69dc" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_4aea3acf-172a-482f-bd00-78c5339dd22c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_65657653-e13b-4798-b2dd-7c8b4c94ac36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3b2285af-58eb-4b6a-ae74-a1b4573c69dc" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_65657653-e13b-4798-b2dd-7c8b4c94ac36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ac515fbd-8a31-45d9-822e-ce0a687bdf76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3b2285af-58eb-4b6a-ae74-a1b4573c69dc" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ac515fbd-8a31-45d9-822e-ce0a687bdf76" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BalancesheetcomponentsPropertyandequipmentDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7dfb8766-2c5b-4cc1-9472-1c06c3e9c67a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_51dbabe9-9e33-49d9-b19f-8f0af586643a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_7dfb8766-2c5b-4cc1-9472-1c06c3e9c67a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_51dbabe9-9e33-49d9-b19f-8f0af586643a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3b90bc3b-8d90-4a8d-8cf2-b20f48596f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_7dfb8766-2c5b-4cc1-9472-1c06c3e9c67a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3b90bc3b-8d90-4a8d-8cf2-b20f48596f05" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BalancesheetcomponentsAccruedliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c9ee8ae9-782f-47e2-9880-6add16b7da7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationAccruedLiabilitiesCurrent_702f9dc2-b6a3-43fb-9da3-2eec60e6bc47" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c9ee8ae9-782f-47e2-9880-6add16b7da7c" xlink:to="loc_nvta_BusinessCombinationAccruedLiabilitiesCurrent_702f9dc2-b6a3-43fb-9da3-2eec60e6bc47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_41611199-dff9-40f2-95f8-e76ba7e800f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c9ee8ae9-782f-47e2-9880-6add16b7da7c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_41611199-dff9-40f2-95f8-e76ba7e800f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_da039cd2-fc11-44e5-bd35-7d90aad52c4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c9ee8ae9-782f-47e2-9880-6add16b7da7c" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_da039cd2-fc11-44e5-bd35-7d90aad52c4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5e6754e8-a375-42c5-b0f4-3deb3890dbaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c9ee8ae9-782f-47e2-9880-6add16b7da7c" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5e6754e8-a375-42c5-b0f4-3deb3890dbaf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BalancesheetcomponentsOtherlongtermliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4f8ab993-6179-4252-a00e-228aeb83c7cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationAccruedLiabilitiesNoncurrent_298d7722-103e-4f4a-9fec-3fe6256a57de" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_4f8ab993-6179-4252-a00e-228aeb83c7cb" xlink:to="loc_nvta_BusinessCombinationAccruedLiabilitiesNoncurrent_298d7722-103e-4f4a-9fec-3fe6256a57de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_4c88d693-5d2d-4ea9-85d7-03aed72f3d9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_4f8ab993-6179-4252-a00e-228aeb83c7cb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_4c88d693-5d2d-4ea9-85d7-03aed72f3d9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_caf060c6-8c9b-460c-8a45-8431db11fbb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_4f8ab993-6179-4252-a00e-228aeb83c7cb" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_caf060c6-8c9b-460c-8a45-8431db11fbb7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Fairvaluemeasurements" xlink:type="simple" xlink:href="nvta-20201231.xsd#Fairvaluemeasurements"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/Fairvaluemeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/FairvaluemeasurementsTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#FairvaluemeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/FairvaluemeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue_8e2e9f85-f25b-40db-9825-e631e2be7c64" xlink:href="nvta-20201231.xsd#nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_28e3f83c-4778-47f7-adae-e64066aea477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue_8e2e9f85-f25b-40db-9825-e631e2be7c64" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_28e3f83c-4778-47f7-adae-e64066aea477" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8786f8ee-77b7-4168-9888-2106010d4c54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue_8e2e9f85-f25b-40db-9825-e631e2be7c64" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8786f8ee-77b7-4168-9888-2106010d4c54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_4e2fae65-4a62-4a33-96d8-cb4b74cc69fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue_8e2e9f85-f25b-40db-9825-e631e2be7c64" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_4e2fae65-4a62-4a33-96d8-cb4b74cc69fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#FairvaluemeasurementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Commitmentsandcontingencies" xlink:type="simple" xlink:href="nvta-20201231.xsd#Commitmentsandcontingencies"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/Commitmentsandcontingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesTables"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesLeaseadditionalinformationDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_ef027e8b-5092-41ff-be50-b461bae09eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_8386ca15-a778-45d1-987a-3cc9ad4aa599" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ef027e8b-5092-41ff-be50-b461bae09eca" xlink:to="loc_us-gaap_OperatingLeaseCost_8386ca15-a778-45d1-987a-3cc9ad4aa599" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_266fdd4e-dd73-4a5c-9ae8-0e2ba93490cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ef027e8b-5092-41ff-be50-b461bae09eca" xlink:to="loc_us-gaap_SubleaseIncome_266fdd4e-dd73-4a5c-9ae8-0e2ba93490cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_9c496809-4427-425a-86b4-eaac8649201a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ef027e8b-5092-41ff-be50-b461bae09eca" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_9c496809-4427-425a-86b4-eaac8649201a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_LeasesExpense_8cd3f509-7fc6-40a1-9bff-4a01cdca2bd6" xlink:href="nvta-20201231.xsd#nvta_LeasesExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseAndRentalExpense_6dd963d3-5130-404e-99c2-da8173564d68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_nvta_LeasesExpense_8cd3f509-7fc6-40a1-9bff-4a01cdca2bd6" xlink:to="loc_us-gaap_LeaseAndRentalExpense_6dd963d3-5130-404e-99c2-da8173564d68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_972befeb-56eb-419d-8a9b-ac4f77a76bae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_nvta_LeasesExpense_8cd3f509-7fc6-40a1-9bff-4a01cdca2bd6" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_972befeb-56eb-419d-8a9b-ac4f77a76bae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesIncomeStatementInterestExpense_b2789b69-3b21-4fe8-b29f-a8b89f81ccf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeasesIncomeStatementInterestExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_nvta_LeasesExpense_8cd3f509-7fc6-40a1-9bff-4a01cdca2bd6" xlink:to="loc_us-gaap_CapitalLeasesIncomeStatementInterestExpense_b2789b69-3b21-4fe8-b29f-a8b89f81ccf5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_0892a95a-7e37-4a2a-97cd-e37b5fc6772a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_3f0c04fc-c4f4-4682-aae4-01c7c8959544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_0892a95a-7e37-4a2a-97cd-e37b5fc6772a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_3f0c04fc-c4f4-4682-aae4-01c7c8959544" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_b11e26b3-8c8a-4415-9053-53e91d0b9db9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_0892a95a-7e37-4a2a-97cd-e37b5fc6772a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_b11e26b3-8c8a-4415-9053-53e91d0b9db9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_48ed0bc0-a6ca-4f45-b4d5-79a64cd1b8ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_48483e49-cda3-47c6-9ee7-947735329981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_48ed0bc0-a6ca-4f45-b4d5-79a64cd1b8ea" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_48483e49-cda3-47c6-9ee7-947735329981" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_0ab43cf9-3454-401a-b10e-678ceb4f79a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_48ed0bc0-a6ca-4f45-b4d5-79a64cd1b8ea" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_0ab43cf9-3454-401a-b10e-678ceb4f79a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_b01c4c7d-e7e1-4a17-bc82-2bb92b93532b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_48ed0bc0-a6ca-4f45-b4d5-79a64cd1b8ea" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_b01c4c7d-e7e1-4a17-bc82-2bb92b93532b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0ec504d0-c8ee-457f-9607-a8bddf6841d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_48ed0bc0-a6ca-4f45-b4d5-79a64cd1b8ea" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0ec504d0-c8ee-457f-9607-a8bddf6841d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_bc688805-1faf-452b-accf-291de2babc21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_48ed0bc0-a6ca-4f45-b4d5-79a64cd1b8ea" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_bc688805-1faf-452b-accf-291de2babc21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_82f7b3fd-7c41-4b1d-b723-8c202e09d77c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_48ed0bc0-a6ca-4f45-b4d5-79a64cd1b8ea" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_82f7b3fd-7c41-4b1d-b723-8c202e09d77c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_12aa739a-adca-4419-92cf-bf2671de316d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_93a857cf-eee3-4241-97a6-cf06c97609af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_12aa739a-adca-4419-92cf-bf2671de316d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_93a857cf-eee3-4241-97a6-cf06c97609af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c2a10603-c895-4bb2-9bcd-8588225b97e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_12aa739a-adca-4419-92cf-bf2671de316d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c2a10603-c895-4bb2-9bcd-8588225b97e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_87949d48-798e-4900-9ffc-c2768c2d7b5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_12aa739a-adca-4419-92cf-bf2671de316d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_87949d48-798e-4900-9ffc-c2768c2d7b5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d4fc6f43-8235-4d1a-9a0d-c398a1441e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_12aa739a-adca-4419-92cf-bf2671de316d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d4fc6f43-8235-4d1a-9a0d-c398a1441e8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e0b2a0a9-bd1c-4f59-95f9-fb5a2c662f23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_12aa739a-adca-4419-92cf-bf2671de316d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e0b2a0a9-bd1c-4f59-95f9-fb5a2c662f23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5d32f8d3-94ba-45c0-b0c1-fbf0b96fff84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_12aa739a-adca-4419-92cf-bf2671de316d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5d32f8d3-94ba-45c0-b0c1-fbf0b96fff84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d447b4cf-3b8b-4288-9e30-9fb41db4e4bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_15843a12-e3d4-4ebe-a796-116118372d7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_d447b4cf-3b8b-4288-9e30-9fb41db4e4bb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_15843a12-e3d4-4ebe-a796-116118372d7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_af83a54c-9420-4ab3-8d88-8f3e8baf4c94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_d447b4cf-3b8b-4288-9e30-9fb41db4e4bb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_af83a54c-9420-4ab3-8d88-8f3e8baf4c94" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails_1" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails_1"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3ec5538a-284f-4eff-b2cf-857af20047cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_60ebc5e5-40aa-4c8f-929c-ea84be7d7224" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3ec5538a-284f-4eff-b2cf-857af20047cc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_60ebc5e5-40aa-4c8f-929c-ea84be7d7224" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_fa76daec-dc51-4431-97d4-a244ff6e8e12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3ec5538a-284f-4eff-b2cf-857af20047cc" xlink:to="loc_us-gaap_OperatingLeaseLiability_fa76daec-dc51-4431-97d4-a244ff6e8e12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e892159a-6b76-493d-917f-585456c5d461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_f55fdade-728f-49c3-8f47-9ac9c318807a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e892159a-6b76-493d-917f-585456c5d461" xlink:to="loc_us-gaap_FinanceLeaseLiability_f55fdade-728f-49c3-8f47-9ac9c318807a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6c33aef1-9a91-4708-aa56-50cbb20cda53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e892159a-6b76-493d-917f-585456c5d461" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6c33aef1-9a91-4708-aa56-50cbb20cda53" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesDebtfinancingDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesConvertibleseniornotesDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesComponentsofdebtDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_fce63df9-cfcd-43ff-a332-9d5c72b7ac53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_712cb041-0676-4993-ab13-10120d14fe56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_fce63df9-cfcd-43ff-a332-9d5c72b7ac53" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_712cb041-0676-4993-ab13-10120d14fe56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_e00b1f0e-cf80-48bf-8c35-097c818c15c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_fce63df9-cfcd-43ff-a332-9d5c72b7ac53" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_e00b1f0e-cf80-48bf-8c35-097c818c15c5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesOthercommitmentsDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligation_9cb2f59d-1ff2-441d-884b-1ba23221b1bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_859f45e6-39dc-4734-8abf-cc6446b6f821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligation_9cb2f59d-1ff2-441d-884b-1ba23221b1bc" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_859f45e6-39dc-4734-8abf-cc6446b6f821" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_48b8aab3-32a4-436b-93ae-0407cf05dfea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligation_9cb2f59d-1ff2-441d-884b-1ba23221b1bc" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_48b8aab3-32a4-436b-93ae-0407cf05dfea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_152c9f88-5c92-4ade-bdfe-b08c76988587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligation_9cb2f59d-1ff2-441d-884b-1ba23221b1bc" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_152c9f88-5c92-4ade-bdfe-b08c76988587" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_f2f8f731-16aa-427f-9747-7d58e22f9b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligation_9cb2f59d-1ff2-441d-884b-1ba23221b1bc" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_f2f8f731-16aa-427f-9747-7d58e22f9b1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_543aad89-1037-4485-bcf4-006f10fcc986" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligation_9cb2f59d-1ff2-441d-884b-1ba23221b1bc" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_543aad89-1037-4485-bcf4-006f10fcc986" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_7cfd4559-54ec-4e99-b244-9e1cd518d871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligation_9cb2f59d-1ff2-441d-884b-1ba23221b1bc" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_7cfd4559-54ec-4e99-b244-9e1cd518d871" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Stockholdersequity" xlink:type="simple" xlink:href="nvta-20201231.xsd#Stockholdersequity"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/Stockholdersequity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/StockholdersequityTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockholdersequityTables"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/StockholdersequityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/StockholdersequityNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockholdersequityNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/StockholdersequityNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Stockincentiveplans" xlink:type="simple" xlink:href="nvta-20201231.xsd#Stockincentiveplans"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/Stockincentiveplans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansTables"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/StockincentiveplansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansSummaryofRSUactivityDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansStockbasedcompensationexpenseDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Incometaxes" xlink:type="simple" xlink:href="nvta-20201231.xsd#Incometaxes"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/Incometaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesTables"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/IncometaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_81a996a2-1723-4d28-b009-18d9c5bfa8ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c4035b84-69be-4514-a055-d072bce8e0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_81a996a2-1723-4d28-b009-18d9c5bfa8ab" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c4035b84-69be-4514-a055-d072bce8e0d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d32e0044-f1f2-446c-8995-50c7be0f1964" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_81a996a2-1723-4d28-b009-18d9c5bfa8ab" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d32e0044-f1f2-446c-8995-50c7be0f1964" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_239a86fd-bf58-4ca0-adf5-441a249cc95f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c659a189-07b3-4da5-98a8-56fd0234d45b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_239a86fd-bf58-4ca0-adf5-441a249cc95f" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c659a189-07b3-4da5-98a8-56fd0234d45b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6025cf31-0b07-444c-82ce-44f36922ab37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_a2750937-feb4-4b21-9951-3c1ab5e3c0f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6025cf31-0b07-444c-82ce-44f36922ab37" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_a2750937-feb4-4b21-9951-3c1ab5e3c0f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_693a86d1-53e5-47a9-a2ce-a974b002a71d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6025cf31-0b07-444c-82ce-44f36922ab37" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_693a86d1-53e5-47a9-a2ce-a974b002a71d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2119f65a-33b6-428e-9cfe-9e9d8fbbe20d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6025cf31-0b07-444c-82ce-44f36922ab37" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2119f65a-33b6-428e-9cfe-9e9d8fbbe20d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a7b136aa-7723-4bc9-a1b0-00179fab4077" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1a7cefc7-7bb2-431a-9ba3-bdcb5de898fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a7b136aa-7723-4bc9-a1b0-00179fab4077" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1a7cefc7-7bb2-431a-9ba3-bdcb5de898fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b238fea7-1887-454a-a8b2-3bab24967e5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a7b136aa-7723-4bc9-a1b0-00179fab4077" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b238fea7-1887-454a-a8b2-3bab24967e5e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_487ce676-8482-4154-b2b1-185a1e8b20bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2ff06fe9-49e8-45e1-a586-e1f1218d1017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_487ce676-8482-4154-b2b1-185a1e8b20bc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2ff06fe9-49e8-45e1-a586-e1f1218d1017" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_720e97d5-86f1-4651-9370-e94358a7db5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_487ce676-8482-4154-b2b1-185a1e8b20bc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_720e97d5-86f1-4651-9370-e94358a7db5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_973a5ce1-57c7-4d4f-9c0d-32a719347f77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_487ce676-8482-4154-b2b1-185a1e8b20bc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_973a5ce1-57c7-4d4f-9c0d-32a719347f77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_ca159b5e-50c8-48a9-b756-8b717247ae3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_487ce676-8482-4154-b2b1-185a1e8b20bc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_ca159b5e-50c8-48a9-b756-8b717247ae3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_fda97266-0170-4bdb-917a-30a00dbf6a5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_487ce676-8482-4154-b2b1-185a1e8b20bc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_fda97266-0170-4bdb-917a-30a00dbf6a5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_be398fcc-c66e-4472-a0d0-42775f8079ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_487ce676-8482-4154-b2b1-185a1e8b20bc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_be398fcc-c66e-4472-a0d0-42775f8079ff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesScheduleofnetdeferredtaxassetsDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_daa138d3-e5cd-4d5e-ba7a-9500987d332a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_447c76f6-df94-4012-9a08-d69a07dbc246" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_daa138d3-e5cd-4d5e-ba7a-9500987d332a" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_447c76f6-df94-4012-9a08-d69a07dbc246" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f0061370-33b9-42cf-9ddc-2974367b774c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_daa138d3-e5cd-4d5e-ba7a-9500987d332a" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f0061370-33b9-42cf-9ddc-2974367b774c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_704204f9-e165-463a-a131-f901da0b27e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_152472e9-cbe9-4eb5-9179-da0acfd60577" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_704204f9-e165-463a-a131-f901da0b27e6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_152472e9-cbe9-4eb5-9179-da0acfd60577" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesFinancingArrangements_3ee9645a-b732-4429-bd8c-6afd71f18896" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesFinancingArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_704204f9-e165-463a-a131-f901da0b27e6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesFinancingArrangements_3ee9645a-b732-4429-bd8c-6afd71f18896" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset_8688790b-2de8-4f64-b1a0-7420f02e6d67" xlink:href="nvta-20201231.xsd#nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_704204f9-e165-463a-a131-f901da0b27e6" xlink:to="loc_nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset_8688790b-2de8-4f64-b1a0-7420f02e6d67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_81684b6a-c644-4717-9c4f-3bbbc4877d0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_0e455f1c-6f31-43f0-82a1-82094e661b9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_81684b6a-c644-4717-9c4f-3bbbc4877d0a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_0e455f1c-6f31-43f0-82a1-82094e661b9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_d0eb1f77-83ed-4c41-80c6-8d48080fa757" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_81684b6a-c644-4717-9c4f-3bbbc4877d0a" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_d0eb1f77-83ed-4c41-80c6-8d48080fa757" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d8506696-10c1-4144-b67b-062e62c7e966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_401ac744-4383-4e0a-9a1f-99aa01d9b33c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d8506696-10c1-4144-b67b-062e62c7e966" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_401ac744-4383-4e0a-9a1f-99aa01d9b33c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_8022726f-0082-40da-b5ca-e8c131078866" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d8506696-10c1-4144-b67b-062e62c7e966" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_8022726f-0082-40da-b5ca-e8c131078866" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DeferredTaxAssetsRevenueRecognitionReserves_31a2886d-a7f6-4501-835c-349dcbc28b1c" xlink:href="nvta-20201231.xsd#nvta_DeferredTaxAssetsRevenueRecognitionReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d8506696-10c1-4144-b67b-062e62c7e966" xlink:to="loc_nvta_DeferredTaxAssetsRevenueRecognitionReserves_31a2886d-a7f6-4501-835c-349dcbc28b1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DeferredTaxAssetsLeaseLiability_5b2a0caf-fd9c-40c9-851f-f4cbfd884737" xlink:href="nvta-20201231.xsd#nvta_DeferredTaxAssetsLeaseLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d8506696-10c1-4144-b67b-062e62c7e966" xlink:to="loc_nvta_DeferredTaxAssetsLeaseLiability_5b2a0caf-fd9c-40c9-851f-f4cbfd884737" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther_7c3a7d87-59f2-491b-98e3-fe59cbcd39de" xlink:href="nvta-20201231.xsd#nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d8506696-10c1-4144-b67b-062e62c7e966" xlink:to="loc_nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther_7c3a7d87-59f2-491b-98e3-fe59cbcd39de" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/IncometaxesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Netlosspershare" xlink:type="simple" xlink:href="nvta-20201231.xsd#Netlosspershare"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/Netlosspershare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/NetlosspershareTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#NetlosspershareTables"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/NetlosspershareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/NetlosspershareScheduleofearningspersharebasicanddilutedDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#NetlosspershareScheduleofearningspersharebasicanddilutedDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/NetlosspershareScheduleofearningspersharebasicanddilutedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Geographicinformation" xlink:type="simple" xlink:href="nvta-20201231.xsd#Geographicinformation"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/Geographicinformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/GeographicinformationTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#GeographicinformationTables"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/GeographicinformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/GeographicinformationDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#GeographicinformationDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/GeographicinformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Selectedquarterlydataunaudited" xlink:type="simple" xlink:href="nvta-20201231.xsd#Selectedquarterlydataunaudited"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/Selectedquarterlydataunaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/SelectedquarterlydataunauditedTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#SelectedquarterlydataunauditedTables"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/SelectedquarterlydataunauditedTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/SelectedquarterlydataunauditedDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SelectedquarterlydataunauditedDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/SelectedquarterlydataunauditedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Subsequentevent" xlink:type="simple" xlink:href="nvta-20201231.xsd#Subsequentevent"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/Subsequentevent" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/SubsequenteventsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SubsequenteventsDetails"/>
  <link:calculationLink xlink:role="http://www.invitae.com/role/SubsequenteventsDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>nvta-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:1a5642af-41c4-4761-89fa-6771b997ee20,g:0d35037d-3d4c-4753-897e-12e6bc13039e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.invitae.com/role/CoverPage" xlink:type="simple" xlink:href="nvta-20201231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/CoverPage" xlink:type="extended" id="i85f26aa81fae4f898167c8e56235b405_CoverPage"/>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="ieeb855bca2ae4f70a9681a32595543c9_ConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i7ff4223a945640ddae0d17a18479c953_ConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/ConsolidatedStatementsofOperations" xlink:type="extended" id="i947f71cbe0a34e9cb168e26c4395394c_ConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b0459745-63fe-474b-b4e1-1eef500b8aaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b0459745-63fe-474b-b4e1-1eef500b8aaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_fd07c168-2c7c-492b-831e-112fb242cb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_CostOfRevenue_fd07c168-2c7c-492b-831e-112fb242cb38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_81cc7281-2faf-40b4-be83-e659f8afd0b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_81cc7281-2faf-40b4-be83-e659f8afd0b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_03eefcfd-88de-4dcd-8315-a4032020b4f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_SellingAndMarketingExpense_03eefcfd-88de-4dcd-8315-a4032020b4f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_078b105c-e378-453b-8024-4a0127988be4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_078b105c-e378-453b-8024-4a0127988be4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c48a1b8d-badd-4234-9264-5d77552608ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_OperatingIncomeLoss_c48a1b8d-badd-4234-9264-5d77552608ef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_aaea67fd-ae9b-4487-bbbf-6f9388995423" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_aaea67fd-ae9b-4487-bbbf-6f9388995423" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8bd16807-819f-4ae2-b553-e3b430b64010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_InterestExpense_8bd16807-819f-4ae2-b553-e3b430b64010" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cedc9be1-b8d6-4edb-bc5a-042dd9cbc324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cedc9be1-b8d6-4edb-bc5a-042dd9cbc324" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ea6ddea5-db52-4bd9-8afe-bdbd65ebdd51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ea6ddea5-db52-4bd9-8afe-bdbd65ebdd51" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4971a329-20d2-4079-a299-356550230309" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_NetIncomeLoss_4971a329-20d2-4079-a299-356550230309" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_ca4500cf-b880-487b-b250-b11f06d0a486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_ca4500cf-b880-487b-b250-b11f06d0a486" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_54d37b0e-1bf2-403c-9942-5864ac6c39ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_54d37b0e-1bf2-403c-9942-5864ac6c39ae" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_46bf0b75-7cfe-4a9f-9ef4-74ca0819a458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_StatementTable_46bf0b75-7cfe-4a9f-9ef4-74ca0819a458" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a3351bfd-a54e-44d2-a933-0977bb61e4bd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_46bf0b75-7cfe-4a9f-9ef4-74ca0819a458" xlink:to="loc_srt_ProductOrServiceAxis_a3351bfd-a54e-44d2-a933-0977bb61e4bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a3351bfd-a54e-44d2-a933-0977bb61e4bd_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a3351bfd-a54e-44d2-a933-0977bb61e4bd" xlink:to="loc_srt_ProductsAndServicesDomain_a3351bfd-a54e-44d2-a933-0977bb61e4bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4cb0ce2e-2db8-4b92-94b9-e396d7acd73f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a3351bfd-a54e-44d2-a933-0977bb61e4bd" xlink:to="loc_srt_ProductsAndServicesDomain_4cb0ce2e-2db8-4b92-94b9-e396d7acd73f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DiagnosticTestsMember_d3905986-ebc0-498e-8d9d-bc37f659988d" xlink:href="nvta-20201231.xsd#nvta_DiagnosticTestsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4cb0ce2e-2db8-4b92-94b9-e396d7acd73f" xlink:to="loc_nvta_DiagnosticTestsMember_d3905986-ebc0-498e-8d9d-bc37f659988d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CollaborationAndGenomeNetworkMember_71e3ae88-2217-4bc3-b4b6-007d731283ec" xlink:href="nvta-20201231.xsd#nvta_CollaborationAndGenomeNetworkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4cb0ce2e-2db8-4b92-94b9-e396d7acd73f" xlink:to="loc_nvta_CollaborationAndGenomeNetworkMember_71e3ae88-2217-4bc3-b4b6-007d731283ec" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended" id="ic37f6b8600bf46c18b6d634789b2701f_ConsolidatedStatementsofComprehensiveLoss"/>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="ie7b0a0426b8441228c001b5c1447c53e_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fe08eb45-c2f7-4e06-b627-2fc6527a3f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fe08eb45-c2f7-4e06-b627-2fc6527a3f3b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_29d981bd-05ec-4171-a865-16cdf70ca766" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_StockholdersEquity_29d981bd-05ec-4171-a865-16cdf70ca766" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_737ba993-2135-4246-bc91-ec4428658886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_737ba993-2135-4246-bc91-ec4428658886" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts_402a6d8a-3ae6-458c-a14b-ed8b58b1ceaa" xlink:href="nvta-20201231.xsd#nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts_402a6d8a-3ae6-458c-a14b-ed8b58b1ceaa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b8fb99eb-e79f-4573-8ae6-0b93f3a44391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b8fb99eb-e79f-4573-8ae6-0b93f3a44391" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fb164812-3e0b-45b4-a078-e604245300bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fb164812-3e0b-45b4-a078-e604245300bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIssuedDuringPeriodValueWarrantsExercised_e340cdad-ec08-4e99-8767-d882180d3a4c" xlink:href="nvta-20201231.xsd#nvta_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_nvta_StockIssuedDuringPeriodValueWarrantsExercised_e340cdad-ec08-4e99-8767-d882180d3a4c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_cfe5b8af-4a9b-4855-868b-1b002ae38a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_cfe5b8af-4a9b-4855-868b-1b002ae38a8c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_854be1ea-008e-45a9-9c65-ba3b5a47090f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_854be1ea-008e-45a9-9c65-ba3b5a47090f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_bebacf4b-f46b-4549-8541-10dffb447847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_bebacf4b-f46b-4549-8541-10dffb447847" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts_fb036317-834c-43ff-8576-87a63ada47d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts_fb036317-834c-43ff-8576-87a63ada47d4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_108d5521-ebe2-48a4-84ee-51b25f19f4a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_108d5521-ebe2-48a4-84ee-51b25f19f4a7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_213638db-d370-4688-9c92-b19b3ddc0f6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_NetIncomeLoss_213638db-d370-4688-9c92-b19b3ddc0f6e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4cc211b7-70d0-4a96-b7c4-5cbf2f62beab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_88a2ec40-9eb5-412a-9c04-b327c3b19aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_fe08eb45-c2f7-4e06-b627-2fc6527a3f3b" xlink:to="loc_us-gaap_StatementTable_88a2ec40-9eb5-412a-9c04-b327c3b19aa1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1e3947aa-0b51-4b0a-84fb-247dd29496b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_88a2ec40-9eb5-412a-9c04-b327c3b19aa1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1e3947aa-0b51-4b0a-84fb-247dd29496b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1e3947aa-0b51-4b0a-84fb-247dd29496b3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1e3947aa-0b51-4b0a-84fb-247dd29496b3" xlink:to="loc_us-gaap_EquityComponentDomain_1e3947aa-0b51-4b0a-84fb-247dd29496b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1d5f0155-cd42-492b-92c9-2db3be9d1bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1e3947aa-0b51-4b0a-84fb-247dd29496b3" xlink:to="loc_us-gaap_EquityComponentDomain_1d5f0155-cd42-492b-92c9-2db3be9d1bf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c4dfccb4-f454-44c5-9d02-652ea782f61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f0155-cd42-492b-92c9-2db3be9d1bf8" xlink:to="loc_us-gaap_CommonStockMember_c4dfccb4-f454-44c5-9d02-652ea782f61e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_590d40bd-26ec-4860-8721-a01d55e26dff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f0155-cd42-492b-92c9-2db3be9d1bf8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_590d40bd-26ec-4860-8721-a01d55e26dff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_09abf6ee-7caf-4706-89ea-790e0f72efb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f0155-cd42-492b-92c9-2db3be9d1bf8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_09abf6ee-7caf-4706-89ea-790e0f72efb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_fc40c2cd-f55b-40ec-acbf-6cf089daf5c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f0155-cd42-492b-92c9-2db3be9d1bf8" xlink:to="loc_us-gaap_RetainedEarningsMember_fc40c2cd-f55b-40ec-acbf-6cf089daf5c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_dfc79d26-a990-4e90-87e4-203be4fae1f1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_88a2ec40-9eb5-412a-9c04-b327c3b19aa1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_dfc79d26-a990-4e90-87e4-203be4fae1f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_dfc79d26-a990-4e90-87e4-203be4fae1f1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_dfc79d26-a990-4e90-87e4-203be4fae1f1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_dfc79d26-a990-4e90-87e4-203be4fae1f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_98470b45-0fb8-4ecc-937f-fa521301eea3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_dfc79d26-a990-4e90-87e4-203be4fae1f1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_98470b45-0fb8-4ecc-937f-fa521301eea3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_91a38d13-2d05-45d4-b1d7-e1cfc4ad0e24" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_98470b45-0fb8-4ecc-937f-fa521301eea3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_91a38d13-2d05-45d4-b1d7-e1cfc4ad0e24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_af4d24ae-f250-4a92-9ea3-891195bf8733" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_88a2ec40-9eb5-412a-9c04-b327c3b19aa1" xlink:to="loc_srt_RestatementAxis_af4d24ae-f250-4a92-9ea3-891195bf8733" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_af4d24ae-f250-4a92-9ea3-891195bf8733_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_af4d24ae-f250-4a92-9ea3-891195bf8733" xlink:to="loc_srt_RestatementDomain_af4d24ae-f250-4a92-9ea3-891195bf8733_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_274b87b8-2b59-4dd3-909f-fff75a6e10ef" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_af4d24ae-f250-4a92-9ea3-891195bf8733" xlink:to="loc_srt_RestatementDomain_274b87b8-2b59-4dd3-909f-fff75a6e10ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_bfa9be1d-479d-469d-b9a9-53849fdbd33f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_274b87b8-2b59-4dd3-909f-fff75a6e10ef" xlink:to="loc_srt_RestatementAdjustmentMember_bfa9be1d-479d-469d-b9a9-53849fdbd33f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_76fa617b-e167-457c-b377-1b11adf4c29c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_88a2ec40-9eb5-412a-9c04-b327c3b19aa1" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_76fa617b-e167-457c-b377-1b11adf4c29c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_76fa617b-e167-457c-b377-1b11adf4c29c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_76fa617b-e167-457c-b377-1b11adf4c29c" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_76fa617b-e167-457c-b377-1b11adf4c29c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_beb10349-259e-4e04-8189-53a05e2598f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_76fa617b-e167-457c-b377-1b11adf4c29c" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_beb10349-259e-4e04-8189-53a05e2598f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember_93fb4ef0-8939-4269-bfa0-c11c5ba21aaf" xlink:href="nvta-20201231.xsd#nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_beb10349-259e-4e04-8189-53a05e2598f5" xlink:to="loc_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember_93fb4ef0-8939-4269-bfa0-c11c5ba21aaf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="i3928433f0b704e55b0ca1b7e67ded1ee_ConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Organizationanddescriptionofbusiness" xlink:type="simple" xlink:href="nvta-20201231.xsd#Organizationanddescriptionofbusiness"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/Organizationanddescriptionofbusiness" xlink:type="extended" id="idcd872ca21394582a32ea250666e94fc_Organizationanddescriptionofbusiness"/>
  <link:roleRef roleURI="http://www.invitae.com/role/OrganizationanddescriptionofbusinessDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#OrganizationanddescriptionofbusinessDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/OrganizationanddescriptionofbusinessDetails" xlink:type="extended" id="i5359027e0f8741a0a62646ad93ac02c1_OrganizationanddescriptionofbusinessDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Summaryofsignificantaccountingpolicies" xlink:type="simple" xlink:href="nvta-20201231.xsd#Summaryofsignificantaccountingpolicies"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/Summaryofsignificantaccountingpolicies" xlink:type="extended" id="ie5876b46d5384280961663205958dc18_Summaryofsignificantaccountingpolicies"/>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="extended" id="i1935a176412c44fdbe307660bd211b32_SummaryofsignificantaccountingpoliciesPolicies"/>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesTables"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesTables" xlink:type="extended" id="i0a63da22ffd24780a7d3c8ba422a1f5b_SummaryofsignificantaccountingpoliciesTables"/>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails" xlink:type="extended" id="i937461ee3c5a48858bff4f4b06d5e266_SummaryofsignificantaccountingpoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:href="nvta-20201231.xsd#nvta_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9f0f72f6-61c3-410c-a32d-5287cee964b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9f0f72f6-61c3-410c-a32d-5287cee964b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9901ce47-a1f2-4e75-8590-0e425daee0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9901ce47-a1f2-4e75-8590-0e425daee0b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_196fdb30-c72b-4768-835a-acefdafc9928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_196fdb30-c72b-4768-835a-acefdafc9928" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3a4a6f51-d2e9-49a8-a24c-48169e41850e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3a4a6f51-d2e9-49a8-a24c-48169e41850e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_0ad3b764-aa6c-44aa-9f05-e49175a17e0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_0ad3b764-aa6c-44aa-9f05-e49175a17e0f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets_1c204574-e528-49fe-add1-9aa881b62346" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets_1c204574-e528-49fe-add1-9aa881b62346" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_b0bb91b9-2cd3-440c-8f03-5e750f937a13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_AdvertisingExpense_b0bb91b9-2cd3-440c-8f03-5e750f937a13" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d9d9303a-9a38-4d39-93d9-ef8a633c871f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d9d9303a-9a38-4d39-93d9-ef8a633c871f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_49d06a34-361e-4040-83a6-4767f3724f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_StockholdersEquity_49d06a34-361e-4040-83a6-4767f3724f03" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6e3b7fba-a223-43a4-8e0a-1ac10a43a10c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6e3b7fba-a223-43a4-8e0a-1ac10a43a10c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:href="nvta-20201231.xsd#nvta_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4257820d-1c35-4fd5-a206-865e80bd6ed9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:to="loc_us-gaap_DebtInstrumentAxis_4257820d-1c35-4fd5-a206-865e80bd6ed9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4257820d-1c35-4fd5-a206-865e80bd6ed9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4257820d-1c35-4fd5-a206-865e80bd6ed9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4257820d-1c35-4fd5-a206-865e80bd6ed9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_027b6282-f2a4-4614-89c7-f64249d28c76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4257820d-1c35-4fd5-a206-865e80bd6ed9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_027b6282-f2a4-4614-89c7-f64249d28c76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ConvertibleSeniorNotesMember_37d25642-ed18-4329-8a1c-7dbb6ee5687b" xlink:href="nvta-20201231.xsd#nvta_ConvertibleSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_027b6282-f2a4-4614-89c7-f64249d28c76" xlink:to="loc_nvta_ConvertibleSeniorNotesMember_37d25642-ed18-4329-8a1c-7dbb6ee5687b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_13e31a51-fccf-4c8c-8660-676659425c11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_13e31a51-fccf-4c8c-8660-676659425c11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_13e31a51-fccf-4c8c-8660-676659425c11_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_13e31a51-fccf-4c8c-8660-676659425c11" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_13e31a51-fccf-4c8c-8660-676659425c11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_59d7b39a-1eb3-49ff-b1bb-7e2f0804ab65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_13e31a51-fccf-4c8c-8660-676659425c11" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_59d7b39a-1eb3-49ff-b1bb-7e2f0804ab65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_c6e808d2-a617-4aec-806e-c1b3ad7c4f62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_59d7b39a-1eb3-49ff-b1bb-7e2f0804ab65" xlink:to="loc_us-gaap_ConvertibleDebtMember_c6e808d2-a617-4aec-806e-c1b3ad7c4f62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e9b03574-90f2-4af4-8619-e3ef80c29052" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:to="loc_srt_RangeAxis_e9b03574-90f2-4af4-8619-e3ef80c29052" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e9b03574-90f2-4af4-8619-e3ef80c29052_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e9b03574-90f2-4af4-8619-e3ef80c29052" xlink:to="loc_srt_RangeMember_e9b03574-90f2-4af4-8619-e3ef80c29052_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5006400b-e175-4563-85e8-69f1c6f5f446" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e9b03574-90f2-4af4-8619-e3ef80c29052" xlink:to="loc_srt_RangeMember_5006400b-e175-4563-85e8-69f1c6f5f446" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5378a6f7-6b48-46b9-85a3-858dec089d25" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5006400b-e175-4563-85e8-69f1c6f5f446" xlink:to="loc_srt_MinimumMember_5378a6f7-6b48-46b9-85a3-858dec089d25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e1d3e22a-a476-47ec-b542-38b61956f901" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5006400b-e175-4563-85e8-69f1c6f5f446" xlink:to="loc_srt_MaximumMember_e1d3e22a-a476-47ec-b542-38b61956f901" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b6773e9d-f822-496e-b8d0-e08ea8d08035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b6773e9d-f822-496e-b8d0-e08ea8d08035" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b6773e9d-f822-496e-b8d0-e08ea8d08035_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b6773e9d-f822-496e-b8d0-e08ea8d08035" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b6773e9d-f822-496e-b8d0-e08ea8d08035_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf97cb73-1d01-4bf5-a0e4-667b92530138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b6773e9d-f822-496e-b8d0-e08ea8d08035" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf97cb73-1d01-4bf5-a0e4-667b92530138" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_8eb5e86a-3ce9-4ad1-aed1-f54fd1dba067" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf97cb73-1d01-4bf5-a0e4-667b92530138" xlink:to="loc_us-gaap_CustomerRelationshipsMember_8eb5e86a-3ce9-4ad1-aed1-f54fd1dba067" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_3e3e428a-ac8f-481c-8051-4e48845759bc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:to="loc_srt_RestatementAxis_3e3e428a-ac8f-481c-8051-4e48845759bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_3e3e428a-ac8f-481c-8051-4e48845759bc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_3e3e428a-ac8f-481c-8051-4e48845759bc" xlink:to="loc_srt_RestatementDomain_3e3e428a-ac8f-481c-8051-4e48845759bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_cc26372b-e834-4f29-be28-4e4e585e7fcd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_3e3e428a-ac8f-481c-8051-4e48845759bc" xlink:to="loc_srt_RestatementDomain_cc26372b-e834-4f29-be28-4e4e585e7fcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_f7b240e0-e5ba-49d8-847e-ced723c63b9d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_cc26372b-e834-4f29-be28-4e4e585e7fcd" xlink:to="loc_srt_RestatementAdjustmentMember_f7b240e0-e5ba-49d8-847e-ced723c63b9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_70ecfac1-3d22-4d82-a933-f6cf8d8946ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_70ecfac1-3d22-4d82-a933-f6cf8d8946ce" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_70ecfac1-3d22-4d82-a933-f6cf8d8946ce_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_70ecfac1-3d22-4d82-a933-f6cf8d8946ce" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_70ecfac1-3d22-4d82-a933-f6cf8d8946ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_97e75ef1-50b5-4bf0-819f-559cad0e78c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_70ecfac1-3d22-4d82-a933-f6cf8d8946ce" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_97e75ef1-50b5-4bf0-819f-559cad0e78c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember_b1494c7e-71d4-4692-81d4-81747c8be36e" xlink:href="nvta-20201231.xsd#nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_97e75ef1-50b5-4bf0-819f-559cad0e78c3" xlink:to="loc_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember_b1494c7e-71d4-4692-81d4-81747c8be36e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d3a9ed82-010c-4c8e-88ee-49e56ef03563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d3a9ed82-010c-4c8e-88ee-49e56ef03563" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d3a9ed82-010c-4c8e-88ee-49e56ef03563_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d3a9ed82-010c-4c8e-88ee-49e56ef03563" xlink:to="loc_us-gaap_EquityComponentDomain_d3a9ed82-010c-4c8e-88ee-49e56ef03563_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_72ce4665-972e-4b41-830b-ed1acb4b7bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d3a9ed82-010c-4c8e-88ee-49e56ef03563" xlink:to="loc_us-gaap_EquityComponentDomain_72ce4665-972e-4b41-830b-ed1acb4b7bd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_05e6d5fd-7c22-4ff5-b7dd-04e0fd1f5c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_72ce4665-972e-4b41-830b-ed1acb4b7bd5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_05e6d5fd-7c22-4ff5-b7dd-04e0fd1f5c86" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails" xlink:type="extended" id="i1da421c7d64046e79f82cc6e4bcd91a6_SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_3f1bd9ca-e38a-4d07-991f-09b3f772f5cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c93ad08f-1216-4235-9ecd-a0c8c7795c54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_3f1bd9ca-e38a-4d07-991f-09b3f772f5cf" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c93ad08f-1216-4235-9ecd-a0c8c7795c54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_9a9af1c7-f653-48b2-8158-b177c56b8560" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_3f1bd9ca-e38a-4d07-991f-09b3f772f5cf" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_9a9af1c7-f653-48b2-8158-b177c56b8560" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_5567570d-7c45-478e-ab36-778c6f6547ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_9a9af1c7-f653-48b2-8158-b177c56b8560" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_5567570d-7c45-478e-ab36-778c6f6547ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5567570d-7c45-478e-ab36-778c6f6547ae_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5567570d-7c45-478e-ab36-778c6f6547ae" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5567570d-7c45-478e-ab36-778c6f6547ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_15649ea3-55a4-4fbd-9cc6-82d0805aa83c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5567570d-7c45-478e-ab36-778c6f6547ae" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_15649ea3-55a4-4fbd-9cc6-82d0805aa83c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_7d76acea-0639-433b-9f04-10868c0275ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_15649ea3-55a4-4fbd-9cc6-82d0805aa83c" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_7d76acea-0639-433b-9f04-10868c0275ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_39b8fb02-00d4-4120-85f4-1af2db808be4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_9a9af1c7-f653-48b2-8158-b177c56b8560" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_39b8fb02-00d4-4120-85f4-1af2db808be4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_39b8fb02-00d4-4120-85f4-1af2db808be4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_39b8fb02-00d4-4120-85f4-1af2db808be4" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_39b8fb02-00d4-4120-85f4-1af2db808be4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f6db7abc-f9f9-4038-9099-7a5e7abc9f09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_39b8fb02-00d4-4120-85f4-1af2db808be4" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f6db7abc-f9f9-4038-9099-7a5e7abc9f09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_e1b71fe6-aea1-4f08-be71-aedb43b44779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f6db7abc-f9f9-4038-9099-7a5e7abc9f09" xlink:to="loc_us-gaap_SalesRevenueNetMember_e1b71fe6-aea1-4f08-be71-aedb43b44779" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_3f1ee943-24d1-4d83-99f2-ef0ddb1e9c09" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_9a9af1c7-f653-48b2-8158-b177c56b8560" xlink:to="loc_srt_MajorCustomersAxis_3f1ee943-24d1-4d83-99f2-ef0ddb1e9c09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_3f1ee943-24d1-4d83-99f2-ef0ddb1e9c09_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_3f1ee943-24d1-4d83-99f2-ef0ddb1e9c09" xlink:to="loc_srt_NameOfMajorCustomerDomain_3f1ee943-24d1-4d83-99f2-ef0ddb1e9c09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_7218d135-95a4-4f82-8d36-d5a854993110" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_3f1ee943-24d1-4d83-99f2-ef0ddb1e9c09" xlink:to="loc_srt_NameOfMajorCustomerDomain_7218d135-95a4-4f82-8d36-d5a854993110" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CustomerMember_31ba654c-cf79-4ba5-bbdb-6b7c710391f5" xlink:href="nvta-20201231.xsd#nvta_CustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_7218d135-95a4-4f82-8d36-d5a854993110" xlink:to="loc_nvta_CustomerMember_31ba654c-cf79-4ba5-bbdb-6b7c710391f5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails" xlink:type="extended" id="i28e0bb8658594870a79ea370a4cc0cc3_SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails" xlink:type="extended" id="i40186401f06f4b2ba744bc1b2d8a1570_SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3299e062-1385-4b96-8e4c-2cc4acac1ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_0d7779f0-d23c-4a3c-84e1-0064e293ccfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3299e062-1385-4b96-8e4c-2cc4acac1ac4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_0d7779f0-d23c-4a3c-84e1-0064e293ccfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ee5c63bb-7f22-4cde-b43c-10103d217f10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3299e062-1385-4b96-8e4c-2cc4acac1ac4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ee5c63bb-7f22-4cde-b43c-10103d217f10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58b2e637-44ba-46bb-958c-80150c414588" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ee5c63bb-7f22-4cde-b43c-10103d217f10" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58b2e637-44ba-46bb-958c-80150c414588" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_58b2e637-44ba-46bb-958c-80150c414588_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58b2e637-44ba-46bb-958c-80150c414588" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_58b2e637-44ba-46bb-958c-80150c414588_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49243094-b918-41f4-86cf-a0b44b0d4892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58b2e637-44ba-46bb-958c-80150c414588" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49243094-b918-41f4-86cf-a0b44b0d4892" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_f527238c-0eff-4ad1-b5e1-9a373c997fb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49243094-b918-41f4-86cf-a0b44b0d4892" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_f527238c-0eff-4ad1-b5e1-9a373c997fb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AutomobilesMember_fa93e507-dfff-44c0-99eb-88ee4c5ea2aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AutomobilesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49243094-b918-41f4-86cf-a0b44b0d4892" xlink:to="loc_us-gaap_AutomobilesMember_fa93e507-dfff-44c0-99eb-88ee4c5ea2aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_1e56d547-eb89-4505-ac8e-6376b0660d9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49243094-b918-41f4-86cf-a0b44b0d4892" xlink:to="loc_us-gaap_EquipmentMember_1e56d547-eb89-4505-ac8e-6376b0660d9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_cb477914-6e3e-4c85-b2fe-eefc27f55092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49243094-b918-41f4-86cf-a0b44b0d4892" xlink:to="loc_us-gaap_ComputerEquipmentMember_cb477914-6e3e-4c85-b2fe-eefc27f55092" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_5c6dd0d2-ccf1-400c-b43e-934f60173ac1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49243094-b918-41f4-86cf-a0b44b0d4892" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_5c6dd0d2-ccf1-400c-b43e-934f60173ac1" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Revenueaccountsreceivableanddeferredrevenue" xlink:type="simple" xlink:href="nvta-20201231.xsd#Revenueaccountsreceivableanddeferredrevenue"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/Revenueaccountsreceivableanddeferredrevenue" xlink:type="extended" id="i2bd5a488e94a40bb92bf43dc6e5cafaf_Revenueaccountsreceivableanddeferredrevenue"/>
  <link:roleRef roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#RevenueaccountsreceivableanddeferredrevenueTables"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueTables" xlink:type="extended" id="ib5aaec0f55434fa991e2e3b8125d5649_RevenueaccountsreceivableanddeferredrevenueTables"/>
  <link:roleRef roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails" xlink:type="extended" id="id6b0d53bc0a74d9db39b3476eeb6c963_RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_08b7ef8d-9fb4-4926-9f53-e62ad2669900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fc601768-9bd1-45d4-b39c-1b75f38509d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_08b7ef8d-9fb4-4926-9f53-e62ad2669900" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fc601768-9bd1-45d4-b39c-1b75f38509d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a52a92d8-f634-41a2-9e2c-8b13ac46a478" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_08b7ef8d-9fb4-4926-9f53-e62ad2669900" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a52a92d8-f634-41a2-9e2c-8b13ac46a478" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5f405552-6e5d-4624-afb2-281362ec194c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a52a92d8-f634-41a2-9e2c-8b13ac46a478" xlink:to="loc_srt_ProductOrServiceAxis_5f405552-6e5d-4624-afb2-281362ec194c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5f405552-6e5d-4624-afb2-281362ec194c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5f405552-6e5d-4624-afb2-281362ec194c" xlink:to="loc_srt_ProductsAndServicesDomain_5f405552-6e5d-4624-afb2-281362ec194c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0ab340bb-e4c1-43ad-81e7-6648ac47016b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5f405552-6e5d-4624-afb2-281362ec194c" xlink:to="loc_srt_ProductsAndServicesDomain_0ab340bb-e4c1-43ad-81e7-6648ac47016b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DiagnosticTestsMember_f67cd6a4-8a9b-49da-b037-b9fd2f42d31e" xlink:href="nvta-20201231.xsd#nvta_DiagnosticTestsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0ab340bb-e4c1-43ad-81e7-6648ac47016b" xlink:to="loc_nvta_DiagnosticTestsMember_f67cd6a4-8a9b-49da-b037-b9fd2f42d31e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_TestRevenueCentralizedMember_1267b5fe-8ddc-490f-b1b4-b7533689ad68" xlink:href="nvta-20201231.xsd#nvta_TestRevenueCentralizedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nvta_DiagnosticTestsMember_f67cd6a4-8a9b-49da-b037-b9fd2f42d31e" xlink:to="loc_nvta_TestRevenueCentralizedMember_1267b5fe-8ddc-490f-b1b4-b7533689ad68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_TestRevenueDecentralizedMember_93495504-c579-4200-967b-12947193244b" xlink:href="nvta-20201231.xsd#nvta_TestRevenueDecentralizedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nvta_DiagnosticTestsMember_f67cd6a4-8a9b-49da-b037-b9fd2f42d31e" xlink:to="loc_nvta_TestRevenueDecentralizedMember_93495504-c579-4200-967b-12947193244b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CollaborationAndGenomeNetworkMember_7d72d5aa-a623-44de-89eb-651e4b50ba8e" xlink:href="nvta-20201231.xsd#nvta_CollaborationAndGenomeNetworkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0ab340bb-e4c1-43ad-81e7-6648ac47016b" xlink:to="loc_nvta_CollaborationAndGenomeNetworkMember_7d72d5aa-a623-44de-89eb-651e4b50ba8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_cb14c7c2-65fc-4d67-a07a-36a6067bf3f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a52a92d8-f634-41a2-9e2c-8b13ac46a478" xlink:to="loc_srt_MajorCustomersAxis_cb14c7c2-65fc-4d67-a07a-36a6067bf3f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_cb14c7c2-65fc-4d67-a07a-36a6067bf3f0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_cb14c7c2-65fc-4d67-a07a-36a6067bf3f0" xlink:to="loc_srt_NameOfMajorCustomerDomain_cb14c7c2-65fc-4d67-a07a-36a6067bf3f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_43c80cf9-0e4b-49c4-86b6-5a2fe78eb7b9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_cb14c7c2-65fc-4d67-a07a-36a6067bf3f0" xlink:to="loc_srt_NameOfMajorCustomerDomain_43c80cf9-0e4b-49c4-86b6-5a2fe78eb7b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PatientInsuranceMember_0ca6be28-e802-434e-ab6d-bb3723659eb8" xlink:href="nvta-20201231.xsd#nvta_PatientInsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_43c80cf9-0e4b-49c4-86b6-5a2fe78eb7b9" xlink:to="loc_nvta_PatientInsuranceMember_0ca6be28-e802-434e-ab6d-bb3723659eb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PatientDirectMember_d9f4035f-6887-4e10-a24d-f28b36dd3859" xlink:href="nvta-20201231.xsd#nvta_PatientDirectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_43c80cf9-0e4b-49c4-86b6-5a2fe78eb7b9" xlink:to="loc_nvta_PatientDirectMember_d9f4035f-6887-4e10-a24d-f28b36dd3859" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PartnerMember_2ccc7284-e8fd-470c-8ebe-dba8368ef223" xlink:href="nvta-20201231.xsd#nvta_PartnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_43c80cf9-0e4b-49c4-86b6-5a2fe78eb7b9" xlink:to="loc_nvta_PartnerMember_2ccc7284-e8fd-470c-8ebe-dba8368ef223" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_OtherBusinessToBusinessMember_f91e66f0-1560-45b5-a69e-88ee0028031c" xlink:href="nvta-20201231.xsd#nvta_OtherBusinessToBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_43c80cf9-0e4b-49c4-86b6-5a2fe78eb7b9" xlink:to="loc_nvta_OtherBusinessToBusinessMember_f91e66f0-1560-45b5-a69e-88ee0028031c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails" xlink:type="extended" id="i2f03138dd97344a1ac5b92c1476d3265_RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateLineItems_6c4e231f-0fd6-40f2-8398-c664e4ee7799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dedfd9a5-a031-44ba-87fb-f27cd51babd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_6c4e231f-0fd6-40f2-8398-c664e4ee7799" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dedfd9a5-a031-44ba-87fb-f27cd51babd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a02e192e-7e05-4c54-8d58-3b5bea0ef372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_6c4e231f-0fd6-40f2-8398-c664e4ee7799" xlink:to="loc_us-gaap_OperatingIncomeLoss_a02e192e-7e05-4c54-8d58-3b5bea0ef372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_45d924ec-808e-4fee-9df3-577a502e2131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_6c4e231f-0fd6-40f2-8398-c664e4ee7799" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_45d924ec-808e-4fee-9df3-577a502e2131" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_ae64a8cd-92e0-485e-a753-4b1f37a869cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfChangeInAccountingEstimateTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_6c4e231f-0fd6-40f2-8398-c664e4ee7799" xlink:to="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_ae64a8cd-92e0-485e-a753-4b1f37a869cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_863ab881-3a73-4a01-b8f5-1314fa26c096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_ae64a8cd-92e0-485e-a753-4b1f37a869cc" xlink:to="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_863ab881-3a73-4a01-b8f5-1314fa26c096" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_863ab881-3a73-4a01-b8f5-1314fa26c096_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_863ab881-3a73-4a01-b8f5-1314fa26c096" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleMember_863ab881-3a73-4a01-b8f5-1314fa26c096_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_d8f97456-d202-44bf-aca5-815d59752e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_863ab881-3a73-4a01-b8f5-1314fa26c096" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleMember_d8f97456-d202-44bf-aca5-815d59752e8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ChangeInEstimateOfRevenueRecognitionMember_4d935082-5aeb-4a51-9da2-8f0448dd48fe" xlink:href="nvta-20201231.xsd#nvta_ChangeInEstimateOfRevenueRecognitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingPrincipleMember_d8f97456-d202-44bf-aca5-815d59752e8d" xlink:to="loc_nvta_ChangeInEstimateOfRevenueRecognitionMember_4d935082-5aeb-4a51-9da2-8f0448dd48fe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails" xlink:type="extended" id="id98468177a914d09bad06f6559577fab_RevenueaccountsreceivableanddeferredrevenueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent_8f571c7a-2e37-42d4-9abd-2141f6a07747" xlink:href="nvta-20201231.xsd#nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:to="loc_nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent_8f571c7a-2e37-42d4-9abd-2141f6a07747" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b78a02df-7f8e-4e64-bb74-7399012bd4b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:to="loc_us-gaap_RestructuringCharges_b78a02df-7f8e-4e64-bb74-7399012bd4b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent_8f9e22d7-3362-4404-8a07-63fe6e3d3d5f" xlink:href="nvta-20201231.xsd#nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:to="loc_nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent_8f9e22d7-3362-4404-8a07-63fe6e3d3d5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemNetGainLoss_914ccb12-3714-46da-829d-0459401f15e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemNetGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:to="loc_us-gaap_UnusualOrInfrequentItemNetGainLoss_914ccb12-3714-46da-829d-0459401f15e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_6eb34d05-1352-4ab5-9942-33dc388ba798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_6eb34d05-1352-4ab5-9942-33dc388ba798" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_cc7020f9-1ec2-4f98-95e4-a3edbc4c4a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_cc7020f9-1ec2-4f98-95e4-a3edbc4c4a86" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_2d5148c3-d95a-46d5-9bb8-d5d133ce6368" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_2d5148c3-d95a-46d5-9bb8-d5d133ce6368" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fcd5f978-803c-48b6-a52c-9028e0867f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fcd5f978-803c-48b6-a52c-9028e0867f03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_448e8c2f-039f-41d0-b771-28c7ba2829b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fcd5f978-803c-48b6-a52c-9028e0867f03" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_448e8c2f-039f-41d0-b771-28c7ba2829b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_448e8c2f-039f-41d0-b771-28c7ba2829b3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_448e8c2f-039f-41d0-b771-28c7ba2829b3" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_448e8c2f-039f-41d0-b771-28c7ba2829b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_c67c2ceb-bbb8-4df0-bbd7-792e46d83ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_448e8c2f-039f-41d0-b771-28c7ba2829b3" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_c67c2ceb-bbb8-4df0-bbd7-792e46d83ec9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CARESActMember_eb79b087-44a9-4742-bdba-11a29f373981" xlink:href="nvta-20201231.xsd#nvta_CARESActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_c67c2ceb-bbb8-4df0-bbd7-792e46d83ec9" xlink:to="loc_nvta_CARESActMember_eb79b087-44a9-4742-bdba-11a29f373981" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_bef820db-4479-41ed-a6da-4d8c2436cbc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fcd5f978-803c-48b6-a52c-9028e0867f03" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_bef820db-4479-41ed-a6da-4d8c2436cbc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_bef820db-4479-41ed-a6da-4d8c2436cbc8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_bef820db-4479-41ed-a6da-4d8c2436cbc8" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_bef820db-4479-41ed-a6da-4d8c2436cbc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_8aead331-02f9-4aed-931b-932a1feb2028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_bef820db-4479-41ed-a6da-4d8c2436cbc8" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_8aead331-02f9-4aed-931b-932a1feb2028" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OneTimeTerminationBenefitsMember_f5f63ad6-0c16-4b70-9746-0e337de2b0fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OneTimeTerminationBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8aead331-02f9-4aed-931b-932a1feb2028" xlink:to="loc_us-gaap_OneTimeTerminationBenefitsMember_f5f63ad6-0c16-4b70-9746-0e337de2b0fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f977b86d-fd01-4b12-8916-c9933cfe4063" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fcd5f978-803c-48b6-a52c-9028e0867f03" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f977b86d-fd01-4b12-8916-c9933cfe4063" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f977b86d-fd01-4b12-8916-c9933cfe4063_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f977b86d-fd01-4b12-8916-c9933cfe4063" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f977b86d-fd01-4b12-8916-c9933cfe4063_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55a89b33-1162-40cd-a3f9-a726a7e724e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f977b86d-fd01-4b12-8916-c9933cfe4063" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55a89b33-1162-40cd-a3f9-a726a7e724e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_7a906e2a-279f-47d8-a873-a9f3c338a30c" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55a89b33-1162-40cd-a3f9-a726a7e724e3" xlink:to="loc_nvta_ArcherDXInc.Member_7a906e2a-279f-47d8-a873-a9f3c338a30c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d98fa039-11fe-4ffd-bfb1-4471f8397906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fcd5f978-803c-48b6-a52c-9028e0867f03" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d98fa039-11fe-4ffd-bfb1-4471f8397906" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d98fa039-11fe-4ffd-bfb1-4471f8397906_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d98fa039-11fe-4ffd-bfb1-4471f8397906" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d98fa039-11fe-4ffd-bfb1-4471f8397906_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1f494a77-419f-4ed1-bbf2-dd07cf67e2ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d98fa039-11fe-4ffd-bfb1-4471f8397906" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1f494a77-419f-4ed1-bbf2-dd07cf67e2ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9ef42ad4-8d47-48a5-9bb0-53201a3d7f93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1f494a77-419f-4ed1-bbf2-dd07cf67e2ab" xlink:to="loc_us-gaap_SubsequentEventMember_9ef42ad4-8d47-48a5-9bb0-53201a3d7f93" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Businesscombinations" xlink:type="simple" xlink:href="nvta-20201231.xsd#Businesscombinations"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/Businesscombinations" xlink:type="extended" id="i936527aa10184784a250dffe6468165e_Businesscombinations"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsTables"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BusinesscombinationsTables" xlink:type="extended" id="i7814c1e4d066497bb33f356bbd2f1d8b_BusinesscombinationsTables"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsSingularBioDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsSingularBioDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BusinesscombinationsSingularBioDetails" xlink:type="extended" id="if1d7171fe0c3486c99a003338eca00be_BusinesscombinationsSingularBioDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_646e55ad-18fc-4506-bd4b-0b4b037fa404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_646e55ad-18fc-4506-bd4b-0b4b037fa404" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9e0a5827-6565-4a95-b166-b89cbeee1a73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9e0a5827-6565-4a95-b166-b89cbeee1a73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_ebe7f9b3-d096-453a-a2b5-17dabfe1f156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_ebe7f9b3-d096-453a-a2b5-17dabfe1f156" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_1e036693-aa4e-4aeb-ab17-6f306ce47b32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_1e036693-aa4e-4aeb-ab17-6f306ce47b32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_6d7b2ba6-91e1-4047-835f-42cedc5425a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_6d7b2ba6-91e1-4047-835f-42cedc5425a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays_c04ceffb-6800-49ac-9eee-14a4d288a2ff" xlink:href="nvta-20201231.xsd#nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays_c04ceffb-6800-49ac-9eee-14a4d288a2ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_48079f6e-56c9-40a0-ab53-9109ee7b82c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_48079f6e-56c9-40a0-ab53-9109ee7b82c1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2b1b20e9-de1f-48cd-9b40-3e33147e99a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2b1b20e9-de1f-48cd-9b40-3e33147e99a5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f63aa240-2de2-4bba-b655-08be53135bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f63aa240-2de2-4bba-b655-08be53135bca" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_987bcd2b-0a9c-45e2-8993-82fa46143c78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_987bcd2b-0a9c-45e2-8993-82fa46143c78" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_6a151531-ad13-437f-8c11-499641f96e43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_6a151531-ad13-437f-8c11-499641f96e43" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4aaf760c-828b-4915-97a5-b388e207d6bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4aaf760c-828b-4915-97a5-b388e207d6bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_eeab051d-8141-4ccf-a0ea-3853f4c8c5c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4aaf760c-828b-4915-97a5-b388e207d6bc" xlink:to="loc_us-gaap_VestingAxis_eeab051d-8141-4ccf-a0ea-3853f4c8c5c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_eeab051d-8141-4ccf-a0ea-3853f4c8c5c0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_eeab051d-8141-4ccf-a0ea-3853f4c8c5c0" xlink:to="loc_us-gaap_VestingDomain_eeab051d-8141-4ccf-a0ea-3853f4c8c5c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_19317cb7-b6bd-4ac4-80d8-5272be3a1669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_eeab051d-8141-4ccf-a0ea-3853f4c8c5c0" xlink:to="loc_us-gaap_VestingDomain_19317cb7-b6bd-4ac4-80d8-5272be3a1669" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_19f5a1f1-b765-42c6-9c02-2c2eb8a342ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_19317cb7-b6bd-4ac4-80d8-5272be3a1669" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_19f5a1f1-b765-42c6-9c02-2c2eb8a342ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_5c058b22-08b4-4be7-9240-f9c6586b229b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_19317cb7-b6bd-4ac4-80d8-5272be3a1669" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_5c058b22-08b4-4be7-9240-f9c6586b229b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_4df0822f-07e8-49cb-992f-55af7e6f7c14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_19317cb7-b6bd-4ac4-80d8-5272be3a1669" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_4df0822f-07e8-49cb-992f-55af7e6f7c14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6252e76b-fa57-4ab9-af49-22dfe956d1c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4aaf760c-828b-4915-97a5-b388e207d6bc" xlink:to="loc_us-gaap_AwardTypeAxis_6252e76b-fa57-4ab9-af49-22dfe956d1c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6252e76b-fa57-4ab9-af49-22dfe956d1c4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6252e76b-fa57-4ab9-af49-22dfe956d1c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6252e76b-fa57-4ab9-af49-22dfe956d1c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9a608df-2d0b-4b18-a943-7fbd3ccd2bea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6252e76b-fa57-4ab9-af49-22dfe956d1c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9a608df-2d0b-4b18-a943-7fbd3ccd2bea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_825bffed-be50-44aa-b014-a0d22247d143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9a608df-2d0b-4b18-a943-7fbd3ccd2bea" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_825bffed-be50-44aa-b014-a0d22247d143" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RestrictedStockUnitsPeriodofTimeMember_04bbae89-fd11-4234-aa11-64fec014bf88" xlink:href="nvta-20201231.xsd#nvta_RestrictedStockUnitsPeriodofTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9a608df-2d0b-4b18-a943-7fbd3ccd2bea" xlink:to="loc_nvta_RestrictedStockUnitsPeriodofTimeMember_04bbae89-fd11-4234-aa11-64fec014bf88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_b5b49242-7b0b-46b4-ad13-b53b42cf7097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9a608df-2d0b-4b18-a943-7fbd3ccd2bea" xlink:to="loc_us-gaap_PerformanceSharesMember_b5b49242-7b0b-46b4-ad13-b53b42cf7097" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d79facb4-2b9e-4867-9b01-2ba49ad0c327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4aaf760c-828b-4915-97a5-b388e207d6bc" xlink:to="loc_us-gaap_PlanNameAxis_d79facb4-2b9e-4867-9b01-2ba49ad0c327" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d79facb4-2b9e-4867-9b01-2ba49ad0c327_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_d79facb4-2b9e-4867-9b01-2ba49ad0c327" xlink:to="loc_us-gaap_PlanNameDomain_d79facb4-2b9e-4867-9b01-2ba49ad0c327_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f7c0f41f-5269-4b2a-9238-2a666183914d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_d79facb4-2b9e-4867-9b01-2ba49ad0c327" xlink:to="loc_us-gaap_PlanNameDomain_f7c0f41f-5269-4b2a-9238-2a666183914d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIncentivePlanMember_b567c1db-6d3b-4335-9ae0-3b95e276d492" xlink:href="nvta-20201231.xsd#nvta_StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_f7c0f41f-5269-4b2a-9238-2a666183914d" xlink:to="loc_nvta_StockIncentivePlanMember_b567c1db-6d3b-4335-9ae0-3b95e276d492" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d1039651-13d5-497b-aad7-24fce9f07e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4aaf760c-828b-4915-97a5-b388e207d6bc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d1039651-13d5-497b-aad7-24fce9f07e30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d1039651-13d5-497b-aad7-24fce9f07e30_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d1039651-13d5-497b-aad7-24fce9f07e30" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d1039651-13d5-497b-aad7-24fce9f07e30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc96bf88-421a-45db-8293-8783f799c2c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d1039651-13d5-497b-aad7-24fce9f07e30" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc96bf88-421a-45db-8293-8783f799c2c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SingularBioMember_fb32a8d9-113c-4e7d-af91-a494e631c9db" xlink:href="nvta-20201231.xsd#nvta_SingularBioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc96bf88-421a-45db-8293-8783f799c2c4" xlink:to="loc_nvta_SingularBioMember_fb32a8d9-113c-4e7d-af91-a494e631c9db" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsJunglaDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsJunglaDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BusinesscombinationsJunglaDetails" xlink:type="extended" id="i42b86869f7f5451aba48405edc5dd690_BusinesscombinationsJunglaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_94b90d42-c4b7-477e-b9dc-c8f8ab386f56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_94b90d42-c4b7-477e-b9dc-c8f8ab386f56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bb34c4a8-5e6f-43ab-903f-5b9841ab9acd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bb34c4a8-5e6f-43ab-903f-5b9841ab9acd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_c662e609-7b89-4db7-9043-32e307ea6e13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_c662e609-7b89-4db7-9043-32e307ea6e13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a03dc0f7-994c-41cc-a496-7fcc2e6233c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a03dc0f7-994c-41cc-a496-7fcc2e6233c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration_d3c7ac7d-49aa-4e66-9dba-d721018fbeea" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:to="loc_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration_d3c7ac7d-49aa-4e66-9dba-d721018fbeea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c38eb1f1-3f22-459e-83a5-657b23973934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c38eb1f1-3f22-459e-83a5-657b23973934" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d42a2cde-a226-4870-92d4-5b01c9864fb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d42a2cde-a226-4870-92d4-5b01c9864fb0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_bc32c840-3112-41ce-b799-2ba04c8a5feb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d42a2cde-a226-4870-92d4-5b01c9864fb0" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_bc32c840-3112-41ce-b799-2ba04c8a5feb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_bc32c840-3112-41ce-b799-2ba04c8a5feb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_bc32c840-3112-41ce-b799-2ba04c8a5feb" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_bc32c840-3112-41ce-b799-2ba04c8a5feb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_5ffd45f7-8b5b-4797-adfd-d74fc9ddfbe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_bc32c840-3112-41ce-b799-2ba04c8a5feb" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_5ffd45f7-8b5b-4797-adfd-d74fc9ddfbe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember_28e715b0-8315-40f1-9be5-56bcb41e0d6d" xlink:href="nvta-20201231.xsd#nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_5ffd45f7-8b5b-4797-adfd-d74fc9ddfbe2" xlink:to="loc_nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember_28e715b0-8315-40f1-9be5-56bcb41e0d6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_IndemnificationObligationsMember_b06cf197-88bb-4e53-aca8-e4c8dbb90d6b" xlink:href="nvta-20201231.xsd#nvta_IndemnificationObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_5ffd45f7-8b5b-4797-adfd-d74fc9ddfbe2" xlink:to="loc_nvta_IndemnificationObligationsMember_b06cf197-88bb-4e53-aca8-e4c8dbb90d6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7562c494-65a6-482c-8263-ad2505acfe22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d42a2cde-a226-4870-92d4-5b01c9864fb0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7562c494-65a6-482c-8263-ad2505acfe22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7562c494-65a6-482c-8263-ad2505acfe22_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7562c494-65a6-482c-8263-ad2505acfe22" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7562c494-65a6-482c-8263-ad2505acfe22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40d08037-6348-433e-858f-174195349cb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7562c494-65a6-482c-8263-ad2505acfe22" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40d08037-6348-433e-858f-174195349cb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_JunglaMember_1ccafe5b-851a-4fdb-a8cc-f155c87d9fc4" xlink:href="nvta-20201231.xsd#nvta_JunglaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40d08037-6348-433e-858f-174195349cb3" xlink:to="loc_nvta_JunglaMember_1ccafe5b-851a-4fdb-a8cc-f155c87d9fc4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsClearGeneticsDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails" xlink:type="extended" id="ib3c95fae71a44d25b56937191ea5d4ea_BusinesscombinationsClearGeneticsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a2222f9b-2444-46a9-9af0-a9d130d943a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ec8492f5-7bcf-48f4-b78b-62778e723714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2222f9b-2444-46a9-9af0-a9d130d943a6" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ec8492f5-7bcf-48f4-b78b-62778e723714" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_59549084-6ee8-4747-aab6-2535bbd1db00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2222f9b-2444-46a9-9af0-a9d130d943a6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_59549084-6ee8-4747-aab6-2535bbd1db00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCash_0c4144c6-3065-4b1a-8ba8-595f34ecaed7" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2222f9b-2444-46a9-9af0-a9d130d943a6" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCash_0c4144c6-3065-4b1a-8ba8-595f34ecaed7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c47a5eb8-b83f-4ff9-9c4c-0c3dc8bd7fbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2222f9b-2444-46a9-9af0-a9d130d943a6" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c47a5eb8-b83f-4ff9-9c4c-0c3dc8bd7fbe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4970c739-d087-47b8-984b-73bd7ea32d78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2222f9b-2444-46a9-9af0-a9d130d943a6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4970c739-d087-47b8-984b-73bd7ea32d78" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_2b8932d3-7dbe-48f2-bf94-7aae16a27d16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4970c739-d087-47b8-984b-73bd7ea32d78" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_2b8932d3-7dbe-48f2-bf94-7aae16a27d16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_2b8932d3-7dbe-48f2-bf94-7aae16a27d16_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_2b8932d3-7dbe-48f2-bf94-7aae16a27d16" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_2b8932d3-7dbe-48f2-bf94-7aae16a27d16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_fd2a98c3-4fbe-4336-aa09-845a7cfa840f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_2b8932d3-7dbe-48f2-bf94-7aae16a27d16" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_fd2a98c3-4fbe-4336-aa09-845a7cfa840f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_IndemnificationObligationsMember_0eab6182-db5f-4779-aae5-1b55b1705fe7" xlink:href="nvta-20201231.xsd#nvta_IndemnificationObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_fd2a98c3-4fbe-4336-aa09-845a7cfa840f" xlink:to="loc_nvta_IndemnificationObligationsMember_0eab6182-db5f-4779-aae5-1b55b1705fe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c93848ed-8409-42d4-91cd-653a6d98028b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4970c739-d087-47b8-984b-73bd7ea32d78" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c93848ed-8409-42d4-91cd-653a6d98028b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c93848ed-8409-42d4-91cd-653a6d98028b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c93848ed-8409-42d4-91cd-653a6d98028b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c93848ed-8409-42d4-91cd-653a6d98028b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b01ecd5-41ea-42db-8333-948683436112" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c93848ed-8409-42d4-91cd-653a6d98028b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b01ecd5-41ea-42db-8333-948683436112" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ClearGeneticsMember_968c691e-7497-43ed-a898-7d4867a1f05c" xlink:href="nvta-20201231.xsd#nvta_ClearGeneticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b01ecd5-41ea-42db-8333-948683436112" xlink:to="loc_nvta_ClearGeneticsMember_968c691e-7497-43ed-a898-7d4867a1f05c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsDiploidDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsDiploidDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BusinesscombinationsDiploidDetails" xlink:type="extended" id="i0ed77ede39ee48749d6f35ce2d20bd68_BusinesscombinationsDiploidDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_430ef79c-907b-4256-b041-462b87217cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_430ef79c-907b-4256-b041-462b87217cbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_80d8bdf4-b12e-4f2a-9725-bd1293e8960a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_80d8bdf4-b12e-4f2a-9725-bd1293e8960a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_572a62ad-6f6f-408f-817d-f36d44dd4bd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_572a62ad-6f6f-408f-817d-f36d44dd4bd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_066c47a6-36a8-45b4-ae7d-969a07b79515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_066c47a6-36a8-45b4-ae7d-969a07b79515" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_5ff32f62-30aa-4e6a-bdea-6763c018c9d9" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_5ff32f62-30aa-4e6a-bdea-6763c018c9d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_5c8a16bc-732c-4169-81a2-00027ad50111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_5c8a16bc-732c-4169-81a2-00027ad50111" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ad636e4f-152f-4829-a657-c9eb6be00ab0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_Goodwill_ad636e4f-152f-4829-a657-c9eb6be00ab0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_79f34b39-42fd-4b01-9e0f-b10e781bf9ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_79f34b39-42fd-4b01-9e0f-b10e781bf9ca" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_97e32eea-4712-4e8d-b967-6dd659243e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_97e32eea-4712-4e8d-b967-6dd659243e8d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_e06365bf-32a1-44eb-8996-3d5b694e7980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_e06365bf-32a1-44eb-8996-3d5b694e7980" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ed70f3d5-f4c4-43a0-b02d-30630f4ebe53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ed70f3d5-f4c4-43a0-b02d-30630f4ebe53" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_106eb1f0-5bc7-41f2-a603-99ec1b028f43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ed70f3d5-f4c4-43a0-b02d-30630f4ebe53" xlink:to="loc_us-gaap_VestingAxis_106eb1f0-5bc7-41f2-a603-99ec1b028f43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_106eb1f0-5bc7-41f2-a603-99ec1b028f43_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_106eb1f0-5bc7-41f2-a603-99ec1b028f43" xlink:to="loc_us-gaap_VestingDomain_106eb1f0-5bc7-41f2-a603-99ec1b028f43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_3559cd2f-c60c-4138-8e75-594bf054a0fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_106eb1f0-5bc7-41f2-a603-99ec1b028f43" xlink:to="loc_us-gaap_VestingDomain_3559cd2f-c60c-4138-8e75-594bf054a0fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_d6a1e19e-e9e5-4faa-9ef9-652abe48af3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_3559cd2f-c60c-4138-8e75-594bf054a0fd" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_d6a1e19e-e9e5-4faa-9ef9-652abe48af3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_cf571d9a-1d52-41c7-ba6d-9e56bba9aa59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_3559cd2f-c60c-4138-8e75-594bf054a0fd" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_cf571d9a-1d52-41c7-ba6d-9e56bba9aa59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_3cb02179-1af0-47b2-b62c-bf46d2b953da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ed70f3d5-f4c4-43a0-b02d-30630f4ebe53" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_3cb02179-1af0-47b2-b62c-bf46d2b953da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_3cb02179-1af0-47b2-b62c-bf46d2b953da_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_3cb02179-1af0-47b2-b62c-bf46d2b953da" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_3cb02179-1af0-47b2-b62c-bf46d2b953da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_19038293-350f-4a32-8d2a-48bf8a123d79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_3cb02179-1af0-47b2-b62c-bf46d2b953da" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_19038293-350f-4a32-8d2a-48bf8a123d79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_IndemnificationObligationsMember_5a64b1f7-83ba-429e-8b04-9c2063bf4ae7" xlink:href="nvta-20201231.xsd#nvta_IndemnificationObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_19038293-350f-4a32-8d2a-48bf8a123d79" xlink:to="loc_nvta_IndemnificationObligationsMember_5a64b1f7-83ba-429e-8b04-9c2063bf4ae7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_68ccb499-5c24-4d43-9fe7-de3051fcd6ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ed70f3d5-f4c4-43a0-b02d-30630f4ebe53" xlink:to="loc_us-gaap_PlanNameAxis_68ccb499-5c24-4d43-9fe7-de3051fcd6ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_68ccb499-5c24-4d43-9fe7-de3051fcd6ec_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_68ccb499-5c24-4d43-9fe7-de3051fcd6ec" xlink:to="loc_us-gaap_PlanNameDomain_68ccb499-5c24-4d43-9fe7-de3051fcd6ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ba21c62e-3a64-4b72-bfef-4416a580acdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_68ccb499-5c24-4d43-9fe7-de3051fcd6ec" xlink:to="loc_us-gaap_PlanNameDomain_ba21c62e-3a64-4b72-bfef-4416a580acdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIncentivePlanMember_6ea48b5c-9e5a-4b7c-b257-70b2ee79608c" xlink:href="nvta-20201231.xsd#nvta_StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_ba21c62e-3a64-4b72-bfef-4416a580acdc" xlink:to="loc_nvta_StockIncentivePlanMember_6ea48b5c-9e5a-4b7c-b257-70b2ee79608c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5cfc15e5-5013-46e8-9ce3-e6917a8ed7d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ed70f3d5-f4c4-43a0-b02d-30630f4ebe53" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5cfc15e5-5013-46e8-9ce3-e6917a8ed7d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5cfc15e5-5013-46e8-9ce3-e6917a8ed7d0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5cfc15e5-5013-46e8-9ce3-e6917a8ed7d0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5cfc15e5-5013-46e8-9ce3-e6917a8ed7d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7c4f422-5f8b-4a71-9a29-76cdad0cb681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5cfc15e5-5013-46e8-9ce3-e6917a8ed7d0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7c4f422-5f8b-4a71-9a29-76cdad0cb681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DiploidMember_2d95fe25-ed85-4d60-9c87-a71c019bec6a" xlink:href="nvta-20201231.xsd#nvta_DiploidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7c4f422-5f8b-4a71-9a29-76cdad0cb681" xlink:to="loc_nvta_DiploidMember_2d95fe25-ed85-4d60-9c87-a71c019bec6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0f6c6adc-6e85-4ba1-b0e7-3a4a639921e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ed70f3d5-f4c4-43a0-b02d-30630f4ebe53" xlink:to="loc_us-gaap_AwardTypeAxis_0f6c6adc-6e85-4ba1-b0e7-3a4a639921e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0f6c6adc-6e85-4ba1-b0e7-3a4a639921e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0f6c6adc-6e85-4ba1-b0e7-3a4a639921e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0f6c6adc-6e85-4ba1-b0e7-3a4a639921e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1cdebc83-7355-46b5-83cf-8d2783b62398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0f6c6adc-6e85-4ba1-b0e7-3a4a639921e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1cdebc83-7355-46b5-83cf-8d2783b62398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_089bd61f-9e04-411f-8557-98db4fca02d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1cdebc83-7355-46b5-83cf-8d2783b62398" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_089bd61f-9e04-411f-8557-98db4fca02d6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails" xlink:type="extended" id="ic6de95b70cae4ef7a7d5d7a98b05753a_BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_99b3aca7-6950-49cb-bf4a-4932c05e63d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_99b3aca7-6950-49cb-bf4a-4932c05e63d5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_62d033f9-8526-43be-b3ee-13d7db302d64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_62d033f9-8526-43be-b3ee-13d7db302d64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCash_b88657cc-ec6d-48f3-9a44-fd89dcf47c8a" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCash_b88657cc-ec6d-48f3-9a44-fd89dcf47c8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_e069e0a7-8870-45ae-938a-d34d0e747a1a" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_e069e0a7-8870-45ae-938a-d34d0e747a1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b32dc5f2-f9ad-4132-ac58-1029c2bdfd01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b32dc5f2-f9ad-4132-ac58-1029c2bdfd01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred_7d8274c8-5b34-4eea-a42e-80f2e90331f1" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:to="loc_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred_7d8274c8-5b34-4eea-a42e-80f2e90331f1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_77f708d5-671b-4995-8c48-6f55d69d56bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_77f708d5-671b-4995-8c48-6f55d69d56bd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_755edf31-b707-4d05-b483-318ccfe57319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_755edf31-b707-4d05-b483-318ccfe57319" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract_4a3a4427-86dc-46a2-8118-0364843f8a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_99b3aca7-6950-49cb-bf4a-4932c05e63d5" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract_4a3a4427-86dc-46a2-8118-0364843f8a86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred_8629db14-80b4-48fb-989c-0f3756ffcf87" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract_4a3a4427-86dc-46a2-8118-0364843f8a86" xlink:to="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred_8629db14-80b4-48fb-989c-0f3756ffcf87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration_fd1154e3-6172-4020-a3a3-9738a6602669" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract_4a3a4427-86dc-46a2-8118-0364843f8a86" xlink:to="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration_fd1154e3-6172-4020-a3a3-9738a6602669" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred_5995c633-64c5-4f74-97d4-7fcbb66c61c5" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract_4a3a4427-86dc-46a2-8118-0364843f8a86" xlink:to="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred_5995c633-64c5-4f74-97d4-7fcbb66c61c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_29db25e2-db2b-4130-89cd-fa56b8eb6b4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract_4a3a4427-86dc-46a2-8118-0364843f8a86" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_29db25e2-db2b-4130-89cd-fa56b8eb6b4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d0eb3b51-a911-49f7-a563-cfacdea4d3e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_99b3aca7-6950-49cb-bf4a-4932c05e63d5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d0eb3b51-a911-49f7-a563-cfacdea4d3e1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_918a3042-9d27-4d75-8eb4-be247013ef1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d0eb3b51-a911-49f7-a563-cfacdea4d3e1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_918a3042-9d27-4d75-8eb4-be247013ef1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_918a3042-9d27-4d75-8eb4-be247013ef1d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_918a3042-9d27-4d75-8eb4-be247013ef1d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_918a3042-9d27-4d75-8eb4-be247013ef1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e16c1b1-e1ce-4565-ba6e-7cbb7fee501b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_918a3042-9d27-4d75-8eb4-be247013ef1d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e16c1b1-e1ce-4565-ba6e-7cbb7fee501b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DiploidMember_05dbb597-1d4f-406f-9509-fb330b947578" xlink:href="nvta-20201231.xsd#nvta_DiploidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e16c1b1-e1ce-4565-ba6e-7cbb7fee501b" xlink:to="loc_nvta_DiploidMember_05dbb597-1d4f-406f-9509-fb330b947578" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_GenelexMember_5690a4c7-94b4-44c1-8f2f-a9942ecf4be7" xlink:href="nvta-20201231.xsd#nvta_GenelexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e16c1b1-e1ce-4565-ba6e-7cbb7fee501b" xlink:to="loc_nvta_GenelexMember_5690a4c7-94b4-44c1-8f2f-a9942ecf4be7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_YouScriptMember_ef684264-e93d-4baf-bb64-7d32f022079d" xlink:href="nvta-20201231.xsd#nvta_YouScriptMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e16c1b1-e1ce-4565-ba6e-7cbb7fee501b" xlink:to="loc_nvta_YouScriptMember_ef684264-e93d-4baf-bb64-7d32f022079d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_ae4107f9-7eb5-439a-9900-0c972c7f20a9" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e16c1b1-e1ce-4565-ba6e-7cbb7fee501b" xlink:to="loc_nvta_ArcherDXInc.Member_ae4107f9-7eb5-439a-9900-0c972c7f20a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_2b0ff22d-07a0-46a1-89ab-bc360c8739f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d0eb3b51-a911-49f7-a563-cfacdea4d3e1" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_2b0ff22d-07a0-46a1-89ab-bc360c8739f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2b0ff22d-07a0-46a1-89ab-bc360c8739f7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_2b0ff22d-07a0-46a1-89ab-bc360c8739f7" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2b0ff22d-07a0-46a1-89ab-bc360c8739f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2aa3c32d-a427-4cd2-adce-27ec41a4918a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_2b0ff22d-07a0-46a1-89ab-bc360c8739f7" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2aa3c32d-a427-4cd2-adce-27ec41a4918a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_AccelerationofVestedEquityMember_f916ce75-ebec-49c5-9ce1-324f0d443a8a" xlink:href="nvta-20201231.xsd#nvta_AccelerationofVestedEquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2aa3c32d-a427-4cd2-adce-27ec41a4918a" xlink:to="loc_nvta_AccelerationofVestedEquityMember_f916ce75-ebec-49c5-9ce1-324f0d443a8a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails" xlink:type="extended" id="i7f2489f0d9324dbe92bd094d5bacd397_BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_bd55ce48-9d9d-487c-a078-389384c3cf4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_bd55ce48-9d9d-487c-a078-389384c3cf4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c6939674-4145-431a-a971-3fac07996194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c6939674-4145-431a-a971-3fac07996194" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_e5010144-45bd-4a6b-a4f3-0afeba642677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_e5010144-45bd-4a6b-a4f3-0afeba642677" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_ddb1c739-352c-4d3e-b4c9-ac19f8c24d57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_ddb1c739-352c-4d3e-b4c9-ac19f8c24d57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_59a88dda-3923-4512-805b-42344587678c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_59a88dda-3923-4512-805b-42344587678c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset_01b92246-fac3-4d33-a208-f0231337c2f6" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset_01b92246-fac3-4d33-a208-f0231337c2f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_54479f31-b624-4a84-8fe7-07dfe835ee1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_54479f31-b624-4a84-8fe7-07dfe835ee1c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_91dc407e-fc19-4aaf-8e18-8e2f8d363bbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_91dc407e-fc19-4aaf-8e18-8e2f8d363bbe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_08cddf59-3448-4e76-b965-4c8826c1c57e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_08cddf59-3448-4e76-b965-4c8826c1c57e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5a5ed5d7-b9fa-48a0-957d-4b27b48ffbe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5a5ed5d7-b9fa-48a0-957d-4b27b48ffbe4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_8e350972-c3c0-4b0a-99e3-7531872aeeac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_8e350972-c3c0-4b0a-99e3-7531872aeeac" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_0fa6fea4-a7f6-415d-846b-e5fa8bfbb633" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_0fa6fea4-a7f6-415d-846b-e5fa8bfbb633" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease_813791e8-24ef-4a7a-819c-20e3989fc934" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease_813791e8-24ef-4a7a-819c-20e3989fc934" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease_443fce04-b538-4a6e-b695-f997619b8cce" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease_443fce04-b538-4a6e-b695-f997619b8cce" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_43df06c3-96ad-45b0-a41c-62b170b268f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_43df06c3-96ad-45b0-a41c-62b170b268f1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_0da30e15-323d-4b20-96da-d77618e0c136" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_0da30e15-323d-4b20-96da-d77618e0c136" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_59632050-c189-439c-b230-097e05163dae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_59632050-c189-439c-b230-097e05163dae" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_270dbbed-c291-42da-8854-49b3bdec2b49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_Goodwill_270dbbed-c291-42da-8854-49b3bdec2b49" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c09b94f8-2dc6-49ca-ab36-39d7102afeba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c09b94f8-2dc6-49ca-ab36-39d7102afeba" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_13745aff-29b6-46c4-97b8-966e084acae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_13745aff-29b6-46c4-97b8-966e084acae9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4f8ad190-e3e5-422e-8360-224bf82d2758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_13745aff-29b6-46c4-97b8-966e084acae9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4f8ad190-e3e5-422e-8360-224bf82d2758" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f8ad190-e3e5-422e-8360-224bf82d2758_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4f8ad190-e3e5-422e-8360-224bf82d2758" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f8ad190-e3e5-422e-8360-224bf82d2758_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e408f7d-76c2-43ca-bdb4-2c3417bd1682" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4f8ad190-e3e5-422e-8360-224bf82d2758" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e408f7d-76c2-43ca-bdb4-2c3417bd1682" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DiploidMember_ed536bd5-772f-4946-baab-11a4c9a6c80c" xlink:href="nvta-20201231.xsd#nvta_DiploidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e408f7d-76c2-43ca-bdb4-2c3417bd1682" xlink:to="loc_nvta_DiploidMember_ed536bd5-772f-4946-baab-11a4c9a6c80c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_GenelexMember_c5aa9827-9f42-4344-9575-fe968f16c64a" xlink:href="nvta-20201231.xsd#nvta_GenelexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e408f7d-76c2-43ca-bdb4-2c3417bd1682" xlink:to="loc_nvta_GenelexMember_c5aa9827-9f42-4344-9575-fe968f16c64a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_YouScriptMember_d615ec93-54f7-435a-851a-94124106de49" xlink:href="nvta-20201231.xsd#nvta_YouScriptMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e408f7d-76c2-43ca-bdb4-2c3417bd1682" xlink:to="loc_nvta_YouScriptMember_d615ec93-54f7-435a-851a-94124106de49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_GenelexandYouScriptMember_928336f4-b6e6-406e-a132-8fca9326ea2c" xlink:href="nvta-20201231.xsd#nvta_GenelexandYouScriptMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e408f7d-76c2-43ca-bdb4-2c3417bd1682" xlink:to="loc_nvta_GenelexandYouScriptMember_928336f4-b6e6-406e-a132-8fca9326ea2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_d6d49dfa-17e8-4355-bfd0-c994d4798883" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e408f7d-76c2-43ca-bdb4-2c3417bd1682" xlink:to="loc_nvta_ArcherDXInc.Member_d6d49dfa-17e8-4355-bfd0-c994d4798883" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsGenelexandYouScriptDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails" xlink:type="extended" id="i30848781f36b41a9a7d1a84e021362af_BusinesscombinationsGenelexandYouScriptDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ea677dbc-8357-4f17-bf4f-862fc3c7589a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ea677dbc-8357-4f17-bf4f-862fc3c7589a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b5bf1bdb-19f9-41a0-910e-8a8120a9d0c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b5bf1bdb-19f9-41a0-910e-8a8120a9d0c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2a735dc1-07b8-4267-afe9-34b6b0085e38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2a735dc1-07b8-4267-afe9-34b6b0085e38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_921364f8-ef2a-4e3c-a5b8-185f6c98a6af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_921364f8-ef2a-4e3c-a5b8-185f6c98a6af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_2b030a01-c7f6-4192-a83a-d3bfe7d8072b" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_2b030a01-c7f6-4192-a83a-d3bfe7d8072b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_5bc1e8db-6d17-43cf-8643-0372356c4d65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_5bc1e8db-6d17-43cf-8643-0372356c4d65" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration_95ed1e38-ee41-459e-86e8-59cf479d1d44" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration_95ed1e38-ee41-459e-86e8-59cf479d1d44" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_30df6707-fced-4024-bd7b-2d73a3ddaf13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_30df6707-fced-4024-bd7b-2d73a3ddaf13" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2baff6db-c213-4bb5-97df-933fbe959559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2baff6db-c213-4bb5-97df-933fbe959559" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5d948a52-daad-4bdd-9c44-5a4d0c1a8e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_Goodwill_5d948a52-daad-4bdd-9c44-5a4d0c1a8e3b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d754452-630b-474d-97f7-2d6b95afe7fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d754452-630b-474d-97f7-2d6b95afe7fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_95e61460-f2df-4981-ba60-f0aa4bcc9b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d754452-630b-474d-97f7-2d6b95afe7fe" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_95e61460-f2df-4981-ba60-f0aa4bcc9b99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_95e61460-f2df-4981-ba60-f0aa4bcc9b99_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_95e61460-f2df-4981-ba60-f0aa4bcc9b99" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_95e61460-f2df-4981-ba60-f0aa4bcc9b99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_eb6c5ae7-af73-44ac-99d4-37afd9cb2b71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_95e61460-f2df-4981-ba60-f0aa4bcc9b99" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_eb6c5ae7-af73-44ac-99d4-37afd9cb2b71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_IndemnificationObligationsMember_f29dc172-f781-4e5d-8b82-512caa7ce80b" xlink:href="nvta-20201231.xsd#nvta_IndemnificationObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_eb6c5ae7-af73-44ac-99d4-37afd9cb2b71" xlink:to="loc_nvta_IndemnificationObligationsMember_f29dc172-f781-4e5d-8b82-512caa7ce80b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f512e11a-04cb-4cd2-b4a9-7ef61fa6f034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d754452-630b-474d-97f7-2d6b95afe7fe" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f512e11a-04cb-4cd2-b4a9-7ef61fa6f034" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f512e11a-04cb-4cd2-b4a9-7ef61fa6f034_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f512e11a-04cb-4cd2-b4a9-7ef61fa6f034" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f512e11a-04cb-4cd2-b4a9-7ef61fa6f034_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_404c2130-1415-41dd-b2d3-bb46cbb45c1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f512e11a-04cb-4cd2-b4a9-7ef61fa6f034" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_404c2130-1415-41dd-b2d3-bb46cbb45c1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_GenelexMember_1b12e0a3-f7e5-4dfc-9ba5-1f9ad00f38c7" xlink:href="nvta-20201231.xsd#nvta_GenelexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_404c2130-1415-41dd-b2d3-bb46cbb45c1b" xlink:to="loc_nvta_GenelexMember_1b12e0a3-f7e5-4dfc-9ba5-1f9ad00f38c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_YouScriptMember_9a8590a9-cc13-4331-b2b0-d9bc319bae17" xlink:href="nvta-20201231.xsd#nvta_YouScriptMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_404c2130-1415-41dd-b2d3-bb46cbb45c1b" xlink:to="loc_nvta_YouScriptMember_9a8590a9-cc13-4331-b2b0-d9bc319bae17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_GenelexandYouScriptMember_fbdf3262-89d3-4a4f-a975-0c3768412ba0" xlink:href="nvta-20201231.xsd#nvta_GenelexandYouScriptMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_404c2130-1415-41dd-b2d3-bb46cbb45c1b" xlink:to="loc_nvta_GenelexandYouScriptMember_fbdf3262-89d3-4a4f-a975-0c3768412ba0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsArcherDXDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsArcherDXDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BusinesscombinationsArcherDXDetails" xlink:type="extended" id="i568222eb8d5b46d2b40853ca908c1e09_BusinesscombinationsArcherDXDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_332c1572-8a62-47af-824f-c2d25ad113b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_332c1572-8a62-47af-824f-c2d25ad113b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_601da61c-5496-4e05-87b4-c47532830a85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_601da61c-5496-4e05-87b4-c47532830a85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_f899cbe6-ef8e-4c32-83ad-7990f9b99bc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_f899cbe6-ef8e-4c32-83ad-7990f9b99bc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_eee7250b-67b8-4182-abbd-221b03d32c27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_eee7250b-67b8-4182-abbd-221b03d32c27" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_a6d458c0-1c3d-4122-85ee-bc001687584a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_a6d458c0-1c3d-4122-85ee-bc001687584a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_07007958-0166-4639-bb80-8d5f9d6702ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_07007958-0166-4639-bb80-8d5f9d6702ce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration_57f65637-8595-40c3-bad3-25df756c002f" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration_57f65637-8595-40c3-bad3-25df756c002f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_372d39e5-8afd-4947-a559-5e440053996c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_372d39e5-8afd-4947-a559-5e440053996c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_81f4ca5a-2b42-42fb-b731-52dc18dcfe66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_81f4ca5a-2b42-42fb-b731-52dc18dcfe66" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a27809f7-3636-4c52-a4a6-bb23039cb811" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a27809f7-3636-4c52-a4a6-bb23039cb811" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_cf802854-b747-400e-b652-bebf1d0a2530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_cf802854-b747-400e-b652-bebf1d0a2530" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9b31137a-18ee-4f21-9b26-02895c6f5ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_Goodwill_9b31137a-18ee-4f21-9b26-02895c6f5ef5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1172b931-a47b-4ea3-88c5-ce8b44841654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1172b931-a47b-4ea3-88c5-ce8b44841654" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_da229ac7-403c-4cd3-a5f3-b6ad288c696b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_da229ac7-403c-4cd3-a5f3-b6ad288c696b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_ef0689f3-baa9-4a9d-9bc8-dbcd9658acaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_ef0689f3-baa9-4a9d-9bc8-dbcd9658acaa" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4a23753b-4fde-42c2-9a2c-88877e0724e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4a23753b-4fde-42c2-9a2c-88877e0724e0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e40e96d9-df7a-4636-8333-1bbd426f04c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e40e96d9-df7a-4636-8333-1bbd426f04c9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_30fc3c4e-cf78-4d71-aacb-ee87538272f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_30fc3c4e-cf78-4d71-aacb-ee87538272f0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_72ecea7f-b55d-4ce3-b10f-315653c3787c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_72ecea7f-b55d-4ce3-b10f-315653c3787c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_03fddd09-3d37-4a7b-b775-fec50478addc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_72ecea7f-b55d-4ce3-b10f-315653c3787c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_03fddd09-3d37-4a7b-b775-fec50478addc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03fddd09-3d37-4a7b-b775-fec50478addc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_03fddd09-3d37-4a7b-b775-fec50478addc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03fddd09-3d37-4a7b-b775-fec50478addc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0db09cd4-4452-458b-9a44-577c841dcd89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_03fddd09-3d37-4a7b-b775-fec50478addc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0db09cd4-4452-458b-9a44-577c841dcd89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_84f5b110-5612-4283-a9bf-f482b4d8d00f" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0db09cd4-4452-458b-9a44-577c841dcd89" xlink:to="loc_nvta_ArcherDXInc.Member_84f5b110-5612-4283-a9bf-f482b4d8d00f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_801794a6-75ae-48b4-9958-0d41be66164a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_72ecea7f-b55d-4ce3-b10f-315653c3787c" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_801794a6-75ae-48b4-9958-0d41be66164a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_801794a6-75ae-48b4-9958-0d41be66164a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_801794a6-75ae-48b4-9958-0d41be66164a" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_801794a6-75ae-48b4-9958-0d41be66164a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_bd52583b-c660-4567-afc3-ba7c7b415b3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_801794a6-75ae-48b4-9958-0d41be66164a" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_bd52583b-c660-4567-afc3-ba7c7b415b3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_AccelerationofVestedEquityMember_923e49b6-7c35-4e84-bb39-a8d2f7307f32" xlink:href="nvta-20201231.xsd#nvta_AccelerationofVestedEquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_bd52583b-c660-4567-afc3-ba7c7b415b3f" xlink:to="loc_nvta_AccelerationofVestedEquityMember_923e49b6-7c35-4e84-bb39-a8d2f7307f32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_e979daf7-9896-4ca0-ba0f-c6faf65ca325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_72ecea7f-b55d-4ce3-b10f-315653c3787c" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_e979daf7-9896-4ca0-ba0f-c6faf65ca325" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_e979daf7-9896-4ca0-ba0f-c6faf65ca325_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_e979daf7-9896-4ca0-ba0f-c6faf65ca325" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_e979daf7-9896-4ca0-ba0f-c6faf65ca325_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_973d60b1-3997-4a8e-9e73-227559b1ec7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_e979daf7-9896-4ca0-ba0f-c6faf65ca325" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_973d60b1-3997-4a8e-9e73-227559b1ec7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_MilestoneAchievementAgreementMember_ffc0f3ca-a82e-4d99-b57d-5054168535e9" xlink:href="nvta-20201231.xsd#nvta_MilestoneAchievementAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_973d60b1-3997-4a8e-9e73-227559b1ec7a" xlink:to="loc_nvta_MilestoneAchievementAgreementMember_ffc0f3ca-a82e-4d99-b57d-5054168535e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_42da2554-afb9-407b-80da-ade8ac83c130" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_72ecea7f-b55d-4ce3-b10f-315653c3787c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_42da2554-afb9-407b-80da-ade8ac83c130" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_42da2554-afb9-407b-80da-ade8ac83c130_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_42da2554-afb9-407b-80da-ade8ac83c130" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_42da2554-afb9-407b-80da-ade8ac83c130_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_bcef87a7-b9ba-401f-8be4-44451d79ce0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_42da2554-afb9-407b-80da-ade8ac83c130" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_bcef87a7-b9ba-401f-8be4-44451d79ce0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_dfea76c5-5af4-4ed9-b405-a075602748c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_bcef87a7-b9ba-401f-8be4-44451d79ce0d" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_dfea76c5-5af4-4ed9-b405-a075602748c9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsSummaryofintangibleassetsacquiredDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails" xlink:type="extended" id="ib62b44e8eb984b7ba565bdf79f0cb3b0_BusinesscombinationsSummaryofintangibleassetsacquiredDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_32ad7c16-92ef-4dcb-8f13-be1d78a9d68b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_92b7b624-a5e7-4d54-84f3-2b8f71ce78eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32ad7c16-92ef-4dcb-8f13-be1d78a9d68b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_92b7b624-a5e7-4d54-84f3-2b8f71ce78eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_35b7fd81-bc1e-4123-86b4-6e703b86d445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32ad7c16-92ef-4dcb-8f13-be1d78a9d68b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_35b7fd81-bc1e-4123-86b4-6e703b86d445" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2fb3e25e-f4b7-4c3e-9eb0-abe075747afb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32ad7c16-92ef-4dcb-8f13-be1d78a9d68b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2fb3e25e-f4b7-4c3e-9eb0-abe075747afb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e621c431-7bf9-4b8b-813a-d1189531bdd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32ad7c16-92ef-4dcb-8f13-be1d78a9d68b" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e621c431-7bf9-4b8b-813a-d1189531bdd6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34761f9f-660d-410a-93f7-0fbb9fc90c48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32ad7c16-92ef-4dcb-8f13-be1d78a9d68b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34761f9f-660d-410a-93f7-0fbb9fc90c48" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6bfd8826-c209-4df9-ac4d-aced829769c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34761f9f-660d-410a-93f7-0fbb9fc90c48" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6bfd8826-c209-4df9-ac4d-aced829769c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6bfd8826-c209-4df9-ac4d-aced829769c6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6bfd8826-c209-4df9-ac4d-aced829769c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6bfd8826-c209-4df9-ac4d-aced829769c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ed84220-86e5-4be0-a9af-b838b1ab389e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6bfd8826-c209-4df9-ac4d-aced829769c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ed84220-86e5-4be0-a9af-b838b1ab389e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_8dc88cf2-2192-4fe7-9abf-656385fc504f" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ed84220-86e5-4be0-a9af-b838b1ab389e" xlink:to="loc_nvta_ArcherDXInc.Member_8dc88cf2-2192-4fe7-9abf-656385fc504f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f15e5514-5bd8-462d-a966-cd3ca301569a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34761f9f-660d-410a-93f7-0fbb9fc90c48" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f15e5514-5bd8-462d-a966-cd3ca301569a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f15e5514-5bd8-462d-a966-cd3ca301569a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f15e5514-5bd8-462d-a966-cd3ca301569a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f15e5514-5bd8-462d-a966-cd3ca301569a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d6d8128-45c0-47b3-8342-43a9808afe7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f15e5514-5bd8-462d-a966-cd3ca301569a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d6d8128-45c0-47b3-8342-43a9808afe7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_542ec97a-1654-430d-9cdc-0c3fa8cb7944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d6d8128-45c0-47b3-8342-43a9808afe7c" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_542ec97a-1654-430d-9cdc-0c3fa8cb7944" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6daeccd1-7dc2-46af-b2fa-0d54a41c5927" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34761f9f-660d-410a-93f7-0fbb9fc90c48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6daeccd1-7dc2-46af-b2fa-0d54a41c5927" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6daeccd1-7dc2-46af-b2fa-0d54a41c5927_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6daeccd1-7dc2-46af-b2fa-0d54a41c5927" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6daeccd1-7dc2-46af-b2fa-0d54a41c5927_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9086f9fe-fba3-46d7-a5c4-6c1d08a2bb48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6daeccd1-7dc2-46af-b2fa-0d54a41c5927" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9086f9fe-fba3-46d7-a5c4-6c1d08a2bb48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_67e37196-fdfb-4b52-9bb8-f45a2d3b5350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9086f9fe-fba3-46d7-a5c4-6c1d08a2bb48" xlink:to="loc_us-gaap_CustomerRelationshipsMember_67e37196-fdfb-4b52-9bb8-f45a2d3b5350" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_1f471d46-406b-4aac-b308-5dccb1b5721a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9086f9fe-fba3-46d7-a5c4-6c1d08a2bb48" xlink:to="loc_us-gaap_TradeNamesMember_1f471d46-406b-4aac-b308-5dccb1b5721a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_7d871594-0ca6-4c13-9e06-e8bc38935b3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9086f9fe-fba3-46d7-a5c4-6c1d08a2bb48" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_7d871594-0ca6-4c13-9e06-e8bc38935b3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_19c0bd95-b44b-4b24-b8bb-a4a220dfca41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9086f9fe-fba3-46d7-a5c4-6c1d08a2bb48" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_19c0bd95-b44b-4b24-b8bb-a4a220dfca41" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsScheduleofproformafinancialinformationDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsScheduleofproformafinancialinformationDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BusinesscombinationsScheduleofproformafinancialinformationDetails" xlink:type="extended" id="i1648b5b318f6455b9e9ebd782275ec67_BusinesscombinationsScheduleofproformafinancialinformationDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Goodwillandintangibleassets" xlink:type="simple" xlink:href="nvta-20201231.xsd#Goodwillandintangibleassets"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/Goodwillandintangibleassets" xlink:type="extended" id="ic13a446928a54fc5b4916ba89ddaa601_Goodwillandintangibleassets"/>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsTables"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsTables" xlink:type="extended" id="ie8394e1635ca4967ba93c44ebc2b58cf_GoodwillandintangibleassetsTables"/>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsSummaryofgoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails" xlink:type="extended" id="id5b300713259468ba115f9fa1c67fd20_GoodwillandintangibleassetsSummaryofgoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_473e0c3b-ca35-4d8c-a60a-b71ad2173930" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_3edf36a0-e625-40f4-9253-8b1ce9840709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_473e0c3b-ca35-4d8c-a60a-b71ad2173930" xlink:to="loc_us-gaap_GoodwillRollForward_3edf36a0-e625-40f4-9253-8b1ce9840709" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6611515b-8818-492b-9b6e-bc2b7e1dc2d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3edf36a0-e625-40f4-9253-8b1ce9840709" xlink:to="loc_us-gaap_Goodwill_6611515b-8818-492b-9b6e-bc2b7e1dc2d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6293bcd3-b0cf-4313-8221-52cba8ca913e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3edf36a0-e625-40f4-9253-8b1ce9840709" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6293bcd3-b0cf-4313-8221-52cba8ca913e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_803c1cf6-7901-47a0-9a25-54a9da74667f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_df7a36f4-e6c0-497f-b408-49f9d6d71911" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_473e0c3b-ca35-4d8c-a60a-b71ad2173930" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_df7a36f4-e6c0-497f-b408-49f9d6d71911" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e45420b8-e6cb-49e6-b549-93801566771f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_df7a36f4-e6c0-497f-b408-49f9d6d71911" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e45420b8-e6cb-49e6-b549-93801566771f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e45420b8-e6cb-49e6-b549-93801566771f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e45420b8-e6cb-49e6-b549-93801566771f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e45420b8-e6cb-49e6-b549-93801566771f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48087128-4816-4d19-8d22-9cf8bd10f7c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e45420b8-e6cb-49e6-b549-93801566771f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48087128-4816-4d19-8d22-9cf8bd10f7c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DiploidMember_0b8b470d-997b-45df-afa3-018922a6c121" xlink:href="nvta-20201231.xsd#nvta_DiploidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48087128-4816-4d19-8d22-9cf8bd10f7c4" xlink:to="loc_nvta_DiploidMember_0b8b470d-997b-45df-afa3-018922a6c121" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_GenelexMember_be362a6c-1d79-49e8-8e82-d3516c685520" xlink:href="nvta-20201231.xsd#nvta_GenelexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48087128-4816-4d19-8d22-9cf8bd10f7c4" xlink:to="loc_nvta_GenelexMember_be362a6c-1d79-49e8-8e82-d3516c685520" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_YouScriptMember_3b0fd0c6-cc7b-496c-9ac8-2d1300ae20a8" xlink:href="nvta-20201231.xsd#nvta_YouScriptMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48087128-4816-4d19-8d22-9cf8bd10f7c4" xlink:to="loc_nvta_YouScriptMember_3b0fd0c6-cc7b-496c-9ac8-2d1300ae20a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_5d1b51f2-0c91-4b01-8c85-05f44ca2ec7e" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48087128-4816-4d19-8d22-9cf8bd10f7c4" xlink:to="loc_nvta_ArcherDXInc.Member_5d1b51f2-0c91-4b01-8c85-05f44ca2ec7e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsScheduleofintangibleassetsDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails" xlink:type="extended" id="i40fdf39482f2484687a700090a46b0d5_GoodwillandintangibleassetsScheduleofintangibleassetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2016ad82-2e8f-4d9e-8dca-023dd3679d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2016ad82-2e8f-4d9e-8dca-023dd3679d4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a0439056-90f4-4c75-8dd3-3aa8f8f7aafc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a0439056-90f4-4c75-8dd3-3aa8f8f7aafc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9014eaa0-02db-470a-972d-63f6d404ed04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9014eaa0-02db-470a-972d-63f6d404ed04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_87cdd9b9-63e1-473c-b763-d8ff5aa3efe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_87cdd9b9-63e1-473c-b763-d8ff5aa3efe4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2f6ff2cc-2630-43a5-8e2f-f143af1e93f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2f6ff2cc-2630-43a5-8e2f-f143af1e93f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6fbe8f05-2ec7-488b-b294-327677a666bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6fbe8f05-2ec7-488b-b294-327677a666bf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_55a35779-f21e-43a2-bca6-fb28597890ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_55a35779-f21e-43a2-bca6-fb28597890ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_5ec0fae1-8ae1-4f8d-8f0c-9bb407940790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_5ec0fae1-8ae1-4f8d-8f0c-9bb407940790" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a03338e5-ee90-40a0-b428-fca19d408e62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a03338e5-ee90-40a0-b428-fca19d408e62" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_61b36470-253e-4f1f-9d28-36300e18b5d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a03338e5-ee90-40a0-b428-fca19d408e62" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_61b36470-253e-4f1f-9d28-36300e18b5d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_61b36470-253e-4f1f-9d28-36300e18b5d3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_61b36470-253e-4f1f-9d28-36300e18b5d3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_61b36470-253e-4f1f-9d28-36300e18b5d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_292d0251-e2b2-442c-b63a-c8863dadee00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_61b36470-253e-4f1f-9d28-36300e18b5d3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_292d0251-e2b2-442c-b63a-c8863dadee00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_09ae1959-5fae-430e-8ace-2ca9327490c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_292d0251-e2b2-442c-b63a-c8863dadee00" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_09ae1959-5fae-430e-8ace-2ca9327490c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c97b7fba-c1a4-46e3-a0af-93ddea73e815" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a03338e5-ee90-40a0-b428-fca19d408e62" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c97b7fba-c1a4-46e3-a0af-93ddea73e815" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c97b7fba-c1a4-46e3-a0af-93ddea73e815_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c97b7fba-c1a4-46e3-a0af-93ddea73e815" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c97b7fba-c1a4-46e3-a0af-93ddea73e815_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c97b7fba-c1a4-46e3-a0af-93ddea73e815" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a2ae0e86-ea0c-4cee-8a0d-aa68507dcc08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a2ae0e86-ea0c-4cee-8a0d-aa68507dcc08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_8f9b1ca2-3349-4091-977c-0905cf5f15b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_8f9b1ca2-3349-4091-977c-0905cf5f15b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_0d7f1b43-9db2-41d3-933e-fc50a82bd26e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_0d7f1b43-9db2-41d3-933e-fc50a82bd26e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_6c5bfbe5-7a65-4606-9070-75f218d47e08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:to="loc_us-gaap_TradeNamesMember_6c5bfbe5-7a65-4606-9070-75f218d47e08" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PatentLicensingAgreementMember_fd1394a4-7cbe-4723-83d6-f1ea93fc2643" xlink:href="nvta-20201231.xsd#nvta_PatentLicensingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:to="loc_nvta_PatentLicensingAgreementMember_fd1394a4-7cbe-4723-83d6-f1ea93fc2643" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_6b9c237f-35c0-44b4-a9c3-f80c025af3be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_6b9c237f-35c0-44b4-a9c3-f80c025af3be" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails" xlink:type="extended" id="i1b7dfa721d8e46e0988fe6b42f0db0b1_GoodwillandintangibleassetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7ac42813-18d6-4508-aac6-49dd5e0e72a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7ac42813-18d6-4508-aac6-49dd5e0e72a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_b8b5dc51-ab80-4bb4-bb30-7fffd729dd9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_b8b5dc51-ab80-4bb4-bb30-7fffd729dd9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2cf28fc5-41a1-41e1-8781-954587ed361a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2cf28fc5-41a1-41e1-8781-954587ed361a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_00c49648-4478-41f6-a979-bfca301a68af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_00c49648-4478-41f6-a979-bfca301a68af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_b681aa2c-fe57-490f-bb96-3cec07d841f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_b681aa2c-fe57-490f-bb96-3cec07d841f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ec3627c3-4641-4ad3-8e37-5dfe80ac4bb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ec3627c3-4641-4ad3-8e37-5dfe80ac4bb3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays_7cd5f58e-8da1-4339-a33c-34c545f97c26" xlink:href="nvta-20201231.xsd#nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays_7cd5f58e-8da1-4339-a33c-34c545f97c26" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5b5b9277-326c-4852-bc4d-dedbfc58c750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5b5b9277-326c-4852-bc4d-dedbfc58c750" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c72ae67d-7bd0-4392-a62e-9b7101a4f38a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c72ae67d-7bd0-4392-a62e-9b7101a4f38a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ac6a24b4-b6cb-4c67-8ef0-102ca2348a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ac6a24b4-b6cb-4c67-8ef0-102ca2348a50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac6a24b4-b6cb-4c67-8ef0-102ca2348a50_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ac6a24b4-b6cb-4c67-8ef0-102ca2348a50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac6a24b4-b6cb-4c67-8ef0-102ca2348a50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_71bfb11c-1d35-4cf0-a282-76050ed85028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ac6a24b4-b6cb-4c67-8ef0-102ca2348a50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_71bfb11c-1d35-4cf0-a282-76050ed85028" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b3a848d7-bab1-4ba0-8077-52043aa329ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_71bfb11c-1d35-4cf0-a282-76050ed85028" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b3a848d7-bab1-4ba0-8077-52043aa329ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1d76b2ae-5789-4f11-860f-ffb3a2af76ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:to="loc_us-gaap_AwardTypeAxis_1d76b2ae-5789-4f11-860f-ffb3a2af76ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1d76b2ae-5789-4f11-860f-ffb3a2af76ea_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1d76b2ae-5789-4f11-860f-ffb3a2af76ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1d76b2ae-5789-4f11-860f-ffb3a2af76ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be98876d-c5e2-401b-a787-b3159abcf8aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1d76b2ae-5789-4f11-860f-ffb3a2af76ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be98876d-c5e2-401b-a787-b3159abcf8aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e9bcedfa-f572-4938-9126-af879eeef3d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be98876d-c5e2-401b-a787-b3159abcf8aa" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e9bcedfa-f572-4938-9126-af879eeef3d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5c7abb6f-a6dc-4b8f-9a4e-44c8bd41648d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:to="loc_us-gaap_PlanNameAxis_5c7abb6f-a6dc-4b8f-9a4e-44c8bd41648d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5c7abb6f-a6dc-4b8f-9a4e-44c8bd41648d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5c7abb6f-a6dc-4b8f-9a4e-44c8bd41648d" xlink:to="loc_us-gaap_PlanNameDomain_5c7abb6f-a6dc-4b8f-9a4e-44c8bd41648d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d2da684d-abbe-46a2-a499-31b3e5e33569" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5c7abb6f-a6dc-4b8f-9a4e-44c8bd41648d" xlink:to="loc_us-gaap_PlanNameDomain_d2da684d-abbe-46a2-a499-31b3e5e33569" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIncentivePlanMember_92d8a7be-a864-4cd3-8539-9e4d64c5f713" xlink:href="nvta-20201231.xsd#nvta_StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d2da684d-abbe-46a2-a499-31b3e5e33569" xlink:to="loc_nvta_StockIncentivePlanMember_92d8a7be-a864-4cd3-8539-9e4d64c5f713" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_4a390015-9db3-4a48-a17c-cb7ed7529fa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:to="loc_us-gaap_VestingAxis_4a390015-9db3-4a48-a17c-cb7ed7529fa8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_4a390015-9db3-4a48-a17c-cb7ed7529fa8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_4a390015-9db3-4a48-a17c-cb7ed7529fa8" xlink:to="loc_us-gaap_VestingDomain_4a390015-9db3-4a48-a17c-cb7ed7529fa8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_3e6b8df9-ddcf-4588-92fa-dadcef668345" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_4a390015-9db3-4a48-a17c-cb7ed7529fa8" xlink:to="loc_us-gaap_VestingDomain_3e6b8df9-ddcf-4588-92fa-dadcef668345" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_5bdd7d41-ec40-4320-bbe8-319f5097da3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_3e6b8df9-ddcf-4588-92fa-dadcef668345" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_5bdd7d41-ec40-4320-bbe8-319f5097da3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_97b7fd53-a19d-4bdf-9134-dafa9f0b2737" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_3e6b8df9-ddcf-4588-92fa-dadcef668345" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_97b7fd53-a19d-4bdf-9134-dafa9f0b2737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ede0f777-7faf-40c0-a762-6e6ffe7850ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ede0f777-7faf-40c0-a762-6e6ffe7850ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ede0f777-7faf-40c0-a762-6e6ffe7850ed_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ede0f777-7faf-40c0-a762-6e6ffe7850ed" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ede0f777-7faf-40c0-a762-6e6ffe7850ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_77f3b4da-768f-4680-b792-78acc4da20bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ede0f777-7faf-40c0-a762-6e6ffe7850ed" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_77f3b4da-768f-4680-b792-78acc4da20bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_05b019e5-30a5-4868-ae2b-8100255cc6d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_77f3b4da-768f-4680-b792-78acc4da20bd" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_05b019e5-30a5-4868-ae2b-8100255cc6d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_90e99e3e-b37a-4624-aaba-7d7cdcd3951f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_90e99e3e-b37a-4624-aaba-7d7cdcd3951f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_90e99e3e-b37a-4624-aaba-7d7cdcd3951f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_90e99e3e-b37a-4624-aaba-7d7cdcd3951f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_90e99e3e-b37a-4624-aaba-7d7cdcd3951f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3a3e2c90-4b5c-4414-8f8f-2f39a747def9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_90e99e3e-b37a-4624-aaba-7d7cdcd3951f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3a3e2c90-4b5c-4414-8f8f-2f39a747def9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_87e3db75-2479-4b10-9e15-abe7d87addcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3a3e2c90-4b5c-4414-8f8f-2f39a747def9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_87e3db75-2479-4b10-9e15-abe7d87addcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_86705803-a24b-4669-9785-c0b817950673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_86705803-a24b-4669-9785-c0b817950673" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_86705803-a24b-4669-9785-c0b817950673_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_86705803-a24b-4669-9785-c0b817950673" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_86705803-a24b-4669-9785-c0b817950673_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4eabde3a-dbc7-49ba-99f8-577edf418e02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_86705803-a24b-4669-9785-c0b817950673" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4eabde3a-dbc7-49ba-99f8-577edf418e02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_f213e106-25e0-4641-baeb-9555335f2dd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4eabde3a-dbc7-49ba-99f8-577edf418e02" xlink:to="loc_us-gaap_WarrantMember_f213e106-25e0-4641-baeb-9555335f2dd5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails" xlink:type="extended" id="i2fa9e462c5a44e87b797491feb2f2f0e_GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Balancesheetcomponents" xlink:type="simple" xlink:href="nvta-20201231.xsd#Balancesheetcomponents"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/Balancesheetcomponents" xlink:type="extended" id="i87c04afa8037431290fd421138615380_Balancesheetcomponents"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BalancesheetcomponentsTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#BalancesheetcomponentsTables"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BalancesheetcomponentsTables" xlink:type="extended" id="i0d8cb037de04495daa23420cefb2250d_BalancesheetcomponentsTables"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BalancesheetcomponentsScheduleofinventoryDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails" xlink:type="extended" id="ia91298b229204578abe6afd11e2b7f5f_BalancesheetcomponentsScheduleofinventoryDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BalancesheetcomponentsPropertyandequipmentDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails" xlink:type="extended" id="i5dd57c99ee3c48479ea277864f05b09f_BalancesheetcomponentsPropertyandequipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0ed92765-c23b-4f6a-8426-d9f414945ea7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_81abe3d0-a647-41bd-bc14-6138caf1c8a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0ed92765-c23b-4f6a-8426-d9f414945ea7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_81abe3d0-a647-41bd-bc14-6138caf1c8a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a6120d18-26b9-48f9-8d95-86a45bb9501b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0ed92765-c23b-4f6a-8426-d9f414945ea7" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a6120d18-26b9-48f9-8d95-86a45bb9501b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_173cc661-f188-4af6-bead-34ca100862d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0ed92765-c23b-4f6a-8426-d9f414945ea7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_173cc661-f188-4af6-bead-34ca100862d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bad856d7-f030-407e-812f-d20fca9d2ba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0ed92765-c23b-4f6a-8426-d9f414945ea7" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bad856d7-f030-407e-812f-d20fca9d2ba4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d27b4e44-25aa-4f10-ab19-962c62b91cce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bad856d7-f030-407e-812f-d20fca9d2ba4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d27b4e44-25aa-4f10-ab19-962c62b91cce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d27b4e44-25aa-4f10-ab19-962c62b91cce_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d27b4e44-25aa-4f10-ab19-962c62b91cce" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d27b4e44-25aa-4f10-ab19-962c62b91cce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d27b4e44-25aa-4f10-ab19-962c62b91cce" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_3a420e2a-2409-432f-9433-77e3d3c23b38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_3a420e2a-2409-432f-9433-77e3d3c23b38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_583317d2-cf9f-4f71-8c8a-35a2886429bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:to="loc_us-gaap_EquipmentMember_583317d2-cf9f-4f71-8c8a-35a2886429bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_b0862b4d-92e9-45c5-94bb-83eff52840ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:to="loc_us-gaap_ComputerEquipmentMember_b0862b4d-92e9-45c5-94bb-83eff52840ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_ed87dafd-249d-47fa-bd90-b851d0b7c519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_ed87dafd-249d-47fa-bd90-b851d0b7c519" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_d5da3c5a-cfc5-4305-937f-d2f1b23a5fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_d5da3c5a-cfc5-4305-937f-d2f1b23a5fe9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AutomobilesMember_f23c2f13-a746-4a03-bb1c-bed20bab19cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AutomobilesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:to="loc_us-gaap_AutomobilesMember_f23c2f13-a746-4a03-bb1c-bed20bab19cf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_aef25baa-9918-46c4-b89c-8db820d460c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:to="loc_us-gaap_ConstructionInProgressMember_aef25baa-9918-46c4-b89c-8db820d460c2" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BalancesheetcomponentsAccruedliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails" xlink:type="extended" id="iebca0c8f2c1a45f485cf88fb8bae7b0e_BalancesheetcomponentsAccruedliabilitiesDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BalancesheetcomponentsOtherlongtermliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails" xlink:type="extended" id="i3ad00aafc20f4fdc8d619abe8422a066_BalancesheetcomponentsOtherlongtermliabilitiesDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Fairvaluemeasurements" xlink:type="simple" xlink:href="nvta-20201231.xsd#Fairvaluemeasurements"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/Fairvaluemeasurements" xlink:type="extended" id="i7ee1df461a74471ab75523275ca261ca_Fairvaluemeasurements"/>
  <link:roleRef roleURI="http://www.invitae.com/role/FairvaluemeasurementsTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#FairvaluemeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/FairvaluemeasurementsTables" xlink:type="extended" id="i5b1e9d93fa4c4ba38082bcf9105713c8_FairvaluemeasurementsTables"/>
  <link:roleRef roleURI="http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails" xlink:type="extended" id="i6eab3e2938c9416da938ce6ac3bba56f_FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost_21c6d406-55ef-498a-8ad3-74cd23fabe05" xlink:href="nvta-20201231.xsd#nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost_21c6d406-55ef-498a-8ad3-74cd23fabe05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax_50bc5f3d-1a20-4fd2-a46d-1dc67a11df85" xlink:href="nvta-20201231.xsd#nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax_50bc5f3d-1a20-4fd2-a46d-1dc67a11df85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax_378f6ea6-4120-4e7e-a9b8-51ed2f368e63" xlink:href="nvta-20201231.xsd#nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax_378f6ea6-4120-4e7e-a9b8-51ed2f368e63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue_384c4f2d-f96f-460b-89f9-76365b8ef319" xlink:href="nvta-20201231.xsd#nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue_384c4f2d-f96f-460b-89f9-76365b8ef319" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_301f77e7-db1d-4bba-be58-382845c449e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_301f77e7-db1d-4bba-be58-382845c449e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_fe044e45-bc8e-4349-9616-abfb95612116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_fe044e45-bc8e-4349-9616-abfb95612116" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_1676a9f0-54f3-4973-9e7a-6c3fa72b1d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_1676a9f0-54f3-4973-9e7a-6c3fa72b1d06" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_cfe21fca-7434-4e3a-acf1-459f8d59cef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_cfe21fca-7434-4e3a-acf1-459f8d59cef4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dcb1b53d-1c3f-40f4-a68d-bd30c174f1c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dcb1b53d-1c3f-40f4-a68d-bd30c174f1c7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1334da0-b89f-4a30-ab6c-f032381d7b5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1334da0-b89f-4a30-ab6c-f032381d7b5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1afdf933-78cd-4ac4-afe8-a0a549fe278a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1334da0-b89f-4a30-ab6c-f032381d7b5b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1afdf933-78cd-4ac4-afe8-a0a549fe278a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1afdf933-78cd-4ac4-afe8-a0a549fe278a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1afdf933-78cd-4ac4-afe8-a0a549fe278a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1afdf933-78cd-4ac4-afe8-a0a549fe278a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1afdf933-78cd-4ac4-afe8-a0a549fe278a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_4349a5ef-6a83-4723-90e9-f5a11ce648da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_4349a5ef-6a83-4723-90e9-f5a11ce648da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_f26bf185-f035-4648-8e5e-bd5a148784b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:to="loc_us-gaap_CertificatesOfDepositMember_f26bf185-f035-4648-8e5e-bd5a148784b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_580f4250-bb16-45a0-a800-e4fcaffdd58b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_580f4250-bb16-45a0-a800-e4fcaffdd58b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e0ce5efb-2ebd-4864-8c63-c1fc1943612b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e0ce5efb-2ebd-4864-8c63-c1fc1943612b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_87202a99-b342-4701-984d-b99e71966cab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_87202a99-b342-4701-984d-b99e71966cab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ContingentConsiderationMember_797a3ef4-ae36-46a5-9406-66d68d27b58d" xlink:href="nvta-20201231.xsd#nvta_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:to="loc_nvta_ContingentConsiderationMember_797a3ef4-ae36-46a5-9406-66d68d27b58d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_86d949c0-fb43-4836-b6e7-86159cdb2e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1334da0-b89f-4a30-ab6c-f032381d7b5b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_86d949c0-fb43-4836-b6e7-86159cdb2e8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_86d949c0-fb43-4836-b6e7-86159cdb2e8d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_86d949c0-fb43-4836-b6e7-86159cdb2e8d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_86d949c0-fb43-4836-b6e7-86159cdb2e8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_403cb28a-06c3-4872-878e-a8f5c9ccdea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_86d949c0-fb43-4836-b6e7-86159cdb2e8d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_403cb28a-06c3-4872-878e-a8f5c9ccdea3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_98cd1aed-9aa3-4b8b-a2a6-07348c8f9c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_403cb28a-06c3-4872-878e-a8f5c9ccdea3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_98cd1aed-9aa3-4b8b-a2a6-07348c8f9c7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3f6f373f-512a-4ee9-986d-e398edee5fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1334da0-b89f-4a30-ab6c-f032381d7b5b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3f6f373f-512a-4ee9-986d-e398edee5fae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3f6f373f-512a-4ee9-986d-e398edee5fae_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3f6f373f-512a-4ee9-986d-e398edee5fae" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3f6f373f-512a-4ee9-986d-e398edee5fae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c9ea895-c77c-472d-85c6-691aca9b3526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3f6f373f-512a-4ee9-986d-e398edee5fae" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c9ea895-c77c-472d-85c6-691aca9b3526" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ef1d04cf-08da-4d47-ab0d-e503c0dc7b40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c9ea895-c77c-472d-85c6-691aca9b3526" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_ef1d04cf-08da-4d47-ab0d-e503c0dc7b40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_fe697428-f8fe-4483-b69d-15031c1957e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c9ea895-c77c-472d-85c6-691aca9b3526" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_fe697428-f8fe-4483-b69d-15031c1957e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9efbe84c-7424-4e43-9a77-febfe27672dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c9ea895-c77c-472d-85c6-691aca9b3526" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9efbe84c-7424-4e43-9a77-febfe27672dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_afbe3813-86a5-4bbb-a3fc-15242b36cf2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1334da0-b89f-4a30-ab6c-f032381d7b5b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_afbe3813-86a5-4bbb-a3fc-15242b36cf2a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_afbe3813-86a5-4bbb-a3fc-15242b36cf2a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_afbe3813-86a5-4bbb-a3fc-15242b36cf2a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_afbe3813-86a5-4bbb-a3fc-15242b36cf2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_dd98e98a-4b60-48f3-a785-1ea02fb2df49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_afbe3813-86a5-4bbb-a3fc-15242b36cf2a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_dd98e98a-4b60-48f3-a785-1ea02fb2df49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_fe6d0ee8-676f-4e65-bf58-3716c6b3fc82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dd98e98a-4b60-48f3-a785-1ea02fb2df49" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_fe6d0ee8-676f-4e65-bf58-3716c6b3fc82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3cf019c2-11bf-48dc-9cbd-04085e2b28be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dd98e98a-4b60-48f3-a785-1ea02fb2df49" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3cf019c2-11bf-48dc-9cbd-04085e2b28be" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#FairvaluemeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails" xlink:type="extended" id="idb17ce01f7d146289c4b2a71f5d30a99_FairvaluemeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_c2c81d23-05ba-4bac-9691-82531766720d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount_95c9b495-b6e4-4b44-bbca-a7e24df96bf2" xlink:href="nvta-20201231.xsd#nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_c2c81d23-05ba-4bac-9691-82531766720d" xlink:to="loc_nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount_95c9b495-b6e4-4b44-bbca-a7e24df96bf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_ad143622-683b-429c-af53-16917a756c11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_c2c81d23-05ba-4bac-9691-82531766720d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_ad143622-683b-429c-af53-16917a756c11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod_4ff564b0-995e-4cab-8cbb-ca85895d56a3" xlink:href="nvta-20201231.xsd#nvta_DebtSecuritiesAvailableForSaleMaturityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_c2c81d23-05ba-4bac-9691-82531766720d" xlink:to="loc_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod_4ff564b0-995e-4cab-8cbb-ca85895d56a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_402b8470-74b4-48b2-bad3-a2bebc58d28a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_c2c81d23-05ba-4bac-9691-82531766720d" xlink:to="loc_us-gaap_InvestmentIncomeInterest_402b8470-74b4-48b2-bad3-a2bebc58d28a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_609b9a72-cc04-4486-9b73-a2ea399e53ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_c2c81d23-05ba-4bac-9691-82531766720d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_609b9a72-cc04-4486-9b73-a2ea399e53ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_cae3955a-1631-4390-b8bf-19f8fa42929b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_c2c81d23-05ba-4bac-9691-82531766720d" xlink:to="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_cae3955a-1631-4390-b8bf-19f8fa42929b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e2c845fb-7020-43a8-a2a2-744465d0cf9d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_cae3955a-1631-4390-b8bf-19f8fa42929b" xlink:to="loc_srt_RangeAxis_e2c845fb-7020-43a8-a2a2-744465d0cf9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e2c845fb-7020-43a8-a2a2-744465d0cf9d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e2c845fb-7020-43a8-a2a2-744465d0cf9d" xlink:to="loc_srt_RangeMember_e2c845fb-7020-43a8-a2a2-744465d0cf9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8012f263-48be-4168-af50-87922b3c404b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e2c845fb-7020-43a8-a2a2-744465d0cf9d" xlink:to="loc_srt_RangeMember_8012f263-48be-4168-af50-87922b3c404b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_93464259-4f08-4aab-9d8d-8eec139cc0fc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8012f263-48be-4168-af50-87922b3c404b" xlink:to="loc_srt_MinimumMember_93464259-4f08-4aab-9d8d-8eec139cc0fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_95f30c88-2e08-4178-b11b-ff7764060946" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8012f263-48be-4168-af50-87922b3c404b" xlink:to="loc_srt_MaximumMember_95f30c88-2e08-4178-b11b-ff7764060946" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Commitmentsandcontingencies" xlink:type="simple" xlink:href="nvta-20201231.xsd#Commitmentsandcontingencies"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/Commitmentsandcontingencies" xlink:type="extended" id="id32857c21a454667bbd3af689aba38d8_Commitmentsandcontingencies"/>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesTables"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesTables" xlink:type="extended" id="i0e98ffd06db149fa87e77c34b98f838b_CommitmentsandcontingenciesTables"/>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesLeaseadditionalinformationDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails" xlink:type="extended" id="icd4dc9ac66f443fea8a59f127afea107_CommitmentsandcontingenciesLeaseadditionalinformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_1f08fc39-e12d-4da4-afee-a3160b46489d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_b0faf2ec-6178-4016-819d-cb3bb792d37f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1f08fc39-e12d-4da4-afee-a3160b46489d" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_b0faf2ec-6178-4016-819d-cb3bb792d37f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1b8161c0-a51a-4824-ab5b-b9fc0d038713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1f08fc39-e12d-4da4-afee-a3160b46489d" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1b8161c0-a51a-4824-ab5b-b9fc0d038713" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecurityDeposit_eafd92ab-73e9-4a44-84d6-c3b2955c3d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecurityDeposit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1f08fc39-e12d-4da4-afee-a3160b46489d" xlink:to="loc_us-gaap_SecurityDeposit_eafd92ab-73e9-4a44-84d6-c3b2955c3d14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_5f56de47-47c3-49cf-a592-8fddfffc9864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1f08fc39-e12d-4da4-afee-a3160b46489d" xlink:to="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_5f56de47-47c3-49cf-a592-8fddfffc9864" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3d290312-e21d-4851-8160-25e5f4b634dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1f08fc39-e12d-4da4-afee-a3160b46489d" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3d290312-e21d-4851-8160-25e5f4b634dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1d94bd7e-b658-4323-a2b6-b7be47dd4b3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3d290312-e21d-4851-8160-25e5f4b634dd" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1d94bd7e-b658-4323-a2b6-b7be47dd4b3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1d94bd7e-b658-4323-a2b6-b7be47dd4b3c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1d94bd7e-b658-4323-a2b6-b7be47dd4b3c" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1d94bd7e-b658-4323-a2b6-b7be47dd4b3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f8936076-95ac-4fcf-8882-e5e9e0b5cd06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1d94bd7e-b658-4323-a2b6-b7be47dd4b3c" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f8936076-95ac-4fcf-8882-e5e9e0b5cd06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_NewLeasesMember_4e614c45-7b6b-44c2-a28e-0522cc8faddb" xlink:href="nvta-20201231.xsd#nvta_NewLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f8936076-95ac-4fcf-8882-e5e9e0b5cd06" xlink:to="loc_nvta_NewLeasesMember_4e614c45-7b6b-44c2-a28e-0522cc8faddb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_80dac5b7-23c4-4230-a2b2-6901bbdfe95d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3d290312-e21d-4851-8160-25e5f4b634dd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_80dac5b7-23c4-4230-a2b2-6901bbdfe95d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_80dac5b7-23c4-4230-a2b2-6901bbdfe95d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_80dac5b7-23c4-4230-a2b2-6901bbdfe95d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_80dac5b7-23c4-4230-a2b2-6901bbdfe95d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02d011f4-5623-4062-aa13-775a8766f8f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_80dac5b7-23c4-4230-a2b2-6901bbdfe95d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02d011f4-5623-4062-aa13-775a8766f8f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_OfficeFacilityInSanFranciscoMember_03acfcfc-3fa3-4f04-86e9-f2039a640509" xlink:href="nvta-20201231.xsd#nvta_OfficeFacilityInSanFranciscoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02d011f4-5623-4062-aa13-775a8766f8f1" xlink:to="loc_nvta_OfficeFacilityInSanFranciscoMember_03acfcfc-3fa3-4f04-86e9-f2039a640509" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails" xlink:type="extended" id="i4450d2b7d890473faa7ac1ce11b9704b_CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails" xlink:type="extended" id="idf729b2cec8b45059f97976e1621f339_CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesDebtfinancingDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails" xlink:type="extended" id="i78dd81e5b02140fd91bee497b03498fb_CommitmentsandcontingenciesDebtfinancingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_767c394d-d528-45ad-aac2-d947ed37bf67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_767c394d-d528-45ad-aac2-d947ed37bf67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_d36d3d4a-1512-4dde-aa87-4685100110e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_DebtInstrumentTerm_d36d3d4a-1512-4dde-aa87-4685100110e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_b4c2eaa8-8543-4a4a-adcc-0bc271d5209e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_b4c2eaa8-8543-4a4a-adcc-0bc271d5209e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_9b80b363-c603-45fc-8c91-31edc7f13a74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_9b80b363-c603-45fc-8c91-31edc7f13a74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_3fc33218-c927-42e6-b857-a3a953b94568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_3fc33218-c927-42e6-b857-a3a953b94568" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RepaymentsofLinesofCreditPrincipal_2a011629-17f9-4186-a647-f729a0eb430b" xlink:href="nvta-20201231.xsd#nvta_RepaymentsofLinesofCreditPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_nvta_RepaymentsofLinesofCreditPrincipal_2a011629-17f9-4186-a647-f729a0eb430b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RepaymentsofLinesofCreditAccruedInterest_db3c65b9-9445-449c-9a59-abbef2a1bc4e" xlink:href="nvta-20201231.xsd#nvta_RepaymentsofLinesofCreditAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_nvta_RepaymentsofLinesofCreditAccruedInterest_db3c65b9-9445-449c-9a59-abbef2a1bc4e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_e4d01579-84d8-45f5-afd4-ace716a6c8e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_e4d01579-84d8-45f5-afd4-ace716a6c8e3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_db901879-31e6-49cb-a4c0-12bb56eec27a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_db901879-31e6-49cb-a4c0-12bb56eec27a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentInterestRateFloorRate_0b097dd0-8cac-4572-9e04-e2536e6e7e7c" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentInterestRateFloorRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_nvta_DebtInstrumentInterestRateFloorRate_0b097dd0-8cac-4572-9e04-e2536e6e7e7c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a5394f1e-851b-4f57-a92a-166dcb117ef8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a5394f1e-851b-4f57-a92a-166dcb117ef8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended_1780bc65-82e3-4346-9a3d-c882356a3844" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended_1780bc65-82e3-4346-9a3d-c882356a3844" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate_45a62e0a-faa1-436f-ae66-b8257c1077e7" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate_45a62e0a-faa1-436f-ae66-b8257c1077e7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentPrepaymentFeePercentage_517f0db8-234c-405a-bef4-f501e1aeba72" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentPrepaymentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_nvta_DebtInstrumentPrepaymentFeePercentage_517f0db8-234c-405a-bef4-f501e1aeba72" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_081fed59-d8b9-4401-95ce-811756408acb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_081fed59-d8b9-4401-95ce-811756408acb" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_14537efd-99d0-4980-8c01-7d8dd412a63d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_14537efd-99d0-4980-8c01-7d8dd412a63d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0da8ba48-28fb-4e13-a4bb-3533990f9a4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0da8ba48-28fb-4e13-a4bb-3533990f9a4f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_45800449-45dd-4f77-88d8-8a6dea78f52d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_45800449-45dd-4f77-88d8-8a6dea78f52d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_17a0e36f-5cdf-4fea-9386-e75032ea6844" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_17a0e36f-5cdf-4fea-9386-e75032ea6844" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_8c247952-e9b5-433d-b13f-bb4a4239bb4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_InterestExpenseDebt_8c247952-e9b5-433d-b13f-bb4a4239bb4a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e793900c-8b59-42fb-b55d-9372fc0e1d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:to="loc_us-gaap_DebtInstrumentAxis_e793900c-8b59-42fb-b55d-9372fc0e1d2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e793900c-8b59-42fb-b55d-9372fc0e1d2b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e793900c-8b59-42fb-b55d-9372fc0e1d2b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e793900c-8b59-42fb-b55d-9372fc0e1d2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_82c1d2a5-3c14-468d-a59b-705908f7dbc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e793900c-8b59-42fb-b55d-9372fc0e1d2b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_82c1d2a5-3c14-468d-a59b-705908f7dbc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_TrancheOneMember_955c199c-644c-49d5-a993-5bbd0f7ce0d0" xlink:href="nvta-20201231.xsd#nvta_TrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_82c1d2a5-3c14-468d-a59b-705908f7dbc3" xlink:to="loc_nvta_TrancheOneMember_955c199c-644c-49d5-a993-5bbd0f7ce0d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_LoanAndSecurityAgreementMember_7fb9a530-0586-48d0-926e-a92be0e38ed5" xlink:href="nvta-20201231.xsd#nvta_LoanAndSecurityAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_82c1d2a5-3c14-468d-a59b-705908f7dbc3" xlink:to="loc_nvta_LoanAndSecurityAgreementMember_7fb9a530-0586-48d0-926e-a92be0e38ed5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SeniorSecuredTermLoanFacilityMember_3eb01046-bf13-4d96-9064-a81b3f180b4a" xlink:href="nvta-20201231.xsd#nvta_SeniorSecuredTermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_82c1d2a5-3c14-468d-a59b-705908f7dbc3" xlink:to="loc_nvta_SeniorSecuredTermLoanFacilityMember_3eb01046-bf13-4d96-9064-a81b3f180b4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ConvertibleSeniorNotesMember_a0b3e8c3-adfb-48bc-a255-cee8352cee09" xlink:href="nvta-20201231.xsd#nvta_ConvertibleSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_82c1d2a5-3c14-468d-a59b-705908f7dbc3" xlink:to="loc_nvta_ConvertibleSeniorNotesMember_a0b3e8c3-adfb-48bc-a255-cee8352cee09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9b143959-c2ee-49c9-9cdf-b0cfb5e5615f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:to="loc_us-gaap_CreditFacilityAxis_9b143959-c2ee-49c9-9cdf-b0cfb5e5615f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9b143959-c2ee-49c9-9cdf-b0cfb5e5615f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_9b143959-c2ee-49c9-9cdf-b0cfb5e5615f" xlink:to="loc_us-gaap_CreditFacilityDomain_9b143959-c2ee-49c9-9cdf-b0cfb5e5615f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_768b75cb-1ff5-4380-a63a-dbfad9c2852a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_9b143959-c2ee-49c9-9cdf-b0cfb5e5615f" xlink:to="loc_us-gaap_CreditFacilityDomain_768b75cb-1ff5-4380-a63a-dbfad9c2852a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_NotePurchaseAgreementMember_0e406ead-7543-48dd-90c6-ed5dbbd64e69" xlink:href="nvta-20201231.xsd#nvta_NotePurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_768b75cb-1ff5-4380-a63a-dbfad9c2852a" xlink:to="loc_nvta_NotePurchaseAgreementMember_0e406ead-7543-48dd-90c6-ed5dbbd64e69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_c19f4d22-f74b-42ca-b064-aed49f9c0b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_768b75cb-1ff5-4380-a63a-dbfad9c2852a" xlink:to="loc_us-gaap_SecuredDebtMember_c19f4d22-f74b-42ca-b064-aed49f9c0b2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7e458d3b-5c2c-4736-8d8e-1bb081975431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7e458d3b-5c2c-4736-8d8e-1bb081975431" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7e458d3b-5c2c-4736-8d8e-1bb081975431_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7e458d3b-5c2c-4736-8d8e-1bb081975431" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7e458d3b-5c2c-4736-8d8e-1bb081975431_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9df93bfe-4911-494d-ac1d-7c870895db2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7e458d3b-5c2c-4736-8d8e-1bb081975431" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9df93bfe-4911-494d-ac1d-7c870895db2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_932ccfef-61c9-4b37-a1d0-ec7c57801e7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9df93bfe-4911-494d-ac1d-7c870895db2c" xlink:to="loc_us-gaap_SecuredDebtMember_932ccfef-61c9-4b37-a1d0-ec7c57801e7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_7dba067b-7b24-43de-959e-a9eb7baeacc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9df93bfe-4911-494d-ac1d-7c870895db2c" xlink:to="loc_us-gaap_ConvertibleDebtMember_7dba067b-7b24-43de-959e-a9eb7baeacc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_c7378cdd-03bf-432e-b4e8-b2c85b1e0d17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:to="loc_us-gaap_VariableRateAxis_c7378cdd-03bf-432e-b4e8-b2c85b1e0d17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c7378cdd-03bf-432e-b4e8-b2c85b1e0d17_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_c7378cdd-03bf-432e-b4e8-b2c85b1e0d17" xlink:to="loc_us-gaap_VariableRateDomain_c7378cdd-03bf-432e-b4e8-b2c85b1e0d17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f5411c9b-6cd6-475a-8eed-b8f8be1c6a35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_c7378cdd-03bf-432e-b4e8-b2c85b1e0d17" xlink:to="loc_us-gaap_VariableRateDomain_f5411c9b-6cd6-475a-8eed-b8f8be1c6a35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_21676fa3-adff-4a92-9b71-2e0c49546c4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_f5411c9b-6cd6-475a-8eed-b8f8be1c6a35" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_21676fa3-adff-4a92-9b71-2e0c49546c4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_972237c2-3c7c-41b9-97a8-ae39ef9ee551" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_972237c2-3c7c-41b9-97a8-ae39ef9ee551" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_972237c2-3c7c-41b9-97a8-ae39ef9ee551_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_972237c2-3c7c-41b9-97a8-ae39ef9ee551" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_972237c2-3c7c-41b9-97a8-ae39ef9ee551_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_f1479e47-52be-40f1-8bb8-23d765a3e867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_972237c2-3c7c-41b9-97a8-ae39ef9ee551" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_f1479e47-52be-40f1-8bb8-23d765a3e867" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtFinancingContingencyMember_4584314a-40bf-4592-b340-e821bba029fd" xlink:href="nvta-20201231.xsd#nvta_DebtFinancingContingencyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_f1479e47-52be-40f1-8bb8-23d765a3e867" xlink:to="loc_nvta_DebtFinancingContingencyMember_4584314a-40bf-4592-b340-e821bba029fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_c2e4e755-5759-423e-a6b1-60f67eb2212e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_c2e4e755-5759-423e-a6b1-60f67eb2212e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c2e4e755-5759-423e-a6b1-60f67eb2212e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_c2e4e755-5759-423e-a6b1-60f67eb2212e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c2e4e755-5759-423e-a6b1-60f67eb2212e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a1ef7f2b-b58e-4486-8faf-7ea8e185d6b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_c2e4e755-5759-423e-a6b1-60f67eb2212e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a1ef7f2b-b58e-4486-8faf-7ea8e185d6b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoteWarrantMember_9e642b2a-613c-4179-bb9e-e8c41693525d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoteWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a1ef7f2b-b58e-4486-8faf-7ea8e185d6b3" xlink:to="loc_us-gaap_NoteWarrantMember_9e642b2a-613c-4179-bb9e-e8c41693525d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_402de419-8890-4a79-8807-36e4097ddf1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_402de419-8890-4a79-8807-36e4097ddf1d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_402de419-8890-4a79-8807-36e4097ddf1d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_402de419-8890-4a79-8807-36e4097ddf1d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_402de419-8890-4a79-8807-36e4097ddf1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_c87c7c6d-2122-4fdf-9f28-de5c8ae7d0f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_402de419-8890-4a79-8807-36e4097ddf1d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_c87c7c6d-2122-4fdf-9f28-de5c8ae7d0f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_c665fb92-e0a3-4047-abd0-83888cd173cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_c87c7c6d-2122-4fdf-9f28-de5c8ae7d0f3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_c665fb92-e0a3-4047-abd0-83888cd173cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_2dd49de9-2221-4bea-8a74-6f80888669f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_c87c7c6d-2122-4fdf-9f28-de5c8ae7d0f3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_2dd49de9-2221-4bea-8a74-6f80888669f8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesConvertibleseniornotesDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails" xlink:type="extended" id="i6f57089fc6494dbe9d8bcf502b0ae48c_CommitmentsandcontingenciesConvertibleseniornotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_373abf3a-468b-4148-afbc-eee7318efb57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_373abf3a-468b-4148-afbc-eee7318efb57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7faa7d97-6a56-444b-a1b5-a99cdd1c7ee5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7faa7d97-6a56-444b-a1b5-a99cdd1c7ee5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_805d9072-07c7-4631-b373-160ced04de00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_805d9072-07c7-4631-b373-160ced04de00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_95696d3b-897d-45e7-9262-889a350b6c39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_95696d3b-897d-45e7-9262-889a350b6c39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cf26733a-7484-4cf0-81a5-b9bea68c623b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cf26733a-7484-4cf0-81a5-b9bea68c623b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4d6f0820-ddb4-42ff-a60b-539a4adf56f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4d6f0820-ddb4-42ff-a60b-539a4adf56f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_d9b90e30-596f-4850-80d6-c622cd73b074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_d9b90e30-596f-4850-80d6-c622cd73b074" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_50f330da-048e-426c-bef0-9d4db09b379f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_50f330da-048e-426c-bef0-9d4db09b379f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays_d4d23197-7c8b-4bf2-8afd-c0dab97154c7" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays_d4d23197-7c8b-4bf2-8afd-c0dab97154c7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum_08a46300-1d6c-419d-a74e-12a5cf378ce1" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum_08a46300-1d6c-419d-a74e-12a5cf378ce1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays_42c9b990-60df-4cc2-98fd-88ff0e48d39a" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays_42c9b990-60df-4cc2-98fd-88ff0e48d39a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_13a7d3ac-d490-46c6-82bb-777e7860215d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_13a7d3ac-d490-46c6-82bb-777e7860215d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_39407e3d-c3d3-4326-b0c1-2035e3f944ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_InterestExpenseDebt_39407e3d-c3d3-4326-b0c1-2035e3f944ad" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1ba180a9-a475-4b2a-a68f-57efb5509ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentTable_1ba180a9-a475-4b2a-a68f-57efb5509ed1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ad4c60f8-d098-4b7d-96b1-d8a5524bb242" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1ba180a9-a475-4b2a-a68f-57efb5509ed1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ad4c60f8-d098-4b7d-96b1-d8a5524bb242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ad4c60f8-d098-4b7d-96b1-d8a5524bb242_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ad4c60f8-d098-4b7d-96b1-d8a5524bb242" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ad4c60f8-d098-4b7d-96b1-d8a5524bb242_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3204e5d6-29aa-4942-8aab-aca964121a6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ad4c60f8-d098-4b7d-96b1-d8a5524bb242" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3204e5d6-29aa-4942-8aab-aca964121a6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ad1e4f0f-03aa-4e8e-a980-f34332418d9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3204e5d6-29aa-4942-8aab-aca964121a6c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ad1e4f0f-03aa-4e8e-a980-f34332418d9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_42a178e6-56e7-4da8-9bdf-ee721da92b77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1ba180a9-a475-4b2a-a68f-57efb5509ed1" xlink:to="loc_us-gaap_DebtInstrumentAxis_42a178e6-56e7-4da8-9bdf-ee721da92b77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_42a178e6-56e7-4da8-9bdf-ee721da92b77_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_42a178e6-56e7-4da8-9bdf-ee721da92b77" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_42a178e6-56e7-4da8-9bdf-ee721da92b77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_67d2e2fd-c3a5-4a92-883d-28f5d5102cf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_42a178e6-56e7-4da8-9bdf-ee721da92b77" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_67d2e2fd-c3a5-4a92-883d-28f5d5102cf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ConvertibleSeniorNotesMember_91166724-492d-45ac-863d-4e2e1a196719" xlink:href="nvta-20201231.xsd#nvta_ConvertibleSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_67d2e2fd-c3a5-4a92-883d-28f5d5102cf8" xlink:to="loc_nvta_ConvertibleSeniorNotesMember_91166724-492d-45ac-863d-4e2e1a196719" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_146fc568-d749-4105-8c11-c04a7d00eab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1ba180a9-a475-4b2a-a68f-57efb5509ed1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_146fc568-d749-4105-8c11-c04a7d00eab2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_146fc568-d749-4105-8c11-c04a7d00eab2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_146fc568-d749-4105-8c11-c04a7d00eab2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_146fc568-d749-4105-8c11-c04a7d00eab2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ab82ba43-2fc9-4a9c-8ff7-97bc3d2d7876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_146fc568-d749-4105-8c11-c04a7d00eab2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ab82ba43-2fc9-4a9c-8ff7-97bc3d2d7876" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_c045dded-6cec-4c36-9c27-32bb7c15767c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ab82ba43-2fc9-4a9c-8ff7-97bc3d2d7876" xlink:to="loc_us-gaap_ConvertibleDebtMember_c045dded-6cec-4c36-9c27-32bb7c15767c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesComponentsofdebtDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails" xlink:type="extended" id="i15515b1aab7c4e7a9253529fadd088ea_CommitmentsandcontingenciesComponentsofdebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_232448c2-e8f3-4f8a-8838-5548f44843d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c8ecfac5-8803-4cc9-bf78-de39a865f4a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_232448c2-e8f3-4f8a-8838-5548f44843d9" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c8ecfac5-8803-4cc9-bf78-de39a865f4a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_8461d34c-7024-4325-b71d-6c66be9dc7c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_232448c2-e8f3-4f8a-8838-5548f44843d9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_8461d34c-7024-4325-b71d-6c66be9dc7c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_27263727-c78c-4314-9439-0bcf4e4b191f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_232448c2-e8f3-4f8a-8838-5548f44843d9" xlink:to="loc_us-gaap_LongTermDebt_27263727-c78c-4314-9439-0bcf4e4b191f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_22c891f7-fdcc-428d-9ace-fcf84f2d6781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_232448c2-e8f3-4f8a-8838-5548f44843d9" xlink:to="loc_us-gaap_DebtInstrumentTable_22c891f7-fdcc-428d-9ace-fcf84f2d6781" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c9349960-abec-4419-9bdf-cf2efedb8211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_22c891f7-fdcc-428d-9ace-fcf84f2d6781" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c9349960-abec-4419-9bdf-cf2efedb8211" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c9349960-abec-4419-9bdf-cf2efedb8211_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c9349960-abec-4419-9bdf-cf2efedb8211" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c9349960-abec-4419-9bdf-cf2efedb8211_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4ec50610-8a7e-4390-bb1d-36ac09865c0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c9349960-abec-4419-9bdf-cf2efedb8211" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4ec50610-8a7e-4390-bb1d-36ac09865c0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_05f23ada-f16d-4c16-9c7d-b0099a608047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4ec50610-8a7e-4390-bb1d-36ac09865c0a" xlink:to="loc_us-gaap_ConvertibleDebtMember_05f23ada-f16d-4c16-9c7d-b0099a608047" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e0959dde-1aef-4d89-8fa4-5437b62dc309" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_22c891f7-fdcc-428d-9ace-fcf84f2d6781" xlink:to="loc_us-gaap_DebtInstrumentAxis_e0959dde-1aef-4d89-8fa4-5437b62dc309" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e0959dde-1aef-4d89-8fa4-5437b62dc309_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e0959dde-1aef-4d89-8fa4-5437b62dc309" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e0959dde-1aef-4d89-8fa4-5437b62dc309_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8a9601a6-8dbe-43d2-bfb4-a8f215ad1d20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e0959dde-1aef-4d89-8fa4-5437b62dc309" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8a9601a6-8dbe-43d2-bfb4-a8f215ad1d20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ConvertibleSeniorNotesMember_c632e40e-9dcc-4bd9-90ca-68346727ea31" xlink:href="nvta-20201231.xsd#nvta_ConvertibleSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a9601a6-8dbe-43d2-bfb4-a8f215ad1d20" xlink:to="loc_nvta_ConvertibleSeniorNotesMember_c632e40e-9dcc-4bd9-90ca-68346727ea31" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesOthercommitmentsDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails" xlink:type="extended" id="ifc4bdd4baf9a4c01a2e9218832900756_CommitmentsandcontingenciesOthercommitmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_e897dcab-a224-470e-b202-915f95a513e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_e897dcab-a224-470e-b202-915f95a513e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_d013843f-b9f5-423e-bfdf-16a889071d54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_d013843f-b9f5-423e-bfdf-16a889071d54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_e55c0345-4d44-422e-8975-65829a8c8aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_e55c0345-4d44-422e-8975-65829a8c8aaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_589a26fb-7b3f-4519-9654-255d9ed55972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_589a26fb-7b3f-4519-9654-255d9ed55972" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_4c491f4f-4eb1-4e94-8ca1-7a5fecb55e24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_4c491f4f-4eb1-4e94-8ca1-7a5fecb55e24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_20940889-993a-42b0-8b61-ce571da3a757" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_20940889-993a-42b0-8b61-ce571da3a757" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligation_f455240f-ca05-4f08-8c43-52685ffa52ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligation_f455240f-ca05-4f08-8c43-52685ffa52ba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_982e284a-b919-4c91-ae56-82072c4970d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_982e284a-b919-4c91-ae56-82072c4970d8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_4d18cad5-a63f-43b1-8d24-50c655800929" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_OtherCommitmentsTable_4d18cad5-a63f-43b1-8d24-50c655800929" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_9c4514af-3496-4da1-9e40-fdc944b9631b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_4d18cad5-a63f-43b1-8d24-50c655800929" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_9c4514af-3496-4da1-9e40-fdc944b9631b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_9c4514af-3496-4da1-9e40-fdc944b9631b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_9c4514af-3496-4da1-9e40-fdc944b9631b" xlink:to="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_9c4514af-3496-4da1-9e40-fdc944b9631b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_b4d1c95f-c777-486d-a03c-54e0d2921f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_9c4514af-3496-4da1-9e40-fdc944b9631b" xlink:to="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_b4d1c95f-c777-486d-a03c-54e0d2921f2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ServiceAgreementsAndLaboratorySuppliesMember_2cfad46d-1573-49c7-b6e2-9c5c113bcf82" xlink:href="nvta-20201231.xsd#nvta_ServiceAgreementsAndLaboratorySuppliesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_b4d1c95f-c777-486d-a03c-54e0d2921f2e" xlink:to="loc_nvta_ServiceAgreementsAndLaboratorySuppliesMember_2cfad46d-1573-49c7-b6e2-9c5c113bcf82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_258e1e24-3b15-41ae-96dc-e6d5fff78b42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_4d18cad5-a63f-43b1-8d24-50c655800929" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_258e1e24-3b15-41ae-96dc-e6d5fff78b42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_258e1e24-3b15-41ae-96dc-e6d5fff78b42_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_258e1e24-3b15-41ae-96dc-e6d5fff78b42" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_258e1e24-3b15-41ae-96dc-e6d5fff78b42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_74c35bc1-9097-4747-bbb0-cb266ead51e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_258e1e24-3b15-41ae-96dc-e6d5fff78b42" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_74c35bc1-9097-4747-bbb0-cb266ead51e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_OfficeFacilityInSanFranciscoTwoMember_0070324a-478a-48c1-a577-0b37b8fe0225" xlink:href="nvta-20201231.xsd#nvta_OfficeFacilityInSanFranciscoTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_74c35bc1-9097-4747-bbb0-cb266ead51e8" xlink:to="loc_nvta_OfficeFacilityInSanFranciscoTwoMember_0070324a-478a-48c1-a577-0b37b8fe0225" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Stockholdersequity" xlink:type="simple" xlink:href="nvta-20201231.xsd#Stockholdersequity"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/Stockholdersequity" xlink:type="extended" id="i2467e6dfcc8946b39b40863d286c71b6_Stockholdersequity"/>
  <link:roleRef roleURI="http://www.invitae.com/role/StockholdersequityTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockholdersequityTables"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/StockholdersequityTables" xlink:type="extended" id="i4fedb5af4f6c4c2f8e41a813be749626_StockholdersequityTables"/>
  <link:roleRef roleURI="http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails" xlink:type="extended" id="idc2af0199be74d47b1dec41cfde5e011_StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_2efdfb39-a7de-4256-8515-4a7b989f4e05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_2efdfb39-a7de-4256-8515-4a7b989f4e05" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_1d385794-186f-40d4-840e-b6972cd695cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_us-gaap_SharesOutstanding_1d385794-186f-40d4-840e-b6972cd695cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_fde68879-465a-4c66-b030-75d041162403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_fde68879-465a-4c66-b030-75d041162403" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts_e07d6860-a161-4732-ba5d-f188581766ca" xlink:href="nvta-20201231.xsd#nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts_e07d6860-a161-4732-ba5d-f188581766ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ff921297-e2b6-4dc2-a370-b1c354ae41c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ff921297-e2b6-4dc2-a370-b1c354ae41c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6151474e-01ad-4d1a-b642-d1d21981800b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6151474e-01ad-4d1a-b642-d1d21981800b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_f6364c56-1f1b-4c00-be4b-091c9255694a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_f6364c56-1f1b-4c00-be4b-091c9255694a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIssuedDuringPeriodSharesWarrantsExercised_cf961f36-8b4f-4014-adca-cc37c03821a0" xlink:href="nvta-20201231.xsd#nvta_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_nvta_StockIssuedDuringPeriodSharesWarrantsExercised_cf961f36-8b4f-4014-adca-cc37c03821a0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_20dfd430-77f3-43fe-ac22-b432d1c2c1b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_20dfd430-77f3-43fe-ac22-b432d1c2c1b2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_5bbb9898-712b-47c1-bdb9-9c1bd467bc0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_5bbb9898-712b-47c1-bdb9-9c1bd467bc0c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_9ccfdb8c-7cca-445b-922a-f7958d7d2dd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f4c5c5e3-f6c2-419c-b272-898c3d28e0f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_2efdfb39-a7de-4256-8515-4a7b989f4e05" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f4c5c5e3-f6c2-419c-b272-898c3d28e0f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3d5bbbf7-ea45-4bfa-a43e-8404b9c8e9e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f4c5c5e3-f6c2-419c-b272-898c3d28e0f9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3d5bbbf7-ea45-4bfa-a43e-8404b9c8e9e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3d5bbbf7-ea45-4bfa-a43e-8404b9c8e9e9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3d5bbbf7-ea45-4bfa-a43e-8404b9c8e9e9" xlink:to="loc_us-gaap_EquityComponentDomain_3d5bbbf7-ea45-4bfa-a43e-8404b9c8e9e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e4d252a5-9f14-4328-b0b3-63c666ca1ef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3d5bbbf7-ea45-4bfa-a43e-8404b9c8e9e9" xlink:to="loc_us-gaap_EquityComponentDomain_e4d252a5-9f14-4328-b0b3-63c666ca1ef7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_922a56b8-ae95-4757-acdb-ab2b9a0bbba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e4d252a5-9f14-4328-b0b3-63c666ca1ef7" xlink:to="loc_us-gaap_PreferredStockMember_922a56b8-ae95-4757-acdb-ab2b9a0bbba5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0bde0ceb-eedf-443e-93e2-b0d43320e5d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e4d252a5-9f14-4328-b0b3-63c666ca1ef7" xlink:to="loc_us-gaap_CommonStockMember_0bde0ceb-eedf-443e-93e2-b0d43320e5d0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockholdersequityNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockholdersequityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/StockholdersequityNarrativeDetails" xlink:type="extended" id="i8c5938c0fd5146b2a2226a683bcce567_StockholdersequityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_883f0dc8-ffa6-4e76-9583-5b9011c7276d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_883f0dc8-ffa6-4e76-9583-5b9011c7276d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PercentageOfCommissionPayableOnGrossProceeds_481368cf-d055-455f-9bc7-1843e6df2c77" xlink:href="nvta-20201231.xsd#nvta_PercentageOfCommissionPayableOnGrossProceeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_nvta_PercentageOfCommissionPayableOnGrossProceeds_481368cf-d055-455f-9bc7-1843e6df2c77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0e4df902-b99b-495d-9ff0-7ca605d0a650" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0e4df902-b99b-495d-9ff0-7ca605d0a650" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_NetProceedsFromIssuanceOfCommonStock_364d2579-66a1-4021-a26b-bb80f1e8cb41" xlink:href="nvta-20201231.xsd#nvta_NetProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_nvta_NetProceedsFromIssuanceOfCommonStock_364d2579-66a1-4021-a26b-bb80f1e8cb41" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_df2d2420-f157-4a6e-b0c5-866296d04f01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_df2d2420-f157-4a6e-b0c5-866296d04f01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_85db396d-6cf7-4ae5-b693-59b3c207df0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_85db396d-6cf7-4ae5-b693-59b3c207df0a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts_8c003926-c907-4c4c-bc35-5b002c3597fc" xlink:href="nvta-20201231.xsd#nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts_8c003926-c907-4c4c-bc35-5b002c3597fc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_678c3366-9996-476b-9a07-c3c1d7c776ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_678c3366-9996-476b-9a07-c3c1d7c776ce" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2c1a38fb-72b5-447b-a033-2ec297a815d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2c1a38fb-72b5-447b-a033-2ec297a815d7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_NetProceedsFromIssuanceOfPrivatePlacement_4a487c1f-e64b-4695-b61a-51870d434ddc" xlink:href="nvta-20201231.xsd#nvta_NetProceedsFromIssuanceOfPrivatePlacement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_nvta_NetProceedsFromIssuanceOfPrivatePlacement_4a487c1f-e64b-4695-b61a-51870d434ddc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PreferredStockToCommonStockConversionRatio_1aaace8e-119f-4666-b6fd-dfed8aa50cca" xlink:href="nvta-20201231.xsd#nvta_PreferredStockToCommonStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_nvta_PreferredStockToCommonStockConversionRatio_1aaace8e-119f-4666-b6fd-dfed8aa50cca" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_0783adbb-a7c4-4c19-a437-4486c1a150a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_0783adbb-a7c4-4c19-a437-4486c1a150a9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_5e3ccc3a-e63b-48da-af64-c54c2ba47a68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_5e3ccc3a-e63b-48da-af64-c54c2ba47a68" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_10f4f076-bbbf-4afa-9f93-885f941eb6fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_10f4f076-bbbf-4afa-9f93-885f941eb6fa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2162597c-a0fa-4f55-9867-4be1fa0feca5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_srt_RangeAxis_2162597c-a0fa-4f55-9867-4be1fa0feca5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2162597c-a0fa-4f55-9867-4be1fa0feca5_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2162597c-a0fa-4f55-9867-4be1fa0feca5" xlink:to="loc_srt_RangeMember_2162597c-a0fa-4f55-9867-4be1fa0feca5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f903f1ff-50cd-49bc-aebd-152b850caf4a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2162597c-a0fa-4f55-9867-4be1fa0feca5" xlink:to="loc_srt_RangeMember_f903f1ff-50cd-49bc-aebd-152b850caf4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_178ad126-801b-4266-93bd-66b83b04c880" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f903f1ff-50cd-49bc-aebd-152b850caf4a" xlink:to="loc_srt_MaximumMember_178ad126-801b-4266-93bd-66b83b04c880" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_bed87aea-1631-442a-8b1f-ecd68dabbc8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_TransactionTypeAxis_bed87aea-1631-442a-8b1f-ecd68dabbc8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_bed87aea-1631-442a-8b1f-ecd68dabbc8f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TransactionTypeAxis_bed87aea-1631-442a-8b1f-ecd68dabbc8f" xlink:to="loc_us-gaap_TransactionDomain_bed87aea-1631-442a-8b1f-ecd68dabbc8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_f8ef9f56-bad1-484b-b0d8-c2ad3f69d1a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TransactionTypeAxis_bed87aea-1631-442a-8b1f-ecd68dabbc8f" xlink:to="loc_us-gaap_TransactionDomain_f8ef9f56-bad1-484b-b0d8-c2ad3f69d1a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CommonStockSalesAgreementMember_0a215a28-4816-40b6-84c1-37d57ef5a874" xlink:href="nvta-20201231.xsd#nvta_CommonStockSalesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransactionDomain_f8ef9f56-bad1-484b-b0d8-c2ad3f69d1a1" xlink:to="loc_nvta_CommonStockSalesAgreementMember_0a215a28-4816-40b6-84c1-37d57ef5a874" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a401715d-ea56-44bd-9de6-738fb25d18f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a401715d-ea56-44bd-9de6-738fb25d18f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a401715d-ea56-44bd-9de6-738fb25d18f5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a401715d-ea56-44bd-9de6-738fb25d18f5" xlink:to="loc_us-gaap_RelatedPartyDomain_a401715d-ea56-44bd-9de6-738fb25d18f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9fd3992d-3ccc-482c-82bd-7f3c708bdad5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a401715d-ea56-44bd-9de6-738fb25d18f5" xlink:to="loc_us-gaap_RelatedPartyDomain_9fd3992d-3ccc-482c-82bd-7f3c708bdad5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CowenAndCompanyLimitedLiabilityCompanyMember_0dffa000-716e-42dd-8219-e132be045817" xlink:href="nvta-20201231.xsd#nvta_CowenAndCompanyLimitedLiabilityCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_9fd3992d-3ccc-482c-82bd-7f3c708bdad5" xlink:to="loc_nvta_CowenAndCompanyLimitedLiabilityCompanyMember_0dffa000-716e-42dd-8219-e132be045817" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_996bdf27-2415-4cbe-81d6-de74a8c14598" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_996bdf27-2415-4cbe-81d6-de74a8c14598" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_996bdf27-2415-4cbe-81d6-de74a8c14598_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_996bdf27-2415-4cbe-81d6-de74a8c14598" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_996bdf27-2415-4cbe-81d6-de74a8c14598_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_90498d30-5237-4731-88aa-e413100c0e89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_996bdf27-2415-4cbe-81d6-de74a8c14598" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_90498d30-5237-4731-88aa-e413100c0e89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_UnderwrittenPublicOfferingMember_43b0a19c-7c2a-4f10-af73-f470089c9042" xlink:href="nvta-20201231.xsd#nvta_UnderwrittenPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_90498d30-5237-4731-88aa-e413100c0e89" xlink:to="loc_nvta_UnderwrittenPublicOfferingMember_43b0a19c-7c2a-4f10-af73-f470089c9042" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_8791c064-e35e-4f84-95a8-b39327f60727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_90498d30-5237-4731-88aa-e413100c0e89" xlink:to="loc_us-gaap_PrivatePlacementMember_8791c064-e35e-4f84-95a8-b39327f60727" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ee9f8e4e-8dc4-47ed-bc3a-0f47c8c2463b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ee9f8e4e-8dc4-47ed-bc3a-0f47c8c2463b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ee9f8e4e-8dc4-47ed-bc3a-0f47c8c2463b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ee9f8e4e-8dc4-47ed-bc3a-0f47c8c2463b" xlink:to="loc_us-gaap_EquityComponentDomain_ee9f8e4e-8dc4-47ed-bc3a-0f47c8c2463b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b5264ab0-0aea-47df-8dc0-78a484f434a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ee9f8e4e-8dc4-47ed-bc3a-0f47c8c2463b" xlink:to="loc_us-gaap_EquityComponentDomain_b5264ab0-0aea-47df-8dc0-78a484f434a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_303330b9-c42f-4f66-ba7e-09708fb86cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b5264ab0-0aea-47df-8dc0-78a484f434a4" xlink:to="loc_us-gaap_CommonStockMember_303330b9-c42f-4f66-ba7e-09708fb86cba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3337283c-dac6-44ea-9405-270daff0903b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3337283c-dac6-44ea-9405-270daff0903b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3337283c-dac6-44ea-9405-270daff0903b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3337283c-dac6-44ea-9405-270daff0903b" xlink:to="loc_us-gaap_ClassOfStockDomain_3337283c-dac6-44ea-9405-270daff0903b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c26772dc-5a53-43a8-9779-426aaf2c0cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3337283c-dac6-44ea-9405-270daff0903b" xlink:to="loc_us-gaap_ClassOfStockDomain_c26772dc-5a53-43a8-9779-426aaf2c0cec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_7bd4973f-eb00-4c23-b008-0849f563d19a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c26772dc-5a53-43a8-9779-426aaf2c0cec" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_7bd4973f-eb00-4c23-b008-0849f563d19a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_e8b62dc7-243b-4558-9567-dbfe8b91ecae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_e8b62dc7-243b-4558-9567-dbfe8b91ecae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_e8b62dc7-243b-4558-9567-dbfe8b91ecae_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_e8b62dc7-243b-4558-9567-dbfe8b91ecae" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_e8b62dc7-243b-4558-9567-dbfe8b91ecae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_306cbb78-0737-471a-ac4d-2bc3d60eebb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_e8b62dc7-243b-4558-9567-dbfe8b91ecae" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_306cbb78-0737-471a-ac4d-2bc3d60eebb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember_5c31dde2-4080-4bfe-a804-473a1f30d31e" xlink:href="nvta-20201231.xsd#nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_306cbb78-0737-471a-ac4d-2bc3d60eebb8" xlink:to="loc_nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember_5c31dde2-4080-4bfe-a804-473a1f30d31e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_889e5e8e-3675-4767-8ae2-8180ae101cfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_889e5e8e-3675-4767-8ae2-8180ae101cfc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_889e5e8e-3675-4767-8ae2-8180ae101cfc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_889e5e8e-3675-4767-8ae2-8180ae101cfc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_889e5e8e-3675-4767-8ae2-8180ae101cfc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7434cec-f9c2-4776-8f8b-dd506d097c9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_889e5e8e-3675-4767-8ae2-8180ae101cfc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7434cec-f9c2-4776-8f8b-dd506d097c9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_babbf5f5-0586-4fb8-bf33-5833786929ef" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7434cec-f9c2-4776-8f8b-dd506d097c9c" xlink:to="loc_nvta_ArcherDXInc.Member_babbf5f5-0586-4fb8-bf33-5833786929ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_47c2be3d-0ada-4fb2-a7d4-536b06eab4c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_47c2be3d-0ada-4fb2-a7d4-536b06eab4c5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_47c2be3d-0ada-4fb2-a7d4-536b06eab4c5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_47c2be3d-0ada-4fb2-a7d4-536b06eab4c5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_47c2be3d-0ada-4fb2-a7d4-536b06eab4c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d84152d1-c2af-4fa3-ba77-cfa7124306d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_47c2be3d-0ada-4fb2-a7d4-536b06eab4c5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d84152d1-c2af-4fa3-ba77-cfa7124306d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f7732624-2330-4939-83e1-9f65be7a3bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d84152d1-c2af-4fa3-ba77-cfa7124306d6" xlink:to="loc_us-gaap_SubsequentEventMember_f7732624-2330-4939-83e1-9f65be7a3bf8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails" xlink:type="extended" id="i5507792d48c140f7aa6070ca7b500863_StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_fe295c09-ce18-4505-802c-deb2662538ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_98137e31-7f30-4ddc-8c2f-18a0ef86a50e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_fe295c09-ce18-4505-802c-deb2662538ad" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_98137e31-7f30-4ddc-8c2f-18a0ef86a50e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_5c87fb88-1122-413f-861e-f088ec4b294e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_fe295c09-ce18-4505-802c-deb2662538ad" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_5c87fb88-1122-413f-861e-f088ec4b294e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_d048ca68-caef-4015-9e6a-1611c3a50bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_fe295c09-ce18-4505-802c-deb2662538ad" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_d048ca68-caef-4015-9e6a-1611c3a50bb6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_56d01603-7ffa-4c83-b126-929b0f57190d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_d048ca68-caef-4015-9e6a-1611c3a50bb6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_56d01603-7ffa-4c83-b126-929b0f57190d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_56d01603-7ffa-4c83-b126-929b0f57190d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_56d01603-7ffa-4c83-b126-929b0f57190d" xlink:to="loc_us-gaap_EquityComponentDomain_56d01603-7ffa-4c83-b126-929b0f57190d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9caf43ab-899e-4378-893f-1a9d55de2b86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_56d01603-7ffa-4c83-b126-929b0f57190d" xlink:to="loc_us-gaap_EquityComponentDomain_9caf43ab-899e-4378-893f-1a9d55de2b86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_114b67f5-a125-41ad-9ded-d6a0fb2259c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9caf43ab-899e-4378-893f-1a9d55de2b86" xlink:to="loc_us-gaap_CommonStockMember_114b67f5-a125-41ad-9ded-d6a0fb2259c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fd600b3f-73ed-43de-b0d6-7f4b3760401b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_d048ca68-caef-4015-9e6a-1611c3a50bb6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fd600b3f-73ed-43de-b0d6-7f4b3760401b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd600b3f-73ed-43de-b0d6-7f4b3760401b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fd600b3f-73ed-43de-b0d6-7f4b3760401b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd600b3f-73ed-43de-b0d6-7f4b3760401b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd658bb9-9d92-4c87-be5f-b76c926cb695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fd600b3f-73ed-43de-b0d6-7f4b3760401b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd658bb9-9d92-4c87-be5f-b76c926cb695" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CombiMatrixCorporationMember_4d88314b-3767-4a21-b81d-aa915e153288" xlink:href="nvta-20201231.xsd#nvta_CombiMatrixCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd658bb9-9d92-4c87-be5f-b76c926cb695" xlink:to="loc_nvta_CombiMatrixCorporationMember_4d88314b-3767-4a21-b81d-aa915e153288" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_666087dd-6ddd-460a-a87b-9eb44ccd2e88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_d048ca68-caef-4015-9e6a-1611c3a50bb6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_666087dd-6ddd-460a-a87b-9eb44ccd2e88" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_666087dd-6ddd-460a-a87b-9eb44ccd2e88_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_666087dd-6ddd-460a-a87b-9eb44ccd2e88" xlink:to="loc_us-gaap_ClassOfStockDomain_666087dd-6ddd-460a-a87b-9eb44ccd2e88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e5f788e6-c8d8-4f57-bef4-5e6e2efa22e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_666087dd-6ddd-460a-a87b-9eb44ccd2e88" xlink:to="loc_us-gaap_ClassOfStockDomain_e5f788e6-c8d8-4f57-bef4-5e6e2efa22e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SeriesFWarrantsMember_5a404382-6cd1-466e-8e60-d6361f7af7c7" xlink:href="nvta-20201231.xsd#nvta_SeriesFWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e5f788e6-c8d8-4f57-bef4-5e6e2efa22e8" xlink:to="loc_nvta_SeriesFWarrantsMember_5a404382-6cd1-466e-8e60-d6361f7af7c7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Stockincentiveplans" xlink:type="simple" xlink:href="nvta-20201231.xsd#Stockincentiveplans"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/Stockincentiveplans" xlink:type="extended" id="i773c6d50838b40968d95b408eb2e4a44_Stockincentiveplans"/>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansTables"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/StockincentiveplansTables" xlink:type="extended" id="i7381a054cb62475db18e00599cbfee67_StockincentiveplansTables"/>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails" xlink:type="extended" id="ia4ed424f593340ab98ee1c022e789d9b_StockincentiveplansAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage_b5d893f0-daa5-4feb-bea0-943ac43382ba" xlink:href="nvta-20201231.xsd#nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage_b5d893f0-daa5-4feb-bea0-943ac43382ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4a00ce28-d0ab-4593-887b-a0e080a9c27a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4a00ce28-d0ab-4593-887b-a0e080a9c27a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_9621c987-cb3f-4f69-93e4-cdb5969beb35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_9621c987-cb3f-4f69-93e4-cdb5969beb35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_183996da-1f89-4ced-8e04-75d7cf9d5dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_183996da-1f89-4ced-8e04-75d7cf9d5dc7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage_046062ee-2e3c-4447-8e5f-26b57f55df51" xlink:href="nvta-20201231.xsd#nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage_046062ee-2e3c-4447-8e5f-26b57f55df51" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e098219a-a851-4d84-af3a-ca64644d4eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e098219a-a851-4d84-af3a-ca64644d4eda" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_97f7f0d2-d53e-40af-9f6c-5ab4eee5c4e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_97f7f0d2-d53e-40af-9f6c-5ab4eee5c4e3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ab252635-5fad-4150-ace3-2c848d9842ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ab252635-5fad-4150-ace3-2c848d9842ba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f6e9abc8-492c-4b8e-9c4c-c325e168967e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f6e9abc8-492c-4b8e-9c4c-c325e168967e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_dea54389-bdd3-4a14-9149-3e137bacbca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_dea54389-bdd3-4a14-9149-3e137bacbca6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_aead4f5d-f3db-4dde-b90a-4d6f3a500a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_aead4f5d-f3db-4dde-b90a-4d6f3a500a1d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_fd6087fd-c121-4a40-a11e-326bc9457b97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_fd6087fd-c121-4a40-a11e-326bc9457b97" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a861bb62-8f10-4378-891c-169d17ee177f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a861bb62-8f10-4378-891c-169d17ee177f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_a360ca8d-4a51-486f-992e-72e0b450caf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_a360ca8d-4a51-486f-992e-72e0b450caf8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9482cbb3-926b-465c-b07e-62aab52b8f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9482cbb3-926b-465c-b07e-62aab52b8f7f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_b08bc896-fc7c-47a8-9d82-998d2c2a3be1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_b08bc896-fc7c-47a8-9d82-998d2c2a3be1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_9d38c17b-6ca3-46a1-9568-eec6a79c13f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_ProceedsFromStockPlans_9d38c17b-6ca3-46a1-9568-eec6a79c13f7" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8853ab7f-bdf0-49fc-be6e-85826ef76c70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8853ab7f-bdf0-49fc-be6e-85826ef76c70" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9f7adb71-7537-4371-867c-19df742e5251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9f7adb71-7537-4371-867c-19df742e5251" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69a20c7c-b017-4a36-8f64-c57cb83aeafa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69a20c7c-b017-4a36-8f64-c57cb83aeafa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1924a3e2-1e05-4caa-b873-3e77e7685a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69a20c7c-b017-4a36-8f64-c57cb83aeafa" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1924a3e2-1e05-4caa-b873-3e77e7685a86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1924a3e2-1e05-4caa-b873-3e77e7685a86_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1924a3e2-1e05-4caa-b873-3e77e7685a86" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1924a3e2-1e05-4caa-b873-3e77e7685a86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad13c9e-289c-424f-b6a4-b2d3b05181ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1924a3e2-1e05-4caa-b873-3e77e7685a86" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad13c9e-289c-424f-b6a4-b2d3b05181ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SingularBioMember_c2dddc27-0c42-40d0-bae7-26bf5e3f98c2" xlink:href="nvta-20201231.xsd#nvta_SingularBioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad13c9e-289c-424f-b6a4-b2d3b05181ac" xlink:to="loc_nvta_SingularBioMember_c2dddc27-0c42-40d0-bae7-26bf5e3f98c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_a49b0f01-f79f-4138-b06b-6fa9991557d1" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad13c9e-289c-424f-b6a4-b2d3b05181ac" xlink:to="loc_nvta_ArcherDXInc.Member_a49b0f01-f79f-4138-b06b-6fa9991557d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_53f8dc3a-a234-4ce7-b890-b16dcc183226" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69a20c7c-b017-4a36-8f64-c57cb83aeafa" xlink:to="loc_srt_RangeAxis_53f8dc3a-a234-4ce7-b890-b16dcc183226" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_53f8dc3a-a234-4ce7-b890-b16dcc183226_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_53f8dc3a-a234-4ce7-b890-b16dcc183226" xlink:to="loc_srt_RangeMember_53f8dc3a-a234-4ce7-b890-b16dcc183226_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5c6e5b4d-7071-4406-a207-f2491bc2ba81" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_53f8dc3a-a234-4ce7-b890-b16dcc183226" xlink:to="loc_srt_RangeMember_5c6e5b4d-7071-4406-a207-f2491bc2ba81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d46bdf81-5fd6-42a5-b04a-d4d3f7b6d878" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5c6e5b4d-7071-4406-a207-f2491bc2ba81" xlink:to="loc_srt_MinimumMember_d46bdf81-5fd6-42a5-b04a-d4d3f7b6d878" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8a75bc11-fc86-465e-a2c0-d7507ac335f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5c6e5b4d-7071-4406-a207-f2491bc2ba81" xlink:to="loc_srt_MaximumMember_8a75bc11-fc86-465e-a2c0-d7507ac335f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_299cd292-ece2-4d35-96b6-1e51d19377da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69a20c7c-b017-4a36-8f64-c57cb83aeafa" xlink:to="loc_us-gaap_PlanNameAxis_299cd292-ece2-4d35-96b6-1e51d19377da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_299cd292-ece2-4d35-96b6-1e51d19377da_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_299cd292-ece2-4d35-96b6-1e51d19377da" xlink:to="loc_us-gaap_PlanNameDomain_299cd292-ece2-4d35-96b6-1e51d19377da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_80ce3aff-eaf0-4eb4-ba51-d8332f64a20c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_299cd292-ece2-4d35-96b6-1e51d19377da" xlink:to="loc_us-gaap_PlanNameDomain_80ce3aff-eaf0-4eb4-ba51-d8332f64a20c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIncentivePlan2010Member_052703e1-e89d-46f2-b137-507cb4710808" xlink:href="nvta-20201231.xsd#nvta_StockIncentivePlan2010Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_80ce3aff-eaf0-4eb4-ba51-d8332f64a20c" xlink:to="loc_nvta_StockIncentivePlan2010Member_052703e1-e89d-46f2-b137-507cb4710808" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIncentivePlanMember_48f80269-19a3-424c-8154-564b3a4e8cb0" xlink:href="nvta-20201231.xsd#nvta_StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_80ce3aff-eaf0-4eb4-ba51-d8332f64a20c" xlink:to="loc_nvta_StockIncentivePlanMember_48f80269-19a3-424c-8154-564b3a4e8cb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_A2019IncentiveCompensationPlanMember_ffa67554-d323-4a51-81f3-9725e67d674c" xlink:href="nvta-20201231.xsd#nvta_A2019IncentiveCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_80ce3aff-eaf0-4eb4-ba51-d8332f64a20c" xlink:to="loc_nvta_A2019IncentiveCompensationPlanMember_ffa67554-d323-4a51-81f3-9725e67d674c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_EmployeeStockPurchasePlan2015Member_70d1ef21-0e2a-420f-86fd-34a8d0e6e98c" xlink:href="nvta-20201231.xsd#nvta_EmployeeStockPurchasePlan2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_80ce3aff-eaf0-4eb4-ba51-d8332f64a20c" xlink:to="loc_nvta_EmployeeStockPurchasePlan2015Member_70d1ef21-0e2a-420f-86fd-34a8d0e6e98c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ea510d1b-2331-41bc-b6ca-c9444204a835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69a20c7c-b017-4a36-8f64-c57cb83aeafa" xlink:to="loc_us-gaap_AwardTypeAxis_ea510d1b-2331-41bc-b6ca-c9444204a835" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ea510d1b-2331-41bc-b6ca-c9444204a835_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ea510d1b-2331-41bc-b6ca-c9444204a835" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ea510d1b-2331-41bc-b6ca-c9444204a835_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8309344-e620-4aa2-a6e9-6411d09951a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ea510d1b-2331-41bc-b6ca-c9444204a835" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8309344-e620-4aa2-a6e9-6411d09951a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1933d568-96f1-4de0-919e-7f9f54d66860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8309344-e620-4aa2-a6e9-6411d09951a9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1933d568-96f1-4de0-919e-7f9f54d66860" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_38db4b63-6f68-4eb6-8971-f9c00b28e828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8309344-e620-4aa2-a6e9-6411d09951a9" xlink:to="loc_us-gaap_PerformanceSharesMember_38db4b63-6f68-4eb6-8971-f9c00b28e828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_baec5fe4-e62a-45fc-835d-c5f08eb5b231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8309344-e620-4aa2-a6e9-6411d09951a9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_baec5fe4-e62a-45fc-835d-c5f08eb5b231" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails" xlink:type="extended" id="id778d4aa0f71419d8f3b0b545f9b56bb_StockincentiveplansScheduleofactivityunderstockincentiveplansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_bb78ee6b-6d6f-4f5c-b6ac-98b3fa8cf411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_bb78ee6b-6d6f-4f5c-b6ac-98b3fa8cf411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d4a8fda1-409b-43a0-9e68-e747594a4316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d4a8fda1-409b-43a0-9e68-e747594a4316" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_cf9ad869-8d32-45b8-9133-11ab2d596958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_cf9ad869-8d32-45b8-9133-11ab2d596958" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ebb9f236-3788-48e1-9568-7cfaccc71639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ebb9f236-3788-48e1-9568-7cfaccc71639" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4e3fef15-f102-4484-9050-22167e0a91ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4e3fef15-f102-4484-9050-22167e0a91ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2b74c435-7a99-49d4-976e-b90377105354" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2b74c435-7a99-49d4-976e-b90377105354" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_19c1c03c-42ce-4676-88d7-64d6539c7be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_19c1c03c-42ce-4676-88d7-64d6539c7be0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1726c64e-8627-47e2-9ffe-db1b34176172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1726c64e-8627-47e2-9ffe-db1b34176172" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_cb19d4d4-738e-49d7-bdbd-7f9bb98c7bb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dd9ee9ae-6dc2-4ba4-9fe0-19b799292c1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_7a130d83-fc06-40cd-a262-c570146d54ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_7a130d83-fc06-40cd-a262-c570146d54ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_43816dbf-b615-43e1-a591-fe266e5eae7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_43816dbf-b615-43e1-a591-fe266e5eae7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd11213c-dbdc-4e51-9905-7c652f86f8a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd11213c-dbdc-4e51-9905-7c652f86f8a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cc663a16-0d4c-4ca3-b6d0-9e0c5302ea07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd11213c-dbdc-4e51-9905-7c652f86f8a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cc663a16-0d4c-4ca3-b6d0-9e0c5302ea07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_85afa697-3e89-4150-9c91-2029b2102707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd11213c-dbdc-4e51-9905-7c652f86f8a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_85afa697-3e89-4150-9c91-2029b2102707" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_cfad267b-6e00-42e8-acb9-f440bac57be4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd11213c-dbdc-4e51-9905-7c652f86f8a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_cfad267b-6e00-42e8-acb9-f440bac57be4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d51518ed-aa73-4410-8bf9-67146e2f7880" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd11213c-dbdc-4e51-9905-7c652f86f8a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d51518ed-aa73-4410-8bf9-67146e2f7880" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_295b5379-4793-4a70-960e-967b07a9c5d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_83fb2b19-5a71-4c81-87f2-e94dc450f01b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_83fb2b19-5a71-4c81-87f2-e94dc450f01b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_a69eb7b9-1b8a-4bfe-b33c-b9a7cfc4e2df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_a69eb7b9-1b8a-4bfe-b33c-b9a7cfc4e2df" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dc6d887b-9b0f-4111-a06e-e2958a8fe62b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dc6d887b-9b0f-4111-a06e-e2958a8fe62b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a8b5fe80-26ee-4046-8933-dd14b3836adc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a8b5fe80-26ee-4046-8933-dd14b3836adc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_43fbdb2a-0ac5-42d0-9b5e-7ec518bb8ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_43fbdb2a-0ac5-42d0-9b5e-7ec518bb8ff7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1b0d854b-f63d-4f9d-a119-3ba7377e4da7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1b0d854b-f63d-4f9d-a119-3ba7377e4da7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4677303e-e14c-4cbd-8b66-cba84d8a395f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4677303e-e14c-4cbd-8b66-cba84d8a395f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_015c3866-1d12-4696-817e-9131bf78ba14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_015c3866-1d12-4696-817e-9131bf78ba14" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c48d814-1ac6-4f60-97ee-5cc69080ca03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c48d814-1ac6-4f60-97ee-5cc69080ca03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0f3e1da8-c8c7-4fe4-86e9-1423cf677b35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c48d814-1ac6-4f60-97ee-5cc69080ca03" xlink:to="loc_us-gaap_PlanNameAxis_0f3e1da8-c8c7-4fe4-86e9-1423cf677b35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0f3e1da8-c8c7-4fe4-86e9-1423cf677b35_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_0f3e1da8-c8c7-4fe4-86e9-1423cf677b35" xlink:to="loc_us-gaap_PlanNameDomain_0f3e1da8-c8c7-4fe4-86e9-1423cf677b35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_164ddd17-d31a-463f-9d34-ac680ef9f685" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_0f3e1da8-c8c7-4fe4-86e9-1423cf677b35" xlink:to="loc_us-gaap_PlanNameDomain_164ddd17-d31a-463f-9d34-ac680ef9f685" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIncentivePlanMember_04af669c-fdae-4bf0-a820-b9bdabc2d1bd" xlink:href="nvta-20201231.xsd#nvta_StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_164ddd17-d31a-463f-9d34-ac680ef9f685" xlink:to="loc_nvta_StockIncentivePlanMember_04af669c-fdae-4bf0-a820-b9bdabc2d1bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fc144518-8d49-44d0-9f2b-1b6dfb9f96fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c48d814-1ac6-4f60-97ee-5cc69080ca03" xlink:to="loc_us-gaap_AwardTypeAxis_fc144518-8d49-44d0-9f2b-1b6dfb9f96fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fc144518-8d49-44d0-9f2b-1b6dfb9f96fc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_fc144518-8d49-44d0-9f2b-1b6dfb9f96fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fc144518-8d49-44d0-9f2b-1b6dfb9f96fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_318b33c9-5a03-4aba-9ca1-b7db9eccc1b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_fc144518-8d49-44d0-9f2b-1b6dfb9f96fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_318b33c9-5a03-4aba-9ca1-b7db9eccc1b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bbb7addb-0fb9-4f63-a9ea-d6553e86f8e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_318b33c9-5a03-4aba-9ca1-b7db9eccc1b0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bbb7addb-0fb9-4f63-a9ea-d6553e86f8e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RSUsAndPRSUsMember_e8734b7e-0014-499d-aef9-da2920111ad3" xlink:href="nvta-20201231.xsd#nvta_RSUsAndPRSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_318b33c9-5a03-4aba-9ca1-b7db9eccc1b0" xlink:to="loc_nvta_RSUsAndPRSUsMember_e8734b7e-0014-499d-aef9-da2920111ad3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansSummaryofRSUactivityDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails" xlink:type="extended" id="i6b312b9aaa60446eb5befd2d8cac1738_StockincentiveplansSummaryofRSUactivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d924ed5-d8a2-44a7-b7ed-c1f91c3430a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_24a73169-70f6-4ce2-89e0-4b9be4e071bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d924ed5-d8a2-44a7-b7ed-c1f91c3430a8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_24a73169-70f6-4ce2-89e0-4b9be4e071bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d6a60d94-3612-4b3e-b54a-5ff92d2fdd67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_24a73169-70f6-4ce2-89e0-4b9be4e071bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d6a60d94-3612-4b3e-b54a-5ff92d2fdd67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbff86aa-211f-48dd-9716-cfca7ca56b4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_24a73169-70f6-4ce2-89e0-4b9be4e071bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbff86aa-211f-48dd-9716-cfca7ca56b4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod_d765d9c2-721e-4d26-af32-adbc76775888" xlink:href="nvta-20201231.xsd#nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_24a73169-70f6-4ce2-89e0-4b9be4e071bd" xlink:to="loc_nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod_d765d9c2-721e-4d26-af32-adbc76775888" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2b5234b9-7c25-4f2d-9b80-3c01c49840f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_24a73169-70f6-4ce2-89e0-4b9be4e071bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2b5234b9-7c25-4f2d-9b80-3c01c49840f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_041b4605-c2a7-408d-b1c7-3b8a43138802" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_24a73169-70f6-4ce2-89e0-4b9be4e071bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_041b4605-c2a7-408d-b1c7-3b8a43138802" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dd6a846f-c251-4894-ac1a-10326ba49e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91ab7212-ca9c-401b-a05b-a4d36506aaa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d924ed5-d8a2-44a7-b7ed-c1f91c3430a8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91ab7212-ca9c-401b-a05b-a4d36506aaa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_064aedac-e694-4708-b194-7b0edf740bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91ab7212-ca9c-401b-a05b-a4d36506aaa2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_064aedac-e694-4708-b194-7b0edf740bfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_447177e3-2216-4c72-9beb-824e0e92bc4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91ab7212-ca9c-401b-a05b-a4d36506aaa2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_447177e3-2216-4c72-9beb-824e0e92bc4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5a4ac622-7d15-4d09-9e64-30d26df8a30a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91ab7212-ca9c-401b-a05b-a4d36506aaa2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5a4ac622-7d15-4d09-9e64-30d26df8a30a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e77a1ae2-e7fe-44fe-82da-79cfadc14b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91ab7212-ca9c-401b-a05b-a4d36506aaa2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e77a1ae2-e7fe-44fe-82da-79cfadc14b47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b741d246-527a-4c6f-b389-3cff8befe788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b511f7c-b6b1-4e0d-b2a7-c70b6a28ccad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d924ed5-d8a2-44a7-b7ed-c1f91c3430a8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b511f7c-b6b1-4e0d-b2a7-c70b6a28ccad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_17e3afd0-af91-4fd9-9643-6ab46d5d6340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b511f7c-b6b1-4e0d-b2a7-c70b6a28ccad" xlink:to="loc_us-gaap_AwardTypeAxis_17e3afd0-af91-4fd9-9643-6ab46d5d6340" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_17e3afd0-af91-4fd9-9643-6ab46d5d6340_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_17e3afd0-af91-4fd9-9643-6ab46d5d6340" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_17e3afd0-af91-4fd9-9643-6ab46d5d6340_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3013b369-3620-4f8b-86be-0341629aad3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_17e3afd0-af91-4fd9-9643-6ab46d5d6340" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3013b369-3620-4f8b-86be-0341629aad3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_43e14d6a-fa17-4669-939c-68d6273ae1f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3013b369-3620-4f8b-86be-0341629aad3f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_43e14d6a-fa17-4669-939c-68d6273ae1f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_TimebasedRSUsandPRSUsMember_66af8443-8c0e-43e1-a197-e4d451d71d8a" xlink:href="nvta-20201231.xsd#nvta_TimebasedRSUsandPRSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3013b369-3620-4f8b-86be-0341629aad3f" xlink:to="loc_nvta_TimebasedRSUsandPRSUsMember_66af8443-8c0e-43e1-a197-e4d451d71d8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_507c5dce-a994-4cc9-a985-ce21b18a85ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3013b369-3620-4f8b-86be-0341629aad3f" xlink:to="loc_us-gaap_PerformanceSharesMember_507c5dce-a994-4cc9-a985-ce21b18a85ee" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails" xlink:type="extended" id="i956301d6173940338fcafc4612d33f92_StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4448662c-4608-4d62-a948-60575e529e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b9e8f2ad-b288-4ca8-93b2-6bfc4ef8e9dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4448662c-4608-4d62-a948-60575e529e51" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b9e8f2ad-b288-4ca8-93b2-6bfc4ef8e9dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5122bba0-e931-40c4-b040-e4c07d58f833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4448662c-4608-4d62-a948-60575e529e51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5122bba0-e931-40c4-b040-e4c07d58f833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0bccfc02-62e5-42e0-8a7f-4e7a1cc2b192" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4448662c-4608-4d62-a948-60575e529e51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0bccfc02-62e5-42e0-8a7f-4e7a1cc2b192" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e73af7b6-2dd3-4922-a916-7376e5d39240" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4448662c-4608-4d62-a948-60575e529e51" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e73af7b6-2dd3-4922-a916-7376e5d39240" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_8df539b2-80e6-431c-b383-9bfefaa0af45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e73af7b6-2dd3-4922-a916-7376e5d39240" xlink:to="loc_us-gaap_PlanNameAxis_8df539b2-80e6-431c-b383-9bfefaa0af45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8df539b2-80e6-431c-b383-9bfefaa0af45_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_8df539b2-80e6-431c-b383-9bfefaa0af45" xlink:to="loc_us-gaap_PlanNameDomain_8df539b2-80e6-431c-b383-9bfefaa0af45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ee4b9eb2-e9f5-4e6b-b323-071c0d9df8e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_8df539b2-80e6-431c-b383-9bfefaa0af45" xlink:to="loc_us-gaap_PlanNameDomain_ee4b9eb2-e9f5-4e6b-b323-071c0d9df8e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_EmployeeStockPurchasePlan2015Member_877c021b-5642-442c-9fca-310c981c5787" xlink:href="nvta-20201231.xsd#nvta_EmployeeStockPurchasePlan2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_ee4b9eb2-e9f5-4e6b-b323-071c0d9df8e4" xlink:to="loc_nvta_EmployeeStockPurchasePlan2015Member_877c021b-5642-442c-9fca-310c981c5787" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_588ce155-1023-4c20-8e82-47906b62fc5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e73af7b6-2dd3-4922-a916-7376e5d39240" xlink:to="loc_us-gaap_AwardTypeAxis_588ce155-1023-4c20-8e82-47906b62fc5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_588ce155-1023-4c20-8e82-47906b62fc5e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_588ce155-1023-4c20-8e82-47906b62fc5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_588ce155-1023-4c20-8e82-47906b62fc5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5fe0417-e6ae-4c17-86c5-e4a59dcb2659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_588ce155-1023-4c20-8e82-47906b62fc5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5fe0417-e6ae-4c17-86c5-e4a59dcb2659" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a6b8739d-54ce-4254-aa6c-3977b987f493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5fe0417-e6ae-4c17-86c5-e4a59dcb2659" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a6b8739d-54ce-4254-aa6c-3977b987f493" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansStockbasedcompensationexpenseDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails" xlink:type="extended" id="ie51fa56cbc1d4a5699764454914c2276_StockincentiveplansStockbasedcompensationexpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a4057a09-67ce-45b3-a43c-92085afb0fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_185414e3-a146-4b59-88f5-22b2937be2de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a4057a09-67ce-45b3-a43c-92085afb0fb3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_185414e3-a146-4b59-88f5-22b2937be2de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_7ea4268f-bc6f-47a8-bec6-3ed505d8d13f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a4057a09-67ce-45b3-a43c-92085afb0fb3" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_7ea4268f-bc6f-47a8-bec6-3ed505d8d13f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_689c5e82-df09-4f39-b731-1750973d2d5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_7ea4268f-bc6f-47a8-bec6-3ed505d8d13f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_689c5e82-df09-4f39-b731-1750973d2d5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_689c5e82-df09-4f39-b731-1750973d2d5d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_689c5e82-df09-4f39-b731-1750973d2d5d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_689c5e82-df09-4f39-b731-1750973d2d5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_314f4316-1731-449f-975a-5df316b1292c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_689c5e82-df09-4f39-b731-1750973d2d5d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_314f4316-1731-449f-975a-5df316b1292c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CostOfTestRevenueMember_c117acbe-e9d1-49b0-abad-a2843a0b2cea" xlink:href="nvta-20201231.xsd#nvta_CostOfTestRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_314f4316-1731-449f-975a-5df316b1292c" xlink:to="loc_nvta_CostOfTestRevenueMember_c117acbe-e9d1-49b0-abad-a2843a0b2cea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ResearchAndDevelopmentMember_6c888c7f-bbbd-4341-9723-9cc88039ae18" xlink:href="nvta-20201231.xsd#nvta_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_314f4316-1731-449f-975a-5df316b1292c" xlink:to="loc_nvta_ResearchAndDevelopmentMember_6c888c7f-bbbd-4341-9723-9cc88039ae18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_490b6677-01b1-4a6f-b120-c5c83e2a4375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_314f4316-1731-449f-975a-5df316b1292c" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_490b6677-01b1-4a6f-b120-c5c83e2a4375" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1a1a1ea5-e6bf-41cd-9799-f611d0a32b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_314f4316-1731-449f-975a-5df316b1292c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1a1a1ea5-e6bf-41cd-9799-f611d0a32b91" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Incometaxes" xlink:type="simple" xlink:href="nvta-20201231.xsd#Incometaxes"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/Incometaxes" xlink:type="extended" id="i8b43bc0b80e34d75ac857b75d4e30bf9_Incometaxes"/>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesTables"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/IncometaxesTables" xlink:type="extended" id="ic15feee93daf4853a84b70e1bae26ffe_IncometaxesTables"/>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails" xlink:type="extended" id="i7245442b9b2247f8b654cee1f269ef08_IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails" xlink:type="extended" id="i5031ffdbd5294ea4808d88cef9bf940a_IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails" xlink:type="extended" id="iaeb102d954f64ae09ea47be4e60dfd7b_IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesScheduleofnetdeferredtaxassetsDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails" xlink:type="extended" id="ic375259ef6fe4dd08dfd9ee12bcd6251_IncometaxesScheduleofnetdeferredtaxassetsDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/IncometaxesNarrativeDetails" xlink:type="extended" id="i7e533f2c216a4ba1ab64e0ea6ced8db3_IncometaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense_4b99c336-b741-4266-b05e-2beb1674c8f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense_4b99c336-b741-4266-b05e-2beb1674c8f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets_de7bd999-ddca-4ec7-bf8c-21e929d3bb3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:to="loc_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets_de7bd999-ddca-4ec7-bf8c-21e929d3bb3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_76253b58-0c56-4508-a19f-9aaa154e7807" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_76253b58-0c56-4508-a19f-9aaa154e7807" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_22623fda-6496-4681-8dbb-5550e4bf5ba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:to="loc_us-gaap_OperatingLossCarryforwards_22623fda-6496-4681-8dbb-5550e4bf5ba4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_7dbacf3b-f715-485d-acb8-00cf4e736439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_7dbacf3b-f715-485d-acb8-00cf4e736439" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_b70ed094-f0f3-40d1-a603-a9fc548bb978" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_b70ed094-f0f3-40d1-a603-a9fc548bb978" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination_0325e4fe-3526-46ec-9e7a-4b62e2a152d0" xlink:href="nvta-20201231.xsd#nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:to="loc_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination_0325e4fe-3526-46ec-9e7a-4b62e2a152d0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_adf4eec2-ce50-41fc-8381-77525c31ed79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_adf4eec2-ce50-41fc-8381-77525c31ed79" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_d46a8705-d527-4aad-a39e-68bcf0ec3bef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_adf4eec2-ce50-41fc-8381-77525c31ed79" xlink:to="loc_us-gaap_TaxPeriodAxis_d46a8705-d527-4aad-a39e-68bcf0ec3bef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_d46a8705-d527-4aad-a39e-68bcf0ec3bef_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_d46a8705-d527-4aad-a39e-68bcf0ec3bef" xlink:to="loc_us-gaap_TaxPeriodDomain_d46a8705-d527-4aad-a39e-68bcf0ec3bef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_d8f26b24-a923-430b-8827-898842fb8ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_d46a8705-d527-4aad-a39e-68bcf0ec3bef" xlink:to="loc_us-gaap_TaxPeriodDomain_d8f26b24-a923-430b-8827-898842fb8ecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SubjectToExpirationMember_0d651a03-100f-4f48-b428-6329e0559970" xlink:href="nvta-20201231.xsd#nvta_SubjectToExpirationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_d8f26b24-a923-430b-8827-898842fb8ecf" xlink:to="loc_nvta_SubjectToExpirationMember_0d651a03-100f-4f48-b428-6329e0559970" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ExpirationTaxYearUnknownMember_5444c27a-cb87-47f7-9318-ff83b1ef523f" xlink:href="nvta-20201231.xsd#nvta_ExpirationTaxYearUnknownMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_d8f26b24-a923-430b-8827-898842fb8ecf" xlink:to="loc_nvta_ExpirationTaxYearUnknownMember_5444c27a-cb87-47f7-9318-ff83b1ef523f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_494207ac-31eb-40e7-8205-360f460bd4e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_adf4eec2-ce50-41fc-8381-77525c31ed79" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_494207ac-31eb-40e7-8205-360f460bd4e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_494207ac-31eb-40e7-8205-360f460bd4e8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_494207ac-31eb-40e7-8205-360f460bd4e8" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_494207ac-31eb-40e7-8205-360f460bd4e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_180be97a-3671-4951-aae1-db26d7cf35d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_494207ac-31eb-40e7-8205-360f460bd4e8" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_180be97a-3671-4951-aae1-db26d7cf35d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_836791ab-00ae-4e23-9952-68fe5b49a33d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_180be97a-3671-4951-aae1-db26d7cf35d2" xlink:to="loc_us-gaap_DomesticCountryMember_836791ab-00ae-4e23-9952-68fe5b49a33d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_c5b6439f-0f3b-4e53-9cab-57313ac05834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_180be97a-3671-4951-aae1-db26d7cf35d2" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_c5b6439f-0f3b-4e53-9cab-57313ac05834" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_8018da92-9e45-4af3-b770-1e6e5f7e960b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_adf4eec2-ce50-41fc-8381-77525c31ed79" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_8018da92-9e45-4af3-b770-1e6e5f7e960b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_8018da92-9e45-4af3-b770-1e6e5f7e960b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_8018da92-9e45-4af3-b770-1e6e5f7e960b" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_8018da92-9e45-4af3-b770-1e6e5f7e960b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_9dde074a-a2bf-4fe0-a0b3-1b9ee5d5aa17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_8018da92-9e45-4af3-b770-1e6e5f7e960b" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_9dde074a-a2bf-4fe0-a0b3-1b9ee5d5aa17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_e699c8ca-e0a7-4c26-adfe-c088ae4b40b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_9dde074a-a2bf-4fe0-a0b3-1b9ee5d5aa17" xlink:to="loc_us-gaap_ResearchMember_e699c8ca-e0a7-4c26-adfe-c088ae4b40b3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails" xlink:type="extended" id="ie3db30ec5c624bddbb81cd7ae204e735_IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Netlosspershare" xlink:type="simple" xlink:href="nvta-20201231.xsd#Netlosspershare"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/Netlosspershare" xlink:type="extended" id="ie6faeebb2f414332a07ece58940c0dcd_Netlosspershare"/>
  <link:roleRef roleURI="http://www.invitae.com/role/NetlosspershareTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#NetlosspershareTables"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/NetlosspershareTables" xlink:type="extended" id="iece4f67259c04bfa9fb81838fced4930_NetlosspershareTables"/>
  <link:roleRef roleURI="http://www.invitae.com/role/NetlosspershareScheduleofearningspersharebasicanddilutedDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#NetlosspershareScheduleofearningspersharebasicanddilutedDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/NetlosspershareScheduleofearningspersharebasicanddilutedDetails" xlink:type="extended" id="ia3c63c399c0b48889ab36da313ee8d7f_NetlosspershareScheduleofearningspersharebasicanddilutedDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails" xlink:type="extended" id="i94b09ae14c294f6884328d626b6f8988_NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_nvta_EarningsPerShareLineItems_9109e6f4-72d9-4e0f-8f52-fae024971771" xlink:href="nvta-20201231.xsd#nvta_EarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b4ed30fd-3fe6-4dbb-b159-b5f213f133d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nvta_EarningsPerShareLineItems_9109e6f4-72d9-4e0f-8f52-fae024971771" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b4ed30fd-3fe6-4dbb-b159-b5f213f133d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_EarningsPerShareTable_84f6d329-baef-4c32-b204-6a25d1c125ed" xlink:href="nvta-20201231.xsd#nvta_EarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_nvta_EarningsPerShareLineItems_9109e6f4-72d9-4e0f-8f52-fae024971771" xlink:to="loc_nvta_EarningsPerShareTable_84f6d329-baef-4c32-b204-6a25d1c125ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b8bab5f8-c010-4456-856d-42a956a17721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nvta_EarningsPerShareTable_84f6d329-baef-4c32-b204-6a25d1c125ed" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b8bab5f8-c010-4456-856d-42a956a17721" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b8bab5f8-c010-4456-856d-42a956a17721_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b8bab5f8-c010-4456-856d-42a956a17721" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b8bab5f8-c010-4456-856d-42a956a17721_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b8bab5f8-c010-4456-856d-42a956a17721" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e35b0a2f-69e6-48c7-8b00-db0dce5c6839" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e35b0a2f-69e6-48c7-8b00-db0dce5c6839" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_de5441c7-c405-4fed-ab72-a0e2499eeb67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:to="loc_us-gaap_WarrantMember_de5441c7-c405-4fed-ab72-a0e2499eeb67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a79bd631-37e0-4cdf-8808-c678d33b5194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a79bd631-37e0-4cdf-8808-c678d33b5194" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PerformanceRestrictedStockUnitsRsusMember_69c57160-68d3-4bfe-9e32-e82446c3d2d0" xlink:href="nvta-20201231.xsd#nvta_PerformanceRestrictedStockUnitsRsusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:to="loc_nvta_PerformanceRestrictedStockUnitsRsusMember_69c57160-68d3-4bfe-9e32-e82446c3d2d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_EmployeeStockPurchasePlan2015Member_a1070910-bc2c-4a73-855c-5744fb619f83" xlink:href="nvta-20201231.xsd#nvta_EmployeeStockPurchasePlan2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:to="loc_nvta_EmployeeStockPurchasePlan2015Member_a1070910-bc2c-4a73-855c-5744fb619f83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SeriesAConvertiblePreferredStockMember_d96c5a50-7225-4273-aa57-362a0f0e8093" xlink:href="nvta-20201231.xsd#nvta_SeriesAConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:to="loc_nvta_SeriesAConvertiblePreferredStockMember_d96c5a50-7225-4273-aa57-362a0f0e8093" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_500407a6-04bb-4134-a173-bc14ae1040f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_500407a6-04bb-4134-a173-bc14ae1040f9" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Geographicinformation" xlink:type="simple" xlink:href="nvta-20201231.xsd#Geographicinformation"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/Geographicinformation" xlink:type="extended" id="i56b95fa36bae4b31a77d93260359a779_Geographicinformation"/>
  <link:roleRef roleURI="http://www.invitae.com/role/GeographicinformationTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#GeographicinformationTables"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/GeographicinformationTables" xlink:type="extended" id="if92d0318913e4402942aec1c854f2b6d_GeographicinformationTables"/>
  <link:roleRef roleURI="http://www.invitae.com/role/GeographicinformationDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#GeographicinformationDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/GeographicinformationDetails" xlink:type="extended" id="ibd32186728184aaba1fac75f6b3c4a0f_GeographicinformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_b0104e12-79cb-4c6c-ba22-0520d44fa5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_99648cd4-d8e1-443a-8800-48df0e276149" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_b0104e12-79cb-4c6c-ba22-0520d44fa5ee" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_99648cd4-d8e1-443a-8800-48df0e276149" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e2009b0a-3c4c-4099-a6cd-ddf9ddf5dad7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_b0104e12-79cb-4c6c-ba22-0520d44fa5ee" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e2009b0a-3c4c-4099-a6cd-ddf9ddf5dad7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2a63edf5-15ca-4f16-961f-37155fe8ca88" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e2009b0a-3c4c-4099-a6cd-ddf9ddf5dad7" xlink:to="loc_srt_StatementGeographicalAxis_2a63edf5-15ca-4f16-961f-37155fe8ca88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2a63edf5-15ca-4f16-961f-37155fe8ca88_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_2a63edf5-15ca-4f16-961f-37155fe8ca88" xlink:to="loc_srt_SegmentGeographicalDomain_2a63edf5-15ca-4f16-961f-37155fe8ca88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8bb42de9-a77c-43a6-b3c9-5ace09072d02" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_2a63edf5-15ca-4f16-961f-37155fe8ca88" xlink:to="loc_srt_SegmentGeographicalDomain_8bb42de9-a77c-43a6-b3c9-5ace09072d02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9afd53a2-bf17-4873-ab22-9bde07384475" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8bb42de9-a77c-43a6-b3c9-5ace09072d02" xlink:to="loc_country_US_9afd53a2-bf17-4873-ab22-9bde07384475" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_6753f452-619a-4b01-87a3-c07d1e4f6b31" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8bb42de9-a77c-43a6-b3c9-5ace09072d02" xlink:to="loc_country_CA_6753f452-619a-4b01-87a3-c07d1e4f6b31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RestOfWorldMember_6aa4a1ed-6adb-49fd-9f0f-52534561ea2c" xlink:href="nvta-20201231.xsd#nvta_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8bb42de9-a77c-43a6-b3c9-5ace09072d02" xlink:to="loc_nvta_RestOfWorldMember_6aa4a1ed-6adb-49fd-9f0f-52534561ea2c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Selectedquarterlydataunaudited" xlink:type="simple" xlink:href="nvta-20201231.xsd#Selectedquarterlydataunaudited"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/Selectedquarterlydataunaudited" xlink:type="extended" id="i525da9d94ac6470b8629c5e2805a4149_Selectedquarterlydataunaudited"/>
  <link:roleRef roleURI="http://www.invitae.com/role/SelectedquarterlydataunauditedTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#SelectedquarterlydataunauditedTables"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/SelectedquarterlydataunauditedTables" xlink:type="extended" id="i69eddb5f7cd54edc92edaa51b0d9f7f7_SelectedquarterlydataunauditedTables"/>
  <link:roleRef roleURI="http://www.invitae.com/role/SelectedquarterlydataunauditedDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SelectedquarterlydataunauditedDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/SelectedquarterlydataunauditedDetails" xlink:type="extended" id="i64ecbb3bb06a4f19974916c3ef900599_SelectedquarterlydataunauditedDetails"/>
  <link:roleRef roleURI="http://www.invitae.com/role/Subsequentevent" xlink:type="simple" xlink:href="nvta-20201231.xsd#Subsequentevent"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/Subsequentevent" xlink:type="extended" id="i6fe9d83c76584dd68e91cca71cf4d6e6_Subsequentevent"/>
  <link:roleRef roleURI="http://www.invitae.com/role/SubsequenteventsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SubsequenteventsDetails"/>
  <link:definitionLink xlink:role="http://www.invitae.com/role/SubsequenteventsDetails" xlink:type="extended" id="ifa55ffaeb5e94bcabb305061dcfde2fb_SubsequenteventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_6d42f486-b45e-4cd0-bd07-5dacdd3b7454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2d3a2060-92db-42cc-8fb0-e12a7a47958b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_6d42f486-b45e-4cd0-bd07-5dacdd3b7454" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2d3a2060-92db-42cc-8fb0-e12a7a47958b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_42a3a283-9081-4af0-bfc5-ee9c90b1d1e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_6d42f486-b45e-4cd0-bd07-5dacdd3b7454" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_42a3a283-9081-4af0-bfc5-ee9c90b1d1e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_599ee7dc-f2df-4e3e-be3c-0497b1edea0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_6d42f486-b45e-4cd0-bd07-5dacdd3b7454" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_599ee7dc-f2df-4e3e-be3c-0497b1edea0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCash_5069fc20-f449-42b0-a7d5-eb19a6bf02a6" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_6d42f486-b45e-4cd0-bd07-5dacdd3b7454" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCash_5069fc20-f449-42b0-a7d5-eb19a6bf02a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_c55f34e2-d087-455c-bf0c-c1ea1fd7a81d" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_6d42f486-b45e-4cd0-bd07-5dacdd3b7454" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_c55f34e2-d087-455c-bf0c-c1ea1fd7a81d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_9b3fd97e-c3ae-4fa4-852f-87364fe14676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_6d42f486-b45e-4cd0-bd07-5dacdd3b7454" xlink:to="loc_us-gaap_SubsequentEventTable_9b3fd97e-c3ae-4fa4-852f-87364fe14676" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e5689415-f097-4ac9-adf6-809b085744f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_9b3fd97e-c3ae-4fa4-852f-87364fe14676" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e5689415-f097-4ac9-adf6-809b085744f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5689415-f097-4ac9-adf6-809b085744f5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e5689415-f097-4ac9-adf6-809b085744f5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5689415-f097-4ac9-adf6-809b085744f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7bb92314-01d9-4cd4-90d1-9ab724371c08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e5689415-f097-4ac9-adf6-809b085744f5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7bb92314-01d9-4cd4-90d1-9ab724371c08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_OneCodexMember_25349617-324a-4715-8535-731c11bc364c" xlink:href="nvta-20201231.xsd#nvta_OneCodexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7bb92314-01d9-4cd4-90d1-9ab724371c08" xlink:to="loc_nvta_OneCodexMember_25349617-324a-4715-8535-731c11bc364c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6a0cbf9c-7c5b-4eb4-829f-89471c5175d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_9b3fd97e-c3ae-4fa4-852f-87364fe14676" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6a0cbf9c-7c5b-4eb4-829f-89471c5175d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6a0cbf9c-7c5b-4eb4-829f-89471c5175d5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6a0cbf9c-7c5b-4eb4-829f-89471c5175d5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6a0cbf9c-7c5b-4eb4-829f-89471c5175d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_67b14adf-f35c-4e35-a8a7-82ef945094df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6a0cbf9c-7c5b-4eb4-829f-89471c5175d5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_67b14adf-f35c-4e35-a8a7-82ef945094df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6e801673-7da1-4c50-a7cb-b313c42e1338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_67b14adf-f35c-4e35-a8a7-82ef945094df" xlink:to="loc_us-gaap_SubsequentEventMember_6e801673-7da1-4c50-a7cb-b313c42e1338" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>nvta-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:1a5642af-41c4-4761-89fa-6771b997ee20,g:0d35037d-3d4c-4753-897e-12e6bc13039e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e2509101-7b50-465c-85b1-95a0f96b1d4c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7036dc12-192a-490b-9b84-b1ef745d5e5c_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_eb24968f-3386-4bc8-ace0-dbeffaf89512_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_594af909-926c-426f-a96c-41b0e78088f9_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentsGeographicalAreasAbstract_37df3614-99bf-40f3-98c4-373df3390c90_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentsGeographicalAreasAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments, Geographical Areas [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentsGeographicalAreasAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentsGeographicalAreasAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments, Geographical Areas [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentsGeographicalAreasAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract" xlink:to="lab_us-gaap_SegmentsGeographicalAreasAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_9c05697e-5cb8-448a-9241-9f4a19a13ae7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount_c38777e5-e8cb-4588-b050-66d14cd9dd54_terseLabel_en-US" xlink:label="lab_nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers of assets and liabilities between Level 1, Level 2 and Level 3</link:label>
    <link:label id="lab_nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount_label_en-US" xlink:label="lab_nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount</link:label>
    <link:label id="lab_nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount_documentation_en-US" xlink:label="lab_nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value assets and liabilities level1 level2 and level3 transfers&#8217; amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount" xlink:href="nvta-20201231.xsd#nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount" xlink:to="lab_nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b1b04303-e166-4e6b-93b3-9c874c51584c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemNetGainLoss_902b0191-e9c9-4725-8c64-b666d42102c0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemNetGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income received under the CARES Act</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemNetGainLoss_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemNetGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both, Net (Gain) Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemNetGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemNetGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemNetGainLoss" xlink:to="lab_us-gaap_UnusualOrInfrequentItemNetGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_20543640-104b-4080-9dd2-a6a8c624051a_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_88dce853-f09e-493b-bf61-17cd62f414f9_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_7e95c87a-217a-4023-bf59-406ec6504b04_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_6d373ce7-b003-439c-b0f1-e9816257e8e5_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation by Category of Item Purchased [Axis]</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation by Category of Item Purchased [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_CommonStockSalesAgreementMember_414b888f-3480-432b-88c5-b922480ed7bb_terseLabel_en-US" xlink:label="lab_nvta_CommonStockSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Sales Agreement</link:label>
    <link:label id="lab_nvta_CommonStockSalesAgreementMember_label_en-US" xlink:label="lab_nvta_CommonStockSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Sales Agreement [Member]</link:label>
    <link:label id="lab_nvta_CommonStockSalesAgreementMember_documentation_en-US" xlink:label="lab_nvta_CommonStockSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock sales agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CommonStockSalesAgreementMember" xlink:href="nvta-20201231.xsd#nvta_CommonStockSalesAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_CommonStockSalesAgreementMember" xlink:to="lab_nvta_CommonStockSalesAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_443a2628-dbc9-4a87-823e-b851a993f436_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares reserved (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_e7cd9714-1c99-4d83-a29c-ff151c0b1a62_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of outstanding warrants to purchase common stock</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_ClearGeneticsMember_c4b0d23f-3b0e-4e44-9e53-46a085f8c30d_terseLabel_en-US" xlink:label="lab_nvta_ClearGeneticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clear Genetics</link:label>
    <link:label id="lab_nvta_ClearGeneticsMember_label_en-US" xlink:label="lab_nvta_ClearGeneticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clear Genetics [Member]</link:label>
    <link:label id="lab_nvta_ClearGeneticsMember_documentation_en-US" xlink:label="lab_nvta_ClearGeneticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clear Genetics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ClearGeneticsMember" xlink:href="nvta-20201231.xsd#nvta_ClearGeneticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_ClearGeneticsMember" xlink:to="lab_nvta_ClearGeneticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_96e9b7ee-5db1-4819-b9e2-0c286559d36a_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e96bee11-9380-4905-806d-4b537279facd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_73fb2462-5693-408c-b734-0d96a25776dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock incentive plan</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_f0a5caba-cc3f-4a53-8c4f-78c20a727365_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_425f06b0-0b7a-4922-babd-82e9b47ade27_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity component of convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_cbee3f36-49ff-4f78-8d3b-395c2b369e96_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_BusinessCombinationRemeasurementOfLiabilities_5cdbc2f8-19bd-4449-ac1c-df20e0df20e3_terseLabel_en-US" xlink:label="lab_nvta_BusinessCombinationRemeasurementOfLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurements of liabilities associated with business combinations</link:label>
    <link:label id="lab_nvta_BusinessCombinationRemeasurementOfLiabilities_label_en-US" xlink:label="lab_nvta_BusinessCombinationRemeasurementOfLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Remeasurement Of Liabilities</link:label>
    <link:label id="lab_nvta_BusinessCombinationRemeasurementOfLiabilities_documentation_en-US" xlink:label="lab_nvta_BusinessCombinationRemeasurementOfLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination remeasurement of liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationRemeasurementOfLiabilities" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationRemeasurementOfLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_BusinessCombinationRemeasurementOfLiabilities" xlink:to="lab_nvta_BusinessCombinationRemeasurementOfLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_dc8cc6ae-1714-47f5-aa61-0b97fb278a7d_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_2d09dc0a-9940-4faa-90b0-59f9706fc757_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_f509ecb2-33ff-44a4-a253-0aff62cec52d_verboseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRSU</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_9b460ac5-4b12-4807-9f40-953ea2b651dd_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRSUs</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c560f6bb-4ec6-4053-8339-a5679dc4d16c_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_67ecdbc5-8124-4efe-b7b9-a051ef09ca20_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_06e4310f-573d-43b8-81a8-16c5874940aa_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_b18dfaf5-5e2a-4c62-bc26-cdfe9210e5dd_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_809e9dbd-054b-4284-a5cb-5bf3fb50a311_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_02b7f541-91be-4628-b1e4-11d7b1a64508_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future non-cancelable minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_3890778f-008f-461b-8524-187ce9a071e1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_65028bb7-a0c8-4b8b-b7d2-18c5684692ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_40601a01-bfc1-4171-926f-02a6b8161a61_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_60370c3c-845b-4572-a3e7-3f011298341f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_888eb0cc-f0f9-481f-b74f-48cc3dd91a0f_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_25b9a6a9-9855-4913-a917-6227378d1417_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d176a372-86eb-4aef-b6f2-f9963536c1a4_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember_987d588c-405a-4529-aa1e-43aa9effc13c_terseLabel_en-US" xlink:label="lab_nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ongoing development post-close milestones</link:label>
    <link:label id="lab_nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember_label_en-US" xlink:label="lab_nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Ongoing Development Post-close Milestones [Member]</link:label>
    <link:label id="lab_nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember_documentation_en-US" xlink:label="lab_nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Ongoing Development Post-close Milestones [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember" xlink:href="nvta-20201231.xsd#nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember" xlink:to="lab_nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2cde0fb4-f988-44cd-bf5b-abea24d629a8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_e959dc63-091b-4dc5-8a1b-c9361279cdba_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_MilestoneAchievementAgreementMember_9889bbc6-e3a7-45eb-bbc3-ff4915fa4e09_terseLabel_en-US" xlink:label="lab_nvta_MilestoneAchievementAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone achievement agreement</link:label>
    <link:label id="lab_nvta_MilestoneAchievementAgreementMember_label_en-US" xlink:label="lab_nvta_MilestoneAchievementAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Achievement Agreement [Member]</link:label>
    <link:label id="lab_nvta_MilestoneAchievementAgreementMember_documentation_en-US" xlink:label="lab_nvta_MilestoneAchievementAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Achievement Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_MilestoneAchievementAgreementMember" xlink:href="nvta-20201231.xsd#nvta_MilestoneAchievementAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_MilestoneAchievementAgreementMember" xlink:to="lab_nvta_MilestoneAchievementAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_328da200-ab2b-42da-bb86-060946033159_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_590b7fdd-e4a8-4d20-92db-44c4a1aa9a07_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_67105fae-3f5e-4b10-9d59-2fa7cc417cad_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d908f85b-a700-40a9-97a1-9563d1401c5b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of financial instruments at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_a30012a1-1aff-4534-921b-37f139cfad8e_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_IndemnificationObligationsMember_753af016-2079-4eb4-af49-b48c9e708b7d_terseLabel_en-US" xlink:label="lab_nvta_IndemnificationObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification obligations</link:label>
    <link:label id="lab_nvta_IndemnificationObligationsMember_label_en-US" xlink:label="lab_nvta_IndemnificationObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Obligations [Member]</link:label>
    <link:label id="lab_nvta_IndemnificationObligationsMember_documentation_en-US" xlink:label="lab_nvta_IndemnificationObligationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_IndemnificationObligationsMember" xlink:href="nvta-20201231.xsd#nvta_IndemnificationObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_IndemnificationObligationsMember" xlink:to="lab_nvta_IndemnificationObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_25e27ab8-8024-4176-a4c2-5a5c1b8e39af_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_a76d0e7d-8b1f-47a6-9d47-df0be40f5c0d_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, beginning of period</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_0dd418eb-03d9-4cdf-8065-28fffb03570e_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, end of period</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_ed9fb0dd-2dca-493b-bd2c-f321ccd4a8d0_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.0001 par value: 20,000 shares authorized; 125 shares issued and outstanding as of December&#160;31, 2020 and 2019</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_SummaryOfSignificantAccountingPoliciesTable_7b22914a-222a-401d-bce4-bc0e8babc238_terseLabel_en-US" xlink:label="lab_nvta_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_nvta_SummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_nvta_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_nvta_SummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_nvta_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of significant accounting policies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SummaryOfSignificantAccountingPoliciesTable" xlink:href="nvta-20201231.xsd#nvta_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_nvta_SummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_StockIncentivePlan2010Member_85b21165-9195-46f5-9fd0-7924b6bf3ac4_terseLabel_en-US" xlink:label="lab_nvta_StockIncentivePlan2010Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Plan</link:label>
    <link:label id="lab_nvta_StockIncentivePlan2010Member_label_en-US" xlink:label="lab_nvta_StockIncentivePlan2010Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plan2010 [Member]</link:label>
    <link:label id="lab_nvta_StockIncentivePlan2010Member_documentation_en-US" xlink:label="lab_nvta_StockIncentivePlan2010Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to the 2010 stock incentive plan, which provides for the granting of stock based awards to employees, directors, and consultants under terms and provisions established by the board of directors.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIncentivePlan2010Member" xlink:href="nvta-20201231.xsd#nvta_StockIncentivePlan2010Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_StockIncentivePlan2010Member" xlink:to="lab_nvta_StockIncentivePlan2010Member" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_DeferredTaxAssetsLeaseLiability_601766d6-d831-4ff3-bee5-f9a8f679eefd_terseLabel_en-US" xlink:label="lab_nvta_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasing Liabilities</link:label>
    <link:label id="lab_nvta_DeferredTaxAssetsLeaseLiability_label_en-US" xlink:label="lab_nvta_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Lease, Liability</link:label>
    <link:label id="lab_nvta_DeferredTaxAssetsLeaseLiability_documentation_en-US" xlink:label="lab_nvta_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DeferredTaxAssetsLeaseLiability" xlink:href="nvta-20201231.xsd#nvta_DeferredTaxAssetsLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_DeferredTaxAssetsLeaseLiability" xlink:to="lab_nvta_DeferredTaxAssetsLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_RSUsAndPRSUsMember_1d1eb8c8-255e-4a35-aa1d-5b01fe1af56e_terseLabel_en-US" xlink:label="lab_nvta_RSUsAndPRSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs and PRSUs</link:label>
    <link:label id="lab_nvta_RSUsAndPRSUsMember_label_en-US" xlink:label="lab_nvta_RSUsAndPRSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs and PRSUs [Member]</link:label>
    <link:label id="lab_nvta_RSUsAndPRSUsMember_documentation_en-US" xlink:label="lab_nvta_RSUsAndPRSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs and PRSUs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RSUsAndPRSUsMember" xlink:href="nvta-20201231.xsd#nvta_RSUsAndPRSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_RSUsAndPRSUsMember" xlink:to="lab_nvta_RSUsAndPRSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0195f490-0c4c-4a6e-9f82-3edf71f8d7ab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_071bb107-cf2d-4525-b5b1-9c80e4f2d1de_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ceb8f74c-12ac-4004-b4e7-fd91f193792c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_a6df3dcb-0037-47fc-a22b-62d20dc9e6f3_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_bde27b64-f156-47ee-a975-e46947011a48_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total grant date fair value of options to purchase common stock vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_afa5be03-d03b-46e7-aacc-9d93c38a04c2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in progress</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_cb74507d-ab7d-44f9-8dfb-d8d7822863f5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Option, Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Option, Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_2cfdf328-24c0-4ae1-8c21-6d93fd58b3be_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_c0012c4a-2935-4ed4-99d5-d6b2e6ef9bb8_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_afc19383-093d-497b-9a63-56d5e326ba49_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoteWarrantMember_4eb9b0c4-1891-4d2c-a5f4-f161cf48a5de_terseLabel_en-US" xlink:label="lab_us-gaap_NoteWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant</link:label>
    <link:label id="lab_us-gaap_NoteWarrantMember_label_en-US" xlink:label="lab_us-gaap_NoteWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoteWarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoteWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoteWarrantMember" xlink:to="lab_us-gaap_NoteWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_132dd03c-8cdb-41fb-a88a-112d63e35e5f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third anniversary</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_DebtInstrumentInterestRateFloorRate_6351b05e-4e66-42ef-ad69-0caf47f23bca_terseLabel_en-US" xlink:label="lab_nvta_DebtInstrumentInterestRateFloorRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floor rate</link:label>
    <link:label id="lab_nvta_DebtInstrumentInterestRateFloorRate_label_en-US" xlink:label="lab_nvta_DebtInstrumentInterestRateFloorRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Floor Rate</link:label>
    <link:label id="lab_nvta_DebtInstrumentInterestRateFloorRate_documentation_en-US" xlink:label="lab_nvta_DebtInstrumentInterestRateFloorRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Floor Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentInterestRateFloorRate" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentInterestRateFloorRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_DebtInstrumentInterestRateFloorRate" xlink:to="lab_nvta_DebtInstrumentInterestRateFloorRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_38b0ff0a-9114-41db-bf4b-2d970872ca7a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1085348e-e4b2-419c-bd26-f2744229d1cb_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of options granted</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_2d754c33-f14a-4b16-9699-bd3d7b7df1dc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5fe86fa8-24cd-4a5c-8fd6-769c8682fd7f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of antidilutive securities excluded from computation of earnings per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_b07b508f-88ca-46fc-b866-49ea5f965f32_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_646d53f2-1a16-442a-a7de-22d77a9825a9_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_9c873f70-efa9-4333-a550-5c96136ad738_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_5d18dbd8-ed7f-4abf-91d0-6c1db6be5bbf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_StockIssuedDuringPeriodValueWarrantsExercised_87a79657-7648-408b-8060-ae6445e25452_terseLabel_en-US" xlink:label="lab_nvta_StockIssuedDuringPeriodValueWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued pursuant to exercises of warrants</link:label>
    <link:label id="lab_nvta_StockIssuedDuringPeriodValueWarrantsExercised_label_en-US" xlink:label="lab_nvta_StockIssuedDuringPeriodValueWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period Value Warrants Exercised</link:label>
    <link:label id="lab_nvta_StockIssuedDuringPeriodValueWarrantsExercised_documentation_en-US" xlink:label="lab_nvta_StockIssuedDuringPeriodValueWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period value warrants exercised.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIssuedDuringPeriodValueWarrantsExercised" xlink:href="nvta-20201231.xsd#nvta_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_StockIssuedDuringPeriodValueWarrantsExercised" xlink:to="lab_nvta_StockIssuedDuringPeriodValueWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_a2977db0-1aee-450a-9b03-11b6a253a2f8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options vested (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_8ea2bef8-8924-4f71-93a5-518d14da85ba_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_1217abeb-4eb7-4d1f-beb9-b5bf051ae0f0_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_edf04eea-1f14-47ed-b4a0-cbd2f784db03_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_8f885031-9190-401c-8608-5b9cfc579c01_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0b487505-cde5-479d-bad0-7fdda64bbaeb_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_d643d914-d286-47f0-8510-1bf9b6f3a47a_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_291f29d7-ad6c-4552-ba01-32837cbc4f54_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_76f535f7-1117-4b30-b55c-1ff404057526_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_03435415-f17a-4b2d-a709-6b869ff4d377_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d890f286-3784-4594-bb30-eefb0dd0807b_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued in transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e668ec4-fa21-4664-8c45-b37ed7e165ed_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_b03208a6-614a-4a80-a2b2-1ef3cc72fffc_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_1550233d-95fc-4269-a561-624cd1b659a2_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_ConvertibleSeniorNotesMember_88fb5caf-6bb4-486b-b7b4-7165084f27fe_terseLabel_en-US" xlink:label="lab_nvta_ConvertibleSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_nvta_ConvertibleSeniorNotesMember_label_en-US" xlink:label="lab_nvta_ConvertibleSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes [Member]</link:label>
    <link:label id="lab_nvta_ConvertibleSeniorNotesMember_documentation_en-US" xlink:label="lab_nvta_ConvertibleSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ConvertibleSeniorNotesMember" xlink:href="nvta-20201231.xsd#nvta_ConvertibleSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_ConvertibleSeniorNotesMember" xlink:to="lab_nvta_ConvertibleSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1dcbc41-abae-43d3-a2d3-00ccb50327ff_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_CostOfTestRevenueMember_c2e369fa-0a4f-4c24-842c-f53692006d19_terseLabel_en-US" xlink:label="lab_nvta_CostOfTestRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_nvta_CostOfTestRevenueMember_label_en-US" xlink:label="lab_nvta_CostOfTestRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Test Revenue [Member]</link:label>
    <link:label id="lab_nvta_CostOfTestRevenueMember_documentation_en-US" xlink:label="lab_nvta_CostOfTestRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of test revenue.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CostOfTestRevenueMember" xlink:href="nvta-20201231.xsd#nvta_CostOfTestRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_CostOfTestRevenueMember" xlink:to="lab_nvta_CostOfTestRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_cd5ba079-6e19-4998-a0be-9b1f76cc9ba9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock transferred</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_ContingentConsiderationMember_2e179ec1-ba8d-4028-a3eb-b5b95fc4c9b0_terseLabel_en-US" xlink:label="lab_nvta_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_nvta_ContingentConsiderationMember_label_en-US" xlink:label="lab_nvta_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_nvta_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_nvta_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ContingentConsiderationMember" xlink:href="nvta-20201231.xsd#nvta_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_ContingentConsiderationMember" xlink:to="lab_nvta_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6b289734-5cd2-4703-a469-c69beea75f10_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for grant, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6a035349-5839-41b9-bfe3-5e60fb4fa243_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for grant, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_e8826f05-34aa-4347-95a4-3ee942e9022e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_6ef958c1-bcea-4d9a-bff1-1df57dd38f64_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from private placement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionTypeAxis_3f45f0cc-1539-4cec-9205-e53fbae74dfa_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:label id="lab_us-gaap_TransactionTypeAxis_label_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionTypeAxis" xlink:to="lab_us-gaap_TransactionTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod_c542ea56-55b2-400f-98ad-6028db14c001_terseLabel_en-US" xlink:label="lab_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities period of available-for-sale securities</link:label>
    <link:label id="lab_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod_label_en-US" xlink:label="lab_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity Period</link:label>
    <link:label id="lab_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod_documentation_en-US" xlink:label="lab_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod" xlink:href="nvta-20201231.xsd#nvta_DebtSecuritiesAvailableForSaleMaturityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod" xlink:to="lab_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_342f0720-b615-40df-8c55-d745f4b5c3de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_b6e05d38-8573-420f-bc7f-f1e92aa2eceb_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b724f195-07a2-412d-b491-33e58528849b_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_35bfaeba-fcbe-45f9-b472-e233514ca417_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_4edfe429-c7c9-4704-a4f7-a018c17c5c40_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_fdcd78ab-4ece-4248-ba41-d7154ec8e4e1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1_46660792-2f09-4173-be3c-58c617ec7228_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration payable for acquisitions</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Payables Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_ccd52f31-7912-4980-a8f0-321c105f46ab_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_cf95008b-af75-40ca-a67a-fdc082340719_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized stock-based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_36d4b22b-9980-4a5f-a853-0a1dd0dbb5a1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense_b43f0296-100c-47cd-ac68-0f90b8262038_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, deferred tax asset, income tax expense</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Change in Tax Rate, Deferred Tax Asset, Income Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7f5a6a55-9f78-45e2-88ab-243025270d28_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_d2e2f1c1-a9dc-4976-82dd-2c420aea21aa_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued or issuable pursuant to acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_e2c84515-1b04-4adf-a3c3-86837854ad41_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_ab5331c5-9280-4183-8654-ecc190de6716_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_NotePurchaseAgreementMember_bc86b3e3-7fb5-43b1-ada9-c390628b3855_terseLabel_en-US" xlink:label="lab_nvta_NotePurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Purchase Agreement</link:label>
    <link:label id="lab_nvta_NotePurchaseAgreementMember_label_en-US" xlink:label="lab_nvta_NotePurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Purchase Agreement [Member]</link:label>
    <link:label id="lab_nvta_NotePurchaseAgreementMember_documentation_en-US" xlink:label="lab_nvta_NotePurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note purchase agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_NotePurchaseAgreementMember" xlink:href="nvta-20201231.xsd#nvta_NotePurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_NotePurchaseAgreementMember" xlink:to="lab_nvta_NotePurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a063f28e-dfc2-41f3-88bd-9a67bed4d975_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_a0ed62e6-8e5f-48cb-a7f6-31a463bb9eab_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_1764a820-9c52-4638-b73e-062dee54caa7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_15f6880a-47b1-4fec-9720-ffaa6bdfda29_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in deferred revenue upon acquisition</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_db680e1b-8da6-4186-a2a9-0399e1304e38_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_dbda91b5-33f7-4da4-8269-8a9520f473f8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration_57bdf972-a23f-49da-abbf-ee8747573736_terseLabel_en-US" xlink:label="lab_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, expected milestone duration</link:label>
    <link:label id="lab_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration_label_en-US" xlink:label="lab_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Expected Milestone Duration</link:label>
    <link:label id="lab_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration_documentation_en-US" xlink:label="lab_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Expected Milestone Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration" xlink:to="lab_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_9d8072fb-75f3-4ad8-aedb-9d1a664cebfb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_0ed53b74-c097-4c72-9bf6-7def33bf0ef9_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_df12a518-6d01-4d14-a4be-3706389f5da1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants issued pursuant to debt agreement</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_d762dc84-4de5-40b1-9860-acc1612045a0_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:to="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b3422432-4ae9-4f8f-a23d-f41074cdde47_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_9e3fad40-21e1-4ad6-835a-9be6183ec3b0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_dd0b166f-027b-40c5-b242-06097b517761_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and description of business</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_46dd8a89-8c3f-47f6-aec6-96e1a3994567_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4ae9e197-cefb-4e48-bcd8-1771c46a6365_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_a6326c30-8620-49d4-867e-d141ea215d8a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, indefinite-lived</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_3768d21e-42e4-4423-8a5f-54e0e96a7004_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_47b5cef9-b6aa-4fc1-a3a3-0260524ecbd1_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays_09018293-c263-4f95-a9d3-b23fac0c7ef2_terseLabel_en-US" xlink:label="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays_label_en-US" xlink:label="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted, Threshold Trading Days</link:label>
    <link:label id="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays_documentation_en-US" xlink:label="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays" xlink:href="nvta-20201231.xsd#nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays" xlink:to="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_3da152de-a273-4077-965c-e86c97fce90b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of credit risk and other risks and uncertainties</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_89e1e206-3c84-4bee-a6fa-1999b6dc3f84_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_177eb5c4-50b8-42c0-80f2-339dfdc9a39e_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_1a736f1c-f99a-42fa-b8f8-9f44d70485a6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_DeferredTaxAssetsRevenueRecognitionReserves_1751bb41-9ef8-4c4c-86a4-ef6af45cefce_terseLabel_en-US" xlink:label="lab_nvta_DeferredTaxAssetsRevenueRecognitionReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition differences</link:label>
    <link:label id="lab_nvta_DeferredTaxAssetsRevenueRecognitionReserves_label_en-US" xlink:label="lab_nvta_DeferredTaxAssetsRevenueRecognitionReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Revenue Recognition Reserves</link:label>
    <link:label id="lab_nvta_DeferredTaxAssetsRevenueRecognitionReserves_documentation_en-US" xlink:label="lab_nvta_DeferredTaxAssetsRevenueRecognitionReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets revenue recognition reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DeferredTaxAssetsRevenueRecognitionReserves" xlink:href="nvta-20201231.xsd#nvta_DeferredTaxAssetsRevenueRecognitionReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_DeferredTaxAssetsRevenueRecognitionReserves" xlink:to="lab_nvta_DeferredTaxAssetsRevenueRecognitionReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_9cc94740-7ffd-4f95-9100-ef8facc976a1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_dcd6e279-82dd-4466-9b46-01b6bf1de4ed_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_2a70d3be-fd61-49c2-af59-1b81cd1a84ae_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_886da053-54ac-4384-8e07-6c76b12308ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of convertible preferred and common stock</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_db7244a5-cbcd-4b83-9bde-aa178f4b038b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_ab096086-999b-4224-9ec3-3cfab922f922_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_56491b43-519c-4a47-8ffe-527943554eca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a72cf191-d698-4dc7-9bfd-8f47896b9bc3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_8ac8fcb9-32e7-4532-b803-9aeeef186acc_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_6250cd0f-5cb5-4aff-9c57-86a6c533e573_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital:</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_6de274d7-6a80-4ead-ae6d-ee9878496a11_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_151f6bc7-7729-4324-8a32-623cbfe2a189_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease costs</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_42c50008-0025-465b-9876-6413589680f2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_488373f2-1264-4806-a34c-015ba434e2dc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a9190e6f-a836-498b-a01a-97707ea4eb87_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_4cfd1d75-68eb-4f26-a045-9a4dc96fec7f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_e7f0e854-4418-4ecd-a513-9386235783ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6121b7a-8a48-4dd0-8bc4-87d0efef355e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss before taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f8611228-137f-4a41-8ffe-d0cf96692d2b_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_EmployeeStockPurchasePlan2015Member_b70e1457-0858-491f-a430-ec3ea875a3f0_terseLabel_en-US" xlink:label="lab_nvta_EmployeeStockPurchasePlan2015Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_nvta_EmployeeStockPurchasePlan2015Member_defe6c7d-2408-4e48-855b-41fdb861c594_verboseLabel_en-US" xlink:label="lab_nvta_EmployeeStockPurchasePlan2015Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock pursuant to ESPP</link:label>
    <link:label id="lab_nvta_EmployeeStockPurchasePlan2015Member_label_en-US" xlink:label="lab_nvta_EmployeeStockPurchasePlan2015Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan2015 [Member]</link:label>
    <link:label id="lab_nvta_EmployeeStockPurchasePlan2015Member_documentation_en-US" xlink:label="lab_nvta_EmployeeStockPurchasePlan2015Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to the 2015 employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_EmployeeStockPurchasePlan2015Member" xlink:href="nvta-20201231.xsd#nvta_EmployeeStockPurchasePlan2015Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_EmployeeStockPurchasePlan2015Member" xlink:to="lab_nvta_EmployeeStockPurchasePlan2015Member" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_NetProceedsFromIssuanceOfPrivatePlacement_3652ad3e-aecc-4611-8994-3d31db0e185d_terseLabel_en-US" xlink:label="lab_nvta_NetProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from private placement</link:label>
    <link:label id="lab_nvta_NetProceedsFromIssuanceOfPrivatePlacement_label_en-US" xlink:label="lab_nvta_NetProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Proceeds From Issuance Of Private Placement</link:label>
    <link:label id="lab_nvta_NetProceedsFromIssuanceOfPrivatePlacement_documentation_en-US" xlink:label="lab_nvta_NetProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of private placement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_NetProceedsFromIssuanceOfPrivatePlacement" xlink:href="nvta-20201231.xsd#nvta_NetProceedsFromIssuanceOfPrivatePlacement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_NetProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_nvta_NetProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_92cfc53f-3174-4945-bfe5-38c400a53f89_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2c83f7c2-9b6b-4544-a9d4-b0b6b7914f8d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_d17a9c47-bf08-4327-85b2-0a54f7d31235_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_59c65b23-b0f2-48af-8f14-fc4892c7890d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_885baef4-a72c-43cc-8a5f-4a1aa401f2a0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_1252138f-61f9-4e62-99ac-a260d6d5a1ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of RSU activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2c5ef2ee-fcd1-4f46-99a3-47f3eb2e7fe9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of interest acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfLoanCosts_b2efd5b7-d08b-4c0f-8e97-0bc217bfb0af_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfLoanCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan payments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfLoanCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfLoanCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Loan Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfLoanCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfLoanCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfLoanCosts" xlink:to="lab_us-gaap_PaymentsOfLoanCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_838a28bb-b6ed-454d-a993-db8b5a691d98_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7c2bd81c-ccab-4d21-88c8-4392d66afdc9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_70f2a4cd-eb68-48f8-ad25-5ee5a69bb01e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_548207ad-a8c6-42c6-833b-b9f7cf7f1299_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c98f5692-3ace-4c9b-83e9-0d7ee4fc83ce_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateLineItems_fb71e92a-2986-4920-b2fc-7b4c2e465383_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate [Line Items]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateLineItems_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="lab_us-gaap_ChangeInAccountingEstimateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTable_53a09c72-1ea4-4959-89af-c5fb86c7f413_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Change in Accounting Estimate [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Change in Accounting Estimate [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfChangeInAccountingEstimateTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable" xlink:to="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_f3e2cea5-1c9d-42a8-a0c0-6fc7283fddfe_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discounts and issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_5ea63d3a-e71e-4e15-80e9-3bb932654846_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt discount and issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_d4012d7c-9aad-4c63-bb3d-b944ac71458a_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_46ada2a6-426b-4af0-971a-4bfb5e8848a3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_JunglaMember_35567119-096f-47be-a343-909a706b7ed4_terseLabel_en-US" xlink:label="lab_nvta_JunglaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jungla</link:label>
    <link:label id="lab_nvta_JunglaMember_label_en-US" xlink:label="lab_nvta_JunglaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jungla [Member]</link:label>
    <link:label id="lab_nvta_JunglaMember_documentation_en-US" xlink:label="lab_nvta_JunglaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jungla [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_JunglaMember" xlink:href="nvta-20201231.xsd#nvta_JunglaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_JunglaMember" xlink:to="lab_nvta_JunglaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_ccda7c0e-f99f-4ebf-9e19-835350df9234_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_SeriesFWarrantsMember_3590549c-4458-44d2-9d13-d2caf035d64e_terseLabel_en-US" xlink:label="lab_nvta_SeriesFWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series F Warrants</link:label>
    <link:label id="lab_nvta_SeriesFWarrantsMember_label_en-US" xlink:label="lab_nvta_SeriesFWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series F Warrants [Member]</link:label>
    <link:label id="lab_nvta_SeriesFWarrantsMember_documentation_en-US" xlink:label="lab_nvta_SeriesFWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series F warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SeriesFWarrantsMember" xlink:href="nvta-20201231.xsd#nvta_SeriesFWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_SeriesFWarrantsMember" xlink:to="lab_nvta_SeriesFWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_66c444b6-bd33-4cfa-8f6f-4f7116f38422_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_eaf057b0-b8b4-4b0a-a924-b07781e4b91b_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of prior period, adjustment</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets_c3738e88-8a46-4731-8df7-e5d16e15ae42_negatedLabel_en-US" xlink:label="lab_nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets_label_en-US" xlink:label="lab_nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Prepaid Expense And Other Current Assets</link:label>
    <link:label id="lab_nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets_documentation_en-US" xlink:label="lab_nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods and also includes other current operating assets not separately disclosed in the statement of cash flows.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets" xlink:href="nvta-20201231.xsd#nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets" xlink:to="lab_nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_60d3fbd6-9c75-465a-9eb2-ea8ea15a57a3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5d645bf0-2342-4e96-b8f4-a0fe28f39d35_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and intangible assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_5ffc65e4-ce8a-4d0c-a2a6-a871c0baf84d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_f5273d67-c924-4bd7-9b4f-a6e1c4cd8ca6_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued upon conversion</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecurityDeposit_1bb6dd1f-6215-41ef-8bdd-e5f41218dd1d_terseLabel_en-US" xlink:label="lab_us-gaap_SecurityDeposit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security deposit</link:label>
    <link:label id="lab_us-gaap_SecurityDeposit_label_en-US" xlink:label="lab_us-gaap_SecurityDeposit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Deposit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecurityDeposit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecurityDeposit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecurityDeposit" xlink:to="lab_us-gaap_SecurityDeposit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_abb7c785-3fc2-4c90-b8d0-34856c46eee0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_a8b8945c-7bb9-47b1-8e01-33a5322d72a5_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_ad97459e-909a-4f87-9690-f988731d4d43_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts_95708b06-fc39-4e8c-b4d2-1135489f52d1_terseLabel_en-US" xlink:label="lab_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued in private placement, net</link:label>
    <link:label id="lab_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts_label_en-US" xlink:label="lab_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period Value In Connection With Private Placement Net Of Offering Costs</link:label>
    <link:label id="lab_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts_documentation_en-US" xlink:label="lab_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period value in connection with private placement, net of offering costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts" xlink:href="nvta-20201231.xsd#nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts" xlink:to="lab_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2df672a8-7516-49c8-b152-403d6d44d3dc_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued pursuant to vesting of restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_1d140598-ba19-4bf1-9f7e-4f37c5871bb6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_95cbf4e6-a88b-4b4e-92a7-d7382a40d970_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected quarterly data (unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_4cdbea68-4277-4197-9aba-a779bb45a3eb_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_e9b86cc3-69bb-46b1-be64-b5f6299f7329_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life, property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_33f54d53-9c67-47df-86a0-0c531c0c4673_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_96e755af-a626-4426-a2e7-1605bf7c9773_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_6db3e3b4-fd19-4745-9721-326e23ca910d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTextBlock_94edf251-2991-414f-a4e0-b7f7dcde20eb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of change in estimate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Change in Accounting Estimate [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfChangeInAccountingEstimateTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_cd46499a-591d-45e2-bd04-515ba7920b95_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9d1f8a5c-5e92-494f-b261-df8de7a13212_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d124c246-aae5-46bc-b01b-9016ec7a4e6c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_d8385b1f-a1d3-4ab9-9d72-3acc283090a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of activity under stock incentive plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_44a2e6b4-72f9-47d6-9bcd-2936c649952f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_fee2ef6c-8f99-4026-8ded-a71ec8782c25_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d9b35d1f-782f-473f-b483-1d92851775ad_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_bb683bbd-8455-492a-b67a-a8143186c54f_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease obligation</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_bf22642e-6e10-4b90-8f9f-283f90b1b3df_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_NewLeasesMember_7f67dc1a-660e-4723-b67f-1d4e0805b60b_terseLabel_en-US" xlink:label="lab_nvta_NewLeasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Leases</link:label>
    <link:label id="lab_nvta_NewLeasesMember_label_en-US" xlink:label="lab_nvta_NewLeasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Leases [Member]</link:label>
    <link:label id="lab_nvta_NewLeasesMember_documentation_en-US" xlink:label="lab_nvta_NewLeasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information pertaining to new lease arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_NewLeasesMember" xlink:href="nvta-20201231.xsd#nvta_NewLeasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_NewLeasesMember" xlink:to="lab_nvta_NewLeasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1a38f69c-6d6c-448d-946e-8f44dab9f5dc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_fd5b8d93-1366-4c7f-ae77-9b92d4c5e31f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of assumptions used in determination of fair value of options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_c3ab7efc-4da3-4f3e-bd99-b03942738831_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_e2aec433-1a84-45f6-827c-eba8e7f0bad1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Estimated Remaining Useful Life (in Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_60c5d172-826b-4475-b18a-fd01f86c1216_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_17c73650-c16b-467b-905c-aca64ea83644_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_91524d41-667c-4ced-85db-e89d0244fe51_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect of accounting change</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_bbe2761b-5266-435d-ac9b-fdcaf634ad75_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets and in-process research and development</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_099f91e2-c4d7-48f1-bd4e-8c97e613d6b6_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_52fefbfa-6538-4dcd-81ca-5830fcc95fde_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_15df0f82-6a7b-4920-a642-3c5783cdaf9a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_76233ae2-7923-4776-b94d-5d754449e471_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_cc9c35e3-828e-44ff-b1d1-7b14f122b3a9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment losses</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70d95d81-1a66-4314-ae82-ff3f601ff0bb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_3e7700e0-2c10-486e-927a-f3a94726c1d2_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_StockIssuedDuringPeriodSharesWarrantsExercised_c4598f4f-0c05-4bf0-917c-13e6f9028ba4_terseLabel_en-US" xlink:label="lab_nvta_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued pursuant to exercises of warrants (in shares)</link:label>
    <link:label id="lab_nvta_StockIssuedDuringPeriodSharesWarrantsExercised_label_en-US" xlink:label="lab_nvta_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period Shares Warrants Exercised</link:label>
    <link:label id="lab_nvta_StockIssuedDuringPeriodSharesWarrantsExercised_documentation_en-US" xlink:label="lab_nvta_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period shares warrants exercised.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:href="nvta-20201231.xsd#nvta_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:to="lab_nvta_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_31a26eff-cc4d-408d-b23b-3f34f7c03006_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_BusinessCombinationAccruedLiabilitiesNoncurrent_99aeab53-7edf-4525-853e-5edd7f2804c6_terseLabel_en-US" xlink:label="lab_nvta_BusinessCombinationAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and other liabilities associated with business combinations, non-current</link:label>
    <link:label id="lab_nvta_BusinessCombinationAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_nvta_BusinessCombinationAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Accrued Liabilities Noncurrent</link:label>
    <link:label id="lab_nvta_BusinessCombinationAccruedLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_nvta_BusinessCombinationAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination accrued liabilities noncurrent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationAccruedLiabilitiesNoncurrent" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_BusinessCombinationAccruedLiabilitiesNoncurrent" xlink:to="lab_nvta_BusinessCombinationAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_ResearchAndDevelopmentMember_c431fa7a-c016-4e37-bd7b-aac579b7229f_terseLabel_en-US" xlink:label="lab_nvta_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_nvta_ResearchAndDevelopmentMember_label_en-US" xlink:label="lab_nvta_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development [Member]</link:label>
    <link:label id="lab_nvta_ResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_nvta_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to research and development expenses included in the income statement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ResearchAndDevelopmentMember" xlink:href="nvta-20201231.xsd#nvta_ResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_ResearchAndDevelopmentMember" xlink:to="lab_nvta_ResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_39e9c192-f21b-4de3-8f79-ffb9dfb0f519_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_b129ecad-9aae-4070-b4a1-427b4984b490_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OneTimeTerminationBenefitsMember_25e90d26-966e-4a8f-b360-aa70f3255ddc_terseLabel_en-US" xlink:label="lab_us-gaap_OneTimeTerminationBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-time termination costs</link:label>
    <link:label id="lab_us-gaap_OneTimeTerminationBenefitsMember_label_en-US" xlink:label="lab_us-gaap_OneTimeTerminationBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-time Termination Benefits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OneTimeTerminationBenefitsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OneTimeTerminationBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OneTimeTerminationBenefitsMember" xlink:to="lab_us-gaap_OneTimeTerminationBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_ca812f24-1be6-469f-9b82-3e66c6ed2db5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination_bfb0b0c3-1d2b-4c5e-9e10-08ac897c762b_terseLabel_en-US" xlink:label="lab_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of tax years open for examination</link:label>
    <link:label id="lab_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination_label_en-US" xlink:label="lab_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination Number Of Period Under Examination</link:label>
    <link:label id="lab_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination_documentation_en-US" xlink:label="lab_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax examination number of period under examination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination" xlink:href="nvta-20201231.xsd#nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination" xlink:to="lab_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_f113b2fe-2179-40d3-928f-d61b75df0d2c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9aa74bec-3fdc-4b2e-8794-17522707f95c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_LoanAndSecurityAgreementMember_319e1a1b-7d40-4e5f-8959-2587dcbe10ab_terseLabel_en-US" xlink:label="lab_nvta_LoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan and Security Agreement</link:label>
    <link:label id="lab_nvta_LoanAndSecurityAgreementMember_label_en-US" xlink:label="lab_nvta_LoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan And Security Agreement [Member]</link:label>
    <link:label id="lab_nvta_LoanAndSecurityAgreementMember_documentation_en-US" xlink:label="lab_nvta_LoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to loan and security agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_LoanAndSecurityAgreementMember" xlink:href="nvta-20201231.xsd#nvta_LoanAndSecurityAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_LoanAndSecurityAgreementMember" xlink:to="lab_nvta_LoanAndSecurityAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_ebd5d2e3-0079-4377-814a-f0190252aa82_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_66f50461-72aa-4ca6-b75b-a1a903f4bd89_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After the third anniversary of closing date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_e05eaa4b-8c55-4bb4-9ae5-1b2e4c3347b3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of options on common stock (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_70bd061f-d385-42ad-b445-1940260b765b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_99c5d944-0e79-43ff-8572-3ee8a3dd0c56_terseLabel_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit from income taxes</link:label>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit" xlink:to="lab_us-gaap_OtherTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_ef29eeb7-0022-49c2-b550-91e991e9cdaf_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of investments with unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_9b8bb225-524e-4e82-ba86-5571aa32d403_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_ebfd0974-8426-455b-a3bf-9cfeaf19d6eb_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_793a01fc-b5c1-4394-80bd-b3df3fcbbb50_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_ae39e453-c0dd-422b-8784-49c9e1339260_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of purchase price and post-combination expense</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5bc47277-0295-47be-933b-5d80e320ba67_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangements and Non-arrangement Transactions</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d11f6c74-b364-44d4-bc20-9107644f0d8a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_670ba498-7bb7-4017-8965-2f4d26a0402e_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_f7decf4b-f688-49ce-9f6e-5d37fa2f19fe_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock underlying warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_d85d8d89-a708-4225-835d-ae243a51612a_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant</link:label>
    <link:label id="lab_us-gaap_WarrantMember_ac7eae96-14a4-4718-afd1-b49b77fba651_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock subject to outstanding warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_616f1a38-5383-4f43-9d90-e570ccb3da6a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_BusinessCombinationAccruedLiabilitiesCurrent_3fb804aa-dae1-40f4-8d72-c28315894734_terseLabel_en-US" xlink:label="lab_nvta_BusinessCombinationAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and other liabilities associated with business combinations</link:label>
    <link:label id="lab_nvta_BusinessCombinationAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_nvta_BusinessCombinationAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Accrued Liabilities Current</link:label>
    <link:label id="lab_nvta_BusinessCombinationAccruedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_nvta_BusinessCombinationAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination accrued liabilities current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationAccruedLiabilitiesCurrent" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_BusinessCombinationAccruedLiabilitiesCurrent" xlink:to="lab_nvta_BusinessCombinationAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4a7e3545-7f3b-49a5-869e-ed54e639e9c5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_defe91a8-ec9d-4193-a293-caeaa3a9e735_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_415cfa4b-8292-4001-85ff-79ea76028627_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_ArcherDXInc.Member_eeb48c2f-148e-42c8-8b4d-a5f6530d482f_terseLabel_en-US" xlink:label="lab_nvta_ArcherDXInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ArcherDX</link:label>
    <link:label id="lab_nvta_ArcherDXInc.Member_label_en-US" xlink:label="lab_nvta_ArcherDXInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ArcherDX, Inc. [Member]</link:label>
    <link:label id="lab_nvta_ArcherDXInc.Member_documentation_en-US" xlink:label="lab_nvta_ArcherDXInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ArcherDX, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_ArcherDXInc.Member" xlink:to="lab_nvta_ArcherDXInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_754a526b-fede-486c-a7cf-f6b3367de25d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_71621ff2-7046-4d36-a4d2-59ffb4bd1c48_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_745b6941-4391-4565-bab5-742eb491086c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_02f6d180-11a1-4c0e-aca8-85aeda737b90_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total financial assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8d4778be-d02c-41e6-ac07-61c6b5dea3ce_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information of non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_5c48e7f6-5d3b-4bf6-85c5-53115ce459b2_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5feb14b6-0538-4af2-8b8f-885f29786afe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_c701678c-f0f7-48b3-8820-f733b2753e25_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer concentration risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_1965da31-0199-40cd-b0f9-9482685161c0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of estimated future amortization expense of intangible assets with finite lives</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_53f8335f-7d31-4c02-9294-23e3ad2fc742_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_f6263e1a-7ffc-4a23-a707-d06d9e8e9125_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockNameDomain" xlink:to="lab_us-gaap_ConversionOfStockNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_1ebe35af-f75e-452d-96cf-21105cb0c4f6_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f58c70fd-1920-4136-ae47-5777d6674e48_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e2ac63e1-991a-47e1-934e-706e5cc32fd9_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_3a951733-f3e4-475e-80d0-6d8d43cf634b_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_69c4e654-b71b-4fd1-bda0-8d2fc9b26bb8_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_57711afc-d05e-4278-84db-f1c6c2e87e3a_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loan</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease_46cb2668-5317-4c9e-bb0a-d1d354e4b09e_negatedTerseLabel_en-US" xlink:label="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease obligations</link:label>
    <link:label id="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease_label_en-US" xlink:label="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Operating Lease</link:label>
    <link:label id="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease_documentation_en-US" xlink:label="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Operating Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease" xlink:to="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_045123c4-480f-4fd2-84ea-7f50446c5287_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_9255aa56-f5c1-4310-b32a-04ac29e3cb8b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic information</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_0e8cb203-6fe4-48ff-8f21-9f793e6b35fb_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_09c060e2-21ea-4623-9f1e-ca46076f49fd_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, beginning of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_a9c8da33-74dc-4613-ae66-38bd46566b31_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, end of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_dc3db280-ae8d-4dba-907c-d7b21c39ba15_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_d472afee-0058-4549-9659-2f1b066d27bf_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.0001 par value: 400,000 shares authorized; 185,886 and 98,796 shares issued and outstanding as of December&#160;31, 2020 and 2019, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_e619a32e-7d62-4967-b9d4-518d10158df8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_534d2912-3673-412e-b3de-1d7d2e4c0632_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0a926cd2-9a14-4438-b1b9-7b91767465a0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum_444a34a8-ed35-45e7-895f-c113d2f568b5_terseLabel_en-US" xlink:label="lab_nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum threshold percentage of stock price trigger</link:label>
    <link:label id="lab_nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum_label_en-US" xlink:label="lab_nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger, Maximum</link:label>
    <link:label id="lab_nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum_documentation_en-US" xlink:label="lab_nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum" xlink:to="lab_nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_be6ceb01-4656-45d6-a798-68327fe78804_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_d5f7757a-0c81-4aa7-a053-6c7272d1f6ba_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_9238f1bc-bdf1-4d8b-a823-d5db6f60bca0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value, expense</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_3faf5c56-2c46-46e5-aeec-629d97d808de_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_2cfddeab-ece8-45d0-9c6a-b5239510516b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_193ab07d-062f-441b-9ccc-f9ab72c3cc3e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8efddb23-4d10-4e61-8789-243234dc9a13_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting rate upon anniversaries</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_87dd70f9-f2c7-4a5d-84ff-9d2643ee16a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_258b8bf9-237f-478a-bcad-65773f981379_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8484edfe-a874-46ac-b5c2-b87ac6b92b9e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_SeriesAConvertiblePreferredStockMember_db789d5f-4215-4f29-86bc-8eeeaa667995_terseLabel_en-US" xlink:label="lab_nvta_SeriesAConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock underlying Series A convertible preferred stock</link:label>
    <link:label id="lab_nvta_SeriesAConvertiblePreferredStockMember_label_en-US" xlink:label="lab_nvta_SeriesAConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_nvta_SeriesAConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_nvta_SeriesAConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A convertible preferred stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SeriesAConvertiblePreferredStockMember" xlink:href="nvta-20201231.xsd#nvta_SeriesAConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_SeriesAConvertiblePreferredStockMember" xlink:to="lab_nvta_SeriesAConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_2f4d5df7-0399-44a5-a1dc-d839e7127dfa_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_0a48a834-4359-43c7-b70e-b135ed50847f_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAbstract_label_en-US" xlink:label="lab_us-gaap_OffsettingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAbstract" xlink:to="lab_us-gaap_OffsettingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_ffd0afba-0083-4a54-999d-24da3b6e9e3b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_11579d43-2976-4163-8a29-681b55b97682_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_629ad1ee-8307-45e1-bea8-5c9939fd961f_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_d92e314f-189b-4e72-8804-7892a353294a_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_4b807a75-f05c-4fb7-9178-2dd09273fd66_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease to additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts_08205943-b19e-487e-8d1e-53782ef010b6_terseLabel_en-US" xlink:label="lab_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of underwritten public offering</link:label>
    <link:label id="lab_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts_label_en-US" xlink:label="lab_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Underwritten Public Offering Of Common Stock Net Of Issuance Costs</link:label>
    <link:label id="lab_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts_documentation_en-US" xlink:label="lab_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of underwritten public offering of common stock net of issuance costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts" xlink:href="nvta-20201231.xsd#nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts" xlink:to="lab_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset_8cf17357-efd1-4247-b976-02b3d48a75ea_negatedTerseLabel_en-US" xlink:label="lab_nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasing Assets</link:label>
    <link:label id="lab_nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset_label_en-US" xlink:label="lab_nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset_documentation_en-US" xlink:label="lab_nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset" xlink:href="nvta-20201231.xsd#nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset" xlink:to="lab_nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_b54c6de5-fd86-4820-b40e-946577816e33_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, total purchase consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_1d0e4926-bfb1-42de-97a4-f5e1b3a89746_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_de2c0417-dd2e-461f-85ca-32d3bfe2ddde_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition common stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a7a552ba-bcdc-476c-af80-acb45927930a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage_f2ba283d-3efc-439a-89bf-32403bac2e06_terseLabel_en-US" xlink:label="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees holding voting rights of all classes of stock (as a percent)</link:label>
    <link:label id="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage_label_en-US" xlink:label="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Voting Rights Of Common Stock Holding Percentage</link:label>
    <link:label id="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage_documentation_en-US" xlink:label="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the percentage of voting rights of all classes of stock held by the employees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage" xlink:href="nvta-20201231.xsd#nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage" xlink:to="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_973ba024-782c-48e3-8f65-f3514e091f2d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_a45a25aa-968f-4a17-808a-30884d005647_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_6870cd34-0e8d-403d-bdfc-44124217136b_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_fe1ce729-6df8-4ce7-b8a9-abe24d869db1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock subject to outstanding RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_96074e10-7436-4488-8f07-6d1bc29af859_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_cf28792b-3311-4ae6-bc09-ba2e2691cc80_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_OtherBusinessToBusinessMember_570ef60a-303c-4e34-a377-3d7144a83d4a_terseLabel_en-US" xlink:label="lab_nvta_OtherBusinessToBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other business-to-business</link:label>
    <link:label id="lab_nvta_OtherBusinessToBusinessMember_label_en-US" xlink:label="lab_nvta_OtherBusinessToBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Business-to-Business [Member]</link:label>
    <link:label id="lab_nvta_OtherBusinessToBusinessMember_documentation_en-US" xlink:label="lab_nvta_OtherBusinessToBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Business-to-Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_OtherBusinessToBusinessMember" xlink:href="nvta-20201231.xsd#nvta_OtherBusinessToBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_OtherBusinessToBusinessMember" xlink:to="lab_nvta_OtherBusinessToBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5148b5e8-3da2-414b-9512-2a5219df1bd9_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_741e928e-c8d6-4cc8-8d9b-e38586831c84_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_da99c77d-e33d-4157-a447-370a71dd57b8_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction-in-progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_ed24ae87-3429-4744-8b44-07ba972b80ca_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_CollaborationAndGenomeNetworkMember_40e26a2e-41d0-4858-872a-513b074f64ab_terseLabel_en-US" xlink:label="lab_nvta_CollaborationAndGenomeNetworkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenue</link:label>
    <link:label id="lab_nvta_CollaborationAndGenomeNetworkMember_label_en-US" xlink:label="lab_nvta_CollaborationAndGenomeNetworkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration And Genome Network [Member]</link:label>
    <link:label id="lab_nvta_CollaborationAndGenomeNetworkMember_documentation_en-US" xlink:label="lab_nvta_CollaborationAndGenomeNetworkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration and genome network.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CollaborationAndGenomeNetworkMember" xlink:href="nvta-20201231.xsd#nvta_CollaborationAndGenomeNetworkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_CollaborationAndGenomeNetworkMember" xlink:to="lab_nvta_CollaborationAndGenomeNetworkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_3433f220-b4f7-4040-a2e1-f9d9c7e2c6a8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, revenue recognition and cost of revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionDomain_8f683cab-599c-44b9-ac28-0d72a1da8f57_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_TransactionDomain_label_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionDomain" xlink:to="lab_us-gaap_TransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_079519c5-3b10-46c5-acc7-70e210f843cf_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligation, net of current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_b63566d0-2757-4129-ae7a-d2d989ce5560_netLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease obligations, net of current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_DebtInstrumentPrepaymentFeePercentage_f8cd8577-dbaf-4397-b19a-35296e6d3e05_terseLabel_en-US" xlink:label="lab_nvta_DebtInstrumentPrepaymentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment fee</link:label>
    <link:label id="lab_nvta_DebtInstrumentPrepaymentFeePercentage_label_en-US" xlink:label="lab_nvta_DebtInstrumentPrepaymentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Fee, Percentage</link:label>
    <link:label id="lab_nvta_DebtInstrumentPrepaymentFeePercentage_documentation_en-US" xlink:label="lab_nvta_DebtInstrumentPrepaymentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Fee, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentPrepaymentFeePercentage" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentPrepaymentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_DebtInstrumentPrepaymentFeePercentage" xlink:to="lab_nvta_DebtInstrumentPrepaymentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_PerformanceRestrictedStockUnitsRsusMember_017cd6dd-0c4d-408b-af1d-dd668a27162c_terseLabel_en-US" xlink:label="lab_nvta_PerformanceRestrictedStockUnitsRsusMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock subject to outstanding PRSUs</link:label>
    <link:label id="lab_nvta_PerformanceRestrictedStockUnitsRsusMember_label_en-US" xlink:label="lab_nvta_PerformanceRestrictedStockUnitsRsusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Units Rsus [Member]</link:label>
    <link:label id="lab_nvta_PerformanceRestrictedStockUnitsRsusMember_documentation_en-US" xlink:label="lab_nvta_PerformanceRestrictedStockUnitsRsusMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share instrument which is convertible to stock or an equivalent amount of cash, when specified performance conditions are met.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PerformanceRestrictedStockUnitsRsusMember" xlink:href="nvta-20201231.xsd#nvta_PerformanceRestrictedStockUnitsRsusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_PerformanceRestrictedStockUnitsRsusMember" xlink:to="lab_nvta_PerformanceRestrictedStockUnitsRsusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_08cba10e-e05f-438b-a99c-cfb9e011328b_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_43c232db-f093-4de7-9fbd-6322b55f8f26_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_0950ffc1-738a-4356-b830-7f8e1fb3241b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_83c269de-a111-4d01-831a-4b8399ce7319_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_5344387b-fb25-4f60-8b00-2a26a0d891c5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_e3b97588-87d8-46c7-8986-ce785012c117_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_e5b19fcf-df32-4e76-90da-d52f7a902aad_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State taxes (net of federal benefit)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_AccelerationofVestedEquityMember_57936226-401b-4a7a-8b67-c033bd4897a9_terseLabel_en-US" xlink:label="lab_nvta_AccelerationofVestedEquityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-combination Expense</link:label>
    <link:label id="lab_nvta_AccelerationofVestedEquityMember_label_en-US" xlink:label="lab_nvta_AccelerationofVestedEquityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acceleration of Vested Equity [Member]</link:label>
    <link:label id="lab_nvta_AccelerationofVestedEquityMember_documentation_en-US" xlink:label="lab_nvta_AccelerationofVestedEquityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acceleration of Vested Equity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_AccelerationofVestedEquityMember" xlink:href="nvta-20201231.xsd#nvta_AccelerationofVestedEquityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_AccelerationofVestedEquityMember" xlink:to="lab_nvta_AccelerationofVestedEquityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod_60c3b8c7-5f5a-4a7f-8d59-43c3e89af5aa_terseLabel_en-US" xlink:label="lab_nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted and adjustments (in shares)</link:label>
    <link:label id="lab_nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod_label_en-US" xlink:label="lab_nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants and Adjustments in Period</link:label>
    <link:label id="lab_nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod_documentation_en-US" xlink:label="lab_nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants and Adjustments in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod" xlink:href="nvta-20201231.xsd#nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod" xlink:to="lab_nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue_a414c42e-32e8-43cd-9028-7c22db628f77_totalLabel_en-US" xlink:label="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets</link:label>
    <link:label id="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue_label_en-US" xlink:label="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents Restricted Cash And Marketable Securities Fair Value</link:label>
    <link:label id="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue_documentation_en-US" xlink:label="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents restricted cash and marketable securities fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" xlink:href="nvta-20201231.xsd#nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" xlink:to="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_0fe5a15a-89de-4a65-b5f5-b41f3735ab53_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8090fae7-7ead-4e72-b1fb-5dcdded04c16_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_5f64c08e-768b-40d3-bbd9-21a1852b98b1_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended_2519b953-5c4e-4529-9488-af91aa2d74b3_terseLabel_en-US" xlink:label="lab_nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of debt extended</link:label>
    <link:label id="lab_nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended_label_en-US" xlink:label="lab_nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Terms, Percent of Debt Extended</link:label>
    <link:label id="lab_nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended_documentation_en-US" xlink:label="lab_nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Terms, Percent of Debt Extended</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended" xlink:to="lab_nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_b8a1020a-fdc3-414a-a4a6-93ff870000a5_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays_e2715a5e-ff64-4c6b-9c39-af2e20115c70_terseLabel_en-US" xlink:label="lab_nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days immediately after five consecutive trading days</link:label>
    <link:label id="lab_nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays_label_en-US" xlink:label="lab_nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days Immediately after Five Consecutive Trading Days</link:label>
    <link:label id="lab_nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays_documentation_en-US" xlink:label="lab_nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days Immediately after Five Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays" xlink:to="lab_nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_CowenAndCompanyLimitedLiabilityCompanyMember_0e4e1407-3d49-4179-b0a9-f6fb6f13c9ea_terseLabel_en-US" xlink:label="lab_nvta_CowenAndCompanyLimitedLiabilityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cowen and Company, LLC</link:label>
    <link:label id="lab_nvta_CowenAndCompanyLimitedLiabilityCompanyMember_label_en-US" xlink:label="lab_nvta_CowenAndCompanyLimitedLiabilityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cowen And Company Limited Liability Company [Member]</link:label>
    <link:label id="lab_nvta_CowenAndCompanyLimitedLiabilityCompanyMember_documentation_en-US" xlink:label="lab_nvta_CowenAndCompanyLimitedLiabilityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cowen and company limited liability company.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CowenAndCompanyLimitedLiabilityCompanyMember" xlink:href="nvta-20201231.xsd#nvta_CowenAndCompanyLimitedLiabilityCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_CowenAndCompanyLimitedLiabilityCompanyMember" xlink:to="lab_nvta_CowenAndCompanyLimitedLiabilityCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dca3a82f-a20f-4034-81a2-1c9345dee866_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible expenses</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_e18ca709-cd06-4e85-a3ff-50a467d52a98_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_ff9b6a25-6a24-46e6-b699-97030f99e4e3_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_61128390-e155-492f-8ef9-85c1f1ab5404_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock:</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_b93bb5ca-5004-4b2f-8775-328f5ade07a0_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_2eb160dd-1be0-429b-98d8-8b43437d7860_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_783faf2a-31ce-42a7-859c-a8cd47c08a08_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_5d19969f-ae83-4a93-99fb-19a6ebeaf86d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_8d8c5cd1-4613-45bf-8b2d-1f1a24d144c1_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_26fa04d5-b6de-49b6-86d0-d0f852d378f0_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_7621e205-f24b-4b89-8df7-9ebe953d5291_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred_76ec888e-6c36-4268-af1e-9b93b94dc673_terseLabel_en-US" xlink:label="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock transferred</link:label>
    <link:label id="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred_label_en-US" xlink:label="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Common Stock Transferred</link:label>
    <link:label id="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred_documentation_en-US" xlink:label="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Common Stock Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred" xlink:to="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_7c4ce404-a1f4-407c-9e52-ccdf71424e65_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_45599685-82a6-4f0d-9aca-e0a6fb0131a5_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_5f09eb86-ff35-4e26-a864-fb24eebaac69_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_6af943e9-d398-422c-b725-ab256f08b633_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsIncurred_8720e21e-e69e-499b-82aa-7ad32fee045f_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment acquired through finance leases</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsIncurred_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Obligation Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsIncurred" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsIncurred" xlink:to="lab_us-gaap_CapitalLeaseObligationsIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2aa9ae9c-ad4d-4eb6-86a6-23c251480fd6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5fe9eabb-9d94-4939-b218-e10159164439_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7fe8de77-ba99-4a89-9020-20abcac663ec_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_526d7918-b6ff-4e20-bb92-c9c868b91cb2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_b324006e-722f-4223-b9e8-7200219ae5e1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock subject to outstanding options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_54d435c0-57dd-4b73-a787-5c171151e0dc_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_RestOfWorldMember_ba0de619-8d47-4597-b376-b49e12870a3e_terseLabel_en-US" xlink:label="lab_nvta_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of world</link:label>
    <link:label id="lab_nvta_RestOfWorldMember_label_en-US" xlink:label="lab_nvta_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of World [Member]</link:label>
    <link:label id="lab_nvta_RestOfWorldMember_documentation_en-US" xlink:label="lab_nvta_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to rest of the world.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RestOfWorldMember" xlink:href="nvta-20201231.xsd#nvta_RestOfWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_RestOfWorldMember" xlink:to="lab_nvta_RestOfWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesFinancingArrangements_022a64c3-2046-4c87-b9ab-3736b01ea7df_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesFinancingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesFinancingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesFinancingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Financing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesFinancingArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesFinancingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesFinancingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesFinancingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_fa975f80-6791-485b-a2c9-70cbdf2d5d4f_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_367fbefd-de8d-4275-94dc-38dfa3d2ce2e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_614a1f21-4a2f-47cf-96b9-4fd65e52ac4c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_7b8eda7b-6c62-41e5-98d0-ed32109d17a8_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_312d463f-0fde-4d04-afef-1e2e8745eec4_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_A2019IncentiveCompensationPlanMember_c7936ad3-d1fc-4fae-bbac-ae56b5e9cdfb_terseLabel_en-US" xlink:label="lab_nvta_A2019IncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Incentive Compensation Plan</link:label>
    <link:label id="lab_nvta_A2019IncentiveCompensationPlanMember_label_en-US" xlink:label="lab_nvta_A2019IncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Incentive Compensation Plan [Member]</link:label>
    <link:label id="lab_nvta_A2019IncentiveCompensationPlanMember_documentation_en-US" xlink:label="lab_nvta_A2019IncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Incentive Compensation Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_A2019IncentiveCompensationPlanMember" xlink:href="nvta-20201231.xsd#nvta_A2019IncentiveCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_A2019IncentiveCompensationPlanMember" xlink:to="lab_nvta_A2019IncentiveCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent_726bdc0f-ac59-43d6-aa07-f8a0773e9463_terseLabel_en-US" xlink:label="lab_nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in officer salary</link:label>
    <link:label id="lab_nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent_label_en-US" xlink:label="lab_nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Reduction in Officer Salary, Percent</link:label>
    <link:label id="lab_nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent_documentation_en-US" xlink:label="lab_nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Reduction in Officer Salary, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent" xlink:href="nvta-20201231.xsd#nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent" xlink:to="lab_nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_GenelexMember_d060a61a-25f3-4f90-a64b-8f0c7e8b3583_terseLabel_en-US" xlink:label="lab_nvta_GenelexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genelex</link:label>
    <link:label id="lab_nvta_GenelexMember_label_en-US" xlink:label="lab_nvta_GenelexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genelex [Member]</link:label>
    <link:label id="lab_nvta_GenelexMember_documentation_en-US" xlink:label="lab_nvta_GenelexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genelex [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_GenelexMember" xlink:href="nvta-20201231.xsd#nvta_GenelexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_GenelexMember" xlink:to="lab_nvta_GenelexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_ab01861d-e28f-40bf-870e-3680934aed8e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0478f4a8-6066-4e33-9e1b-10e87e335bd1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_23fb7265-87fe-4b01-bb33-abbe27fcec2a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_cc8a9ecb-ca5f-4ce9-ad12-41a7b4336ebf_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total financial liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_9a909d96-e2ff-4f11-9e21-a2dca19b4d37_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_88b21cc8-174d-4d36-acbe-73883912c858_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_dabe2063-70cc-4865-a5f2-727181ef4f5e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of revenue by geographic region</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract_8572eb3b-bbe9-4520-b483-d4ca372194bc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-combination Expense</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2a46a0e7-0fbc-4be0-ae09-201329347d4b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligation_c0b53dee-312e-4058-8254-ae3122769807_totalLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligation_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligation" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_96d5bd3a-8f55-4296-bb01-5ae94dd8bf21_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_6005761d-e3dc-4d1f-9be0-6b3b0527212f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_6a12becd-76c1-4360-819d-2d1235e91a75_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_LeasesExpense_494034ea-2891-46dc-8437-7b51315ee62a_totalLabel_en-US" xlink:label="lab_nvta_LeasesExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease costs</link:label>
    <link:label id="lab_nvta_LeasesExpense_label_en-US" xlink:label="lab_nvta_LeasesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Expense</link:label>
    <link:label id="lab_nvta_LeasesExpense_documentation_en-US" xlink:label="lab_nvta_LeasesExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_LeasesExpense" xlink:href="nvta-20201231.xsd#nvta_LeasesExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_LeasesExpense" xlink:to="lab_nvta_LeasesExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_f3a782e8-e4af-4a41-9ee7-c5fc8f053a49_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_a7c1f2d8-353a-4976-a2bb-e02edc38dc95_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d6beb88b-f101-44bc-b0db-f47ea0f2b4c4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_9e922240-39c9-41f0-89c6-59509686de5a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete agreement</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a495b86f-1958-4068-b2dc-d6b3e62b07f8_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f2722704-0265-455b-afd3-7241d492e1d7_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_77438cc7-eabc-4e04-8cce-5372958719e1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_83bea2a6-96f2-4a61-bf70-0750e3407180_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred benefit for income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_b65496a1-f399-4680-bc5c-95a8b55eb065_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_35bee241-742a-4abd-8bfe-cfb8c716a9fd_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived asset impairment losses</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c2754830-988a-46cd-8f01-051383f71f0b_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_fb51e25a-c092-4bae-b537-b05bfe5b2dd1_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_8600c647-37a4-4234-96dc-7667e47ca4a8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_CustomerMember_46fecf75-84be-4754-8b47-c780b8e5fb02_terseLabel_en-US" xlink:label="lab_nvta_CustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_nvta_CustomerMember_label_en-US" xlink:label="lab_nvta_CustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Member]</link:label>
    <link:label id="lab_nvta_CustomerMember_documentation_en-US" xlink:label="lab_nvta_CustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to Customer A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CustomerMember" xlink:href="nvta-20201231.xsd#nvta_CustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_CustomerMember" xlink:to="lab_nvta_CustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts_3071163c-19ce-405f-89ce-bd7d96e40c06_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants issued pursuant to loan agreement</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b6495cd2-8042-45b3-b737-ffdf687cd8ba_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a532337-80ce-45b9-805c-e290f43904d4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_543f1df8-3484-4f6c-92f9-8c5b3b75e4f3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_fef01855-1f5e-4d36-8301-e9c6d931b193_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_7c0da262-1308-452f-ae86-aa5930af1a37_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivatePlacementMember_e38e6992-92f2-40ef-90e9-e725c4c2190f_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private placement</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_PatientInsuranceMember_097811cb-bd04-448a-a9cd-e6594a3ba89f_terseLabel_en-US" xlink:label="lab_nvta_PatientInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Insurance</link:label>
    <link:label id="lab_nvta_PatientInsuranceMember_label_en-US" xlink:label="lab_nvta_PatientInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Insurance [Member]</link:label>
    <link:label id="lab_nvta_PatientInsuranceMember_documentation_en-US" xlink:label="lab_nvta_PatientInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient insurance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PatientInsuranceMember" xlink:href="nvta-20201231.xsd#nvta_PatientInsuranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_PatientInsuranceMember" xlink:to="lab_nvta_PatientInsuranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6dd191c8-e39f-4851-b2e9-4c05ccb9e41c_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_LeasesWeightedAverageRemainingLeaseTermAbstract_549c8866-6f59-43df-859d-88e7710fb1be_terseLabel_en-US" xlink:label="lab_nvta_LeasesWeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term:</link:label>
    <link:label id="lab_nvta_LeasesWeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_nvta_LeasesWeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted-Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_nvta_LeasesWeightedAverageRemainingLeaseTermAbstract_documentation_en-US" xlink:label="lab_nvta_LeasesWeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted-Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_LeasesWeightedAverageRemainingLeaseTermAbstract" xlink:href="nvta-20201231.xsd#nvta_LeasesWeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_LeasesWeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_nvta_LeasesWeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_fb2b7f8f-0f90-4378-8f6a-72e3974312a3_verboseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing and Laboratory equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_ba791e00-6e3d-4a4d-b995-d2b09752db25_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_12b2a873-1417-4e04-98f3-e17b237d428c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_73024fa1-011c-430d-85b8-7e09882c8e71_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_dcc68a50-7ce2-4cfe-a5b8-db4c8796ec82_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_ddd3b29f-82f9-4e53-a9c5-394fd6fefb31_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments_bd8df2dc-d92e-410b-98ea-8f6c65d78f82_terseLabel_en-US" xlink:label="lab_nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments_label_en-US" xlink:label="lab_nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments and Other Ancillary Payments</link:label>
    <link:label id="lab_nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments_documentation_en-US" xlink:label="lab_nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments and Other Ancillary Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments" xlink:href="nvta-20201231.xsd#nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments" xlink:to="lab_nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_39387be7-9253-4085-94a2-79122426525f_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_44c0c932-b80c-48c6-be7f-7a96c2948e69_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combinations and License agreements</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_8eb1a790-b015-495b-91a4-9bae711bef50_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_320b7ce0-aa98-4232-b2ee-84ecc88c31c7_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5482fe05-8a8a-4e0a-a14b-27936696868c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e2a4d7e4-9678-42e7-8ef1-b53051fcb79b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_af36c51f-1c02-4d83-8a0d-e7e32f694bc9_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_b49185c4-353a-443f-a5ba-8cf47fba05ea_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0cff93c1-b128-4b88-b52b-cbf73e476418_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_a15ea4fa-f926-4321-be0e-3634a6ea0810_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_9eea4824-1408-4676-9c3b-012f48395e1a_verboseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_RepaymentsofLinesofCreditAccruedInterest_85b6326b-b15f-4689-8683-14bd9374e121_terseLabel_en-US" xlink:label="lab_nvta_RepaymentsofLinesofCreditAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of accrued interest</link:label>
    <link:label id="lab_nvta_RepaymentsofLinesofCreditAccruedInterest_label_en-US" xlink:label="lab_nvta_RepaymentsofLinesofCreditAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit, Accrued Interest</link:label>
    <link:label id="lab_nvta_RepaymentsofLinesofCreditAccruedInterest_documentation_en-US" xlink:label="lab_nvta_RepaymentsofLinesofCreditAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit, Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RepaymentsofLinesofCreditAccruedInterest" xlink:href="nvta-20201231.xsd#nvta_RepaymentsofLinesofCreditAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_RepaymentsofLinesofCreditAccruedInterest" xlink:to="lab_nvta_RepaymentsofLinesofCreditAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_4f00bbe8-4c16-4c3a-aa5a-6d920f058d2b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4b748a15-fbda-4525-8a6e-41270164a2ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_683e919d-5507-475d-b450-f288641c3b01_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_EarningsPerShareLineItems_805bfa94-24b0-46f4-bf61-235b09d48703_terseLabel_en-US" xlink:label="lab_nvta_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_nvta_EarningsPerShareLineItems_label_en-US" xlink:label="lab_nvta_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_nvta_EarningsPerShareLineItems_documentation_en-US" xlink:label="lab_nvta_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_EarningsPerShareLineItems" xlink:href="nvta-20201231.xsd#nvta_EarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_EarningsPerShareLineItems" xlink:to="lab_nvta_EarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_becc9a20-eec8-4277-8f3b-86a65077701d_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract" xlink:to="lab_us-gaap_LeasesOperatingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_YouScriptMember_5b999677-1708-4a45-990b-9cc444afd566_terseLabel_en-US" xlink:label="lab_nvta_YouScriptMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">YouScript</link:label>
    <link:label id="lab_nvta_YouScriptMember_label_en-US" xlink:label="lab_nvta_YouScriptMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">YouScript [Member]</link:label>
    <link:label id="lab_nvta_YouScriptMember_documentation_en-US" xlink:label="lab_nvta_YouScriptMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">YouScript [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_YouScriptMember" xlink:href="nvta-20201231.xsd#nvta_YouScriptMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_YouScriptMember" xlink:to="lab_nvta_YouScriptMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_6ab98ec3-4012-4aa4-8b1c-2c5aee086ba8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_TimebasedRSUsandPRSUsMember_4d2d5461-c149-44e5-a0ed-08e0dcd311ca_terseLabel_en-US" xlink:label="lab_nvta_TimebasedRSUsandPRSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-based RSUs and PRSUs</link:label>
    <link:label id="lab_nvta_TimebasedRSUsandPRSUsMember_label_en-US" xlink:label="lab_nvta_TimebasedRSUsandPRSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-based RSUs and PRSUs [Member]</link:label>
    <link:label id="lab_nvta_TimebasedRSUsandPRSUsMember_documentation_en-US" xlink:label="lab_nvta_TimebasedRSUsandPRSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-based RSUs and PRSUs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_TimebasedRSUsandPRSUsMember" xlink:href="nvta-20201231.xsd#nvta_TimebasedRSUsandPRSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_TimebasedRSUsandPRSUsMember" xlink:to="lab_nvta_TimebasedRSUsandPRSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_9266828c-a560-4220-9af4-9e70b01ee7b9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_1b4da34c-9b23-481c-8956-b02e996ebf50_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_249b1f53-49a6-4b5d-b023-f241a0d60f48_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_3498f04f-3278-45c2-a096-67012998627f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_acb6ba19-bfb0-4b0b-8ca0-6a7899d46c3a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price, percent of fair market value of common stock</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f6bbe56e-f9f1-4718-8671-1d0c4cb150cc_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_831b2fd9-6cc7-438e-8057-ef2ab5946d30_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebtNoncurrent_8c1f432e-ab27-49c1-a170-66ff356a8461_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebtNoncurrent" xlink:to="lab_us-gaap_OtherLongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_RepaymentsofLinesofCreditPrincipal_5afd7091-0ae5-4f82-b08f-8e2eacc73263_terseLabel_en-US" xlink:label="lab_nvta_RepaymentsofLinesofCreditPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of principal</link:label>
    <link:label id="lab_nvta_RepaymentsofLinesofCreditPrincipal_label_en-US" xlink:label="lab_nvta_RepaymentsofLinesofCreditPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit, Principal</link:label>
    <link:label id="lab_nvta_RepaymentsofLinesofCreditPrincipal_documentation_en-US" xlink:label="lab_nvta_RepaymentsofLinesofCreditPrincipal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RepaymentsofLinesofCreditPrincipal" xlink:href="nvta-20201231.xsd#nvta_RepaymentsofLinesofCreditPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_RepaymentsofLinesofCreditPrincipal" xlink:to="lab_nvta_RepaymentsofLinesofCreditPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_SubjectToExpirationMember_2507a231-9b32-41af-adb2-fee19b1fe7a2_terseLabel_en-US" xlink:label="lab_nvta_SubjectToExpirationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Begins to expire 2030</link:label>
    <link:label id="lab_nvta_SubjectToExpirationMember_label_en-US" xlink:label="lab_nvta_SubjectToExpirationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subject To Expiration [Member]</link:label>
    <link:label id="lab_nvta_SubjectToExpirationMember_documentation_en-US" xlink:label="lab_nvta_SubjectToExpirationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration, Tax Year 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SubjectToExpirationMember" xlink:href="nvta-20201231.xsd#nvta_SubjectToExpirationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_SubjectToExpirationMember" xlink:to="lab_nvta_SubjectToExpirationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_ceab4308-0892-4802-9da0-841ac863e267_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a8ba37a2-89d2-4bb5-9618-ba8709b9b42e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_6961f83d-6da0-4c38-b3a5-8ef0ca723754_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 8)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays_5cf45deb-6004-482b-b07e-32f3be37eaa9_terseLabel_en-US" xlink:label="lab_nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays_label_en-US" xlink:label="lab_nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Period, Threshold Trading Days</link:label>
    <link:label id="lab_nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays_documentation_en-US" xlink:label="lab_nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Period, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays" xlink:to="lab_nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_011d4f97-edb4-454b-b786-b3356eb701b0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second anniversary</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_31a6eb3c-ae74-4765-8a52-ee6d100d52bf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Description [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:to="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8878a430-d26c-4b54-b9b0-c0a5eed53463_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_b203bbf3-1588-4974-833d-2cacffffae95_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_32e9b766-19d4-47f2-b7c9-5b0b8a837139_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_83f3315d-14fb-4844-a8a0-302d29b4a613_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_abee208a-1b26-4b4c-b958-66a44ad34fca_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_fbd4927d-ff12-46c6-a3ec-e9f08b1754a5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested stock units awarded (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_bd36c608-8d31-4bd5-91ea-e0ba00c6f935_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_e9ea3d78-63b0-48f8-8c5c-ec4086009f04_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_12d8061b-569a-42d5-8a7d-44ef0a697883_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_7ddf114a-58e7-45c1-8341-483d240be506_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_50f44499-c214-41f9-94aa-b77f3eada3ab_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_30fffd11-8b1e-4f66-a6c4-9d08840949c0_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_779612b3-e082-4f4b-94ea-30056312959e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_6eef1ccc-8308-4910-8261-61c6cd42938b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_e636826c-bd52-4f8e-b15d-d4f781fbb310_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment costs</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_ae23d764-f5c1-4d6c-82a7-92e514a7ba95_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and depreciation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_BusinessCombinationHoldbackConsiderationCash_aceb0edd-99ed-4454-97d5-68271a545c61_terseLabel_en-US" xlink:label="lab_nvta_BusinessCombinationHoldbackConsiderationCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hold-back consideration - cash</link:label>
    <link:label id="lab_nvta_BusinessCombinationHoldbackConsiderationCash_label_en-US" xlink:label="lab_nvta_BusinessCombinationHoldbackConsiderationCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Hold-back Consideration, Cash</link:label>
    <link:label id="lab_nvta_BusinessCombinationHoldbackConsiderationCash_documentation_en-US" xlink:label="lab_nvta_BusinessCombinationHoldbackConsiderationCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Hold-back Consideration, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCash" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_BusinessCombinationHoldbackConsiderationCash" xlink:to="lab_nvta_BusinessCombinationHoldbackConsiderationCash" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_PreferredStockToCommonStockConversionRatio_23fd5baf-210b-4a15-bb50-2810bf45ef88_terseLabel_en-US" xlink:label="lab_nvta_PreferredStockToCommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion basis</link:label>
    <link:label id="lab_nvta_PreferredStockToCommonStockConversionRatio_label_en-US" xlink:label="lab_nvta_PreferredStockToCommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock To Common Stock Conversion Ratio</link:label>
    <link:label id="lab_nvta_PreferredStockToCommonStockConversionRatio_documentation_en-US" xlink:label="lab_nvta_PreferredStockToCommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock to common stock conversion ratio.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PreferredStockToCommonStockConversionRatio" xlink:href="nvta-20201231.xsd#nvta_PreferredStockToCommonStockConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_PreferredStockToCommonStockConversionRatio" xlink:to="lab_nvta_PreferredStockToCommonStockConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_6f6764cc-072d-4736-870d-91fb5f7071f7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a658c26f-c9f4-48df-9063-c7da31e30034_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_TestRevenueDecentralizedMember_bcd4aea7-d018-49c3-b211-97fef7c92aca_terseLabel_en-US" xlink:label="lab_nvta_TestRevenueDecentralizedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decentralized</link:label>
    <link:label id="lab_nvta_TestRevenueDecentralizedMember_label_en-US" xlink:label="lab_nvta_TestRevenueDecentralizedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Test Revenue, Decentralized [Member]</link:label>
    <link:label id="lab_nvta_TestRevenueDecentralizedMember_documentation_en-US" xlink:label="lab_nvta_TestRevenueDecentralizedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Test Revenue, Decentralized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_TestRevenueDecentralizedMember" xlink:href="nvta-20201231.xsd#nvta_TestRevenueDecentralizedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_TestRevenueDecentralizedMember" xlink:to="lab_nvta_TestRevenueDecentralizedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_30f420b3-7ba4-4476-95bb-3db2b62d9c8b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Sublease Rentals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_3f673e1b-716c-4a63-8491-d11747ca2c9c_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_4ca3bf2f-8c75-4178-bd86-b03078f900eb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_1c711856-4e8b-4699-b25f-9e4848d3db0e_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_80640a44-1f8d-455b-9a8d-f9b3bd8caa5f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_777e1dda-aa2f-4ca6-a90e-3603a2e6d2a8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of debt extinguishment costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_f714c75f-37d4-4f3f-a883-0fe2755f7966_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_a8935568-cbd0-449e-bd26-9ef4ece7aa76_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e019aa3d-78f7-4db6-90c3-89abe26052f0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_LeasesWeightedAverageDiscountRateAbstract_7d8311fa-98f8-435d-919b-29c44b221bf5_terseLabel_en-US" xlink:label="lab_nvta_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate:</link:label>
    <link:label id="lab_nvta_LeasesWeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_nvta_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted-Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_nvta_LeasesWeightedAverageDiscountRateAbstract_documentation_en-US" xlink:label="lab_nvta_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted-Average Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_LeasesWeightedAverageDiscountRateAbstract" xlink:href="nvta-20201231.xsd#nvta_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_LeasesWeightedAverageDiscountRateAbstract" xlink:to="lab_nvta_LeasesWeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c895e7bb-d890-441e-8a29-3a9964539b57_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_561912fd-5c39-4220-8ad6-18b13ac26b21_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_e1038ca2-8148-4305-805b-16511940f782_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising expense</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_OfficeFacilityInSanFranciscoTwoMember_22190772-159b-4008-8da4-acfe38fe31e2_terseLabel_en-US" xlink:label="lab_nvta_OfficeFacilityInSanFranciscoTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional office facility in San Francisco</link:label>
    <link:label id="lab_nvta_OfficeFacilityInSanFranciscoTwoMember_label_en-US" xlink:label="lab_nvta_OfficeFacilityInSanFranciscoTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Facility In San Francisco, Two [Member]</link:label>
    <link:label id="lab_nvta_OfficeFacilityInSanFranciscoTwoMember_documentation_en-US" xlink:label="lab_nvta_OfficeFacilityInSanFranciscoTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Facility In San Francisco, Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_OfficeFacilityInSanFranciscoTwoMember" xlink:href="nvta-20201231.xsd#nvta_OfficeFacilityInSanFranciscoTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_OfficeFacilityInSanFranciscoTwoMember" xlink:to="lab_nvta_OfficeFacilityInSanFranciscoTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_d186d41e-0e5f-4296-952f-8853ff219c08_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_8c84c36b-ff1c-4982-a0e6-651b89c9e41d_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_65d067d3-3116-47e6-b128-12940aded3c6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_15848e05-d4ed-4950-ba30-b46590664477_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued pursuant to acquisitions (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_18cf363d-34fd-4278-8e2d-04d5e9f79d77_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_48fd411b-bb74-4879-9610-6696d86c4fcc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_f9199a71-f3e9-43cb-a03d-6294ad0ab73f_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_6663323c-a461-4f46-b985-8e961babfe33_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_198d0f3a-8f09-4b77-8444-39bc3dfd73a6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_399f7d82-e4bc-46b0-877a-e2ec8a202969_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock subject to Convertible Senior Notes conversion</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_b64d56cc-4e85-4881-bef9-ca812cd8bf36_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_961a184d-2230-494d-846e-4e022b55dd50_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_PercentageOfCommissionPayableOnGrossProceeds_89524cf8-4262-414b-b089-80d0e986574b_terseLabel_en-US" xlink:label="lab_nvta_PercentageOfCommissionPayableOnGrossProceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of commission payable on gross proceeds</link:label>
    <link:label id="lab_nvta_PercentageOfCommissionPayableOnGrossProceeds_label_en-US" xlink:label="lab_nvta_PercentageOfCommissionPayableOnGrossProceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Commission Payable On Gross Proceeds</link:label>
    <link:label id="lab_nvta_PercentageOfCommissionPayableOnGrossProceeds_documentation_en-US" xlink:label="lab_nvta_PercentageOfCommissionPayableOnGrossProceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of commission payable on gross proceeds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PercentageOfCommissionPayableOnGrossProceeds" xlink:href="nvta-20201231.xsd#nvta_PercentageOfCommissionPayableOnGrossProceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_PercentageOfCommissionPayableOnGrossProceeds" xlink:to="lab_nvta_PercentageOfCommissionPayableOnGrossProceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax_29719ad9-ca6a-457e-8114-3508840e77a6_terseLabel_en-US" xlink:label="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost Gross Unrealized Gain Before Tax</link:label>
    <link:label id="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost Gross Unrealized Gain Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" xlink:href="nvta-20201231.xsd#nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" xlink:to="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9ee49b21-67b1-4d3f-9a2f-7904167c6c5a_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_PatentLicensingAgreementMember_54e3caa4-c532-4e02-a9d8-6e94140be579_terseLabel_en-US" xlink:label="lab_nvta_PatentLicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent licensing agreement</link:label>
    <link:label id="lab_nvta_PatentLicensingAgreementMember_label_en-US" xlink:label="lab_nvta_PatentLicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent Licensing Agreement [Member]</link:label>
    <link:label id="lab_nvta_PatentLicensingAgreementMember_documentation_en-US" xlink:label="lab_nvta_PatentLicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent licensing agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PatentLicensingAgreementMember" xlink:href="nvta-20201231.xsd#nvta_PatentLicensingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_PatentLicensingAgreementMember" xlink:to="lab_nvta_PatentLicensingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_StockIncentivePlanMember_761be283-fcf4-44a3-8b19-7edda0e15811_terseLabel_en-US" xlink:label="lab_nvta_StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock incentive plans</link:label>
    <link:label id="lab_nvta_StockIncentivePlanMember_label_en-US" xlink:label="lab_nvta_StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_nvta_StockIncentivePlanMember_documentation_en-US" xlink:label="lab_nvta_StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the stock incentive plans of the entity, which includes the 2010 plan, the 2015 plan, employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIncentivePlanMember" xlink:href="nvta-20201231.xsd#nvta_StockIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_StockIncentivePlanMember" xlink:to="lab_nvta_StockIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_d08ea00b-e7d8-4d07-98bc-c486a438a1f5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_95bbc5f2-9974-44a6-9aa7-02d9760520f8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, basic and diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1eae2e15-d2a7-49dd-ad83-013a49258a66_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Deficit</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_164bc3be-c5a7-4ab1-b161-eeb26650c2d2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, weighted-average remaining contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_5eb5c7bf-7636-4960-86da-71f1999cafa0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AutomobilesMember_bac5b20f-7ec7-424b-8580-1cb3032262d7_terseLabel_en-US" xlink:label="lab_us-gaap_AutomobilesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Automobiles</link:label>
    <link:label id="lab_us-gaap_AutomobilesMember_label_en-US" xlink:label="lab_us-gaap_AutomobilesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Automobiles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AutomobilesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AutomobilesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AutomobilesMember" xlink:to="lab_us-gaap_AutomobilesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_c67e3137-83c9-448c-ab56-152f1274270f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior to third anniversary of closing date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_db3b2d87-207e-4f79-85bb-e9529314155a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1fc48c98-61f4-414e-93d4-9155e3602903_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of earnings per share, basic and diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_c819004a-b66b-4193-9ccb-aa16ce36f7a1_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_834e244f-d1a8-40b5-af91-22730a28ab82_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_718f917c-0c43-4099-9c33-8c426c2ec560_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of fair values of assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_6d327230-9ee6-4817-a92f-d5ff472a403f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_518e6620-0591-44b1-b09d-405bd97c4172_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance sheet components</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bfc3042-df87-4958-8cf8-9d5017e016c9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther_c5d737c7-9995-47f8-a960-3d8d4345921b_terseLabel_en-US" xlink:label="lab_nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals and other</link:label>
    <link:label id="lab_nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther_label_en-US" xlink:label="lab_nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Tax Accrued Liabilities And Other</link:label>
    <link:label id="lab_nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther_documentation_en-US" xlink:label="lab_nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accruals and not separately disclosed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther" xlink:href="nvta-20201231.xsd#nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther" xlink:to="lab_nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_88dd093d-647b-4366-a86d-f36a7c67bfc7_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_34199ce3-7e1f-4a2c-bc20-615757bf8638_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_96e32f9a-1aa1-4404-84e3-826213a8869f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_99174ff4-e252-482f-8455-96154b2959d8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_1a8a4bc9-6b2b-4427-86e9-d1abda655617_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_650524c2-4c33-4c07-86f7-9295fa5d5472_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseTermOfContract1_aa2ce23d-08ed-423f-a136-bf4060417516_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:to="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_aec04c0a-19c5-448e-92d3-0fa3f0db40f9_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_SingularBioMember_e6084314-f2ae-4871-917d-648f0373d9dc_terseLabel_en-US" xlink:label="lab_nvta_SingularBioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singular Bio</link:label>
    <link:label id="lab_nvta_SingularBioMember_label_en-US" xlink:label="lab_nvta_SingularBioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singular Bio [Member]</link:label>
    <link:label id="lab_nvta_SingularBioMember_documentation_en-US" xlink:label="lab_nvta_SingularBioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singular Bio [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SingularBioMember" xlink:href="nvta-20201231.xsd#nvta_SingularBioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_SingularBioMember" xlink:to="lab_nvta_SingularBioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_ade24d1e-5e46-41f0-b2fd-7dfb2b0f4218_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_3a5b6c15-a731-45f9-9243-b1f1719fc56e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_d4b8ca85-8ebf-4027-a2f2-301619838c9e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of debt, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_0271469f-025b-4274-b079-b54618867835_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_e660f670-b7fc-48a0-b99f-2afad5b9081c_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_0f738fe2-b413-48e0-89ba-b51c08911539_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingPrincipleMember_14b551fe-70e5-4a25-967b-cb7ac63329cb_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingPrincipleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for Change in Accounting Principle [Domain]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingPrincipleMember_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingPrincipleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Principle, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingPrincipleMember" xlink:to="lab_us-gaap_ChangeInAccountingPrincipleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_107e5749-5a57-4cbb-af5a-12ff67cbc035_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_UnderwrittenPublicOfferingMember_3a16e1ef-8a6d-44e3-afd0-d44c117064aa_terseLabel_en-US" xlink:label="lab_nvta_UnderwrittenPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwritten public offering</link:label>
    <link:label id="lab_nvta_UnderwrittenPublicOfferingMember_label_en-US" xlink:label="lab_nvta_UnderwrittenPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwritten Public Offering [Member]</link:label>
    <link:label id="lab_nvta_UnderwrittenPublicOfferingMember_documentation_en-US" xlink:label="lab_nvta_UnderwrittenPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwritten public offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_UnderwrittenPublicOfferingMember" xlink:href="nvta-20201231.xsd#nvta_UnderwrittenPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_UnderwrittenPublicOfferingMember" xlink:to="lab_nvta_UnderwrittenPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_220f5756-1d6b-4fcc-a6da-ea13be25569f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold percentage of stock price trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_ed22be75-f023-4cfd-a464-16b62f44fefd_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_a36c1dbb-2ff4-47eb-8f63-1fe8b2f846af_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued in connection with public offering, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_RestrictedStockUnitsPeriodofTimeMember_ce659bc1-821d-44c0-b7cc-77461d0a7073_terseLabel_en-US" xlink:label="lab_nvta_RestrictedStockUnitsPeriodofTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-based RSUs</link:label>
    <link:label id="lab_nvta_RestrictedStockUnitsPeriodofTimeMember_label_en-US" xlink:label="lab_nvta_RestrictedStockUnitsPeriodofTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Period of Time [Member]</link:label>
    <link:label id="lab_nvta_RestrictedStockUnitsPeriodofTimeMember_documentation_en-US" xlink:label="lab_nvta_RestrictedStockUnitsPeriodofTimeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Period of Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RestrictedStockUnitsPeriodofTimeMember" xlink:href="nvta-20201231.xsd#nvta_RestrictedStockUnitsPeriodofTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_RestrictedStockUnitsPeriodofTimeMember" xlink:to="lab_nvta_RestrictedStockUnitsPeriodofTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_629fcf59-a5cb-4dc5-b147-1af9134c95ce_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_5f13c16d-aaae-473c-98f4-84cce981055f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accrued liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_NetProceedsFromIssuanceOfCommonStock_7525d34a-929e-4f17-8b87-516136fa058c_terseLabel_en-US" xlink:label="lab_nvta_NetProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock</link:label>
    <link:label id="lab_nvta_NetProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_nvta_NetProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Proceeds From Issuance Of Common Stock</link:label>
    <link:label id="lab_nvta_NetProceedsFromIssuanceOfCommonStock_documentation_en-US" xlink:label="lab_nvta_NetProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_NetProceedsFromIssuanceOfCommonStock" xlink:href="nvta-20201231.xsd#nvta_NetProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_NetProceedsFromIssuanceOfCommonStock" xlink:to="lab_nvta_NetProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_87282615-2518-445f-9480-6777e4490efb_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net, finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_10959ff9-c0ac-449d-8a53-244866726875_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0f81fe6c-008c-4867-a4a7-625ea6f02151_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_f1cfe5d9-10c6-4c7c-ba82-986fa95e3f63_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of future lease payments under finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_0a38842c-794c-48f4-b844-5b0a7ab2ed12_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_ba1cda36-e55b-4245-bfc8-6aa7c78cb698_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchMember_f1009489-c373-40fc-bf7b-9579c1670cf9_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchMember_label_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_54f8d996-9b21-48ac-9eb0-12a5069f53b8_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_9acc1b45-fbdc-45e8-b0bf-b4a6fbaaec70_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of components of the provision for income taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_ServiceAgreementsAndLaboratorySuppliesMember_cc2adf45-bf77-4650-af8d-69858b96404d_terseLabel_en-US" xlink:label="lab_nvta_ServiceAgreementsAndLaboratorySuppliesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service agreements and laboratory supplies</link:label>
    <link:label id="lab_nvta_ServiceAgreementsAndLaboratorySuppliesMember_label_en-US" xlink:label="lab_nvta_ServiceAgreementsAndLaboratorySuppliesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Agreements And Laboratory Supplies [Member]</link:label>
    <link:label id="lab_nvta_ServiceAgreementsAndLaboratorySuppliesMember_documentation_en-US" xlink:label="lab_nvta_ServiceAgreementsAndLaboratorySuppliesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service agreements and laboratory supplies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ServiceAgreementsAndLaboratorySuppliesMember" xlink:href="nvta-20201231.xsd#nvta_ServiceAgreementsAndLaboratorySuppliesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_ServiceAgreementsAndLaboratorySuppliesMember" xlink:to="lab_nvta_ServiceAgreementsAndLaboratorySuppliesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_17444282-7177-45e1-9307-52f932c66827_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_ChangeInEstimateOfRevenueRecognitionMember_586f17ff-2092-41c2-be35-dffd1e27f5f4_terseLabel_en-US" xlink:label="lab_nvta_ChangeInEstimateOfRevenueRecognitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimate of revenue recognition</link:label>
    <link:label id="lab_nvta_ChangeInEstimateOfRevenueRecognitionMember_label_en-US" xlink:label="lab_nvta_ChangeInEstimateOfRevenueRecognitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Estimate Of Revenue Recognition [Member]</link:label>
    <link:label id="lab_nvta_ChangeInEstimateOfRevenueRecognitionMember_documentation_en-US" xlink:label="lab_nvta_ChangeInEstimateOfRevenueRecognitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimate of revenue recognition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ChangeInEstimateOfRevenueRecognitionMember" xlink:href="nvta-20201231.xsd#nvta_ChangeInEstimateOfRevenueRecognitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_ChangeInEstimateOfRevenueRecognitionMember" xlink:to="lab_nvta_ChangeInEstimateOfRevenueRecognitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8dae7c74-9b8a-4b7e-a2e1-d75385c99d35_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected period to recognize on a straight-line basis</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate_5ccc7cc0-1cf6-4dfd-8b9a-fae796256959_terseLabel_en-US" xlink:label="lab_nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Days prior to convertible debt extended maturity date</link:label>
    <link:label id="lab_nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate_label_en-US" xlink:label="lab_nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Terms, Days Prior to Convertible Debt Extended Maturity Date</link:label>
    <link:label id="lab_nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate_documentation_en-US" xlink:label="lab_nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Terms, Days Prior to Convertible Debt Extended Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate" xlink:to="lab_nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_662f12e0-ca21-4b0c-aa1c-0a62be9c86a0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from notes sold</link:label>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromNotesPayable" xlink:to="lab_us-gaap_ProceedsFromNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_77bd481c-77b4-424e-8340-08e460452f0b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d84693ce-c498-493b-98eb-6dd3b419dfc4_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage_51d68afc-7d07-4208-8afa-a70e79e91c3d_terseLabel_en-US" xlink:label="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly vesting percentage</link:label>
    <link:label id="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage_label_en-US" xlink:label="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Vesting Rights Equal Monthly Vesting Percentage</link:label>
    <link:label id="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage_documentation_en-US" xlink:label="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the monthly percentage of vesting of share-based compensation awards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage" xlink:href="nvta-20201231.xsd#nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage" xlink:to="lab_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_885396f5-90f3-439b-997d-725f50dde37a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_7d04a8eb-b5cb-461c-87b2-9802b4f27541_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_ad844a99-a7ec-46bf-b28d-ee38843fc6bc_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_a162accd-1eca-4113-acd0-feef4df111c8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of units granted</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_c53d59c0-924c-4f78-bd49-9f32a703c82e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_55546ceb-8633-46de-90e3-6e61cb4385ac_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_63bd5369-db2b-4f53-ab1c-ff42de3d6a6a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of selected quarterly data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_cf078444-825a-4123-beb8-e4d848915a9b_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_900bf9b8-bc4a-423f-9075-e9e55d7eaba1_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_8e908269-e341-44ff-b1a3-5559353476f4_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent_160fc47c-bfec-4ce7-967b-b89c0b1f9e67_terseLabel_en-US" xlink:label="lab_nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Positions eliminated, percent of total workforce</link:label>
    <link:label id="lab_nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent_label_en-US" xlink:label="lab_nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated, Percent</link:label>
    <link:label id="lab_nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent_documentation_en-US" xlink:label="lab_nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent" xlink:href="nvta-20201231.xsd#nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent" xlink:to="lab_nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2dafe02b-56a6-4c6a-903a-716e6f26d11d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_c6ab1d08-123b-4c2a-a6bc-41bdd968ce1f_terseLabel_en-US" xlink:label="lab_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unconditional Purchase Obligation, Category of Goods or Services Acquired [Domain]</link:label>
    <link:label id="lab_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_label_en-US" xlink:label="lab_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unconditional Purchase Obligation, Category of Goods or Services Acquired [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain" xlink:to="lab_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_64fbd3ae-027b-467c-889d-aa58ab186fd8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_99238392-ba3d-4daa-af57-9bcbb0e3bfca_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_OfficeFacilityInSanFranciscoMember_ff2354b6-0a1d-4cd5-ad6a-3bc0e30d2b8d_terseLabel_en-US" xlink:label="lab_nvta_OfficeFacilityInSanFranciscoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Facility In San Francisco</link:label>
    <link:label id="lab_nvta_OfficeFacilityInSanFranciscoMember_label_en-US" xlink:label="lab_nvta_OfficeFacilityInSanFranciscoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Facility In San Francisco [Member]</link:label>
    <link:label id="lab_nvta_OfficeFacilityInSanFranciscoMember_documentation_en-US" xlink:label="lab_nvta_OfficeFacilityInSanFranciscoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to office facility in San Francisco.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_OfficeFacilityInSanFranciscoMember" xlink:href="nvta-20201231.xsd#nvta_OfficeFacilityInSanFranciscoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_OfficeFacilityInSanFranciscoMember" xlink:to="lab_nvta_OfficeFacilityInSanFranciscoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_66bf28cd-e856-4567-9abc-507453ca6640_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember_2599536e-51a3-4248-b892-aa7d6e3048fa_terseLabel_en-US" xlink:label="lab_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of stock payable liabilities</link:label>
    <link:label id="lab_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember_label_en-US" xlink:label="lab_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immaterial Error Related to Classification of Indemnification from Acquisition [Member]</link:label>
    <link:label id="lab_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember_documentation_en-US" xlink:label="lab_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immaterial Error Related to Classification of Indemnification from Acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember" xlink:href="nvta-20201231.xsd#nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember" xlink:to="lab_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_60a0b27f-b072-4c81-ac65-f30ce9588a4a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_c71c2289-2dc1-4deb-88fe-c333fb67b194_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_9d2cd0a2-389a-444e-b29f-3116733f6fd6_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior period reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_1bb42d8c-788f-4782-888c-cf62cc455371_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration_df107f72-3abe-489d-aaea-431d32bbf7a6_terseLabel_en-US" xlink:label="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration and liabilities incurred</link:label>
    <link:label id="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration_label_en-US" xlink:label="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Contingent Consideration</link:label>
    <link:label id="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration_documentation_en-US" xlink:label="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration" xlink:to="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_SeniorSecuredTermLoanFacilityMember_b6b9776a-ba58-426b-8341-b011aa5936d8_terseLabel_en-US" xlink:label="lab_nvta_SeniorSecuredTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Term Loan</link:label>
    <link:label id="lab_nvta_SeniorSecuredTermLoanFacilityMember_label_en-US" xlink:label="lab_nvta_SeniorSecuredTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Term Loan Facility [Member]</link:label>
    <link:label id="lab_nvta_SeniorSecuredTermLoanFacilityMember_documentation_en-US" xlink:label="lab_nvta_SeniorSecuredTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Term Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SeniorSecuredTermLoanFacilityMember" xlink:href="nvta-20201231.xsd#nvta_SeniorSecuredTermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_SeniorSecuredTermLoanFacilityMember" xlink:to="lab_nvta_SeniorSecuredTermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_60f10de5-91b8-42a6-99c8-196c59bdbfb1_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_caa165ab-d8ed-4efd-93e3-db976e80c7c2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_23684921-468c-4861-b2f9-8aa7124590ca_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities incurred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_8d8b942b-726c-4fa6-9351-a83e2e10c9f8_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_b1d1d5be-3101-4b1c-b6a9-024ccabd6d2c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-combination expense</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ac4f627c-5542-495e-bc69-bbda78d9590d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease obligation, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_469b1e8e-0a25-450a-a44a-3889e18f41b5_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease obligations, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2db5b852-016b-4f0f-9c59-fcdbb7893694_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_1d4afcb6-4618-42cd-8d3a-9cebb91f7936_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_label_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseAndRentalExpense" xlink:to="lab_us-gaap_LeaseAndRentalExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_87299ad1-d5a4-4c1a-8fb3-8131546f8107_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, finite-lived</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_ad04a0ec-734d-49c3-99cd-ab7a24d4aec8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for Change in Accounting Principle [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Principle, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:to="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_CombiMatrixCorporationMember_12757714-f030-4517-9f0d-de38761d66f6_terseLabel_en-US" xlink:label="lab_nvta_CombiMatrixCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CombiMatrix</link:label>
    <link:label id="lab_nvta_CombiMatrixCorporationMember_label_en-US" xlink:label="lab_nvta_CombiMatrixCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combi Matrix Corporation [Member]</link:label>
    <link:label id="lab_nvta_CombiMatrixCorporationMember_documentation_en-US" xlink:label="lab_nvta_CombiMatrixCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CombiMatrix Corporation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CombiMatrixCorporationMember" xlink:href="nvta-20201231.xsd#nvta_CombiMatrixCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_CombiMatrixCorporationMember" xlink:to="lab_nvta_CombiMatrixCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_627e3d5c-4857-40b7-adb4-f72229f78d61_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_0a1e7140-4af2-4615-98a2-1140f049122e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets_b05adee8-816e-4142-94f5-8cfa18df7a1a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance available to reduce intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Taxes, Business Combination, Valuation Allowance, Available to Reduce Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_690e4a13-d4de-4d11-a03c-32403eea766e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_0899ca36-7328-4598-b1c7-82ca62d3e8c2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_7c5dd1f0-8f3a-4091-a8a8-b7eb8bc532ef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Option, Quantitative Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Option, Quantitative Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_3161f534-5ae2-47e4-9f61-6282b82e927b_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_ecb538e7-ff82-4036-963d-26f824285c3b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_c4bb39ac-52c8-49e9-bb4a-fef5ede59bd8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_b7f47735-fb98-475e-b581-e0b6b802c9c0_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_7565b0cf-a546-4a29-99bd-87e98038d1f2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation of the tax expense computed at the statutory federal rate and Company's tax expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_TrancheOneMember_ee4bfccb-bf21-48d8-b825-df5c22bdce6a_terseLabel_en-US" xlink:label="lab_nvta_TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial sale of notes</link:label>
    <link:label id="lab_nvta_TrancheOneMember_label_en-US" xlink:label="lab_nvta_TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche One [Member]</link:label>
    <link:label id="lab_nvta_TrancheOneMember_documentation_en-US" xlink:label="lab_nvta_TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche one.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_TrancheOneMember" xlink:href="nvta-20201231.xsd#nvta_TrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_TrancheOneMember" xlink:to="lab_nvta_TrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_a00bc502-756f-435c-a113-7053f7db5d05_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ec5e1a50-c8b6-4c64-98ab-e181085db9d8_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_049d9bfe-f3ca-49c0-8a21-fcce3afa02e6_terseLabel_en-US" xlink:label="lab_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hold-back consideration - common stock</link:label>
    <link:label id="lab_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_label_en-US" xlink:label="lab_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Hold-back Consideration, Common Stock, Value Assigned</link:label>
    <link:label id="lab_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_documentation_en-US" xlink:label="lab_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Hold-back Consideration, Common Stock, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" xlink:to="lab_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_2da8521b-783f-4c69-a615-6af477082491_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3d8a6638-d63f-4bdd-a218-89b0126a06bc_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_538dfb67-5819-4c67-a724-66f0ee58d18e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of disaggregated revenue by payer category</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_ae5c9b8a-d21e-49b2-85c9-2a09385bd2a2_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_ee4381a3-5e52-4ba1-90fb-51e1e09443bd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease_a0bb00df-9432-4c78-9670-4b44a8e80549_negatedTerseLabel_en-US" xlink:label="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease obligations, net of current portion</link:label>
    <link:label id="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease_label_en-US" xlink:label="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Operating Lease</link:label>
    <link:label id="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease_documentation_en-US" xlink:label="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Operating Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease" xlink:to="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_a1a51e76-7de0-4d79-8ad0-b604b7211ca7_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_173f89dd-aaed-417d-b8ed-8de6561b3b9b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of stock based compensation expense related to stock options included in consolidated statements of operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred_379efecc-f7a6-4a21-b55a-d61e90209912_terseLabel_en-US" xlink:label="lab_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration and liabilities incurred</link:label>
    <link:label id="lab_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred_label_en-US" xlink:label="lab_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable and Liabilities Incurred</link:label>
    <link:label id="lab_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred_documentation_en-US" xlink:label="lab_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable and Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred" xlink:to="lab_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_e4754c86-6ad5-421b-b797-3624337f05f1_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_55f751a1-81a9-4a32-b1c5-c1bfb8de1f22_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b1a093c9-5545-43ce-b6b4-74b91391f7ed_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_5f2a34ce-0085-433d-b36c-88bdca8b9a1f_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_e78f3ef7-015d-4a90-a4e5-4d4ca1abc4b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_8b65ae8b-faaf-436f-919b-4d76122d8924_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of components of loss before income taxes by U.S. and foreign jurisdictions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts_afea72c7-559d-4e7d-848a-f40b23d6d28a_terseLabel_en-US" xlink:label="lab_nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from public offerings of common stock, net of issuance costs</link:label>
    <link:label id="lab_nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts_label_en-US" xlink:label="lab_nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Public Offerings Of Common Stock Net Of Issuance Costs</link:label>
    <link:label id="lab_nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts_documentation_en-US" xlink:label="lab_nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of public offerings of common stock net of issuance costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts" xlink:href="nvta-20201231.xsd#nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts" xlink:to="lab_nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_2af239b9-0649-4e30-b354-64cdd45f6ab4_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying amount, liability component</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_PartnerMember_1a94d418-1f7e-4ecf-8e76-794df76d7867_terseLabel_en-US" xlink:label="lab_nvta_PartnerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biopharma partner</link:label>
    <link:label id="lab_nvta_PartnerMember_label_en-US" xlink:label="lab_nvta_PartnerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner [Member]</link:label>
    <link:label id="lab_nvta_PartnerMember_documentation_en-US" xlink:label="lab_nvta_PartnerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PartnerMember" xlink:href="nvta-20201231.xsd#nvta_PartnerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_PartnerMember" xlink:to="lab_nvta_PartnerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_246e856d-af55-461a-bdbc-a5a09c77a552_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_1fdcdb00-6c2b-4752-80b9-b8bc9a60f284_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_cb5a1f0d-1243-42a3-add3-93329618f35d_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_d8b7f6e0-ec72-4470-94d1-9d01425b699e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_9fa0f143-5bee-4de3-9ed4-a20f1490491f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_00de723f-5185-4968-9f59-9ca9183d749e_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_dd94528f-a772-4f68-a78d-ed7d0e815d0d_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_9b9d60c2-45fb-4f7e-9c83-9b4c1a9bcc4c_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4562e97b-06ab-4f50-887f-a0558e34860e_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total identifiable assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_CARESActMember_baea90db-21c4-47c5-88c2-37c30413570d_terseLabel_en-US" xlink:label="lab_nvta_CARESActMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act</link:label>
    <link:label id="lab_nvta_CARESActMember_label_en-US" xlink:label="lab_nvta_CARESActMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act [Member]</link:label>
    <link:label id="lab_nvta_CARESActMember_documentation_en-US" xlink:label="lab_nvta_CARESActMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CARESActMember" xlink:href="nvta-20201231.xsd#nvta_CARESActMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_CARESActMember" xlink:to="lab_nvta_CARESActMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_SummaryOfSignificantAccountingPoliciesLineItems_539f6d5c-88b3-4ec8-bee4-eb3c9dbf0ecf_terseLabel_en-US" xlink:label="lab_nvta_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_nvta_SummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_nvta_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_nvta_SummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_nvta_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of significant accounting policies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="nvta-20201231.xsd#nvta_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_nvta_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_50a4507a-865d-48ac-a103-43cec2425b34_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_9a88b317-a882-4a8b-829f-720769103635_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_7483af69-1308-4292-8ba9-6dd42c56a895_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_641a12e3-23d2-43c2-b986-b6f9926070a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of restrictions on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e32204c8-e016-4d8f-bdb7-d77a35c82bd1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts_559e627b-3192-4bb2-adc0-67dd9a45e64c_terseLabel_en-US" xlink:label="lab_nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued in private placement (in shares)</link:label>
    <link:label id="lab_nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts_label_en-US" xlink:label="lab_nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Connection With Private Placement, Net Of Offering Costs</link:label>
    <link:label id="lab_nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts_documentation_en-US" xlink:label="lab_nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period shares in connection with private placement, net of offering costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts" xlink:href="nvta-20201231.xsd#nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts" xlink:to="lab_nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_GenelexandYouScriptMember_a181a008-41b7-4808-af90-1fbb1c96e3b8_terseLabel_en-US" xlink:label="lab_nvta_GenelexandYouScriptMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genelex and YouScript</link:label>
    <link:label id="lab_nvta_GenelexandYouScriptMember_label_en-US" xlink:label="lab_nvta_GenelexandYouScriptMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genelex and YouScript [Member]</link:label>
    <link:label id="lab_nvta_GenelexandYouScriptMember_documentation_en-US" xlink:label="lab_nvta_GenelexandYouScriptMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genelex and YouScript [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_GenelexandYouScriptMember" xlink:href="nvta-20201231.xsd#nvta_GenelexandYouScriptMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_GenelexandYouScriptMember" xlink:to="lab_nvta_GenelexandYouScriptMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_21133c23-df71-4bc8-b991-1fa4994118e9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_ea10ebc7-b5ca-4ae7-835c-f5b3066532f9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_6b455cf5-bc18-41f6-b9f6-65b7f2338b22_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_3c0583ca-36db-4832-bfc1-db423edf6939_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_TestRevenueCentralizedMember_8d198268-5f17-4d11-9dcd-7062eb324a13_terseLabel_en-US" xlink:label="lab_nvta_TestRevenueCentralizedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centralized</link:label>
    <link:label id="lab_nvta_TestRevenueCentralizedMember_label_en-US" xlink:label="lab_nvta_TestRevenueCentralizedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Test Revenue, Centralized [Member]</link:label>
    <link:label id="lab_nvta_TestRevenueCentralizedMember_documentation_en-US" xlink:label="lab_nvta_TestRevenueCentralizedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Test Revenue, Centralized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_TestRevenueCentralizedMember" xlink:href="nvta-20201231.xsd#nvta_TestRevenueCentralizedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_TestRevenueCentralizedMember" xlink:to="lab_nvta_TestRevenueCentralizedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_ba90e917-2ac4-4513-a8b5-dea29a0cc26a_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_d23722ea-886c-468e-acf2-61c566d4f9e8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_914ae5ec-9c8a-4958-9038-e120ff30dcff_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_7be00ca7-407b-4d97-aac7-1d26f3c2207e_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_6828f3bf-1a3d-43c0-9e1b-7aca140b5a78_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_738e226b-61d2-4474-abeb-67874260d9ee_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in amount of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_a9950ccf-cd53-404d-a953-cb846012c1ba_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock payable liability</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_c401e60b-28b7-49c3-ad62-f1754d4a4bdd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_a5577bbb-b5cd-4413-9d85-caff26bc548e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b0a25561-51ba-4b75-9e97-804face6dd5c_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future non-cancelable minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d5d2f698-cd85-4b9f-b79a-a6fc5268dde6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future non-cancelable minimum operating lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_508a3dda-9bb4-497a-b897-23fb2ec61889_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_024cdf3b-6730-44ed-ba59-678b9ad57f13_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_f933f212-83dd-46cf-8f6f-80d8638b1f03_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in computing net loss per share, basic and diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock_1a02cc94-ad8d-4cc1-90da-7abe6b67163c_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of future payments under noncancelable unconditional purchase commitments</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeasesIncomeStatementInterestExpense_ec0052fe-60ff-40ad-8cf2-e76a48924996_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesIncomeStatementInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease costs</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesIncomeStatementInterestExpense_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesIncomeStatementInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leases, Income Statement, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesIncomeStatementInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeasesIncomeStatementInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesIncomeStatementInterestExpense" xlink:to="lab_us-gaap_CapitalLeasesIncomeStatementInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_4022923e-6f9c-4ae1-90da-8e64e0c44b2f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule significant customer, revenue as a percentage</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_8d765e8e-2d6f-463a-8385-69a9bc765802_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_990183b3-4485-4194-8032-3e481ef3bd15_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_a812c80a-f69d-4db1-b72b-ba7d42cf3094_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4c713ea5-a928-4100-9d5e-a1fb4e0fb579_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_af551439-c193-4fcc-a32b-5edf8ea93793_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized income (loss) on available-for-sale marketable securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_6df87f4a-403f-46e0-89d2-d75c45dd7046_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_a3860927-3444-4272-b396-70262e2fd353_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b144cea9-3711-479d-89f3-bea4f096e617_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_8e39ef88-96e2-4286-a8e7-85bcc17780bd_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockSharesConverted1_2c832908-8030-4787-a57f-f4e44d17f330_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued upon conversion of preferred stock (in shares)</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockSharesConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Shares Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesConverted1" xlink:to="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_PatientDirectMember_8d4011bf-1748-4d65-a997-2f23357d25c0_terseLabel_en-US" xlink:label="lab_nvta_PatientDirectMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Direct</link:label>
    <link:label id="lab_nvta_PatientDirectMember_label_en-US" xlink:label="lab_nvta_PatientDirectMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Direct [Member]</link:label>
    <link:label id="lab_nvta_PatientDirectMember_documentation_en-US" xlink:label="lab_nvta_PatientDirectMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient direct.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PatientDirectMember" xlink:href="nvta-20201231.xsd#nvta_PatientDirectMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_PatientDirectMember" xlink:to="lab_nvta_PatientDirectMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_69c0d638-e14d-49a6-a184-4bc4fab9efeb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_a9dd9cd1-c5bc-4ab8-80cb-c8c88cc7f766_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_e3731bd9-3e14-4fb7-8bef-d8837deaee45_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_dd0d2342-4f85-4143-9143-745c897d1d82_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_20433df8-f462-4d36-82a0-546e0c3f0ee1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_edbe2d1c-f191-466f-84a5-4e68dbb5ceaf_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_33a5ece1-eb45-4cbf-affb-a180b6def184_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_14c31a23-ab8a-4039-a85c-298a0e181758_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_b6236198-ab64-407c-9f57-f6eb102bd9c4_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_ccb9b0b2-f949-4b50-8cba-f780f6d7b6e6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_12cc4b16-2389-4908-8838-a328d48309ba_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_d3c57766-816c-484c-b77c-85094c2a6409_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_0fa368d5-1f70-4f09-8e0d-7713daf83d87_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_942ad3e7-3833-4aa5-9dca-417f30a05485_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_19bf1ac4-b922-467a-ab53-0837a10e91fb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued pursuant to employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4bf93a09-476b-47dc-b3c3-7147089649cc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred_d69cca40-856a-4983-a231-5b8ad07ae51d_terseLabel_en-US" xlink:label="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash transferred</link:label>
    <link:label id="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred_label_en-US" xlink:label="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Cash Transferred</link:label>
    <link:label id="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred_documentation_en-US" xlink:label="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Cash Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred" xlink:to="lab_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_1bd1027b-d0ba-45f4-b99c-2e626cb820ff_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_19a21ade-5f74-423b-bd14-207fd64d517c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_d01c8194-8bed-48c7-8c45-a1d1e81bfc9e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_d22426a5-9b7a-4937-af11-d2b9e0a2c59b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_197387ec-18a0-43a4-8c42-836ec8c138bf_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation of gross unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_df2d5a58-a27c-4882-ac5d-c71e20c4b062_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6d2bc4e1-b136-44d4-8b7b-e3fe5c6f9b6f_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net identifiable assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_91397158-9022-49fc-a717-9135b2069dac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_66f4fdec-af82-473e-b9fc-001fbcdc0cc8_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1558a9f8-2a03-41d3-9f2e-c501516b7d53_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_d2bfb55f-a074-43fa-a974-031b266ce48f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_2dc9452f-e0de-4dcc-88f9-12dfa0aa3baf_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_bec8e928-0542-4a11-857b-2c37b66d83b5_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of businesses acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_45bf506e-0b63-4699-a381-1ff3cce9806a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_39d064b3-3e05-47cc-974a-5e790bead858_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_0c5742fa-dd4d-4bd5-a32d-931393211fbb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, basic and diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic and Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_f6661b4a-7f07-4755-948a-97f4f901270e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_db09fdbf-6854-4d39-acad-e9946c9d802c_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_6e299eb3-256e-453e-9e67-789e9f5d2ee4_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_b389df7d-11c7-4575-abe1-11c3b3165f53_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b0e3e69f-0ca7-4258-98c4-1a55d6aed1b2_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_40847586-0626-4bd5-897a-ea06b7466e40_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current benefit for income taxes</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_75a27860-4924-4acf-ba2d-7e96168fcbfb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_edf95c69-0231-4be8-8e6a-259d92736298_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross increases&#8212;prior period tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5fd8c665-6e9a-473d-9c99-c7fbd1492522_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross increases&#8212;current period tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_724004f2-c085-4cec-8c81-411e6202cdc5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life, intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d740c5ae-e074-4a0e-b604-10a54a964478_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Useful Life (in Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_895e392f-6525-43a3-9222-7e392e222973_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_538edce7-f41f-4341-b25f-48d2e7c01966_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized income (loss) on available-for-sale marketable securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b5a75212-5daf-4ba0-9b45-010280267cd1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_573d74d2-9b75-45f8-838b-17b6e6eccac2_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_a7c44748-a3ab-478f-9d9a-4f5eda1ee3ff_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ad09d1fd-ae09-4c4b-97a5-079988a2a9dc_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock incentive plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_f0d02ea0-2e13-4da8-91fe-4c5df5226a9b_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_6bb3bcc1-515c-4a8a-93f5-a7e41e5c1035_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset_9b22c921-fcf9-4982-9c6f-4e44a7e8989f_terseLabel_en-US" xlink:label="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset_label_en-US" xlink:label="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset_documentation_en-US" xlink:label="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset" xlink:to="lab_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c01c3df8-a452-4387-b437-3db79d89a95a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of businesses acquired:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_fc9241ad-38ec-4dea-80c8-c06c1ff32716_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_00a9ea8c-ebce-4d54-9458-6a94018dad1e_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tradename</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_98e11703-e49c-4bd7-a7cd-88e7b25b4e81_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_65405d1c-fead-4400-877a-6512a652d056_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_9e34a3c8-879b-431d-9642-9e93e1bbfa84_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_648b06f4-3954-4475-9bfc-8b2f145a6f01_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_cdb9ceec-d5e4-40d4-a038-c57a69961162_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_720c40f8-da2b-4efb-aaeb-09fd94e8cfd2_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_LeasesCashPaymentsIncludedInMeasurementAbstract_69470294-8b5a-468e-a31f-f697be5709c9_terseLabel_en-US" xlink:label="lab_nvta_LeasesCashPaymentsIncludedInMeasurementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments included in the measurement of lease liabilities (in millions):</link:label>
    <link:label id="lab_nvta_LeasesCashPaymentsIncludedInMeasurementAbstract_label_en-US" xlink:label="lab_nvta_LeasesCashPaymentsIncludedInMeasurementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Cash Payments Included in Measurement [Abstract]</link:label>
    <link:label id="lab_nvta_LeasesCashPaymentsIncludedInMeasurementAbstract_documentation_en-US" xlink:label="lab_nvta_LeasesCashPaymentsIncludedInMeasurementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Cash Payments Included in Measurement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_LeasesCashPaymentsIncludedInMeasurementAbstract" xlink:href="nvta-20201231.xsd#nvta_LeasesCashPaymentsIncludedInMeasurementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_LeasesCashPaymentsIncludedInMeasurementAbstract" xlink:to="lab_nvta_LeasesCashPaymentsIncludedInMeasurementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_cedd0e4e-1a46-4ecd-baa4-63bdbbe1bab9_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right to develop new technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_55299526-6247-4c2e-8935-2c20e658b309_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right to develop new technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_96cac077-7bbc-4e92-87af-3196b97d1ffd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_83cf0cb0-75b5-4f7a-901b-9de50e9af2f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity under the plan</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_DiploidMember_4ae44295-35ee-4a66-ba4b-a861ecdaf07a_terseLabel_en-US" xlink:label="lab_nvta_DiploidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diploid</link:label>
    <link:label id="lab_nvta_DiploidMember_label_en-US" xlink:label="lab_nvta_DiploidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diploid [Member]</link:label>
    <link:label id="lab_nvta_DiploidMember_documentation_en-US" xlink:label="lab_nvta_DiploidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diploid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DiploidMember" xlink:href="nvta-20201231.xsd#nvta_DiploidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_DiploidMember" xlink:to="lab_nvta_DiploidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_f7a03aa7-fe4d-4d0e-ab13-38b5358d7496_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_512fba88-d9aa-47ea-a5de-f29b6b003302_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, non-current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_OneCodexMember_fa5d9b6c-a9fe-4825-a42f-33b4d5f2493b_terseLabel_en-US" xlink:label="lab_nvta_OneCodexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OneCodex</link:label>
    <link:label id="lab_nvta_OneCodexMember_label_en-US" xlink:label="lab_nvta_OneCodexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OneCodex [Member]</link:label>
    <link:label id="lab_nvta_OneCodexMember_documentation_en-US" xlink:label="lab_nvta_OneCodexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OneCodex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_OneCodexMember" xlink:href="nvta-20201231.xsd#nvta_OneCodexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_OneCodexMember" xlink:to="lab_nvta_OneCodexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_e233b79c-940f-42e9-bbfb-3237ca50762d_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_398a6552-320e-409c-8beb-e93e8a43f5b6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_4c97c41b-c71c-49ed-a3a7-0ce5afd02769_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the tax expense computed at the statutory federal rate and Company's tax expense</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_d8bb0137-0c20-4bc5-88cc-c1f66fa2dde6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued pursuant to employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_97db2573-8650-4d6f-aa4b-c12fa22e2bdb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_d659fcae-ddd5-48b2-9e7d-de565ac153ec_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_EarningsPerShareTable_799a017b-87b3-4476-baf9-85afd305a4ab_terseLabel_en-US" xlink:label="lab_nvta_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_nvta_EarningsPerShareTable_label_en-US" xlink:label="lab_nvta_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_nvta_EarningsPerShareTable_documentation_en-US" xlink:label="lab_nvta_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_EarningsPerShareTable" xlink:href="nvta-20201231.xsd#nvta_EarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_EarningsPerShareTable" xlink:to="lab_nvta_EarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_aa9d777a-c1f4-4018-bd2f-12082f251817_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_4ab77791-e95c-45ba-a2c0-eae800ad7c9f_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_3390441d-b5f2-4289-a531-a3c81da2d9da_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_35138787-19c4-4194-abca-a12712ab6251_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasury notes</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_da8fc3fe-1a51-4094-9553-3012fc40b9e8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued in connection with initial public offering, net of offering costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_85e066c7-3d7a-44b8-b356-77b33eca1d6d_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued during period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_7536aa8f-bc41-4592-9a52-b5ca6eb28320_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_2266d424-0b5f-4326-8913-0aa62e3e5fa5_verboseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2d9df6cb-3701-431c-900e-44d01b164fb7_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_4e22e213-459d-432f-9cab-210be12216c8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_babeb071-979f-4e94-95d6-bdeca3c1139d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_fa0ce7a2-038f-4c76-b8f1-a37c2328dea2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of future payments under operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_99b39a96-3d55-4354-b040-2db7c49007a7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued for acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_55884b3c-9e66-44c2-b485-6b4206ad5457_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f6e94c6e-df61-450c-9664-1718d59301c0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_e52db20c-5dd0-4f72-ab77-52b3618e729c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options cancelled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_0d77d2b5-0c9c-42be-8da2-191b58b91c53_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_658a5df3-e919-43dc-a656-764852a7167e_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_9ff9ae56-1ddf-4202-a3bc-3b7a789fe026_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_b8c1774f-f2b2-46c3-a255-5d7154f1fa54_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, accounts receivable and deferred revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_DebtFinancingContingencyMember_50c13c09-34ba-4eae-9da0-4a3583c09159_terseLabel_en-US" xlink:label="lab_nvta_DebtFinancingContingencyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt financing contingency</link:label>
    <link:label id="lab_nvta_DebtFinancingContingencyMember_label_en-US" xlink:label="lab_nvta_DebtFinancingContingencyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Financing Contingency [Member]</link:label>
    <link:label id="lab_nvta_DebtFinancingContingencyMember_documentation_en-US" xlink:label="lab_nvta_DebtFinancingContingencyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Financing Contingency [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtFinancingContingencyMember" xlink:href="nvta-20201231.xsd#nvta_DebtFinancingContingencyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_DebtFinancingContingencyMember" xlink:to="lab_nvta_DebtFinancingContingencyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ebda5e6e-881b-4718-93fe-d801a1da157e_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets obtained in exchange for lease obligations, net</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_DiagnosticTestsMember_0852e4b0-8d93-4125-8679-ffeb49cfcf22_terseLabel_en-US" xlink:label="lab_nvta_DiagnosticTestsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Test revenue</link:label>
    <link:label id="lab_nvta_DiagnosticTestsMember_label_en-US" xlink:label="lab_nvta_DiagnosticTestsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Tests [Member]</link:label>
    <link:label id="lab_nvta_DiagnosticTestsMember_documentation_en-US" xlink:label="lab_nvta_DiagnosticTestsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic tests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DiagnosticTestsMember" xlink:href="nvta-20201231.xsd#nvta_DiagnosticTestsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_DiagnosticTestsMember" xlink:to="lab_nvta_DiagnosticTestsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_6a1b357b-c1e7-4d3e-b1fd-40224f504cf5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_250e6cb2-b888-4dd9-94ae-b098b67d9960_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d30e254e-0164-4550-a15a-6c3d2943377d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d938f583-71b9-4c9b-a735-2e45499c968e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_348b14f8-d494-452c-9f1d-68144fb12726_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7da84490-4dd8-448c-aa03-be21ffc5005f_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fb5604b3-582e-463c-a69b-7c05c1af096f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_dd8326db-cb3d-4f76-a1ac-2bebf5084fbc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost_46b51d34-b98f-4e6c-a533-12160bc7426e_terseLabel_en-US" xlink:label="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost_label_en-US" xlink:label="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost</link:label>
    <link:label id="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost_documentation_en-US" xlink:label="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents restricted cash and marketable securities amortized cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" xlink:href="nvta-20201231.xsd#nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" xlink:to="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_638ed545-9ae6-4198-8483-694e9f8e7d0f_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_685bc5a0-286b-424b-8f9b-a8552a7ca037_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligation</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_79b997af-c9f7-422b-adab-6c2d83b7575c_negatedNetLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_444108e7-92b9-4995-9765-221ea91357b1_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_c2a88f95-dbd8-4749-893a-112f54137af3_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash transferred</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_3ca06abf-1b6e-494a-88d8-b71d38cd7645_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of pro forma financial information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_36e078a5-8203-4e2f-a32f-ca1bd0c5b05f_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_b45b8c73-3833-40de-85d2-2d9d7f5d7496_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First anniversary</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_5e2ae427-a02f-4b50-8716-dacc9c4629d4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_4a211559-2439-42b5-af80-d5f90d3e9e32_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense, accelerated cost</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Accelerated Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_7a195784-ba0c-4e24-a477-cdb89bf8a7bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_89e1ad28-7c68-4c8d-ab59-9668b903c29b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract_8471ae9a-8ed1-4d1b-9ae6-0b3259228546_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax_f0fa60ce-6f3c-457d-9a48-ceedb89261dd_negatedTerseLabel_en-US" xlink:label="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost Gross Unrealized Loss Before Tax</link:label>
    <link:label id="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents restricted cash and marketable securities amortized cost gross unrealized loss before tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" xlink:href="nvta-20201231.xsd#nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" xlink:to="lab_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_a941aa40-286c-4a77-97d0-fce4b4119867_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross decreases&#8212;prior period tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5bdf91cc-6d59-436f-a68e-1c5be30b4835_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9a7f50a3-b193-4769-ba3d-cd345568384b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued on exercise of stock options, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6e3ca694-b636-4fa7-a9a5-d59e53501761_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b99f2df9-f5ec-4e65-9f3a-1093dba99876_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_a52759ed-407c-41ea-9a38-0b51e3ecaea3_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_419800d3-fb5a-4084-b80b-8e2348b83c46_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c719c8bc-9230-4f4a-8651-08670f9369d3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8ddc72bc-7720-4ccd-8f0f-66ca352ef999_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_e6a21640-32c9-4ac2-beec-02a1e18809cd_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit:</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_18e405d7-ee00-43f7-81b6-b1b1890e4a03_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_7290ee08-f55d-4652-a633-a5110e2dfed2_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of significant accounting policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_b589398a-c295-4481-9ed6-bcce318f4d40_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_04074f12-2b4d-4483-bedc-2be71a5e254d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional information</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_af32ef06-d99a-4bcd-9ffc-64f2756a4ed4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ff201c99-5b89-4a44-b639-2af61fdfcc0f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity_c0a818c6-9dce-4aae-9e83-78fd8527cfdb_terseLabel_en-US" xlink:label="lab_nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-combination expense for acceleration of unvested equity</link:label>
    <link:label id="lab_nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity_label_en-US" xlink:label="lab_nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Post-Combination Expense for Acceleration of Unvested Equity</link:label>
    <link:label id="lab_nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity_documentation_en-US" xlink:label="lab_nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Post-Combination Expense for Acceleration of Unvested Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity" xlink:to="lab_nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6657bd74-7ec2-4aad-93a9-c41dd38c761b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, weighted-average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember_85f8f8b5-9354-43b1-a58b-3881b6182883_terseLabel_en-US" xlink:label="lab_nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A convertible preferred stock converted to common stock</link:label>
    <link:label id="lab_nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember_label_en-US" xlink:label="lab_nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Convertible Preferred Stock Converted to Common Stock [Member]</link:label>
    <link:label id="lab_nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember_documentation_en-US" xlink:label="lab_nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Convertible Preferred Stock Converted to Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember" xlink:href="nvta-20201231.xsd#nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember" xlink:to="lab_nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_cb5a89f3-d44a-4e9f-9273-3ab8c815c752_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nvta_ExpirationTaxYearUnknownMember_89fb130a-b83f-40d8-b2c2-16680660d731_terseLabel_en-US" xlink:label="lab_nvta_ExpirationTaxYearUnknownMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No expiration date</link:label>
    <link:label id="lab_nvta_ExpirationTaxYearUnknownMember_label_en-US" xlink:label="lab_nvta_ExpirationTaxYearUnknownMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration, Tax Year Unknown [Member]</link:label>
    <link:label id="lab_nvta_ExpirationTaxYearUnknownMember_documentation_en-US" xlink:label="lab_nvta_ExpirationTaxYearUnknownMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration, Tax Year Unknown [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ExpirationTaxYearUnknownMember" xlink:href="nvta-20201231.xsd#nvta_ExpirationTaxYearUnknownMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nvta_ExpirationTaxYearUnknownMember" xlink:to="lab_nvta_ExpirationTaxYearUnknownMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_31b3e6f7-a736-484e-9b2a-00936fd67c65_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_253455ba-53de-49e8-9410-aaa15631dbcd_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal taxes at statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_697763ea-7f49-4b16-94aa-90e6ec9e67a5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_25edbcc1-0dea-416f-950d-f63e946fa9b3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_84753be2-c252-40de-8924-c17a9ca09c04_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_99a58255-2714-4a7f-8e87-923edf75d2f5_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent accounting pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_dd6c83be-cf19-4a34-af8f-cf71618e1ab4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>nvta-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:1a5642af-41c4-4761-89fa-6771b997ee20,g:0d35037d-3d4c-4753-897e-12e6bc13039e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.invitae.com/role/CoverPage" xlink:type="simple" xlink:href="nvta-20201231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_23778589-bc7d-4dca-b8b9-b0447cefb7ce" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityRegistrantName_23778589-bc7d-4dca-b8b9-b0447cefb7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_917c2e77-bade-4937-93f8-8a41d1ec38c3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_DocumentType_917c2e77-bade-4937-93f8-8a41d1ec38c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_6f9fbf5e-32c3-4507-bd6f-4f120097b782" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_DocumentAnnualReport_6f9fbf5e-32c3-4507-bd6f-4f120097b782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_f824aa97-12cf-4038-a5dd-6727ff028c0b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_DocumentTransitionReport_f824aa97-12cf-4038-a5dd-6727ff028c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a086737e-710f-4ed4-b19a-ff127eae5c3d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_DocumentPeriodEndDate_a086737e-710f-4ed4-b19a-ff127eae5c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c4ccaf79-2301-491e-a89a-9a300e67bcfd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_CurrentFiscalYearEndDate_c4ccaf79-2301-491e-a89a-9a300e67bcfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d6b50fa0-2afb-4216-9da2-d212d312a6c9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_DocumentFiscalYearFocus_d6b50fa0-2afb-4216-9da2-d212d312a6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_6a58bd95-fc96-4040-8f87-c01f2198292f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_DocumentFiscalPeriodFocus_6a58bd95-fc96-4040-8f87-c01f2198292f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7ee04402-8ea2-4f51-9ab4-a1051324213f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityCentralIndexKey_7ee04402-8ea2-4f51-9ab4-a1051324213f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_87c942b2-af1c-4721-9f4b-2d22bf08ec26" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityFileNumber_87c942b2-af1c-4721-9f4b-2d22bf08ec26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ceb39c4d-9192-4385-81f0-bcba60d218da" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ceb39c4d-9192-4385-81f0-bcba60d218da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6505182e-e99c-417a-ba77-e967ad50fc14" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityTaxIdentificationNumber_6505182e-e99c-417a-ba77-e967ad50fc14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7893a3d3-473b-49b0-8e67-df89a1d10827" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityAddressAddressLine1_7893a3d3-473b-49b0-8e67-df89a1d10827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_0eb84ee3-c524-4a5e-8d3d-b0912c1a0dd9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityAddressCityOrTown_0eb84ee3-c524-4a5e-8d3d-b0912c1a0dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0a9c0ef2-de26-46bb-b7b6-2ded5f1300f5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityAddressStateOrProvince_0a9c0ef2-de26-46bb-b7b6-2ded5f1300f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4e9d9864-194d-4fa1-a315-a8ae21de7c1f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityAddressPostalZipCode_4e9d9864-194d-4fa1-a315-a8ae21de7c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fc0aaef1-493e-468c-a2ea-1a1d2b8a8525" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_CityAreaCode_fc0aaef1-493e-468c-a2ea-1a1d2b8a8525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_675a7fc4-958b-4975-9c3a-6ff6caba076b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_LocalPhoneNumber_675a7fc4-958b-4975-9c3a-6ff6caba076b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_62fcd4c2-f1b9-4c56-b889-7a8bc588a0e7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_62fcd4c2-f1b9-4c56-b889-7a8bc588a0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_a5a0e069-07fe-476f-9ae2-4b98ebb0feba" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityVoluntaryFilers_a5a0e069-07fe-476f-9ae2-4b98ebb0feba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_f04fb56b-630f-4d8a-8281-2bb604104367" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityCurrentReportingStatus_f04fb56b-630f-4d8a-8281-2bb604104367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b24dacbb-49d0-4aa4-b0ca-a9bffbc1fa66" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityInteractiveDataCurrent_b24dacbb-49d0-4aa4-b0ca-a9bffbc1fa66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_f018735a-7c91-408d-8be9-471eafa92c8b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityFilerCategory_f018735a-7c91-408d-8be9-471eafa92c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_40e8914a-e251-465c-b205-5a7d0e844310" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntitySmallBusiness_40e8914a-e251-465c-b205-5a7d0e844310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_9893e410-05f7-4dc2-8abb-cf6064305ab5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityEmergingGrowthCompany_9893e410-05f7-4dc2-8abb-cf6064305ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4b06fc61-77bc-49a0-80ed-18c952c73e03" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_Security12bTitle_4b06fc61-77bc-49a0-80ed-18c952c73e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8dc80e1f-30f9-4a89-acc5-95a582b303db" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_TradingSymbol_8dc80e1f-30f9-4a89-acc5-95a582b303db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_26adc931-b145-43c0-83b2-3eb4b684378e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_SecurityExchangeName_26adc931-b145-43c0-83b2-3eb4b684378e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_fea7a519-3e47-49bf-a768-b11bb86c2c0f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_IcfrAuditorAttestationFlag_fea7a519-3e47-49bf-a768-b11bb86c2c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_aa9a46ec-f68f-4e6e-b726-d320677d8f38" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityShellCompany_aa9a46ec-f68f-4e6e-b726-d320677d8f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_2d839c4b-0ba5-437b-82b8-d9ce068b7586" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityPublicFloat_2d839c4b-0ba5-437b-82b8-d9ce068b7586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_af2ab2a3-df64-4621-803b-e6ebc7ffc87d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_af2ab2a3-df64-4621-803b-e6ebc7ffc87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_58f43752-0396-4844-80b9-a9f251dd2189" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_AmendmentFlag_58f43752-0396-4844-80b9-a9f251dd2189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_c7850155-8391-42bb-91d3-1cc162ec11d3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84dcbca8-3dfd-492d-8f3b-d621da937887" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_c7850155-8391-42bb-91d3-1cc162ec11d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c119465d-56b3-4b6d-95a8-70fa273a77fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_3f4ea6ae-bd4a-4cf2-9e2c-8a4145060abc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c119465d-56b3-4b6d-95a8-70fa273a77fa" xlink:to="loc_us-gaap_AssetsAbstract_3f4ea6ae-bd4a-4cf2-9e2c-8a4145060abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_671061ff-1e87-4b35-a21d-73b74d86a5bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3f4ea6ae-bd4a-4cf2-9e2c-8a4145060abc" xlink:to="loc_us-gaap_AssetsCurrentAbstract_671061ff-1e87-4b35-a21d-73b74d86a5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7d4abb02-62e6-44df-9e74-8a83285e6d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_671061ff-1e87-4b35-a21d-73b74d86a5bd" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7d4abb02-62e6-44df-9e74-8a83285e6d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_fcb028cc-8770-42e5-a56b-7f26a769656a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_671061ff-1e87-4b35-a21d-73b74d86a5bd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_fcb028cc-8770-42e5-a56b-7f26a769656a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f5a15861-8037-48a0-93e0-5f3391968272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_671061ff-1e87-4b35-a21d-73b74d86a5bd" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f5a15861-8037-48a0-93e0-5f3391968272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3db2b420-8b27-4407-a118-4d255d26bf2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_671061ff-1e87-4b35-a21d-73b74d86a5bd" xlink:to="loc_us-gaap_InventoryNet_3db2b420-8b27-4407-a118-4d255d26bf2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_53a00036-e46b-41df-8873-353773ae645b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_671061ff-1e87-4b35-a21d-73b74d86a5bd" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_53a00036-e46b-41df-8873-353773ae645b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3256a3e0-1afc-4c14-84c6-cd999ace14bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_671061ff-1e87-4b35-a21d-73b74d86a5bd" xlink:to="loc_us-gaap_AssetsCurrent_3256a3e0-1afc-4c14-84c6-cd999ace14bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_289674e1-0e11-4580-90e4-b23cb1444a74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3f4ea6ae-bd4a-4cf2-9e2c-8a4145060abc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_289674e1-0e11-4580-90e4-b23cb1444a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a5483e57-a3f5-4df1-b138-8f5caea0965c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3f4ea6ae-bd4a-4cf2-9e2c-8a4145060abc" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a5483e57-a3f5-4df1-b138-8f5caea0965c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_3de54f82-5e4c-4823-b3d4-0aac48b404ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3f4ea6ae-bd4a-4cf2-9e2c-8a4145060abc" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_3de54f82-5e4c-4823-b3d4-0aac48b404ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_959f6e8a-c982-43a6-9048-bae0a9613d85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3f4ea6ae-bd4a-4cf2-9e2c-8a4145060abc" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_959f6e8a-c982-43a6-9048-bae0a9613d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b55aea19-87b4-4670-9e91-0a0235131a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3f4ea6ae-bd4a-4cf2-9e2c-8a4145060abc" xlink:to="loc_us-gaap_Goodwill_b55aea19-87b4-4670-9e91-0a0235131a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c89d4a66-c7d4-4f31-b077-1715a403d919" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3f4ea6ae-bd4a-4cf2-9e2c-8a4145060abc" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c89d4a66-c7d4-4f31-b077-1715a403d919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_459ac3b2-1995-48c0-886a-14cd88e8a73e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3f4ea6ae-bd4a-4cf2-9e2c-8a4145060abc" xlink:to="loc_us-gaap_Assets_459ac3b2-1995-48c0-886a-14cd88e8a73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2a0270ee-712c-4208-b514-e1b1ce9e48c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c119465d-56b3-4b6d-95a8-70fa273a77fa" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2a0270ee-712c-4208-b514-e1b1ce9e48c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_30abd7c3-37b1-4ed1-a570-c9fbe437187c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2a0270ee-712c-4208-b514-e1b1ce9e48c9" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_30abd7c3-37b1-4ed1-a570-c9fbe437187c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c97d52e8-9809-439c-9379-f640325fec18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_30abd7c3-37b1-4ed1-a570-c9fbe437187c" xlink:to="loc_us-gaap_AccountsPayableCurrent_c97d52e8-9809-439c-9379-f640325fec18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ddccdbd8-072f-4f2a-b547-c94c4dd2ca39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_30abd7c3-37b1-4ed1-a570-c9fbe437187c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ddccdbd8-072f-4f2a-b547-c94c4dd2ca39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0d380a8d-f31a-44ea-8a3f-e6a2a3a83421" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_30abd7c3-37b1-4ed1-a570-c9fbe437187c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0d380a8d-f31a-44ea-8a3f-e6a2a3a83421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_53671fb4-c6a5-47ca-88f7-e3eaf09888e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_30abd7c3-37b1-4ed1-a570-c9fbe437187c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_53671fb4-c6a5-47ca-88f7-e3eaf09888e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_dab4a478-84cf-4498-ad46-4b993c19b97b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_30abd7c3-37b1-4ed1-a570-c9fbe437187c" xlink:to="loc_us-gaap_LiabilitiesCurrent_dab4a478-84cf-4498-ad46-4b993c19b97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_78107335-42e7-42e1-a2bc-2a17c4115ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2a0270ee-712c-4208-b514-e1b1ce9e48c9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_78107335-42e7-42e1-a2bc-2a17c4115ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_41dff44b-b34c-4f29-84f6-8f74dafe98c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2a0270ee-712c-4208-b514-e1b1ce9e48c9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_41dff44b-b34c-4f29-84f6-8f74dafe98c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent_69ac67e3-49a7-4a7e-913c-3325a165f4e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2a0270ee-712c-4208-b514-e1b1ce9e48c9" xlink:to="loc_us-gaap_OtherLongTermDebtNoncurrent_69ac67e3-49a7-4a7e-913c-3325a165f4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_0891eba1-4c2c-4a52-abcf-57e6b81ed711" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2a0270ee-712c-4208-b514-e1b1ce9e48c9" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_0891eba1-4c2c-4a52-abcf-57e6b81ed711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4d0238ec-64cb-4c9d-b323-83ca1ffde294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2a0270ee-712c-4208-b514-e1b1ce9e48c9" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4d0238ec-64cb-4c9d-b323-83ca1ffde294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_170aa007-8857-48b5-af70-3a700aaa29a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2a0270ee-712c-4208-b514-e1b1ce9e48c9" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_170aa007-8857-48b5-af70-3a700aaa29a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_847a1b86-61ca-4be8-bb08-5bc273d39f75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2a0270ee-712c-4208-b514-e1b1ce9e48c9" xlink:to="loc_us-gaap_Liabilities_847a1b86-61ca-4be8-bb08-5bc273d39f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_6e45cbf4-e8c4-4eeb-9802-3fec9a98a6cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2a0270ee-712c-4208-b514-e1b1ce9e48c9" xlink:to="loc_us-gaap_CommitmentsAndContingencies_6e45cbf4-e8c4-4eeb-9802-3fec9a98a6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_cf781b39-1146-4f86-b3d8-2ac5a427fc85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2a0270ee-712c-4208-b514-e1b1ce9e48c9" xlink:to="loc_us-gaap_StockholdersEquityAbstract_cf781b39-1146-4f86-b3d8-2ac5a427fc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_760dc053-1001-4cad-955b-c73a9228b367" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cf781b39-1146-4f86-b3d8-2ac5a427fc85" xlink:to="loc_us-gaap_PreferredStockValue_760dc053-1001-4cad-955b-c73a9228b367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_75eb5228-d6d3-4ca1-9dbc-4788924031df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cf781b39-1146-4f86-b3d8-2ac5a427fc85" xlink:to="loc_us-gaap_CommonStockValue_75eb5228-d6d3-4ca1-9dbc-4788924031df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_800665b3-10c8-489c-acf3-1567704982d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cf781b39-1146-4f86-b3d8-2ac5a427fc85" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_800665b3-10c8-489c-acf3-1567704982d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_c0ca21a6-1209-4b40-b3ae-e43de503bbd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cf781b39-1146-4f86-b3d8-2ac5a427fc85" xlink:to="loc_us-gaap_AdditionalPaidInCapital_c0ca21a6-1209-4b40-b3ae-e43de503bbd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_50e9b8ea-486f-4b3b-b19f-8d4d99a670ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cf781b39-1146-4f86-b3d8-2ac5a427fc85" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_50e9b8ea-486f-4b3b-b19f-8d4d99a670ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3b5cf2b2-9e90-4224-871b-97820487f3cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cf781b39-1146-4f86-b3d8-2ac5a427fc85" xlink:to="loc_us-gaap_StockholdersEquity_3b5cf2b2-9e90-4224-871b-97820487f3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7d06f770-3872-417e-bbf9-4b225c2de1fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2a0270ee-712c-4208-b514-e1b1ce9e48c9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_7d06f770-3872-417e-bbf9-4b225c2de1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3aecf5e3-d384-4073-a2dd-126c4c58e4d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6ceeb97d-dfcf-4bf6-82b4-90de86b0283d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3aecf5e3-d384-4073-a2dd-126c4c58e4d1" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6ceeb97d-dfcf-4bf6-82b4-90de86b0283d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_3f831e56-f777-431b-858e-a98d68a5e97d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3aecf5e3-d384-4073-a2dd-126c4c58e4d1" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_3f831e56-f777-431b-858e-a98d68a5e97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4a92ef78-baf8-42dc-8c08-728f27af3e12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3aecf5e3-d384-4073-a2dd-126c4c58e4d1" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4a92ef78-baf8-42dc-8c08-728f27af3e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_0f3d74ec-bb37-42ec-b4f1-c9cf8a98337d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3aecf5e3-d384-4073-a2dd-126c4c58e4d1" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_0f3d74ec-bb37-42ec-b4f1-c9cf8a98337d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_594fa1f0-91e2-4e27-9aec-4178ca98810a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3aecf5e3-d384-4073-a2dd-126c4c58e4d1" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_594fa1f0-91e2-4e27-9aec-4178ca98810a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f5a88be5-978d-4495-8f24-b6f248a73efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3aecf5e3-d384-4073-a2dd-126c4c58e4d1" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f5a88be5-978d-4495-8f24-b6f248a73efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_78573d61-0824-4342-b537-69cfa6c6cf0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3aecf5e3-d384-4073-a2dd-126c4c58e4d1" xlink:to="loc_us-gaap_CommonStockSharesIssued_78573d61-0824-4342-b537-69cfa6c6cf0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b94205f7-82d8-4218-a90d-898b50e4b3d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3aecf5e3-d384-4073-a2dd-126c4c58e4d1" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b94205f7-82d8-4218-a90d-898b50e4b3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_757e6616-754f-4d23-b33d-cd674078f6b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_46bf0b75-7cfe-4a9f-9ef4-74ca0819a458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_757e6616-754f-4d23-b33d-cd674078f6b4" xlink:to="loc_us-gaap_StatementTable_46bf0b75-7cfe-4a9f-9ef4-74ca0819a458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a3351bfd-a54e-44d2-a933-0977bb61e4bd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_46bf0b75-7cfe-4a9f-9ef4-74ca0819a458" xlink:to="loc_srt_ProductOrServiceAxis_a3351bfd-a54e-44d2-a933-0977bb61e4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4cb0ce2e-2db8-4b92-94b9-e396d7acd73f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a3351bfd-a54e-44d2-a933-0977bb61e4bd" xlink:to="loc_srt_ProductsAndServicesDomain_4cb0ce2e-2db8-4b92-94b9-e396d7acd73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DiagnosticTestsMember_d3905986-ebc0-498e-8d9d-bc37f659988d" xlink:href="nvta-20201231.xsd#nvta_DiagnosticTestsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4cb0ce2e-2db8-4b92-94b9-e396d7acd73f" xlink:to="loc_nvta_DiagnosticTestsMember_d3905986-ebc0-498e-8d9d-bc37f659988d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CollaborationAndGenomeNetworkMember_71e3ae88-2217-4bc3-b4b6-007d731283ec" xlink:href="nvta-20201231.xsd#nvta_CollaborationAndGenomeNetworkMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4cb0ce2e-2db8-4b92-94b9-e396d7acd73f" xlink:to="loc_nvta_CollaborationAndGenomeNetworkMember_71e3ae88-2217-4bc3-b4b6-007d731283ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_46bf0b75-7cfe-4a9f-9ef4-74ca0819a458" xlink:to="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b0459745-63fe-474b-b4e1-1eef500b8aaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b0459745-63fe-474b-b4e1-1eef500b8aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_fd07c168-2c7c-492b-831e-112fb242cb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_CostOfRevenue_fd07c168-2c7c-492b-831e-112fb242cb38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_81cc7281-2faf-40b4-be83-e659f8afd0b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_81cc7281-2faf-40b4-be83-e659f8afd0b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_03eefcfd-88de-4dcd-8315-a4032020b4f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_SellingAndMarketingExpense_03eefcfd-88de-4dcd-8315-a4032020b4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_078b105c-e378-453b-8024-4a0127988be4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_078b105c-e378-453b-8024-4a0127988be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c48a1b8d-badd-4234-9264-5d77552608ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_OperatingIncomeLoss_c48a1b8d-badd-4234-9264-5d77552608ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_aaea67fd-ae9b-4487-bbbf-6f9388995423" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_aaea67fd-ae9b-4487-bbbf-6f9388995423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8bd16807-819f-4ae2-b553-e3b430b64010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_InterestExpense_8bd16807-819f-4ae2-b553-e3b430b64010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cedc9be1-b8d6-4edb-bc5a-042dd9cbc324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cedc9be1-b8d6-4edb-bc5a-042dd9cbc324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ea6ddea5-db52-4bd9-8afe-bdbd65ebdd51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ea6ddea5-db52-4bd9-8afe-bdbd65ebdd51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4971a329-20d2-4079-a299-356550230309" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_NetIncomeLoss_4971a329-20d2-4079-a299-356550230309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_ca4500cf-b880-487b-b250-b11f06d0a486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_ca4500cf-b880-487b-b250-b11f06d0a486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_54d37b0e-1bf2-403c-9942-5864ac6c39ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b20fa143-dc0c-45b7-b72a-067f2801a04f" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_54d37b0e-1bf2-403c-9942-5864ac6c39ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_818e8764-ea27-4cb3-af20-e5296aaa9dd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_df8e0a69-18e7-4eae-9030-2836ebef50b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_818e8764-ea27-4cb3-af20-e5296aaa9dd0" xlink:to="loc_us-gaap_NetIncomeLoss_df8e0a69-18e7-4eae-9030-2836ebef50b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8661625f-cf05-48e3-b88d-4da9f87f1d97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_818e8764-ea27-4cb3-af20-e5296aaa9dd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8661625f-cf05-48e3-b88d-4da9f87f1d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_ba72a459-d410-4b23-b1eb-e4f406e73d5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8661625f-cf05-48e3-b88d-4da9f87f1d97" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_ba72a459-d410-4b23-b1eb-e4f406e73d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e4db1f93-59d3-4ab4-9409-817e8fa83161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_818e8764-ea27-4cb3-af20-e5296aaa9dd0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e4db1f93-59d3-4ab4-9409-817e8fa83161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_970cd5be-d89c-488e-a8e0-5869e1a5774b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_88a2ec40-9eb5-412a-9c04-b327c3b19aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_970cd5be-d89c-488e-a8e0-5869e1a5774b" xlink:to="loc_us-gaap_StatementTable_88a2ec40-9eb5-412a-9c04-b327c3b19aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1e3947aa-0b51-4b0a-84fb-247dd29496b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_88a2ec40-9eb5-412a-9c04-b327c3b19aa1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1e3947aa-0b51-4b0a-84fb-247dd29496b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1d5f0155-cd42-492b-92c9-2db3be9d1bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1e3947aa-0b51-4b0a-84fb-247dd29496b3" xlink:to="loc_us-gaap_EquityComponentDomain_1d5f0155-cd42-492b-92c9-2db3be9d1bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c4dfccb4-f454-44c5-9d02-652ea782f61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f0155-cd42-492b-92c9-2db3be9d1bf8" xlink:to="loc_us-gaap_CommonStockMember_c4dfccb4-f454-44c5-9d02-652ea782f61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_590d40bd-26ec-4860-8721-a01d55e26dff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f0155-cd42-492b-92c9-2db3be9d1bf8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_590d40bd-26ec-4860-8721-a01d55e26dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_09abf6ee-7caf-4706-89ea-790e0f72efb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f0155-cd42-492b-92c9-2db3be9d1bf8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_09abf6ee-7caf-4706-89ea-790e0f72efb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_fc40c2cd-f55b-40ec-acbf-6cf089daf5c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f0155-cd42-492b-92c9-2db3be9d1bf8" xlink:to="loc_us-gaap_RetainedEarningsMember_fc40c2cd-f55b-40ec-acbf-6cf089daf5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_dfc79d26-a990-4e90-87e4-203be4fae1f1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_88a2ec40-9eb5-412a-9c04-b327c3b19aa1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_dfc79d26-a990-4e90-87e4-203be4fae1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_98470b45-0fb8-4ecc-937f-fa521301eea3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_dfc79d26-a990-4e90-87e4-203be4fae1f1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_98470b45-0fb8-4ecc-937f-fa521301eea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_91a38d13-2d05-45d4-b1d7-e1cfc4ad0e24" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_98470b45-0fb8-4ecc-937f-fa521301eea3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_91a38d13-2d05-45d4-b1d7-e1cfc4ad0e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_af4d24ae-f250-4a92-9ea3-891195bf8733" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_88a2ec40-9eb5-412a-9c04-b327c3b19aa1" xlink:to="loc_srt_RestatementAxis_af4d24ae-f250-4a92-9ea3-891195bf8733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_274b87b8-2b59-4dd3-909f-fff75a6e10ef" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_af4d24ae-f250-4a92-9ea3-891195bf8733" xlink:to="loc_srt_RestatementDomain_274b87b8-2b59-4dd3-909f-fff75a6e10ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_bfa9be1d-479d-469d-b9a9-53849fdbd33f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_274b87b8-2b59-4dd3-909f-fff75a6e10ef" xlink:to="loc_srt_RestatementAdjustmentMember_bfa9be1d-479d-469d-b9a9-53849fdbd33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_76fa617b-e167-457c-b377-1b11adf4c29c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_88a2ec40-9eb5-412a-9c04-b327c3b19aa1" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_76fa617b-e167-457c-b377-1b11adf4c29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_beb10349-259e-4e04-8189-53a05e2598f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_76fa617b-e167-457c-b377-1b11adf4c29c" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_beb10349-259e-4e04-8189-53a05e2598f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember_93fb4ef0-8939-4269-bfa0-c11c5ba21aaf" xlink:href="nvta-20201231.xsd#nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_beb10349-259e-4e04-8189-53a05e2598f5" xlink:to="loc_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember_93fb4ef0-8939-4269-bfa0-c11c5ba21aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fe08eb45-c2f7-4e06-b627-2fc6527a3f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_88a2ec40-9eb5-412a-9c04-b327c3b19aa1" xlink:to="loc_us-gaap_StatementLineItems_fe08eb45-c2f7-4e06-b627-2fc6527a3f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fe08eb45-c2f7-4e06-b627-2fc6527a3f3b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_29d981bd-05ec-4171-a865-16cdf70ca766" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_StockholdersEquity_29d981bd-05ec-4171-a865-16cdf70ca766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_737ba993-2135-4246-bc91-ec4428658886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_737ba993-2135-4246-bc91-ec4428658886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts_402a6d8a-3ae6-458c-a14b-ed8b58b1ceaa" xlink:href="nvta-20201231.xsd#nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts_402a6d8a-3ae6-458c-a14b-ed8b58b1ceaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b8fb99eb-e79f-4573-8ae6-0b93f3a44391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b8fb99eb-e79f-4573-8ae6-0b93f3a44391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fb164812-3e0b-45b4-a078-e604245300bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fb164812-3e0b-45b4-a078-e604245300bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIssuedDuringPeriodValueWarrantsExercised_e340cdad-ec08-4e99-8767-d882180d3a4c" xlink:href="nvta-20201231.xsd#nvta_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_nvta_StockIssuedDuringPeriodValueWarrantsExercised_e340cdad-ec08-4e99-8767-d882180d3a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_cfe5b8af-4a9b-4855-868b-1b002ae38a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_cfe5b8af-4a9b-4855-868b-1b002ae38a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_854be1ea-008e-45a9-9c65-ba3b5a47090f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_854be1ea-008e-45a9-9c65-ba3b5a47090f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_bebacf4b-f46b-4549-8541-10dffb447847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_bebacf4b-f46b-4549-8541-10dffb447847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts_fb036317-834c-43ff-8576-87a63ada47d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts_fb036317-834c-43ff-8576-87a63ada47d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_108d5521-ebe2-48a4-84ee-51b25f19f4a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_108d5521-ebe2-48a4-84ee-51b25f19f4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_213638db-d370-4688-9c92-b19b3ddc0f6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_NetIncomeLoss_213638db-d370-4688-9c92-b19b3ddc0f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4cc211b7-70d0-4a96-b7c4-5cbf2f62beab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ed52ba1-0f78-47dd-81b9-5666ffbbb9ac" xlink:to="loc_us-gaap_StockholdersEquity_4cc211b7-70d0-4a96-b7c4-5cbf2f62beab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="nvta-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_7f9671f0-6b89-4b5d-b38f-8e8480da2202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_7f259b42-7f90-480a-b4d7-ec93956da358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7f9671f0-6b89-4b5d-b38f-8e8480da2202" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_7f259b42-7f90-480a-b4d7-ec93956da358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_98261c93-2c4d-41a1-9c38-2c6725bd6574" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_7f259b42-7f90-480a-b4d7-ec93956da358" xlink:to="loc_us-gaap_NetIncomeLoss_98261c93-2c4d-41a1-9c38-2c6725bd6574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cea3c2f2-47bd-4de6-856a-3365b5fc1daf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_7f259b42-7f90-480a-b4d7-ec93956da358" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cea3c2f2-47bd-4de6-856a-3365b5fc1daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e299e560-025e-4ca3-8ea9-79a6f5233bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cea3c2f2-47bd-4de6-856a-3365b5fc1daf" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e299e560-025e-4ca3-8ea9-79a6f5233bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ccfe4554-dea4-48b2-bf94-a0613efe9300" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cea3c2f2-47bd-4de6-856a-3365b5fc1daf" xlink:to="loc_us-gaap_ShareBasedCompensation_ccfe4554-dea4-48b2-bf94-a0613efe9300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_b8a73d90-6ee3-47a9-977f-45ce2baf1ce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cea3c2f2-47bd-4de6-856a-3365b5fc1daf" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_b8a73d90-6ee3-47a9-977f-45ce2baf1ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_1696e3b6-08ef-4883-8c0e-461d54d579b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cea3c2f2-47bd-4de6-856a-3365b5fc1daf" xlink:to="loc_us-gaap_AssetImpairmentCharges_1696e3b6-08ef-4883-8c0e-461d54d579b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationRemeasurementOfLiabilities_90e83b46-6cac-4995-a6f6-fc9b1380afff" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationRemeasurementOfLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cea3c2f2-47bd-4de6-856a-3365b5fc1daf" xlink:to="loc_nvta_BusinessCombinationRemeasurementOfLiabilities_90e83b46-6cac-4995-a6f6-fc9b1380afff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_be0105ab-deeb-4d47-9fc0-53a4c5dc8917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cea3c2f2-47bd-4de6-856a-3365b5fc1daf" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_be0105ab-deeb-4d47-9fc0-53a4c5dc8917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_63213326-d546-4a76-bc11-782953efe638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cea3c2f2-47bd-4de6-856a-3365b5fc1daf" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_63213326-d546-4a76-bc11-782953efe638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity_6b5a284d-a6fb-4124-b805-24ea501370f4" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cea3c2f2-47bd-4de6-856a-3365b5fc1daf" xlink:to="loc_nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity_6b5a284d-a6fb-4124-b805-24ea501370f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_9d820345-6dff-4257-b263-448832bdc86e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cea3c2f2-47bd-4de6-856a-3365b5fc1daf" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_9d820345-6dff-4257-b263-448832bdc86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cbcc1f8f-c2ec-433b-aa54-9e8a57c5816c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_7f259b42-7f90-480a-b4d7-ec93956da358" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cbcc1f8f-c2ec-433b-aa54-9e8a57c5816c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7fc7f086-6cc6-4412-b396-2f15bf047bc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cbcc1f8f-c2ec-433b-aa54-9e8a57c5816c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7fc7f086-6cc6-4412-b396-2f15bf047bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_71ac81db-37ef-4e9a-ab6d-1712d1b98b72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cbcc1f8f-c2ec-433b-aa54-9e8a57c5816c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_71ac81db-37ef-4e9a-ab6d-1712d1b98b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets_2cce66ce-bcf1-4e00-bbd2-e6e39876d909" xlink:href="nvta-20201231.xsd#nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cbcc1f8f-c2ec-433b-aa54-9e8a57c5816c" xlink:to="loc_nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets_2cce66ce-bcf1-4e00-bbd2-e6e39876d909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_aa4b9949-4b4f-4435-9f36-2042a25bf41b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cbcc1f8f-c2ec-433b-aa54-9e8a57c5816c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_aa4b9949-4b4f-4435-9f36-2042a25bf41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1373c609-3d7f-4222-a5a6-41a5e642c852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cbcc1f8f-c2ec-433b-aa54-9e8a57c5816c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1373c609-3d7f-4222-a5a6-41a5e642c852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_a17e696a-b838-4c54-9548-2b37a1644001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cbcc1f8f-c2ec-433b-aa54-9e8a57c5816c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_a17e696a-b838-4c54-9548-2b37a1644001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bcc719f-c9d4-405c-b047-c07baa3989f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_7f259b42-7f90-480a-b4d7-ec93956da358" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bcc719f-c9d4-405c-b047-c07baa3989f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_a965da4e-5e94-40d7-a0d9-9764f81c59c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7f9671f0-6b89-4b5d-b38f-8e8480da2202" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_a965da4e-5e94-40d7-a0d9-9764f81c59c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_dc9a16f2-fa12-46fb-bcef-0da8598334f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_a965da4e-5e94-40d7-a0d9-9764f81c59c9" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_dc9a16f2-fa12-46fb-bcef-0da8598334f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1755a3db-7227-4b0f-b278-4026485fd072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_a965da4e-5e94-40d7-a0d9-9764f81c59c9" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1755a3db-7227-4b0f-b278-4026485fd072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_41447ba2-e400-45df-b260-73474f1d64b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_a965da4e-5e94-40d7-a0d9-9764f81c59c9" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_41447ba2-e400-45df-b260-73474f1d64b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_771bdbaa-dc60-46cd-ae2b-acb7326e2d56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_a965da4e-5e94-40d7-a0d9-9764f81c59c9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_771bdbaa-dc60-46cd-ae2b-acb7326e2d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_da2db5cb-ce6d-4971-89c7-b3adda89b320" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_a965da4e-5e94-40d7-a0d9-9764f81c59c9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_da2db5cb-ce6d-4971-89c7-b3adda89b320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6cd8e509-e8e4-4244-b277-c6981ac829ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_a965da4e-5e94-40d7-a0d9-9764f81c59c9" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6cd8e509-e8e4-4244-b277-c6981ac829ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d1ed4d0-dcd1-41b0-8d5c-71988b7964cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_a965da4e-5e94-40d7-a0d9-9764f81c59c9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d1ed4d0-dcd1-41b0-8d5c-71988b7964cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_aa155dea-1680-4e25-880d-c8319d39e2e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7f9671f0-6b89-4b5d-b38f-8e8480da2202" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_aa155dea-1680-4e25-880d-c8319d39e2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts_99b959c2-1ad6-476c-9b20-3c31c61fcda4" xlink:href="nvta-20201231.xsd#nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_aa155dea-1680-4e25-880d-c8319d39e2e4" xlink:to="loc_nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts_99b959c2-1ad6-476c-9b20-3c31c61fcda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_812ce6d1-fc9f-4b5c-bb87-94a6bade0c84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_aa155dea-1680-4e25-880d-c8319d39e2e4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_812ce6d1-fc9f-4b5c-bb87-94a6bade0c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_a6484308-ff77-49ce-ae4c-7feb6e068056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_aa155dea-1680-4e25-880d-c8319d39e2e4" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_a6484308-ff77-49ce-ae4c-7feb6e068056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_9271adb1-071a-436e-9b79-5d2639ea807c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_aa155dea-1680-4e25-880d-c8319d39e2e4" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_9271adb1-071a-436e-9b79-5d2639ea807c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_d2a5a164-f52f-4134-9657-92161c262503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_aa155dea-1680-4e25-880d-c8319d39e2e4" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_d2a5a164-f52f-4134-9657-92161c262503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfLoanCosts_ea69a977-9f63-442d-9f8f-5a97df5a082f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfLoanCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_aa155dea-1680-4e25-880d-c8319d39e2e4" xlink:to="loc_us-gaap_PaymentsOfLoanCosts_ea69a977-9f63-442d-9f8f-5a97df5a082f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_542ba266-b43b-485a-a240-954d26c66c18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_aa155dea-1680-4e25-880d-c8319d39e2e4" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_542ba266-b43b-485a-a240-954d26c66c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_564e2e42-9e2a-42aa-9c22-d8bee49821c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_aa155dea-1680-4e25-880d-c8319d39e2e4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_564e2e42-9e2a-42aa-9c22-d8bee49821c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67f5c242-bf7b-4d40-bbf9-7c133fab0dc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7f9671f0-6b89-4b5d-b38f-8e8480da2202" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67f5c242-bf7b-4d40-bbf9-7c133fab0dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fc516521-18b5-4270-9fb1-88eafd125429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7f9671f0-6b89-4b5d-b38f-8e8480da2202" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fc516521-18b5-4270-9fb1-88eafd125429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fdb80657-5249-406d-85ac-ef98dca96686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7f9671f0-6b89-4b5d-b38f-8e8480da2202" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fdb80657-5249-406d-85ac-ef98dca96686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_0e8ba714-740b-457f-a0c3-2cdcacac5724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7f9671f0-6b89-4b5d-b38f-8e8480da2202" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_0e8ba714-740b-457f-a0c3-2cdcacac5724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_402bf430-91a4-450a-b465-470989bc0ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0e8ba714-740b-457f-a0c3-2cdcacac5724" xlink:to="loc_us-gaap_InterestPaidNet_402bf430-91a4-450a-b465-470989bc0ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b2058947-5d28-4483-99f4-dedf082eb1db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7f9671f0-6b89-4b5d-b38f-8e8480da2202" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b2058947-5d28-4483-99f4-dedf082eb1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsIncurred_da7c31bd-782a-4750-9a8b-3f4103cc18a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsIncurred"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b2058947-5d28-4483-99f4-dedf082eb1db" xlink:to="loc_us-gaap_CapitalLeaseObligationsIncurred_da7c31bd-782a-4750-9a8b-3f4103cc18a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_739e378f-1579-46c2-86fc-6fb739e658af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b2058947-5d28-4483-99f4-dedf082eb1db" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_739e378f-1579-46c2-86fc-6fb739e658af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_eebd4232-5f51-4175-8566-2319b1efc36e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b2058947-5d28-4483-99f4-dedf082eb1db" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_eebd4232-5f51-4175-8566-2319b1efc36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_0537492b-e04c-488b-8f3a-d2df5f730e00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b2058947-5d28-4483-99f4-dedf082eb1db" xlink:to="loc_us-gaap_StockIssued1_0537492b-e04c-488b-8f3a-d2df5f730e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1_3c723ca7-94fe-44a9-bdac-d177a25474e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b2058947-5d28-4483-99f4-dedf082eb1db" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1_3c723ca7-94fe-44a9-bdac-d177a25474e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cb911db4-9b4d-4dd0-9777-a983f5808791" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b2058947-5d28-4483-99f4-dedf082eb1db" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cb911db4-9b4d-4dd0-9777-a983f5808791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Organizationanddescriptionofbusiness" xlink:type="simple" xlink:href="nvta-20201231.xsd#Organizationanddescriptionofbusiness"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/Organizationanddescriptionofbusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0e536732-0ac6-4e74-86e8-b49bd6ad1235" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_0d64e558-ff01-4671-91a8-4305e7ad0b0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0e536732-0ac6-4e74-86e8-b49bd6ad1235" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_0d64e558-ff01-4671-91a8-4305e7ad0b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/OrganizationanddescriptionofbusinessDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#OrganizationanddescriptionofbusinessDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/OrganizationanddescriptionofbusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_50957a47-484b-4c1c-8bcd-1cb19017a845" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_a44b8382-41b7-419f-a622-180675b3fa56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_50957a47-484b-4c1c-8bcd-1cb19017a845" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_a44b8382-41b7-419f-a622-180675b3fa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_1ea33d97-905e-4e99-b18f-1a8e5ff890c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_50957a47-484b-4c1c-8bcd-1cb19017a845" xlink:to="loc_us-gaap_NumberOfOperatingSegments_1ea33d97-905e-4e99-b18f-1a8e5ff890c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Summaryofsignificantaccountingpolicies" xlink:type="simple" xlink:href="nvta-20201231.xsd#Summaryofsignificantaccountingpolicies"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/Summaryofsignificantaccountingpolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_751e64e9-1e86-4a3e-a170-6cfad1f27be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_de241525-59e7-4833-9f78-3d1860476936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_751e64e9-1e86-4a3e-a170-6cfad1f27be8" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_de241525-59e7-4833-9f78-3d1860476936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_16d02798-891f-4878-bc1e-a3df3e527c14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_16d02798-891f-4878-bc1e-a3df3e527c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_f1c939f0-69e9-4d4c-80ae-9371dd8b1f4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_UseOfEstimates_f1c939f0-69e9-4d4c-80ae-9371dd8b1f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_e2d9533c-8fd3-4468-9609-22b747707c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_e2d9533c-8fd3-4468-9609-22b747707c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_d9eb83f7-f9eb-4f52-b7fc-1437c15bd7b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_d9eb83f7-f9eb-4f52-b7fc-1437c15bd7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_249c0949-3f59-44d1-9630-ab5910c2c35c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_249c0949-3f59-44d1-9630-ab5910c2c35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_8ef2ea25-e9e8-4aa4-99d8-f3dd46e36d15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_8ef2ea25-e9e8-4aa4-99d8-f3dd46e36d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_03bbabef-459d-4025-8c66-37b329532951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_03bbabef-459d-4025-8c66-37b329532951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_5394c364-ec21-4d1b-a47a-1ef5d4554ea7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_5394c364-ec21-4d1b-a47a-1ef5d4554ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_30e000e1-94d4-4547-a30f-51be03dd2058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_30e000e1-94d4-4547-a30f-51be03dd2058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_5b1bd924-3616-4e4e-bc3a-533c3c44cf8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_5b1bd924-3616-4e4e-bc3a-533c3c44cf8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_ced42e14-5906-4948-9ed9-543678bd655c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_ced42e14-5906-4948-9ed9-543678bd655c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_d516356e-8430-4454-9298-88247bd70e98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_d516356e-8430-4454-9298-88247bd70e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a0bf8e17-e111-4424-9a54-3be551f626fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a0bf8e17-e111-4424-9a54-3be551f626fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_fdafb5ac-2875-4b2a-8a62-547d4b6047af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_fdafb5ac-2875-4b2a-8a62-547d4b6047af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_8c672806-c8ce-4093-a312-096425fca9ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_8c672806-c8ce-4093-a312-096425fca9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_1294aa15-0e91-47f8-bf15-dc638029c24d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_1294aa15-0e91-47f8-bf15-dc638029c24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_d31529fa-63d5-406b-80e5-b0a1331c5e6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_d31529fa-63d5-406b-80e5-b0a1331c5e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_995191a6-5d65-46d0-a9b6-c69afebb868e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_995191a6-5d65-46d0-a9b6-c69afebb868e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_ab291a39-5dd3-45cc-804f-9d5073862755" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_ab291a39-5dd3-45cc-804f-9d5073862755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_89907836-85f2-49ed-996d-c5b380f8321e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_89907836-85f2-49ed-996d-c5b380f8321e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_ca306879-f2ac-4f18-a0a3-a78e8f3c4358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_ca306879-f2ac-4f18-a0a3-a78e8f3c4358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c6b2479c-9f6b-406e-9f3c-9b19b67f2623" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47c14ca6-b348-4745-953c-33c8f70999ba" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c6b2479c-9f6b-406e-9f3c-9b19b67f2623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesTables"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cd5beee2-2d7c-498f-8b66-d1e17d029691" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_bc1fbcd8-9bf4-4ecc-ab79-813ff2c3a018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cd5beee2-2d7c-498f-8b66-d1e17d029691" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_bc1fbcd8-9bf4-4ecc-ab79-813ff2c3a018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_1ef00b91-5bbc-4d95-9e0f-40a77b35c2da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cd5beee2-2d7c-498f-8b66-d1e17d029691" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_1ef00b91-5bbc-4d95-9e0f-40a77b35c2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_65a17d95-a6fe-4c8d-a650-5e61d299c9e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cd5beee2-2d7c-498f-8b66-d1e17d029691" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_65a17d95-a6fe-4c8d-a650-5e61d299c9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_07b6d527-6d21-4e76-8d41-19cf2e0a67d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cd5beee2-2d7c-498f-8b66-d1e17d029691" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_07b6d527-6d21-4e76-8d41-19cf2e0a67d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2912cd6d-9482-40e8-a373-90d476d1594c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:href="nvta-20201231.xsd#nvta_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2912cd6d-9482-40e8-a373-90d476d1594c" xlink:to="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4257820d-1c35-4fd5-a206-865e80bd6ed9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:to="loc_us-gaap_DebtInstrumentAxis_4257820d-1c35-4fd5-a206-865e80bd6ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_027b6282-f2a4-4614-89c7-f64249d28c76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4257820d-1c35-4fd5-a206-865e80bd6ed9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_027b6282-f2a4-4614-89c7-f64249d28c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ConvertibleSeniorNotesMember_37d25642-ed18-4329-8a1c-7dbb6ee5687b" xlink:href="nvta-20201231.xsd#nvta_ConvertibleSeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_027b6282-f2a4-4614-89c7-f64249d28c76" xlink:to="loc_nvta_ConvertibleSeniorNotesMember_37d25642-ed18-4329-8a1c-7dbb6ee5687b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_13e31a51-fccf-4c8c-8660-676659425c11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_13e31a51-fccf-4c8c-8660-676659425c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_59d7b39a-1eb3-49ff-b1bb-7e2f0804ab65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_13e31a51-fccf-4c8c-8660-676659425c11" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_59d7b39a-1eb3-49ff-b1bb-7e2f0804ab65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_c6e808d2-a617-4aec-806e-c1b3ad7c4f62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_59d7b39a-1eb3-49ff-b1bb-7e2f0804ab65" xlink:to="loc_us-gaap_ConvertibleDebtMember_c6e808d2-a617-4aec-806e-c1b3ad7c4f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e9b03574-90f2-4af4-8619-e3ef80c29052" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:to="loc_srt_RangeAxis_e9b03574-90f2-4af4-8619-e3ef80c29052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5006400b-e175-4563-85e8-69f1c6f5f446" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e9b03574-90f2-4af4-8619-e3ef80c29052" xlink:to="loc_srt_RangeMember_5006400b-e175-4563-85e8-69f1c6f5f446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5378a6f7-6b48-46b9-85a3-858dec089d25" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5006400b-e175-4563-85e8-69f1c6f5f446" xlink:to="loc_srt_MinimumMember_5378a6f7-6b48-46b9-85a3-858dec089d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e1d3e22a-a476-47ec-b542-38b61956f901" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5006400b-e175-4563-85e8-69f1c6f5f446" xlink:to="loc_srt_MaximumMember_e1d3e22a-a476-47ec-b542-38b61956f901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b6773e9d-f822-496e-b8d0-e08ea8d08035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b6773e9d-f822-496e-b8d0-e08ea8d08035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf97cb73-1d01-4bf5-a0e4-667b92530138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b6773e9d-f822-496e-b8d0-e08ea8d08035" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf97cb73-1d01-4bf5-a0e4-667b92530138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_8eb5e86a-3ce9-4ad1-aed1-f54fd1dba067" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf97cb73-1d01-4bf5-a0e4-667b92530138" xlink:to="loc_us-gaap_CustomerRelationshipsMember_8eb5e86a-3ce9-4ad1-aed1-f54fd1dba067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_3e3e428a-ac8f-481c-8051-4e48845759bc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:to="loc_srt_RestatementAxis_3e3e428a-ac8f-481c-8051-4e48845759bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_cc26372b-e834-4f29-be28-4e4e585e7fcd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_3e3e428a-ac8f-481c-8051-4e48845759bc" xlink:to="loc_srt_RestatementDomain_cc26372b-e834-4f29-be28-4e4e585e7fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_f7b240e0-e5ba-49d8-847e-ced723c63b9d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_cc26372b-e834-4f29-be28-4e4e585e7fcd" xlink:to="loc_srt_RestatementAdjustmentMember_f7b240e0-e5ba-49d8-847e-ced723c63b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_70ecfac1-3d22-4d82-a933-f6cf8d8946ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_70ecfac1-3d22-4d82-a933-f6cf8d8946ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_97e75ef1-50b5-4bf0-819f-559cad0e78c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_70ecfac1-3d22-4d82-a933-f6cf8d8946ce" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_97e75ef1-50b5-4bf0-819f-559cad0e78c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember_b1494c7e-71d4-4692-81d4-81747c8be36e" xlink:href="nvta-20201231.xsd#nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_97e75ef1-50b5-4bf0-819f-559cad0e78c3" xlink:to="loc_nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember_b1494c7e-71d4-4692-81d4-81747c8be36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d3a9ed82-010c-4c8e-88ee-49e56ef03563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d3a9ed82-010c-4c8e-88ee-49e56ef03563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_72ce4665-972e-4b41-830b-ed1acb4b7bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d3a9ed82-010c-4c8e-88ee-49e56ef03563" xlink:to="loc_us-gaap_EquityComponentDomain_72ce4665-972e-4b41-830b-ed1acb4b7bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_05e6d5fd-7c22-4ff5-b7dd-04e0fd1f5c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_72ce4665-972e-4b41-830b-ed1acb4b7bd5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_05e6d5fd-7c22-4ff5-b7dd-04e0fd1f5c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:href="nvta-20201231.xsd#nvta_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesTable_aa3f1a1d-715a-4abd-b5b6-586bd71b4e3d" xlink:to="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9f0f72f6-61c3-410c-a32d-5287cee964b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9f0f72f6-61c3-410c-a32d-5287cee964b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9901ce47-a1f2-4e75-8590-0e425daee0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9901ce47-a1f2-4e75-8590-0e425daee0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_196fdb30-c72b-4768-835a-acefdafc9928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_196fdb30-c72b-4768-835a-acefdafc9928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3a4a6f51-d2e9-49a8-a24c-48169e41850e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3a4a6f51-d2e9-49a8-a24c-48169e41850e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_0ad3b764-aa6c-44aa-9f05-e49175a17e0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_0ad3b764-aa6c-44aa-9f05-e49175a17e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets_1c204574-e528-49fe-add1-9aa881b62346" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets_1c204574-e528-49fe-add1-9aa881b62346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_b0bb91b9-2cd3-440c-8f03-5e750f937a13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_AdvertisingExpense_b0bb91b9-2cd3-440c-8f03-5e750f937a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d9d9303a-9a38-4d39-93d9-ef8a633c871f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d9d9303a-9a38-4d39-93d9-ef8a633c871f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_49d06a34-361e-4040-83a6-4767f3724f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_StockholdersEquity_49d06a34-361e-4040-83a6-4767f3724f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6e3b7fba-a223-43a4-8e0a-1ac10a43a10c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_SummaryOfSignificantAccountingPoliciesLineItems_0c566fbb-f1bc-4111-975d-e091e4083c18" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6e3b7fba-a223-43a4-8e0a-1ac10a43a10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_22cecd1f-4664-46c0-9426-c3a5b86d4271" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_9a9af1c7-f653-48b2-8158-b177c56b8560" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22cecd1f-4664-46c0-9426-c3a5b86d4271" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_9a9af1c7-f653-48b2-8158-b177c56b8560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_5567570d-7c45-478e-ab36-778c6f6547ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_9a9af1c7-f653-48b2-8158-b177c56b8560" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_5567570d-7c45-478e-ab36-778c6f6547ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_15649ea3-55a4-4fbd-9cc6-82d0805aa83c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5567570d-7c45-478e-ab36-778c6f6547ae" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_15649ea3-55a4-4fbd-9cc6-82d0805aa83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_7d76acea-0639-433b-9f04-10868c0275ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_15649ea3-55a4-4fbd-9cc6-82d0805aa83c" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_7d76acea-0639-433b-9f04-10868c0275ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_39b8fb02-00d4-4120-85f4-1af2db808be4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_9a9af1c7-f653-48b2-8158-b177c56b8560" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_39b8fb02-00d4-4120-85f4-1af2db808be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f6db7abc-f9f9-4038-9099-7a5e7abc9f09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_39b8fb02-00d4-4120-85f4-1af2db808be4" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f6db7abc-f9f9-4038-9099-7a5e7abc9f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_e1b71fe6-aea1-4f08-be71-aedb43b44779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f6db7abc-f9f9-4038-9099-7a5e7abc9f09" xlink:to="loc_us-gaap_SalesRevenueNetMember_e1b71fe6-aea1-4f08-be71-aedb43b44779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_3f1ee943-24d1-4d83-99f2-ef0ddb1e9c09" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_9a9af1c7-f653-48b2-8158-b177c56b8560" xlink:to="loc_srt_MajorCustomersAxis_3f1ee943-24d1-4d83-99f2-ef0ddb1e9c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_7218d135-95a4-4f82-8d36-d5a854993110" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_3f1ee943-24d1-4d83-99f2-ef0ddb1e9c09" xlink:to="loc_srt_NameOfMajorCustomerDomain_7218d135-95a4-4f82-8d36-d5a854993110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CustomerMember_31ba654c-cf79-4ba5-bbdb-6b7c710391f5" xlink:href="nvta-20201231.xsd#nvta_CustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7218d135-95a4-4f82-8d36-d5a854993110" xlink:to="loc_nvta_CustomerMember_31ba654c-cf79-4ba5-bbdb-6b7c710391f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_3f1bd9ca-e38a-4d07-991f-09b3f772f5cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_9a9af1c7-f653-48b2-8158-b177c56b8560" xlink:to="loc_us-gaap_ProductInformationLineItems_3f1bd9ca-e38a-4d07-991f-09b3f772f5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c93ad08f-1216-4235-9ecd-a0c8c7795c54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_3f1bd9ca-e38a-4d07-991f-09b3f772f5cf" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c93ad08f-1216-4235-9ecd-a0c8c7795c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_79dce90a-0b97-487a-b238-208825bd4ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_09fe9d0f-aa77-4c0c-a212-929f8c9bd038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_79dce90a-0b97-487a-b238-208825bd4ef5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_09fe9d0f-aa77-4c0c-a212-929f8c9bd038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_338d2e42-7996-4650-b815-86acf1b911e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_79dce90a-0b97-487a-b238-208825bd4ef5" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_338d2e42-7996-4650-b815-86acf1b911e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9cd415ca-8b3a-4ba3-aaf7-c55acc25747f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_79dce90a-0b97-487a-b238-208825bd4ef5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9cd415ca-8b3a-4ba3-aaf7-c55acc25747f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_77d3ef4d-fe08-4312-bb02-b191900c1c19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ee5c63bb-7f22-4cde-b43c-10103d217f10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_77d3ef4d-fe08-4312-bb02-b191900c1c19" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ee5c63bb-7f22-4cde-b43c-10103d217f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58b2e637-44ba-46bb-958c-80150c414588" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ee5c63bb-7f22-4cde-b43c-10103d217f10" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58b2e637-44ba-46bb-958c-80150c414588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49243094-b918-41f4-86cf-a0b44b0d4892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58b2e637-44ba-46bb-958c-80150c414588" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49243094-b918-41f4-86cf-a0b44b0d4892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_f527238c-0eff-4ad1-b5e1-9a373c997fb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49243094-b918-41f4-86cf-a0b44b0d4892" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_f527238c-0eff-4ad1-b5e1-9a373c997fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AutomobilesMember_fa93e507-dfff-44c0-99eb-88ee4c5ea2aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AutomobilesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49243094-b918-41f4-86cf-a0b44b0d4892" xlink:to="loc_us-gaap_AutomobilesMember_fa93e507-dfff-44c0-99eb-88ee4c5ea2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_1e56d547-eb89-4505-ac8e-6376b0660d9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49243094-b918-41f4-86cf-a0b44b0d4892" xlink:to="loc_us-gaap_EquipmentMember_1e56d547-eb89-4505-ac8e-6376b0660d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_cb477914-6e3e-4c85-b2fe-eefc27f55092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49243094-b918-41f4-86cf-a0b44b0d4892" xlink:to="loc_us-gaap_ComputerEquipmentMember_cb477914-6e3e-4c85-b2fe-eefc27f55092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_5c6dd0d2-ccf1-400c-b43e-934f60173ac1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49243094-b918-41f4-86cf-a0b44b0d4892" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_5c6dd0d2-ccf1-400c-b43e-934f60173ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3299e062-1385-4b96-8e4c-2cc4acac1ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ee5c63bb-7f22-4cde-b43c-10103d217f10" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3299e062-1385-4b96-8e4c-2cc4acac1ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_0d7779f0-d23c-4a3c-84e1-0064e293ccfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3299e062-1385-4b96-8e4c-2cc4acac1ac4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_0d7779f0-d23c-4a3c-84e1-0064e293ccfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Revenueaccountsreceivableanddeferredrevenue" xlink:type="simple" xlink:href="nvta-20201231.xsd#Revenueaccountsreceivableanddeferredrevenue"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/Revenueaccountsreceivableanddeferredrevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1e606cd8-89df-4631-9f91-3399ab4aed11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_800ddf34-4a65-481d-8aa5-c61b48b7cefb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1e606cd8-89df-4631-9f91-3399ab4aed11" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_800ddf34-4a65-481d-8aa5-c61b48b7cefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#RevenueaccountsreceivableanddeferredrevenueTables"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eec6c27b-126a-41e6-9b80-b68278a17ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_0c6bf58c-dadb-4c57-b2d5-4ff87e2f047f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eec6c27b-126a-41e6-9b80-b68278a17ee3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_0c6bf58c-dadb-4c57-b2d5-4ff87e2f047f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTextBlock_be858ee3-bfbd-4bbd-a35c-84bc19124cf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfChangeInAccountingEstimateTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eec6c27b-126a-41e6-9b80-b68278a17ee3" xlink:to="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTextBlock_be858ee3-bfbd-4bbd-a35c-84bc19124cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_320ded18-3c5c-4c2c-93f4-0d365ced8cde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a52a92d8-f634-41a2-9e2c-8b13ac46a478" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_320ded18-3c5c-4c2c-93f4-0d365ced8cde" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a52a92d8-f634-41a2-9e2c-8b13ac46a478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5f405552-6e5d-4624-afb2-281362ec194c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a52a92d8-f634-41a2-9e2c-8b13ac46a478" xlink:to="loc_srt_ProductOrServiceAxis_5f405552-6e5d-4624-afb2-281362ec194c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0ab340bb-e4c1-43ad-81e7-6648ac47016b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5f405552-6e5d-4624-afb2-281362ec194c" xlink:to="loc_srt_ProductsAndServicesDomain_0ab340bb-e4c1-43ad-81e7-6648ac47016b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DiagnosticTestsMember_f67cd6a4-8a9b-49da-b037-b9fd2f42d31e" xlink:href="nvta-20201231.xsd#nvta_DiagnosticTestsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0ab340bb-e4c1-43ad-81e7-6648ac47016b" xlink:to="loc_nvta_DiagnosticTestsMember_f67cd6a4-8a9b-49da-b037-b9fd2f42d31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_TestRevenueCentralizedMember_1267b5fe-8ddc-490f-b1b4-b7533689ad68" xlink:href="nvta-20201231.xsd#nvta_TestRevenueCentralizedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_DiagnosticTestsMember_f67cd6a4-8a9b-49da-b037-b9fd2f42d31e" xlink:to="loc_nvta_TestRevenueCentralizedMember_1267b5fe-8ddc-490f-b1b4-b7533689ad68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_TestRevenueDecentralizedMember_93495504-c579-4200-967b-12947193244b" xlink:href="nvta-20201231.xsd#nvta_TestRevenueDecentralizedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_DiagnosticTestsMember_f67cd6a4-8a9b-49da-b037-b9fd2f42d31e" xlink:to="loc_nvta_TestRevenueDecentralizedMember_93495504-c579-4200-967b-12947193244b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CollaborationAndGenomeNetworkMember_7d72d5aa-a623-44de-89eb-651e4b50ba8e" xlink:href="nvta-20201231.xsd#nvta_CollaborationAndGenomeNetworkMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0ab340bb-e4c1-43ad-81e7-6648ac47016b" xlink:to="loc_nvta_CollaborationAndGenomeNetworkMember_7d72d5aa-a623-44de-89eb-651e4b50ba8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_cb14c7c2-65fc-4d67-a07a-36a6067bf3f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a52a92d8-f634-41a2-9e2c-8b13ac46a478" xlink:to="loc_srt_MajorCustomersAxis_cb14c7c2-65fc-4d67-a07a-36a6067bf3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_43c80cf9-0e4b-49c4-86b6-5a2fe78eb7b9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_cb14c7c2-65fc-4d67-a07a-36a6067bf3f0" xlink:to="loc_srt_NameOfMajorCustomerDomain_43c80cf9-0e4b-49c4-86b6-5a2fe78eb7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PatientInsuranceMember_0ca6be28-e802-434e-ab6d-bb3723659eb8" xlink:href="nvta-20201231.xsd#nvta_PatientInsuranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_43c80cf9-0e4b-49c4-86b6-5a2fe78eb7b9" xlink:to="loc_nvta_PatientInsuranceMember_0ca6be28-e802-434e-ab6d-bb3723659eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PatientDirectMember_d9f4035f-6887-4e10-a24d-f28b36dd3859" xlink:href="nvta-20201231.xsd#nvta_PatientDirectMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_43c80cf9-0e4b-49c4-86b6-5a2fe78eb7b9" xlink:to="loc_nvta_PatientDirectMember_d9f4035f-6887-4e10-a24d-f28b36dd3859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PartnerMember_2ccc7284-e8fd-470c-8ebe-dba8368ef223" xlink:href="nvta-20201231.xsd#nvta_PartnerMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_43c80cf9-0e4b-49c4-86b6-5a2fe78eb7b9" xlink:to="loc_nvta_PartnerMember_2ccc7284-e8fd-470c-8ebe-dba8368ef223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_OtherBusinessToBusinessMember_f91e66f0-1560-45b5-a69e-88ee0028031c" xlink:href="nvta-20201231.xsd#nvta_OtherBusinessToBusinessMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_43c80cf9-0e4b-49c4-86b6-5a2fe78eb7b9" xlink:to="loc_nvta_OtherBusinessToBusinessMember_f91e66f0-1560-45b5-a69e-88ee0028031c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_08b7ef8d-9fb4-4926-9f53-e62ad2669900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a52a92d8-f634-41a2-9e2c-8b13ac46a478" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_08b7ef8d-9fb4-4926-9f53-e62ad2669900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fc601768-9bd1-45d4-b39c-1b75f38509d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_08b7ef8d-9fb4-4926-9f53-e62ad2669900" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fc601768-9bd1-45d4-b39c-1b75f38509d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5f9c150f-0387-498c-aa10-a72ea39e76de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_ae64a8cd-92e0-485e-a753-4b1f37a869cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfChangeInAccountingEstimateTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5f9c150f-0387-498c-aa10-a72ea39e76de" xlink:to="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_ae64a8cd-92e0-485e-a753-4b1f37a869cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_863ab881-3a73-4a01-b8f5-1314fa26c096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_ae64a8cd-92e0-485e-a753-4b1f37a869cc" xlink:to="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_863ab881-3a73-4a01-b8f5-1314fa26c096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_d8f97456-d202-44bf-aca5-815d59752e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_863ab881-3a73-4a01-b8f5-1314fa26c096" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleMember_d8f97456-d202-44bf-aca5-815d59752e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ChangeInEstimateOfRevenueRecognitionMember_4d935082-5aeb-4a51-9da2-8f0448dd48fe" xlink:href="nvta-20201231.xsd#nvta_ChangeInEstimateOfRevenueRecognitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingPrincipleMember_d8f97456-d202-44bf-aca5-815d59752e8d" xlink:to="loc_nvta_ChangeInEstimateOfRevenueRecognitionMember_4d935082-5aeb-4a51-9da2-8f0448dd48fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateLineItems_6c4e231f-0fd6-40f2-8398-c664e4ee7799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_ae64a8cd-92e0-485e-a753-4b1f37a869cc" xlink:to="loc_us-gaap_ChangeInAccountingEstimateLineItems_6c4e231f-0fd6-40f2-8398-c664e4ee7799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dedfd9a5-a031-44ba-87fb-f27cd51babd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_6c4e231f-0fd6-40f2-8398-c664e4ee7799" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dedfd9a5-a031-44ba-87fb-f27cd51babd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a02e192e-7e05-4c54-8d58-3b5bea0ef372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_6c4e231f-0fd6-40f2-8398-c664e4ee7799" xlink:to="loc_us-gaap_OperatingIncomeLoss_a02e192e-7e05-4c54-8d58-3b5bea0ef372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_45d924ec-808e-4fee-9df3-577a502e2131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_6c4e231f-0fd6-40f2-8398-c664e4ee7799" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_45d924ec-808e-4fee-9df3-577a502e2131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_db04e153-6f42-41eb-bee0-50dc6cc61cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fcd5f978-803c-48b6-a52c-9028e0867f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_db04e153-6f42-41eb-bee0-50dc6cc61cea" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fcd5f978-803c-48b6-a52c-9028e0867f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_448e8c2f-039f-41d0-b771-28c7ba2829b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fcd5f978-803c-48b6-a52c-9028e0867f03" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_448e8c2f-039f-41d0-b771-28c7ba2829b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_c67c2ceb-bbb8-4df0-bbd7-792e46d83ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_448e8c2f-039f-41d0-b771-28c7ba2829b3" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_c67c2ceb-bbb8-4df0-bbd7-792e46d83ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CARESActMember_eb79b087-44a9-4742-bdba-11a29f373981" xlink:href="nvta-20201231.xsd#nvta_CARESActMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_c67c2ceb-bbb8-4df0-bbd7-792e46d83ec9" xlink:to="loc_nvta_CARESActMember_eb79b087-44a9-4742-bdba-11a29f373981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_bef820db-4479-41ed-a6da-4d8c2436cbc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fcd5f978-803c-48b6-a52c-9028e0867f03" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_bef820db-4479-41ed-a6da-4d8c2436cbc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_8aead331-02f9-4aed-931b-932a1feb2028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_bef820db-4479-41ed-a6da-4d8c2436cbc8" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_8aead331-02f9-4aed-931b-932a1feb2028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OneTimeTerminationBenefitsMember_f5f63ad6-0c16-4b70-9746-0e337de2b0fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OneTimeTerminationBenefitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8aead331-02f9-4aed-931b-932a1feb2028" xlink:to="loc_us-gaap_OneTimeTerminationBenefitsMember_f5f63ad6-0c16-4b70-9746-0e337de2b0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f977b86d-fd01-4b12-8916-c9933cfe4063" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fcd5f978-803c-48b6-a52c-9028e0867f03" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f977b86d-fd01-4b12-8916-c9933cfe4063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55a89b33-1162-40cd-a3f9-a726a7e724e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f977b86d-fd01-4b12-8916-c9933cfe4063" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55a89b33-1162-40cd-a3f9-a726a7e724e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_7a906e2a-279f-47d8-a873-a9f3c338a30c" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55a89b33-1162-40cd-a3f9-a726a7e724e3" xlink:to="loc_nvta_ArcherDXInc.Member_7a906e2a-279f-47d8-a873-a9f3c338a30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d98fa039-11fe-4ffd-bfb1-4471f8397906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fcd5f978-803c-48b6-a52c-9028e0867f03" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d98fa039-11fe-4ffd-bfb1-4471f8397906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1f494a77-419f-4ed1-bbf2-dd07cf67e2ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d98fa039-11fe-4ffd-bfb1-4471f8397906" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1f494a77-419f-4ed1-bbf2-dd07cf67e2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9ef42ad4-8d47-48a5-9bb0-53201a3d7f93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1f494a77-419f-4ed1-bbf2-dd07cf67e2ab" xlink:to="loc_us-gaap_SubsequentEventMember_9ef42ad4-8d47-48a5-9bb0-53201a3d7f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fcd5f978-803c-48b6-a52c-9028e0867f03" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent_8f571c7a-2e37-42d4-9abd-2141f6a07747" xlink:href="nvta-20201231.xsd#nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:to="loc_nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent_8f571c7a-2e37-42d4-9abd-2141f6a07747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b78a02df-7f8e-4e64-bb74-7399012bd4b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:to="loc_us-gaap_RestructuringCharges_b78a02df-7f8e-4e64-bb74-7399012bd4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent_8f9e22d7-3362-4404-8a07-63fe6e3d3d5f" xlink:href="nvta-20201231.xsd#nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:to="loc_nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent_8f9e22d7-3362-4404-8a07-63fe6e3d3d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemNetGainLoss_914ccb12-3714-46da-829d-0459401f15e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemNetGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:to="loc_us-gaap_UnusualOrInfrequentItemNetGainLoss_914ccb12-3714-46da-829d-0459401f15e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_6eb34d05-1352-4ab5-9942-33dc388ba798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_6eb34d05-1352-4ab5-9942-33dc388ba798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_cc7020f9-1ec2-4f98-95e4-a3edbc4c4a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_cc7020f9-1ec2-4f98-95e4-a3edbc4c4a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_2d5148c3-d95a-46d5-9bb8-d5d133ce6368" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_48908f26-6926-41e8-9a54-7ac932a241f6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_2d5148c3-d95a-46d5-9bb8-d5d133ce6368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Businesscombinations" xlink:type="simple" xlink:href="nvta-20201231.xsd#Businesscombinations"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/Businesscombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_92e8bbae-4b39-4d1c-bf7b-b945931d2019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_c83113ab-f31a-4b84-8b70-1a0ef8e6e903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_92e8bbae-4b39-4d1c-bf7b-b945931d2019" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_c83113ab-f31a-4b84-8b70-1a0ef8e6e903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsTables"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_2df4fd1f-b5d2-4985-9b37-2a524d0e9502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_8dd0fcb5-6aaa-4e3d-8a33-012fcccbd4d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_2df4fd1f-b5d2-4985-9b37-2a524d0e9502" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_8dd0fcb5-6aaa-4e3d-8a33-012fcccbd4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_33ee7ab8-5f2c-4684-924d-e1aac711c4a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_2df4fd1f-b5d2-4985-9b37-2a524d0e9502" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_33ee7ab8-5f2c-4684-924d-e1aac711c4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_6e2c76c5-874b-4604-ae2e-849d230ace6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_2df4fd1f-b5d2-4985-9b37-2a524d0e9502" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_6e2c76c5-874b-4604-ae2e-849d230ace6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_31d3e7b6-c347-4856-8ad3-c3ec23daaa9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_2df4fd1f-b5d2-4985-9b37-2a524d0e9502" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_31d3e7b6-c347-4856-8ad3-c3ec23daaa9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsSingularBioDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsSingularBioDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsSingularBioDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6f2b1e06-0736-4595-9738-65844b53879b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4aaf760c-828b-4915-97a5-b388e207d6bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6f2b1e06-0736-4595-9738-65844b53879b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4aaf760c-828b-4915-97a5-b388e207d6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_eeab051d-8141-4ccf-a0ea-3853f4c8c5c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4aaf760c-828b-4915-97a5-b388e207d6bc" xlink:to="loc_us-gaap_VestingAxis_eeab051d-8141-4ccf-a0ea-3853f4c8c5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_19317cb7-b6bd-4ac4-80d8-5272be3a1669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_eeab051d-8141-4ccf-a0ea-3853f4c8c5c0" xlink:to="loc_us-gaap_VestingDomain_19317cb7-b6bd-4ac4-80d8-5272be3a1669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_19f5a1f1-b765-42c6-9c02-2c2eb8a342ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_19317cb7-b6bd-4ac4-80d8-5272be3a1669" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_19f5a1f1-b765-42c6-9c02-2c2eb8a342ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_5c058b22-08b4-4be7-9240-f9c6586b229b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_19317cb7-b6bd-4ac4-80d8-5272be3a1669" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_5c058b22-08b4-4be7-9240-f9c6586b229b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_4df0822f-07e8-49cb-992f-55af7e6f7c14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_19317cb7-b6bd-4ac4-80d8-5272be3a1669" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_4df0822f-07e8-49cb-992f-55af7e6f7c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6252e76b-fa57-4ab9-af49-22dfe956d1c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4aaf760c-828b-4915-97a5-b388e207d6bc" xlink:to="loc_us-gaap_AwardTypeAxis_6252e76b-fa57-4ab9-af49-22dfe956d1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9a608df-2d0b-4b18-a943-7fbd3ccd2bea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6252e76b-fa57-4ab9-af49-22dfe956d1c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9a608df-2d0b-4b18-a943-7fbd3ccd2bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_825bffed-be50-44aa-b014-a0d22247d143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9a608df-2d0b-4b18-a943-7fbd3ccd2bea" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_825bffed-be50-44aa-b014-a0d22247d143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RestrictedStockUnitsPeriodofTimeMember_04bbae89-fd11-4234-aa11-64fec014bf88" xlink:href="nvta-20201231.xsd#nvta_RestrictedStockUnitsPeriodofTimeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9a608df-2d0b-4b18-a943-7fbd3ccd2bea" xlink:to="loc_nvta_RestrictedStockUnitsPeriodofTimeMember_04bbae89-fd11-4234-aa11-64fec014bf88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_b5b49242-7b0b-46b4-ad13-b53b42cf7097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9a608df-2d0b-4b18-a943-7fbd3ccd2bea" xlink:to="loc_us-gaap_PerformanceSharesMember_b5b49242-7b0b-46b4-ad13-b53b42cf7097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d79facb4-2b9e-4867-9b01-2ba49ad0c327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4aaf760c-828b-4915-97a5-b388e207d6bc" xlink:to="loc_us-gaap_PlanNameAxis_d79facb4-2b9e-4867-9b01-2ba49ad0c327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f7c0f41f-5269-4b2a-9238-2a666183914d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_d79facb4-2b9e-4867-9b01-2ba49ad0c327" xlink:to="loc_us-gaap_PlanNameDomain_f7c0f41f-5269-4b2a-9238-2a666183914d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIncentivePlanMember_b567c1db-6d3b-4335-9ae0-3b95e276d492" xlink:href="nvta-20201231.xsd#nvta_StockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f7c0f41f-5269-4b2a-9238-2a666183914d" xlink:to="loc_nvta_StockIncentivePlanMember_b567c1db-6d3b-4335-9ae0-3b95e276d492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d1039651-13d5-497b-aad7-24fce9f07e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4aaf760c-828b-4915-97a5-b388e207d6bc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d1039651-13d5-497b-aad7-24fce9f07e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc96bf88-421a-45db-8293-8783f799c2c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d1039651-13d5-497b-aad7-24fce9f07e30" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc96bf88-421a-45db-8293-8783f799c2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SingularBioMember_fb32a8d9-113c-4e7d-af91-a494e631c9db" xlink:href="nvta-20201231.xsd#nvta_SingularBioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc96bf88-421a-45db-8293-8783f799c2c4" xlink:to="loc_nvta_SingularBioMember_fb32a8d9-113c-4e7d-af91-a494e631c9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4aaf760c-828b-4915-97a5-b388e207d6bc" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_646e55ad-18fc-4506-bd4b-0b4b037fa404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_646e55ad-18fc-4506-bd4b-0b4b037fa404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9e0a5827-6565-4a95-b166-b89cbeee1a73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9e0a5827-6565-4a95-b166-b89cbeee1a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_ebe7f9b3-d096-453a-a2b5-17dabfe1f156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_ebe7f9b3-d096-453a-a2b5-17dabfe1f156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_1e036693-aa4e-4aeb-ab17-6f306ce47b32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_1e036693-aa4e-4aeb-ab17-6f306ce47b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_6d7b2ba6-91e1-4047-835f-42cedc5425a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_6d7b2ba6-91e1-4047-835f-42cedc5425a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays_c04ceffb-6800-49ac-9eee-14a4d288a2ff" xlink:href="nvta-20201231.xsd#nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays_c04ceffb-6800-49ac-9eee-14a4d288a2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_48079f6e-56c9-40a0-ab53-9109ee7b82c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_48079f6e-56c9-40a0-ab53-9109ee7b82c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2b1b20e9-de1f-48cd-9b40-3e33147e99a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2b1b20e9-de1f-48cd-9b40-3e33147e99a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f63aa240-2de2-4bba-b655-08be53135bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f63aa240-2de2-4bba-b655-08be53135bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_987bcd2b-0a9c-45e2-8993-82fa46143c78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_987bcd2b-0a9c-45e2-8993-82fa46143c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_6a151531-ad13-437f-8c11-499641f96e43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1899f79-dfcc-4b71-b485-ecefb78dd568" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_6a151531-ad13-437f-8c11-499641f96e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsJunglaDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsJunglaDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsJunglaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_694801f8-0123-46be-b9e4-a8cd88f0aa7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d42a2cde-a226-4870-92d4-5b01c9864fb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_694801f8-0123-46be-b9e4-a8cd88f0aa7e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d42a2cde-a226-4870-92d4-5b01c9864fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_bc32c840-3112-41ce-b799-2ba04c8a5feb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d42a2cde-a226-4870-92d4-5b01c9864fb0" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_bc32c840-3112-41ce-b799-2ba04c8a5feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_5ffd45f7-8b5b-4797-adfd-d74fc9ddfbe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_bc32c840-3112-41ce-b799-2ba04c8a5feb" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_5ffd45f7-8b5b-4797-adfd-d74fc9ddfbe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember_28e715b0-8315-40f1-9be5-56bcb41e0d6d" xlink:href="nvta-20201231.xsd#nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_5ffd45f7-8b5b-4797-adfd-d74fc9ddfbe2" xlink:to="loc_nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember_28e715b0-8315-40f1-9be5-56bcb41e0d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_IndemnificationObligationsMember_b06cf197-88bb-4e53-aca8-e4c8dbb90d6b" xlink:href="nvta-20201231.xsd#nvta_IndemnificationObligationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_5ffd45f7-8b5b-4797-adfd-d74fc9ddfbe2" xlink:to="loc_nvta_IndemnificationObligationsMember_b06cf197-88bb-4e53-aca8-e4c8dbb90d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7562c494-65a6-482c-8263-ad2505acfe22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d42a2cde-a226-4870-92d4-5b01c9864fb0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7562c494-65a6-482c-8263-ad2505acfe22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40d08037-6348-433e-858f-174195349cb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7562c494-65a6-482c-8263-ad2505acfe22" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40d08037-6348-433e-858f-174195349cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_JunglaMember_1ccafe5b-851a-4fdb-a8cc-f155c87d9fc4" xlink:href="nvta-20201231.xsd#nvta_JunglaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40d08037-6348-433e-858f-174195349cb3" xlink:to="loc_nvta_JunglaMember_1ccafe5b-851a-4fdb-a8cc-f155c87d9fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d42a2cde-a226-4870-92d4-5b01c9864fb0" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_94b90d42-c4b7-477e-b9dc-c8f8ab386f56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_94b90d42-c4b7-477e-b9dc-c8f8ab386f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bb34c4a8-5e6f-43ab-903f-5b9841ab9acd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bb34c4a8-5e6f-43ab-903f-5b9841ab9acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_c662e609-7b89-4db7-9043-32e307ea6e13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_c662e609-7b89-4db7-9043-32e307ea6e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a03dc0f7-994c-41cc-a496-7fcc2e6233c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a03dc0f7-994c-41cc-a496-7fcc2e6233c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration_d3c7ac7d-49aa-4e66-9dba-d721018fbeea" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:to="loc_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration_d3c7ac7d-49aa-4e66-9dba-d721018fbeea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c38eb1f1-3f22-459e-83a5-657b23973934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15129b25-1a1f-4145-9ffd-7769b814b63a" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c38eb1f1-3f22-459e-83a5-657b23973934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsClearGeneticsDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1aa59afa-5fb4-40d2-a382-2a3bf293d832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4970c739-d087-47b8-984b-73bd7ea32d78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1aa59afa-5fb4-40d2-a382-2a3bf293d832" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4970c739-d087-47b8-984b-73bd7ea32d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_2b8932d3-7dbe-48f2-bf94-7aae16a27d16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4970c739-d087-47b8-984b-73bd7ea32d78" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_2b8932d3-7dbe-48f2-bf94-7aae16a27d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_fd2a98c3-4fbe-4336-aa09-845a7cfa840f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_2b8932d3-7dbe-48f2-bf94-7aae16a27d16" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_fd2a98c3-4fbe-4336-aa09-845a7cfa840f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_IndemnificationObligationsMember_0eab6182-db5f-4779-aae5-1b55b1705fe7" xlink:href="nvta-20201231.xsd#nvta_IndemnificationObligationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_fd2a98c3-4fbe-4336-aa09-845a7cfa840f" xlink:to="loc_nvta_IndemnificationObligationsMember_0eab6182-db5f-4779-aae5-1b55b1705fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c93848ed-8409-42d4-91cd-653a6d98028b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4970c739-d087-47b8-984b-73bd7ea32d78" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c93848ed-8409-42d4-91cd-653a6d98028b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b01ecd5-41ea-42db-8333-948683436112" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c93848ed-8409-42d4-91cd-653a6d98028b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b01ecd5-41ea-42db-8333-948683436112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ClearGeneticsMember_968c691e-7497-43ed-a898-7d4867a1f05c" xlink:href="nvta-20201231.xsd#nvta_ClearGeneticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b01ecd5-41ea-42db-8333-948683436112" xlink:to="loc_nvta_ClearGeneticsMember_968c691e-7497-43ed-a898-7d4867a1f05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a2222f9b-2444-46a9-9af0-a9d130d943a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4970c739-d087-47b8-984b-73bd7ea32d78" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a2222f9b-2444-46a9-9af0-a9d130d943a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ec8492f5-7bcf-48f4-b78b-62778e723714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2222f9b-2444-46a9-9af0-a9d130d943a6" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ec8492f5-7bcf-48f4-b78b-62778e723714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_59549084-6ee8-4747-aab6-2535bbd1db00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2222f9b-2444-46a9-9af0-a9d130d943a6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_59549084-6ee8-4747-aab6-2535bbd1db00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCash_0c4144c6-3065-4b1a-8ba8-595f34ecaed7" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2222f9b-2444-46a9-9af0-a9d130d943a6" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCash_0c4144c6-3065-4b1a-8ba8-595f34ecaed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c47a5eb8-b83f-4ff9-9c4c-0c3dc8bd7fbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2222f9b-2444-46a9-9af0-a9d130d943a6" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c47a5eb8-b83f-4ff9-9c4c-0c3dc8bd7fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsDiploidDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsDiploidDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsDiploidDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_ab9d1e53-9f4f-40a6-96d2-0c500af88255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ed70f3d5-f4c4-43a0-b02d-30630f4ebe53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_ab9d1e53-9f4f-40a6-96d2-0c500af88255" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ed70f3d5-f4c4-43a0-b02d-30630f4ebe53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_106eb1f0-5bc7-41f2-a603-99ec1b028f43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ed70f3d5-f4c4-43a0-b02d-30630f4ebe53" xlink:to="loc_us-gaap_VestingAxis_106eb1f0-5bc7-41f2-a603-99ec1b028f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_3559cd2f-c60c-4138-8e75-594bf054a0fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_106eb1f0-5bc7-41f2-a603-99ec1b028f43" xlink:to="loc_us-gaap_VestingDomain_3559cd2f-c60c-4138-8e75-594bf054a0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_d6a1e19e-e9e5-4faa-9ef9-652abe48af3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_3559cd2f-c60c-4138-8e75-594bf054a0fd" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_d6a1e19e-e9e5-4faa-9ef9-652abe48af3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_cf571d9a-1d52-41c7-ba6d-9e56bba9aa59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_3559cd2f-c60c-4138-8e75-594bf054a0fd" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_cf571d9a-1d52-41c7-ba6d-9e56bba9aa59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_3cb02179-1af0-47b2-b62c-bf46d2b953da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ed70f3d5-f4c4-43a0-b02d-30630f4ebe53" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_3cb02179-1af0-47b2-b62c-bf46d2b953da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_19038293-350f-4a32-8d2a-48bf8a123d79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_3cb02179-1af0-47b2-b62c-bf46d2b953da" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_19038293-350f-4a32-8d2a-48bf8a123d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_IndemnificationObligationsMember_5a64b1f7-83ba-429e-8b04-9c2063bf4ae7" xlink:href="nvta-20201231.xsd#nvta_IndemnificationObligationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_19038293-350f-4a32-8d2a-48bf8a123d79" xlink:to="loc_nvta_IndemnificationObligationsMember_5a64b1f7-83ba-429e-8b04-9c2063bf4ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_68ccb499-5c24-4d43-9fe7-de3051fcd6ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ed70f3d5-f4c4-43a0-b02d-30630f4ebe53" xlink:to="loc_us-gaap_PlanNameAxis_68ccb499-5c24-4d43-9fe7-de3051fcd6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ba21c62e-3a64-4b72-bfef-4416a580acdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_68ccb499-5c24-4d43-9fe7-de3051fcd6ec" xlink:to="loc_us-gaap_PlanNameDomain_ba21c62e-3a64-4b72-bfef-4416a580acdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIncentivePlanMember_6ea48b5c-9e5a-4b7c-b257-70b2ee79608c" xlink:href="nvta-20201231.xsd#nvta_StockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_ba21c62e-3a64-4b72-bfef-4416a580acdc" xlink:to="loc_nvta_StockIncentivePlanMember_6ea48b5c-9e5a-4b7c-b257-70b2ee79608c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5cfc15e5-5013-46e8-9ce3-e6917a8ed7d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ed70f3d5-f4c4-43a0-b02d-30630f4ebe53" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5cfc15e5-5013-46e8-9ce3-e6917a8ed7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7c4f422-5f8b-4a71-9a29-76cdad0cb681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5cfc15e5-5013-46e8-9ce3-e6917a8ed7d0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7c4f422-5f8b-4a71-9a29-76cdad0cb681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DiploidMember_2d95fe25-ed85-4d60-9c87-a71c019bec6a" xlink:href="nvta-20201231.xsd#nvta_DiploidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7c4f422-5f8b-4a71-9a29-76cdad0cb681" xlink:to="loc_nvta_DiploidMember_2d95fe25-ed85-4d60-9c87-a71c019bec6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0f6c6adc-6e85-4ba1-b0e7-3a4a639921e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ed70f3d5-f4c4-43a0-b02d-30630f4ebe53" xlink:to="loc_us-gaap_AwardTypeAxis_0f6c6adc-6e85-4ba1-b0e7-3a4a639921e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1cdebc83-7355-46b5-83cf-8d2783b62398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0f6c6adc-6e85-4ba1-b0e7-3a4a639921e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1cdebc83-7355-46b5-83cf-8d2783b62398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_089bd61f-9e04-411f-8557-98db4fca02d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1cdebc83-7355-46b5-83cf-8d2783b62398" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_089bd61f-9e04-411f-8557-98db4fca02d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ed70f3d5-f4c4-43a0-b02d-30630f4ebe53" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_430ef79c-907b-4256-b041-462b87217cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_430ef79c-907b-4256-b041-462b87217cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_80d8bdf4-b12e-4f2a-9725-bd1293e8960a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_80d8bdf4-b12e-4f2a-9725-bd1293e8960a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_572a62ad-6f6f-408f-817d-f36d44dd4bd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_572a62ad-6f6f-408f-817d-f36d44dd4bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_066c47a6-36a8-45b4-ae7d-969a07b79515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_066c47a6-36a8-45b4-ae7d-969a07b79515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_5ff32f62-30aa-4e6a-bdea-6763c018c9d9" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_5ff32f62-30aa-4e6a-bdea-6763c018c9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_5c8a16bc-732c-4169-81a2-00027ad50111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_5c8a16bc-732c-4169-81a2-00027ad50111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ad636e4f-152f-4829-a657-c9eb6be00ab0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_Goodwill_ad636e4f-152f-4829-a657-c9eb6be00ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_79f34b39-42fd-4b01-9e0f-b10e781bf9ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_79f34b39-42fd-4b01-9e0f-b10e781bf9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_97e32eea-4712-4e8d-b967-6dd659243e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_97e32eea-4712-4e8d-b967-6dd659243e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_e06365bf-32a1-44eb-8996-3d5b694e7980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1ad69334-e17a-4add-aa11-b1b50cbc91a4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_e06365bf-32a1-44eb-8996-3d5b694e7980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_9ae8f69e-49e9-4567-8faf-211bbf8e577d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d0eb3b51-a911-49f7-a563-cfacdea4d3e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_9ae8f69e-49e9-4567-8faf-211bbf8e577d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d0eb3b51-a911-49f7-a563-cfacdea4d3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_918a3042-9d27-4d75-8eb4-be247013ef1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d0eb3b51-a911-49f7-a563-cfacdea4d3e1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_918a3042-9d27-4d75-8eb4-be247013ef1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e16c1b1-e1ce-4565-ba6e-7cbb7fee501b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_918a3042-9d27-4d75-8eb4-be247013ef1d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e16c1b1-e1ce-4565-ba6e-7cbb7fee501b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DiploidMember_05dbb597-1d4f-406f-9509-fb330b947578" xlink:href="nvta-20201231.xsd#nvta_DiploidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e16c1b1-e1ce-4565-ba6e-7cbb7fee501b" xlink:to="loc_nvta_DiploidMember_05dbb597-1d4f-406f-9509-fb330b947578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_GenelexMember_5690a4c7-94b4-44c1-8f2f-a9942ecf4be7" xlink:href="nvta-20201231.xsd#nvta_GenelexMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e16c1b1-e1ce-4565-ba6e-7cbb7fee501b" xlink:to="loc_nvta_GenelexMember_5690a4c7-94b4-44c1-8f2f-a9942ecf4be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_YouScriptMember_ef684264-e93d-4baf-bb64-7d32f022079d" xlink:href="nvta-20201231.xsd#nvta_YouScriptMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e16c1b1-e1ce-4565-ba6e-7cbb7fee501b" xlink:to="loc_nvta_YouScriptMember_ef684264-e93d-4baf-bb64-7d32f022079d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_ae4107f9-7eb5-439a-9900-0c972c7f20a9" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e16c1b1-e1ce-4565-ba6e-7cbb7fee501b" xlink:to="loc_nvta_ArcherDXInc.Member_ae4107f9-7eb5-439a-9900-0c972c7f20a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_2b0ff22d-07a0-46a1-89ab-bc360c8739f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d0eb3b51-a911-49f7-a563-cfacdea4d3e1" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_2b0ff22d-07a0-46a1-89ab-bc360c8739f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2aa3c32d-a427-4cd2-adce-27ec41a4918a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_2b0ff22d-07a0-46a1-89ab-bc360c8739f7" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2aa3c32d-a427-4cd2-adce-27ec41a4918a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_AccelerationofVestedEquityMember_f916ce75-ebec-49c5-9ce1-324f0d443a8a" xlink:href="nvta-20201231.xsd#nvta_AccelerationofVestedEquityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2aa3c32d-a427-4cd2-adce-27ec41a4918a" xlink:to="loc_nvta_AccelerationofVestedEquityMember_f916ce75-ebec-49c5-9ce1-324f0d443a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_99b3aca7-6950-49cb-bf4a-4932c05e63d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d0eb3b51-a911-49f7-a563-cfacdea4d3e1" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_99b3aca7-6950-49cb-bf4a-4932c05e63d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_99b3aca7-6950-49cb-bf4a-4932c05e63d5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_62d033f9-8526-43be-b3ee-13d7db302d64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_62d033f9-8526-43be-b3ee-13d7db302d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCash_b88657cc-ec6d-48f3-9a44-fd89dcf47c8a" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCash_b88657cc-ec6d-48f3-9a44-fd89dcf47c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_e069e0a7-8870-45ae-938a-d34d0e747a1a" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_e069e0a7-8870-45ae-938a-d34d0e747a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b32dc5f2-f9ad-4132-ac58-1029c2bdfd01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b32dc5f2-f9ad-4132-ac58-1029c2bdfd01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred_7d8274c8-5b34-4eea-a42e-80f2e90331f1" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:to="loc_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred_7d8274c8-5b34-4eea-a42e-80f2e90331f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_77f708d5-671b-4995-8c48-6f55d69d56bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_77f708d5-671b-4995-8c48-6f55d69d56bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_755edf31-b707-4d05-b483-318ccfe57319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_da83caf7-35c2-4030-b1db-a0dbd9a3483b" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_755edf31-b707-4d05-b483-318ccfe57319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract_4a3a4427-86dc-46a2-8118-0364843f8a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_99b3aca7-6950-49cb-bf4a-4932c05e63d5" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract_4a3a4427-86dc-46a2-8118-0364843f8a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred_8629db14-80b4-48fb-989c-0f3756ffcf87" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract_4a3a4427-86dc-46a2-8118-0364843f8a86" xlink:to="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred_8629db14-80b4-48fb-989c-0f3756ffcf87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration_fd1154e3-6172-4020-a3a3-9738a6602669" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract_4a3a4427-86dc-46a2-8118-0364843f8a86" xlink:to="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration_fd1154e3-6172-4020-a3a3-9738a6602669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred_5995c633-64c5-4f74-97d4-7fcbb66c61c5" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract_4a3a4427-86dc-46a2-8118-0364843f8a86" xlink:to="loc_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred_5995c633-64c5-4f74-97d4-7fcbb66c61c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_29db25e2-db2b-4130-89cd-fa56b8eb6b4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract_4a3a4427-86dc-46a2-8118-0364843f8a86" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_29db25e2-db2b-4130-89cd-fa56b8eb6b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_3a051ccc-ebb8-4b2f-816d-2509fd13c90c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_13745aff-29b6-46c4-97b8-966e084acae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3a051ccc-ebb8-4b2f-816d-2509fd13c90c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_13745aff-29b6-46c4-97b8-966e084acae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4f8ad190-e3e5-422e-8360-224bf82d2758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_13745aff-29b6-46c4-97b8-966e084acae9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4f8ad190-e3e5-422e-8360-224bf82d2758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e408f7d-76c2-43ca-bdb4-2c3417bd1682" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4f8ad190-e3e5-422e-8360-224bf82d2758" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e408f7d-76c2-43ca-bdb4-2c3417bd1682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DiploidMember_ed536bd5-772f-4946-baab-11a4c9a6c80c" xlink:href="nvta-20201231.xsd#nvta_DiploidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e408f7d-76c2-43ca-bdb4-2c3417bd1682" xlink:to="loc_nvta_DiploidMember_ed536bd5-772f-4946-baab-11a4c9a6c80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_GenelexMember_c5aa9827-9f42-4344-9575-fe968f16c64a" xlink:href="nvta-20201231.xsd#nvta_GenelexMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e408f7d-76c2-43ca-bdb4-2c3417bd1682" xlink:to="loc_nvta_GenelexMember_c5aa9827-9f42-4344-9575-fe968f16c64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_YouScriptMember_d615ec93-54f7-435a-851a-94124106de49" xlink:href="nvta-20201231.xsd#nvta_YouScriptMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e408f7d-76c2-43ca-bdb4-2c3417bd1682" xlink:to="loc_nvta_YouScriptMember_d615ec93-54f7-435a-851a-94124106de49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_GenelexandYouScriptMember_928336f4-b6e6-406e-a132-8fca9326ea2c" xlink:href="nvta-20201231.xsd#nvta_GenelexandYouScriptMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e408f7d-76c2-43ca-bdb4-2c3417bd1682" xlink:to="loc_nvta_GenelexandYouScriptMember_928336f4-b6e6-406e-a132-8fca9326ea2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_d6d49dfa-17e8-4355-bfd0-c994d4798883" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e408f7d-76c2-43ca-bdb4-2c3417bd1682" xlink:to="loc_nvta_ArcherDXInc.Member_d6d49dfa-17e8-4355-bfd0-c994d4798883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_13745aff-29b6-46c4-97b8-966e084acae9" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_bd55ce48-9d9d-487c-a078-389384c3cf4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_bd55ce48-9d9d-487c-a078-389384c3cf4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c6939674-4145-431a-a971-3fac07996194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c6939674-4145-431a-a971-3fac07996194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_e5010144-45bd-4a6b-a4f3-0afeba642677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_e5010144-45bd-4a6b-a4f3-0afeba642677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_ddb1c739-352c-4d3e-b4c9-ac19f8c24d57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_ddb1c739-352c-4d3e-b4c9-ac19f8c24d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_59a88dda-3923-4512-805b-42344587678c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_59a88dda-3923-4512-805b-42344587678c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset_01b92246-fac3-4d33-a208-f0231337c2f6" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset_01b92246-fac3-4d33-a208-f0231337c2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_54479f31-b624-4a84-8fe7-07dfe835ee1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_54479f31-b624-4a84-8fe7-07dfe835ee1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_91dc407e-fc19-4aaf-8e18-8e2f8d363bbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_91dc407e-fc19-4aaf-8e18-8e2f8d363bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_08cddf59-3448-4e76-b965-4c8826c1c57e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_08cddf59-3448-4e76-b965-4c8826c1c57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5a5ed5d7-b9fa-48a0-957d-4b27b48ffbe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5a5ed5d7-b9fa-48a0-957d-4b27b48ffbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_8e350972-c3c0-4b0a-99e3-7531872aeeac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_8e350972-c3c0-4b0a-99e3-7531872aeeac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_0fa6fea4-a7f6-415d-846b-e5fa8bfbb633" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_0fa6fea4-a7f6-415d-846b-e5fa8bfbb633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease_813791e8-24ef-4a7a-819c-20e3989fc934" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease_813791e8-24ef-4a7a-819c-20e3989fc934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease_443fce04-b538-4a6e-b695-f997619b8cce" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease_443fce04-b538-4a6e-b695-f997619b8cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_43df06c3-96ad-45b0-a41c-62b170b268f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_43df06c3-96ad-45b0-a41c-62b170b268f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_0da30e15-323d-4b20-96da-d77618e0c136" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_0da30e15-323d-4b20-96da-d77618e0c136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_59632050-c189-439c-b230-097e05163dae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_59632050-c189-439c-b230-097e05163dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_270dbbed-c291-42da-8854-49b3bdec2b49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_Goodwill_270dbbed-c291-42da-8854-49b3bdec2b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c09b94f8-2dc6-49ca-ab36-39d7102afeba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b224f979-3bff-42db-8181-002a03ff491e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c09b94f8-2dc6-49ca-ab36-39d7102afeba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsGenelexandYouScriptDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6ceddb70-744c-407e-925d-47d7c2ae7b0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d754452-630b-474d-97f7-2d6b95afe7fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6ceddb70-744c-407e-925d-47d7c2ae7b0a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d754452-630b-474d-97f7-2d6b95afe7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_95e61460-f2df-4981-ba60-f0aa4bcc9b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d754452-630b-474d-97f7-2d6b95afe7fe" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_95e61460-f2df-4981-ba60-f0aa4bcc9b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_eb6c5ae7-af73-44ac-99d4-37afd9cb2b71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_95e61460-f2df-4981-ba60-f0aa4bcc9b99" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_eb6c5ae7-af73-44ac-99d4-37afd9cb2b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_IndemnificationObligationsMember_f29dc172-f781-4e5d-8b82-512caa7ce80b" xlink:href="nvta-20201231.xsd#nvta_IndemnificationObligationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_eb6c5ae7-af73-44ac-99d4-37afd9cb2b71" xlink:to="loc_nvta_IndemnificationObligationsMember_f29dc172-f781-4e5d-8b82-512caa7ce80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f512e11a-04cb-4cd2-b4a9-7ef61fa6f034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d754452-630b-474d-97f7-2d6b95afe7fe" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f512e11a-04cb-4cd2-b4a9-7ef61fa6f034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_404c2130-1415-41dd-b2d3-bb46cbb45c1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f512e11a-04cb-4cd2-b4a9-7ef61fa6f034" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_404c2130-1415-41dd-b2d3-bb46cbb45c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_GenelexMember_1b12e0a3-f7e5-4dfc-9ba5-1f9ad00f38c7" xlink:href="nvta-20201231.xsd#nvta_GenelexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_404c2130-1415-41dd-b2d3-bb46cbb45c1b" xlink:to="loc_nvta_GenelexMember_1b12e0a3-f7e5-4dfc-9ba5-1f9ad00f38c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_YouScriptMember_9a8590a9-cc13-4331-b2b0-d9bc319bae17" xlink:href="nvta-20201231.xsd#nvta_YouScriptMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_404c2130-1415-41dd-b2d3-bb46cbb45c1b" xlink:to="loc_nvta_YouScriptMember_9a8590a9-cc13-4331-b2b0-d9bc319bae17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_GenelexandYouScriptMember_fbdf3262-89d3-4a4f-a975-0c3768412ba0" xlink:href="nvta-20201231.xsd#nvta_GenelexandYouScriptMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_404c2130-1415-41dd-b2d3-bb46cbb45c1b" xlink:to="loc_nvta_GenelexandYouScriptMember_fbdf3262-89d3-4a4f-a975-0c3768412ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d754452-630b-474d-97f7-2d6b95afe7fe" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ea677dbc-8357-4f17-bf4f-862fc3c7589a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ea677dbc-8357-4f17-bf4f-862fc3c7589a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b5bf1bdb-19f9-41a0-910e-8a8120a9d0c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b5bf1bdb-19f9-41a0-910e-8a8120a9d0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2a735dc1-07b8-4267-afe9-34b6b0085e38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2a735dc1-07b8-4267-afe9-34b6b0085e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_921364f8-ef2a-4e3c-a5b8-185f6c98a6af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_921364f8-ef2a-4e3c-a5b8-185f6c98a6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_2b030a01-c7f6-4192-a83a-d3bfe7d8072b" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_2b030a01-c7f6-4192-a83a-d3bfe7d8072b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_5bc1e8db-6d17-43cf-8643-0372356c4d65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_5bc1e8db-6d17-43cf-8643-0372356c4d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration_95ed1e38-ee41-459e-86e8-59cf479d1d44" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration_95ed1e38-ee41-459e-86e8-59cf479d1d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_30df6707-fced-4024-bd7b-2d73a3ddaf13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_30df6707-fced-4024-bd7b-2d73a3ddaf13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2baff6db-c213-4bb5-97df-933fbe959559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2baff6db-c213-4bb5-97df-933fbe959559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5d948a52-daad-4bdd-9c44-5a4d0c1a8e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9411c2b1-233e-408c-9f02-80c53397701e" xlink:to="loc_us-gaap_Goodwill_5d948a52-daad-4bdd-9c44-5a4d0c1a8e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsArcherDXDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsArcherDXDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsArcherDXDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_63f0675a-57f2-4eb2-aa50-29db4795c907" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_72ecea7f-b55d-4ce3-b10f-315653c3787c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_63f0675a-57f2-4eb2-aa50-29db4795c907" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_72ecea7f-b55d-4ce3-b10f-315653c3787c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_03fddd09-3d37-4a7b-b775-fec50478addc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_72ecea7f-b55d-4ce3-b10f-315653c3787c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_03fddd09-3d37-4a7b-b775-fec50478addc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0db09cd4-4452-458b-9a44-577c841dcd89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_03fddd09-3d37-4a7b-b775-fec50478addc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0db09cd4-4452-458b-9a44-577c841dcd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_84f5b110-5612-4283-a9bf-f482b4d8d00f" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0db09cd4-4452-458b-9a44-577c841dcd89" xlink:to="loc_nvta_ArcherDXInc.Member_84f5b110-5612-4283-a9bf-f482b4d8d00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_801794a6-75ae-48b4-9958-0d41be66164a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_72ecea7f-b55d-4ce3-b10f-315653c3787c" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_801794a6-75ae-48b4-9958-0d41be66164a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_bd52583b-c660-4567-afc3-ba7c7b415b3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_801794a6-75ae-48b4-9958-0d41be66164a" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_bd52583b-c660-4567-afc3-ba7c7b415b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_AccelerationofVestedEquityMember_923e49b6-7c35-4e84-bb39-a8d2f7307f32" xlink:href="nvta-20201231.xsd#nvta_AccelerationofVestedEquityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_bd52583b-c660-4567-afc3-ba7c7b415b3f" xlink:to="loc_nvta_AccelerationofVestedEquityMember_923e49b6-7c35-4e84-bb39-a8d2f7307f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_e979daf7-9896-4ca0-ba0f-c6faf65ca325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_72ecea7f-b55d-4ce3-b10f-315653c3787c" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_e979daf7-9896-4ca0-ba0f-c6faf65ca325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_973d60b1-3997-4a8e-9e73-227559b1ec7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_e979daf7-9896-4ca0-ba0f-c6faf65ca325" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_973d60b1-3997-4a8e-9e73-227559b1ec7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_MilestoneAchievementAgreementMember_ffc0f3ca-a82e-4d99-b57d-5054168535e9" xlink:href="nvta-20201231.xsd#nvta_MilestoneAchievementAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_973d60b1-3997-4a8e-9e73-227559b1ec7a" xlink:to="loc_nvta_MilestoneAchievementAgreementMember_ffc0f3ca-a82e-4d99-b57d-5054168535e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_42da2554-afb9-407b-80da-ade8ac83c130" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_72ecea7f-b55d-4ce3-b10f-315653c3787c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_42da2554-afb9-407b-80da-ade8ac83c130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_bcef87a7-b9ba-401f-8be4-44451d79ce0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_42da2554-afb9-407b-80da-ade8ac83c130" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_bcef87a7-b9ba-401f-8be4-44451d79ce0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_dfea76c5-5af4-4ed9-b405-a075602748c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_bcef87a7-b9ba-401f-8be4-44451d79ce0d" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_dfea76c5-5af4-4ed9-b405-a075602748c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_72ecea7f-b55d-4ce3-b10f-315653c3787c" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_332c1572-8a62-47af-824f-c2d25ad113b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_332c1572-8a62-47af-824f-c2d25ad113b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_601da61c-5496-4e05-87b4-c47532830a85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_601da61c-5496-4e05-87b4-c47532830a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_f899cbe6-ef8e-4c32-83ad-7990f9b99bc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_f899cbe6-ef8e-4c32-83ad-7990f9b99bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_eee7250b-67b8-4182-abbd-221b03d32c27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_eee7250b-67b8-4182-abbd-221b03d32c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_a6d458c0-1c3d-4122-85ee-bc001687584a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_a6d458c0-1c3d-4122-85ee-bc001687584a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_07007958-0166-4639-bb80-8d5f9d6702ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_07007958-0166-4639-bb80-8d5f9d6702ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration_57f65637-8595-40c3-bad3-25df756c002f" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration_57f65637-8595-40c3-bad3-25df756c002f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_372d39e5-8afd-4947-a559-5e440053996c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_372d39e5-8afd-4947-a559-5e440053996c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_81f4ca5a-2b42-42fb-b731-52dc18dcfe66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_81f4ca5a-2b42-42fb-b731-52dc18dcfe66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a27809f7-3636-4c52-a4a6-bb23039cb811" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a27809f7-3636-4c52-a4a6-bb23039cb811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_cf802854-b747-400e-b652-bebf1d0a2530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_cf802854-b747-400e-b652-bebf1d0a2530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9b31137a-18ee-4f21-9b26-02895c6f5ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_Goodwill_9b31137a-18ee-4f21-9b26-02895c6f5ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1172b931-a47b-4ea3-88c5-ce8b44841654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1172b931-a47b-4ea3-88c5-ce8b44841654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_da229ac7-403c-4cd3-a5f3-b6ad288c696b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_da229ac7-403c-4cd3-a5f3-b6ad288c696b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_ef0689f3-baa9-4a9d-9bc8-dbcd9658acaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_ef0689f3-baa9-4a9d-9bc8-dbcd9658acaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4a23753b-4fde-42c2-9a2c-88877e0724e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4a23753b-4fde-42c2-9a2c-88877e0724e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e40e96d9-df7a-4636-8333-1bbd426f04c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e40e96d9-df7a-4636-8333-1bbd426f04c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_30fc3c4e-cf78-4d71-aacb-ee87538272f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_abf494f5-84b3-4806-8cca-53f4339597e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_30fc3c4e-cf78-4d71-aacb-ee87538272f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsSummaryofintangibleassetsacquiredDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_98e9de9c-023d-4da6-bfe2-7aea51924dd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34761f9f-660d-410a-93f7-0fbb9fc90c48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_98e9de9c-023d-4da6-bfe2-7aea51924dd9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34761f9f-660d-410a-93f7-0fbb9fc90c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6bfd8826-c209-4df9-ac4d-aced829769c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34761f9f-660d-410a-93f7-0fbb9fc90c48" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6bfd8826-c209-4df9-ac4d-aced829769c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ed84220-86e5-4be0-a9af-b838b1ab389e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6bfd8826-c209-4df9-ac4d-aced829769c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ed84220-86e5-4be0-a9af-b838b1ab389e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_8dc88cf2-2192-4fe7-9abf-656385fc504f" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ed84220-86e5-4be0-a9af-b838b1ab389e" xlink:to="loc_nvta_ArcherDXInc.Member_8dc88cf2-2192-4fe7-9abf-656385fc504f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f15e5514-5bd8-462d-a966-cd3ca301569a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34761f9f-660d-410a-93f7-0fbb9fc90c48" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f15e5514-5bd8-462d-a966-cd3ca301569a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d6d8128-45c0-47b3-8342-43a9808afe7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f15e5514-5bd8-462d-a966-cd3ca301569a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d6d8128-45c0-47b3-8342-43a9808afe7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_542ec97a-1654-430d-9cdc-0c3fa8cb7944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d6d8128-45c0-47b3-8342-43a9808afe7c" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_542ec97a-1654-430d-9cdc-0c3fa8cb7944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6daeccd1-7dc2-46af-b2fa-0d54a41c5927" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34761f9f-660d-410a-93f7-0fbb9fc90c48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6daeccd1-7dc2-46af-b2fa-0d54a41c5927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9086f9fe-fba3-46d7-a5c4-6c1d08a2bb48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6daeccd1-7dc2-46af-b2fa-0d54a41c5927" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9086f9fe-fba3-46d7-a5c4-6c1d08a2bb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_67e37196-fdfb-4b52-9bb8-f45a2d3b5350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9086f9fe-fba3-46d7-a5c4-6c1d08a2bb48" xlink:to="loc_us-gaap_CustomerRelationshipsMember_67e37196-fdfb-4b52-9bb8-f45a2d3b5350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_1f471d46-406b-4aac-b308-5dccb1b5721a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9086f9fe-fba3-46d7-a5c4-6c1d08a2bb48" xlink:to="loc_us-gaap_TradeNamesMember_1f471d46-406b-4aac-b308-5dccb1b5721a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_7d871594-0ca6-4c13-9e06-e8bc38935b3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9086f9fe-fba3-46d7-a5c4-6c1d08a2bb48" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_7d871594-0ca6-4c13-9e06-e8bc38935b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_19c0bd95-b44b-4b24-b8bb-a4a220dfca41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9086f9fe-fba3-46d7-a5c4-6c1d08a2bb48" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_19c0bd95-b44b-4b24-b8bb-a4a220dfca41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_32ad7c16-92ef-4dcb-8f13-be1d78a9d68b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34761f9f-660d-410a-93f7-0fbb9fc90c48" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_32ad7c16-92ef-4dcb-8f13-be1d78a9d68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_92b7b624-a5e7-4d54-84f3-2b8f71ce78eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32ad7c16-92ef-4dcb-8f13-be1d78a9d68b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_92b7b624-a5e7-4d54-84f3-2b8f71ce78eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_35b7fd81-bc1e-4123-86b4-6e703b86d445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32ad7c16-92ef-4dcb-8f13-be1d78a9d68b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_35b7fd81-bc1e-4123-86b4-6e703b86d445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2fb3e25e-f4b7-4c3e-9eb0-abe075747afb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32ad7c16-92ef-4dcb-8f13-be1d78a9d68b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2fb3e25e-f4b7-4c3e-9eb0-abe075747afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e621c431-7bf9-4b8b-813a-d1189531bdd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32ad7c16-92ef-4dcb-8f13-be1d78a9d68b" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e621c431-7bf9-4b8b-813a-d1189531bdd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BusinesscombinationsScheduleofproformafinancialinformationDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BusinesscombinationsScheduleofproformafinancialinformationDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BusinesscombinationsScheduleofproformafinancialinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_9092c32a-087b-46d9-b4c6-677edb9bdf5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_3b0fa570-f0d5-4391-88d1-ec5588b90f3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_9092c32a-087b-46d9-b4c6-677edb9bdf5a" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_3b0fa570-f0d5-4391-88d1-ec5588b90f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_b61bd1e0-9050-4cb2-8a20-f30b8353d54a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_9092c32a-087b-46d9-b4c6-677edb9bdf5a" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_b61bd1e0-9050-4cb2-8a20-f30b8353d54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Goodwillandintangibleassets" xlink:type="simple" xlink:href="nvta-20201231.xsd#Goodwillandintangibleassets"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/Goodwillandintangibleassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8ba15dd-b6d8-4842-a738-f58c807936cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_20b0c16e-1b98-40ed-aae0-7d4e966ad3bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8ba15dd-b6d8-4842-a738-f58c807936cd" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_20b0c16e-1b98-40ed-aae0-7d4e966ad3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsTables"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f4dd87a9-cf8a-41b9-8575-182f52c1b33e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_480ebd49-4cab-478f-8afd-cabf8eb13607" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f4dd87a9-cf8a-41b9-8575-182f52c1b33e" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_480ebd49-4cab-478f-8afd-cabf8eb13607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_5ffe1d95-f29a-41b8-81c3-3e2f29d7859c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f4dd87a9-cf8a-41b9-8575-182f52c1b33e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_5ffe1d95-f29a-41b8-81c3-3e2f29d7859c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_845146df-15ed-4efd-941e-7a99d9f73b9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f4dd87a9-cf8a-41b9-8575-182f52c1b33e" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_845146df-15ed-4efd-941e-7a99d9f73b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_259526c5-7852-48ed-81e3-d7af459e6b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f4dd87a9-cf8a-41b9-8575-182f52c1b33e" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_259526c5-7852-48ed-81e3-d7af459e6b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsSummaryofgoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_af3d1941-0a4c-4141-9d0f-60f22c4b2871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_df7a36f4-e6c0-497f-b408-49f9d6d71911" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_af3d1941-0a4c-4141-9d0f-60f22c4b2871" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_df7a36f4-e6c0-497f-b408-49f9d6d71911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e45420b8-e6cb-49e6-b549-93801566771f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_df7a36f4-e6c0-497f-b408-49f9d6d71911" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e45420b8-e6cb-49e6-b549-93801566771f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48087128-4816-4d19-8d22-9cf8bd10f7c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e45420b8-e6cb-49e6-b549-93801566771f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48087128-4816-4d19-8d22-9cf8bd10f7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DiploidMember_0b8b470d-997b-45df-afa3-018922a6c121" xlink:href="nvta-20201231.xsd#nvta_DiploidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48087128-4816-4d19-8d22-9cf8bd10f7c4" xlink:to="loc_nvta_DiploidMember_0b8b470d-997b-45df-afa3-018922a6c121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_GenelexMember_be362a6c-1d79-49e8-8e82-d3516c685520" xlink:href="nvta-20201231.xsd#nvta_GenelexMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48087128-4816-4d19-8d22-9cf8bd10f7c4" xlink:to="loc_nvta_GenelexMember_be362a6c-1d79-49e8-8e82-d3516c685520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_YouScriptMember_3b0fd0c6-cc7b-496c-9ac8-2d1300ae20a8" xlink:href="nvta-20201231.xsd#nvta_YouScriptMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48087128-4816-4d19-8d22-9cf8bd10f7c4" xlink:to="loc_nvta_YouScriptMember_3b0fd0c6-cc7b-496c-9ac8-2d1300ae20a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_5d1b51f2-0c91-4b01-8c85-05f44ca2ec7e" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48087128-4816-4d19-8d22-9cf8bd10f7c4" xlink:to="loc_nvta_ArcherDXInc.Member_5d1b51f2-0c91-4b01-8c85-05f44ca2ec7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_473e0c3b-ca35-4d8c-a60a-b71ad2173930" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_df7a36f4-e6c0-497f-b408-49f9d6d71911" xlink:to="loc_us-gaap_GoodwillLineItems_473e0c3b-ca35-4d8c-a60a-b71ad2173930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_3edf36a0-e625-40f4-9253-8b1ce9840709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_473e0c3b-ca35-4d8c-a60a-b71ad2173930" xlink:to="loc_us-gaap_GoodwillRollForward_3edf36a0-e625-40f4-9253-8b1ce9840709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6611515b-8818-492b-9b6e-bc2b7e1dc2d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3edf36a0-e625-40f4-9253-8b1ce9840709" xlink:to="loc_us-gaap_Goodwill_6611515b-8818-492b-9b6e-bc2b7e1dc2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6293bcd3-b0cf-4313-8221-52cba8ca913e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3edf36a0-e625-40f4-9253-8b1ce9840709" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6293bcd3-b0cf-4313-8221-52cba8ca913e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_803c1cf6-7901-47a0-9a25-54a9da74667f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3edf36a0-e625-40f4-9253-8b1ce9840709" xlink:to="loc_us-gaap_Goodwill_803c1cf6-7901-47a0-9a25-54a9da74667f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsScheduleofintangibleassetsDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8715404a-d57b-4897-ab8d-5a67a8d8f9b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a03338e5-ee90-40a0-b428-fca19d408e62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8715404a-d57b-4897-ab8d-5a67a8d8f9b6" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a03338e5-ee90-40a0-b428-fca19d408e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_61b36470-253e-4f1f-9d28-36300e18b5d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a03338e5-ee90-40a0-b428-fca19d408e62" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_61b36470-253e-4f1f-9d28-36300e18b5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_292d0251-e2b2-442c-b63a-c8863dadee00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_61b36470-253e-4f1f-9d28-36300e18b5d3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_292d0251-e2b2-442c-b63a-c8863dadee00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_09ae1959-5fae-430e-8ace-2ca9327490c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_292d0251-e2b2-442c-b63a-c8863dadee00" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_09ae1959-5fae-430e-8ace-2ca9327490c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c97b7fba-c1a4-46e3-a0af-93ddea73e815" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a03338e5-ee90-40a0-b428-fca19d408e62" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c97b7fba-c1a4-46e3-a0af-93ddea73e815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c97b7fba-c1a4-46e3-a0af-93ddea73e815" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a2ae0e86-ea0c-4cee-8a0d-aa68507dcc08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a2ae0e86-ea0c-4cee-8a0d-aa68507dcc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_8f9b1ca2-3349-4091-977c-0905cf5f15b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_8f9b1ca2-3349-4091-977c-0905cf5f15b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_0d7f1b43-9db2-41d3-933e-fc50a82bd26e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_0d7f1b43-9db2-41d3-933e-fc50a82bd26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_6c5bfbe5-7a65-4606-9070-75f218d47e08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:to="loc_us-gaap_TradeNamesMember_6c5bfbe5-7a65-4606-9070-75f218d47e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PatentLicensingAgreementMember_fd1394a4-7cbe-4723-83d6-f1ea93fc2643" xlink:href="nvta-20201231.xsd#nvta_PatentLicensingAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:to="loc_nvta_PatentLicensingAgreementMember_fd1394a4-7cbe-4723-83d6-f1ea93fc2643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_6b9c237f-35c0-44b4-a9c3-f80c025af3be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feba300a-1e78-4758-8373-14eff9aba82d" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_6b9c237f-35c0-44b4-a9c3-f80c025af3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a03338e5-ee90-40a0-b428-fca19d408e62" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2016ad82-2e8f-4d9e-8dca-023dd3679d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2016ad82-2e8f-4d9e-8dca-023dd3679d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a0439056-90f4-4c75-8dd3-3aa8f8f7aafc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a0439056-90f4-4c75-8dd3-3aa8f8f7aafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9014eaa0-02db-470a-972d-63f6d404ed04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9014eaa0-02db-470a-972d-63f6d404ed04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_87cdd9b9-63e1-473c-b763-d8ff5aa3efe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_87cdd9b9-63e1-473c-b763-d8ff5aa3efe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2f6ff2cc-2630-43a5-8e2f-f143af1e93f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2f6ff2cc-2630-43a5-8e2f-f143af1e93f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6fbe8f05-2ec7-488b-b294-327677a666bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6fbe8f05-2ec7-488b-b294-327677a666bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_55a35779-f21e-43a2-bca6-fb28597890ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_55a35779-f21e-43a2-bca6-fb28597890ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_5ec0fae1-8ae1-4f8d-8f0c-9bb407940790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b75841cc-812f-45e0-8328-cc9ef039ef6b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_5ec0fae1-8ae1-4f8d-8f0c-9bb407940790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails_1" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsScheduleofintangibleassetsDetails_1"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a78277b6-6933-41bb-be43-e9731780b9ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a78277b6-6933-41bb-be43-e9731780b9ec" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ac6a24b4-b6cb-4c67-8ef0-102ca2348a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ac6a24b4-b6cb-4c67-8ef0-102ca2348a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_71bfb11c-1d35-4cf0-a282-76050ed85028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ac6a24b4-b6cb-4c67-8ef0-102ca2348a50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_71bfb11c-1d35-4cf0-a282-76050ed85028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b3a848d7-bab1-4ba0-8077-52043aa329ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_71bfb11c-1d35-4cf0-a282-76050ed85028" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b3a848d7-bab1-4ba0-8077-52043aa329ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1d76b2ae-5789-4f11-860f-ffb3a2af76ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:to="loc_us-gaap_AwardTypeAxis_1d76b2ae-5789-4f11-860f-ffb3a2af76ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be98876d-c5e2-401b-a787-b3159abcf8aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1d76b2ae-5789-4f11-860f-ffb3a2af76ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be98876d-c5e2-401b-a787-b3159abcf8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e9bcedfa-f572-4938-9126-af879eeef3d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be98876d-c5e2-401b-a787-b3159abcf8aa" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e9bcedfa-f572-4938-9126-af879eeef3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5c7abb6f-a6dc-4b8f-9a4e-44c8bd41648d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:to="loc_us-gaap_PlanNameAxis_5c7abb6f-a6dc-4b8f-9a4e-44c8bd41648d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d2da684d-abbe-46a2-a499-31b3e5e33569" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5c7abb6f-a6dc-4b8f-9a4e-44c8bd41648d" xlink:to="loc_us-gaap_PlanNameDomain_d2da684d-abbe-46a2-a499-31b3e5e33569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIncentivePlanMember_92d8a7be-a864-4cd3-8539-9e4d64c5f713" xlink:href="nvta-20201231.xsd#nvta_StockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d2da684d-abbe-46a2-a499-31b3e5e33569" xlink:to="loc_nvta_StockIncentivePlanMember_92d8a7be-a864-4cd3-8539-9e4d64c5f713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_4a390015-9db3-4a48-a17c-cb7ed7529fa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:to="loc_us-gaap_VestingAxis_4a390015-9db3-4a48-a17c-cb7ed7529fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_3e6b8df9-ddcf-4588-92fa-dadcef668345" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_4a390015-9db3-4a48-a17c-cb7ed7529fa8" xlink:to="loc_us-gaap_VestingDomain_3e6b8df9-ddcf-4588-92fa-dadcef668345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_5bdd7d41-ec40-4320-bbe8-319f5097da3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_3e6b8df9-ddcf-4588-92fa-dadcef668345" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_5bdd7d41-ec40-4320-bbe8-319f5097da3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_97b7fd53-a19d-4bdf-9134-dafa9f0b2737" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_3e6b8df9-ddcf-4588-92fa-dadcef668345" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_97b7fd53-a19d-4bdf-9134-dafa9f0b2737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ede0f777-7faf-40c0-a762-6e6ffe7850ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ede0f777-7faf-40c0-a762-6e6ffe7850ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_77f3b4da-768f-4680-b792-78acc4da20bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ede0f777-7faf-40c0-a762-6e6ffe7850ed" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_77f3b4da-768f-4680-b792-78acc4da20bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_05b019e5-30a5-4868-ae2b-8100255cc6d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_77f3b4da-768f-4680-b792-78acc4da20bd" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_05b019e5-30a5-4868-ae2b-8100255cc6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_90e99e3e-b37a-4624-aaba-7d7cdcd3951f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_90e99e3e-b37a-4624-aaba-7d7cdcd3951f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3a3e2c90-4b5c-4414-8f8f-2f39a747def9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_90e99e3e-b37a-4624-aaba-7d7cdcd3951f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3a3e2c90-4b5c-4414-8f8f-2f39a747def9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_87e3db75-2479-4b10-9e15-abe7d87addcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3a3e2c90-4b5c-4414-8f8f-2f39a747def9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_87e3db75-2479-4b10-9e15-abe7d87addcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_86705803-a24b-4669-9785-c0b817950673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_86705803-a24b-4669-9785-c0b817950673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4eabde3a-dbc7-49ba-99f8-577edf418e02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_86705803-a24b-4669-9785-c0b817950673" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4eabde3a-dbc7-49ba-99f8-577edf418e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_f213e106-25e0-4641-baeb-9555335f2dd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4eabde3a-dbc7-49ba-99f8-577edf418e02" xlink:to="loc_us-gaap_WarrantMember_f213e106-25e0-4641-baeb-9555335f2dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997124f6-7c01-4c44-94f4-3718b5456af8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7ac42813-18d6-4508-aac6-49dd5e0e72a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7ac42813-18d6-4508-aac6-49dd5e0e72a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_b8b5dc51-ab80-4bb4-bb30-7fffd729dd9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_b8b5dc51-ab80-4bb4-bb30-7fffd729dd9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2cf28fc5-41a1-41e1-8781-954587ed361a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2cf28fc5-41a1-41e1-8781-954587ed361a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_00c49648-4478-41f6-a979-bfca301a68af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_00c49648-4478-41f6-a979-bfca301a68af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_b681aa2c-fe57-490f-bb96-3cec07d841f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_b681aa2c-fe57-490f-bb96-3cec07d841f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ec3627c3-4641-4ad3-8e37-5dfe80ac4bb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ec3627c3-4641-4ad3-8e37-5dfe80ac4bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays_7cd5f58e-8da1-4339-a33c-34c545f97c26" xlink:href="nvta-20201231.xsd#nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays_7cd5f58e-8da1-4339-a33c-34c545f97c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5b5b9277-326c-4852-bc4d-dedbfc58c750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5b5b9277-326c-4852-bc4d-dedbfc58c750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c72ae67d-7bd0-4392-a62e-9b7101a4f38a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9b74015f-2ef4-4308-8922-a10c65f3102a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c72ae67d-7bd0-4392-a62e-9b7101a4f38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e2882d12-1be6-4a97-9812-2882e981d8a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_42b2685e-7dc4-44a7-b807-25282685309a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e2882d12-1be6-4a97-9812-2882e981d8a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_42b2685e-7dc4-44a7-b807-25282685309a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_57ae0d7e-1bed-4337-85a4-dd3ab3a9c035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e2882d12-1be6-4a97-9812-2882e981d8a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_57ae0d7e-1bed-4337-85a4-dd3ab3a9c035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_5891fd1b-b3c8-4bcb-b34a-e431cefc5ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e2882d12-1be6-4a97-9812-2882e981d8a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_5891fd1b-b3c8-4bcb-b34a-e431cefc5ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_902f528d-3f39-4849-99c7-702970f1742d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e2882d12-1be6-4a97-9812-2882e981d8a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_902f528d-3f39-4849-99c7-702970f1742d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_347458c6-deb6-4b8d-bc89-95e5a882a79d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e2882d12-1be6-4a97-9812-2882e981d8a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_347458c6-deb6-4b8d-bc89-95e5a882a79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2bc77dd5-2db1-4f6b-baaf-3428528d267e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e2882d12-1be6-4a97-9812-2882e981d8a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2bc77dd5-2db1-4f6b-baaf-3428528d267e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_02734c19-1b01-45b7-81c4-a91c55d84a24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e2882d12-1be6-4a97-9812-2882e981d8a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_02734c19-1b01-45b7-81c4-a91c55d84a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Balancesheetcomponents" xlink:type="simple" xlink:href="nvta-20201231.xsd#Balancesheetcomponents"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/Balancesheetcomponents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_5c89bdf5-ae05-4697-b741-a22e7db3cdd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_97e1941d-d3fa-47c6-a018-b993e12fd904" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_5c89bdf5-ae05-4697-b741-a22e7db3cdd2" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_97e1941d-d3fa-47c6-a018-b993e12fd904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BalancesheetcomponentsTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#BalancesheetcomponentsTables"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BalancesheetcomponentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_30e669b7-e4ec-453d-a7d3-72d453364125" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_24d02a5e-6da8-498c-919d-cae64bd96900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_30e669b7-e4ec-453d-a7d3-72d453364125" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_24d02a5e-6da8-498c-919d-cae64bd96900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_8b237d51-ec98-4cf6-8b80-20f9ba2ccfcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_30e669b7-e4ec-453d-a7d3-72d453364125" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_8b237d51-ec98-4cf6-8b80-20f9ba2ccfcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_415b85ff-c514-4230-8020-be673dd3623a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_30e669b7-e4ec-453d-a7d3-72d453364125" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_415b85ff-c514-4230-8020-be673dd3623a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_6b63f344-4dd9-469f-8ad7-459130733f16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_30e669b7-e4ec-453d-a7d3-72d453364125" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_6b63f344-4dd9-469f-8ad7-459130733f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BalancesheetcomponentsScheduleofinventoryDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAbstract_eba03877-cefd-46e3-b7ed-ce128b300428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_27fdb601-1803-4e92-8b03-fa8a893b9c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAbstract_eba03877-cefd-46e3-b7ed-ce128b300428" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_27fdb601-1803-4e92-8b03-fa8a893b9c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_3b33b73b-5c61-4512-b750-58f040d98dd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAbstract_eba03877-cefd-46e3-b7ed-ce128b300428" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_3b33b73b-5c61-4512-b750-58f040d98dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_954ea81f-a0a0-4e70-8f78-d2a1b7585340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAbstract_eba03877-cefd-46e3-b7ed-ce128b300428" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_954ea81f-a0a0-4e70-8f78-d2a1b7585340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_efda3192-1f57-407e-b802-68657c3d64e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAbstract_eba03877-cefd-46e3-b7ed-ce128b300428" xlink:to="loc_us-gaap_InventoryNet_efda3192-1f57-407e-b802-68657c3d64e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BalancesheetcomponentsPropertyandequipmentDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7971313b-0825-4b74-976c-4c2468c28492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bad856d7-f030-407e-812f-d20fca9d2ba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7971313b-0825-4b74-976c-4c2468c28492" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bad856d7-f030-407e-812f-d20fca9d2ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d27b4e44-25aa-4f10-ab19-962c62b91cce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bad856d7-f030-407e-812f-d20fca9d2ba4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d27b4e44-25aa-4f10-ab19-962c62b91cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d27b4e44-25aa-4f10-ab19-962c62b91cce" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_3a420e2a-2409-432f-9433-77e3d3c23b38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_3a420e2a-2409-432f-9433-77e3d3c23b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_583317d2-cf9f-4f71-8c8a-35a2886429bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:to="loc_us-gaap_EquipmentMember_583317d2-cf9f-4f71-8c8a-35a2886429bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_b0862b4d-92e9-45c5-94bb-83eff52840ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:to="loc_us-gaap_ComputerEquipmentMember_b0862b4d-92e9-45c5-94bb-83eff52840ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_ed87dafd-249d-47fa-bd90-b851d0b7c519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_ed87dafd-249d-47fa-bd90-b851d0b7c519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_d5da3c5a-cfc5-4305-937f-d2f1b23a5fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_d5da3c5a-cfc5-4305-937f-d2f1b23a5fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AutomobilesMember_f23c2f13-a746-4a03-bb1c-bed20bab19cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AutomobilesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:to="loc_us-gaap_AutomobilesMember_f23c2f13-a746-4a03-bb1c-bed20bab19cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_aef25baa-9918-46c4-b89c-8db820d460c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_879f6265-d32b-425a-bab0-1a80517f717b" xlink:to="loc_us-gaap_ConstructionInProgressMember_aef25baa-9918-46c4-b89c-8db820d460c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0ed92765-c23b-4f6a-8426-d9f414945ea7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bad856d7-f030-407e-812f-d20fca9d2ba4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0ed92765-c23b-4f6a-8426-d9f414945ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_81abe3d0-a647-41bd-bc14-6138caf1c8a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0ed92765-c23b-4f6a-8426-d9f414945ea7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_81abe3d0-a647-41bd-bc14-6138caf1c8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a6120d18-26b9-48f9-8d95-86a45bb9501b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0ed92765-c23b-4f6a-8426-d9f414945ea7" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a6120d18-26b9-48f9-8d95-86a45bb9501b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_173cc661-f188-4af6-bead-34ca100862d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0ed92765-c23b-4f6a-8426-d9f414945ea7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_173cc661-f188-4af6-bead-34ca100862d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_d23f34ac-2854-4db9-a333-706820e23ce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7971313b-0825-4b74-976c-4c2468c28492" xlink:to="loc_us-gaap_Depreciation_d23f34ac-2854-4db9-a333-706820e23ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BalancesheetcomponentsAccruedliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_512b8ced-65e1-4c05-8bf1-26ddc742f038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_38d66b00-e11d-49d9-8d39-e1f7ee5b540b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_512b8ced-65e1-4c05-8bf1-26ddc742f038" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_38d66b00-e11d-49d9-8d39-e1f7ee5b540b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7d46759f-dae2-4207-b08d-ad20eab5065d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_512b8ced-65e1-4c05-8bf1-26ddc742f038" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7d46759f-dae2-4207-b08d-ad20eab5065d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationAccruedLiabilitiesCurrent_fdb94372-1701-4483-89f5-10a6ecfb4b66" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_512b8ced-65e1-4c05-8bf1-26ddc742f038" xlink:to="loc_nvta_BusinessCombinationAccruedLiabilitiesCurrent_fdb94372-1701-4483-89f5-10a6ecfb4b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019f0fb3-fa5f-40f2-a6d3-b5038acbe260" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_512b8ced-65e1-4c05-8bf1-26ddc742f038" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019f0fb3-fa5f-40f2-a6d3-b5038acbe260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_86587ff7-0b88-4a48-bfe2-76e381fde2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_512b8ced-65e1-4c05-8bf1-26ddc742f038" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_86587ff7-0b88-4a48-bfe2-76e381fde2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#BalancesheetcomponentsOtherlongtermliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0ba197dc-daa9-4a9a-8343-fbb654a08e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_0382803d-86bd-46ea-b930-288b65f163be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0ba197dc-daa9-4a9a-8343-fbb654a08e8d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_0382803d-86bd-46ea-b930-288b65f163be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationAccruedLiabilitiesNoncurrent_7666e159-383b-4611-89a0-6f99b1258006" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0ba197dc-daa9-4a9a-8343-fbb654a08e8d" xlink:to="loc_nvta_BusinessCombinationAccruedLiabilitiesNoncurrent_7666e159-383b-4611-89a0-6f99b1258006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_9f7e3ecd-d03c-4c1c-9d61-ccc2f18a0629" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0ba197dc-daa9-4a9a-8343-fbb654a08e8d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_9f7e3ecd-d03c-4c1c-9d61-ccc2f18a0629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b90e9fa7-4a18-4328-b2a7-b9a0cc8b88a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0ba197dc-daa9-4a9a-8343-fbb654a08e8d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b90e9fa7-4a18-4328-b2a7-b9a0cc8b88a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Fairvaluemeasurements" xlink:type="simple" xlink:href="nvta-20201231.xsd#Fairvaluemeasurements"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/Fairvaluemeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6c4c96df-dc9c-4fa4-af0b-677b7a2cf7e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_3ee104a8-4ba8-4a12-872f-fd8473a44c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6c4c96df-dc9c-4fa4-af0b-677b7a2cf7e0" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_3ee104a8-4ba8-4a12-872f-fd8473a44c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/FairvaluemeasurementsTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#FairvaluemeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/FairvaluemeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_62963e27-3309-4618-906c-2c6f71ea1933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d639e6b4-20c1-4a92-833d-fe50476dffdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_62963e27-3309-4618-906c-2c6f71ea1933" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d639e6b4-20c1-4a92-833d-fe50476dffdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f99ec52d-88d1-4c12-bffb-2ae3db4aeddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1334da0-b89f-4a30-ab6c-f032381d7b5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f99ec52d-88d1-4c12-bffb-2ae3db4aeddb" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1334da0-b89f-4a30-ab6c-f032381d7b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1afdf933-78cd-4ac4-afe8-a0a549fe278a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1334da0-b89f-4a30-ab6c-f032381d7b5b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1afdf933-78cd-4ac4-afe8-a0a549fe278a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1afdf933-78cd-4ac4-afe8-a0a549fe278a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_4349a5ef-6a83-4723-90e9-f5a11ce648da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_4349a5ef-6a83-4723-90e9-f5a11ce648da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_f26bf185-f035-4648-8e5e-bd5a148784b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:to="loc_us-gaap_CertificatesOfDepositMember_f26bf185-f035-4648-8e5e-bd5a148784b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_580f4250-bb16-45a0-a800-e4fcaffdd58b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_580f4250-bb16-45a0-a800-e4fcaffdd58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e0ce5efb-2ebd-4864-8c63-c1fc1943612b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e0ce5efb-2ebd-4864-8c63-c1fc1943612b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_87202a99-b342-4701-984d-b99e71966cab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_87202a99-b342-4701-984d-b99e71966cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ContingentConsiderationMember_797a3ef4-ae36-46a5-9406-66d68d27b58d" xlink:href="nvta-20201231.xsd#nvta_ContingentConsiderationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2878ba84-8994-4fd7-a375-e55e0358918c" xlink:to="loc_nvta_ContingentConsiderationMember_797a3ef4-ae36-46a5-9406-66d68d27b58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_86d949c0-fb43-4836-b6e7-86159cdb2e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1334da0-b89f-4a30-ab6c-f032381d7b5b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_86d949c0-fb43-4836-b6e7-86159cdb2e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_403cb28a-06c3-4872-878e-a8f5c9ccdea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_86d949c0-fb43-4836-b6e7-86159cdb2e8d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_403cb28a-06c3-4872-878e-a8f5c9ccdea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_98cd1aed-9aa3-4b8b-a2a6-07348c8f9c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_403cb28a-06c3-4872-878e-a8f5c9ccdea3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_98cd1aed-9aa3-4b8b-a2a6-07348c8f9c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3f6f373f-512a-4ee9-986d-e398edee5fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1334da0-b89f-4a30-ab6c-f032381d7b5b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3f6f373f-512a-4ee9-986d-e398edee5fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c9ea895-c77c-472d-85c6-691aca9b3526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3f6f373f-512a-4ee9-986d-e398edee5fae" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c9ea895-c77c-472d-85c6-691aca9b3526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ef1d04cf-08da-4d47-ab0d-e503c0dc7b40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c9ea895-c77c-472d-85c6-691aca9b3526" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_ef1d04cf-08da-4d47-ab0d-e503c0dc7b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_fe697428-f8fe-4483-b69d-15031c1957e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c9ea895-c77c-472d-85c6-691aca9b3526" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_fe697428-f8fe-4483-b69d-15031c1957e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9efbe84c-7424-4e43-9a77-febfe27672dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c9ea895-c77c-472d-85c6-691aca9b3526" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9efbe84c-7424-4e43-9a77-febfe27672dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_afbe3813-86a5-4bbb-a3fc-15242b36cf2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1334da0-b89f-4a30-ab6c-f032381d7b5b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_afbe3813-86a5-4bbb-a3fc-15242b36cf2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_dd98e98a-4b60-48f3-a785-1ea02fb2df49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_afbe3813-86a5-4bbb-a3fc-15242b36cf2a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_dd98e98a-4b60-48f3-a785-1ea02fb2df49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_fe6d0ee8-676f-4e65-bf58-3716c6b3fc82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dd98e98a-4b60-48f3-a785-1ea02fb2df49" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_fe6d0ee8-676f-4e65-bf58-3716c6b3fc82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3cf019c2-11bf-48dc-9cbd-04085e2b28be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dd98e98a-4b60-48f3-a785-1ea02fb2df49" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3cf019c2-11bf-48dc-9cbd-04085e2b28be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1334da0-b89f-4a30-ab6c-f032381d7b5b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost_21c6d406-55ef-498a-8ad3-74cd23fabe05" xlink:href="nvta-20201231.xsd#nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost_21c6d406-55ef-498a-8ad3-74cd23fabe05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax_50bc5f3d-1a20-4fd2-a46d-1dc67a11df85" xlink:href="nvta-20201231.xsd#nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax_50bc5f3d-1a20-4fd2-a46d-1dc67a11df85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax_378f6ea6-4120-4e7e-a9b8-51ed2f368e63" xlink:href="nvta-20201231.xsd#nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax_378f6ea6-4120-4e7e-a9b8-51ed2f368e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue_384c4f2d-f96f-460b-89f9-76365b8ef319" xlink:href="nvta-20201231.xsd#nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue_384c4f2d-f96f-460b-89f9-76365b8ef319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_301f77e7-db1d-4bba-be58-382845c449e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_301f77e7-db1d-4bba-be58-382845c449e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_fe044e45-bc8e-4349-9616-abfb95612116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_fe044e45-bc8e-4349-9616-abfb95612116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_1676a9f0-54f3-4973-9e7a-6c3fa72b1d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_1676a9f0-54f3-4973-9e7a-6c3fa72b1d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_cfe21fca-7434-4e3a-acf1-459f8d59cef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_cfe21fca-7434-4e3a-acf1-459f8d59cef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dcb1b53d-1c3f-40f4-a68d-bd30c174f1c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eedb207e-2b1e-4aab-ad9d-07ef4852ecc3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dcb1b53d-1c3f-40f4-a68d-bd30c174f1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#FairvaluemeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b7f1f823-7abe-4b7c-aa0e-0c073b8f6815" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_cae3955a-1631-4390-b8bf-19f8fa42929b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b7f1f823-7abe-4b7c-aa0e-0c073b8f6815" xlink:to="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_cae3955a-1631-4390-b8bf-19f8fa42929b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e2c845fb-7020-43a8-a2a2-744465d0cf9d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_cae3955a-1631-4390-b8bf-19f8fa42929b" xlink:to="loc_srt_RangeAxis_e2c845fb-7020-43a8-a2a2-744465d0cf9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8012f263-48be-4168-af50-87922b3c404b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e2c845fb-7020-43a8-a2a2-744465d0cf9d" xlink:to="loc_srt_RangeMember_8012f263-48be-4168-af50-87922b3c404b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_93464259-4f08-4aab-9d8d-8eec139cc0fc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8012f263-48be-4168-af50-87922b3c404b" xlink:to="loc_srt_MinimumMember_93464259-4f08-4aab-9d8d-8eec139cc0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_95f30c88-2e08-4178-b11b-ff7764060946" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8012f263-48be-4168-af50-87922b3c404b" xlink:to="loc_srt_MaximumMember_95f30c88-2e08-4178-b11b-ff7764060946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_c2c81d23-05ba-4bac-9691-82531766720d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_cae3955a-1631-4390-b8bf-19f8fa42929b" xlink:to="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_c2c81d23-05ba-4bac-9691-82531766720d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount_95c9b495-b6e4-4b44-bbca-a7e24df96bf2" xlink:href="nvta-20201231.xsd#nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_c2c81d23-05ba-4bac-9691-82531766720d" xlink:to="loc_nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount_95c9b495-b6e4-4b44-bbca-a7e24df96bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_ad143622-683b-429c-af53-16917a756c11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_c2c81d23-05ba-4bac-9691-82531766720d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_ad143622-683b-429c-af53-16917a756c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod_4ff564b0-995e-4cab-8cbb-ca85895d56a3" xlink:href="nvta-20201231.xsd#nvta_DebtSecuritiesAvailableForSaleMaturityPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_c2c81d23-05ba-4bac-9691-82531766720d" xlink:to="loc_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod_4ff564b0-995e-4cab-8cbb-ca85895d56a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_402b8470-74b4-48b2-bad3-a2bebc58d28a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_c2c81d23-05ba-4bac-9691-82531766720d" xlink:to="loc_us-gaap_InvestmentIncomeInterest_402b8470-74b4-48b2-bad3-a2bebc58d28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_609b9a72-cc04-4486-9b73-a2ea399e53ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_c2c81d23-05ba-4bac-9691-82531766720d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_609b9a72-cc04-4486-9b73-a2ea399e53ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Commitmentsandcontingencies" xlink:type="simple" xlink:href="nvta-20201231.xsd#Commitmentsandcontingencies"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/Commitmentsandcontingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2338ab0a-58ea-4304-b1c9-e0faf0da2ee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2e539c68-7f55-4f3a-845e-695991ef6e13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2338ab0a-58ea-4304-b1c9-e0faf0da2ee6" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2e539c68-7f55-4f3a-845e-695991ef6e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesTables"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4faa6997-ee7e-4e87-9b91-5f4d8836dac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_067cc056-42e9-4df6-9f4f-638f140447ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4faa6997-ee7e-4e87-9b91-5f4d8836dac6" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_067cc056-42e9-4df6-9f4f-638f140447ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_87335ee0-f8b9-4885-a2d8-968ec2babe49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4faa6997-ee7e-4e87-9b91-5f4d8836dac6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_87335ee0-f8b9-4885-a2d8-968ec2babe49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_269f2938-ab64-44c3-ab44-d42cee6fa855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4faa6997-ee7e-4e87-9b91-5f4d8836dac6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_269f2938-ab64-44c3-ab44-d42cee6fa855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_600ced9a-3d0b-4201-afbe-8b32692c31fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4faa6997-ee7e-4e87-9b91-5f4d8836dac6" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_600ced9a-3d0b-4201-afbe-8b32692c31fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock_5dd499c1-2ca7-4ab7-8595-78c629f5603f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4faa6997-ee7e-4e87-9b91-5f4d8836dac6" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock_5dd499c1-2ca7-4ab7-8595-78c629f5603f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesLeaseadditionalinformationDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_dab5d7c6-9201-4a32-8739-2fdf66df12f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3d290312-e21d-4851-8160-25e5f4b634dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_dab5d7c6-9201-4a32-8739-2fdf66df12f8" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3d290312-e21d-4851-8160-25e5f4b634dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1d94bd7e-b658-4323-a2b6-b7be47dd4b3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3d290312-e21d-4851-8160-25e5f4b634dd" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1d94bd7e-b658-4323-a2b6-b7be47dd4b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f8936076-95ac-4fcf-8882-e5e9e0b5cd06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1d94bd7e-b658-4323-a2b6-b7be47dd4b3c" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f8936076-95ac-4fcf-8882-e5e9e0b5cd06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_NewLeasesMember_4e614c45-7b6b-44c2-a28e-0522cc8faddb" xlink:href="nvta-20201231.xsd#nvta_NewLeasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f8936076-95ac-4fcf-8882-e5e9e0b5cd06" xlink:to="loc_nvta_NewLeasesMember_4e614c45-7b6b-44c2-a28e-0522cc8faddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_80dac5b7-23c4-4230-a2b2-6901bbdfe95d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3d290312-e21d-4851-8160-25e5f4b634dd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_80dac5b7-23c4-4230-a2b2-6901bbdfe95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02d011f4-5623-4062-aa13-775a8766f8f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_80dac5b7-23c4-4230-a2b2-6901bbdfe95d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02d011f4-5623-4062-aa13-775a8766f8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_OfficeFacilityInSanFranciscoMember_03acfcfc-3fa3-4f04-86e9-f2039a640509" xlink:href="nvta-20201231.xsd#nvta_OfficeFacilityInSanFranciscoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02d011f4-5623-4062-aa13-775a8766f8f1" xlink:to="loc_nvta_OfficeFacilityInSanFranciscoMember_03acfcfc-3fa3-4f04-86e9-f2039a640509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_1f08fc39-e12d-4da4-afee-a3160b46489d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3d290312-e21d-4851-8160-25e5f4b634dd" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_1f08fc39-e12d-4da4-afee-a3160b46489d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_b0faf2ec-6178-4016-819d-cb3bb792d37f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1f08fc39-e12d-4da4-afee-a3160b46489d" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_b0faf2ec-6178-4016-819d-cb3bb792d37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1b8161c0-a51a-4824-ab5b-b9fc0d038713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1f08fc39-e12d-4da4-afee-a3160b46489d" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1b8161c0-a51a-4824-ab5b-b9fc0d038713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecurityDeposit_eafd92ab-73e9-4a44-84d6-c3b2955c3d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecurityDeposit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1f08fc39-e12d-4da4-afee-a3160b46489d" xlink:to="loc_us-gaap_SecurityDeposit_eafd92ab-73e9-4a44-84d6-c3b2955c3d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_5f56de47-47c3-49cf-a592-8fddfffc9864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1f08fc39-e12d-4da4-afee-a3160b46489d" xlink:to="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_5f56de47-47c3-49cf-a592-8fddfffc9864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9ca8f9ba-1e6f-4ce5-983f-8b50331995cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_LeasesWeightedAverageRemainingLeaseTermAbstract_e14df23b-3a68-49e4-9221-840c3de72ea5" xlink:href="nvta-20201231.xsd#nvta_LeasesWeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9ca8f9ba-1e6f-4ce5-983f-8b50331995cc" xlink:to="loc_nvta_LeasesWeightedAverageRemainingLeaseTermAbstract_e14df23b-3a68-49e4-9221-840c3de72ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_36cbade0-8b53-437e-b959-d520ac52d1ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_LeasesWeightedAverageRemainingLeaseTermAbstract_e14df23b-3a68-49e4-9221-840c3de72ea5" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_36cbade0-8b53-437e-b959-d520ac52d1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_e77a8712-02ec-4443-9b1c-9abe98e036b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_LeasesWeightedAverageRemainingLeaseTermAbstract_e14df23b-3a68-49e4-9221-840c3de72ea5" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_e77a8712-02ec-4443-9b1c-9abe98e036b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_LeasesWeightedAverageDiscountRateAbstract_6ae2ab14-ab74-47d5-847c-f570798d7bce" xlink:href="nvta-20201231.xsd#nvta_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9ca8f9ba-1e6f-4ce5-983f-8b50331995cc" xlink:to="loc_nvta_LeasesWeightedAverageDiscountRateAbstract_6ae2ab14-ab74-47d5-847c-f570798d7bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_599efe11-8345-44e2-9d43-92d515b06529" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_LeasesWeightedAverageDiscountRateAbstract_6ae2ab14-ab74-47d5-847c-f570798d7bce" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_599efe11-8345-44e2-9d43-92d515b06529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_daa3781e-8108-4138-8524-b1851d88714c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_LeasesWeightedAverageDiscountRateAbstract_6ae2ab14-ab74-47d5-847c-f570798d7bce" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_daa3781e-8108-4138-8524-b1851d88714c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_LeasesCashPaymentsIncludedInMeasurementAbstract_e257d379-b003-4249-b18c-61d57df13a52" xlink:href="nvta-20201231.xsd#nvta_LeasesCashPaymentsIncludedInMeasurementAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9ca8f9ba-1e6f-4ce5-983f-8b50331995cc" xlink:to="loc_nvta_LeasesCashPaymentsIncludedInMeasurementAbstract_e257d379-b003-4249-b18c-61d57df13a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_00d5ccdd-817e-4aec-bffd-f05ce165af78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_LeasesCashPaymentsIncludedInMeasurementAbstract_e257d379-b003-4249-b18c-61d57df13a52" xlink:to="loc_us-gaap_OperatingLeasePayments_00d5ccdd-817e-4aec-bffd-f05ce165af78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments_32a95162-b3e8-424e-9824-146ea90754e3" xlink:href="nvta-20201231.xsd#nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_LeasesCashPaymentsIncludedInMeasurementAbstract_e257d379-b003-4249-b18c-61d57df13a52" xlink:to="loc_nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments_32a95162-b3e8-424e-9824-146ea90754e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_e599dc64-a172-419c-8904-e3d6d91c951c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9ca8f9ba-1e6f-4ce5-983f-8b50331995cc" xlink:to="loc_us-gaap_LeaseCostAbstract_e599dc64-a172-419c-8904-e3d6d91c951c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_d4c4dd22-afad-4d75-9cb7-2a661efb02f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e599dc64-a172-419c-8904-e3d6d91c951c" xlink:to="loc_us-gaap_OperatingLeaseCost_d4c4dd22-afad-4d75-9cb7-2a661efb02f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseAndRentalExpense_279e43b3-220d-4b23-87d4-44b6ae9623e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e599dc64-a172-419c-8904-e3d6d91c951c" xlink:to="loc_us-gaap_LeaseAndRentalExpense_279e43b3-220d-4b23-87d4-44b6ae9623e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_ed9dc13c-c274-416e-9ec3-0faffe7f3654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e599dc64-a172-419c-8904-e3d6d91c951c" xlink:to="loc_us-gaap_SubleaseIncome_ed9dc13c-c274-416e-9ec3-0faffe7f3654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_25ca8f47-427d-40c6-a108-6d0d004cbb8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e599dc64-a172-419c-8904-e3d6d91c951c" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_25ca8f47-427d-40c6-a108-6d0d004cbb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_b32425b3-1e0f-4047-bb4a-fd0f1d1d759c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e599dc64-a172-419c-8904-e3d6d91c951c" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_b32425b3-1e0f-4047-bb4a-fd0f1d1d759c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesIncomeStatementInterestExpense_1799c86e-12ad-46e6-a54b-133a8f3349e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeasesIncomeStatementInterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e599dc64-a172-419c-8904-e3d6d91c951c" xlink:to="loc_us-gaap_CapitalLeasesIncomeStatementInterestExpense_1799c86e-12ad-46e6-a54b-133a8f3349e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_0ae1218c-c0cd-4891-80e1-d2b6c8257555" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e599dc64-a172-419c-8904-e3d6d91c951c" xlink:to="loc_us-gaap_LeaseCost_0ae1218c-c0cd-4891-80e1-d2b6c8257555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_LeasesExpense_ca52e1fe-b06d-485a-8e04-0f79f1787b8d" xlink:href="nvta-20201231.xsd#nvta_LeasesExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e599dc64-a172-419c-8904-e3d6d91c951c" xlink:to="loc_nvta_LeasesExpense_ca52e1fe-b06d-485a-8e04-0f79f1787b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1189b11b-28e9-4e2d-b36f-d8e843b2344f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_5f1d854d-5e72-4103-a90c-462144041bef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1189b11b-28e9-4e2d-b36f-d8e843b2344f" xlink:to="loc_us-gaap_LeasesOperatingAbstract_5f1d854d-5e72-4103-a90c-462144041bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ef53dda4-29b7-4cbf-be4b-642e3ff67e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5f1d854d-5e72-4103-a90c-462144041bef" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ef53dda4-29b7-4cbf-be4b-642e3ff67e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f960e68a-6bea-4ef0-9573-8ccd06f34c5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5f1d854d-5e72-4103-a90c-462144041bef" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f960e68a-6bea-4ef0-9573-8ccd06f34c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1cd6bdb9-3f14-4924-8cf0-de6219a1d389" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5f1d854d-5e72-4103-a90c-462144041bef" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1cd6bdb9-3f14-4924-8cf0-de6219a1d389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9ce3369b-05b0-4679-817c-32635841ecf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5f1d854d-5e72-4103-a90c-462144041bef" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9ce3369b-05b0-4679-817c-32635841ecf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_37d26e3c-808e-4cf9-983c-5b066fb11ed0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5f1d854d-5e72-4103-a90c-462144041bef" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_37d26e3c-808e-4cf9-983c-5b066fb11ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6f707697-e6d3-4c84-bc95-dc8789bc886e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5f1d854d-5e72-4103-a90c-462144041bef" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6f707697-e6d3-4c84-bc95-dc8789bc886e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_19d0a7c1-38c6-4527-97ec-aa14cd5cc617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5f1d854d-5e72-4103-a90c-462144041bef" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_19d0a7c1-38c6-4527-97ec-aa14cd5cc617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_95dd5697-3200-4013-be65-ca285b4ab3d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5f1d854d-5e72-4103-a90c-462144041bef" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_95dd5697-3200-4013-be65-ca285b4ab3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_685ab9f0-6697-4b59-87ee-0f2b358ed552" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5f1d854d-5e72-4103-a90c-462144041bef" xlink:to="loc_us-gaap_OperatingLeaseLiability_685ab9f0-6697-4b59-87ee-0f2b358ed552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_828ece6f-1049-4313-9c37-2c5a51446c93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5f1d854d-5e72-4103-a90c-462144041bef" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_828ece6f-1049-4313-9c37-2c5a51446c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f220f808-9c7e-43ff-8c6e-f7eb5da84b6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5f1d854d-5e72-4103-a90c-462144041bef" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f220f808-9c7e-43ff-8c6e-f7eb5da84b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_7a0df2d7-cec0-476c-be32-d99b0a0791f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1189b11b-28e9-4e2d-b36f-d8e843b2344f" xlink:to="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_7a0df2d7-cec0-476c-be32-d99b0a0791f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_07c1d3aa-6b45-41e8-90e0-0b99bfb8dd41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_7a0df2d7-cec0-476c-be32-d99b0a0791f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_07c1d3aa-6b45-41e8-90e0-0b99bfb8dd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_52e299ff-a47c-4e35-8aee-01d507265e59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_7a0df2d7-cec0-476c-be32-d99b0a0791f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_52e299ff-a47c-4e35-8aee-01d507265e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_90d5412c-eeed-4895-8dd9-991d9730cebb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_7a0df2d7-cec0-476c-be32-d99b0a0791f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_90d5412c-eeed-4895-8dd9-991d9730cebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_253c52a3-b4b7-4a83-bb8b-281c1092325d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_7a0df2d7-cec0-476c-be32-d99b0a0791f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_253c52a3-b4b7-4a83-bb8b-281c1092325d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_66116e1f-ebd4-4b00-acd7-57eed8116759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_7a0df2d7-cec0-476c-be32-d99b0a0791f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_66116e1f-ebd4-4b00-acd7-57eed8116759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_a5083a21-e1f0-465c-8fa9-3164b4cc5d97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_7a0df2d7-cec0-476c-be32-d99b0a0791f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_a5083a21-e1f0-465c-8fa9-3164b4cc5d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c08bc76f-ab8d-4409-9479-557fe24d0322" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_7a0df2d7-cec0-476c-be32-d99b0a0791f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c08bc76f-ab8d-4409-9479-557fe24d0322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_600329b2-13bf-4d87-a649-b742b42f6069" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_7a0df2d7-cec0-476c-be32-d99b0a0791f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_600329b2-13bf-4d87-a649-b742b42f6069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_032a241c-34f4-404b-93e8-5b43d6f74983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_7a0df2d7-cec0-476c-be32-d99b0a0791f7" xlink:to="loc_us-gaap_FinanceLeaseLiability_032a241c-34f4-404b-93e8-5b43d6f74983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_07cbc0f3-328c-45e6-aab7-4343651d85dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_7a0df2d7-cec0-476c-be32-d99b0a0791f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_07cbc0f3-328c-45e6-aab7-4343651d85dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_d4e45cce-3244-4056-bbd0-4505c0cc2bea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_7a0df2d7-cec0-476c-be32-d99b0a0791f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_d4e45cce-3244-4056-bbd0-4505c0cc2bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails_1" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails_1"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesDebtfinancingDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4939abb3-ab20-448f-abda-f499953b5474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4939abb3-ab20-448f-abda-f499953b5474" xlink:to="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e793900c-8b59-42fb-b55d-9372fc0e1d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:to="loc_us-gaap_DebtInstrumentAxis_e793900c-8b59-42fb-b55d-9372fc0e1d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_82c1d2a5-3c14-468d-a59b-705908f7dbc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e793900c-8b59-42fb-b55d-9372fc0e1d2b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_82c1d2a5-3c14-468d-a59b-705908f7dbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_TrancheOneMember_955c199c-644c-49d5-a993-5bbd0f7ce0d0" xlink:href="nvta-20201231.xsd#nvta_TrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_82c1d2a5-3c14-468d-a59b-705908f7dbc3" xlink:to="loc_nvta_TrancheOneMember_955c199c-644c-49d5-a993-5bbd0f7ce0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_LoanAndSecurityAgreementMember_7fb9a530-0586-48d0-926e-a92be0e38ed5" xlink:href="nvta-20201231.xsd#nvta_LoanAndSecurityAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_82c1d2a5-3c14-468d-a59b-705908f7dbc3" xlink:to="loc_nvta_LoanAndSecurityAgreementMember_7fb9a530-0586-48d0-926e-a92be0e38ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SeniorSecuredTermLoanFacilityMember_3eb01046-bf13-4d96-9064-a81b3f180b4a" xlink:href="nvta-20201231.xsd#nvta_SeniorSecuredTermLoanFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_82c1d2a5-3c14-468d-a59b-705908f7dbc3" xlink:to="loc_nvta_SeniorSecuredTermLoanFacilityMember_3eb01046-bf13-4d96-9064-a81b3f180b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ConvertibleSeniorNotesMember_a0b3e8c3-adfb-48bc-a255-cee8352cee09" xlink:href="nvta-20201231.xsd#nvta_ConvertibleSeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_82c1d2a5-3c14-468d-a59b-705908f7dbc3" xlink:to="loc_nvta_ConvertibleSeniorNotesMember_a0b3e8c3-adfb-48bc-a255-cee8352cee09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9b143959-c2ee-49c9-9cdf-b0cfb5e5615f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:to="loc_us-gaap_CreditFacilityAxis_9b143959-c2ee-49c9-9cdf-b0cfb5e5615f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_768b75cb-1ff5-4380-a63a-dbfad9c2852a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_9b143959-c2ee-49c9-9cdf-b0cfb5e5615f" xlink:to="loc_us-gaap_CreditFacilityDomain_768b75cb-1ff5-4380-a63a-dbfad9c2852a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_NotePurchaseAgreementMember_0e406ead-7543-48dd-90c6-ed5dbbd64e69" xlink:href="nvta-20201231.xsd#nvta_NotePurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_768b75cb-1ff5-4380-a63a-dbfad9c2852a" xlink:to="loc_nvta_NotePurchaseAgreementMember_0e406ead-7543-48dd-90c6-ed5dbbd64e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_c19f4d22-f74b-42ca-b064-aed49f9c0b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_768b75cb-1ff5-4380-a63a-dbfad9c2852a" xlink:to="loc_us-gaap_SecuredDebtMember_c19f4d22-f74b-42ca-b064-aed49f9c0b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7e458d3b-5c2c-4736-8d8e-1bb081975431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7e458d3b-5c2c-4736-8d8e-1bb081975431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9df93bfe-4911-494d-ac1d-7c870895db2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7e458d3b-5c2c-4736-8d8e-1bb081975431" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9df93bfe-4911-494d-ac1d-7c870895db2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_932ccfef-61c9-4b37-a1d0-ec7c57801e7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9df93bfe-4911-494d-ac1d-7c870895db2c" xlink:to="loc_us-gaap_SecuredDebtMember_932ccfef-61c9-4b37-a1d0-ec7c57801e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_7dba067b-7b24-43de-959e-a9eb7baeacc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9df93bfe-4911-494d-ac1d-7c870895db2c" xlink:to="loc_us-gaap_ConvertibleDebtMember_7dba067b-7b24-43de-959e-a9eb7baeacc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_c7378cdd-03bf-432e-b4e8-b2c85b1e0d17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:to="loc_us-gaap_VariableRateAxis_c7378cdd-03bf-432e-b4e8-b2c85b1e0d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f5411c9b-6cd6-475a-8eed-b8f8be1c6a35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_c7378cdd-03bf-432e-b4e8-b2c85b1e0d17" xlink:to="loc_us-gaap_VariableRateDomain_f5411c9b-6cd6-475a-8eed-b8f8be1c6a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_21676fa3-adff-4a92-9b71-2e0c49546c4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_f5411c9b-6cd6-475a-8eed-b8f8be1c6a35" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_21676fa3-adff-4a92-9b71-2e0c49546c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_972237c2-3c7c-41b9-97a8-ae39ef9ee551" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_972237c2-3c7c-41b9-97a8-ae39ef9ee551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_f1479e47-52be-40f1-8bb8-23d765a3e867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_972237c2-3c7c-41b9-97a8-ae39ef9ee551" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_f1479e47-52be-40f1-8bb8-23d765a3e867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtFinancingContingencyMember_4584314a-40bf-4592-b340-e821bba029fd" xlink:href="nvta-20201231.xsd#nvta_DebtFinancingContingencyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_f1479e47-52be-40f1-8bb8-23d765a3e867" xlink:to="loc_nvta_DebtFinancingContingencyMember_4584314a-40bf-4592-b340-e821bba029fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_c2e4e755-5759-423e-a6b1-60f67eb2212e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_c2e4e755-5759-423e-a6b1-60f67eb2212e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a1ef7f2b-b58e-4486-8faf-7ea8e185d6b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_c2e4e755-5759-423e-a6b1-60f67eb2212e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a1ef7f2b-b58e-4486-8faf-7ea8e185d6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoteWarrantMember_9e642b2a-613c-4179-bb9e-e8c41693525d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoteWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a1ef7f2b-b58e-4486-8faf-7ea8e185d6b3" xlink:to="loc_us-gaap_NoteWarrantMember_9e642b2a-613c-4179-bb9e-e8c41693525d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_402de419-8890-4a79-8807-36e4097ddf1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_402de419-8890-4a79-8807-36e4097ddf1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_c87c7c6d-2122-4fdf-9f28-de5c8ae7d0f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_402de419-8890-4a79-8807-36e4097ddf1d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_c87c7c6d-2122-4fdf-9f28-de5c8ae7d0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_c665fb92-e0a3-4047-abd0-83888cd173cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_c87c7c6d-2122-4fdf-9f28-de5c8ae7d0f3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_c665fb92-e0a3-4047-abd0-83888cd173cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_2dd49de9-2221-4bea-8a74-6f80888669f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_c87c7c6d-2122-4fdf-9f28-de5c8ae7d0f3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_2dd49de9-2221-4bea-8a74-6f80888669f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7fa2db63-b8d7-4808-8db1-2e4778d0b142" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_767c394d-d528-45ad-aac2-d947ed37bf67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_767c394d-d528-45ad-aac2-d947ed37bf67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_d36d3d4a-1512-4dde-aa87-4685100110e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_DebtInstrumentTerm_d36d3d4a-1512-4dde-aa87-4685100110e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_b4c2eaa8-8543-4a4a-adcc-0bc271d5209e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_b4c2eaa8-8543-4a4a-adcc-0bc271d5209e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_9b80b363-c603-45fc-8c91-31edc7f13a74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_9b80b363-c603-45fc-8c91-31edc7f13a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_3fc33218-c927-42e6-b857-a3a953b94568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_3fc33218-c927-42e6-b857-a3a953b94568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RepaymentsofLinesofCreditPrincipal_2a011629-17f9-4186-a647-f729a0eb430b" xlink:href="nvta-20201231.xsd#nvta_RepaymentsofLinesofCreditPrincipal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_nvta_RepaymentsofLinesofCreditPrincipal_2a011629-17f9-4186-a647-f729a0eb430b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RepaymentsofLinesofCreditAccruedInterest_db3c65b9-9445-449c-9a59-abbef2a1bc4e" xlink:href="nvta-20201231.xsd#nvta_RepaymentsofLinesofCreditAccruedInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_nvta_RepaymentsofLinesofCreditAccruedInterest_db3c65b9-9445-449c-9a59-abbef2a1bc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_e4d01579-84d8-45f5-afd4-ace716a6c8e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_e4d01579-84d8-45f5-afd4-ace716a6c8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_db901879-31e6-49cb-a4c0-12bb56eec27a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_db901879-31e6-49cb-a4c0-12bb56eec27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentInterestRateFloorRate_0b097dd0-8cac-4572-9e04-e2536e6e7e7c" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentInterestRateFloorRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_nvta_DebtInstrumentInterestRateFloorRate_0b097dd0-8cac-4572-9e04-e2536e6e7e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a5394f1e-851b-4f57-a92a-166dcb117ef8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a5394f1e-851b-4f57-a92a-166dcb117ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended_1780bc65-82e3-4346-9a3d-c882356a3844" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended_1780bc65-82e3-4346-9a3d-c882356a3844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate_45a62e0a-faa1-436f-ae66-b8257c1077e7" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate_45a62e0a-faa1-436f-ae66-b8257c1077e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentPrepaymentFeePercentage_517f0db8-234c-405a-bef4-f501e1aeba72" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentPrepaymentFeePercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_nvta_DebtInstrumentPrepaymentFeePercentage_517f0db8-234c-405a-bef4-f501e1aeba72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_081fed59-d8b9-4401-95ce-811756408acb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_081fed59-d8b9-4401-95ce-811756408acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_14537efd-99d0-4980-8c01-7d8dd412a63d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_14537efd-99d0-4980-8c01-7d8dd412a63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0da8ba48-28fb-4e13-a4bb-3533990f9a4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0da8ba48-28fb-4e13-a4bb-3533990f9a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_45800449-45dd-4f77-88d8-8a6dea78f52d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_45800449-45dd-4f77-88d8-8a6dea78f52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_17a0e36f-5cdf-4fea-9386-e75032ea6844" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_17a0e36f-5cdf-4fea-9386-e75032ea6844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_8c247952-e9b5-433d-b13f-bb4a4239bb4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_a5915df3-8703-4063-8b50-fbfa53f3e0d5" xlink:to="loc_us-gaap_InterestExpenseDebt_8c247952-e9b5-433d-b13f-bb4a4239bb4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesConvertibleseniornotesDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6acab622-d9ab-4dc2-8984-624c0a94acae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1ba180a9-a475-4b2a-a68f-57efb5509ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6acab622-d9ab-4dc2-8984-624c0a94acae" xlink:to="loc_us-gaap_DebtInstrumentTable_1ba180a9-a475-4b2a-a68f-57efb5509ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ad4c60f8-d098-4b7d-96b1-d8a5524bb242" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1ba180a9-a475-4b2a-a68f-57efb5509ed1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ad4c60f8-d098-4b7d-96b1-d8a5524bb242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3204e5d6-29aa-4942-8aab-aca964121a6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ad4c60f8-d098-4b7d-96b1-d8a5524bb242" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3204e5d6-29aa-4942-8aab-aca964121a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ad1e4f0f-03aa-4e8e-a980-f34332418d9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3204e5d6-29aa-4942-8aab-aca964121a6c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ad1e4f0f-03aa-4e8e-a980-f34332418d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_42a178e6-56e7-4da8-9bdf-ee721da92b77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1ba180a9-a475-4b2a-a68f-57efb5509ed1" xlink:to="loc_us-gaap_DebtInstrumentAxis_42a178e6-56e7-4da8-9bdf-ee721da92b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_67d2e2fd-c3a5-4a92-883d-28f5d5102cf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_42a178e6-56e7-4da8-9bdf-ee721da92b77" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_67d2e2fd-c3a5-4a92-883d-28f5d5102cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ConvertibleSeniorNotesMember_91166724-492d-45ac-863d-4e2e1a196719" xlink:href="nvta-20201231.xsd#nvta_ConvertibleSeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_67d2e2fd-c3a5-4a92-883d-28f5d5102cf8" xlink:to="loc_nvta_ConvertibleSeniorNotesMember_91166724-492d-45ac-863d-4e2e1a196719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_146fc568-d749-4105-8c11-c04a7d00eab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1ba180a9-a475-4b2a-a68f-57efb5509ed1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_146fc568-d749-4105-8c11-c04a7d00eab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ab82ba43-2fc9-4a9c-8ff7-97bc3d2d7876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_146fc568-d749-4105-8c11-c04a7d00eab2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ab82ba43-2fc9-4a9c-8ff7-97bc3d2d7876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_c045dded-6cec-4c36-9c27-32bb7c15767c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ab82ba43-2fc9-4a9c-8ff7-97bc3d2d7876" xlink:to="loc_us-gaap_ConvertibleDebtMember_c045dded-6cec-4c36-9c27-32bb7c15767c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1ba180a9-a475-4b2a-a68f-57efb5509ed1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_373abf3a-468b-4148-afbc-eee7318efb57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_373abf3a-468b-4148-afbc-eee7318efb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7faa7d97-6a56-444b-a1b5-a99cdd1c7ee5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7faa7d97-6a56-444b-a1b5-a99cdd1c7ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_805d9072-07c7-4631-b373-160ced04de00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_805d9072-07c7-4631-b373-160ced04de00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_95696d3b-897d-45e7-9262-889a350b6c39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_95696d3b-897d-45e7-9262-889a350b6c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cf26733a-7484-4cf0-81a5-b9bea68c623b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cf26733a-7484-4cf0-81a5-b9bea68c623b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4d6f0820-ddb4-42ff-a60b-539a4adf56f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4d6f0820-ddb4-42ff-a60b-539a4adf56f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_d9b90e30-596f-4850-80d6-c622cd73b074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_d9b90e30-596f-4850-80d6-c622cd73b074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_50f330da-048e-426c-bef0-9d4db09b379f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_50f330da-048e-426c-bef0-9d4db09b379f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays_d4d23197-7c8b-4bf2-8afd-c0dab97154c7" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays_d4d23197-7c8b-4bf2-8afd-c0dab97154c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum_08a46300-1d6c-419d-a74e-12a5cf378ce1" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum_08a46300-1d6c-419d-a74e-12a5cf378ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays_42c9b990-60df-4cc2-98fd-88ff0e48d39a" xlink:href="nvta-20201231.xsd#nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays_42c9b990-60df-4cc2-98fd-88ff0e48d39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_13a7d3ac-d490-46c6-82bb-777e7860215d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_13a7d3ac-d490-46c6-82bb-777e7860215d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_39407e3d-c3d3-4326-b0c1-2035e3f944ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3c29672-eb6b-40f5-b5ba-5fd02f933cfd" xlink:to="loc_us-gaap_InterestExpenseDebt_39407e3d-c3d3-4326-b0c1-2035e3f944ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesComponentsofdebtDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a0c954f0-e406-4904-95c3-bf6a9dc91c2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_22c891f7-fdcc-428d-9ace-fcf84f2d6781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a0c954f0-e406-4904-95c3-bf6a9dc91c2b" xlink:to="loc_us-gaap_DebtInstrumentTable_22c891f7-fdcc-428d-9ace-fcf84f2d6781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c9349960-abec-4419-9bdf-cf2efedb8211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_22c891f7-fdcc-428d-9ace-fcf84f2d6781" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c9349960-abec-4419-9bdf-cf2efedb8211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4ec50610-8a7e-4390-bb1d-36ac09865c0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c9349960-abec-4419-9bdf-cf2efedb8211" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4ec50610-8a7e-4390-bb1d-36ac09865c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_05f23ada-f16d-4c16-9c7d-b0099a608047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4ec50610-8a7e-4390-bb1d-36ac09865c0a" xlink:to="loc_us-gaap_ConvertibleDebtMember_05f23ada-f16d-4c16-9c7d-b0099a608047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e0959dde-1aef-4d89-8fa4-5437b62dc309" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_22c891f7-fdcc-428d-9ace-fcf84f2d6781" xlink:to="loc_us-gaap_DebtInstrumentAxis_e0959dde-1aef-4d89-8fa4-5437b62dc309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8a9601a6-8dbe-43d2-bfb4-a8f215ad1d20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e0959dde-1aef-4d89-8fa4-5437b62dc309" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8a9601a6-8dbe-43d2-bfb4-a8f215ad1d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ConvertibleSeniorNotesMember_c632e40e-9dcc-4bd9-90ca-68346727ea31" xlink:href="nvta-20201231.xsd#nvta_ConvertibleSeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a9601a6-8dbe-43d2-bfb4-a8f215ad1d20" xlink:to="loc_nvta_ConvertibleSeniorNotesMember_c632e40e-9dcc-4bd9-90ca-68346727ea31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_232448c2-e8f3-4f8a-8838-5548f44843d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_22c891f7-fdcc-428d-9ace-fcf84f2d6781" xlink:to="loc_us-gaap_DebtInstrumentLineItems_232448c2-e8f3-4f8a-8838-5548f44843d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c8ecfac5-8803-4cc9-bf78-de39a865f4a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_232448c2-e8f3-4f8a-8838-5548f44843d9" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c8ecfac5-8803-4cc9-bf78-de39a865f4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_8461d34c-7024-4325-b71d-6c66be9dc7c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_232448c2-e8f3-4f8a-8838-5548f44843d9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_8461d34c-7024-4325-b71d-6c66be9dc7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_27263727-c78c-4314-9439-0bcf4e4b191f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_232448c2-e8f3-4f8a-8838-5548f44843d9" xlink:to="loc_us-gaap_LongTermDebt_27263727-c78c-4314-9439-0bcf4e4b191f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#CommitmentsandcontingenciesOthercommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0c0c1f32-0a18-4746-a14c-48a4b7a7cfc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_4d18cad5-a63f-43b1-8d24-50c655800929" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0c0c1f32-0a18-4746-a14c-48a4b7a7cfc3" xlink:to="loc_us-gaap_OtherCommitmentsTable_4d18cad5-a63f-43b1-8d24-50c655800929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_9c4514af-3496-4da1-9e40-fdc944b9631b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_4d18cad5-a63f-43b1-8d24-50c655800929" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_9c4514af-3496-4da1-9e40-fdc944b9631b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_b4d1c95f-c777-486d-a03c-54e0d2921f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_9c4514af-3496-4da1-9e40-fdc944b9631b" xlink:to="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_b4d1c95f-c777-486d-a03c-54e0d2921f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ServiceAgreementsAndLaboratorySuppliesMember_2cfad46d-1573-49c7-b6e2-9c5c113bcf82" xlink:href="nvta-20201231.xsd#nvta_ServiceAgreementsAndLaboratorySuppliesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_b4d1c95f-c777-486d-a03c-54e0d2921f2e" xlink:to="loc_nvta_ServiceAgreementsAndLaboratorySuppliesMember_2cfad46d-1573-49c7-b6e2-9c5c113bcf82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_258e1e24-3b15-41ae-96dc-e6d5fff78b42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_4d18cad5-a63f-43b1-8d24-50c655800929" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_258e1e24-3b15-41ae-96dc-e6d5fff78b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_74c35bc1-9097-4747-bbb0-cb266ead51e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_258e1e24-3b15-41ae-96dc-e6d5fff78b42" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_74c35bc1-9097-4747-bbb0-cb266ead51e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_OfficeFacilityInSanFranciscoTwoMember_0070324a-478a-48c1-a577-0b37b8fe0225" xlink:href="nvta-20201231.xsd#nvta_OfficeFacilityInSanFranciscoTwoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_74c35bc1-9097-4747-bbb0-cb266ead51e8" xlink:to="loc_nvta_OfficeFacilityInSanFranciscoTwoMember_0070324a-478a-48c1-a577-0b37b8fe0225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_4d18cad5-a63f-43b1-8d24-50c655800929" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_e897dcab-a224-470e-b202-915f95a513e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_e897dcab-a224-470e-b202-915f95a513e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_d013843f-b9f5-423e-bfdf-16a889071d54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_d013843f-b9f5-423e-bfdf-16a889071d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_e55c0345-4d44-422e-8975-65829a8c8aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_e55c0345-4d44-422e-8975-65829a8c8aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_589a26fb-7b3f-4519-9654-255d9ed55972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_589a26fb-7b3f-4519-9654-255d9ed55972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_4c491f4f-4eb1-4e94-8ca1-7a5fecb55e24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_4c491f4f-4eb1-4e94-8ca1-7a5fecb55e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_20940889-993a-42b0-8b61-ce571da3a757" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_20940889-993a-42b0-8b61-ce571da3a757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligation_f455240f-ca05-4f08-8c43-52685ffa52ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligation_f455240f-ca05-4f08-8c43-52685ffa52ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_982e284a-b919-4c91-ae56-82072c4970d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_53fba250-0373-4036-aa16-6a56bf824354" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_982e284a-b919-4c91-ae56-82072c4970d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Stockholdersequity" xlink:type="simple" xlink:href="nvta-20201231.xsd#Stockholdersequity"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/Stockholdersequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_74ecf263-7f68-4054-8283-18928822cc04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_78009244-8938-4d84-ada8-4117db4a624b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_74ecf263-7f68-4054-8283-18928822cc04" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_78009244-8938-4d84-ada8-4117db4a624b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockholdersequityTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockholdersequityTables"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/StockholdersequityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a1cbfc8b-c40d-44e2-aab3-e6f8403bea43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_c3fb042b-a30e-4586-ad4e-f59953ed4af5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a1cbfc8b-c40d-44e2-aab3-e6f8403bea43" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_c3fb042b-a30e-4586-ad4e-f59953ed4af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_c269bbda-5078-441b-b03f-018cb14102ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a1cbfc8b-c40d-44e2-aab3-e6f8403bea43" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_c269bbda-5078-441b-b03f-018cb14102ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d986d496-b630-4e3a-8b48-bf330797791b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f4c5c5e3-f6c2-419c-b272-898c3d28e0f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d986d496-b630-4e3a-8b48-bf330797791b" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f4c5c5e3-f6c2-419c-b272-898c3d28e0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3d5bbbf7-ea45-4bfa-a43e-8404b9c8e9e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f4c5c5e3-f6c2-419c-b272-898c3d28e0f9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3d5bbbf7-ea45-4bfa-a43e-8404b9c8e9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e4d252a5-9f14-4328-b0b3-63c666ca1ef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3d5bbbf7-ea45-4bfa-a43e-8404b9c8e9e9" xlink:to="loc_us-gaap_EquityComponentDomain_e4d252a5-9f14-4328-b0b3-63c666ca1ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_922a56b8-ae95-4757-acdb-ab2b9a0bbba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e4d252a5-9f14-4328-b0b3-63c666ca1ef7" xlink:to="loc_us-gaap_PreferredStockMember_922a56b8-ae95-4757-acdb-ab2b9a0bbba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0bde0ceb-eedf-443e-93e2-b0d43320e5d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e4d252a5-9f14-4328-b0b3-63c666ca1ef7" xlink:to="loc_us-gaap_CommonStockMember_0bde0ceb-eedf-443e-93e2-b0d43320e5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_2efdfb39-a7de-4256-8515-4a7b989f4e05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f4c5c5e3-f6c2-419c-b272-898c3d28e0f9" xlink:to="loc_us-gaap_ClassOfStockLineItems_2efdfb39-a7de-4256-8515-4a7b989f4e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_2efdfb39-a7de-4256-8515-4a7b989f4e05" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_1d385794-186f-40d4-840e-b6972cd695cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_us-gaap_SharesOutstanding_1d385794-186f-40d4-840e-b6972cd695cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_fde68879-465a-4c66-b030-75d041162403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_fde68879-465a-4c66-b030-75d041162403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts_e07d6860-a161-4732-ba5d-f188581766ca" xlink:href="nvta-20201231.xsd#nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts_e07d6860-a161-4732-ba5d-f188581766ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ff921297-e2b6-4dc2-a370-b1c354ae41c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ff921297-e2b6-4dc2-a370-b1c354ae41c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6151474e-01ad-4d1a-b642-d1d21981800b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6151474e-01ad-4d1a-b642-d1d21981800b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_f6364c56-1f1b-4c00-be4b-091c9255694a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_f6364c56-1f1b-4c00-be4b-091c9255694a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIssuedDuringPeriodSharesWarrantsExercised_cf961f36-8b4f-4014-adca-cc37c03821a0" xlink:href="nvta-20201231.xsd#nvta_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_nvta_StockIssuedDuringPeriodSharesWarrantsExercised_cf961f36-8b4f-4014-adca-cc37c03821a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_20dfd430-77f3-43fe-ac22-b432d1c2c1b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_20dfd430-77f3-43fe-ac22-b432d1c2c1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_5bbb9898-712b-47c1-bdb9-9c1bd467bc0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_5bbb9898-712b-47c1-bdb9-9c1bd467bc0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_9ccfdb8c-7cca-445b-922a-f7958d7d2dd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc26b642-d6d3-482b-b768-0d47ad2e0204" xlink:to="loc_us-gaap_SharesOutstanding_9ccfdb8c-7cca-445b-922a-f7958d7d2dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockholdersequityNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockholdersequityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/StockholdersequityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9dbaef38-3310-476c-84c5-a06d3fdfd423" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9dbaef38-3310-476c-84c5-a06d3fdfd423" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2162597c-a0fa-4f55-9867-4be1fa0feca5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_srt_RangeAxis_2162597c-a0fa-4f55-9867-4be1fa0feca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f903f1ff-50cd-49bc-aebd-152b850caf4a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2162597c-a0fa-4f55-9867-4be1fa0feca5" xlink:to="loc_srt_RangeMember_f903f1ff-50cd-49bc-aebd-152b850caf4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_178ad126-801b-4266-93bd-66b83b04c880" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f903f1ff-50cd-49bc-aebd-152b850caf4a" xlink:to="loc_srt_MaximumMember_178ad126-801b-4266-93bd-66b83b04c880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_bed87aea-1631-442a-8b1f-ecd68dabbc8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_TransactionTypeAxis_bed87aea-1631-442a-8b1f-ecd68dabbc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_f8ef9f56-bad1-484b-b0d8-c2ad3f69d1a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionTypeAxis_bed87aea-1631-442a-8b1f-ecd68dabbc8f" xlink:to="loc_us-gaap_TransactionDomain_f8ef9f56-bad1-484b-b0d8-c2ad3f69d1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CommonStockSalesAgreementMember_0a215a28-4816-40b6-84c1-37d57ef5a874" xlink:href="nvta-20201231.xsd#nvta_CommonStockSalesAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionDomain_f8ef9f56-bad1-484b-b0d8-c2ad3f69d1a1" xlink:to="loc_nvta_CommonStockSalesAgreementMember_0a215a28-4816-40b6-84c1-37d57ef5a874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a401715d-ea56-44bd-9de6-738fb25d18f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a401715d-ea56-44bd-9de6-738fb25d18f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9fd3992d-3ccc-482c-82bd-7f3c708bdad5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a401715d-ea56-44bd-9de6-738fb25d18f5" xlink:to="loc_us-gaap_RelatedPartyDomain_9fd3992d-3ccc-482c-82bd-7f3c708bdad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CowenAndCompanyLimitedLiabilityCompanyMember_0dffa000-716e-42dd-8219-e132be045817" xlink:href="nvta-20201231.xsd#nvta_CowenAndCompanyLimitedLiabilityCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_9fd3992d-3ccc-482c-82bd-7f3c708bdad5" xlink:to="loc_nvta_CowenAndCompanyLimitedLiabilityCompanyMember_0dffa000-716e-42dd-8219-e132be045817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_996bdf27-2415-4cbe-81d6-de74a8c14598" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_996bdf27-2415-4cbe-81d6-de74a8c14598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_90498d30-5237-4731-88aa-e413100c0e89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_996bdf27-2415-4cbe-81d6-de74a8c14598" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_90498d30-5237-4731-88aa-e413100c0e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_UnderwrittenPublicOfferingMember_43b0a19c-7c2a-4f10-af73-f470089c9042" xlink:href="nvta-20201231.xsd#nvta_UnderwrittenPublicOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_90498d30-5237-4731-88aa-e413100c0e89" xlink:to="loc_nvta_UnderwrittenPublicOfferingMember_43b0a19c-7c2a-4f10-af73-f470089c9042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_8791c064-e35e-4f84-95a8-b39327f60727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_90498d30-5237-4731-88aa-e413100c0e89" xlink:to="loc_us-gaap_PrivatePlacementMember_8791c064-e35e-4f84-95a8-b39327f60727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ee9f8e4e-8dc4-47ed-bc3a-0f47c8c2463b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ee9f8e4e-8dc4-47ed-bc3a-0f47c8c2463b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b5264ab0-0aea-47df-8dc0-78a484f434a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ee9f8e4e-8dc4-47ed-bc3a-0f47c8c2463b" xlink:to="loc_us-gaap_EquityComponentDomain_b5264ab0-0aea-47df-8dc0-78a484f434a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_303330b9-c42f-4f66-ba7e-09708fb86cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b5264ab0-0aea-47df-8dc0-78a484f434a4" xlink:to="loc_us-gaap_CommonStockMember_303330b9-c42f-4f66-ba7e-09708fb86cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3337283c-dac6-44ea-9405-270daff0903b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3337283c-dac6-44ea-9405-270daff0903b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c26772dc-5a53-43a8-9779-426aaf2c0cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3337283c-dac6-44ea-9405-270daff0903b" xlink:to="loc_us-gaap_ClassOfStockDomain_c26772dc-5a53-43a8-9779-426aaf2c0cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_7bd4973f-eb00-4c23-b008-0849f563d19a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c26772dc-5a53-43a8-9779-426aaf2c0cec" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_7bd4973f-eb00-4c23-b008-0849f563d19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_e8b62dc7-243b-4558-9567-dbfe8b91ecae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_e8b62dc7-243b-4558-9567-dbfe8b91ecae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_306cbb78-0737-471a-ac4d-2bc3d60eebb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_e8b62dc7-243b-4558-9567-dbfe8b91ecae" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_306cbb78-0737-471a-ac4d-2bc3d60eebb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember_5c31dde2-4080-4bfe-a804-473a1f30d31e" xlink:href="nvta-20201231.xsd#nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_306cbb78-0737-471a-ac4d-2bc3d60eebb8" xlink:to="loc_nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember_5c31dde2-4080-4bfe-a804-473a1f30d31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_889e5e8e-3675-4767-8ae2-8180ae101cfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_889e5e8e-3675-4767-8ae2-8180ae101cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7434cec-f9c2-4776-8f8b-dd506d097c9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_889e5e8e-3675-4767-8ae2-8180ae101cfc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7434cec-f9c2-4776-8f8b-dd506d097c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_babbf5f5-0586-4fb8-bf33-5833786929ef" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7434cec-f9c2-4776-8f8b-dd506d097c9c" xlink:to="loc_nvta_ArcherDXInc.Member_babbf5f5-0586-4fb8-bf33-5833786929ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_47c2be3d-0ada-4fb2-a7d4-536b06eab4c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_47c2be3d-0ada-4fb2-a7d4-536b06eab4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d84152d1-c2af-4fa3-ba77-cfa7124306d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_47c2be3d-0ada-4fb2-a7d4-536b06eab4c5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d84152d1-c2af-4fa3-ba77-cfa7124306d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f7732624-2330-4939-83e1-9f65be7a3bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d84152d1-c2af-4fa3-ba77-cfa7124306d6" xlink:to="loc_us-gaap_SubsequentEventMember_f7732624-2330-4939-83e1-9f65be7a3bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_131536df-8a5d-48f6-ae0a-0c2fbec080ea" xlink:to="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_883f0dc8-ffa6-4e76-9583-5b9011c7276d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_883f0dc8-ffa6-4e76-9583-5b9011c7276d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PercentageOfCommissionPayableOnGrossProceeds_481368cf-d055-455f-9bc7-1843e6df2c77" xlink:href="nvta-20201231.xsd#nvta_PercentageOfCommissionPayableOnGrossProceeds"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_nvta_PercentageOfCommissionPayableOnGrossProceeds_481368cf-d055-455f-9bc7-1843e6df2c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0e4df902-b99b-495d-9ff0-7ca605d0a650" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0e4df902-b99b-495d-9ff0-7ca605d0a650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_NetProceedsFromIssuanceOfCommonStock_364d2579-66a1-4021-a26b-bb80f1e8cb41" xlink:href="nvta-20201231.xsd#nvta_NetProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_nvta_NetProceedsFromIssuanceOfCommonStock_364d2579-66a1-4021-a26b-bb80f1e8cb41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_df2d2420-f157-4a6e-b0c5-866296d04f01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_df2d2420-f157-4a6e-b0c5-866296d04f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_85db396d-6cf7-4ae5-b693-59b3c207df0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_85db396d-6cf7-4ae5-b693-59b3c207df0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts_8c003926-c907-4c4c-bc35-5b002c3597fc" xlink:href="nvta-20201231.xsd#nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts_8c003926-c907-4c4c-bc35-5b002c3597fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_678c3366-9996-476b-9a07-c3c1d7c776ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_678c3366-9996-476b-9a07-c3c1d7c776ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2c1a38fb-72b5-447b-a033-2ec297a815d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2c1a38fb-72b5-447b-a033-2ec297a815d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_NetProceedsFromIssuanceOfPrivatePlacement_4a487c1f-e64b-4695-b61a-51870d434ddc" xlink:href="nvta-20201231.xsd#nvta_NetProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_nvta_NetProceedsFromIssuanceOfPrivatePlacement_4a487c1f-e64b-4695-b61a-51870d434ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PreferredStockToCommonStockConversionRatio_1aaace8e-119f-4666-b6fd-dfed8aa50cca" xlink:href="nvta-20201231.xsd#nvta_PreferredStockToCommonStockConversionRatio"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_nvta_PreferredStockToCommonStockConversionRatio_1aaace8e-119f-4666-b6fd-dfed8aa50cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_0783adbb-a7c4-4c19-a437-4486c1a150a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_0783adbb-a7c4-4c19-a437-4486c1a150a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_5e3ccc3a-e63b-48da-af64-c54c2ba47a68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_5e3ccc3a-e63b-48da-af64-c54c2ba47a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_10f4f076-bbbf-4afa-9f93-885f941eb6fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e228c000-4e83-4e6e-a1fb-02db49b332fc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_10f4f076-bbbf-4afa-9f93-885f941eb6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7bc7471f-9f43-49be-a029-f7fc7e6925a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_d048ca68-caef-4015-9e6a-1611c3a50bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7bc7471f-9f43-49be-a029-f7fc7e6925a4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_d048ca68-caef-4015-9e6a-1611c3a50bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_56d01603-7ffa-4c83-b126-929b0f57190d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_d048ca68-caef-4015-9e6a-1611c3a50bb6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_56d01603-7ffa-4c83-b126-929b0f57190d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9caf43ab-899e-4378-893f-1a9d55de2b86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_56d01603-7ffa-4c83-b126-929b0f57190d" xlink:to="loc_us-gaap_EquityComponentDomain_9caf43ab-899e-4378-893f-1a9d55de2b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_114b67f5-a125-41ad-9ded-d6a0fb2259c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9caf43ab-899e-4378-893f-1a9d55de2b86" xlink:to="loc_us-gaap_CommonStockMember_114b67f5-a125-41ad-9ded-d6a0fb2259c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fd600b3f-73ed-43de-b0d6-7f4b3760401b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_d048ca68-caef-4015-9e6a-1611c3a50bb6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fd600b3f-73ed-43de-b0d6-7f4b3760401b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd658bb9-9d92-4c87-be5f-b76c926cb695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fd600b3f-73ed-43de-b0d6-7f4b3760401b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd658bb9-9d92-4c87-be5f-b76c926cb695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CombiMatrixCorporationMember_4d88314b-3767-4a21-b81d-aa915e153288" xlink:href="nvta-20201231.xsd#nvta_CombiMatrixCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd658bb9-9d92-4c87-be5f-b76c926cb695" xlink:to="loc_nvta_CombiMatrixCorporationMember_4d88314b-3767-4a21-b81d-aa915e153288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_666087dd-6ddd-460a-a87b-9eb44ccd2e88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_d048ca68-caef-4015-9e6a-1611c3a50bb6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_666087dd-6ddd-460a-a87b-9eb44ccd2e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e5f788e6-c8d8-4f57-bef4-5e6e2efa22e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_666087dd-6ddd-460a-a87b-9eb44ccd2e88" xlink:to="loc_us-gaap_ClassOfStockDomain_e5f788e6-c8d8-4f57-bef4-5e6e2efa22e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SeriesFWarrantsMember_5a404382-6cd1-466e-8e60-d6361f7af7c7" xlink:href="nvta-20201231.xsd#nvta_SeriesFWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e5f788e6-c8d8-4f57-bef4-5e6e2efa22e8" xlink:to="loc_nvta_SeriesFWarrantsMember_5a404382-6cd1-466e-8e60-d6361f7af7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_fe295c09-ce18-4505-802c-deb2662538ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_d048ca68-caef-4015-9e6a-1611c3a50bb6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_fe295c09-ce18-4505-802c-deb2662538ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_98137e31-7f30-4ddc-8c2f-18a0ef86a50e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_fe295c09-ce18-4505-802c-deb2662538ad" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_98137e31-7f30-4ddc-8c2f-18a0ef86a50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_5c87fb88-1122-413f-861e-f088ec4b294e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_fe295c09-ce18-4505-802c-deb2662538ad" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_5c87fb88-1122-413f-861e-f088ec4b294e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Stockincentiveplans" xlink:type="simple" xlink:href="nvta-20201231.xsd#Stockincentiveplans"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/Stockincentiveplans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f46e13b6-ca72-46e5-b2fe-3b6e9d81b96d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f91140f1-16b8-49d3-b261-e28cfe8a474d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f46e13b6-ca72-46e5-b2fe-3b6e9d81b96d" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f91140f1-16b8-49d3-b261-e28cfe8a474d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansTables"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/StockincentiveplansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7037be69-7426-4b77-bf61-c04c9a23b390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_e921cfd6-b25c-4533-8610-d6fb4e946eae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7037be69-7426-4b77-bf61-c04c9a23b390" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_e921cfd6-b25c-4533-8610-d6fb4e946eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_376338ff-74a5-4bc5-93cf-5522a0f33b06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7037be69-7426-4b77-bf61-c04c9a23b390" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_376338ff-74a5-4bc5-93cf-5522a0f33b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_aa908433-5f0b-447d-bc5d-368eea3928bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7037be69-7426-4b77-bf61-c04c9a23b390" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_aa908433-5f0b-447d-bc5d-368eea3928bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_fd886abc-081b-4133-a673-16aed260f4a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7037be69-7426-4b77-bf61-c04c9a23b390" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_fd886abc-081b-4133-a673-16aed260f4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ab835fb0-6dcb-4dee-9c8f-01a0611814c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69a20c7c-b017-4a36-8f64-c57cb83aeafa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ab835fb0-6dcb-4dee-9c8f-01a0611814c2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69a20c7c-b017-4a36-8f64-c57cb83aeafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1924a3e2-1e05-4caa-b873-3e77e7685a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69a20c7c-b017-4a36-8f64-c57cb83aeafa" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1924a3e2-1e05-4caa-b873-3e77e7685a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad13c9e-289c-424f-b6a4-b2d3b05181ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1924a3e2-1e05-4caa-b873-3e77e7685a86" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad13c9e-289c-424f-b6a4-b2d3b05181ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SingularBioMember_c2dddc27-0c42-40d0-bae7-26bf5e3f98c2" xlink:href="nvta-20201231.xsd#nvta_SingularBioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad13c9e-289c-424f-b6a4-b2d3b05181ac" xlink:to="loc_nvta_SingularBioMember_c2dddc27-0c42-40d0-bae7-26bf5e3f98c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ArcherDXInc.Member_a49b0f01-f79f-4138-b06b-6fa9991557d1" xlink:href="nvta-20201231.xsd#nvta_ArcherDXInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad13c9e-289c-424f-b6a4-b2d3b05181ac" xlink:to="loc_nvta_ArcherDXInc.Member_a49b0f01-f79f-4138-b06b-6fa9991557d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_53f8dc3a-a234-4ce7-b890-b16dcc183226" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69a20c7c-b017-4a36-8f64-c57cb83aeafa" xlink:to="loc_srt_RangeAxis_53f8dc3a-a234-4ce7-b890-b16dcc183226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5c6e5b4d-7071-4406-a207-f2491bc2ba81" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_53f8dc3a-a234-4ce7-b890-b16dcc183226" xlink:to="loc_srt_RangeMember_5c6e5b4d-7071-4406-a207-f2491bc2ba81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d46bdf81-5fd6-42a5-b04a-d4d3f7b6d878" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5c6e5b4d-7071-4406-a207-f2491bc2ba81" xlink:to="loc_srt_MinimumMember_d46bdf81-5fd6-42a5-b04a-d4d3f7b6d878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8a75bc11-fc86-465e-a2c0-d7507ac335f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5c6e5b4d-7071-4406-a207-f2491bc2ba81" xlink:to="loc_srt_MaximumMember_8a75bc11-fc86-465e-a2c0-d7507ac335f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_299cd292-ece2-4d35-96b6-1e51d19377da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69a20c7c-b017-4a36-8f64-c57cb83aeafa" xlink:to="loc_us-gaap_PlanNameAxis_299cd292-ece2-4d35-96b6-1e51d19377da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_80ce3aff-eaf0-4eb4-ba51-d8332f64a20c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_299cd292-ece2-4d35-96b6-1e51d19377da" xlink:to="loc_us-gaap_PlanNameDomain_80ce3aff-eaf0-4eb4-ba51-d8332f64a20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIncentivePlan2010Member_052703e1-e89d-46f2-b137-507cb4710808" xlink:href="nvta-20201231.xsd#nvta_StockIncentivePlan2010Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_80ce3aff-eaf0-4eb4-ba51-d8332f64a20c" xlink:to="loc_nvta_StockIncentivePlan2010Member_052703e1-e89d-46f2-b137-507cb4710808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIncentivePlanMember_48f80269-19a3-424c-8154-564b3a4e8cb0" xlink:href="nvta-20201231.xsd#nvta_StockIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_80ce3aff-eaf0-4eb4-ba51-d8332f64a20c" xlink:to="loc_nvta_StockIncentivePlanMember_48f80269-19a3-424c-8154-564b3a4e8cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_A2019IncentiveCompensationPlanMember_ffa67554-d323-4a51-81f3-9725e67d674c" xlink:href="nvta-20201231.xsd#nvta_A2019IncentiveCompensationPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_80ce3aff-eaf0-4eb4-ba51-d8332f64a20c" xlink:to="loc_nvta_A2019IncentiveCompensationPlanMember_ffa67554-d323-4a51-81f3-9725e67d674c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_EmployeeStockPurchasePlan2015Member_70d1ef21-0e2a-420f-86fd-34a8d0e6e98c" xlink:href="nvta-20201231.xsd#nvta_EmployeeStockPurchasePlan2015Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_80ce3aff-eaf0-4eb4-ba51-d8332f64a20c" xlink:to="loc_nvta_EmployeeStockPurchasePlan2015Member_70d1ef21-0e2a-420f-86fd-34a8d0e6e98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ea510d1b-2331-41bc-b6ca-c9444204a835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69a20c7c-b017-4a36-8f64-c57cb83aeafa" xlink:to="loc_us-gaap_AwardTypeAxis_ea510d1b-2331-41bc-b6ca-c9444204a835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8309344-e620-4aa2-a6e9-6411d09951a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ea510d1b-2331-41bc-b6ca-c9444204a835" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8309344-e620-4aa2-a6e9-6411d09951a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1933d568-96f1-4de0-919e-7f9f54d66860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8309344-e620-4aa2-a6e9-6411d09951a9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1933d568-96f1-4de0-919e-7f9f54d66860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_38db4b63-6f68-4eb6-8971-f9c00b28e828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8309344-e620-4aa2-a6e9-6411d09951a9" xlink:to="loc_us-gaap_PerformanceSharesMember_38db4b63-6f68-4eb6-8971-f9c00b28e828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_baec5fe4-e62a-45fc-835d-c5f08eb5b231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8309344-e620-4aa2-a6e9-6411d09951a9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_baec5fe4-e62a-45fc-835d-c5f08eb5b231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69a20c7c-b017-4a36-8f64-c57cb83aeafa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage_b5d893f0-daa5-4feb-bea0-943ac43382ba" xlink:href="nvta-20201231.xsd#nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage_b5d893f0-daa5-4feb-bea0-943ac43382ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4a00ce28-d0ab-4593-887b-a0e080a9c27a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4a00ce28-d0ab-4593-887b-a0e080a9c27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_9621c987-cb3f-4f69-93e4-cdb5969beb35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_9621c987-cb3f-4f69-93e4-cdb5969beb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_183996da-1f89-4ced-8e04-75d7cf9d5dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_183996da-1f89-4ced-8e04-75d7cf9d5dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage_046062ee-2e3c-4447-8e5f-26b57f55df51" xlink:href="nvta-20201231.xsd#nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage_046062ee-2e3c-4447-8e5f-26b57f55df51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e098219a-a851-4d84-af3a-ca64644d4eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e098219a-a851-4d84-af3a-ca64644d4eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_97f7f0d2-d53e-40af-9f6c-5ab4eee5c4e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_97f7f0d2-d53e-40af-9f6c-5ab4eee5c4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ab252635-5fad-4150-ace3-2c848d9842ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ab252635-5fad-4150-ace3-2c848d9842ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f6e9abc8-492c-4b8e-9c4c-c325e168967e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f6e9abc8-492c-4b8e-9c4c-c325e168967e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_dea54389-bdd3-4a14-9149-3e137bacbca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_dea54389-bdd3-4a14-9149-3e137bacbca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_aead4f5d-f3db-4dde-b90a-4d6f3a500a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_aead4f5d-f3db-4dde-b90a-4d6f3a500a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_fd6087fd-c121-4a40-a11e-326bc9457b97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_fd6087fd-c121-4a40-a11e-326bc9457b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a861bb62-8f10-4378-891c-169d17ee177f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a861bb62-8f10-4378-891c-169d17ee177f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_a360ca8d-4a51-486f-992e-72e0b450caf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_a360ca8d-4a51-486f-992e-72e0b450caf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9482cbb3-926b-465c-b07e-62aab52b8f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9482cbb3-926b-465c-b07e-62aab52b8f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_b08bc896-fc7c-47a8-9d82-998d2c2a3be1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_b08bc896-fc7c-47a8-9d82-998d2c2a3be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_9d38c17b-6ca3-46a1-9568-eec6a79c13f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_ProceedsFromStockPlans_9d38c17b-6ca3-46a1-9568-eec6a79c13f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8853ab7f-bdf0-49fc-be6e-85826ef76c70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8853ab7f-bdf0-49fc-be6e-85826ef76c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9f7adb71-7537-4371-867c-19df742e5251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abe77309-7bef-4c37-9a95-4465d0c943cb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9f7adb71-7537-4371-867c-19df742e5251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1bea8f61-6de3-40e4-bae7-76e910b397d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c48d814-1ac6-4f60-97ee-5cc69080ca03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1bea8f61-6de3-40e4-bae7-76e910b397d1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c48d814-1ac6-4f60-97ee-5cc69080ca03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0f3e1da8-c8c7-4fe4-86e9-1423cf677b35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c48d814-1ac6-4f60-97ee-5cc69080ca03" xlink:to="loc_us-gaap_PlanNameAxis_0f3e1da8-c8c7-4fe4-86e9-1423cf677b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_164ddd17-d31a-463f-9d34-ac680ef9f685" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_0f3e1da8-c8c7-4fe4-86e9-1423cf677b35" xlink:to="loc_us-gaap_PlanNameDomain_164ddd17-d31a-463f-9d34-ac680ef9f685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_StockIncentivePlanMember_04af669c-fdae-4bf0-a820-b9bdabc2d1bd" xlink:href="nvta-20201231.xsd#nvta_StockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_164ddd17-d31a-463f-9d34-ac680ef9f685" xlink:to="loc_nvta_StockIncentivePlanMember_04af669c-fdae-4bf0-a820-b9bdabc2d1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fc144518-8d49-44d0-9f2b-1b6dfb9f96fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c48d814-1ac6-4f60-97ee-5cc69080ca03" xlink:to="loc_us-gaap_AwardTypeAxis_fc144518-8d49-44d0-9f2b-1b6dfb9f96fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_318b33c9-5a03-4aba-9ca1-b7db9eccc1b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_fc144518-8d49-44d0-9f2b-1b6dfb9f96fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_318b33c9-5a03-4aba-9ca1-b7db9eccc1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bbb7addb-0fb9-4f63-a9ea-d6553e86f8e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_318b33c9-5a03-4aba-9ca1-b7db9eccc1b0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bbb7addb-0fb9-4f63-a9ea-d6553e86f8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RSUsAndPRSUsMember_e8734b7e-0014-499d-aef9-da2920111ad3" xlink:href="nvta-20201231.xsd#nvta_RSUsAndPRSUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_318b33c9-5a03-4aba-9ca1-b7db9eccc1b0" xlink:to="loc_nvta_RSUsAndPRSUsMember_e8734b7e-0014-499d-aef9-da2920111ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c48d814-1ac6-4f60-97ee-5cc69080ca03" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_bb78ee6b-6d6f-4f5c-b6ac-98b3fa8cf411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_bb78ee6b-6d6f-4f5c-b6ac-98b3fa8cf411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d4a8fda1-409b-43a0-9e68-e747594a4316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d4a8fda1-409b-43a0-9e68-e747594a4316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_cf9ad869-8d32-45b8-9133-11ab2d596958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_cf9ad869-8d32-45b8-9133-11ab2d596958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ebb9f236-3788-48e1-9568-7cfaccc71639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ebb9f236-3788-48e1-9568-7cfaccc71639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4e3fef15-f102-4484-9050-22167e0a91ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4e3fef15-f102-4484-9050-22167e0a91ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2b74c435-7a99-49d4-976e-b90377105354" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2b74c435-7a99-49d4-976e-b90377105354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_19c1c03c-42ce-4676-88d7-64d6539c7be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_19c1c03c-42ce-4676-88d7-64d6539c7be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1726c64e-8627-47e2-9ffe-db1b34176172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1726c64e-8627-47e2-9ffe-db1b34176172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_cb19d4d4-738e-49d7-bdbd-7f9bb98c7bb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_cb19d4d4-738e-49d7-bdbd-7f9bb98c7bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dd9ee9ae-6dc2-4ba4-9fe0-19b799292c1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_23105855-1552-42ca-a2b6-f10babe0a948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dd9ee9ae-6dc2-4ba4-9fe0-19b799292c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_7a130d83-fc06-40cd-a262-c570146d54ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_7a130d83-fc06-40cd-a262-c570146d54ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_43816dbf-b615-43e1-a591-fe266e5eae7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_43816dbf-b615-43e1-a591-fe266e5eae7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd11213c-dbdc-4e51-9905-7c652f86f8a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd11213c-dbdc-4e51-9905-7c652f86f8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cc663a16-0d4c-4ca3-b6d0-9e0c5302ea07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd11213c-dbdc-4e51-9905-7c652f86f8a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cc663a16-0d4c-4ca3-b6d0-9e0c5302ea07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_85afa697-3e89-4150-9c91-2029b2102707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd11213c-dbdc-4e51-9905-7c652f86f8a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_85afa697-3e89-4150-9c91-2029b2102707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_cfad267b-6e00-42e8-acb9-f440bac57be4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd11213c-dbdc-4e51-9905-7c652f86f8a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_cfad267b-6e00-42e8-acb9-f440bac57be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d51518ed-aa73-4410-8bf9-67146e2f7880" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd11213c-dbdc-4e51-9905-7c652f86f8a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d51518ed-aa73-4410-8bf9-67146e2f7880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_295b5379-4793-4a70-960e-967b07a9c5d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd11213c-dbdc-4e51-9905-7c652f86f8a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_295b5379-4793-4a70-960e-967b07a9c5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_83fb2b19-5a71-4c81-87f2-e94dc450f01b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_83fb2b19-5a71-4c81-87f2-e94dc450f01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_a69eb7b9-1b8a-4bfe-b33c-b9a7cfc4e2df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_a69eb7b9-1b8a-4bfe-b33c-b9a7cfc4e2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_06dfeaa3-6cb2-4fdd-aed2-acf6b74f6b7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dc6d887b-9b0f-4111-a06e-e2958a8fe62b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dc6d887b-9b0f-4111-a06e-e2958a8fe62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a8b5fe80-26ee-4046-8933-dd14b3836adc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a8b5fe80-26ee-4046-8933-dd14b3836adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_43fbdb2a-0ac5-42d0-9b5e-7ec518bb8ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_43fbdb2a-0ac5-42d0-9b5e-7ec518bb8ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1b0d854b-f63d-4f9d-a119-3ba7377e4da7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1b0d854b-f63d-4f9d-a119-3ba7377e4da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4677303e-e14c-4cbd-8b66-cba84d8a395f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4677303e-e14c-4cbd-8b66-cba84d8a395f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_015c3866-1d12-4696-817e-9131bf78ba14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1db06080-3fb1-4910-a505-34549b2a363f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_015c3866-1d12-4696-817e-9131bf78ba14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansSummaryofRSUactivityDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f44ad360-cb51-4a70-834e-71277183b18b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b511f7c-b6b1-4e0d-b2a7-c70b6a28ccad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f44ad360-cb51-4a70-834e-71277183b18b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b511f7c-b6b1-4e0d-b2a7-c70b6a28ccad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_17e3afd0-af91-4fd9-9643-6ab46d5d6340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b511f7c-b6b1-4e0d-b2a7-c70b6a28ccad" xlink:to="loc_us-gaap_AwardTypeAxis_17e3afd0-af91-4fd9-9643-6ab46d5d6340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3013b369-3620-4f8b-86be-0341629aad3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_17e3afd0-af91-4fd9-9643-6ab46d5d6340" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3013b369-3620-4f8b-86be-0341629aad3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_43e14d6a-fa17-4669-939c-68d6273ae1f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3013b369-3620-4f8b-86be-0341629aad3f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_43e14d6a-fa17-4669-939c-68d6273ae1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_TimebasedRSUsandPRSUsMember_66af8443-8c0e-43e1-a197-e4d451d71d8a" xlink:href="nvta-20201231.xsd#nvta_TimebasedRSUsandPRSUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3013b369-3620-4f8b-86be-0341629aad3f" xlink:to="loc_nvta_TimebasedRSUsandPRSUsMember_66af8443-8c0e-43e1-a197-e4d451d71d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_507c5dce-a994-4cc9-a985-ce21b18a85ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3013b369-3620-4f8b-86be-0341629aad3f" xlink:to="loc_us-gaap_PerformanceSharesMember_507c5dce-a994-4cc9-a985-ce21b18a85ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d924ed5-d8a2-44a7-b7ed-c1f91c3430a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b511f7c-b6b1-4e0d-b2a7-c70b6a28ccad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d924ed5-d8a2-44a7-b7ed-c1f91c3430a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_24a73169-70f6-4ce2-89e0-4b9be4e071bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d924ed5-d8a2-44a7-b7ed-c1f91c3430a8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_24a73169-70f6-4ce2-89e0-4b9be4e071bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d6a60d94-3612-4b3e-b54a-5ff92d2fdd67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_24a73169-70f6-4ce2-89e0-4b9be4e071bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d6a60d94-3612-4b3e-b54a-5ff92d2fdd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbff86aa-211f-48dd-9716-cfca7ca56b4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_24a73169-70f6-4ce2-89e0-4b9be4e071bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbff86aa-211f-48dd-9716-cfca7ca56b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod_d765d9c2-721e-4d26-af32-adbc76775888" xlink:href="nvta-20201231.xsd#nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_24a73169-70f6-4ce2-89e0-4b9be4e071bd" xlink:to="loc_nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod_d765d9c2-721e-4d26-af32-adbc76775888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2b5234b9-7c25-4f2d-9b80-3c01c49840f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_24a73169-70f6-4ce2-89e0-4b9be4e071bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2b5234b9-7c25-4f2d-9b80-3c01c49840f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_041b4605-c2a7-408d-b1c7-3b8a43138802" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_24a73169-70f6-4ce2-89e0-4b9be4e071bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_041b4605-c2a7-408d-b1c7-3b8a43138802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dd6a846f-c251-4894-ac1a-10326ba49e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_24a73169-70f6-4ce2-89e0-4b9be4e071bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dd6a846f-c251-4894-ac1a-10326ba49e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91ab7212-ca9c-401b-a05b-a4d36506aaa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d924ed5-d8a2-44a7-b7ed-c1f91c3430a8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91ab7212-ca9c-401b-a05b-a4d36506aaa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_064aedac-e694-4708-b194-7b0edf740bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91ab7212-ca9c-401b-a05b-a4d36506aaa2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_064aedac-e694-4708-b194-7b0edf740bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_447177e3-2216-4c72-9beb-824e0e92bc4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91ab7212-ca9c-401b-a05b-a4d36506aaa2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_447177e3-2216-4c72-9beb-824e0e92bc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5a4ac622-7d15-4d09-9e64-30d26df8a30a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91ab7212-ca9c-401b-a05b-a4d36506aaa2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5a4ac622-7d15-4d09-9e64-30d26df8a30a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e77a1ae2-e7fe-44fe-82da-79cfadc14b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91ab7212-ca9c-401b-a05b-a4d36506aaa2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e77a1ae2-e7fe-44fe-82da-79cfadc14b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b741d246-527a-4c6f-b389-3cff8befe788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91ab7212-ca9c-401b-a05b-a4d36506aaa2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b741d246-527a-4c6f-b389-3cff8befe788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_339fa9a8-c9a6-46ca-867e-9c0a7c111c3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e73af7b6-2dd3-4922-a916-7376e5d39240" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_339fa9a8-c9a6-46ca-867e-9c0a7c111c3c" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e73af7b6-2dd3-4922-a916-7376e5d39240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_8df539b2-80e6-431c-b383-9bfefaa0af45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e73af7b6-2dd3-4922-a916-7376e5d39240" xlink:to="loc_us-gaap_PlanNameAxis_8df539b2-80e6-431c-b383-9bfefaa0af45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ee4b9eb2-e9f5-4e6b-b323-071c0d9df8e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_8df539b2-80e6-431c-b383-9bfefaa0af45" xlink:to="loc_us-gaap_PlanNameDomain_ee4b9eb2-e9f5-4e6b-b323-071c0d9df8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_EmployeeStockPurchasePlan2015Member_877c021b-5642-442c-9fca-310c981c5787" xlink:href="nvta-20201231.xsd#nvta_EmployeeStockPurchasePlan2015Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_ee4b9eb2-e9f5-4e6b-b323-071c0d9df8e4" xlink:to="loc_nvta_EmployeeStockPurchasePlan2015Member_877c021b-5642-442c-9fca-310c981c5787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_588ce155-1023-4c20-8e82-47906b62fc5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e73af7b6-2dd3-4922-a916-7376e5d39240" xlink:to="loc_us-gaap_AwardTypeAxis_588ce155-1023-4c20-8e82-47906b62fc5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5fe0417-e6ae-4c17-86c5-e4a59dcb2659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_588ce155-1023-4c20-8e82-47906b62fc5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5fe0417-e6ae-4c17-86c5-e4a59dcb2659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a6b8739d-54ce-4254-aa6c-3977b987f493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5fe0417-e6ae-4c17-86c5-e4a59dcb2659" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a6b8739d-54ce-4254-aa6c-3977b987f493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4448662c-4608-4d62-a948-60575e529e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e73af7b6-2dd3-4922-a916-7376e5d39240" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4448662c-4608-4d62-a948-60575e529e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b9e8f2ad-b288-4ca8-93b2-6bfc4ef8e9dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4448662c-4608-4d62-a948-60575e529e51" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b9e8f2ad-b288-4ca8-93b2-6bfc4ef8e9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5122bba0-e931-40c4-b040-e4c07d58f833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4448662c-4608-4d62-a948-60575e529e51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5122bba0-e931-40c4-b040-e4c07d58f833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0bccfc02-62e5-42e0-8a7f-4e7a1cc2b192" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4448662c-4608-4d62-a948-60575e529e51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0bccfc02-62e5-42e0-8a7f-4e7a1cc2b192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#StockincentiveplansStockbasedcompensationexpenseDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b051002b-4c9c-468b-8ca8-0df02af7556f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_7ea4268f-bc6f-47a8-bec6-3ed505d8d13f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b051002b-4c9c-468b-8ca8-0df02af7556f" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_7ea4268f-bc6f-47a8-bec6-3ed505d8d13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_689c5e82-df09-4f39-b731-1750973d2d5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_7ea4268f-bc6f-47a8-bec6-3ed505d8d13f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_689c5e82-df09-4f39-b731-1750973d2d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_314f4316-1731-449f-975a-5df316b1292c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_689c5e82-df09-4f39-b731-1750973d2d5d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_314f4316-1731-449f-975a-5df316b1292c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_CostOfTestRevenueMember_c117acbe-e9d1-49b0-abad-a2843a0b2cea" xlink:href="nvta-20201231.xsd#nvta_CostOfTestRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_314f4316-1731-449f-975a-5df316b1292c" xlink:to="loc_nvta_CostOfTestRevenueMember_c117acbe-e9d1-49b0-abad-a2843a0b2cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ResearchAndDevelopmentMember_6c888c7f-bbbd-4341-9723-9cc88039ae18" xlink:href="nvta-20201231.xsd#nvta_ResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_314f4316-1731-449f-975a-5df316b1292c" xlink:to="loc_nvta_ResearchAndDevelopmentMember_6c888c7f-bbbd-4341-9723-9cc88039ae18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_490b6677-01b1-4a6f-b120-c5c83e2a4375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_314f4316-1731-449f-975a-5df316b1292c" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_490b6677-01b1-4a6f-b120-c5c83e2a4375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1a1a1ea5-e6bf-41cd-9799-f611d0a32b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_314f4316-1731-449f-975a-5df316b1292c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1a1a1ea5-e6bf-41cd-9799-f611d0a32b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a4057a09-67ce-45b3-a43c-92085afb0fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_7ea4268f-bc6f-47a8-bec6-3ed505d8d13f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a4057a09-67ce-45b3-a43c-92085afb0fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_185414e3-a146-4b59-88f5-22b2937be2de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a4057a09-67ce-45b3-a43c-92085afb0fb3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_185414e3-a146-4b59-88f5-22b2937be2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Incometaxes" xlink:type="simple" xlink:href="nvta-20201231.xsd#Incometaxes"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/Incometaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_693ff838-7a45-4898-b7e1-2a74a4b6e9ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_b1baf1dd-39db-4cd1-9193-9f03415d0e56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_693ff838-7a45-4898-b7e1-2a74a4b6e9ea" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_b1baf1dd-39db-4cd1-9193-9f03415d0e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesTables"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/IncometaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_cab24a04-88de-4196-8e8d-c05cd2e86946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_60c61b38-ff46-4557-8b1d-10c9ba6d2394" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cab24a04-88de-4196-8e8d-c05cd2e86946" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_60c61b38-ff46-4557-8b1d-10c9ba6d2394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_648ee361-c4e6-47d3-ad9e-f1b7053a708b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cab24a04-88de-4196-8e8d-c05cd2e86946" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_648ee361-c4e6-47d3-ad9e-f1b7053a708b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_d0989a89-778c-4f65-9c1b-2b2cb6c0cfd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cab24a04-88de-4196-8e8d-c05cd2e86946" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_d0989a89-778c-4f65-9c1b-2b2cb6c0cfd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a5f225ef-fb79-4aa1-8e13-1517c037f015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cab24a04-88de-4196-8e8d-c05cd2e86946" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a5f225ef-fb79-4aa1-8e13-1517c037f015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_de1684f2-c1ad-4801-a13f-b18852605ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cab24a04-88de-4196-8e8d-c05cd2e86946" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_de1684f2-c1ad-4801-a13f-b18852605ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a3abe2a4-822c-477e-86f0-ff4c5e32a02f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_193abe5d-087f-4950-ba6b-b4620491e396" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a3abe2a4-822c-477e-86f0-ff4c5e32a02f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_193abe5d-087f-4950-ba6b-b4620491e396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_212bb5c3-1d5b-421d-a123-7a4538065004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a3abe2a4-822c-477e-86f0-ff4c5e32a02f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_212bb5c3-1d5b-421d-a123-7a4538065004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fb744eec-0bea-4957-84e2-ff1793ea2cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a3abe2a4-822c-477e-86f0-ff4c5e32a02f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fb744eec-0bea-4957-84e2-ff1793ea2cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_99282ed2-23c8-4dde-9f9a-2f21556e6933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1cb8b741-efc8-477a-8dad-df7b9e31b9f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_99282ed2-23c8-4dde-9f9a-2f21556e6933" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1cb8b741-efc8-477a-8dad-df7b9e31b9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_9ec496f5-435a-45d3-99b7-15c480288d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1cb8b741-efc8-477a-8dad-df7b9e31b9f0" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_9ec496f5-435a-45d3-99b7-15c480288d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4d9ff7a4-6208-479b-9140-86bfd810a984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1cb8b741-efc8-477a-8dad-df7b9e31b9f0" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4d9ff7a4-6208-479b-9140-86bfd810a984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_b8dcc031-2e23-4de5-ad5f-e4be71cce54f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_99282ed2-23c8-4dde-9f9a-2f21556e6933" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_b8dcc031-2e23-4de5-ad5f-e4be71cce54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_80a0158d-0617-43d4-ae16-c4810b0ab2d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_b8dcc031-2e23-4de5-ad5f-e4be71cce54f" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_80a0158d-0617-43d4-ae16-c4810b0ab2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d3e908fd-6def-4950-8f71-94a43fc8dabd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_b8dcc031-2e23-4de5-ad5f-e4be71cce54f" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d3e908fd-6def-4950-8f71-94a43fc8dabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_42cc91a9-0755-4d87-9582-45c0112777d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_b8dcc031-2e23-4de5-ad5f-e4be71cce54f" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_42cc91a9-0755-4d87-9582-45c0112777d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a0d95361-c4ba-4419-8580-bcda3d6bc9a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_b8dcc031-2e23-4de5-ad5f-e4be71cce54f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a0d95361-c4ba-4419-8580-bcda3d6bc9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8151ab82-eb4c-401c-b24e-d9b696bc4c25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_99282ed2-23c8-4dde-9f9a-2f21556e6933" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8151ab82-eb4c-401c-b24e-d9b696bc4c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_56dd573c-5251-4dbc-b35e-cd315986e060" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_d436cb60-3dc5-4b49-9493-0b4c3f529036" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_56dd573c-5251-4dbc-b35e-cd315986e060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_d436cb60-3dc5-4b49-9493-0b4c3f529036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_95fda25e-9308-40a6-a76a-14f32e0d2b86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_d436cb60-3dc5-4b49-9493-0b4c3f529036" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_95fda25e-9308-40a6-a76a-14f32e0d2b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_3ec68c1d-2aa8-4767-8b36-99ab8212bd3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_d436cb60-3dc5-4b49-9493-0b4c3f529036" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_3ec68c1d-2aa8-4767-8b36-99ab8212bd3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_1a5da0f4-dc8f-4702-80bf-26a4a6880e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_d436cb60-3dc5-4b49-9493-0b4c3f529036" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_1a5da0f4-dc8f-4702-80bf-26a4a6880e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_f7798a19-86cb-4d6c-a3df-a53ee38560d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_d436cb60-3dc5-4b49-9493-0b4c3f529036" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_f7798a19-86cb-4d6c-a3df-a53ee38560d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_107c90dd-66fc-4b3d-92dc-e175e1a72c76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_d436cb60-3dc5-4b49-9493-0b4c3f529036" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_107c90dd-66fc-4b3d-92dc-e175e1a72c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c1e08aa9-d660-4ffe-879e-eba4a318a995" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_d436cb60-3dc5-4b49-9493-0b4c3f529036" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c1e08aa9-d660-4ffe-879e-eba4a318a995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7d6fd41f-d407-4a75-a841-86eeba15236a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_d436cb60-3dc5-4b49-9493-0b4c3f529036" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7d6fd41f-d407-4a75-a841-86eeba15236a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesScheduleofnetdeferredtaxassetsDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_04094a97-7a25-4fae-800e-98981235493f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_2703df6a-c55a-415b-abae-16fb6fd92b7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_04094a97-7a25-4fae-800e-98981235493f" xlink:to="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_2703df6a-c55a-415b-abae-16fb6fd92b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b775bccc-85e5-4650-9a2f-818a2889b9d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_2703df6a-c55a-415b-abae-16fb6fd92b7b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b775bccc-85e5-4650-9a2f-818a2889b9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_364714f2-336d-4a33-bb7b-93f480748a74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_2703df6a-c55a-415b-abae-16fb6fd92b7b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_364714f2-336d-4a33-bb7b-93f480748a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DeferredTaxAssetsRevenueRecognitionReserves_43f99dd2-c964-4240-b3bf-f12216d0e805" xlink:href="nvta-20201231.xsd#nvta_DeferredTaxAssetsRevenueRecognitionReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_2703df6a-c55a-415b-abae-16fb6fd92b7b" xlink:to="loc_nvta_DeferredTaxAssetsRevenueRecognitionReserves_43f99dd2-c964-4240-b3bf-f12216d0e805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DeferredTaxAssetsLeaseLiability_f4f088a2-c817-4f2d-89a9-3d9f6ed36191" xlink:href="nvta-20201231.xsd#nvta_DeferredTaxAssetsLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_2703df6a-c55a-415b-abae-16fb6fd92b7b" xlink:to="loc_nvta_DeferredTaxAssetsLeaseLiability_f4f088a2-c817-4f2d-89a9-3d9f6ed36191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther_b81ede2d-64f7-41b5-965e-df5b41b5bf6f" xlink:href="nvta-20201231.xsd#nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_2703df6a-c55a-415b-abae-16fb6fd92b7b" xlink:to="loc_nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther_b81ede2d-64f7-41b5-965e-df5b41b5bf6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_165f4abd-fcd9-4b0f-bd34-72245fce14b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_2703df6a-c55a-415b-abae-16fb6fd92b7b" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_165f4abd-fcd9-4b0f-bd34-72245fce14b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_036f85f1-91ad-44fb-a1cd-e2d830c75146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_2703df6a-c55a-415b-abae-16fb6fd92b7b" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_036f85f1-91ad-44fb-a1cd-e2d830c75146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_fc9aceed-d62b-467c-8ea7-d5d87a926bf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_2703df6a-c55a-415b-abae-16fb6fd92b7b" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_fc9aceed-d62b-467c-8ea7-d5d87a926bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_001a9c2f-4d54-46b7-9e4f-b00964ed359f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_04094a97-7a25-4fae-800e-98981235493f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_001a9c2f-4d54-46b7-9e4f-b00964ed359f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_6a9c39f7-7e93-4284-81ee-820bde40a6a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_001a9c2f-4d54-46b7-9e4f-b00964ed359f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_6a9c39f7-7e93-4284-81ee-820bde40a6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesFinancingArrangements_ef384e0c-aeb7-4ccb-8221-caa66f3d3399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesFinancingArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_001a9c2f-4d54-46b7-9e4f-b00964ed359f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesFinancingArrangements_ef384e0c-aeb7-4ccb-8221-caa66f3d3399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset_d7fe864e-5974-4a7a-b3f5-f3d9980aa036" xlink:href="nvta-20201231.xsd#nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_001a9c2f-4d54-46b7-9e4f-b00964ed359f" xlink:to="loc_nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset_d7fe864e-5974-4a7a-b3f5-f3d9980aa036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_38bb2682-e288-4185-be6b-9948b5796342" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_001a9c2f-4d54-46b7-9e4f-b00964ed359f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_38bb2682-e288-4185-be6b-9948b5796342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_bc0c6d5f-5bfd-44f8-bc8d-b9e9fdef7319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_001a9c2f-4d54-46b7-9e4f-b00964ed359f" xlink:to="loc_us-gaap_DeferredTaxLiabilities_bc0c6d5f-5bfd-44f8-bc8d-b9e9fdef7319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesNarrativeDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/IncometaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_375c2853-7f78-4995-94a6-4aed12374543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_adf4eec2-ce50-41fc-8381-77525c31ed79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_375c2853-7f78-4995-94a6-4aed12374543" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_adf4eec2-ce50-41fc-8381-77525c31ed79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_d46a8705-d527-4aad-a39e-68bcf0ec3bef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_adf4eec2-ce50-41fc-8381-77525c31ed79" xlink:to="loc_us-gaap_TaxPeriodAxis_d46a8705-d527-4aad-a39e-68bcf0ec3bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_d8f26b24-a923-430b-8827-898842fb8ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_d46a8705-d527-4aad-a39e-68bcf0ec3bef" xlink:to="loc_us-gaap_TaxPeriodDomain_d8f26b24-a923-430b-8827-898842fb8ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SubjectToExpirationMember_0d651a03-100f-4f48-b428-6329e0559970" xlink:href="nvta-20201231.xsd#nvta_SubjectToExpirationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_d8f26b24-a923-430b-8827-898842fb8ecf" xlink:to="loc_nvta_SubjectToExpirationMember_0d651a03-100f-4f48-b428-6329e0559970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_ExpirationTaxYearUnknownMember_5444c27a-cb87-47f7-9318-ff83b1ef523f" xlink:href="nvta-20201231.xsd#nvta_ExpirationTaxYearUnknownMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_d8f26b24-a923-430b-8827-898842fb8ecf" xlink:to="loc_nvta_ExpirationTaxYearUnknownMember_5444c27a-cb87-47f7-9318-ff83b1ef523f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_494207ac-31eb-40e7-8205-360f460bd4e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_adf4eec2-ce50-41fc-8381-77525c31ed79" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_494207ac-31eb-40e7-8205-360f460bd4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_180be97a-3671-4951-aae1-db26d7cf35d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_494207ac-31eb-40e7-8205-360f460bd4e8" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_180be97a-3671-4951-aae1-db26d7cf35d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_836791ab-00ae-4e23-9952-68fe5b49a33d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_180be97a-3671-4951-aae1-db26d7cf35d2" xlink:to="loc_us-gaap_DomesticCountryMember_836791ab-00ae-4e23-9952-68fe5b49a33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_c5b6439f-0f3b-4e53-9cab-57313ac05834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_180be97a-3671-4951-aae1-db26d7cf35d2" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_c5b6439f-0f3b-4e53-9cab-57313ac05834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_8018da92-9e45-4af3-b770-1e6e5f7e960b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_adf4eec2-ce50-41fc-8381-77525c31ed79" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_8018da92-9e45-4af3-b770-1e6e5f7e960b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_9dde074a-a2bf-4fe0-a0b3-1b9ee5d5aa17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_8018da92-9e45-4af3-b770-1e6e5f7e960b" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_9dde074a-a2bf-4fe0-a0b3-1b9ee5d5aa17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_e699c8ca-e0a7-4c26-adfe-c088ae4b40b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_9dde074a-a2bf-4fe0-a0b3-1b9ee5d5aa17" xlink:to="loc_us-gaap_ResearchMember_e699c8ca-e0a7-4c26-adfe-c088ae4b40b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_adf4eec2-ce50-41fc-8381-77525c31ed79" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense_4b99c336-b741-4266-b05e-2beb1674c8f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense_4b99c336-b741-4266-b05e-2beb1674c8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets_de7bd999-ddca-4ec7-bf8c-21e929d3bb3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:to="loc_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets_de7bd999-ddca-4ec7-bf8c-21e929d3bb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_76253b58-0c56-4508-a19f-9aaa154e7807" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_76253b58-0c56-4508-a19f-9aaa154e7807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_22623fda-6496-4681-8dbb-5550e4bf5ba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:to="loc_us-gaap_OperatingLossCarryforwards_22623fda-6496-4681-8dbb-5550e4bf5ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_7dbacf3b-f715-485d-acb8-00cf4e736439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_7dbacf3b-f715-485d-acb8-00cf4e736439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_b70ed094-f0f3-40d1-a603-a9fc548bb978" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_b70ed094-f0f3-40d1-a603-a9fc548bb978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination_0325e4fe-3526-46ec-9e7a-4b62e2a152d0" xlink:href="nvta-20201231.xsd#nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_988c4a46-14a3-43c6-9c90-5805b2d5d1f0" xlink:to="loc_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination_0325e4fe-3526-46ec-9e7a-4b62e2a152d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d2ab014b-f945-4ddb-858a-fe7c1ed09c45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_87a8061a-debd-4318-a1af-bcd995b5f740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d2ab014b-f945-4ddb-858a-fe7c1ed09c45" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_87a8061a-debd-4318-a1af-bcd995b5f740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_53505fba-5fca-4b14-af0a-ebab2c1edeea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d2ab014b-f945-4ddb-858a-fe7c1ed09c45" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_53505fba-5fca-4b14-af0a-ebab2c1edeea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_83860127-7c1b-4c88-b805-cff1bf5c12ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d2ab014b-f945-4ddb-858a-fe7c1ed09c45" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_83860127-7c1b-4c88-b805-cff1bf5c12ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_fde6913e-eafc-4596-a6e6-7f37264e28e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d2ab014b-f945-4ddb-858a-fe7c1ed09c45" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_fde6913e-eafc-4596-a6e6-7f37264e28e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_c8eab9b8-b3db-4130-bac0-4af0ff2e695e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d2ab014b-f945-4ddb-858a-fe7c1ed09c45" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_c8eab9b8-b3db-4130-bac0-4af0ff2e695e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Netlosspershare" xlink:type="simple" xlink:href="nvta-20201231.xsd#Netlosspershare"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/Netlosspershare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_48079267-39a1-437b-ab52-a55b97c8d82f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_19ecbf95-1ef1-4a83-8497-306f5efdf916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_48079267-39a1-437b-ab52-a55b97c8d82f" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_19ecbf95-1ef1-4a83-8497-306f5efdf916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/NetlosspershareTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#NetlosspershareTables"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/NetlosspershareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_38935a91-d1e3-428a-9f7c-0278909ee5b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_55764695-9002-4f65-a877-09f549937f72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_38935a91-d1e3-428a-9f7c-0278909ee5b0" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_55764695-9002-4f65-a877-09f549937f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_9eba130c-9a70-49ba-b6d7-6a3b1871adf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_38935a91-d1e3-428a-9f7c-0278909ee5b0" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_9eba130c-9a70-49ba-b6d7-6a3b1871adf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/NetlosspershareScheduleofearningspersharebasicanddilutedDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#NetlosspershareScheduleofearningspersharebasicanddilutedDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/NetlosspershareScheduleofearningspersharebasicanddilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_48de5c4c-0f8e-44de-a345-81a47388fae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_73fd612e-1443-479b-a938-065ed671cbd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_48de5c4c-0f8e-44de-a345-81a47388fae2" xlink:to="loc_us-gaap_NetIncomeLoss_73fd612e-1443-479b-a938-065ed671cbd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_307bdd18-d65f-4a95-8f85-33653538ad6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_48de5c4c-0f8e-44de-a345-81a47388fae2" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_307bdd18-d65f-4a95-8f85-33653538ad6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_2bdca209-7c8e-4b97-bc9a-8ef63af10b10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_48de5c4c-0f8e-44de-a345-81a47388fae2" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_2bdca209-7c8e-4b97-bc9a-8ef63af10b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c51447a6-3a25-41e8-9017-154e0c1fb75c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_EarningsPerShareTable_84f6d329-baef-4c32-b204-6a25d1c125ed" xlink:href="nvta-20201231.xsd#nvta_EarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c51447a6-3a25-41e8-9017-154e0c1fb75c" xlink:to="loc_nvta_EarningsPerShareTable_84f6d329-baef-4c32-b204-6a25d1c125ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b8bab5f8-c010-4456-856d-42a956a17721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_EarningsPerShareTable_84f6d329-baef-4c32-b204-6a25d1c125ed" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b8bab5f8-c010-4456-856d-42a956a17721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b8bab5f8-c010-4456-856d-42a956a17721" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e35b0a2f-69e6-48c7-8b00-db0dce5c6839" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e35b0a2f-69e6-48c7-8b00-db0dce5c6839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_de5441c7-c405-4fed-ab72-a0e2499eeb67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:to="loc_us-gaap_WarrantMember_de5441c7-c405-4fed-ab72-a0e2499eeb67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a79bd631-37e0-4cdf-8808-c678d33b5194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a79bd631-37e0-4cdf-8808-c678d33b5194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_PerformanceRestrictedStockUnitsRsusMember_69c57160-68d3-4bfe-9e32-e82446c3d2d0" xlink:href="nvta-20201231.xsd#nvta_PerformanceRestrictedStockUnitsRsusMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:to="loc_nvta_PerformanceRestrictedStockUnitsRsusMember_69c57160-68d3-4bfe-9e32-e82446c3d2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_EmployeeStockPurchasePlan2015Member_a1070910-bc2c-4a73-855c-5744fb619f83" xlink:href="nvta-20201231.xsd#nvta_EmployeeStockPurchasePlan2015Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:to="loc_nvta_EmployeeStockPurchasePlan2015Member_a1070910-bc2c-4a73-855c-5744fb619f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_SeriesAConvertiblePreferredStockMember_d96c5a50-7225-4273-aa57-362a0f0e8093" xlink:href="nvta-20201231.xsd#nvta_SeriesAConvertiblePreferredStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:to="loc_nvta_SeriesAConvertiblePreferredStockMember_d96c5a50-7225-4273-aa57-362a0f0e8093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_500407a6-04bb-4134-a173-bc14ae1040f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_75e1ca96-77ee-4c48-88de-e32bd0145790" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_500407a6-04bb-4134-a173-bc14ae1040f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_EarningsPerShareLineItems_9109e6f4-72d9-4e0f-8f52-fae024971771" xlink:href="nvta-20201231.xsd#nvta_EarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_EarningsPerShareTable_84f6d329-baef-4c32-b204-6a25d1c125ed" xlink:to="loc_nvta_EarningsPerShareLineItems_9109e6f4-72d9-4e0f-8f52-fae024971771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b4ed30fd-3fe6-4dbb-b159-b5f213f133d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nvta_EarningsPerShareLineItems_9109e6f4-72d9-4e0f-8f52-fae024971771" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b4ed30fd-3fe6-4dbb-b159-b5f213f133d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Geographicinformation" xlink:type="simple" xlink:href="nvta-20201231.xsd#Geographicinformation"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/Geographicinformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentsGeographicalAreasAbstract_7b548846-efe7-4dce-a048-56731459da5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_14da59ec-bfac-487d-8349-1db6c1770938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract_7b548846-efe7-4dce-a048-56731459da5d" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_14da59ec-bfac-487d-8349-1db6c1770938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/GeographicinformationTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#GeographicinformationTables"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/GeographicinformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentsGeographicalAreasAbstract_08fa8aee-47af-4d1e-b56e-f80c017cf655" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_ae2b4ab8-3e04-4355-be48-342fae48a91f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract_08fa8aee-47af-4d1e-b56e-f80c017cf655" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_ae2b4ab8-3e04-4355-be48-342fae48a91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/GeographicinformationDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#GeographicinformationDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/GeographicinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentsGeographicalAreasAbstract_3f9bd597-6409-41a4-b98f-a10eb28bb4b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e2009b0a-3c4c-4099-a6cd-ddf9ddf5dad7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract_3f9bd597-6409-41a4-b98f-a10eb28bb4b7" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e2009b0a-3c4c-4099-a6cd-ddf9ddf5dad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2a63edf5-15ca-4f16-961f-37155fe8ca88" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e2009b0a-3c4c-4099-a6cd-ddf9ddf5dad7" xlink:to="loc_srt_StatementGeographicalAxis_2a63edf5-15ca-4f16-961f-37155fe8ca88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8bb42de9-a77c-43a6-b3c9-5ace09072d02" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_2a63edf5-15ca-4f16-961f-37155fe8ca88" xlink:to="loc_srt_SegmentGeographicalDomain_8bb42de9-a77c-43a6-b3c9-5ace09072d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9afd53a2-bf17-4873-ab22-9bde07384475" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8bb42de9-a77c-43a6-b3c9-5ace09072d02" xlink:to="loc_country_US_9afd53a2-bf17-4873-ab22-9bde07384475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_6753f452-619a-4b01-87a3-c07d1e4f6b31" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8bb42de9-a77c-43a6-b3c9-5ace09072d02" xlink:to="loc_country_CA_6753f452-619a-4b01-87a3-c07d1e4f6b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_RestOfWorldMember_6aa4a1ed-6adb-49fd-9f0f-52534561ea2c" xlink:href="nvta-20201231.xsd#nvta_RestOfWorldMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8bb42de9-a77c-43a6-b3c9-5ace09072d02" xlink:to="loc_nvta_RestOfWorldMember_6aa4a1ed-6adb-49fd-9f0f-52534561ea2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_b0104e12-79cb-4c6c-ba22-0520d44fa5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e2009b0a-3c4c-4099-a6cd-ddf9ddf5dad7" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_b0104e12-79cb-4c6c-ba22-0520d44fa5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_99648cd4-d8e1-443a-8800-48df0e276149" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_b0104e12-79cb-4c6c-ba22-0520d44fa5ee" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_99648cd4-d8e1-443a-8800-48df0e276149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Selectedquarterlydataunaudited" xlink:type="simple" xlink:href="nvta-20201231.xsd#Selectedquarterlydataunaudited"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/Selectedquarterlydataunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_a9c9bd19-94f1-4a83-91d7-9317ee18533a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_e610605d-4d43-4ab3-89c5-8299560738dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_a9c9bd19-94f1-4a83-91d7-9317ee18533a" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_e610605d-4d43-4ab3-89c5-8299560738dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/SelectedquarterlydataunauditedTables" xlink:type="simple" xlink:href="nvta-20201231.xsd#SelectedquarterlydataunauditedTables"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/SelectedquarterlydataunauditedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_ea214dfa-6be7-4774-aab2-1ad902cc39dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_a527a988-7cce-458d-a459-b442a8c67f47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_ea214dfa-6be7-4774-aab2-1ad902cc39dc" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_a527a988-7cce-458d-a459-b442a8c67f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/SelectedquarterlydataunauditedDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SelectedquarterlydataunauditedDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/SelectedquarterlydataunauditedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ac853c7-479c-418c-96ce-e64e4c447ef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_083b43bf-4833-4809-ae5d-8cd15bc6851e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ac853c7-479c-418c-96ce-e64e4c447ef9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_083b43bf-4833-4809-ae5d-8cd15bc6851e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_f45ae78e-b1c8-42ca-9de2-4f6d6e9faa2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ac853c7-479c-418c-96ce-e64e4c447ef9" xlink:to="loc_us-gaap_CostOfRevenue_f45ae78e-b1c8-42ca-9de2-4f6d6e9faa2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_02f48feb-26dc-4963-9557-eb6facf31ab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ac853c7-479c-418c-96ce-e64e4c447ef9" xlink:to="loc_us-gaap_OperatingIncomeLoss_02f48feb-26dc-4963-9557-eb6facf31ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2ef3ab3b-1e17-4a30-8f41-031c84e57d1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ac853c7-479c-418c-96ce-e64e4c447ef9" xlink:to="loc_us-gaap_NetIncomeLoss_2ef3ab3b-1e17-4a30-8f41-031c84e57d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_11adb115-8706-422b-8be1-8aad2e2872e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ac853c7-479c-418c-96ce-e64e4c447ef9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_11adb115-8706-422b-8be1-8aad2e2872e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/Subsequentevent" xlink:type="simple" xlink:href="nvta-20201231.xsd#Subsequentevent"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/Subsequentevent" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_9e3e4cd2-e712-44f5-a698-25e6042650c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_85dccd42-6273-421d-b209-21b0ef46ccac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_9e3e4cd2-e712-44f5-a698-25e6042650c0" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_85dccd42-6273-421d-b209-21b0ef46ccac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.invitae.com/role/SubsequenteventsDetails" xlink:type="simple" xlink:href="nvta-20201231.xsd#SubsequenteventsDetails"/>
  <link:presentationLink xlink:role="http://www.invitae.com/role/SubsequenteventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_fdfbc1ac-e341-41df-ae7b-ff4ff350e253" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_9b3fd97e-c3ae-4fa4-852f-87364fe14676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_fdfbc1ac-e341-41df-ae7b-ff4ff350e253" xlink:to="loc_us-gaap_SubsequentEventTable_9b3fd97e-c3ae-4fa4-852f-87364fe14676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e5689415-f097-4ac9-adf6-809b085744f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_9b3fd97e-c3ae-4fa4-852f-87364fe14676" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e5689415-f097-4ac9-adf6-809b085744f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7bb92314-01d9-4cd4-90d1-9ab724371c08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e5689415-f097-4ac9-adf6-809b085744f5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7bb92314-01d9-4cd4-90d1-9ab724371c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_OneCodexMember_25349617-324a-4715-8535-731c11bc364c" xlink:href="nvta-20201231.xsd#nvta_OneCodexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7bb92314-01d9-4cd4-90d1-9ab724371c08" xlink:to="loc_nvta_OneCodexMember_25349617-324a-4715-8535-731c11bc364c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6a0cbf9c-7c5b-4eb4-829f-89471c5175d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_9b3fd97e-c3ae-4fa4-852f-87364fe14676" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6a0cbf9c-7c5b-4eb4-829f-89471c5175d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_67b14adf-f35c-4e35-a8a7-82ef945094df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6a0cbf9c-7c5b-4eb4-829f-89471c5175d5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_67b14adf-f35c-4e35-a8a7-82ef945094df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6e801673-7da1-4c50-a7cb-b313c42e1338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_67b14adf-f35c-4e35-a8a7-82ef945094df" xlink:to="loc_us-gaap_SubsequentEventMember_6e801673-7da1-4c50-a7cb-b313c42e1338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_6d42f486-b45e-4cd0-bd07-5dacdd3b7454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_9b3fd97e-c3ae-4fa4-852f-87364fe14676" xlink:to="loc_us-gaap_SubsequentEventLineItems_6d42f486-b45e-4cd0-bd07-5dacdd3b7454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2d3a2060-92db-42cc-8fb0-e12a7a47958b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_6d42f486-b45e-4cd0-bd07-5dacdd3b7454" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2d3a2060-92db-42cc-8fb0-e12a7a47958b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_42a3a283-9081-4af0-bfc5-ee9c90b1d1e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_6d42f486-b45e-4cd0-bd07-5dacdd3b7454" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_42a3a283-9081-4af0-bfc5-ee9c90b1d1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_599ee7dc-f2df-4e3e-be3c-0497b1edea0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_6d42f486-b45e-4cd0-bd07-5dacdd3b7454" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_599ee7dc-f2df-4e3e-be3c-0497b1edea0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCash_5069fc20-f449-42b0-a7d5-eb19a6bf02a6" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_6d42f486-b45e-4cd0-bd07-5dacdd3b7454" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCash_5069fc20-f449-42b0-a7d5-eb19a6bf02a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_c55f34e2-d087-455c-bf0c-c1ea1fd7a81d" xlink:href="nvta-20201231.xsd#nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_6d42f486-b45e-4cd0-bd07-5dacdd3b7454" xlink:to="loc_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned_c55f34e2-d087-455c-bf0c-c1ea1fd7a81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
MB5!.1PT*&@H    -24A$4@   CP   +0" 8   "4B:IC   @ $E$051X >R]
MCW<41;K___E/PCFYYWL^X2S?BW+]+.?NBI^[A[L;\EUS,0>]NODHL$,T[(<
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M)L *#_<!)L $F  38 ),8,P38(5GS#<Q5Y ), $FP 28 !-@A8?[ !-@ DR
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M=?B0"8Q" JSPC,)&8Y&'0Z!;*AVD@'2;&21CS5B5/Q&Y>:6H;]<G8Y6D!Y%
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M@,5)F0 38 ),@ DP@=%)@!6>T=EN+#438 ),@ DP 28P! *L\ P!%B=E DR
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M-$#58GYP'S[P3;,I/-92P@3DFH.A,0FI:Y-\-3B@QVW2%1YQK*Q&'G+3)+&
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MF  3N*L$6.&YJ[BY,"; !)@ $V "3.!>$&"%YUY0YS*9 !-@ DR "3"!NTJ
M%9[;P)V(!# E9P)RO?[SA1#+*O\DXI$:%(A\BE$?[;??E8B@>O($Y$X.X*M6
MH\PI@0@2]E39_14+H61R )%AW:P7D4 L5(;<G!FHCL3E!;=S^CU#/,Y6UFS3
M#;%XS^14'K55UNWKF=/P+Z@^89.A XV^(JT]!LE^R/4PVG?8?2]-G*'D-\2Z
MI94UG!-4Y@/(S2E#8RS;!Z8'D4"1,284!A%-#J?<3/=DRM]+WJ%PSE2VUS4]
M_R3BT1 J\B?>008N<F39E]68/240QE>!&8[Q2_(;D?'11<:[<<IU7+@;!2:4
MT6P  "  241!5(^.,ECAN8UV2D0:L#'2 T ;C),7T+AA-R*D#-@FHTP%:?=[
M)3,G=7UP\4I\M\Z[R>UV[@[(D^Q$>.6:(4Q$(RF#T0;9M^](EFWE)0;OK/N8
M=1],=OV&TCJ</+3L[MSA &+A]:@(==RY(EQSULH5$^D0%![S.77-^/9/NN9_
M&_(.6R*M3%L>W0C[IV-FL!U#U?62L6:L\N_.\B715BB ;)])??QT&:M<^3K+
MNA-_>_$<>EG#'A>&7M2HNX,5GA%I,N>#(Q^^_#DHH3>=O,5H[.S7WGP*L2K<
M*0<$F59:B>CM>2!V"#6^J>(-:9)O,P['!@#S0=0?V '$VC:C)(^L3%-1LN$0
M.MJDU6ER,4J*Z>UT LRWF>)Y*)&6HDB'M%+D+T8%E25D'( 8=,3;F2XC0:('
M<HVT0DU$0: -<:'H3<=<WY.8E#,!DWQ;T1X_CT:??FX+#@1+D9LS$06^.2B@
MM^7H"33Z"XUS*YLMF>E:1ZNP9DVI"F"MDG6 E!M*3_4D"T8,T6"Q_%M:V.1;
M6=+)[LA[AC7&5L]^Q-NW"FZ3\N?A;=-"974&]2:8Z\;1M]U0:#.V[P5T"@O8
M1!24EQMEE8;0*68!U>8/H"34HED1KJ(]6(I).0^@H*@.D40?HJ&5!O/\-0A3
M/TC&<'C#/$S*F8B?YD_')%-9B2-BOK&>DGD68KE_#B;E3,7\T 79W_HU=B4(
M_*8$N;9Z# #Q=EO[Q.3,I9A,";2BP[5N?0[Y]?Y)_>D0=@F+R0R4^.CMVF@[
MLW_FJ/-341(\@;YH$#-E&B.MM"::#"8@-V\>:MI:9;YN]87&++OT2;/<!U#R
MFU=1HLEE<'1I%]%U:!PPGCFR?*X/[<(J9>G(KT$DGH35/R>B8&4S8DFOO$AL
MYSAPQI:_LJP.)N^ M$0+RUS\!.K%\SX=L[8<M:S$.E/1UYSCE7O;Y>8\@*=]
MQ<+2;;6C?"9%VQG*HE476>^$XYEN.X3Z0FD5\NU$U+02.<<A]8PF'<]PCZ&\
MV_IRW&7,TL=/Y[@-8YS->Q(E<VC\-?IAW.-Y($G2ZZ6>3]77.CS& ?NS<OA4
M>E_7GY%<->;DT)AQ/GTN,=O/.2XH7OQ+!%CA&9%^X'QPY(0F!KG+"/MGH&3G
M/M07/HGJ2 ^2G2',G[P2X3[U#J3?3V](A<8$)=[$"S')'T:?F\+3%T;%9%*F
ME*(R'17-A]%8.DV\827$P&TLD26CVU$3[DY3G')U&4/GT1=>B4EDBD^TH[YP
MFE"BU(2G4(F)3YCK2>[IAJSQ-E3G3T=%..)Q;JI\ZZ,)=XZA,)$UK+00%>%O
MQ3* J"?BB&RH,=B8=58ETZ1>:.1#U]12@YG.C5T3VFERMM4SBFBP#!7$P^N?
MD,V+8TP.KC2)96I?4OZF&G6EMLK3+07$;AI*R'JAZG+Q!.J+*LU^(28R(7<_
M.D.+,<7?C YJ'^V<I?!01;1^)/(DY?"JT::F8B0'=<%.6GC2V#C;1W%R3A:.
MNCGDA^B?I:AO[[%D$'*I95LM/_/\#3F149JHQ<BL6Y_(:XI0'J42GK<2X?:=
M*!'*L+.^R2&F5QSUMK%S[*3G2FN#*?1\JGY$]7 NB8AE!JI/AWBV29F+R_ZP
MZY,ZC[S<^K(^#J@"!Y<W)JT?XF4J&L0L75Z1C60D7E@R]&?!6+6=UG^U_!.B
MG71VU.=C:?6VE@C5,WW"4 RHGR9I[/$:*U6]:1S1GV&7,5>S#%ICEM;GS#ZE
MEN25PB-?4&F;0=YB5*\K=HQ7ZGDPVLAJSU)L"98CK6_VN8P#SF<EC9OB+.LE
MGE_)/&TN68$/=JW(,"XH9OS+"L^(] %MHA'YZ9V4'N@BE&S?;NS#,=]8G9.?
MVGMASTL\J-39S8%4>V#-<U2H+$<I+?E5^"#HQ\Q\4C0.XD!@BWC#=%J*C&49
M=6\'( 8;^::EK J*43*&2"A@6)3$H*[+JO+X7-M'HI^3@Z"0TWJ[IS=$FO3%
MY$Y6IE--J-Y UB,Y^)B6FP@: V39((M5! FJ.TUTI#2:''1Y (.=M,:( 4/)
MTX%DK U;_44H\#<@0I:3M'_&)##)E>. MA0D\W1MWW/6A"TF/6>;.R>&&XA%
M&E"17X2*W[=IEB_YQNQK0#A8;-2?C/CTYB[JI837ZD],I$*8ELYDYU*/T"EI
M*5)OZ4;[&"5H?4\?H,VZN<COG/PUN=0RA-F>2H$5^9$UARQ5,Z1BJNIFO,F+
M>T@H5?:1[1[UU67.)CUE2F7)<C5Y%<<.Y]X]O0THO5GG <0B(50+:^T,5+>&
M43U9W_,FV] <$_1]8:J^QF2LRK;& =7F@\NK*SP)>H9_[T=!OA];(S%I]:,^
M/,/L5R)GP57U ?HM0Z/&V,9H,(5'6&WM]:8RDC']F3:LAN*EQZULESU4]F?X
M1OHS20I/VIBE]P<[8U%OO?V$'+-0XIMF6B/5>&4QTNNEYZWUM9C;.&!_5F))
M]SZGGA%CG*8TTUSFDJ?A7U%DMI_95X20_#^= "L\.HUA'SL?'*/CVY0)H947
MR:4LVMC7JDVT^OVT*?%):>X>D&_V^IN=]E )JXK,T[26=)M*RR1E$9C^)%;M
MEDL:Y@/M(B.92B.UF.^Z_F[))9;-3(5'3@Q"%GHK.V9-%K9S2N&1%AYASB<]
M+8J#8N"EMZ7I^&EA)3[JE J(DK6'K$=4SW8<5@,S74M3>"P98TG%3EIX; K/
M*40VK$%CIS%(FI.GL_VE\I?.T86=:_O2$H2LMYJ8S8&;VIR4T5/H$QO6C>6\
MFL6T[&7TA_7! &::2F<?H@<C:&]6%IZ$934QY=;Z$?$9EL)#UJ\YLO_I[4.%
M:'W/3>'I:(4N?W4HB)(<N21!$\_!*.*:7+;\Q'EZJY46'F$!I3=CI\+39VSP
MEUQ,:ZFP/A@*I7W EQ\$9)V>ZDD<O14>P\(CEQA![7(4IA64ZB&>#:W<CD-2
MT2$%;JKY;,<BK6B/O.5H8Y676U_6QP&ST0>55U=X^B.;\3PM;YIR6NV:JQC%
MCN)@>ROJ"QWCE5@>5DJ[QLBK7YAM31.^O=[16*OCF=84'O'<.<I.>RDA2[#^
M#,ME5MMS?LP<2ZTQR]F'U8NFY$DRBW$E(?O9?Z,^4.SQ/! #O5Z'$ D'4* X
MFI9\ZL>.<<#YK.C*O<F--LK+L88LZGTT#DZ5JP4ZGT,X$/RUM/"XC0MZ7QG?
MQZSPW';[4Z=7Z_9R,! =5G\[HN-2U#=OL>VW,09)V:'%6YY\6U#K[&)?S&8<
M%@.F,S]*VV>N8ZL]/$:>I%3XQ?*9L-B4UAK6'>W-24SR\0N(RH%$3!(V&:D\
M?>\'#<#T]4DA*K:L1TD>362G<$KL.:&TA:@(M2,.M3:MSIU 5.SWH+\E'V?]
MI QDY3'-[;JL_O582WLA\OUXFZP\-*!</&:M^<LW9*-.<H^"8D=YI]5S%DI6
M+);[JVC)I4]:"O3Z4L?PX)AU^R81/WM63H;&6[2UT=E0R&A_38E_L=BG,Z6J
M!G4+:)^3V@_5(_?$J/T ,21-=E/EWBEE@9'Y$PLQX?;A;/2R\08O6*IT]&I-
M2P;2BJ=;%\0Q[;$Z:NSST!F*%U;U5:+L>\ZZ%9?"[Y#?VH.T$HW1;ZQGQ1>"
M92F9 4,YFH:"?'J6U+X-XN^V5TOK8V(/#UDJ,M17[Y-9I7<IU^1$'+]);Q<Q
MCFACP>3U"+?2EY<34>"O1;5O&@I6[D>T77W!Y/*\F++)0<EL:^H/M)=/V\-C
M6I%4/W5PTN15>VQH7]':0  +Q?XIN3]%%F7;M^4/(1I/.,:6WR,P6XYS0JE0
MC*9AJ;],?JTZ#26^69HUA)YYLEK9]^2(<4*\#-F?Z0.?;!9[MN@%HU/NL;/&
M-:-_3S+WP<41"99;SW#S6\9>/;/>5':!W"MFC5FTIVVB+8UZ7M*9Y^93G^T#
MTMI!683U+](RM:?+.)#VK-Q([^O2<BB4^CSJ ^583N,@]:T3QAY$DT^?&O><
MXX)J8/XE JSP<#_0"-!$LA(U:A-OO TU@8/6_@0MY=@[I+J78U6F?3UCK]+W
M3XUL;[7WCU@LR?U"P-BD/'^EME_J?A&-Y1@U!%CA&35-=3<$U=Z<Q9NIU_Z6
MNR'+W2Y#LQ#<[:+'?7E.Z]2X!\( T@CH5I*TBWR""61%@!6>K#!Q(B; !)@
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M<J3%I++'?[/:R)#'\K*M@&G]3+(PGROY'&<<*TP%VZ[P.,>T.Q]W3M6'?YG
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M)A:2"3 !)L $F  3N!T"K/#<#CV^EPDP 2; !)@ $Q@5!%CA&17-Q$(R 2;
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M--2@.A"0_RW"/^<\A76>?Z_#BB7+M>OKL/0'/\"L=>K^P?X.H/J_EF")F3Z
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M+H<), $FP 28 !.X9P18X;EGZ._7@C6G7?>KB"P7$V "3( ),($A$F"%9XC
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MCH$A2\$WC$4"MZ7P)*-!S,R9AHIPMPL;,B7.0&Y.F;D>"[&>JL[U(Q8JPY1
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M$I>A  4H0 $*4*"@!1CP%'3U,?,4H  %*$ !"F0BP( G$R4N0P$*4( "%*!
M00LPX"GHZF/F*4 !"E"  A3(1( !3R9*7(8"%*  !2A @8(68,!3T-7'S%.
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M @QX<JG/M"E  0I0@ (4R(H  YZL,#,1"E"  A2@  5R*<" )Y?Z3)L"%*
M!2A @:P(C#_@&;V&CW9NQB;_2E0^78^=A\[@>KP3.S<UHF'G1Q@8-?(].O 1
M=F[:@)JGGT*E;RF6K7H1K=$;QI>I*SAUI!<)LXAWD;@00;-_#1I">W'HS#DK
M#=]25#ZU"G5O1'%3+#]Z#5T[&[%A4PL^[OD .X,'T).X*[[ R)<'L+F^">U?
MWG)M[QH&.D-HV.C'2K$]7Q56KW\=A][=J3ZKPIK 7G1&CZ)UDQ\KGWX>=?YG
ML-*_V<JS2"%Q'I'F6E1O>@UM!S]7^;F%KT_L1MVR%:@+?8BO95[$LA?0V=J
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MQ./?(J'';R03&!!C;<Q_UW S,93VV>#@#5R-7\/-8=%38]_.7223(T@,7,-
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M+T/K!6.VGK29G6_%TF;#EK-7RW**V9*7HEG^A%[\2.P[?-W=C2^^&X9W'8J
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M#'@>F) ;*!0!!CR%4E/,)P4H0(')%V# ,_FFW&*>"C#@R=.*8;8H0 $*9$&
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M1 $*4( "%*! K@08\.1*GNE2@ (4H  %*) U 08\6:-F0A2@  4H0 $*Y$J
M 4^NY)DN!2A  0I0@ )9$V# DS5J)D0!"E"  A2@0*X$&/#D2I[I4@*DW>T
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M5( !3Z927(X"%*  !2A @8(58,!3L%7'C%.  A2@  4HD*D  YY,I;@<!2A
M 0I0@ (%*\" IV"KCAFG  4H0 $*4"!3 08\F4IQ.0I0@ (4H  %"E:  4_!
M5ATS3@$*4( "%*! I@(,>#*5XG(4H  %*$ !"A2L  .>@JTZ9IP"%*  !2A
M@4P%&/!D*L7E*$ !"E"  A0H6 $&/ 5;=<PX!2A  0I0@ *9"C#@R52*RU&
M A2@  4H4+ "#'@*MNJ8<0I0@ (4H  %,A5@P).I%)>C  4H0 $*4*!@!1CP
M%&S5,>,4H  %*$ !"F0JP( G4RDN1P$*4( "%*! P0HPX"G8JF/&*4 !"E"
M A3(5( !3Z927(X"%*  !2A @8(58,!3L%7'C%.  A2@  4HD*D  YY,I;@<
M!2A  0I0@ (%*\" IV"KCAFG  4H0 $*4"!3 08\F4IQ.0I0@ (4H  %"E:
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M"E# *<" Q^G!=Q2@  4H0 $*%*$  YXBK%06B0(4H  %*$ !IP #'J<'WU&
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M3!DM-TP!"E"  A2@0+X(,.#)EYI@/BA  0I0@ (4F#(!!CQ31LL-4X "%*
M!2B0+P(,>/*E)I@/"E"  A2@  6F3( !SY31<L,4H  %*$ !"N2+  .>?*D)
MYH,"%*  !2A @2D38, S9;3<, 4H0 $*4( "^2+ @"=?:H+YH  %*$ !"E!@
MR@08\$P9+3=, 0I0@ (4H$"^"##@R9>:8#XH0 $*4( "%)@R 08\4T;+#5.
M A2@  4HD"\"#'CRI2:8#PI0@ (4H  %IDQ@_ %//(S*:=,Q@_]HP#; -L V
MP#; -L VD-4VL!#!:&)"0='X YX))<.5*$ !"E"  A2@0.X$&/#DSIXI4X "
M%*  !2B0)0$&/%F"9C(4H  %*$ !"N1.@ %/[NR9,@4H0 $*4( "61)@P),E
M:"9# 0I0@ (4H$#N!!CPY,Z>*5.  A2@  4HD"4!!CQ9@F8R%*  !2A  0KD
M3H !3^[LF3(%:QX[Q0  ( !)1$%4*$ !"E"  ED28,"3)6@F0P$*4( "%*!
M[@08\.3.GBE3@ (4H  %*) E 08\68)F,A2@  4H0 $*Y$Z  4_N[)DR!2A
M 0I0@ )9$F# DR5H)D,!"E"  A2@0.X$&/#DSIXI4X "%*  !2B0)0$&/%F"
M9C(4H  %*$ !"N1.@ %/[NR9,@4H0 $*4( "61)@P),E:"9# 0I0@ (4H$#N
M!!CPY,Z>*5.  A2@  4HD"4!!CQ9@F8R%*  !2A  0KD3H !3^[LF3(%*$ !
M"E"  ED28,"3)6@F0P$*4( "%*! [@08\.3.GBE3@ (4H  %*) E 08\68)F
M,A2@  4H0 $*Y$Z  4_N[)DR!2A  0I0@ )9$F# DR5H)D,!"E"  A2@0.X$
M&/#DSIXI4X "%*  !2B0)0$&/%F"9C(4H  %*$ !"N1.@ %/[NR9,@4H0 $*
M4( "61)@P),E:"9# 0I0@ (4H$#N!!CPY,Z>*5.  A2@  4HD"4!!CQ9@F8R
M%*  !2A  0KD3H !3^[LF3(%*$ !"E"  ED28,"3)6@F0P$*4( "%*! [@08
M\.3.GBE3@ (4H  %*) E 08\68)F,A2@  4H0 $*Y$Z  4_N[)DR!2A  0I0
M@ )9$F# DR5H)D,!"E"  A2@0.X$&/#DSIXI4X "%*  !2B0)0$&/%F"9C(4
MH  %*$ !"N1.@ %/[NR9,@4H0 $*4( "61(8?\ 3#Z-RVG3,X#\:L VP#; -
ML VP#; -9+4-+$0PFIA0B#3^@&="R7 E"E"  A2@  4HD#L!!CRYLV?*%*
M!2A  0ID28 !3Y:@F0P%*$ !"E"  KD38,"3.WNF3 $*4( "%*! E@08\&0)
MFLE0@ (4H  %*) [ 08\N;-GRA2@  4H0 $*9$F  4^6H)D,!2A  0I0@ *Y
M$V# DSM[IDP!"E"  A2@0)8$&/!D"9K)4( "%*  !2B0.P$&/+FS9\H4H  %
M*$ !"F1)@ %/EJ"9# 4H0 $*4( "N1-@P),[>Z9, 0I0@ (4H$"6!!CP9 F:
MR5"  A2@  4HD#L!!CRYLV?*%*  !2A  0ID28 !3Y:@F0P%*$ !"E"  KD3
M8,"3.WNF3 $*4( "%*! E@08\&0)FLE0@ (4H  %*) [ 08\N;-GRA2@  4H
M0 $*9$F  4^6H)D,!2A  0I0@ *Y$V# DSM[IDP!"E"  A2@0)8$&/!D"9K)
M4( "%*  !2B0.P$&/+FS9\H4H  %*$ !"F1)@ %/EJ"9# 4H0 $*4( "N1-@
MP),[>Z9, 0I0@ (4H$"6!!CP9 F:R5"  A2@  4HD#L!!CRYLV?*%*  !2A
M 0ID28 !3Y:@F0P%*$ !"E"  KD38,"3.WNF3 $*4( "%*! E@08\&0)FLE0
M@ (4H  %*) [ 08\N;-GRA2@  4H0 $*9$F  4^6H)D,!2A  0I0@ *Y$V#
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M+15UB R9D92UC7&\8L S#BPN2@$*4( "%*# O06,'IPE:(DE;+>T$H@&*E3
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M_I6#L!R52Q.:L VP#; -L T45QN8&XAB@F.')Q903<):XP]X)B%1;H("%*
M!2A  0ID4X !3S:UF18%*$ !"E"  CD18,"3$W8F2@$*4( "%*! -@48\&13
MFVE1@ (4H  %*) 3 08\.6%GHA2@  4H0 $*9%-@$@.>E/';>OD+)3%SXK"S
M'/K77>-\B%@JWHT]_G+UL[5YJ QL1UWHTSP9'9ZR_7RN'#6!S6B9P/P R6@
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M8D*IF55H.?*JX2M[57J,<MBN<%.Q$!Z5;6H.*K=N1*4VF#9/!9E#B#DL=!T
MQM7B=,R8O0B5BXR)K>8&(C@E>B@6+46E: NS _BDQY9&^(1\GHOQ +OI$&6^
MU"UZWT1]=*%/MG&7B1F(W*N]BME"[>W\$OKUMN3#\M+GYQ#U/RQ[_NS?J5Y
M^21B6_NY? &16MT+*F8AC=OV.Z\'\9D-&,84\!X/\;/7>\JXT) 3@2U8B+*9
MKH#'S(^]WFWKZ,G#3"L5\#B.!:)-ZMXL5QL<\X&"8M]8@"=]3\A]J<2W"T?E
M0PB%V0JT]W7)?=[:EW0/E9[95>]7\]4Q:NR'%XZ8=6'?[DGT=;_BG"#-;C7-
M>/!ATO&@1/%,H8NN?*N)U&3 LPGM;?I8:D_+=I%G>NOC1Z;'KF&S1[JD="E>
MZ_[$VI\]]PG=]D2[T\>F%=A_K-G:+T.'50^DJ+,CCBG_G6VK"='8/L_CJ77<
MG8^R4M>%GPQ [&V[S^-X=Q(1V?-H/P:>1<+N-',IFKKCT/4X-]"&M^4QLAS/
M^9>@1!Y3>M%KGJ]<;=S:9?BJ@ 4F$/#8>C548RSQ1S DKXX]IGPVK\S58^)+
M;0\1VW<8+>6NAX29#P=3!T7;"=!R]L[##7%0,K<_7YZPC)-TN>SVEB?!,;__
MVNJM,<O5@5YQ8C+7<3WX3&0H%4<T'$#E3'&[K</HB3++'/?8YA'T16HQ5\X6
MJ1^F)DZT\U$9ZL#1;:_@O7[KQ"W+++=GW,Z008#,SS#ZP]68*^S-[V^K ]HB
MM!QK1>6TL=<9C(7PF*PWD8((TI:@+-"-1.H2VJO*41.)&B=_\=E0!#7R)*?J
MT!=&OPA&'/DPRE5B^\PSX!&!4VI0/E.EQ'\8/>%JLP<C%6M#4V3 JF9[CXLL
MHVA?-XQ>#\\\B':H_I/EF"\?1I>4@9.V4&F([<FV)4Z:^B K7L\S'%QE-DZ:
M7M_K7KQ[M%>OA^$-B9.>>EB>?L">#!"-[1CIJ6W*SW4^+\KR.]N/?AB?.*&7
M&P_@DUXKT'[Y[#WV,8T%$2$Z'N(GVX(VZ.U S4QAKQ[FYPAX5*#GKG>Q[FS[
MDY'%-/.Z;E6YY#IZ'XB-V0;'?*"@-%Q@!+]Z*OLCGZ"]RJCWE&C7NW>Y+IB$
MHSI.F?N-N/UNU.W8:8D+BPH8Q[H$HMN:$.D[DE[&_6^B9G856GH'S78:U\P.
M8U>^A8UNDR-B'QRK#(:WL_ZC'L<9KV.7,%Z17@_ZPD2GG]1M3;0KVVO=IN(7
MU#[C56>ZCG6A[6U+/5?)4>\B[PMLQYX%8]S:=[=ML3]['>_T9X]C<Z :<^7Q
M1O1(;4"9O'@>D1?G<O^2Y7$>4^)F&?5^;2L'7Q:\P 0"'ML!0[;E .::!V1U
M(+&SB 9D:V@SY+*JZ[*MS>AU43U#SC$:8UPQBP#C^/MHT0<M6Q[Z1,!C;G^A
MZB6Q\FMUMQM7>M9)3.1;/+S,RK^Q;!NB(N QMZD??&8OH'HM@Z0*ZV0CRRQ.
M:NYMAM >T'G3VQ%Y-'HAG+U%ZGO;3FCV7&@SD3?;]\:):R&"X1 JU9@7SW6$
MXVX_RDK]V!.-X1-YA62_HE-!F+B=9-[&, (><="7P:7.@_CK:T4DM,CLF;*L
M=1GM)W+5 R/R+@.3A5@>[L;1P"Y$'5.&"Y>%Q@':5D:];5G?CCR$;;?:](EX
M$]X)^?%HJ0@NCEMIB.V9 8]*PWYP=Y79:BOV!]S9KP+OT5Z/A% C>I3,O(KU
M]$E#G%0,&^-D:G=2@8%L?\)"I&WTA!GYT;8B[E9/*9:]45$D1?E$&[S1?8]]
M3*Q_OX?XJ2MZ?>%ANN@3@M&CJ?.CZT:V2;T.U/YN/B797B[]G>KA,XU$KX*[
M#7H9ZOU+;Z=//6&Y&NT]'0ANZX9SA(]U/'#>)M6^NKV[TTI"7FR(WF*]7;,-
M"4<C_9_[%F&N66Y=/U[&Z?DV YZDN"LNGA)M2TMO2J;C=?S0V]/[EO>QRQAC
M5H$R?RNBJF?>:'>P BX9\'CL$^8^*-JN^/YKU=NBK=SC$-WE'DQ_KI*\Z#4N
M2+6AXVG:\IK2HVWK\7RR/3J/=\;Q:CXJ?8^9QR/W,4RV5[,\2:-'6!]+Y;';
M[(XTY?FB\ 4F$/"(J_,G5/?EB-7+($\6UDYGTN@#[Y 163N"!]G870\)B]MZ
M-]QC(F07914>#1Q&Q",/\B0L3P[BX*,/"M8!SCP8.PX:^GO15>HNE[I*,K?I
M"GB2430]+6[IB3SK7@O5XR)W&G%5.,8VY:TLT17]*8['OE GL_/2LT1]YS!4
M.[C1PR-N@XDTAQ [_BGB\GDEMBN>V;6(](KN8^.$[+6.Z(I_5HP]D@?M.K0T
M+[&ZI!,Q'(]V8;_N^3!/<E; (WJ('C7S*?(11>^16A@]/,GTJUO'25VU(=%[
M!#78?4$YEN_NA?,P(^IF[(#'Z&5R6=@W('M69J'$KWJ?%CR!=0?$>*L,#NZN
M,M\_X!'G//' /-N8,]U>&YL1+'>W<WT;<[P!SP7CI&%O/]'W$2P5V^^5@:MY
M,!=M<+ '+6EIZWU,V8MM>3W$3QO8>GB@>WW,P>,ZL!0]M[9ZEQ:JS&:OH;[Z
M]PIX5&^!OBWB;H->#Q24MX)5^Y#I&;W%QK[X!'Y86HT][A]/V(]3MA.>HR?#
M,RUA)GJ6%^"'Y75&+ZQ7&4/;4:EN9:7DQ5DOXIX/2O3(M]P7]4!Z8Q])+X.R
ML]=_[-+8QQG'L:L'T6T;T-YO#$'0MVGO'_"(BX4>#(ERR&.*#GCZC%XY1YW%
MU3[LU;8\ IZPK8='^KIZT4UC5]N6O=>J-\<\WMF/@<_CW2,!XP&5\1$50(KA
M$>X>'N,8:9X;S/.5_4!B'HGYHL %)A#PB .[&O\A'^3E'L/C^M6$.NE85[?Z
M:D#\%>,X=KGN@3M%TW_UHFX;N?.@Q_!,FP-YE26O%$647V&[LA9ICO&]N"H;
M=)=+C"NXA)@*PN1.H:\L9#;[\%Z@":^I7]&8O3.ZS.*$TW_&&"MC6KG&*OC#
MZ(ELEN-$9DRK0*5/C2<PKQ+%2=_H_3&"Q2'TAJJ,\3_JOK0,6J:)^]]B.3%N
MX"3VWV>=D6@(*\68(#GFYRP2;L_X,!+GSZM[\D8 *=*7088HBW\_3KGS86YC
MGAI78;_BL_^B33PT3@]$%Y=PE]#^]";7K0<!;!\/96\W1CU6AK](MW T'[&^
M7]Z*@:B3JNU&#Y(\D1O;FQOH1(^\;S\'9:6/N-J*/4W1KH<\3<Q;%O)JU/VK
M0M%>D^;8">-A>,?5&"FQ?5M0:O9NB,_U5:L]#VKYV%EKW(1PC'<A6#H+,TK]
M>"VP%#)@OGS&&)\Q\WF\VQ4:8Q_3OZS4#_&;C[+:]Q&+N>O]53DV1HPY,\=@
MR1.IPO:L]XNN,I^TQG?(0,.K7)_:]I4F[-^Z1-6',/)XH&#*MB],*T=-N-?L
MS1$])"MK;;<X9595.Q;.MK%=,WRJ-T3ZCY66459Q\6#="K:W:?60PY1]7%DM
MVF.#ZM>K=N,V''U5[<,ZWXXV:8S7\2Z#./[:QCKI_<BL SVNTNO8]1@JGZ]&
MI6@K8@Q=[Y#1:R7J=94?SZE>2&N?F(^:2+]Q$2:.$_YJ.7;0\7W[45N=Z8L_
M8>75MHX@/N0^GMK. 3.?0.62>>8^8529N(APM6TYMM)^O.LW+MP<Q\!^I&!K
M'ZXQ/'+_BO;C?.R:$:!)_SFHE!?APL=[[*C1"OC_0A686,!3J*4MUGP[KE0+
ML)")*%I"4?-D58 E8);S2D"<;'^/ENA@7N5J?)DIAC*,K\09+^UUO//Z+.,-
M<L&'18 !3\'7M/VJ57>'%TJA5.^5>6NL4/+-?.:M@#SQI?]B*&_SZY6Q8BB#
M5[DFY3.OXYW79Y.2&#=29 (,>(JL0ED<"E"  A2@  72!1CPI)OP$PI0@ (4
MH  %BDR  4^152B+0P$*4( "%*! N@ #GG03?D(!"E"  A2@0)$),. IL@IE
M<2A  0I0@ (42!=@P)-NPD\H0 $*4( "%"@R 08\15:A+ X%*$ !"E"  ND"
M#'C23?@)!2A  0I0@ )%)L" I\@JE,6A  4H0 $*4"!=@ %/N@D_H0 %*$ !
M"E"@R 08\!19A;(X%*  !2A  0JD"S#@23?A)Q2@  4H0 $*%)D  YXBJU 6
MAP(4H  %*$"!= $&/.DF_(0"%*  !2A @2(38,!39!7*XE"  A2@  4HD"[
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M!/8# 35X]@-%+4,14 04 45 $5 $7FL$U.!YK9M'B5,$% %%0!%0!!2!_4!
M#9[]0%'+4 04 45 $5 $%('7&@$U>%[KYE'B% %%0!%0!!0!16 _$%"#9S]0
MU#(4 45 $5 $% %%X+5&0 V>U[IYE#A%0!%0!!0!14 1V \$U.#9#Q2U#$5
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M%:PX7J?1:#]&@SU,$OJ?O%0!;[T.'ET_A^&!H_C9^ D,I\+^FY21V2;6.XJ
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MO6=H3)W!I>8:>AE>?D!W91&EPCQ:HN"VXOC=NEO#^9$I+*S0\+^!=GT6D]Y
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MS'(.EYJK/!C(@,:=(G@G>R^A>Y,-D5@GWT+G\[MHW+^"DSS@DVS;CQ8  "
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MDVQ W\!E-C9%1D,9VJY-#.3I=I*RS!*^;10SZ<S3P?)0GHYE#&2PIB6M+[#
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M;ZOF#A+."&RDXR%BXHE+>)>=Z9LR3(.&8=+-;V96G:2 2#',G=X"QLL(3TV
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MD3W8LHI&^8I-(/U:47S@Q*C!<^"0:X6*@"*@""@"BH B<- (J,%ST(AK?8J
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MK5[&^_PY;=,41-J=EJI][+E<\8Q^FR_+?OUR'<W-=A2<"-(^8_JYGS]L%SG
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"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image2.jpg
<TEXT>
begin 644 image2.jpg
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M<\:%*3["(KQ@HW/F9W,TWIS.X3(L^,L^>F)LGYUS#>]I.G[R#;?^=<.=6I[
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M' 6 @"ON&FS$  B'(Y82'-&1BI"[#DB"@72 D&1V6Q >&/?==W\+#(&2J,9
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M!#.+8 X2.(3P<EWB:9X #'3/$3>D(^:(2I@$!F#Y5<B]_OQ%HVA<S]E]4(P
MMK:7XN2Z=X5$8#4[%K9\T:Q*,HNT++)[0B"PPH0P[";$B&V7?O1^-A)*UY&#
M$+)9,BM(@DVL?&:/75T)P288*8@$"4F0C(C#U[T(I0 HWOZ,#$X3\Y<TT=&
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MQP6%$T8*I +F'C;RCT#BKOC* SPSMMUR0@IS[_A+1W"!B/K+!/,E)\0_AQR
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MP ,^X"0NBPN;S.O',8LMF@#GU$IU$S_U"%D(^>%,K77@ +L\CS,6TW++F+1
M+L(%3^B*G+3@DH=P$4NQ%GNY;"YKD&RJFL-U.L87/. #7/ #CCCI$'M\@Y7\
M<E[.F5,/9)V@/TROQV[K$K$S[KB7')*'<))3[AGW3O/DED6BNBYOC>^EG[#&
M27^&%^[3,QA;/N$)[.F#'_C@2O_T&G(I8^EOW.N%TV+B1Q#<YH<?@W">;L&(
M]N)7#GRS06 \.*H'= 0G^$K+Q$W.63.YCTZ(I[61.9R'@;X)UC!9UV-:%\!$
M+J*@421,'+9@B,AICC5: L(A!<JN$+$'L@1#,(MC[VF@@$LXW"NYC4%<D-W.
M%]$5# 31-!(,<Q&(-)9 EG!$D9UL0!9%D# A@F)JH7/2Q*(6X)# @HT \R.+
M8B00,(N<$&>J=\EI_/SB-=5]%D.(H<#U]W@>"1PP45 E'F&6M,2=R+I'4MA8
M(#"2G]A%\(A'7P L?-QK/(55K @A@84?C"01N]+L!#,[16R$O5TZSXN/)$YS
MI/&1-!9LB.U^R2;YQ O!W6]\!<;"50R\B*EB)X86[J[U288?\4M3ADMX9S&A
M&*6H*P1V. FZQ2[,[-R&6\;Q77.%KY)/ 6,W08Y/! "WS($7<+$()';\TNCD
M(,3BHN KD#F<PQ_^XJXD]^X^Q9"(^DY4\ JFXDAL")XB2;PBQGP@V(J4<XJ1
M9^'&'XMX@F<7'PYR2%/%9V-E'/9IBN"V?-5DRS'Q\=VB1^S@FD(C']@F-@J<
M.,+ #J0%/XZX7ZZRV\*% &HL%$W<<K]\\%FA,@:[X0,7BUH:H<$3.P7-N'P@
MZF*: P[\<BAN.&V!:'Z[T^:2]VQP'U[[[L"A<,%WO_2P75'& ;$TCL950R(/
MV,=.-K(;+OB@^)F+S<'6?/)!+L(A^6=</'"_\>F+V,L'F-I0A*_X:QHL-#0D
MN !'G,7[-%!\@#U<S$U#Z9A-!)C!TLMX\AP&,/*<F..0V/ =3C26IGL&AJ,'
MS1$7-LH]G.H//'5-3#4*\H[NBB.>TSE^X(=W6.*;A5,6X?UX]?F1@8 X9R,#
MQ_Q'X<075_ ?MW&8/N&5^^6:6DI;P^=X*Y_I)B[1M^1/KD?W;#"KR?_+WMWK
MV'5681R_@-P"MY K0**DH*!&"A)TT!$AT2%'B$@H$H6=.T"13.DP0V,QIK"B
M*$TT(UG82'%*IJ"B ]$$_7;F[RPV8\<#SI!COULZ[#/G[/U^K(_G>=;:QP'>
MB3E<AY?$*9$O/N4<L2;^Y0[NEV_6(<[EC,_-(7[Q5H<Q"#EYA\OEK&* Z"02
M[4&.$G(P 49NG/_&Y\TB>:[ DVL.N69NV,\V%=\X+KU$('H2 FOE"WQ0&)B'
MD,1)L$@Q#&/L'5<J &N\FLM^PD?YSS9XWGN\&E=:CW6PMWM@ GXIMYWM/]T&
M]V"+?1K#O/P(_V@6]N$WA1#[]@LQUQC']VQE[7  Y^!>_J-)\"W-QM8UH'VG
M(6<^=H&)FMW6PG<*&^-;M^^*)VM7""M6O&</ZS6>^\2D-;(-K*9%Q0,[N(>_
ML@.!SW;F@)7F]C>_\)W8QE4X7?/3OM@6W_&U6(#]XMDAAN-)9]SLT'2!E:Y7
MW"HFC%MA1^?B'3$$KW&(7,-_8H6?Z %%>P>\][G#ONS3_ME![)A+/EBO'. C
M.I$=%)*3*^66\?$QVWDO%FAR^Q1']L^'?IW U_PCKEUC+OI";MDW/\.(WLM5
M/C9_.LOX,$2LLZLGP^**7?A;HXE-Y",[\8^<PRVS60IWZ&7[$0NNM^>P@*WY
MM%^9B$M^BF.S@R*:-K"7^9H/T.;G\_UKK_]XLPG<FI\_[;V?@=.3]+'ZA\V]
MZ%$VE1<>UMDW++5VM8V8M#<Q%-:(70V%YJ)G%,3LZBRV8)FXHH/@*[STO?%]
M)N[8E69BCVS"1O(.#AB?+<6(?!(#8M0XZ24Q;KWB%JZYEC;A-YAY$ 6P+H=-
M"5["2S&J0.  !I,(C($L9L+UTPZDU"&H&)9A!+0 83Q& ?;FD>" M2Z&#@?
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MLR-A99WF -B UMY\IY %M C-O8T%.,50_D( @#TB1I[N!R3\!D#Y72R[U^?
M!^!YNFZ]NI/6IG$$Q'LR0>@!10T;_N5SX&+="BWCL1_R8GOKY%/7VI.]=BB(
MV5C,R5D^0KJZR@C4]?S"AD#1"V 1$>S%%AH2_3L4=G/-/A;\;3]B%) C "0#
M/WPGO@@>Z^139W:0BWSK;X0->"O&Q+"8= T,$"_L[3T0-J[]6;NGB[[W\JL#
M^^03!U(WKO'-8V_(ROQ(43SSC2<OP-FX&@'LC4@5LN*L0S/)_EPG=]E&KB5.
M89%[V%$LB#'YH$EH;>8V'Y_*!XTX<2<68)C<8_,.-N!S<Q _<D0.B1D^%V/&
M@Z/\(\<)(3Y'3.Z'KY<=; U/[-O+.LQAW^Z'+7 9/HDCMES'LL!5+:!1*E[%
M)A$M?BM*"2-Q*H_AWF6%L?GD%?QTK1=.D2OP R8HGISAC&803L03<D&>>,$S
M]W40R[#!6L2_V,?WL*"B6/$!)W"^?*<=8(C/"?(*")RM>('[KH,/_H:[';A&
M+MNGM= ;>!8^PF%YK.BE ^ T;+(V6D$.3ZZ$W_*SO<$K.@V&P&%\A!O8 -8H
M_-@8KQR=G#YIX/*- D"3RUCXP_SPT3UL:MV>-"GR[ ^6L2/^H"UP+=ZV9W9B
M+^^]<*$]>^^A!!U(?]!IUH4+V0!O^'FLS\-'\^ J<UD;CB?&Q4('_VOJ6@N<
MUKC#B_ XV^ 2MF(/W_D<#N.B#G'G.MQA++&JP+%F'.TS#TRLC8Y5^-F7/1C+
M/L-M\\#BJ0?%O9CIX%M[H]&\[U>'8@%GF(]/V9Z-S>MO',9?\Q<UBA![P3DX
M\*U;[V_?\X.X87N<*1;%.Y]:GR:T_#.6@V_@/)W!1FS )V*)_:S5.MA%+!E7
M,<0'_"]FV<I]OO-R3^\58=;G;WJ>YJ&C%$IB$H>)'WK:_GUNOAX>T>1RSV=X
MB;_F@P/QD<_9  ;02JZ#&;A;@T-.T"O&L@\QR'[S9[[V;2RYAQ?9LKCQ< /.
ML NM8%_\9/WM]6EG^>.!F%P20_24,?B8W^W9//+8?F"%^()+?A71 PP8"J]@
MC.OI1/842_:D064-"O8>NGC/1_8BKNT1#OG>?7)'/&O&S?7;6S@G3M08'N0I
M=NE$X]F+6@)>B6O80?>*!QJ#?Q71M!/<XQOKONIQK06P BD"($0%":!G*$'.
M.8!8<DL$A3##(1!B22&"9!+WA. T;.\Y7I#G/(9!"(*8P$0Z@L!Z%)(,SI'N
M9U1=&T%>8<7P$DB2(S*=//<;MY? E@@*+-<#-P$,U.;+OCF1H[U<)X"-,SL\
MUJHC)3'[W+V23K)8M\Z'^Q2CSNV?W8"*A@)P8EOV$$3 3J*Q.: A)(A3U[&+
M<0""=1&T;"Y ^8IP]1V1;*^(64=(<T)RL1%@$.#60J #2G-:.Q)DM[I(DLJU
MUB.!%6$ 2"*YW[Z!K'$%/$#6$+%OQ&+?OD/0_K9.! QXC>%^Z[4^2<S/?NJ3
MH+$.X"P& UK RV[B 4BSF=@3<W7[B IC6K,S( $ _&6>"J,*-D33 8@D=D#.
MAM8%)*:XL2?Q"=".+PC;7O@ < ,,P(D V!!@\1&_6BO?N=9^ &(=O&VO'_UY
MVS.BX\OLP<; 60QXL:W[Q#$_LH/\8Q-Y8&ZD9W\U9<2G;K=[K5<N\R400^CR
MBGT2AO+2]V(6F(EKXE/W6X'*![X'U'+!N)Y" $:=7N!'A!B'O^W9?CP=4/P#
M6KEI+>)'[K()6VE^R'&-#G/8(P)@%X5>L1"P^YM=C2NFS<-/\AVNN==ZQ#GL
MX6/K91_Y: YV[2!LQ(A]^4XLV#OQ@[@ZY*CO-(F(=C%G7$3 KAIO;&$^>V0/
M0@0I]_,^<<X^[.NL(216C0%_K!]I6BL[/.W0).!_><XW\)I@E?]\THMMQ&)-
MI*>-MSY?%GB1%L !L$E>XS7Q"%=\IHB1HV)7?LKA9QW$/C$G9_ 6?!;[$Q_Q
M)!['6_!1?L!8N(##X2.>A>/X#M[Z3O[B7.N3^YX EW?P&\?+2WDM]]UO?LW4
M&J6X3J'G?EBLZ(9S\MZ]GC#YIV-T51AF;G][6H8G81GLQ"$P :?!!863A@!>
MI6EP],/'%S^'O?A_=' -#K)&6$!GP$<XK['&QKC+V I18VMHXR]<PSYLB1-A
M&#U'I\ 3N,*NFM3&L4<O>\25-"'<M$;VP*D*7_C(9^R+TS7AC8'/B7QKP!]L
M8&WA(\RW;T_$B'CK@O<X0LS@+;CI<S]!A[4PE=U]9CZ-;/NT?H?"6E%D'O;Q
M'7LJ>.U!X0Y_NU_<>#C U_;5 9OQ!VYE ]?8.^Y0@'6DF^@7#6-KHM/83-S0
M33XWGKW@:3RG2*7SQ"]N$4.TH''X&)_@(/83HPH?#6%C*3S$-PWC>FMD1_8I
M%FJNX^:XDCT4>IJV_"%'Z0*\C/_LT>>*:;J+!I$_\CK=3YNPB^OY@=WY$X^Q
MD['LQ[CBBH;@7['&#W+$NNDY^DD.6[,Y:5=:@0WYQ^ONQ2\F[=G>Y;[X$$NX
M3L/$=6RGZ*9QBEN8(V;94#[WN3/M(W[I4?LQ#INS%3\5=ZVCLVNLV[G/NK8S
MC*$%-*+L1QZPHZ:Z>*19Q2"?RU-VA)MR![Z('VM4:(LO]A!'\IB?Q3 ?LJ/Q
M^57,T)'V.A]VM6=ZE)UI,W,XV)0=Q+Y[--9H1WEI/7#+.JW'"Z[ZGDT5S@=1
M #,40 "X-L1) (OH$EPVQA&<0 @RA,! *A).(G$XX-%A,UY&W9^!JP27!.8!
M H)+,G"4 /69KJ![?>9O3I%$UL/@DD_P6I<Q%<' F9,K& LV9\F )#EM'Y3^
M=@WP0A8"R&?&D> ZI4!4D6??NB"25)!9H\17^" C/S5 GB6=?68#WR-M26P.
M-B:VV9X=)8&  7YL"^ %*]&-H 4YNPA"(.0>)*.H &P(R_X!  *T5W,+7GZ5
M2&S)C@K#-]_^O/  CN91W+"I-0EB0.;)E2*9CQ H.R,R?D#BQK=.S00V,0X[
MLR7@LS[=2&0)Z#10^$P<V1<R"U"!%S)G)\26?20M'_.'^\T%A'13=<.)>?8"
MIA*^&$8HQB=:K+/.(O#55>NP;X+%Y\8#7%Z$F9AG _ZL.V9=XH6?S&%L0LD]
M?KE@'&M0X"%9Y*3K"#2 '")7C%F7.!,+[&[O",#>^5#,BFG^8"-"BU"P=S8$
M>&))7+ Q&V@D6!=;.@-3G4\Y+&^)$?%F7NL@!L26^&9?3SO8$(&+8[8G *R'
MH.)?!,_F8DXL(%!BAAW8!2 G[)"8.#2>6/!2E-D_/UH'0C*OF'.]_2(' D '
MV=ZLP>>^1[9BDW@0TV()@<I=)$D(\9UY"6RVLAZV8R_KM =CN=\^\RVR1=3L
M9N]PS3Z-)W=@ ;\B"H<G*O;,-^QF;/E&?,A!N4/XNM=8GNZPN=P@$.">/"+D
MQ1+BT"WG._EM7>)&/HD1^6V\_1,TUY;_UB%ND:A86L>RP-?1 @H]0I7.@-/R
M$+X0A;"L0P$ H^6]'' =7*SAGAB#8W@-!L-$376"#,[)-S@,2V"_%XR$"7(:
M[L)'S2PX A?@[/G%/U.0[_@*5\(5^L-ZX#R.AR^:7N&"N6!;^4\SP 9SP@4X
MI+B \3ZS+KBEP")670/38!>L\V(;.. ZZZ<5<*7F DRU)FN'*7"97ND71@H[
MWUL7V\)%F&7]^(KM^  F62?.@U?V "?96(& A^@47.%>OK,N:X$Y'G+ <1CH
MVD>?GF_CNP;/$>R:LNP-\]F'O^D*&!\^PGZ<9"^NA_&NL1YXZXD_N]N+SV">
M>_ &/O)9+W[$>V("YX@%&*S90*N()YQH3V+!9_PE'G"Z?1F#SG7 9 6,]<-U
M>Q<3\!??XPX<@O,=XM?U]DHW*5+8F*81-V+4]W"=EC(/.]B/M> Y.MCZ\:8X
M%#O\PJ>T";_RC[VEF]B5W<6.6# _C2:N^%\<F0>ORBMV,X?KV8+-K9/FLNYT
M$PX73^)?_.$KL6+O;,D>[,(^XE"\F-M\["@?^5^N><D!^Y.+8D#\^%Y<XV.Y
MP4;\KAC3$+).:Q13M T>UA 2$[2*>XPA_JQ%++A'C>/?XMN7%RYG(_%3O#B;
M2]/:]7C9_F@\-A;#W>_L@8C/U2[L:PUJ(/KNLI=KV)/FI$DU@VAC=N=_?C4?
M6XG_]"&[THCB"M_33=9-RR@V^<&:-?O=)];9"(:(3]@ )\3U7'_OZ;M^':#&
M$AL:<7+<-1I$8D*LL"5_TTCLS(?RTV<:+O 9_EHS>U[UN-8GP(HZ"4*$$4TZ
M?)((R#*$PH*P1%82D+$%G&0KZ8$IT>=)+8-DU/U9L2C!):<$ KKFY2C@*R )
M>\G#R )><C@XPQH8U_S6)5@87>(0C8!,$6,<03R#6N)QB"0MR)W-WU-A A3H
M"!X%EL)69T1P(#@)(5'=9_WFGG-(5*1C;GMG$XGAO<X:P!.<DAB(2="CD].M
M,) LNM_N<68C  Q0S2_X!#/[1R:^EW#L(NDEN[D!G*<].D:ZB%Y$A/G8TWH$
M-+OG(\GG_>SL A,=:Y\C!T3(AGSAQ1<(7$*S@_D58:Y#@&PDX=ZZ]?[6* "(
M[*V0=V8##1&)S8?V(,846)++.,8WMKT##PGN;T]X_:V $+<2W/VZ?GQ-2+"M
MN #R%3EL!4 DLO58 Q"S1S[@/_^&RQS3-GSO'FN:'5XQCX2 EF+).I$9 .%#
MN20&-$QT$X&4-?.3&!<+YD)FXA>IL[L]N1]1LR4[B 7CN$\L 1GO$8FX$@_\
M(U\1B7'9Q?WL##SY31RP"9"U1P)!7LS] GH%EQST.<"5%][7I)"#8HOPDY-B
M3DP$W/QJ+CDEKMD9V8L)=I)3NI[V0&@@8?[)?@IKA)L($]=BB>W<*R_XVKCF
M=!9'MX\^_U4%7\D5<Q)LXA&FU>$D,CQ1LG<89JR*>;C(?@28&,DV[$KHB07[
MYW_$X2!@^4W,P4'WVS>!(A?908S)/3A+L.O<$Z#\PY;/.L2P/'8O\H2??"1N
MQ/XZE@4.V0)P1,[B-/A-=&L:BG%%RY<=\ U_:33#AL0@SH0OOH./,#5\Q!'>
MPYX*;PTF^D:^P@8B%5>$ <8A>MV7(,8;"F3KKH$E[QV$O/R&([ ,+M@3D8]+
M%+;^-CZL@KF*!ER!?^%^/.NI'[ZQ/EAB##H$SL(W8WO1*?$,'4,_L <^P"MX
MVIK@< +9?N$9'(*1N,O?-%EK4]QZCR/QE+&-D6UPH/=LCL.]V-68L!:V$]5L
M!,?MQ?=XFT!7^!J;WL W-0)PA,8$T>\Z7& \N*V(81<<!&_9V?X5!=;FI]V*
M$IJ##L/EYE=(FQL_LIG]XU!KIA$<UOWP\?DV'Q]YR#'Y@,WM%?_@8WN'[]9K
MK:XU%GL[\"_>L&;V=Q^]RI^T,=ZP-G&%ZXQG#SA'3,L)G.9>U[.G&,!;4S?Q
M,3XSOOBE/;RGP:T-Y]/ON -OB4,YHI"1"];@%P-R$K_1>-8HMZQ)HTEQZ[W_
MUPA[90?V\)F7/::MQ!CN90LV8'?ST S6P?[R@&ZBA6" 1I$8E@<*<<U\ZW/F
M2[Z2%^+ 6.*"IO6+./NR?C&6UIIQR@[6(X_YU4,>-N=#30?VEC/LDN:P1F,Y
M]QXN\(D"7/$G)\4PC82C_:W U;@0;_8D;]Q#OQJ';A9C?,\'/N,K-9BXIJGH
M%SF2=J'_V+C_W@#_FTMLB!-[$O_R48[!59HYW^S/M(2':; $OLDE,:2!HSYR
M/<U#-_(A'0(?V-PZ:1A8JG93R[$KK+67JQ[76@ ++,87H#;HJ8%SW31@1;PI
M[AA!4M6I%*0(0I*[7](0E742]T;V-])@4 6#^Q"&CJ>S+HL  %B$I\  V!V<
M@4S,3^0+#@'* :YE;,E-A'H)(I_U$KSFY33S(!DO@6)_@DK'1\)QM"!U;TDT
M@]]]$E!"ZL)(*.0ER-QCKQ).8 D&?UN/SYS9D=T%-D  !/:&((&E8#>VL72'
M%.3N!4#L)5&MT[B24 )++@$L,)$\<+1FB<E/$HEMW>-5T>L]$";Z^;[O@5D=
M(X47D+$?P6YNH A\V5KPFU\3 ?D8P[H0INLU$NS9V7KL"VA:$P!SOZ?,R,B9
M721D-G.]_4MR!33?*!X "\)1!%H[\'&=1HC895L'40/0= RMNWU92S^+X4-V
M,A=@L0=S(-EL JS%FYBQ;@>2$%?R1!P"3T!$.'@I-(&K^" 8Q+\U D)V!.+B
M'*EYLL&']HZ(=4[90J[QI<+/'H&R?TO#QM9M/FL4&\2#O<IA8VFH "Q^, :;
M\EE^<E_"Q7OQ!D1G?%@[ >5[/D0N"$O< 5MV)5(1C_7:%QQH7>S,IH2()PQB
M10Q;OVO8G._%OOO90:SQG[CS.7QQG1QWUEB0KP0-H<R/QK9&L=6_TR4X$EJ;
MPS[[;"-0-I7G[.<>ZV,W[[W81,.HPM]GR*'OK>^W%_\.!@%VB"_^Y%>^(-Q@
MFQBP7F0E3A"$PI7-X)\7')6W2-SA%QO$7OC,)VP?$3;G.B\+O(P6$/_R5_R7
M'[A180(C"#5YZCO8+:<5!G #E\(X_)M@5*3B,A@L[^ Y#=$!@XP%<QSVT3L
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ME,. .^ 1](0LX6GS/E>T23;!*6%\+R"(6)MG<-?4*=H;F],X'9 :5]!QEF+
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MD#^^MP]VT_3 A:[-KNQ&8_(G/_MWP+X7M\:AUVL8\Z67:^@@^6!_FL&:Q3"
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M:327Z[RRHWN\IST]7-(@=2A@Z05<23\;@Q_9@T_2$A6K?,MW8IH^PAW-Y:Q
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MO]:FZ/,Y<!2S0) 8L#\$*1;,"4"M7S%)B  R>Q07S>F>WO-U[ZVWA@" SU>
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MRUF<&\=<]''%L7/O^=XOWN20)M)\V#''ZKUY:%-QRD_BD8;5_*&Q^%3=1>/
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MFE\"BV/=-/M7P.@<[P]=1" D9A7$_,R&Y@:68M]G&B;F4Q#R@P-0B5L$R@Z
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M-K0/URAR=2VMP]KXS_P T)-Z"<(^$LW8_"* $:QD\F2470"G^QJ##1(&2 ,
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M_G:_?\O1.,X$N400](+)&; (1H!M/YY"Z^C9.WLH(H -8I8$"A3)*1G9RCC
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M'K_ *!P!NQ0/.)8P]C !+[@/EL%PN*;0P14*%MB(OV@). S'/,51 ,!78RM
MX15\Q!O&-1:-@EMA(2[!7>$C/,/G./?O__CGIAD4N\2J>>%NG  ?78<#8"\^
MMA<\Y7I<#.]AH7GLP35X5N&";^R/=H"YN CNV[<Y[ $'XXX_??*7S7::#?2.
M-<%_7&D=[.>!"%O0JG@:SRLL8;KQO.R?*,?!"B;8;D_LZ(Q[K UWF$?ABL-Q
M&B[VGIW9UKV:&E[XPOA\R*=TC,,8-)(&N *!SF$#>L"AJ*,;V8!NP&TTDKW[
MS$,6^Z-Q<"ZN<K]UN4YQZ#M\S8=L99WT)=U H["[,SUKC;@\OL9KULK.\;1Q
MVA/.%'?I1[]R,Q=.9E=:4!S9/T[U((M=-"-H #' SFQK3OMB!WZR']>)-_;6
M5*B!X'O\:G\>,-FS]8L#.M4A%N@\MJ!_^$W\\*'\,9:U:#BPB7AA_V+!OS^E
M9?I;#'BOB!.#=#U-X#-G-8<]>&_=M.'\OG'$G'Q73XA!-I:?-(;]T#[R1*Z;
MTS[Y58'I7CK+9[2W?W*E!A$OXB!_R7T:4;SQASV[OF):[- E\D1.V[<<\S*_
M_*?1K4LLBV_OK8>M88C/^-=#-?>IO^S1>&H7+_=F'V?VIFO[C*]AC[^]^)"O
M80(?TZIBEAVO>OS??@*MBP/PVE1=@((!L FBC."L@*EKP/""C[$X6T''07XJ
MP*F*'D8G.!G39[HQ@MA<DDUB"3!C2VX_E22H!9DGTI($&5FK>SSU 4+NU:D3
M3()*($H6SN5\R:S@!401$="46 HA3_/LW1X4"@+-O@&\ /:$SD\1LDTV*;D$
MMN0"PA5*TT[6"1!]Q@:- Y0$:'\[LY\D!?[^_9"$MRZ=6V"@P*SK++@4F'YZ
M(\D\"6>;0):- 8VB2S*R%7^81R>.CY"&M0M<P BP?.Y[UP%K-G&_Y/.W_1A'
MU\I:V-Q]1 "2[/ >H'D""9 EEG']+!6P\H$"R-C90)?5_EV'9,R%\/G;/8HY
M!&VODEHG#LD"8=?[>?+=^P\V %6HB1>V=YWF 9\!LL@,T9A;$P>IB,%^C2!.
M';K&_.0^-K1N8[O6O<#>>EPO-HSM;S&(L+P43@!(80I [9%?K=6ZY9(XS0[V
MP_^^,[]N*GN;@UWYS"\D^*PG%$B!\"&&Q#91HE W)GO:(U^(*?%4P\FX<E<W
MSW?\+=;XQCZ+!>/8F[S2;/&DE5V-8T[W$!/6[2=7Q_?."H5-Q(E=/K0GV*"C
M35BP@?T"46/W*PQY*4?8W?<$D'@6+_8MYHDE^P;(P-W\XL*8UF%-GE!K+HDM
M@D!.PP.^0I;(PV%,?KAQ\\Z&*7#%7,C!>]WQ=2P++ N\6A;09(YKX $L\(+7
M!*/FF,,3(=A)ARB<"44:AV["?7@*7\)A!0B\\X0')L,FS3O8 V\(7P)844T#
MP3\-0WP(,V&QHI#F\!E.PC,P#PXJFND &DHQ 7<=&I,PT_?PT]GWL+SB4D'@
M<]P9?]@G'>9,7Q&X]@-#:3L%F%_-6)?"Q;[9PKKME[U\IW#""[C1FFDZ3R4=
M. .6XS6\C"N-I>B"[PHT_(2K<);QO(P#MWV'*ZV%'=F&-H'YYL!5;,F7UF<M
M]*?"QS[Q9>/%E;Y3D-"'FN4.NM!U]NM%-_B;;L([#G,9C]ZCOS2R^4_AH]BF
MI>R=?]G2]7B=#]E7D4V3X2H\:7UXT6?V:_WBI <H_((G^<SWXHQ&,Y[[Q:3X
MHM%P9 ?.4W"*&[:Q+NNC"_V"CB80._;!EO:9C6@#&L%]?&U>/.L!3EK&./C>
M0P5SB=WT!(U$A\@I3U7MF2T<XE1\T8^N$1<>;/ KC<>FXEZ.L7OKLO99G*75
M[2__]IFS>H"-Y9H]&(L-.S=N#\,\].%#Q1[[TT/V9RSY+/84Y>6&'&1',226
MJW44S=9.-_G. SB:$&[PEQPVKCEH&'&J0/:]G#:N-2IB%;YBVK7TK8)4+*C#
MU "*<NLVM_K*O7)(["J^Q:#[[57.T*G>N]ZY)H'WV:[O?&9_XE[\>JEA#J(
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M'K!.>L7?8I:/:#!C6*<&D'F\MPZ^$G_6:EPV,Z=UT4SBEJ; R^;G$TTC<]"
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MU%F@6X-]2R9!AR2 C$1RGR8$OP!YON0'0*.@ ]"(!&D"1?L%!CI-;.TZUR,
M209\K1=P1;H  (FPH[4!/]?RN\130/.WHMB36T2!./D&$2#Y&S?O;/NW9R_K
M=XUD]-3>./P&$!":) /4_&Z_]@^LQ(YF ]($E&+:6/QKW A<[#B0(9L!/$T
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M3;ZS!SR(6Q7&QJ\PI5L4[>S/#_@,OQK'M9K>XD?LW#[ZZ$F3@T[$?\848]G
MF4_Y5Y&#[_E&C(D%<QC/N,97%.-4/*CX8B_:#T_C;^OTU)?OK*LG@&FJ.#^=
MQ*ZXVO[C6G;%J]9&"XH1^[,'N@LWNX__U <>)&A<LXE8H!WXP-HU,!3"<DC]
M,?>=MG6?L?O;-=ZS!ZW5Y_,LGL4LO>!S37\/C12S_12X<9SM01RSC2:!>]B*
MUK(GVMAU]D27NMX<]!+_^ X&B&E:1R[2].).7L &NIBF\Q"+?V"-F#6'_;.9
M7S>HL12^FEG\R3[J*K^DV!_RP^%!FE_G69M\UL2IF01C>IKN@86BWGI=H^#V
M/MNQF?CVF1?,XC-Q23,?1 %L4XI6(-0&;48PZ'+, GANWGO@[ R8.$WB^.F*
M8D&G"2EX[U!<,)P@=@TGZ4QR'H=PI((.\ D,@>*G$+I,$EK1P8'N!QR<S4$"
MN^)*)TN'2' JE#A!P0L )*'$%8S]=$!1(.G<+Q$%@RX&T)#L$AN0'YV<;B20
MX^U9AX- !J"Z-K[S0F "58"Y3H+,L\0ROL^\&A.I 6_@T7>=D8BB 7"8TQZM
MR=\"GYW8S'M=-T4. A2  $GRL"_[ 5E [W[ #VS\S<[ W5E1PA>^MP_)YC[?
M(VKCLS$P143^-K]B30)8C[D0"(*K>R6AV=?A7K8'&-9B[^W7&>!+2H"FBPX(
MQ%@_U;5.0&X,P"$>^)8O^1LY 1R%E_@$9NX%S!)4\B,%?A<;SOM#O"!C),,&
M[,FWXD\A*T;%DN^ F/D!&"&!,)"D^WU/1  LG4O Z5I@XW["Q9E?IPWDGOQ
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MN(2&80<\B!=I!$UU?(J;[=':<*']XUR%KWDT<_$Y[G/-W?L/-E&.*UQK;,6
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M C'J18=:M^OY@XWYP'UI\FF+I[U7*]J/6-,,.(@"V-,0A1; L&'.\H2JCHG
M @J"@"AG9(GH6ETFS@ BC)+H%[ <" " KT3C3$[2&0!^#*WSIIO!X)P#" 2E
MPH&8%6#&421Y\F,, >MO0:1 Y6R (;  A6)91TE0"62/Z75-K<EUQO-O'MVO
M^ %(_V+OSI_UJL[\T.=O2')SD]R;KM2M2G[)O:F;JENY;HS=3:<3N]MVMSN)
MV^[<U.WNI*O=Q.VI\=C&T!AL#)C!V,8V-H.9P=@"R8 %$I.$)A"2$)J0A 8D
M(:%Y.II9J<\Z? ^+5^<<G2.=(^F@O:OVN_>[]QJ?]:RUGN_S/&MM=1/?X&&
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M]"MQ/$O^)@"TD:YGM)#*[I0_'M87T-A[X?"2\2UIR=]SO*C^VD(_SL8M(Q&
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M 9KFQ&!-X\C:8W,CS([(!A6,)QX-FP$>:/1?ND L[1<&,R@9(.0IG%W<E,D
MB4'<!W0J([<3'41GQ.0:G!N&P1/@UCG4P]4 K[ZT0QA*.0V&GF$2Y<78T@>8
M@7]QI<^M!T-AXKC5T)SH),*T)[JVA\XD'X.?R;4]U!%-U=E E,- ;D#300PV
M[6&"D)9VE78.$PPZ9"#,<^E*Q\"JC=HC$XP)ODW+1&9P%L]@VU]97F,  "
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MYH0V?W.&L=,<8B[)8?PTU\C?W-,>YB;IJ'_O_.F9,=<<UQX (EJ:$]O\([\
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M&=K9R(TE'OV$=3*>BA\<!*--& "L\1!%A5,A1$[%H7[:.._<TT)P=V:II!T
M"#6T!D8 <:5'LP(@!@#3(K"^2L<S3"JN>$ X .DYXM*0: PN%1K3O<;F)@(P
M!@2[#P@&9(%'[L@85KTT"G< =9$^:R[K)VNM,@.JM$<LP1A!!\ X3F >@*<5
M41^,K_[24 =UI\U)QPH=6=0QHCC"J)/P.B;K-V:,RS/%@S)X[XQ%V3W&14/W
MF+T[.@IT%.@HT%&@HT!'@8X"'04Z"IQK% " >4["&)&9R?+ 7_X#JBR0_@<
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M (.LD"R2, KP1RX'2@$[,CX/4M@%IF')):,#H, =*RJYG^68_ X+D,-A"^D
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MN7GOJFH-GOW:_17T+GWCZ?K_F;6W5_?HN$R/IIQ=V(X"'04Z"G04Z"AP*A2
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M&\7R:^VLS7*MU65 RX97< J\ .#"!>HA#9MTP03<E>$'=?Z#3WZW8ALNTL+
M3*S7C&PPB[*'-K"<M<QP%! ,RZ"+> QT\(=[ %J^P1_R<B^NLKJWK%.=8"_>
MK?(#OKUS,E9*9\*X0+.JLC9B"A7 2!@B%4+8]C^0%B(!=<+Q [>K&?==3-8"
M8(2E(<$H-"O9-EL\C,GL#T@"M4 KT,CDSPHM;\"4959X5PQ+XX"I^.0C=$"P
M!N>N#&C2MF#F@.##1XY64.N97=XP,^V1;<,!;]N:*SO 3%N#P>7!3UXY,+ T
M;9J%25F7:7> >N4 \L7ECBTLV@@75P<:)6EB'N5E)1</N)8/S4GHJ:[J:!>Y
M[N@HT%&@H\")* #$_G+I-\HS:W]6EKSQ9-FP>TG9T;>A@ER67U9<+M!S-_RB
M@M8 XZFKOE>MQ=+O.[R[/+7FE@J"9ZR[JTCSX)']9=*R;]9UPWL/[:C/'E[^
M[?J,-7G]KI=J^,5;IM4BKMZQKUPYH_MN^8G:JWO?4:"C0$>!C@(G3P&;1O4:
M[K+$D7Q-'N=A"J^X,E[!%>1V5DT@%1"&*;QC<(,?@&' #AZ %QBW;&H%Q_#@
M9$"#@WAU IW2 XR!999@7J= ,V (RU@3#.<PE&W<LK-^?A5N@ -@*U9=1C48
M":"%'^ P5E[NU@"LM.0'&R@?EVU>I[Q)Y0&_P"?J#]<P4F8':-@.8 7L>9@J
M,ZP!FRD'[*5>RN>9/. JM'$/ PGCWLG56MGR'V[+/<.E\DP8 ,RRB@&8M%5"
M15D?4R&$BC^\9QJ,9H#%-<0*$34>8(B0&-/[$-I5(P*IT4Q(CU55&5A<Q<,L
M "F& 7XU/@LMH&X#*OEJ&)9@+@#RP^!.#*ALXCII5 !JC<*EF>8#F 6D,82X
M\I"^/%F8,0Z?>F4':M67YH9KA/>T1.YIFZ1C)VEQ=2#69%HA'82VQJE3T?*H
M'P;5\3 X+1&FS=;A:!%ZAO;^=T='@8X"'05&2X%]A_O*YOW;RN;]6\L;?=O+
M@2/O5*9Q6[:.][ZWU@+;%(O%UZ96/HT$(#^Q^H?ER+%#9=O^]=7J^\@KUU4
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MP\ G-A5F267P X2G3%]8RP*7P#3*QW-76?U/G7-5YRQCA4G4%8!'NV";8+4
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MY#$L'-PS(5R@\QU@A48D8 -ZUTBT$AH%Z-/8P%LT)ZUV "$Q#5?AC_SE=P>
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M^N]*1H5!K!]6;^GE/5KBGZ3E"JLH+_F4TH67 CD8;2EER.O>H1.:,F).F#7
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M$2 :&)D\;4&5/5H+9M;7QL.0#$?6HW@GKP'5 <*M/,/:"XP!,^*28\EYYFP
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MI,,*#$3K5,"0=(!?=4)C964%5T[:)FD#5\K"\CA>A\%).]+\:%MK0= ,DSH
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M%_*!]^WF6>02SRBU>P] U3NRSJ9F*109W/->&:LW?OL?Z.=^JVYDDLCLY!3
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M-!" 19L!+,DKS).&S'^-P5]=F<(@@&J^U47S!7CJ!, Q<(,A#! 85;T=F-V
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M8,J!CWSDPP-E7[-FS3O*OGW[]H'-L+A\[]T[LLUNH@P @+OCW*$ F8A<>3H
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M&CJ@#>,.UV]I,$"2:96? 9&E./LDR0^.8[!$!]@&B+<$<D( X+C[(A1 ZT1
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MUS&6 )AU5]NH/RV63LVMHOWX^WC5X]V<+E!LET$\:N T(%.FZ(.9H-O)I0/
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M%9_A,E!<>LKRW%4&\3*X3"XHG/C-[UR;RP3RE&'G#?BF/)O&3%W/>!=HONM
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MN?692M.)U_$BI3L_T ;># UT*<"VE:4Q\"U7OCFRYB( :_ GG'1NF+J[G@R
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M&EWSVH[2N_^*-+RMI.4GT^B73VY]MCN6GSG[<I>O #QSZJ->2;5 M4"U0+5
MQP)E'Z4"\-QL%16 IZ[W &!NWSSS,!K E0L)"U%=,1H%5QPO[PLNSE1B'!73
M(4DXAK$HP9XUTR%)0(;I8D89W(;GE/WQOS\O>^T"6RQ(U?4=5W0A#<(P97C^
MYR]8DEV>N:O;!X030H4YV&]@LD +<F8\"BW0E''9S5*&&>R()2OSO%!&#ZBQ
M?/3#$&#8"(+* :Z 68(#,,PP?,D9E&++?9KQR/%\TXU0<.VU;?3 : &W:_$B
M*ER<,,!V?8!<UF>@S&73" 0?\PK $Q^B\I_+7 '@DTX\,UVX8G'CPGQ(.F;H
MSM1!VS8 IS2N A^0CERSH=DOI;3MTK3JQ,%7?[6(Z;A 3VPY]9-J@6J!:H%J
M@6J!Y]<"91^E O#S:^N96GH%X*EK)@"8 LQU&2<!7%ZQ.,FL/::OY:U+K14>
MB>-BIAS*,+XB(.(T$$PQ]KSQYL5Q@-6SB-<HQUR='<<CUY151$R\!8"5C>DH
MS[@K\CN!;=Z\+WOM)_(QXH !]<\><MQ@*,!<B?ES&S&0H9G+\[\ZX,W94&Z&
M9,XXDAM(5,7]F3JK@BA-H!@D&XVPS3! .OS'Q0L'_$J"I7Q&ML@@!J IR"9X
MYN(L0YE*UHD/L&9\%:FBN%$SN JM #SQ(2K_N<P9 /[<2-JY_<:T=LDA#00O
M3A\8WI+&Q/;V*,#L=7\:7GY89[_%:])H)F7NSR>G4T>?G&C0 ?R$RXH?.L^H
M)=K$ -Y*O>1J@6J!:H%J@5ED@?A_I']9 7@65>QNW$H%X*F-%0!," 2PO&9Q
MCR3# !4["1.5#T@^I$@:1N']P(GK,J=A-0M0)AZ"U(!@SR"NXE&K7,*G9,64
M7R(DL!9;#'ZY05.+ 3/&X_+L?&#8\VN.8MZZQ$K'8CC,-Q NT)15!G3AD:S*
MQ8-8<C997-9AHPS>,Q8EER'"V *D?^7P]^;*D-E9[+ 88B^5QP==YC''A/I+
M 0;<1A!4! "G!$O,PX]<4AX #)I)\2#;G%@:@%$)B;0J $]\B,I_+G,*@%-*
M8ULO3A]8>$#CXKPLK=VPI0\ IS0VNB8=F>.&#TO'#]^?TMB&=.J)EZ9M$\TY
MD)]4%^B!K+9ZT=4"U0+5 K/> F4?I0+PK*_NOC=8 ;BO6;H?!@#C(F[-PC]E
M?Z;2<F'FH4M(!*.F'L)-0DT)EJ#XA2]_7W915J!87NSVBC=])G.3XR4G!K'$
M31Q%[:4L V6*L\]>_ZY_S!P&;B,!EV170F$Q&?&2H,D=VG-L0(M0ZC4P"C!?
M<",)X?+,11FP F.&1?-N'O0:66!D(,I0#",[M)$&X,L%FD$!-./:EY'XL3_X
MR&/=RK7!GUUE.1? %ALLPYB* [XAM?L.&(L[5K[K ^?VJP#<8]+\IOSG,M<
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M<KU]I/=6F8*J2?S.)9[8J()ID\0@^Z%D6/!+@@?29'K'>U4 GOC@E/]<9@L
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M> 2\/'F%K?+@Q7@47K#+_9KW+T$R1$K0:]HDXB>QTPQ"IK#%8\);L2 F' @
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M^<KVS*N6BW.HP<K[R.?.R0JR:9&" [D\\QS&8K)#W[[Y_NYU\0"F!@NM'0@
M)I%OV_Y$O@%QMY)AQ>C =-;D=& ;"F\< VC!+^,+R ;(1A_ ;BP48[[L<8R*
M$\QMA(/Q&;>]: BQ?P7@MG52,D^7Q<#!RU__Z?2__,J2]*?'_6/ZYK=OZ/Z#
MJ?]<)MIM-GPB)D/R.C].]]R_+=^2M3B-NE0+5 M4"U0+5 OL:PO(!P."+-^^
M](;TKW_US]//_L9Q/4IP[:/LZUIZ?LZO7THDTX<G9($MD ;RZC)N@0!@=N(U
MRU;MA<@%6/7Y0:S,S<%&PEK+Y7\<^W<Y8[.04VPFB[/9=R0HCF.L"9O_Y0\_
ME/;_O??W?%[NT]X&U$#]W@<Z?4[7!,P' H 9EW1M0?*RA(4+<OM&V^^EQ!;?
MRUAM !:[RY JSK:D6!JYS-*Q .!#7O61KJ'YK*M,/NGBBL7\MA>C#G$=%8#;
MUDFYD<? @7\R_^.M)V5[O>+U*].YYU^?(;C^<YEHMT'_!/SZT2GAURBAZ<JF
M&],_Z#:HUU\M4"U0+5 M,+,M0&C160\(YK5$"?Z9%Q^;_N'+E]8^RLRNOF=]
M=11,RB.^H%1:M $BF1Q!=1FW0 G U-3W?_H;XU\V6[QJN483%GG=1MXE? 1P
M8S'(8-"!:S(6\\)BX5(=/&6-XR0EQF[EYU-M_ZL#WMS3SQ3>ZK.! & *+) L
M7:#%V3*HX&DNT%0E!A!3NF#1\9GVC22$RJ014WAEC^:VO/I+%^4&_1<?.+6;
MZ5DE26"E'-_'\N133^?SB__EOZ[B03F_]I>_X=,]<<D"N(UL4)%)]A6 PXJ]
M:PU=0[9H_$O>VTE(]OM+3DSGG']=J@#<:Z]!?V>B=,\H-Y6[FZR UD;:GVM<
M_Z#;IEY_M4"U0+5 M<#,LH".N]C&2+1SZ54;<O_Q9U[\E^GDTZZH?92955W/
M^6HDM\4:X%=?WX(Y#(1H"W7IM4  \!O>]<5TW E?G> ";2JDWWK-Q_*\O$)&
MQ?H*(95#R=2TX<;,QC@,=^D/.L:VNB!.FF*6X(BG,-?-=]S;O1 \A@/%$.-
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MZS9<.#$^,%3;E@(\'D/Z9'\%-!]7NC"GE**LM@+<$[/849#'(2@ZX)/ 21O
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M^2O>])GTZK>>E!-:,:Y ;>[47J#;.56 :S(B ;:-.!A54''D]K5G7I$KM"K
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M8E4459B,+A.9T00!UT8KJ, ,*_6VZZ!"JW3'@'$C("#=0S/OL'?F0&LC$Q6
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MC0[$ EH97AE\TP5@,[XTVJ>?MSY/V@R:&1TH,QC79S MGMCB7*\\^K,Y7EC
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M.[<\F,$4=X%4":QP'4[#<]1??";$%=A:@UQNU+$XQO$!T8X#N[)!VQ?/N58
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MU]"QWR%-:$[C91/3GK4+":^-"..).HL!KO;^Q?OIM(MB]UF_&0!,20671$-
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MRM4HR.T>%J\*P-GD]4^U0+5 M4"U0+5 M4"UP(RV0 6=&5T]^^SB:KOH-7T
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MO98/ ):C"9!27GG%@EF)IRBTPD&Q$5[:<-O6M/#/5F88E5@8 '-U%O?+ Y?
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MRR4U/S0T:M$F+5)<U(3K=N?)XP#/>H_I9HN242U'FH!_\8W1ERKHUEN9= ?
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MKAO?GUF%U%$.<*>Y&.\Z#D7_[ ]%R]@CLU_>O0(5**#S"IST+FZY_"Y:1<H
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M8^_&?]LXP-6OV^8:YQW,U>@<X.VSKXES,L#G75M@-F]LZ-M="/18<S'>=10
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M% 5.A *= -AV+JQ<6X8B#I(3K$HSKF(@RNW%;VHZJ;T$>+':!>^Z,4%JE:-
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M)1Q::#.75LIIWL=K9K+JMHF\?]W;/YORAE_UAH_V!@ 31MRW>/')A#]G<3(
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MS9Q@E:+S\?GU= +@!),YWR2IT0R/OOB*N.[V.^..&1<V<TP:D'B>$O7V \2
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M$XHK+/45%..S2Z?-C)N^?&=RCKG S% 0W3-5H)&^FV!IR\4%K&QP$"RNFQ!
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ML%6]S,1QF+F\'L#9I(-@I;JM=@!D$V<5PD3^Q&6?2<G:XM[9\\4!SNJ7UZ)
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M(M9MC-BZ/6+GSL9SQ],13R[O+C1Y*IS.%J>U6[B[+V)7KNY[(N9N*&+3 Q4
MKK<&.A2Q?*PB7E-1];@60MP5U,V-6'A_Q(HG(I[:%K'WA8@C73J<@[LB^BJ5
MIU<TBFP>E[K'GHNXM^)B+]MZ7,-U/OA8Q'.;)I@7[+<V+V)#LT!6Y\'+-T6!
MHD"/*) !6"%A[BX75AO9[S_[RA8V^KX?F18_^G._DR)B.<'24?-# :W,3_E5
MRUN1N ,'#B<3,AN;& ^_8;;,<?;S ,TXD(EIFWVXR IA >@Z-_K\;W[JFMX
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M7L!8L6=R@/61XLI:'>#L2I"6Z"R1V6H >SR',1/7S;M1P)KCS0D.CI7IMB(
M6EGU5BT(;$SMC^0"@US6N_=<9:#M<=.7[TSEO(T+C+5#,NG_X4T?3]OM;X5#
M0G@."R@ G*0K_RD*% 6* J= @:,1N[X;L62,2L+S[HU8_D3$YJT1*=^WTK[F
MR.%&+G"JV+PBXIY*]=Z.H%QKY=/M7;>$L-;A8;+.<OWD-:=Y."]3==_OC!UJ
MG.]WRO*!:T6Y.A:#.A:QI5ED+%]#_74JX'3OVC'@33_?>H&NNK:G^O-+$:LK
M"SQ343E\HK<TN#=B>>4:ZO.T=,M$1RS[%P6* B]#!3( 8Z!_\IJKXK]==5LR
M%C'5^S[RE52X2JTD\*M=+4?V';_YI<14;H>["U+MCYTXQT#7JX+&G%J?<5DU
MES<#M#& +>AE7(H$YBXS25V;<;_ZK24)IC'=#;?>D8HCVT>T+V[KB1#HL]\R
M(P$J2)WU[0?3C7%>__2O[DL"6BW([BT[G',+=H%K7BG(OQ^@3,Q/?.%;<?DG
MOIJ*7(%B8[/(Y?Z: -]SB,&U%08/H=3.>_&OWY)*?9MD FNRG/-^.;_<8R*7
M(EA9]?):%"@*% 5.L@*'=D<L7]0!:N9&+%D5\<R>[MO7I,MO.LEC ;5_]*]J
MM&>8T!VWA+"V > Y4Y%#66_Y4QWSR,G-!SZZH[6G[%B:C0>G4U'U>-PV49-Q
M]B?T"VB_\Y$#$3NW1FQI."?M=[*UOE P!;VC.Y^L\S=#!R/6=7#3IZ2:>>=3
MEV^* D6!DZ- !N#IGYZ5@!(OY5:RHF0!ISI+> D(XRWF)"/3@U/+: 2X>$MX
MLB)9>@;CL8_]C[]+J::__JFO#P,P8*T^Y/4:S[C E\O+M#1F3H<5\0N0P;1\
M8ORGUM.__LD/]P8 Z[DK]U>+(\!)&$0/<MGAMA&:2\PAUB_*RH#"6.+)6>"^
MDU@M.9HK:X6!V*QZ?7T)KH"5R0+ '_CDUQ( <Y@5Q_(PMF)7P!<8O^M#?Y):
M*XEO%[,N#-N*QIO?]X4TX59&B@-<_;F6]T6!HD!1X$0K<"QBSX;.+7X6/!RQ
M8R0]9G)7\U+$MC41\RN]5ZMNUV3R@,?-=5T0L6,*<D5;JBK7QCR9^< M4'M7
MQ)87.T_%N'!:[Q_<>:C.W^R/6#*6PW\J<E@K"Q:+-W6^]/S-OG65!9\IRAO/
M8T_H]6C$]B?:Y 4OCMAWW/V\)G0E9>>B0%%@ZA7( (QS@.\O7OU'R84%HO)S
M.<*<8<8BT%48BQN,V3SLAX]$S=J'$?F6#_QA8C,\=M&OW1RB?_$>:/W+.QX*
MP*O%;:[X_,*+AQ+G27$5[@RJ&9:X34ZP2%W[9[X31LTQSL6*>\(!EDO+KM9,
M62-EX<M<8?U[$3T %?^-_.7E$A_TRA,F@(E2M$K"M0<[WC$@V*O61=Q:*Q#
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M6ORK*P ^%+&\6O!M0<2VJ?H;.XY[&1J(>'Q)X^^C;\-Q#%0.+0H4!5X."F0
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MR'.B56/]8_W.Q1'/O-#FVMIMZJ+?[%3T.VUW:KV)]QUH]\W8VP8VC;^ <+H
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M4O$9;S$LA2SC-V,H,LSX9&9B,RV1JOR7GZM&K6Z3RL]'CM8BI<"R"M'>:PL
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MK!<'."M4'HL"8U"@=W=$QP ARXN[QJ?'9\^&)@@>:QCT,%R[I9O'($C>=1@
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MWC]G!$ VT'7-B7AP2>UZ]O>O5]!TM+'_.6C?Y?IYC;9R]:C.K#=B0P5FAP7
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MYT6LKU6O']FXX[GUT8BMSPQ# QK-CWAH2<2JKHC-VR-ZCHSGB92QB@)%@:)
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M:3"I;'_'O/4K\Q(<6XG0!+J$0*?/>?E/46!\%5!$:DX=#N];'G'H9(4*#^4
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M'"<<VCGB0#V!&9]M4P2+0\O1S2'/0HV) 8J!KGZ_0J39X1Q9[VE%1"B38J6
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M!4_4GSC_FL;KU14) "W6G*-K4ECK0J'E_AJ;M6X\2=8FE^6NL;,8\WR<_%@
M^$SXAZ$W>CIGQ&67S(C.?N':9\*UE6LH"A0%B@)%@:) 4: H4!0H"@Q/@<$
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MF8-L4JK;$^??_?)'4R-E8JDLQF9735H9;X*:#-7$K&C8UT1F.!8271W/\^(
MG_HO:CF#HD!1H"A0%"@*% 6* D6!HD!18.P*# ; 7@>>C$(%JG 0UU:!*ARG
MAI.Z34Q(;C'NPF*B?,$P![C*4?;Q-P[$6'H)@VS%K+!9*PX$T3C0L73J$2F,
M[[C";1$"+<=7HK0>4N^^]J_ZB5,5:JCG@%<<^*_]SI^E0EE6)18O79N*964!
M/_NEV4F4ZCARB<61=SV_+?6OTN]7%6H0;#NQZR8,8%MYJ.[K>0'@L7_1R@A%
M@:) 4: H4!0H"A0%B@)%@:+ J5=@, #6%E8DK113\(F#Y/MB+SV 1>(*35:H
M2HASE9FPE<A;KS$P0;/H7;PF!18+,B*K^PSW.<[C.,M!-@:SLRT ^&=^[>/)
M^1TM_&:!A$;GYQXYO%H:66$P01ZM%%2WR6*;;'VIP*[5"C:]%8CW_=%?IQ6-
M L"G_@M9SJ H4!0H"A0%B@)%@:) 4: H4!0X>0H,!L#,2JSU2.>ZU(GGR]]Z
M,+FO.OC@I<Q2"EFILU3E+6PEC-G^^$J$K<X^U6V:.:[ZWG">@W.&IASDM@!@
M-CKW5S&KX5S@8-MD*SV_SWHW">QYS^4 FP ]@O,VS0#,Y56EC,7O/;F_"FX!
MXN( G[PO6QFY*% 4* H4!8H"18&B0%&@*% 4.+4*# 7 0I353,)'*C2#8FUI
MU7'* *P@E?9(F;6$)/]@\<H4W@R,U6+2 4@^<-[&8VZ15'UM),_5;#I\Y%C[
M.,# EVA:#;&M1W*Q>5M-F:TH^%L?*:L,^OA*S :T[/:/?O;;C=S>O)_5!N'3
M2G6K1I9[25G5L(])8^,7!_C4?AG+T8L"18&B0%&@*% 4* H4!8H"18&3J\!@
M *Q>$B/QOH>?2;RET+#Z2_A+*UDAT""6T=CLYJK\?,$[;DQ<)42:R2ALVNL_
M_2O7I?&:]\FL-IQ'U:45S6*&J@75%@[P:][V)\EE5=7YA2V[X[>N^5++Q.<L
M!O 55W[UM&\DAU<LN41J1:RRNYNWS0ZQN'5%MJP\B#^7QRMFW:-MM$R2P&T_
M(=._^[&_3LV5BP-\<K]P9?2B0%&@*% 4* H4!8H"18&B0%'@U"DP& ![G;&H
M.+"B5CCIFAOO3JV-1-HJ+*P-+2 &H IBO?9MTQ+3X;)<7ZG*98I=Y<X[C,OW
M7O>55  K;]/J$6QC0&V4-G7OB1^NW93:V+8% .O]JP*8YLE*7V_?M3_%<"MJ
MI941JN<,Z\O+5B>6V'$QYZI^[=C]8BJ7S887]TTL^Y@4SR5'G__V&])*@PD"
MQK_W\;^)MUWQA50 RS96';164MI;)6@NLN<JDFGF;%*4UFZ>B%($Z]1]0<N1
MBP)%@:) 4: H4!0H"A0%B@)%@?%38#  5OR*X^M12//[K_]J,@P9C]A))&TV
M"_$1]O(WQG(73?L?W_2)!DM5'5]\IYHSD&6(Z@RDHK/Z4" Z<Z#0Z===?E/B
M.-&Z7%_MEU2FYB;K/]PV1;"$&NLK)7[\BL_,3-7#V.-/K]F4XLS%<S??UCZ_
M+=GL@%D/J5^<=&-R<_6E(HQ5!@#-T74'O1F(,\3J+?R?W_*I-!$J1.LY93RN
ML!!J8UI)L+W*9S=_\7N-2<MC% !NGIGR=U&@*% 4* H4!8H"18&B0%&@*-".
M"@P&P(Q"^;X_=>%UJ=,.;E-X2BBS%D@X2A0M1M+[5_NCS$O,2"PE-Y@9"9@=
M!VO99_>^E^+OYSV1PJ&!LW!K]UU[>TZ0$"1OV+PK&9>.<>U-WTS'4O,)1XKT
M;0L'>,)_^TP"5B=]^=5?3/</?O)OD^,KEER,.9%ON./>E*^K:-:B)6O2W\*3
M@2R!@31@/?9R;^S<TY-$S2V05'@^ZZ+^1;8(#W1-1,?CJU/_*''CP-EXOWGE
M%])QV/PFMKI2D2>T / )G\OR0E&@*% 4* H4!8H"18&B0%&@*-"&"@P&P&HU
MZ9;SKW_QFA1]JU4L'F(R<ET/'CH2WUW0F;@*7^7:3)F9,-NO_\Z?I7W^V<__
M?G)W>WN/)]>7@VL[W(;]1.KB/JXP-A,%S/$%WUQD[XGZ!=2XD O]SJN_& Q-
MV[8% $N*=K':%@'*C_WIWZ7<6T3O(C($ZQE%$ *QW=G<%W_@MF3#YU4&<>"V
M <"<WPS X/7?_M)'4IGN&5^_/[YY[V/)+C_GS9],XUE](!81A5?K:<7*-]G$
M=6YY<O)$>BP W(;?['+*18&B0%&@*' &*W LNF?='+=WGN@<G,$772ZM*% 4
M* J,BP*# ?#F;7M2OJY*SAQ8VW%K%<9B5@)@=9WPT7F_.2W!J]I,6$E-)<P%
M7+V/[Q8O79M23!F9G&#.K713U:6EL@J?]CJ6 [8,26/(0P;0(G-Q&TZ4;\RL
M="S;M04 "UF69^NDYSRP(KG!P),]+LY<LK4JS2Y(<K2JSL0CABK-"F&I2&9"
MP+15!Z'->D$):=9G2G4R0@%; ELI,#G&<9_R^7MBWXL'TSCVL<)!T)SWZ]Q,
M5-X^/WK=!Z#<B@)%@5.E0$]T3K\TSCGK[!/ODV=%]Q"G=:QS>EQ@OTDSHZLW
MCW-N7#YS3?0.L5_UK<88E>-/G/SE>++[2'6S$3[/YW)^7#EKTPCW;;UYXYR;
M]3G6&;>?1\=WQ>V=>^L#@8EK&]I>,+TS3DQ*:7W,(;?H?2'N_?"MT;%_N*H/
M.=HXOIGG(7]&JD/G]T;V>4DC]'9'YZSI<>6$^F?VDBEQ=^>2F#/KZ?'7MGK*
MX_[\2'0O_7+C.B9.OBV^-N53<5?7H3$?J?$9/>M](QAO?W0MG%$YGQGQ0-?^
M^KGLCZY9T^*R]#V],*Z<^4P,C,=#;->S)NZ=,JGV79AP5=RU)H_=&SU=LV+J
M)>>F]R9.OCO6]/1]EH=S+7W;]/T[-O9_1R*B\9TV[J7U18'J=WJ0?V,:^XU$
M_]%/>V_WPKB!?A.FG8;_#HS^NLJ>18%V5& @  :A1X^]G*)T,1#75XCR)V[]
M^V1$*G[E)O0Y,Q)#\DV_>VN"8U&U(FRUI 6\ %5+)> ,BK4P8E;F:-M<[\E8
MNOA@-J_AN9MF?"\YS3@QIZTR*7-;)E6EVP* 5?"2GTM,E<  +T=77#F7%]"R
MV5VT]SFS(!C\YB;*A%/4RFH!4 6Y7%VYPHIC-8<_*Z"5*X^QU(5.N]E6*+6P
M:$ZP"?6:/L62K/.DYL<"P$FV\I^BP"E68&=T3+FH#K*U4^GMNCL^TA)D[7=Q
M'_#N[XBI$T;Z@R__F*SMU[ME5EP]X>R8.*4C\L_C0<7IGA57GG5MW-L] %*.
MZEP&/5+3&TW777VW=TW<->G<IO.O7>/$JV;%EK[?]=6]QO#\2&R9=5U,'!'H
MC.%P(]TUZ7%Q3.W8>>*>HYFCGF?BKLD7QCD)>KMK"RT)K-YS4A8[3CSI<7PE
M77^&R=[H67-W7'GA].A,'^?>Z.F\,VX?2+=AG<*AZ)KYOJ;/X= []G;-C,LG
M7!?W;GHZ[KIJ2MP^95)]__IG[))I<6_7_JA]1P?ZG@^QG46:JRZ*RZ;,BJZ>
M0[7/;%HXB_IXDV+JK#714]^N_R):;^SOF!83Z]L/?!5C^'=DX $;K]:N-\-O
M_>6>I7'[)>^I+'0U-J\_&<XY-^\SVK_W1N?T]_3].SS:8<I^18&BP+@H,!
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M\)ZX^G/_$,]VWAF7UT/N!S].Q(CFL7=+=$R;%'T+ RZE]EG,G['!.'NNF@
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M>*XRV)M_[R_2?O* C6-%@6! 6[$K0/SMV4MBX];=:37#\:PRF&@ATAE^/18
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MG *&^0P927 KV%V89$ U9M:XLY+^" M<8C>!O\".^ P#D*F+5]H"=@.T#PL
M_(F_^H'I%. 7LV20/9V$5L?L>6IYQG262%]0Z0CE%R^]800/,PLHANT% *--
M(%HSX)@<P!N;7C+7$OT9@(MO\*>^<JMAA1$8MNDPO;PGXAC7(#P. F;!'C/(
M@&!,L:GW5__ZEID$*0 >QG=WVO14 JD$4@FD$D@ED$H@E4 J@50"J00B$G
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MRWD(DH3+ &RB12-(!@&:'A#-]V@Y$"R#3QMP_"90%D 98 S QLX=;0.)EU,
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MU/6*[..M \#@'-Q2(2 !GQ"&'(!:TA%A70L)"?C]\A5WFX#%_ Y.PE2::,^
M57 5OT,R\IY@6H!@3*3!:_C[POX2_PF?8K =F ],!]Z#V*1^O@?XXH=,'8!B
MK'P!YECGDL6'.GYO['>&!P &L2, .D&G *68.P.&Z;"+\(7@88 1$,PL@H@?
M_$99^!.33_C*RGHC; 2"@ #!M]=N,*\,()H,@#8'C"\@'';WO_[Y]:8<V@.
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M^ __8JZ)#HW#-<[4^!$368PH9K"_!,8BXAEFT"D#[$8@?4TED$H@E4 I"13
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MDGM5;^U]3FLSU^OBL64J^]CW])0/@-NWZ"?9PSK=<TPM#]^K1_>="?0-JG0
M&"(07 8!"(&(BRGNH;R"RP"L8",B.H.[P$<<N*IBR0O6 IA2'NPMUX'K<"DE
M:C2@F.NPQN5< *\[R.8#[N,W&&A87]H"-B3',$ 8:V P(^RP"Y1,NPAZS"OL
M\F"/#Y0!)IHRH)4T19@HP\1"JP-T87SI,*;0"(P.(03G"TS',%T&[")4V&&
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ML,,PKI=<_2-]?/+-NKCB'AT]'@V\19 KR@*3<:W+V -K2]8>?(3!9 [#@>/
M53"Z[W7W&,(3OUY,I!U )J 6[R$\'>"&=08O8LG+W[#Q 89MQ=9[T0.;3  J
MG*71)A#("E86_U_"76,:[03);S"['-B'(R "9@&@ ;+X O-'1&@$A<8!NW-^
M0TCX#\,8,U@(C@-03(Y?!A;G[AG?66X -0 88/S5JW]DS+#Y':88348*@(WH
MTG^I!%()I!)()9!*()5 *H%4 JD$AJ\$S@D [L\'N$?M&Y>K9EW!O+FQX4EM
MW^>#R58]N?9%=;4^JWO*I^M;2YJ4?ZY!3_H 6#UZI^.@\L\LT:63;E#C$)A
MDQ''@5W *6PO0!<7U>_,7VU2Q(*1P$Q\C_4M!S[ $)=8YX+#(# ): PNXSTX
M[*6]^TT08\A%9\6+FRN?L?#E .2"#4F'"_Y[>MO+)N,/91%5&C!.4&-P(Q&@
M"5 ,Z3ERTC Q@?[T]-M,JB,ZCA,T_K\@>#J+<S.: X2*P#B'CO/>9W!ABV&"
MT49P#6&P*0<M H.'K3@@&U88&W*T#X32ADUFD#@ R(3W)N$S D<K 9O,X%;<
M4F_R SMM"*]H1%( ;$27_DLED$H@E4 J@50"J012":022"4P?"5P3@!P_S[
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MEAHMQ:X]^XQ=.F"< 7>FT)Q#?>F12B"50"J!5 *I!%()I!)()9!*()7 ,)7
M.0/ U:J<^3E]9N8M 1"N6:>7NWJMD(@"W:(#[J-.Z,V]^Q5-8G12[:]NU9JJ
MRS1^4I5^MK-9VQ[\L7[N@^C3Q_3RQI]KURLOZ*E[K]?%L]8HW]VG777)07(
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MI+?E .QBK0O##)N,:RO@E\!9_ 8QBJ4O1"8L,("9[#Q8#!/[B39@F@U3/2P
M,%H A/FWWUUN! 7+"T!% &@7H-YQ<$:@@&*86@)>(32 *12X[PN,$-$ (&1
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M8A"S9>(C03S"\/Z/O_J!"88%.TLF'L L> I\!)EY_1T/&Y=1L-HGIU:9E$F
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MS(#%'#5;2Y?,UA@':+I>4;UAY"9JVI0)NJ1NMW8;S3!:WR:]4C='8T:XC2N
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M97'.L/$!A@'&;!F!X2 -^(7)7;YZJ[$!QQP9X0-.H=Z))H:@8'RAUJ=\.V.
M*!H*!,W D6_*"1AZ'&%R'7[#@%D.@F1AW@S(Q:0:< Q%#\L,T 800Z5S+7[)
M# ;E M8QJT; *0 VHNSC'UK&R[WHO'V<FO[TT9% 5[-JIEQNTTM]=)HUH)88
MQF=X;AP'U+_P)-@C&X K_.Y\? ,KM4+SA\V&^@S;>\',VZ&>H^?7,\: ^>GW
M:^NZN0I<-X9:7N>XO*YFU59O#%.QG>/:+LCB88,_:ZQA+)M>,K#D!2F>L^MT
MST[=^K</*\J]GEV1@-?0!+JF3IOW^<&M*-L#P)GYJOCJ?7JY"+L>5\N+SVO]
MO"MTW6UWZM['LGJYM;.02O+T21WO.*@]&W^N7:^\H*?JZO3TAG_6G9L/G5'C
M'0#^H\_?:+ 0IM#X V-M"]B\O7:#\<D%%X&IKIBWTH!1B$N86YA:,!Q6MJ=/
MGS9Y@6%VOS[W 8/-^ V2$<:6##M@0' >.(YX3S?<^9BQY@47@KGX[$RB =H0
MD6 [OAOWU_,-;L3L&4P&R0DP'A8^P !@9Z8,^(7.ALH&Y (^$0Q"!_R2"YCH
MS2!]G*HQ<T8 # )4.2;3)%;&V1I3:NS)\15&(Q$_& SJ1E"PQH!=R@)P,X!H
M$BB/NF%\ =<X>$.OE__@(9$@.@7 <:D6/IL'>9@'U$7G+?R>OOLH2L":DOLF
ML1_%9I9L4V"Z9?)FEC#?+GGIL/K!^C.;_*$NR-.PZL# &NO<"7 SB%LB#JR$
M#_:L,V[OA3)OAW8XSLMGC%$^XM) _NSA]-RTYL?.Q6!HASHMS9> 22-E\ZPG
MNJ+X)Z?O!R6![L=,GOC\H"[JX^33![5KR[-Z9OFM^J?-^V.FS^XZ'P#7ZL'-
M;ZC8[L,!X%F:?<5D?7S$>%U\W<-Z]5WHX/>T[_$?:?D#R_7 EI>5?[%)6_8<
M*H!C5\T@7AT !NN QW %)0@5>(A@Q%C&_I^?NMI8UX*+8%W!:)A%0TI"$$)0
M$BTZ?F!)"Z8"LV&E"_&)VRIQEL!?F#Q7W]-@7IU[*N5#8H*Y +X 9ZR J0L@
M[>(\81+-]\,&  -Z^4.8='[\W]QF0.Q?7[G,")3T2(!@'*MQG ;=@_[) 8RO
M,-<@; 0)\,74&6T$)LM0Y&@!W$'*HW=/=H>ALF%^T50@1  WY1$(BU1'##:V
M[]0-(_S?+_J^L5\'' .4:6<*@)UDT]=4 JD$4@FD$D@ED$H@E4 J@50"PT4"
M/>HZ<EC'3UH-ZY";0)]63_M./;)\A3;L/1Z+[#P8&:$D':_QTZY7#>QO^PFO
MK"[E5C6HY3=K]*VOS=:2-5NU><5=6C,$:9 @_ "D$(D 54R521$+#@.(XCY*
M<.'_^*DY!H/A;HIY-+@)'U_87")%=YUX3Z=.%;38^/B"O2 B(1LA+L&!8"J"
M'T-JXFO\S'._-N= ?H(%(4 !Q_@5<RZ,,=@-# =+# !VF')8,, T%IH=A(^3
M-3;G: X N*0G0L@(D!#7"!LM 2;((R;>8 1!8"JT ;RB1<"L&>T"0@0H<[SS
M[GL&#%,.@F50,6=&8*1;HC[ ,IH-F&.886AUS*,Y#SMW&&(T%F@Y,*7&5WGX
M V"?22(PE?\W43=67JOQ?)?@9X@9SJ1,;H!:)@*&-*C&!$$* H;4[MBD]9M:
M![,"1,]EH;HHHYQ-TV<B!E=:K6A">Z,7?YB?;."3$:.#:+DEFA($O4B6?8E+
M2GX]E&65K.1"^,&8J7*/Q$RL2WU_QC(IW)?1X'!G7. YOM QF-$@6T&E05\^
M&@%5!G;O)0DKO(<^+,N"D/499]/2Q5MYYGTK"DZX9*&N6S;0M3W>CK/XG-C'
MPKT0>3Z% 8A*U!?>D^>9A438K]@:5$(, _TZG-]G\>PD&-UUU03*&\S!O)T=
MI))+NBSL[[D9QUX7.3Z2TLJM9ZSUYZ;>I*Z>R^\8WX'OU\YE2S[\LD_W]!1\
M<$^_K=_^RWU:O,'N19EO0QX%>BCZ?%S_NG.OCB6F-CJMGH.;-.^R6]30\I+6
M7%&NJMON&!( 3)RDU]\,K&/!8K"]8":B.0-("6Y%\"I *80B/KY@-$RF<67%
M+!E2$OS&M1"3F$1S\/T7_F&Q*0<+6V(Y$:R8ZW@/3@/88B%\T^*U)O QP!E<
M"+9[=E>+<7G%K!K75<ROP620F.#*80& 0?\ 2YRK\?/%K!F*G%>^A]K&#AQA
MP,S"!&-^#&C%=AS0# L, \PU:"G0)O!*5&<.*'$$PL!AN\Z@HGT@UQ0:!MA<
M- >4A;:#B&2PO#A=8X;]>V._8P896W2G!:'=PQ\ 'U&V>EZ09B:22H(@+BN5
M[0PB^9[=YK7;IE#RHL*:*,\+53NH,.V4LU15#4F@V9E?K59+/-V1F0$#^==7
M^0.Y?A#GE IP8C: "]5H<KL%&]JSD[UKTU"6Y<H\3UXC,N^O3Z4#3YD-Y)""
MHV$6%*G4G.Y/I*5^+SDN@[]/S2:W<J/:J<MLJ,]D4QO<0Q^.0J+TO!N2OIE
M.A-UM?&S)EIMM>9GCTA$.BZYYA8&+M*&PM>#?%>ZCX7<LA9<]0;IS<:,<.F
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M?-TXI=8U1PI]N^SX%%,@!N7VXXH#Z(>E8]T6R<7N#?M?8MS1L=T!IWB^E,V
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ML=QZ:S((5J=<_9D[Y>"85O'4)M GGKE3:K]_PS ,<!( WR@=!]\>TU*&B1D
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MYCK8B[P@.,%ZN,@2)!F\!ZE)&2 Z,8_F'%=6,"-DYW_YT,6580(-\@<$4RE
M)8("W!($BSVA"&2%H(DNAL#8(@E&EGVE +,(#M]</@&^: ((E4V@+*AU#@)B
M85]..NSEBZ:!Y_$A1N, _8[F@"!< &/RP!2:,@&<^<Y^5V@]T$RP]Q24? J
M5;SIOU0"J012":022"602B"50"J!5 (36@(G!P<+$9F3)1W:+]LV=LEOD]?/
MZ#L ^"/RY;O_39[?_"WYV'LFRX>_OD5>,O Z>% >OW.#W'+_\W$P'LOSH+3?
M>EML*Z7[;FZ1]M=#^CKVP!E],1]@ @03K1E@2< IR$FP#T0@OL'L]\N./;"P
MX"NP& 2E;4O$-K;$</KQ=N<Z"E!ERR,.]@D&V *4"8SUEW]_G;JX J@Q<8;T
MY'=B.&$231!B\"! F?*!UV"EL1PF?RQ[89_9 @E<61$,L-'D!+8"4 (\ ;B8
M10,V ;0(GTHB*  L+"U@&$888(M-.9J#/_K(MQ7<HCF P07 PN+:P1Z_[.U+
M&I@R ["Q,0=P\QU!H^E Z B/!B;O?2\>5$T$6@6 .8V8^@";5-//5 *I!%()
MI!)()9!*()5 *H%4 A-9 H.2WW:[;'[N=8FVX0V+.RX,\) <SW?+XX__2HZ>
M')+C1P[+T>.C=9JS2-)?D*KI'Y:J1=6R>&&MW)^/[ST25N5,SD, C%4N!"2D
M(BZH[ <,OB+Z\O:=3RD6PO(6\A S9 A&,!:,+$&R"%S5DW\SVIZ6<CW8\;3B
MO)\\^JR"76(Z@07!@%CC@K'8[Q>\Q3TPR3#'D);@0]AH[B&&$\PPX)DTS#VU
M8@ P%#=@EP(C1/QQL1&GHM#< &!,E4'V^ ,3" M@BSDSV@A *L[1- @L,$+X
MO\__I@H,NW3 ,B&\DP?1H3%EAI(G/UA= #;Y '[10 "&N0:];YH'-!&4 8&G
M#'!2JNGW5 *I!%()I!)()9!*()5 *H%4 A-- B?DZ)-[Y/$]M\GERU?+C7?N
MEE?Z Q Y+@#XJ'3O.UC8'[QH'^"1R.A->>[I9^6Y+5=)U1]7R:6W[I;>5U^6
ME]\*[;='DL[([C$ #)B%( 27@8MLNR$P$-:Q,,0PLA"%@-XG]QU0,V6 *,_!
M"B</@#%XBDC.!"T&6),^F(KO7 =;@>^PT 7@XNL+)N0ZS^+R"A:#+<9$&H+4
MR%3*7#%!L*"M ;$( (%2"5 ]()<MCS!K!H!BUHQM.!&9H=<1!/[!F"]C\PV#
MRWUH!O[P TO4;YAGL1%G.R7,I0_TOB$'7S^J[?':X3Y]#NH<)IB]J&!X":Y%
M(P*H?_7R(14^C4SC8O\.TPS(!CBG #C9M=/OJ012":022"602B"50"J!5 *I
M!":H!/(_DWMV9&77^J_)M/?,E^L[WW %'1< ;.SM8JFI7BPU7UTH<Y9DXM&G
M3RDFMS?S>^=>)??L.RHG^Y^5S<M6C#L#C%4M)"3,+^;,$(J8/&,Y"R &^+YX
MX) "47Q\/_RWU\C>9W\=!:9Z9]"9:(.WN!_0"IN+JRN$)GB*&$Q@*=AD@#4^
MP5CQ$JL)W(99-?C0R$B>A9'&Q14?9/R"P8W@,]+A-ZR"R8_X4:,]SC__?/F#
MT3XTVOLI&!4! (/Z88(!HP!1*H,=.4)FBR0BB %L$2SFR%#B %Z"6^&[BZ (
MUXU6 /0/6$80")=\2 /0C&TX#.\O]Q^4P1-#&DV,/-!2(%SLT&ELF&0T"I2+
M]+I?RBO=CMDU6@ELX0'?*0 >;:NG]Z<22"602B"50"J!5 *I!%()I!)XMR6
M"?0-4EO_9?E8U:72>/=CDCOR3J$0@YUR]6?NE(.%*V-P=NI]@$^=R4'YZ<T_
MDNSK;_M;3\I;S^R6+@VD=>JG1WN',<#@(RQP,46&>848!#]A-0O0!'P23XE
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M&+=3L!8^P^ Z@EQA'<PY)"@FT.!!&&C2@G$F+<H#8.8ZZ5*&BC&!1AN 1@%
M"_"$@07AP^QB$HW6@,H"BJD\MN PMCAFV[Y2.$73"#_>WJE: ,RDT23@UTLZ
M!J@!R/@5(W B0Y\\>5(U"@!F&@-M O< PM%NX-!-?M#O4/N4"SH>VW:^IPSP
MZ;]@Z9.I!%()I!)()9!*()5 *H%4 JD$QET"0_OEGJ]\5K[QO2:YZ[&?RT.W
MW2[W8TX<9CPN)M #\LJ6>KEZ_;52<W&3W).Y5VZ]_#IY:%01G ?DZ)%COJPG
MY9V>1^669=>.,HVPHL.?&P"&0 3\L@,.F M+79A7(CA#*(+-< ^%> 3X[OFW
M%Y7]M1UX"'X%Y@(W8>U+]&B>Y1E(1K 86,VVO\6?&* +D 7?@0O!71"5$*"X
MLV+]"_#%4A?@#?8#<(,?P8 0F14#@/_D$]_52,YH&:#7,5<&6++U$(#WO L<
MQ8UFH/.I_2HT;,ZAV=%&0(D#<A$.0D,@4.YH#! <@F)?*NS. =1H"VA00GMS
MX-3-O0B11B=M F1U/?.2-B:"??V-WVH^E.N%7[^F#8R_\+D!@ <EGUGF-[X_
M3V8V=,CC#?-D\J2%TI@]XM^2?LGJM?-D\O0&R08Q V*O43XC-6S(/HETML@]
MU3-\NLND+7^DD$9U1O+!O9.G+Y*:17:O>UXW=B>M*?6RHWVMS)PT5:H:NJ3?
M9SB8;9"9FM<\:<SF"VG[_-WS4V5!2[<,R9#T=V^2FBFD/4MJUJR22]9E_7YK
M?=+=LD2F:5Z+9>V:6FG*6BZQVKDO0;E/5<>>J(PFMT".DRAWOQ3JD:CW_!;)
M#87WV^_SI2[3[>3 8#W=KH>?BZ0U=]P7?D#RV8PT5L_R;1$\SQU!?2*9(XOA
MVKF$6/125)XP_W(WC^#Z4%ZRF0;?;N?)M.H-LB>S51X:I\B'(RC1*&ZA[19K
M&X_BH1'<:GW"^O8('JFP6Z)W0M^!D19^>+F0Y@4-]LZ/-,W"?4/YK+0U+';C
M!&/(NH>E;6N'Y NWG-994;F&>J6C?KY,GC1#:C+[QJD/G5911_E085Z95MLA
M?:-\>F2WC]<[5LA]9'W1^>=-GC1;ZCK<NJ*0PIF=C2S_D>8Q(/F.55+%^,X<
M/-+'AKN/,?\OAUD3E'@V[/-1_4YGOBF1MET*\[!KY_QG;.SH*5_=TVBS\HE5
MT"^#6;EY/>O2I7+]FAODUEU[Y*&&S?'U++*Y>(S>C5 TQ_?)YJ]])%IGO_=S
MK9*S;9#"^\J>]\BV:VKEAH8&:?1_-RQ?+=O&:2UD !B_7RQ>87O!8%C?8HH,
M@&6O7XA#@EJ!BS"!AIPD%A/W<6"E:Y:W_WGFQ6J>_*=S:W6?7\ Q& [@2AX0
MF7R"Z<!E,,& 62QY*0\FS18P&3-IP/=??.Z?]!F"80'2^0-05\P^P"!UP"NV
MX]B#8^*,F3'")A@6["N4-D 6<,R>4@!C /.AW_2I@-BC%V&A,2!X%H[3;'>$
M<&%KT3I@&PZ;BZ,T L)_F&/@G4$5&K\A8+9- E 3" MM S0\6@K*1^CNCW]Q
MC0)HS*;/#0",% Y+1^T<#Q;Y[B;T:4LRTFO1VAD89ETF;;T#*K?2__RBQR;7
MH6YIG3\_ @%#O1FYI-X60T/2UU$OTUCD'NF0%4LV27?_D$A?A]1-\0!JJ%LV
MK=LE?>+3G1+FS^+G0EF:.>"CZ_%]?E 'TE\K*UB0:#EF^WL'I#=3[ZZ+R%"N
M1198ND,'I.WBU=+19Y4N5<O1U/&XY%H626P!&-;/)Z^+@'"QW]<A*TQ.6O8Y
M?F&%$F&A*@6B,M(NTT/ >5@ZZM?Z.E#7RV3:E,72V)Z3_D@1$"[4@G:P:D=R
M+U7_Q#6==%=)FQ^(M2YCL9BQR7QNK6S*YET;TSZ7;8A/6(GBG+6O"3F,:SFT
MS9T"95SS.6N))\>C,@5)RGR<Y#*4;Y<5<V=(5>UFR>;=^,=8]LU(B5:F?"4N
M:UJUV\J CQ+O8HDT1GPI*9\1/^AN'+ZL(TELA.TXDJ3.VCTCK$.)<?WTB@Q(
M72MU&0,P3K$S\PR4-U$YQJR,48IC<.+J%YLCQR#5<4OB#-^I<2N7G.[8D>QO
MXU?"LY_R(6EON4EN6'2IM#[X0[GD"POD@K^!: A*QAPR'@!81$X>/RC///*0
MM#WX\[C?<9!]^=.S X#!8$1GAF2-_?L  "  241!5 D&Z(*; +]@(:(O XS!
M2X!4<!C6M_P&KL+\F1A*[.>+Z3,8"]=13)?!>,1T8A]?L!S8#= +>0GY^/*K
MOU$K7=AF\!=Y8"W,3D%@P"]??KLRP;#%X#FP'N;2$)98]))/1?@ LY$R-MX4
MW/Q[T3 @!(3!-6AQA$=T9ZAVA 'X1+O0>^B(,KC8HF.#3J1G]JGJ/_:VH'&
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M3Y%WZ5H53(AM+"YZKXQ%QTH*"ZH=DE,S?)>W4Y2&_3OLGZ<8YZUNW=WJ)D'
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M9J,!@:['EYAR$'@+NW:B2:< V*2??IY3$HA,7\^!6BDC$#>//P=JE5;AG)(
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M\@&P!WK&$NDBW(//:/%S) Y0H^O'571N8>19DXW-<: I 8@0M^!W9JENX:R
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M%AV:3X2$]@ !PB;SW<R?20<&&"=LZ'GV)OY?W[=8/K;H>K51URAECW=KF6"
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M\"$F'[:S9<M;P"^_ Y+9IA9 2[[@O^=_U:O!D@F:!5[D[])K[U0L"/%9,3[
M%@0+7U\"7T&=<\  <PV*G"AB5!ZP2XAK4#Z1G"U4MFV0S//0Z0@ )I?[$"X
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M;^Z48V\](8T?GRD7MNR3_L[[Y8&$^]M8"=T ,. 6?UX(0W 0N(H]=L%($($
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MI*VAUFVQHFV2,"$N(_/N[.W>A'RH8%I>WR[YOBYIU" [2Z15_3R#X&!12QH
MQ)<[+T-EZA[=SDGL'OQ5O*8RNDZP,JM[X<FAW#9IK+U(IEF?X+%2SY2IIP.3
M9DY:2J8C;%_MUZN]WS63)A$C"Y.E,G23#)R&\GDU8+D]0"W1?]SSLZ1FW1[)
MJUFX9WJU'UL;%/K)Y"F+I;$]H2R(,;;&IB+7%GD</V+>CTRW]$?RLWXU)"7E
MK$#'OR\:^,@SU%JFXO(=U>!-)@,'VJ*Q(<KSW6CG0O_1LRCO\-TL@,HD_^O&
M"<JY0?;F\9T^U;A3D&,B9QG*=\DF#?H6OL?)OA^6RX]MD2\Y*3HK@*JYLT7'
M.-I0,PK[\RG&OG+OQY$N#6CEZNH#!T;C2-#?@BC63EGCXRAH7[ QU2\FC4%.
M"B/]GDH@E4 J@0DE@9/RSBL/2WW5G\F,CZ^0APXF?8 G*@ ^)KG,C7+-Q57R
MOJKKY2=/[)";ES;*[F/CLRV2 6!P#B"U_L:, E-P$-\O^/QJ97^KJAL5!+,]
M$@ 9O,4!PPM3RW=P&%B)<]+!8A?\!6.,Y2YXC;^UMST<8Y A00&] &2VLR5B
M-#[!@%^N$7F:&%$K;[I?GP4GPC!#:K(M4T4 8*(W7_6#>Q6D(EB$ AN+.3.5
M0WMP^Y9=6AF$3\,@" !S\B B&(($\**56%J_4>W4^0ZX7?[]NZ-]IH@FA@TZ
M@)<#S07 %\?M__'1R]44FK+0T#06OWVZYL:(D<9,NO(!<%*"I_/]N.0V-A4'
M,CJ=I-Z59RQBKX'1L<S4F%(?!5<7B\8&CV4^:5JI!-"9X#]?RJ<UE4Z1!"I)
M5NFX4=1\Z854 JD$4@F<N010VMTB]_2\H_/GYHU/R-$CORU$@A[:+]LV=DDQ
MNCCSG,\XA9/')+_O>?GUD0$9[/^-Y%\[(L?'!_\JSL+-\TN7WZ8 %RR$A2S;
M''WURCN$77# 1?@!XV\+$ ;T&BD)84E49G 6F RS9AAB[@>/?>NZN]2ZEJV5
M^!T,"/L;'C#!$)1<Q[45C ;+"TZ$!"5_B%+(3RQ\+2] ]G_[\TLK P!#G</:
M$J@*0%G]W3OT.PPO)M!H!:@D@!?4CT (B(5#-&B?ZV@*H,HQGX8]1I@(>LZ7
MUJKSM0F8R,VPQ-B+DRY^QF9*#<C&'QF-A 6[8L\KM!@<I \8IS$ R40S2P'P
MD/1G;_5!@<*N^WMZW@^;>J&L;5DM"^9OD)U;+Y.9)0-5_9[*)ZWV&$J =Z])
MJLRT>0Q3/O>2JBQ9A?Z_YUY;I#5*)9!*()7 V9+ 27F[\WJ9@0GT>V;)!7_Q
M?IGY5^LE^[9'DA/6!+IX'^!W(P@6N^* R;""-<M;6@X02YPD@@03P^G;U]VE
M4:"YCP,74_ 1["Q@%P(2-U)VY(&(_,N_OT[W! :K@<\@(W$OQ;_88C0!IHG3
MQ'>88-Q;P7\PR6 T&%Y,GK'(_<H5S4J48A:-->___H&EE0. B:S\%Y_[)V5]
M : S_GJ%"A0!4CE87X0/2":X%5H(_'/QTX4EKKFJ56W $3Q^O?CM(EB -8&L
M *P69&OVA=]7<VBT$8!@V&8 -9&>,9/FVF>7W:+:!GR.,7NF46@\M RDS]9-
MYX8)M/;5T_NG+(4WX1P?/_S3*]=9><J;?YK9KID51Z:%9Z50::;GJ@24S9RJ
MYK&A6?:Y6MTSJE>ER4H#4;F]BHO\^\]($.G#J012":022"4@)T_(X(DRU.F$
M!< ]<O_R1;*XNEJ^./?C4K6H6A8OK)7[Q]D'&)RS8.E-&G\);/:=Z[<H'@*8
MXK.+-2[8"% *")[UF6NU@_$;6RA]X9L_5%?6#RVX1O$88!@+6W;B :,!I-E]
M!Q]>#O =N_7P/."6? #"L,M\AY $+!M^P\IWYM]\3P$Q##"NJQ^<_SUAR]J*
M,(%FHV. )@)LN.,GNM<OZ!ZT#]V-SR_" /P^E^M5%MA,I0&J('_SX[57&RW#
M?_G0Q?H;=/CG+_MGI<01-I0^5#XT/OG!(J-YP&F;/-%F +AAA"G73QY]5@5)
M(],96K?N5HT%;''* )O$T\]4 JD$4@FD$D@ED$H@E4 J@50"%2J!"0N !^3H
MD6,R\$J[K/G27\N7U_Q4?KGS7MD^S@ 8, K&PH_WWT^IT?UY#1,1G1G,Q&]8
MZ7(=/$5P8HA%\!&@&#=2/B$F,9>&H<42E^V1_L/4KZE_K_46_'=Q-X40A2D&
M"X(-L?YE%Q]\@&&# <'DP74":V$&C4\P^ W@6S';(!&N&H=ED#PFQ@!-?'FI
M.,[..#^C%> /@</ \CM1OF"'88:)1!8>[!6,=F'2[.5*A9N=.4)! X'@,96&
M%28 %X+E.T[4Y$'T:/X Q@3B(@\$CY!AG6EP6.H4 (=23\]3":022"602B"5
M0"J!5 *I!%()3$0)#$I^VWIIW)J1M@Q_6Z7UFDV2M<B(@YUR]6?NE(,3L>A1
MF4[(T:?OE>LOOUEVOQG;Q"FZXTQ/+ @69"&^MN >,!AD)+@)8A(?71A9R$)V
MYV&W'5A?V%RV.@)KL;4M%KH+O[%>=\X!9\'^8CX-^0EXM=U\K,Q@//R'V7^8
M78)P/^4/?$;,)F)!@0TM;^)%08:"V=BWF'3_TP<KA '&%AR[<= ^PD4S0.6H
M#*"3_:$P9>8Z=N0 9301L, ("6H<?V 87"*1X2A-PV#*S'/\L;41@)EKF#J3
M#N&]:30.M!AH'?A$NP" )DWLR0FFA48!YA<Z'RT#YS1,"H"MRZ:?J012":02
M2"602B"50"J!5 *I!":J! ;EM?8MDNEZ1#9?>9UL[NJ2'>OO+@#@@;ME\J1E
MDIMPQ3\[/L"PM@3  BO!RH*)V&86# 48!2?A0HHI-* 9D QNPW09< L@A7#\
MJZ_<H.;.Q%7"1)F@6& K,!=NIK_<?U"?9;LEGN4[&!#_X__CSY;J_9R#X? 9
M9DM;RH(++"3IZG]^4/V.*1?Y0WY6A DT%#@T.UH%&%T )@+&_!E&&+")M@$F
M%M;U_YS^#14"=#O7<9 FD!7?889A<_$/1@N!'3B:!@0'P"8OA/[1+ZQ6YVR$
M". EX)8)$9-IZ'5CD6E$&HF\*1- '$J>"&DI )YPHT1:H%0"J012":022"60
M2B"50"J!5 +%$CC9)[G,6OGNTAODONYNV;&ZI0" )ZP)]-GQ 0;_$#28+6IA
M@FVKHTV9/8J%$"Z8":M8L!'@DS\(17 <YLZXF_(< 8]A@#_^Q37J3@H.@ZS$
M;!IVETC/!,_:]^)!W7?XP8ZG%?\1T/A_^9-J98Z)TP11"N %E$.6PD#CS@I8
M)WV88X(45P0 )J 49L=0W!081V> *0)%X#"^5):H7N==L%R!,-0Z :D0,IH'
M "SFR0@>C0#.T+\YTJ]T/([;!-E"@)A%P]QB9@W81GM!GI@X_^KE0ZK1(!TH
M>309 %_H>/(A#SXI)\^19@J B\>6]$HJ@50"J012"9R9!-C1 ,TZ<PZ:=N8I
M^V.NXCH+![3GZ9%*()5 *H%4 B.1P*"\]M -<OV.E^7X.Z_*[M8?RJ;.@Q*-
MHA,8 #^PY0GI[WE$;JR>+U]>TRZY1S/RP#C[ &.^S % 9=Z!F<7J%N*0X,#L
MP -9R+9'D(^ 5YA;[F5^PO?W Y^Z6KZX_#8U4R:.$KOQ8"J-_RZ[Z@!D88_)
M Y*1-#"YQM09+$<9N/\//[!$,2" EVV8 ,S@.P QV(_R$"L*R^#_^N%+=+Z$
M+1[M<?[YY\L?C/:AT=Y/P= NO.\3W]5*8-*,X*@L0!7J_)O_].-(:.=_=I6:
M2L,0(VP *D[0VW<^I6 9Y(\& B89AVP6"&@0$#CVX(!5P#9_- K/L7A X !N
M&&; -'\<!-8B8!;1QFA,@EZQ "%OS+))-P7 HVWU]/Y4 JD$4@FD$@#<LLT?
M2EXB:V)1Q)821,A$V<O\,M(_+)UP[4&CSIR%1AY%,',5,2[2(Y5 *H%4 JD$
MD,!)>6O?W7+9W/?+>S]8+;<^?30NE@D+@%^7QZZ_4M8\V"W])]\]'V#<37$M
M-9];K'7!79"(!!4&Y$(($C 8P(II,_..$85@)/Z8HP"^8"^L<F%H <^8,8,#
M"5S,EDD 77QZS=\7Y2_!CYG3 +RXL_+L9:ON5,MA\")^QJ2+!3!D*6E43! L
MF%185H0&" ;!@_"Q.__CCU^ABP <G ',@%8 +J 5\V?NH[*PN5Q':-O:GU0P
M"U6.IN)C_W"]7+M^FYI.__?SOZGFTS0>X!?:G$4&]ND$W<)Y&K!+ Z.%($^<
MN>D :"AH; )C <93 !P?-])OJ012":022"50+ '<<7#187'PZ9H;A7EHI.#V
M3._#\NF]<Z[4G0^8[]"XIZQQ<1NE5U()I!+X?9# H.0S#=*:R\D#/[I=;KOS
M*;'X5UK[H?VR;6.7_';"B0(?X%OE[LUWRCT:O"LC[\8^P,P_F""#??#/A:T%
ME(*M4-P2<PF "N"=^E>U2@ZBC&7>8<Y# ?OG"Z]5W 5P!=-!-A(("P4P9"=,
M,-@.BUL(3MQ5 <-$=,;T&G87@(Q++'B/;8\H%S[)N*-"2!* "W=93*@A*BN&
M 88>A^E%F+"MG_CR#U0H^.LB1(2!_3C(GFC.5!"3900%8$;S@) 0]IPOK96J
MZD8-?(76@88B"!;"8ELD0/'_->LRO1<@B_:!2&*86^-'3'KL,<QSI(=F@GVE
M ,2 7JA^J'E;E*0,\(0;)=("I1)()9!*X*Q* +\FYA:4LKC<,/';G!%^_L<_
M_9J:AQ$A$PTV2ECF-A8&S#DH7EETV!Z)5BFNL2#!R@GE,:9?6$\Q'^%SQ1S(
M0@-->YB?G1-4!#\IS,M0]*9'*H%4 JD$?E\D<++_:;G[_EVR9\M6>3R?L)"9
ML RP]P'^ZD*YX(/SY(O5B]^U?8#QW65. Q/AD@H(?O^\.K4R IQ"$@*(L;P%
M"(.C<&5E'B.@%< 4RR8P'',AK#+S'"0FP!:BD?D/_,9U\!PD)X"7.8I/[H7I
MY0^<B,44\QFXCGD/"UU88N(]81;]W_[\TLHP@?[/,R]6P1 9#-]>V%DJQB2-
MP%A H+GF-^S.88A!^(!3A$+4+^X!Z")( "L-!%V.8! L&G? +P&T2(LT>!;S
M,P2-Z311H6E %AU$>^:@(:#^H?9??\/IA#"UMH5$"H!_7X;,M)ZI!%()I!(H
M+P$4J@12). 'YE<V1]@GT2_9#Q&%+AIK@">+BE,=[(L(X$W^C83%Y5GF.N9*
M@C]BX50*%,,0H^7'"BL]4@FD$D@E<&Y*X)CD-E\JG[MXI=R2>4@RMVVI( !\
M7/+/[Y3-=9^3F1?4R3V=7;+KMMOE7U\?WVV0;/X"V#)?$6 8QA?&E6LPP&R5
MQ/P':PM^ Q>A (:D!"##[ )<W_/1[RBF@]P$JV'J#*@&9S$W\2R8#W"[8.E-
MJM@E/A162\1@PM<7@(MB&7-J,!^ &J(48(YY-@0JOY,'.)%\1GN\JS[ F$#C
M[PO21T (G$^$AA\3BP4J0N4Q>88I!K!BULR"@HI#H[.7, T"8(6"1SC\09$#
M6J'< <8PO306&G,<J?&[@H*G#"Q*:% T&#0<YM1H$M!FD <'8-LZ10J 1]NU
MTOM3":022"5P[D@ @ GKF@2] $WF"K32S!\$M4H>+"9@;YFCF%\ QS9OV2=F
MT\PSR3\TYW8/G\R+-C<2?1/+J+[^MY)9*I!F7L-MB'@8-I?9)]>87W$%2H]4
M JD$4@F<.Q+HD;;KM\CCF5JI6=HD;<_ND,:6)^,FT!.8 6ZK_KA\;N46^<6C
MK7+I!3/ET]<^(J^?')_6L7V ;5Y@;H+-!5#"Z/Z_?_EMQ5H 78A$=N-A+L-:
M%_(10$O@*W <SX&M ,18)V$"C2DSH)CTB-X,MH.4)(X%6(S?883!=V!#,!DX
M#2P(S@/+P1:#XXCQ1#F9;P'A &%8ZXH P-ASP\IB#D8E/K;H>ET,L#\P3M8P
MN#0&"P 6"3"Y" Z39 2)0/']!?AB@\XS.%Q#DV-#SG4$RV( \V:T%SP/V\NS
M+%!H)!H5*I^% 8+%)IW?T(H3&9J@6YBBA>9L*0 >GY<O33650"J!5 (350*X
MPC!A8[5D"P0^T3JS " *I5D,61T(>H6F&^"*-1,+"A8$:-(Q91X)&VQI#?=)
MV3"?QK6'Q0#YD!]S52D@CG43OV%"%M8%K3I642PTQJILPY4[_2V50"J!5 +C
M*X&WY:6MM\DM:VKEG__U+OGF!;/EZ_>^+#$,.=@I5W_F3IEXCB$#<O1P7QRL
MCZ.PD@ 8G,:!>RB!@G=G?Z78# 87+,7^O,P[S'$\BS(6TA&,AFL/KJ-@,*R2
M ,R.+BSI   @ $E$052XLN+ZBO(6,V;;+@ES9P N0!C\!8C&10AF&,4LZ9$?
M5KK,6[C0\AND)_,7BFB ,JZN%0& L0>WB1=ZFXI18?:>8K% 99C( <)4]/.7
M_;,N,-!RHQE X(!GA$68;(2*)@ M!.PQ6@FT%-S_1Q_YMM+L")&%!P 9T$S^
M &#,RLB3!H0)_LH5S:I-@'Y'V !E*RN?7./>]$@ED$H@E4 J@7-; D2M1,%*
M@(UP'ICUF6O5G(NM]^R \66.06F+FPY^24SZ -33.;!:.MUGR0_E+F"6!0?E
M8>YB7@L/6%\89PL^:77$?PL-?!I1.I16>IY*()5 Q4G@9+_LV[!<+OE!@S1>
MLTR^TY:3EW9LE^P1;TH\<+=,GK1,<A57L;$M<!( 8]$$ <C<P3Q!X&"(1!2[
M8#2P&7,4C"[W$O@*$O''VSO5 I=@Q(!H .YKA_L4>X'1F!,A%<%O8$',EV%O
M<2="D0S&8]XB/RQYL?P%;&_*[%&,R/T$PT+)"Z')G(7REK0J @!38  L$R]"
M@X$US0&-P,2+(!$(VQK! $./8_Z,7Q/.V !5@"S4-P 6OUZ$".AEXB>B-"PP
M#?7__,6WHL4+3"^:"DS0V H)33Q^PI0)#3I@&L&B)<=<#>';HH#/% "/[4N7
MII9*()5 *H&))@'V-R0 8[@]$?,$5D8AB,34BTF=.0SFE7D+JZ,S/7[SQN_D
MF>=?E5_M?UUZ7GWS3)/3YYG/T,2;&1KQ->PX>?*D!C!!V1PJJ '^+$*20;GL
MN?0SE4 J@50"$UL"0]+_XG.R[V!>\OG7Y'#_.S+XN]_)<:.!)ZP)] GI?_YN
MN?KK5TOS$Z_'6>MQ$'@2 (-W"&H%,0BAB-DRV S%+K^Q/1&60I@D$U08K!3&
M2X*A)6 C<P[$(_="<D)VPNCR#&ZL;.,'IH,(1;',7 H[#'8#PX'I<$\%&.,B
MBT*7LK!3$*;3S-, 8,I4$0 8'UO +2 4;0&,+F 4LV.T S"_5!1?7<Y!^P!>
MJ&\ , L1M !H&! 0IEQH(1  =N=,\)RCE4#+P#T 8C069F+-[S0  !A?8XL*
M38,3C(OO4/_X#'.O_:4 >!S>O#3)5 *I!%()3  )$&F9X% A\,6*" TT/D]V
MX";#?<Q/N-R,I<GPVV\/RN-/_-JRDA=>/"2'?U-@FJ,?SN"$ %M80 'HF=-Z
M#QV)4@,HL\C K<CF/8 P5E0 _O1()9!*()5 Y4C@A+SYTQODVRV;Y8?+OR'7
M=^3C8'+" N"#\M#%\^3+J^^0.ZZ]6JY>\2WYSBU[WC4?8,9^7'8P3P:X$BL"
M4V@P$MB-<Q3%_,:]@%S\=WD&O 6N(D"5S2&0C]R#^3//@*T W6;2S'T0G> [
M@/2DV<MU;@(',E>!W[:U/ZFFU2B:.8==!BOR.T$G*P8 8V+%H@)6%Z$ . &K
M1 -#@###,+M$JP3<LB#A?K33W(^ 87*)(@;0!=BB@>"P!F 2_]"":]2_%PT!
MP)8]&<V)F^C/4.T(#T8:4$V>-"Q:?NC]]R6"AJ0 N'*&O;2DJ012":02&(D$
M&.N)2\'D;!,V$S 3O06S OQAHL4DS\0[%DQOJ;+MZSXHO^T_+OM>R,M3S_;(
MT;ZWI'/O2S(X.#[1/U]^]3>ZX$#KCOL0;# '_ELL1$+S;^9ME-9V3ZGRI]=2
M":022"4P<20P*/GMS;+^QJ_)@N_?)#>T)H-@350?X+=D_X\;Y<;F.OGT'_^9
M_'EUH_SH^ZNE+3\^2LA2#'#-5:V"FP_$)/Z^,,!8ZZ(4YISX2H!.Y@0LH2 E
MB8N!\A3F%[]>0"WX#@",2P^LK1&68"X87, L3##S+S@./(;"%;(4X(LI-6ZQ
M &=P'VF3)G&CL!"F/ #GB@# 1'S&_!G[;<)B VRAU2TD-HPNE;6MC "O+#BH
M*&PN;#"+%-+@-T TC#(:>7RV5JQKT]_/NV"Y:KC1%D"YHW% 2(33IA%M7T4:
MCWO0)-" - Z1/O$/#LW!R#,%P!-G6$M+DDH@E4 J@3.5 '$>+"X$8SS!-&[:
MV!X!7^8))F%\H4*S8?(=>.>$@M4S+8,]_];Q=^2Y7QZ4O?_VLKSSS@D9'!R2
MYW]Y4 [TO*'FT';?F7X>?_N=HG+#8N,&Q"(#LS;;=@GF&\5PR(H3N#(T!3_3
M\J3/IQ)()9!*8'PD<%(&7\G()1]=))=?]27YG_]PDW2&>P%/6!_@/GEZ_87R
MWDE5LO*!3NF\MU&N:.R0@X-FNSVVTBH%@ &P' !+(C0#5E$4PP*#R9@;<#]E
M?@#7,7>"SXB%<<<]C^EV26Q[R[P*ON+ U)D="\!BN*UBA02.(\@D:9,NREC
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M]O( ;<U>^B=^&.\]7FR -AX*V&?;'[&^7 NEF #99"S#DP&%#XCF/.SK/CD
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M R$FATQ:;\9SZ@$7%A4; ,P8#\$)LUQC&&"0.E0[%PUPQ9#_\>'WQLM C2?
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M DAA=ID#> &F?/QP\V1I!O BFP:<8B!29@-:,0S[8D0TZLB=T::_VVZ\,2B
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M=3[_61L [(<VZ,?:KZE!7V\MV[)?/\T9I4X>BQ1]QP4VD^-"-,RCK?HL"5?
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M]@&@@%?680#F7;];:NI0 7JY:8 IAJ0V%0 8KP/> /9E&_T0'\84>R'=&!_
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MAS.-,9RQ%H\^#FJG.19P+.!8X,DM4*+BY"T:.7"LI@[HK3'!5TKC:DM[K+8
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M5D]B;0'!> 4P(!2YE1MC/)A7!D4DS3$)Z69_P"L> \ Q;#%L+88%(&,\0"W
M%: *)4_\+OW@*8!1X'@DV !FEO$HD(42KP;GP+!(HI%&0[\CR^*!VDQC#@!^
M'O_UG#X="S@6<"SPP *H<8CY9< C](7&NYX![]<:[.W5[%M*NIAMXE6I<3MT
MZ"A-&#]131HU,DQET/X@+??=50[$ 9II<?&GY?U%4_7=<E'1L6E*3HS0N+9-
MU6GFX3)9LTHR%#C&4^NHX5MR3V?C,DU2JCMW"LM=WO7KUS5NW$0M7;)4J]=L
MU)+%2\QVDD<!PKT\O70@*$@7+Z4KY-AIK5ZURLB=HTZG*"LKVRS;&.'(R$C%
MQETP][5TR1+Y_NRKPT?"RL QP'[2I"GZO&LW Y97+"^?T*NHZ)X!I,0'/T@P
M5:*B9#]Y+HP0!3<N'U^I-G_NK06'+AK&]_;M IV_D*"5GMU-ENOC&7D*##Y7
MSFXPY@';]\E[]FR]^W9M _ O7+B@C5L.F(19V=?SC"."\_]:(_XK,\N5I(8/
M+Y[_VQ[C3 C3KQWK;'<LX%C L<!?6L#%  ^?Y2V?<;W5;WV<D@-W*.I&Z?NH
MVDJ@\Y6PTDNCUP;I>%24HHYNUZ(9VUR.V;^\R:=>XPZ P5@D$H;]A6B$'.0W
MS"WO9_ 28:*0CP!8JOE0KA;9<W9.G@&_*&]Y?X/I2'@%4TRI6T)1P6P<AUP:
M)I?MG)/^&><A/6U"+7 = )J^4 E!= *V89_!< !G,"0QP34" /^A\2@#4 &V
MW(CU!. M@-$%]</>$BB-QP&9,X8%W )(>1C<,%X&/ -X%# &#P8),_)G)-7T
M@Y> .E0 ;3*+T:#Q,1R&!&"3\(J&5^.#CI.,1IT'Q;&<;]N^*',,#\ !P,94
MSC^.!1P+.!9X;A;@G<[[%A!,K!'J';S%M@'@8";=)V)WR=I,W5[B4S.OWM39
MN'03JPM#2:-DS^!!@^7G%Z!#(7$&R.W:=[8<(UI45*R0'8O4]KUA6G\BS07V
MMJ[5F$\Z:D9X=GGY7.D%<6[*+,$ZY]Z\(X OTF0DSH!=VO2I4_5)DT_,-:Q<
MZ;J7PR&G2GN02=(%0TLCOM@V@#F)OV@6#+-L[YWS4"9C^HSY.G_^O$9[>9E]
M88=GSYJE6B_]IZ9,GEQ6H]<RTF8GMW]*;D5HCL=GZK\DW-SSB9.7=#SRO#;X
M?*]/O_K95>>8ZL>%Q:($$\QO<,CY,JFU__;]!OS"1/?O]ZV)K=ZPR=\ :6P"
M&P_+;J_;SMV=!GP\68<'#FG&<?X.^%!RFF,!QP*.!1[? FX,<.859><5J?CV
M[;)ZZ]4W"5:J_*?[*=6M@$!QU"[M?LYED,C,3.4%JNF NP"=,+LDHZ1D+:"8
M\1@<A:(6W 9HY3<-)Z:-TT6V#*:S8SGO=S :B;,@/,%3 %S -_B+<%3Z1)'+
ML6P'SU'U!X#<Z(N9)O05XI)MC M@.]3!E+FM$0 83P'4.D8#:")QBHY/-?IQ
M;IP!D&TPQ23'XD:10@-XDU*RS$T2&,W-0L/#U )HR0J*%AU03'PQ1L=0/$ 8
M95A?V%P\&CQ8/!KTPYQC*<D & 9@(WVV#X44X'R84%*):V&]TQP+.!9P+.!8
MX-E; $4.,3Z\OWGGTPA9X7U/@]F-.'G))(X"4+E/U.8%_&9=RS/)F@X=/J$?
M/:>HP<=-3;9BF,D?/2<8T :(MA+>G;MV:<(7W\H[X*SRS ='OH[,^5(M)QY0
M?'*6,C)O*'3'(O5O.$2;DRN78,?%NZ3.8\9.4T! @'Q]?57_HX^,/!DP&AP<
MK!LW;NG0D9/F/O@G)BZ];)D,U)E7<G7__GT#I.V&0B] ^   ( !)1$%4*U=O
M*N.*BQ5U+YED 23[D;6:C-$T$FG-FS=?V[9M,^ 79IC8X6W;=NCTZ7-*+LUM
M8?MWS>\I-WJ-1LT/4UATBCE?U.D+.KS:4ZU;SE1XSCT5%!;I>/ !39^T0!-\
M=FGC[K-EYP14;]AR5%.FS5>']IU-C6" _Y+%BY65?<N >T"PN9<*SXP$83#>
MMN',YGN 1EP8?P>HN5!P.<VQ@&,!QP*/9P$8X*F:L.N"\K*"-<,WNKP$NMHR
MP+<5NWJ-CI&]6B4JSCFKS5/6F5"5Q[O_JNUM&6"<SXR-Y-L U(*OP$.PLK"^
MA" 1&VSS),$&(U=F&_B,)%?(D2$V"7<EA(D87Q2[@%7VLX 9' ;@96Q'=0L>
M@ZCL\^-* ZS)"T6<,'@1#(A3%&88S 9NY'@F)- XRVL$ (:J_K#S%(/H"5[&
M&\ '#H'3?/#@&2 ;- PMW@.\P!C3!F&3)(.8,'Z3&0RCXUG@P9 0BP$3L K5
MSH-H^_5\$R1MM>+L#Z@ER'JUWS&3FALZ'MD=G@L -%*[;D.7&H:8:P0\0_<[
M +AJ_YF<O1P+.!9P+/ D%L !RCN<4);"HF+CG,3+;!OQIS3+\,*0PHQ2M@CF
ME/(_Q)W&7[ABZM4"  &@K5JT5N\^WVOQ,C^3Z(K]]P;%ZES".87L.*H] :OU
MM4=]->BW0,')MU12KGZNE)"4J="]AW3Q5K&]E')S@&UZ>KH:?=S K(<)W;5S
MIXCI7;I\;=F^"8E7=3O?)95V!\#L , %V)(TRS: (TFM )+<LVWN )C[M>U*
MU@/ 3$PN0#0L+$Q?]^MOY-%C1H\NRS1MCV%.'+0KT1>_"I1Q<*H\6D\MC3LK
MD/^2L6KSI_KJ/G*B?NS?48WZK=/NT N&!<:1@-0\Z- YM6O7V<0#8_,A0X9K
M\^8]QFE!W61L#DMOGMFY#"4D7172:'Y;B33/G%AO&A]A, #\/5""PVF.!1P+
M.!9X/ L4*W/G&JW;Z:TA8V9IVMK3Y0'P_21M7QVA6X_7Z0O9NR1CLS[[W5NJ
M][O_-,[,/WCM4<I#:LH_[059 &P35*&^1:$+> 7_$*8*TXH:B;!2JN@0KTN9
M)# 5!"*AJ. DL!M8#  ,<PN9R3N<+,\T"$="8 &VX#B.9QV8#$DS?: "!C0S
ML2]*8')'$3X+7D1!;$LI$2938^H 8Q0\"Q@3VALCQB5F&*DQGE\86(P+N,43
M0+9G"AWC#>8AP!KCH4 :EW7]EHGAY:$@D</ :,H;?#[=Q/^B0V_>R]N 8))K
M0>NS+T:$BF=.?W@XH/5A@#$N#X1X8!X^^\ PPUP[ /AI_YLYQSL6<"S@6*!R
M"S"(6O:7<8'&.Y?WL6W4\Z7!'!86$7^;;H!C\J5L%P@^D6Q^[]@=HN^'C3:U
M?@%CQ/VNVQC\@/7==];(<G4W43N].JGYD+7:<?*\=O[L+:^.[35HZ7Y%^HU1
MN^EAND4^K)(2 Q !<H!2]S9JY$@#LI<O6Z:/ZM8U":P6S%]@9-#L%Y_@JHG(
M,FHB"UBCCP5IC]\Z+?/QEH_W(GEO/JUS25G*N^W*T$R6Z;LYE[5Y6ZC"SSY@
MB^G' F  /\NV\=M>'^OW[#UF &^#>O5-4BWV Q@CTZ8!/+%A1-2ETGY*5'1^
MI3ZSX+<D5P<7?*LZ];[3]O,W1*DD%<7(N_D C?GE5#E[XIQ8M&25IDZ=J<8-
M7:P[-9>]YZPPSP: 3RDEXK2Y-EO+V++G]AX NRBU:'C^^7@B,8N5B-O]G+EC
M <<"C@4>;8%BI2YT 4C"06KU"2D/@*LS [QRFN;L#%&4B0$.T)PQZQ1;Z*:)
M?O2-/]96"X"IPH.TF/<O"8K!8RQ3L@B<AA+G2O9-DR@8L,QV\!P$)-B)$DFU
MVXPSQ&+WX<L-D(5,A%B$S077,9:27!C\1D@-Y"-,,\?7_VR:J0( ,4K=8$ O
MRV!%L!I@&*88? 9@!D>"VTBB7",88.1,!$3# H/B,3@> SP% %SH<6AQO+^V
MH#+ %587#3H/"MK=O6%,#$Q?> Z8TQ]UJ6" &41A@ '3R*#1N,/^8D@&6ZAY
M'@ #+%IW/!P 9/8A3AAF&B^# X#=K>XL.Q9P+.!8X-E9@/<S8(?!#*4/7F%R
M.;@W),_4Y 5,P:86%A8;)A$&$Z84-IAX4^)? ;Y??=E+C1M]HI$CR4SL2N!T
MZ&B"R88<%YMJ/H;NY&?)SWN@&C7\3E,V1>O^W71%^<U0SV;U5>^_^FMSBHNQ
M1:),G=T+25EE\E_*&5'"B(;$^O3ITTI(2# L+M=#*XO=+<Y3=G:>,K)OF>VG
M=_NH[3N#M.Q N**.^.J;.@,U)< 52V6R38=,ET?]]FK7JH'>;#!:(5D/V.>L
M,SLT;N)/\O6/5%[Q@X\BXI!I@&#L8-N6;7NU;MTZ;=^^W;#4? Q^^\TW.G+T
MK*E%##-;UDKRE9O+/=]33OAL->TP1VN#$TQ_=PN*5)B^0X->'ZG)6Z--;+&)
M!SYZ7A%1%PV;&[@_K*PL$@#8+\"5$ N9-N"?/KC.*UDN5MM=VLTU\)%%#!@-
MYP<E+OB[8.QWFF,!QP*.!:IN@6)E^GEK94*"=JY=H>7K*S# U18 IVJW7WFY
M]HN( 89]!9?!S.X[<M9@)$))B=4%'R$]AA&&'09P0@ZBVH&01+UELS:#EUKW
MG6L4O;#!D)@ 83 49*-M](FBEQ)*)"@F9!6Y-=B,<X$# ;H[#YXV0!@L!I[C
M.L%M$)-4[B'74XT!P !:9,9X&J"\T75ST]PH>FZ23V$4XL'XS?YX(/@8LF6*
MW+W!&)7ZPK#+@&D"L:'=,28L,#6GT+9C/, S#P"0C?< ^3,>!"A_O!DL8T@>
M!H,N2;#P3-"W X#MGZTS=RS@6,"QP+.S )Y@F^T1YR6-]S/)#RLVP!J@Z7+J
M=9%E&(#)="/WCF$8B1%NW=)5'HACY\Q9J-#C2296%IGTS5MW%1NQ70,^>D/U
MNWGJQ]F;M.O8>06LFJWN'WAHM%^\\DI*5'PC08?VGU7. WQIZM]RK:M6;=:*
MY2LT>>(D$^M+V:(A0[XO*[O$><\E9"K[VG4=W^>G3=Z#U>K-6JKUTH?JM_*,
M#D0D*3KT%PU_>[J.%W""JPH<UDE#-Y26_2D\K85->FGE^7R=/'->H3Y=],FR
M6+D^'>XJ8L$7^JC;<$T?T%;U.\XJ*Y$1&I%DG (6"%O;P9B3, OF%_ +6*=-
MGCS%9+#&*_\7[7Z\5GITUYSP+,/TQB$U/[1;R[_R4/>ED0H.NR 57]?J=<>4
MFU]@Y,TP]'OWAVK!@H4F"=A'=>L;H#UQXD3#H%OFFNOC&2)_SB^5A+N?GP\K
MQF@:'TZ,Q3C!G>98P+& 8X''L4!)7K0V!AQ6Z*:M.IYIU36E/51; 'Q;L64,
M<*2.!V]Y(0PPF(GQ%[S%.Q>PB5093 8AR3)8#2:6\1F<!A8#L**^Q8EMI<\P
MON1?(LLS!"28C(16D(VVX>B&8884!5_!*I/DF'/ $!-K3,@J1"7C 00IK##8
M$74N<Z37-2H+- ,:J;.Y<  P+"W!TX!BXKTP+.PK-TO ,Q\<L '4YR7HF8<"
MZTO#F'4Z3#0&!OP2/T2F:>33]$EF9SP:,+MX,0C"QK"L9Y!E/V32K,>K@1R:
M9%STQ7:88,HI\<?@ &#[9^O,'0LX%G L\.PL@ >8=RR.3*30>)7=8W_=SW3S
MEHO=A$T$#",Q!D@!KC9MVF'8QPGC)ZC.NW74LGE+S5^PTC"NR'VIQTN[>SU&
M4[_Z1+]_[5,-&3=>/9K5TSM-^VKXB&_5Z>TZZC1MCY+S'GBJ[?FI*QP3EZ)7
M__BR6060W+9UFY$9W[E;9-AANR_SF'/QVCJRN9J-VZV4O&*5Y!S4Z#K#%)!6
MH,C(O5I8M[=61L4I.F2-1C3L*\]?HLUX5Y*Z23WJ+M"9>]*!(_%*W3=!M0?L
MDN&42Q*UJ&UG33O(O=Q1@F\/U?:.4L&]^T*BC:099MPV5$\PY+8!@)&$$Q_\
MXP^>:M^VHW;NW&DW/YB7)&MSCR\U\U"Z=@6>TM95BS2DX<?J,NV@_ Z<57)D
M@!;T;:S?O_6CMIW/,:PS4FJ89ZZAZV?=S#F(PY[C,\]<FY% QV<8MIYG 9M>
M67-__GP$\;?!9$%Q9<<XZQP+.!9P+%#> B4JS@C2Q!9OZ*V&8[6[8BW=XG"-
M[K!>&>4/JA:_RM<!GJZ \S<KK4+P+"[62J!YQ\+>(FLF(16J7  JF(E]>/^"
MG<!'X"E*S-)@C"$8P5G@+JKH *11[=(?[#"YG) U(Y$F;Q.-_L!S &Q"8'GO
M(Z<&CT%^ H@!UA"8D)$H@TAV#.XC82),,+'  .L:P0"3KAHC84R :;TN4PU5
MOCWHE*'<J?$+^.4C"$\ V<&0+.,I  B3@8QE;A9#$1P]?EZ H=J) Z9@,D;&
M^"31HC\,S[EX8!Q'8YD'B28=XQ)[]N\??&<>/-OQ,@#08R^DRZ/?7)-FVP'
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MV0D)LWLC-!4@#!:$[:4N,-\#],GU,"=,%MP&H4D_9(DFS+7&),%JTF.6N6?
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M>,!PL,-@*I:1.^/\8Q_ ."68R $"K@,D@]? =^QO,2,UA\DP#6N,$YWKK/8
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MC$.\,,:#6>:CJN+T86G*;OZ+([^&-J^XC_OOOW^YC\EFAB>"AXFA\4XXS;'
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MBYY7=DW/\QH>=3ZVV6?YU[;+\[2!T_>36J!8F3L#2FNMTT>14OVV*\H.,0X
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M<C/P7@7<T #$#)2/TQ8N6&AB?@&_W;_HH>.1%\J %_)H"[X ;^Z,:<5S,%[
MNL*TTM;_LDDC1GBI0X?.VK7G@"D'!.MZXN0E%12D*]BKK7JN2Y KDE&*B]ZO
MN:V^U+2@RT;*?+?@CD)"$PUHL^=R9Y?M.N:PO[#/G)\&$":Y%Z"63,E\Z*=G
MWC L*S+IRIH[^RK=T_%-,S1F]1G%7+[FNIZ[^0K\98X&UJNC'BOC=+=$*KD5
MH3F=A\EG?[)@PFE9V;<4<RY=>P-#-7/&#+,.L'HV-KW,-I6=GW5<VYZ@6&/S
M(Z$/G@-L,(G#IDZ=:IAZP")])B0D/*RKOUB/EY]QF8;RB[^;1ZD%+"BK.,_/
MSQ<.K3-GSFC__OU:O7JUO+V]-6G2) T=.E1=NG21AX>'F=JT::.6+5NJ4:-&
M>N^]]_3FFV^:Z=577U6M6K7T'__Q'V;ZUW_]5_W+O_R+_L?_^!_ZAW_X!_W]
MW_^]_O$?_]%,__9O_Z9___=_US_]TS_IG__YG\VZO_N[OQ-3QXX=R\!CQ1NN
M>-W\IE5<7_&X%_7;7@=,M5VN;/XDUT,_56V/LV]5^W3V^RU9X+[^?_;N ]RJ
MZLP?__22R61F,K_)Y)_)3-I,DLEH8DLTFL08>S>)O40-HH*"J& #&S84!50L
M@(H:.P@(@GI!4$$%I#<!"PA2!!00+ G*^C^?=7D/F^.YEPNB<O&LYSEW[;+J
MN_?=>W_7]RTK7IZ2ILU?D!8LF)Z>'C8R/=OUVK5,ZA\?3-_Y1HO4\"?1IRV;
MU6G5_&?2S6U:I@OOF[P6N&_B800#[+D:-K]\+[#QA<U@,8ZOL+5?^4G+M/-A
MEV?/T(!J>>*K"=B%OX+)!8ZI5L-IU*#A-OB-HRW1=@!=^(X38^#ZKC[/9@_2
M 8[AN,"*@1>UI4W[C<8+- -I<7I#[SMB.XG_"]$#Q4"N;8ZJ_#"]174GP@T7
MV@ O 0"]+[XR/\<1)FQL@KI4JJ?,G)?/ [V$+-4,GY+^;Y^VZ;1+_I##)P'5
M7K)4K;ZPU2GY(KO8QNF";'_P)54 7'ZG5_?KE4#_1QY)P&X )VK/@!-G,YLB
M81WU@5G>ZU>[E_K1'SO4B1-JPX<TI"]CTM89I[?(K#1/QI^W9,ZWWGQ+PNJ2
M7UPW.8_./#M/GC3I\R:63V2^7IQ>M%ZXGM%2J+G6U:&P/-.F+\A,)P=1@%6+
MEN=E,$7]^?GGGLNL(E5EP)>#+"K%5I)?G+D@/;G&$59=[3O.,53;MA=G1F_2
MQ(D9I"U=5AMJ2=^OS%J<1H^=G?ZT](5T\^%'98:54MH?__A^&GIKB[1MZYKT
MQI\^R.T\_\*KF;45$HC:-6 +1)<G0)>M[-)E[V2FEI,M8Y:6O+DBSUE]H!B0
MKY2 :^PU]6FVPIQ18:RUF5:_G8;=<7[:?Z]ST@./=D_-#K\F#5^D_=5IQKAI
M:>2+"W,?G'"%5VO/@PY7797FO3XOW7I+]XKC+HY#7: W0B=1QW8-+!A(WKO/
M/3\NM;OPLK37GONG'7_\TW1*LS;IA?&S,W FF_H233#.*"7F4>Z;T!PHU@L0
M-G_^_ QH#SGDD/2+7_PB_?=__W?ZK__ZK_2%+WPA_>5?_F4&JE_[VM<2,/N3
MG_PD'7OLL:E%BQ:I;=NVJ5NW;OGWP ,/I($#!Z8^??ID%A>C.W;LV#1JU*@,
MH/7!3GSAPH5I\>+%V;O[TJ5+\\(F9I3:;@ T^<J5*],/?_C#W'^[=NURN1AO
MS*&X7ZP;VU'NL\R-)8"O'.L;J3C^XO$XOZGSHESJVM[4?5;;:TP26)46#NZ9
MNO?IF_KUO3U=W/:F-&#$2VN!Y&:K CT_#>EQ?WI^YJ*\6/E)2SP ,%-2> <N
MXC,)BQO:KPA&/I<PO\>U[I'Q$T=6$NT<N(Q&KG"S\!4\9M$2>,;V\NWDO'.
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M.;@"AC?VA8Z9O/+R*Y(XLD6P:UO;34XX,:M^8G W) G-PUMQL4T,]9DMSTB
MX9::V%GSWER\1B&#7^R\2^K8X>I497H_O:O/O,2+U;->LEI<E_TOP!/L+Y!%
M%1F3^GC-\]FITFG-F^?_!9Z&@2WL[V-#IF3PMXIJUIPE:UC(*6GX\R]G>UN,
M:3&LD#'X +_EEENR$Z-^??OF<$38U0"4Y=)AMPM@.J\/0 Y %Z^73:WP2QQQ
M!;,)&+*%!?2 V@!\&.6AS\Q($R:_G@&D%6\ &S,;-LD J;!/0*WD>*@Y ZJ
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MI%?H9K,ZQ/D7N^9RE7$R:'[*J>FQ@8.2,";5]-E(P,LO%A6]M*3P! V$ 4Y
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M2S,@-AXJXA( KAY&G2.P2LG8PBZZTGEC-A;C!V ONO"BM/4/_B_'1JY4WC$
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M6AC,#0' P!,U9PPPYEIHHE6K/LS@<.!C(RKV_4"O(1EP MN#:J:D>07VM2X
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M.<=9V&,.M\XZHU4J]JL,^^0 ]<5V&[IM/EAS['?T*=>/\5;M>QLJR2VG7#D
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MGR2+X+ ?)M=Q@-BW ##MV$D7],S'$9)P'Q ,ZV&9$9_.>^8SG[4-O]'X;10
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M X0)+:2=8"(C;].Z3>+=&*O\S+,3/G*>?2XV4\BEYLWKUXS 1$G4MX$_;"?
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MZU&\OXKE0@;5?$N5P#MIYIWMTH7W#$FCQHY-8T?T3S=?TR?-_-/:^W]3SCP
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M 'B=2_"YW&'S&JP)+\AUQ=']7 JG.NFJ!!H@ 8N6GKDT<B2,WNA)M7%CL7X
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M6E:7W2\ A44\K7GS],@C W-]#J+\A/FAGDL%&1!M2+KWGGMR,6U.F5*W=A(
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MCA>/V8[C\LT]Q5@#_+I?BMO. [EQ+\7]%'G4C[F6[V_N\Z^.KW%((  P#]!
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M.3O?W+F<YNG% P;^OM0AF9P\]:URSVZU#DFIQ-B*K]58Q=9J2:HB.;9Z6TT
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MCA@QHKG+$CT_"U2;K+[WW@>E[>83F_YY_J5Y):&L'A\[_LV/;-<F UNEJT4
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MW',O+?=;N^_ZEU==528G;'O65ZOSJ2/O$N(<CW'G%FSVEL_K@,M:3!S.9PD
M3$M$\"\>8.<"=CS)C[(]/,"WX3F89JL*?RK \H[?^$H^TV>K/ (XOIP=XQ!^
M!B>S9;:F70&<V :?2T+Y#C;"QTB0V;/K<+# D!_7/O_,+[ YL0Q;L"K%#^%Z
M<M N/\('L-E1X^<6^Q?S&*=MB>(>OHQ-.E^[[%=].!UW:D/2PG>R>>/BS[2!
M\_3%F-BSL3B.<](OZ+\DCC_P+F:@.^_XC]S%-61L8B]7"P]'ET=Z+OW@:GY
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MB!BW<2!23DI0SR@X>WWCE!@\L)$/<M W@8+^  G0&Z- @%P9%K!S0(+;-%Y
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M%6$65_O^4&."TNFF/Y_X"C!C!V:D6"T$36 $D86 '6<P$AV#Y50H6\ ('(1
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MA[\V#M7_^D@33_Z?SUY8?OG0_*HGW;XVYALC?P=]XTTSRZ1)4\K"9]97'?U
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M2V8V) _;J&G(*3]Y9C-KLHU8%W?\S7[\&AG8W!QBHJ>OO_J"KLYE#SB$:3B
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M!$7LVQ(8_SJ>+20*1*F(D120AJ! 0@IM9*K)<'R"G)SF]NQ[KUUEY!_^2K/
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M" $%#!R,["5-P!5@DFZN_)&?HQS'&0@>20L:\DGL 8JDUR8^24,@D]4.FP8
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MVTB@KSG9/@!#8'2A$_T5Q[E*)UFR!_G9B'R2:':&-'>:?W9%.HI40-?0*$2
M-7J%X+T7H&S*-OF>[]KDQO\PP39DTZ )#KO?"A_RP%$*)K+S$?_P'_O!C"9
M8 @\>FK8-4\P(-A=(9(X?!Z;.=YK9(UPD"%Y$:1$B2#(G@T&\_(/8C&0>H*4
M'M&1W=*X(Q<R*0@$LF,4!$D6WL._1*@P2U/ERA1;BA&$A%0E/^>Z4DU625X\
M\"/BHHL&UFVOSI4$Z&PNMD0R;*(!AI$D$[IK=NA"7G;A(S@GGTTC\TH\2(S/
MX0#1AC@5'M;(QHGSZ.39@W\EO_8SODQRXTNX)Y.$([8D&^0I69";7)(6>YB3
M39"^XE629V/)!';=ZNAX\\$^.X@)R9X]O!?+;"]^V Z7L"U9Q1I_B3&%A_7$
MD^1N7C8@(Q+/P"62%2X*QN$@2<<<\,/6,.6]AYC(:W&,NV#&!HZA62(G+H-'
M"0VF%9R20NR1#3)^\J"#8YW+AK!O3O,H).W*VF'WG<*#_C8J^9I-X-^<9!.;
M=,)M/F-C<M.5+7 O3"I 8!(GMW'O-5G-E3LG8!2W^0R?)^E;5ZR1B:T4J'*&
M1A&GI- VGT;&$.?\)M?\ML,/7/G%Y]U[WJRW_[J-6A.L(5ZR;* \MV1U>?#A
M!?77E$_]W*EE_&7C.XWG<9W&TX]HG7#\QVIC.G'"A'+SS;?5AO2"BZXNUUUW
M4_U[W+7K7RE77?G],G_!T_56Y)NG3R\'_NW7Y?JIMY1[?SJG//UL?[GPPDOJ
M#W--G#BYC+_L\N(83>U'/OSG]4JOUY_^U&=&&O&SOW)>;<0OONBB<M<]]Y?K
M?W!]F=^WLC;Q_A]??^OLZJX&>-.63G'TV]H(!_&; 9=P%NPJ!OD,+\( KI '
M\;MF+\?!CKCU/DTK#&ML?(;/4[1Y+_;-)6;$LSB$!6O9Q!$S> ?V%)RN8,H7
MN3+F"HG\@&_,B[/HH3G#@^05<W)G3U]_Y1RXAKG$!&SB1[F'SAJ*Q(:Y84\3
MZ!SRBK$,19U<:6X-7>S CGE-)QN,W9_A>\?@3O+27SQGV-"5F]F"7'*E7.X<
M/L#G=,:+Y$\C*+[QNSBS<:0><=6+'&*)7? [7L1W'EZKN>1[]9+:1HV2*UWL
MC^NL2RZRXER?DT^,^\S<T1O?I%G#+_(#/ZMW',.?;8/L?!QJ?<]T)K?:TI4C
MO(F_Y%<YA?[T-A=]-4'R! RX^NQ\LN% _J<S/L./BFVVT63$OL[A:UC"4^%>
M?(S+V!<><2%^E,-@/T,^ASVY4IZ.'=J\J%:6>^B7[]4[V>" "?8U!STS;*[(
M/VHG_H)+OC"'>-#TVD31V,)JKG[2!1Z2(^@. S[W+%>R@QAT7![BC*S6<<>A
M7)<[ <BEQB0'&Z@A795E2WQ.#C9E#SXA(UX7;]&9_=C!&NUG>0V/XE9NLAZ;
MR_7DA['@A!YT=AY\>$[=SS[J/?$-"V*+O&H\,:%FXC_UHWG5>6+9L6HN<XLO
MW 4+,$ N/(';R 4OGM4W\F(V#M739#=?VTLX%N[)*0YL'HD!?.8SNJB#O/;
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MC _8QG'BGQQTDA<SY#W\ZC/<A7/40>PD1L4NW=D(UR@X\2,YQ9[8T72*>]Q
M'KQ#;ASB7+Y(H4M^O"F6\ 59U77\P!8V+ 8&AZJ=G:^@)0-><#S.9F-YGK_@
MA7V<CW,4XSA#S&M0Q36.(H?S< 3YY!6?X6T\@[/-@7?9V=PV_/"$F&=_-289
M<0V^PX\:9CB5DZQ+?_DOG*>QL0Y=?,:&\@6L9M/-Y^P' ^H4<[&ES4\<J>;
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M*5F2DPX"C[WRWBZ4H IHLR:=R Y0=N',Q6:2D<)$\9!F4!!ZGX8A<VB2D 3
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ML)!Q;I%2I",Y]G,L<$IL=IOYR5I\9VZR\PTR2\&4(HG,1II<.GNP%UL K_?
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M:0/L-A^&YCC-5 C,;AV# "^ <#J%/) @116WCI-D!8LF%B'$(1J$ +(%+4,
M7AH=@2(Y(\5V !$G(6=D*N 1(; C,O)Q%(<B$^ T!T=P#(<)M@2LUW;=?N?$
M<15$64N :UHR!* "CDP<"\ <"@AVO@2"A D@]$=:YD5BB@!Z"4RR BKR!PK
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MW?#!=WVEN@ECX^&"\_A5[^4=Y^2?G@>_X>H[K!^]^_ZF2S32O&S4;],T6-F
M%"^U'%<ZZ%BZX)X.O))3GJ<Q<,<E^=YF%'M@SQ=K!O.(C;_4HC]X*'9B(OYX
M+<[6%?C/;CD!!]K61BIMD+<X"RN\IQEZCP>/GFY^JN/XK4:(K]C"MKZ)_S@$
M%UHJ1W#9)H/SL//9F'BCOS,F>_A^T^-6%\ 2P4**H<1!$(@3 @$6((3(KP+
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MD!TA-"[K@: =$;7OU[T32T0TG\5'.)J7/1HW22"9-4^*O7M=5Y#MO+'3OV%
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M/8)N7)^)F$:E0Y'VRX%K1,5XZWWFD4B2R_CF)@H6MA8H@BO8R.4Y/A%3S;F
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M7Q1IXW@14^_\-!ZQ0T;-"]&$-;(J&,0&ENY1T/;-C06?/RNQ4< 7?THIR?"
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MT"OCZ+WY*_[XGT;X+.ZXRE:VT 3XB;$Z!1_URW7CJI7L9$L;QCC$#GE%JW#
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M/:WKKR'8!7=CX#^?V.QE'#B($]^=,X>X^O\?543X0@,WW[_YXVTLG\7+.R[
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M0-_4J+E_$!@$!H%!8! 8! :!06 0& 0&@4%@$#@T K, /C2B,]X@, @, H/
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M! :!0R,P"^!#(SKC#0*#P" P" P"@\ @, @, H/ (# ('"4"LP ^RK",48/
M(# (# *#P" P" P"@\ @, @, H=&8!; AT9TQAL$!H%!8! 8! :!06 0& 0&
M@4%@$#A*!&8!?)1A&:,&@4%@$!@$!H%!8! 8! :!06 0& 0.C< L@ ^-Z(PW
M" P"@\ @, @, H/ (# (# *#P"!PE C, O@HPS)&#0*#P" P" P"@\ @, @,
M H/ (# ('!J!60 ?&M$9;Q 8! :!06 0& 0&@4%@$!@$!H%!X"@1F 7P489E
MC!H$!H%!8! 8! :!06 0& 0&@4%@$#@T K, /C2B,]X@, @, H/ (# (# *#
MP" P" P"@\!1(K M@/W/O :#X<!P8#@P'!@.# >& \.!X<!P8#@P'/A_Y\"_
5 !Q'&$U(789L     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>nvta-20201231_g1.jpg
<TEXT>
begin 644 nvta-20201231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %L!0 # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HK&G\0VUO.\+1R90X)&,4T>)K(]4E'
M_ 1_C6+Q%-.S9//$VJ6LM->T]^/.*_[RFKD5Y;3_ .JGC?/HP)JE4@]F-23+
M%13RB&"21NB*6/X<U)4<\*7,+12<JPP0#5.]M!G(#Q!?A\^8I&>A45HVWB=3
M\MS"5_VDZ47'AA3S;S$>BN,BL:[TN[LP3+%E1_$O(_\ K?C7EMXBD[O4P;FC
ML[:\M[M=T$JO]#R/PJQ7G<<CQ.'C=D8="IP16U9>(YH\+=#S%_O 8(_H:Z*6
M-C+2>C*C574ZJF32I#$TDAPJC)-1VMW#=Q>9"X9?;M3+ZT%[:M S%0W<5UN3
M<;QU-+Z:&%!XE<7+>>@,)8X(ZJ/ZUT<$\5S$)(G#*>A%<3?Z7<6#_.NZ,G D
M X_'T-1V=]/92AX7(!/S*>A^HKSJ>*G3ERU48JHT[2.^I:S].U2'4$^4A90/
MF0]?_P!57Z]*,E)71LG<6BBBJ&%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%)F@!:*,T9H XO4-.O'OYY%M
MI&5G)! SD54:PO%'-K-CUV'_  KON**X98*$FW<R=)-W/.FC>,X=&4^A!%-K
MT4JI&" :JRZ78S#Y[9/JHP?S%92P#^S(3I=F<?;ZE>6V/+N'P.Q.1^1K3M_$
MTRG%Q$KCU7@U<G\,VSC,,CQGT/(K*NM O+?+(HE4?W>OY5')B*6VQ-IQ.BM-
M8L[PA4DVN?X7X)K0X(Z5YRRLC%64JP/((P16A9ZU=V?&\R1C^%ST'L>M:T\=
MTJ(I5>YT5YH5G= E4\J0]TX_3I7.7^CW-CEF7?$/XUZ#ZCM726&M6MZ0F?+E
M/\+'K]/6M(@,,$9!K65"E67-'<IPC+5'GUO<RVLOF0N48=_4>A]:Z?3=>CNB
ML5QB.4\ ]FIFH^'HY09+3"/UV?PG_"N9DC>&4QR*4=3@@C!%<EZN&EKL9^]!
M^1Z%)&LJ%'4,K#!!&<US.J: T(::T!9!R8^X^E)I6O-$5ANCNCX D[CZ^U=.
MK!U!!R#TKL_=XF/F:>[-'GL4LD$JR1L5=3P:[#2=734$\M\+.HY'K[BJ6L:&
M)-US:K\_5D'0^_UKFXY'AE5T8JZG((X(-<<93PL[/8S3<'KL>BUB:UK#69-O
M ,2D9+$<*/;U-6M*U-=0@Y^651\R_P!1[4:II::C#V65?NM_GM7?4E*I3O3-
MFVXWB96BZTWF"VNG+;C\LC'GZ$UTU>=RQ/#*T<BX920<^M=3H.I_:HOL\S9E
M0<$_Q#_&N?"XAW]G/<BG/HS<HHHKT#4**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA!!F.Q FDZ;SPH_J:O\ B73WO]+81$^9&=ZJ#][':N L["ZOY?+MHF=L\G&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&N&:]0Q>F/B_0]YHHHKR3Z,**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** $K,UR:\M]-D>R3=(!R>X'<@=S6G0
M1ZT-:$R3:LCR$[YI3G<\C'W))/\ ,UW'AWP\ME&MU=J#<'E5/(3_ .O6I'HM
ME%J37RQ 2D?@#Z@>M6;R\@L;9IYW"HH_/Z5C"FHN[..EA53;E-W)994AB,DC
MJB*,ECVKB]:\5O<%K>P)2+H9>A;Z?YS]*R]8UVXU:7&3';@_+&#_ #J#3-*N
M=4N!'"N%'WG(X7_/I43J.3M$RK8F51\E,IA7ED 4,[L>  22?ZUT^E>#Y9B)
M=0)B3J(P?F/U/;^?TKI-*T*TTM 8UWR]Y&Y)_P *T)98X8S)(X1 ,DL>E5"D
MMY&E+!J/O5-R&TT^TL4VVT*QCV')_&I99XH$WRR*BCJ6. *Y35/&(!:+3USV
M\UAQ^ _Q_*N5N;RYO'+W$SR'/\1R!]!VIRJQCHBJF+A#W8([:\\86%N2L :X
M<?W>%_,UAW'C'492?)$4(]AG^=8EO:7%T^RW@DD;T53Q]?2MZU\&7\N&N)(X
M >HSN8?T_6L^:<]CF]KB*K]W8RY=;U.4_->2X/8-@?I75^#KF2>QN%ED9V67
MJQ)."!Z_2DA\%6*#][--(?8@#]!6QIVDVFF*XM4*[\;LL3G'UJX0DI7;-Z%&
MK&?-)FA1116YWA1110 4444 %%%% !1110 4444 %%%% !1110 F >U&!Z4M
M% "'I7G<C;Y6;U8G\S7>7TODV,\F<%4)'UQQ7 5YN/>L48U>B.UT-=NCV_N"
M?S)K-\4M\UNOU/\ *MRPC\FQ@C(Y6-0?KBN:\32;M0C3^ZG/XDUK7]W#V*GI
M C\.KNU93Z*377L0JLQ. !FN7\,1YO97_NIC\S6UK=Q]ET.^GSC9 Y!]\&JP
M$?W:\R8OEIML^?+F3S;J:0\;Y"WYDFO</ D?E>#-.7U5F_-B?ZUX43DD^IKZ
M%\/6_P!D\.Z?!W2W0'ZX&?UKZ#'NU.*/#R=7JRD<I\5F T"T3UN@?R5O\:XC
MP(N_QEIX]&8_DI-=7\69\)IEN#U,CD?3:!_,US_PV@,WB^-_^>43N?\ T'_V
M:BC[N%;]18GWLP2[6/:J/I574+O[#IUQ=8#>3&SX)QT&:\[C^++ ?O=)!]UG
MQ_2O/IT9U%>*N>W6Q5*BTJCM<].I:KVD_P!IM89]I7S$#;3VR,U8K+8W3NKH
M****!A1110 4444 %%%% !1110 4444 %%<1\3O$NI>%_#]K>:8Z)-)=B)BZ
M!AM*L>A]P*\J_P"%P>+O^?JW_P"_"_X4 ?1E%?/5G\6_%<]]!$]S;E7D53B!
M1P3@]J^A: "BBB@ HHHH **** "BBO'?B'\0O$'ASQ;-I^GSPI;K$C /$&.2
M,GDB@#V*BOG/_A<'B[_GZM_^_"_X5HZ%\8M:76(/[9DBEL&;;*$B"E0>-P(Y
MXZXH ][HJ*&>.Y@CGA=7BD4,K*<@@]#4M !1110 4444 %%%% !17G_Q1\5Z
MKX5L]/ETN2-&GD=7WQAL@ $=?J:\S_X7!XN_Y^K?_OPO^% 'T917D'PY^(.O
M>)/%0L-1GA> P.^$B"G((QR/J:]?H **** "BBHY0[1.L;;'*D*V,X- $E%?
M/NH_%+QGIFIW-C/<6ZRV\K1L#;KU!QZ55_X7!XN_Y^K?_OPO^% 'T917EOPR
M^(5_XDU2ZTW6)(VG\OS;=D0)D _,N!U/((]@:]2H **** "BBB@ HHHH **I
MZIJ$.E:7=:A<'$5O$TC>X S@>YZ5X WQ@\6%B5N+=1G('V=3@>G2@#Z+HKYS
M_P"%P>+O^?JW_P"_"_X5Z;\,?$.O^)K&\O\ 5I8VMUD$4(2(+EARQR/3('XG
MTH [^BBB@ HHHH ***\Y^*?B_5_"@THZ5)&GVDR^9OC#9V[,8ST^\: /1J*^
M<_\ A<'B[_GZM_\ OPO^%:7AWXI>*-1\2Z78W%Q T%Q=Q12 0J"59@#@@>F:
M />J*** "BBB@ HHK(\37T^F>&=1OK8A9X(&D0D9 (''% &O17SG_P +@\7?
M\_5O_P!^%_PH_P"%P>+O^?JW_P"_"_X4 ?1E%?.?_"X/%W_/U;_]^%_PH_X7
M!XN_Y^K?_OPO^% 'T917SG_PN#Q=_P _5O\ ]^%_PH_X7!XN_P"?JW_[\+_A
M0!]&45\Y_P#"X/%W_/U;_P#?A?\ "C_A<'B[_GZM_P#OPO\ A0!]&45\Y_\
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M?\+@\7?\_5O_ -^%_P * /HRBOG/_A<'B[_GZM_^_"_X4?\ "X/%W_/U;_\
M?A?\* /HRBOG/_A<'B[_ )^K?_OPO^%'_"X/%W_/U;_]^%_PH ^C**^<_P#A
M<'B[_GZM_P#OPO\ A7:?#/QWKGB?Q%/9ZG-$\*6S2 )$%.X,H'(]B: /6***
M8\BQHSNP55!))[ 4 0WEW#8VSSSL%C4<GUKS?5]7GU:YWN2L2G"1YX'U]3[U
M-K^LMJMWA"1;(3L7U]R/>ET'1&U:Y)?*V\9^=NY/H*YIS<WRH\NO5E6E[.&P
M:'H4FJS;VRELI^9O7V%>A6MI#96ZPP1JB+V%.@MXK:%8H4"1J,!1T%8OB#Q
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M?^@>_P#W];_&@#YLHKZ3_P"%4>$?^@>__?UO\:^=]4@2VU:[@B&(XYF51G.
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MS<<;%Y(/UX'XT >W_"_P_P#V%X-MWD3;=7O^D2YZ@$?*/P&/Q)KMJ0 *H &
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M9'4]S^'3ZY]*X[P_HD^OZM'9Q?*IYD?'"J/Z^E>\V%C!IME#:6Z!(HE"J/\
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M(RJ<$@=AFO8/^%Y:3_T"KO\ [[6@#U2BO*_^%Y:3_P! J[_[[6C_ (7EI/\
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M@ZM7GET._,*JP^'5*&[$\/Z8^LZ[:V*YP[@N1V4<D_D#^.*^@HU6-%11A5&
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M7A/79/#GB:QU-.4CD E4?Q1GAA^1)'N!0!]745'%*DT22QL&1U#*1W!Y%24
M%%%% !1110 4444 >-?'?[V@_2?_ -DKQRO8_CO][0?I/_[)7CE !15_0]+;
M6M;L]-241M<R",.1D*3W(KTS_A1E[_T&;?\ []-0!Y)17K?_  HR]_Z#-O\
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M(;:)=L<2!5'L*L445Y#U=SZ5))60M%%% PHHHH **** "BBB@ HHHH ****
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MO^0[4=2M=*L)+NZD"11C)YZ^@'N:\+\2>(+GQ%JCW4Q*Q+E88L\(O^)ZD_\
MUJL>*?%%SXCOLG,=I&?W4.?U/N?TZ5)X2\*S^(KX,ZLEC&P,LG3/^R/K^E=%
M"C&A'VE3<XL7BIXN?L:6QJ^ ?"3ZC=1ZM>)BSA;,:$?ZUA_0']1CUKUX<5%!
M!%:6Z0PHJ11KM50. *\Q\8>.KE-7CMM'GV16KY=QR)6Z8/JHY&.Y^@KC?M,5
M4T/2@J67T5?<]4HKF/"?BV'Q+"R&)HKN)09$P2OU!]/KS73USSA*$N61WTZD
M:D5*.PM%%%26%%%% !1110 4444 %%%% !1110!YA\</^11L?^O]?_1;UX-7
MO/QP_P"11L?^O]?_ $6]>#4 6M-_Y"EI_P!=D_\ 0A7U]7R#IO\ R%+3_KLG
M_H0KZ^H **** "BBB@ HHHH *^=/C!_R4&X_ZX1?^@U]%U\Z?&#_ )*#<?\
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M"RM%5\<RM\SGZD\UU2Q5&DK4T<$,OQ.(ES5G9'F_A[X<7U^ZSZINM;;KY?\
MRT?_  'UY]J]2T_3+/2K5;:RMTAB'91U^IZFIKJ[M[*%IKF9(HU'+.P %>>>
M)/B7&JM;:'EF.0URR\#_ '0>OX_D:Y&ZV)EY'H1CAL#&_7\3KM?\3:?X>MB]
MR^^8C]W I^9C_0?6O&M?\17WB&\,UT^(U)\N%3\J?0=SZDUFSW$]Y<--/(\T
MSG)9R22:[/PGX N=1F2[U6-H+,8*QGAI?3W ]SR>WK7;"E2PT>:>K/,JXBOC
MI\E-67];F7X5\)77B*Z5F5HK%#^\E(QGV7W_ )5[5965OI]G':VL0CAC&%4"
MI(+>*U@6&"-8XT&%51@ 5R7C+QG#HEN]G9N)-0<8P.1%GN??T'XGWX:E2>)G
MRK8]2C1I8&ES2W*WCSQ@FFVTFEV$F;V48D=3_JE/_LQ_0<UY3:VTU[=QV\"&
M2:5@JJ.^::3-=W!)+232-R>26)/ZFO7_  /X071;87U[&#?RCC//E*>P]SW/
MX5W-PPE.RW9Y2]IF%>[V1L^&- B\/:3';+AIF^:9P/O-_@.E;E %%>1*3D[L
M^DIPC"*C'H+1112+"BBB@ HHHH **** "BBB@ HHHH \P^.'_(HV/_7^O_HM
MZ\&KWGXX?\BC8_\ 7^O_ *+>O!J +6F_\A2T_P"NR?\ H0KZ^KY!TW_D*6G_
M %V3_P!"%?7U !1110 4444 %%%% !7SI\8/^2@W'_7"+_T&OHNOG3XP?\E!
MN/\ KA%_Z#0!P5>U_ G_ (\=:_ZZQ?R:O%*]K^!/_'CK7_76+^34 >NT444
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MDT6T:1V+,Q3DD\FNCHH YK_A7_A3_H!6?_?%:NE:+IVB0/!IMI%;1.V]DC&
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M)H]2G/G@I=QU%%%2:!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQV?XG/GXC>(S_P O$0^D0JK+XY\1R_\ ,2=,_P!U%']*ZI?A.,_-JIQ[1?\
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MX]&A*E*%Z6PM%%%2;!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUD=8K-O^ ,/_ &:GGXD:MCBVM/\ OEC_ %I>QJ(V_M?!O?\ (](73;%/NV<
M^D8J=8T085% '8"O*G^(FML/E6U3W6,_XFG:5XQUFYURSCN+O,,DRHR!% .>
M.N,_K0Z,[78HYOA7)1BM_(]6P/2EH'2BL#V0HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5$DC88*L,@UQ^K?#RRNBTNGR&UD/.P_,G^(_E[5I&NFK21Q5\GJTI>TPTO\
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M-+O^"_A_%#4?_"M-0_Y_;?\ (UZ=2T>VGW)_L?"?RGFJ?#.Y/W]0B'^ZA/\
M.KUI\.(H)XYGU*1BC!AMC Y!SW)KNZ*'6F^I<<JPL7=1%'2BBBLCT0HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
<B@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>nvta-20201231_g2.jpg
<TEXT>
begin 644 nvta-20201231_g2.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" /6!6@# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHIHD5F*A@2.HS0 ZBBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9'E/Z4 ?0[2(K*I90S?=4GD_2G5\J:/^S?KGQ;L;3QKXB\5RV>K:ILO(K>*
MN((6.Y%5MXV_+MP /E]Z^J(8E@A2-<[44*-Q). ,=3UH ?1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>2FK(^EITXTX\L%9!1116QH%%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M117NGL!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7 ?%+X0Z;\2+(R?+9ZQ&N(;Q5_)7'<?RKOZ*32:LS
M&K1A7@Z=173/@/Q-X9U+PAJTNFZK;-;74?8\JP[,I[BL5F[5]U_$/X<Z7\1M
M%:SOX]DZ@F"Z0#?$WJ/4>H[U\:>// >J_#W6GT_4XN#\T-P@_=S+Z@_T[5SN
MGRL_/LQR^>#?,M8/K_F<XS;:8'96#*2K Y!!Y%(6S36;'UK6,3P;GTS\"?CX
M+[[/X<\2W %SQ':7TA_UG8(Y_O>A[]Z^AJ_-LMCIUKZ9^ 7Q]^V?9_#7B6Y_
MTCA+._E;_6>D;GU]#WZ&M;,^RRG-[VP^(?H_T?\ F?1=%%%(^S"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\>6NHZ;I&MI+?M;2[+>:*2%I,(?N[U 8^PY]J\^_8C_Y$?Q!_P!A$?\ HI:
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MZKZS 8%4%[2I\3_ ^UR[ +#Q]I4^)_@%%%%>R>X%%%% !1110 4444 %%%%
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M,JJTH=W )+8")PN/O'L*Z3]D'3]<T/P/JVEZUIFH:88;[S8$O[=XB5=%R%#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS(?Q8L?QJ]JGA'0M<OX+[4M%T_4+VWP(;FZM8Y9(\'(VLP)&#SQWK6H ^1/
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M:]/ X7VTN>?PH][*\#]9G[2?PK\6:<,*6\2QQHJ(HP%48 I]%%?5GW84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445S_ (J\<:7X1AW7
MDNZ=AE+>/EV_P'N:SJ5(48N=1V2)E)15Y,WF=8U+,P51R23@"O&?C)XJTC68
M[:SM)/M-U;N6,T?* $8*Y[]JY;Q?\2M4\5LT1?[)9=K>(\'_ 'CWKD\U\+F>
M=+$0E0HQ]U]7^B/(KXM5$X06@ZBBBOD#S0HHHH .>U>D?#'X=SZS,NHWPD@T
M]""J9*F8C_V7^=.^&'PU.M21ZIJ<9%@IS%$W_+8^O^[_ #KV]5$:A5 50,
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MTZ<:45".R/TRC2C0@J<%H@HHHK0V"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *9-,D$;22.L<:C+,QP /4FLWQ%XFT_P +V)NM0G$2]%0<LY]
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MWHN__ _,]'#8;F]^>PL<:PQJB*$11A548 'I3J**^_/9"BBB@ HHHH ****
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MDB'(8'N#7T%.HJBNC[+#8JEBH\U-_+J2T445H=@4444 %%%% !1110 4444
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M\G_P?S/KJBBBOFS]4"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M* "BBB@ HHHH **** "BBB@ HHHH ***0G R>!0 M>.?%#XO?9S<:/HK@O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MSJPTVZU2X\FT@DN)3SLC7)J*:WDMW*2(48=F%?2?[.O@ :9ISZ_=Q_Z1-E(
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M*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXGUJUTVS7=-.X4>BCN3[ <U]B>%_#=IX3T.VTVS3;%$.6[NQZL?J:\]^ O@
M>']%&M7<>+Z^3]V#UCBZC\3U_*O6*^GR_#>QA[22U?Y'WV4X/V%+VLU[TOP0
M4445ZY[P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4
M-W:PWUK-;7$:S03(8Y(V&0RD8(/X5-10&Y^:W[07PEF^$OCJXLXU+:1=9GL9
M>VPG[A/JIX_(]Z\M9LU^F7Q^^%,'Q8^']YIX0?VI; W%A)W$H'W?HW0U^9U]
M:S:?=S6UQ&T,\+F.2-A@JP."#]#7Z'E>*^M4K2^*._\ F?A/$65_V;BKP7[N
M>J\NZ^7Y$+-70?#OQY?_  U\8:=K^G.5GM9 73/$D9X9#[$?TKFV;BJ\CXZU
M[WLXU(N,E=,^2C6G1FJL'9K5'ZY^#O%5CXX\,:;KFG.'M+Z%94YR5R.5/N#P
M?I6S7Q/^PM\7OL6HW7@/4)/W5T6NK!F;A9 /GC'U S^!K[8K\NQV$E@Z\J3V
MZ>A_1.3YC'-,'#$1WV:[-;_Y^@4445YY[04444 %%%% !1110 4444 %%%%
M!1110!Y;^TI\/1\2/A'K5C&FZ_M4^VVG'/F1@G'XC(_&OS <G.",$>M?L@RA
ME((R#P17Y;_M'> O^%<_%[7=,BC,=E++]KM?^N<GS8'T.1^%?;\.8CX\._5?
MK^A^2\<8&WL\=%?W7^:_7\#S0FI;*]FTV\@N[=S'/!(LL;CLRG(/YBH*0FON
M;=#\ENT[GZW?"_QI#\0OA_H7B"$K_IUJDCJI^[)C#K^# BNIKY'_ & /'POO
M#FN>$9Y"9;&;[;;J3_RS? 8#Z,,_\"KZXK\?Q^'^JXF=+HGIZ=#^F\GQW]HX
M"EB>K6OJM'^(4445YY[(4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<IXR^&FA^-
MX7^VVJQW1'RW4(VR#Z_WOQ_#%=714RBI*TD9U*<*L7"HKH^1_'WP/UKP>TEQ
M AO]/&2)X03M'^T/X?Y>YKS9XVC;:RE6''-?H 1D8(R*\S\>? G1?%BR7%DJ
MZ7?'G,:_NV..ZCI]1^5>56P76G]Q\=C<@WGA7\G^C/DFBNJ\9?#?6O!-TT5_
M;-Y>3LF3E''J#7+?A7E2BXNS/CZE.=*3A-6:"I;6[FLKB.>"5X98V#*Z'!!'
M((-14E29K1Z'MOP]_:.O=+\NS\1J^HVO072X\Y![_P![\>?>OH+P_P")]+\5
M6(N]*O8[R$]=APR^S*>0?J*^$*U/#_B;4_"]\EYIEY+:3K_%&W4>A'0CV/%>
MA1QDZ>D]4?2X+.ZV'M"M[T?Q_P""?=]%>(_#_P#:0L]4,=GXCC6QN#P+R('R
MC_O#JOU&1["O:;>YBO+>.>"5)H9!N22-@RL#W!'6O9IU855>+/N,-BZ.+CS4
M97_,EHHHK4[ I.G)I:\[^.'C3_A$_!LL,$FR^O\ ,$6#RJ_Q-^7'U(K.I-4X
MN;Z&%>M'#TY59[(\*^-'C9O%WC"=8I"VGV9,$"YX./O-^)_0"N"S32=QR:,U
M\=4DZDG.74_*JU:5>I*K+=DF:[[X.>!?^$V\4()USI]H!-/_ +7/"_B?T!K@
MH8VFD2- 6=C@*!R37V%\+/!*>!_"MO;,J_;9AYMR^.=Q'W?H!Q^==.#P_MJE
MWLCULJPGUJO>2]V.K_1'7HBQHJ(H55& JC  ]*=117UA^C!1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7+>-/']KX*FLDN+>2X^T;B?*8;D QS@]<Y]1TKJ:\;^+GAG7=6U\W
ML%A+<V,4*QQM#ASW))4<]2>W:O,S&M5H8=SH*\M.ES"M*4(7CN=]HOQ'\/Z[
MM6&_2&9O^6-S^[;Z<\'\":Z6ODJ2-XG9'5D=3@JPP16[X?\ '>M>&BJV=ZQ@
M'_+O-\\?TP>GX8KY_#\0._+B(?-?Y?\ !..&,Z31],T5YWX7^,VF:J4@U-/[
M,N#QYA.8F_'^'\>/>O0HY$FC5XV5T895E.01Z@U]3A\31Q4>:E*YZ$*D:BO%
MCJQ]:\6Z7X=N[2WU"Z6WDN<["PX&.['L/<UL5\U_$*YU.\\4W<NJ6\EK*3MC
MB?HL8^Z >A'N.Y-<69XV6!I*4%=M_(QKU72C=(^DDD61%=&#(PR&4Y!'K3J^
M=/!?Q&U'PC(L1)N].S\ULY^[[H>Q_3^=>\>'_$=AXGT];NPF$B=&0\.A]&'8
MT\#F5'&JT=)=O\NXZ5:-5>9IT445ZQT!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\._ML?"'_A'_$$?C33
M8"+#4F\N]"+\L4X'#?\  @/S!]:^W;BZALXC+/*D,8ZO(P4#\37@7QX_: ^%
MC^&=5\,:MJ7]M/<PE##IJ^;Y;XRK;P=H(('>O8RN=:GB%*E%R[V['S/$-'"X
MC RIXB:@]XMNVO3_ "/SVDDJNS9Y--FGW,VS[N>,]:B+%NIK]7C _G*50T=%
MURZ\.ZQ9ZG8S-!>6DJS12*<$,IR*^G/%/_!0#Q%>6JPZ#H=GITGE@-<W1,K;
M\#)"\ #.>N:^4:*YZ^!P^)E&5:%VCT,'F^-R^$Z>%J.*EO\ UT^1]X_L3^*O
M$WQ$OO%OB+Q'JM[J;*8K:(S2?NDR6=@J#@'I^!KZJKYN_8/T'^S?@_<WYC='
MU#4)'RQX94 4$?J/PKZ1K\NS9Q>-J*"LD[?=H?T#P]&:RNC*JVY25VWOJ[A1
M117DGT04444 %%%% !1110 4444 %%%% !7R/^W]X"^V>']"\70)F2RE-E<X
M'_+-^5)^C#'_  *OKBO*/VA->\&77PW\0:!XA\0Z=ILEU:L(XYIE,HD W(0@
M^;[RCH*]/+:LZ.+A."OKT[/<\'/</3Q675:51I76C>FJU7XGY?DTW-&<>]-K
M]@L?S,Y'JG[,?CY?A[\9M!O[B806%RYLKIF.%"2<9/L&VG\*^\/&?[47PU\#
M^;'=^(X;ZZ0?\>NF@W#GVRORC\2*_+NBO$QN3T<=656HVK*VG4^KRKB;%91A
MI8>C%.[O=WT^6A^H?P3_ &@++XY7^M_V1I%U9:9IGEK]JNW4-*[[N @S@ +G
MKWZ5ZQ7S7^P9X;72O@_=:H5(EU34)'SZJ@"#]0U?2E?G&84Z5'%3IT5:*=O\
M_P 3]RR6O7Q67TJ^)=YR5^V[T_"P4445YQ[04444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&[S5X]UL<[1245S'E"YIZOCWJ.EI 3*P/0UZG^S[X0/B#Q@+^:/=:::/-)Z
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M_4X%8MQ\=M+7/D:=>2?]="J?R)KQRTT^ZU!MMK;37+>D,98_H*VK;X=^)+H
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M#*PR&4Y!%?*^LZ'?>'[YK2_MVMYE[-T8>H/0CZ5TG@?XE7WA.1;>;=>:83S
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUQJ&GVVJV4UI>0)<VTRE)(I!E6'H:YWP-\-]'^'ZW@TR-S)=2%FEF.YPO\*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M']]"7E^IS\)2_P!FJ1[2_1?Y!1117RQ]T%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;F9MSR2,6=V/<GN:WKXM4_<I[GHX[-X8?]SAM6ON1U/CKXIZ[X^F9;R?[/8
MY2Q@)$8],_WC[G\,5@:'X=U+Q-?+::7937MP?X8ES@>I/0#W/%>J?#G]GF]U
MM8K_ ,1&33K)OF6T7B>0?[6?N#]?IUKZ$T'P[IOAFP6STNSBLK=?X8UY8^K'
MJ3[GFN>GA:E9\]1V_,\S#Y7B,=+VV*DTG][_ ,OZT/$?"'[,C,$G\27^SO\
M8[(Y/T9R/T _&O8O#G@30/": :5I=O:N!CSMNZ4_5SEOUJWK_B;2_"]F;O5;
MZ&R@[&1N6]E'5C[ 5XQXL_:<2-G@\.Z=YG87=]P/J$!S^9'TKNM0PWK^)[W+
ME^5K6R?WO^OP/>JQ=6\::!H3,NH:S8VKKUCDG4/_ -\YS^E?(GB'XE^)O%#,
M+_6+EXFZP1-Y<?TVK@'\:YFN:6/_ )(GF5N(%M1I_?\ Y?\ !/KNY^._@JWD
M$:ZL;AR<8AMY"/S*@?K7H%?!=K875\VVVMIKAO2)"Q_2ONK2YVNM-M)G5E>2
M%'96&""5!(-=&%KRK7YD>CE>/JXUS]JDK6M;YEJBBBNX]\**** "BBB@ HHH
MH **** "BBB@ HHHH *JZK:'4-+O+52%:>%X@6Z#<I']:M44FE)-,-SQ1/@1
MJ9^_J5HO^Z&/]*]ATNU:PTRTMG8.\,*1EAT)"@9_2K5%<&%P-#!MNBK7\S&G
M2A3^$^?/C$V[QU=#TBC'_CHKJ?@&I\K6V[%H1_Z'_C7%?%"Y%UX[U5@<A76/
M_OE%!_45Z#\"+<KH>I3XXDN0G_?*@_\ LU?)X/W\WE)=Y?J>?3UQ#?J;GQ=?
M;X#U ?WFB'_D13_2O!]"7?KFG*.IN(Q_X\*]K^-EQY/@U(\\S72)^09OZ5X_
MX+MS=>+M&CZ_Z7$3] P)_049Q[^/A%=DOQ88G6LD?3]?G'^U9,+CX_>*V'0-
M;I^5M$/Z5^CE?F1\?-2&J?&CQE.#N"ZE+#G_ *YGR_\ V6OV/A^/^T3EY?JC
MY[BR7^R4X]Y?H_\ ,^H/V$8BOPXU^3'#:L5_*&,_UKKOVP6 ^ ^M ]3/; ?]
M_DK)_8DL#9_!F68C'VK5)YOKA8T_]DJ?]M*\%K\$Y8R<?:-0MXA[XW/_ .R5
MC/WLVT_F7X'337L\@U_D?XIGQ9\)E,GQ4\&J.K:U9#_R.E?J77YB_ >S-]\9
MO!D8&=NJ02_]\.'_ /9:_3JNKB!_O8+R_4XN$E_L]5^?Z!1117RA]V%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (%"]  .M?/OQG^
M-S3-/H'AVXQ$,I=7\9Y;U2,^GJW?MQUN?'?XO&U\_P ,Z+-B4C9?749^[ZQ*
M?7U/;IZX\*T'0K[Q+JMOIVG0-<7<[;51?U)/8#N:\G$XAM^RIGR&:9E)R^JX
M;?9M?DAFCZ/>Z]J,%AI]N]U=S-M2.,<G_ >YX%?4'PM^"=AX)CBO]1$=_K>,
MA\9C@]D!ZG_://ICOM?#/X8V'P[TO:FVYU291]HO".3_ +*^BC]>I]NDU_Q!
MI_A?2YM1U.Y6UM8ARS=2>P [D^@K7#X:-)<]3?\ (Z<ORN&%C[?$?%^"_P""
M7Y)$AC:21E1%&YF8X  ZDFO$_B)^T5;::TMAX85+VX'RM?R#,2'_ &!_$??I
M]:\W^)WQDU+QY,]I;E[#10?EME/S2^AD(Z_[O0>_6N+T#P[J/BC4H['2[22\
MN7_A0<*/5CT ]S6%;%N3Y*1PXW.9U)>QPGW]7Z#-9US4/$5\]YJ5W+>W+]9)
M6R?H/0>PXK7\)_#KQ!XVD']EZ?))!G#74GR1+_P(]?H,GVKW/P!^SMINBK'=
M^(635;WK]F7/V=#[]W_'CVKV"&&.WB2*)%BC0;51  %'H!2IX.4O>JLG"Y'4
MJ_O,5*U^G7YL\0\,_LPV<"I+KVIR74G4V]F-B?0L1DCZ 5Z5HOPQ\*Z J_8]
M"LPZ]))H_-?_ +Z?)JIXN^+OAGP;OCN[\7-XO_+I:8DDSZ'G"_\  B*Z;1M6
M@UW2;/4;5MUO=1+,GKAAG!]Z[Z=.C%\L$KH^AP^'P5*3IT4N9?-EN.-8E"HH
M11T51@"G445U'JA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(S
M!%+,<*!DDTM-DC66-D=0R,,%2,@@]J /E76+XZIJU[>'_EXF>7_OIB:]Z^$M
M@;'P/9$C#7#/,?Q8@?H!2:I\)/#>I9*VCV3G^*VD*_H<C]*ZK3;"/2]/M;.'
M/E6\2Q+GKA1CFOF<MRVMA<1*K5:=UT\V<-&A*G-RD>7?'J__ '>DV0/),DS#
MZ8 _FU<E\([$WGCFR;&5@5Y6_!2!^I%/^+NK#4_&EPBMNCM$6W'U'+?JQ'X5
MTGP'TO=<:IJ++PJK;HWU.YOY+^=>._\ :\WTV3_])_X8YOXF)^?Y'KEQ<1VM
MO+-*P2*-2[L>P R37Y.:]JCZYKFHZE)GS+RYDN&SZNQ8_P Z_23]H+Q./"/P
M;\57P?9*]FUK$1UWRXC!'N-^?PK\T;6VEO+F*WA0R32N(T4=2Q. /SK]SX?I
MVA4JOK9?=_PY\9Q;6YJE*@NB;^_1?DS]'_V8='.B_ OPK$PP\T#W1]_,D=Q^
MC"O,?V\M6$/@KPSIF<&XU![C'KY<97_VK7T;X9T5/#GAO2M)BQY=A:16JXZ8
M1 H_E7QG^W5X@%]\0M#TA&W+I^GF5O9Y7.1_WS&A_&O*R[_:,Q]IYM_F>]G'
M^QY.Z76T8_E^B9Q7[).EG5/CQX?;&8[5;BX?\(7 _P#'F6OT \47W]E^&=7O
M VTV]G--N]-J$Y_2OCG]A#03=>.?$6L%<I96"VX/8-+("/TB;\Z^G_CKJ@T?
MX-^,KDG:3ID\(/H9%,8_5A6N;OVV/C3[67WZ_J<_#\?J^52JOKS/[E;]#\^+
M'XT^/M-QY'C/7 !T5[^5U_)F(K]'/AE=7E]\.?"UUJ,[W-_<:7;37$TGWGD:
M)68G\2:_+%$:1U1069C@ =S7ZS:'IXTG1=/L1TM;>.#C_94+_2NS/XPA&FHQ
M2;N>=PI.K5G5<Y-I);OO?_(O4445\<?HH4444 %%%% !1110 4444 %<-\:_
M&]_\.?AMJOB#3([>6]M6A")=*S1G?*B'(!!Z,>]=S7DO[5'_ "0SQ#_O6W_I
M1'0!TWP;\97WQ ^&VC:_J4<$5[>+*9$ME*QC;*Z# ))Z*.]=I7E'[-\QMO@!
MX?F4 M'#<N >G$\IKSGPK^U9XC\8:.+#2/#,&J>,Y[EUAM+=76WBMU13YLA9
MO[Q88W <<D<9 /IVBOF9?VBO'GP[\4:?8?$KPU::?IUZW%Q: Y1<@%@RNZN%
MR,KUP?<9T]0^-?Q*\:M<7WP[\&QW/AV%V6._U 8>ZVG!9%+IQG/ W'Z'( !]
M#45X]\!_CO-\4KC4M'UG3DTKQ%IPWRPQ!@CJ&VL0K9*E6(!!)ZCZ!/CE\<+O
MX1^(?"]LEI;3Z=J+L;R657:2.-70,4 (YVL>N>0* /8J*^=K?XL?&/QI:MKG
MA3P581>'VRULNH-^_G3UP94SD<\#'H378_!7X[0_%"6]TG4M/;1?$U@"9[)L
MX=0=K,H/(()P5/(R.3V /6**\+^*G[1D_P +_B=#H=U8V\VB_8#=22@-YY<I
M)L13G:,NB#)'&XU6^&?Q<^*'BKQQI]GK?@Q-+T"^5Y/M+VD\7DHJD@[V)!)(
M P0,YXP* /?:*\*^('[1U[;^,'\(> ]#_P"$EU^)S'-))DPQL/O* I!.#P6)
M4#'>L/4/CA\5/AOY%[XZ\%6G]B/(%DN-.;YH\]LB1U!] V,],]Z /I&BN9L_
M%Z^+/ +>(/"ICO9+BT>:R2X!VM( <1N <@[AM//!KD?V?_C'/\7M U*:_MK>
MRU2PN!'+!;[MNQERC88D\D./^ T >J45P_QE^(P^%O@&]UQ(XY[M72&U@FSM
MDD8]#@@X"AF_X#3?"'Q N)/A3:^,/%B6^E[[5KV9+=6VI$22F 2269=IQZMB
M@#NJ*^<;/XZ?$SXE37-Q\/\ P9;-HL4FQ+O5& 9\>YD1<^H7=C/7O6[X!_:#
MU*;QG'X/\?:#_P (WKT[!;:2+/D2DCA>2>I& 0S GC@T >XT444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV.*,8 '^>]><_%CXU6O@A9--TSR[S6R/F!YCM\]V]6]%_$^_=3I4\+'FEO\
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M,/A71?,WJ>WEN52P<_:SGK;9;!1117H'T84444 %%%% !1110 4444 %%%%
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M(K!RQBMKU)4R>!O3! _[X!_&J7A^/_A3O[5E[II_<Z-XI0O".BAI"67\I5=
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M];&=\)_@)%IZPZOXFA6:[X>'3VY2+T,GJW^ST'?)Z>V2RQVT+22.L42#)9B
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M9:98Q&>]O)D@AC7JSL0 /S-?J1\/?!MM\/\ P5H_AZTP8K"W6-G QYC]7?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMU==KQ. "49>Q&1[<\$U6^(/Q0\.?#'3DNM>OA TG$-M&-\TOKM3T'J< >M
M'645X1IW[9'@>\O5AN+36-/@=L)=7%LA3&<$D*Y./H#7MNF:I::UI\%]87,5
MY9SKOBGA<,CKZ@B@"U17FVK?M >$]#\2>(-%OY;JUN=$M_M%S(\0\MAF,!4(
M;+,3*H QZU6^%_[1'ASXK:]<:1I=GJ5M=11-.#=0J$:,$ G*LV.2.OK0!ZE1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD0#4+C$]VW?>1POT4<?7)[UX%\!?!X\4>-XKF>/?9:8!<R9'!?/[M?SY_P"
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M[R2V+K_MKC],FN^^#/[)P\'ZY;:]XIO8-1OK9A+;V5J"84D'(=F8 L0>0,
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M.YF^0*BD<L>I/:K'Q(^$?AKXJ6<<.N69,\0Q#>VY"3Q#/0-@Y'L01[9KLZ*
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M;X%T/1@H5[6U19<#K(1ND/XL6/XUOB[0IJ"/$X3]MCLRK8R<G;5O71N3TO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<JI[N1P6_ <9)^G;P^2X>RUD_O;_ ,OZW/B$L7Q+B[O2"^Z*_5O^M#2_9K^
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MSI+L8V2*H^4?NT[$9X]* /6**** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^,?[QZ=EL?=8#*L+EZ_<Q][N]_\ @?(****\X]@**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI&8(I8\ #)H \AA^-T6E
M_$[5="U211I?G"*WN-NWR6"@$-ZKG//;Z5Z\K!U#*0RD9!'0U\*>+-0;4_%&
MJW9D,OFW4CASP2"QQ^E>W_ OXS(\=OX;UN54*@1V=TW ([1L?Y'\*\NABKS<
M)_(^0R_..>M*C7>C;Y7\]O\ (]]HHHKU#Z\**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *\2^-WPEU;QEXHTZ_T6W20RP&&Y=Y%18]I^5C
MGDY#8XS]VO;:*RJ4XU8\LCDQ6&ABZ?LJFQY=\(O@_=_#J\N+ZZU5;F:XA\I[
M:",^6.00=QY)&#V'4UW'C+P[%XN\*:MHLV E];/"&/\ "Q'RM^!P?PK9HJJ<
M%224 IX6E2HNA%>Z[_CN?F%>6<VGWD]K<(8KB"1HI$;JK*<$?F*_03X)^,QX
MZ^&NC:DS[[M(OLUUSSYL?RL3]<!O^!5\M?M4>!SX5^)4NHPQ[;'6D^U*0.!*
M.)1]<X;_ ('70?L@>/AH_B:\\+W4FVVU0>=;;CP)T'(_X$@_\<%>[B%[:BIK
MI_3/R+(:DLESF>!JO23Y?GO%_/\ 4[S]L+P4=6\'V'B*"/=/I4OES$#_ )8R
M$#)^CA?^^C7S?\(_&Q^'_P 0M(UAF(M4E\JZ [PO\K_7 .[ZJ*_0/7M%M?$F
MB7VE7J>9:7D+P2+_ ++#&1[U^</BWPU=>#O$NI:+>C%S93-$QQ@,!T8>Q&"/
M8U&$DJE-TI'1Q;A9X''4LSHZ7M_X%';[U^3/TKCD66-71@Z,,JRG((/>OB;]
MJ?X>GPCX_;5K:+;INM9N!M'"SC'FK^)(;_@1]*]V_9=^(P\9> 4TNYEW:GHN
MVW?<>7A_Y9-^ !7_ (#[UUWQB^'<7Q,\"WVDX47RCS[*1OX)E!V\]@02I]FK
MDIR>'JVD?79EAX<190JE#XK<T?5;K\UZGS'^RG\2!X3\:-H5Y+LTW62L:ECP
MEP/N'_@62OU*^E?9E]90:E9SVEU$L]M/&T4L3C*NK#!!]B#7YE3PW&EWTD,J
MR6UW;R%&4Y5XW4X(]B"*^\O@+\4D^)W@J*6>1?[9L0L%\G<MCY9,>C 9^H8=
MJZ,92L_:Q/!X/S13A++:^ZNXW[=5\M_O['Q[\8/AO<?"_P :76EN&>QD/G64
M[?\ +2$GCG^\OW3[C/<5Z9^RO\81X;U3_A$]6GVZ9?29LY9#Q!.?X/97_1OJ
M:^@/C5\*[;XJ^$9+/Y(M5MLRV-PW\+XY4G^ZV,'\#VKX&U+3;O1=2N+&]@>U
MO+:0QRQ.,,C X(K>G*.*I<DM_P"M3P,RPM?AC,XXK#+]V]NUNL7^GR>Z/TPU
M+3;;6-/N+&]@2YM+B-HI89!E74C!!KX1^.'P:O/A3KY:)7N- NW)L[H\[>_E
M.?[P_4<^H'T!^S=\=%\:Z?%X<UN<#7[5,0S2'F\C ZY[N!U]1SZU['XF\,Z;
MXPT2ZTG5K5;NQN%VO&W4>C ]B#R".E<,)SPM2TMC[O'8/"\48"-:@[2Z/L^L
M7_7FO/X0^#_Q@U/X3ZYYT.ZZTFX(%Y8DX#C^\OHX['OT-?=7A'Q?I7CC0X-6
MT>Z6ZLYAU'#(W=6'9AZ5\/?&3X)ZK\*=4+X>]T*9\6U^%Z?[$F/NM^AZCN!A
M_#CXG:Y\,-:%]I$_[IR!<6<F3%.H[,/7T(Y'YUW5J,<1'GI[GP^4YUB>'ZSP
M..B^1/;K'S7=/_@KS^QOC!\!=%^*=NUT-NFZ\BXCOXUX?'19!_$/?J/IQ7QE
MX[^'.O?#C5#8ZW9- 6)\JX3YH9@.Z-W^G4=P*^W_ (6_&?0/BI8@V,WV35$7
M,^FSL/-3U*_WU]Q^(%=?KF@Z=XDTV6PU6RAO[.4?-#.@93[^Q]QR*XJ>(G0?
M)-:'V699#@<^I_6\))*;^TMGZKO^/>Y^>O@/XG^(_AO>>?HFH/!&QS):R?/!
M+_O(>,^XP?>OISX?_M<^']=6*V\26[:#>G@SJ#);,?J/F7\00/6N<^(W['H9
MI;SP;>[?XO[-OGX^B2?T;_OJOG7Q-X-UOP9?&TUO2[G39^PF3"M[JW1A[@FN
MZU#%:K?\3X:-;.^&9<LE>GYZP^3Z?@_(_1_2]7L=<LTN].O(+ZU?E9K>02(?
MQ!IVH:;::M:M;7MK#>6[?>AN(PZ'Z@C%?FQH/B?5_"]U]ITC4[K39^[VLK)N
M]C@\CV->N>&?VNO&>C*D>I1V6N1#@M-'Y4O_ 'TF!^:FN66#G%W@[GUF$XTP
M=9<N+@X/RU7^?X,^A/$'[,WPT\1,S3^%;6UD/\>GL]MC_@,9"_I7"ZG^PWX%
MNV+6FHZU8GLJSQR(/P://ZT_0_VSO#UTJC5=#U#3W/4V[).@_$E#^E=KIO[3
M7PZU  '7C:N?X;FUE7]=I'ZU<:^.HZ*4OS/76(X?QNO-3U[VB_QLSRF?]@G1
MV8^3XMOHQ_TTM$;^3"HX_P!@?3 ?WGC"[8?[-DH_]G->[P?&KP'<#*^+-*'_
M %TN%3^>*E;XP>!E&3XMT;\+V,_UK3^TL?\ SO[E_D:?V?D;U]W_ ,"_X)XS
M8_L(^$(F!O->UJX'I$8H\_FC5UVC?L@_#+265I-'N-2=>C7EY(?S"E0?Q%=/
M>?'_ .'MBI,GBFS8#_GB'E_]!4URVK?M;^ ]/5OLSZAJC=OL]KM!_P"_A6HE
MB\?4^W+\A/\ L#"ZMT_O3_S/2?#OP\\+^$<'1?#^FZ8X_P"6EM:HCGZL!D_B
M:Z&OE7Q#^VG=2*Z:'X<BA/\ #-J$Y?\ \<4#_P!"KR?Q7\>O'/C /'=Z[-;6
MS<&WL?W"8]#MY(^I-8K"UJCO-_><&(XMRO"QY<.G/T5E^-OP3/L_QK\8/"7@
M!7&KZQ"ETO\ RYP'S9S[;%Y'U; ]ZY'X5_M&6'Q0\:7FB0:=)IT*VYFM9)Y
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MB.&=594Z=)Q45=MM?<>DT445\^?8!1110 4444 %%%% !1110 4444 %%%%
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MV(>O1_HSVRBBBO5/L0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,?L7V4.R3Q!X@FN3U,&GQ",?3>V2?^^17TO17/+%U9=;'OX;A+*\.[RBYO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:Z?X;^.KCP!XIM=2B):#/EW$6>'C/4?7N/<5TT*GLY>1Z64Y@\!7O+X):/\
MS^1]RT53TG5K77--MK^RE$UK<()(W'<&KE>T?K2:DKK8****!A1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHHKR3ZH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.Q'I70F?L^49Q2S2GVJ+=?JO(U:***9] %%%% !1110 4444 %%%% !1110
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M*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "OF[]HCX*N9)O%&A6R[,;KVUA7D
M'O(!_/\ .OI&D90RD$9!X(-)JYYN88&EF%!T:OR?9GYNL>:97T'\?O@.=):?
MQ)X>@S8D[[JSC'^I/=U']WV[?3I\]L<<=ZBQ^'YA@JV7UG1K+T?1KNA"U=Y\
M)/BWJ'PQUH2)NN-*F8"YM,\$?WE]&'_UJX"D+5HD<-#$U<+5C6HNTD?HGX2\
M7:9XVT6'5-)N!<6TG![,C=U8=C6S7P#\-?BCJ_PSU;[5I\N^VD(%Q:/RDJ@_
MH?<5]K^ ?B)H_P 1M'6_TJ?<R@":W?B2%B.C#^O0TVK'[/DN>TLTAR2]VJMU
MW\U_6AT]%%%(^I"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ KP[]HW]HBU^%6FMI.DO'=>)[E/D7JMJI
M_C?W]!65^T1^T]9^ X+SP]X<E6Z\2$>7).N#':9'//=_;MFOAF^OKG4KR6ZN
MYI+BYE;<\LC%F8^I)KW\OR_VK56LO=[=_P#@'Y;Q1Q9'!*6"P+O4V<OY?)?W
MOR]1VJZI>:WJ$]]?W$EW=SL7DED;+,3U.:I%:DIN*^PCHK'X7*3D^9N[8RKN
MBZ+>>(M6M--L(&N;RZD6**-1DEB<4W3=+NM:OX+&Q@DN;NX<1Q0Q#+.QZ "O
MOS]G']G6U^%&F+JNJI'<^*+E/G?JMJI_@3W]37'C,9#"0N]WLCZ;(<CKYUB.
M2&E-?%+MY+S9N? ;X$:;\&]!&0EWK]TH-W>XZ?[">BC]>M>JT45\#4J3K3<Y
MN[9_2V%PM'!48X>A'EC'9!11161U!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7B'QJ_9VM?&BS:OH"QV6M\O+$>([GC]&SW[YYKV^B
MFFUL<.,P5#'TG1Q$;K\5YH_-34M-NM'O9K.]MY+:YB;:\<BX93]*IEJ^\_BK
M\%=%^*%J9)Q]BU:--L5]&.?8./XA^M?%GCGP#K/P^UA]/UBU:%^J2CF.5?56
M[UV4Y*1^&YUD6(RF7-\5-[2_S[/\SG#244QFKJ2/DFSUCX3?M#ZW\.9([*Z+
M:KH><&VD;YXAZQL>GTZ?2OL/P3\0-#^(6EK?:->+<+TDA/$D1]&7M7YPDUI>
M'/$VI^$]4BU'2;R2RNXSD21G&?8CN/8UG.@IZK1GV>3\4XC+;4:_OT_Q7H_T
M?X'Z7T5\]?"O]J_3M>,6G>*UCTN^8[5O4X@?_>_NG]*^@;>XBNH4FAD6:&0;
MDD0@JP/0@CK7GRA*#M)'[/@,RPN94_:X:=U^*]424445!Z84444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 45\W?M!_M,#PM>#P_X6G674(Y%-Y>(01%@Y,:
M]B3C!/;I7O\ X:UJ'Q)X?TW58"&AO+=)UQ_M*#BMI49PBIR6C/(PN:X7&8FK
MA*$KRIVOVUOMZ=32HJCK.N:?X=T^2^U.\AL;2,9::=PJC\Z^3?C%^V%<:@MQ
MI/@I6M(,[&U608D<8Y\M?X?J>:NCAZE=V@C'-<ZP>3T^?%3UZ);OT7Z['MWQ
M?_:"\._"BW>"20:EK9'[O3X6Y'NY_A'ZU\-?$KXJ>(/BEK#WVLW;-$#^YM(R
M1%"/15_KUKE[RZGOKF2XN97GGD;<\DC%F8^I)J"OJ<+@Z>'UWEW/P#/.)L7G
M4G3?N4ND5^KZ_D,Q3<5(?I337IGQFQ'BND\ _#W6OB3K\.DZ+:M/*[#?+@^7
M"O=G;L.M=1\'_@3KWQ<U-1;(UCI"']_J,J'8N/X5_O-["OOCX=_#70OACH:Z
M9H=HL"G!FF;F29P,;F/].@KR\9CXX=<L=9?D?H'#O"E?-I*O7O"CWZR]/\_N
MN<U\%/@7HWPAT9!'''>:[*O^DZBR_,<]53/W5'Z]Z].HHKY*I4E4DYS=VS^A
M<+A:."HQH8>/+&.R"BBBLSJ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "L3Q=X-TCQQH\FFZQ:+=6[<C/#(W]Y3V-
M;=%!%2G"K%PFKI[IGP_\7_V>=9^'LLU_8*^J:%DD31C,D(]' _F./I7CS?K7
MZ?R1K+&R.H=&&&5AD$>AKY_^+W[+-AXC\_5/"HCT[4CEWLCQ#,>IV_W3^E=U
M*OTF?DN=\'RC>OENJ_E_R_R/CZBM'7_#NI>%]1DL=5LIK&ZCZQS(5/U'J/<5
MELWH:]*/<_*:D94Y.,U9KH(S>G6O0?AK\=/$WPSFB2UNFO-,!^?3[AB8R/\
M9[K^%>=D]Z8S?E5N"FK216'Q=?!U%5P\W&2ZH^^?AG^T5X6^(S16@F.E:L_'
MV.Z(&X_[#=#_ #KU2ORQ61HW#HQ1E.0P."*]@^'/[47BOP3Y-K>R_P!N:8A
M,5T29%7T5^O3US7!4P3WIGZGE/'47:EF4;/^9?JO\ON/NZBO,?AW^T-X1^(4
M:11WJZ9J)'-G>L$;_@+=&KTT,& (.0>AKS91E!VDK'ZGA<70QE-5</-2B^J%
MHHHJ3K"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 <UXX^'>@_$/36L]:L4N.,1S@8EB]U;J*^0_BI
M^S'X@\"F6]TI7US2%&XR1)^]B'^THZ_45]PTAYX/(K>G6E3VV/FLVR#!YO&]
M56GTDM_GW^9^6DF0Q!&".*837WM\3OV<?#'Q!AFN+>!-&UAN1=VRX5C_ +:#
M@_7K7R5\1O@7XK^&TCR7UBUUIX/RWUKEXR/?NOXU[%'$0J:;,_$<WX9Q^57F
MX\]/^9?JMU^7F>>9IM!I":[D?&-AN*MD'!]17J/P]_:0\8?#]8[9+P:IIRD?
MZ+?9? ]%;JM>64C42IQJ*TE<Z<+C<3@:GM<-4<9>7]:GZ+_!GXM0?%[PW-J4
M5B]A-;R^3+$S;EW8SE3Z5Z!7SG^Q/_R(VM_]?H_] KZ,KYFO%4ZLHQV/Z@R/
M%5<;EM#$5W>4EJ%%%%8'NA1110 4444 %<Q\2_&9^'O@?5?$(M/MYL45_LYD
M\O?EU7[V#C[V>G:NGKS/]I/_ )(CXI_ZXQ?^CHZ /++3]L;6=0@6>U^'-S<P
MMTDAO'93CKR(*L0_MG_8;B-=;\#7^F0L<&1+G<WOA7C3/YUW'[)__)$=&_Z[
M7/\ Z.>O5-4TFRUS3YK'4+6&]LYEVR03H'1A[@T 9'@7Q]HGQ&T--5T*[%S;
M$['5AMDB?&2CKV/Z'MD5T5?(O@JV?X$?M//X:MI7&@ZP5B2-VSE)!F+\5D^3
M)YQGUKW#XH?&RS^%WB3PWIE[8&:#6)-CWAG$:VRAT4NPVG( ?/4=* /2J\NT
MGXUMJ?QLU'P!_8XC6TC+_P!H?:<EL1J^/+V<?>Q][M7$:-^UU'XB\;6&D:=X
M3NI]-OKM;."]-QM=B6QNV;,#@@D;N!WKN=*^,5KJ7QIU#P*NB^5<VL9<ZEYH
M._$:OC;MS_%CKVH ]/HKS'PC\;HO$GQ0UGP/>:1)I6H:>)#'*\XD6X"L.@VC
M&58./;->E3SQVL,DTKK'%&I=W8X"@#))H DHKS;X.?&9?C -8GM=&ET[3["5
M8DN99@_GL<G 7:,8 !//\0K!\>?M,:;X;\2/X=\/:->>,-<C9DEM['(5'7JF
M0K%B.<X! ]<YH ]GHKP71_VJ$L=:MM,\<>$]1\&-<<)<W.YH_J0R*0O/49Q7
MO$<BRQJZ,'1AE64Y!'J* '4444 %%%% !1110 4444 %?-?[27[1J^'TN/"W
MABY#:FP*7E[&<BW!ZHI_O>I[?6I_VD/VC$\+0S^&/#-RKZS(NVZO(SD6RD?=
M4_WS^GUKXUDD:1V=V+NQR68Y)/K7L8/"<W[RIMT/R/BSBKV'-E^ E[VTI+IY
M+S[OIMOL.[2,68EF8Y)/4TE%%>Z?B(4AYI:*!$%/CC::1416=V. JC))]*[_
M .%OP3\0_%JZE_LI(H;*!PD]Y.V$C)&<8ZDX[5]C_"S]G+PO\-8X+GR!JNM(
M 6OKD9VM_L+T7^?O7-7QE.CIN^Q]=DO"V.SBU1+DI?S/KZ+K^7F?.GPA_9,U
MGQEY.I>(_,T32& =8B/](E&?[I^Z#ZG\J^Q/!_@G1? >CQZ;HEC'96R]=H^9
MS_>9NK'ZUNT5\[7Q-3$/WGIV/WG)\@P62PM0C>?63W?^2\D%%%%<I](%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#&<<@DX]\=U\.=6UG7O!>F:EK]A#IFIW4?FR6D*LHC!)V@AB2#MP2#T)QVH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSFT.;]PQ8DJ-[)(@S_"&4$?[QK-\#_\ )YGBC_KA)_Z+BJ+]DU9/$GQ&\?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQD<@@]^3G@[/]F3Q'JK167BOXBZGK&@0D?\ $OC:0>:HZ!BSD#\C[$5]#44
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..1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>nvta-20201231_g3.jpg
<TEXT>
begin 644 nvta-20201231_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ%ILVM_#;X&:CX'DU-]6TSYFM4O]3>59(IIT565H0%(E1B(LE4]<^(W[;/\
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MHMCG$OV>WDFV<<\[,<>M?GM_P:S_  AT:\_X)U?\-V>,1'K'Q.^/OC/7]?\
M'/BZ\C#7MVT.JW5FD!D(R(@UM)*$'RAIW/?@ ]W_ &*O^"U_[$G[;WQ=N/V<
MO"]SXO\  7Q-AMFN4^''Q6\+2:)J]S"JEV>&-V:.8A0S%$<N%5FV[5+#ZXKY
M_P#VQ_\ @FQ^SM^VU\3_ (5?&SXE3:[HOC#X.^+H=?\ "/B;PG>0VMZ2AW&R
MFD>*0R6CNL;M&-I)C # ,X;S3X;?MS_'+Q3_ ,%TOB)_P3VU5M'_ .%?>&?@
M39^+=,$>GD7W]HRWEG"V^;=AH]L[X7:.<<\4 ?9=%?'_ ,3_ -MOXV>$O^"V
MWPS_ &!M);2?^$"\5_!34_%.JB6P+7OV^"ZGB39-NPL>V-<KM.3GFOFKX)?M
MA_\ !9S_ (*&_M*?M'_LY?LT_$_X7_"_PW\%?C/K&@0?$?6O![ZI>75LDS1V
M6G0VA?RBZ+!+)/<R$DB>$(@VMD _56BOR4_8O_;0_P""Y_\ P47LOB'^S3X/
M\8?"3X4>+?@+XVU'PG\2?BS<>&9=57Q%JD%Q+'%#8:>Y$4"!(F::9RP;S(3$
MBY91TOP,_P""NW[8NN?\$I/VJOBI\8=+\)0_'7]ESQ-XA\*ZOJ6D63OI&JWN
MG;0EV(68$!F\Q&4$ ^6' 0/L4 _4:O)OVOOVU/@=^P_X3\*^-/CQ?ZE;V/C'
MQYIWA#16TS3FN6;4[T2F!7 (V(?*?+]!QZUQOPF_:>^)WC/_ ()*>&?VS]9;
M3_\ A,]6_9TLO&MV8K0K:?VI+H*7S;8MW$7G,<)N^[QGO7YP?MZ?M/?$[]L[
M_@BQ^Q'^U!\9FT\^*/&/[3_@R\U@Z5:&"W\T7&JQC9&6;:-J+QD\YH _:JBO
MCS]MSXD_\%4/'?[5/AS]DS]@7P?H/@7PO-X4EUSQI\?/''AZ35+*SE$WE1Z7
M8VRR(DMU]V1O,)4HYQM\ML^/_L[_ +9/_!1?]E[_ (*N^#?^"9G[=WQH\ ?%
M_2?BCX,U+6?"'CGPMX8&B:EIMS8Q2SR07EI'(T:HT4+XP"270A^&6@#[N\(_
MM%?!#Q]\9_%O[//@KXDZ;JGC/P'9V%UXRT&RD,DNCI>K(UJ)R!M1Y$B=Q&3O
M";6*A70MS?[(/[:GP._;@\)^*O&GP'O]2N+'P=X\U'PAK3:GIS6S+J=D(C.J
M D[T'FIA^AY]*_,K_@E3X$_;^L_^"]'[72^,?V@?A_>2:3?>"7^+S6?@F>(>
M(+=]'G-BFG@W!^Q-$F!(S^9YA&0%KJ]%_P""IG_!0KQ9_P $HOVCOVTOA-IG
M@RX\8_ _]H37=,725\-D6^H>%]->T^TJZK)D3I#/+.T^?NP$;>: /UCHKXW_
M ."AW_!4C2OV?/\ @DZW[?7[/:6^KZQXY\/Z./A+IUS 9O[0U/5Q$+.,Q*09
M&C65Y6CR"1 Z]>*\[_:A_;L_X* Z9\9_@O\ \$L/V8!X&F_:*\8?#6+Q7\6?
MB#X@T^1]$\)6,8\FXN8+2)B99)+I)DBC9B%'E!@PEWH ?H917YT:#^U]_P %
M&/\ @G;^V=\)_P!FO_@H_P#%+P3\6OA[\==8?P]X-^)_A;PI_8-_HOB+"F&R
MO+19'ADAG+K'&R'?N)8D!=K?HO0!^<NN_P#!T7_P3-\+Z5-KWB;P]\9-.L;<
M SWM_P#">^ABC!(4;G? &20.3U(%=E\ _P#@X6_8+_:1^+'A7X._#?PM\6O[
M3\8ZM;:?HUWJ7PPO;>R,D[!8WDG8;4C^8$N> .:@_P"#FC_E!S\=_P#L'Z)_
MZ?\ 3J^H/V(O^3+_ (0_]DOT#_TW04 >GTDDD<,;2RR*J*I+,QP !U)-?F3\
M*?VNO^"JG_!6WXF?$?Q?_P $^OC+X ^"7P2^'GC*\\*^'_%GB/P9_P )!JWC
M+4;3;Y\XBDD2*WLSN3:P <"3^-@PCZ#]F3]NO]OG]HK3/V@O^"<OQCE\ ^!/
MVHO@W:V,UMXOL](GOO#GB#1[HQRIJ45HTBR M;DJR;P%>YB;"D/$@!]R? 3]
MH7X*_M1_#:W^,7[/GQ%T[Q9X6O+Z\M++7](<O:W4MK<R6T_E.0!(BS12*)%R
MC[=RLRD$]G7X]?\ !M]XK_;)^!O_  0Y;XZ:-ING?$KPW8:'KT_PJ^%'AK0G
M@UJ;5(]8OA)%/=M(RRI-/R"L8,2$\.1@][\5M;_X.)_AU^R'JW[?'CC]KSX)
M>%=2T7PA+XIU+X%WOPQ9;.UAC@-RVFR:E)<&?[4$!B*@A3+\HD ^>@#[O_:^
M_;4^!W[#_A/PKXT^/%_J5O8^,?'FG>$-%;3-.:Y9M3O1*8%< C8A\I\OT''K
M7K-?CU_P5/\ VKW_ &Y?^"2G[%O[6EQX;BT>Y\<?M+> M0O]+@E+QVMUMU".
M>.-FY*"5'VD\[<9YK]A: /CW]K7_ (+@_L6?L:?M(7O[*/Q.TGXBZMXTT_1+
M;5KO3_!G@.YU98[2?[DA,&2!D@'(P"0.]<%9_P#!RW_P3"L?$>F:#\4=6^)/
MP^M]6NUMK36O'OPOU+3['S6Z*TQC8(/5B-JC)8@ D?,WQX_;Z_9\_P"">/\
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M/8F%:@#]9**_)7]AW]M'_@N9_P %3?A3XE\+_#+QC\(_@QK?P=\5ZAX0\?\
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M?\&I=,C\;0W>FM%!$U_"\UOY,I.)<I&V<8P>*]?K\T/^"5W_ "G>_P""B/\
MV$/ 7_ILNJ\\_8&_:W_X+M_\%:?@#JWQ0^#/QH^$?P?TSPIXKU70U\1:EX(D
MU2Z\4WL$[,%6!W,5G:1PR01&0"21Y5F8# "@ _7*BORN^'G_  58_P""B_QG
M_P"".'QT_:*\,^#?!VF?M!?LW>/=5\.^-;&WTJ2ZTC6%T=K>74)8HC)O0_9)
M96X;F2V)4*L@5?HC]L3_ (*N>$OA!_P1QN_^"FOPG2VN;KQ)X!T^^^'^F7(\
M[S-8U-8XK2V>-<&4Q3S9EC&&VP2CC!( /:_B9^W!\"/A+^UU\-/V(_&&H:FG
MCOXLV&J7GA"WM]-:2VDBT^VDN;GS9@<1$1Q/@$?,<#O75>$OVB/@EX]^,OBS
M]GOP7\2=,U3QGX$L["Z\8Z!92F2;1TO5D:U$Y VQO(D3N(R=^S:Q4*Z%OBO4
M/VW/VT_A7_P43_8D_8Q^-9\*3W_Q=^&^OZC\7)+?0 DL&KV>BSW9BLG\P^1$
MDZ;#]XNJ\XS7SS_P2Z\"?M_0?\%[OVOAKO[0/P_G.E:KX(D^+9@\$SI_;]F^
ME3&RBL,W!^Q/'%A9'?S [<@+TH _8ZBOSUMM3_X+O_MH>/?'WBWX;?$7P;^R
MYX#\-^*[K2/ FC>+_AM_;NM^)+6#;C4KIIIEBMX9MV4\H94!E(;8)'I?\$\_
M^"PWQ'UO]EC]I7QC^W_'X8N/$W[*?B74],\7^(/AXK?8/$EM;0R/#/;)(V!+
M*T,D87*J2T9VQY*@ _1>BOS%^"?C/_@X=_;'_9[T[]O3X8?&GX+?#ZT\4Z2N
MO_#WX#:MX'EOX[_2Y4\VS2_U8S++#-/%L;,0"_O5)\KE4^L_^"6O[?.A_P#!
M2?\ 8S\.?M.V7A"3PYJ]S/<Z7XN\,2REVTC5[20Q7-ON(!9<A9$)&=DJ;L-D
M  ]V\7>+O"O@#PMJ/CCQSXDL='T72+*6\U75M3ND@MK.WC4O)++(Y"HBJ"2Q
M(  )-? 6N?\ !S)^P ;S4;_X4?"OXZ?$CPII%Q)%JGQ"\ _":ZN]"MC']]FN
M)7B;:N#\P0@@9&1@GD/^#FGQ'XC^('@3]F[]@6Q\07>EZ'^T)^T/H7AKQE=6
M<I1IM+%S"K6Y([&6X@E]2;<=LBOTD^'GP[\"_"3P+I/PQ^&/A*PT'P]H-A'9
M:-HVEVRPV]G;QJ%2.-%X50!0!Q7[(O[9/[-?[=OP7LOC_P#LK?%.Q\6>&+V5
MH&N[57CEM+A0"]O<0R!9()E#*2CJ#AE895E)].KY7^'?[&W[(?\ P2HU;]HC
M]O/P3J7B'1-#\8V,OC#X@>&8KF%M(L/[/M9IIIK"U2)#%))F=V!=MSR8&U0B
MK\R_LZ?%+_@O[_P47^!-M^W9\%/C=\'O@UX:\30RZC\,_A)KG@B35WU/3@S"
MW?4]1+B2!I@H8- F-C*VQ,[0 ?J%17Y8?$G_ (+I?'77_P#@A;\7_P!N[P/\
M.M'\&?''X,^,;3P=XZ\*:G U[8:=KB:WIUE=A%+AGA>"\+("Q*.67=)Y>YM>
M/]HO_@MS\+OV/_BY_P %'_VB/'_PBT_P@_P.U+Q;\//AAI6@SSZAX;U#RX[B
MPAN[AEC%P%MRXG^=@92 @5>0 ?IQ17Y;?";XI?\ !PW^U#^QMH?_  4,^&GQ
M5^$'A:34?!UOK_A?X#7O@.2\/B6S%NDJR7.I&=)+:>[4-+%#$ B+-"C.IW,O
M2_$?_@OC+XA_X)@?!?\ :S_9=^#5MKOQ8_:$\3V_@SX>_#[5+XFVM/$;3R6U
MS]ID4HSVL$T38(*-(LL))C#LR 'Z245^7O[2_P ;_P#@NC_P2W^$2?MQ?M'_
M !M^%7QT^'^A75K)\5?A[X:\"OHMYHEC-,D4D^E78?-UY3.N3<(/E))3 ++L
M_P#!1C_@I[^VGH7[6?[.'[-?_!-JT\&:S_PTA\/]2U'PWJ7BZSD^SVC^3%<0
MZG(Z9;R8+0S7#1!&+F-1@\@@'Z4T5\!^/?'/_!=;X&?L_P#P\^ =AI?P^^*/
MQI\>>/+RQU?XMV'ARXA\,>#= 18V2]OK>/RFDN2&;8JJL9*E<.5'F>7_ !M_
M:O\ ^"L__!*[]I#X&V_[7W[5?PQ^-WPY^,?Q/T_P7J]E8> E\/:QH4]ZVU+J
MV6"5Q-#&0Q9I-V=H0A3(KJ ?HKK_ .TA\#/#'QWT#]F+6_B9ID/Q \3Z1<ZK
MHOA(2E[R>Q@R);HHH/EQ JRAWVJS*RJ25('.?##]M3X'?%W]JWXG_L9>#;_4
MG\;_  BM=(N/&4%QIS1VT::E:K=6OE2DXE)B8%L#Y3Q7Y?\ [5_@7]O?4O\
M@Z(\"V?PS^/O@'3-:N_@7>W?@Z]U/P7-<0Z?X=%_>"2QN(UN%,]T7$Q$X*J
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M_@JE^SK\+;Q],\/^!/C;+8^$["TRJ:7IWB/48+"6TAP,)$L+%0JGC<QX+$D
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M3QZ/^Q5<6,<[J TBQ:M<QAB!T)"YK5_;]_Y6*_V _P#L7_B5_P"H_-7Z/T4
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MZJ&;GU)J[JFCZ3KEF=/UO2[:\MRP8P74"R(2#D':P(R#S0!^3'@[]I;X8?\
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M_P!NZ0(-Q_;>\9@MCD@3C _4_G7Z.V]O;V=O':6D"111($BBC4*J*!@  <
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MG]M#_@BU^W;\+_@1H4^K^,-(_;H\5>(M"T2V0O)J3V+Z1-+;QH.9)&@$VR,
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M?5->B_:3T_X?+X,?X'R>&+[^WI/%J68LA!Y/E?ZIK@"3?G(0[2/-'EU]C?\
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M^ _QR^%_[3'P:\-?'WX+>*H-;\*^+=(AU+1-3MSQ+#(,X8=4=3E'0X9'5E8
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MX8+\;O\ @X._;?\ @N^H_8QXO_9BT?13=X)\@75A:0;^/3S,_A6'_P $G_\
M@KK^RE_P3?\ V%=._8%_X*'^(M1^&7QB^![WVB:KX*O] O)KG7H_MD\MI<:9
MY43+>+.DJ*FUOF8;Q^[97/Z\5GZCX2\*ZQJ]IX@U;PSI]U?Z>2;"^N;*-YK8
MGKY;L"R?@10!^;/_  :X^,_$/Q'_ &;OVD_B%XN\&7GAS5M>_;(\8ZCJ?A[4
M8C'<:7<3V>DRR6LJG[LD;LR,.Q4BO7/^#C;P7XD\??\ !%/X]>'O">CW-]>)
MX?L+TV]I TC^3:ZK97,S[5YPL4,CD]E4D\"OMJ@@$8(H _%3]O?]L3]G/]M/
M_@FK^Q!X\_9K^(J>(]-\-_MD?#;PYKTJZ=<VS66JVVD7+SVKK<1HQ9%FC.Y0
M4.[Y6->^_P#!VQ_RA;\8_P#8X>'_ /TN2OTETK1='T&U-CH>DVUE"7+F&T@6
M-2QZMA0!D^M6: /Q?_X+C_LJ_LO^#/\ @KC\.OVX_P#@I'\ ]1\:_LT^*/AB
M/!OBG7;+^T#%X.UR&[FFM;VZ_LYTF$+I*L8Y(.^8[69%%<_\$?A1_P $"?'?
M_!0SX/?";_@DU_P3XL?B_K.G^(8/$'C3XD:1XY\2VNE?#RVM)8Y[>^>6=Y(K
MJ?>A*6Y 5W1(V8&3 _;VZM;:]MI+.]MXYH94*2Q2H&5U(P00>"".U4O#?A+P
MKX-T\Z3X/\,Z?I5J9"YMM-LHX(RQZMM0 9/K0!H4444 %%%% !1110 4444
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M%$CQQ[%=EE@9I(URY9BN\Y0H!( ?IG17YY?&7]L__@H%^V=_P4+^('_!/O\
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MGP6\4W_A3Q)H-W;M>Z%=ZS9,&4Q>8X9;6[171'+DQ."Q+HHW@'WS17Y*V/\
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MQ7,K3RQ/RWEHJ%0S&@#Z9_:%_;;^!W[.W[/'B+]J/4]1NO%?A#PA?+!XKO?
MA@U2324$Z17$\R)*#LMA())U7=(D:LVPXQ7J7A_7]#\5Z#9>*?#&KVVH:;J5
MI%=:??V<RR0W,$BAXY8W4D,C*0P8<$$$5X;^Q%^Q/X3_ &=/V%]$_9.\??##
MX=VDMWX;>S^(5A\/= ^P:-K-W/!Y%W/Y1568S( '9@"W8*H55^>/^#='XH>+
M?^&4OB#^Q7\0=9GU#5OV9OC+K_PWM+V[;=+<:59S[K)V/HJ.\*XX\NW3% 'Z
M"4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Y9>#_\ @LS\
M2/\ @F=^UI\5OV8O^"V?B3Q%9^&]5\<W.J_ SXR0>!]^CWGA^4#R--?^S+8'
MS855=S%))-\DHE<*L;/^IM5-;T'0_$NF2Z+XCT:TU"SF&)K2]MUEBD'HRL"#
M^(H _%O]M?\ :<_9._X+7?MS?LW>$O\ @E5X0O\ QCX]^'?Q?TGQ3X\^.NF>
M#KO3;;PWX=M"SS6D]W<PQ22F1A&\:,-A>$(I+2D5V?Q0^-?P\_X);_\ !Q#\
M3/VM?^"A-A=Z7\.OC-\.=*TSX2?%FYTF>[L-!EM;>VCN]*9H8W-LTDD,DAVC
MH49OEE=E_6[P[X7\,^$--&C>$_#MCI=FKEEM-.M$@B#'J=J #)^E/US0-"\3
MZ7+HGB71;34;*< 36E];+-%( <C<C@@\^HH _F-_X*)?\,^_M"_MC>,?VNO^
M">GPC^*OC#]D"'Q3X?\ $7[5S>$]&>RT#6+^UOG:>:QBN%1I2(99'E.P!7ED
ME)2-Q)7Z0?\ !5WQ=\*_VF/V^_\ @F5X^T#38]9\'>-/&&O:CIUOK6C/&EW8
MW%CI<L1DMKE%90493L= 1QQ7ZI6>@:%IVC+X<T_1;2#3DA,*6$-LJPK&1@H$
M VA<$\8QS5J...&-8HHU5%4!548  Z "@#DO"W[/WP&\#ZO'X@\%?!+PCH]_
M%_JKW2_#=K;S)]'CC##\ZZZBB@#X\_X*L_\ !0#]H3_@G)K7PI^..E_!ZS\1
M_ FY\2S:?\=]>M-&N[S5O"UG(J"UU"!8)0H@#F4RL\<GW$1<-*M?&?\ P6%_
M;=_9O_X+8?"?P7_P2[_X)K^,S\4O%OC[QQI6I>)/$&A:1<_V?X+T2VD,DVHW
M=Q+&BQ,,A0G+8WJ<.T:2?L<Z)(ACD4,K##*1D$5F^&O!?@[P9#-;>#_">F:3
M'<2>9/'IMA' LC_WF" 9/N: /S*_:F^(GAO_ ()0?\%S_P#AOG]H.VU#3_@C
M\=OA%:^$-<\>Q:?-<VWAWQ)97$1MQ>F)7:**6WAC57(^9I'/W8G85/"'QG\"
M?\%BO^"X_P (?CO^RE>7?B3X,_LK^$]>N-9^(::?-#INJ>(M6MQ;+I]J\BJ9
MFCC$,S,!M_=/V*%_U+U32M+US3IM(UO3;>\M+A"EQ:W4*R1RJ>JLK AA[&F:
M)H.A^&=+BT3PYHUII]E "(+2QMUBBC&<X5%  Y/84 ?DY^QU^U?\$/\ @B5^
MVU^TW^R/^WCXJG^'OA+XE_%F_P#BC\(?&NK:?</I.LVNHI']KM$GC1@L]N8X
M8RK8+%&_V-_H/_!'_P#M/]M3_@I!^TE_P5_T/PIJNF?#7QKI^C^"?@[?:QIT
MEK+KVFV$48N]12.55<023P1-&Q SO=" T3"OT=\2>$O"OC*P&E>+_#.GZK:K
M()%MM2LDGC#CHVUP1D9ZU>AAAMH4M[>)8XXU"HB+@*!P  .@H \R_;=_Y,O^
M+W_9+]?_ /3=/7S?_P &WO\ RA*^ ?\ V+^H?^G:]K[?HH _-']M/_E9L_8R
M_P"R7^-?_3=?5\7^*OV/O^"47[+_ /P55_:,\'_\%P_@48=)^*GQ N_'/P5^
M*^KWNLV^CWUK?S2W-WIK3:?,B1S0RR@?O%_@?+*&A\S]_JI>(/#7ASQ;IC:+
MXJ\/V6IV;L"]IJ%HDT3$="5<$''TH _)'_@E'X._X)Z:Q^U]\5?BM_P1Q_X)
MO1VWA7P'\.[NP\._'Z^\7ZXMGXBU^4*3I%I9:@S+/#E%WS[E*>7TVRQLWR]^
MQ1XR_P"".7[0GP(G^,/_  6^_:*^(OQ"_:./B74H?&?PI\::[X@2XLK]+V9+
M73]/T:Q,8=3$(=L0#(KNR$1A=B_T+:=IVGZ18Q:9I-A#:VT"!(+>WB")&HZ*
MJK@ >PJD?!?@YO$H\:-X3TPZP(O+&K&PC^T[,8V^;C?C'&,XH _ ?]A2?3],
M_P"""/\ P4>\$CX8W'@*]L/B5XJNI/A]?VOV>Y\.6T]C9B"SDB/,?EB)XL=/
MW) Z5[=_P4T\06GPS_X(Z?\ !.;]H+Q39WH\)_#CXD_"3Q#XTU.SL9+C^S--
M@T4F2X=(U9MH.U!@<NZ*/F=0?V=J.\L[34+62QO[6.>"5"DL,R!D=3U!!X(]
MJ /RD^.WQ]^$7[4G_!?'_@GC\?\ X"^,XO$/A#Q/X$^(5UH>LPVTT*W40T:_
MC+!)D21<,C##*#D=*]!_X+7_ /*03_@GU_V<!<_^D]O7Z,V5C9:9:1Z?IUG%
M;P0H%B@@C"(BCH !P!4M 'Y.?#K]H?X;_P#!&K_@L/\ M+M^W'J-WX0^&_[2
M-]HWBGX:?$V^TZ>72I;RVMYDO--GGB1_)F5YV*J^ $A!.!+'GI/B+_P5R_:[
M_;,^'7[3OC+_ ();_"Q==^&?PX^$\J?#_P"*D>@78OO$'BTLIN$TV&?"W45O
M;&9P/)+&:*,8=9D!_3/7O#V@>*=,DT3Q/H=GJ-E-CS;2_MDFB?!R,HX(/Y5-
MI^G:?I-C%IFE6,-M;0($@M[>((D:CHJJ. !Z"@#^??X(VO\ P05^*O['/AWX
MF?%;QK\0?VH?VHO$/A)77P!XG\1^(=8UR]\726W[VT&G1N((XDN2RB696C$2
M;O,?JV'?:W9ZC_P9B^ M#AD7[3H?Q1%CJ,.[YX)CXQO)]CKU1MDR':><,#WK
M^A?3/!?@[1=:NO$FC^$],M-1OO\ C^O[:PCCFN/]]U 9_P 2:TZ /A__ (.)
MOV/?BM^VS_P2G\>_"SX'^'IM:\5Z3=Z?XATG0+="TFJ?8[A9)K9 .6D: S%$
M7EW54'+5^:.J:E_P:1#]EIOB=X8_8W?4OBS+I@M[+X#C6O%B:_)XA*[!I3)]
MH(4"?Y#,-R[02NYL(?Z#JRU\$>#$\2GQHGA'2QK#1[&U86$?VDKC&WS=N_&.
M,9H \A_X)J?"_3_@W^PI\-? .F?LS0_!N*#0/M3?"^'Q'<:M_P ([)=3274E
MLUU< 2R2!YF9PWW'9D!(4$_&?_!QW_R5+]AC_L\#PU_Z/CK]/J* /S1^-O\
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MVN_%/A'2]3ELGWV<FH6$<S0-_>0NI*G@<C'2M2@#\&O"7P8_;V_X)D:KH/\
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M\/ZKJNH?9K?1S=$0RZBS@%BUO$\DR(JL7DC1<8)(M_L7_LH_#;]AS]ECP/\
MLH?"6%AH?@G0H["&XD0+)>S9+W%W(!P))IWEF;'&Z0XXQ0!Z?1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\
MP&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_
M ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_
M /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&
M_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q
M16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P#
M8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\
MP&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\
M]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_
M /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%
M8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C
M_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P#
M8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T
M&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\
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ML45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\
MP&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_
M ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_
M /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&
M_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q
M16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P#
M8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\
MP&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\
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MBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\ Z#=E_P"
MQ_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !112.Z1(9)'"JHRS,< #UH \ _;T\4:WXGT+P[^R=X"OFBU[XI:G]@N
M9H>6LM(CQ)?7!]O+&S!^\&?'(KW#PIX8T3P3X8T[P=X:L5M=.TJQBM+&W3I'
M#&@1%_  5X#^R8C_ +07QS\:?MF:DADTIY&\,?#O>/E&FV\A\^Z3VFG!(/!&
MUUZ&OHZNO$_NXQHKIJ_5[_=HO6Y\IP[?,L17SF6U5\M+_KS!M1:_Z^2<JE^L
M903V"BBBN0^K"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >4_ME
M?&O5O@E\$KN_\'0M/XJU^ZBT3P?9QX+S:C<G9&5!Z[!ND]#LQWK;_9H^".E_
ML\_!30OA7I\JS3V-KOU2]&2;N]D.^>8D\G=(6QGD*%':O*?"3-^U+^VUJ'CU
MCYW@WX-"32M%[Q7FOS*/M4H[-Y*8CYZ-M8'DU](UUUOW-&-'J]7^B^2_%L^4
MR?\ X5\VKYJ]81O1H_X8O]Y-?XZBY?.-.+7Q!1117(?5A1110 4444 %%%%
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M[3L' D>%R78 %VY;)YK] J "BBB@ HJIJNH76GQH]KI4MT6;!6(C*^_-4O\
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M_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH
MV**Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_
M (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK
M'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X
M275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A
M)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\
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M^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\
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M%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\
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MZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX@^%_P )X_"GPY8OXU\<7Z:!X0@C;#K<S_*UQ_LK$A+[N@;9G@U[%TZU\V?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\
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M/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\
M^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@
M"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8
M?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[
M.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?
M&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'
M^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^
M_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T
M_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'
M_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^S
MM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0
MJ:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__
M )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_O
MT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/
M_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:
MB@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y
M\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*
M/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\
M^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@
M"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8
M?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[
M.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?
M&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'
M^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^
M_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T
M_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'
M_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^S
MM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0
MJ:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__
M )\8?^_0J:B@#$\<>(_!?PY\'ZGX\\82VUGI>D64EU?7,D8PD:*2<#N>, #D
MD@#DUXG^Q?X UGXAZOK?[9WQ5T(6^M>.56/PQI<\8/\ 8^@H<V\0'0-+@2N1
M][Y3P6851^/L\W[6W[0UA^R3HDK/X/\ ";P:S\4[F)ODN'SOM-+)']]AYCCT
M'!#(17TG###;0I;V\2QQQJ%1$7 4#@  =!79+_9\/R_:GOY1Z+Y[^ENY\E1_
MX7\\==ZX?"MQCVG6VG+S5)-PC_?<^L$R/^SM/_Y\8?\ OT*/[.T__GQA_P"_
M0J:BN,^M(?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L
M[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA
M_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?
M[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[
M]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3
M_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?
M^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.
MT_\ Y\8?^_0H_L[3_P#GQA_[]"IJ*    8 P!T HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O,
M_P!J_P"/H_9]^%<FN:+I_P#:/B;6+I-+\'Z*@W/?ZE-\L2A>ZJ?G;IPN,@L*
M](N[NUL+66^OKF.&&&-I)II7"JB@9+$G@ #DFOF[]GZVNOVM_C[>?M>^(K:0
M^$/#+3Z1\*K*=2%GY*76J;3W<@HA[ 8(!0&NG#TXMNI/X8_B^B^?Y7/G>(,=
MB80IX#!.V(KW47_)%?'5?^!/W;Z.;A'9GI'[)_P"/[/_ ,*X]%US4/[1\3ZS
M=/JOC'6G.Y[[49OFE;=W53\B].%S@%C7IM%%8U*DJLW.6[/7P&!PV68*GA<.
MK0@DE\NK?5O=MZMW;U"BBBH.L**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\
MX%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;
M%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_S\WO_@6U
M'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44
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M &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\
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M% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% "1H(HUC4G"J ,GFEHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEW8  9))X KR_P#9 ^&W[3_PJ^#,'A7]KS]I:R^*_C/^T)Y[CQ78>#+?0HA
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M[K4_"7Q!TZS-U?> ?%0C2ZE@4@-/:2QL4NHE)&[;MD7.6C4$$_QNUZ;^Q?\
M'_Q_^RQ^UE\._P!H7X7ZC<6VM^$_%UC?6GV9B&G595$MN0/O)+&7B9>C+(P/
M!H _NOHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^;-*7"N5^U57&.6(FM4ZLN=)]XPTIQ?G&$6>Q0PPVT*6]O$L<<:A41%P% X
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MES^(]4=[>)+:.UL;"&S^U?8T<VUM$TC^3]PQ$?.[L #\:*^__P#@UQ_Y3K_
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN_X33_A"_P"S/^*9_MO^SOMGVS5+2P_X^/(G\O9]J\S_ %;;MFWC=N'Y ?\
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M'+GX7W.@V<7A;PY:Z2Z:G9ZBK'[3-/<$[9(G&-J 97%?R^?\';WP'^('PO\
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M?\*N_P",7?\ A97_  LK^V_^9V_L;^SO[/\ L'_3E<^=YGV[_8V^5_%N^7X
M_P"(YS_K%U_YFS_[RT ?O]17X _\1SG_ %BZ_P#,V?\ WEK]_J "BBB@ HHH
MH **Q_'OQ!\"?"SP5J?Q)^)?C/2_#_A[1;)[S5]<UF_CMK2RMT&6EEED(1$
MZL2!7S-X/_X+F_\ !*'XC_'#PY^SC\-/VS?#WB;QCXLU>/3- TOPY87M]'<W
M+G"J;F&!H(P<?>>15]Z /K&BO$/VX/VKOBS^RGX/T36_@[^Q=X_^-6JZWJ3V
M:Z-X$^SI]@VQEQ-=2S,%AB)&T/@\\'J*YW]A[]I#_@H/\?O%6O3_ +7W_!.^
M#X&^'+>PBD\,R3_%"P\07VH3%R'66.T51;@)A@#DYR#0!](T5\E?M=?LK?\
M!5#X\?&F\N/V=O\ @IYI?P8^&TEE;I!H^D_".QUK5WE" 3DW5W(!&&;)5D&5
MSBO:_P!DOX'?$']G;X(Z=\+?BC^T9XF^*VM6ES<S7?C3Q='$E[=^;,T@0K$
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MK/AZQNY[<$6\UU:)(\0/7:6!*Y]JN0PQ6\2P01*B(H5$1<!0.  !T%.HH ^
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M^T3\.O&9T;X;ZCX%TFTU6'X@Z3XL\&17^J:@'A']GK97,BL+=(YS(\BG[P(
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MMD'@5D>D?,W[*O\ P6__ &5/VMOVFM&_94\)?"GXN^%?$/B31K_4O#E[\0O
M#Z-9:K'9JCSI;O-)YDKA'WX$> JG)!P#'_P4%_X*B?'G]DW]JCX?_L<_LW?L
M ZM\:?&?Q(\-7VK^'XX/']EX?M2+-F^TQ-/=Q.@:./9(22!B10,FOK74_A_X
M#UOQ?I?Q!UGP3I%WK^AQ3Q:+KEUIL4EYIZ3*%F6"9E+Q+(H <*0&  .<5KT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNHC+:W4%S;LT5W:S(K%)D(SL/ !4M]#4 %%%% !1110 4444 %%%% !1110
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M#^S5:_M V7P-\8:1J5]X7DU>#X>>)=/6RUR*81,ZV$T)9EBN&90FTL0"PYH
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MTW3;_74ED\BU$KRB(('"$;Y';E2?F/:NT_9T_90_9J_9$\(W7@+]F#X&^&?
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\
M 8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\
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MI;_@V6^!O[17BN\^)=W\6;2W\7:SXABU/Q+XFUGP)8ZK<:HH?=-&_G;0&E
M,G+#K@YK]/J*YOK%6UM/N7^1]&N'LL4U-*=TV[^TJ:WMO[_O;+1W2/BS7/\
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ML_*#7UG10\0W?W(_<*'#\(<ML56TOO4;OY/TZ;'R5\7_ (A_\%E/ 6A6%_\
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MB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\
M@,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_
M (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_
M .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-
M_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V**
M ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P"
MQ_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
M@,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\
MZ#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_
M .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH
MQ_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'
M_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P"
MQ_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H
M-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\
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MMK]!**]..<9C&*2GHO*/^1^;U_"/P]Q-:5:K@^:4FVVZM:[;=VW^\ZL_/O\
MX<4?]72_^61_]VU]2_L8?LP^)/V2_AG<_"S5/BS_ ,)5I_\ :#76EEM%-FUD
M'&9(Q^_EW*7&\=,,S]=W'K]%95\RQF*I\E65UZ+_ "/3R+P\X/X:QZQN6X;V
M=2S5_:5'H]TU*;3^:W2>Z"BBBN$^U"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJMK6LZ/
MX<T>[\0^(=5MK"PL+:2XOKZ\G6*&WA12SR.[$!%5026)  !)H LT5\2_#O\
MX.%O^"5_Q._:'@_9[\.?'VXB.HI9Q^'_ !GJ?AN^M- UB]N+B[MUL[>]FA6,
ML'M'Q*^V"4MMBED9)%3Z,_:F_;-_9:_8F\#VWQ&_:J^-VA^"M)OKP6FG3:M.
MWFWL^,^5!#&&EG<#DK&K$#DX% 'IU%>??LT_M6?LY?MC?#6/XP?LP?&+1/&O
MAQ[E[9]2T2ZWB"=0"T,R$!X90&4F.158!E.,$$^@T %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %>1?M^?L[>)?VN/V)?BK^S'X-\41Z+JWCOP)J6BZ;J<Y810SSV
M[HGF[,MY18A7P"=C-@'I7KM>:?MC?#/XT?&+]ESQU\,_V=/BU/X$\>:OX>GB
M\(^++<X.G7X&Z%F.UBJ,ZA'8 L$=B 2!0!^/WAK]H_X!?#OXM:K^QU_P7#_8
M2U[X<>%6_9^^&?@75YK>W;4/"D$ND:UXA>RU-M0TR0-I]K<RR+Y!)!5K6Y1V
MVQEF^Q-$M-%^-?\ P<A74/BN.+5=,^#O[+-I=> [>Y;SXK*_U352MQJ,3,3B
M9[9%@\P')3\Z^3/C+<_\%5/VW_B)\5?V'O%W_!/]]!^)_P 0OV</ /@SX@^+
M-=\9Z;-H&BVEOK?B5YO$:-#*TMQ%<^;+Y%O&IF26"7<"(U,GUO\ &[]E+]IW
M]A[]LCX9_MV?LA_!:]^,FD:3\#;?X4?$_P $V.LVEAK$]A9SI<6.L6GVITAG
MF5U>.2(NI*,NW.2R #O@%9:=\%/^#C3XT_"7X?V$6G:)\3OV<-#\?>)-/M(Q
M'#+K5KJ\NF_:=@X$CPN2[  NW+9/-?H%7Q1_P3Y_9]_:;\?_ +;'Q7_X*>?M
M>_!T?#;5_&?AG2_!OPZ^'5QK5O?W^C^'K-WGDFOIK9FA\ZYN7$@B1CY04JQ)
M.:^UZ "BBB@#S/\ :6^.?Q&^!NBZ9JGPZ_9P\2_$>:_NGBN;/PW-$CV:JH(D
M?S.H)X&.XKQ__AX)^T]_TBZ^*?\ X'6E?5E% 'RG_P /!/VGO^D77Q3_ / Z
MTH_X>"?M/?\ 2+KXI_\ @=:5]644 ?*?_#P3]I[_ *1=?%/_ ,#K2C_AX)^T
M]_TBZ^*?_@=:5]644 ?*?_#P3]I[_I%U\4__  .M*/\ AX)^T]_TBZ^*?_@=
M:5]644 ?*?\ P\$_:>_Z1=?%/_P.M*/^'@G[3W_2+KXI_P#@=:5]644 ?*?_
M  \$_:>_Z1=?%/\ \#K2C_AX)^T]_P!(NOBG_P"!UI7U910!\I_\/!/VGO\
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MZ1=?%/\ \#K2C_AX)^T]_P!(NOBG_P"!UI7U910!\I_\/!/VGO\ I%U\4_\
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M_AX)^T]_TBZ^*?\ X'6E?5E% 'RG_P /!/VGO^D77Q3_ / ZTH_X>"?M/?\
M2+KXI_\ @=:5]644 ?*?_#P3]I[_ *1=?%/_ ,#K2C_AX)^T]_TBZ^*?_@=:
M5]644 ?*?_#P3]I[_I%U\4__  .M*/\ AX)^T]_TBZ^*?_@=:5]644 ?*?\
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M:>_Z1=?%/_P.M*/^'@G[3W_2+KXI_P#@=:5]644 ?*?_  \$_:>_Z1=?%/\
M\#K2C_AX)^T]_P!(NOBG_P"!UI7U910!\I_\/!/VGO\ I%U\4_\ P.M*/^'@
MG[3W_2+KXI_^!UI7U910!\I_\/!/VGO^D77Q3_\  ZTH_P"'@G[3W_2+KXI_
M^!UI7U910!\I_P##P3]I[_I%U\4__ ZTH_X>"?M/?](NOBG_ .!UI7U910!\
MI_\ #P3]I[_I%U\4_P#P.M*/^'@G[3W_ $BZ^*?_ ('6E?5E% 'RG_P\$_:>
M_P"D77Q3_P# ZTH_X>"?M/?](NOBG_X'6E?5E% 'RG_P\$_:>_Z1=?%/_P #
MK2C_ (>"?M/?](NOBG_X'6E?5E% 'RG_ ,/!/VGO^D77Q3_\#K2C_AX)^T]_
MTBZ^*?\ X'6E?5E% 'RG_P /!/VGO^D77Q3_ / ZTH_X>"?M/?\ 2+KXI_\
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M7U910!\I_P##P3]I[_I%U\4__ ZTH_X>"?M/?](NOBG_ .!UI7U910!\I_\
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MP'\6OV>OV<_@%XK_ +)\2_%7XO0Q:Q<BQMYV7POIEI/J.L8$\;JIDBAAM@X
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MN@K#8R7EK:1C4-7U*X@2.UL+))RS$ H6R$0 $NNM^QK_ ,%!=<D_X(K^&/\
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MB/\ AJ+X8+X#E\"_$2RTKPYX E2)KK0+.2P64074T?,UPV5DDW'Y'=D 4+M
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M  2]_;&^*_AOXJW)^$$7Q%\)_$KP]X370[E+7^T1I\UAJ%E'-+$K^80\4D9
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MO)IATRW\8^.O&.HZ_J-E8$Y^R6TM_-+]FBQP1$%+#ABPKZ-H **** "BBB@
MHHHH **** "BBB@ HHHH **** "O@']E;_E8?_:M_P"R/^!?_1<U??U>?^%?
MV7/@3X)_:(\5_M7>&/ WV7Q_XWT>PTOQ1K_]IW3_ &VTLP1;1^0\I@CV!C\T
M:*S9^8F@#YF_;;_;Z^/7C?X\WO\ P34_X)B>'[+6?C)_9T-QX^^(.L1[]!^%
MFGW S'=7?!^T7[I\UO9@'/#N"BE3P?[4'[,'AK_@F!_P1K\6_LI?L\^*=1UC
MQ[\7]:A\*-XOUN0OJ?BGQ9XHO(=.N=3F;)/G;)Y)0 242V4;F*[CZ;\2O^"
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MIOP%O?[.TW7_ .W-+\!3^,=4E\+66I[R_P!KBT=[@V:-N)(3R_+&>$'%?8%
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M)X@UB&&?7-*U6_G:*;3M2U!$62_>1,7$3W):5(L*&8<U]8_M?_\ !./]DO\
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M2_:?M_@[\4='^,&F3? CQO>:6UY _BATE6'39HL;9(KF,2*R,5!V _,%*/\
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M.L1[]!^%FGW S'=7?!^T7[I\UO9@'/#N"BE3],^%?V7/@3X)_:(\5_M7>&/
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MG>"=?^&G[+'PT^''BJ.1-4\/_#_1M-U))CEUN(+&&*0-[[D.:] HHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?%#X=V>K:;%\7_A_X1\ 3Z1<>$[.\N8K8W.E7S74K:AY,TT8*SQJ73/W?OJ
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MMH /OBBOSA^ O[2/_!6+_@J'X5\5_M8?L6?'+X6_"CX8:?XIU32?A3X?\5>
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M?QOH[Z9X(T6#X*:C:_V?J,I AU!KF[MXTMDMWVRF3=P(\'"EB/TV_9%^'?Q
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MG_!5O]N#X_\ C:QCOO$&A>-="\"Z!<W*"0Z9HUIIH<VT!/\ JTFF<RR*,!G
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M L0* .R^%'_!:'_@EE\<_B1HOP@^$?[;?@K7O$WB*_2RT31K"ZE,UY</PL:
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M.L@+(4;.U"26+@)POP;_ &@_^"YO[97[*H_X*2_L[>+?A/H.D:S;W.L?#?\
M9UU7P5+=W.O:1'*XACO-:-Y&8+V>.,E/+C$.9(]QC!8* ?IG17Q=^TW\9?\
M@ICXO\6^#_#?P[OO /[,_@6\^'=OKGCGXJ_$XZ?K\]AKTI&[P]:V::A!&SP#
M<TEU(QB?'[LG;\_C/[+7_!5?]I77_AM^VA\-O&?QM^%?Q7\1_LT_#W_A(O!7
MQ<^&]JBZ5XA%QH]_>1)<VT5Q-&DT$]GY<B1R;22R<%-[@'Z;T5^6GPP_X*3_
M /!2#X)?\$[=3_X+&_MQ>)OAO=_#2_\ A%9:KX4^$WA;0IH-2?5[N6SM]-FE
MOV8A8[IYFDE0*_DK,@4-L:N8^(__  57_;0_8\^$NE_MI_&S_@H1^R[\6-*B
MO-/E^(_P"^'BVL&I:-87,\<4QTB_34II;^XM_-#,DT05TCD(/ - 'ZY457TC
M5M-U_2;77='NUN+2]MTGM9T^[)&ZAE8>Q!!_&K% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MYT:2VAD\N619)MTK!=L2NPSD@#FOK.BB@ HHHH **** "BBB@#RO]J?]B/\
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M3K7;/[3]GM8K6']S:WT4*;88(D^5!G;DY8DGS_\ XA<?^"%'_1C/_F3?$_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
@ !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>nvta-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:nvta="http://www.invitae.com/20201231"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="nvta-20201231.xsd" xlink:type="simple"/>
    <context id="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifc8bfb591e99451c9a0fcc043f9c90de_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i3580f7eb63464181853f57b89cae8eeb_I20210219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <instant>2021-02-19</instant>
        </period>
    </context>
    <context id="ica8df88fbc13471181f2a555e9880399_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7fe154ccb77e426d92286dae5aeff26e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id9b882f2b7c04e7297a6e4005b4ccdd9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i437a19f6fb264a83b0e5e51fec25eb41_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i58cad0e4115a408fb292a43a94deba31_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id8d899ddc8834e689efc87de396289f8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie4f2ead9ac6540068a6b97873f3f9752_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i616089384d754359aaf3b67545a021a0_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7f3778e5a29f4a89b8566f4904cf689f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2809c9d3c7ed495ea105d1d0909333c7_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie554d3df8b1f425f9be76437e8b27488_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8214f3614960469ea38d28cf9303f211_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id753156daf9b430195e021dca2c527bb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i23abde67124a40d590374be251a1dee1_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i37dd50d3619f4aff904889d2b15d5117_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ib4e2421641034f4f9c940f901e1fbdef_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7c3a7b53ff0f4c5ba0b9fc100703d37d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i82869c0962ef4cf1bddc91ff73996c6e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7ec2e6bbc47e4933af77c2c3a21ca309_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3bfa576bed044795b85e3c7f95992d6a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifbef3252651e4df5be4e543eeb29b46a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i65fbe0254a9a4420a86969e2d6309651_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3c6a38f48b1244e19aff28ddf6d53576_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">nvta:ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia370e5ff06d5431fa9bca439bb1b889b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia58ce6bc9aca49d9aa127557c52c11a9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id8594685f80541b1b4777011ea3b8353_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib2ce8df417b84195a8e55c791ce044b8_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ibfbbd53bd90042b58ef516ba23872688_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i34b06356d84b48aabb5a47a229bf0277_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2a108a141584487ca8dbd201dfd46516_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i24ea52a8309a4413a699941e900a6c44_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib6cd188a85204aaf8d02aeae0c5dfe1a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i133819ff76b24d47a6fe9cf8b026d64f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if1dffb2fad8b40ca9e2827b034550280_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i70c89bb06a7246a1bb3d4f7eec32e812_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i7e1175abf83148d8836d04d1ecf72a47_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id09edfceda314a48a3bae75a5376813e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i654d4e6d51c24784b92cf81e78d322ef_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i34f5ec56f0f64fb1a6076e5b2da4e8bb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idd5dd2727548445bba930982eb5e164a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i317a0d3674754e8eadf2100b8122a12e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i23413efbba8a4bce99ca014f751cd629_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ife1d8cfb66ed44aebe09b9526f251933_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i479bb752e9834ff889d964d04d4fd5f8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9cc8be4a617648da91ede3d8cd832c3b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8ef676364d144f13b1b75fad36a56028_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic7aecb12307a4028a550cb1bdd7c0949_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0f632804fdba4dc8928d0db037568eff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">nvta:ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i16fc5f68786d447999f8e4e68164aebb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">nvta:ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i799d7ced2b4d4f649c58a173693d0e85_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">nvta:ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id8c91c8e1cbc46d49aa79331ab90dcd2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id9c67b77700048fab0585b6066fa04c5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6871dfde02ea4071998e693ce797f046_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idbcb07071f07445fafa80ea82f6b1aa1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9b8929e13ba7497294e5422447cdf72c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i07eda2ee4f144ad196ef401a7db1bffe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueDecentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie8e9734305bb4650bd1c5a51bad8c420_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueDecentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i48186d64febd4653a8f230b2dee4ce39_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueDecentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia6be0b9df48b4580a4f57239b6c93c95_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueDecentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8b1d5edf779f44dc9cb12c8fa50f37f7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueDecentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0883ec36ca8f4b61abb4136ad60dfd6c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i54c647460d3a4f2ca2462ceef18be368_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if9bff46bd60c485b87b8b76a524b891b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibd3bd1b58fce419091528683f64e06f4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8f2c32a0a92c4d75956a7049d4a3d2ea_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1ac952c0d68641358df70ac8ca6a5650_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie754d8f483fb4e51858045ccc2f3ce90_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i74e133af2bf04b16807d4769bdb0cb72_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0865c1b494ba451ab270138139c94f26_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3e1ebc0d9c8f4fa49f8160f97e726c28_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5822641e200b480e91f0f00410faaa4f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i930f6e9c37794d87a77e92a1acdd9d20_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie9ceb9d1a9ba4fefab7b0de9a46a08f5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id351fd76aed144bd8c8d86224002492a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib3e33012667e4e30a31dc4fd2506de06_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i04c0ca3a9d3842ebb3e2454a419f73db_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id48ae029801d40a797835dbbc0b21225_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i569b0aa5a6f34fb192244d9b4ba6eda3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i58747813981d448b9d05d26c6c6d5246_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3f82f2edd74c43e996978b02294c3f96_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6829414e2ffa46ec8834efbb42474a0a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i491dfe25cfb649818908611d2258015f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6ba34653ed3d4026b109adcc85e47692_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7194b23e865e4e6985412838b83facfa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib4a31b78347c4b40b403d983d215552b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7296e71c4e804c2c81cdefbc5ff88c20_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i969948f32a3e419e836b2483a8c32d1b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ied3c3598292b417c808a16a8f89056d5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if00851ed8e674d059de41cc8a623702e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8fd4026968274daa9db97163c9bf7adb_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iddcdbd12b8c7475aba56d81dda39e665_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8d4f784ba21340fca1b9b756750631dc_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i63d5268d5fcc418f821908f9c967fc66_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic3b56aad901d4542b70fef47b9e041b7_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:TestRevenueCentralizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5c178e50df2e482c954755b5678ede25_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3fd6d6acd7ce4ad4bca9f6796da9e37a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib1e9baa6d9c74475a1b214d6a20dd9a3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifeca44f7c289448bba37ead51a718ccb_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:DiagnosticTestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie19147196bf74f8a98a96a08aa4ff4ef_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0d25782f3f414458ad4852af49306b8a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i82f3fed101ff476eac77b5bae97ef149_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3f15ba33a7ce4679b90a0c0de0249127_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvta:CollaborationAndGenomeNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i98f5fa2ae5e04ed4892542827e4eda04_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="icf399717bf28435a89aca26b773c0386_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PatientDirectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i31abe8effbe949ff872826205878e9e6_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:PartnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i35a9b0c466f0496cad68a4ecd841c041_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvta:OtherBusinessToBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if46861699db14e22b253710d388c79d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForChangeInAccountingPrincipleAxis">nvta:ChangeInEstimateOfRevenueRecognitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idcf84e334a474c329adf523e6663178a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForChangeInAccountingPrincipleAxis">nvta:ChangeInEstimateOfRevenueRecognitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie3516e7ca9c34c0eb58ee7744a7f3850_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForChangeInAccountingPrincipleAxis">nvta:ChangeInEstimateOfRevenueRecognitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic1f0935550d444fa90ce07c61f19769c_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="iffa172b7ed5b4b2d868c2ae82bbc52a8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2cfd56d90ca84309ab029f02e8df5f24_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="i7780db32fd364ad99995fb2cdcbfc4fc_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">nvta:CARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i05128bf9cc8243f2bc27b6e1f8a3f4b1_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">nvta:CARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i088f81f066a440d084e5a4dba897c8f8_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="if97a189b033643b79b8524895f6a78c7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i175aab7c76c643de95548d9a1cb45a8e_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ic8c530faa72844268e7ba46c4a287907_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie7db43ef787b49d99180bd32eb0c2d09_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="icefe8e19fd8546d5821a526b27974ab7_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvta:RestrictedStockUnitsPeriodofTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="idbe2c42636474f38911d7bec038c9f4a_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i664d8f88777d401d939dcc07f67fa240_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i76b34857279b4a77ad109619d8a570f6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvta:RestrictedStockUnitsPeriodofTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8beb45e3e6464392a4fe1aeb393268c9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvta:RestrictedStockUnitsPeriodofTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iece04e5008c1410393b57b628e274295_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4451a9390a774709818e6fbfd6084973_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1d36b97f4bad4698aa59cb3ac9774f0a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvta:RestrictedStockUnitsPeriodofTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i34ac12069b86446385fba11d5714dfa1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i20988f3b4f3842aca296183226b1191c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iabffd0b7435a46ab8001e51bc9e0f884_I20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:JunglaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="if5c0b15b91a8498db2213d6c5cd2acbd_D20190701-20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:JunglaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="id813b06cc8204234a74cd25abe6470b0_I20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:JunglaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="i34ca71f207834945b160a2a860186500_D20190701-20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:JunglaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="i3849bfee08db4045a8d579e08dc78573_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:JunglaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iedca751c89a74c22904be3c69b76ea13_D20190701-20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:JunglaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:IndemnificationObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="icad31fda692c44d6b3ebd405fc1f5bfb_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ClearGeneticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i1b7028fd67c14ce39c1a361bf67387ac_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ClearGeneticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i3c0220e1f83a4ee1a04a467bc49d5677_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ClearGeneticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:IndemnificationObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="id28b9a63ced0431fa69e448208ef5a4b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i61df02f3966840fc94c9ac82e9b14a0a_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:IndemnificationObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i21aa382eb1b9450d946befd8e9d905ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if78d990dbf00451cac45ceb3bfbb2548_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icf11c41e83954282a4bbb12523482153_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i4fa43003f790492f944ab337f15b503e_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:YouScriptMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i920e93e600db4f87ad9b6f58a894b7ed_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:IndemnificationObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:YouScriptMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="id10eb65b4a854730b97cac8b3b292344_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:YouScriptMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:IndemnificationObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i0be3804e02eb472fa855c077d75a96ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexandYouScriptMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia4a51d4bcba64524baa8cc419ee0d7bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i604983240be1439382d7e6de61b44b46_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="iaee9d8368b47462ebefed8a888e444ac_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexandYouScriptMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i49c0120db25348e6a3ad6bfc5753b6e0_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexandYouScriptMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i376851875deb457fb8f3344dfc678b71_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexandYouScriptMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i098aab9e153f4c929328dfcb7cfaab20_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i76b9ebec35b749d1bea22642506ec50a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i96044be6fb014778a5e4a8af9e0dfbbb_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ifd1c00bbb2f5471097e760d29754a813_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">nvta:AccelerationofVestedEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i0bf4bd068321410598134af3a04bf469_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:MilestoneAchievementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ia4c5e282814b430c8949b3e79a822850_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:MilestoneAchievementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i19caca01816142a3b5b28f51ca27894b_D20201101-20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:MilestoneAchievementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="i911717b1170c40cf972400c897d04ea0_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">nvta:AccelerationofVestedEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i0c4c49beaa8748e88bf241eeb61857e2_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i22c6518824a44e32968c6279d316dbfe_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i4ba4d5c315834206a2dfed011b842a81_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i4faeb825368e4fbebb63eb99ebd16fe1_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i50a8e75f54fb41df880dd13c66ec40f7_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ic1faba8c669949feb0448beb8f5f7f73_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i7afe4132b22c414b94a24036e21c8d41_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="id04b1d5d7d6f42a7972c2a960edf12fa_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i7cba339628964b39a0875938b2811685_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i43a9b372cb9d4068a0c794bfc92b1120_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieaa221a30dbd47088197aad0397a06dd_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i12c1cc42834c4cf6a61f40ac2f7ef3ce_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i047bbad9f41248d784dfd314328495e2_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia8407226615949bfb9526b70f7a7df3e_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib8a01b84d4884fd689e8d6d16e307111_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic716b0d977014b47953f608abb21ee07_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:DiploidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46f04de7671548948145a3408339daf3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:GenelexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia1859f563a61401391afb23698e3d1f0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:YouScriptMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i185c1e74a04443a291a72f01a6c8a9f5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i214eccad6a7f4c09b2611b0dd7b962db_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5869dcd08fba40eaad37b756d9760bb6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3a9ae61cda6d4c61b9b7cbc0b7d88e7d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i44f6002ca8f94affa0c1cb580edec0ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic9b892712a0a4fdc91399aedf309b228_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iad65ac656fd04a3d9861477f940eb9ec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i20ab20c5638141578c0fa5ed16421662_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4b08ae6f22a34f9ca4efcdd7622c90b6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">nvta:PatentLicensingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1145d52e94e041bc8011849883eb468c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">nvta:PatentLicensingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i83741d505a5c43ce85ad0ffbef5d30fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id489f9ef13794b19800824a2e713d3e3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i76054c8277e34b278fb7cb28ef0095cc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8bfd608ebc2f4679bbacfd7c6509b051_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i92c98fa4920d4181bdc4e4ebafa5d57d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if61da7ae894b44d3a17390db3eb337f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i67b31cc1f5c4428988fc99230afca7da_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iae69da4291404d09846bdd7eea1b3df7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id0de66aa513b490fa2a83655afd401b3_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i82a2c1c8bfbc441895243a5d3091ba15_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ide3fcab1d351422aa89b205d3c4e9817_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i109c3eeeb37142eeaff5dbcd7fb30a51_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0d6c19c668184c16ab5abb3b2f56e025_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia86d7ba53b5946f4a663cf20df932e8c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4fa0c386cddc4e38a421e7ec46fd9828_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie41b32eea41a4075bd7d4ef22299e442_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaed14ac220d841b784c269f25af4118e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1e9a07f9f51544b588b193d821061957_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i950327dbdb864aa59bae2e677d3cc59e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5f1d4c48e1794eef98c5bba9a22a83d2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifbb2e86c476945ceb7204aa84003647f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f5901d15dd341af989b63f1e1be596d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i221de2cc80ed4f658ae2b575f1e37709_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99c28c17201b43acb7779bcb565aff06_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie9f5a000cae84d829d333a825f105334_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i130e2d48b5004c6e9a3aeb316acff2f7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27addbbb2eb641a0b57afd4322937765_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54333500eabc422aa4fb7b50ec024580_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i28fae00650bb4a91b726c9ae7389e05c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i08aad59bfa6646eb872d92df4fe25c56_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i188d8124d1e9488595a24ed023c83ec0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4c5de93de50148019914bf27c7db6355_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia032f7f120de4f9c8d66f9fc7b25aca0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i473285deb1174f398238bf9d728acff8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if082e3e8efba43fc80a4f205e0fe9272_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ec63a96541542f6a5bd94b8d12a174b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0e46526580a74ee5aa03b64dbd08a141_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if3b0d2fd70ee437db964f0f6171b13e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib5b55a4267c44c95b43de4a61c59e2f8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i62eb3a1e610e4f46ac59f207fd5c2df3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3372e8a93caa498bb1f1a10e5af5a318_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if2590f9ee0bf41149e7cf8182ba63d51_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8cceadd9383544c5a008badc36969778_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i858f7fb75312498eac5fbdd977be8915_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b9ca881766247fdba01b8fa00874e5d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d4614b08b464e53b288d71792d75a12_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia093c7d811d143d4ae900c0461f04e11_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iac515eea33b64659b00dd874246c95ae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9bcaa1c58b304863a4d0704739b31457_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ied2ebd117b5349d18d84166bce5ec784_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i360a34815adf46b48fc3bc240b973154_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieef125570a5d410a9ae17d5d2ed6cb95_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f3a2163cfa940a4aa419fae83424ede_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06993cb5d1c6406493c955e36efe376c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5d1e92459dfa4c3c86e03c46590cf11e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib528de6cd5d94b218ca6a72049368aa7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iea18a70d0f8f4bc58647fa548740fb30_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3c59cd454de14e7b98c76fd5c5755dd8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2d259a569c8740668939cd2c6f008b27_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6db56f1860564b5c948005ffd0e54da2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib787a31ca31242e590f07fd32f7f3247_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i43b1dc051d8642cd979ce95901f997a3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic93726820e244b3e870907dd6bf88b60_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i038907853f764077b79a59ffd5d636f8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i09a2305fa55f403db2e53d3b4c66fdf4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i862cbc61396149b4a904c89b1e7af8f4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib57776d437354dc2ac23cfa698397058_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i820b4148e0c34bafbdd13e8562a3b4f7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i205c8b0c236749ab8849be640e1c99ba_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iec01bbe55f3a4c9eb2bb920d009b727d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7df43ef9d55e4c67ac7eb55388c00aca_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie763bd4d168247b5a8706e65eafef728_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6c5983241a3e4da6ba46a2a2e89d89fe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib13c4fca32874b758541909197f604c5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i763bfe6fa0b547ce82fc98bd8524a4fe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8d2ff72b9ebd43228f6d29da67e34f55_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id715584d8ddc40bbbff675871872b46e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i595e483b9f0344c4aca995e6a572302d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9192e09ee4e24faaa76e6fc28d55f441_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i73e6634d1bca4bdc955007d68d05ebaf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i531f978b6c494fe5962f9f63ddfd8712_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nvta:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icecfd6fced1c453ba8fe7e4e77e3c937_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2d0f0692653f4d25aaef40c6c24a8aac_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id23b32f856364b628d82e533acbde8ae_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nvta:OfficeFacilityInSanFranciscoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nvta:NewLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i4fe976692891413ba81c58b02db5d00d_I20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">nvta:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="i1f703415354e4db28b8eb792013da139_D20181101-20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">nvta:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="id859a147fbaa47b580a323a7f9e4189d_I20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">nvta:NotePurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:TrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="ie5fd4ad3c7b6406383062accfcffbe19_D20181101-20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">nvta:NotePurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:TrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="i63443cb782824ffab2f81095d44a8e69_D20181101-20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="ie3449298aceb411e8995fb489e02c922_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">nvta:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i69711d9dc55a46288486cf518a43bbe2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">nvta:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i117de729dbf54fc8b1c7825fc2b3e06d_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:SeniorSecuredTermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="if4f48e652c334267bca5c0f3175f3e6d_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:SeniorSecuredTermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i9bf76301d2c04d1fa068a5ac5c9c4e49_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ibccee1e9674b4a1394120efaba533158_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:SeniorSecuredTermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i9f033130abcd435b987c4fb6e75bdba0_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:SeniorSecuredTermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i89b10cf6330f40a29dfcad173848efc4_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:SeniorSecuredTermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i02d506f5f7744c309e1d6654a886c893_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">nvta:DebtFinancingContingencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i8beb7cf99ebe46ce83c4c7ac46d96be8_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="iad8e118b6e0b43acac375dbb27f97699_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id14582e54d2c40feb9322c61bbb86ebe_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3bbfab5b3a264c389f363d3c5993ae97_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i74cd37df131042188edd2e1114ee7668_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i272e3fbf659b47e08751fee97f870e59_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i190b1aad115641d5b928506daad609a7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i266c72c2a75741499dc45fa4f1f47af3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8065d0a2eaf64cef95166d99a6cbe527_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvta:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8f47c08fe00946e393ea1524efcfa65c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis">nvta:ServiceAgreementsAndLaboratorySuppliesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36aab3b4c6bf4533beccf6b9244c271d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nvta:OfficeFacilityInSanFranciscoTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i468f27e028dd4eabbd6a49ffcfef1827_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i81554310853b4484b5d45f21ba86a785_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i226038a1ff7c4ae9a815cea5810f19b6_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ifbede5a1c6e74525ab5e6cb2315db66f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icd21f307a6594587965e4a37c05d759c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id9861d9436174ce2b7457414cdf1a8a5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i586e2494307941b4b023e85dc64835bc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id86f15571c184f4ab4dc89850a302590_D20180801-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i65858024a6ee4670bd95a107e05b518c_D20180801-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i7be9af2688664a66b2e3f803d85e8307_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ic85e5a44169e47ba9cd182e29953f08a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i91467e89bd9d48e69c729af397fac23a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0937db87178b4e798b350becedc51ccc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icb647a44d30c450faf1555b120835483_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9d8cf03a0e974c96bbcca6588d723e4b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i50983d9ab9d24b97a4405cc2c8508678_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nvta:CowenAndCompanyLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nvta:CommonStockSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3fc482b9b4e6420fa7de24243abc75c8_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ic835049fa580444680cccf150af3d6d5_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i743deb0ca96048c0ad0d0d994c7de3bc_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ia72cba2cf21e4e85808615721f1799df_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i16d33aaa9e224dbeb56cab5c37d2117e_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="ie5a08f2fb5df43589f4951124966ba71_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="iab0062e9ec3943238240137781cd0e8e_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ie2395cc0a9644defb0e33c2083cde3e1_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i407b882e58514927b4d6e234330fb0af_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nvta:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i6d039501b157438480d3f00c8b7489fc_D20170801-20170831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-08-01</startDate>
            <endDate>2017-08-31</endDate>
        </period>
    </context>
    <context id="i32e8155326254dfdbe5fdaa570c6e110_I20170831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-31</instant>
        </period>
    </context>
    <context id="i42987b8252bd433a93091bf2d1686bc0_D20170801-20170831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-08-01</startDate>
            <endDate>2017-08-31</endDate>
        </period>
    </context>
    <context id="if2efecf6d7544e109ede0602218829c7_I20170831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-31</instant>
        </period>
    </context>
    <context id="i82a6b8eccfb740329aeaa15bd047f71b_D20170801-20170831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-08-01</startDate>
            <endDate>2017-08-31</endDate>
        </period>
    </context>
    <context id="ib58041aa8f654c0bbf3e16262383a5bd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">nvta:SeriesAConvertiblePreferredStockConvertedtoCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib7027e57e0c047a4b6418f097ab58a3e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">nvta:SeriesAConvertiblePreferredStockConvertedtoCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if2455da1e7a143d7851eb9d50d083334_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="iebaff4dc5d934f078872f079f91ec08d_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="id57225c75bc24501b26be0327fa8bcbb_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id2406ee2925e4cdfa9b0c5c418c48d97_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:CombiMatrixCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nvta:SeriesFWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibf0c262e5e494ba1a0b9dd846e947808_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if94fe272d7e54bc5a7c51daac714d62e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ief4a6302d24a4af294e7028833fe7fb2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5a98899500704f17a6fcfb0d3cdf1f52_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ibb3a6b1e9224415e90b51c05440aa312_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:SingularBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5411d1bf0e774eac8fe3c0f582fa2af1_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:ArcherDXInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie879d74e4a2947429031c4d39f6c60f1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:A2019IncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2f83a392f53641de82f099c66bcd8add_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:A2019IncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5b24e569ebe043d1bcd9a86c0d20cfa2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:A2019IncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79688bef1f2243f8af291580e680c142_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2a15e9739bdb4dd3ba91eff47a68dee8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifc2ccdad682745929752c4bdbabe6ad4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4a23a8c0acc9467b8816b6d8750a8e4e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvta:RSUsAndPRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i22b5947ce6b3433694f42047bef22a47_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i043b18d384cc4cbbbd4ea576bf1e0ee8_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8df5ce0c23374e0f96f0da2ab94af033_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7d14ed300bd94484b318f56f0730a43a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvta:TimebasedRSUsandPRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i97e8d6d759574ef190efeec1fa288be0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib230a508963e4077bf9c329a3d9e10af_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie1bf01002c574012aeba2a32221405d2_D20150101-20150131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2015-01-31</endDate>
        </period>
    </context>
    <context id="i842c32fb0e4d4001b6d4b09acb1051bc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ice92feeec65b4c99bf48cdc4f7ae3064_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9687cb514ee64df88920c8e6d2c79f5b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i212150697d1b4df0b9d350151ba23788_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i39d9c671420c4cbfb753905344bfe23e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie5f75e5a153a43f58048be8074c30cd4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaca634719b854efb84813c2dc3f0fd0e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie3381401fa094fc08b04b11cc3984e08_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nvta:CostOfTestRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id8599a661d45463f82a2aba708062fcf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nvta:CostOfTestRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i18c7b5a94cb34e1680e560d7a9eaae4c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nvta:CostOfTestRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9ea80e59e1504ea393646ffa29e23426_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nvta:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i513eed0ba1b74e578f8b16b9d3528e41_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nvta:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ida02d0b10c2a4069bcefe8098bf63928_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nvta:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5cf68f6fddea486e8c354682f35dc67a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia7bbe3658f5441e29fe16218b50948b6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i74963f7211644269a32529bd0993cd1f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i85ac1d76e52246da9b9419a6cfe9a0bc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9c65f7d592aa4164a8822f00359cee73_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2cecaa430d444086b81cce9a00a27278_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ief55ba984c4f4d3db6d80102c5abb216_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i859858a3113c4e09b4edddb15541a2ca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i61559c3568b9476ea2715a4b590e704a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i865f60d02fe3450983596a2fbd237a90_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">nvta:SubjectToExpirationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54c826b980cc42e1988fb3773b439e74_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">nvta:ExpirationTaxYearUnknownMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i56b9662e01b744d1affd87e3dbdd024d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i92d0ca5609ab4791a50bc6f0f888d703_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i29d2feec4499443ba9d3aee65162bf6d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i627cf3443eb34249aeaac7655a38320d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia8b8eff0cc4e4594a303839728013b12_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i42aa1ffe56be41719edfa03ee1a676ad_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icdc9926f8d9440acbfcda346d7729365_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i50d11234658f4896a2cb7ac1ea474e67_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i60b5dacd6ae24b4eace690f79d47b5c8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5cc357735b2e4b579432134168aed0ea_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i74957556027a49b782337f801d6e878f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i11b22b79bd2d4bc687f04292330d55b3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ied097690f5dc477a99c5073e45f85740_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="idffc47e14f9e48b0a7c357f2a1edd12b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:PerformanceRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i056d7c98eb70405abd4b0748fbcab7e9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:PerformanceRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id7824b6f46524c12b4e8ecb3fee953ff_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:PerformanceRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iec867c6aa9fe4723b6c30bd3d93f4b55_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia20172a5e2204ead90215591879a2beb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3995f1e95bed45a6aeef8542e96511ae_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8a2c42a62e2e4aefb13cd19623905faf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5615bcaf3cb24df28897143410b35483_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4ee3478f49dc43bdb576001358749eff_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvta:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i20c6e963b50d4140ad7de3d98e256dab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieb07f61948004d04843b243732524e95_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i72ab58f3157e4792a29e684275f6f509_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifdb77ef12cba40759cb6e357bad02f51_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i90fd9f70a9fd4afa806aa085235719e1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icd3c433db9754198990763fc88d3b083_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia5f0bb9d47b64539b838c7aa19d3033f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i916d5790c5474c6cb3f18a4b6f227ba6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ied08cb30dbfd48dcb62017c3f188ee2a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i515b20f3a9db410289d47edad55e5a77_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nvta:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0264e9789ee44e2ab9f703d1a70e7335_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nvta:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i84d0c14c0a5d4355a536eea3dc700eca_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nvta:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if177aa5c31294d399a4f1b9ea9366117_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iaba7a2a4e309410f8a88976be58969ff_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7c5bd43459294503984672c6404ac8b8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i272dd1562cfd41dbab6bd49a206984bc_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="idb8a205c97a741eabfc5c124772fda7e_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iaa9952ab3c9045afa4ce575e3df76321_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i16a3b4edc4c5441aa3a7b118f61cc1ed_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2c5ed2de4b2b4acc8e01d44e041365bc_I20210226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:OneCodexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-26</instant>
        </period>
    </context>
    <context id="i99d734e257e9441f812ed6b0c9affac9_D20210201-20210226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501134</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nvta:OneCodexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-26</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="business">
        <measure>nvta:business</measure>
    </unit>
    <unit id="segment">
        <measure>nvta:Segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="tradingday">
        <measure>nvta:tradingDay</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV80L2ZyYWc6NWM2MjVjODRlOTU5NGRiMDlkOWZlNTg0NDJiNzU3YWYvdGFibGU6MmI3NTdlYjBjYjFhNDE4Njk4MjI5YjY3YTUxYWE2MTcvdGFibGVyYW5nZToyYjc1N2ViMGNiMWE0MTg2OTgyMjliNjdhNTFhYTYxN18zLTEtMS0xLTA_d8f5204f-cabc-413d-bff1-1dea2e5318ac">0001501134</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV80L2ZyYWc6NWM2MjVjODRlOTU5NGRiMDlkOWZlNTg0NDJiNzU3YWYvdGFibGU6MmI3NTdlYjBjYjFhNDE4Njk4MjI5YjY3YTUxYWE2MTcvdGFibGVyYW5nZToyYjc1N2ViMGNiMWE0MTg2OTgyMjliNjdhNTFhYTYxN180LTEtMS0xLTA_26fc2223-1f28-4ab9-8941-a887109a62b6">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV80L2ZyYWc6NWM2MjVjODRlOTU5NGRiMDlkOWZlNTg0NDJiNzU3YWYvdGFibGU6MmI3NTdlYjBjYjFhNDE4Njk4MjI5YjY3YTUxYWE2MTcvdGFibGVyYW5nZToyYjc1N2ViMGNiMWE0MTg2OTgyMjliNjdhNTFhYTYxN182LTEtMS0xLTA_63f7a23b-7555-47ee-a0b9-b9a3fe79301f">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV80L2ZyYWc6NWM2MjVjODRlOTU5NGRiMDlkOWZlNTg0NDJiNzU3YWYvdGFibGU6MmI3NTdlYjBjYjFhNDE4Njk4MjI5YjY3YTUxYWE2MTcvdGFibGVyYW5nZToyYjc1N2ViMGNiMWE0MTg2OTgyMjliNjdhNTFhYTYxN183LTEtMS0xLTA_5dbdade9-bafc-4a4d-b84c-e242e0320b58">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i34f5ec56f0f64fb1a6076e5b2da4e8bb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzY4NQ_d2037801-faba-4d7d-9a9d-b880ce2dc05c">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i317a0d3674754e8eadf2100b8122a12e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzgzOQ_4c24a27f-0da2-4313-a3a1-cf19d3484ec4">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i317a0d3674754e8eadf2100b8122a12e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMTE2Mjg_1217d9ea-71ec-462e-9a23-2257607bd016">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ieaa221a30dbd47088197aad0397a06dd_D20190601-20190630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84OC9mcmFnOjYxOTViYzE2NmMxMzQwMjFhZTc2ZTNhNzAzMzFmZGZjL3RhYmxlOjRlZjY2Y2QxZjRhZjRmNGZhOTMxMjllZTFmMzE2ZDA4L3RhYmxlcmFuZ2U6NGVmNjZjZDFmNGFmNGY0ZmE5MzEyOWVlMWYzMTZkMDhfMi0xLTEtMS0w_e47ba71b-bfaf-4556-a0f8-0c385bdb2dc9"
      unitRef="number">0.3333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i12c1cc42834c4cf6a61f40ac2f7ef3ce_D20190601-20190630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84OC9mcmFnOjYxOTViYzE2NmMxMzQwMjFhZTc2ZTNhNzAzMzFmZGZjL3RhYmxlOjRlZjY2Y2QxZjRhZjRmNGZhOTMxMjllZTFmMzE2ZDA4L3RhYmxlcmFuZ2U6NGVmNjZjZDFmNGFmNGY0ZmE5MzEyOWVlMWYzMTZkMDhfMy0xLTEtMS0w_4227a5d7-388d-4c4d-b402-cba6b6213cbd"
      unitRef="number">0.3333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i047bbad9f41248d784dfd314328495e2_D20190601-20190630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84OC9mcmFnOjYxOTViYzE2NmMxMzQwMjFhZTc2ZTNhNzAzMzFmZGZjL3RhYmxlOjRlZjY2Y2QxZjRhZjRmNGZhOTMxMjllZTFmMzE2ZDA4L3RhYmxlcmFuZ2U6NGVmNjZjZDFmNGFmNGY0ZmE5MzEyOWVlMWYzMTZkMDhfNC0xLTEtMS0w_5594858e-7c39-4b08-b70a-3ffc6a5a5906"
      unitRef="number">0.3333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ia8407226615949bfb9526b70f7a7df3e_D20200601-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84OC9mcmFnOjYxOTViYzE2NmMxMzQwMjFhZTc2ZTNhNzAzMzFmZGZjL3RhYmxlOmNkZjJlNzBjOTMyNDQ0MzM4NjMzOGM5ZTY4OTljNmU4L3RhYmxlcmFuZ2U6Y2RmMmU3MGM5MzI0NDQzMzg2MzM4YzllNjg5OWM2ZThfMS0xLTEtMS01MTIz_73ced9e6-f198-412f-9303-a63711b5523a"
      unitRef="number">0.5</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ib8a01b84d4884fd689e8d6d16e307111_D20200601-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84OC9mcmFnOjYxOTViYzE2NmMxMzQwMjFhZTc2ZTNhNzAzMzFmZGZjL3RhYmxlOmNkZjJlNzBjOTMyNDQ0MzM4NjMzOGM5ZTY4OTljNmU4L3RhYmxlcmFuZ2U6Y2RmMmU3MGM5MzI0NDQzMzg2MzM4YzllNjg5OWM2ZThfMi0xLTEtMS01MTIz_d1849a64-3a02-4460-99d1-09a3e03a973f"
      unitRef="number">0.5</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="id0de66aa513b490fa2a83655afd401b3_D20201201-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xNjg3L2ZyYWc6YzJhYzVkMjBmYjk0NDhjYjgzODJlM2NjNWQxMzk3ZWUvdGFibGU6M2ZmOWQxOWUxZmEwNDNmYjhhM2MwODA5ZWYwZjUyZDYvdGFibGVyYW5nZTozZmY5ZDE5ZTFmYTA0M2ZiOGEzYzA4MDllZjBmNTJkNl8xLTEtMS0xLTY0NjA_68aff98d-78a8-4b63-845d-d4ed396f8992"
      unitRef="number">0.5</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i82a2c1c8bfbc441895243a5d3091ba15_D20201201-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xNjg3L2ZyYWc6YzJhYzVkMjBmYjk0NDhjYjgzODJlM2NjNWQxMzk3ZWUvdGFibGU6M2ZmOWQxOWUxZmEwNDNmYjhhM2MwODA5ZWYwZjUyZDYvdGFibGVyYW5nZTozZmY5ZDE5ZTFmYTA0M2ZiOGEzYzA4MDllZjBmNTJkNl8yLTEtMS0xLTY0NjA_c1d95f59-eb72-4017-bc41-3860257aabff"
      unitRef="number">0.5</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <nvta:DebtSecuritiesAvailableForSaleMaturityPeriod
      contextRef="i317a0d3674754e8eadf2100b8122a12e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfNzY5NjU4MTQxMDEzMQ_d4b367b6-e09c-49d9-900c-330dab11d098">P1M</nvta:DebtSecuritiesAvailableForSaleMaturityPeriod>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xNjk5L2ZyYWc6MzdhZGYyY2JlZTBmNGU0ZGE0MmE5MGE1NmE0MThkM2IvdGFibGU6ODM2ZDc5NzUyZTY4NGFhZThlYzMyZDM1NDA4OGI5YmQvdGFibGVyYW5nZTo4MzZkNzk3NTJlNjg0YWFlOGVjMzJkMzU0MDg4YjliZF8wLTItMS0xLTY0OTg_7c136f8e-6d53-429e-99e8-42d73a57b798"
      unitRef="number">0.0336293</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i5411d1bf0e774eac8fe3c0f582fa2af1_D20201201-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzIyNTM5OTg4Mzg2Njgy_3f341498-9f73-4766-bb53-9c8f75c67d63">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTUvZnJhZzo0OWI4Y2M4NjFjMTA0OGZjYmM5OGJmMzM0MTQwOTc1Mi90YWJsZTpiZDJkOTkyMDA5N2Q0NmE3OWY4MzNhMjBmMzdlZGFlZS90YWJsZXJhbmdlOmJkMmQ5OTIwMDk3ZDQ2YTc5ZjgzM2EyMGYzN2VkYWVlXzUtMS0xLTEtMA_870ddb50-1a1c-4fe7-88bb-a47f1e8cb217"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <nvta:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTUvZnJhZzo0OWI4Y2M4NjFjMTA0OGZjYmM5OGJmMzM0MTQwOTc1Mi90YWJsZTpiZDJkOTkyMDA5N2Q0NmE3OWY4MzNhMjBmMzdlZGFlZS90YWJsZXJhbmdlOmJkMmQ5OTIwMDk3ZDQ2YTc5ZjgzM2EyMGYzN2VkYWVlXzYtMS0xLTEtMA_33502561-954c-4f4a-81b6-dc67a89abe6b"
      unitRef="number">0.0208</nvta:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage>
    <nvta:IncomeTaxExaminationNumberOfPeriodUnderExamination
      contextRef="i29d2feec4499443ba9d3aee65162bf6d_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzQ5NTQ_150b999c-d788-453b-aa59-382e59e7d0d3">P3Y</nvta:IncomeTaxExaminationNumberOfPeriodUnderExamination>
    <dei:DocumentType
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6NGMxMjlmNjM4MDU2NDg3NmEyYWJiZTJlYmUzZWY1M2YvdGFibGVyYW5nZTo0YzEyOWY2MzgwNTY0ODc2YTJhYmJlMmViZTNlZjUzZl8wLTEtMS0xLTA_8c6ce993-7b5f-4e24-a97a-e20c2db2a5bd">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6MmM3YjdhOGQ1MDQ2NDg1NWIwOWVjZTY1MDZkODVmOTAvdGFibGVyYW5nZToyYzdiN2E4ZDUwNDY0ODU1YjA5ZWNlNjUwNmQ4NWY5MF8wLTAtMS0xLTA_5c087ac5-31ed-4d83-a7b5-7e8822f541f5">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8xMDg_c4002d46-7338-4848-99f6-1078ba020d2c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8xMDg_51dae979-cbca-4847-90dd-02f03bf3dd03">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6ZGYxOTBjZjk2YmIyNGExMGFjODMxZTQyMTBiY2MwYzEvdGFibGVyYW5nZTpkZjE5MGNmOTZiYjI0YTEwYWM4MzFlNDIxMGJjYzBjMV8wLTAtMS0xLTA_de260400-64e4-497b-9c2c-56b8637aaddb">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODA5_39800881-b1ef-427b-a725-3bba5cdb60c0">001-36847</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6ZTIwMjczYmQ1OWNjNGRmNWJkNGExODNkMjc4YjkyMTkvdGFibGVyYW5nZTplMjAyNzNiZDU5Y2M0ZGY1YmQ0YTE4M2QyNzhiOTIxOV8wLTAtMS0xLTA_55618fba-f1ac-43a1-847a-15bef67bc15a">Invitae Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6ZWMwYjhmZDgwYmM1NGEzZWJhMjRlMzY2YzExYzE4MTEvdGFibGVyYW5nZTplYzBiOGZkODBiYzU0YTNlYmEyNGUzNjZjMTFjMTgxMV8wLTAtMS0xLTA_10f10676-9bcf-4902-a76e-7a60e130e451">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6ZWMwYjhmZDgwYmM1NGEzZWJhMjRlMzY2YzExYzE4MTEvdGFibGVyYW5nZTplYzBiOGZkODBiYzU0YTNlYmEyNGUzNjZjMTFjMTgxMV8wLTEtMS0xLTA_30405424-8e4e-4f8f-a9b0-fdb72a75af33">27-1701898</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODE5_6f29e329-b34e-44af-8601-5bfffc0bd27a">1400 16th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODE2_40063011-f9aa-4780-82ca-b33682088fd4">San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODEz_99687434-9ac0-4716-874a-33bafec66ee8">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODE3_b9018a43-3e8c-4d45-8197-5102360d02bb">94103</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODIw_d4921f56-dd8f-4661-8f31-32779c81dfcf">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODIx_86e0c860-2d92-4d0a-9ef9-56d1e95fab9c">374-7782</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6ZjU0NmQ3MGEzZGRiNGNiN2E1ZmQwOWU2MTg3M2RhNTUvdGFibGVyYW5nZTpmNTQ2ZDcwYTNkZGI0Y2I3YTVmZDA5ZTYxODczZGE1NV8xLTAtMS0xLTA_df04b984-7573-46b8-a5ff-9fbc06a0d38d">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6ZjU0NmQ3MGEzZGRiNGNiN2E1ZmQwOWU2MTg3M2RhNTUvdGFibGVyYW5nZTpmNTQ2ZDcwYTNkZGI0Y2I3YTVmZDA5ZTYxODczZGE1NV8xLTItMS0xLTA_2c95a5c1-0459-4c75-b980-7c6f7c96f4d9">NVTA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6ZjU0NmQ3MGEzZGRiNGNiN2E1ZmQwOWU2MTg3M2RhNTUvdGFibGVyYW5nZTpmNTQ2ZDcwYTNkZGI0Y2I3YTVmZDA5ZTYxODczZGE1NV8xLTQtMS0xLTA_e2d9c021-a1d7-4a95-8c65-dd513b3028c3">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODEw_c46557da-09c4-4e65-9149-06200f2a5bb3">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODEx_e7759ee6-f3f1-4825-b9ba-6f702f69df1b">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODEy_99a94153-a708-43ed-8f34-522242f051fa">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODE0_229fabb9-ee3c-4f52-a317-b6153ec8cf75">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6MWEyZDgzZDg4MDgwNDM5Njg5MGJhNTMwNDc2YzY2YjQvdGFibGVyYW5nZToxYTJkODNkODgwODA0Mzk2ODkwYmE1MzA0NzZjNjZiNF8wLTAtMS0xLTA_7beefae4-53ea-4ea6-9a3b-14e5f5602e6e">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6MWEyZDgzZDg4MDgwNDM5Njg5MGJhNTMwNDc2YzY2YjQvdGFibGVyYW5nZToxYTJkODNkODgwODA0Mzk2ODkwYmE1MzA0NzZjNjZiNF8wLTctMS0xLTA_96fd6835-13a5-4290-b1e8-3dcb3c489f63">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGFibGU6MWEyZDgzZDg4MDgwNDM5Njg5MGJhNTMwNDc2YzY2YjQvdGFibGVyYW5nZToxYTJkODNkODgwODA0Mzk2ODkwYmE1MzA0NzZjNjZiNF8wLTktMS0xLTA_e4fc84f1-79cc-4077-a15d-5ec7752b3f3c">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yMjUzOTk4ODM3NDU3MA_d75f1410-0cae-422f-9fb2-580cf088a2d1">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODE1_045057e8-b06c-4818-86f1-6e502b78f699">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="ifc8bfb591e99451c9a0fcc043f9c90de_I20200630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yMjI5_6ae7ed63-1e17-4044-a54e-114354ceda10"
      unitRef="usd">4000000000.0</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i3580f7eb63464181853f57b89cae8eeb_I20210219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yNDE3_fac790ad-d8b2-4b76-a677-6f8f6a8c7c0a"
      unitRef="shares">196654925</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xL2ZyYWc6YzI4NjU2MzFhMGRjNDcxNmJhN2JkYzg1MGQ3MDU0M2EvdGV4dHJlZ2lvbjpjMjg2NTYzMWEwZGM0NzE2YmE3YmRjODUwZDcwNTQzYV8yODIy_4eec0eb2-b043-4e3d-ac50-07ab084ca11d">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Items&#160;10 (as to directors and Section&#160;16(a) Beneficial Ownership Reporting Compliance), 11, 12, 13 and 14 of Part&#160;III incorporate by reference information from the registrant&#x2019;s proxy statement to be filed with the Securities and Exchange Commission in connection with the solicitation of proxies for the registrant&#x2019;s 2021 Annual Meeting of Stockholders&lt;/span&gt;&lt;span style="color:#1f497d;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNC0xLTEtMS0w_639bd98b-7b0a-494f-8740-df1e3d0447ea"
      unitRef="usd">124794000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNC0zLTEtMS0w_6c9d622d-3fde-4450-9a9a-ac17843ca964"
      unitRef="usd">151389000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNS0xLTEtMS0w_af890e2f-28d0-40e7-9727-359c2ad0c935"
      unitRef="usd">229186000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNS0zLTEtMS0w_9f575b32-c1c0-405d-9627-cfefe5628508"
      unitRef="usd">240436000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNi0xLTEtMS0w_e2e77a8a-80ae-4a3b-b8df-cb7f3cfa0393"
      unitRef="usd">47722000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNi0zLTEtMS0w_26548c72-3c01-441a-acf2-429172521a75"
      unitRef="usd">32541000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNy0xLTEtMS00NDU2_9166c7ad-2218-4c66-9278-493ba2719b89"
      unitRef="usd">32030000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNy0zLTEtMS00NDU2_e9ceded1-d2e5-42c2-bb1e-407723c99a72"
      unitRef="usd">6648000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNy0xLTEtMS0w_8cff570a-d355-4c2d-9530-ce6c1f00ac08"
      unitRef="usd">20200000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfNy0zLTEtMS0w_4d1dbbf6-8c3a-40ee-89c8-e48c6172f911"
      unitRef="usd">11384000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfOC0xLTEtMS0w_8dd43390-364d-496a-a257-3432b57401ab"
      unitRef="usd">453932000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfOC0zLTEtMS0w_ecf729bd-c47a-4cfb-8d99-9323c75b62a6"
      unitRef="usd">442398000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfOS0xLTEtMS0w_c0620dfb-6f29-44a3-afce-c30bba504a0b"
      unitRef="usd">66102000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfOS0zLTEtMS0w_55cd74c1-31e0-4cca-8d66-51ba402fd47a"
      unitRef="usd">37747000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTAtMS0xLTEtMA_2199d02e-ee2d-4a32-a199-67b03d19a166"
      unitRef="usd">45109000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTAtMy0xLTEtMA_eb50e9ff-843d-4247-a23d-9b239a56cd38"
      unitRef="usd">36640000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTEtMS0xLTEtMA_920217f4-665b-4e6d-8e2e-165e669374bf"
      unitRef="usd">6686000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTEtMy0xLTEtMA_01318495-d0d5-4bdd-ae46-b13ee8b8ba35"
      unitRef="usd">6183000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTMtMS0xLTEtMA_fa3603cb-b28b-4bb5-96da-c6d4e7782343"
      unitRef="usd">981845000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTMtMy0xLTEtMA_2fd1511a-0fe0-4321-9b27-7b7a5c1a13ac"
      unitRef="usd">125175000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTQtMS0xLTEtMA_520c60bf-1a4b-419f-9d44-7a49edaee40c"
      unitRef="usd">1863623000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTQtMy0xLTEtMA_2fd659fa-dbef-4f47-8935-bd84c3881a8b"
      unitRef="usd">126777000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTUtMS0xLTEtMA_a906c0d6-ab9f-4b35-baf9-9f1c7c2fe2ef"
      unitRef="usd">13188000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTUtMy0xLTEtMA_62c26cc3-1607-47a3-86f8-042690711151"
      unitRef="usd">6681000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTYtMS0xLTEtMA_e242c630-66bf-4900-83c0-d56443e97810"
      unitRef="usd">3430485000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTYtMy0xLTEtMA_d467886c-be3e-4046-bc83-e82b69bd1661"
      unitRef="usd">781601000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTktMS0xLTEtMA_00b4a26d-53ee-43f1-9c87-78744bfd0c2c"
      unitRef="usd">25203000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMTktMy0xLTEtMA_3e80e798-d436-4559-b296-80653fc5e7c4"
      unitRef="usd">10321000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjAtMS0xLTEtMA_73be4a2d-2990-49f3-80bc-72073c70690f"
      unitRef="usd">86058000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjAtMy0xLTEtMA_7c11b114-558b-4ad6-bb85-4341e51a508f"
      unitRef="usd">64814000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjEtMS0xLTEtMA_535f54b4-18bd-49bb-94ac-4c6694297d4c"
      unitRef="usd">8789000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjEtMy0xLTEtMA_cb0a4878-c5bf-4bdb-a648-639f33b5ac14"
      unitRef="usd">4870000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjItMS0xLTEtMA_2976766c-3fd4-46c4-be00-886220d7cc92"
      unitRef="usd">1695000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjItMy0xLTEtMA_874457e4-a680-4c5f-9943-d9da6fdba57c"
      unitRef="usd">1855000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjQtMS0xLTEtMA_888706b0-13a1-4eff-9df0-6361d17d7128"
      unitRef="usd">121745000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjQtMy0xLTEtMA_bb1d397d-6cb5-4129-bbfe-1c3ef2c52843"
      unitRef="usd">81860000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjUtMS0xLTEtMA_66f6b200-b216-4f48-8d33-d307251d513f"
      unitRef="usd">48357000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjUtMy0xLTEtMA_c6623153-88fb-4086-90ae-5f20a5d43e9f"
      unitRef="usd">42191000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjYtMS0xLTEtMA_a686c82a-f214-4b30-a41f-dad218839232"
      unitRef="usd">3123000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjYtMy0xLTEtMA_8d21d9dd-34de-4fdf-ad11-44cf280d1b0e"
      unitRef="usd">1155000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OtherLongTermDebtNoncurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjctMS0xLTEtMA_40b3fc32-7925-4cea-8cb9-052aaabb6996"
      unitRef="usd">104449000</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:OtherLongTermDebtNoncurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjctMy0xLTEtMA_aa2b7825-46d8-4abf-87a3-a697f73caf3e"
      unitRef="usd">0</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjgtMS0xLTEtMA_9651d44f-3eb4-49b5-8c88-b14c6d552841"
      unitRef="usd">283724000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjgtMy0xLTEtMA_255d1e19-9334-4da6-9c4c-9543ac20c82b"
      unitRef="usd">268755000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjktMS0xLTEtNDkx_83cd5a62-2934-4301-b8cd-af8ad0d2cfc9"
      unitRef="usd">51538000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjktMy0xLTEtNDg4_cf38b292-b71b-42a8-9521-ade78f3e05d0"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjktMS0xLTEtMA_1f254d08-657f-4f4b-82fd-112e34d23b33"
      unitRef="usd">841256000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMjktMy0xLTEtMA_aa5d1fcf-d3a6-45d1-886a-0e5ec5482a21"
      unitRef="usd">8000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzAtMS0xLTEtMA_e0a2f013-6cdc-4a1d-bcdd-5a6f58a57159"
      unitRef="usd">1454192000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzAtMy0xLTEtMA_59d967d8-e93a-4801-8624-00697c302bf9"
      unitRef="usd">401961000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzEtMS0xLTEtMA_05f0d1a3-60d9-46a5-b59c-df8a9544ebc3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzEtMy0xLTEtMA_4e1743d7-53c5-45a8-9c7a-58e65175621b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTgx_4dcaa471-d14f-4310-b70f-b98479d6b8d0"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTgx_fadb4449-0076-4825-ab36-2e9fe7fbe165"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTkw_499cbd23-6138-45e7-bf9c-aa3397686e7c"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTkw_aca949d9-edb0-4323-8192-479a1dcfc91e"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTk2_46f8b1ad-4db2-449b-97a2-c38cb97c7a71"
      unitRef="shares">125000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTk2_6dd30187-5d5b-4884-a0ad-e40be6097e14"
      unitRef="shares">125000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTk2_7e75b11e-6fae-4ff9-b1df-400bfcd46436"
      unitRef="shares">125000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjU0ODU3YzM5YjNjNjRlYmE5OWMzMGNhOTBlMzk4YTY0XzIyNTM5OTg4MzY5NTk2_c5c5c1d8-d7af-4c9d-838a-df2efe1f6217"
      unitRef="shares">125000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMS0xLTEtMA_220d7c7a-3d67-44b1-bbde-e6950f82d694"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzMtMy0xLTEtMA_84cc6c0d-9e67-4ecd-9a02-62eb65347574"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjAy_a2dcdff8-b321-4244-9c6a-3d6e447ae560"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjAy_ea85c2be-b02e-432f-8bcd-a0a063075197"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjEy_2c1c6f32-521c-4def-a79f-fdda6dde8392"
      unitRef="shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjEy_7f9cdd13-94a1-4f5f-89f3-d2fc1bb490ac"
      unitRef="shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjIx_09a4e71b-3bc3-48f3-a2a3-aa9c13bd8940"
      unitRef="shares">185886000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjIx_9cdd241c-f0e3-448d-a48c-e3280e261068"
      unitRef="shares">185886000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjMw_49b69604-39ed-4fa6-82a3-3b1d73a0c04e"
      unitRef="shares">98796000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE4MzlkZTU5N2EwZjQ1MGU5NDAzNjk5YjEzYTIzNjQzXzIyNTM5OTg4MzY5NjMw_bdd6b44f-f62d-4eba-adfe-773e943bd830"
      unitRef="shares">98796000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMS0xLTEtMA_f5a1069f-40b6-4bb9-8444-bb43657f3795"
      unitRef="usd">19000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzQtMy0xLTEtMA_5d4cff77-df0b-4125-847d-0e6f9611f39f"
      unitRef="usd">10000</us-gaap:CommonStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzUtMS0xLTEtMA_401dca7e-9b20-46c0-a511-429ca8a7d35e"
      unitRef="usd">1000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzUtMy0xLTEtMA_d427fbc6-cc18-466b-ad9a-05c647e86681"
      unitRef="usd">-9000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzYtMS0xLTEtMA_3a4bfa6c-2360-418e-9523-826ccbbc7acf"
      unitRef="usd">3337120000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzYtMy0xLTEtMA_7e5fdc41-3052-413c-acda-3f40304dc215"
      unitRef="usd">1138316000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzctMS0xLTEtMA_c80abc7c-bd40-4d54-8f31-683e849a56e2"
      unitRef="usd">-1360847000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzctMy0xLTEtMA_da939a3f-76d1-49aa-8111-984b3ebc679f"
      unitRef="usd">-758677000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzgtMS0xLTEtMA_2947adf9-7c2d-4e4f-9e8b-3a3b8c94857e"
      unitRef="usd">1976293000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzgtMy0xLTEtMA_9f615702-b7e7-4889-8feb-beb77609b488"
      unitRef="usd">379640000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzktMS0xLTEtMA_9dd5dcd7-823a-42b2-8a06-49f0280ff135"
      unitRef="usd">3430485000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81Mi9mcmFnOmJhMGI1ZmNiODBiNzRlZWJiNDg1NjRiYzhiMTY4MTA0L3RhYmxlOmYzYjk5ODA1ZmE5ZDQ4OGI5Yjc1ZGE2MTA5NTg5ZDI2L3RhYmxlcmFuZ2U6ZjNiOTk4MDVmYTlkNDg4YjliNzVkYTYxMDk1ODlkMjZfMzktMy0xLTEtMA_46913b3c-0af4-4204-92bb-b7a05f2b287b"
      unitRef="usd">781601000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9b882f2b7c04e7297a6e4005b4ccdd9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMy0xLTEtMS0w_6a687ece-6ebe-4837-afa6-002273337e5a"
      unitRef="usd">272310000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i437a19f6fb264a83b0e5e51fec25eb41_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMy0zLTEtMS0w_9a4a85de-ff5d-4ce7-8920-37b43703caa5"
      unitRef="usd">212473000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58cad0e4115a408fb292a43a94deba31_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMy01LTEtMS0w_cbac4fdb-c5e4-49d6-939a-4a7d8f54dc59"
      unitRef="usd">144560000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8d899ddc8834e689efc87de396289f8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNC0xLTEtMS0w_c809ea67-d78a-407e-86e5-e8ca0295a62e"
      unitRef="usd">7288000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4f2ead9ac6540068a6b97873f3f9752_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNC0zLTEtMS0w_1a6a3af0-01db-4244-8d95-9be47e34462f"
      unitRef="usd">4351000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i616089384d754359aaf3b67545a021a0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNC01LTEtMS0w_26df5e48-3cca-4f14-950d-3a03eec62dba"
      unitRef="usd">3139000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNS0xLTEtMS0w_908696e7-e855-4dc8-889e-768781cfa3de"
      unitRef="usd">279598000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNS0zLTEtMS0w_2e0fe379-8b28-4a23-a1fa-9c9262ca7c22"
      unitRef="usd">216824000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNS01LTEtMS0w_29ac02c1-e1e4-431e-a0ac-ae4859c38743"
      unitRef="usd">147699000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNi0xLTEtMS0w_d5e24935-85e3-425b-85e5-b1da14c178fc"
      unitRef="usd">198275000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNi0zLTEtMS0w_e1165101-4d1e-4ce4-9639-f7900c04dbf9"
      unitRef="usd">118103000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNi01LTEtMS0w_df41025e-10e6-4826-8440-93740b517a82"
      unitRef="usd">80105000</us-gaap:CostOfRevenue>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNy0xLTEtMS0w_fd33c6b1-dfe9-43bc-8522-647360feae2c"
      unitRef="usd">240605000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNy0zLTEtMS0w_50e2f3b9-32e1-421d-a253-4ea202efd808"
      unitRef="usd">141526000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfNy01LTEtMS0w_8062c620-3fb5-49f5-9976-bda2fbdc5625"
      unitRef="usd">63496000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfOC0xLTEtMS0w_4d76d6d3-f7c9-4293-8f53-28c520944308"
      unitRef="usd">168317000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfOC0zLTEtMS0w_7a133902-a413-404d-b3a4-534afd307d47"
      unitRef="usd">122237000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfOC01LTEtMS0w_2d857ae6-2d02-47e2-8ed3-faa904268aee"
      unitRef="usd">74428000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfOS0xLTEtMS0w_3e74c002-af5a-45d1-bb04-5ab7243522d1"
      unitRef="usd">324573000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfOS0zLTEtMS0w_96f3764d-e676-459a-a690-18c86ad74168"
      unitRef="usd">79070000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfOS01LTEtMS0w_61f845a5-615a-4ff0-9e2b-dab8b001cecd"
      unitRef="usd">52227000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTEtMS0xLTEtMA_01a0f6be-8ee0-4762-9c60-529cf77d976b"
      unitRef="usd">-652172000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTEtMy0xLTEtMA_06c81013-e16c-4bd8-9239-57aab96ec633"
      unitRef="usd">-244112000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTEtNS0xLTEtMA_0674782d-0e56-467d-9c3a-392bbd50cfeb"
      unitRef="usd">-122557000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTItMS0xLTEtMA_c6abcddf-649f-4886-b440-48d4b1522cfe"
      unitRef="usd">-32332000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTItMy0xLTEtMA_a5e14920-5e20-4021-98b3-0ec884d98bc3"
      unitRef="usd">-3891000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTItNS0xLTEtMA_031a3362-3165-45ef-b22a-bd7ca0199fb8"
      unitRef="usd">-2568000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTMtMS0xLTEtMA_10eba01b-7635-41e5-a2cb-78ac1a553719"
      unitRef="usd">29766000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTMtMy0xLTEtMA_b1df317a-ffde-45ce-ab78-68ba3aa2ad56"
      unitRef="usd">12412000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTMtNS0xLTEtMA_a1d4b6b9-e703-416b-aa59-ffd981b2601c"
      unitRef="usd">7030000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTQtMS0xLTEtMA_2884b55d-5afd-42b9-8b45-c7defbe7ef24"
      unitRef="usd">-714270000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTQtMy0xLTEtMA_2e0271ce-e61b-41e9-9580-ea4b2989c9b8"
      unitRef="usd">-260415000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTQtNS0xLTEtMA_c0483419-785c-4177-953e-f918f6b6df86"
      unitRef="usd">-132155000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTUtMS0xLTEtMA_4886f6f2-06ca-43ab-9bbe-f6a74362f543"
      unitRef="usd">-112100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTUtMy0xLTEtMA_190f8c80-e954-4bf7-bf57-69d0d17ec011"
      unitRef="usd">-18450000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTUtNS0xLTEtMA_b56a443f-7723-4347-b5d1-f8cb9aac8063"
      unitRef="usd">-2800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTYtMS0xLTEtMA_5c824880-f371-4a13-b1de-6349c1a5532c"
      unitRef="usd">-602170000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTYtMy0xLTEtMA_90986e80-940a-4ea5-b1d3-d0e8c3a54aef"
      unitRef="usd">-241965000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTYtNS0xLTEtMA_1d8362fe-5b0f-4b84-a23b-7c22f417a4ce"
      unitRef="usd">-129355000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTctMS0xLTEtMA_07af50dc-7549-436e-b570-2c15ec24719b"
      unitRef="usdPerShare">-4.47</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTctMy0xLTEtMA_0ebc3fed-b8ba-4de0-9d0e-f9fa8781cfff"
      unitRef="usdPerShare">-2.66</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTctNS0xLTEtMA_6b6f3d27-43bf-4a0a-a956-88d2049e6d4b"
      unitRef="usdPerShare">-1.94</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTgtMS0xLTEtMA_f2d847c2-3701-46b3-86fc-65ce7de0f069"
      unitRef="shares">134587000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTgtMy0xLTEtMA_f0ac1199-0ee3-45c8-bb1a-37f507ac57ea"
      unitRef="shares">90859000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV81OC9mcmFnOjBjOWRhYjg3NTdmZDRmYjdhNDYyNTA3NjdhYWEzYTU4L3RhYmxlOjc5YWRkMTNjMjZkMDRkMDc5MjkwNTUxMzEyZmJhNmMzL3RhYmxlcmFuZ2U6NzlhZGQxM2MyNmQwNGQwNzkyOTA1NTEzMTJmYmE2YzNfMTgtNS0xLTEtMA_f9ba42d2-8924-4108-ab90-beda528745f6"
      unitRef="shares">66747000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfMy0xLTEtMS0w_18688fdf-cc02-4ab9-b7de-12b9d506c6f7"
      unitRef="usd">-602170000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfMy0zLTEtMS0w_fc207d5e-bd50-44d6-b8ab-c9ccb047e95c"
      unitRef="usd">-241965000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfMy01LTEtMS0w_5c7c7a21-950c-447d-912a-a10b2d3d0dd3"
      unitRef="usd">-129355000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfNS0xLTEtMS0w_c4d61d70-e8d6-420a-b402-919efe86ac4d"
      unitRef="usd">10000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfNS0zLTEtMS0w_10ca26c0-c869-45e9-93ae-500ff2121b42"
      unitRef="usd">-4000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfNS01LTEtMS0w_7fb083da-e3ed-4672-9c4a-f0b984614b53"
      unitRef="usd">166000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfNi0xLTEtMS0w_d27c67d5-3e74-4512-9842-d2cc00e12bbb"
      unitRef="usd">-602160000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfNi0zLTEtMS0w_a79a02ca-08e7-4830-b41b-d75f6a4fb128"
      unitRef="usd">-241969000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82MS9mcmFnOmNjYzE5Y2NmM2JhNzQ5NWY5OGUxMjY1ZjdhZDg4YmUwL3RhYmxlOmUxMmU1MjhlYzM1ODQzNzE4YzNlMGFjMjgzMWE1Y2VlL3RhYmxlcmFuZ2U6ZTEyZTUyOGVjMzU4NDM3MThjM2UwYWMyODMxYTVjZWVfNi01LTEtMS0w_dc51c5ab-9a1d-4e19-b30f-da4eec7e666d"
      unitRef="usd">-129189000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i7f3778e5a29f4a89b8566f4904cf689f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMy0xLTEtMS0w_e329bd74-8248-4f5d-a6c4-2f4b42cead49"
      unitRef="usd">10000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2809c9d3c7ed495ea105d1d0909333c7_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMy0zLTEtMS0w_9ffe9155-6f27-4532-b47a-4009e79e581c"
      unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie554d3df8b1f425f9be76437e8b27488_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMy01LTEtMS0w_98ee50c4-8860-4239-a8ca-e6ef50168629"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfNC0xLTEtMS0w_21951b9f-1db9-400b-8577-d3864d46d980"
      unitRef="usd">9000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfNC0zLTEtMS0w_30827ff6-922d-4afa-b446-1c0f3028c5ec"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfNC01LTEtMS0w_4fd2845e-bd01-4be9-b048-9b1ad656ba61"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockholdersEquity
      contextRef="i8214f3614960469ea38d28cf9303f211_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfNS0xLTEtMS0w_2b7ad58f-deed-4989-8d26-c6fc3994ba65"
      unitRef="usd">19000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7f3778e5a29f4a89b8566f4904cf689f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfNS0zLTEtMS0w_1149b126-3213-4ed8-820d-210bc049bb02"
      unitRef="usd">10000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2809c9d3c7ed495ea105d1d0909333c7_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfNS01LTEtMS0w_93c20447-2c95-4934-8ba3-e6bc26a59d27"
      unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id753156daf9b430195e021dca2c527bb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfOC0xLTEtMS0w_ecf7bb66-6be8-4d8e-af68-70be800d5403"
      unitRef="usd">-9000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i23abde67124a40d590374be251a1dee1_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfOC0zLTEtMS0w_8ebbbed0-3402-4dc0-bbee-a8d3decb3063"
      unitRef="usd">-5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i37dd50d3619f4aff904889d2b15d5117_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfOC01LTEtMS0w_409eff30-9570-44e6-91f6-902ee27a4fc5"
      unitRef="usd">-171000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="ib4e2421641034f4f9c940f901e1fbdef_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfOS0xLTEtMS0w_e482240c-33d1-4b40-9a82-e332becac91d"
      unitRef="usd">10000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i7c3a7b53ff0f4c5ba0b9fc100703d37d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfOS0zLTEtMS0w_1be16f28-49c2-412e-ba36-46cdc5972490"
      unitRef="usd">-4000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i82869c0962ef4cf1bddc91ff73996c6e_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfOS01LTEtMS0w_e48e44e5-699f-4489-b647-4705e2f8fbdb"
      unitRef="usd">166000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:StockholdersEquity
      contextRef="i7ec2e6bbc47e4933af77c2c3a21ca309_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTAtMS0xLTEtMA_45ae10eb-2c8f-4e9c-a7a3-5e0c2ebf21ef"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id753156daf9b430195e021dca2c527bb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTAtMy0xLTEtMA_e1ee6cf8-4c1f-4d7d-8013-3cb34ae4914c"
      unitRef="usd">-9000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i23abde67124a40d590374be251a1dee1_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTAtNS0xLTEtMA_2d208425-39f8-47ee-bddf-b253e9806a02"
      unitRef="usd">-5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3bfa576bed044795b85e3c7f95992d6a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTMtMS0xLTEtMA_6677887e-ca2b-48ec-aa58-6c91117f065f"
      unitRef="usd">1138316000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifbef3252651e4df5be4e543eeb29b46a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTMtMy0xLTEtMA_efdb61b5-db9d-4218-8f75-06088bdc03ed"
      unitRef="usd">678548000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i65fbe0254a9a4420a86969e2d6309651_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTMtNS0xLTEtMA_01b96a73-5343-4f62-8207-eddc99b68fe4"
      unitRef="usd">520558000</us-gaap:StockholdersEquity>
    <nvta:StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts
      contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTQtMS0xLTEtMA_56898a6d-8bfc-4afc-a2af-13bf5809a9d1"
      unitRef="usd">263628000</nvta:StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts>
    <nvta:StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts
      contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTQtNS0xLTEtMA_2e9701fe-368f-4ec1-9308-956f4d70dd53"
      unitRef="usd">5353000</nvta:StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTUtMS0xLTEtMA_9bfe1669-3437-428c-a135-823bd9132233"
      unitRef="usd">263685000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTUtMy0xLTEtMA_0af0f952-9818-41b5-8e35-0f8b566cce78"
      unitRef="usd">204024000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTUtNS0xLTEtMA_4f7656d2-cdd7-4039-b3d7-ebd1c285ce3d"
      unitRef="usd">112438000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTYtMS0xLTEtMA_2612313c-f442-4c03-82c4-59f19492b9bb"
      unitRef="usd">10730000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTYtMy0xLTEtMA_59bd63e7-1906-4add-89e0-5ec36da0b502"
      unitRef="usd">3456000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTYtNS0xLTEtMA_8dca1a43-bfb7-4ddb-b36f-f30463b8e415"
      unitRef="usd">2741000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <nvta:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTctMS0xLTEtMA_c5976f45-5681-4a66-af0d-5ec3e4a5fb8e"
      unitRef="usd">974000</nvta:StockIssuedDuringPeriodValueWarrantsExercised>
    <nvta:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTctMy0xLTEtMA_44eefde3-79cb-4229-a3b9-d3672dfa4d89"
      unitRef="usd">181000</nvta:StockIssuedDuringPeriodValueWarrantsExercised>
    <nvta:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTctNS0xLTEtMA_230b8e83-a051-479b-923f-aa1eca4066c2"
      unitRef="usd">6539000</nvta:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTgtMS0xLTEtMA_833317d5-0e0d-4a26-89f1-6c8cfb9e7e35"
      unitRef="usd">8871000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTgtMy0xLTEtMA_1dfec71c-cd30-4679-bc31-cb70371601cb"
      unitRef="usd">5833000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTgtNS0xLTEtMA_34c1f18e-eee7-4fdd-b88b-933f7306b07e"
      unitRef="usd">3231000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTktMS0xLTEtMA_a037859f-06f5-48c2-8735-1ab1c37ce03c"
      unitRef="usd">1524227000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTktMy0xLTEtMA_48f99e15-4573-40db-a605-082c6775ad8e"
      unitRef="usd">133942000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMTktNS0xLTEtMA_24964612-0a9e-4538-9413-c77183010092"
      unitRef="usd">6455000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjAtMy0xLTEtMA_646988d9-f023-406b-b490-8d750a6fcb9f"
      unitRef="usd">75488000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts
      contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjEtMS0xLTEtMA_3015f891-bebd-4f0a-b142-946bd0aaf0b4"
      unitRef="usd">27000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts
      contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjEtNS0xLTEtMA_9b0eeb60-a742-4a10-a525-20becd740d9d"
      unitRef="usd">383000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i75361ae959b34e388e3b1106b3c557cd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjMtMS0xLTEtMA_528f78d6-3301-48fd-a285-f38860a601b7"
      unitRef="usd">110076000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8f94616d086349009e4fbcb5cb536d18_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjMtMy0xLTEtMA_2d17dcdf-406b-45de-b72b-4f54a3672e4e"
      unitRef="usd">36844000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4daea3d304d54bc683e198d5795415d6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjMtNS0xLTEtMA_4b1daa08-3439-4d86-9186-22aec7932812"
      unitRef="usd">20850000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity
      contextRef="i3c6a38f48b1244e19aff28ddf6d53576_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjQtMS0xLTEtNTAw_6d4cae28-08c7-491d-bd25-fa2c097978c4"
      unitRef="usd">-10387000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia370e5ff06d5431fa9bca439bb1b889b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjUtMS0xLTEtMA_bf239802-adaf-4573-b736-980aeed346aa"
      unitRef="usd">3337120000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3bfa576bed044795b85e3c7f95992d6a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjUtMy0xLTEtMA_28700b0a-e2d5-461b-b409-416f82db11ce"
      unitRef="usd">1138316000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifbef3252651e4df5be4e543eeb29b46a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjUtNS0xLTEtMA_c4a03567-6de8-41d7-8c67-970cead07689"
      unitRef="usd">678548000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia58ce6bc9aca49d9aa127557c52c11a9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjgtMS0xLTEtMA_14fe675f-bc67-45b5-8747-cf6c36dd5c88"
      unitRef="usd">-758677000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id8594685f80541b1b4777011ea3b8353_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjgtMy0xLTEtMA_39e78635-9a4f-4413-8ad7-4b20bdbacd8e"
      unitRef="usd">-516712000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib2ce8df417b84195a8e55c791ce044b8_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjgtNS0xLTEtMA_24328eab-27f7-4e8c-8e5a-f5492ebd001f"
      unitRef="usd">-398598000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibfbbd53bd90042b58ef516ba23872688_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMjktNS0xLTEtMA_968f6a0a-6b04-4238-87da-ed3e219ed140"
      unitRef="usd">11241000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i34b06356d84b48aabb5a47a229bf0277_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzAtMS0xLTEtMA_becc2d6e-14cc-46a1-ba93-7f27d79befe0"
      unitRef="usd">-602170000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2a108a141584487ca8dbd201dfd46516_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzAtMy0xLTEtMA_e539d840-35d8-4b9f-8259-459f022ac785"
      unitRef="usd">-241965000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i24ea52a8309a4413a699941e900a6c44_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzAtNS0xLTEtMA_4537d3b1-e3b3-4f59-89cb-68aa825a10c7"
      unitRef="usd">-129355000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="ib6cd188a85204aaf8d02aeae0c5dfe1a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzEtMS0xLTEtMA_ea9535ab-0575-45f9-9075-f45fa5ccf058"
      unitRef="usd">-1360847000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia58ce6bc9aca49d9aa127557c52c11a9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzEtMy0xLTEtMA_53c2decb-4897-4021-97ab-f5dfc5684f43"
      unitRef="usd">-758677000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id8594685f80541b1b4777011ea3b8353_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzEtNS0xLTEtMA_52beadc8-6648-43ad-9279-75f264f2dec5"
      unitRef="usd">-516712000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzItMS0xLTEtMA_28a797bf-17cb-4224-be97-8f83006a520a"
      unitRef="usd">1976293000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzItMy0xLTEtMA_6a9fbd2d-d4bf-4a95-9d25-47ae4fd8cd54"
      unitRef="usd">379640000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i133819ff76b24d47a6fe9cf8b026d64f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82NC9mcmFnOjc5NDcwYjFmMDAzNzQ4YjY4MDc2ZTk3NDAzODkyMzJhL3RhYmxlOjI1MTA5OWMxNzFlNDQ1M2RhZjVkYmFkYWNiZDJhNDM3L3RhYmxlcmFuZ2U6MjUxMDk5YzE3MWU0NDUzZGFmNWRiYWRhY2JkMmE0MzdfMzItNS0xLTEtMA_21285f14-e261-41e8-8734-5093c71c30ad"
      unitRef="usd">161839000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMy0xLTEtMS0w_672777cc-0062-459e-b623-baf53152cfd1"
      unitRef="usd">-602170000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMy0zLTEtMS0w_3657667a-614b-4a80-a0aa-3ef722d38609"
      unitRef="usd">-241965000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMy01LTEtMS0w_35efa694-748b-462d-88ce-b1b0d75814f1"
      unitRef="usd">-129355000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNS0xLTEtMS0w_6222ed3a-e0ca-4267-96d5-b176ba0be083"
      unitRef="usd">39050000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNS0zLTEtMS0w_196ad82d-b23e-4dfa-b06e-c837f54313fe"
      unitRef="usd">16206000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNS01LTEtMS0w_9d4ef7aa-0aa9-42a9-afc8-ce6a3250341c"
      unitRef="usd">13540000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNi0xLTEtMS0w_33b1a7fa-4e29-40e2-83dd-11478d4c6a93"
      unitRef="usd">158747000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNi0zLTEtMS0w_1c95ff77-b6cd-49eb-91ff-02ea795a99f2"
      unitRef="usd">75948000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNi01LTEtMS0w_89ae4333-a0c6-4654-a2b4-8ca64af52f4a"
      unitRef="usd">20850000</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNy0xLTEtMS0w_d19da460-f390-4380-ba6f-d3053bc3e572"
      unitRef="usd">17204000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNy0zLTEtMS0w_2ec4a84f-ed6c-4efe-9dc3-30efe3d95201"
      unitRef="usd">4416000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNy01LTEtMS0w_d2894b59-3713-44c8-97d7-cd58284a09f9"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AssetImpairmentCharges
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfOS0xLTEtMS0w_70ec6776-893c-466f-a431-c4d1a8445395"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfOS0zLTEtMS0w_95d792e6-2a46-4773-9e48-aaf370634249"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfOS01LTEtMS0w_b7a7aa8d-c30e-451f-be34-cac4df352b2a"
      unitRef="usd">2925000</us-gaap:AssetImpairmentCharges>
    <nvta:BusinessCombinationRemeasurementOfLiabilities
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTItMS0xLTEtMA_13bd2850-6769-4d9e-b147-4ad3d16fbd21"
      unitRef="usd">92348000</nvta:BusinessCombinationRemeasurementOfLiabilities>
    <nvta:BusinessCombinationRemeasurementOfLiabilities
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTItMy0xLTEtMA_f4f47033-a67c-48e3-b688-400a2cac5056"
      unitRef="usd">0</nvta:BusinessCombinationRemeasurementOfLiabilities>
    <nvta:BusinessCombinationRemeasurementOfLiabilities
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTItNS0xLTEtMA_3d3eb64a-8668-47ce-9c1e-c3c96cdee0ea"
      unitRef="usd">0</nvta:BusinessCombinationRemeasurementOfLiabilities>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTMtMS0xLTEtMA_2cfc8538-7c19-4237-9b6d-706baf6715e3"
      unitRef="usd">-112100000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTMtMy0xLTEtMA_e8f4aedc-756f-42cc-be8d-25e71612c2db"
      unitRef="usd">-18450000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTMtNS0xLTEtMA_2cd1837d-c78d-4bb0-a741-47d27ffdb09c"
      unitRef="usd">-2862000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTQtMS0xLTEtMA_003d7576-2638-49ba-8597-8196b018d099"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTQtMy0xLTEtMA_5c9f793e-e029-4782-9e02-af00ee2df256"
      unitRef="usd">-8926000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTQtNS0xLTEtMA_206af902-7eed-4718-abad-fd5f5809dd68"
      unitRef="usd">-5266000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <nvta:BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTUtMS0xLTEtOTE0Mw_756bd13d-95cf-4fa7-b748-a3f8cde4254e"
      unitRef="usd">91021000</nvta:BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity>
    <nvta:BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTUtMy0xLTEtOTE0Mw_fa20c0f8-90a3-4e64-b8f7-5e7d0c8968ff"
      unitRef="usd">0</nvta:BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity>
    <nvta:BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTUtNS0xLTEtOTE0Mw_980c5a1e-5a1c-439e-8eb9-fd191d313247"
      unitRef="usd">0</nvta:BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTUtMS0xLTEtMA_d6725006-06be-4923-a957-397a486124e2"
      unitRef="usd">1425000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTUtMy0xLTEtMA_e06a0567-4d5f-4fea-87ac-bf71f8658863"
      unitRef="usd">1095000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTUtNS0xLTEtMA_c0424b79-8811-4c4a-a85b-d735abb62544"
      unitRef="usd">1168000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTctMS0xLTEtMA_2ee9c767-493a-4341-8312-79a99b883505"
      unitRef="usd">2814000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTctMy0xLTEtMA_8b2caa55-dc4a-49c7-bc4e-11aa8683cacf"
      unitRef="usd">6131000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTctNS0xLTEtMA_a1f87856-d52a-4a32-93a1-1b932e389014"
      unitRef="usd">5291000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTgtMS0xLTEtOTEzNA_74b86b6d-1972-49d0-8b8e-a81aa4ca6344"
      unitRef="usd">7832000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTgtMy0xLTEtOTEzNA_556e5a88-8880-470b-ac8c-2431f6279a18"
      unitRef="usd">-1645000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTgtNS0xLTEtOTEzNA_bdcd6587-f475-4cd0-a477-300b6d55d4b4"
      unitRef="usd">2848000</us-gaap:IncreaseDecreaseInInventories>
    <nvta:IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTgtMS0xLTEtMA_71a786ad-65f5-4660-aada-3d52b4b39a87"
      unitRef="usd">2010000</nvta:IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets>
    <nvta:IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTgtMy0xLTEtMA_66690a7c-b143-43fa-b3ec-9e622c9bfd4f"
      unitRef="usd">6624000</nvta:IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets>
    <nvta:IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTgtNS0xLTEtMA_c13b1280-5500-4ecd-999d-c734c524d4f2"
      unitRef="usd">-1403000</nvta:IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTktMS0xLTEtMA_2a4a8c2a-51bf-4c2d-a889-bf2bc2c62073"
      unitRef="usd">-895000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTktMy0xLTEtMA_287b7698-0437-44b1-9203-c8d2e926dc19"
      unitRef="usd">-2026000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMTktNS0xLTEtMA_8fcd6226-9ec5-49f0-ac01-c65e9ece84b7"
      unitRef="usd">163000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjAtMS0xLTEtMA_33227387-767b-4584-acae-9fe8e567e2dd"
      unitRef="usd">10186000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjAtMy0xLTEtMA_46ff83f7-17e6-4e5a-935b-dbc283aeef9a"
      unitRef="usd">1558000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjAtNS0xLTEtMA_62cd47bb-b49f-43e2-b056-58308ecea55d"
      unitRef="usd">-417000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjEtMS0xLTEtMA_0e850ee9-10e1-44e2-8fe2-78e8a435f790"
      unitRef="usd">17548000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjEtMy0xLTEtMA_9666ce54-0689-464d-bc7b-c80e4c4c4178"
      unitRef="usd">16297000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjEtNS0xLTEtMA_ae7e250f-4cf4-4e0b-b7f9-bca1e9f75290"
      unitRef="usd">3564000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjItMS0xLTEtMA_adc76f99-4c2c-4463-ab33-0f582d0133da"
      unitRef="usd">-298502000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjItMy0xLTEtMA_01c7dac8-8ebc-4333-a002-71d7677d09ee"
      unitRef="usd">-145053000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjItNS0xLTEtMA_17bea9c5-d458-4899-aea1-6e9aeef81037"
      unitRef="usd">-92220000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjQtMS0xLTEtMA_34cdb59b-2793-42ba-87ca-e2cbac5d1a57"
      unitRef="usd">280258000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjQtMy0xLTEtMA_f5431784-723a-4580-8f1e-b96ff1523af3"
      unitRef="usd">260917000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjQtNS0xLTEtMA_38c66ddc-2051-44ab-b9e0-f9848e49a369"
      unitRef="usd">9680000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjUtMS0xLTEtMA_d614a060-4770-4992-aab7-eb4c67306dd6"
      unitRef="usd">12832000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjUtMy0xLTEtMA_81f4a375-c4c1-4691-b845-007ffbd86549"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjUtNS0xLTEtMA_bbbb2392-9c7c-4fd7-bd1a-bd4e2dc96b18"
      unitRef="usd">19965000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjYtMS0xLTEtMA_3c3a8272-e22a-4151-8a88-dcfefede7a13"
      unitRef="usd">277487000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjYtMy0xLTEtMA_a5b9af4f-6c43-455d-9fa4-0d957fc7c025"
      unitRef="usd">34500000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjYtNS0xLTEtMA_96fd69c5-fdac-442d-96e3-c54a3076e522"
      unitRef="usd">32458000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjctMS0xLTEtMA_4e67b977-c1ff-490d-93a0-f5418fb3040e"
      unitRef="usd">383753000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjctMy0xLTEtMA_ac515120-df6a-47a8-af73-16a196d0ab7a"
      unitRef="usd">33846000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjctNS0xLTEtMA_8951c2c5-5c5d-4e99-b52b-73e5cb8df5b9"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjgtMS0xLTEtMA_c243407d-f3ca-4409-8056-44d4c7ff259e"
      unitRef="usd">22865000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjgtMy0xLTEtMA_4346b470-4f0c-443f-84fa-46e0a4fa8b87"
      unitRef="usd">20047000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjgtNS0xLTEtMA_f95cdfbf-c37c-4ce0-8082-5ebc89e052c5"
      unitRef="usd">5970000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjktMS0xLTEtMA_4b5ccb65-cc3d-44e3-ac9f-0950b1a65f52"
      unitRef="usd">4026000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjktMy0xLTEtMA_65ae1986-d797-4ad0-a0dc-d0a41d165a95"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMjktNS0xLTEtMA_2cfa91c9-1ff4-4e5c-a81a-24de69cccc64"
      unitRef="usd">1000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzAtMS0xLTEtMA_3c2f40bd-2846-4ded-acb7-75c7fe4db426"
      unitRef="usd">-400583000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzAtMy0xLTEtMA_80838da4-70ec-4856-b4e3-19547ccf0416"
      unitRef="usd">-280310000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzAtNS0xLTEtMA_160e1bac-abf4-4bf1-9162-782ec4d11daf"
      unitRef="usd">35773000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <nvta:ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzItMS0xLTEtMA_7179c1a3-76f0-427e-9d93-e0c01c7aef4c"
      unitRef="usd">263688000</nvta:ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts>
    <nvta:ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzItMy0xLTEtMA_b4f598ff-e917-4302-b9b3-b8a0fd305855"
      unitRef="usd">204024000</nvta:ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts>
    <nvta:ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzItNS0xLTEtMA_b06f7f06-d8fe-47a2-bc86-5d3a3ed8a721"
      unitRef="usd">112441000</nvta:ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzMtMS0xLTEtMA_1cc70715-29fb-4670-98cb-03d3028d7387"
      unitRef="usd">284203000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzMtMy0xLTEtMA_f55c815e-0cb9-4b82-a612-a55c6fd9c20e"
      unitRef="usd">9470000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzMtNS0xLTEtMA_1a8190cb-b6ec-47af-9224-58c986153b1e"
      unitRef="usd">17511000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzQtMS0xLTEtMA_c9caf7ba-f02a-4231-b2ee-ea247a35500d"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzQtMy0xLTEtMA_4ab83343-974d-4ec5-971a-9bee18fac005"
      unitRef="usd">339900000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzQtNS0xLTEtMA_9d9c9284-ab51-4feb-87bc-97ae1a770e65"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzUtMS0xLTEtMA_865a6895-c9da-4837-b539-2afe03626c67"
      unitRef="usd">129214000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzUtMy0xLTEtMA_66766596-3af1-4508-8604-6646fd4e88e4"
      unitRef="usd">0</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzUtNS0xLTEtMA_b1918be6-6157-42ef-84e9-e78c32bc8e45"
      unitRef="usd">93909000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzYtMS0xLTEtMA_4c853606-7e30-47d6-aa60-1335592ed71e"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzYtMy0xLTEtMA_f31ea82a-db28-4061-afab-14d3bcdc1738"
      unitRef="usd">10638000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzYtNS0xLTEtMA_b5316422-fc47-473b-a175-7155264858e1"
      unitRef="usd">4609000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfLoanCosts
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzctMS0xLTEtMA_eb1bd2e9-298a-41c1-b5a3-3790ade3c412"
      unitRef="usd">0</us-gaap:PaymentsOfLoanCosts>
    <us-gaap:PaymentsOfLoanCosts
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzctMy0xLTEtMA_4659c1f8-ddec-46d2-a40d-f1eae8df38da"
      unitRef="usd">75000000</us-gaap:PaymentsOfLoanCosts>
    <us-gaap:PaymentsOfLoanCosts
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzctNS0xLTEtMA_6301712c-3596-4908-9419-4ed8abb8e96a"
      unitRef="usd">60000000</us-gaap:PaymentsOfLoanCosts>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzktMS0xLTEtMA_c674ce62-e232-419a-8ed2-5300e954362d"
      unitRef="usd">-4112000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzktMy0xLTEtMA_f8bd7b95-5c89-400a-b122-9b83b658b1af"
      unitRef="usd">-2985000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfMzktNS0xLTEtMA_8854bb02-62f4-4eaf-900e-f73d0d06922c"
      unitRef="usd">-2100000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDAtMS0xLTEtMA_eee50c6e-a2c9-48b6-b679-e307c583718c"
      unitRef="usd">672993000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDAtMy0xLTEtMA_ece3ced7-2022-4db1-82c2-ea321224779d"
      unitRef="usd">464771000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDAtNS0xLTEtMA_0f5e7d5b-fbb6-4399-a554-3d06fbf19fd2"
      unitRef="usd">157152000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDEtMS0xLTEtMA_0d741c96-a256-4a35-a23a-15291062598a"
      unitRef="usd">-26092000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDEtMy0xLTEtMA_e1c29f15-76ca-48e4-9a31-d8bad905d1e4"
      unitRef="usd">39408000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDEtNS0xLTEtMA_b7d1c5c8-b7b9-4b9d-ac84-0f0677e556e0"
      unitRef="usd">100705000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDItMS0xLTEtMA_ae49723d-6b66-407a-9105-281e65e611a9"
      unitRef="usd">157572000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i133819ff76b24d47a6fe9cf8b026d64f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDItMy0xLTEtMA_cca29dfe-b131-4330-89e8-6a3fddba409c"
      unitRef="usd">118164000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if1dffb2fad8b40ca9e2827b034550280_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDItNS0xLTEtMA_8b973a28-e8dd-46b7-8511-46ca1b9727ad"
      unitRef="usd">17459000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDMtMS0xLTEtMA_bec4a623-e562-45e4-a8aa-35c5a65f393d"
      unitRef="usd">131480000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDMtMy0xLTEtMA_2a702014-9aad-4034-9bc2-60ce9084d325"
      unitRef="usd">157572000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i133819ff76b24d47a6fe9cf8b026d64f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDMtNS0xLTEtMA_f1e7533c-c4c3-43b3-bea8-ab41132c2cfc"
      unitRef="usd">118164000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDYtMS0xLTEtMA_504a94b0-a771-4f17-af45-9297f59e13ed"
      unitRef="usd">12130000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDYtMy0xLTEtMA_573d978b-7cfe-4a72-a93b-87b13ff7c84c"
      unitRef="usd">4731000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDYtNS0xLTEtMA_c3915866-ef6e-4940-9d07-c49e3714395c"
      unitRef="usd">6231000</us-gaap:InterestPaidNet>
    <us-gaap:CapitalLeaseObligationsIncurred
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDgtMS0xLTEtMA_a761ee3f-de77-45b6-bdc0-027c99b3d17d"
      unitRef="usd">4463000</us-gaap:CapitalLeaseObligationsIncurred>
    <us-gaap:CapitalLeaseObligationsIncurred
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDgtMy0xLTEtMA_234ca3fd-977a-4407-8d98-ce329503da85"
      unitRef="usd">1892000</us-gaap:CapitalLeaseObligationsIncurred>
    <us-gaap:CapitalLeaseObligationsIncurred
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNDgtNS0xLTEtMA_eede69b3-96d6-4cea-b1aa-6ed5b8fbcf95"
      unitRef="usd">0</us-gaap:CapitalLeaseObligationsIncurred>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTAtMS0xLTEtMA_008a9174-31c2-457c-a0a2-392464a77cb9"
      unitRef="usd">1869000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTAtMy0xLTEtMA_d45a617a-167c-4d64-858d-34844c84b89c"
      unitRef="usd">2422000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTAtNS0xLTEtMA_a25da844-40da-4c77-b4b2-a1e550b60af2"
      unitRef="usd">510000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTItMS0xLTEtMA_4b5c4f33-17da-42fa-96da-4420da53ff42"
      unitRef="usd">27000000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTItMy0xLTEtMA_cb195ec3-c74d-45ed-98a3-ab0d3bac8b71"
      unitRef="usd">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTItNS0xLTEtMA_b359c567-8f9a-4ec7-9428-5dc360ac92a0"
      unitRef="usd">383000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:StockIssued1
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTMtMS0xLTEtMA_8d0c192c-06fe-4228-aa60-e449c4b68b75"
      unitRef="usd">1157958000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTMtMy0xLTEtMA_b61de2a2-9e19-4fcc-9086-d93cec99d9f0"
      unitRef="usd">108573000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTMtNS0xLTEtMA_a7a5f982-c6b3-4f67-a6a2-07d48d070aef"
      unitRef="usd">6445000</us-gaap:StockIssued1>
    <us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTQtMS0xLTEtMA_fb6fce4f-266e-4716-a62c-41ee2cc5b98d"
      unitRef="usd">940829000</us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTQtMy0xLTEtMA_fd534a00-7090-4f2e-872d-e2c45eec6d48"
      unitRef="usd">21449000</us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTQtNS0xLTEtMA_2ee17156-6ea4-4ccf-b699-9d1936757d8e"
      unitRef="usd">0</us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTYtMS0xLTEtMA_07e70424-5b17-4e41-8e87-5fc1ec85b5fb"
      unitRef="usd">14058000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV82Ny9mcmFnOjYyZTY1YWU5NmFlMDQ3ZjFiZTc1YjIzMTQ3NTY0MDIwL3RhYmxlOmE5MTYwNWI0NDNkYzRiNTNiZTRhZmE1ZDkwODcwNmU0L3RhYmxlcmFuZ2U6YTkxNjA1YjQ0M2RjNGI1M2JlNGFmYTVkOTA4NzA2ZTRfNTYtMy0xLTEtMA_0b567b2f-6eb5-40cb-81ac-6a00c5cbaad1"
      unitRef="usd">4261000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83My9mcmFnOjhiNTcwZmE1NGFlMDQ0ZDRhNjIzNjA5NzExNWE5M2MzL3RleHRyZWdpb246OGI1NzBmYTU0YWUwNDRkNGE2MjM2MDk3MTE1YTkzYzNfMTY1Mw_7caa9977-347f-4512-a614-046125098082">Organization and description of businessInvitae Corporation ("Invitae," &#x201c;the Company," "we," "us," and "our") was incorporated in the State of Delaware on January 13, 2010, as Locus Development, Inc. and we changed our name to Invitae Corporation in 2012. We offer high-quality, comprehensive, affordable genetic testing across multiple clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, personalized oncology, metabolic conditions and rare diseases. To augment our offering and realize our mission, we have acquired multiple assets including four businesses in 2020, which expanded our suite of genome management offerings and established a broader entry into oncology therapy selection and personalized cancer monitoring.In October 2020, we completed the acquisition of ArcherDX, Inc. (&#x201c;ArcherDX&#x201d;). ArcherDX is a genomics company democratizing precision oncology by offering a suite of products and services that are accurate, personal, actionable and easy to use in local settings, thereby empowering clinicians to control the sample, data, patient care and economics. ArcherDX&#x2019;s development platform, including its proprietary Anchored Multiplex PCR, ("AMP"), chemistry at the core, is enabling clinical tests and services that allow for therapy selection and cancer monitoring in community locations for the first time at scale. Invitae operates in one segment.</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83My9mcmFnOjhiNTcwZmE1NGFlMDQ0ZDRhNjIzNjA5NzExNWE5M2MzL3RleHRyZWdpb246OGI1NzBmYTU0YWUwNDRkNGE2MjM2MDk3MTE1YTkzYzNfNzY5NjU4MTQxODQ2NA_b581c30b-50d7-4241-b71a-b3acd4e1da3e"
      unitRef="business">4</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfOperatingSegments
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83My9mcmFnOjhiNTcwZmE1NGFlMDQ0ZDRhNjIzNjA5NzExNWE5M2MzL3RleHRyZWdpb246OGI1NzBmYTU0YWUwNDRkNGE2MjM2MDk3MTE1YTkzYzNfMTI2NDQzODM3MzgxNTI_11f4f6c7-b359-4620-bc30-f3a09e0b9737"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MjU_a383c9a0-af55-48b4-beeb-766dff8e603e">Summary of significant accounting policies&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements include our accounts and the accounts of our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We base these estimates on current facts, historical and anticipated results, trends and various other assumptions that we believe are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those judgments, estimates and assumptions. We evaluate our estimates on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant estimates and assumptions made by management include the determination of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;revenue recognition; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;the fair value of assets and liabilities associated with business combinations; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;the impairment assessment of goodwill and intangible assets; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;the valuation of our 2.00% convertible senior notes due 2024 issued in September 2019 ("Convertible Senior Notes");&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;the recoverability of long-lived assets; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;our incremental borrowing rates used to calculate our lease balances;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;stock-based compensation expense and the fair value of awards and warrants issued; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;income tax uncertainties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of credit risk and other risks and uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to a concentration of credit risk consist of cash, cash equivalents, marketable securities and accounts receivable. Our cash and cash equivalents are held by financial institutions in the United States. Such deposits may exceed federally insured limits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant customers are those that represent 10% or more of our total revenue for each year presented on the consolidated statements of operations. Our revenue from significant customers as a percentage of our total revenue was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No customers represented more than 10% of accounts receivable as of December&#160;31, 2020 or 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider all highly liquid investments with original maturities of three months or less from the date of purchase to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds, U.S. treasury notes and government agency securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash consists primarily of money market funds that secure irrevocable standby letters of credit that serve as collateral for security deposits for our facility leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All marketable securities have been classified as &#x201c;available-for-sale&#x201d; and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its marketable debt securities at the time of purchase and reevaluates such designation at each balance sheet date. Short-term marketable securities have maturities one year or less at the balance sheet date. Unrealized gains and losses are excluded from earnings and are reported as a component of other comprehensive loss. Realized gains and losses and impairments, if any, on available-for-sale securities are included in other expense, net. The cost of securities sold is based on the specific-identification method. Interest on marketable securities is included in other income (expense), net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For marketable securities in an unrealized loss position, we assess our intent to sell, or whether it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis. If either of these criteria are met, the security&#x2019;s amortized cost basis is written down to fair value through other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive payment from patients, biopharmaceutical partners, third-party payers and other business-to-business customers. See Note 3, "Revenue, accounts receivable and deferred revenue" for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record a contract liability when cash payments are received or due in advance of our performance related to one or more performance obligations. See Note 3, "Revenue, accounts receivable and deferred revenue" for further information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our inventory consists of raw materials, work in progress, and finished goods, which are stated at the lower of cost or net realizable value on a first-in, first-out basis. We periodically analyze our inventory levels and expiration dates, and write down inventory that has become obsolete, inventory that has a cost basis in excess of its net realizable value, and inventory in excess of expected sales requirements as cost of revenue. We record an allowance for obsolete inventory using an estimate based on historical trends and evaluation of near-term expirations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply Financial Accounting Standards Board ("FASB"), Accounting Standards Codification ("ASC") 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires recognition of assets acquired, liabilities assumed, and contingent consideration at their fair value on the acquisition date with subsequent changes recognized in earnings; requires acquisition-related expenses and restructuring costs to be recognized separately from the business combination and expensed as incurred; requires in-process research and development to be capitalized at fair value as an indefinite-lived intangible asset until completion or abandonment; and requires that changes in accounting for deferred tax asset valuation allowances and acquired income tax uncertainties after the measurement period be recognized as a component of provision for taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for acquisitions of entities that include inputs and processes and have the ability to create outputs as business combinations. The tangible and identifiable intangible assets acquired and liabilities assumed in a business combination are recorded based on their estimated fair values as of the business combination date, including identifiable intangible assets which either arise from a contractual or legal right or are separable from goodwill. We base the estimated fair value of identifiable intangible assets acquired in a business combination on independent third-party valuations that use information and assumptions provided by our management, which consider our estimates of inputs and assumptions that a market participant would use. Any excess purchase price over the estimated fair value assigned to the net tangible and identifiable intangible assets acquired and liabilities assumed is recorded to goodwill. The use of alternative valuation assumptions, including estimated revenue projections, growth rates, estimated cost savings, cash flows, discount rates, estimated useful lives and probabilities surrounding the achievement of contingent milestones could result in different purchase price allocations and amortization expense in current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In circumstances where an acquisition involves a contingent consideration arrangement that meets the definition of a liability under ASC Topic 480, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We remeasure this liability each reporting period and record changes in the fair value as general and administrative expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction costs associated with acquisitions are expensed as incurred in general and administrative expenses. Results of operations and cash flows of acquired companies are included in our operating results from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortizable intangible assets include trade names, non-compete agreements, patent licensing agreements, favorable leases, developed technology, customer relationships, and rights to develop new technology acquired as part of business combinations. Customer relationships acquired through our business combinations in 2017 are amortized on an accelerated basis, utilizing free cash flows, over periods ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzY4NQ_d2037801-faba-4d7d-9a9d-b880ce2dc05c"&gt;five&lt;/span&gt; to 12 years. All other intangible assets subject to amortization are amortized using the straight-line method over their estimated useful lives ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzgzOQ_4c24a27f-0da2-4313-a3a1-cf19d3484ec4"&gt;two&lt;/span&gt; to 15 years. All intangible assets subject to amortization are reviewed for impairment in accordance with ASC 360, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles-Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 350&#x201d;), our goodwill is not amortized but is tested for impairment on an annual basis or whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. Under ASC 350, we perform annual impairment reviews of our goodwill balance during the fourth fiscal quarter or more frequently if business factors indicate. In testing for impairment, we compare the fair value of our reporting unit to its carrying value including the goodwill of that unit. If the carrying value, including goodwill, exceeds the reporting unit&#x2019;s fair value, we will recognize an impairment loss for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value. The loss recognized cannot exceed the total amount of goodwill allocated to that reporting unit. We did not incur any goodwill impairment losses in any of the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;In-process research and development &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets related to in-process research and development costs (&#x201c;IPR&amp;amp;D&#x201d;) are considered to be indefinite-lived until the completion or abandonment of the associated research and development efforts. If and when development is complete, the associated assets would be deemed finite-lived and would then be amortized based on their respective estimated useful lives at that point in time. During this period, the assets will not be amortized but will be tested for impairment on an annual basis and between annual tests if we become aware of any events occurring or changes in circumstances that would indicate a reduction in the fair value of the IPR&amp;amp;D projects below their respective carrying amounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter and if business factors indicate more frequently, we perform an assessment of the qualitative factors affecting the fair value of our IPR&amp;amp;D projects. If the fair value exceeds the carrying value, there is no impairment. Impairment losses on indefinite-lived intangible assets are recognized based solely on a comparison of the fair value of an asset to its carrying value, without consideration of any recoverability test. We have not identified any such impairment losses to date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we determine if an arrangement is a lease at inception. Operating leases are included in operating lease assets and operating lease obligations in our consolidated balance sheets. Finance leases are included in other assets and finance lease obligations in our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at commencement based on the present value of lease payments over the lease term. We generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments. The operating lease asset also includes any lease payments made and is adjusted for lease incentives. Our lease terms may include options to extend or terminate the lease which are recognized when it is reasonably certain that we will exercise that option. Leases with terms of 12 months or less are not recorded on our balance sheet. Lease expense is recognized on a straight-line basis over the lease terms, or in some cases, the useful life of the underlying asset. We account for the lease and non-lease components as a single lease component.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally between &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMTE2Mjg_1217d9ea-71ec-462e-9a23-2257607bd016"&gt;three&lt;/span&gt; and seven years. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the term of the lease. Maintenance and repairs are charged to expense as incurred, and improvements and betterments are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in the consolidated statements of operations in the period realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated useful lives of property and equipment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Automobiles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing and Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shorter of lease term or estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-lived assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. An impairment loss is recognized when the total estimated future undiscounted cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount. Impairment, if any, is assessed using discounted cash flows or other appropriate measures of fair value. There were no long-lived asset impairment losses recorded for any period presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial instruments consist principally of cash and cash equivalents, marketable securities, accounts payable, accrued liabilities, finance leases, and liabilities associated with business combinations. The carrying amounts of certain of these financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued and other current liabilities approximate their current fair value due to the relatively short-term nature of these accounts. Based on borrowing rates available to us, the carrying value of finance leases approximate their fair values. Liabilities associated with business combinations are recorded at their estimated fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration it expects to be entitled to in exchange for those goods or services. All revenues are generated from contracts with customers. We utilize the following practical expedients and exemptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:63pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Costs to obtain or fulfill a contract are expensed when incurred because the amortization period would have been one year or less, and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:63pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;No adjustments to promised consideration were made for financing as we expect, at contract inception, that the period between the transfer of a promised good or service and when the customer pays for that good or service will be one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Test revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Test revenue is comprised of testing services and sales of distributed precision oncology products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of our test revenue is generated from genetic testing, in addition to somatic testing for therapy selection and personalized cancer monitoring. These testing services provide analysis and associated interpretation of the sequencing of parts of the genome. Test orders are placed under signed requisitions or contractual agreements, and we often enter into contracts with biopharmaceutical partners, other business-to-business customers (e.g., hospitals, clinics, medical centers) and insurance companies that include pricing provisions under which such tests are billed. Billing terms are generally net 30 to 60 days.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the transaction price of diagnostic tests is originally established either via contract or pursuant to our standard list price, we often provide concessions for tests billed to insurance carriers, and therefore the transaction price for patient insurance-billed tests is considered to be variable and revenue is recognized based on an estimate of the consideration to which we will be entitled at an amount for which it is probable that a reversal of cumulative consideration will not occur. Making these estimates requires significant judgments based upon such factors as length of payer relationship, historical payment patterns, changes in contract provisions and insurance reimbursement policies. These judgments are reviewed each reporting period and updated as necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We look to transfer of control in assessing timing of recognition of revenue in connection with each performance obligation. In general, revenue in connection with the service portion of our diagnostic tests is recognized upon delivery of the underlying clinical report or when the report is made available on our web portal. Outstanding performance obligations pertaining to orders received but for which the underlying report has not been issued are generally satisfied within a 30-day period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also generate test revenue through the sale of our precision oncology products, which is comprised primarily of sales of our distributed research use only ("RUO ") and in vitro diagnostics ("IVD") products for therapy selection. We recognize revenue on these sales once shipment has occurred. Product sales are recorded net of discounts and other deductions. Billing terms are generally net 30 days. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling fees billed to customers are recorded as revenue on the consolidated statements of operations. The associated shipping and handling costs are recorded as cost of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other revenue is primarily generated from pharma development services provided to biopharmaceutical companies related to companion diagnostic development as well as through collaboration agreements and genome network contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contracts for companion diagnostic development consist primarily of milestone-based payments along with annual fees and marked-up pass-through costs. The arrangements are treated as short-term contracts for revenue recognition purposes because they allow termination of the agreements by the customers with 30 to 120 days&#x2019; written notice without a termination penalty. Upon termination, customers are required to pay for the proportion of services provided under milestones that were in progress. We recognize revenue in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. We recognize revenue over time based on the progress made toward achieving the performance obligation, utilizing both input or output methods, depending on the performance obligation, including labor hours expended, tests processed, or time elapsed, that measure our progress toward the achievement of the milestone.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We also enter into collaboration and genome network contracts. Collaboration agreements provide customers with diagnostic testing and related data aggregation reporting services that are provided over the contract term. Collaboration revenue is recognized as the data and reporting services are delivered to the customer. Genome network offerings consist of subscription services related to a proprietary software platform designed to connect patients, clinicians, advocacy organizations, researchers and therapeutic developers to accelerate the understanding, diagnosis and treatment of hereditary disease. Such services are recognized on a straight-line basis over the subscription periods. Amounts due under collaboration and genome network agreements are typically billable on net 30-day terms. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue reflects the aggregate costs incurred in delivering our genetic offerings and includes expenses for personnel-related costs including stock-based compensation, materials and supplies, royalties, regulatory fees, commercialization fees, equipment and infrastructure expenses associated with testing and allocated overhead including rent, equipment depreciation, information technology costs, amortization of acquired intangibles and utilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;License Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered and may continue to enter into license agreements to access and utilize certain technology. We evaluate if the license agreement results in the acquisition of an asset or a business and then determine if the acquired asset has the ability to generate revenues or is subject to regulatory approval. When regulatory approval is not required, we record the license as an asset and amortize it over the estimated economic life. When regulatory approval is required, we record the amount paid as a research and development expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. Significant judgment is required in determining the net valuation allowance which includes our evaluation of all available evidence including past operating results, estimates on future taxable income and acquisition-related tax assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We historically established a full valuation allowance against our deferred tax assets due to the uncertainty surrounding realization of such assets. In 2020, we released approximately $112.1&#160;million of our valuation allowance to account for acquired intangibles that support the future realization of some of our deferred tax assets. Due to the overall increase of deferred tax assets, our valuation allowance has also increased from the prior year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measure stock-based payment awards made to employees and directors based on the estimated fair values of the awards and recognize the compensation expense over the requisite service period. We use the Black-Scholes option-pricing model to estimate the fair value of stock option awards and employee stock purchase plan (&#x201c;ESPP&#x201d;) purchases. The fair value of restricted stock unit (&#x201c;RSU&#x201d;) awards with time-based vesting terms is based on the grant date share price. We grant performance-based restricted stock unit (&#x201c;PRSU&#x201d;) awards to certain employees which vest upon the achievement of certain performance conditions, subject to the employees&#x2019; continued service relationship with us. The probability of vesting is assessed at each reporting period and compensation cost is adjusted based on this probability assessment. We recognize such compensation expense on an accelerated vesting method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense for awards without a performance condition is recognized using the straight-line method. Stock-based compensation expense is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. As such, our stock-based compensation is reduced for estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for stock issued in connection with business combinations based on the fair value on the date of issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising expenses are expensed as incurred. We incurred advertising expenses of $11.4 million, $9.9 million and $0.6 million during the years ended December&#160;31, 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive loss is composed of two components: net loss and other comprehensive income (loss). Other comprehensive income (loss) refers to gains and losses that under U.S. GAAP are recorded as an element of stockholders&#x2019; equity, but are excluded from net loss. Our other comprehensive income (loss) consists of unrealized gains or losses on investments in available-for-sale securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net loss per share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, without consideration of common stock equivalents. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common share equivalents outstanding for the period determined using the treasury stock method. Potentially dilutive securities, consisting of preferred stock, options to purchase common stock, common stock warrants, shares of common stock pursuant to ESPP, common stock issuable in connection with our Convertible Senior Notes, RSUs and PRSUs, are considered to be common stock equivalents and were excluded from the calculation of diluted net loss per share because their effect would be antidilutive for all periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prior period reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have reclassified certain amounts in prior periods to conform with current presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Immaterial correction of an error&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined the historical classification of certain acquisition-related obligations as equity and the subsequent measurement of such obligations was inappropriate and instead should have been classified as liabilities and subsequently measured at fair value with changes recognized in other expense, net during the year ended December 31, 2020. We determined that the impact of the error to previously issued consolidated financial statements was not material and have corrected the immaterial error in the current period financial statements.&#160;The impact of this correction was an increase to other long-term liabilities of $10.1&#160;million, a corresponding decrease to additional paid-in capital of $10.4&#160;million and an increase to other income, net of $0.3&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate all Accounting Standards Updates (&#x201c;ASUs&#x201d;) issued by the Financial Accounting Standards Board ("FASB") for consideration of their applicability. ASUs not included in the disclosures in this report were assessed and determined to be either not applicable or are not expected to have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently issued accounting pronouncements not yet adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU No. 2020-06,&#160;Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which simplifies the accounting for certain convertible instruments, amends the guidance on derivative scope exceptions for contracts in an entity's own equity, and modifies the guidance on diluted earnings per share calculations as a result of these changes. This new standard is effective for our interim and annual periods beginning January 1, 2022, and earlier adoption is permitted. We may elect to apply the amendments on a retrospective or modified retrospective basis. We are currently evaluating the impact of the adoption of this standard on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently adopted accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016,&#160;FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires measurement and recognition of expected credit losses for financial assets. This guidance became effective for us beginning in the first quarter of 2020 and was adopted using a modified retrospective approach, with certain exceptions. The adoption of Topic 326 did not have a material impact on our consolidated financial statements as credit losses are not expected to be significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of our adoption of Topic 326, we assess our accounts receivables for expected credit losses at each reporting period by disaggregating by payer type and further by portfolios of customers with similar characteristics, such as customer type and geographic location. We then review each portfolio for expected credit losses based on historical payment trends as well as forward looking data and current economic trends. If a credit loss is determined, we record a reduction to our accounts receivable balance with a corresponding general and administrative expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with Topic 326, we no longer evaluate whether our available-for-sale debt securities in an unrealized loss position are other than temporarily impaired. Instead, we assess whether such unrealized loss positions are credit-related. Our expected loss allowance methodology for these securities is developed by reviewing the extent of the unrealized loss, the issuers&#x2019; credit ratings and any changes in those ratings, as well as reviewing current and future economic market conditions and the issuers&#x2019; current status and financial condition. The credit-related portion of unrealized losses, and any subsequent improvements, are recorded in other income (expense), net. Unrealized gains and losses that are not credit-related are included in accumulated other comprehensive income (loss). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2019, we adopted the provisions of ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; using the modified retrospective approach in accordance with Topic 842. Adoption of Topic 842 had a material impact on our consolidated balance sheets, but did not have an impact on our consolidated statements of operations. We elected the package of practical expedients permitted under the transition guidance which, among other things, allowed us to carry forward the historical classification of leases in place as of January 1, 2019. We did not identify any material embedded leases with the adoption of Topic 842 and therefore the implementation of Topic 842 primarily focused on the treatment of our previously identified leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior period amounts were not adjusted and continue to be reported in accordance with our historic accounting under previous lease guidance, ASC 840, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 840, we rented facilities under operating lease agreements and recognized related rent expense on a straight-line basis over the term of the applicable lease agreement. Some of the lease agreements contained rent holidays, scheduled rent increases, lease incentives, and renewal options. Rent holidays and scheduled rent increases were included in the determination of rent expense recorded over the lease term. Lease incentives were recognized as a reduction of rent expense on a straight-line basis over the term of the lease. Renewals were not assumed in the determination of the lease term unless they were deemed to be reasonably assured at the inception of the lease. We recognized rent expense beginning on the date we obtained the legal right to use and control the leased space.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2ODY_3814ba61-a461-4218-80d9-38a00bbc64a2">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements include our accounts and the accounts of our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NTY_ea7a9567-2ac7-4e5f-b5b6-2c8b5b1b0fee">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We base these estimates on current facts, historical and anticipated results, trends and various other assumptions that we believe are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those judgments, estimates and assumptions. We evaluate our estimates on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant estimates and assumptions made by management include the determination of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;revenue recognition; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;the fair value of assets and liabilities associated with business combinations; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;the impairment assessment of goodwill and intangible assets; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;the valuation of our 2.00% convertible senior notes due 2024 issued in September 2019 ("Convertible Senior Notes");&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;the recoverability of long-lived assets; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;our incremental borrowing rates used to calculate our lease balances;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;stock-based compensation expense and the fair value of awards and warrants issued; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;income tax uncertainties.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i70c89bb06a7246a1bb3d4f7eec32e812_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNjU5NzA2OTgxNDc5Mg_763211de-e8a0-4a80-90fc-48b0c126023a"
      unitRef="number">0.0200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2OTk_41210f4c-1bc4-4267-9dbe-85af074cb8e0">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of credit risk and other risks and uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to a concentration of credit risk consist of cash, cash equivalents, marketable securities and accounts receivable. Our cash and cash equivalents are held by financial institutions in the United States. Such deposits may exceed federally insured limits.&lt;/span&gt;&lt;/div&gt;Significant customers are those that represent 10% or more of our total revenue for each year presented on the consolidated statements of operations.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NjM_7a5a865b-c93b-4d3f-b4a4-073df8b0357b">Our revenue from significant customers as a percentage of our total revenue was as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7e1175abf83148d8836d04d1ecf72a47_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOjA3MmVkODUxNDRjYTQzZTE5YThhMzVkODAxYzEwMmRmL3RhYmxlcmFuZ2U6MDcyZWQ4NTE0NGNhNDNlMTlhOGEzNWQ4MDFjMTAyZGZfMi0yLTEtMS0w_32990bf3-40c6-4407-9b2b-973875a7f07e"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id09edfceda314a48a3bae75a5376813e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOjA3MmVkODUxNDRjYTQzZTE5YThhMzVkODAxYzEwMmRmL3RhYmxlcmFuZ2U6MDcyZWQ4NTE0NGNhNDNlMTlhOGEzNWQ4MDFjMTAyZGZfMi00LTEtMS0w_f292eefa-2de0-479e-a125-93ffcaf3481f"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i654d4e6d51c24784b92cf81e78d322ef_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOjA3MmVkODUxNDRjYTQzZTE5YThhMzVkODAxYzEwMmRmL3RhYmxlcmFuZ2U6MDcyZWQ4NTE0NGNhNDNlMTlhOGEzNWQ4MDFjMTAyZGZfMi02LTEtMS0w_1bc167e4-7e4b-4761-85b4-cc14150dd36a"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2ODE_0aeeac39-6f46-4c6e-82a7-39dce7071aaa">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider all highly liquid investments with original maturities of three months or less from the date of purchase to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds, U.S. treasury notes and government agency securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash consists primarily of money market funds that secure irrevocable standby letters of credit that serve as collateral for security deposits for our facility leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NzU_943e06ba-53f9-4d5e-9403-8d796704aaaa">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MTU_9d96493e-93d1-48ad-a17a-142ead8aaa5e">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmIxMjdjYTljOTRmNTQ0ZGNhNTg4MDdjMjcxMDk4ZDg1L3RhYmxlcmFuZ2U6YjEyN2NhOWM5NGY1NDRkY2E1ODgwN2MyNzEwOThkODVfMi0xLTEtMS0w_639bd98b-7b0a-494f-8740-df1e3d0447ea"
      unitRef="usd">124794000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmIxMjdjYTljOTRmNTQ0ZGNhNTg4MDdjMjcxMDk4ZDg1L3RhYmxlcmFuZ2U6YjEyN2NhOWM5NGY1NDRkY2E1ODgwN2MyNzEwOThkODVfMi0zLTEtMS0w_6c9d622d-3fde-4450-9a9a-ac17843ca964"
      unitRef="usd">151389000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmIxMjdjYTljOTRmNTQ0ZGNhNTg4MDdjMjcxMDk4ZDg1L3RhYmxlcmFuZ2U6YjEyN2NhOWM5NGY1NDRkY2E1ODgwN2MyNzEwOThkODVfMy0xLTEtMS0w_920217f4-665b-4e6d-8e2e-165e669374bf"
      unitRef="usd">6686000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmIxMjdjYTljOTRmNTQ0ZGNhNTg4MDdjMjcxMDk4ZDg1L3RhYmxlcmFuZ2U6YjEyN2NhOWM5NGY1NDRkY2E1ODgwN2MyNzEwOThkODVfMy0zLTEtMS0w_01318495-d0d5-4bdd-ae46-b13ee8b8ba35"
      unitRef="usd">6183000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmIxMjdjYTljOTRmNTQ0ZGNhNTg4MDdjMjcxMDk4ZDg1L3RhYmxlcmFuZ2U6YjEyN2NhOWM5NGY1NDRkY2E1ODgwN2MyNzEwOThkODVfNC0xLTEtMS0w_195c8d72-db1a-4a16-b68d-023f815db0f6"
      unitRef="usd">131480000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmIxMjdjYTljOTRmNTQ0ZGNhNTg4MDdjMjcxMDk4ZDg1L3RhYmxlcmFuZ2U6YjEyN2NhOWM5NGY1NDRkY2E1ODgwN2MyNzEwOThkODVfNC0zLTEtMS0w_21382b06-8ddd-4d9c-81d1-1c308e22888c"
      unitRef="usd">157572000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NzM_33ee7940-8761-4269-a58f-c1cbba2c7e15">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All marketable securities have been classified as &#x201c;available-for-sale&#x201d; and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its marketable debt securities at the time of purchase and reevaluates such designation at each balance sheet date. Short-term marketable securities have maturities one year or less at the balance sheet date. Unrealized gains and losses are excluded from earnings and are reported as a component of other comprehensive loss. Realized gains and losses and impairments, if any, on available-for-sale securities are included in other expense, net. The cost of securities sold is based on the specific-identification method. Interest on marketable securities is included in other income (expense), net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For marketable securities in an unrealized loss position, we assess our intent to sell, or whether it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis. If either of these criteria are met, the security&#x2019;s amortized cost basis is written down to fair value through other income (expense), net.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MjI_ebc5b8cc-21d6-47eb-81c4-58894f94a9fa">Accounts receivableWe receive payment from patients, biopharmaceutical partners, third-party payers and other business-to-business customers.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjI1Mzk5ODg0NTc1MDM_b9f63a7a-10e4-4156-9188-f3cb71586a7a">Deferred revenueWe record a contract liability when cash payments are received or due in advance of our performance related to one or more performance obligations.&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration it expects to be entitled to in exchange for those goods or services. All revenues are generated from contracts with customers. We utilize the following practical expedients and exemptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:63pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Costs to obtain or fulfill a contract are expensed when incurred because the amortization period would have been one year or less, and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:63pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;No adjustments to promised consideration were made for financing as we expect, at contract inception, that the period between the transfer of a promised good or service and when the customer pays for that good or service will be one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Test revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Test revenue is comprised of testing services and sales of distributed precision oncology products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of our test revenue is generated from genetic testing, in addition to somatic testing for therapy selection and personalized cancer monitoring. These testing services provide analysis and associated interpretation of the sequencing of parts of the genome. Test orders are placed under signed requisitions or contractual agreements, and we often enter into contracts with biopharmaceutical partners, other business-to-business customers (e.g., hospitals, clinics, medical centers) and insurance companies that include pricing provisions under which such tests are billed. Billing terms are generally net 30 to 60 days.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the transaction price of diagnostic tests is originally established either via contract or pursuant to our standard list price, we often provide concessions for tests billed to insurance carriers, and therefore the transaction price for patient insurance-billed tests is considered to be variable and revenue is recognized based on an estimate of the consideration to which we will be entitled at an amount for which it is probable that a reversal of cumulative consideration will not occur. Making these estimates requires significant judgments based upon such factors as length of payer relationship, historical payment patterns, changes in contract provisions and insurance reimbursement policies. These judgments are reviewed each reporting period and updated as necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We look to transfer of control in assessing timing of recognition of revenue in connection with each performance obligation. In general, revenue in connection with the service portion of our diagnostic tests is recognized upon delivery of the underlying clinical report or when the report is made available on our web portal. Outstanding performance obligations pertaining to orders received but for which the underlying report has not been issued are generally satisfied within a 30-day period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also generate test revenue through the sale of our precision oncology products, which is comprised primarily of sales of our distributed research use only ("RUO ") and in vitro diagnostics ("IVD") products for therapy selection. We recognize revenue on these sales once shipment has occurred. Product sales are recorded net of discounts and other deductions. Billing terms are generally net 30 days. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling fees billed to customers are recorded as revenue on the consolidated statements of operations. The associated shipping and handling costs are recorded as cost of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other revenue is primarily generated from pharma development services provided to biopharmaceutical companies related to companion diagnostic development as well as through collaboration agreements and genome network contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contracts for companion diagnostic development consist primarily of milestone-based payments along with annual fees and marked-up pass-through costs. The arrangements are treated as short-term contracts for revenue recognition purposes because they allow termination of the agreements by the customers with 30 to 120 days&#x2019; written notice without a termination penalty. Upon termination, customers are required to pay for the proportion of services provided under milestones that were in progress. We recognize revenue in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. We recognize revenue over time based on the progress made toward achieving the performance obligation, utilizing both input or output methods, depending on the performance obligation, including labor hours expended, tests processed, or time elapsed, that measure our progress toward the achievement of the milestone.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We also enter into collaboration and genome network contracts. Collaboration agreements provide customers with diagnostic testing and related data aggregation reporting services that are provided over the contract term. Collaboration revenue is recognized as the data and reporting services are delivered to the customer. Genome network offerings consist of subscription services related to a proprietary software platform designed to connect patients, clinicians, advocacy organizations, researchers and therapeutic developers to accelerate the understanding, diagnosis and treatment of hereditary disease. Such services are recognized on a straight-line basis over the subscription periods. Amounts due under collaboration and genome network agreements are typically billable on net 30-day terms. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue reflects the aggregate costs incurred in delivering our genetic offerings and includes expenses for personnel-related costs including stock-based compensation, materials and supplies, royalties, regulatory fees, commercialization fees, equipment and infrastructure expenses associated with testing and allocated overhead including rent, equipment depreciation, information technology costs, amortization of acquired intangibles and utilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NzY_9685175d-46fb-44ec-9943-b69a5e73a7a0">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our inventory consists of raw materials, work in progress, and finished goods, which are stated at the lower of cost or net realizable value on a first-in, first-out basis. We periodically analyze our inventory levels and expiration dates, and write down inventory that has become obsolete, inventory that has a cost basis in excess of its net realizable value, and inventory in excess of expected sales requirements as cost of revenue. We record an allowance for obsolete inventory using an estimate based on historical trends and evaluation of near-term expirations.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NjY_036a33af-f2cc-4fdc-a645-7fe65de19157">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply Financial Accounting Standards Board ("FASB"), Accounting Standards Codification ("ASC") 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires recognition of assets acquired, liabilities assumed, and contingent consideration at their fair value on the acquisition date with subsequent changes recognized in earnings; requires acquisition-related expenses and restructuring costs to be recognized separately from the business combination and expensed as incurred; requires in-process research and development to be capitalized at fair value as an indefinite-lived intangible asset until completion or abandonment; and requires that changes in accounting for deferred tax asset valuation allowances and acquired income tax uncertainties after the measurement period be recognized as a component of provision for taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for acquisitions of entities that include inputs and processes and have the ability to create outputs as business combinations. The tangible and identifiable intangible assets acquired and liabilities assumed in a business combination are recorded based on their estimated fair values as of the business combination date, including identifiable intangible assets which either arise from a contractual or legal right or are separable from goodwill. We base the estimated fair value of identifiable intangible assets acquired in a business combination on independent third-party valuations that use information and assumptions provided by our management, which consider our estimates of inputs and assumptions that a market participant would use. Any excess purchase price over the estimated fair value assigned to the net tangible and identifiable intangible assets acquired and liabilities assumed is recorded to goodwill. The use of alternative valuation assumptions, including estimated revenue projections, growth rates, estimated cost savings, cash flows, discount rates, estimated useful lives and probabilities surrounding the achievement of contingent milestones could result in different purchase price allocations and amortization expense in current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In circumstances where an acquisition involves a contingent consideration arrangement that meets the definition of a liability under ASC Topic 480, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We remeasure this liability each reporting period and record changes in the fair value as general and administrative expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction costs associated with acquisitions are expensed as incurred in general and administrative expenses. Results of operations and cash flows of acquired companies are included in our operating results from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;License Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered and may continue to enter into license agreements to access and utilize certain technology. We evaluate if the license agreement results in the acquisition of an asset or a business and then determine if the acquired asset has the ability to generate revenues or is subject to regulatory approval. When regulatory approval is not required, we record the license as an asset and amortize it over the estimated economic life. When regulatory approval is required, we record the amount paid as a research and development expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MTY_ed0ee8f6-934c-43b5-a1f7-62ed8cd34f31">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortizable intangible assets include trade names, non-compete agreements, patent licensing agreements, favorable leases, developed technology, customer relationships, and rights to develop new technology acquired as part of business combinations. Customer relationships acquired through our business combinations in 2017 are amortized on an accelerated basis, utilizing free cash flows, over periods ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzY4NQ_d2037801-faba-4d7d-9a9d-b880ce2dc05c"&gt;five&lt;/span&gt; to 12 years. All other intangible assets subject to amortization are amortized using the straight-line method over their estimated useful lives ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzgzOQ_4c24a27f-0da2-4313-a3a1-cf19d3484ec4"&gt;two&lt;/span&gt; to 15 years. All intangible assets subject to amortization are reviewed for impairment in accordance with ASC 360, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;In-process research and development &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets related to in-process research and development costs (&#x201c;IPR&amp;amp;D&#x201d;) are considered to be indefinite-lived until the completion or abandonment of the associated research and development efforts. If and when development is complete, the associated assets would be deemed finite-lived and would then be amortized based on their respective estimated useful lives at that point in time. During this period, the assets will not be amortized but will be tested for impairment on an annual basis and between annual tests if we become aware of any events occurring or changes in circumstances that would indicate a reduction in the fair value of the IPR&amp;amp;D projects below their respective carrying amounts. &lt;/span&gt;&lt;/div&gt;During the fourth quarter and if business factors indicate more frequently, we perform an assessment of the qualitative factors affecting the fair value of our IPR&amp;amp;D projects. If the fair value exceeds the carrying value, there is no impairment. Impairment losses on indefinite-lived intangible assets are recognized based solely on a comparison of the fair value of an asset to its carrying value, without consideration of any recoverability test. We have not identified any such impairment losses to date.</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="idd5dd2727548445bba930982eb5e164a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzY5MQ_6004539b-b80f-4e6b-a22e-ebc3091d8aa5">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i23413efbba8a4bce99ca014f751cd629_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzg0NQ_04a12535-3ac0-4aed-84c1-425c3b97b897">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2OTU_f13ae65e-e076-43ac-a7a9-c64b10b42bf7">Goodwill&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles-Goodwill and Other&lt;/span&gt; (&#x201c;ASC 350&#x201d;), our goodwill is not amortized but is tested for impairment on an annual basis or whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. Under ASC 350, we perform annual impairment reviews of our goodwill balance during the fourth fiscal quarter or more frequently if business factors indicate. In testing for impairment, we compare the fair value of our reporting unit to its carrying value including the goodwill of that unit. If the carrying value, including goodwill, exceeds the reporting unit&#x2019;s fair value, we will recognize an impairment loss for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value. The loss recognized cannot exceed the total amount of goodwill allocated to that reporting unit.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjMwODk3NDQyNTU1OTI_1d91f341-125a-4436-adea-6c6bc9e2cf84"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjMwODk3NDQyNTU1OTI_200628b0-26f3-49bc-b140-0d6e6b38a78e"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjMwODk3NDQyNTU1OTI_ea7abd07-fb4a-4b40-a19a-2aeffde1d6e9"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NTg_48ed0606-d70c-4b78-bc30-4f99a31bd456">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we determine if an arrangement is a lease at inception. Operating leases are included in operating lease assets and operating lease obligations in our consolidated balance sheets. Finance leases are included in other assets and finance lease obligations in our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at commencement based on the present value of lease payments over the lease term. We generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments. The operating lease asset also includes any lease payments made and is adjusted for lease incentives. Our lease terms may include options to extend or terminate the lease which are recognized when it is reasonably certain that we will exercise that option. Leases with terms of 12 months or less are not recorded on our balance sheet. Lease expense is recognized on a straight-line basis over the lease terms, or in some cases, the useful life of the underlying asset. We account for the lease and non-lease components as a single lease component.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MTI_8b83c11a-1f55-4ecb-b745-cbc1d8c9aa6c">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally between &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMTE2Mjg_1217d9ea-71ec-462e-9a23-2257607bd016"&gt;three&lt;/span&gt; and seven years. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the term of the lease. Maintenance and repairs are charged to expense as incurred, and improvements and betterments are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in the consolidated statements of operations in the period realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated useful lives of property and equipment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Automobiles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing and Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shorter of lease term or estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i23413efbba8a4bce99ca014f751cd629_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMTE2MzU_af6f9313-c9d3-4a4f-852c-b094283870d0">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MjY_f6d65ccb-245d-44c9-8700-6fb4ef0b35bf">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated useful lives of property and equipment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Automobiles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing and Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shorter of lease term or estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Automobiles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ife1d8cfb66ed44aebe09b9526f251933_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmRjMzhkMjQ3M2IwMzQwOWE5MGU5M2RjNmNhNGIzZTg2L3RhYmxlcmFuZ2U6ZGMzOGQyNDczYjAzNDA5YTkwZTkzZGM2Y2E0YjNlODZfMC0xLTEtMS0w_5df26b00-f942-4ba3-b1aa-feea97a0603d">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i479bb752e9834ff889d964d04d4fd5f8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmRjMzhkMjQ3M2IwMzQwOWE5MGU5M2RjNmNhNGIzZTg2L3RhYmxlcmFuZ2U6ZGMzOGQyNDczYjAzNDA5YTkwZTkzZGM2Y2E0YjNlODZfMS0xLTEtMS0w_c4c8b5f4-99c5-4224-ae1b-24609a26e60f">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9cc8be4a617648da91ede3d8cd832c3b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmRjMzhkMjQ3M2IwMzQwOWE5MGU5M2RjNmNhNGIzZTg2L3RhYmxlcmFuZ2U6ZGMzOGQyNDczYjAzNDA5YTkwZTkzZGM2Y2E0YjNlODZfMi0xLTEtMS0w_908d70de-e243-491d-9c4d-c8b70c977db5">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8ef676364d144f13b1b75fad36a56028_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmRjMzhkMjQ3M2IwMzQwOWE5MGU5M2RjNmNhNGIzZTg2L3RhYmxlcmFuZ2U6ZGMzOGQyNDczYjAzNDA5YTkwZTkzZGM2Y2E0YjNlODZfMy0xLTEtMS0w_f89f7b7b-6ecb-443a-a370-93fb6ca37bd9">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ic7aecb12307a4028a550cb1bdd7c0949_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RhYmxlOmRjMzhkMjQ3M2IwMzQwOWE5MGU5M2RjNmNhNGIzZTg2L3RhYmxlcmFuZ2U6ZGMzOGQyNDczYjAzNDA5YTkwZTkzZGM2Y2E0YjNlODZfNC0xLTEtMS0w_b24c3b23-3418-46e4-ae7e-96c37e165dac">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2Nzc_a5baaf28-149e-4146-8120-7fbd1ff5478d">Long-lived assetsWe review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. An impairment loss is recognized when the total estimated future undiscounted cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount. Impairment, if any, is assessed using discounted cash flows or other appropriate measures of fair value.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMTI2ODc_80f7bfc6-b49d-4341-8cb6-29c61fb8cb10"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMTI2ODc_d02d52ee-fe6c-4b93-84ce-9726bf5fa0d2"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMTI2ODc_f18eaa59-ba19-416e-aae3-befc44f13fba"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MTM_304fe499-01e2-44ae-b705-916ab01fae49">Fair value of financial instrumentsOur financial instruments consist principally of cash and cash equivalents, marketable securities, accounts payable, accrued liabilities, finance leases, and liabilities associated with business combinations. The carrying amounts of certain of these financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued and other current liabilities approximate their current fair value due to the relatively short-term nature of these accounts. Based on borrowing rates available to us, the carrying value of finance leases approximate their fair values. Liabilities associated with business combinations are recorded at their estimated fair value.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NDk_50a76219-550d-4980-bb6b-f00192490840">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. Significant judgment is required in determining the net valuation allowance which includes our evaluation of all available evidence including past operating results, estimates on future taxable income and acquisition-related tax assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We historically established a full valuation allowance against our deferred tax assets due to the uncertainty surrounding realization of such assets. In 2020, we released approximately $112.1&#160;million of our valuation allowance to account for acquired intangibles that support the future realization of some of our deferred tax assets. Due to the overall increase of deferred tax assets, our valuation allowance has also increased from the prior year.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzY5NjU4MTQ4NzEzNw_4c706089-b461-462b-af21-8ef93c796ff8"
      unitRef="usd">112100000</us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2Nzg_2649a6ca-b3ac-4813-835b-fc56d7ad6aef">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measure stock-based payment awards made to employees and directors based on the estimated fair values of the awards and recognize the compensation expense over the requisite service period. We use the Black-Scholes option-pricing model to estimate the fair value of stock option awards and employee stock purchase plan (&#x201c;ESPP&#x201d;) purchases. The fair value of restricted stock unit (&#x201c;RSU&#x201d;) awards with time-based vesting terms is based on the grant date share price. We grant performance-based restricted stock unit (&#x201c;PRSU&#x201d;) awards to certain employees which vest upon the achievement of certain performance conditions, subject to the employees&#x2019; continued service relationship with us. The probability of vesting is assessed at each reporting period and compensation cost is adjusted based on this probability assessment. We recognize such compensation expense on an accelerated vesting method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense for awards without a performance condition is recognized using the straight-line method. Stock-based compensation expense is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. As such, our stock-based compensation is reduced for estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for stock issued in connection with business combinations based on the fair value on the date of issuance.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3Mjk_4ee2c090-bd8a-4156-8d6b-7fb3f57ea2a6">AdvertisingAdvertising expenses are expensed as incurred.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjA2ODI_c01238d5-12bc-4133-ac38-02b4a7e45bf0"
      unitRef="usd">11400000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjA2ODY_e963ddff-6f98-403d-ad0e-375913d2f9b9"
      unitRef="usd">9900000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjA2OTM_8f1adece-a4ef-4ed8-8ef2-33b6ec6ce7e0"
      unitRef="usd">600000</us-gaap:AdvertisingExpense>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NTQ_25a4f1ff-ef23-4d5f-8162-a649eb94d43e">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive loss is composed of two components: net loss and other comprehensive income (loss). Other comprehensive income (loss) refers to gains and losses that under U.S. GAAP are recorded as an element of stockholders&#x2019; equity, but are excluded from net loss. Our other comprehensive income (loss) consists of unrealized gains or losses on investments in available-for-sale securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk2NjI_5fd9dac6-bc50-41ce-accc-7c1f0a73d5eb">Net loss per shareBasic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, without consideration of common stock equivalents. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common share equivalents outstanding for the period determined using the treasury stock method. Potentially dilutive securities, consisting of preferred stock, options to purchase common stock, common stock warrants, shares of common stock pursuant to ESPP, common stock issuable in connection with our Convertible Senior Notes, RSUs and PRSUs, are considered to be common stock equivalents and were excluded from the calculation of diluted net loss per share because their effect would be antidilutive for all periods presented.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MDE_8cfa9f32-fc38-4e1d-82f2-70bfd5d33d33">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prior period reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have reclassified certain amounts in prior periods to conform with current presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0f632804fdba4dc8928d0db037568eff_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjMwODk3NDQyNTU1OTc_6a92f7a8-aa10-4028-baa4-48925f7034b7"
      unitRef="usd">10100000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:StockholdersEquity
      contextRef="i16fc5f68786d447999f8e4e68164aebb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjMwODk3NDQyNTU2MTI_e24ec45e-37e9-431a-8851-0ce91e1dbd07"
      unitRef="usd">-10400000</us-gaap:StockholdersEquity>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i799d7ced2b4d4f649c58a173693d0e85_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjMwODk3NDQyNTU2Mjc_c1efb4e9-5a59-435d-a0e8-941296178ab6"
      unitRef="usd">300000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMjk3MDI_490bbf53-5089-4161-9347-3010041399cd">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate all Accounting Standards Updates (&#x201c;ASUs&#x201d;) issued by the Financial Accounting Standards Board ("FASB") for consideration of their applicability. ASUs not included in the disclosures in this report were assessed and determined to be either not applicable or are not expected to have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently issued accounting pronouncements not yet adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU No. 2020-06,&#160;Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which simplifies the accounting for certain convertible instruments, amends the guidance on derivative scope exceptions for contracts in an entity's own equity, and modifies the guidance on diluted earnings per share calculations as a result of these changes. This new standard is effective for our interim and annual periods beginning January 1, 2022, and earlier adoption is permitted. We may elect to apply the amendments on a retrospective or modified retrospective basis. We are currently evaluating the impact of the adoption of this standard on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently adopted accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016,&#160;FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires measurement and recognition of expected credit losses for financial assets. This guidance became effective for us beginning in the first quarter of 2020 and was adopted using a modified retrospective approach, with certain exceptions. The adoption of Topic 326 did not have a material impact on our consolidated financial statements as credit losses are not expected to be significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of our adoption of Topic 326, we assess our accounts receivables for expected credit losses at each reporting period by disaggregating by payer type and further by portfolios of customers with similar characteristics, such as customer type and geographic location. We then review each portfolio for expected credit losses based on historical payment trends as well as forward looking data and current economic trends. If a credit loss is determined, we record a reduction to our accounts receivable balance with a corresponding general and administrative expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with Topic 326, we no longer evaluate whether our available-for-sale debt securities in an unrealized loss position are other than temporarily impaired. Instead, we assess whether such unrealized loss positions are credit-related. Our expected loss allowance methodology for these securities is developed by reviewing the extent of the unrealized loss, the issuers&#x2019; credit ratings and any changes in those ratings, as well as reviewing current and future economic market conditions and the issuers&#x2019; current status and financial condition. The credit-related portion of unrealized losses, and any subsequent improvements, are recorded in other income (expense), net. Unrealized gains and losses that are not credit-related are included in accumulated other comprehensive income (loss). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2019, we adopted the provisions of ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; using the modified retrospective approach in accordance with Topic 842. Adoption of Topic 842 had a material impact on our consolidated balance sheets, but did not have an impact on our consolidated statements of operations. We elected the package of practical expedients permitted under the transition guidance which, among other things, allowed us to carry forward the historical classification of leases in place as of January 1, 2019. We did not identify any material embedded leases with the adoption of Topic 842 and therefore the implementation of Topic 842 primarily focused on the treatment of our previously identified leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior period amounts were not adjusted and continue to be reported in accordance with our historic accounting under previous lease guidance, ASC 840, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 840, we rented facilities under operating lease agreements and recognized related rent expense on a straight-line basis over the term of the applicable lease agreement. Some of the lease agreements contained rent holidays, scheduled rent increases, lease incentives, and renewal options. Rent holidays and scheduled rent increases were included in the determination of rent expense recorded over the lease term. Lease incentives were recognized as a reduction of rent expense on a straight-line basis over the term of the lease. Renewals were not assumed in the determination of the lease term unless they were deemed to be reasonably assured at the inception of the lease. We recognized rent expense beginning on the date we obtained the legal right to use and control the leased space.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMjI1OA_af3af264-26e0-441e-853e-50262fd85275">Revenue, accounts receivable and deferred revenue &lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Test revenue is generated from sales of diagnostic tests and precision oncology products to four groups of customers: biopharmaceutical partners; patients who pay directly; patients' insurance carriers; and other business-to-business customers (e.g., hospitals, clinics, medical centers). Test revenue is generated in two ways: through a centralized lab and decentralized through the shipment of reactions to biopharma partners and other business-to-business customers. We refer to the set of reagents needed to perform a next-generation sequencing test as a "reaction." Amounts billed and collected, and the timing of collections, vary based on the type of payer. Other revenue consists principally of revenue recognized under contracts for pharma development services and other collaboration and genome network agreements and is accounted for under the provisions provided in ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue as disaggregated by payer category and revenue subtype is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Patient&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Biopharma partner&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other business-to-business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Test revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centralized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decentralized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Total test revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center;text-indent:31.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Patient&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Biopharma partner&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other business-to-business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Test revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centralized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Total test revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Patient&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Biopharma partner&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other business-to-business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Test revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centralized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Total test revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue related to billings based on estimates of the amount that will ultimately be realized. Cash collections for certain tests delivered may differ from rates originally estimated. As a result of new information, we update our estimate quarterly of the amounts to be recognized for previously delivered tests which resulted in the following increases to revenue and decreases to our loss from operations and basic and diluted net loss per share (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impact of COVID-19&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our billable volumes decreased significantly in the second half of March 2020 as compared to the first few months of 2020 as a result of COVID-19 and related limitations and priorities across the healthcare system. Our daily test volumes have consistently increased from the low in March 2020, although we are currently still experiencing changes in product mix due to the impact of COVID-19. COVID-19 could have a material impact on our financial results for the foreseeable future, particularly on product mix and as a result, the revenue we recognize. We have reviewed and adjusted for the impact of COVID-19 on our estimates related to revenue recognition and expected credit losses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximately 8% of our workforce as of March 31, 2020 was impacted by a reduction in force in April 2020 in an initiative to manage costs and cash burn that resulted in one-time costs in the second quarter of 2020 of $3.8&#160;million. In addition, effective May 2020, we have reduced the salaries of our named executive officers by approximately 20%, which reductions ceased as of January 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was signed into law which was a stimulus bill intended to bolster the economy, among other things, and provide assistance to qualifying businesses and individuals. The CARES Act included an infusion of funds into the healthcare system, and in April 2020, we received $3.8&#160;million as a part of this initiative. This payment was recognized as other income (expense), net in our consolidated statement of operations during the year ended December 31, 2020. We also received $2.3&#160;million in January 2021 which we recognized as other income (expense), net during the three months ended March 31, 2021. At this time, we are not certain of the availability, extent or impact of any future relief provided under the CARES Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of our accounts receivable represents amounts billed to pharmaceutical partners and other business-to-business customers for test and other revenue recognized, and estimated amounts to be collected from third-party insurance payers for genetic testing revenue recognized. Also included are amounts due under the terms of collaboration and genome network agreements for diagnostic testing and data aggregation reporting services provided and proprietary platform access rights transferred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also record unbilled revenue for revenue recognized but yet to be billed for services provided to biopharmaceutical companies related to companion diagnostic development. The amount is a contract receivable and is included in accounts receivable on the consolidated balance sheets; unbilled revenue was $4.3&#160;million and nil as of December&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record a contract liability when cash payments are received or due in advance of our performance related to one or more performance obligations. The deferred revenue balance primarily consists of advanced billings for pharma development services, including billings at the initiation of a performance-based milestones, and recognized as revenue in the applicable future period when the revenue is earned. Also included are prepayments related to our consumer direct channel. We recognized revenue of $1.4 million from deferred revenue for the year ended as of December&#160;31, 2020. In addition, we recognized deferred revenue of $4.8 million upon the acquisition of ArcherDX in October 2020, $2.0 million of which was recognized as revenue during the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMjI2Mg_6afeb905-1c7a-4ea3-9ac7-114c9dc996b2">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue as disaggregated by payer category and revenue subtype is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Patient&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Biopharma partner&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other business-to-business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Test revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centralized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decentralized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Total test revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center;text-indent:31.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Patient&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Biopharma partner&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other business-to-business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Test revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centralized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Total test revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Patient&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Biopharma partner&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other business-to-business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Test revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centralized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Total test revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8c91c8e1cbc46d49aa79331ab90dcd2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfMy0yLTEtMS03MzMz_e30d9dfc-ba06-41de-8908-e071e6ae2f73"
      unitRef="usd">181026000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9c67b77700048fab0585b6066fa04c5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfMy00LTEtMS03MzM4_1d100290-1a3c-42eb-acbb-512035fc89b2"
      unitRef="usd">23972000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6871dfde02ea4071998e693ce797f046_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfMy02LTEtMS03MzQ1_99788ce8-6185-47cd-a8cf-0cbb1988b2b6"
      unitRef="usd">26228000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idbcb07071f07445fafa80ea82f6b1aa1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfMy04LTEtMS03MzQ3_cb512675-f000-4954-afe0-81fbf5679b29"
      unitRef="usd">32736000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b8929e13ba7497294e5422447cdf72c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfMy0xMC0xLTEtNzM1MQ_0f46346d-06fc-44d5-9113-61f07d160cd0"
      unitRef="usd">263962000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07eda2ee4f144ad196ef401a7db1bffe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNC0yLTEtMS03MzMz_b9fbaa7a-9b7d-4fdf-ba0e-c65b30443461"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie8e9734305bb4650bd1c5a51bad8c420_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNC00LTEtMS03MzM4_a1c4c1a4-17c0-43fc-8eb4-d2c15534a722"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48186d64febd4653a8f230b2dee4ce39_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNC02LTEtMS03MzQ1_e769c73d-f7b3-4d6c-b867-edadf7723d0f"
      unitRef="usd">837000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia6be0b9df48b4580a4f57239b6c93c95_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNC04LTEtMS03MzQ3_7bb678db-3f95-48d9-8ba7-baf5c0b6558f"
      unitRef="usd">7511000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b1d5edf779f44dc9cb12c8fa50f37f7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNC0xMC0xLTEtNzM1MQ_2c62f2c4-dc07-438c-ac63-77bc84765995"
      unitRef="usd">8348000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0883ec36ca8f4b61abb4136ad60dfd6c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNS0yLTEtMS03MzMz_d0141b19-2f5c-4fce-a327-16a25ed02247"
      unitRef="usd">181026000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54c647460d3a4f2ca2462ceef18be368_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNS00LTEtMS03MzM4_5ddff351-1c2f-4bf3-b06e-83e6e6ec9b74"
      unitRef="usd">23972000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9bff46bd60c485b87b8b76a524b891b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNS02LTEtMS03MzQ1_da15a03f-a622-49b0-9baa-4dffa561a7df"
      unitRef="usd">27065000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd3bd1b58fce419091528683f64e06f4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNS04LTEtMS03MzQ3_e70537cb-708d-46c3-aac7-b944ea83ba29"
      unitRef="usd">40247000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9b882f2b7c04e7297a6e4005b4ccdd9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNS0xMC0xLTEtNzM1MQ_b3c68289-f37b-4716-984d-16778e06c1c2"
      unitRef="usd">272310000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f2c32a0a92c4d75956a7049d4a3d2ea_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNi0yLTEtMS03MzMz_48073220-fe38-4949-9886-1ba49db5589a"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ac952c0d68641358df70ac8ca6a5650_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNi00LTEtMS03MzM4_e8cb4205-b9b8-42c2-b96e-2b55c1ba4de4"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie754d8f483fb4e51858045ccc2f3ce90_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNi02LTEtMS03MzQ1_c71e87f5-39d0-4d25-a12e-8c8665bae31e"
      unitRef="usd">4488000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74e133af2bf04b16807d4769bdb0cb72_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNi04LTEtMS03MzQ3_bfa83d8f-eaff-429e-8c34-4a1831b5ba53"
      unitRef="usd">2800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8d899ddc8834e689efc87de396289f8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNi0xMC0xLTEtNzM1MQ_073c09c7-5541-4305-9b96-23146ea98d13"
      unitRef="usd">7288000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0865c1b494ba451ab270138139c94f26_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNy0yLTEtMS03MzMz_8840cd61-a50b-4fe3-91b6-b6d48fb1b01d"
      unitRef="usd">181026000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e1ebc0d9c8f4fa49f8160f97e726c28_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNy00LTEtMS03MzM4_2bbfaff9-4b90-45ad-874c-1b41364d6a08"
      unitRef="usd">23972000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5822641e200b480e91f0f00410faaa4f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNy02LTEtMS03MzQ1_39477b14-d018-45ea-b86f-bca9cc65474b"
      unitRef="usd">31553000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i930f6e9c37794d87a77e92a1acdd9d20_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNy04LTEtMS03MzQ3_43a04486-6128-46ee-a46e-2a6224b98404"
      unitRef="usd">43047000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmEzZWMyZWEwZDZjMjRlZDdhZmE1NmZiNTk0NGEyNTMyL3RhYmxlcmFuZ2U6YTNlYzJlYTBkNmMyNGVkN2FmYTU2ZmI1OTQ0YTI1MzJfNy0xMC0xLTEtNzM1MQ_bf57cc46-78e5-421c-b438-58683dd6fb91"
      unitRef="usd">279598000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9ceb9d1a9ba4fefab7b0de9a46a08f5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfMy0yLTEtMS03MzUz_ba4991a5-19e6-4c47-81cf-9bac612ef326"
      unitRef="usd">153827000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id351fd76aed144bd8c8d86224002492a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfMy00LTEtMS03MzUz_c3866d5c-3f15-4034-aa70-0b70e389582c"
      unitRef="usd">17597000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3e33012667e4e30a31dc4fd2506de06_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfMy02LTEtMS03MzUz_500f28a4-ff99-411c-a08d-685d6c07c4e1"
      unitRef="usd">10876000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04c0ca3a9d3842ebb3e2454a419f73db_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfMy04LTEtMS03MzUz_e5b7df38-9860-4f14-bc41-617328387adc"
      unitRef="usd">30173000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id48ae029801d40a797835dbbc0b21225_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfMy0xMC0xLTEtNzM1Mw_ffadfb1e-5aee-424d-b03a-0e481ef72d47"
      unitRef="usd">212473000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i569b0aa5a6f34fb192244d9b4ba6eda3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNS0yLTEtMS03MzUz_b1d6895d-8fd7-48ce-bedd-520ed261c254"
      unitRef="usd">153827000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58747813981d448b9d05d26c6c6d5246_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNS00LTEtMS03MzUz_21c784cc-7cb5-4add-925e-c948e3fdf293"
      unitRef="usd">17597000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f82f2edd74c43e996978b02294c3f96_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNS02LTEtMS03MzUz_66a78ab4-4c7a-4940-9cb1-8b7e8b1527c5"
      unitRef="usd">10876000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6829414e2ffa46ec8834efbb42474a0a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNS04LTEtMS03MzUz_1bffe88c-fdb0-459c-83b8-bc45f7b86dbc"
      unitRef="usd">30173000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i437a19f6fb264a83b0e5e51fec25eb41_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNS0xMC0xLTEtNzM1Mw_2ea8622f-a32f-4d9c-a376-6eceb6599c9f"
      unitRef="usd">212473000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i491dfe25cfb649818908611d2258015f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNi0yLTEtMS03MzUz_3cededa7-50bb-4001-b33e-71fc868cfc25"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ba34653ed3d4026b109adcc85e47692_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNi00LTEtMS03MzUz_714e60a5-356b-4f82-bb02-a3a044ce2098"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7194b23e865e4e6985412838b83facfa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNi02LTEtMS03MzUz_54b47a9d-6d08-4eef-aa43-cc31ac1ba132"
      unitRef="usd">2077000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4a31b78347c4b40b403d983d215552b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNi04LTEtMS03MzUz_0b878510-79e4-484b-b3fd-bb0c694f2271"
      unitRef="usd">2274000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4f2ead9ac6540068a6b97873f3f9752_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNi0xMC0xLTEtNzM1Mw_1b43840c-ef79-450e-90a4-af05e70f63e8"
      unitRef="usd">4351000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7296e71c4e804c2c81cdefbc5ff88c20_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNy0yLTEtMS03MzUz_d465f31c-2330-438f-bb05-cfccdf60b0ae"
      unitRef="usd">153827000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i969948f32a3e419e836b2483a8c32d1b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNy00LTEtMS03MzUz_c86d0a12-b6a5-4812-a433-cfcc023ba3d9"
      unitRef="usd">17597000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied3c3598292b417c808a16a8f89056d5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNy02LTEtMS03MzUz_57cec00a-175b-4719-820e-1db597b15b61"
      unitRef="usd">12953000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if00851ed8e674d059de41cc8a623702e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNy04LTEtMS03MzUz_894b083d-6570-4912-af04-816aa834f19c"
      unitRef="usd">32447000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOmM5YjQ3YjJlZjc2MDQwYjdhZGQ0ZTk2YWU2MTcxZTY5L3RhYmxlcmFuZ2U6YzliNDdiMmVmNzYwNDBiN2FkZDRlOTZhZTYxNzFlNjlfNy0xMC0xLTEtNzM1Mw_abafaf11-af9e-485c-ada0-a9f68d3404c7"
      unitRef="usd">216824000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8fd4026968274daa9db97163c9bf7adb_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfMy0yLTEtMS03MzU1_2c92bab3-a93f-49e7-9cd2-3eaa4d7f939d"
      unitRef="usd">96352000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iddcdbd12b8c7475aba56d81dda39e665_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfMy00LTEtMS03MzU1_fe001b23-e7a1-4e2c-82b0-01f8d0f062c2"
      unitRef="usd">13589000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d4f784ba21340fca1b9b756750631dc_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfMy02LTEtMS03MzU1_62b270f0-bbe3-4204-b592-617efe917ecb"
      unitRef="usd">6231000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63d5268d5fcc418f821908f9c967fc66_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfMy04LTEtMS03MzU1_54a70a4e-0fa8-45b4-b971-fb27c535d654"
      unitRef="usd">28388000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3b56aad901d4542b70fef47b9e041b7_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfMy0xMC0xLTEtNzM1NQ_5c2f172f-c37a-4143-9fe6-85a9db9bfc79"
      unitRef="usd">144560000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c178e50df2e482c954755b5678ede25_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNS0yLTEtMS03MzU1_b770a942-09fe-4847-b03f-539b0ee508d5"
      unitRef="usd">96352000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fd6d6acd7ce4ad4bca9f6796da9e37a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNS00LTEtMS03MzU1_ee01d213-d284-4f4e-8b1e-7d110490e5b0"
      unitRef="usd">13589000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1e9baa6d9c74475a1b214d6a20dd9a3_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNS02LTEtMS03MzU1_5694cc0c-3211-42a6-9939-bb6ddc146bdf"
      unitRef="usd">6231000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifeca44f7c289448bba37ead51a718ccb_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNS04LTEtMS03MzU1_adbe08d4-bb2b-42aa-afe6-7284eb8e100a"
      unitRef="usd">28388000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58cad0e4115a408fb292a43a94deba31_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNS0xMC0xLTEtNzM1NQ_17e271a6-6b99-43c5-89dd-1c9cc6f1111d"
      unitRef="usd">144560000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie19147196bf74f8a98a96a08aa4ff4ef_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNi0yLTEtMS03MzU1_a78ba177-8770-4419-9620-5afa45a13f9d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d25782f3f414458ad4852af49306b8a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNi00LTEtMS03MzU1_abd0d989-c8f3-45af-acdc-b6c9681cd71b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82f3fed101ff476eac77b5bae97ef149_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNi02LTEtMS03MzU1_399c2193-1456-4e08-b956-bdaff08628eb"
      unitRef="usd">1565000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f15ba33a7ce4679b90a0c0de0249127_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNi04LTEtMS03MzU1_e9d8bfe4-880d-470e-a28f-49a724558b1e"
      unitRef="usd">1574000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i616089384d754359aaf3b67545a021a0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNi0xMC0xLTEtNzM1NQ_abd148f3-adb5-4e48-a3cf-6bc23acc2cc4"
      unitRef="usd">3139000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98f5fa2ae5e04ed4892542827e4eda04_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNy0yLTEtMS03MzU1_fb4cbd25-7459-4353-8424-9935ddbb36e5"
      unitRef="usd">96352000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf399717bf28435a89aca26b773c0386_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNy00LTEtMS03MzU1_87e11735-bedd-42ba-9ae5-731c87f6c6cc"
      unitRef="usd">13589000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i31abe8effbe949ff872826205878e9e6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNy02LTEtMS03MzU1_094f4d3d-bb39-411e-8ada-ccf6aee3edff"
      unitRef="usd">7796000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35a9b0c466f0496cad68a4ecd841c041_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNy04LTEtMS03MzU1_0423690d-2ed1-4975-8935-29f06a5fbf02"
      unitRef="usd">29962000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjdjZDU0MjU5NDBiYzQyNjhiMTk2ZGYxZDdhOWJhZTMyL3RhYmxlcmFuZ2U6N2NkNTQyNTk0MGJjNDI2OGIxOTZkZjFkN2E5YmFlMzJfNy0xMC0xLTEtNzM1NQ_3097dcc8-b9b0-4446-9efd-141041a474ee"
      unitRef="usd">147699000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfChangeInAccountingEstimateTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMjI2Mw_1278dee8-89c3-4ed2-a979-8eae0975b7be">As a result of new information, we update our estimate quarterly of the amounts to be recognized for previously delivered tests which resulted in the following increases to revenue and decreases to our loss from operations and basic and diluted net loss per share (in millions, except per share amounts):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfChangeInAccountingEstimateTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if46861699db14e22b253710d388c79d1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfMi0xLTEtMS02MjMx_5383e11f-530a-4676-8dc7-ca10dc13a61d"
      unitRef="usd">4400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idcf84e334a474c329adf523e6663178a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfMi0xLTEtMS0w_2c9b482b-606d-4ae4-9588-f290c73970fc"
      unitRef="usd">4100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3516e7ca9c34c0eb58ee7744a7f3850_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfMi0zLTEtMS0w_38cc6fba-dcbd-4a25-b2ac-80c1a1084b8a"
      unitRef="usd">4500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="if46861699db14e22b253710d388c79d1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfMy0xLTEtMS02MjMx_f4fa8913-19d3-4ef5-a808-a1ae32769a52"
      unitRef="usd">-4400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idcf84e334a474c329adf523e6663178a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfMy0xLTEtMS0w_fe460320-497a-476a-a52f-3490ed7c4076"
      unitRef="usd">-4100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie3516e7ca9c34c0eb58ee7744a7f3850_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfMy0zLTEtMS0w_9e3718fa-9963-416c-9159-1a9b2978901d"
      unitRef="usd">-4500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="if46861699db14e22b253710d388c79d1_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfNC0xLTEtMS02MjMx_d72d9aca-0918-4f4b-8dcd-30745dbb8096"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="idcf84e334a474c329adf523e6663178a_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfNC0xLTEtMS0w_d7603642-202c-44bb-aa27-cac7d1bf351c"
      unitRef="usdPerShare">-0.05</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="ie3516e7ca9c34c0eb58ee7744a7f3850_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RhYmxlOjJmNTUxZTNiYTY4MjRiM2VhMGQ2MzhjYWZlZTllZDVmL3RhYmxlcmFuZ2U6MmY1NTFlM2JhNjgyNGIzZWEwZDYzOGNhZmVlOWVkNWZfNC0zLTEtMS0w_b1f7797e-3af9-4976-9037-ef050e1c96ec"
      unitRef="usdPerShare">-0.07</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <nvta:RestructuringandRelatedCostNumberofPositionsEliminatedPercent
      contextRef="ic1f0935550d444fa90ce07c61f19769c_D20200401-20200430"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMTI2NDQzODM3MjU3MDA_1b596774-5500-465b-827b-4f2c8aea2ead"
      unitRef="number">0.08</nvta:RestructuringandRelatedCostNumberofPositionsEliminatedPercent>
    <us-gaap:RestructuringCharges
      contextRef="iffa172b7ed5b4b2d868c2ae82bbc52a8_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMTI2NDQzODM3MjU3MDQ_618082cd-d02a-4c1e-b2e3-dddaffdcb47b"
      unitRef="usd">3800000</us-gaap:RestructuringCharges>
    <nvta:RestructuringandRelatedCostReductioninOfficerSalaryPercent
      contextRef="i2cfd56d90ca84309ab029f02e8df5f24_D20200501-20200531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMTI2NDQzODM3MjU3MTg_590b5c51-27cf-49cc-915b-42441bfa3b65"
      unitRef="number">0.20</nvta:RestructuringandRelatedCostReductioninOfficerSalaryPercent>
    <us-gaap:UnusualOrInfrequentItemNetGainLoss
      contextRef="i7780db32fd364ad99995fb2cdcbfc4fc_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMTI2NDQzODM3MjU3MjM_8ab90933-3b0e-4b94-80f1-837853065aae"
      unitRef="usd">-3800000</us-gaap:UnusualOrInfrequentItemNetGainLoss>
    <us-gaap:UnusualOrInfrequentItemNetGainLoss
      contextRef="i05128bf9cc8243f2bc27b6e1f8a3f4b1_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfNzY5NjU4MTQxMTY4OA_f3519f0b-d257-4445-b512-3e60ab439683"
      unitRef="usd">-2300000</us-gaap:UnusualOrInfrequentItemNetGainLoss>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfODI0NjMzNzIyNDY4Ng_16fd651f-ce06-43df-9299-f2db301da947"
      unitRef="usd">4300000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfODI0NjMzNzIyNDcwNA_b533c61b-a03f-4741-b5fb-b161f692c785"
      unitRef="usd">0</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMjI1Mzk5ODgzODY0NDU_f35e75f4-ba0a-415c-97b7-e3392a517872"
      unitRef="usd">1400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
      contextRef="i088f81f066a440d084e5a4dba897c8f8_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMjI1Mzk5ODgzODY0Mjg_f935dc77-e6d1-4c4e-8272-1e0e3eedc826"
      unitRef="usd">4800000</us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="if97a189b033643b79b8524895f6a78c7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84Mi9mcmFnOmIxMjI0NGM5NWZkODRkMWNiMjIxZTA3NTE0ZmM0OTIzL3RleHRyZWdpb246YjEyMjQ0Yzk1ZmQ4NGQxY2IyMjFlMDc1MTRmYzQ5MjNfMjI1Mzk5ODgzODY0NjI_41b1949c-09fc-4395-802e-affac62eec9b"
      unitRef="usd">2000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMTU5MDM_0d2e2a51-9a04-4dae-bd80-2d04138846d4">Business combinations&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Singular Bio&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2019, we acquired 100% of the fully diluted equity of Singular Bio, a privately held company developing single molecule detection technology, for approximately $57.3&#160;million, comprised of $53.9&#160;million in the form of 2.5&#160;million shares of our common stock and the remainder in cash. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We granted approximately $90.0&#160;million of restricted stock units ("RSU") under our 2015 Stock Incentive Plan as inducement awards to new employees who joined Invitae in connection with our acquisition of Singular Bio. $45.0&#160;million of the RSUs are time-based and vested in three equal installments in December 2019, June 2020, and December 2020, subject to the employee's continued service with us ("Time-based RSUs") and $45.0&#160;million of the RSUs are performance-based RSUs ("PRSU") that vest upon the achievement of certain performance conditions. Since the number of awards granted is based on a 30-day volume weighted-average share price with a fixed dollar value, these Time-based RSUs and PRSUs are liability-classified and the fair value is estimated at each reporting period based on the number of shares that are expected to be issued at each reporting date and our closing stock price, which combined are categorized as Level 3 inputs. Therefore, fair value of the RSUs and PRSUs and the number of shares to be issued will not be fixed until the awards vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2020 and 2019, we recorded research and development stock-based compensation expense of $29.1&#160;million and $14.7&#160;million, respectively, related to the Time-based RSUs, and $19.4&#160;million and $24.4&#160;million, respectively, related to the PRSUs based on our evaluations of the probability of achieving performance conditions. As of December&#160;31, 2020, the Time-based RSUs and PRSUs had a total fair value of $43.9&#160;million and $43.8&#160;million, respectively, based on a total estimated issuance of 3.5&#160;million shares and expectation of the achievement of the performance conditions. As of December&#160;31, 2020, 2.0&#160;million of the Time-based RSUs and 1.2&#160;million of the PRSUs had vested with a total fair value of $75.0&#160;million which was recorded in common stock issued or issuable pursuant to acquisitions in the consolidated statements of stockholders' equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Jungla&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2019, we acquired 100% of the equity interest of Jungla, a privately held company developing a platform for molecular evidence testing in genes, for approximately $59.0&#160;million, comprised of $44.9&#160;million in the form of shares of our common stock and the remainder in cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may be required to pay contingent consideration based on achievement of post-closing development milestones. As of the acquisition date, the fair value of this contingent consideration was $10.7&#160;million including cash and common stock. These milestones are expected to be completed within two years of the date of acquisition, two of which were completed during the year ended December&#160;31, 2020. The material factors that may impact the fair value of the contingent consideration, and therefore, this liability, are the probabilities and timing of achieving the related milestones and the discount rate we used to estimate the fair value, which are Level 3 inputs not supported by market activity. Significant changes in any of the probabilities of success would result in a significant change in the fair value, which will be estimated at each reporting date with changes reflected as a general and administrative expense. As of December&#160;31, 2020, the fair value of this contingent consideration was $7.1&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon acquisition, we had a stock payable liability related to our acquisition of Jungla which represents the hold-back obligation to issue 0.2&#160;million shares subject to indemnification claims that may arise. This liability was adjusted at each reporting period based on the fair value of our common stock, which is a Level 3 input, with the change recorded in other income (expense), net. During July 2020, the hold-back shares were remitted in full to the former owners of Jungla. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Clear Genetics&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, we acquired 100% of the equity interest of Clear Genetics, a developer of software for providing genetic services at scale, for approximately $50.1&#160;million. Of the cash and stock purchase price consideration issued, $0.2&#160;million of cash and approximately 0.4&#160;million shares of our common stock were subject to a 12-month hold back to satisfy indemnification obligations that  were released during the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Diploid&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, we acquired 100% of the equity interest of Diploid, a developer of artificial intelligence software capable of diagnosing genetic disorders using sequencing data and patient information, for approximately $82.3&#160;million in cash and shares of our common stock. Of the stock purchase price consideration issued, approximately 0.4&#160;million shares are subject to a hold-back to satisfy indemnification obligations that may arise. We included the financial results of Diploid in our consolidated financial statements from the acquisition date, which were not material for the year ended December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the purchase price recorded as a part of the acquisition of Diploid (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hold-back consideration - common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:31.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets acquired and liabilities assumed are recorded based on valuations derived from estimated fair value assessments and assumptions used by us. While we believe that our estimates and assumptions underlying the valuations are reasonable, different estimates and assumptions could result in different valuations assigned to the individual assets acquired and liabilities assumed, and the resulting amount of goodwill. The following table summarizes the fair values of assets acquired and liabilities assumed through our acquisition of Diploid at the date of acquisition (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:31.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the guidance provided in ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we accounted for the acquisition of Diploid as a business combination and determined that 1) Diploid was a business which combines inputs and processes to create outputs, and 2) substantially all of the fair value of gross assets acquired was not concentrated in a single identifiable asset or group of similar identifiable assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our purchase price allocation for the acquisition is preliminary and subject to revision as additional information about fair value of assets and liabilities becomes available, primarily related to our deferred tax liability assumed in connection with the acquisition. Additional information that existed as of the acquisition date but at the time was unknown to us may become known to us during the remainder of the measurement period, a period not to exceed 12 months from the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measured the identifiable assets and liabilities assumed at their acquisition date fair values separately from goodwill. The intangible asset acquired is developed technology related to Diploid's artificial intelligence technology platform. The fair value of the developed technology was estimated using an income approach with an estimated useful life of nine years. As of the acquisition date, we recorded a stock payable liability of $7.5&#160;million to represent the hold-back obligation to issue 0.4&#160;million shares subject to indemnification claims that may arise. This liability is adjusted at each reporting period based on the fair value of our common stock, which is a Level 3 input. As of December&#160;31, 2020, the value of this liability was $17.7&#160;million with the change recorded in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired. The acquisition of Diploid resulted in the recognition of $50.7&#160;million of goodwill which we believe relates primarily to expansion of the acquired technology to apply to new areas of genetic testing. The goodwill created as a result of the acquisition of Diploid is not deductible for the foreign local tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2020, we granted 0.2&#160;million RSUs with a fair value of $3.6&#160;million under our 2015 Stock Incentive Plan as inducement awards in connection with our acquisition of Diploid. These RSUs vest in two equal installments, in April 2021 and April 2022. The value of the awards was recognized as research and development stock-based compensation upon grant in June 2020 as there were no ongoing obligations required by the award recipients. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Genelex and YouScript&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, we acquired 100% of the equity interest of Genelex and YouScript to bring pharmacogenetic testing and integrated clinical decision support to Invitae. We acquired Genelex for approximately $13.2&#160;million, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;primarily in shares of our common stock. Of the stock purchase price consideration issued, approximately 0.1&#160;million shares are subject to a hold-back to satisfy indemnification obligations that may arise. We acquired YouScript for approximately $52.7&#160;million, including cash consideration of $24.5&#160;million and the remaining in shares of our common stock. Of the purchase price consideration for YouScript, approximately $1.4&#160;million and 0.5&#160;million shares of our common stock are subject to a hold-back to satisfy indemnification obligations that may arise. We included the financial results of Genelex and YouScript in our consolidated financial statements from the acquisition date, which were not material for the year ended December 31, 2020. We recorded $1.7&#160;million of transaction costs related to the acquisition of Genelex and YouScript as general and administrative expense during the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may be required to pay contingent consideration in the form of additional shares of our common stock in connection with the acquisition of Genelex if, within a specified period following the closing, we achieve a certain product milestone, in which case we would issue shares of our common stock with a value equal to a portion of the gross revenues actually received by us for a pharmacogenetic product reimbursed through certain payers during an earn-out period of up to four years. As of the acquisition date, the fair value of this contingent consideration was $2.0&#160;million in the form of shares of our common stock. The material factors that may impact the fair value of the contingent consideration, and therefore, this liability, are the probabilities and timing of achieving the related milestone, the estimated revenues achieved for a pharmacogenetic product and the discount rate we used to estimate the fair value, which are Level 3 inputs not supported by market activity. Significant changes in any of the probabilities of success would result in a significant change in the fair value, which is estimated at each reporting date with changes reflected as general and administrative expense. As of December&#160;31, 2020, the fair value of this contingent consideration was $1.2&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the purchase prices recorded as a part of the acquisition of Genelex and YouScript (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Genelex&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;YouScript&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Cash transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Hold-back consideration - cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Hold-back consideration - common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Common stock transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;13,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;52,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;65,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets acquired and liabilities assumed are recorded based on valuations derived from estimated fair value assessments and assumptions used by us. While we believe that our estimates and assumptions underlying the valuations are reasonable, different estimates and assumptions could result in different valuations assigned to the individual assets acquired and liabilities assumed, and the resulting amount of goodwill. The following table summarizes the fair values of assets acquired and liabilities assumed through our acquisitions of Genelex and YouScript at the date of acquisition (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.686%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Genelex&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;YouScript&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;9,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;25,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;34,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;9,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;26,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;35,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(481)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(801)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(2,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;9,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;22,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;32,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;29,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;13,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;52,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;65,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the guidance provided in ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we accounted for the acquisitions of Genelex and YouScript as business combinations and determined that 1) Genelex and YouScript were businesses which combine inputs and processes to create outputs, and 2) substantially all of the fair value of gross assets acquired were not concentrated in a single identifiable asset or group of similar identifiable assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our purchase price allocation for the acquisitions is preliminary and subject to revision as additional information about fair value of assets and liabilities becomes available, primarily related to our deferred tax liability assumed. Additional information that existed as of the acquisition date but at the time was unknown to us may become known to us during the remainder of the measurement period, a period not to exceed 12 months from the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measured the identifiable assets and liabilities assumed at their acquisition date fair values separately from goodwill. The intangible assets acquired are the developed technologies related to Genelex's and YouScript's technology platforms. The fair value of the developed technologies were estimated using an income approach with an estimated useful life of eight years. As of the acquisition date, we recorded stock payable liabilities of $6.2&#160;million to represent the hold-back obligation to issue shares subject to indemnification claims that may arise. These liabilities are adjusted at each reporting period based on the fair value of our common stock, which is a Level 3 input. As of December&#160;31, 2020, the value of this liability was $21.6&#160;million with the change recorded in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired. The acquisitions of Genelex and YouScript resulted in the recognition of $33.8&#160;million of goodwill which we believe relates primarily to future functionality and expansion of the acquired technologies. Of the goodwill recognized, $29.7&#160;million related to the YouScript acquisition is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ArcherDX&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2020, we entered into a definitive agreement with ArcherDX, a genomics analysis company democratizing precision oncology, and in October 2020, the closing conditions were met and the transaction was consummated. Under the terms of the agreement, we acquired 100% of the equity interest of ArcherDX&#160;for $2.3&#160;billion, comprised of $2.0&#160;billion in the form of our common stock, $2.0&#160;million in liabilities, and the remainder in cash. We incurred $20.9&#160;million of transaction costs related to the acquisition of ArcherDX which we recorded as general and administrative expense during the year ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may be required to pay contingent consideration based on achievement of post-closing development and revenue milestones. As of the acquisition date, the total fair value of the contingent consideration was $945.2&#160;million, $933.6&#160;million of which was included in the purchase price and $11.6&#160;million recognized as non-recurring post-combination compensation expense. Of this $933.6&#160;million, $925.1 million would be in the form of shares of our common stock which will be priced at the time of the milestone achievement, and the remainder in cash. The milestones are expected to be completed within approximately two years from the date of the acquisition, with one of them being achieved during November 2020 which resulted in the issuance of 5.0&#160;million shares of our common stock and a cash payment of $1.9&#160;million. This milestone achievement subsequent to the acquisition date resulted in the recognition of $40.6&#160;million general and administrative expense. The material factors that may impact the fair value of the contingent consideration, and therefore the liability, are (i) the estimated number of shares issued, (ii) the volatility assumptions of our common stock used in the Monte Carlo simulation, (iii) the probabilities and timing of achievement of milestones and (iv) discount rates, all of which are Level 3 inputs not supported by market activity. Significant changes in any of these inputs may result in a significant change in fair value, which is estimated at each reporting date with changes reflected as general and administrative expense. As of December&#160;31, 2020, the fair value of the contingent consideration representing the remaining milestones was $788.3&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the acquisition, all of ArcherDX's equity awards outstanding and unvested prior to the acquisition became fully vested per the terms of the agreement. The acceleration of vesting required us to allocate the fair value of the equity attributable to the pre-combination service to the purchase price and the remaining amount of $125.8&#160;million, inclusive of $11.6&#160;million in contingent consideration, to non-recurring post-combination expense which we recognized as general and administrative expense during the year ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We included the financial results of ArcherDX in our consolidated financial statements from the acquisition date, which contributed $16.2&#160;million and $24.8&#160;million of revenue and net loss, respectively, during the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the purchase price and post-combination expense recorded as a part of the acquisition of ArcherDX (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Post-combination Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration and liabilities incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;935.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,331.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets acquired and liabilities assumed are recorded based on valuations derived from estimated fair value assessments and assumptions used by us. While we believe that our estimates and assumptions underlying the valuations are reasonable, different estimates and assumptions could result in different valuations assigned to the individual assets acquired and liabilities assumed, and the resulting amount of goodwill. The following table summarizes the fair values of assets acquired and liabilities assumed through our acquisition of ArcherDX at the date of acquisition (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;803.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease obligations, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,652.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,331.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the guidance provided in ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we accounted for the acquisition of ArcherDX as a business combination and determined that 1) ArcherDX was a business which combines inputs and processes to create outputs, and 2) substantially all of the fair value of gross assets acquired was not concentrated in a single identifiable asset or group of similar identifiable assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our purchase price allocation for the acquisition is preliminary and subject to revision as additional information about fair value of assets and liabilities becomes available, primarily related to our deferred tax liability assumed in connection with the acquisition. Additional information that existed as of the acquisition date but at the time was unknown to us may become known to us during the remainder of the measurement period, a period not to exceed 12 months from the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measured the identifiable assets and liabilities assumed at their acquisition date fair values separately from goodwill. The intangible assets acquired are the developed technology related to ArcherDX's artificial intelligence technology platform, IPR&amp;amp;D for its STRATAFIDE and PCM products, ArcherDX's customer relationships in place at the time of acquisition, and the ArcherDX tradename. We also acquired the right to develop new technology through an existing agreement for the development and commercialization of sequencing-based companion diagnostics between ArcherDX and a vendor. The fair value of our intangible assets acquired as of the acquisition date and the method used to value these assets as well as the estimated economic lives for amortizable intangible assets were as follows (in millions, except estimated useful life which is in years):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;With-and-without&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Relief from royalty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;233.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Multi-period excess earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right to develop new technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;512.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Multi-period excess earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Not applicable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;803.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired. The acquisition of ArcherDX resulted in the recognition of $1.7&#160;billion of goodwill which we believe relates primarily to the anticipated benefits of synergies created through the acquisition and assembled workforce. The acquisition of ArcherDX advances our objectives to create a comprehensive offering that provides testing services for disease risk, therapy selection and personalized cancer monitoring to enable precision approaches to cancer treatment. Goodwill created as a result of the acquisition of ArcherDX is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded an income tax benefit of $109.5&#160;million in the three months ended December 31, 2020 due to net deferred tax liabilities assumed in connection with our acquisition of ArcherDX which provided a future source of income to support the realization of our deferred tax assets and resulted in a partial release of our valuation allowance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the acquisition, we granted inducement awards of Invitae common stock to new employees who joined Invitae in connection with our acquisition of ArcherDX with an estimated fair value of $112.2&#160;million, net of estimated forfeitures. These awards vest upon the achievement of the contingent consideration milestones discussed above and are subject to the employee&#x2019;s continued service with us, unless terminated without cause in which case vesting is only dependent on milestone achievement. As the number of shares that are expected to be issued are fixed, the awards are equity-classified. During the year ended December&#160;31, 2020, we recorded $41.2&#160;million in stock-based compensation expense based on our probability of milestone achievement. Included in the stock-based compensation expense is $2.1&#160;million related to the acceleration of stock-based compensation expense due to the termination of an employee without cause whereby the employee's continued service is not required. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pro forma financial information (unaudited)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The audited pro forma financial information in the table below summarizes the combined results of operations for Invitae and ArcherDX as though the companies had been combined as of January 1, 2019. The pro forma amounts have been adjusted for:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;transaction expenses incurred by ArcherDX and us,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;depreciation expense resulting from the fair value of the acquired property and equipment,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;amortization expense resulting from the acquired intangible assets,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the elimination of historical interest expense incurred by ArcherDX on its debt and debt-like items and the incurrence of interest expense related to the issuance of debt in connection with the acquisition,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;lease expense resulting from the step-up in the operating lease obligation and operating lease asset,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;nonrecurring post-combination expense,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;income tax benefits resulting from the deferred tax liabilities acquired, and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the 26.3&#160;million shares of our common stock issued upon the closing of the ArcherDX transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following unaudited pro forma financial information is for informational purposes only and is not necessarily indicative of the results of operations that would have been achieved as if the acquisition had taken place as of January 1, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.852%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(685,589)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(355,818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i175aab7c76c643de95548d9a1cb45a8e_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTE5NTk_51df41b4-f11c-47ad-8132-1b2d1c25af83"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ic8c530faa72844268e7ba46c4a287907_D20190601-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0MjgyNQ_88a08269-3a44-4809-b41a-ace595c0b343"
      unitRef="usd">57300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i175aab7c76c643de95548d9a1cb45a8e_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0Mjg0MA_75546e7e-96d0-48af-a03a-3a70447cbdd7"
      unitRef="usd">53900000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="ic8c530faa72844268e7ba46c4a287907_D20190601-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0Mjg1NQ_6dbd2450-15ce-4d68-ba75-c9ab2e43ee1d"
      unitRef="shares">2500000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="ie7db43ef787b49d99180bd32eb0c2d09_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0Mjg2OA_a120197f-56fe-4ffc-86b0-351437c16c2d"
      unitRef="usd">90000000.0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="icefe8e19fd8546d5821a526b27974ab7_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0Mjg4Mw_ba9c8e8c-5f65-4c10-bd7e-772ffaf0c89f"
      unitRef="usd">45000000.0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="idbe2c42636474f38911d7bec038c9f4a_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0Mjg5OA_176900aa-ccee-47a0-a9de-91339acface6"
      unitRef="usd">45000000.0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <nvta:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays
      contextRef="i664d8f88777d401d939dcc07f67fa240_D20190601-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTM3MDE_83d9ea59-e91b-4f5e-a517-91c860715481"
      unitRef="tradingday">30</nvta:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i76b34857279b4a77ad109619d8a570f6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTE5Njc_3853bdfa-74db-40e7-a893-e4bf67a8ec44"
      unitRef="usd">29100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8beb45e3e6464392a4fe1aeb393268c9_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNzcyNA_a4af2551-1ab9-42c3-bef4-07b70ea4f9d5"
      unitRef="usd">14700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iece04e5008c1410393b57b628e274295_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIwMTA_5edc47ad-8c74-42e8-bb4d-2d173a319d84"
      unitRef="usd">19400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4451a9390a774709818e6fbfd6084973_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNzc3MA_03913bcf-37a9-4019-9169-e6e7ca8b6926"
      unitRef="usd">24400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="i1d36b97f4bad4698aa59cb3ac9774f0a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIwODQ_f828244a-715e-45cd-aa4b-f091163dea78"
      unitRef="usd">43900000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="i34ac12069b86446385fba11d5714dfa1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIwOTk_b80768a6-ec9c-4495-b13a-661298e64521"
      unitRef="usd">43800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i20988f3b4f3842aca296183226b1191c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIxMTQ_52dfcb23-b1d4-4b6c-8149-5e06f587dfae"
      unitRef="shares">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i76b34857279b4a77ad109619d8a570f6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIxMjc_2a631920-71e0-4a64-a0fe-4dd90ceee7dd"
      unitRef="shares">2000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="iece04e5008c1410393b57b628e274295_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIxNDA_3ee6c425-1083-43a9-9a11-abc0d2c9bfa9"
      unitRef="shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i20988f3b4f3842aca296183226b1191c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIxNTc_585d9b8f-fafc-49d9-b218-f89fed6c6d59"
      unitRef="usd">75000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="iabffd0b7435a46ab8001e51bc9e0f884_I20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIxNzI_a1949b60-0f23-40cb-9e08-4158dbd30836"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="if5c0b15b91a8498db2213d6c5cd2acbd_D20190701-20190731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0NDE4Nw_f8c4d5b0-d4ec-45c1-8525-84d7fab54b0d"
      unitRef="usd">59000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="iabffd0b7435a46ab8001e51bc9e0f884_I20190731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0NDIwMg_8dfd3f7d-2599-4cf6-a410-342d797213a8"
      unitRef="usd">44900000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id813b06cc8204234a74cd25abe6470b0_I20190731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0NDE3Mg_f4b258b8-1dfd-444d-b548-ca3a87f0ff45"
      unitRef="usd">10700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <nvta:BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration
      contextRef="i34ca71f207834945b160a2a860186500_D20190701-20190731"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIxODE_16f66b93-60bc-4b30-a5aa-fae4f9b36048">P2Y</nvta:BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i3849bfee08db4045a8d579e08dc78573_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxOTc1OA_09a573b9-a381-4a0f-9739-794ef9d50c8b"
      unitRef="usd">7100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="iedca751c89a74c22904be3c69b76ea13_D20190701-20190731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0NDIxNw_206fe240-45e1-40fa-abe5-91af36109d83"
      unitRef="shares">200000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="icad31fda692c44d6b3ebd405fc1f5bfb_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIxOTY_f8adfd1c-6835-45d4-aaba-96163eb0e4d1"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i1b7028fd67c14ce39c1a361bf67387ac_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIyMDI_c6160458-bf6e-43e8-92f7-94d7924252a3"
      unitRef="usd">50100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <nvta:BusinessCombinationHoldbackConsiderationCash
      contextRef="i3c0220e1f83a4ee1a04a467bc49d5677_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODc5NjA5MzE0NDIzMA_6d432aaa-9d46-43cc-a9b0-04605cd47f8f"
      unitRef="usd">200000</nvta:BusinessCombinationHoldbackConsiderationCash>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i3c0220e1f83a4ee1a04a467bc49d5677_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIyMTc_1395b1aa-ee84-4edf-add3-0099f07ed2d6"
      unitRef="shares">400000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTQ5MzkxMA_1793b01f-2fb6-46f7-92f2-dca4a4a0c567"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNjU5NzA2OTc5NTIyMA_42e2db35-1811-4308-aa17-02d822fc31ce"
      unitRef="usd">82300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i61df02f3966840fc94c9ac82e9b14a0a_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNjU5NzA2OTc5NTIzNQ_bf959264-4502-49fc-81c9-4238555fd444"
      unitRef="shares">400000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0ODk0MDY_38619b72-2c80-42ee-bb92-3b702ca18264">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the purchase price recorded as a part of the acquisition of Diploid (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hold-back consideration - common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the purchase prices recorded as a part of the acquisition of Genelex and YouScript (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Genelex&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;YouScript&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Cash transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Hold-back consideration - cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Hold-back consideration - common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Common stock transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;13,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;52,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;65,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the purchase price and post-combination expense recorded as a part of the acquisition of ArcherDX (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Post-combination Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration and liabilities incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;935.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,331.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjY4ZGE2ZDA4MWE0YzQ2NDI4ZWFjZDAzZmQxOGU2ODRiL3RhYmxlcmFuZ2U6NjhkYTZkMDgxYTRjNDY0MjhlYWNkMDNmZDE4ZTY4NGJfMS0xLTEtMS01MTI1_8ac677be-59bc-4a25-a055-0f9b220f273d"
      unitRef="usd">32323000</us-gaap:PaymentsToAcquireBusinessesGross>
    <nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned
      contextRef="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjY4ZGE2ZDA4MWE0YzQ2NDI4ZWFjZDAzZmQxOGU2ODRiL3RhYmxlcmFuZ2U6NjhkYTZkMDgxYTRjNDY0MjhlYWNkMDNmZDE4ZTY4NGJfNS0xLTEtMS01MTI1_123eaf67-ae79-4e85-9f67-72821df48591"
      unitRef="usd">7538000</nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjY4ZGE2ZDA4MWE0YzQ2NDI4ZWFjZDAzZmQxOGU2ODRiL3RhYmxlcmFuZ2U6NjhkYTZkMDgxYTRjNDY0MjhlYWNkMDNmZDE4ZTY4NGJfOC0xLTEtMS01MTI1_d7b59757-cc74-4916-8495-db9ffff04fcc"
      unitRef="usd">42453000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjY4ZGE2ZDA4MWE0YzQ2NDI4ZWFjZDAzZmQxOGU2ODRiL3RhYmxlcmFuZ2U6NjhkYTZkMDgxYTRjNDY0MjhlYWNkMDNmZDE4ZTY4NGJfOS0xLTEtMS01MTI1_8f123c05-44e7-44b9-9b47-bb4a00957ded"
      unitRef="usd">82314000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0ODk0MDc_af8b49e3-2974-43d2-9027-bdaaf5d5e8b8">The following table summarizes the fair values of assets acquired and liabilities assumed through our acquisition of Diploid at the date of acquisition (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;The following table summarizes the fair values of assets acquired and liabilities assumed through our acquisitions of Genelex and YouScript at the date of acquisition (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.686%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Genelex&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;YouScript&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;9,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;25,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;34,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;9,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;26,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;35,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(481)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(801)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(2,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;9,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;22,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;32,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;29,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;13,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;52,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;65,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;The following table summarizes the fair values of assets acquired and liabilities assumed through our acquisition of ArcherDX at the date of acquisition (in millions):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;803.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease obligations, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,652.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,331.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfMC0xLTEtMS01MTI3_f70f068a-299d-4991-8f71-4f2d90356a6f"
      unitRef="usd">124000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfMS0xLTEtMS01MTI3_a2e8982f-8cb8-4e7b-baba-65255994c810"
      unitRef="usd">26000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfMi0xLTEtMS01MTI3_88a21806-7865-45b5-8977-9f67330bb383"
      unitRef="usd">41789000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfMy0xLTEtMS01MTI3_10dfa35e-6312-4613-abae-1a91b1dcfbf8"
      unitRef="usd">41939000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfNC0xLTEtMS01MTI3_40c4f159-1876-4c6a-9d11-f62134c9b5c8"
      unitRef="usd">30000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfNy0xLTEtMS01MTI3_214d0aba-bd5a-48fe-93df-53da14896d80"
      unitRef="usd">10250000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfOC0xLTEtMS01MTI3_ffc10ea4-0209-4c02-8c67-c5d2c588b533"
      unitRef="usd">31659000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfOS0xLTEtMS01MTI3_5e9caac7-377a-4cf1-850f-e2a547696ef3"
      unitRef="usd">50655000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjQ1NTM4ZDllOGU0MzQ0YWM5YTExN2FiZDdhZDkwNDgzL3RhYmxlcmFuZ2U6NDU1MzhkOWU4ZTQzNDRhYzlhMTE3YWJkN2FkOTA0ODNfMTAtMS0xLTEtNTEyNw_6d6dec94-b8c5-4260-ace9-5340ccbf60ad"
      unitRef="usd">82314000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIyNDY_5a404369-a821-4ec1-890e-cb778b2199f3">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned
      contextRef="i4ee5f3390cc241feb0a2fa01b8ac699c_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNjU5NzA2OTc5NTQwMw_68f04094-b9f3-4c98-a64f-57af858e59be"
      unitRef="usd">7500000</nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i61df02f3966840fc94c9ac82e9b14a0a_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNjU5NzA2OTc5NTQxNw_7b07fcaa-592b-424b-9dd3-e77c2f03eeb4"
      unitRef="shares">400000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i21aa382eb1b9450d946befd8e9d905ff_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNjU5NzA2OTc5NTQ0Ng_4b8b544b-7e94-4ae5-801f-d96b72342ae2"
      unitRef="usd">17700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:Goodwill
      contextRef="id28b9a63ced0431fa69e448208ef5a4b_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNjU5NzA2OTc5NTQ4NA_62dd449a-db19-4778-b807-27b440b7d065"
      unitRef="usd">50700000</us-gaap:Goodwill>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if78d990dbf00451cac45ceb3bfbb2548_D20200601-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDkzNA_9c72e8ee-2a0c-4227-bd16-2b1c1f2a65a4"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="icf11c41e83954282a4bbb12523482153_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDk0Nw_21ee730e-cdb5-419a-a284-2cb256733881"
      unitRef="usd">3600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDQzNw_6ae02ec5-87db-4b90-9264-033e4963b5f6"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i4fa43003f790492f944ab337f15b503e_I20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDQzNw_700627ad-befd-46f1-bb1d-709d5e99ea67"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDQ0Mw_c35c7f58-3c8c-4796-a168-aced0b05b285"
      unitRef="usd">13200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i920e93e600db4f87ad9b6f58a894b7ed_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDQ1OA_477bc556-fe18-4608-9877-b39642161b24"
      unitRef="shares">100000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDQ3MQ_2ea8511a-d445-47c5-8ada-6471383bd931"
      unitRef="usd">52700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDQ4Ng_304f06a4-7253-402a-aae4-6968b18f1285"
      unitRef="usd">24500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned
      contextRef="id10eb65b4a854730b97cac8b3b292344_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDUwMQ_1901d373-9f30-4be6-9d2d-2e91e47db843"
      unitRef="usd">1400000</nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="id10eb65b4a854730b97cac8b3b292344_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDUxNQ_59616dfe-f4e6-43af-93dd-b1fdb3febb54"
      unitRef="shares">500000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="i0be3804e02eb472fa855c077d75a96ad_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDc2Mg_affbb7a7-6314-4496-b569-36f5f926c888"
      unitRef="usd">1700000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <nvta:BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration
      contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIyNjU_2fad3a18-4b8d-46c0-89f9-e2714a8a5564">P4Y</nvta:BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDgxNA_61048bc4-0e4f-467e-85c8-2d9b39a29dc4"
      unitRef="usd">2000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia4a51d4bcba64524baa8cc419ee0d7bf_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTQ4MDU_453ec194-8e2e-4857-84b0-aee1e82bba53"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMS0xLTEtMS01MTcy_f0697ffb-fe66-4f34-84fd-6f1157c8cf44"
      unitRef="usd">972000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMS0zLTEtMS01MTcy_555049db-ead0-4d38-94b5-b61c43d8ffe3"
      unitRef="usd">24462000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i604983240be1439382d7e6de61b44b46_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMS01LTEtMS01MTcy_eb24617a-b236-4827-89bf-2bfaffc53c43"
      unitRef="usd">25434000</us-gaap:PaymentsToAcquireBusinessesGross>
    <nvta:BusinessCombinationHoldbackConsiderationCash
      contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMi0xLTEtMS01MTcy_f4635147-ce1b-445b-9490-71c8038f7719"
      unitRef="usd">0</nvta:BusinessCombinationHoldbackConsiderationCash>
    <nvta:BusinessCombinationHoldbackConsiderationCash
      contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMi0zLTEtMS01MTcy_d7a1e22b-db7f-466a-b72a-3c3c99daa99b"
      unitRef="usd">1385000</nvta:BusinessCombinationHoldbackConsiderationCash>
    <nvta:BusinessCombinationHoldbackConsiderationCash
      contextRef="i604983240be1439382d7e6de61b44b46_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMi01LTEtMS01MTcy_78e68c35-eb58-43f5-8560-32b65e33e749"
      unitRef="usd">1385000</nvta:BusinessCombinationHoldbackConsiderationCash>
    <nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned
      contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMy0xLTEtMS01MTcy_cbef6272-18b4-44a2-8ec4-7dddaf7d358b"
      unitRef="usd">781000</nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned>
    <nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned
      contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMy0zLTEtMS01MTcy_e830fd79-5da1-4722-8896-a5523ffc3921"
      unitRef="usd">5392000</nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned>
    <nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned
      contextRef="i604983240be1439382d7e6de61b44b46_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfMy01LTEtMS01MTcy_1d535a7e-9862-4908-b718-e46a165c1785"
      unitRef="usd">6173000</nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNC0xLTEtMS01MTcy_bcc0eeca-6857-4388-9cc2-dab92b905737"
      unitRef="usd">1994000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNC0zLTEtMS01MTcy_a59dca21-83c8-4a44-a877-099994b06465"
      unitRef="usd">0</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i604983240be1439382d7e6de61b44b46_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNC01LTEtMS01MTcy_b4e19e29-4d85-42a3-8aee-298bf748d398"
      unitRef="usd">1994000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNS0xLTEtMS01MTcy_8d22f773-615a-4dab-af21-5290b4d10fbd"
      unitRef="usd">9463000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNS0zLTEtMS01MTcy_78e92042-c43c-42bb-9080-24c51da57f30"
      unitRef="usd">21464000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i604983240be1439382d7e6de61b44b46_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNS01LTEtMS01MTcy_506b7b67-737d-466f-a82b-ba9749c828ed"
      unitRef="usd">30927000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNi0xLTEtMS01MTcy_ba8dbec1-93e6-4ca4-a857-d4cc1c04351f"
      unitRef="usd">13210000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNi0zLTEtMS01MTcy_4f10011e-4e4b-4599-8dd3-a32a6cda7448"
      unitRef="usd">52703000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i604983240be1439382d7e6de61b44b46_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmJkNDU0ODYxM2JmMjQ2MWY5YjBhYWVhZWU1MGIwYTJjL3RhYmxlcmFuZ2U6YmQ0NTQ4NjEzYmYyNDYxZjliMGFhZWFlZTUwYjBhMmNfNi01LTEtMS01MTcy_53f4df71-2adb-41c4-87c7-bdf1ec341568"
      unitRef="usd">65913000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMS0xLTEtMS01MTg0_d6ec5e66-3508-480b-b7f1-d8690c27382f"
      unitRef="usd">33000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i4fa43003f790492f944ab337f15b503e_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMS0zLTEtMS01MTg0_0cc7129c-c488-4826-a790-d41e5e0ee2d1"
      unitRef="usd">24000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMS01LTEtMS01MTg0_b91fd91b-c52b-439f-bb32-b3e3cf3034e2"
      unitRef="usd">57000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMi0xLTEtMS01MTg0_c749c45b-bc58-4983-9e0a-314706e140a8"
      unitRef="usd">221000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i4fa43003f790492f944ab337f15b503e_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMi0zLTEtMS01MTg0_df4f8b8e-530d-48e1-8a4a-d00ba8af440e"
      unitRef="usd">56000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMi01LTEtMS01MTg0_1dc0cf75-be5a-4680-8850-02bc6ba5e0f1"
      unitRef="usd">277000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMy0xLTEtMS01MTg0_5f770dd9-d58d-4021-87cb-49c4104eca02"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i4fa43003f790492f944ab337f15b503e_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMy0zLTEtMS01MTg0_0bbaa4ce-edb1-4b72-a1dd-bcea0b2663f2"
      unitRef="usd">70000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMy01LTEtMS01MTg0_5f5169ba-a56b-40b1-b227-375c5e6b5ad7"
      unitRef="usd">70000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset
      contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNC0xLTEtMS01MTg0_1e3c15f1-8cec-4990-b601-d087d373810b"
      unitRef="usd">0</nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset>
    <nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset
      contextRef="i4fa43003f790492f944ab337f15b503e_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNC0zLTEtMS01MTg0_47b6c167-6e49-47e0-8375-5f73edeaa126"
      unitRef="usd">355000</nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset>
    <nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset
      contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNC01LTEtMS01MTg0_196c5f9c-0696-4742-a94f-80f02d0b0b19"
      unitRef="usd">355000</nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNS0xLTEtMS01MTg0_56d36420-3775-4dcb-95ac-01c45dc358cb"
      unitRef="usd">9209000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i4fa43003f790492f944ab337f15b503e_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNS0zLTEtMS01MTg0_4132ffaa-e84c-4006-8cd8-8328f5b031b9"
      unitRef="usd">25716000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNS01LTEtMS01MTg0_b90b0bd2-9290-457d-bbc0-bf287d974f55"
      unitRef="usd">34925000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNi0xLTEtMS01MTg0_5a72454a-e3ed-42f9-a60e-f5aa7267506c"
      unitRef="usd">9463000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i4fa43003f790492f944ab337f15b503e_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNi0zLTEtMS01MTg0_05ebe67c-81fc-4e20-a7e9-a6a329701d60"
      unitRef="usd">26221000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNi01LTEtMS01MTg0_e5c4d625-a8a7-477b-a93d-a101fe53fc8d"
      unitRef="usd">35684000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNy0xLTEtMS01MTg0_a1dc3ecb-c590-4a1c-a05b-f470c9a0b30e"
      unitRef="usd">320000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i4fa43003f790492f944ab337f15b503e_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNy0zLTEtMS01MTg0_1a8bc807-ec76-4f1f-a346-5b1236ed2de3"
      unitRef="usd">481000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfNy01LTEtMS01MTg0_412ff45b-41d2-4d14-a849-95560ea94785"
      unitRef="usd">801000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfOC0xLTEtMS01MTg0_2588f4fb-1b78-4584-8f25-b1e6ca026b88"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i4fa43003f790492f944ab337f15b503e_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfOC0zLTEtMS01MTg0_fa38c7f6-4ab4-498d-a6ae-763444eff31d"
      unitRef="usd">2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfOC01LTEtMS01MTg0_6d3f0492-ee0f-45c4-8964-fde9ecefad19"
      unitRef="usd">2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfOS0xLTEtMS01MTg0_06b3336c-f55a-4815-a7b6-9de72d7c54fb"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i4fa43003f790492f944ab337f15b503e_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfOS0zLTEtMS01MTg0_d8a22697-4c41-4d74-8b31-701d25c9aab3"
      unitRef="usd">163000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfOS01LTEtMS01MTg0_37b05ef0-4b61-4acb-8f92-26272ae49488"
      unitRef="usd">163000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTAtMS0xLTEtNTE4NA_646457d4-b38a-4020-b53c-7577284885dc"
      unitRef="usd">9143000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i4fa43003f790492f944ab337f15b503e_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTAtMy0xLTEtNTE4NA_56737638-75b1-4b56-bfe6-f142374bf9fa"
      unitRef="usd">22977000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTAtNS0xLTEtNTE4NA_81cc4863-5896-47d8-8cc5-1d76e8beeaa4"
      unitRef="usd">32120000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTEtMS0xLTEtNTE4NA_2f4732d5-bf8e-43cb-88b0-b84b2c2b9cdb"
      unitRef="usd">4067000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4fa43003f790492f944ab337f15b503e_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTEtMy0xLTEtNTE4NA_01dcd8ff-d82c-4444-bdf4-7fa8260a2526"
      unitRef="usd">29726000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTEtNS0xLTEtNTE4NA_1e212163-9891-485d-a4fc-f9d8d0eac711"
      unitRef="usd">33793000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTItMS0xLTEtNTE4NA_183269b6-b8ec-4041-b4d2-d2f75c1602f7"
      unitRef="usd">13210000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i4fa43003f790492f944ab337f15b503e_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTItMy0xLTEtNTE4NA_83dcf327-9f0e-4cc7-8e3d-206c1e011954"
      unitRef="usd">52703000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmFjODg0NDgwZjUzZDQ3NzI4MWU0OGJiMTdmZjA3Y2IxL3RhYmxlcmFuZ2U6YWM4ODQ0ODBmNTNkNDc3MjgxZTQ4YmIxN2ZmMDdjYjFfMTItNS0xLTEtNTE4NA_b6edb8fe-dcfb-443a-8843-14e4d25633c6"
      unitRef="usd">65913000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i789e429a48a04385b75f1ec46013e2d9_D20200401-20200430"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIyOTU_0c2fd3aa-2d9a-48c4-ba73-ae862b42494f">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i676f0eb471b748259508b1b9576c5e17_D20200401-20200430"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIyOTU_263b0ca8-61bd-482c-908d-84e2ba5b4d44">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned
      contextRef="i49c0120db25348e6a3ad6bfc5753b6e0_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDg0MA_e322bb55-423b-4de1-bce1-918e42585fd1"
      unitRef="usd">6200000</nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned>
    <nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned
      contextRef="i376851875deb457fb8f3344dfc678b71_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDg3NQ_541d1684-24be-46a7-9d06-b36aa562c113"
      unitRef="usd">21600000</nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned>
    <us-gaap:Goodwill
      contextRef="iaee9d8368b47462ebefed8a888e444ac_I20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDg5MQ_1484c7e0-292d-42d5-9016-02989d2f7de1"
      unitRef="usd">33800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4fa43003f790492f944ab337f15b503e_I20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUxNDkwNg_245d7b85-0265-44ea-8ea3-61975678513c"
      unitRef="usd">29700000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i098aab9e153f4c929328dfcb7cfaab20_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg1MDE1MTM_73590a08-1ff0-4ab2-bc10-3dbd32103aee"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIzNDU_2f5eede4-a9d1-4ce1-b7a0-5c424694b721"
      unitRef="usd">2300000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIzNTk_dcf5c004-8850-4cc0-837f-79ac2eda9958"
      unitRef="usd">2000000000.0</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTk0NTQ_c6698012-1564-49a2-842d-776b15029f0c"
      unitRef="usd">2000000.0</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="i76b9ebec35b749d1bea22642506ec50a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIzNzM_d7439e10-0d9d-4d53-84d9-7e68da129056"
      unitRef="usd">20900000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i96044be6fb014778a5e4a8af9e0dfbbb_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTIzODg_e44bc393-b71b-483b-8dc5-47402f33c7a9"
      unitRef="usd">945200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyNTQwOQ_8283acc9-d6c7-4e02-83c5-d1694f51ea3c"
      unitRef="usd">933600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ifd1c00bbb2f5471097e760d29754a813_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyNTA5OA_85baadb8-8727-4adc-b2cd-0c8e92233376"
      unitRef="usd">11600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyNTA4Mg_e890d1f0-d576-4bf9-bc5a-e483260466ed"
      unitRef="usd">933600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0bf4bd068321410598134af3a04bf469_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjMwODk3NDQzMDYyOTI_7d979805-3eb9-4c96-a9f1-7d2fc9725eec"
      unitRef="usd">925100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <nvta:BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration
      contextRef="ia4c5e282814b430c8949b3e79a822850_D20201001-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjMwODk3NDQzMDYzMDY_82ff7ebf-8a51-4ad3-992e-dc1ccae79163">P2Y</nvta:BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i19caca01816142a3b5b28f51ca27894b_D20201101-20201130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODI0NjMzNzMzNDQwOQ_2f4e881f-807a-45c6-8ccd-412cae29b2b5"
      unitRef="shares">5000000.0</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i19caca01816142a3b5b28f51ca27894b_D20201101-20201130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyMTg2NQ_25c92ca2-3dba-41d1-ada9-c9586481f62a"
      unitRef="usd">1900000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i19caca01816142a3b5b28f51ca27894b_D20201101-20201130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTk0Njg_88d72c77-a916-4ff7-b134-ae4122bd940c"
      unitRef="usd">40600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i76b9ebec35b749d1bea22642506ec50a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjMwODk3NDQzMDYzMjQ_e4daa41b-6069-4ff0-8d91-e37a3c21c499"
      unitRef="usd">788300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized
      contextRef="i911717b1170c40cf972400c897d04ea0_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjMwODk3NDQzMDYzMzk_7edcebee-1b2a-4f4c-a0e5-5825b6f212ca"
      unitRef="usd">125800000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ifd1c00bbb2f5471097e760d29754a813_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyNTE4Mw_731a10ae-e44a-485d-b97a-bd7e78743712"
      unitRef="usd">11600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="if97a189b033643b79b8524895f6a78c7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODI0NjMzNzMzNDQzOA_76fa3f38-7c0b-4041-890b-4257edf01d71"
      unitRef="usd">16200000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="if97a189b033643b79b8524895f6a78c7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfODI0NjMzNzMzNDQ1Mw_809b6657-2ebc-4d13-a66f-a41bc55fd503"
      unitRef="usd">-24800000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfMS0xLTEtMS01NjUz_2f4ab856-e350-470e-baff-c0dd416cf0c2"
      unitRef="usd">335300000</us-gaap:PaymentsToAcquireBusinessesGross>
    <nvta:BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred
      contextRef="i911717b1170c40cf972400c897d04ea0_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfMS0zLTEtMS01NjM4_94c575a3-7520-4d4b-a72d-7067a47acb7b"
      unitRef="usd">22500000</nvta:BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred>
    <nvta:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred
      contextRef="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfNS0xLTEtMS01NjUz_301183a9-df56-4af5-b9b6-55598aa0a246"
      unitRef="usd">935600000</nvta:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred>
    <nvta:BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration
      contextRef="i911717b1170c40cf972400c897d04ea0_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfNS0zLTEtMS01NjQw_c09eb0fa-1f43-4ea6-9b01-c076eba48d46"
      unitRef="usd">12300000</nvta:BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfOC0xLTEtMS01NjUz_bad7f46d-b6d8-46a7-b16d-550942af69fd"
      unitRef="usd">1060600000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <nvta:BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred
      contextRef="i911717b1170c40cf972400c897d04ea0_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfOC0zLTEtMS01NjQy_0d5f9925-b627-4ac3-9573-8401dcd9c7ce"
      unitRef="usd">91000000.0</nvta:BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfOS0xLTEtMS01NjUz_d008ba40-87b1-4b82-a54a-f67861e091f4"
      unitRef="usd">2331500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized
      contextRef="i911717b1170c40cf972400c897d04ea0_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmE2MmEwODEyMjRkMTRhY2JiMGVjMzg4OTg1Mjc1MTRlL3RhYmxlcmFuZ2U6YTYyYTA4MTIyNGQxNGFjYmIwZWMzODg5ODUyNzUxNGVfOS0zLTEtMS01NjMz_3aa5f2c7-f8ba-48ee-a7c8-aa39b5a23640"
      unitRef="usd">125800000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMC0xLTEtMS01NjYw_7c5625af-726b-4455-8af8-d973ec14f975"
      unitRef="usd">9100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMS0xLTEtMS01NjYy_df564a71-6db5-4cae-a417-763dbc7f3f80"
      unitRef="usd">12100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMi0xLTEtMS05NjUz_7284adee-5277-4aae-aa90-8039a371c457"
      unitRef="usd">17600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMi0xLTEtMS01NjYy_6053838a-3eeb-4783-99ce-de691ca60963"
      unitRef="usd">6800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMy0xLTEtMS01NjYy_df97445a-c203-4cb8-a813-66cfaf013bf7"
      unitRef="usd">17100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfNC0xLTEtMS01NjYy_e538d7f6-8801-4811-b57e-262f130a7651"
      unitRef="usd">7900000</nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfNS0xLTEtMS01NjYy_a327810b-653a-42d2-a929-f3c7af5d90ee"
      unitRef="usd">803800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfNi0xLTEtMS01NjYy_ceed9a68-fe12-42cc-a1ae-ecf5c54c953f"
      unitRef="usd">700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfNy0xLTEtMS01NjYy_6573bb38-9087-41a0-ae7b-5cef4ec9ebc8"
      unitRef="usd">875100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfOC0xLTEtMS01NjYy_f223a566-6422-41fc-be91-2fac97e0bd1b"
      unitRef="usd">4600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfOS0xLTEtMS01NjYy_aee1c715-df19-4ceb-95c1-931d4aafa107"
      unitRef="usd">18000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMTAtMS0xLTEtNTY2Mg_a07bcdbe-52b6-4802-a781-c49aa9d75e98"
      unitRef="usd">1300000</nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease>
    <nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMTEtMS0xLTEtNTY2Mg_4daf6f09-bd7c-47d3-a0f2-ac16ae66bd28"
      unitRef="usd">7400000</nvta:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMTItMS0xLTEtNTY2Mg_2ad72c87-7d67-4d42-bcc4-c0b01efff641"
      unitRef="usd">151100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMTMtMS0xLTEtNTY2Mg_68975849-14bb-4d13-b9ec-0061b2e2bd7f"
      unitRef="usd">13600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMTQtMS0xLTEtNTY2Mg_baa7cb05-db8f-4f83-82a7-185079502819"
      unitRef="usd">679100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMTUtMS0xLTEtNTY2Mg_07565703-4e3c-4334-8a06-32e5180c349f"
      unitRef="usd">1652400000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOmM0NDMyMjhhMjZiNjRiMzc4ZjhiNDk3MTNhMDRlNzczL3RhYmxlcmFuZ2U6YzQ0MzIyOGEyNmI2NGIzNzhmOGI0OTcxM2EwNGU3NzNfMTYtMS0xLTEtNTY2Mg_6e20341c-b747-4676-9c3e-9f607dd34e2c"
      unitRef="usd">2331500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjMwODk3NDQzMDYzNTQ_750e933a-a9f7-49ac-a721-17131ab4e9a6">The fair value of our intangible assets acquired as of the acquisition date and the method used to value these assets as well as the estimated economic lives for amortizable intangible assets were as follows (in millions, except estimated useful life which is in years):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;With-and-without&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Relief from royalty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;233.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Multi-period excess earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right to develop new technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;512.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Multi-period excess earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Not applicable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;803.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i0c4c49beaa8748e88bf241eeb61857e2_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfMi0xLTEtMS01NzA3_38f35958-6ec2-472f-b478-4c25249906c4"
      unitRef="usd">17300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i22c6518824a44e32968c6279d316dbfe_D20201001-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfMi0zLTEtMS01NzI4_02578a7d-8af1-4532-835e-217413a802f4">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4ba4d5c315834206a2dfed011b842a81_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfMy0xLTEtMS01NzA3_6bed121e-a2b8-4a7f-a31a-6735dc3dcd67"
      unitRef="usd">21100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i4faeb825368e4fbebb63eb99ebd16fe1_D20201001-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfMy0zLTEtMS01NzI4_8dda886f-722d-42ba-9a49-f0b6666c9928">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i50a8e75f54fb41df880dd13c66ec40f7_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfNS0xLTEtMS01NzA5_100c3d00-9740-47ed-a2a0-e46783d883e7"
      unitRef="usd">233600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ic1faba8c669949feb0448beb8f5f7f73_D20201001-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfNS0zLTEtMS01NzMw_f8f8621e-620e-4b04-90e8-00be43eebddd">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7afe4132b22c414b94a24036e21c8d41_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfNi0xLTEtMS01NzA5_b5e434db-6b61-487f-92b3-088f1d7fbe36"
      unitRef="usd">19400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="id04b1d5d7d6f42a7972c2a960edf12fa_D20201001-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfNi0zLTEtMS01NzMw_55bfed21-b344-407f-a5c7-29aba99c5812">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i7cba339628964b39a0875938b2811685_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfOS0xLTEtMS05NjU3_1ae51fe6-eef6-487d-aa4e-0322e7d3463b"
      unitRef="usd">512400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjE0ZTUyNzBmYTc4ZDRlZjg5OWQ2ZDRlNTFiMWZmN2UwL3RhYmxlcmFuZ2U6MTRlNTI3MGZhNzhkNGVmODk5ZDZkNGU1MWIxZmY3ZTBfOS0xLTEtMS01NzE0_e064c51c-3663-4963-82b2-9cfe8fc9a5d2"
      unitRef="usd">803800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyNjU1Ng_d984cb6f-3b22-4b46-9e35-50e63e7b13d7"
      unitRef="usd">1700000000</us-gaap:Goodwill>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i43a9b372cb9d4068a0c794bfc92b1120_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjMwODk3NDQzMDYzODU_18880448-7f0b-4378-820c-35931f829e1e"
      unitRef="usd">-109500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="i2ec5a50099674bd6ac444d2cb1bfa1f3_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTM2ODU_cba5ed86-ca8d-4507-a73f-04460c117031"
      unitRef="usd">112200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if97a189b033643b79b8524895f6a78c7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyMzgzOA_973cd8f6-6ae4-4d08-af83-08ad4cc7d0c4"
      unitRef="usd">41200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
      contextRef="if97a189b033643b79b8524895f6a78c7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfNzY5NjU4MTUyMzg1Mw_6c70ba7a-2687-4736-9e06-97744f21e0b5"
      unitRef="usd">2100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="icb5b3faf92304625a507c157ed44ca8f_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjMwODk3NDQzMDYzNTc_254b2516-c0b9-42cf-bf95-a4beddb60b7d"
      unitRef="shares">26300000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RleHRyZWdpb246M2I3YmRkMzEyZDZiNDNhMmI2NjQxMDAwN2M1OTNjNDVfMjI1Mzk5ODg0OTI0Njc_140ab068-6ce4-4221-ba98-4c8aa0a88a5c">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following unaudited pro forma financial information is for informational purposes only and is not necessarily indicative of the results of operations that would have been achieved as if the acquisition had taken place as of January 1, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.852%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(685,589)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(355,818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjEzZmFmMTI3ZTE2YzQ2NDc4OWZmZTk0N2ZhNDQ2MWNiL3RhYmxlcmFuZ2U6MTNmYWYxMjdlMTZjNDY0Nzg5ZmZlOTQ3ZmE0NDYxY2JfMy02LTEtMS01NjE0_0cf3af81-39df-45d4-8bae-9e66c3fe4d23"
      unitRef="usd">327233000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjEzZmFmMTI3ZTE2YzQ2NDc4OWZmZTk0N2ZhNDQ2MWNiL3RhYmxlcmFuZ2U6MTNmYWYxMjdlMTZjNDY0Nzg5ZmZlOTQ3ZmE0NDYxY2JfMy0xMi0xLTEtNTYwMA_6f469a6c-b3bc-4cac-95e1-49f7b379cf11"
      unitRef="usd">267389000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjEzZmFmMTI3ZTE2YzQ2NDc4OWZmZTk0N2ZhNDQ2MWNiL3RhYmxlcmFuZ2U6MTNmYWYxMjdlMTZjNDY0Nzg5ZmZlOTQ3ZmE0NDYxY2JfNC02LTEtMS01NjE0_e4f46bf2-2b8b-4829-b65a-b15d137c8391"
      unitRef="usd">-685589000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV84NS9mcmFnOjNiN2JkZDMxMmQ2YjQzYTJiNjY0MTAwMDdjNTkzYzQ1L3RhYmxlOjEzZmFmMTI3ZTE2YzQ2NDc4OWZmZTk0N2ZhNDQ2MWNiL3RhYmxlcmFuZ2U6MTNmYWYxMjdlMTZjNDY0Nzg5ZmZlOTQ3ZmE0NDYxY2JfNC0xMi0xLTEtNTYwMA_cd6db01f-28db-459c-82ee-6cd89bd58e68"
      unitRef="usd">-355818000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMTIzMQ_3e730e1d-0449-4cf5-9e4c-eba61c081c0e">Goodwill and intangible assets&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amounts of goodwill were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired - Diploid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired - Genelex&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired - YouScript&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired - ArcherDX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,652,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,863,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents details of our acquired intangible assets as of December&#160;31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Useful Life&lt;br/&gt;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Estimated Remaining&lt;br/&gt;Useful Life&lt;br/&gt;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patent licensing agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right to develop new technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquisition-related intangibles included in the above table are finite-lived, other than in-process research and development which has an indefinite life, and are carried at cost less accumulated amortization. Customer relationships related to our 2017 business combinations are being amortized on an accelerated basis, in proportion to estimated cash flows. All other finite-lived acquisition-related intangibles are being amortized on a straight-line basis over their estimated lives, which approximates the pattern in which the economic benefits of the intangible assets are expected to be realized. Amortization expense was $26.6 million, $7.7 million, and $5.0 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. Intangible assets are carried at cost less accumulated amortization. Amortization expense is recorded to cost of revenue, research and development, sales and marketing and general and administrative expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our estimated future amortization expense of intangible assets with finite lives as of December&#160;31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total estimated future amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;In December 2020, we entered into an agreement to acquire technology focused on informing clinical decisions for $2.9&#160;million. We accounted for this transaction as an asset acquisition of developed technology which will be amortized over eight years, initially to research and development expense. In connection with this transaction, we granted approximately $6.2&#160;million of RSUs under our 2015 Stock Incentive Plan as inducement awards to new employees who joined Invitae. These RSUs are time-based and vest in two equal installments in December 2021 and December 2022, subject to the employee's continued service with us. For $5.4&#160;million of these awards, the number of awards granted are based on the lower of the 20-day volume weighted-average share price prior to the vesting date and the date of close, both with a fixed dollar value, and therefore, these RSUs are liability-classified and the fair value is estimated at each reporting period based on the number of shares that are expected to be issued at each reporting date and our closing stock price, which combined are categorized as Level 3 inputs. Therefore, fair value of these RSUs and the number of shares to be issued will not be fixed until the awards vest. During the year ended December&#160;31, 2020, we recorded research and development stock-based compensation expense of $0.2&#160;million related to the RSUs based on an estimated issuance of 0.1&#160;million shares</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMTIzOA_432750f5-7b7c-4e1f-bc5f-d56ebd9f1b88">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amounts of goodwill were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired - Diploid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired - Genelex&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired - YouScript&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired - ArcherDX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,652,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,863,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjllMDJjOTkwZmQzMTRkNzM5OWY1YTMxMjk1ZDgzM2E3L3RhYmxlcmFuZ2U6OWUwMmM5OTBmZDMxNGQ3Mzk5ZjVhMzEyOTVkODMzYTdfMC0yLTEtMS0w_d48f57a6-39cf-4def-a16c-c469cfb53b99"
      unitRef="usd">126777000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic716b0d977014b47953f608abb21ee07_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjllMDJjOTkwZmQzMTRkNzM5OWY1YTMxMjk1ZDgzM2E3L3RhYmxlcmFuZ2U6OWUwMmM5OTBmZDMxNGQ3Mzk5ZjVhMzEyOTVkODMzYTdfMS0yLTEtMS0w_e12d35b2-64dd-41f1-96ac-2ed5701039e9"
      unitRef="usd">50655000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i46f04de7671548948145a3408339daf3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjllMDJjOTkwZmQzMTRkNzM5OWY1YTMxMjk1ZDgzM2E3L3RhYmxlcmFuZ2U6OWUwMmM5OTBmZDMxNGQ3Mzk5ZjVhMzEyOTVkODMzYTdfMi0yLTEtMS0w_0f58342e-78c6-41ef-bd65-13c695f7fbf8"
      unitRef="usd">4067000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia1859f563a61401391afb23698e3d1f0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjllMDJjOTkwZmQzMTRkNzM5OWY1YTMxMjk1ZDgzM2E3L3RhYmxlcmFuZ2U6OWUwMmM5OTBmZDMxNGQ3Mzk5ZjVhMzEyOTVkODMzYTdfMy0yLTEtMS0w_4013f279-5f0d-46a5-83e5-72aeeafa8180"
      unitRef="usd">29726000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="if97a189b033643b79b8524895f6a78c7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjllMDJjOTkwZmQzMTRkNzM5OWY1YTMxMjk1ZDgzM2E3L3RhYmxlcmFuZ2U6OWUwMmM5OTBmZDMxNGQ3Mzk5ZjVhMzEyOTVkODMzYTdfNC0yLTEtMS02NDA4_6b951784-410c-4aec-825a-20438faafd66"
      unitRef="usd">1652398000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjllMDJjOTkwZmQzMTRkNzM5OWY1YTMxMjk1ZDgzM2E3L3RhYmxlcmFuZ2U6OWUwMmM5OTBmZDMxNGQ3Mzk5ZjVhMzEyOTVkODMzYTdfNC0yLTEtMS0w_c4a52ef3-584c-4f49-b054-bb84e2e94f4e"
      unitRef="usd">1863623000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMTIzMw_94991eff-b93d-4825-a365-fd74836a3e4b">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents details of our acquired intangible assets as of December&#160;31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Useful Life&lt;br/&gt;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Estimated Remaining&lt;br/&gt;Useful Life&lt;br/&gt;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patent licensing agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right to develop new technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMTIzNQ_1dabd06c-238b-4fc0-900f-ffcd07af49ad">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents details of our acquired intangible assets as of December&#160;31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Useful Life&lt;br/&gt;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Estimated Remaining&lt;br/&gt;Useful Life&lt;br/&gt;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patent licensing agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right to develop new technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i185c1e74a04443a291a72f01a6c8a9f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMS0xLTEtMS0w_1b44e1f9-70b0-455f-95c1-7940a63b5bdb"
      unitRef="usd">41075000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i185c1e74a04443a291a72f01a6c8a9f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMS0zLTEtMS0w_bf14e2ae-c403-40e3-8bdb-de8efb964477"
      unitRef="usd">8292000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i185c1e74a04443a291a72f01a6c8a9f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMS01LTEtMS0w_0e1269c9-7150-4641-8a1c-01326f809cc8"
      unitRef="usd">32783000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i214eccad6a7f4c09b2611b0dd7b962db_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMS03LTEtMS0w_e0b8c0ae-6771-4e90-8c02-fe3a133a71f7">P10Y9M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i214eccad6a7f4c09b2611b0dd7b962db_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMS05LTEtMS0w_d1b49730-6125-4893-abc4-d9cdc2348963">P8Y9M18D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5869dcd08fba40eaad37b756d9760bb6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMi0xLTEtMS0w_377d13f1-7173-4886-8a8a-6508f3300fa2"
      unitRef="usd">397563000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5869dcd08fba40eaad37b756d9760bb6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMi0zLTEtMS0w_305a6c6d-e1d6-431c-aca4-9f90072d6fb5"
      unitRef="usd">31013000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5869dcd08fba40eaad37b756d9760bb6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMi01LTEtMS0w_57c491e9-b764-498b-9b68-945811926436"
      unitRef="usd">366550000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3a9ae61cda6d4c61b9b7cbc0b7d88e7d_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMi03LTEtMS0w_8ba9f34a-8954-4066-aa42-9c53c2559002">P10Y7M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i3a9ae61cda6d4c61b9b7cbc0b7d88e7d_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMi05LTEtMS0w_d31df23a-cafc-43a4-983f-6f9d6d2dc4f3">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i44f6002ca8f94affa0c1cb580edec0ab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMy0xLTEtMS0w_a5889750-5f10-4299-b9cc-794c9e8b5a64"
      unitRef="usd">286000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i44f6002ca8f94affa0c1cb580edec0ab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMy0zLTEtMS0w_0da6e824-1842-448a-85b3-d37680f09df4"
      unitRef="usd">229000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i44f6002ca8f94affa0c1cb580edec0ab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMy01LTEtMS0w_4f576856-c0de-4447-9fb6-fecf90d1db1b"
      unitRef="usd">57000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic9b892712a0a4fdc91399aedf309b228_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMy03LTEtMS0w_ab8d651a-be64-450c-bc2f-37a98fd056a5">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ic9b892712a0a4fdc91399aedf309b228_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfMy05LTEtMS0w_4e21d5db-7e43-4ea1-ac4e-a30cd97e2b7a">P1Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iad65ac656fd04a3d9861477f940eb9ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNC0xLTEtMS0w_4cd92206-b064-4fca-a5e7-5f1d84f29eb8"
      unitRef="usd">21085000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iad65ac656fd04a3d9861477f940eb9ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNC0zLTEtMS0w_b953a89f-6a80-4a88-aff1-7637199171d5"
      unitRef="usd">447000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iad65ac656fd04a3d9861477f940eb9ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNC01LTEtMS0w_967294e4-eb5f-4e45-843a-be1355425df8"
      unitRef="usd">20638000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i20ab20c5638141578c0fa5ed16421662_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNC03LTEtMS0w_e03d9d76-1d91-41b2-928c-015e1ec6a059">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i20ab20c5638141578c0fa5ed16421662_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNC05LTEtMS0w_81d13129-98d1-4a3c-8e06-4d5063e1a46c">P11Y9M18D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4b08ae6f22a34f9ca4efcdd7622c90b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNS0xLTEtMS0w_7fdbfcbe-b2c7-4439-ad05-8b6d2400e79f"
      unitRef="usd">496000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4b08ae6f22a34f9ca4efcdd7622c90b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNS0zLTEtMS0w_384cfc09-c907-4206-a0e0-9c56b3b1091f"
      unitRef="usd">103000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4b08ae6f22a34f9ca4efcdd7622c90b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNS01LTEtMS0w_be899d2e-0de2-4c37-83c3-8bf2fcfd2eab"
      unitRef="usd">393000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i1145d52e94e041bc8011849883eb468c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNS03LTEtMS0w_06c785fb-5d79-4a58-bd87-9cdd92f02b65">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i1145d52e94e041bc8011849883eb468c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNS05LTEtMS0w_cffa7acc-aef2-4474-b061-f7c646959418">P11Y10M24D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i83741d505a5c43ce85ad0ffbef5d30fa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNy0xLTEtMS02NDEw_0133fe5f-418e-48b9-a922-036c7a566b32"
      unitRef="usd">19359000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i83741d505a5c43ce85ad0ffbef5d30fa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNy0zLTEtMS02NDEw_3d2a7758-7dac-4cb0-bbc5-0fca989b9784"
      unitRef="usd">323000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i83741d505a5c43ce85ad0ffbef5d30fa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNy01LTEtMS02NDEw_6145e2b0-6883-4d3b-8fd1-e8c947d9c48b"
      unitRef="usd">19036000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id489f9ef13794b19800824a2e713d3e3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNy03LTEtMS02NDEw_89aade1e-a311-4e88-bfc2-9dbb407a0d2c">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="id489f9ef13794b19800824a2e713d3e3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNy05LTEtMS02NDEw_37aaa978-31d1-421b-90b6-3ba5f5c1e611">P14Y9M18D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i76054c8277e34b278fb7cb28ef0095cc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNy0xLTEtMS0w_ced0d926-6aaa-466a-a31d-2e69f974313e"
      unitRef="usd">542388000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i76054c8277e34b278fb7cb28ef0095cc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfNy01LTEtMS0w_38fa7032-f428-440c-81c4-f8bd6c1c5a79"
      unitRef="usd">542388000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfOC0xLTEtMS0w_741de547-d5ba-4792-92a5-9963d9e1e6fc"
      unitRef="usd">1022252000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfOC0zLTEtMS0w_533b4c81-f873-4a92-abe3-b7db05f5fdc0"
      unitRef="usd">40407000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfOC01LTEtMS0w_97be604d-1128-43ab-8680-affe14cfb8a9"
      unitRef="usd">981845000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfOC03LTEtMS0w_a640d668-e8e5-4abd-9537-c77150aef77d">P10Y10M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOjczZjY1OThjNTM0ZDQzNDQ4ZDY2YTFkNjljMmJmOTRkL3RhYmxlcmFuZ2U6NzNmNjU5OGM1MzRkNDM0NDhkNjZhMWQ2OWMyYmY5NGRfOC05LTEtMS0w_a55c7041-5d97-4529-aa8f-5a2ab044b998">P10Y2M12D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfODE4_4648543f-8935-495b-b0a4-c1a6bfba38ac"
      unitRef="usd">26600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfODIy_3d13393b-6632-43e2-b8aa-5d668055cff3"
      unitRef="usd">7700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfODMw_d6559bbd-c48f-4227-a8b2-ab1bb7006429"
      unitRef="usd">5000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMTIzNg_ef35588c-714f-4784-9285-8d596e2f0155">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our estimated future amortization expense of intangible assets with finite lives as of December&#160;31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total estimated future amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOmVjMWUyZTRiZDFhODQ2YWJhODZmYWE3MzAyZDQ5MzI1L3RhYmxlcmFuZ2U6ZWMxZTJlNGJkMWE4NDZhYmE4NmZhYTczMDJkNDkzMjVfMS0xLTEtMS0w_1a6ca23c-6892-432a-864e-3bc515dafbf9"
      unitRef="usd">46910000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOmVjMWUyZTRiZDFhODQ2YWJhODZmYWE3MzAyZDQ5MzI1L3RhYmxlcmFuZ2U6ZWMxZTJlNGJkMWE4NDZhYmE4NmZhYTczMDJkNDkzMjVfMi0xLTEtMS0w_30652820-0f92-4f86-8e81-92031204bdf7"
      unitRef="usd">45401000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOmVjMWUyZTRiZDFhODQ2YWJhODZmYWE3MzAyZDQ5MzI1L3RhYmxlcmFuZ2U6ZWMxZTJlNGJkMWE4NDZhYmE4NmZhYTczMDJkNDkzMjVfMy0xLTEtMS0w_9adae2b2-b044-41e0-be7e-7691cba60d8c"
      unitRef="usd">44388000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOmVjMWUyZTRiZDFhODQ2YWJhODZmYWE3MzAyZDQ5MzI1L3RhYmxlcmFuZ2U6ZWMxZTJlNGJkMWE4NDZhYmE4NmZhYTczMDJkNDkzMjVfNC0xLTEtMS0w_9361201a-2847-44cf-be11-a03389505090"
      unitRef="usd">44110000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOmVjMWUyZTRiZDFhODQ2YWJhODZmYWE3MzAyZDQ5MzI1L3RhYmxlcmFuZ2U6ZWMxZTJlNGJkMWE4NDZhYmE4NmZhYTczMDJkNDkzMjVfNS0xLTEtMS0w_a2d5e751-176a-4b03-acd4-1b85e6a75658"
      unitRef="usd">42356000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOmVjMWUyZTRiZDFhODQ2YWJhODZmYWE3MzAyZDQ5MzI1L3RhYmxlcmFuZ2U6ZWMxZTJlNGJkMWE4NDZhYmE4NmZhYTczMDJkNDkzMjVfNi0xLTEtMS0w_c33bbf56-63f3-4be8-b18d-031b2721ce7f"
      unitRef="usd">216292000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RhYmxlOmVjMWUyZTRiZDFhODQ2YWJhODZmYWE3MzAyZDQ5MzI1L3RhYmxlcmFuZ2U6ZWMxZTJlNGJkMWE4NDZhYmE4NmZhYTczMDJkNDkzMjVfNy0xLTEtMS0w_a30cce73-51dc-47ca-843b-75c2fc299a2d"
      unitRef="usd">439457000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i8bfd608ebc2f4679bbacfd7c6509b051_D20201201-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMjI1Mzk5ODgzNzc2OTA_d5af08b9-883f-4b7f-9ca0-7dd645f59f2f"
      unitRef="usd">2900000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i8bfd608ebc2f4679bbacfd7c6509b051_D20201201-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMjI1Mzk5ODgzNzc5NjI_25091855-4609-4516-b40b-aff4578d1510">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="i92c98fa4920d4181bdc4e4ebafa5d57d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMjI1Mzk5ODgzNzc3MDQ_4fc418d1-9190-4fc3-b2db-d3e1bdecd5e7"
      unitRef="usd">6200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if61da7ae894b44d3a17390db3eb337f9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfNzY5NjU4MTQwMzA3OQ_67eab045-a679-496e-9aa0-2bb6a69eed06"
      unitRef="usd">5400000</us-gaap:LiabilitiesFairValueDisclosure>
    <nvta:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays
      contextRef="i67b31cc1f5c4428988fc99230afca7da_D20201201-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfMjI1Mzk5ODgzNzc3MTg_bebd411f-09bf-435a-bb1e-4806d0fbb5f9"
      unitRef="tradingday">20</nvta:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iae69da4291404d09846bdd7eea1b3df7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfNzY5NjU4MTQwMzA1Mg_68558529-6524-40e7-baa6-04e3a2799a5b"
      unitRef="usd">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iae69da4291404d09846bdd7eea1b3df7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85MS9mcmFnOmY3YjgzZmFjNTU3MTQxNjM5MDRhNzBlYmZlZjhlNjY2L3RleHRyZWdpb246ZjdiODNmYWM1NTcxNDE2MzkwNGE3MGViZmVmOGU2NjZfNzY5NjU4MTQwMzA2Ng_37fa8a21-b215-4ba8-a546-a9c5d91208c2"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RleHRyZWdpb246Y2Y4NjAzNzcyMWQyNDAzNmEwYjA0OTIyNjFiMjVkYTZfNDA1_65fec449-6771-47d7-a27e-dc534ffd8266">Balance sheet components&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Automobiles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $10.5 million, $7.1 million and $8.5 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and other liabilities associated with business combinations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and other liabilities associated with business combinations, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RleHRyZWdpb246Y2Y4NjAzNzcyMWQyNDAzNmEwYjA0OTIyNjFiMjVkYTZfMjMwODk3NDQxODQ3ODQ_fbe88a79-7d36-42bf-82f0-86e83fb2d147">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfMi0xLTEtMS00NDY4_f5e331b5-ae72-4f6d-ace3-161c85b574d5"
      unitRef="usd">21324000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfMi0zLTEtMS00NDY4_5a495880-1768-491b-a975-dbdc5ca43bc6"
      unitRef="usd">6569000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfNi0xLTEtMS00NDY4_315cd9e9-d972-4e9e-ac31-a86e517593c2"
      unitRef="usd">8847000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfNi0zLTEtMS00NDY4_c085c5c8-2b40-4c6d-89cb-5133d807e14a"
      unitRef="usd">79000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfOS0xLTEtMS00NDY4_28b327d0-45e0-40d7-a3af-bde168c11a55"
      unitRef="usd">1859000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfOS0zLTEtMS00NDY4_aa40d945-3dc4-428e-8e8a-06031df0141a"
      unitRef="usd">0</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfMTAtMS0xLTEtNDQ2OA_995497ea-534a-4f67-be97-f66ba2fe342c"
      unitRef="usd">32030000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjdjMDJkM2YwNTMwMDQ5MjU4NGZiMDJjNGU5MmM4NmQyL3RhYmxlcmFuZ2U6N2MwMmQzZjA1MzAwNDkyNTg0ZmIwMmM0ZTkyYzg2ZDJfMTAtMy0xLTEtNDQ2OA_1a9f6e85-32b8-4dba-bcd0-e0c362cbde93"
      unitRef="usd">6648000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ide3fcab1d351422aa89b205d3c4e9817_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMi0xLTEtMS0w_f87c6078-7e9b-4e47-9a77-a37309f08645"
      unitRef="usd">26516000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i109c3eeeb37142eeaff5dbcd7fb30a51_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMi0zLTEtMS0w_44d4266a-8331-4335-a538-126bbc353fad"
      unitRef="usd">18352000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0d6c19c668184c16ab5abb3b2f56e025_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMy0xLTEtMS0w_d0856a78-d495-4ee5-91ff-365491a6cad6"
      unitRef="usd">45342000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia86d7ba53b5946f4a663cf20df932e8c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMy0zLTEtMS0w_cfcf3991-ff86-4246-aa1d-b5e8b64b0e11"
      unitRef="usd">24873000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4fa0c386cddc4e38a421e7ec46fd9828_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfNS0xLTEtMS0w_2e38be90-4dcb-471c-93bf-18ca241e8e5d"
      unitRef="usd">10939000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie41b32eea41a4075bd7d4ef22299e442_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfNS0zLTEtMS0w_cb24681e-eff3-484f-b146-69e251b13b77"
      unitRef="usd">5995000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iaed14ac220d841b784c269f25af4118e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfNi0xLTEtMS0w_ad51009d-75ff-4b98-a260-4155337b1614"
      unitRef="usd">566000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1e9a07f9f51544b588b193d821061957_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfNi0zLTEtMS0w_857c3194-689e-4848-b6af-41d4a9cef0f5"
      unitRef="usd">2611000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i950327dbdb864aa59bae2e677d3cc59e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfNy0xLTEtMS0w_69bcf1d3-5b51-4a21-9e6b-b41bc03abad0"
      unitRef="usd">1967000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5f1d4c48e1794eef98c5bba9a22a83d2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfNy0zLTEtMS0w_b2872520-ac81-4d57-8404-7517634dfacd"
      unitRef="usd">1198000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ifbb2e86c476945ceb7204aa84003647f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfOC0xLTEtMS0w_dd19070b-5c41-4328-bf12-01f149c53bdd"
      unitRef="usd">58000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0f5901d15dd341af989b63f1e1be596d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfOC0zLTEtMS0w_20c2347c-cd17-4c7e-840c-01453569d71d"
      unitRef="usd">58000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i221de2cc80ed4f658ae2b575f1e37709_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfOS0xLTEtMS0w_40f9f3ec-a478-49c6-9c9c-457c48cbbbdd"
      unitRef="usd">12061000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i99c28c17201b43acb7779bcb565aff06_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfOS0zLTEtMS0w_71e70616-d78d-4d7c-a11b-5a61d543a034"
      unitRef="usd">10795000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMTAtMS0xLTEtMA_06973a27-dbd1-470b-92e5-c78315479097"
      unitRef="usd">97449000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMTAtMy0xLTEtMA_8b111e25-b435-4f9e-9a53-57d9bde72168"
      unitRef="usd">63882000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMTEtMS0xLTEtMA_d7d39e25-f64e-4f7d-849d-542feb52c3e5"
      unitRef="usd">31347000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMTEtMy0xLTEtMA_f6e8354c-8daa-45fe-a212-ac83c42182e1"
      unitRef="usd">26135000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMTItMS0xLTEtMA_265f141f-d34b-49ad-9fb5-28a105cf22bf"
      unitRef="usd">66102000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjk0YmVkOWJmOThmZjRjOTE4ZGE3MWRmMWI5MTFjYmMwL3RhYmxlcmFuZ2U6OTRiZWQ5YmY5OGZmNGM5MThkYTcxZGYxYjkxMWNiYzBfMTItMy0xLTEtMA_10efd3a2-18cb-4351-aa84-6c8fb27f207c"
      unitRef="usd">37747000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RleHRyZWdpb246Y2Y4NjAzNzcyMWQyNDAzNmEwYjA0OTIyNjFiMjVkYTZfMTU1_65e52a9e-b7c7-4eb4-a95e-33011dc4387b"
      unitRef="usd">10500000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RleHRyZWdpb246Y2Y4NjAzNzcyMWQyNDAzNmEwYjA0OTIyNjFiMjVkYTZfMTU5_69b95628-5304-42b6-b093-ba847fec0dc6"
      unitRef="usd">7100000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RleHRyZWdpb246Y2Y4NjAzNzcyMWQyNDAzNmEwYjA0OTIyNjFiMjVkYTZfMTY2_151ef656-da84-4e04-a80b-9bfd51b0ff8f"
      unitRef="usd">8500000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RleHRyZWdpb246Y2Y4NjAzNzcyMWQyNDAzNmEwYjA0OTIyNjFiMjVkYTZfNDA3_790c1a4a-1979-46d0-ab05-823ad958e674">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and other liabilities associated with business combinations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfMi0xLTEtMS0w_ecf35581-7b4c-4b62-8d26-bea0166ba893"
      unitRef="usd">25221000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfMi0zLTEtMS0w_f94a0685-03ea-44d9-a708-16c20dc34665"
      unitRef="usd">16440000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfMy0xLTEtMS0w_a36c7050-311c-48c8-ac6f-88b92c163f35"
      unitRef="usd">6378000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfMy0zLTEtMS0w_a06f3bd1-7172-4b50-9e2d-2d4d2c19db19"
      unitRef="usd">1429000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <nvta:BusinessCombinationAccruedLiabilitiesCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfNS0xLTEtMS0w_747fab45-e7d4-4fff-89dc-4aad0e9858f1"
      unitRef="usd">25600000</nvta:BusinessCombinationAccruedLiabilitiesCurrent>
    <nvta:BusinessCombinationAccruedLiabilitiesCurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfNS0zLTEtMS0w_814d51c1-530b-423b-bf30-88a90aa2c942"
      unitRef="usd">30560000</nvta:BusinessCombinationAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfNy0xLTEtMS0w_dd9e91eb-02af-4661-9ef4-fb233b9fc2a3"
      unitRef="usd">28859000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfNy0zLTEtMS0w_5e5e6c61-fc7a-4c99-88e6-c358842368e9"
      unitRef="usd">16385000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfOC0xLTEtMS0w_dbda6e7b-a04f-4b84-842a-5316d62ac8ce"
      unitRef="usd">86058000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOmEyZmE4YmViMDk1NzRhN2JhNWEyZGRlNjcyZDQ2MWI3L3RhYmxlcmFuZ2U6YTJmYThiZWIwOTU3NGE3YmE1YTJkZGU2NzJkNDYxYjdfOC0zLTEtMS0w_0d84d500-8de6-4bfd-8198-bccfb51eddd2"
      unitRef="usd">64814000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RleHRyZWdpb246Y2Y4NjAzNzcyMWQyNDAzNmEwYjA0OTIyNjFiMjVkYTZfNDAz_3237ca2b-f0b7-4527-9fc9-f83656e72812">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and other liabilities associated with business combinations, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfMy0xLTEtMS0w_bdea6aea-4d9a-44f7-9603-b653d690d7c7"
      unitRef="usd">1380000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfMy0zLTEtMS0w_6d35ae72-a384-4f8e-af03-6799a0c4b9a9"
      unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <nvta:BusinessCombinationAccruedLiabilitiesNoncurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfNC0xLTEtMS0w_05633de3-a1d0-44ba-b94b-deb82728f1f1"
      unitRef="usd">825976000</nvta:BusinessCombinationAccruedLiabilitiesNoncurrent>
    <nvta:BusinessCombinationAccruedLiabilitiesNoncurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfNC0zLTEtMS0w_705d7f0b-f743-4b94-b76d-ea467155eed8"
      unitRef="usd">8000000</nvta:BusinessCombinationAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfNS0xLTEtMS0w_11fb3fe4-bd01-42fb-80d9-b5491dcdec4c"
      unitRef="usd">13900000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfNS0zLTEtMS0w_97283a85-03b3-4d05-aedf-5a42878f96f3"
      unitRef="usd">0</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfNi0xLTEtMS0w_634bc1bb-cc68-4652-acf7-181d899dc72c"
      unitRef="usd">841256000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85NC9mcmFnOmNmODYwMzc3MjFkMjQwMzZhMGIwNDkyMjYxYjI1ZGE2L3RhYmxlOjVmNmQzMDkxMzJhODRlNGM4ODc3YWRjZjFkMmZlMjE0L3RhYmxlcmFuZ2U6NWY2ZDMwOTEzMmE4NGU0Yzg4NzdhZGNmMWQyZmUyMTRfNi0zLTEtMS0w_f8689a21-6452-4f50-9f42-02793da29353"
      unitRef="usd">8000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfNDY1MA_3d0ced15-cb01-4e02-9deb-9bbc051ca4ce">Fair value measurements&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities are recorded at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The authoritative guidance establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The three-level hierarchy for the inputs to valuation techniques is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Observable inputs such as quoted prices (unadjusted) for identical instruments in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Observable inputs such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, or model-derived valuations whose significant inputs are observable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Unobservable inputs that reflect the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the fair value of our consolidated financial instruments that were measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock payable liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents, restricted cash, and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.963%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents, restricted cash, and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers between Level&#160;1, Level 2 and Level&#160;3 during the periods presented. The total fair value of investments with unrealized losses at December&#160;31, 2020 was $109.3 million. None of the available-for-sale securities held as of December&#160;31, 2020 have been in an unrealized loss position for more than one year. At December&#160;31, 2020, the remaining contractual maturities of available-for-sale securities ranged from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfNzY5NjU4MTQxMDEzMQ_d4b367b6-e09c-49d9-900c-330dab11d098"&gt;one&lt;/span&gt; to nine months. Interest income generated from our investments was $4.0 million and $5.2 million during the years ended December&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our certificates of deposit and debt securities of U.S. government agency entities are classified as Level&#160;2 as they are valued based upon quoted market prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs obtained from various third-party data providers, including but not limited to benchmark yields, interest rate curves, reported trades, broker/dealer quotes and reference data.&lt;/span&gt;&lt;/div&gt;Stock payable liabilities relate to certain indemnification hold-backs resulting from business combinations that are settled in shares of our common stock. We elected to account for these liabilities using the fair value option due to the inherent nature of the liabilities and the changes in value of the underlying shares that will ultimately be issued to settle the liabilities. The estimated fair value of these liabilities is classified as Level 3 and determined based upon the number of shares that are issuable to the sellers and the quoted closing price of our common stock as of the reporting date. The number of shares that will ultimately be issued is subject to adjustment for indemnified claims that existed as of the closing date for each acquisition. Changes in the number of shares issued and share price can significantly affect the estimated fair value of the liabilities. During the year ended December&#160;31, 2020, the change in fair value related to stock payable liabilities recorded to other income (expense), net was expense of $37.5&#160;million.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfNDY1Mg_0af2220b-77f1-4307-ae8f-990f298cc0fd">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the fair value of our consolidated financial instruments that were measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock payable liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents, restricted cash, and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.963%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents, restricted cash, and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost
      contextRef="ie9f5a000cae84d829d333a825f105334_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMy0yLTEtMS0w_86b50de2-bd24-42f5-a5ad-138be0a40090"
      unitRef="usd">83109000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax
      contextRef="ie9f5a000cae84d829d333a825f105334_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMy00LTEtMS0w_88cb4b10-608a-4e8a-b999-a6f518e7da50"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax
      contextRef="ie9f5a000cae84d829d333a825f105334_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMy02LTEtMS0w_81f0ba5c-f1f5-4352-87b6-23868429f127"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i130e2d48b5004c6e9a3aeb316acff2f7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMy04LTEtMS0w_ad819c10-fd0c-409a-abda-d2f9e051de6f"
      unitRef="usd">83109000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i27addbbb2eb641a0b57afd4322937765_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMy0xMC0xLTEtMA_a3e535cb-862f-4e5a-80f6-d3c657912a13"
      unitRef="usd">83109000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i54333500eabc422aa4fb7b50ec024580_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMy0xMi0xLTEtMA_6fe0fc8a-1035-4497-8a06-f81f7e6b66e4"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i28fae00650bb4a91b726c9ae7389e05c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMy0xNC0xLTEtMA_65779608-a603-4725-9a7b-3afebd0b81e7"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost
      contextRef="i08aad59bfa6646eb872d92df4fe25c56_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNi0yLTEtMS0w_1f08f5ed-c37b-4440-a986-63969e100b7f"
      unitRef="usd">164894000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax
      contextRef="i08aad59bfa6646eb872d92df4fe25c56_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNi00LTEtMS0w_a707c78a-a22b-4136-95da-d61609f0d7d7"
      unitRef="usd">7000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax
      contextRef="i08aad59bfa6646eb872d92df4fe25c56_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNi02LTEtMS0w_034e92a0-24e0-441c-a80f-785268cb8b48"
      unitRef="usd">15000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i188d8124d1e9488595a24ed023c83ec0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNi04LTEtMS0w_0e7e9fac-f214-4018-8a00-86b0823b1685"
      unitRef="usd">164886000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i4c5de93de50148019914bf27c7db6355_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNi0xMC0xLTEtMA_d0af874d-3873-476b-9940-2155f676050f"
      unitRef="usd">164886000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="ia032f7f120de4f9c8d66f9fc7b25aca0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNi0xMi0xLTEtMA_91fc42cc-f9a6-46d3-b890-546f440132b2"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i473285deb1174f398238bf9d728acff8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNi0xNC0xLTEtMA_f48ac347-58a0-4c33-9e90-4092fbe6365e"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost
      contextRef="if082e3e8efba43fc80a4f205e0fe9272_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNy0yLTEtMS0w_be704931-c6e0-4c46-843e-4f59c5f3d131"
      unitRef="usd">64291000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax
      contextRef="if082e3e8efba43fc80a4f205e0fe9272_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNy00LTEtMS0w_70d54804-5280-44fd-bbf2-78429e5e2e1e"
      unitRef="usd">9000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax
      contextRef="if082e3e8efba43fc80a4f205e0fe9272_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNy02LTEtMS0w_d27c7db8-c34b-4a7a-8a1c-d63b70270fb0"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i9ec63a96541542f6a5bd94b8d12a174b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNy04LTEtMS0w_a3d0a8f4-c74e-4ada-8f50-360acf148e27"
      unitRef="usd">64300000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i0e46526580a74ee5aa03b64dbd08a141_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNy0xMC0xLTEtMA_679b19cd-ceb7-4bc2-b615-e5fe976df621"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="if3b0d2fd70ee437db964f0f6171b13e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNy0xMi0xLTEtMA_51610b35-6f4e-4dfa-8d2a-7e986b63c5ac"
      unitRef="usd">64300000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="ib5b55a4267c44c95b43de4a61c59e2f8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfNy0xNC0xLTEtMA_025292a3-86b7-4100-a15f-58ea70539001"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfOC0yLTEtMS0w_b469767c-c5d8-4094-9804-dd7f58923d74"
      unitRef="usd">312294000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfOC00LTEtMS0w_6e8ba74e-9207-4d71-a6bd-599a9f5f15f8"
      unitRef="usd">16000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfOC02LTEtMS0w_a04a20c8-f03f-4cf3-b9ea-c4b2a278018c"
      unitRef="usd">15000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i62eb3a1e610e4f46ac59f207fd5c2df3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfOC04LTEtMS0w_034764e9-5842-4c4e-a97b-87167637c883"
      unitRef="usd">312295000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3372e8a93caa498bb1f1a10e5af5a318_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfOC0xMC0xLTEtMA_98fe1f75-77eb-4409-93b4-e09b99c81f07"
      unitRef="usd">247995000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if2590f9ee0bf41149e7cf8182ba63d51_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfOC0xMi0xLTEtMA_2c202956-7c49-440f-bb6c-e1958c9f58a3"
      unitRef="usd">64300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8cceadd9383544c5a008badc36969778_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfOC0xNC0xLTEtMjc2NA_35759d8f-a4f7-4fa8-9691-9f859afe1cac"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i858f7fb75312498eac5fbdd977be8915_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtOC0xLTEtNzUzMA_26a6f02a-68d9-4df8-a7be-6afa6ed4fb50"
      unitRef="usd">39237000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0b9ca881766247fdba01b8fa00874e5d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtMTAtMS0xLTc1MzA_3a8b69df-580a-4a6b-b9a1-2a9aadff2cd0"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3d4614b08b464e53b288d71792d75a12_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtMTItMS0xLTc1MzA_8ee6a0c5-bbb7-48bc-bb9f-dfb0de209010"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia093c7d811d143d4ae900c0461f04e11_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtMTQtMS0xLTc1MzA_6b7c1f7c-99d3-4776-97ce-f0a773553193"
      unitRef="usd">39237000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iac515eea33b64659b00dd874246c95ae_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtOC0xLTEtMA_c4de1ebb-c3fd-44f8-9ac3-0353fa21f1b4"
      unitRef="usd">796639000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9bcaa1c58b304863a4d0704739b31457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtMTAtMS0xLTA_a7bebb48-0c49-4303-8cbe-401cb9d3f8a0"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ied2ebd117b5349d18d84166bce5ec784_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtMTItMS0xLTA_77cab00f-a068-46be-a2e9-a9944254e23f"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i360a34815adf46b48fc3bc240b973154_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTEtMTQtMS0xLTA_55c5255b-30c6-4420-a12a-0d8b8ce91b64"
      unitRef="usd">796639000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i62eb3a1e610e4f46ac59f207fd5c2df3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTItOC0xLTEtMA_47fe7bcf-0842-40b9-abba-30200467c112"
      unitRef="usd">835876000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3372e8a93caa498bb1f1a10e5af5a318_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTItMTAtMS0xLTA_aeed5f78-9557-462e-bcbe-8c8142b496b4"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if2590f9ee0bf41149e7cf8182ba63d51_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTItMTItMS0xLTA_c4c80e5b-1122-43d0-9b13-3631e77c5a77"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8cceadd9383544c5a008badc36969778_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTItMTQtMS0xLTA_e3cc2c88-041d-4d7d-bbe5-90b0a0ac4181"
      unitRef="usd">835876000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTYtMTItMS0zLTI3NjY_71432769-efc5-4dd2-86bc-fc830f7c896c"
      unitRef="usd">76423000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTctMTItMS0zLTI3NjY_927f7d09-ef83-4a97-b65c-3e863cde839f"
      unitRef="usd">6686000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTgtMTItMS0zLTI3NjY_b9209e7f-265d-49cf-82d6-b083b813c32c"
      unitRef="usd">229186000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMTktMTItMS0zLTI3NjY_165d8fe9-3b9d-4219-9004-5768f5785b7c"
      unitRef="usd">312295000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ieef125570a5d410a9ae17d5d2ed6cb95_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMjEtMTItMS0zLTI3NTg_9b10203c-2253-4133-a75e-a56db45531df"
      unitRef="usd">10592000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8f3a2163cfa940a4aa419fae83424ede_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjAwZmQxYmNjMWZjYzQ1NmNiZjQyYmUwOGRiMDQ1MjQzL3RhYmxlcmFuZ2U6MDBmZDFiY2MxZmNjNDU2Y2JmNDJiZTA4ZGIwNDUyNDNfMjItMTItMS0zLTI3NTg_6abad499-ac53-43f0-a466-b2790e9a062f"
      unitRef="usd">825284000</us-gaap:LiabilitiesFairValueDisclosure>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost
      contextRef="i06993cb5d1c6406493c955e36efe376c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMy0yLTEtMS0w_7b4eaa14-b17e-4cc7-99f9-490995219dbb"
      unitRef="usd">39396000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax
      contextRef="i06993cb5d1c6406493c955e36efe376c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMy00LTEtMS0w_a699dd6a-aec3-42e1-8552-463d5b4f5e39"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax
      contextRef="i06993cb5d1c6406493c955e36efe376c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMy02LTEtMS0w_bea5af4b-7098-446d-a4ce-b196febd88d6"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i5d1e92459dfa4c3c86e03c46590cf11e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMy04LTEtMS0w_d7c7d0b3-2203-40d0-b323-e0b06d10673a"
      unitRef="usd">39396000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="ib528de6cd5d94b218ca6a72049368aa7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMy0xMC0xLTEtMA_7f11c138-1746-4449-af91-e6e3fb9f68dd"
      unitRef="usd">39396000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="iea18a70d0f8f4bc58647fa548740fb30_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMy0xMi0xLTEtMA_d6dc134b-47f8-40fe-b0b0-54f7d4785e75"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i3c59cd454de14e7b98c76fd5c5755dd8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMy0xNC0xLTEtMA_b2b37611-f25a-41af-9c49-2af24dac760f"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost
      contextRef="i2d259a569c8740668939cd2c6f008b27_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNC0yLTEtMS0w_8f3b291d-00f3-4d15-a1d2-b71a22e58dd1"
      unitRef="usd">300000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax
      contextRef="i2d259a569c8740668939cd2c6f008b27_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNC00LTEtMS0w_7c82206a-7d9c-48c8-8b0e-dea0f3712887"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax
      contextRef="i2d259a569c8740668939cd2c6f008b27_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNC02LTEtMS0w_d1dddd30-5760-4cdb-b137-9e3ae9bf0d1f"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i6db56f1860564b5c948005ffd0e54da2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNC04LTEtMS0w_37a67e00-b55c-4c61-b462-e566cdb045f3"
      unitRef="usd">300000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="ib787a31ca31242e590f07fd32f7f3247_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNC0xMC0xLTEtMA_60173ab9-1e23-4489-882b-c03cb88da232"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i43b1dc051d8642cd979ce95901f997a3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNC0xMi0xLTEtMA_052f34d9-60a2-43c0-afa6-2d680134b270"
      unitRef="usd">300000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="ic93726820e244b3e870907dd6bf88b60_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNC0xNC0xLTEtMA_2971b5af-124f-41c0-848f-4a07bbcb9d86"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost
      contextRef="i038907853f764077b79a59ffd5d636f8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNi0yLTEtMS0w_d77eb74a-752d-4736-ada2-2a4d329b8851"
      unitRef="usd">150627000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax
      contextRef="i038907853f764077b79a59ffd5d636f8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNi00LTEtMS0w_708e7c7f-2198-45e5-b721-e492d30af21e"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax
      contextRef="i038907853f764077b79a59ffd5d636f8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNi02LTEtMS0w_820a1e1b-0d61-40be-9e77-7d1c32818db0"
      unitRef="usd">15000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i09a2305fa55f403db2e53d3b4c66fdf4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNi04LTEtMS0w_f7436c36-022d-4de1-a342-3df70b67f827"
      unitRef="usd">150612000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i862cbc61396149b4a904c89b1e7af8f4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNi0xMC0xLTEtMA_657ab8bf-87a0-4ee1-bd58-b746e6f02404"
      unitRef="usd">150612000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="ib57776d437354dc2ac23cfa698397058_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNi0xMi0xLTEtMA_7fa8ffb0-32e1-473f-96f3-4fd1388df43d"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i820b4148e0c34bafbdd13e8562a3b4f7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNi0xNC0xLTEtMA_863f410c-839d-4ea0-b6db-c8197d75c3f4"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost
      contextRef="i205c8b0c236749ab8849be640e1c99ba_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNy0yLTEtMS0w_2a5e76ef-151e-4325-954b-5dd81ed6b2b5"
      unitRef="usd">193302000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax
      contextRef="i205c8b0c236749ab8849be640e1c99ba_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNy00LTEtMS0w_9b89d709-34da-4a39-9f57-53ee940f4f37"
      unitRef="usd">6000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax
      contextRef="i205c8b0c236749ab8849be640e1c99ba_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNy02LTEtMS0w_0c2d35e7-104c-4757-a51d-3c4598ac089f"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="iec01bbe55f3a4c9eb2bb920d009b727d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNy04LTEtMS0w_47487970-6a7a-4846-85b1-253acbb6799f"
      unitRef="usd">193308000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i7df43ef9d55e4c67ac7eb55388c00aca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNy0xMC0xLTEtMA_52a03635-408e-43a9-9a76-219da338e67a"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="ie763bd4d168247b5a8706e65eafef728_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNy0xMi0xLTEtMA_c0e485dd-5073-4da0-8a8b-ff1bcc5c5a66"
      unitRef="usd">193308000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i6c5983241a3e4da6ba46a2a2e89d89fe_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfNy0xNC0xLTEtMA_c8f94539-12fd-415d-bea0-43c789f2052e"
      unitRef="usd">0</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfOC0yLTEtMS0w_799a2e20-7e01-4fe5-8f8c-a7a8da3401d0"
      unitRef="usd">383625000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfOC00LTEtMS0w_ca104aab-3668-4d20-8e57-cac19885e240"
      unitRef="usd">6000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfOC02LTEtMS0w_06e2f3aa-7fa8-4e0f-bc1f-f3b229beb16a"
      unitRef="usd">15000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib13c4fca32874b758541909197f604c5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfOC04LTEtMS0w_af83b1c4-7f84-4b4a-9ea5-f2a62e44a53a"
      unitRef="usd">383616000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i763bfe6fa0b547ce82fc98bd8524a4fe_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfOC0xMC0xLTEtMA_5a5db5b2-475a-45a0-a302-a2d493e8edcb"
      unitRef="usd">190008000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8d2ff72b9ebd43228f6d29da67e34f55_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfOC0xMi0xLTEtMA_58f2169e-23e4-4b9b-b592-bd3075fee693"
      unitRef="usd">193608000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id715584d8ddc40bbbff675871872b46e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfOC0xNC0xLTEtMA_236336f4-d5bb-4709-917e-d610eff9b20e"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i595e483b9f0344c4aca995e6a572302d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTEtOC0xLTEtMA_199f3a60-da7d-4f68-8e26-ce61df6cefa6"
      unitRef="usd">11300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9192e09ee4e24faaa76e6fc28d55f441_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTEtMTAtMS0xLTA_03d8dbdc-f47e-4a62-abf9-b2cdaba629d5"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i73e6634d1bca4bdc955007d68d05ebaf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTEtMTItMS0xLTA_2d9e0692-208b-4d36-8222-f49a955998d2"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i531f978b6c494fe5962f9f63ddfd8712_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTEtMTQtMS0xLTA_4b7ffd1f-8044-4763-b818-e84bfeebaba3"
      unitRef="usd">11300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib13c4fca32874b758541909197f604c5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTItOC0xLTEtMA_e457570d-48a5-404e-a8d6-329a02bb13b1"
      unitRef="usd">11300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i763bfe6fa0b547ce82fc98bd8524a4fe_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTItMTAtMS0xLTA_85558f22-3897-460e-9f43-7143bc4ff324"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8d2ff72b9ebd43228f6d29da67e34f55_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTItMTItMS0xLTA_3a38fea4-e572-4c6d-9036-fba6a52063de"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id715584d8ddc40bbbff675871872b46e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTItMTQtMS0xLTA_cf401629-521d-437c-8776-6ba3e5c2c498"
      unitRef="usd">11300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTYtMTItMS0xLTA_26accc9c-afbd-4954-8bbd-26da3c13bcd0"
      unitRef="usd">136997000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTctMTItMS0zLTI3MzU_57c4412a-c1b6-41d4-8297-a165a48e41c2"
      unitRef="usd">6183000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTgtMTItMS0xLTA_10716f5d-6908-4bbd-80e9-d1df711722fb"
      unitRef="usd">240436000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMTktMTItMS0xLTA_f4e769f0-5cb2-4e2b-881f-d368f834a649"
      unitRef="usd">383616000</nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="icecfd6fced1c453ba8fe7e4e77e3c937_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMjEtMTItMS0zLTI3MzU_bad6a6a5-fc5b-493c-af7e-6cfd547e198c"
      unitRef="usd">3300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2d0f0692653f4d25aaef40c6c24a8aac_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RhYmxlOjA4YWVkNWUxYjBlMDQwY2NiNTIyZTAxYTY2NjE5OTUwL3RhYmxlcmFuZ2U6MDhhZWQ1ZTFiMGUwNDBjY2I1MjJlMDFhNjY2MTk5NTBfMjItMTItMS0zLTI3MzU_3e2b8d58-3790-4b6b-82e0-ea9b5103ea55"
      unitRef="usd">8000000</us-gaap:LiabilitiesFairValueDisclosure>
    <nvta:FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfMjMwODk3NDQxOTEwMTc_18f63146-84fb-4618-b31b-22675614ad11"
      unitRef="usd">0</nvta:FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount>
    <nvta:FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfMjMwODk3NDQxOTEwMTc_eef34941-a723-4b39-a9ba-ed6e960a6897"
      unitRef="usd">0</nvta:FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfMTUwOQ_99ffdbf4-9adc-4779-900d-d83774f00371"
      unitRef="usd">109300000</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <nvta:DebtSecuritiesAvailableForSaleMaturityPeriod
      contextRef="i23413efbba8a4bce99ca014f751cd629_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfNzY5NjU4MTQxMDEzMA_136c1bda-8154-4894-a846-acd54564706f">P9M</nvta:DebtSecuritiesAvailableForSaleMaturityPeriod>
    <us-gaap:InvestmentIncomeInterest
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfNzY5NjU4MTQwMTE5MQ_9b91abeb-cf07-41d2-9560-f47dbd2111ae"
      unitRef="usd">4000000.0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfNzY5NjU4MTQwMTIxNQ_0571e4aa-dd00-4a5d-a2ea-28ab31814035"
      unitRef="usd">5200000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfMjI1Mzk5ODgzNzk0MzQ_22c9d52f-285c-455f-9e6c-fd2d2ee442af"
      unitRef="usd">-37500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzEwNzI3_8f69003f-b7b9-4960-bb0c-bcddea014890">Commitments and contingencies&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In&#160;2015, we entered into an operating lease agreement for our headquarters and main production facility in San Francisco, California which commenced in 2016. This lease expires in&#160;2026 and we may renew the lease for an additional ten years. This optional period was not considered reasonably certain to be exercised and therefore we determined the lease term to be a ten-year period expiring in 2026. In connection with the execution of the lease, we provided a security deposit of approximately $4.6 million which is included in restricted cash in our consolidated balance sheets. We also have other operating leases for office and laboratory space in California, Colorado, Massachusetts, New York and Washington and internationally in Australia and Israel. We expect to enter into new leases and modify existing leases as we support continued growth of our operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into various finance lease agreements to obtain laboratory equipment. The terms of our finance leases are generally three years and are typically secured by the underlying equipment. The portion of the future payments designated as principal repayment and related interest was classified as a finance lease obligation on our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information regarding our operating and finance leases were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments included in the measurement of lease liabilities (in millions):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease costs, which were included in cost of revenue, research and development, selling and marketing and general and administrative expenses on our consolidated statements of operations, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.691%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future payments under operating and finance leases as of December&#160;31, 2020 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.428%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Future non-cancelable minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,787)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease obligations, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, we entered into a Note Purchase Agreement (the "2018 Note Purchase Agreement") pursuant to which we were eligible to borrow an aggregate principal amount up to $200.0 million over a seven year maturity term which included an initial borrowing of $75.0 million in November 2018. We received net proceeds of $10.3 million after terminating and repaying the balance of our obligations of approximately $64.7 million with our previous lender. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2019, we settled our obligations under the 2018 Note Purchase Agreement in full for $85.7 million, which included repayment of principal of $75.0 million, accrued interest of $2.4 million, and prepayment fees of $8.9 million which were recorded as debt extinguishment costs in other expense, net in our consolidated statement of operations during the year ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, we entered into a credit agreement with a financial institution under which we borrowed $135.0&#160;million (the "2020 Term Loan") concurrent with the closing of the ArcherDX transaction (the "closing date"). The 2020 Term Loan is secured by a first priority lien on all of our and our subsidiaries' assets (including our intellectual property), and is guaranteed by our subsidiaries, in each case, excluding certain excluded assets and immaterial foreign subsidiaries. The 2020 Term Loan bears interest at an annual rate equal to LIBOR, subject to a 2.00% LIBOR floor, plus a margin of 8.75%. The 2020 Term Loan will mature on (i) June 1, 2024 if at such time our Convertible Senior Notes are outstanding and are due to mature on September 1, 2024 (provided that if, prior to such date, the maturity date of at least 80% of the Convertible Senior Notes is extended to a date that is prior to September 1, 2025 the maturity date for the 2020 Term Loan will be automatically extended to a date that is 90 days prior to such Convertible Senior Notes maturity date as extended), or (ii) otherwise, on June 1, 2025. The full amount of the 2020 Term Loan is due upon maturity. If the 2020 Term Loan is prepaid (whether such prepayment is optional or mandatory), we must pay a prepayment fee of 6% if the prepayment occurs prior to the third anniversary of the closing date or 4% if the prepayment occurs after the third anniversary of the closing date and we must also pay a make-whole fee if the prepayment occurs prior to the second anniversary of the closing date. In connection with the 2020 Term Loan, we issued warrants to purchase 1.0&#160;million shares of our common stock with an exercise price of $16.85 per share, exercisable through October 2027. The warrants, which were classified as equity, were recorded at an amount based on the allocated proceeds and do not require subsequent remeasurement. In October 2020, these warrants were exercised in full through net settlement resulting in the issuance of 0.7&#160;million shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit agreement contains customary events of default and covenants, including among others, covenants limiting our ability to incur debt, incur liens, undergo a change in control, merge with or acquire other entities, make investments, pay dividends or other distributions to holders of our equity securities, repurchase stock, and dispose of assets, in each case subject to certain customary exceptions. In addition, the credit agreement contains financial covenants that require us to maintain a minimum cash balance and minimum quarterly revenue levels. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt discounts, including debt issuance costs, related to the 2020 Term Loan of $32.8&#160;million were recorded as a direct deduction from the debt liability and are being amortized to interest expense over the term of the 2020 Term Loan. Interest expense related to our debt financings, excluding the impact of our Convertible Senior Notes, was $7.4 million, $5.7 million and $6.7 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2019, we issued, at par value, $350.0 million aggregate principal amount of 2.00% Convertible Senior Notes due 2024 in a private offering. The Convertible Senior Notes are our senior unsecured obligations and will mature on September 1, 2024, unless earlier converted, redeemed or repurchased. The Convertible Senior Notes bear cash interest at a rate of 2.0% per year, payable semi-annually in arrears on March 1 and September 1 of each year, beginning on March 1, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon conversion, the Convertible Senior Notes will be convertible into cash, shares of our common stock or a combination of cash and shares of our common stock, at our election. Our current intent is to settle the principal amount of the Convertible Senior Notes in cash upon conversion, with any remaining conversion value being delivered in shares of our common stock. The initial conversion rate for the Convertible Senior Notes is 33.6293 shares of our common stock per $1,000 principal amount of the Convertible Senior Notes (equivalent to an initial conversion price of approximately $29.74 per share of common stock). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If we undergo a fundamental change (as defined in the indenture governing the Convertible Senior Notes), the holders of the Convertible Senior Notes may require us to repurchase all or any portion of their Convertible Senior Notes for cash at a repurchase price equal to 100% of the principal amount of the Convertible Senior Notes to be repurchased plus accrued and unpaid interest to, but excluding, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Convertible Senior Notes will be convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding March 1, 2024, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on December 31, 2019 (and only during such calendar quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the Convertible Senior Notes on each applicable trading day; (2) during the five business day period after any five consecutive trading day period (the &#x201c;measurement period&#x201d;) in which the trading price per $1,000 principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; (3) if we call any or all of the Convertible Senior Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On or after March 1, 2024 until the close of business on the business day immediately preceding the maturity date, holders may convert their Convertible Senior Notes at any time, regardless of the foregoing circumstances. As of December&#160;31, 2020, none of the above circumstances had occurred and therefore the Convertible Senior Notes could not have been converted. However, these notes were convertible at the option of the holders during the quarter beginning on January 1, 2021 due to the sale price of our common stock during the quarter ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may not redeem the Convertible Senior Notes prior to September 6, 2022. We may redeem for cash all or any portion of the Convertible Senior Notes, at our option, on or after September 6, 2022 and on or before the 30th scheduled trading day immediately before the maturity date if the last reported sale price of the Common Stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Convertible Senior Notes consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt discount and issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying amount, liability component&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the fair value of the Convertible Senior Notes was $586.0 million. The estimated fair value of the Convertible Senior Notes, which are classified as Level 2 financial instruments, was determined based on the estimated or actual bid prices of the Convertible Senior Notes in an over-the-counter market. We recognized $22.0&#160;million and $6.5 million of interest expense related to the Convertible Senior Notes during the years ended December&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guarantees and indemnifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As permitted under Delaware law and in accordance with our bylaws, we indemnify our directors and officers for certain events or occurrences while the officer or director is or was serving in such capacity. The maximum amount of potential future indemnification is unlimited; however, we maintain director and officer liability insurance. This insurance allows the transfer of the risk associated with our exposure and may enable us to recover a portion of any future amounts paid. We believe the fair value of these indemnification agreements is minimal. Accordingly, we did not record any liabilities associated with these indemnification agreements at December&#160;31, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, we enter into various purchase commitments primarily related to service agreements and laboratory supplies. At December&#160;31, 2020, our total future payments under noncancelable unconditional purchase commitments having a remaining term of over one year were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, we entered into a lease agreement in San Francisco, California for additional office and lab space. We determined the lease commencement date to be in January 2021 when we took possession of the leased premises. Total lease payments over the course of this lease will be $45.0&#160;million and are included in the purchase commitments above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We were not a party to any material legal proceedings at December&#160;31, 2020, or at the date of this report except for matters listed below which are related to ArcherDX which we acquired in October 2020. We cannot currently predict the outcome of these actions. The outcome of any such proceedings, regardless of the merits, is inherently uncertain. If we were unable to prevail in any such proceedings, our consolidated financial position, results of operations, and future cash flows may be materially impacted. In addition, we are and may from time to time become involved in various legal proceedings and claims arising in the ordinary course of business. While we believe any such claims are unsubstantiated, and we believe we are in compliance with applicable laws and regulations applicable to our business, the resolution of any such claims could be material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Natera, Inc. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;27, 2020, Natera filed a lawsuit against ArcherDX (a subsidiary of Invitae effective October 2, 2020) in the United States District Court for the District of Delaware, alleging that ArcherDX&#x2019;s products using AMP chemistry, and the manufacture, use, sale, and offer for sale of such products, infringe U.S. Patent No. 10,538,814. On March&#160;25, 2020, ArcherDX filed an answer denying Natera&#x2019;s allegations and asserting certain affirmative defenses and counterclaims, including that U.S. Patent No. 10,538,814 is invalid and not infringed. On April&#160;15, 2020, Natera filed an answer denying ArcherDX&#x2019;s counterclaims and filed an amended complaint alleging that ArcherDX&#x2019;s products using AMP chemistry, including STRATAFIDE, PCM, LiquidPlex, ArcherMET, FusionPlex, and VariantPlex, and the manufacture, use, sale, and offer for sale of such products, infringe U.S. Patent No. 10,538,814, U.S. Patent No. 10,557,172, U.S. Patent No. 10,590,482, and U.S. Patent No. 10,597,708, each of which are held by Natera. Natera seeks, among other things, damages and other monetary relief, costs and attorneys&#x2019; fees, and an order enjoining ArcherDX from further infringement of such patents. On May&#160;13, 2020, ArcherDX filed an answer to Natera&#x2019;s amended complaint denying Natera&#x2019;s allegations and asserting certain affirmative defenses and counterclaims, including that the asserted patents are invalid and not infringed. On June&#160;3, 2020, Natera filed an answer denying ArcherDX&#x2019;s counterclaims. On June&#160;4, 2020, ArcherDX filed a motion seeking dismissal of Natera&#x2019;s infringement claims against STRATAFIDE, PCM, and ArcherMET, and for a judgment that U.S. Patent No.&#160;10,538,814, U.S. Patent No. 10,557,172, and U.S. Patent No. 10,590,482 are invalid. On August 6, 2020, Natera filed another complaint against ArcherDX in the United States District Court for the District of Delaware alleging that ArcherDX&#x2019;s products using AMP chemistry, including STRATAFIDE, PCM, LiquidPlex, ArcherMET, and VariantPlex, and the manufacture, use, sale, and offer for sale of such products, infringe U.S. Patent No. 10,731,220. Natera seeks, among other things, damages and other monetary relief, costs and attorneys&#x2019; fees, and an order enjoining ArcherDX from further infringement of the patent. On October 13, 2020, the court issued an order denying ArcherDX's motion for dismissal of Natera&#x2019;s infringement claims against STRATAFIDE, PCM, and ArcherMET, and declined to enter judgment that U.S.&#160;Patent No.&#160;10,538,814, U.S. Patent No. 10,557,172, and U.S. Patent No. 10,590,482 are invalid.&#160;On January 12, 2021, the court issued an order granting Natera leave to amend its complaint to add Invitae  as a co-defendant and plead allegations that ArcherDX and Invitae induce end-users to infringe the patents-in-suit. Natera filed its Second Amended Complaint on the same day, with service completed on January 15, 2021. ArcherDX and Invitae filed answers to the Second Amended Complaint on January 26, 2021 and February 5, 2021, respectively, denying Natera's allegations and restating certain affirmative defenses and counterclaims of non-infringement and invalidity. The litigations have now been consolidated for all purposes, are ongoing, and trial has been scheduled for May 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;QIAGEN Sciences &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July&#160;10, 2018, ArcherDX and the General Hospital Corporation d/b/a Massachusetts General Hospital, which we refer to as MGH, filed a lawsuit in the United States District Court for the District of Delaware against QIAGEN Sciences, LLC, QIAGEN LLC, QIAGEN Beverly, Inc., QIAGEN Gaithersburg, Inc., QIAGEN GmbH and QIAGEN N.V., which is collectively referred to herein as QIAGEN, and a named QIAGEN executive who was a former member of ArcherDX&#x2019;s board of directors, alleging several causes of action, including infringement of the &#x2019;810 Patent, trade secret misappropriation, breach of fiduciary duty, false advertising, tortious interference and deceptive trade practices. The &#x2019;810 Patent relates to methods for preparing a nucleic acid for sequencing and aspects of ArcherDX&#x2019;s AMP technology. On October&#160;30, 2019, with the permission of the Court, ArcherDX amended ArcherDX&#x2019;s complaint to add a claim for infringement of the &#x2019;597 Patent. The &#x2019;597 Patent relates to methods of preparing and analyzing nucleic acids, such as by enriching target sequences prior to sequencing, and aspects of ArcherDX&#x2019;s AMP technology. The QIAGEN products that ArcherDX alleges infringe the &#x2019;810 Patent and the &#x2019;597 Patent include, but are not limited to, QIAseq Targeted DNA Panels, QIAseq Targeted RNAscan Panels, QIAseq Index Kits and QIAseq Immune Repertoire RNA Library Kits. ArcherDX is seeking, among other things, damages for ArcherDX&#x2019;s lost profits due to QIAGEN&#x2019;s infringement and a permanent injunction enjoining QIAGEN from marketing and selling the infringing products and from using ArcherDX&#x2019;s trade secrets. On December&#160;5, 2019, QIAGEN and the named QIAGEN executive submitted their answer denying the allegations in ArcherDX&#x2019;s complaint and asserting affirmative defenses that, among other things, the &#x2019;810 Patent and &#x2019;597 Patent are not infringed by QIAGEN&#x2019;s products, that both patents are invalid, and that the complaint fails to state any claim for which relief may be granted. This litigation is ongoing, and trial is currently scheduled for August 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="id23b32f856364b628d82e533acbde8ae_I20161231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI4Mw_def2900d-fc89-4458-850f-a6995e03566c">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="id23b32f856364b628d82e533acbde8ae_I20161231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIzMDg5NzQ0MjA2MjU2_1ca7b8af-ced2-445c-93db-afd5b2e023cb">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:SecurityDeposit
      contextRef="id23b32f856364b628d82e533acbde8ae_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzU0Mg_ea932d8b-34e7-42c8-90ff-7a74b313f5b0"
      unitRef="usd">4600000</us-gaap:SecurityDeposit>
    <us-gaap:LesseeFinanceLeaseTermOfContract1
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzYwNDczMTM5ODk1MTk_0b64ff9d-030e-4c3b-9f5c-18f1eb9f6417">P3Y</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzEwNzI4_77ff8ac8-21c8-49fb-9841-164d349e9497">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information regarding our operating and finance leases were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments included in the measurement of lease liabilities (in millions):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease costs, which were included in cost of revenue, research and development, selling and marketing and general and administrative expenses on our consolidated statements of operations, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.691%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzMtMi0xLTEtMTAyNTM_1bea22a9-bfe4-4edb-b8af-64c1895fdcf0">P5Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzMtNC0xLTEtMTEyNjY_eddaaa50-85ef-45e9-bde4-cde0d0fc1138">P6Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzQtMi0xLTEtMTEyNjQ_d1aa5b58-0a7f-454f-b51f-f984f5307a0c">P2Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzQtNC0xLTEtMTEyNjY_806cb5bf-05dd-419a-be28-cd28da921678">P2Y</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzYtMi0xLTEtMTEyNjc_2c082708-7795-4a78-80c2-46d9538ea645"
      unitRef="number">0.106</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzYtNC0xLTEtMTEyNzA_916482f3-c232-4cf1-a2ec-0af7870075c9"
      unitRef="number">0.118</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzctMi0xLTEtMTEyNjc_cc44c09d-a0b9-4aea-8dd8-694050029caa"
      unitRef="number">0.048</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzctNC0xLTEtMTEyNzA_a36fad12-08f1-4406-8e9f-faf836fff2ff"
      unitRef="number">0.055</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeasePayments
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzktMi0xLTEtMTEyNTE_3c57b52d-ccc9-4030-85f6-0e096535e518"
      unitRef="usd">11600000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzktNC0xLTEtMTEyNTM_ab797803-83c1-4c88-b38e-12488bc77f87"
      unitRef="usd">10200000</us-gaap:OperatingLeasePayments>
    <nvta:FinanceLeasePrincipalPaymentsandOtherAncillaryPayments
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzEwLTItMS0xLTExMjU1_5fef7ef2-202f-4bab-b405-7909056dd45c"
      unitRef="usd">2000000.0</nvta:FinanceLeasePrincipalPaymentsandOtherAncillaryPayments>
    <nvta:FinanceLeasePrincipalPaymentsandOtherAncillaryPayments
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2MTVhZTIwYzM1Mzk0ZDgwOGIzZDE2YzY3N2IxNmVmNy90YWJsZXJhbmdlOjYxNWFlMjBjMzUzOTRkODA4YjNkMTZjNjc3YjE2ZWY3XzEwLTQtMS0xLTExMjU1_2a6ae205-8dd8-47f4-8457-80b1c5f8ae37"
      unitRef="usd">2100000</nvta:FinanceLeasePrincipalPaymentsandOtherAncillaryPayments>
    <us-gaap:OperatingLeaseCost
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzItMi0xLTEtMA_feda3a57-149a-4cd8-bbee-8f867952df87"
      unitRef="usd">11329000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzItNC0xLTEtMA_1860b33e-1504-4087-bd0e-c5873622ea72"
      unitRef="usd">10329000</us-gaap:OperatingLeaseCost>
    <us-gaap:LeaseAndRentalExpense
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzItNi0xLTEtMA_f0620043-eff7-4e6e-9f16-f831e550ac65"
      unitRef="usd">9648000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:SubleaseIncome
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzMtMi0xLTEtMA_5f4e0967-4fe0-4b2e-8d11-e9a79edaed24"
      unitRef="usd">0</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzMtNC0xLTEtMA_8f8cfd62-f275-4b9b-af54-1b9d32e056e3"
      unitRef="usd">173000</us-gaap:SubleaseIncome>
    <us-gaap:OperatingLeasesRentExpenseSubleaseRentals1
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzMtNi0xLTEtMA_d458393b-7207-4af9-ac58-81e54afe9a62"
      unitRef="usd">156000</us-gaap:OperatingLeasesRentExpenseSubleaseRentals1>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzUtMi0xLTEtMA_1b7af447-d401-4fb9-a025-75d1901baad6"
      unitRef="usd">2084000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzUtNC0xLTEtMA_85812419-e19b-476a-b41c-f50565358153"
      unitRef="usd">1546000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:CapitalLeasesIncomeStatementInterestExpense
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzUtNi0xLTEtMA_eaf7b64a-e6b7-406b-8cbc-a66ff75c3b13"
      unitRef="usd">1820000</us-gaap:CapitalLeasesIncomeStatementInterestExpense>
    <us-gaap:LeaseCost
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzYtMi0xLTEtMA_01c7a16e-8116-4aac-95e2-1392d146fb67"
      unitRef="usd">13413000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzYtNC0xLTEtMA_1eab8bb4-3bcd-42cb-b790-8188f72b6c43"
      unitRef="usd">11702000</us-gaap:LeaseCost>
    <nvta:LeasesExpense
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToxZGFlNWYwMDE0ZjQ0YWRmODFmZDIyM2I5ZTk1ZmU2ZS90YWJsZXJhbmdlOjFkYWU1ZjAwMTRmNDRhZGY4MWZkMjIzYjllOTVmZTZlXzYtNi0xLTEtMA_f30a4eb6-5c27-401b-8819-76b0754e401c"
      unitRef="usd">11312000</nvta:LeasesExpense>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIyNTM5OTg4NDA4Mjk2_0c2f4d3d-e3e0-4eac-a7b9-f4fec212b95f">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future payments under operating and finance leases as of December&#160;31, 2020 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.428%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Future non-cancelable minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,787)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease obligations, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIyNTM5OTg4NDA4Mjk2_69011b4f-8843-4cce-8022-1a050118a8ef">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future payments under operating and finance leases as of December&#160;31, 2020 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.428%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Future non-cancelable minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,787)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease obligations, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzAtMS0xLTEtOTgzNw_e488eb10-de21-49c1-8447-d078f964de84"
      unitRef="usd">14338000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEtMy0xLTEtMTAwNDQ_b294021d-99e7-4302-97e1-85129f546bd6"
      unitRef="usd">2006000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEtMS0xLTEtOTgzNw_fd25d500-7ab7-4b8e-b073-2bd1e1c4f4fb"
      unitRef="usd">13788000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzItMy0xLTEtMTAwNDQ_d5adea08-0c2c-4f60-94d1-4bcf53dadb2c"
      unitRef="usd">1908000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzItMS0xLTEtOTgzNw_886395bd-42c0-4b54-b37d-50b3ea0b8067"
      unitRef="usd">13229000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzMtMy0xLTEtMTAwNDQ_ab9e8198-0019-4056-b182-5037316cd12e"
      unitRef="usd">1199000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzMtMS0xLTEtOTgzNw_8fc9501f-ab03-4c89-be81-22bfd071d8f5"
      unitRef="usd">13407000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzQtMy0xLTEtMTAwNDQ_9fe7bf37-625c-42e4-b6d3-359ffa93c61c"
      unitRef="usd">26000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzQtMS0xLTEtOTgzNw_2a908544-8218-42f8-b5f2-d509e2549c4e"
      unitRef="usd">11672000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzUtMy0xLTEtMTEyODg_f89473b5-46cc-4300-8daa-24173d81fa46"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzUtMS0xLTEtOTgzNw_5f16b483-c467-4f9c-bc51-23d139f47ee2"
      unitRef="usd">9499000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzYtMy0xLTEtMTEyOTE_920f653b-397f-4b30-afea-cc606a1620c0"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzctMS0xLTEtMTEzMDU_04edbfcc-7733-4a59-b869-6723bde07e38"
      unitRef="usd">75933000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzctMy0xLTEtMTEyOTU_60e211ac-c8ae-4e07-b354-ddc5cf473735"
      unitRef="usd">5139000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEwLTEtMS0xLTExMzEx_8cfbb3f4-d9f1-402b-ac52-f3668d75be1e"
      unitRef="usd">18787000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEwLTMtMS0xLTExMjk3_05b9bc8c-d77d-4510-a405-8b58181e4ae5"
      unitRef="usd">321000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzExLTEtMS0xLTExMzEz_2f9470da-a14a-4978-b45c-eb4ee45966ed"
      unitRef="usd">57146000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzExLTMtMS0xLTExMjk5_d271586a-2c73-4f72-be3e-f4af38e77ede"
      unitRef="usd">4818000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEyLTEtMS0xLTExMzA3_5e3ad0e1-f2a6-4bbd-b0d3-52169bae0751"
      unitRef="usd">8789000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEyLTMtMS0xLTExMzAx_2a10c719-67b4-41d0-bc6f-e101b77af932"
      unitRef="usd">1695000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEzLTEtMS0xLTExMzA5_63588fe4-313d-4add-b704-1492278f1760"
      unitRef="usd">48357000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2NDMxZjkxZjkyZWQ0YTUwODA5NjdhMzE0M2ZjZjA4Ni90YWJsZXJhbmdlOjY0MzFmOTFmOTJlZDRhNTA4MDk2N2EzMTQzZmNmMDg2XzEzLTMtMS0xLTExMzAz_c18d4902-da12-463f-9788-ef0c035bfff6"
      unitRef="usd">3123000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4fe976692891413ba81c58b02db5d00d_I20181130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIzNTY_6f0d743a-f324-4732-b112-8ca60db753ca"
      unitRef="usd">200000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i1f703415354e4db28b8eb792013da139_D20181101-20181130"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIzMDg5NzQ0MjA2Mjcx_07fb92ee-2d87-40aa-b66e-1424d5e70330">P7Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="id859a147fbaa47b580a323a7f9e4189d_I20181130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI0MzA_d2adc316-cc59-4c7c-a0b5-4e721a59b7d2"
      unitRef="usd">75000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="ie5fd4ad3c7b6406383062accfcffbe19_D20181101-20181130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI0Nzk_afaa9461-34c7-4bc2-bd57-1e34d25463c2"
      unitRef="usd">10300000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i63443cb782824ffab2f81095d44a8e69_D20181101-20181130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI1NjE_d3af9261-5be5-47cf-a7d9-a9e74d3e72c8"
      unitRef="usd">64700000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ie3449298aceb411e8995fb489e02c922_D20190901-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI2ODg_198f708e-7fb4-44de-b7b6-a77357bbabf7"
      unitRef="usd">85700000</us-gaap:RepaymentsOfLinesOfCredit>
    <nvta:RepaymentsofLinesofCreditPrincipal
      contextRef="ie3449298aceb411e8995fb489e02c922_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI3MzM_dd6e82ef-d853-45ae-b3d4-d23d844a6aae"
      unitRef="usd">75000000.0</nvta:RepaymentsofLinesofCreditPrincipal>
    <nvta:RepaymentsofLinesofCreditAccruedInterest
      contextRef="ie3449298aceb411e8995fb489e02c922_D20190901-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI3NTc_0362dfbe-1467-48d0-9e9e-a1f01509e016"
      unitRef="usd">2400000</nvta:RepaymentsofLinesofCreditAccruedInterest>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i69711d9dc55a46288486cf518a43bbe2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzI3ODQ_ae71f287-ab4e-4dfe-98d7-5cb0b5372c19"
      unitRef="usd">8900000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i117de729dbf54fc8b1c7825fc2b3e06d_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg3OTYwOTMwNTM0MzY_e033f671-b9bc-4e42-ac3b-4a9cb86defcd"
      unitRef="usd">135000000.0</us-gaap:DebtInstrumentFaceAmount>
    <nvta:DebtInstrumentInterestRateFloorRate
      contextRef="if4f48e652c334267bca5c0f3175f3e6d_D20201001-20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIyNTM5OTg4NDAxNzY4_48debb49-e004-4cf5-8be0-825e0cc86fc6"
      unitRef="number">0.0200</nvta:DebtInstrumentInterestRateFloorRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if4f48e652c334267bca5c0f3175f3e6d_D20201001-20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg3OTYwOTMwNTM0Mjk_732e7fcf-06ff-4dc5-bcbc-610a578421cf"
      unitRef="number">0.0875</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <nvta:DebtInstrumentMaturityTermsPercentOfDebtExtended
      contextRef="i9bf76301d2c04d1fa068a5ac5c9c4e49_D20201001-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIyNTM5OTg4NDEwNTUy_c1b5eeb2-bd4b-4533-88ad-08e4445c7364"
      unitRef="number">0.80</nvta:DebtInstrumentMaturityTermsPercentOfDebtExtended>
    <nvta:DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate
      contextRef="ibccee1e9674b4a1394120efaba533158_D20201001-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIyNTM5OTg4NDEwNTU5_87c5fe90-91b3-4398-93c1-fa75c517dd6f">P90D</nvta:DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate>
    <nvta:DebtInstrumentPrepaymentFeePercentage
      contextRef="i9f033130abcd435b987c4fb6e75bdba0_D20201001-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIyNTM5OTg4NDEwNTcx_c9315d2c-e7e0-4f86-923f-3e89dfeb0a56"
      unitRef="number">0.06</nvta:DebtInstrumentPrepaymentFeePercentage>
    <nvta:DebtInstrumentPrepaymentFeePercentage
      contextRef="i89b10cf6330f40a29dfcad173848efc4_D20201001-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzIyNTM5OTg4NDEwNTc1_f6f9d316-2c7a-4dd8-bc4c-87344aa3b06c"
      unitRef="number">0.04</nvta:DebtInstrumentPrepaymentFeePercentage>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i02d506f5f7744c309e1d6654a886c893_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg3OTYwOTMwNTM0NTI_5a37136d-a808-49e2-bd2b-2118f9e2985b"
      unitRef="shares">1000000.0</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i02d506f5f7744c309e1d6654a886c893_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg3OTYwOTMwNTM0MjE_e18eda30-0def-4dbb-bb91-adbc3e50993f"
      unitRef="usdPerShare">16.85</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i8beb7cf99ebe46ce83c4c7ac46d96be8_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg3OTYwOTMwNTM0MDg_70a9076e-826c-4020-8b1c-b63fd0bfecbc"
      unitRef="shares">700000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i117de729dbf54fc8b1c7825fc2b3e06d_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzgyNDYzMzcyNDAxOTc_7fd31bab-642a-4315-bc90-bd8698a9cbfb"
      unitRef="usd">32800000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:InterestExpenseDebt
      contextRef="iad8e118b6e0b43acac375dbb27f97699_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzMwMjI_7ea50d72-43ef-4e65-bb86-a54ffbab9eae"
      unitRef="usd">7400000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="id14582e54d2c40feb9322c61bbb86ebe_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzMwMjY_b82793b0-999c-44b2-96a9-c3c681ea8e10"
      unitRef="usd">5700000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i3bbfab5b3a264c389f363d3c5993ae97_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzMwMzM_99893afb-1ebc-41ba-a82d-55214a158ab6"
      unitRef="usd">6700000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i70c89bb06a7246a1bb3d4f7eec32e812_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzMxNTQ_4a117202-4fee-472a-9ce5-77783052a5ef"
      unitRef="usd">350000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i70c89bb06a7246a1bb3d4f7eec32e812_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzMxODc_763211de-e8a0-4a80-90fc-48b0c126023a"
      unitRef="number">0.0200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i70c89bb06a7246a1bb3d4f7eec32e812_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzM0NjM_32bf2bb2-d69c-419d-b144-61c218453b14"
      unitRef="number">0.020</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i70c89bb06a7246a1bb3d4f7eec32e812_I20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzU0ODA_d454dadc-7812-4fd4-bfc9-73618205fcfd"
      unitRef="usdPerShare">29.74</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzYyNzM_edebdda0-1cb5-4831-a498-7abdc096a12f"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzY4NDU_a39e6fcd-2c72-456e-be7c-62949bc99ae5"
      unitRef="tradingday">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzY5MDk_bfbc149f-9a24-4635-90b6-b88fecc8cf4f"
      unitRef="tradingday">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzcwNTg_1761eca2-8850-4cab-a48f-d7a58df5efe9"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <nvta:DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays
      contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzcxNjU_00f3383e-39fb-4937-988d-6b80b0e2d3fa"
      unitRef="tradingday">5</nvta:DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays>
    <nvta:DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum
      contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzc0MDE_54538a7b-8cff-4a49-8c1e-669f9df054a8"
      unitRef="number">0.98</nvta:DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum>
    <nvta:DebtInstrumentRedemptionPeriodThresholdTradingDays
      contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzgzMzU_96afb33a-14b7-41e9-ac19-1a8617eb5409"
      unitRef="tradingday">30</nvta:DebtInstrumentRedemptionPeriodThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg0Njk_2c80edbf-dfe5-42d3-9c65-ab31209bfac1"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg1MjQ_3f4b3987-7bfc-4cf7-9ee0-453ae1440ea9"
      unitRef="tradingday">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg1ODA_76a43635-4f02-4e71-8e4e-d60c444ad455"
      unitRef="tradingday">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i3578f2eff04c4780ab9ff1d8494885fa_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzg4MDc_7ca59ce4-52ca-4383-b581-71d3733b5563"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzEwNzMx_147c6f7b-a548-4039-a61e-21f957550d6f">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Convertible Senior Notes consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt discount and issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying amount, liability component&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i74cd37df131042188edd2e1114ee7668_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToyNmM4NDZjOTc5NjM0OTYyODVhMzUxMWIxMWI4YWY5OC90YWJsZXJhbmdlOjI2Yzg0NmM5Nzk2MzQ5NjI4NWEzNTExYjExYjhhZjk4XzAtMS0xLTEtMA_9fc76f81-016e-4c91-9cc5-5a02a7abf361"
      unitRef="usd">350000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i272e3fbf659b47e08751fee97f870e59_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToyNmM4NDZjOTc5NjM0OTYyODVhMzUxMWIxMWI4YWY5OC90YWJsZXJhbmdlOjI2Yzg0NmM5Nzk2MzQ5NjI4NWEzNTExYjExYjhhZjk4XzAtMy0xLTEtMTc2NQ_b370d4cc-fa0f-463e-8c9c-88404844e95d"
      unitRef="usd">350000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i74cd37df131042188edd2e1114ee7668_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToyNmM4NDZjOTc5NjM0OTYyODVhMzUxMWIxMWI4YWY5OC90YWJsZXJhbmdlOjI2Yzg0NmM5Nzk2MzQ5NjI4NWEzNTExYjExYjhhZjk4XzEtMS0xLTEtMA_e4116203-7165-488b-81bf-7411b6b4232f"
      unitRef="usd">66276000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i272e3fbf659b47e08751fee97f870e59_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToyNmM4NDZjOTc5NjM0OTYyODVhMzUxMWIxMWI4YWY5OC90YWJsZXJhbmdlOjI2Yzg0NmM5Nzk2MzQ5NjI4NWEzNTExYjExYjhhZjk4XzEtMy0xLTEtMTc2NQ_5276b202-2b46-415c-b52b-bb8d167fcfb3"
      unitRef="usd">81245000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i74cd37df131042188edd2e1114ee7668_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToyNmM4NDZjOTc5NjM0OTYyODVhMzUxMWIxMWI4YWY5OC90YWJsZXJhbmdlOjI2Yzg0NmM5Nzk2MzQ5NjI4NWEzNTExYjExYjhhZjk4XzItMS0xLTEtMA_8a497881-2bc3-4ab3-bc9c-fc257552e6f8"
      unitRef="usd">283724000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i272e3fbf659b47e08751fee97f870e59_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZToyNmM4NDZjOTc5NjM0OTYyODVhMzUxMWIxMWI4YWY5OC90YWJsZXJhbmdlOjI2Yzg0NmM5Nzk2MzQ5NjI4NWEzNTExYjExYjhhZjk4XzItMy0xLTEtMTc2NQ_09d0834b-8115-41ed-8790-5e135f898b16"
      unitRef="usd">268755000</us-gaap:LongTermDebt>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i190b1aad115641d5b928506daad609a7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzkwODA_c42f35a2-15dd-4ef5-baf3-ebc9750c2bdb"
      unitRef="usd">586000000.0</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:InterestExpenseDebt
      contextRef="i266c72c2a75741499dc45fa4f1f47af3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzgyNDYzMzcyNDA2NjM_15862270-03ae-4424-bf37-ad633e01caf5"
      unitRef="usd">22000000.0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i8065d0a2eaf64cef95166d99a6cbe527_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzkzMzE_d4531b21-35a7-4303-ae59-4cabace3fd97"
      unitRef="usd">6500000</us-gaap:InterestExpenseDebt>
    <us-gaap:RecordedUnconditionalPurchaseObligationsTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzEwNzMy_7c45bf2b-d520-41e0-8c04-300eb06cd896">At December&#160;31, 2020, our total future payments under noncancelable unconditional purchase commitments having a remaining term of over one year were as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RecordedUnconditionalPurchaseObligationsTextBlock>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear
      contextRef="i8f47c08fe00946e393ea1524efcfa65c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2YTE4MzVlN2IxNmM0YmFiODM3MmYwYjVjNmJiZjMwNy90YWJsZXJhbmdlOjZhMTgzNWU3YjE2YzRiYWI4MzcyZjBiNWM2YmJmMzA3XzEtMS0xLTEtMA_241191b9-89a6-4781-a433-75a0790945d6"
      unitRef="usd">23064000</us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear
      contextRef="i8f47c08fe00946e393ea1524efcfa65c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2YTE4MzVlN2IxNmM0YmFiODM3MmYwYjVjNmJiZjMwNy90YWJsZXJhbmdlOjZhMTgzNWU3YjE2YzRiYWI4MzcyZjBiNWM2YmJmMzA3XzItMS0xLTEtMA_3bf195c5-422f-43d7-9861-465c33a93c71"
      unitRef="usd">20372000</us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInThirdYear
      contextRef="i8f47c08fe00946e393ea1524efcfa65c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2YTE4MzVlN2IxNmM0YmFiODM3MmYwYjVjNmJiZjMwNy90YWJsZXJhbmdlOjZhMTgzNWU3YjE2YzRiYWI4MzcyZjBiNWM2YmJmMzA3XzMtMS0xLTEtMA_f3b76fc5-2794-465a-9754-2d606e882129"
      unitRef="usd">19451000</us-gaap:RecordedUnconditionalPurchaseObligationDueInThirdYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInFourthYear
      contextRef="i8f47c08fe00946e393ea1524efcfa65c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2YTE4MzVlN2IxNmM0YmFiODM3MmYwYjVjNmJiZjMwNy90YWJsZXJhbmdlOjZhMTgzNWU3YjE2YzRiYWI4MzcyZjBiNWM2YmJmMzA3XzQtMS0xLTEtODkwMg_1f4ca474-264f-46ca-ab20-d5d6b6ffceb3"
      unitRef="usd">9220000</us-gaap:RecordedUnconditionalPurchaseObligationDueInFourthYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInFifthYear
      contextRef="i8f47c08fe00946e393ea1524efcfa65c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2YTE4MzVlN2IxNmM0YmFiODM3MmYwYjVjNmJiZjMwNy90YWJsZXJhbmdlOjZhMTgzNWU3YjE2YzRiYWI4MzcyZjBiNWM2YmJmMzA3XzUtMS0xLTEtODkwMg_2aa07cb8-2df4-4935-9774-93cc4e49406f"
      unitRef="usd">4530000</us-gaap:RecordedUnconditionalPurchaseObligationDueInFifthYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueAfterFifthYear
      contextRef="i8f47c08fe00946e393ea1524efcfa65c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2YTE4MzVlN2IxNmM0YmFiODM3MmYwYjVjNmJiZjMwNy90YWJsZXJhbmdlOjZhMTgzNWU3YjE2YzRiYWI4MzcyZjBiNWM2YmJmMzA3XzYtMS0xLTEtODkwMg_2cb4a969-a16e-4398-85d8-99e7a38d78a6"
      unitRef="usd">25501000</us-gaap:RecordedUnconditionalPurchaseObligationDueAfterFifthYear>
    <us-gaap:RecordedUnconditionalPurchaseObligation
      contextRef="i8f47c08fe00946e393ea1524efcfa65c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90YWJsZTo2YTE4MzVlN2IxNmM0YmFiODM3MmYwYjVjNmJiZjMwNy90YWJsZXJhbmdlOjZhMTgzNWU3YjE2YzRiYWI4MzcyZjBiNWM2YmJmMzA3XzQtMS0xLTEtMA_a1c17a0c-ede2-42bd-be0b-c480a607a1a0"
      unitRef="usd">102138000</us-gaap:RecordedUnconditionalPurchaseObligation>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i36aab3b4c6bf4533beccf6b9244c271d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDMvZnJhZzoxZmQ5OTlmOWMyZWQ0Y2M1OTQxYmI0NTRlZWU5NWE1My90ZXh0cmVnaW9uOjFmZDk5OWY5YzJlZDRjYzU5NDFiYjQ1NGVlZTk1YTUzXzgyNDYzMzcyNDI3MDQ_2d03d7ab-bd20-472d-89db-a5f040e6ccce"
      unitRef="usd">45000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzI5ODY_6ecb3518-8c39-447a-8119-6ab00bd54bcf">Stockholders&#x2019; equity&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shares outstanding&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares of convertible preferred and common stock were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible preferred stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Conversion into common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued in private placement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued in connection with public offering&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued on exercise of stock options, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued pursuant to vesting of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued pursuant to exercises of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued pursuant to employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued pursuant to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued upon conversion of preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2018 Sales Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, we entered into a Common Stock Sales Agreement (the &#x201c;2018 Sales Agreement&#x201d;) with Cowen and Company, LLC (&#x201c;Cowen&#x201d;), under which we could offer and sell from time to time at our sole discretion shares of our common stock through Cowen as our sales agent, in an aggregate amount not to exceed $75.0 million. Cowen may sell the shares by any method permitted by law deemed to be an &#x201c;at the market&#x201d; offering as defined in Rule 415 of the Securities Act of 1933, including without limitation sales made directly on The New York Stock Exchange, and also may sell the shares in privately negotiated transactions, subject to our prior approval. Per the terms of the agreement, Cowen receives a commission equal to 3% of the gross proceeds of the sales price of all shares sold through it as sales agent under the 2018 Sales Agreement. In March 2019, we amended the 2018 Sales Agreement to increase the aggregate amount of our common stock to be sold under this agreement to an amount not to exceed $175.0 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2020, we sold a total of 3.6 million shares of common stock under the 2018 Sales Agreement at an average price of $26.33 per share, for gross proceeds of $93.7 million and net proceeds of $90.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2019, we sold a total of 0.8&#160;million shares of common stock under the 2018 Sales Agreement at an average price of $25.71 per share, for gross proceeds of $20.2&#160;million and net proceeds of $19.5&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2018, we sold a total of 4.3 million shares of common stock under the 2018 Sales Agreement at an average price of $14.13 per share, for aggregate gross proceeds of $61.1 million and net proceeds of $58.9 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Public offerings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, we issued, in an underwritten public offering, an aggregate of 8.9&#160;million shares of our common stock at a price of $51.50 per share, for gross proceeds of $460.0&#160;million and net proceeds of approximately $434.3&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, we issued, in an underwritten public offering, an aggregate of 20.4&#160;million shares of our common stock at a price of $9.00 per share, for gross proceeds of $184.0 million and net proceeds of $173.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2019, we sold, in an underwritten public offering, an aggregate of 10.4 million shares of our common stock at a price of $19.00 per share, for gross proceeds of $196.7 million and net proceeds of $184.5 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Private placement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2017, in a private placement to certain accredited investors, we issued 5.2 million shares of common stock at a price of $8.50 per share, and 3.5 million shares of our Series A convertible preferred stock at a price of $8.50 per share, for gross proceeds of approximately $73.5 million and net proceeds of $68.9 million. The Series A preferred stock is convertible into common stock on a one-for-one basis, subject to adjustment for events such as stock splits, combinations and the like. During the year ended December 31, 2019, 3.3 million shares of Series A convertible preferred stock were converted to 3.3 million shares of common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with our acquisition of ArcherDX, in June 2020 we entered into a definitive agreement to sell $275.0&#160;million in common stock in a private placement at a price of $16.85 per share. The private placement closed in October 2020, concurrently with our acquisition of ArcherDX. We received proceeds of $5.0&#160;million from the private placement during September 2020 and the remainder of the proceeds were received in October 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common stock warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, we had outstanding warrants to purchase common stock as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expiration Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise&lt;br/&gt;Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares of Common Stock Underlying Warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants issued in exchange for CombiMatrix Series F warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The exercise price of warrants issued in exchange for CombiMatrix Series F warrants was determined pursuant to the terms of the acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockByClassTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzI5ODc_032d4e30-19ec-47de-ad04-bce42123a9fb">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares of convertible preferred and common stock were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible preferred stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Conversion into common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued in private placement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued in connection with public offering&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued on exercise of stock options, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued pursuant to vesting of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued pursuant to exercises of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued pursuant to employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued pursuant to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued upon conversion of preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockByClassTextBlock>
    <us-gaap:SharesOutstanding
      contextRef="i468f27e028dd4eabbd6a49ffcfef1827_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzMtMi0xLTEtMA_938a17e8-329f-46cb-9c9c-342b0e5997cc"
      unitRef="shares">125000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i81554310853b4484b5d45f21ba86a785_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzMtNC0xLTEtMA_e6f552f9-79e6-473c-a32f-e9e0543bc63f"
      unitRef="shares">3459000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i226038a1ff7c4ae9a815cea5810f19b6_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzMtNi0xLTEtMA_f274fa26-253a-456a-aeba-701e9dda4709"
      unitRef="shares">3459000</us-gaap:SharesOutstanding>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="ifbede5a1c6e74525ab5e6cb2315db66f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzUtMi0xLTEtMA_50aceaf0-0220-4b53-ab95-de652236983d"
      unitRef="shares">0</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="icd21f307a6594587965e4a37c05d759c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzUtNC0xLTEtMA_6341f527-58ae-495f-aad2-64b22a345ea3"
      unitRef="shares">3334000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="id9861d9436174ce2b7457414cdf1a8a5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzUtNi0xLTEtMA_35948e2b-03c3-43fe-bf15-748aa6574409"
      unitRef="shares">0</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:SharesOutstanding
      contextRef="i586e2494307941b4b023e85dc64835bc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzYtMi0xLTEtMA_b68d729a-b909-4bb4-8a3f-c5c8c2d3d039"
      unitRef="shares">125000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i468f27e028dd4eabbd6a49ffcfef1827_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzYtNC0xLTEtMA_a7a04e35-9621-402e-ab6e-dde223a78dbb"
      unitRef="shares">125000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i81554310853b4484b5d45f21ba86a785_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzYtNi0xLTEtMA_3f27a649-02d2-4493-81e6-4f92963e748e"
      unitRef="shares">3459000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i7f3778e5a29f4a89b8566f4904cf689f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzktMi0xLTEtMA_31e4f582-d092-4f64-bc8f-49a8216b1461"
      unitRef="shares">98796000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i2809c9d3c7ed495ea105d1d0909333c7_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzktNC0xLTEtMA_caf1ee30-668b-4382-adb4-c71ec0015d51"
      unitRef="shares">75481000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="ie554d3df8b1f425f9be76437e8b27488_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzktNi0xLTEtMA_e19f9198-0447-40f8-844f-807e2258ab1f"
      unitRef="shares">53597000</us-gaap:SharesOutstanding>
    <nvta:StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts
      contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEwLTItMS0xLTA_04c6d448-c578-496b-ba59-1a5860f21ca5"
      unitRef="shares">16320000</nvta:StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts>
    <nvta:StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts
      contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEwLTQtMS0xLTA_460f506a-bf77-46ef-bafa-c16eee38ebe5"
      unitRef="shares">0</nvta:StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts>
    <nvta:StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts
      contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEwLTYtMS0xLTA_c3764b7f-9f6c-4113-99bd-d13b89a33aa2"
      unitRef="shares">374000</nvta:StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzExLTItMS0xLTA_1f296ebb-559a-474b-8a55-7fddecffde1a"
      unitRef="shares">24005000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzExLTQtMS0xLTA_fd95ecf8-3943-46e9-865c-ed901492fc3a"
      unitRef="shares">11136000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzExLTYtMS0xLTA_0423182f-43be-4a3f-940b-6860983041ad"
      unitRef="shares">17103000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEyLTItMS0xLTA_1bc4cc94-d47b-46cd-a62a-702f768ed7c4"
      unitRef="shares">2659000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEyLTQtMS0xLTA_65083ef0-c756-4f80-800e-b667372a3ce5"
      unitRef="shares">468000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEyLTYtMS0xLTA_93e1a237-1772-419f-a881-36ed4840b75d"
      unitRef="shares">351000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEzLTItMS0xLTA_7aa8f4da-405a-425d-9215-84ce04f5b804"
      unitRef="shares">5304000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEzLTQtMS0xLTA_da881794-3b44-45b6-959f-747a6a0edc2a"
      unitRef="shares">2683000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzEzLTYtMS0xLTA_842d3207-1a11-4f6f-a00c-14db4a190283"
      unitRef="shares">1369000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <nvta:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE0LTItMS0xLTA_e3c84bb9-445f-4bbe-8852-ef9765275bb0"
      unitRef="shares">968000</nvta:StockIssuedDuringPeriodSharesWarrantsExercised>
    <nvta:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE0LTQtMS0xLTA_72475f0c-0cb1-4ee1-ad09-5ee547ae2157"
      unitRef="shares">31000</nvta:StockIssuedDuringPeriodSharesWarrantsExercised>
    <nvta:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE0LTYtMS0xLTA_f4fd8aad-e217-41af-aff1-14055f0a7ffe"
      unitRef="shares">1099000</nvta:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE1LTItMS0xLTA_1fc9d208-5067-4f34-ab45-e162d166d6c7"
      unitRef="shares">671000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE1LTQtMS0xLTA_2d2785bf-0e3e-44ad-8d61-6dd03a7e197b"
      unitRef="shares">455000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE1LTYtMS0xLTA_d5cc60b5-7f06-4568-aba3-246f7bd0b887"
      unitRef="shares">566000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE2LTItMS0xLTA_03ab9568-0730-4e81-9b30-b27cca055158"
      unitRef="shares">37163000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE2LTQtMS0xLTA_fcdb05e6-d61b-4569-a0ea-34623f5be18f"
      unitRef="shares">5208000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE2LTYtMS0xLTA_a3c941a9-964b-42d3-8d60-bccb6fb9acf4"
      unitRef="shares">1022000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="icf1d3c6abe394ac8929bd35ab7264bb6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE4LTItMS0xLTA_a2a01aba-3c95-4190-a3e9-96b4529fa4c9"
      unitRef="shares">0</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="i5280e5bfc27d4fa5a233da4236710f76_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE4LTQtMS0xLTA_71ee8a11-bde1-496c-80eb-b0c59147b12f"
      unitRef="shares">3334000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="ifb5cc921b0d54d34ae29de988bf5c43a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzE4LTYtMS0xLTA_8e06dbbc-a569-4e3c-8b86-309b7f733101"
      unitRef="shares">0</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:SharesOutstanding
      contextRef="i8214f3614960469ea38d28cf9303f211_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzIwLTItMS0xLTA_73d622ce-49ff-494d-85dd-a7781c040077"
      unitRef="shares">185886000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i7f3778e5a29f4a89b8566f4904cf689f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzIwLTQtMS0xLTA_9997c16c-02f4-41fd-8332-7ce1a1acc8bb"
      unitRef="shares">98796000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i2809c9d3c7ed495ea105d1d0909333c7_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTpkNjVlMTdiZGRiZWY0NGUwOGYxZjgwNzBjNWU4MTA4MC90YWJsZXJhbmdlOmQ2NWUxN2JkZGJlZjQ0ZTA4ZjFmODA3MGM1ZTgxMDgwXzIwLTYtMS0xLTA_a32c87fe-8fdd-45a2-90dc-10d4867ca5e4"
      unitRef="shares">75481000</us-gaap:SharesOutstanding>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="id86f15571c184f4ab4dc89850a302590_D20180801-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzQ1OQ_31f48be0-af32-445f-ac6e-943a9886f56e"
      unitRef="usd">75000000.0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <nvta:PercentageOfCommissionPayableOnGrossProceeds
      contextRef="i65858024a6ee4670bd95a107e05b518c_D20180801-20180831"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzg2Mw_4a8494e5-f62f-4ced-ac07-e182ed8d10eb"
      unitRef="number">0.03</nvta:PercentageOfCommissionPayableOnGrossProceeds>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i7be9af2688664a66b2e3f803d85e8307_D20190301-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzExNDc_3ffe22df-9a53-43b7-8669-67bcd03addc6"
      unitRef="usd">175000000.0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ic85e5a44169e47ba9cd182e29953f08a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDI4ODY_4cf10f10-189f-491e-88ee-0598bb2046a0"
      unitRef="shares">3600000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i91467e89bd9d48e69c729af397fac23a_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDI5Njc_67aea6e8-d6c1-44dc-8555-a764c9a9043d"
      unitRef="usdPerShare">26.33</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ic85e5a44169e47ba9cd182e29953f08a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDMwMDQ_02a129d1-4794-4e0b-b58b-b56f2b95900e"
      unitRef="usd">93700000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <nvta:NetProceedsFromIssuanceOfCommonStock
      contextRef="ic85e5a44169e47ba9cd182e29953f08a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDMwMjg_f26bc662-c2d6-48b1-97b4-426c47af66d0"
      unitRef="usd">90700000</nvta:NetProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i0937db87178b4e798b350becedc51ccc_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDMyODg_8246a3b7-8fa9-41c2-9331-18122a9efb35"
      unitRef="shares">800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="icb647a44d30c450faf1555b120835483_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDMzNjk_198b05a0-a5c1-495e-b761-b6656de0309a"
      unitRef="usdPerShare">25.71</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i0937db87178b4e798b350becedc51ccc_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDM0MDY_f02310dd-3564-4da8-9448-a11a0229d271"
      unitRef="usd">20200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <nvta:NetProceedsFromIssuanceOfCommonStock
      contextRef="i0937db87178b4e798b350becedc51ccc_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDM0MzA_aec57717-462c-44f3-bb91-a7e104cff841"
      unitRef="usd">19500000</nvta:NetProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i9d8cf03a0e974c96bbcca6588d723e4b_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzExODM_6669c138-d8bc-42ab-badf-edc691452621"
      unitRef="shares">4300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i50983d9ab9d24b97a4405cc2c8508678_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzEyNjM_dd3e64fd-1900-4868-8c9e-ad7ad11b56b4"
      unitRef="usdPerShare">14.13</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i9d8cf03a0e974c96bbcca6588d723e4b_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzEzMDk_976ea088-6c6d-4dc3-a1f7-316895d0e8b7"
      unitRef="usd">61100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <nvta:NetProceedsFromIssuanceOfCommonStock
      contextRef="i9d8cf03a0e974c96bbcca6588d723e4b_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzEzMzI_6fea1436-6b50-4b58-affa-9d54a061a011"
      unitRef="usd">58900000</nvta:NetProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i3fc482b9b4e6420fa7de24243abc75c8_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDEyNjA_b29abb68-cd7a-43a5-a6a8-2d1e4fd3970f"
      unitRef="shares">8900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ic835049fa580444680cccf150af3d6d5_I20210131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDEyNzM_39081ad1-0eb5-4dd2-b8bc-cc5d34a4418c"
      unitRef="usdPerShare">51.50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i743deb0ca96048c0ad0d0d994c7de3bc_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDEzMTE_abcf7d5d-ce95-4333-9a32-390b7d728496"
      unitRef="usd">460000000.0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <nvta:ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts
      contextRef="i743deb0ca96048c0ad0d0d994c7de3bc_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzc2OTY1ODE0MDEzMjc_de88e79b-f815-4e6c-adfb-82a5585bcb32"
      unitRef="usd">434300000</nvta:ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ia72cba2cf21e4e85808615721f1799df_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzYwNDczMTM5NTYwOTE_aefac65f-1e7c-4f5b-bc35-1e1095924dd9"
      unitRef="shares">20400000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i16d33aaa9e224dbeb56cab5c37d2117e_I20200430"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzYwNDczMTM5NTYwNzY_bfecc881-9ceb-4143-a1a7-6d6e72ba756c"
      unitRef="usdPerShare">9.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ie5a08f2fb5df43589f4951124966ba71_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzYwNDczMTM5NTYwODM_228f2ac8-5e81-47c0-8920-be3fdeda525f"
      unitRef="usd">184000000.0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <nvta:ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts
      contextRef="ie5a08f2fb5df43589f4951124966ba71_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzYwNDczMTM5NTYxMDU_d03ca799-87ab-4cc7-97e9-7558681c0463"
      unitRef="usd">173000000.0</nvta:ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="iab0062e9ec3943238240137781cd0e8e_D20190301-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzE2MTg_63d23903-9972-4b4a-a5eb-cf6fb901b158"
      unitRef="shares">10400000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ie2395cc0a9644defb0e33c2083cde3e1_I20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzE2NjI_0220f5b8-d8e4-4508-b97b-3dff683bba6d"
      unitRef="usdPerShare">19.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i407b882e58514927b4d6e234330fb0af_D20190301-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzE2OTg_bf2e56a4-7322-47bd-ada7-972c6d479f51"
      unitRef="usd">196700000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <nvta:ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts
      contextRef="i407b882e58514927b4d6e234330fb0af_D20190301-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzE3MjE_a6bed459-5959-4a62-b57b-d8dca8862993"
      unitRef="usd">184500000</nvta:ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i6d039501b157438480d3f00c8b7489fc_D20170801-20170831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIwMDg_481bfd94-c2ff-460a-9972-36eabaa9536f"
      unitRef="shares">5200000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i32e8155326254dfdbe5fdaa570c6e110_I20170831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIwNDg_9523b12d-9d64-4eb5-b92f-d763aa2abace"
      unitRef="usdPerShare">8.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i42987b8252bd433a93091bf2d1686bc0_D20170801-20170831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIwNjY_77ec03e3-793a-42a0-ac26-ac3a282d65ec"
      unitRef="shares">3500000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="if2efecf6d7544e109ede0602218829c7_I20170831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIxMzQ_6f535837-86df-4f78-a91e-7501cef9fc9a"
      unitRef="usdPerShare">8.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="i82a6b8eccfb740329aeaa15bd047f71b_D20170801-20170831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIxODQ_add14711-8006-4243-bdfd-49aff567c9bb"
      unitRef="usd">73500000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <nvta:NetProceedsFromIssuanceOfPrivatePlacement
      contextRef="i82a6b8eccfb740329aeaa15bd047f71b_D20170801-20170831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIyMDc_bd4c5df0-9aaa-4157-85cb-27899d1822c3"
      unitRef="usd">68900000</nvta:NetProceedsFromIssuanceOfPrivatePlacement>
    <nvta:PreferredStockToCommonStockConversionRatio
      contextRef="i82a6b8eccfb740329aeaa15bd047f71b_D20170801-20170831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIyNzg_d0154502-d27c-4f92-95a2-3843d407cea0"
      unitRef="number">1</nvta:PreferredStockToCommonStockConversionRatio>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="ib58041aa8f654c0bbf3e16262383a5bd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzI0MDQ_7f326999-c1a7-4834-bbc8-47597798e241"
      unitRef="shares">3300000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="ib7027e57e0c047a4b6418f097ab58a3e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzI0NzI_8d485541-8106-432d-a028-b548b6b75e4d"
      unitRef="shares">3300000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if2455da1e7a143d7851eb9d50d083334_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIyNTM5OTg4Mzc1MDY3_ada9bfca-da9c-45d7-bf5e-118f3b636d5c"
      unitRef="usd">275000000.0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="iebaff4dc5d934f078872f079f91ec08d_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIyNTM5OTg4Mzc1MDgz_19deb0e9-7fa2-4451-8a4e-73f49d591b4c"
      unitRef="usdPerShare">16.85</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="id57225c75bc24501b26be0327fa8bcbb_D20200901-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzIyNTM5OTg4Mzc1MDkx_48fbd32a-0446-4162-a636-95e77594ddfe"
      unitRef="usd">5000000.0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90ZXh0cmVnaW9uOjA0OTExZmI5NTc3YzRjNzI4NDllNmY2OGIwMGQ5OTAyXzI5OTA_3bbb7e8b-64b9-40e2-80ec-caddfe79a53d">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, we had outstanding warrants to purchase common stock as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expiration Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise&lt;br/&gt;Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares of Common Stock Underlying Warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants issued in exchange for CombiMatrix Series F warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="id2406ee2925e4cdfa9b0c5c418c48d97_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTphMTY2M2I3NDcxM2Q0MGMxYTdmYjkxODc5NTdlMDQ5NC90YWJsZXJhbmdlOmExNjYzYjc0NzEzZDQwYzFhN2ZiOTE4Nzk1N2UwNDk0XzEtNi0xLTEtMA_ffc85173-ce7f-414b-93b4-5cc1e8d3f06c"
      unitRef="usdPerShare">5.95</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="id2406ee2925e4cdfa9b0c5c418c48d97_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMDkvZnJhZzowNDkxMWZiOTU3N2M0YzcyODQ5ZTZmNjhiMDBkOTkwMi90YWJsZTphMTY2M2I3NDcxM2Q0MGMxYTdmYjkxODc5NTdlMDQ5NC90YWJsZXJhbmdlOmExNjYzYjc0NzEzZDQwYzFhN2ZiOTE4Nzk1N2UwNDk0XzEtOC0xLTEtMA_cfd20cc7-4ace-403c-baf0-74ed18c97d35"
      unitRef="shares">214154</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgyMzI_8799f795-8c14-4332-ade3-da48a1020d9c">Stock incentive plans&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock incentive plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2010, we adopted the 2010 Incentive Plan (the &#x201c;2010 Plan&#x201d;). The 2010 Plan provides for the granting of stock-based awards to employees, directors and consultants under terms and provisions established by our Board of Directors. Under the terms of the 2010 Plan, options may be granted at an exercise price not less than the fair market value of our common stock. For employees holding more than 10% of the voting rights of all classes of stock, the exercise prices for incentive and nonstatutory stock options must be at least 110% of fair market of our common stock on the grant date, as determined by our Board of Directors. The terms of options granted under the 2010 Plan may not exceed ten years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January&#160;2015, we adopted the 2015 Stock Incentive Plan (the &#x201c;2015 Plan&#x201d;), which became effective upon the closing of our initial public offering (&#x201c;IPO&#x201d;). Shares outstanding under the 2010 Plan were transferred to the 2015 Plan upon effectiveness of the 2015 Plan. The 2015 Plan provides for automatic annual increases in shares available for grant, beginning on January&#160;1, 2016 through January&#160;1, 2025. In addition, shares subject to awards under the 2010 Plan that are forfeited or terminated will be added to the 2015 Plan. The 2015 Plan provides for the grant of incentive stock options, nonstatutory stock options, restricted stock awards, stock units, stock appreciation rights and other forms of equity compensation, all of which may be granted to employees, including officers, non-employee directors and consultants. Additionally, the 2015 Plan provides for the grant of cash-based awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options granted generally vest over a period of four years. Typically, the vesting schedule for options granted to newly hired employees provides that 1/4 of the award vests upon the first anniversary of the employee&#x2019;s date of hire, with the remainder of the award vesting monthly thereafter at a rate of 1/48 of the total shares subject to the option. All other options typically vest in equal monthly installments over the four-year vesting schedule. Upon the acquisition of ArcherDX, any option that was outstanding was converted into a fully vested option to purchase a share of our common stock which resulted in the issuance of 3.7&#160;million options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs generally vest over a period of three years. Typically, the vesting schedule for RSUs provides that 1/3 of the award vests upon each anniversary of the grant date, with certain awards that include a portion that vests immediately upon grant. In June 2019, we granted Time-based RSUs in connection with the acquisition of Singular Bio which vest in three equal installments over a period of 18 months and PRSUs that vest based on the achievement of performance conditions. In December 2020, we granted RSUs in connection with an asset acquisition which vest in &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzIyNTM5OTg4Mzg2Njgy_3f341498-9f73-4766-bb53-9c8f75c67d63"&gt;two&lt;/span&gt; equal installments in December 2021 and December 2022, subject to the employee's continued service with us. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under our management incentive compensation plan, in July 2019 we granted PRSUs to our executive officers as well as other specified senior level employees based on the level of achievement of a specified 2019 revenue goal. One-third of the 0.8&#160;million shares that were ultimately awarded under this plan vested during the year ended December&#160;31, 2020 and the remaining shares will vest through March 2022. In June 2020, we granted 0.3&#160;million PRSUs under this plan which are based on the level of achievement of a specified 2020 cash burn goal. Upon achievement of the specified 2020 cash burn goal, 0.3&#160;million shares were ultimately awarded and began vesting in 2021 over a one year period. These PRSUs had a grant date fair value of $4.2&#160;million based on an estimated issuance of 0.3&#160;million shares and expectation of the performance conditions. During the year ended December&#160;31, 2020, $2.1 million was recorded as stock-based compensation expense related to the awards. No PRSUs were granted during the year ended December&#160;31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the 2010 Plan and the 2015 Plan is set forth below (in thousands, except per share amounts and years):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.844%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.428%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.212%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares Available For Grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Contractual Life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional shares reserved&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs and PRSUs granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs and PRSUs cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes the changes in time-based RSUs and PRSUs&#160;granted as a part of the Singular Bio acquisition in June 2019 and shares granted in an asset acquisition in December 2020 which are based on a fixed dollar value. The number of shares issued will be variable until the awards vest. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock options and the fair value of our common stock for stock options that were in-the-money.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average fair value of options to purchase common stock granted was $10.10, $14.52 and $4.87 in the years ended December&#160;31, 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total grant-date fair value of options to purchase common stock vested was $2.8 million, $4.3 million and $5.9 million in the year ended December&#160;31, 2020, 2019, and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intrinsic value of options to purchase common stock exercised was $104.4 million, $6.3 million and $1.7 million in the years ended December&#160;31, 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes RSU, including PRSU, activity (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time-based RSUs and PRSUs granted - variable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PRSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;&#160;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes the changes in the Time-based RSUs and PRSUs&#160;granted as a part of the Singular Bio acquisition in June 2019 and the shares granted in an asset acquisition in December 2020 which are based on a fixed dollar value. The number of shares issued will be variable until the awards vest. The weighted-average grant date fair value per share reflects the fair value pricing of the full award. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2015 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January&#160;2015, we adopted the 2015 Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;), which became effective upon the closing of the IPO. Employees participating in the ESPP may purchase common stock at 85% of the lesser of the fair market value of common stock on the purchase date or last trading day preceding the offering date. At December&#160;31, 2020, cash received from payroll deductions pursuant to the ESPP was $1.8 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ESPP provides for automatic annual increases in shares available for grant, beginning on January&#160;1, 2016 and continuing through January&#160;1, 2025. At December&#160;31, 2020, a total of 0.9&#160;million shares of common stock are reserved for issuance under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the grant date fair value of our common stock to value options when granted. In determining the fair value of stock options and ESPP purchases, we use the Black-Scholes option-pricing model and, for stock options, the assumptions discussed below. Each of these inputs is subjective and its determination generally requires significant judgment. The fair value of RSU and PRSU awards is based on the grant date share price. Compensation cost is recognized as expense on a straight-line basis over the vesting period for options and RSUs and on an accelerated basis for PRSUs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected term&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The expected term represents the period that our stock-based awards are expected to be outstanding and is determined using the simplified method (based on the midpoint between the vesting date and the end of the contractual term).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;We estimate expected volatility based on the historical volatility of our common stock over a period equal to the expected term of stock option grants and RSUs and over the expected six-month term ESPP purchase periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of the option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividend yield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;We have never paid dividends on our common stock and have no plans to pay dividends on our common stock. Therefore, we used an expected dividend yield of zero.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of share-based payments for stock options granted to employees and directors was estimated on the date of grant using the Black-Scholes option-pricing model based on the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of shares purchased pursuant to the ESPP is estimated using the Black-Scholes option pricing model. For the years ended December&#160;31, 2020, 2019 and 2018, the weighted-average grant date fair value per share for the ESPP was $10.98, $6.05 and $3.26, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the shares purchased pursuant to the ESPP was estimated using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock-based compensation expense for the years ended December&#160;31, 2020, 2019 and 2018, included in the consolidated statements of operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, unrecognized compensation expense related to unvested stock options, net of estimated forfeitures, was $3.1 million, which we expect to recognize on a straight-line basis over a weighted-average period of 2.4 years. Unrecognized compensation expense related to RSUs, including PRSUs, and awards that are contingently issuable upon the completion of certain milestones related to our acquisition of ArcherDX at December&#160;31, 2020, net of estimated forfeitures, was $144.2 million, which we expect to recognize on a straight-line basis over a weighted-average period of 1.6 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <nvta:ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage
      contextRef="ibf0c262e5e494ba1a0b9dd846e947808_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQyOA_ae20b2c9-6159-4b3b-8a8b-5d2b50ec6f50"
      unitRef="number">0.10</nvta:ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ibf0c262e5e494ba1a0b9dd846e947808_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzU1OQ_6a5d1f8a-392e-4449-9ef2-b231c53d3de9"
      unitRef="number">1.10</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="if94fe272d7e54bc5a7c51daac714d62e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzcyMQ_7743ed58-1453-4e03-adf3-da49127c7f75">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ief4a6302d24a4af294e7028833fe7fb2_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzE4MTQ_394164ed-3231-4b01-b42b-a1a4ef091ad3">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ief4a6302d24a4af294e7028833fe7fb2_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzIzMDg5NzQ0MTk1MjM0_a0d8a68f-7981-4c79-b8e1-83e6b4d514f4">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="i5a98899500704f17a6fcfb0d3cdf1f52_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzIyNTM5OTg4Mzg2NjYz_ed796af8-afad-4649-86b6-2ddfdef65b12"
      unitRef="shares">3700000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iae69da4291404d09846bdd7eea1b3df7_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzIyNDg_b51a9b32-1b10-46dd-8692-fdd758a0018c">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ibb3a6b1e9224415e90b51c05440aa312_D20190601-20190630"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzI1OTc_c4876f34-16fe-46c2-8a2e-10107a938fcb">P18M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ie879d74e4a2947429031c4d39f6c60f1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzYwNDczMTM5NjMxNzI_b2e47714-b65f-46fb-b2f3-eb238e2734e7"
      unitRef="shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2f83a392f53641de82f099c66bcd8add_D20200601-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzYwNDczMTM5NjQ0MDM_aeed2325-c7bc-4e35-a6d2-f6248fb552e4"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2f83a392f53641de82f099c66bcd8add_D20200601-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzIyNTM5OTg4Mzg3MTI0_9cd34f16-8a4a-4407-91f2-7b00623b8b10"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2f83a392f53641de82f099c66bcd8add_D20200601-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzIyNTM5OTg4MzgyMTM5_7cc3cc77-0d98-49ed-828a-20bfb62bfb8c">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="i5b24e569ebe043d1bcd9a86c0d20cfa2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzYwNDczMTM5NjQ0MzE_cc4ddfcf-3454-41af-90ca-b4d5788ece29"
      unitRef="usd">4200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i5b24e569ebe043d1bcd9a86c0d20cfa2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzYwNDczMTM5NjQ0NDY_7f5a0c5f-21c0-42f7-a1f5-4bfc88d02ae4"
      unitRef="shares">300000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie879d74e4a2947429031c4d39f6c60f1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzMyMzY_b2232656-f7b7-4c0c-894a-92f2195ee9a6"
      unitRef="usd">2100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i79688bef1f2243f8af291580e680c142_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzMzMTQ_90020926-9ad4-4520-9149-f929d3cdf73e"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgyNDY_9ae4667f-8bf9-45e0-a042-08c17b87d2af">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the 2010 Plan and the 2015 Plan is set forth below (in thousands, except per share amounts and years):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.844%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.428%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.212%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares Available For Grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Contractual Life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional shares reserved&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs and PRSUs granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs and PRSUs cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Includes the changes in time-based RSUs and PRSUs&#160;granted as a part of the Singular Bio acquisition in June 2019 and shares granted in an asset acquisition in December 2020 which are based on a fixed dollar value. The number of shares issued will be variable until the awards vest.</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i2a15e9739bdb4dd3ba91eff47a68dee8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEtMS0xLTEtMA_bc4ff232-a2f4-441c-b81c-11b90e1ec12b"
      unitRef="shares">5444000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2a15e9739bdb4dd3ba91eff47a68dee8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEtMy0xLTEtMA_6488e5f6-2825-4084-8a41-272a7b5b1a17"
      unitRef="shares">3542000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i2a15e9739bdb4dd3ba91eff47a68dee8_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEtNS0xLTEtMA_479a5238-985f-43c7-b484-a88e94513a61"
      unitRef="usdPerShare">9.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ifc2ccdad682745929752c4bdbabe6ad4_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEtNy0xLTEtMA_89db87a9-d91e-41b4-a096-704d9538d73d">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i2a15e9739bdb4dd3ba91eff47a68dee8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEtOS0xLTEtMA_363fbeea-589b-4450-8bb7-265329ec1f7c"
      unitRef="usd">24966000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzItMS0xLTEtMA_7c0e0068-07a6-4722-bea7-0cff91d35b8e"
      unitRef="shares">9019000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzMtMS0xLTEtMA_694fc3ca-b6e6-44d9-a2bf-793e81ddd0b2"
      unitRef="shares">4005000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzMtMy0xLTEtMA_ca5fd034-c600-4c2f-9848-b1c08a5f4d62"
      unitRef="shares">4005000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzMtNS0xLTEtMA_20b4d350-5a74-4099-8fa9-9e029f525c9c"
      unitRef="usdPerShare">3.74</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzQtMS0xLTEtMA_979aa475-09c1-4485-9b52-9b1524e0fc95"
      unitRef="shares">11000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzQtMy0xLTEtMA_443dd80b-15a8-44db-94c5-ec302defdcb8"
      unitRef="shares">11000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzQtNS0xLTEtMA_683af4e9-5b07-454c-b360-da8afad8d44f"
      unitRef="usdPerShare">7.05</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzUtMy0xLTEtMA_645a2199-c7b8-4d9b-a682-02f2ca63e2d0"
      unitRef="shares">2659000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzUtNS0xLTEtMA_f146d981-adc3-4038-a9b5-e55e552c56a0"
      unitRef="usdPerShare">4.04</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i4a23a8c0acc9467b8816b6d8750a8e4e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzYtMS0xLTEtMA_8a6c35c1-eb02-4a40-aeeb-ef613f6633f3"
      unitRef="shares">3502000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i4a23a8c0acc9467b8816b6d8750a8e4e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzctMS0xLTEtMA_801390f3-f8bc-416a-b620-1892488593fe"
      unitRef="shares">480000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzktMS0xLTEtMA_2584a532-bd85-429a-8ebd-7fee38cc9d5a"
      unitRef="shares">7447000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzktMy0xLTEtMA_aecf82a2-f4ad-45af-9587-7672ce8fed64"
      unitRef="shares">4877000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzktNS0xLTEtMA_040b6aea-87f5-498f-a9d3-cb0c7b3f4126"
      unitRef="usdPerShare">7.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzktNy0xLTEtMA_aa0a2863-3e82-47cd-b7a5-9ba69ffb6c4e">P6Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzktOS0xLTEtMA_da6b68b1-9d7a-462a-98b0-e94e03f18b2f"
      unitRef="usd">166130000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEwLTMtMS0xLTA_e1ddc342-3b89-455c-9cb2-8c76bbb45327"
      unitRef="shares">4432000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEwLTUtMS0xLTA_43e95927-26ed-48da-bcce-13c6ce279add"
      unitRef="usdPerShare">6.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEwLTctMS0xLTA_6801f51f-3f6a-465a-b129-0553eac26736">P6Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzEwLTktMS0xLTA_46b2e6cf-6a6d-462d-b144-b81c7f6c8ec7"
      unitRef="usd">154907000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzExLTMtMS0xLTA_36326ea1-773d-4392-81f7-e1a70f572640"
      unitRef="shares">4809000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzExLTUtMS0xLTA_a0b9579f-854f-4f5a-84e6-3503e209797c"
      unitRef="usdPerShare">7.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzExLTctMS0xLTA_f884c486-ef08-4069-bcc8-44a51a877a5f">P6Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i22b5947ce6b3433694f42047bef22a47_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZToxMzM3ZTlhOTdhNWM0YmZmOTJjZDliMDk4YzUwYjI3My90YWJsZXJhbmdlOjEzMzdlOWE5N2E1YzRiZmY5MmNkOWIwOThjNTBiMjczXzExLTktMS0xLTA_8ce76619-9069-48ab-a9a9-83363849eccf"
      unitRef="usd">164410000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQwNDQ_fcb62f62-b7c0-449f-a135-fd36f1a6ccc6"
      unitRef="usdPerShare">10.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifc2ccdad682745929752c4bdbabe6ad4_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQwNDg_98814611-e739-49da-80bc-2486f61ea2d2"
      unitRef="usdPerShare">14.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i043b18d384cc4cbbbd4ea576bf1e0ee8_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQwNTU_1806646c-183e-4620-911d-a79d4dcb45c6"
      unitRef="usdPerShare">4.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQxODU_91c9bfca-89c0-405e-b008-5d777271deec"
      unitRef="usd">2800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="ifc2ccdad682745929752c4bdbabe6ad4_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQxODk_7545b54b-d2b6-4209-a30b-55f5634e9ce1"
      unitRef="usd">4300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i043b18d384cc4cbbbd4ea576bf1e0ee8_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQxOTY_d1f9bf23-eef2-45c6-8362-db5d76b1bedc"
      unitRef="usd">5900000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQzMTc_01a7773a-01f4-48f5-b809-922ea1b73248"
      unitRef="usd">104400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ifc2ccdad682745929752c4bdbabe6ad4_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQzMjE_d1cbc394-422b-48b4-b725-f13d2affc340"
      unitRef="usd">6300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i043b18d384cc4cbbbd4ea576bf1e0ee8_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzQzMjg_35eef271-46de-43d8-99e1-cc5680fada80"
      unitRef="usd">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgyNDc_f94a26f0-3f8b-4ad1-8bae-258cf46bfa0d">&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes RSU, including PRSU, activity (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time-based RSUs and PRSUs granted - variable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PRSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&#160;(1) Includes the changes in the Time-based RSUs and PRSUs&#160;granted as a part of the Singular Bio acquisition in June 2019 and the shares granted in an asset acquisition in December 2020 which are based on a fixed dollar value. The number of shares issued will be variable until the awards vest. The weighted-average grant date fair value per share reflects the fair value pricing of the full award.</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i8df5ce0c23374e0f96f0da2ab94af033_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzEtMS0xLTEtMA_5ddae288-cb3b-40cf-822a-26e75925964a"
      unitRef="shares">8885000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i8df5ce0c23374e0f96f0da2ab94af033_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzEtMy0xLTEtMA_5c296a31-ad89-4fe7-b909-47b3121cb6d2"
      unitRef="usdPerShare">15.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzItMS0xLTEtMA_55c83930-c17b-422b-b3d0-c023db73c0e6"
      unitRef="shares">4874000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzItMy0xLTEtMA_7652d759-ab7e-4996-9a16-f45678b374d6"
      unitRef="usdPerShare">20.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <nvta:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod
      contextRef="i7d14ed300bd94484b318f56f0730a43a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzMtMS0xLTEtMA_4f61d27a-882c-4528-a6bf-0cb99aa5ed32"
      unitRef="shares">-1646000</nvta:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i7d14ed300bd94484b318f56f0730a43a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzMtMy0xLTEtMA_d16ef60f-4fde-4318-9ee3-d27417280889"
      unitRef="usdPerShare">24.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i97e8d6d759574ef190efeec1fa288be0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzQtMS0xLTEtMA_e0ef83f1-790a-4045-b224-01a72d627002"
      unitRef="shares">274000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i97e8d6d759574ef190efeec1fa288be0_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzQtMy0xLTEtMA_4d4a196b-5e61-4948-a825-e91b2e9784ed"
      unitRef="usdPerShare">16.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzUtMS0xLTEtMA_959d1905-3ffe-4d6c-a74a-03cdabf2a3db"
      unitRef="shares">5305000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzUtMy0xLTEtMA_7b213c9c-0a2f-4632-bd3e-6887f425d500"
      unitRef="usdPerShare">19.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzYtMS0xLTEtMA_973d6841-d194-49ff-b125-2ab91ed2e736"
      unitRef="shares">480000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzYtMy0xLTEtMA_99859f79-0515-42b2-a926-2fd6fdb01893"
      unitRef="usdPerShare">18.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ib230a508963e4077bf9c329a3d9e10af_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzctMS0xLTEtMA_83f39db9-d9d5-4264-afd6-0d76ffbfac45"
      unitRef="shares">6602000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ib230a508963e4077bf9c329a3d9e10af_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTo2ZjYzMzgyYjJhMmI0MjhmYTI4OTQ2ODc2YjE3YWUzMS90YWJsZXJhbmdlOjZmNjMzODJiMmEyYjQyOGZhMjg5NDY4NzZiMTdhZTMxXzctMy0xLTEtMA_6fc06be4-961d-4c70-b00f-bc2a848c5351"
      unitRef="usdPerShare">12.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="ie1bf01002c574012aeba2a32221405d2_D20150101-20150131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzUxODI_d627287d-1993-4360-856e-fa452004e291"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i842c32fb0e4d4001b6d4b09acb1051bc_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzUzODA_1d047794-5ff1-4095-bce9-4415a82d7231"
      unitRef="usd">1800000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ice92feeec65b4c99bf48cdc4f7ae3064_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzYwNDczMTM5Njc2ODk_8c2b0944-3391-48eb-a593-891beb4b2d01"
      unitRef="shares">900000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgyNDM_d5b584d9-ff74-4920-ad8f-631465d2753b">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of share-based payments for stock options granted to employees and directors was estimated on the date of grant using the Black-Scholes option-pricing model based on the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the shares purchased pursuant to the ESPP was estimated using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i9687cb514ee64df88920c8e6d2c79f5b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzItMS0xLTEtMA_3f55b497-3873-4dfb-98ad-9893faa52148">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i212150697d1b4df0b9d350151ba23788_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzItMy0xLTEtMA_0e7241aa-868d-4a52-a452-5538f028d368">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i39d9c671420c4cbfb753905344bfe23e_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzItNS0xLTEtMA_edecdef5-e5f5-4510-99ab-196c1770ff3c">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i9687cb514ee64df88920c8e6d2c79f5b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzMtMS0xLTEtMA_75d76bf8-a7a5-416b-bdfc-7e59984a13f4"
      unitRef="number">0.710</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i212150697d1b4df0b9d350151ba23788_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzMtMy0xLTEtMA_2bf14f45-7e5f-4652-a0d0-399c18a9d60c"
      unitRef="number">0.642</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i39d9c671420c4cbfb753905344bfe23e_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzMtNS0xLTEtMA_4385f481-01a8-4be8-81be-1d1cef341495"
      unitRef="number">0.596</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i9687cb514ee64df88920c8e6d2c79f5b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzQtMS0xLTEtMA_643afa1c-b48e-41f4-bb5e-0ac40a5e99af"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i212150697d1b4df0b9d350151ba23788_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzQtMy0xLTEtMA_29abc82b-1759-49f5-8a82-ed735bd08fe7"
      unitRef="number">0.026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i39d9c671420c4cbfb753905344bfe23e_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTplNDllMzMzNmVhOWQ0Mjk4YjgxZWY2OGRjM2ZmYjBkNS90YWJsZXJhbmdlOmU0OWUzMzM2ZWE5ZDQyOThiODFlZjY4ZGMzZmZiMGQ1XzQtNS0xLTEtMA_b421380d-46f8-4835-98ab-af345992e568"
      unitRef="number">0.028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i842c32fb0e4d4001b6d4b09acb1051bc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1Xzc1MTE_e7136b7c-6a42-422b-b73f-28bee59f1a39"
      unitRef="usdPerShare">10.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie5f75e5a153a43f58048be8074c30cd4_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1Xzc1MTU_566e7727-df4e-4dcb-a9e4-f53d435141b4"
      unitRef="usdPerShare">6.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iaca634719b854efb84813c2dc3f0fd0e_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1Xzc1MjI_054773fa-ebb8-411f-80d2-78ba3fd68ebf"
      unitRef="usdPerShare">3.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i842c32fb0e4d4001b6d4b09acb1051bc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzItMS0xLTEtMA_a6d10e35-0ff8-4fe4-9828-6889a2bf3f87">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ie5f75e5a153a43f58048be8074c30cd4_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzItMy0xLTEtMA_86f20018-2948-4476-9fd4-01483754acb3">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="iaca634719b854efb84813c2dc3f0fd0e_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzItNS0xLTEtMA_1ceb2a4d-9b4a-424f-a37e-416d8a38b119">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i842c32fb0e4d4001b6d4b09acb1051bc_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzMtMS0xLTEtMA_e84dc4c9-74c8-44c6-a291-458f205f369a"
      unitRef="number">1.057</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ie5f75e5a153a43f58048be8074c30cd4_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzMtMy0xLTEtMA_dba249cf-3f11-40a3-b585-86c2b57f3461"
      unitRef="number">0.663</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="iaca634719b854efb84813c2dc3f0fd0e_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzMtNS0xLTEtMA_9a9b012a-d483-4fd9-8709-c89671b28632"
      unitRef="number">0.717</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i842c32fb0e4d4001b6d4b09acb1051bc_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzQtMS0xLTEtMA_ee927dcf-8886-4f4e-a923-230657c4fcd1"
      unitRef="number">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie5f75e5a153a43f58048be8074c30cd4_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzQtMy0xLTEtMA_b336843b-56cb-4694-96c8-a18c7d210a53"
      unitRef="number">0.020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="iaca634719b854efb84813c2dc3f0fd0e_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpiNTRhNjhkOTFjMTk0Nzg2OWI3MDk4MGE0NWQ1ZjllNS90YWJsZXJhbmdlOmI1NGE2OGQ5MWMxOTQ3ODY5YjcwOTgwYTQ1ZDVmOWU1XzQtNS0xLTEtMA_1e66dcd9-ff3e-4143-8944-2bc13366ffde"
      unitRef="number">0.021</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgyNDA_952f4aff-9502-4264-aef3-501ade60c59c">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock-based compensation expense for the years ended December&#160;31, 2020, 2019 and 2018, included in the consolidated statements of operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie3381401fa094fc08b04b11cc3984e08_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzItMS0xLTEtMA_19ac5b46-f39f-491b-ab2f-d0372dae7dd6"
      unitRef="usd">8713000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id8599a661d45463f82a2aba708062fcf_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzItMy0xLTEtMA_a46aa487-602a-4ccc-862f-e4f0f9eabd83"
      unitRef="usd">4563000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i18c7b5a94cb34e1680e560d7a9eaae4c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzItNS0xLTEtMA_c75d113a-e9bb-4871-9b4d-5eac97681769"
      unitRef="usd">2960000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9ea80e59e1504ea393646ffa29e23426_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzMtMS0xLTEtMA_8a554917-28d6-4f25-a87c-4fae00f99b36"
      unitRef="usd">91762000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i513eed0ba1b74e578f8b16b9d3528e41_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzMtMy0xLTEtMA_41ab6e5e-41ca-4acf-971f-65a094900484"
      unitRef="usd">52450000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ida02d0b10c2a4069bcefe8098bf63928_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzMtNS0xLTEtMA_d828da10-f3ed-439d-954a-df1a05e7114d"
      unitRef="usd">7017000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5cf68f6fddea486e8c354682f35dc67a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzQtMS0xLTEtMA_ef5024e0-cc6d-40fd-985a-14b2f8eff50e"
      unitRef="usd">14418000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia7bbe3658f5441e29fe16218b50948b6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzQtMy0xLTEtMA_8b040f10-0164-4d61-8179-ca02d2e5e6f6"
      unitRef="usd">7641000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i74963f7211644269a32529bd0993cd1f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzQtNS0xLTEtMA_adaab54e-1d6a-4b65-91f5-54f694a0262e"
      unitRef="usd">4887000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i85ac1d76e52246da9b9419a6cfe9a0bc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzUtMS0xLTEtMA_668a45ba-b653-4416-84e6-54b770800527"
      unitRef="usd">43854000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9c65f7d592aa4164a8822f00359cee73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzUtMy0xLTEtMA_ac33c35b-8e80-4e74-8597-017c9a2d46ef"
      unitRef="usd">11294000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2cecaa430d444086b81cce9a00a27278_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzUtNS0xLTEtMA_203c0ce5-26cc-4705-ae50-94683c0b0a3f"
      unitRef="usd">5986000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzYtMS0xLTEtMA_f6fdacb2-f56c-4480-aa1b-8923c0a32f6c"
      unitRef="usd">158747000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzYtMy0xLTEtMA_93180256-cf3f-4bcb-967e-6c352a83d7d1"
      unitRef="usd">75948000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90YWJsZTpmNzliNGQ0YjAzYTg0MjdjODkwMTk5ODQwYmE4MGJhMS90YWJsZXJhbmdlOmY3OWI0ZDRiMDNhODQyN2M4OTAxOTk4NDBiYTgwYmExXzYtNS0xLTEtMA_acabfbd7-ad7f-49e0-8028-1e66042c6113"
      unitRef="usd">20850000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1Xzc5MzA_cee5a8e5-1ed3-45d1-af58-173d4aa179cf"
      unitRef="usd">3100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgwMjI_5084b8a6-6c9b-4330-814a-de661711e83e">P2Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="ib230a508963e4077bf9c329a3d9e10af_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgxMzU_323a80d8-fd2f-4e42-816b-2bf06ac461b5"
      unitRef="usd">144200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i8710f259943b46248d8a443d2b3a530a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzgyMjc_2d4d2999-5fdf-4f82-84b6-8b3f4526f03b">P1Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzUxMTE_3f89e5d3-f861-46f4-9c07-616b0a8b70eb">Income taxes&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded a benefit for income taxes in the years ended December&#160;31, 2020, 2019 and 2018. The components of net loss before taxes by U.S. and foreign jurisdictions are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the provision for income taxes are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current benefit for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94,279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,011)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred benefit for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,535)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of the tax expense computed at the statutory federal rate and our tax expense for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal taxes at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State taxes (net of federal benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences and carryforwards that give rise to significant portions of the deferred tax assets are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognition differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasing Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(209,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145,318)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization and depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,720)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasing Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(261,115)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, the Tax Cuts and Jobs Act of 2017 (the &#x201c;Tax Act&#x201d;) was signed into law making significant changes to the Internal Revenue Code. Changes included among other items, a reduction of the corporate tax rate from a top marginal rate of 35% to a flat rate of 21%. Although the Tax Act was generally effective January 1, 2018, GAAP required recognition of the tax effects of new legislation during the reporting period that includes the enactment date, which was December 22, 2017. As a result of the lower corporate tax rate enacted as part of the Tax Act, during 2017, the Company recorded a provisional estimate to reduce deferred tax assets by $48.8&#160;million offset by a corresponding reduction in the valuation allowance resulting in no net impact to our income tax benefit or expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 ("SAB 118") to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the Tax Act. In accordance with SAB 118, during 2017, we recorded a provisional estimate which resulted in a $48.8&#160;million reduction in deferred tax assets and in the fourth quarter of 2018, we completed our analysis of the impact of the Tax Act and determined that no material adjustments were required to the provisional amounts previously recorded. &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We historically established a full valuation allowance against our deferred tax assets due to the uncertainty surrounding realization of such assets. In 2020, we released approximately $112.1&#160;million of our valuation allowance to account for acquired intangibles that support the future realization of some of our deferred tax assets. Due to the overall increase of deferred tax assets, our valuation allowance also increased from the prior year. Our valuation allowance increased by $64.0&#160;million, $23.4&#160;million, and $26.3&#160;million during the years ended December 31, 2020, 2019, and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, we had net operating loss carryforwards of approximately $1.4&#160;billion and $890.6&#160;million available to reduce future taxable income, if any, for federal and state income tax purposes, respectively. Of the $1.4&#160;billion, $284.9&#160;million will begin to expire in 2030 while $1.1&#160;billion have no expiration date. The state net operating loss carryforwards will begin to expire in 2030.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, we had research and development credit carryforwards of approximately $26.2&#160;million and $17.6&#160;million available to reduce our future tax liability, if any, for federal and state income tax purposes, respectively. The federal credit carryforwards begin to expire in 2030. California credit carryforwards have no expiration date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Internal Revenue Code ("IRC") section 382 places a limitation (the &#x201c;Section 382 limitation&#x201d; or &#x201c;annual limitation&#x201d;) on the amount of taxable income that can be offset by net operating loss carryforwards after a change in control (generally greater than 50% change in ownership) of a loss corporation. Similar provisions exist for states. In addition, and as a result of the acquisitions of Good Start Genetics and CombiMatrix in 2017, acquisitions of Singular Bio, Jungla, and Clear Genetics in 2019, and acquisitions of YouScript and ArcherDX in 2020, tax loss carryforwards from acquired entities are also subject to the Section 382 limitation due to the change in control in the acquired entities in the current year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, as a result of equity issued in connection with various acquisitions, we also performed a section 382 analysis in 2020 with respect to our operating loss and credit carryforwards. We concluded while an ownership change occurred in 2019 as defined under IRC section 382, none of our net operating loss carryforwards would expire unused solely as a result of annual limitations imposed on the use of the carryforwards under IRC sections 382 and 383.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, we had unrecognized tax benefits of $22.0 million, which primarily relates to research and development credits, none of which would currently affect our effective tax rate if recognized due to our valuation allowance against our deferred tax assets. During the year, we benchmarked the reserves of similar tax positions within the industry based on IRS and state audits of comparable companies. Based on our analysis, we decreased our unrecognized tax benefits to more closely align with other comparable companies within the industry. As these reserves relate primarily to research and development credits which have a full valuation allowance, such adjustments did not impact our income tax provision. Unrecognized tax benefits are not expected to materially change in the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases&#x2014;current period tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases&#x2014;prior period tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases&#x2014;prior period tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our policy is to include penalties and interest expense related to income taxes as a component of tax expense. We have not accrued interest and penalties related to the unrecognized tax benefits reflected in the financial statements for the years ended December&#160;31, 2020, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our major tax jurisdictions are the United States and California. All of our tax years will remain open for examination by the Federal and state tax authorities for &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzQ5NTQ_150b999c-d788-453b-aa59-382e59e7d0d3"&gt;three&lt;/span&gt; and four years, respectively, from the date of utilization of the net operating loss or research and development credit. We do not have any tax audits pending.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzUxMTQ_bf78f8be-05a9-4147-903f-518922bdcc25">The components of net loss before taxes by U.S. and foreign jurisdictions are as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzItMS0xLTEtMA_52426acb-2022-40af-ad2e-d0c783e37f1f"
      unitRef="usd">-712409000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzItMy0xLTEtMA_47fa826e-a040-4f58-b700-ade40c54c8fb"
      unitRef="usd">-260531000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzItNS0xLTEtMA_5118052e-9364-454e-bb82-7d516c8df212"
      unitRef="usd">-132194000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzMtMS0xLTEtMA_783698ae-38ac-4ae8-94ea-ae29cbee5689"
      unitRef="usd">-1861000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzMtMy0xLTEtMA_3fb3a23c-bea8-4906-b053-ccc699be41fd"
      unitRef="usd">116000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzMtNS0xLTEtMA_67566231-27b7-457d-9b8a-928c8b4d173f"
      unitRef="usd">39000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzQtMS0xLTEtMA_b48f32a6-8f52-4599-b23b-bcdc881edcb9"
      unitRef="usd">-714270000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzQtMy0xLTEtMA_8afd7ad2-ad79-4fbf-833f-3c404c13a404"
      unitRef="usd">-260415000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTo3ZWVlYzQzYmRjMWE0ZGUwYTUzNDYwNjk1MDU0NDQxNi90YWJsZXJhbmdlOjdlZWVjNDNiZGMxYTRkZTBhNTM0NjA2OTUwNTQ0NDE2XzQtNS0xLTEtMA_71fc37c1-8858-4809-987f-f35643ac6864"
      unitRef="usd">-132155000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzUxMjA_c57b143c-7f9f-4796-89ca-666a4e26c2de">&lt;div style="margin-top:12pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the provision for income taxes are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current benefit for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94,279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,011)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred benefit for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,535)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzUtMS0xLTEtMA_a5e432f9-af97-46fe-a3ac-7d6997f70d51"
      unitRef="usd">171000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzUtMy0xLTEtMA_23f253e6-32cb-4adb-9a5c-24e0e09e9832"
      unitRef="usd">85000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzUtNS0xLTEtMA_aadc6757-7d8c-4bb5-b54a-6eafa403dc8d"
      unitRef="usd">62000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzYtMS0xLTEtMA_9b68624f-aa08-4a1c-aa9b-832b744ee147"
      unitRef="usd">171000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzYtMy0xLTEtMA_b925e294-da2d-466d-9969-3266193a087b"
      unitRef="usd">85000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzYtNS0xLTEtMA_3e7e372d-a2b7-42fe-b6af-c41ae64bbc5d"
      unitRef="usd">62000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzgtMS0xLTEtMA_d55a3c27-4d99-4cd5-b559-af8fe770e415"
      unitRef="usd">-94279000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzgtMy0xLTEtMA_6fbde43d-feb3-466d-ba0b-698f92d4f86d"
      unitRef="usd">-16011000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzgtNS0xLTEtMA_620fbb95-f480-48ba-9c02-75358b2b6204"
      unitRef="usd">-2862000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzktMS0xLTEtMA_c6f90cd4-2c1b-409b-9fd1-4312925a977d"
      unitRef="usd">-17730000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzktMy0xLTEtMA_71b21f72-dd0f-4b88-8379-6d569609c9fb"
      unitRef="usd">-2524000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzktNS0xLTEtMA_58d1219e-0e1e-4e27-8c8c-1cd9717ec0cc"
      unitRef="usd">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzEwLTEtMS0xLTA_2c4428f3-659e-43f2-b0f7-f6b83a81eb62"
      unitRef="usd">-262000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzEwLTMtMS0xLTA_c9bb07d7-18c8-440d-b2f7-49499e65e9a5"
      unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzEwLTUtMS0xLTA_edc5f5bd-c965-42fb-9162-a9526295c101"
      unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzExLTEtMS0xLTA_cd3ecd09-8948-4f00-94af-bdac7326395b"
      unitRef="usd">-112271000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzExLTMtMS0xLTA_1462b56b-659b-4a7a-9827-2778126c6bd3"
      unitRef="usd">-18535000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzExLTUtMS0xLTA_777161f1-b529-4790-8084-5f0fb571c2c5"
      unitRef="usd">-2862000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzEyLTEtMS0xLTA_4352390e-daff-416b-86b8-8b9a5ccbb6e0"
      unitRef="usd">-112100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzEyLTMtMS0xLTA_f805f6bf-d721-4850-aa49-588926857dd5"
      unitRef="usd">-18450000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozZDQ3YTI3NTg1MDE0MDcwODMyNGY5NjIxOTBlYzExYy90YWJsZXJhbmdlOjNkNDdhMjc1ODUwMTQwNzA4MzI0Zjk2MjE5MGVjMTFjXzEyLTUtMS0xLTA_c1bbd44e-0b0f-4bea-aae2-e1b3ec663e9a"
      unitRef="usd">-2800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzUxMTU_3380c944-9fa6-49b5-972d-8c56639e25e9">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of the tax expense computed at the statutory federal rate and our tax expense for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal taxes at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State taxes (net of federal benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzItMS0xLTEtMA_13bd4ea3-5b3a-482b-a990-e0da2ef6755f"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzItMy0xLTEtMA_439a30ae-61cf-4ad4-b101-5f16c451810d"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzItNS0xLTEtMA_aa2c96d7-1b1f-4c75-86e5-704d4b6986ae"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzMtMS0xLTEtMA_b648921d-78bb-4fe6-83e6-11f0d1e6a0e1"
      unitRef="number">0.034</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzMtMy0xLTEtMA_acf40a7e-1d4b-4df1-a6f1-698ae2974a94"
      unitRef="number">0.037</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzMtNS0xLTEtMA_dc9ce275-4eb7-4dd1-9ea8-bc7ac43e058b"
      unitRef="number">0.052</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzQtMS0xLTEtMA_390a49d2-55fc-4c8f-b034-344bbf6cb6da"
      unitRef="number">-0.016</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzQtMy0xLTEtMA_1cc52676-dc5a-4c4f-87d3-f4262daea257"
      unitRef="number">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzQtNS0xLTEtMA_e3d06c61-7782-464e-b20f-a30fae1871fe"
      unitRef="number">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzUtMS0xLTEtMA_09bac28b-e899-462c-a52b-7c5edf60bef1"
      unitRef="number">-0.011</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzUtMy0xLTEtMA_97364a56-8155-424a-8d9c-68ac511f0034"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzUtNS0xLTEtMA_d33786a5-b4a1-4722-ac10-ae3d24174a57"
      unitRef="number">-0.027</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzYtMS0xLTEtMA_7a1a0736-8783-4920-af81-e66a9f4e5184"
      unitRef="number">-0.015</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzYtMy0xLTEtMA_7a522582-c3e2-4e39-8551-bb8d1421cb34"
      unitRef="number">-0.016</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzYtNS0xLTEtMA_b9b0001d-0ba2-4353-a13f-69d7a21e6b4a"
      unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzktMS0xLTEtMA_59ffdeb9-b0d6-4131-a640-abfc6a59affd"
      unitRef="number">-0.067</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzktMy0xLTEtMA_5e73aeec-d96a-4250-be1d-8e442ee22c0f"
      unitRef="number">-0.173</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzktNS0xLTEtMA_f03912a1-59ed-4000-9a5a-d6e10e7bb351"
      unitRef="number">-0.255</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzEyLTEtMS0xLTA_0f5b0596-d049-46a0-8252-fcbdad6ee6a0"
      unitRef="number">0.157</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzEyLTMtMS0xLTA_426a901a-be73-4f63-9dad-e8ace4cbd702"
      unitRef="number">0.071</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTphNGY1YTI5N2NjZWY0ZDAxOGM3ODMwYmIyYzI3ZTExNi90YWJsZXJhbmdlOmE0ZjVhMjk3Y2NlZjRkMDE4Yzc4MzBiYjJjMjdlMTE2XzEyLTUtMS0xLTA_b6b25fb2-4d9f-4ece-8773-dc60f5050aa8"
      unitRef="number">0.021</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzUxMDk_32d8668d-75a8-4134-880a-1cb0d5ba0fe3">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences and carryforwards that give rise to significant portions of the deferred tax assets are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognition differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasing Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(209,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145,318)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization and depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,720)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasing Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(261,115)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzMtMS0xLTEtMA_c142f287-fb53-4877-833e-908fac2786e2"
      unitRef="usd">337866000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzMtMy0xLTEtMA_99ae83c1-4dc6-49b5-af3f-457ec037e255"
      unitRef="usd">173182000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzQtMS0xLTEtMA_36e122ee-eda7-49f8-82e1-19b1c9d6ac0e"
      unitRef="usd">19969000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzQtMy0xLTEtMA_e96df17e-84b5-4055-954c-25bb2352378b"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <nvta:DeferredTaxAssetsRevenueRecognitionReserves
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzUtMS0xLTEtMA_fe829d83-2fe3-413a-8f13-ef20ccee1343"
      unitRef="usd">9099000</nvta:DeferredTaxAssetsRevenueRecognitionReserves>
    <nvta:DeferredTaxAssetsRevenueRecognitionReserves
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzUtMy0xLTEtMA_6fd9533c-9f8b-4397-ab53-5298a49cba87"
      unitRef="usd">5138000</nvta:DeferredTaxAssetsRevenueRecognitionReserves>
    <nvta:DeferredTaxAssetsLeaseLiability
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzYtMS0xLTEtMA_d0d9a40b-e015-4c61-aa28-e2a22dfe4143"
      unitRef="usd">14274000</nvta:DeferredTaxAssetsLeaseLiability>
    <nvta:DeferredTaxAssetsLeaseLiability
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzYtMy0xLTEtMA_b648bd3d-f8dd-4ceb-a4a4-7628f89d6126"
      unitRef="usd">11626000</nvta:DeferredTaxAssetsLeaseLiability>
    <nvta:DeferredTaxAssetsTaxAccruedLiabilitiesAndOther
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzctMS0xLTEtMA_e258a593-aea3-410b-8b28-2bd3409b7ac4"
      unitRef="usd">37677000</nvta:DeferredTaxAssetsTaxAccruedLiabilitiesAndOther>
    <nvta:DeferredTaxAssetsTaxAccruedLiabilitiesAndOther
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzctMy0xLTEtMA_248386fb-a87c-47a9-8d10-7ee0f55f76f7"
      unitRef="usd">14391000</nvta:DeferredTaxAssetsTaxAccruedLiabilitiesAndOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzgtMS0xLTEtMA_469e9831-80f2-4f2d-9bf5-34c8e13cace6"
      unitRef="usd">418885000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzgtMy0xLTEtMA_fed49bcf-d87f-4dc9-8ec5-812e964113dd"
      unitRef="usd">204337000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzktMS0xLTEtMA_74155929-0106-40e6-b584-bfe47fa8d3b2"
      unitRef="usd">209308000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzktMy0xLTEtMA_533d87da-9c4c-4738-9dec-1ad398277278"
      unitRef="usd">145318000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzEwLTEtMS0xLTA_a96558b4-6075-467d-b960-6afd4358940a"
      unitRef="usd">209577000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzEwLTMtMS0xLTA_524f3dab-cc01-4659-8379-62a98636bc89"
      unitRef="usd">59019000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzEyLTEtMS0xLTA_d6874004-97ca-40dd-bdc0-646b2e979eb8"
      unitRef="usd">233150000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzEyLTMtMS0xLTA_df3b72b7-7a8c-4a20-8003-530b8d72c5b8"
      unitRef="usd">30875000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesFinancingArrangements
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzEzLTEtMS0xLTA_6d5d613f-6f44-4377-ac54-1e6265db5efc"
      unitRef="usd">14658000</us-gaap:DeferredTaxLiabilitiesFinancingArrangements>
    <us-gaap:DeferredTaxLiabilitiesFinancingArrangements
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzEzLTMtMS0xLTA_c8d6e9eb-0b66-471b-91b4-1b805b3e85b1"
      unitRef="usd">17720000</us-gaap:DeferredTaxLiabilitiesFinancingArrangements>
    <nvta:DeferredTaxLiabilitiesLeaseRightofUseAsset
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzE0LTEtMS0xLTA_b166c3fa-de65-49ad-90df-343b877526f1"
      unitRef="usd">13307000</nvta:DeferredTaxLiabilitiesLeaseRightofUseAsset>
    <nvta:DeferredTaxLiabilitiesLeaseRightofUseAsset
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzE0LTMtMS0xLTA_b47fe119-0ce1-4c2e-a3ab-afc8c6bd0398"
      unitRef="usd">10424000</nvta:DeferredTaxLiabilitiesLeaseRightofUseAsset>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzE1LTEtMS0xLTA_def21759-3f7b-44e6-8ce0-203bcc22aa13"
      unitRef="usd">261115000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzE1LTMtMS0xLTA_419fc8fd-6cbb-40e5-b21c-a7867bae6fda"
      unitRef="usd">59019000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzE2LTEtMS0xLTA_3ceba766-327d-44b3-9243-c289fec272bf"
      unitRef="usd">51538000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZTozMDA5ZTVhNzZkNjA0YjVhOGE2OWY3NTQwY2Y3MWQwOS90YWJsZXJhbmdlOjMwMDllNWE3NmQ2MDRiNWE4YTY5Zjc1NDBjZjcxZDA5XzE2LTMtMS0xLTA_0e205ab8-9288-4f0c-bac2-609ec371e459"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilities>
    <us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense
      contextRef="ief55ba984c4f4d3db6d80102c5abb216_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzIyNTM5OTg4MzkxMTM0_2e3dd76b-6973-419a-aaf7-13b1ec48031a"
      unitRef="usd">48800000</us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense>
    <us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense
      contextRef="ief55ba984c4f4d3db6d80102c5abb216_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzIyNTM5OTg4MzkxMTQ5_3bfc7c05-2135-4344-9d85-9eac82c3d167"
      unitRef="usd">48800000</us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense>
    <us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI2MzE_dd00ea2c-f4d2-4d2f-becf-5ef48be44b66"
      unitRef="usd">112100000</us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI2NDc_48e5fb17-aad4-48b6-a1ad-84bc244a4250"
      unitRef="usd">64000000.0</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI2NjI_e5809b8b-461f-45f4-9297-63faaa53a97c"
      unitRef="usd">23400000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI2Nzc_5b79bf53-c649-446c-b488-6e83c12a06fa"
      unitRef="usd">26300000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i859858a3113c4e09b4edddb15541a2ca_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI2OTY_1196933b-d77c-4b28-96ce-071fc573f04f"
      unitRef="usd">1400000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i61559c3568b9476ea2715a4b590e704a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI3MTA_d62db9a8-3e9f-4cd9-b52a-cce3c7f815f2"
      unitRef="usd">890600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i859858a3113c4e09b4edddb15541a2ca_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI3MjY_a3ac4122-2034-4ae5-b528-c8f381629354"
      unitRef="usd">1400000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i865f60d02fe3450983596a2fbd237a90_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI3NDA_08ff3535-dc2d-4b6d-9eb3-4a701ae509a6"
      unitRef="usd">284900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i54c826b980cc42e1988fb3773b439e74_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI3NTY_157bace5-5528-494f-9cd8-1194601a5c00"
      unitRef="usd">1100000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i56b9662e01b744d1affd87e3dbdd024d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI3NzA_34a2ed85-1d0e-4d6a-8e9a-04c5c643217d"
      unitRef="usd">26200000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i92d0ca5609ab4791a50bc6f0f888d703_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzc2OTY1ODE0MTI3ODU_5ff10fc8-287d-46a2-88be-42dd2f7979ae"
      unitRef="usd">17600000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzQxMDc_ef429c0e-f184-4f6b-91f7-f02a267cccdd"
      unitRef="usd">22000000.0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzUxMjQ_71ef1fed-defd-403e-aad8-07fa84b88696">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases&#x2014;current period tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases&#x2014;prior period tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases&#x2014;prior period tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzItMS0xLTEtMA_ff26e662-850f-4ad0-b094-e926357bdfec"
      unitRef="usd">26985000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i133819ff76b24d47a6fe9cf8b026d64f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzItMy0xLTEtMA_d715ac75-74e5-4f1a-afe4-3a65e81988d6"
      unitRef="usd">16375000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if1dffb2fad8b40ca9e2827b034550280_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzItNS0xLTEtMA_65ce8188-6463-4085-a3be-9a8aa82a3f44"
      unitRef="usd">10561000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzMtMS0xLTEtMA_24e7e080-e31c-439e-8989-fa717a39c837"
      unitRef="usd">8368000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzMtMy0xLTEtMA_46794719-4a1a-4742-8eac-59f86c3253f7"
      unitRef="usd">10311000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzMtNS0xLTEtMA_e2a68357-30c1-4c9d-992e-df3bdbccc330"
      unitRef="usd">5686000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzQtMS0xLTEtMA_e749829e-981f-4ac3-b276-bdc7054864f4"
      unitRef="usd">53000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzQtMy0xLTEtMA_49488d41-eea8-47b1-b839-9760934b6576"
      unitRef="usd">299000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzQtNS0xLTEtMA_600ba768-36fd-41e8-8cfe-c7e0f1fbc5a1"
      unitRef="usd">128000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzUtMS0xLTEtMTIyMDI_3ec4ed3b-65c4-40db-bf38-30e47828e053"
      unitRef="usd">13441000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzUtMy0xLTEtMTIyMDI_38e84d8a-68ed-4ddd-bd17-aff1e91c959c"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzUtNS0xLTEtMTIyMDI_836dcade-2ff7-4096-bf99-4e4e1ce3f3c1"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ica8df88fbc13471181f2a555e9880399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzUtMS0xLTEtMA_66f6eb6e-5138-405f-8345-0087a54d01ff"
      unitRef="usd">21965000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i7fe154ccb77e426d92286dae5aeff26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzUtMy0xLTEtMA_4c102a46-3f2a-4eee-8909-9f7f1b22b56b"
      unitRef="usd">26985000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i133819ff76b24d47a6fe9cf8b026d64f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90YWJsZToxMjNkMDA3NzUwOTM0ZDI0OGE4MjFkNTIyNmVlOGZiZi90YWJsZXJhbmdlOjEyM2QwMDc3NTA5MzRkMjQ4YTgyMWQ1MjI2ZWU4ZmJmXzUtNS0xLTEtMA_33ddb0fb-07ae-4c78-895b-3b8727179a28"
      unitRef="usd">16375000</us-gaap:UnrecognizedTaxBenefits>
    <nvta:IncomeTaxExaminationNumberOfPeriodUnderExamination
      contextRef="i627cf3443eb34249aeaac7655a38320d_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzQ5NjE_ee5e3996-e4b5-4a39-8353-bf18b7898ae2">P4Y</nvta:IncomeTaxExaminationNumberOfPeriodUnderExamination>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90ZXh0cmVnaW9uOjc5Zjg0ZjdlOGI5MjQzMTA4YzYyNWVmODE1ZjcwM2JjXzMxNg_ef67164b-3411-4035-bd28-e49746fcb262">Net loss per share&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(602,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(241,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129,355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in computing net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock equivalents have been excluded from diluted net loss per share because their inclusion would be anti-dilutive (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of common stock subject to outstanding options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of common stock subject to outstanding warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of common stock subject to outstanding RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of common stock subject to outstanding PRSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of common stock pursuant to ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of common stock underlying Series A convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of common stock subject to Convertible Senior Notes conversion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shares of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90ZXh0cmVnaW9uOjc5Zjg0ZjdlOGI5MjQzMTA4YzYyNWVmODE1ZjcwM2JjXzMxMg_48224f50-da0c-43b2-9705-c6234912c0e1">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(602,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(241,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129,355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in computing net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzItMS0xLTEtMA_52e78758-8449-4e01-b515-1a6de7ece342"
      unitRef="usd">-602170000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzItMy0xLTEtMA_80d29353-f4f4-4741-afed-79d5833b6dba"
      unitRef="usd">-241965000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzItNS0xLTEtMA_0458dfe4-3ed1-4da9-9a7f-7e10c859e1b4"
      unitRef="usd">-129355000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzMtMS0xLTEtMA_9a9a8939-e550-4e17-9aa8-9f24106b2b0f"
      unitRef="shares">134587000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzMtMy0xLTEtMA_986f0c25-b914-4869-b074-f424df82787d"
      unitRef="shares">90859000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzMtNS0xLTEtMA_ec88ff03-a966-42eb-a4a3-a967d724b5a3"
      unitRef="shares">66747000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzQtMS0xLTEtMA_840dcded-2210-4078-9a64-acefe7ef89c5"
      unitRef="usdPerShare">-4.47</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzQtMy0xLTEtMA_cb948ae6-ff35-4eac-b98d-747febaac0ea"
      unitRef="usdPerShare">-2.66</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTplYzNhOTAzNTYwZDU0MTI4YjM3ZTFhMjUxN2IwNTZiMy90YWJsZXJhbmdlOmVjM2E5MDM1NjBkNTQxMjhiMzdlMWEyNTE3YjA1NmIzXzQtNS0xLTEtMA_9de6c359-66e0-4ed1-9cfa-781d0bac5b8e"
      unitRef="usdPerShare">-1.94</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90ZXh0cmVnaW9uOjc5Zjg0ZjdlOGI5MjQzMTA4YzYyNWVmODE1ZjcwM2JjXzMxNA_50a60bc3-cf7b-4012-a3bb-31d1dd9de872">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock equivalents have been excluded from diluted net loss per share because their inclusion would be anti-dilutive (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of common stock subject to outstanding options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of common stock subject to outstanding warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of common stock subject to outstanding RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of common stock subject to outstanding PRSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of common stock pursuant to ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of common stock underlying Series A convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of common stock subject to Convertible Senior Notes conversion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shares of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia8b8eff0cc4e4594a303839728013b12_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzItMS0xLTEtMA_8a21d6c3-1ea6-4682-a729-e54deec9d578"
      unitRef="shares">6878000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i42aa1ffe56be41719edfa03ee1a676ad_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzItMy0xLTEtMA_6d352558-fc2c-4efe-bd29-f47e395de968"
      unitRef="shares">3662000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icdc9926f8d9440acbfcda346d7729365_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzItNS0xLTEtMA_03018e43-05e8-4358-8ba5-3a32870197cf"
      unitRef="shares">4028000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i50d11234658f4896a2cb7ac1ea474e67_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzMtMS0xLTEtMA_c2b3b788-9958-47dd-8e70-74196da0faf4"
      unitRef="shares">405000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i60b5dacd6ae24b4eace690f79d47b5c8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzMtMy0xLTEtMA_795da611-6fc0-469f-83dc-c151c490a656"
      unitRef="shares">592000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5cc357735b2e4b579432134168aed0ea_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzMtNS0xLTEtMA_070a0846-1037-4478-be1a-80fc12eb0e99"
      unitRef="shares">1513000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i74957556027a49b782337f801d6e878f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzQtMS0xLTEtMA_e29aca7c-8a39-480b-813f-27cc0b7aca73"
      unitRef="shares">5590000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i11b22b79bd2d4bc687f04292330d55b3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzQtMy0xLTEtMA_b92cc1c3-0355-40ed-8d07-096af29a0a3f"
      unitRef="shares">5293000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ied097690f5dc477a99c5073e45f85740_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzQtNS0xLTEtMA_10c40d36-fd5e-4d78-bbd4-7f403dffac95"
      unitRef="shares">3476000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idffc47e14f9e48b0a7c357f2a1edd12b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzUtMS0xLTEtMA_aa7c0fcf-6bea-4618-b7a1-27b1a07d495f"
      unitRef="shares">1658000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i056d7c98eb70405abd4b0748fbcab7e9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzUtMy0xLTEtMA_d2fed531-35b7-4335-b05d-3d2987684caa"
      unitRef="shares">1860000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id7824b6f46524c12b4e8ecb3fee953ff_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzUtNS0xLTEtMA_cbaa4a18-4ef5-44b5-99ea-6d1d7caff806"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iec867c6aa9fe4723b6c30bd3d93f4b55_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzYtMS0xLTEtMA_9e77c17f-cb52-41eb-bfc7-398accfb679b"
      unitRef="shares">294000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia20172a5e2204ead90215591879a2beb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzYtMy0xLTEtMA_94e2af60-3ef0-405d-8681-a19ab0c5a8b4"
      unitRef="shares">239000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3995f1e95bed45a6aeef8542e96511ae_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzYtNS0xLTEtMA_989c6ca9-7808-4cf2-9a83-bf3238ddb6ae"
      unitRef="shares">294000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8a2c42a62e2e4aefb13cd19623905faf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzctMS0xLTEtMA_f53f1bab-d6b6-4be5-9f2e-49186bd79dba"
      unitRef="shares">125000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5615bcaf3cb24df28897143410b35483_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzctMy0xLTEtMA_f86bdd8f-b474-4fb5-bdde-bdc2649ad2c4"
      unitRef="shares">702000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4ee3478f49dc43bdb576001358749eff_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzctNS0xLTEtMA_0c2d6e6e-7b77-4eb9-a621-b07b4e267dfb"
      unitRef="shares">3459000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i20c6e963b50d4140ad7de3d98e256dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzgtMS0xLTEtMA_6dd41330-9f92-4331-8c9c-60c8a9c6e167"
      unitRef="shares">8371000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ieb07f61948004d04843b243732524e95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzgtMy0xLTEtMA_a3679e5d-b394-42de-9535-0e210660dc80"
      unitRef="shares">3612000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i72ab58f3157e4792a29e684275f6f509_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzgtNS0xLTEtMA_bd83c8b8-daeb-46d0-9aa0-e874be545d79"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzktMS0xLTEtMA_7011c737-871d-455a-8375-4cd25dffa8ac"
      unitRef="shares">23321000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzktMy0xLTEtMA_edd0474f-c514-4888-bb32-58c819fbc505"
      unitRef="shares">15960000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjQvZnJhZzo3OWY4NGY3ZThiOTI0MzEwOGM2MjVlZjgxNWY3MDNiYy90YWJsZTo2MWI0ODgzOTdlOWI0YjRhYTlkOTY1NTE2NzUyOGY1Ny90YWJsZXJhbmdlOjYxYjQ4ODM5N2U5YjRiNGFhOWQ5NjU1MTY3NTI4ZjU3XzktNS0xLTEtMA_efa660e9-ad36-41d0-83aa-b6dfb6411f9d"
      unitRef="shares">12770000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90ZXh0cmVnaW9uOjUyMzVjNWNmMTY5MDRhZTBhYzIzOWMxNGM3NDRmY2E1XzIzMg_c16b1805-e541-4b43-8722-c41a58494efc">Geographic information&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue by country is determined based on the billing address of the customer and is summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, 2019 and 2018, our long-lived assets were primarily located in the United States other than operating lease assets representing our right-of-use for leased facilities in Israel and Australia.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90ZXh0cmVnaW9uOjUyMzVjNWNmMTY5MDRhZTBhYzIzOWMxNGM3NDRmY2E1XzIzNQ_5b9605c8-3175-463e-8772-b8f6826437f2">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue by country is determined based on the billing address of the customer and is summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifdb77ef12cba40759cb6e357bad02f51_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzItMS0xLTEtMA_536b1270-efd0-4d50-95dd-13b58cd66908"
      unitRef="usd">255680000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i90fd9f70a9fd4afa806aa085235719e1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzItMy0xLTEtMA_0c2acee0-b064-463d-b90c-79566b7cba79"
      unitRef="usd">202550000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd3c433db9754198990763fc88d3b083_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzItNS0xLTEtMA_fe995e0c-871a-4336-8a49-a19cd5f6e527"
      unitRef="usd">138239000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5f0bb9d47b64539b838c7aa19d3033f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzMtMS0xLTEtMA_0f07a90c-4155-4b5d-8526-77298b57f027"
      unitRef="usd">4529000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i916d5790c5474c6cb3f18a4b6f227ba6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzMtMy0xLTEtMA_c37b4e17-b71b-4d2b-963e-7229d747d6ba"
      unitRef="usd">4356000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied08cb30dbfd48dcb62017c3f188ee2a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzMtNS0xLTEtMA_56e546bb-6650-41ad-8cfd-ad90624fd0cc"
      unitRef="usd">4206000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i515b20f3a9db410289d47edad55e5a77_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzQtMS0xLTEtMA_ff9618d2-2202-4bac-aea1-03bdde5e4142"
      unitRef="usd">19389000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0264e9789ee44e2ab9f703d1a70e7335_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzQtMy0xLTEtMA_4efc7dd9-8525-43e1-b015-b88cf515477c"
      unitRef="usd">9918000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i84d0c14c0a5d4355a536eea3dc700eca_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzQtNS0xLTEtMA_4b1ef1b2-564b-4e10-9dbd-0cc8d7b3d90b"
      unitRef="usd">5254000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzUtMS0xLTEtMA_18b6f29a-22ff-4ec4-ac56-f8ce10deb7c3"
      unitRef="usd">279598000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99ced4db5a8d4a309d163b2e916a4f27_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzUtMy0xLTEtMA_c7dc0aaa-50a2-4fe6-8737-a47c54ffe23d"
      unitRef="usd">216824000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0ed1dcb2aa94c9d998ca664783907b4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMjcvZnJhZzo1MjM1YzVjZjE2OTA0YWUwYWMyMzljMTRjNzQ0ZmNhNS90YWJsZTpmNjgyMTlhMGMzYzc0ZTYxODBmNTcxNDFhNGYxMmNlMS90YWJsZXJhbmdlOmY2ODIxOWEwYzNjNzRlNjE4MGY1NzE0MWE0ZjEyY2UxXzUtNS0xLTEtMA_4c764fea-6de4-4e13-a96a-88ed34c9f4a4"
      unitRef="usd">147699000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90ZXh0cmVnaW9uOjRkNzYwNmRmM2VkOTRiOTVhYzA5ZjM1N2VkNjJjY2FjXzYzNw_0057ed7a-5dbe-4d34-8965-6b1bca76f35d">Selected quarterly data (unaudited)&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our quarterly financial information for 2020 and 2019 (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97,784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331,483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102,902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(234,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,677)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;___________________________________________________________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net loss per share is computed independently for each of the quarters presented. Therefore, the sum of quarterly net loss per share information may not equal annual net loss per share.&lt;/span&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90ZXh0cmVnaW9uOjRkNzYwNmRmM2VkOTRiOTVhYzA5ZjM1N2VkNjJjY2FjXzY0MA_a5e35020-c79f-4ca8-8ff7-b2748c9a2b66">&lt;div style="margin-top:6pt;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our quarterly financial information for 2020 and 2019 (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97,784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331,483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102,902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(234,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,677)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;___________________________________________________________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net loss per share is computed independently for each of the quarters presented. Therefore, the sum of quarterly net loss per share information may not equal annual net loss per share.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if177aa5c31294d399a4f1b9ea9366117_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzItMi0xLTEtMA_2b7f8ff6-b195-48a2-a277-e15c36cbd3e2"
      unitRef="usd">64248000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaba7a2a4e309410f8a88976be58969ff_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzItNC0xLTEtMA_139b31b4-c49e-4fe0-8171-7b0242cf0aaa"
      unitRef="usd">46191000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c5bd43459294503984672c6404ac8b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzItNi0xLTEtMA_2b137c3d-284a-453d-9966-043909011500"
      unitRef="usd">68728000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzItOC0xLTEtMA_346544b9-7c5b-427c-aba8-e0b8db276984"
      unitRef="usd">100431000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="if177aa5c31294d399a4f1b9ea9366117_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzMtMi0xLTEtMA_ed00743c-6ebd-4ed9-b079-960773ac976d"
      unitRef="usd">40422000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="iaba7a2a4e309410f8a88976be58969ff_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzMtNC0xLTEtMA_fd3853f3-3e67-4383-9aeb-30950b9fd1e5"
      unitRef="usd">42952000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i7c5bd43459294503984672c6404ac8b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzMtNi0xLTEtMA_18a1bf31-b345-4e66-beba-8791e1e00e4e"
      unitRef="usd">46643000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzMtOC0xLTEtMA_5f304afd-b027-4fb2-8a60-098b58631e91"
      unitRef="usd">68258000</us-gaap:CostOfRevenue>
    <us-gaap:OperatingIncomeLoss
      contextRef="if177aa5c31294d399a4f1b9ea9366117_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzQtMi0xLTEtMA_9450da89-fd6e-409b-aae6-b5301d6b0170"
      unitRef="usd">-97784000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaba7a2a4e309410f8a88976be58969ff_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzQtNC0xLTEtMA_855db237-7c2e-415d-8c66-75f67e57b58f"
      unitRef="usd">-142082000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7c5bd43459294503984672c6404ac8b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzQtNi0xLTEtMA_fd91891f-7cbd-4459-8df0-3c7eed17b80b"
      unitRef="usd">-80823000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzQtOC0xLTEtMA_6e791690-6b03-46ac-bf5c-4cc8d4f82cf1"
      unitRef="usd">-331483000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if177aa5c31294d399a4f1b9ea9366117_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzUtMi0xLTEtMA_b1b1c0d7-8cd5-4eac-8ffa-39f326847318"
      unitRef="usd">-98527000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaba7a2a4e309410f8a88976be58969ff_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzUtNC0xLTEtMA_870a4ec7-e912-4560-9c22-23fd9db05816"
      unitRef="usd">-166403000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7c5bd43459294503984672c6404ac8b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzUtNi0xLTEtMA_e671fbfd-67af-4362-b7cc-c39a818d8022"
      unitRef="usd">-102902000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzUtOC0xLTEtMA_cd2ba223-6db1-4414-9988-0d4fdb471ac4"
      unitRef="usd">-234338000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="if177aa5c31294d399a4f1b9ea9366117_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzYtMi0xLTEtMA_ab4d9cc9-d868-479f-83e4-930ca5fa4fdf"
      unitRef="usdPerShare">-0.99</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="iaba7a2a4e309410f8a88976be58969ff_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzYtNC0xLTEtMA_f0a212d0-9483-425d-a36d-d60e005a1675"
      unitRef="usdPerShare">-1.29</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="i7c5bd43459294503984672c6404ac8b8_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzYtNi0xLTEtMA_ac344aa7-a56c-4443-b1ae-26fa7ae8554b"
      unitRef="usdPerShare">-0.78</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzYtOC0xLTEtMA_093a0b30-4340-46cc-b89c-4249f2d7f0af"
      unitRef="usdPerShare">-1.30</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i272dd1562cfd41dbab6bd49a206984bc_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEwLTItMS0xLTA_1b0f07e5-d0cf-4956-a1cc-1199c7b7b862"
      unitRef="usd">40553000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb8a205c97a741eabfc5c124772fda7e_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEwLTQtMS0xLTA_17f4f934-9920-4e94-8db5-c3f0a6c9ba83"
      unitRef="usd">53475000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa9952ab3c9045afa4ce575e3df76321_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEwLTYtMS0xLTA_b107551b-4ee7-4ef7-b9e0-0a1a3f75355b"
      unitRef="usd">56511000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16a3b4edc4c5441aa3a7b118f61cc1ed_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEwLTgtMS0xLTA_41059e50-18b7-4fbe-b468-d84fdc9d9bb8"
      unitRef="usd">66285000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i272dd1562cfd41dbab6bd49a206984bc_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzExLTItMS0xLTA_cd965e9f-3e5f-4f6e-8920-b38296da6bea"
      unitRef="usd">21254000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="idb8a205c97a741eabfc5c124772fda7e_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzExLTQtMS0xLTA_353d0faf-54ed-4282-8d65-02524bec8bf0"
      unitRef="usd">28006000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="iaa9952ab3c9045afa4ce575e3df76321_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzExLTYtMS0xLTA_a8145fc0-f80d-4132-8c1d-fe5dcb11e40d"
      unitRef="usd">32120000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i16a3b4edc4c5441aa3a7b118f61cc1ed_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzExLTgtMS0xLTA_917efef6-402c-47c5-b425-7ea78e7b1124"
      unitRef="usd">36723000</us-gaap:CostOfRevenue>
    <us-gaap:OperatingIncomeLoss
      contextRef="i272dd1562cfd41dbab6bd49a206984bc_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEyLTItMS0xLTA_97dcb805-9ae0-4a2f-9f5e-ce5996721145"
      unitRef="usd">-36207000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idb8a205c97a741eabfc5c124772fda7e_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEyLTQtMS0xLTA_26b40c58-b53e-47bf-95f8-16fe1870a02b"
      unitRef="usd">-51886000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaa9952ab3c9045afa4ce575e3df76321_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEyLTYtMS0xLTA_3825641a-9b66-43c2-b3f5-74c885f0227a"
      unitRef="usd">-76983000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i16a3b4edc4c5441aa3a7b118f61cc1ed_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEyLTgtMS0xLTA_3f91306d-40e5-4c27-a8aa-4607ae5f5db3"
      unitRef="usd">-79036000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i272dd1562cfd41dbab6bd49a206984bc_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEzLTItMS0xLTA_0302afe3-8bf8-471b-8e22-7d335540bb92"
      unitRef="usd">-37677000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idb8a205c97a741eabfc5c124772fda7e_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEzLTQtMS0xLTA_6e8379d1-96b2-4b35-9319-e2255be315d1"
      unitRef="usd">-48676000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaa9952ab3c9045afa4ce575e3df76321_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEzLTYtMS0xLTA_e536ea02-447d-4b48-b61c-d1701aa217f8"
      unitRef="usd">-78707000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i16a3b4edc4c5441aa3a7b118f61cc1ed_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzEzLTgtMS0xLTA_f0817cb0-2c23-4aa6-a38e-f194614d3e77"
      unitRef="usd">-76905000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="i272dd1562cfd41dbab6bd49a206984bc_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzE0LTItMS0xLTA_40042451-498d-4c17-a6c3-ebba4472f3c0"
      unitRef="usdPerShare">-0.47</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="idb8a205c97a741eabfc5c124772fda7e_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzE0LTQtMS0xLTA_9db34d6c-c0dc-45e7-a8e0-38f6d7ee5cfe"
      unitRef="usdPerShare">-0.54</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="iaa9952ab3c9045afa4ce575e3df76321_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzE0LTYtMS0xLTA_29024c71-e266-49ba-9873-b3ba66de213d"
      unitRef="usdPerShare">-0.82</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="i16a3b4edc4c5441aa3a7b118f61cc1ed_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzAvZnJhZzo0ZDc2MDZkZjNlZDk0Yjk1YWMwOWYzNTdlZDYyY2NhYy90YWJsZTpiYzY4MmE3MjFiZWI0NzRlOTgwNWZhMDQxZWQwMjQ5NC90YWJsZXJhbmdlOmJjNjgyYTcyMWJlYjQ3NGU5ODA1ZmEwNDFlZDAyNDk0XzE0LTgtMS0xLTA_be1c0ec2-9f7c-4575-9ea2-bef4d89fad44"
      unitRef="usdPerShare">-0.79</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzMvZnJhZzplMzA1MTRmMDczYjI0ZmIwYjc0MWE1Mzc4Yzg3NGRiMi90ZXh0cmVnaW9uOmUzMDUxNGYwNzNiMjRmYjBiNzQxYTUzNzhjODc0ZGIyXzIyNTM5OTg4Mzc5MzAz_f1ff7c4e-abc9-42ee-a5d4-9e6a98e3385b">Subsequent eventIn February 2021, we acquired 100% of the equity interest of Reference Genomics, Inc. d/b/a One Codex "One Codex", a company developing and commercializing products and services relating to microbiome sequencing, analysis and reporting, for upfront consideration consisting of 1.2&#160;million shares of our common stock and $17.0&#160;million in cash. Up to approximately $0.1&#160;million in cash and 0.2&#160;million additional shares of our common stock are subject to a hold back to satisfy indemnification obligations that may arise following the closing. Given the timing of the closing of the transaction with One Codex, we are currently in the process of valuing the assets acquired and liabilities assumed. As a result, we are not yet able to provide the amounts to be recognized as of the acquisition date for the major classes of assets acquired and liabilities assumed and other related disclosures. We will disclose this and other related information in our Quarterly Report on Form 10-Q for the three months ending March 31, 2021.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i2c5ed2de4b2b4acc8e01d44e041365bc_I20210226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzMvZnJhZzplMzA1MTRmMDczYjI0ZmIwYjc0MWE1Mzc4Yzg3NGRiMi90ZXh0cmVnaW9uOmUzMDUxNGYwNzNiMjRmYjBiNzQxYTUzNzhjODc0ZGIyXzIyNTM5OTg4Mzc5MzA1_43718725-ee25-4314-9b4e-53a893d88db7"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i99d734e257e9441f812ed6b0c9affac9_D20210201-20210226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzMvZnJhZzplMzA1MTRmMDczYjI0ZmIwYjc0MWE1Mzc4Yzg3NGRiMi90ZXh0cmVnaW9uOmUzMDUxNGYwNzNiMjRmYjBiNzQxYTUzNzhjODc0ZGIyXzc2OTY1ODE0MDY2NTI_fdce93b6-b50c-41e8-8c41-e43b764860d4"
      unitRef="shares">1200000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i99d734e257e9441f812ed6b0c9affac9_D20210201-20210226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzMvZnJhZzplMzA1MTRmMDczYjI0ZmIwYjc0MWE1Mzc4Yzg3NGRiMi90ZXh0cmVnaW9uOmUzMDUxNGYwNzNiMjRmYjBiNzQxYTUzNzhjODc0ZGIyXzc2OTY1ODE0MDY2NjU_93bf8a96-a2a1-4a7b-b2ea-1e5586c09b89"
      unitRef="usd">17000000.0</us-gaap:PaymentsToAcquireBusinessesGross>
    <nvta:BusinessCombinationHoldbackConsiderationCash
      contextRef="i99d734e257e9441f812ed6b0c9affac9_D20210201-20210226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzMvZnJhZzplMzA1MTRmMDczYjI0ZmIwYjc0MWE1Mzc4Yzg3NGRiMi90ZXh0cmVnaW9uOmUzMDUxNGYwNzNiMjRmYjBiNzQxYTUzNzhjODc0ZGIyXzc2OTY1ODE0MDY2ODA_4b704d28-810e-46f1-9712-4f802c3270b9"
      unitRef="usd">100000</nvta:BusinessCombinationHoldbackConsiderationCash>
    <nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned
      contextRef="i99d734e257e9441f812ed6b0c9affac9_D20210201-20210226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMzMvZnJhZzplMzA1MTRmMDczYjI0ZmIwYjc0MWE1Mzc4Yzg3NGRiMi90ZXh0cmVnaW9uOmUzMDUxNGYwNzNiMjRmYjBiNzQxYTUzNzhjODc0ZGIyXzc2OTY1ODE0MDY2OTQ_64c94767-8dee-453f-ad79-17c6aee55a5d"
      unitRef="usd">200000</nvta:BusinessCombinationHoldbackConsiderationCommonStockValueAssigned>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328933592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 19, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Invitae Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001501134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-1701898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1400 16th Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Francisco<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">374-7782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NVTA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196,654,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Items&#160;10 (as to directors and Section&#160;16(a) Beneficial Ownership Reporting Compliance), 11, 12, 13 and 14 of Part&#160;III incorporate by reference information from the registrant&#8217;s proxy statement to be filed with the Securities and Exchange Commission in connection with the solicitation of proxies for the registrant&#8217;s 2021 Annual Meeting of Stockholders</span><span style="color:#1f497d;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328951192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 124,794<span></span>
</td>
<td class="nump">$ 151,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">229,186<span></span>
</td>
<td class="nump">240,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">47,722<span></span>
</td>
<td class="nump">32,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">32,030<span></span>
</td>
<td class="nump">6,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">20,200<span></span>
</td>
<td class="nump">11,384<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">453,932<span></span>
</td>
<td class="nump">442,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">66,102<span></span>
</td>
<td class="nump">37,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">45,109<span></span>
</td>
<td class="nump">36,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">6,686<span></span>
</td>
<td class="nump">6,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">981,845<span></span>
</td>
<td class="nump">125,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,863,623<span></span>
</td>
<td class="nump">126,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">13,188<span></span>
</td>
<td class="nump">6,681<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">3,430,485<span></span>
</td>
<td class="nump">781,601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">25,203<span></span>
</td>
<td class="nump">10,321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">86,058<span></span>
</td>
<td class="nump">64,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease obligation</a></td>
<td class="nump">8,789<span></span>
</td>
<td class="nump">4,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease obligation</a></td>
<td class="nump">1,695<span></span>
</td>
<td class="nump">1,855<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">121,745<span></span>
</td>
<td class="nump">81,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease obligation, net of current portion</a></td>
<td class="nump">48,357<span></span>
</td>
<td class="nump">42,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligation, net of current portion</a></td>
<td class="nump">3,123<span></span>
</td>
<td class="nump">1,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtNoncurrent', window );">Debt</a></td>
<td class="nump">104,449<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible senior notes, net</a></td>
<td class="nump">283,724<span></span>
</td>
<td class="nump">268,755<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">51,538<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">841,256<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,454,192<span></span>
</td>
<td class="nump">401,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 8)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value: 20,000 shares authorized; 125 shares issued and outstanding as of December&#160;31, 2020 and 2019</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value: 400,000 shares authorized; 185,886 and 98,796 shares issued and outstanding as of December&#160;31, 2020 and 2019, respectively</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">3,337,120<span></span>
</td>
<td class="nump">1,138,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,360,847)<span></span>
</td>
<td class="num">(758,677)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">1,976,293<span></span>
</td>
<td class="nump">379,640<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 3,430,485<span></span>
</td>
<td class="nump">$ 781,601<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238320991864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">125,000<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">125,000<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">185,886,000<span></span>
</td>
<td class="nump">98,796,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">185,886,000<span></span>
</td>
<td class="nump">98,796,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328421112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 279,598<span></span>
</td>
<td class="nump">$ 216,824<span></span>
</td>
<td class="nump">$ 147,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">198,275<span></span>
</td>
<td class="nump">118,103<span></span>
</td>
<td class="nump">80,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">240,605<span></span>
</td>
<td class="nump">141,526<span></span>
</td>
<td class="nump">63,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">168,317<span></span>
</td>
<td class="nump">122,237<span></span>
</td>
<td class="nump">74,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">324,573<span></span>
</td>
<td class="nump">79,070<span></span>
</td>
<td class="nump">52,227<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(652,172)<span></span>
</td>
<td class="num">(244,112)<span></span>
</td>
<td class="num">(122,557)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(32,332)<span></span>
</td>
<td class="num">(3,891)<span></span>
</td>
<td class="num">(2,568)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(29,766)<span></span>
</td>
<td class="num">(12,412)<span></span>
</td>
<td class="num">(7,030)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before taxes</a></td>
<td class="num">(714,270)<span></span>
</td>
<td class="num">(260,415)<span></span>
</td>
<td class="num">(132,155)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(112,100)<span></span>
</td>
<td class="num">(18,450)<span></span>
</td>
<td class="num">(2,800)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (602,170)<span></span>
</td>
<td class="num">$ (241,965)<span></span>
</td>
<td class="num">$ (129,355)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare', window );">Net loss per share, basic and diluted (in dollars per share)</a></td>
<td class="num">$ (4.47)<span></span>
</td>
<td class="num">$ (2.66)<span></span>
</td>
<td class="num">$ (1.94)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Shares used in computing net loss per share, basic and diluted</a></td>
<td class="nump">134,587<span></span>
</td>
<td class="nump">90,859<span></span>
</td>
<td class="nump">66,747<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_DiagnosticTestsMember', window );">Test revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 272,310<span></span>
</td>
<td class="nump">$ 212,473<span></span>
</td>
<td class="nump">$ 144,560<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_CollaborationAndGenomeNetworkMember', window );">Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 7,288<span></span>
</td>
<td class="nump">$ 4,351<span></span>
</td>
<td class="nump">$ 3,139<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=nvta_DiagnosticTestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=nvta_DiagnosticTestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=nvta_CollaborationAndGenomeNetworkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=nvta_CollaborationAndGenomeNetworkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328002472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (602,170)<span></span>
</td>
<td class="num">$ (241,965)<span></span>
</td>
<td class="num">$ (129,355)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized income (loss) on available-for-sale marketable securities, net of tax</a></td>
<td class="nump">10<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (602,160)<span></span>
</td>
<td class="num">$ (241,969)<span></span>
</td>
<td class="num">$ (129,189)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238329926296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common stock:</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss):</div></th>
<th class="th"><div>Additional paid-in capital:</div></th>
<th class="th">
<div>Additional paid-in capital: </div>
<div>Revision of prior period, adjustment</div>
</th>
<th class="th"><div>Accumulated deficit:</div></th>
<th class="th">
<div>Accumulated deficit: </div>
<div>Cumulative effect of accounting change</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="num">$ (171)<span></span>
</td>
<td class="nump">$ 520,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (398,598)<span></span>
</td>
<td class="nump">$ 11,241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Unrealized income (loss) on available-for-sale marketable securities, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts', window );">Common stock issued in private placement, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock issued in connection with public offering, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued on exercise of stock options, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_StockIssuedDuringPeriodValueWarrantsExercised', window );">Common stock issued pursuant to exercises of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued pursuant to employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Common stock issued or issuable pursuant to acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts', window );">Warrants issued pursuant to loan agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (129,355)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(129,355)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Dec. 31, 2018</a></td>
<td class="nump">161,839<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">678,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(516,712)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Unrealized income (loss) on available-for-sale marketable securities, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock issued in connection with public offering, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">204,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued on exercise of stock options, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_StockIssuedDuringPeriodValueWarrantsExercised', window );">Common stock issued pursuant to exercises of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued pursuant to employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Common stock issued or issuable pursuant to acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible senior notes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(241,965)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(241,965)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Dec. 31, 2019</a></td>
<td class="nump">379,640<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">1,138,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(758,677)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period (Reclassification of stock payable liabilities) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,387)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Unrealized income (loss) on available-for-sale marketable securities, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts', window );">Common stock issued in private placement, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock issued in connection with public offering, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued on exercise of stock options, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_StockIssuedDuringPeriodValueWarrantsExercised', window );">Common stock issued pursuant to exercises of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued pursuant to employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Common stock issued or issuable pursuant to acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,524,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts', window );">Warrants issued pursuant to loan agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(602,170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(602,170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Dec. 31, 2020</a></td>
<td class="nump">$ 1,976,293<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 3,337,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,360,847)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period (Reclassification of stock payable liabilities) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value in connection with private placement, net of offering costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_StockIssuedDuringPeriodValueWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_StockIssuedDuringPeriodValueWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=51819886&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from issuance costs from a share-lending arrangement entered into, in contemplation of a convertible debt offering or other financing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 20A<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=SL6757427-112606<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328305704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (602,170)<span></span>
</td>
<td class="num">$ (241,965)<span></span>
</td>
<td class="num">$ (129,355)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">39,050<span></span>
</td>
<td class="nump">16,206<span></span>
</td>
<td class="nump">13,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">158,747<span></span>
</td>
<td class="nump">75,948<span></span>
</td>
<td class="nump">20,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="nump">17,204<span></span>
</td>
<td class="nump">4,416<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationRemeasurementOfLiabilities', window );">Remeasurements of liabilities associated with business combinations</a></td>
<td class="nump">92,348<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="num">(112,100)<span></span>
</td>
<td class="num">(18,450)<span></span>
</td>
<td class="num">(2,862)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,926<span></span>
</td>
<td class="nump">5,266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity', window );">Post-combination expense for acceleration of unvested equity</a></td>
<td class="nump">91,021<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">1,425<span></span>
</td>
<td class="nump">1,095<span></span>
</td>
<td class="nump">1,168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of businesses acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(2,814)<span></span>
</td>
<td class="num">(6,131)<span></span>
</td>
<td class="num">(5,291)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(7,832)<span></span>
</td>
<td class="nump">1,645<span></span>
</td>
<td class="num">(2,848)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(2,010)<span></span>
</td>
<td class="num">(6,624)<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">895<span></span>
</td>
<td class="nump">2,026<span></span>
</td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">10,186<span></span>
</td>
<td class="nump">1,558<span></span>
</td>
<td class="num">(417)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other long-term liabilities</a></td>
<td class="nump">17,548<span></span>
</td>
<td class="nump">16,297<span></span>
</td>
<td class="nump">3,564<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(298,502)<span></span>
</td>
<td class="num">(145,053)<span></span>
</td>
<td class="num">(92,220)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable securities</a></td>
<td class="num">(280,258)<span></span>
</td>
<td class="num">(260,917)<span></span>
</td>
<td class="num">(9,680)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales of marketable securities</a></td>
<td class="nump">12,832<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,965<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from maturities of marketable securities</a></td>
<td class="nump">277,487<span></span>
</td>
<td class="nump">34,500<span></span>
</td>
<td class="nump">32,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of businesses, net of cash acquired</a></td>
<td class="num">(383,753)<span></span>
</td>
<td class="num">(33,846)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(22,865)<span></span>
</td>
<td class="num">(20,047)<span></span>
</td>
<td class="num">(5,970)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(4,026)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="num">(400,583)<span></span>
</td>
<td class="num">(280,310)<span></span>
</td>
<td class="nump">35,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts', window );">Proceeds from public offerings of common stock, net of issuance costs</a></td>
<td class="nump">263,688<span></span>
</td>
<td class="nump">204,024<span></span>
</td>
<td class="nump">112,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net</a></td>
<td class="nump">284,203<span></span>
</td>
<td class="nump">9,470<span></span>
</td>
<td class="nump">17,511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible senior notes, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">339,900<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from issuance of debt, net</a></td>
<td class="nump">129,214<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">93,909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments of debt extinguishment costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,638)<span></span>
</td>
<td class="num">(4,609)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfLoanCosts', window );">Loan payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(75,000)<span></span>
</td>
<td class="num">(60,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(4,112)<span></span>
</td>
<td class="num">(2,985)<span></span>
</td>
<td class="num">(2,100)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">672,993<span></span>
</td>
<td class="nump">464,771<span></span>
</td>
<td class="nump">157,152<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(26,092)<span></span>
</td>
<td class="nump">39,408<span></span>
</td>
<td class="nump">100,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">157,572<span></span>
</td>
<td class="nump">118,164<span></span>
</td>
<td class="nump">17,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">131,480<span></span>
</td>
<td class="nump">157,572<span></span>
</td>
<td class="nump">118,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">12,130<span></span>
</td>
<td class="nump">4,731<span></span>
</td>
<td class="nump">6,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental cash flow information of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsIncurred', window );">Equipment acquired through finance leases</a></td>
<td class="nump">4,463<span></span>
</td>
<td class="nump">1,892<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property and equipment in accounts payable and accrued liabilities</a></td>
<td class="nump">1,869<span></span>
</td>
<td class="nump">2,422<span></span>
</td>
<td class="nump">510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Warrants issued pursuant to debt agreement</a></td>
<td class="nump">27,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common stock issued for acquisitions</a></td>
<td class="nump">1,157,958<span></span>
</td>
<td class="nump">108,573<span></span>
</td>
<td class="nump">6,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1', window );">Consideration payable for acquisitions</a></td>
<td class="nump">940,829<span></span>
</td>
<td class="nump">21,449<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease assets obtained in exchange for lease obligations, net</a></td>
<td class="nump">$ 14,058<span></span>
</td>
<td class="nump">$ 4,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Post-Combination Expense for Acceleration of Unvested Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationRemeasurementOfLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination remeasurement of liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationRemeasurementOfLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods and also includes other current operating assets not separately disclosed in the statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of public offerings of common stock net of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in lease obligation from new lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payables that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfLoanCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan origination associated cost which is usually collected through escrow.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfLoanCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328310024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and description of business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Organization and description of business</a></td>
<td class="text">Organization and description of businessInvitae Corporation ("Invitae," &#8220;the Company," "we," "us," and "our") was incorporated in the State of Delaware on January 13, 2010, as Locus Development, Inc. and we changed our name to Invitae Corporation in 2012. We offer high-quality, comprehensive, affordable genetic testing across multiple clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, personalized oncology, metabolic conditions and rare diseases. To augment our offering and realize our mission, we have acquired multiple assets including four businesses in 2020, which expanded our suite of genome management offerings and established a broader entry into oncology therapy selection and personalized cancer monitoring.In October 2020, we completed the acquisition of ArcherDX, Inc. (&#8220;ArcherDX&#8221;). ArcherDX is a genomics company democratizing precision oncology by offering a suite of products and services that are accurate, personal, actionable and easy to use in local settings, thereby empowering clinicians to control the sample, data, patient care and economics. ArcherDX&#8217;s development platform, including its proprietary Anchored Multiplex PCR, ("AMP"), chemistry at the core, is enabling clinical tests and services that allow for therapy selection and cancer monitoring in community locations for the first time at scale. Invitae operates in one segment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238325085160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of significant accounting policies</a></td>
<td class="text">Summary of significant accounting policies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of consolidation</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include our accounts and the accounts of our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We base these estimates on current facts, historical and anticipated results, trends and various other assumptions that we believe are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those judgments, estimates and assumptions. We evaluate our estimates on an ongoing basis.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates and assumptions made by management include the determination of:</span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">revenue recognition; </span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the fair value of assets and liabilities associated with business combinations; </span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the impairment assessment of goodwill and intangible assets; </span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the valuation of our 2.00% convertible senior notes due 2024 issued in September 2019 ("Convertible Senior Notes");</span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the recoverability of long-lived assets; </span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our incremental borrowing rates used to calculate our lease balances;</span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">stock-based compensation expense and the fair value of awards and warrants issued; and</span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">income tax uncertainties.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of credit risk and other risks and uncertainties</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to a concentration of credit risk consist of cash, cash equivalents, marketable securities and accounts receivable. Our cash and cash equivalents are held by financial institutions in the United States. Such deposits may exceed federally insured limits.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant customers are those that represent 10% or more of our total revenue for each year presented on the consolidated statements of operations. Our revenue from significant customers as a percentage of our total revenue was as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:26.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.878%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.979%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.979%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No customers represented more than 10% of accounts receivable as of December&#160;31, 2020 or 2019. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, cash equivalents, and restricted cash</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all highly liquid investments with original maturities of three months or less from the date of purchase to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds, U.S. treasury notes and government agency securities.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash consists primarily of money market funds that secure irrevocable standby letters of credit that serve as collateral for security deposits for our facility leases.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:70.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,389&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,572&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable securities</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All marketable securities have been classified as &#8220;available-for-sale&#8221; and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its marketable debt securities at the time of purchase and reevaluates such designation at each balance sheet date. Short-term marketable securities have maturities one year or less at the balance sheet date. Unrealized gains and losses are excluded from earnings and are reported as a component of other comprehensive loss. Realized gains and losses and impairments, if any, on available-for-sale securities are included in other expense, net. The cost of securities sold is based on the specific-identification method. Interest on marketable securities is included in other income (expense), net. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For marketable securities in an unrealized loss position, we assess our intent to sell, or whether it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis. If either of these criteria are met, the security&#8217;s amortized cost basis is written down to fair value through other income (expense), net.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts receivable</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive payment from patients, biopharmaceutical partners, third-party payers and other business-to-business customers. See Note 3, "Revenue, accounts receivable and deferred revenue" for further information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a contract liability when cash payments are received or due in advance of our performance related to one or more performance obligations. See Note 3, "Revenue, accounts receivable and deferred revenue" for further information. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our inventory consists of raw materials, work in progress, and finished goods, which are stated at the lower of cost or net realizable value on a first-in, first-out basis. We periodically analyze our inventory levels and expiration dates, and write down inventory that has become obsolete, inventory that has a cost basis in excess of its net realizable value, and inventory in excess of expected sales requirements as cost of revenue. We record an allowance for obsolete inventory using an estimate based on historical trends and evaluation of near-term expirations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply Financial Accounting Standards Board ("FASB"), Accounting Standards Codification ("ASC") 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires recognition of assets acquired, liabilities assumed, and contingent consideration at their fair value on the acquisition date with subsequent changes recognized in earnings; requires acquisition-related expenses and restructuring costs to be recognized separately from the business combination and expensed as incurred; requires in-process research and development to be capitalized at fair value as an indefinite-lived intangible asset until completion or abandonment; and requires that changes in accounting for deferred tax asset valuation allowances and acquired income tax uncertainties after the measurement period be recognized as a component of provision for taxes.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for acquisitions of entities that include inputs and processes and have the ability to create outputs as business combinations. The tangible and identifiable intangible assets acquired and liabilities assumed in a business combination are recorded based on their estimated fair values as of the business combination date, including identifiable intangible assets which either arise from a contractual or legal right or are separable from goodwill. We base the estimated fair value of identifiable intangible assets acquired in a business combination on independent third-party valuations that use information and assumptions provided by our management, which consider our estimates of inputs and assumptions that a market participant would use. Any excess purchase price over the estimated fair value assigned to the net tangible and identifiable intangible assets acquired and liabilities assumed is recorded to goodwill. The use of alternative valuation assumptions, including estimated revenue projections, growth rates, estimated cost savings, cash flows, discount rates, estimated useful lives and probabilities surrounding the achievement of contingent milestones could result in different purchase price allocations and amortization expense in current and future periods.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In circumstances where an acquisition involves a contingent consideration arrangement that meets the definition of a liability under ASC Topic 480, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities from Equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We remeasure this liability each reporting period and record changes in the fair value as general and administrative expense.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs associated with acquisitions are expensed as incurred in general and administrative expenses. Results of operations and cash flows of acquired companies are included in our operating results from the date of acquisition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortizable intangible assets include trade names, non-compete agreements, patent licensing agreements, favorable leases, developed technology, customer relationships, and rights to develop new technology acquired as part of business combinations. Customer relationships acquired through our business combinations in 2017 are amortized on an accelerated basis, utilizing free cash flows, over periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzY4NQ_d2037801-faba-4d7d-9a9d-b880ce2dc05c">five</span> to 12 years. All other intangible assets subject to amortization are amortized using the straight-line method over their estimated useful lives ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzgzOQ_4c24a27f-0da2-4313-a3a1-cf19d3484ec4">two</span> to 15 years. All intangible assets subject to amortization are reviewed for impairment in accordance with ASC 360, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 350, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 350&#8221;), our goodwill is not amortized but is tested for impairment on an annual basis or whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. Under ASC 350, we perform annual impairment reviews of our goodwill balance during the fourth fiscal quarter or more frequently if business factors indicate. In testing for impairment, we compare the fair value of our reporting unit to its carrying value including the goodwill of that unit. If the carrying value, including goodwill, exceeds the reporting unit&#8217;s fair value, we will recognize an impairment loss for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. The loss recognized cannot exceed the total amount of goodwill allocated to that reporting unit. We did not incur any goodwill impairment losses in any of the periods presented.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In-process research and development </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets related to in-process research and development costs (&#8220;IPR&amp;D&#8221;) are considered to be indefinite-lived until the completion or abandonment of the associated research and development efforts. If and when development is complete, the associated assets would be deemed finite-lived and would then be amortized based on their respective estimated useful lives at that point in time. During this period, the assets will not be amortized but will be tested for impairment on an annual basis and between annual tests if we become aware of any events occurring or changes in circumstances that would indicate a reduction in the fair value of the IPR&amp;D projects below their respective carrying amounts. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter and if business factors indicate more frequently, we perform an assessment of the qualitative factors affecting the fair value of our IPR&amp;D projects. If the fair value exceeds the carrying value, there is no impairment. Impairment losses on indefinite-lived intangible assets are recognized based solely on a comparison of the fair value of an asset to its carrying value, without consideration of any recoverability test. We have not identified any such impairment losses to date. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 842, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we determine if an arrangement is a lease at inception. Operating leases are included in operating lease assets and operating lease obligations in our consolidated balance sheets. Finance leases are included in other assets and finance lease obligations in our consolidated balance sheets. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at commencement based on the present value of lease payments over the lease term. We generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments. The operating lease asset also includes any lease payments made and is adjusted for lease incentives. Our lease terms may include options to extend or terminate the lease which are recognized when it is reasonably certain that we will exercise that option. Leases with terms of 12 months or less are not recorded on our balance sheet. Lease expense is recognized on a straight-line basis over the lease terms, or in some cases, the useful life of the underlying asset. We account for the lease and non-lease components as a single lease component.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and equipment, net</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMTE2Mjg_1217d9ea-71ec-462e-9a23-2257607bd016">three</span> and seven years. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the term of the lease. Maintenance and repairs are charged to expense as incurred, and improvements and betterments are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in the consolidated statements of operations in the period realized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated useful lives of property and equipment are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:50.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.000%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Automobiles</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing and Laboratory equipment</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of lease term or estimated useful life</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-lived assets</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. An impairment loss is recognized when the total estimated future undiscounted cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount. Impairment, if any, is assessed using discounted cash flows or other appropriate measures of fair value. There were no long-lived asset impairment losses recorded for any period presented.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair value of financial instruments</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments consist principally of cash and cash equivalents, marketable securities, accounts payable, accrued liabilities, finance leases, and liabilities associated with business combinations. The carrying amounts of certain of these financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued and other current liabilities approximate their current fair value due to the relatively short-term nature of these accounts. Based on borrowing rates available to us, the carrying value of finance leases approximate their fair values. Liabilities associated with business combinations are recorded at their estimated fair value. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration it expects to be entitled to in exchange for those goods or services. All revenues are generated from contracts with customers. We utilize the following practical expedients and exemptions:</span></div><div style="margin-top:3pt;padding-left:63pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Costs to obtain or fulfill a contract are expensed when incurred because the amortization period would have been one year or less, and</span></div><div style="margin-top:3pt;padding-left:63pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">No adjustments to promised consideration were made for financing as we expect, at contract inception, that the period between the transfer of a promised good or service and when the customer pays for that good or service will be one year or less.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Test revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Test revenue is comprised of testing services and sales of distributed precision oncology products. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our test revenue is generated from genetic testing, in addition to somatic testing for therapy selection and personalized cancer monitoring. These testing services provide analysis and associated interpretation of the sequencing of parts of the genome. Test orders are placed under signed requisitions or contractual agreements, and we often enter into contracts with biopharmaceutical partners, other business-to-business customers (e.g., hospitals, clinics, medical centers) and insurance companies that include pricing provisions under which such tests are billed. Billing terms are generally net 30 to 60 days.  </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the transaction price of diagnostic tests is originally established either via contract or pursuant to our standard list price, we often provide concessions for tests billed to insurance carriers, and therefore the transaction price for patient insurance-billed tests is considered to be variable and revenue is recognized based on an estimate of the consideration to which we will be entitled at an amount for which it is probable that a reversal of cumulative consideration will not occur. Making these estimates requires significant judgments based upon such factors as length of payer relationship, historical payment patterns, changes in contract provisions and insurance reimbursement policies. These judgments are reviewed each reporting period and updated as necessary.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We look to transfer of control in assessing timing of recognition of revenue in connection with each performance obligation. In general, revenue in connection with the service portion of our diagnostic tests is recognized upon delivery of the underlying clinical report or when the report is made available on our web portal. Outstanding performance obligations pertaining to orders received but for which the underlying report has not been issued are generally satisfied within a 30-day period. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also generate test revenue through the sale of our precision oncology products, which is comprised primarily of sales of our distributed research use only ("RUO ") and in vitro diagnostics ("IVD") products for therapy selection. We recognize revenue on these sales once shipment has occurred. Product sales are recorded net of discounts and other deductions. Billing terms are generally net 30 days. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling fees billed to customers are recorded as revenue on the consolidated statements of operations. The associated shipping and handling costs are recorded as cost of revenue.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue is primarily generated from pharma development services provided to biopharmaceutical companies related to companion diagnostic development as well as through collaboration agreements and genome network contracts.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts for companion diagnostic development consist primarily of milestone-based payments along with annual fees and marked-up pass-through costs. The arrangements are treated as short-term contracts for revenue recognition purposes because they allow termination of the agreements by the customers with 30 to 120 days&#8217; written notice without a termination penalty. Upon termination, customers are required to pay for the proportion of services provided under milestones that were in progress. We recognize revenue in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. We recognize revenue over time based on the progress made toward achieving the performance obligation, utilizing both input or output methods, depending on the performance obligation, including labor hours expended, tests processed, or time elapsed, that measure our progress toward the achievement of the milestone.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We also enter into collaboration and genome network contracts. Collaboration agreements provide customers with diagnostic testing and related data aggregation reporting services that are provided over the contract term. Collaboration revenue is recognized as the data and reporting services are delivered to the customer. Genome network offerings consist of subscription services related to a proprietary software platform designed to connect patients, clinicians, advocacy organizations, researchers and therapeutic developers to accelerate the understanding, diagnosis and treatment of hereditary disease. Such services are recognized on a straight-line basis over the subscription periods. Amounts due under collaboration and genome network agreements are typically billable on net 30-day terms. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue reflects the aggregate costs incurred in delivering our genetic offerings and includes expenses for personnel-related costs including stock-based compensation, materials and supplies, royalties, regulatory fees, commercialization fees, equipment and infrastructure expenses associated with testing and allocated overhead including rent, equipment depreciation, information technology costs, amortization of acquired intangibles and utilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License Agreements</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered and may continue to enter into license agreements to access and utilize certain technology. We evaluate if the license agreement results in the acquisition of an asset or a business and then determine if the acquired asset has the ability to generate revenues or is subject to regulatory approval. When regulatory approval is not required, we record the license as an asset and amortize it over the estimated economic life. When regulatory approval is required, we record the amount paid as a research and development expense.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. Significant judgment is required in determining the net valuation allowance which includes our evaluation of all available evidence including past operating results, estimates on future taxable income and acquisition-related tax assets and liabilities.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We historically established a full valuation allowance against our deferred tax assets due to the uncertainty surrounding realization of such assets. In 2020, we released approximately $112.1&#160;million of our valuation allowance to account for acquired intangibles that support the future realization of some of our deferred tax assets. Due to the overall increase of deferred tax assets, our valuation allowance has also increased from the prior year.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure stock-based payment awards made to employees and directors based on the estimated fair values of the awards and recognize the compensation expense over the requisite service period. We use the Black-Scholes option-pricing model to estimate the fair value of stock option awards and employee stock purchase plan (&#8220;ESPP&#8221;) purchases. The fair value of restricted stock unit (&#8220;RSU&#8221;) awards with time-based vesting terms is based on the grant date share price. We grant performance-based restricted stock unit (&#8220;PRSU&#8221;) awards to certain employees which vest upon the achievement of certain performance conditions, subject to the employees&#8217; continued service relationship with us. The probability of vesting is assessed at each reporting period and compensation cost is adjusted based on this probability assessment. We recognize such compensation expense on an accelerated vesting method.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense for awards without a performance condition is recognized using the straight-line method. Stock-based compensation expense is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. As such, our stock-based compensation is reduced for estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for stock issued in connection with business combinations based on the fair value on the date of issuance.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising expenses are expensed as incurred. We incurred advertising expenses of $11.4 million, $9.9 million and $0.6 million during the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive loss</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss is composed of two components: net loss and other comprehensive income (loss). Other comprehensive income (loss) refers to gains and losses that under U.S. GAAP are recorded as an element of stockholders&#8217; equity, but are excluded from net loss. Our other comprehensive income (loss) consists of unrealized gains or losses on investments in available-for-sale securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net loss per share</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, without consideration of common stock equivalents. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common share equivalents outstanding for the period determined using the treasury stock method. Potentially dilutive securities, consisting of preferred stock, options to purchase common stock, common stock warrants, shares of common stock pursuant to ESPP, common stock issuable in connection with our Convertible Senior Notes, RSUs and PRSUs, are considered to be common stock equivalents and were excluded from the calculation of diluted net loss per share because their effect would be antidilutive for all periods presented. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prior period reclassifications</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts in prior periods to conform with current presentation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Immaterial correction of an error</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined the historical classification of certain acquisition-related obligations as equity and the subsequent measurement of such obligations was inappropriate and instead should have been classified as liabilities and subsequently measured at fair value with changes recognized in other expense, net during the year ended December 31, 2020. We determined that the impact of the error to previously issued consolidated financial statements was not material and have corrected the immaterial error in the current period financial statements.&#160;The impact of this correction was an increase to other long-term liabilities of $10.1&#160;million, a corresponding decrease to additional paid-in capital of $10.4&#160;million and an increase to other income, net of $0.3&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent accounting pronouncements</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate all Accounting Standards Updates (&#8220;ASUs&#8221;) issued by the Financial Accounting Standards Board ("FASB") for consideration of their applicability. ASUs not included in the disclosures in this report were assessed and determined to be either not applicable or are not expected to have a material impact on our consolidated financial statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently issued accounting pronouncements not yet adopted </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06,&#160;Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which simplifies the accounting for certain convertible instruments, amends the guidance on derivative scope exceptions for contracts in an entity's own equity, and modifies the guidance on diluted earnings per share calculations as a result of these changes. This new standard is effective for our interim and annual periods beginning January 1, 2022, and earlier adoption is permitted. We may elect to apply the amendments on a retrospective or modified retrospective basis. We are currently evaluating the impact of the adoption of this standard on our consolidated financial statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently adopted accounting pronouncements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016,&#160;FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires measurement and recognition of expected credit losses for financial assets. This guidance became effective for us beginning in the first quarter of 2020 and was adopted using a modified retrospective approach, with certain exceptions. The adoption of Topic 326 did not have a material impact on our consolidated financial statements as credit losses are not expected to be significant.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our adoption of Topic 326, we assess our accounts receivables for expected credit losses at each reporting period by disaggregating by payer type and further by portfolios of customers with similar characteristics, such as customer type and geographic location. We then review each portfolio for expected credit losses based on historical payment trends as well as forward looking data and current economic trends. If a credit loss is determined, we record a reduction to our accounts receivable balance with a corresponding general and administrative expense.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Topic 326, we no longer evaluate whether our available-for-sale debt securities in an unrealized loss position are other than temporarily impaired. Instead, we assess whether such unrealized loss positions are credit-related. Our expected loss allowance methodology for these securities is developed by reviewing the extent of the unrealized loss, the issuers&#8217; credit ratings and any changes in those ratings, as well as reviewing current and future economic market conditions and the issuers&#8217; current status and financial condition. The credit-related portion of unrealized losses, and any subsequent improvements, are recorded in other income (expense), net. Unrealized gains and losses that are not credit-related are included in accumulated other comprehensive income (loss). </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2019, we adopted the provisions of ASC Topic 842, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> using the modified retrospective approach in accordance with Topic 842. Adoption of Topic 842 had a material impact on our consolidated balance sheets, but did not have an impact on our consolidated statements of operations. We elected the package of practical expedients permitted under the transition guidance which, among other things, allowed us to carry forward the historical classification of leases in place as of January 1, 2019. We did not identify any material embedded leases with the adoption of Topic 842 and therefore the implementation of Topic 842 primarily focused on the treatment of our previously identified leases. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period amounts were not adjusted and continue to be reported in accordance with our historic accounting under previous lease guidance, ASC 840, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 840, we rented facilities under operating lease agreements and recognized related rent expense on a straight-line basis over the term of the applicable lease agreement. Some of the lease agreements contained rent holidays, scheduled rent increases, lease incentives, and renewal options. Rent holidays and scheduled rent increases were included in the determination of rent expense recorded over the lease term. Lease incentives were recognized as a reduction of rent expense on a straight-line basis over the term of the lease. Renewals were not assumed in the determination of the lease term unless they were deemed to be reasonably assured at the inception of the lease. We recognized rent expense beginning on the date we obtained the legal right to use and control the leased space.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238323794360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue, accounts receivable and deferred revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue, accounts receivable and deferred revenue</a></td>
<td class="text">Revenue, accounts receivable and deferred revenue <span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Test revenue is generated from sales of diagnostic tests and precision oncology products to four groups of customers: biopharmaceutical partners; patients who pay directly; patients' insurance carriers; and other business-to-business customers (e.g., hospitals, clinics, medical centers). Test revenue is generated in two ways: through a centralized lab and decentralized through the shipment of reactions to biopharma partners and other business-to-business customers. We refer to the set of reagents needed to perform a next-generation sequencing test as a "reaction." Amounts billed and collected, and the timing of collections, vary based on the type of payer. Other revenue consists principally of revenue recognized under contracts for pharma development services and other collaboration and genome network agreements and is accounted for under the provisions provided in ASC 606, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue as disaggregated by payer category and revenue subtype is as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"><tr><td style="width:1.0%"/><td style="width:29.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.289%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Patient</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biopharma partner</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other business-to-business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Direct</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Test revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centralized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decentralized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total test revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,026&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,972&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,065&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,247&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272,310&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,026&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,972&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,553&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,047&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,598&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"><tr><td style="width:1.0%"/><td style="width:29.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.289%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Patient</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biopharma partner</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other business-to-business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Direct</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Test revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centralized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total test revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,597&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,953&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,447&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,824&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"><tr><td style="width:1.0%"/><td style="width:29.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.289%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Patient</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biopharma partner</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other business-to-business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Direct</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Test revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centralized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total test revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,352&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,796&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,962&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,699&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue related to billings based on estimates of the amount that will ultimately be realized. Cash collections for certain tests delivered may differ from rates originally estimated. As a result of new information, we update our estimate quarterly of the amounts to be recognized for previously delivered tests which resulted in the following increases to revenue and decreases to our loss from operations and basic and diluted net loss per share (in millions, except per share amounts):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.05)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our billable volumes decreased significantly in the second half of March 2020 as compared to the first few months of 2020 as a result of COVID-19 and related limitations and priorities across the healthcare system. Our daily test volumes have consistently increased from the low in March 2020, although we are currently still experiencing changes in product mix due to the impact of COVID-19. COVID-19 could have a material impact on our financial results for the foreseeable future, particularly on product mix and as a result, the revenue we recognize. We have reviewed and adjusted for the impact of COVID-19 on our estimates related to revenue recognition and expected credit losses. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 8% of our workforce as of March 31, 2020 was impacted by a reduction in force in April 2020 in an initiative to manage costs and cash burn that resulted in one-time costs in the second quarter of 2020 of $3.8&#160;million. In addition, effective May 2020, we have reduced the salaries of our named executive officers by approximately 20%, which reductions ceased as of January 2021.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was signed into law which was a stimulus bill intended to bolster the economy, among other things, and provide assistance to qualifying businesses and individuals. The CARES Act included an infusion of funds into the healthcare system, and in April 2020, we received $3.8&#160;million as a part of this initiative. This payment was recognized as other income (expense), net in our consolidated statement of operations during the year ended December 31, 2020. We also received $2.3&#160;million in January 2021 which we recognized as other income (expense), net during the three months ended March 31, 2021. At this time, we are not certain of the availability, extent or impact of any future relief provided under the CARES Act.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our accounts receivable represents amounts billed to pharmaceutical partners and other business-to-business customers for test and other revenue recognized, and estimated amounts to be collected from third-party insurance payers for genetic testing revenue recognized. Also included are amounts due under the terms of collaboration and genome network agreements for diagnostic testing and data aggregation reporting services provided and proprietary platform access rights transferred. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also record unbilled revenue for revenue recognized but yet to be billed for services provided to biopharmaceutical companies related to companion diagnostic development. The amount is a contract receivable and is included in accounts receivable on the consolidated balance sheets; unbilled revenue was $4.3&#160;million and nil as of December&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a contract liability when cash payments are received or due in advance of our performance related to one or more performance obligations. The deferred revenue balance primarily consists of advanced billings for pharma development services, including billings at the initiation of a performance-based milestones, and recognized as revenue in the applicable future period when the revenue is earned. Also included are prepayments related to our consumer direct channel. We recognized revenue of $1.4 million from deferred revenue for the year ended as of December&#160;31, 2020. In addition, we recognized deferred revenue of $4.8 million upon the acquisition of ArcherDX in October 2020, $2.0 million of which was recognized as revenue during the year ended December 31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238323897496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business combinations</a></td>
<td class="text">Business combinations<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Singular Bio</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, we acquired 100% of the fully diluted equity of Singular Bio, a privately held company developing single molecule detection technology, for approximately $57.3&#160;million, comprised of $53.9&#160;million in the form of 2.5&#160;million shares of our common stock and the remainder in cash. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We granted approximately $90.0&#160;million of restricted stock units ("RSU") under our 2015 Stock Incentive Plan as inducement awards to new employees who joined Invitae in connection with our acquisition of Singular Bio. $45.0&#160;million of the RSUs are time-based and vested in three equal installments in December 2019, June 2020, and December 2020, subject to the employee's continued service with us ("Time-based RSUs") and $45.0&#160;million of the RSUs are performance-based RSUs ("PRSU") that vest upon the achievement of certain performance conditions. Since the number of awards granted is based on a 30-day volume weighted-average share price with a fixed dollar value, these Time-based RSUs and PRSUs are liability-classified and the fair value is estimated at each reporting period based on the number of shares that are expected to be issued at each reporting date and our closing stock price, which combined are categorized as Level 3 inputs. Therefore, fair value of the RSUs and PRSUs and the number of shares to be issued will not be fixed until the awards vest.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2020 and 2019, we recorded research and development stock-based compensation expense of $29.1&#160;million and $14.7&#160;million, respectively, related to the Time-based RSUs, and $19.4&#160;million and $24.4&#160;million, respectively, related to the PRSUs based on our evaluations of the probability of achieving performance conditions. As of December&#160;31, 2020, the Time-based RSUs and PRSUs had a total fair value of $43.9&#160;million and $43.8&#160;million, respectively, based on a total estimated issuance of 3.5&#160;million shares and expectation of the achievement of the performance conditions. As of December&#160;31, 2020, 2.0&#160;million of the Time-based RSUs and 1.2&#160;million of the PRSUs had vested with a total fair value of $75.0&#160;million which was recorded in common stock issued or issuable pursuant to acquisitions in the consolidated statements of stockholders' equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Jungla</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, we acquired 100% of the equity interest of Jungla, a privately held company developing a platform for molecular evidence testing in genes, for approximately $59.0&#160;million, comprised of $44.9&#160;million in the form of shares of our common stock and the remainder in cash.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to pay contingent consideration based on achievement of post-closing development milestones. As of the acquisition date, the fair value of this contingent consideration was $10.7&#160;million including cash and common stock. These milestones are expected to be completed within two years of the date of acquisition, two of which were completed during the year ended December&#160;31, 2020. The material factors that may impact the fair value of the contingent consideration, and therefore, this liability, are the probabilities and timing of achieving the related milestones and the discount rate we used to estimate the fair value, which are Level 3 inputs not supported by market activity. Significant changes in any of the probabilities of success would result in a significant change in the fair value, which will be estimated at each reporting date with changes reflected as a general and administrative expense. As of December&#160;31, 2020, the fair value of this contingent consideration was $7.1&#160;million. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon acquisition, we had a stock payable liability related to our acquisition of Jungla which represents the hold-back obligation to issue 0.2&#160;million shares subject to indemnification claims that may arise. This liability was adjusted at each reporting period based on the fair value of our common stock, which is a Level 3 input, with the change recorded in other income (expense), net. During July 2020, the hold-back shares were remitted in full to the former owners of Jungla. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clear Genetics</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we acquired 100% of the equity interest of Clear Genetics, a developer of software for providing genetic services at scale, for approximately $50.1&#160;million. Of the cash and stock purchase price consideration issued, $0.2&#160;million of cash and approximately 0.4&#160;million shares of our common stock were subject to a 12-month hold back to satisfy indemnification obligations that  were released during the year ended December 31, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diploid</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we acquired 100% of the equity interest of Diploid, a developer of artificial intelligence software capable of diagnosing genetic disorders using sequencing data and patient information, for approximately $82.3&#160;million in cash and shares of our common stock. Of the stock purchase price consideration issued, approximately 0.4&#160;million shares are subject to a hold-back to satisfy indemnification obligations that may arise. We included the financial results of Diploid in our consolidated financial statements from the acquisition date, which were not material for the year ended December&#160;31, 2020.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the purchase price recorded as a part of the acquisition of Diploid (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hold-back consideration - common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,314&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:31.5pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired and liabilities assumed are recorded based on valuations derived from estimated fair value assessments and assumptions used by us. While we believe that our estimates and assumptions underlying the valuations are reasonable, different estimates and assumptions could result in different valuations assigned to the individual assets acquired and liabilities assumed, and the resulting amount of goodwill. The following table summarizes the fair values of assets acquired and liabilities assumed through our acquisition of Diploid at the date of acquisition (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identifiable assets acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,314&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:31.5pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the guidance provided in ASC 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accounted for the acquisition of Diploid as a business combination and determined that 1) Diploid was a business which combines inputs and processes to create outputs, and 2) substantially all of the fair value of gross assets acquired was not concentrated in a single identifiable asset or group of similar identifiable assets. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchase price allocation for the acquisition is preliminary and subject to revision as additional information about fair value of assets and liabilities becomes available, primarily related to our deferred tax liability assumed in connection with the acquisition. Additional information that existed as of the acquisition date but at the time was unknown to us may become known to us during the remainder of the measurement period, a period not to exceed 12 months from the acquisition date. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measured the identifiable assets and liabilities assumed at their acquisition date fair values separately from goodwill. The intangible asset acquired is developed technology related to Diploid's artificial intelligence technology platform. The fair value of the developed technology was estimated using an income approach with an estimated useful life of nine years. As of the acquisition date, we recorded a stock payable liability of $7.5&#160;million to represent the hold-back obligation to issue 0.4&#160;million shares subject to indemnification claims that may arise. This liability is adjusted at each reporting period based on the fair value of our common stock, which is a Level 3 input. As of December&#160;31, 2020, the value of this liability was $17.7&#160;million with the change recorded in other income (expense), net.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired. The acquisition of Diploid resulted in the recognition of $50.7&#160;million of goodwill which we believe relates primarily to expansion of the acquired technology to apply to new areas of genetic testing. The goodwill created as a result of the acquisition of Diploid is not deductible for the foreign local tax purposes.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we granted 0.2&#160;million RSUs with a fair value of $3.6&#160;million under our 2015 Stock Incentive Plan as inducement awards in connection with our acquisition of Diploid. These RSUs vest in two equal installments, in April 2021 and April 2022. The value of the awards was recognized as research and development stock-based compensation upon grant in June 2020 as there were no ongoing obligations required by the award recipients. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Genelex and YouScript</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, we acquired 100% of the equity interest of Genelex and YouScript to bring pharmacogenetic testing and integrated clinical decision support to Invitae. We acquired Genelex for approximately $13.2&#160;million, </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily in shares of our common stock. Of the stock purchase price consideration issued, approximately 0.1&#160;million shares are subject to a hold-back to satisfy indemnification obligations that may arise. We acquired YouScript for approximately $52.7&#160;million, including cash consideration of $24.5&#160;million and the remaining in shares of our common stock. Of the purchase price consideration for YouScript, approximately $1.4&#160;million and 0.5&#160;million shares of our common stock are subject to a hold-back to satisfy indemnification obligations that may arise. We included the financial results of Genelex and YouScript in our consolidated financial statements from the acquisition date, which were not material for the year ended December 31, 2020. We recorded $1.7&#160;million of transaction costs related to the acquisition of Genelex and YouScript as general and administrative expense during the year ended December 31, 2020.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to pay contingent consideration in the form of additional shares of our common stock in connection with the acquisition of Genelex if, within a specified period following the closing, we achieve a certain product milestone, in which case we would issue shares of our common stock with a value equal to a portion of the gross revenues actually received by us for a pharmacogenetic product reimbursed through certain payers during an earn-out period of up to four years. As of the acquisition date, the fair value of this contingent consideration was $2.0&#160;million in the form of shares of our common stock. The material factors that may impact the fair value of the contingent consideration, and therefore, this liability, are the probabilities and timing of achieving the related milestone, the estimated revenues achieved for a pharmacogenetic product and the discount rate we used to estimate the fair value, which are Level 3 inputs not supported by market activity. Significant changes in any of the probabilities of success would result in a significant change in the fair value, which is estimated at each reporting date with changes reflected as general and administrative expense. As of December&#160;31, 2020, the fair value of this contingent consideration was $1.2&#160;million. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the purchase prices recorded as a part of the acquisition of Genelex and YouScript (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.290%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.290%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Genelex</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">YouScript</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash transferred</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Hold-back consideration - cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Hold-back consideration - common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Common stock transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13,210&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">52,703&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">65,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired and liabilities assumed are recorded based on valuations derived from estimated fair value assessments and assumptions used by us. While we believe that our estimates and assumptions underlying the valuations are reasonable, different estimates and assumptions could result in different valuations assigned to the individual assets acquired and liabilities assumed, and the resulting amount of goodwill. The following table summarizes the fair values of assets acquired and liabilities assumed through our acquisitions of Genelex and YouScript at the date of acquisition (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"><tr><td style="width:1.0%"/><td style="width:42.686%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.254%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Genelex</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">YouScript</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">25,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total identifiable assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9,463&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">35,684&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(481)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(801)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net identifiable assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9,143&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22,977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">32,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13,210&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">52,703&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">65,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the guidance provided in ASC 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accounted for the acquisitions of Genelex and YouScript as business combinations and determined that 1) Genelex and YouScript were businesses which combine inputs and processes to create outputs, and 2) substantially all of the fair value of gross assets acquired were not concentrated in a single identifiable asset or group of similar identifiable assets. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchase price allocation for the acquisitions is preliminary and subject to revision as additional information about fair value of assets and liabilities becomes available, primarily related to our deferred tax liability assumed. Additional information that existed as of the acquisition date but at the time was unknown to us may become known to us during the remainder of the measurement period, a period not to exceed 12 months from the acquisition date. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measured the identifiable assets and liabilities assumed at their acquisition date fair values separately from goodwill. The intangible assets acquired are the developed technologies related to Genelex's and YouScript's technology platforms. The fair value of the developed technologies were estimated using an income approach with an estimated useful life of eight years. As of the acquisition date, we recorded stock payable liabilities of $6.2&#160;million to represent the hold-back obligation to issue shares subject to indemnification claims that may arise. These liabilities are adjusted at each reporting period based on the fair value of our common stock, which is a Level 3 input. As of December&#160;31, 2020, the value of this liability was $21.6&#160;million with the change recorded in other income (expense), net.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired. The acquisitions of Genelex and YouScript resulted in the recognition of $33.8&#160;million of goodwill which we believe relates primarily to future functionality and expansion of the acquired technologies. Of the goodwill recognized, $29.7&#160;million related to the YouScript acquisition is not deductible for tax purposes.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ArcherDX</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we entered into a definitive agreement with ArcherDX, a genomics analysis company democratizing precision oncology, and in October 2020, the closing conditions were met and the transaction was consummated. Under the terms of the agreement, we acquired 100% of the equity interest of ArcherDX&#160;for $2.3&#160;billion, comprised of $2.0&#160;billion in the form of our common stock, $2.0&#160;million in liabilities, and the remainder in cash. We incurred $20.9&#160;million of transaction costs related to the acquisition of ArcherDX which we recorded as general and administrative expense during the year ended December 31, 2020. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to pay contingent consideration based on achievement of post-closing development and revenue milestones. As of the acquisition date, the total fair value of the contingent consideration was $945.2&#160;million, $933.6&#160;million of which was included in the purchase price and $11.6&#160;million recognized as non-recurring post-combination compensation expense. Of this $933.6&#160;million, $925.1 million would be in the form of shares of our common stock which will be priced at the time of the milestone achievement, and the remainder in cash. The milestones are expected to be completed within approximately two years from the date of the acquisition, with one of them being achieved during November 2020 which resulted in the issuance of 5.0&#160;million shares of our common stock and a cash payment of $1.9&#160;million. This milestone achievement subsequent to the acquisition date resulted in the recognition of $40.6&#160;million general and administrative expense. The material factors that may impact the fair value of the contingent consideration, and therefore the liability, are (i) the estimated number of shares issued, (ii) the volatility assumptions of our common stock used in the Monte Carlo simulation, (iii) the probabilities and timing of achievement of milestones and (iv) discount rates, all of which are Level 3 inputs not supported by market activity. Significant changes in any of these inputs may result in a significant change in fair value, which is estimated at each reporting date with changes reflected as general and administrative expense. As of December&#160;31, 2020, the fair value of the contingent consideration representing the remaining milestones was $788.3&#160;million.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition, all of ArcherDX's equity awards outstanding and unvested prior to the acquisition became fully vested per the terms of the agreement. The acceleration of vesting required us to allocate the fair value of the equity attributable to the pre-combination service to the purchase price and the remaining amount of $125.8&#160;million, inclusive of $11.6&#160;million in contingent consideration, to non-recurring post-combination expense which we recognized as general and administrative expense during the year ended December 31, 2020. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We included the financial results of ArcherDX in our consolidated financial statements from the acquisition date, which contributed $16.2&#160;million and $24.8&#160;million of revenue and net loss, respectively, during the year ended December 31, 2020.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the purchase price and post-combination expense recorded as a part of the acquisition of ArcherDX (in millions):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.463%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.465%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Post-combination Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration and liabilities incurred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,331.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired and liabilities assumed are recorded based on valuations derived from estimated fair value assessments and assumptions used by us. While we believe that our estimates and assumptions underlying the valuations are reasonable, different estimates and assumptions could result in different valuations assigned to the individual assets acquired and liabilities assumed, and the resulting amount of goodwill. The following table summarizes the fair values of assets acquired and liabilities assumed through our acquisition of ArcherDX at the date of acquisition (in millions):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable assets acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identifiable assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,652.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,331.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the guidance provided in ASC 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accounted for the acquisition of ArcherDX as a business combination and determined that 1) ArcherDX was a business which combines inputs and processes to create outputs, and 2) substantially all of the fair value of gross assets acquired was not concentrated in a single identifiable asset or group of similar identifiable assets. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchase price allocation for the acquisition is preliminary and subject to revision as additional information about fair value of assets and liabilities becomes available, primarily related to our deferred tax liability assumed in connection with the acquisition. Additional information that existed as of the acquisition date but at the time was unknown to us may become known to us during the remainder of the measurement period, a period not to exceed 12 months from the acquisition date. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measured the identifiable assets and liabilities assumed at their acquisition date fair values separately from goodwill. The intangible assets acquired are the developed technology related to ArcherDX's artificial intelligence technology platform, IPR&amp;D for its STRATAFIDE and PCM products, ArcherDX's customer relationships in place at the time of acquisition, and the ArcherDX tradename. We also acquired the right to develop new technology through an existing agreement for the development and commercialization of sequencing-based companion diagnostics between ArcherDX and a vendor. The fair value of our intangible assets acquired as of the acquisition date and the method used to value these assets as well as the estimated economic lives for amortizable intangible assets were as follows (in millions, except estimated useful life which is in years):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.244%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.744%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.744%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated useful life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation method</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization expense</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">With-and-without</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling and marketing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Relief from royalty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling and marketing</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Multi-period excess earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right to develop new technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost approach</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">512.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Multi-period excess earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Not applicable</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">803.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired. The acquisition of ArcherDX resulted in the recognition of $1.7&#160;billion of goodwill which we believe relates primarily to the anticipated benefits of synergies created through the acquisition and assembled workforce. The acquisition of ArcherDX advances our objectives to create a comprehensive offering that provides testing services for disease risk, therapy selection and personalized cancer monitoring to enable precision approaches to cancer treatment. Goodwill created as a result of the acquisition of ArcherDX is not deductible for tax purposes.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded an income tax benefit of $109.5&#160;million in the three months ended December 31, 2020 due to net deferred tax liabilities assumed in connection with our acquisition of ArcherDX which provided a future source of income to support the realization of our deferred tax assets and resulted in a partial release of our valuation allowance.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition, we granted inducement awards of Invitae common stock to new employees who joined Invitae in connection with our acquisition of ArcherDX with an estimated fair value of $112.2&#160;million, net of estimated forfeitures. These awards vest upon the achievement of the contingent consideration milestones discussed above and are subject to the employee&#8217;s continued service with us, unless terminated without cause in which case vesting is only dependent on milestone achievement. As the number of shares that are expected to be issued are fixed, the awards are equity-classified. During the year ended December&#160;31, 2020, we recorded $41.2&#160;million in stock-based compensation expense based on our probability of milestone achievement. Included in the stock-based compensation expense is $2.1&#160;million related to the acceleration of stock-based compensation expense due to the termination of an employee without cause whereby the employee's continued service is not required. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pro forma financial information (unaudited)</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audited pro forma financial information in the table below summarizes the combined results of operations for Invitae and ArcherDX as though the companies had been combined as of January 1, 2019. The pro forma amounts have been adjusted for:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">transaction expenses incurred by ArcherDX and us,</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">depreciation expense resulting from the fair value of the acquired property and equipment,</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">amortization expense resulting from the acquired intangible assets,</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the elimination of historical interest expense incurred by ArcherDX on its debt and debt-like items and the incurrence of interest expense related to the issuance of debt in connection with the acquisition,</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lease expense resulting from the step-up in the operating lease obligation and operating lease asset,</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">nonrecurring post-combination expense,</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">income tax benefits resulting from the deferred tax liabilities acquired, and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the 26.3&#160;million shares of our common stock issued upon the closing of the ArcherDX transaction.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma financial information is for informational purposes only and is not necessarily indicative of the results of operations that would have been achieved as if the acquisition had taken place as of January 1, 2019 (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.704%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.852%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,389&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(685,589)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(355,818)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238323792552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and intangible assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and intangible assets</a></td>
<td class="text">Goodwill and intangible assets<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amounts of goodwill were as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,777&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired - Diploid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired - Genelex</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,067&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired - YouScript</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired - ArcherDX</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,652,398&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,863,623&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents details of our acquired intangible assets as of December&#160;31, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:33.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Useful Life<br/>(in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Estimated Remaining<br/>Useful Life<br/>(in Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,075&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,013)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patent licensing agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right to develop new technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022,252&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,407)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition-related intangibles included in the above table are finite-lived, other than in-process research and development which has an indefinite life, and are carried at cost less accumulated amortization. Customer relationships related to our 2017 business combinations are being amortized on an accelerated basis, in proportion to estimated cash flows. All other finite-lived acquisition-related intangibles are being amortized on a straight-line basis over their estimated lives, which approximates the pattern in which the economic benefits of the intangible assets are expected to be realized. Amortization expense was $26.6 million, $7.7 million, and $5.0 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. Intangible assets are carried at cost less accumulated amortization. Amortization expense is recorded to cost of revenue, research and development, sales and marketing and general and administrative expense.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our estimated future amortization expense of intangible assets with finite lives as of December&#160;31, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:84.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,910&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,401&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,388&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,356&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,292&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated future amortization expense</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,457&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>In December 2020, we entered into an agreement to acquire technology focused on informing clinical decisions for $2.9&#160;million. We accounted for this transaction as an asset acquisition of developed technology which will be amortized over eight years, initially to research and development expense. In connection with this transaction, we granted approximately $6.2&#160;million of RSUs under our 2015 Stock Incentive Plan as inducement awards to new employees who joined Invitae. These RSUs are time-based and vest in two equal installments in December 2021 and December 2022, subject to the employee's continued service with us. For $5.4&#160;million of these awards, the number of awards granted are based on the lower of the 20-day volume weighted-average share price prior to the vesting date and the date of close, both with a fixed dollar value, and therefore, these RSUs are liability-classified and the fair value is estimated at each reporting period based on the number of shares that are expected to be issued at each reporting date and our closing stock price, which combined are categorized as Level 3 inputs. Therefore, fair value of these RSUs and the number of shares to be issued will not be fixed until the awards vest. During the year ended December&#160;31, 2020, we recorded research and development stock-based compensation expense of $0.2&#160;million related to the RSUs based on an estimated issuance of 0.1&#160;million shares<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238322527816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance sheet components<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance sheet components</a></td>
<td class="text">Balance sheet components<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,324&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,569&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,030&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and equipment, net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,516&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,352&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,939&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,995&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,198&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Automobiles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,061&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,795&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,449&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,347)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,135)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,102&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,747&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $10.5 million, $7.1 million and $8.5 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and other liabilities associated with business combinations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,058&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,814&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, non-current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and other liabilities associated with business combinations, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841,256&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238322170856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair value measurements</a></td>
<td class="text">Fair value measurements<div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities are recorded at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The authoritative guidance establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The three-level hierarchy for the inputs to valuation techniques is summarized as follows:</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Observable inputs such as quoted prices (unadjusted) for identical instruments in active markets.</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Observable inputs such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, or model-derived valuations whose significant inputs are observable.</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Unobservable inputs that reflect the reporting entity&#8217;s own assumptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the fair value of our consolidated financial instruments that were measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:28.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.540%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.540%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.540%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,995&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock payable liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835,876&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835,876&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="8" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,186&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents, restricted cash, and marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,592&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,284&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:30.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.540%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.540%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.540%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,302&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,308&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,308&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,625&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,608&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,300&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,300&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="8" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,436&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents, restricted cash, and marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between Level&#160;1, Level 2 and Level&#160;3 during the periods presented. The total fair value of investments with unrealized losses at December&#160;31, 2020 was $109.3 million. None of the available-for-sale securities held as of December&#160;31, 2020 have been in an unrealized loss position for more than one year. At December&#160;31, 2020, the remaining contractual maturities of available-for-sale securities ranged from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV85Ny9mcmFnOmFjYjI1OTMwMjMyODQyZTdiN2Y5OTUxOTJhNjYyY2NlL3RleHRyZWdpb246YWNiMjU5MzAyMzI4NDJlN2I3Zjk5NTE5MmE2NjJjY2VfNzY5NjU4MTQxMDEzMQ_d4b367b6-e09c-49d9-900c-330dab11d098">one</span> to nine months. Interest income generated from our investments was $4.0 million and $5.2 million during the years ended December&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificates of deposit and debt securities of U.S. government agency entities are classified as Level&#160;2 as they are valued based upon quoted market prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs obtained from various third-party data providers, including but not limited to benchmark yields, interest rate curves, reported trades, broker/dealer quotes and reference data.</span></div>Stock payable liabilities relate to certain indemnification hold-backs resulting from business combinations that are settled in shares of our common stock. We elected to account for these liabilities using the fair value option due to the inherent nature of the liabilities and the changes in value of the underlying shares that will ultimately be issued to settle the liabilities. The estimated fair value of these liabilities is classified as Level 3 and determined based upon the number of shares that are issuable to the sellers and the quoted closing price of our common stock as of the reporting date. The number of shares that will ultimately be issued is subject to adjustment for indemnified claims that existed as of the closing date for each acquisition. Changes in the number of shares issued and share price can significantly affect the estimated fair value of the liabilities. During the year ended December&#160;31, 2020, the change in fair value related to stock payable liabilities recorded to other income (expense), net was expense of $37.5&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238323679544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and contingencies</a></td>
<td class="text">Commitments and contingencies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In&#160;2015, we entered into an operating lease agreement for our headquarters and main production facility in San Francisco, California which commenced in 2016. This lease expires in&#160;2026 and we may renew the lease for an additional ten years. This optional period was not considered reasonably certain to be exercised and therefore we determined the lease term to be a ten-year period expiring in 2026. In connection with the execution of the lease, we provided a security deposit of approximately $4.6 million which is included in restricted cash in our consolidated balance sheets. We also have other operating leases for office and laboratory space in California, Colorado, Massachusetts, New York and Washington and internationally in Australia and Israel. We expect to enter into new leases and modify existing leases as we support continued growth of our operations.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into various finance lease agreements to obtain laboratory equipment. The terms of our finance leases are generally three years and are typically secured by the underlying equipment. The portion of the future payments designated as principal repayment and related interest was classified as a finance lease obligation on our consolidated balance sheets. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information regarding our operating and finance leases were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments included in the measurement of lease liabilities (in millions):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease costs, which were included in cost of revenue, research and development, selling and marketing and general and administrative expenses on our consolidated statements of operations, were as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:63.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.691%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.982%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,413&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,702&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,312&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future payments under operating and finance leases as of December&#160;31, 2020 are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.850%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Future non-cancelable minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,787)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations, net of current portion</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt financing</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we entered into a Note Purchase Agreement (the "2018 Note Purchase Agreement") pursuant to which we were eligible to borrow an aggregate principal amount up to $200.0 million over a seven year maturity term which included an initial borrowing of $75.0 million in November 2018. We received net proceeds of $10.3 million after terminating and repaying the balance of our obligations of approximately $64.7 million with our previous lender. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, we settled our obligations under the 2018 Note Purchase Agreement in full for $85.7 million, which included repayment of principal of $75.0 million, accrued interest of $2.4 million, and prepayment fees of $8.9 million which were recorded as debt extinguishment costs in other expense, net in our consolidated statement of operations during the year ended December 31, 2019.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we entered into a credit agreement with a financial institution under which we borrowed $135.0&#160;million (the "2020 Term Loan") concurrent with the closing of the ArcherDX transaction (the "closing date"). The 2020 Term Loan is secured by a first priority lien on all of our and our subsidiaries' assets (including our intellectual property), and is guaranteed by our subsidiaries, in each case, excluding certain excluded assets and immaterial foreign subsidiaries. The 2020 Term Loan bears interest at an annual rate equal to LIBOR, subject to a 2.00% LIBOR floor, plus a margin of 8.75%. The 2020 Term Loan will mature on (i) June 1, 2024 if at such time our Convertible Senior Notes are outstanding and are due to mature on September 1, 2024 (provided that if, prior to such date, the maturity date of at least 80% of the Convertible Senior Notes is extended to a date that is prior to September 1, 2025 the maturity date for the 2020 Term Loan will be automatically extended to a date that is 90 days prior to such Convertible Senior Notes maturity date as extended), or (ii) otherwise, on June 1, 2025. The full amount of the 2020 Term Loan is due upon maturity. If the 2020 Term Loan is prepaid (whether such prepayment is optional or mandatory), we must pay a prepayment fee of 6% if the prepayment occurs prior to the third anniversary of the closing date or 4% if the prepayment occurs after the third anniversary of the closing date and we must also pay a make-whole fee if the prepayment occurs prior to the second anniversary of the closing date. In connection with the 2020 Term Loan, we issued warrants to purchase 1.0&#160;million shares of our common stock with an exercise price of $16.85 per share, exercisable through October 2027. The warrants, which were classified as equity, were recorded at an amount based on the allocated proceeds and do not require subsequent remeasurement. In October 2020, these warrants were exercised in full through net settlement resulting in the issuance of 0.7&#160;million shares.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit agreement contains customary events of default and covenants, including among others, covenants limiting our ability to incur debt, incur liens, undergo a change in control, merge with or acquire other entities, make investments, pay dividends or other distributions to holders of our equity securities, repurchase stock, and dispose of assets, in each case subject to certain customary exceptions. In addition, the credit agreement contains financial covenants that require us to maintain a minimum cash balance and minimum quarterly revenue levels. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt discounts, including debt issuance costs, related to the 2020 Term Loan of $32.8&#160;million were recorded as a direct deduction from the debt liability and are being amortized to interest expense over the term of the 2020 Term Loan. Interest expense related to our debt financings, excluding the impact of our Convertible Senior Notes, was $7.4 million, $5.7 million and $6.7 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-top:3pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, we issued, at par value, $350.0 million aggregate principal amount of 2.00% Convertible Senior Notes due 2024 in a private offering. The Convertible Senior Notes are our senior unsecured obligations and will mature on September 1, 2024, unless earlier converted, redeemed or repurchased. The Convertible Senior Notes bear cash interest at a rate of 2.0% per year, payable semi-annually in arrears on March 1 and September 1 of each year, beginning on March 1, 2020. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion, the Convertible Senior Notes will be convertible into cash, shares of our common stock or a combination of cash and shares of our common stock, at our election. Our current intent is to settle the principal amount of the Convertible Senior Notes in cash upon conversion, with any remaining conversion value being delivered in shares of our common stock. The initial conversion rate for the Convertible Senior Notes is 33.6293 shares of our common stock per $1,000 principal amount of the Convertible Senior Notes (equivalent to an initial conversion price of approximately $29.74 per share of common stock). </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we undergo a fundamental change (as defined in the indenture governing the Convertible Senior Notes), the holders of the Convertible Senior Notes may require us to repurchase all or any portion of their Convertible Senior Notes for cash at a repurchase price equal to 100% of the principal amount of the Convertible Senior Notes to be repurchased plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Senior Notes will be convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding March 1, 2024, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on December 31, 2019 (and only during such calendar quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the Convertible Senior Notes on each applicable trading day; (2) during the five business day period after any five consecutive trading day period (the &#8220;measurement period&#8221;) in which the trading price per $1,000 principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; (3) if we call any or all of the Convertible Senior Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On or after March 1, 2024 until the close of business on the business day immediately preceding the maturity date, holders may convert their Convertible Senior Notes at any time, regardless of the foregoing circumstances. As of December&#160;31, 2020, none of the above circumstances had occurred and therefore the Convertible Senior Notes could not have been converted. However, these notes were convertible at the option of the holders during the quarter beginning on January 1, 2021 due to the sale price of our common stock during the quarter ended December 31, 2020.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not redeem the Convertible Senior Notes prior to September 6, 2022. We may redeem for cash all or any portion of the Convertible Senior Notes, at our option, on or after September 6, 2022 and on or before the 30th scheduled trading day immediately before the maturity date if the last reported sale price of the Common Stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Senior Notes consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.486%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.321%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount, liability component</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,724&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,755&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the fair value of the Convertible Senior Notes was $586.0 million. The estimated fair value of the Convertible Senior Notes, which are classified as Level 2 financial instruments, was determined based on the estimated or actual bid prices of the Convertible Senior Notes in an over-the-counter market. We recognized $22.0&#160;million and $6.5 million of interest expense related to the Convertible Senior Notes during the years ended December&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees and indemnifications</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As permitted under Delaware law and in accordance with our bylaws, we indemnify our directors and officers for certain events or occurrences while the officer or director is or was serving in such capacity. The maximum amount of potential future indemnification is unlimited; however, we maintain director and officer liability insurance. This insurance allows the transfer of the risk associated with our exposure and may enable us to recover a portion of any future amounts paid. We believe the fair value of these indemnification agreements is minimal. Accordingly, we did not record any liabilities associated with these indemnification agreements at December&#160;31, 2020 or 2019.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other commitments</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we enter into various purchase commitments primarily related to service agreements and laboratory supplies. At December&#160;31, 2020, our total future payments under noncancelable unconditional purchase commitments having a remaining term of over one year were as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,064&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,451&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,530&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,138&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we entered into a lease agreement in San Francisco, California for additional office and lab space. We determined the lease commencement date to be in January 2021 when we took possession of the leased premises. Total lease payments over the course of this lease will be $45.0&#160;million and are included in the purchase commitments above. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were not a party to any material legal proceedings at December&#160;31, 2020, or at the date of this report except for matters listed below which are related to ArcherDX which we acquired in October 2020. We cannot currently predict the outcome of these actions. The outcome of any such proceedings, regardless of the merits, is inherently uncertain. If we were unable to prevail in any such proceedings, our consolidated financial position, results of operations, and future cash flows may be materially impacted. In addition, we are and may from time to time become involved in various legal proceedings and claims arising in the ordinary course of business. While we believe any such claims are unsubstantiated, and we believe we are in compliance with applicable laws and regulations applicable to our business, the resolution of any such claims could be material.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Natera, Inc. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;27, 2020, Natera filed a lawsuit against ArcherDX (a subsidiary of Invitae effective October 2, 2020) in the United States District Court for the District of Delaware, alleging that ArcherDX&#8217;s products using AMP chemistry, and the manufacture, use, sale, and offer for sale of such products, infringe U.S. Patent No. 10,538,814. On March&#160;25, 2020, ArcherDX filed an answer denying Natera&#8217;s allegations and asserting certain affirmative defenses and counterclaims, including that U.S. Patent No. 10,538,814 is invalid and not infringed. On April&#160;15, 2020, Natera filed an answer denying ArcherDX&#8217;s counterclaims and filed an amended complaint alleging that ArcherDX&#8217;s products using AMP chemistry, including STRATAFIDE, PCM, LiquidPlex, ArcherMET, FusionPlex, and VariantPlex, and the manufacture, use, sale, and offer for sale of such products, infringe U.S. Patent No. 10,538,814, U.S. Patent No. 10,557,172, U.S. Patent No. 10,590,482, and U.S. Patent No. 10,597,708, each of which are held by Natera. Natera seeks, among other things, damages and other monetary relief, costs and attorneys&#8217; fees, and an order enjoining ArcherDX from further infringement of such patents. On May&#160;13, 2020, ArcherDX filed an answer to Natera&#8217;s amended complaint denying Natera&#8217;s allegations and asserting certain affirmative defenses and counterclaims, including that the asserted patents are invalid and not infringed. On June&#160;3, 2020, Natera filed an answer denying ArcherDX&#8217;s counterclaims. On June&#160;4, 2020, ArcherDX filed a motion seeking dismissal of Natera&#8217;s infringement claims against STRATAFIDE, PCM, and ArcherMET, and for a judgment that U.S. Patent No.&#160;10,538,814, U.S. Patent No. 10,557,172, and U.S. Patent No. 10,590,482 are invalid. On August 6, 2020, Natera filed another complaint against ArcherDX in the United States District Court for the District of Delaware alleging that ArcherDX&#8217;s products using AMP chemistry, including STRATAFIDE, PCM, LiquidPlex, ArcherMET, and VariantPlex, and the manufacture, use, sale, and offer for sale of such products, infringe U.S. Patent No. 10,731,220. Natera seeks, among other things, damages and other monetary relief, costs and attorneys&#8217; fees, and an order enjoining ArcherDX from further infringement of the patent. On October 13, 2020, the court issued an order denying ArcherDX's motion for dismissal of Natera&#8217;s infringement claims against STRATAFIDE, PCM, and ArcherMET, and declined to enter judgment that U.S.&#160;Patent No.&#160;10,538,814, U.S. Patent No. 10,557,172, and U.S. Patent No. 10,590,482 are invalid.&#160;On January 12, 2021, the court issued an order granting Natera leave to amend its complaint to add Invitae  as a co-defendant and plead allegations that ArcherDX and Invitae induce end-users to infringe the patents-in-suit. Natera filed its Second Amended Complaint on the same day, with service completed on January 15, 2021. ArcherDX and Invitae filed answers to the Second Amended Complaint on January 26, 2021 and February 5, 2021, respectively, denying Natera's allegations and restating certain affirmative defenses and counterclaims of non-infringement and invalidity. The litigations have now been consolidated for all purposes, are ongoing, and trial has been scheduled for May 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">QIAGEN Sciences </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;10, 2018, ArcherDX and the General Hospital Corporation d/b/a Massachusetts General Hospital, which we refer to as MGH, filed a lawsuit in the United States District Court for the District of Delaware against QIAGEN Sciences, LLC, QIAGEN LLC, QIAGEN Beverly, Inc., QIAGEN Gaithersburg, Inc., QIAGEN GmbH and QIAGEN N.V., which is collectively referred to herein as QIAGEN, and a named QIAGEN executive who was a former member of ArcherDX&#8217;s board of directors, alleging several causes of action, including infringement of the &#8217;810 Patent, trade secret misappropriation, breach of fiduciary duty, false advertising, tortious interference and deceptive trade practices. The &#8217;810 Patent relates to methods for preparing a nucleic acid for sequencing and aspects of ArcherDX&#8217;s AMP technology. On October&#160;30, 2019, with the permission of the Court, ArcherDX amended ArcherDX&#8217;s complaint to add a claim for infringement of the &#8217;597 Patent. The &#8217;597 Patent relates to methods of preparing and analyzing nucleic acids, such as by enriching target sequences prior to sequencing, and aspects of ArcherDX&#8217;s AMP technology. The QIAGEN products that ArcherDX alleges infringe the &#8217;810 Patent and the &#8217;597 Patent include, but are not limited to, QIAseq Targeted DNA Panels, QIAseq Targeted RNAscan Panels, QIAseq Index Kits and QIAseq Immune Repertoire RNA Library Kits. ArcherDX is seeking, among other things, damages for ArcherDX&#8217;s lost profits due to QIAGEN&#8217;s infringement and a permanent injunction enjoining QIAGEN from marketing and selling the infringing products and from using ArcherDX&#8217;s trade secrets. On December&#160;5, 2019, QIAGEN and the named QIAGEN executive submitted their answer denying the allegations in ArcherDX&#8217;s complaint and asserting affirmative defenses that, among other things, the &#8217;810 Patent and &#8217;597 Patent are not infringed by QIAGEN&#8217;s products, that both patents are invalid, and that the complaint fails to state any claim for which relief may be granted. This litigation is ongoing, and trial is currently scheduled for August 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238323768296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders&#8217; equity</a></td>
<td class="text">Stockholders&#8217; equity<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shares outstanding</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of convertible preferred and common stock were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:62.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, beginning of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion into common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued in private placement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued in connection with public offering</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued on exercise of stock options, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued pursuant to vesting of RSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued pursuant to exercises of warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued pursuant to employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued pursuant to acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued upon conversion of preferred stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,886&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,796&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,481&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2018 Sales Agreement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, we entered into a Common Stock Sales Agreement (the &#8220;2018 Sales Agreement&#8221;) with Cowen and Company, LLC (&#8220;Cowen&#8221;), under which we could offer and sell from time to time at our sole discretion shares of our common stock through Cowen as our sales agent, in an aggregate amount not to exceed $75.0 million. Cowen may sell the shares by any method permitted by law deemed to be an &#8220;at the market&#8221; offering as defined in Rule 415 of the Securities Act of 1933, including without limitation sales made directly on The New York Stock Exchange, and also may sell the shares in privately negotiated transactions, subject to our prior approval. Per the terms of the agreement, Cowen receives a commission equal to 3% of the gross proceeds of the sales price of all shares sold through it as sales agent under the 2018 Sales Agreement. In March 2019, we amended the 2018 Sales Agreement to increase the aggregate amount of our common stock to be sold under this agreement to an amount not to exceed $175.0 million. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, we sold a total of 3.6 million shares of common stock under the 2018 Sales Agreement at an average price of $26.33 per share, for gross proceeds of $93.7 million and net proceeds of $90.7 million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, we sold a total of 0.8&#160;million shares of common stock under the 2018 Sales Agreement at an average price of $25.71 per share, for gross proceeds of $20.2&#160;million and net proceeds of $19.5&#160;million. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2018, we sold a total of 4.3 million shares of common stock under the 2018 Sales Agreement at an average price of $14.13 per share, for aggregate gross proceeds of $61.1 million and net proceeds of $58.9 million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public offerings</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we issued, in an underwritten public offering, an aggregate of 8.9&#160;million shares of our common stock at a price of $51.50 per share, for gross proceeds of $460.0&#160;million and net proceeds of approximately $434.3&#160;million. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, we issued, in an underwritten public offering, an aggregate of 20.4&#160;million shares of our common stock at a price of $9.00 per share, for gross proceeds of $184.0 million and net proceeds of $173.0&#160;million.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, we sold, in an underwritten public offering, an aggregate of 10.4 million shares of our common stock at a price of $19.00 per share, for gross proceeds of $196.7 million and net proceeds of $184.5 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private placement</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2017, in a private placement to certain accredited investors, we issued 5.2 million shares of common stock at a price of $8.50 per share, and 3.5 million shares of our Series A convertible preferred stock at a price of $8.50 per share, for gross proceeds of approximately $73.5 million and net proceeds of $68.9 million. The Series A preferred stock is convertible into common stock on a one-for-one basis, subject to adjustment for events such as stock splits, combinations and the like. During the year ended December 31, 2019, 3.3 million shares of Series A convertible preferred stock were converted to 3.3 million shares of common stock.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our acquisition of ArcherDX, in June 2020 we entered into a definitive agreement to sell $275.0&#160;million in common stock in a private placement at a price of $16.85 per share. The private placement closed in October 2020, concurrently with our acquisition of ArcherDX. We received proceeds of $5.0&#160;million from the private placement during September 2020 and the remainder of the proceeds were received in October 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common stock warrants</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had outstanding warrants to purchase common stock as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.880%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrant</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise<br/>Price<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares of Common Stock Underlying Warrants</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants issued in exchange for CombiMatrix Series F warrants</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2017</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2021</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.95&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,154&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exercise price of warrants issued in exchange for CombiMatrix Series F warrants was determined pursuant to the terms of the acquisition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238418648376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock incentive plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock incentive plans</a></td>
<td class="text">Stock incentive plans<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock incentive plans</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2010, we adopted the 2010 Incentive Plan (the &#8220;2010 Plan&#8221;). The 2010 Plan provides for the granting of stock-based awards to employees, directors and consultants under terms and provisions established by our Board of Directors. Under the terms of the 2010 Plan, options may be granted at an exercise price not less than the fair market value of our common stock. For employees holding more than 10% of the voting rights of all classes of stock, the exercise prices for incentive and nonstatutory stock options must be at least 110% of fair market of our common stock on the grant date, as determined by our Board of Directors. The terms of options granted under the 2010 Plan may not exceed ten years.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January&#160;2015, we adopted the 2015 Stock Incentive Plan (the &#8220;2015 Plan&#8221;), which became effective upon the closing of our initial public offering (&#8220;IPO&#8221;). Shares outstanding under the 2010 Plan were transferred to the 2015 Plan upon effectiveness of the 2015 Plan. The 2015 Plan provides for automatic annual increases in shares available for grant, beginning on January&#160;1, 2016 through January&#160;1, 2025. In addition, shares subject to awards under the 2010 Plan that are forfeited or terminated will be added to the 2015 Plan. The 2015 Plan provides for the grant of incentive stock options, nonstatutory stock options, restricted stock awards, stock units, stock appreciation rights and other forms of equity compensation, all of which may be granted to employees, including officers, non-employee directors and consultants. Additionally, the 2015 Plan provides for the grant of cash-based awards.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted generally vest over a period of four years. Typically, the vesting schedule for options granted to newly hired employees provides that 1/4 of the award vests upon the first anniversary of the employee&#8217;s date of hire, with the remainder of the award vesting monthly thereafter at a rate of 1/48 of the total shares subject to the option. All other options typically vest in equal monthly installments over the four-year vesting schedule. Upon the acquisition of ArcherDX, any option that was outstanding was converted into a fully vested option to purchase a share of our common stock which resulted in the issuance of 3.7&#160;million options.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs generally vest over a period of three years. Typically, the vesting schedule for RSUs provides that 1/3 of the award vests upon each anniversary of the grant date, with certain awards that include a portion that vests immediately upon grant. In June 2019, we granted Time-based RSUs in connection with the acquisition of Singular Bio which vest in three equal installments over a period of 18 months and PRSUs that vest based on the achievement of performance conditions. In December 2020, we granted RSUs in connection with an asset acquisition which vest in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTIvZnJhZzphZThmNTM4OTkwYTQ0MTAxYTIyYThhYTRlZGNmNWZlNS90ZXh0cmVnaW9uOmFlOGY1Mzg5OTBhNDQxMDFhMjJhOGFhNGVkY2Y1ZmU1XzIyNTM5OTg4Mzg2Njgy_3f341498-9f73-4766-bb53-9c8f75c67d63">two</span> equal installments in December 2021 and December 2022, subject to the employee's continued service with us. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our management incentive compensation plan, in July 2019 we granted PRSUs to our executive officers as well as other specified senior level employees based on the level of achievement of a specified 2019 revenue goal. One-third of the 0.8&#160;million shares that were ultimately awarded under this plan vested during the year ended December&#160;31, 2020 and the remaining shares will vest through March 2022. In June 2020, we granted 0.3&#160;million PRSUs under this plan which are based on the level of achievement of a specified 2020 cash burn goal. Upon achievement of the specified 2020 cash burn goal, 0.3&#160;million shares were ultimately awarded and began vesting in 2021 over a one year period. These PRSUs had a grant date fair value of $4.2&#160;million based on an estimated issuance of 0.3&#160;million shares and expectation of the performance conditions. During the year ended December&#160;31, 2020, $2.1 million was recorded as stock-based compensation expense related to the awards. No PRSUs were granted during the year ended December&#160;31, 2018.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the 2010 Plan and the 2015 Plan is set forth below (in thousands, except per share amounts and years):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.844%"><tr><td style="width:1.0%"/><td style="width:39.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.212%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Available For Grant</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Life (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,005)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,659)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs and PRSUs granted</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,502)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs and PRSUs cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,432&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,809&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes the changes in time-based RSUs and PRSUs&#160;granted as a part of the Singular Bio acquisition in June 2019 and shares granted in an asset acquisition in December 2020 which are based on a fixed dollar value. The number of shares issued will be variable until the awards vest. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock options and the fair value of our common stock for stock options that were in-the-money.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair value of options to purchase common stock granted was $10.10, $14.52 and $4.87 in the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total grant-date fair value of options to purchase common stock vested was $2.8 million, $4.3 million and $5.9 million in the year ended December&#160;31, 2020, 2019, and 2018, respectively.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intrinsic value of options to purchase common stock exercised was $104.4 million, $6.3 million and $1.7 million in the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes RSU, including PRSU, activity (in thousands, except per share data):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,885&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time-based RSUs and PRSUs granted - variable </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,602&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#160;(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes the changes in the Time-based RSUs and PRSUs&#160;granted as a part of the Singular Bio acquisition in June 2019 and the shares granted in an asset acquisition in December 2020 which are based on a fixed dollar value. The number of shares issued will be variable until the awards vest. The weighted-average grant date fair value per share reflects the fair value pricing of the full award. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2015 Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January&#160;2015, we adopted the 2015 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;), which became effective upon the closing of the IPO. Employees participating in the ESPP may purchase common stock at 85% of the lesser of the fair market value of common stock on the purchase date or last trading day preceding the offering date. At December&#160;31, 2020, cash received from payroll deductions pursuant to the ESPP was $1.8 million.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP provides for automatic annual increases in shares available for grant, beginning on January&#160;1, 2016 and continuing through January&#160;1, 2025. At December&#160;31, 2020, a total of 0.9&#160;million shares of common stock are reserved for issuance under the ESPP.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the grant date fair value of our common stock to value options when granted. In determining the fair value of stock options and ESPP purchases, we use the Black-Scholes option-pricing model and, for stock options, the assumptions discussed below. Each of these inputs is subjective and its determination generally requires significant judgment. The fair value of RSU and PRSU awards is based on the grant date share price. Compensation cost is recognized as expense on a straight-line basis over the vesting period for options and RSUs and on an accelerated basis for PRSUs.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected term</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The expected term represents the period that our stock-based awards are expected to be outstanding and is determined using the simplified method (based on the midpoint between the vesting date and the end of the contractual term).</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected volatility</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;We estimate expected volatility based on the historical volatility of our common stock over a period equal to the expected term of stock option grants and RSUs and over the expected six-month term ESPP purchase periods.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-free interest rate</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of the option.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend yield</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;We have never paid dividends on our common stock and have no plans to pay dividends on our common stock. Therefore, we used an expected dividend yield of zero.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of share-based payments for stock options granted to employees and directors was estimated on the date of grant using the Black-Scholes option-pricing model based on the following assumptions:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.2%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of shares purchased pursuant to the ESPP is estimated using the Black-Scholes option pricing model. For the years ended December&#160;31, 2020, 2019 and 2018, the weighted-average grant date fair value per share for the ESPP was $10.98, $6.05 and $3.26, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the shares purchased pursuant to the ESPP was estimated using the following assumptions:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.7%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.3%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock-based compensation expense for the years ended December&#160;31, 2020, 2019 and 2018, included in the consolidated statements of operations (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,713&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,563&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,960&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,762&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,017&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,418&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,641&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,854&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,986&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,747&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,948&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,850&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, unrecognized compensation expense related to unvested stock options, net of estimated forfeitures, was $3.1 million, which we expect to recognize on a straight-line basis over a weighted-average period of 2.4 years. Unrecognized compensation expense related to RSUs, including PRSUs, and awards that are contingently issuable upon the completion of certain milestones related to our acquisition of ArcherDX at December&#160;31, 2020, net of estimated forfeitures, was $144.2 million, which we expect to recognize on a straight-line basis over a weighted-average period of 1.6 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238323935208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income taxes</a></td>
<td class="text">Income taxes<div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a benefit for income taxes in the years ended December&#160;31, 2020, 2019 and 2018. The components of net loss before taxes by U.S. and foreign jurisdictions are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,409&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,531&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,194&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714,270&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,415&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,155&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the provision for income taxes are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current benefit for income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94,279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,011)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,862)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred benefit for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,271)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,535)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,862)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,100)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,450)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,800)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the tax expense computed at the statutory federal rate and our tax expense for the periods presented:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal taxes at statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes (net of federal benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences and carryforwards that give rise to significant portions of the deferred tax assets are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337,866&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,182&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,969&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognition differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,099&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasing Liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,274&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,626&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,677&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,391&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418,885&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209,308)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145,318)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization and depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,875)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Senior Notes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,658)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,720)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasing Assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261,115)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,019)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,538)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the Tax Cuts and Jobs Act of 2017 (the &#8220;Tax Act&#8221;) was signed into law making significant changes to the Internal Revenue Code. Changes included among other items, a reduction of the corporate tax rate from a top marginal rate of 35% to a flat rate of 21%. Although the Tax Act was generally effective January 1, 2018, GAAP required recognition of the tax effects of new legislation during the reporting period that includes the enactment date, which was December 22, 2017. As a result of the lower corporate tax rate enacted as part of the Tax Act, during 2017, the Company recorded a provisional estimate to reduce deferred tax assets by $48.8&#160;million offset by a corresponding reduction in the valuation allowance resulting in no net impact to our income tax benefit or expense.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 ("SAB 118") to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the Tax Act. In accordance with SAB 118, during 2017, we recorded a provisional estimate which resulted in a $48.8&#160;million reduction in deferred tax assets and in the fourth quarter of 2018, we completed our analysis of the impact of the Tax Act and determined that no material adjustments were required to the provisional amounts previously recorded. &#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We historically established a full valuation allowance against our deferred tax assets due to the uncertainty surrounding realization of such assets. In 2020, we released approximately $112.1&#160;million of our valuation allowance to account for acquired intangibles that support the future realization of some of our deferred tax assets. Due to the overall increase of deferred tax assets, our valuation allowance also increased from the prior year. Our valuation allowance increased by $64.0&#160;million, $23.4&#160;million, and $26.3&#160;million during the years ended December 31, 2020, 2019, and 2018, respectively.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had net operating loss carryforwards of approximately $1.4&#160;billion and $890.6&#160;million available to reduce future taxable income, if any, for federal and state income tax purposes, respectively. Of the $1.4&#160;billion, $284.9&#160;million will begin to expire in 2030 while $1.1&#160;billion have no expiration date. The state net operating loss carryforwards will begin to expire in 2030.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had research and development credit carryforwards of approximately $26.2&#160;million and $17.6&#160;million available to reduce our future tax liability, if any, for federal and state income tax purposes, respectively. The federal credit carryforwards begin to expire in 2030. California credit carryforwards have no expiration date.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal Revenue Code ("IRC") section 382 places a limitation (the &#8220;Section 382 limitation&#8221; or &#8220;annual limitation&#8221;) on the amount of taxable income that can be offset by net operating loss carryforwards after a change in control (generally greater than 50% change in ownership) of a loss corporation. Similar provisions exist for states. In addition, and as a result of the acquisitions of Good Start Genetics and CombiMatrix in 2017, acquisitions of Singular Bio, Jungla, and Clear Genetics in 2019, and acquisitions of YouScript and ArcherDX in 2020, tax loss carryforwards from acquired entities are also subject to the Section 382 limitation due to the change in control in the acquired entities in the current year.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a result of equity issued in connection with various acquisitions, we also performed a section 382 analysis in 2020 with respect to our operating loss and credit carryforwards. We concluded while an ownership change occurred in 2019 as defined under IRC section 382, none of our net operating loss carryforwards would expire unused solely as a result of annual limitations imposed on the use of the carryforwards under IRC sections 382 and 383.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had unrecognized tax benefits of $22.0 million, which primarily relates to research and development credits, none of which would currently affect our effective tax rate if recognized due to our valuation allowance against our deferred tax assets. During the year, we benchmarked the reserves of similar tax positions within the industry based on IRS and state audits of comparable companies. Based on our analysis, we decreased our unrecognized tax benefits to more closely align with other comparable companies within the industry. As these reserves relate primarily to research and development credits which have a full valuation allowance, such adjustments did not impact our income tax provision. Unrecognized tax benefits are not expected to materially change in the next 12 months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases&#8212;current period tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases&#8212;prior period tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases&#8212;prior period tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,441)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,965&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,985&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,375&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our policy is to include penalties and interest expense related to income taxes as a component of tax expense. We have not accrued interest and penalties related to the unrecognized tax benefits reflected in the financial statements for the years ended December&#160;31, 2020, 2019 and 2018.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our major tax jurisdictions are the United States and California. All of our tax years will remain open for examination by the Federal and state tax authorities for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV8xMTgvZnJhZzpjNGZmODM5ZjcxNGI0N2U3YTA4YmZiOTUzZjViYzA4Yi90ZXh0cmVnaW9uOmM0ZmY4MzlmNzE0YjQ3ZTdhMDhiZmI5NTNmNWJjMDhiXzQ5NTQ_150b999c-d788-453b-aa59-382e59e7d0d3">three</span> and four years, respectively, from the date of utilization of the net operating loss or research and development credit. We do not have any tax audits pending.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238323774888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net loss per share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net loss per share</a></td>
<td class="text">Net loss per share<div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(602,170)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241,965)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,355)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing net loss per share, basic and diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,587&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,859&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,747&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.47)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.66)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.94)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents have been excluded from diluted net loss per share because their inclusion would be anti-dilutive (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock subject to outstanding options</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,878&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,662&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,028&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock subject to outstanding warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock subject to outstanding RSUs</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,590&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,293&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock subject to outstanding PRSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock pursuant to ESPP</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock underlying Series A convertible preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock subject to Convertible Senior Notes conversion</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,371&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,612&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,321&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,960&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,770&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238322170856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Geographic information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Segments, Geographical Areas [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Geographic information</a></td>
<td class="text">Geographic information<div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by country is determined based on the billing address of the customer and is summarized as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.330%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,680&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,550&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,239&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,529&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,356&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,389&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,918&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,254&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,598&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,824&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,699&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, 2019 and 2018, our long-lived assets were primarily located in the United States other than operating lease assets representing our right-of-use for leased facilities in Israel and Australia.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentsGeographicalAreasAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentsGeographicalAreasAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238415486904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected quarterly data (unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Selected quarterly data (unaudited)</a></td>
<td class="text">Selected quarterly data (unaudited)<div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our quarterly financial information for 2020 and 2019 (in thousands, except per share amounts):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:35.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,248&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,191&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,728&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,431&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97,784)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,082)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,823)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331,483)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,527)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166,403)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102,902)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.99)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.29)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.78)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.30)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,553&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,475&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,511&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,285&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,207)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,886)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,983)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,036)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,677)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,676)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,707)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,905)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.54)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.82)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.79)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">___________________________________________________________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss per share is computed independently for each of the quarters presented. Therefore, the sum of quarterly net loss per share information may not equal annual net loss per share.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238323835368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent event<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent event</a></td>
<td class="text">Subsequent eventIn February 2021, we acquired 100% of the equity interest of Reference Genomics, Inc. d/b/a One Codex "One Codex", a company developing and commercializing products and services relating to microbiome sequencing, analysis and reporting, for upfront consideration consisting of 1.2&#160;million shares of our common stock and $17.0&#160;million in cash. Up to approximately $0.1&#160;million in cash and 0.2&#160;million additional shares of our common stock are subject to a hold back to satisfy indemnification obligations that may arise following the closing. Given the timing of the closing of the transaction with One Codex, we are currently in the process of valuing the assets acquired and liabilities assumed. As a result, we are not yet able to provide the amounts to be recognized as of the acquisition date for the major classes of assets acquired and liabilities assumed and other related disclosures. We will disclose this and other related information in our Quarterly Report on Form 10-Q for the three months ending March 31, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238427846520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of consolidation</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include our accounts and the accounts of our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We base these estimates on current facts, historical and anticipated results, trends and various other assumptions that we believe are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those judgments, estimates and assumptions. We evaluate our estimates on an ongoing basis.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates and assumptions made by management include the determination of:</span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">revenue recognition; </span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the fair value of assets and liabilities associated with business combinations; </span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the impairment assessment of goodwill and intangible assets; </span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the valuation of our 2.00% convertible senior notes due 2024 issued in September 2019 ("Convertible Senior Notes");</span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the recoverability of long-lived assets; </span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our incremental borrowing rates used to calculate our lease balances;</span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">stock-based compensation expense and the fair value of awards and warrants issued; and</span></div><div style="margin-top:3pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">income tax uncertainties.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of credit risk and other risks and uncertainties</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of credit risk and other risks and uncertainties</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to a concentration of credit risk consist of cash, cash equivalents, marketable securities and accounts receivable. Our cash and cash equivalents are held by financial institutions in the United States. Such deposits may exceed federally insured limits.</span></div>Significant customers are those that represent 10% or more of our total revenue for each year presented on the consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, cash equivalents, and restricted cash</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all highly liquid investments with original maturities of three months or less from the date of purchase to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds, U.S. treasury notes and government agency securities.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash consists primarily of money market funds that secure irrevocable standby letters of credit that serve as collateral for security deposits for our facility leases.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable securities</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable securities</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All marketable securities have been classified as &#8220;available-for-sale&#8221; and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its marketable debt securities at the time of purchase and reevaluates such designation at each balance sheet date. Short-term marketable securities have maturities one year or less at the balance sheet date. Unrealized gains and losses are excluded from earnings and are reported as a component of other comprehensive loss. Realized gains and losses and impairments, if any, on available-for-sale securities are included in other expense, net. The cost of securities sold is based on the specific-identification method. Interest on marketable securities is included in other income (expense), net. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For marketable securities in an unrealized loss position, we assess our intent to sell, or whether it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis. If either of these criteria are met, the security&#8217;s amortized cost basis is written down to fair value through other income (expense), net.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts receivable</a></td>
<td class="text">Accounts receivableWe receive payment from patients, biopharmaceutical partners, third-party payers and other business-to-business customers.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Deferred revenue, revenue recognition and cost of revenue</a></td>
<td class="text">Deferred revenueWe record a contract liability when cash payments are received or due in advance of our performance related to one or more performance obligations.<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration it expects to be entitled to in exchange for those goods or services. All revenues are generated from contracts with customers. We utilize the following practical expedients and exemptions:</span></div><div style="margin-top:3pt;padding-left:63pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Costs to obtain or fulfill a contract are expensed when incurred because the amortization period would have been one year or less, and</span></div><div style="margin-top:3pt;padding-left:63pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">No adjustments to promised consideration were made for financing as we expect, at contract inception, that the period between the transfer of a promised good or service and when the customer pays for that good or service will be one year or less.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Test revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Test revenue is comprised of testing services and sales of distributed precision oncology products. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our test revenue is generated from genetic testing, in addition to somatic testing for therapy selection and personalized cancer monitoring. These testing services provide analysis and associated interpretation of the sequencing of parts of the genome. Test orders are placed under signed requisitions or contractual agreements, and we often enter into contracts with biopharmaceutical partners, other business-to-business customers (e.g., hospitals, clinics, medical centers) and insurance companies that include pricing provisions under which such tests are billed. Billing terms are generally net 30 to 60 days.  </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the transaction price of diagnostic tests is originally established either via contract or pursuant to our standard list price, we often provide concessions for tests billed to insurance carriers, and therefore the transaction price for patient insurance-billed tests is considered to be variable and revenue is recognized based on an estimate of the consideration to which we will be entitled at an amount for which it is probable that a reversal of cumulative consideration will not occur. Making these estimates requires significant judgments based upon such factors as length of payer relationship, historical payment patterns, changes in contract provisions and insurance reimbursement policies. These judgments are reviewed each reporting period and updated as necessary.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We look to transfer of control in assessing timing of recognition of revenue in connection with each performance obligation. In general, revenue in connection with the service portion of our diagnostic tests is recognized upon delivery of the underlying clinical report or when the report is made available on our web portal. Outstanding performance obligations pertaining to orders received but for which the underlying report has not been issued are generally satisfied within a 30-day period. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also generate test revenue through the sale of our precision oncology products, which is comprised primarily of sales of our distributed research use only ("RUO ") and in vitro diagnostics ("IVD") products for therapy selection. We recognize revenue on these sales once shipment has occurred. Product sales are recorded net of discounts and other deductions. Billing terms are generally net 30 days. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling fees billed to customers are recorded as revenue on the consolidated statements of operations. The associated shipping and handling costs are recorded as cost of revenue.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue is primarily generated from pharma development services provided to biopharmaceutical companies related to companion diagnostic development as well as through collaboration agreements and genome network contracts.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts for companion diagnostic development consist primarily of milestone-based payments along with annual fees and marked-up pass-through costs. The arrangements are treated as short-term contracts for revenue recognition purposes because they allow termination of the agreements by the customers with 30 to 120 days&#8217; written notice without a termination penalty. Upon termination, customers are required to pay for the proportion of services provided under milestones that were in progress. We recognize revenue in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. We recognize revenue over time based on the progress made toward achieving the performance obligation, utilizing both input or output methods, depending on the performance obligation, including labor hours expended, tests processed, or time elapsed, that measure our progress toward the achievement of the milestone.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We also enter into collaboration and genome network contracts. Collaboration agreements provide customers with diagnostic testing and related data aggregation reporting services that are provided over the contract term. Collaboration revenue is recognized as the data and reporting services are delivered to the customer. Genome network offerings consist of subscription services related to a proprietary software platform designed to connect patients, clinicians, advocacy organizations, researchers and therapeutic developers to accelerate the understanding, diagnosis and treatment of hereditary disease. Such services are recognized on a straight-line basis over the subscription periods. Amounts due under collaboration and genome network agreements are typically billable on net 30-day terms. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of revenue</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue reflects the aggregate costs incurred in delivering our genetic offerings and includes expenses for personnel-related costs including stock-based compensation, materials and supplies, royalties, regulatory fees, commercialization fees, equipment and infrastructure expenses associated with testing and allocated overhead including rent, equipment depreciation, information technology costs, amortization of acquired intangibles and utilities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our inventory consists of raw materials, work in progress, and finished goods, which are stated at the lower of cost or net realizable value on a first-in, first-out basis. We periodically analyze our inventory levels and expiration dates, and write down inventory that has become obsolete, inventory that has a cost basis in excess of its net realizable value, and inventory in excess of expected sales requirements as cost of revenue. We record an allowance for obsolete inventory using an estimate based on historical trends and evaluation of near-term expirations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business combinations and License agreements</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply Financial Accounting Standards Board ("FASB"), Accounting Standards Codification ("ASC") 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires recognition of assets acquired, liabilities assumed, and contingent consideration at their fair value on the acquisition date with subsequent changes recognized in earnings; requires acquisition-related expenses and restructuring costs to be recognized separately from the business combination and expensed as incurred; requires in-process research and development to be capitalized at fair value as an indefinite-lived intangible asset until completion or abandonment; and requires that changes in accounting for deferred tax asset valuation allowances and acquired income tax uncertainties after the measurement period be recognized as a component of provision for taxes.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for acquisitions of entities that include inputs and processes and have the ability to create outputs as business combinations. The tangible and identifiable intangible assets acquired and liabilities assumed in a business combination are recorded based on their estimated fair values as of the business combination date, including identifiable intangible assets which either arise from a contractual or legal right or are separable from goodwill. We base the estimated fair value of identifiable intangible assets acquired in a business combination on independent third-party valuations that use information and assumptions provided by our management, which consider our estimates of inputs and assumptions that a market participant would use. Any excess purchase price over the estimated fair value assigned to the net tangible and identifiable intangible assets acquired and liabilities assumed is recorded to goodwill. The use of alternative valuation assumptions, including estimated revenue projections, growth rates, estimated cost savings, cash flows, discount rates, estimated useful lives and probabilities surrounding the achievement of contingent milestones could result in different purchase price allocations and amortization expense in current and future periods.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In circumstances where an acquisition involves a contingent consideration arrangement that meets the definition of a liability under ASC Topic 480, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities from Equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We remeasure this liability each reporting period and record changes in the fair value as general and administrative expense.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs associated with acquisitions are expensed as incurred in general and administrative expenses. Results of operations and cash flows of acquired companies are included in our operating results from the date of acquisition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License Agreements</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered and may continue to enter into license agreements to access and utilize certain technology. We evaluate if the license agreement results in the acquisition of an asset or a business and then determine if the acquired asset has the ability to generate revenues or is subject to regulatory approval. When regulatory approval is not required, we record the license as an asset and amortize it over the estimated economic life. When regulatory approval is required, we record the amount paid as a research and development expense.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible assets and in-process research and development</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortizable intangible assets include trade names, non-compete agreements, patent licensing agreements, favorable leases, developed technology, customer relationships, and rights to develop new technology acquired as part of business combinations. Customer relationships acquired through our business combinations in 2017 are amortized on an accelerated basis, utilizing free cash flows, over periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzY4NQ_d2037801-faba-4d7d-9a9d-b880ce2dc05c">five</span> to 12 years. All other intangible assets subject to amortization are amortized using the straight-line method over their estimated useful lives ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfNzgzOQ_4c24a27f-0da2-4313-a3a1-cf19d3484ec4">two</span> to 15 years. All intangible assets subject to amortization are reviewed for impairment in accordance with ASC 360, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In-process research and development </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets related to in-process research and development costs (&#8220;IPR&amp;D&#8221;) are considered to be indefinite-lived until the completion or abandonment of the associated research and development efforts. If and when development is complete, the associated assets would be deemed finite-lived and would then be amortized based on their respective estimated useful lives at that point in time. During this period, the assets will not be amortized but will be tested for impairment on an annual basis and between annual tests if we become aware of any events occurring or changes in circumstances that would indicate a reduction in the fair value of the IPR&amp;D projects below their respective carrying amounts. </span></div>During the fourth quarter and if business factors indicate more frequently, we perform an assessment of the qualitative factors affecting the fair value of our IPR&amp;D projects. If the fair value exceeds the carrying value, there is no impairment. Impairment losses on indefinite-lived intangible assets are recognized based solely on a comparison of the fair value of an asset to its carrying value, without consideration of any recoverability test. We have not identified any such impairment losses to date.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text">Goodwill<span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 350, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other</span> (&#8220;ASC 350&#8221;), our goodwill is not amortized but is tested for impairment on an annual basis or whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. Under ASC 350, we perform annual impairment reviews of our goodwill balance during the fourth fiscal quarter or more frequently if business factors indicate. In testing for impairment, we compare the fair value of our reporting unit to its carrying value including the goodwill of that unit. If the carrying value, including goodwill, exceeds the reporting unit&#8217;s fair value, we will recognize an impairment loss for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. The loss recognized cannot exceed the total amount of goodwill allocated to that reporting unit.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 842, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we determine if an arrangement is a lease at inception. Operating leases are included in operating lease assets and operating lease obligations in our consolidated balance sheets. Finance leases are included in other assets and finance lease obligations in our consolidated balance sheets. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at commencement based on the present value of lease payments over the lease term. We generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments. The operating lease asset also includes any lease payments made and is adjusted for lease incentives. Our lease terms may include options to extend or terminate the lease which are recognized when it is reasonably certain that we will exercise that option. Leases with terms of 12 months or less are not recorded on our balance sheet. Lease expense is recognized on a straight-line basis over the lease terms, or in some cases, the useful life of the underlying asset. We account for the lease and non-lease components as a single lease component.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment, net</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and equipment, net</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxMzAyOWNkZDdkNjRjNWJhYzk3MWYwZTg2ZThmMTlhL3NlYzplMTMwMjljZGQ3ZDY0YzViYWM5NzFmMGU4NmU4ZjE5YV83Ni9mcmFnOjQ2NDkyMGVlMDQ2MDQ3MTc4ODMxMGYwMWY3ZjgxNGIyL3RleHRyZWdpb246NDY0OTIwZWUwNDYwNDcxNzg4MzEwZjAxZjdmODE0YjJfMTE2Mjg_1217d9ea-71ec-462e-9a23-2257607bd016">three</span> and seven years. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the term of the lease. Maintenance and repairs are charged to expense as incurred, and improvements and betterments are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in the consolidated statements of operations in the period realized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated useful lives of property and equipment are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:50.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.000%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Automobiles</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing and Laboratory equipment</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of lease term or estimated useful life</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-lived assets</a></td>
<td class="text">Long-lived assetsWe review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. An impairment loss is recognized when the total estimated future undiscounted cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount. Impairment, if any, is assessed using discounted cash flows or other appropriate measures of fair value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value of financial instruments</a></td>
<td class="text">Fair value of financial instrumentsOur financial instruments consist principally of cash and cash equivalents, marketable securities, accounts payable, accrued liabilities, finance leases, and liabilities associated with business combinations. The carrying amounts of certain of these financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued and other current liabilities approximate their current fair value due to the relatively short-term nature of these accounts. Based on borrowing rates available to us, the carrying value of finance leases approximate their fair values. Liabilities associated with business combinations are recorded at their estimated fair value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. Significant judgment is required in determining the net valuation allowance which includes our evaluation of all available evidence including past operating results, estimates on future taxable income and acquisition-related tax assets and liabilities.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We historically established a full valuation allowance against our deferred tax assets due to the uncertainty surrounding realization of such assets. In 2020, we released approximately $112.1&#160;million of our valuation allowance to account for acquired intangibles that support the future realization of some of our deferred tax assets. Due to the overall increase of deferred tax assets, our valuation allowance has also increased from the prior year.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-based compensation</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure stock-based payment awards made to employees and directors based on the estimated fair values of the awards and recognize the compensation expense over the requisite service period. We use the Black-Scholes option-pricing model to estimate the fair value of stock option awards and employee stock purchase plan (&#8220;ESPP&#8221;) purchases. The fair value of restricted stock unit (&#8220;RSU&#8221;) awards with time-based vesting terms is based on the grant date share price. We grant performance-based restricted stock unit (&#8220;PRSU&#8221;) awards to certain employees which vest upon the achievement of certain performance conditions, subject to the employees&#8217; continued service relationship with us. The probability of vesting is assessed at each reporting period and compensation cost is adjusted based on this probability assessment. We recognize such compensation expense on an accelerated vesting method.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense for awards without a performance condition is recognized using the straight-line method. Stock-based compensation expense is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. As such, our stock-based compensation is reduced for estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for stock issued in connection with business combinations based on the fair value on the date of issuance.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising</a></td>
<td class="text">AdvertisingAdvertising expenses are expensed as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive loss</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive loss</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss is composed of two components: net loss and other comprehensive income (loss). Other comprehensive income (loss) refers to gains and losses that under U.S. GAAP are recorded as an element of stockholders&#8217; equity, but are excluded from net loss. Our other comprehensive income (loss) consists of unrealized gains or losses on investments in available-for-sale securities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net loss per share</a></td>
<td class="text">Net loss per shareBasic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, without consideration of common stock equivalents. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common share equivalents outstanding for the period determined using the treasury stock method. Potentially dilutive securities, consisting of preferred stock, options to purchase common stock, common stock warrants, shares of common stock pursuant to ESPP, common stock issuable in connection with our Convertible Senior Notes, RSUs and PRSUs, are considered to be common stock equivalents and were excluded from the calculation of diluted net loss per share because their effect would be antidilutive for all periods presented.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Prior period reclassifications</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prior period reclassifications</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts in prior periods to conform with current presentation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent accounting pronouncements</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent accounting pronouncements</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate all Accounting Standards Updates (&#8220;ASUs&#8221;) issued by the Financial Accounting Standards Board ("FASB") for consideration of their applicability. ASUs not included in the disclosures in this report were assessed and determined to be either not applicable or are not expected to have a material impact on our consolidated financial statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently issued accounting pronouncements not yet adopted </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06,&#160;Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which simplifies the accounting for certain convertible instruments, amends the guidance on derivative scope exceptions for contracts in an entity's own equity, and modifies the guidance on diluted earnings per share calculations as a result of these changes. This new standard is effective for our interim and annual periods beginning January 1, 2022, and earlier adoption is permitted. We may elect to apply the amendments on a retrospective or modified retrospective basis. We are currently evaluating the impact of the adoption of this standard on our consolidated financial statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently adopted accounting pronouncements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016,&#160;FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires measurement and recognition of expected credit losses for financial assets. This guidance became effective for us beginning in the first quarter of 2020 and was adopted using a modified retrospective approach, with certain exceptions. The adoption of Topic 326 did not have a material impact on our consolidated financial statements as credit losses are not expected to be significant.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our adoption of Topic 326, we assess our accounts receivables for expected credit losses at each reporting period by disaggregating by payer type and further by portfolios of customers with similar characteristics, such as customer type and geographic location. We then review each portfolio for expected credit losses based on historical payment trends as well as forward looking data and current economic trends. If a credit loss is determined, we record a reduction to our accounts receivable balance with a corresponding general and administrative expense.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Topic 326, we no longer evaluate whether our available-for-sale debt securities in an unrealized loss position are other than temporarily impaired. Instead, we assess whether such unrealized loss positions are credit-related. Our expected loss allowance methodology for these securities is developed by reviewing the extent of the unrealized loss, the issuers&#8217; credit ratings and any changes in those ratings, as well as reviewing current and future economic market conditions and the issuers&#8217; current status and financial condition. The credit-related portion of unrealized losses, and any subsequent improvements, are recorded in other income (expense), net. Unrealized gains and losses that are not credit-related are included in accumulated other comprehensive income (loss). </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2019, we adopted the provisions of ASC Topic 842, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> using the modified retrospective approach in accordance with Topic 842. Adoption of Topic 842 had a material impact on our consolidated balance sheets, but did not have an impact on our consolidated statements of operations. We elected the package of practical expedients permitted under the transition guidance which, among other things, allowed us to carry forward the historical classification of leases in place as of January 1, 2019. We did not identify any material embedded leases with the adoption of Topic 842 and therefore the implementation of Topic 842 primarily focused on the treatment of our previously identified leases. </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period amounts were not adjusted and continue to be reported in accordance with our historic accounting under previous lease guidance, ASC 840, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 840, we rented facilities under operating lease agreements and recognized related rent expense on a straight-line basis over the term of the applicable lease agreement. Some of the lease agreements contained rent holidays, scheduled rent increases, lease incentives, and renewal options. Rent holidays and scheduled rent increases were included in the determination of rent expense recorded over the lease term. Lease incentives were recognized as a reduction of rent expense on a straight-line basis over the term of the lease. Renewals were not assumed in the determination of the lease term unless they were deemed to be reasonably assured at the inception of the lease. We recognized rent expense beginning on the date we obtained the legal right to use and control the leased space.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238330562248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Schedule significant customer, revenue as a percentage</a></td>
<td class="text">Our revenue from significant customers as a percentage of our total revenue was as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:26.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.878%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.979%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.979%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of restrictions on cash and cash equivalents</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:70.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,389&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,572&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of cash, cash equivalents and restricted cash</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:70.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,389&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,572&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment, net</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated useful lives of property and equipment are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:50.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.000%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Automobiles</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing and Laboratory equipment</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of lease term or estimated useful life</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,516&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,352&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,939&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,995&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,198&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Automobiles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,061&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,795&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,449&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,347)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,135)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,102&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,747&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238323787368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue, accounts receivable and deferred revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of disaggregated revenue by payer category</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue as disaggregated by payer category and revenue subtype is as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"><tr><td style="width:1.0%"/><td style="width:29.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.289%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Patient</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biopharma partner</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other business-to-business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Direct</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Test revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centralized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decentralized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total test revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,026&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,972&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,065&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,247&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272,310&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,026&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,972&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,553&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,047&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,598&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:center;text-indent:31.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"><tr><td style="width:1.0%"/><td style="width:29.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.289%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Patient</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biopharma partner</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other business-to-business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Direct</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Test revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centralized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total test revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,597&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,953&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,447&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,824&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"><tr><td style="width:1.0%"/><td style="width:29.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.289%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Patient</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biopharma partner</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other business-to-business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Direct</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Test revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centralized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total test revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,352&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,796&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,962&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,699&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfChangeInAccountingEstimateTextBlock', window );">Schedule of change in estimate</a></td>
<td class="text">As a result of new information, we update our estimate quarterly of the amounts to be recognized for previously delivered tests which resulted in the following increases to revenue and decreases to our loss from operations and basic and diluted net loss per share (in millions, except per share amounts):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.05)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangeInAccountingEstimateTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in an accounting estimate, including a change that occurs in an interim period. If a change in accounting estimate affects several future periods (for example, a change in the service life of a depreciable asset) disclose the effect on income from continuing operations, net income (or other appropriate captions of changes in the applicable net assets or performance indicator), and any related per-share amounts of the current period. Disclosure of the effects of a change in an accounting estimate that occurs in the ordinary course of business (such as uncollectible accounts or inventory obsolescence) is not required, unless the effect is material.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e777-108305<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangeInAccountingEstimateTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238332067336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock', window );">Summary of purchase price and post-combination expense</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the purchase price recorded as a part of the acquisition of Diploid (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hold-back consideration - common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,314&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the purchase prices recorded as a part of the acquisition of Genelex and YouScript (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.290%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.290%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Genelex</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">YouScript</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash transferred</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Hold-back consideration - cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Hold-back consideration - common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Common stock transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13,210&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">52,703&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">65,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the purchase price and post-combination expense recorded as a part of the acquisition of ArcherDX (in millions):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.463%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.465%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Post-combination Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration and liabilities incurred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,331.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Summary of fair values of assets acquired and liabilities assumed</a></td>
<td class="text">The following table summarizes the fair values of assets acquired and liabilities assumed through our acquisition of Diploid at the date of acquisition (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identifiable assets acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,314&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The following table summarizes the fair values of assets acquired and liabilities assumed through our acquisitions of Genelex and YouScript at the date of acquisition (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"><tr><td style="width:1.0%"/><td style="width:42.686%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.254%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Genelex</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">YouScript</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">25,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total identifiable assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9,463&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">35,684&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(481)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(801)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net identifiable assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9,143&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22,977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">32,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13,210&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">52,703&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">65,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table>The following table summarizes the fair values of assets acquired and liabilities assumed through our acquisition of ArcherDX at the date of acquisition (in millions):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable assets acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identifiable assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,652.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,331.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Summary of intangible assets acquired</a></td>
<td class="text">The fair value of our intangible assets acquired as of the acquisition date and the method used to value these assets as well as the estimated economic lives for amortizable intangible assets were as follows (in millions, except estimated useful life which is in years):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.244%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.744%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.744%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated useful life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation method</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization expense</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">With-and-without</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling and marketing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Relief from royalty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling and marketing</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Multi-period excess earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right to develop new technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost approach</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">512.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Multi-period excess earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Not applicable</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">803.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Schedule of pro forma financial information</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma financial information is for informational purposes only and is not necessarily indicative of the results of operations that would have been achieved as if the acquisition had taken place as of January 1, 2019 (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.704%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.852%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,389&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(685,589)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(355,818)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238332025144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and intangible assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Summary of goodwill</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amounts of goodwill were as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,777&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired - Diploid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired - Genelex</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,067&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired - YouScript</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired - ArcherDX</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,652,398&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,863,623&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of intangible assets</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents details of our acquired intangible assets as of December&#160;31, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:33.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Useful Life<br/>(in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Estimated Remaining<br/>Useful Life<br/>(in Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,075&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,013)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patent licensing agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right to develop new technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022,252&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,407)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of intangible assets</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents details of our acquired intangible assets as of December&#160;31, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:33.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Useful Life<br/>(in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Estimated Remaining<br/>Useful Life<br/>(in Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,075&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,013)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patent licensing agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right to develop new technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022,252&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,407)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Summary of estimated future amortization expense of intangible assets with finite lives</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our estimated future amortization expense of intangible assets with finite lives as of December&#160;31, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:84.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,910&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,401&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,388&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,356&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,292&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated future amortization expense</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,457&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238332082792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance sheet components (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventory</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,324&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,569&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,030&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment, net</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated useful lives of property and equipment are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:50.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.000%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Automobiles</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing and Laboratory equipment</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of lease term or estimated useful life</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,516&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,352&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,939&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,995&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,198&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Automobiles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,061&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,795&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,449&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,347)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,135)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,102&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,747&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of accrued liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and other liabilities associated with business combinations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,058&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,814&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Schedule of other long-term liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, non-current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and other liabilities associated with business combinations, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841,256&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238323954408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of financial instruments at fair value on a recurring basis</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the fair value of our consolidated financial instruments that were measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:28.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.540%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.540%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.540%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,995&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock payable liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835,876&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835,876&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="8" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,186&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents, restricted cash, and marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,592&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,284&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:30.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.540%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.540%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.540%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,302&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,308&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,308&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,625&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,608&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,300&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,300&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="8" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,436&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents, restricted cash, and marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238323881736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of lease cost</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information regarding our operating and finance leases were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments included in the measurement of lease liabilities (in millions):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease costs, which were included in cost of revenue, research and development, selling and marketing and general and administrative expenses on our consolidated statements of operations, were as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:63.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.691%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.982%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,413&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,702&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,312&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of future payments under operating leases</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future payments under operating and finance leases as of December&#160;31, 2020 are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.850%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Future non-cancelable minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,787)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations, net of current portion</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of future lease payments under finance leases</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future payments under operating and finance leases as of December&#160;31, 2020 are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.850%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Future non-cancelable minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,787)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations, net of current portion</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Components of debt</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Senior Notes consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.486%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.321%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount, liability component</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,724&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,755&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock', window );">Schedule of future payments under noncancelable unconditional purchase commitments</a></td>
<td class="text">At December&#160;31, 2020, our total future payments under noncancelable unconditional purchase commitments having a remaining term of over one year were as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,064&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,451&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,530&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,138&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unconditional purchase obligation recognized as liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238415188936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockByClassTextBlock', window );">Schedule of convertible preferred and common stock</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of convertible preferred and common stock were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:62.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, beginning of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion into common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued in private placement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued in connection with public offering</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued on exercise of stock options, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued pursuant to vesting of RSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued pursuant to exercises of warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued pursuant to employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued pursuant to acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued upon conversion of preferred stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,886&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,796&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,481&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of outstanding warrants to purchase common stock</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had outstanding warrants to purchase common stock as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.880%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrant</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise<br/>Price<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares of Common Stock Underlying Warrants</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants issued in exchange for CombiMatrix Series F warrants</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2017</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2021</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.95&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,154&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information.  Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21553-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21488-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21484-112644<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238319918376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock incentive plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of activity under stock incentive plans</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the 2010 Plan and the 2015 Plan is set forth below (in thousands, except per share amounts and years):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.844%"><tr><td style="width:1.0%"/><td style="width:39.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.212%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Available For Grant</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Life (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,005)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,659)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs and PRSUs granted</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,502)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs and PRSUs cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,432&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,809&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1) Includes the changes in time-based RSUs and PRSUs&#160;granted as a part of the Singular Bio acquisition in June 2019 and shares granted in an asset acquisition in December 2020 which are based on a fixed dollar value. The number of shares issued will be variable until the awards vest.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of RSU activity</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes RSU, including PRSU, activity (in thousands, except per share data):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,885&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time-based RSUs and PRSUs granted - variable </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,602&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>&#160;(1) Includes the changes in the Time-based RSUs and PRSUs&#160;granted as a part of the Singular Bio acquisition in June 2019 and the shares granted in an asset acquisition in December 2020 which are based on a fixed dollar value. The number of shares issued will be variable until the awards vest. The weighted-average grant date fair value per share reflects the fair value pricing of the full award.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of assumptions used in determination of fair value of options</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of share-based payments for stock options granted to employees and directors was estimated on the date of grant using the Black-Scholes option-pricing model based on the following assumptions:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.2%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the shares purchased pursuant to the ESPP was estimated using the following assumptions:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.7%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.3%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Summary of stock based compensation expense related to stock options included in consolidated statements of operations</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock-based compensation expense for the years ended December&#160;31, 2020, 2019 and 2018, included in the consolidated statements of operations (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,713&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,563&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,960&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,762&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,017&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,418&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,641&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,854&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,986&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,747&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,948&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,850&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238332053848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of components of loss before income taxes by U.S. and foreign jurisdictions</a></td>
<td class="text">The components of net loss before taxes by U.S. and foreign jurisdictions are as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,409&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,531&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,194&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714,270&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,415&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,155&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of components of the provision for income taxes</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the provision for income taxes are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current benefit for income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94,279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,011)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,862)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred benefit for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,271)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,535)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,862)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,100)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,450)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,800)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation of the tax expense computed at the statutory federal rate and Company's tax expense</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the tax expense computed at the statutory federal rate and our tax expense for the periods presented:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal taxes at statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes (net of federal benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of net deferred tax assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences and carryforwards that give rise to significant portions of the deferred tax assets are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337,866&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,182&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,969&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognition differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,099&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasing Liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,274&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,626&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,677&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,391&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418,885&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209,308)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145,318)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization and depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,875)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Senior Notes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,658)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,720)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasing Assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261,115)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,019)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,538)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Schedule of reconciliation of gross unrecognized tax benefits</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases&#8212;current period tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases&#8212;prior period tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases&#8212;prior period tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,441)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,965&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,985&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,375&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238415500456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net loss per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of earnings per share, basic and diluted</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(602,170)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241,965)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,355)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing net loss per share, basic and diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,587&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,859&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,747&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.47)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.66)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.94)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of antidilutive securities excluded from computation of earnings per share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents have been excluded from diluted net loss per share because their inclusion would be anti-dilutive (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock subject to outstanding options</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,878&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,662&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,028&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock subject to outstanding warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock subject to outstanding RSUs</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,590&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,293&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock subject to outstanding PRSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock pursuant to ESPP</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock underlying Series A convertible preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock subject to Convertible Senior Notes conversion</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,371&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,612&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,321&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,960&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,770&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238323722168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Geographic information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Segments, Geographical Areas [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of revenue by geographic region</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by country is determined based on the billing address of the customer and is summarized as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.330%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,680&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,550&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,239&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,529&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,356&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,389&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,918&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,254&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,598&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,824&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,699&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentsGeographicalAreasAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentsGeographicalAreasAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238415501848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected quarterly data (unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Schedule of selected quarterly data</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our quarterly financial information for 2020 and 2019 (in thousands, except per share amounts):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.275%"><tr><td style="width:1.0%"/><td style="width:35.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,248&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,191&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,728&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,431&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97,784)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,082)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,823)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331,483)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,527)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166,403)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102,902)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.99)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.29)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.78)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.30)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,553&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,475&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,511&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,285&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,207)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,886)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,983)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,036)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,677)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,676)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,707)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,905)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.54)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.82)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.79)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">___________________________________________________________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss per share is computed independently for each of the quarters presented. Therefore, the sum of quarterly net loss per share information may not equal annual net loss per share.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121640914&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238415498488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and description of business (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>business </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | business</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | Segment</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238429351400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life, intangible assets</a></td>
<td class="text">10 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Long-lived asset impairment losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets', window );">Valuation allowance available to reduce intangible assets</a></td>
<td class="nump">112,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense</a></td>
<td class="nump">11,400,000<span></span>
</td>
<td class="nump">9,900,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">841,256,000<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease to additional paid-in-capital</a></td>
<td class="num">(1,976,293,000)<span></span>
</td>
<td class="num">(379,640,000)<span></span>
</td>
<td class="num">(161,839,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(32,332,000)<span></span>
</td>
<td class="num">(3,891,000)<span></span>
</td>
<td class="num">(2,568,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid-in capital:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease to additional paid-in-capital</a></td>
<td class="num">(3,337,120,000)<span></span>
</td>
<td class="num">(1,138,316,000)<span></span>
</td>
<td class="num">$ (678,548,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (520,558,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of prior period, adjustment | Reclassification of stock payable liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">10,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of prior period, adjustment | Reclassification of stock payable liabilities | Additional paid-in capital:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease to additional paid-in-capital</a></td>
<td class="nump">$ 10,400,000<span></span>
</td>
<td class="nump">$ 10,387,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life, intangible assets</a></td>
<td class="text">10 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life, intangible assets</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life, property and equipment</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life, intangible assets</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life, intangible assets</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life, property and equipment</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life, intangible assets</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvta_ConvertibleSeniorNotesMember', window );">Convertible Senior Notes | Convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the valuation allowance recorded in a business combination against deductible temporary differences for which related tax benefits will be recorded as a reduction of the acquired entity's other noncurrent intangible assets if those tax benefits subsequently become realizable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121554379&amp;loc=d3e9901-128506<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvta_ConvertibleSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvta_ConvertibleSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238331878488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Schedule of significant customers, revenue as a percentage (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer concentration risk | Revenue | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=nvta_CustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=nvta_CustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238322597208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of significant accounting policies - Schedule of cash, cash equivalents and restricted cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 124,794<span></span>
</td>
<td class="nump">$ 151,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">6,686<span></span>
</td>
<td class="nump">6,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 131,480<span></span>
</td>
<td class="nump">$ 157,572<span></span>
</td>
<td class="nump">$ 118,164<span></span>
</td>
<td class="nump">$ 17,459<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238329501528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Schedule of useful lives of property and equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful lives</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember', window );">Automobiles</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful lives</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Manufacturing and Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238411527880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue, accounts receivable and deferred revenue - Schedule of disaggregated revenue by payer category (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 100,431<span></span>
</td>
<td class="nump">$ 68,728<span></span>
</td>
<td class="nump">$ 46,191<span></span>
</td>
<td class="nump">$ 64,248<span></span>
</td>
<td class="nump">$ 66,285<span></span>
</td>
<td class="nump">$ 56,511<span></span>
</td>
<td class="nump">$ 53,475<span></span>
</td>
<td class="nump">$ 40,553<span></span>
</td>
<td class="nump">$ 279,598<span></span>
</td>
<td class="nump">$ 216,824<span></span>
</td>
<td class="nump">$ 147,699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=nvta_PatientInsuranceMember', window );">Patient Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,026<span></span>
</td>
<td class="nump">153,827<span></span>
</td>
<td class="nump">96,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=nvta_PatientDirectMember', window );">Patient Direct</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,972<span></span>
</td>
<td class="nump">17,597<span></span>
</td>
<td class="nump">13,589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=nvta_PartnerMember', window );">Biopharma partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,553<span></span>
</td>
<td class="nump">12,953<span></span>
</td>
<td class="nump">7,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=nvta_OtherBusinessToBusinessMember', window );">Other business-to-business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,047<span></span>
</td>
<td class="nump">32,447<span></span>
</td>
<td class="nump">29,962<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_DiagnosticTestsMember', window );">Test revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,310<span></span>
</td>
<td class="nump">212,473<span></span>
</td>
<td class="nump">144,560<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_DiagnosticTestsMember', window );">Test revenue | Patient Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,026<span></span>
</td>
<td class="nump">153,827<span></span>
</td>
<td class="nump">96,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_DiagnosticTestsMember', window );">Test revenue | Patient Direct</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,972<span></span>
</td>
<td class="nump">17,597<span></span>
</td>
<td class="nump">13,589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_DiagnosticTestsMember', window );">Test revenue | Biopharma partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,065<span></span>
</td>
<td class="nump">10,876<span></span>
</td>
<td class="nump">6,231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_DiagnosticTestsMember', window );">Test revenue | Other business-to-business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,247<span></span>
</td>
<td class="nump">30,173<span></span>
</td>
<td class="nump">28,388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_TestRevenueCentralizedMember', window );">Centralized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,962<span></span>
</td>
<td class="nump">212,473<span></span>
</td>
<td class="nump">144,560<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_TestRevenueCentralizedMember', window );">Centralized | Patient Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,026<span></span>
</td>
<td class="nump">153,827<span></span>
</td>
<td class="nump">96,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_TestRevenueCentralizedMember', window );">Centralized | Patient Direct</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,972<span></span>
</td>
<td class="nump">17,597<span></span>
</td>
<td class="nump">13,589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_TestRevenueCentralizedMember', window );">Centralized | Biopharma partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,228<span></span>
</td>
<td class="nump">10,876<span></span>
</td>
<td class="nump">6,231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_TestRevenueCentralizedMember', window );">Centralized | Other business-to-business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,736<span></span>
</td>
<td class="nump">30,173<span></span>
</td>
<td class="nump">28,388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_TestRevenueDecentralizedMember', window );">Decentralized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_TestRevenueDecentralizedMember', window );">Decentralized | Patient Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_TestRevenueDecentralizedMember', window );">Decentralized | Patient Direct</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_TestRevenueDecentralizedMember', window );">Decentralized | Biopharma partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_TestRevenueDecentralizedMember', window );">Decentralized | Other business-to-business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_CollaborationAndGenomeNetworkMember', window );">Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,288<span></span>
</td>
<td class="nump">4,351<span></span>
</td>
<td class="nump">3,139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_CollaborationAndGenomeNetworkMember', window );">Other revenue | Patient Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_CollaborationAndGenomeNetworkMember', window );">Other revenue | Patient Direct</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_CollaborationAndGenomeNetworkMember', window );">Other revenue | Biopharma partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,488<span></span>
</td>
<td class="nump">2,077<span></span>
</td>
<td class="nump">1,565<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvta_CollaborationAndGenomeNetworkMember', window );">Other revenue | Other business-to-business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="nump">$ 2,274<span></span>
</td>
<td class="nump">$ 1,574<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=nvta_PatientInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=nvta_PatientInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=nvta_PatientDirectMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=nvta_PatientDirectMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=nvta_PartnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=nvta_PartnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=nvta_OtherBusinessToBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=nvta_OtherBusinessToBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=nvta_DiagnosticTestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=nvta_DiagnosticTestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=nvta_TestRevenueCentralizedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=nvta_TestRevenueCentralizedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=nvta_TestRevenueDecentralizedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=nvta_TestRevenueDecentralizedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=nvta_CollaborationAndGenomeNetworkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=nvta_CollaborationAndGenomeNetworkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328407656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue, accounts receivable and deferred revenue - Schedule of change in estimate (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateLineItems', window );"><strong>Change in Accounting Estimate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 100,431<span></span>
</td>
<td class="nump">$ 68,728<span></span>
</td>
<td class="nump">$ 46,191<span></span>
</td>
<td class="nump">$ 64,248<span></span>
</td>
<td class="nump">$ 66,285<span></span>
</td>
<td class="nump">$ 56,511<span></span>
</td>
<td class="nump">$ 53,475<span></span>
</td>
<td class="nump">$ 40,553<span></span>
</td>
<td class="nump">$ 279,598<span></span>
</td>
<td class="nump">$ 216,824<span></span>
</td>
<td class="nump">$ 147,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">$ (331,483)<span></span>
</td>
<td class="num">$ (80,823)<span></span>
</td>
<td class="num">$ (142,082)<span></span>
</td>
<td class="num">$ (97,784)<span></span>
</td>
<td class="num">$ (79,036)<span></span>
</td>
<td class="num">$ (76,983)<span></span>
</td>
<td class="num">$ (51,886)<span></span>
</td>
<td class="num">$ (36,207)<span></span>
</td>
<td class="num">$ (652,172)<span></span>
</td>
<td class="num">$ (244,112)<span></span>
</td>
<td class="num">$ (122,557)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare', window );">Net loss per share, basic and diluted (in dollars per share)</a></td>
<td class="num">$ (1.30)<span></span>
</td>
<td class="num">$ (0.78)<span></span>
</td>
<td class="num">$ (1.29)<span></span>
</td>
<td class="num">$ (0.99)<span></span>
</td>
<td class="num">$ (0.79)<span></span>
</td>
<td class="num">$ (0.82)<span></span>
</td>
<td class="num">$ (0.54)<span></span>
</td>
<td class="num">$ (0.47)<span></span>
</td>
<td class="num">$ (4.47)<span></span>
</td>
<td class="num">$ (2.66)<span></span>
</td>
<td class="num">$ (1.94)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis=nvta_ChangeInEstimateOfRevenueRecognitionMember', window );">Change in estimate of revenue recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateLineItems', window );"><strong>Change in Accounting Estimate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="nump">$ 4,100<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,400)<span></span>
</td>
<td class="num">$ (4,100)<span></span>
</td>
<td class="num">$ (4,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare', window );">Net loss per share, basic and diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis=nvta_ChangeInEstimateOfRevenueRecognitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis=nvta_ChangeInEstimateOfRevenueRecognitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238327989144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue, accounts receivable and deferred revenue - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Unbilled revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Deferred revenue, revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination', window );">Increase in deferred revenue upon acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Deferred revenue, revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OneTimeTerminationBenefitsMember', window );">One-time termination costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent', window );">Positions eliminated, percent of total workforce</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent', window );">Reduction in officer salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=nvta_CARESActMember', window );">CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemNetGainLoss', window );">Income received under the CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=nvta_CARESActMember', window );">CARES Act | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemNetGainLoss', window );">Income received under the CARES Act</a></td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Related Cost, Number of Positions Eliminated, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Related Cost, Reduction in Officer Salary, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemNetGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of (gain) loss for an event or transaction that is unusual in nature or occurs infrequently, or both.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=114868879&amp;loc=SL114871939-224231<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=114868883&amp;loc=SL114871943-224233<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemNetGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OneTimeTerminationBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OneTimeTerminationBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=nvta_CARESActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=nvta_CARESActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328970616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations - Singular Bio (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>tradingDay</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>tradingDay </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 158,747<span></span>
</td>
<td class="nump">$ 75,948<span></span>
</td>
<td class="nump">$ 20,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_SingularBioMember', window );">Singular Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Common stock transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition common stock issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember', window );">Stock incentive plans | Singular Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,874,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested stock units awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,305,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Stock incentive plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Value of units granted</a></td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays', window );">Threshold trading days | tradingDay</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Stock incentive plans | Singular Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Value of units granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays', window );">Threshold trading days | tradingDay</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nvta_RestrictedStockUnitsPeriodofTimeMember', window );">Time-based RSUs | Stock incentive plans | Singular Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Value of units granted</a></td>
<td class="nump">$ 43,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="nump">$ 43,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,100<span></span>
</td>
<td class="nump">14,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested stock units awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PRSU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PRSU | Stock incentive plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PRSU | Stock incentive plans | Singular Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Value of units granted</a></td>
<td class="nump">$ 43,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="nump">$ 43,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,400<span></span>
</td>
<td class="nump">$ 24,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested stock units awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">First anniversary | RSUs | Stock incentive plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate upon anniversaries</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">First anniversary | RSUs | Stock incentive plans | Singular Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate upon anniversaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Second anniversary | RSUs | Stock incentive plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate upon anniversaries</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Second anniversary | RSUs | Stock incentive plans | Singular Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate upon anniversaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember', window );">Third anniversary | RSUs | Stock incentive plans | Singular Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate upon anniversaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_SingularBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_SingularBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvta_RestrictedStockUnitsPeriodofTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvta_RestrictedStockUnitsPeriodofTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238327999464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations - Jungla (Details) - USD ($)<br> $ in Thousands, shares in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, total purchase consideration</a></td>
<td class="nump">$ 65,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_JunglaMember', window );">Jungla</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Common stock transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember', window );">Ongoing development post-close milestones | Jungla</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,700<span></span>
</td>
<td class="nump">$ 7,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration', window );">Business acquisition, expected milestone duration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=nvta_IndemnificationObligationsMember', window );">Indemnification obligations | Jungla</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition common stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Expected Milestone Duration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_JunglaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_JunglaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=nvta_IndemnificationObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=nvta_IndemnificationObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238330003224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations - Clear Genetics (Details) - USD ($)<br> $ in Thousands, shares in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, total purchase consideration</a></td>
<td class="nump">$ 65,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCash', window );">Hold-back consideration - cash</a></td>
<td class="nump">$ 1,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ClearGeneticsMember', window );">Clear Genetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=nvta_IndemnificationObligationsMember', window );">Indemnification obligations | Clear Genetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCash', window );">Hold-back consideration - cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition common stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationHoldbackConsiderationCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Hold-back Consideration, Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationHoldbackConsiderationCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_ClearGeneticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_ClearGeneticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=nvta_IndemnificationObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=nvta_IndemnificationObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238329964968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations - Diploid (Details) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life, intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned', window );">Hold-back consideration - common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 1,863,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,863,623<span></span>
</td>
<td class="nump">$ 126,777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_DiploidMember', window );">Diploid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life, intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned', window );">Hold-back consideration - common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">17,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember', window );">Stock incentive plans | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Value of units granted</a></td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember', window );">Stock incentive plans | Diploid | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Value of units granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=nvta_IndemnificationObligationsMember', window );">Indemnification obligations | Diploid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition common stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">First anniversary | Stock incentive plans | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate upon anniversaries</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">First anniversary | Stock incentive plans | Diploid | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate upon anniversaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Second anniversary | Stock incentive plans | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate upon anniversaries</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Second anniversary | Stock incentive plans | Diploid | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate upon anniversaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Hold-back Consideration, Common Stock, Value Assigned</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_DiploidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_DiploidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=nvta_IndemnificationObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=nvta_IndemnificationObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238329923496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations - Summary of the purchase price and post-combination expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Purchase Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCash', window );">Hold-back consideration - cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned', window );">Hold-back consideration - common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_DiploidMember', window );">Diploid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Purchase Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned', window );">Hold-back consideration - common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,453<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,314<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_GenelexMember', window );">Genelex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Purchase Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCash', window );">Hold-back consideration - cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned', window );">Hold-back consideration - common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_YouScriptMember', window );">YouScript</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Purchase Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCash', window );">Hold-back consideration - cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned', window );">Hold-back consideration - common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Purchase Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash transferred</a></td>
<td class="nump">$ 335,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Contingent consideration</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred', window );">Contingent consideration and liabilities incurred</a></td>
<td class="nump">935,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock transferred</a></td>
<td class="nump">1,060,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total</a></td>
<td class="nump">2,331,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX | Post-combination Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract', window );"><strong>Post-combination Expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred', window );">Cash transferred</a></td>
<td class="nump">22,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration', window );">Contingent consideration and liabilities incurred</a></td>
<td class="nump">12,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred', window );">Common stock transferred</a></td>
<td class="nump">91,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized', window );">Total</a></td>
<td class="nump">$ 125,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Equity Interests Issued and Issuable and Liabilities Incurred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationHoldbackConsiderationCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Hold-back Consideration, Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationHoldbackConsiderationCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Hold-back Consideration, Common Stock, Value Assigned</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Separately Recognized Transactions, Cash Transferred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Separately Recognized Transactions, Common Stock Transferred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Separately Recognized Transactions, Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expenses and losses recorded for each transaction with the acquiree that was recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_DiploidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_DiploidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_GenelexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_GenelexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_YouScriptMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_YouScriptMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=nvta_AccelerationofVestedEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=nvta_AccelerationofVestedEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328045256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business combinations - Summary of fair values of assets acquired and liabilities assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 1,863,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 126,777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_DiploidMember', window );">Diploid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total identifiable assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identifiable assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_GenelexMember', window );">Genelex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset', window );">Operating lease assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total identifiable assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(320)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identifiable assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_YouScriptMember', window );">YouScript</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset', window );">Operating lease assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total identifiable assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(481)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(163)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identifiable assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_GenelexandYouScriptMember', window );">Genelex and YouScript</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset', window );">Operating lease assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total identifiable assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(801)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(163)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identifiable assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset', window );">Operating lease assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">803,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total identifiable assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">875,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease', window );">Operating lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease', window );">Operating lease obligations, net of current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identifiable assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">679,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,652,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,331,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Operating Lease</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Operating Lease</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Operating Lease, Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_DiploidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_DiploidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_GenelexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_GenelexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_YouScriptMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_YouScriptMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_GenelexandYouScriptMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_GenelexandYouScriptMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238327031624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations - Genelex and YouScript (Details) - USD ($)<br> $ in Thousands, shares in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, total purchase consideration</a></td>
<td class="nump">$ 65,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash transferred</a></td>
<td class="nump">25,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned', window );">Hold-back consideration - common stock</a></td>
<td class="nump">$ 6,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life, intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,863,623<span></span>
</td>
<td class="nump">$ 126,777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_GenelexMember', window );">Genelex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, total purchase consideration</a></td>
<td class="nump">$ 13,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash transferred</a></td>
<td class="nump">972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned', window );">Hold-back consideration - common stock</a></td>
<td class="nump">$ 781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration', window );">Business acquisition, expected milestone duration</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life, intangible assets</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 4,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_YouScriptMember', window );">YouScript</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, total purchase consideration</a></td>
<td class="nump">$ 52,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash transferred</a></td>
<td class="nump">24,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned', window );">Hold-back consideration - common stock</a></td>
<td class="nump">$ 5,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life, intangible assets</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 29,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_GenelexandYouScriptMember', window );">Genelex and YouScript</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned', window );">Hold-back consideration - common stock</a></td>
<td class="nump">6,200<span></span>
</td>
<td class="nump">21,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 33,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=nvta_IndemnificationObligationsMember', window );">Indemnification obligations | Genelex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition common stock issued (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=nvta_IndemnificationObligationsMember', window );">Indemnification obligations | YouScript</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition common stock issued (in shares)</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned', window );">Hold-back consideration - common stock</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Expected Milestone Duration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Hold-back Consideration, Common Stock, Value Assigned</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_GenelexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_GenelexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_YouScriptMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_YouScriptMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_GenelexandYouScriptMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_GenelexandYouScriptMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=nvta_IndemnificationObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=nvta_IndemnificationObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238325858744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations - ArcherDX (Details) - USD ($)<br> $ in Thousands, shares in Millions</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Liabilities incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,863,623<span></span>
</td>
<td class="nump">$ 1,863,623<span></span>
</td>
<td class="nump">$ 126,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,100<span></span>
</td>
<td class="nump">18,450<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327,233<span></span>
</td>
<td class="nump">267,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">685,589<span></span>
</td>
<td class="nump">355,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,747<span></span>
</td>
<td class="nump">$ 75,948<span></span>
</td>
<td class="nump">$ 20,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,331,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Common stock transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Liabilities incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,900<span></span>
</td>
<td class="nump">20,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 933,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">788,300<span></span>
</td>
<td class="nump">788,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition common stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 335,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,652,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Value of units granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost', window );">Stock-based compensation expense, accelerated cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX | Recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">945,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX | Milestone achievement agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 925,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration', window );">Business acquisition, expected milestone duration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition common stock issued (in shares)</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash transferred</a></td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Increase in amount of contingent consideration</a></td>
<td class="nump">$ 40,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX | Post-combination Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized', window );">Post-combination expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Expected Milestone Duration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expenses and losses recorded for each transaction with the acquiree that was recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=nvta_MilestoneAchievementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=nvta_MilestoneAchievementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=nvta_AccelerationofVestedEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=nvta_AccelerationofVestedEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328188328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations - Summary of intangible assets acquired (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated useful life</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 803.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets, finite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX | Tradename</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets, finite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets, finite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 233.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX | Right to develop new technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets, finite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets, indefinite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 512.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238327810520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations - Schedule of pro forma financial information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 327,233<span></span>
</td>
<td class="nump">$ 267,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 685,589<span></span>
</td>
<td class="nump">$ 355,818<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238329905848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and intangible assets - Summary of goodwill (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 126,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">1,863,623<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_DiploidMember', window );">Diploid</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">50,655<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_GenelexMember', window );">Genelex</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">4,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_YouScriptMember', window );">YouScript</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">29,726<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">$ 1,652,398<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_DiploidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_DiploidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_GenelexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_GenelexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_YouScriptMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_YouScriptMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238329052056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and intangible assets - Schedule of intangible assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">$ (40,407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net, finite-lived intangible assets</a></td>
<td class="nump">439,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">1,022,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 981,845<span></span>
</td>
<td class="nump">$ 125,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-Average Useful Life (in Years)</a></td>
<td class="text">10 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted-Average Estimated Remaining Useful Life (in Years)</a></td>
<td class="text">10 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost, finite-lived intangible assets</a></td>
<td class="nump">$ 41,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(8,292)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net, finite-lived intangible assets</a></td>
<td class="nump">$ 32,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-Average Useful Life (in Years)</a></td>
<td class="text">10 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted-Average Estimated Remaining Useful Life (in Years)</a></td>
<td class="text">8 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost, finite-lived intangible assets</a></td>
<td class="nump">$ 397,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(31,013)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net, finite-lived intangible assets</a></td>
<td class="nump">$ 366,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-Average Useful Life (in Years)</a></td>
<td class="text">10 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted-Average Estimated Remaining Useful Life (in Years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost, finite-lived intangible assets</a></td>
<td class="nump">$ 286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(229)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net, finite-lived intangible assets</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-Average Useful Life (in Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted-Average Estimated Remaining Useful Life (in Years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Tradename</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost, finite-lived intangible assets</a></td>
<td class="nump">$ 21,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(447)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net, finite-lived intangible assets</a></td>
<td class="nump">$ 20,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-Average Useful Life (in Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted-Average Estimated Remaining Useful Life (in Years)</a></td>
<td class="text">11 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=nvta_PatentLicensingAgreementMember', window );">Patent licensing agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost, finite-lived intangible assets</a></td>
<td class="nump">$ 496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(103)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net, finite-lived intangible assets</a></td>
<td class="nump">$ 393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-Average Useful Life (in Years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted-Average Estimated Remaining Useful Life (in Years)</a></td>
<td class="text">11 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Right to develop new technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost, finite-lived intangible assets</a></td>
<td class="nump">$ 19,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(323)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net, finite-lived intangible assets</a></td>
<td class="nump">$ 19,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-Average Useful Life (in Years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted-Average Estimated Remaining Useful Life (in Years)</a></td>
<td class="text">14 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="nump">$ 542,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=nvta_PatentLicensingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=nvta_PatentLicensingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238329210072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and intangible assets - Narrative (Details)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>tradingDay</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,600<span></span>
</td>
<td class="nump">$ 7,700<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,747<span></span>
</td>
<td class="nump">75,948<span></span>
</td>
<td class="nump">$ 20,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">$ 835,876<span></span>
</td>
<td class="nump">835,876<span></span>
</td>
<td class="nump">11,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">835,876<span></span>
</td>
<td class="nump">835,876<span></span>
</td>
<td class="nump">$ 11,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Level 3 | Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">5,400<span></span>
</td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Stock incentive plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Value of units granted</a></td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays', window );">Threshold trading days | tradingDay</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Stock incentive plans | First anniversary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate upon anniversaries</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Stock incentive plans | Second anniversary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate upon anniversaries</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated useful life</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238332086120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and intangible assets - Summary of estimated future amortization expense of intangible assets with finite lives (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 46,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">45,401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">44,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">44,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2025</a></td>
<td class="nump">42,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">216,292<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net, finite-lived intangible assets</a></td>
<td class="nump">$ 439,457<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238322265048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance sheet components - Schedule of inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAbstract', window );"><strong>Offsetting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 21,324<span></span>
</td>
<td class="nump">$ 6,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in progress</a></td>
<td class="nump">8,847<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">1,859<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 32,030<span></span>
</td>
<td class="nump">$ 6,648<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238324103848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance sheet components - Property and equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 97,449<span></span>
</td>
<td class="nump">$ 63,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(31,347)<span></span>
</td>
<td class="num">(26,135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">66,102<span></span>
</td>
<td class="nump">37,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">10,500<span></span>
</td>
<td class="nump">7,100<span></span>
</td>
<td class="nump">$ 8,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">26,516<span></span>
</td>
<td class="nump">18,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">45,342<span></span>
</td>
<td class="nump">24,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">10,939<span></span>
</td>
<td class="nump">5,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">566<span></span>
</td>
<td class="nump">2,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,967<span></span>
</td>
<td class="nump">1,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember', window );">Automobiles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction-in-progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 12,061<span></span>
</td>
<td class="nump">$ 10,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238324321112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance sheet components - Accrued liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and related expenses</a></td>
<td class="nump">$ 25,221<span></span>
</td>
<td class="nump">$ 16,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">6,378<span></span>
</td>
<td class="nump">1,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationAccruedLiabilitiesCurrent', window );">Compensation and other liabilities associated with business combinations</a></td>
<td class="nump">25,600<span></span>
</td>
<td class="nump">30,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">28,859<span></span>
</td>
<td class="nump">16,385<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 86,058<span></span>
</td>
<td class="nump">$ 64,814<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination accrued liabilities current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238322231912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance sheet components - Other long-term liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, non-current</a></td>
<td class="nump">$ 1,380<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationAccruedLiabilitiesNoncurrent', window );">Compensation and other liabilities associated with business combinations, non-current</a></td>
<td class="nump">825,976<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other</a></td>
<td class="nump">13,900<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total other long-term liabilities</a></td>
<td class="nump">$ 841,256<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination accrued liabilities noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238325416920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair value measurements - Financial instruments at fair value on a recurring basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">$ 312,294<span></span>
</td>
<td class="nump">$ 383,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="nump">312,295<span></span>
</td>
<td class="nump">383,616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">76,423<span></span>
</td>
<td class="nump">136,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">6,686<span></span>
</td>
<td class="nump">6,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">229,186<span></span>
</td>
<td class="nump">240,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">10,592<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">825,284<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">312,295<span></span>
</td>
<td class="nump">383,616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">835,876<span></span>
</td>
<td class="nump">11,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">247,995<span></span>
</td>
<td class="nump">190,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">64,300<span></span>
</td>
<td class="nump">193,608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">835,876<span></span>
</td>
<td class="nump">11,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">83,109<span></span>
</td>
<td class="nump">39,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="nump">83,109<span></span>
</td>
<td class="nump">39,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Recurring basis | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="nump">83,109<span></span>
</td>
<td class="nump">39,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Recurring basis | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Recurring basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Recurring basis | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Recurring basis | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Recurring basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">164,894<span></span>
</td>
<td class="nump">150,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury notes | Recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="nump">164,886<span></span>
</td>
<td class="nump">150,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury notes | Recurring basis | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="nump">164,886<span></span>
</td>
<td class="nump">150,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury notes | Recurring basis | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury notes | Recurring basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">64,291<span></span>
</td>
<td class="nump">193,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government agency securities | Recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="nump">64,300<span></span>
</td>
<td class="nump">193,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government agency securities | Recurring basis | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government agency securities | Recurring basis | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="nump">64,300<span></span>
</td>
<td class="nump">193,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government agency securities | Recurring basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue', window );">Financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AccruedLiabilitiesMember', window );">Stock payable liability | Recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">39,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AccruedLiabilitiesMember', window );">Stock payable liability | Recurring basis | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AccruedLiabilitiesMember', window );">Stock payable liability | Recurring basis | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AccruedLiabilitiesMember', window );">Stock payable liability | Recurring basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">39,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=nvta_ContingentConsiderationMember', window );">Contingent consideration | Recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">796,639<span></span>
</td>
<td class="nump">11,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=nvta_ContingentConsiderationMember', window );">Contingent consideration | Recurring basis | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=nvta_ContingentConsiderationMember', window );">Contingent consideration | Recurring basis | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=nvta_ContingentConsiderationMember', window );">Contingent consideration | Recurring basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">$ 796,639<span></span>
</td>
<td class="nump">$ 11,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents restricted cash and marketable securities amortized cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost Gross Unrealized Gain Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents restricted cash and marketable securities amortized cost gross unrealized loss before tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents restricted cash and marketable securities fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=nvta_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=nvta_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238329915144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value measurements - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount', window );">Transfers of assets and liabilities between Level 1, Level 2 and Level 3</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss', window );">Total fair value of investments with unrealized losses</a></td>
<td class="nump">109,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Investments, interest income</a></td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value, expense</a></td>
<td class="nump">$ 37,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod', window );">Maturities period of available-for-sale securities</a></td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod', window );">Maturities period of available-for-sale securities</a></td>
<td class="text">9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_DebtSecuritiesAvailableForSaleMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Maturity Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_DebtSecuritiesAvailableForSaleMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value assets and liabilities level1 level2 and level3 transfers&#8217; amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionQuantitativeDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238323650200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and contingencies - Lease additional information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseTermOfContract1', window );">Finance lease, term of contract</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nvta_NewLeasesMember', window );">New Leases | Office Facility In San Francisco</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nvta_NewLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nvta_NewLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nvta_OfficeFacilityInSanFranciscoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=nvta_OfficeFacilityInSanFranciscoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328666152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies - Supplemental information regarding our operating and finance leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_LeasesWeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted-average remaining lease term:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases</a></td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_LeasesWeightedAverageDiscountRateAbstract', window );"><strong>Weighted-average discount rate:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">10.60%<span></span>
</td>
<td class="nump">11.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_LeasesCashPaymentsIncludedInMeasurementAbstract', window );"><strong>Cash payments included in the measurement of lease liabilities (in millions):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating leases</a></td>
<td class="nump">$ 11,600<span></span>
</td>
<td class="nump">$ 10,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments', window );">Finance leases</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">11,329<span></span>
</td>
<td class="nump">10,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating lease costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(173)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1', window );">Sublease income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(156)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Finance lease costs</a></td>
<td class="nump">2,084<span></span>
</td>
<td class="nump">1,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesIncomeStatementInterestExpense', window );">Finance lease costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,820<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease costs</a></td>
<td class="nump">$ 13,413<span></span>
</td>
<td class="nump">$ 11,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_LeasesExpense', window );">Total lease costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,312<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Principal Payments and Other Ancillary Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_LeasesCashPaymentsIncludedInMeasurementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases, Cash Payments Included in Measurement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_LeasesCashPaymentsIncludedInMeasurementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_LeasesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases, Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_LeasesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_LeasesWeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases, Weighted-Average Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_LeasesWeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_LeasesWeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases, Weighted-Average Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_LeasesWeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesIncomeStatementInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The financing charge for leasing arrangements meeting the criteria for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121569800&amp;loc=d3e45031-112735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesIncomeStatementInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of sublease rental income recognized during the period that reduces the entity's rent expense incurred under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseSubleaseRentals1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328040984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and contingencies - Schedule of future payments under operating and finance leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 14,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">13,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">13,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">13,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">11,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">9,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Future non-cancelable minimum lease payments</a></td>
<td class="nump">75,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: interest</a></td>
<td class="num">(18,787)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">57,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="num">(8,789)<span></span>
</td>
<td class="num">$ (4,870)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease obligations, net of current portion</a></td>
<td class="nump">48,357<span></span>
</td>
<td class="nump">42,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract', window );"><strong>Finance leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">2,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">1,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">1,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Future non-cancelable minimum lease payments</a></td>
<td class="nump">5,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: interest</a></td>
<td class="num">(321)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">4,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="num">(1,695)<span></span>
</td>
<td class="num">(1,855)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Lease obligations, net of current portion</a></td>
<td class="nump">$ 3,123<span></span>
</td>
<td class="nump">$ 1,155<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328976104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies - Debt financing (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Debt extinguishment costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10,638,000<span></span>
</td>
<td class="nump">$ 4,609,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember', window );">Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=nvta_DebtFinancingContingencyMember', window );">Debt financing contingency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="nump">$ 16.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=nvta_NotePurchaseAgreementMember', window );">Note Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Maturity term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_RepaymentsofLinesofCreditPrincipal', window );">Repayment of principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_RepaymentsofLinesofCreditAccruedInterest', window );">Repayment of accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Debt extinguishment costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvta_TrancheOneMember', window );">Initial sale of notes | Note Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from notes sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvta_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,400,000<span></span>
</td>
<td class="nump">5,700,000<span></span>
</td>
<td class="nump">$ 6,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvta_SeniorSecuredTermLoanFacilityMember', window );">2020 Term Loan | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 135,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate', window );">Days prior to convertible debt extended maturity date</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt discounts and issuance costs</a></td>
<td class="nump">$ 32,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvta_SeniorSecuredTermLoanFacilityMember', window );">2020 Term Loan | Secured Debt | Prior to third anniversary of closing date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_DebtInstrumentPrepaymentFeePercentage', window );">Prepayment fee</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvta_SeniorSecuredTermLoanFacilityMember', window );">2020 Term Loan | Secured Debt | After the third anniversary of closing date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_DebtInstrumentPrepaymentFeePercentage', window );">Prepayment fee</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvta_SeniorSecuredTermLoanFacilityMember', window );">2020 Term Loan | Secured Debt | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_DebtInstrumentInterestRateFloorRate', window );">Floor rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">8.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvta_ConvertibleSeniorNotesMember', window );">Convertible Senior Notes | Convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended', window );">Percent of debt extended</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt discounts and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,276,000<span></span>
</td>
<td class="nump">81,245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000,000.0<span></span>
</td>
<td class="nump">$ 6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_DebtInstrumentInterestRateFloorRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Rate, Floor Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_DebtInstrumentInterestRateFloorRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maturity Terms, Days Prior to Convertible Debt Extended Maturity Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maturity Terms, Percent of Debt Extended</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_DebtInstrumentPrepaymentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Fee, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_DebtInstrumentPrepaymentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_RepaymentsofLinesofCreditAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayments of Lines of Credit, Accrued Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_RepaymentsofLinesofCreditAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_RepaymentsofLinesofCreditPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayments of Lines of Credit, Principal</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_RepaymentsofLinesofCreditPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=nvta_DebtFinancingContingencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=nvta_DebtFinancingContingencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=nvta_NotePurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=nvta_NotePurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvta_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvta_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvta_LoanAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvta_LoanAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvta_SeniorSecuredTermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvta_SeniorSecuredTermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvta_ConvertibleSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvta_ConvertibleSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238327404744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies - Convertible senior notes (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>tradingDay </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvta_ConvertibleSeniorNotesMember', window );">Convertible Senior Notes | Convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount | $</a></td>
<td class="nump">$ 350,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="nump">0.0336293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 29.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Number of threshold trading days</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of consecutive trading days</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage of stock price trigger</a></td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays', window );">Threshold trading days immediately after five consecutive trading days</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum', window );">Maximum threshold percentage of stock price trigger</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays', window );">Threshold trading days</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000,000.0<span></span>
</td>
<td class="nump">$ 6,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 586,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Threshold Trading Days Immediately after Five Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption Period, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvta_ConvertibleSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvta_ConvertibleSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238322414696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and contingencies - Components of debt (Details) - Convertible debt - Convertible Senior Notes - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal</a></td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized debt discount and issuance costs</a></td>
<td class="num">(66,276)<span></span>
</td>
<td class="num">(81,245)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net carrying amount, liability component</a></td>
<td class="nump">$ 283,724<span></span>
</td>
<td class="nump">$ 268,755<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvta_ConvertibleSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvta_ConvertibleSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238329078168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and contingencies - Other commitments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Future non-cancelable minimum operating lease payments</a></td>
<td class="nump">$ 75,933<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nvta_OfficeFacilityInSanFranciscoTwoMember', window );">Additional office facility in San Francisco</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Future non-cancelable minimum operating lease payments</a></td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=nvta_ServiceAgreementsAndLaboratorySuppliesMember', window );">Service agreements and laboratory supplies</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear', window );">2021</a></td>
<td class="nump">23,064<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear', window );">2022</a></td>
<td class="nump">20,372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear', window );">2023</a></td>
<td class="nump">19,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear', window );">2024</a></td>
<td class="nump">9,220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear', window );">2025</a></td>
<td class="nump">4,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear', window );">Thereafter</a></td>
<td class="nump">25,501<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligation', window );">Total</a></td>
<td class="nump">$ 102,138<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the recorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nvta_OfficeFacilityInSanFranciscoTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=nvta_OfficeFacilityInSanFranciscoTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=nvta_ServiceAgreementsAndLaboratorySuppliesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=nvta_ServiceAgreementsAndLaboratorySuppliesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328289208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' equity - Schedule of convertible preferred and common stock (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, beginning of period</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">3,459<span></span>
</td>
<td class="nump">3,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Common stock issued upon conversion of preferred stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,334<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, end of period</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">3,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, beginning of period</a></td>
<td class="nump">98,796<span></span>
</td>
<td class="nump">75,481<span></span>
</td>
<td class="nump">53,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Common stock issued upon conversion of preferred stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,334<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts', window );">Common stock issued in private placement (in shares)</a></td>
<td class="nump">16,320<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock issued in connection with initial public offering, net of offering costs (in shares)</a></td>
<td class="nump">24,005<span></span>
</td>
<td class="nump">11,136<span></span>
</td>
<td class="nump">17,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="nump">2,659<span></span>
</td>
<td class="nump">468<span></span>
</td>
<td class="nump">351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Common stock issued pursuant to vesting of restricted stock units (in shares)</a></td>
<td class="nump">5,304<span></span>
</td>
<td class="nump">2,683<span></span>
</td>
<td class="nump">1,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Common stock issued pursuant to exercises of warrants (in shares)</a></td>
<td class="nump">968<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">1,099<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued pursuant to employee stock purchase plan (in shares)</a></td>
<td class="nump">671<span></span>
</td>
<td class="nump">455<span></span>
</td>
<td class="nump">566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Common stock issued pursuant to acquisitions (in shares)</a></td>
<td class="nump">37,163<span></span>
</td>
<td class="nump">5,208<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, end of period</a></td>
<td class="nump">185,886<span></span>
</td>
<td class="nump">98,796<span></span>
</td>
<td class="nump">75,481<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares in connection with private placement, net of offering costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238330644696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' equity - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Thousands</strong></div></th>
<th class="th" colspan="7">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Aug. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 284,203,000<span></span>
</td>
<td class="nump">$ 9,470,000<span></span>
</td>
<td class="nump">$ 17,511,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Convertible Preferred Stock | Series A convertible preferred stock converted to common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Common stock issued upon conversion of preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock issued during period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,005<span></span>
</td>
<td class="nump">11,136<span></span>
</td>
<td class="nump">17,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Common stock issued upon conversion of preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,334<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock issued in connection with public offering, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock | Series A convertible preferred stock converted to common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Shares issued upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=nvta_UnderwrittenPublicOfferingMember', window );">Underwritten public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 184,000,000.0<span></span>
</td>
<td class="nump">$ 196,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts', window );">Net proceeds from issuance of underwritten public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 173,000,000.0<span></span>
</td>
<td class="nump">$ 184,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=nvta_UnderwrittenPublicOfferingMember', window );">Underwritten public offering | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net</a></td>
<td class="nump">$ 460,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts', window );">Net proceeds from issuance of underwritten public offering</a></td>
<td class="nump">$ 434,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=nvta_UnderwrittenPublicOfferingMember', window );">Underwritten public offering | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Shares issued price per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="nump">$ 19.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,400<span></span>
</td>
<td class="nump">10,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=nvta_UnderwrittenPublicOfferingMember', window );">Underwritten public offering | Common stock | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Shares issued price per share (in dollars per share)</a></td>
<td class="nump">$ 51.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction</a></td>
<td class="nump">8,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross proceeds from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_NetProceedsFromIssuanceOfPrivatePlacement', window );">Net proceeds from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_PreferredStockToCommonStockConversionRatio', window );">Conversion basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private placement | Series A Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private placement | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private placement | Common stock | ArcherDX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Shares issued price per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock issued in connection with public offering, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=nvta_CommonStockSalesAgreementMember', window );">2018 Sales Agreement | Cowen and Company, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_PercentageOfCommissionPayableOnGrossProceeds', window );">Percentage of commission payable on gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=nvta_CommonStockSalesAgreementMember', window );">2018 Sales Agreement | Cowen and Company, LLC | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,700,000<span></span>
</td>
<td class="nump">$ 20,200,000<span></span>
</td>
<td class="nump">$ 61,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock issued during period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="nump">4,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_NetProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,700,000<span></span>
</td>
<td class="nump">$ 19,500,000<span></span>
</td>
<td class="nump">$ 58,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Shares issued price per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.33<span></span>
</td>
<td class="nump">$ 25.71<span></span>
</td>
<td class="nump">$ 14.13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | 2018 Sales Agreement | Cowen and Company, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000,000.0<span></span>
</td>
<td class="nump">$ 75,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_NetProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net proceeds from issuance of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_NetProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_NetProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net proceeds from issuance of private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_NetProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_PercentageOfCommissionPayableOnGrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of commission payable on gross proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_PercentageOfCommissionPayableOnGrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_PreferredStockToCommonStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred stock to common stock conversion ratio.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_PreferredStockToCommonStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of underwritten public offering of common stock net of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=nvta_UnderwrittenPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=nvta_UnderwrittenPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=nvta_CommonStockSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=nvta_CommonStockSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nvta_CowenAndCompanyLimitedLiabilityCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nvta_CowenAndCompanyLimitedLiabilityCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328168744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' equity - Schedule of outstanding warrants to purchase common stock (Details) - Common stock - CombiMatrix - Series F Warrants<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Common stock underlying warrants (in shares) | shares</a></td>
<td class="nump">214,154<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_CombiMatrixCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_CombiMatrixCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nvta_SeriesFWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nvta_SeriesFWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238330412536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock incentive plans - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jan. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 158,747<span></span>
</td>
<td class="nump">$ 75,948<span></span>
</td>
<td class="nump">$ 20,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation</a></td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected period to recognize on a straight-line basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested stock units awarded (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,305,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,874,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation</a></td>
<td class="nump">144,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 144,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected period to recognize on a straight-line basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PRSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember', window );">Stock incentive plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember', window );">Stock incentive plans | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Value of units granted</a></td>
<td class="nump">6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember', window );">Stock incentive plans | PRSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember', window );">Stock incentive plans | Shares of common stock subject to outstanding options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate upon anniversaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage', window );">Monthly vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="nump">$ 14.52<span></span>
</td>
<td class="nump">$ 4.87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total grant date fair value of options to purchase common stock vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">$ 5,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Exercised, aggregate intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,400<span></span>
</td>
<td class="nump">$ 6,300<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvta_A2019IncentiveCompensationPlanMember', window );">2019 Incentive Compensation Plan | PRSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested stock units awarded (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Value of units granted</a></td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvta_EmployeeStockPurchasePlan2015Member', window );">2015 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.98<span></span>
</td>
<td class="nump">$ 6.05<span></span>
</td>
<td class="nump">$ 3.26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate', window );">Purchase price, percent of fair market value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from stock plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | 2010 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage', window );">Employees holding voting rights of all classes of stock (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Exercise price of options on common stock (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | 2010 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Term of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_SingularBioMember', window );">Singular Bio | Stock incentive plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_SingularBioMember', window );">Singular Bio | Stock incentive plans | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Value of units granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_SingularBioMember', window );">Singular Bio | Stock incentive plans | PRSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested stock units awarded (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Value of units granted</a></td>
<td class="nump">$ 43,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,400<span></span>
</td>
<td class="nump">$ 24,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Value of units granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX | Stock incentive plans | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member', window );">ArcherDX | Stock incentive plans | Shares of common stock subject to outstanding options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock incentive plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monthly percentage of vesting of share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of voting rights of all classes of stock held by the employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on purchase date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nvta_A2019IncentiveCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nvta_A2019IncentiveCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nvta_EmployeeStockPurchasePlan2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nvta_EmployeeStockPurchasePlan2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nvta_StockIncentivePlan2010Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nvta_StockIncentivePlan2010Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_SingularBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_SingularBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_ArcherDXInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328465816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock incentive plans - Schedule of activity under stock incentive plans (Details) - Stock incentive plans - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Activity under the plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant, beginning balance (in shares)</a></td>
<td class="nump">5,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding, beginning balance (in shares)</a></td>
<td class="nump">3,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional shares reserved (in shares)</a></td>
<td class="nump">9,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">4,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Option cancelled (in shares)</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="num">(2,659)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant, ending balance (in shares)</a></td>
<td class="nump">7,447<span></span>
</td>
<td class="nump">5,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding, ending balance (in shares)</a></td>
<td class="nump">4,877<span></span>
</td>
<td class="nump">3,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">4,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of options (in shares)</a></td>
<td class="nump">4,809<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at the beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 9.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in dollars per share)</a></td>
<td class="nump">3.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options cancelled (in dollars per share)</a></td>
<td class="nump">7.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (in dollars per share)</a></td>
<td class="nump">4.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at the end of the period (in dollars per share)</a></td>
<td class="nump">7.75<span></span>
</td>
<td class="nump">$ 9.49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, weighted-average exercise price (in dollars per share)</a></td>
<td class="nump">6.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted-average exercise price (in dollars per share)</a></td>
<td class="nump">$ 7.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Additional information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual life</a></td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, weighted-average remaining contractual life</a></td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual life</a></td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value</a></td>
<td class="nump">$ 166,130<span></span>
</td>
<td class="nump">$ 24,966<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable, aggregate intrinsic value</a></td>
<td class="nump">154,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value</a></td>
<td class="nump">$ 164,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember', window );">RSUs and PRSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Activity under the plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Units granted (in shares)</a></td>
<td class="num">(3,502)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Units cancelled (in shares)</a></td>
<td class="nump">480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nvta_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvta_RSUsAndPRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvta_RSUsAndPRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328276168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock incentive plans - Summary of RSU activity (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at the beginning of the period (in shares) | shares</a></td>
<td class="nump">8,885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">4,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(5,305)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancelled (in shares) | shares</a></td>
<td class="num">(480)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at the end of the period (in shares) | shares</a></td>
<td class="nump">6,602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at the beginning of the period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 15.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">20.35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">19.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled (in dollars per share) | $ / shares</a></td>
<td class="nump">18.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at the end of the period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 12.89<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nvta_TimebasedRSUsandPRSUsMember', window );">Time-based RSUs and PRSUs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod', window );">Granted and adjustments (in shares) | shares</a></td>
<td class="num">(1,646)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 24.12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PRSUs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 16.17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants and Adjustments in Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvta_TimebasedRSUsandPRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvta_TimebasedRSUsandPRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238330017528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock incentive plans - Schedule of assumptions used in determination of fair value of options (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">71.00%<span></span>
</td>
<td class="nump">64.20%<span></span>
</td>
<td class="nump">59.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvta_EmployeeStockPurchasePlan2015Member', window );">2015 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">105.70%<span></span>
</td>
<td class="nump">66.30%<span></span>
</td>
<td class="nump">71.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nvta_EmployeeStockPurchasePlan2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nvta_EmployeeStockPurchasePlan2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238419385000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock incentive plans - Stock-based compensation expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 158,747<span></span>
</td>
<td class="nump">$ 75,948<span></span>
</td>
<td class="nump">$ 20,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=nvta_CostOfTestRevenueMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">8,713<span></span>
</td>
<td class="nump">4,563<span></span>
</td>
<td class="nump">2,960<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=nvta_ResearchAndDevelopmentMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">91,762<span></span>
</td>
<td class="nump">52,450<span></span>
</td>
<td class="nump">7,017<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">14,418<span></span>
</td>
<td class="nump">7,641<span></span>
</td>
<td class="nump">4,887<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 43,854<span></span>
</td>
<td class="nump">$ 11,294<span></span>
</td>
<td class="nump">$ 5,986<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=nvta_CostOfTestRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=nvta_CostOfTestRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=nvta_ResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=nvta_ResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238332053848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Schedule of components of loss before income taxes by U.S. and foreign jurisdictions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="nump">$ 712,409<span></span>
</td>
<td class="nump">$ 260,531<span></span>
</td>
<td class="nump">$ 132,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">1,861<span></span>
</td>
<td class="num">(116)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total</a></td>
<td class="nump">$ 714,270<span></span>
</td>
<td class="nump">$ 260,415<span></span>
</td>
<td class="nump">$ 132,155<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238329557320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Schedule of components of the provision for income taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">$ 171<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current benefit for income taxes</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(94,279)<span></span>
</td>
<td class="num">(16,011)<span></span>
</td>
<td class="num">(2,862)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(17,730)<span></span>
</td>
<td class="num">(2,524)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(262)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred benefit for income taxes</a></td>
<td class="num">(112,271)<span></span>
</td>
<td class="num">(18,535)<span></span>
</td>
<td class="num">(2,862)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax benefit</a></td>
<td class="num">$ (112,100)<span></span>
</td>
<td class="num">$ (18,450)<span></span>
</td>
<td class="num">$ (2,800)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238327769624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Schedule of reconciliation of the tax expense computed at the statutory federal rate and Company's tax expense (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Reconciliation of the tax expense computed at the statutory federal rate and Company's tax expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal taxes at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes (net of federal benefit)</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="num">(1.60%)<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development credits</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Non-deductible expenses</a></td>
<td class="num">(1.50%)<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(6.70%)<span></span>
</td>
<td class="num">(17.30%)<span></span>
</td>
<td class="num">(25.50%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total</a></td>
<td class="nump">15.70%<span></span>
</td>
<td class="nump">7.10%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238446497304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income taxes - Schedule of net deferred tax assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 337,866<span></span>
</td>
<td class="nump">$ 173,182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">19,969<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_DeferredTaxAssetsRevenueRecognitionReserves', window );">Revenue recognition differences</a></td>
<td class="nump">9,099<span></span>
</td>
<td class="nump">5,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_DeferredTaxAssetsLeaseLiability', window );">Leasing Liabilities</a></td>
<td class="nump">14,274<span></span>
</td>
<td class="nump">11,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther', window );">Accruals and other</a></td>
<td class="nump">37,677<span></span>
</td>
<td class="nump">14,391<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">418,885<span></span>
</td>
<td class="nump">204,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(209,308)<span></span>
</td>
<td class="num">(145,318)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">209,577<span></span>
</td>
<td class="nump">59,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Amortization and depreciation</a></td>
<td class="num">(233,150)<span></span>
</td>
<td class="num">(30,875)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesFinancingArrangements', window );">Convertible Senior Notes</a></td>
<td class="num">(14,658)<span></span>
</td>
<td class="num">(17,720)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset', window );">Leasing Assets</a></td>
<td class="num">(13,307)<span></span>
</td>
<td class="num">(10,424)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(261,115)<span></span>
</td>
<td class="num">(59,019)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">$ (51,538)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_DeferredTaxAssetsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_DeferredTaxAssetsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_DeferredTaxAssetsRevenueRecognitionReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets revenue recognition reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_DeferredTaxAssetsRevenueRecognitionReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accruals and not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Lease, Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesFinancingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from financing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesFinancingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238320306536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense', window );">Tax Cuts and Jobs Act, deferred tax asset, income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets', window );">Valuation allowance available to reduce intangible assets</a></td>
<td class="nump">$ 112,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">64,000<span></span>
</td>
<td class="nump">$ 23,400<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">21,965<span></span>
</td>
<td class="nump">$ 26,985<span></span>
</td>
<td class="nump">$ 16,375<span></span>
</td>
<td class="nump">$ 10,561<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination', window );">Number of tax years open for examination</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">$ 26,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 890,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination', window );">Number of tax years open for examination</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">$ 17,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=nvta_SubjectToExpirationMember', window );">Begins to expire 2030 | Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">284,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=nvta_ExpirationTaxYearUnknownMember', window );">No expiration date | Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax examination number of period under examination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the valuation allowance recorded in a business combination against deductible temporary differences for which related tax benefits will be recorded as a reduction of the acquired entity's other noncurrent intangible assets if those tax benefits subsequently become realizable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121554379&amp;loc=d3e9901-128506<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense for remeasurement of deferred tax asset from change in tax rate pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=nvta_SubjectToExpirationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=nvta_SubjectToExpirationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=nvta_ExpirationTaxYearUnknownMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=nvta_ExpirationTaxYearUnknownMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238418856920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Schedule of reconciliation of unrecognized tax benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits, beginning of period</a></td>
<td class="nump">$ 26,985<span></span>
</td>
<td class="nump">$ 16,375<span></span>
</td>
<td class="nump">$ 10,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Gross increases&#8212;current period tax positions</a></td>
<td class="nump">8,368<span></span>
</td>
<td class="nump">10,311<span></span>
</td>
<td class="nump">5,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Gross increases&#8212;prior period tax positions</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Gross decreases&#8212;prior period tax positions</a></td>
<td class="num">(13,441)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits, end of period</a></td>
<td class="nump">$ 21,965<span></span>
</td>
<td class="nump">$ 26,985<span></span>
</td>
<td class="nump">$ 16,375<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238329199720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net loss per share - Schedule of earnings per share, basic and diluted (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (234,338)<span></span>
</td>
<td class="num">$ (102,902)<span></span>
</td>
<td class="num">$ (166,403)<span></span>
</td>
<td class="num">$ (98,527)<span></span>
</td>
<td class="num">$ (76,905)<span></span>
</td>
<td class="num">$ (78,707)<span></span>
</td>
<td class="num">$ (48,676)<span></span>
</td>
<td class="num">$ (37,677)<span></span>
</td>
<td class="num">$ (602,170)<span></span>
</td>
<td class="num">$ (241,965)<span></span>
</td>
<td class="num">$ (129,355)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Shares used in computing net loss per share, basic and diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,587<span></span>
</td>
<td class="nump">90,859<span></span>
</td>
<td class="nump">66,747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share, basic and diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4.47)<span></span>
</td>
<td class="num">$ (2.66)<span></span>
</td>
<td class="num">$ (1.94)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328663944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net loss per share - Schedule of antidilutive securities excluded from computation of earnings per share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">23,321<span></span>
</td>
<td class="nump">15,960<span></span>
</td>
<td class="nump">12,770<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Shares of common stock subject to outstanding options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">6,878<span></span>
</td>
<td class="nump">3,662<span></span>
</td>
<td class="nump">4,028<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Shares of common stock subject to outstanding warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">405<span></span>
</td>
<td class="nump">592<span></span>
</td>
<td class="nump">1,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Shares of common stock subject to outstanding RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">5,590<span></span>
</td>
<td class="nump">5,293<span></span>
</td>
<td class="nump">3,476<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=nvta_PerformanceRestrictedStockUnitsRsusMember', window );">Shares of common stock subject to outstanding PRSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">1,658<span></span>
</td>
<td class="nump">1,860<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=nvta_EmployeeStockPurchasePlan2015Member', window );">Shares of common stock pursuant to ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">239<span></span>
</td>
<td class="nump">294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=nvta_SeriesAConvertiblePreferredStockMember', window );">Shares of common stock underlying Series A convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">702<span></span>
</td>
<td class="nump">3,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Shares of common stock subject to Convertible Senior Notes conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">8,371<span></span>
</td>
<td class="nump">3,612<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=nvta_PerformanceRestrictedStockUnitsRsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=nvta_PerformanceRestrictedStockUnitsRsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=nvta_EmployeeStockPurchasePlan2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=nvta_EmployeeStockPurchasePlan2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=nvta_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=nvta_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238408857128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Geographic information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Geographic information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 100,431<span></span>
</td>
<td class="nump">$ 68,728<span></span>
</td>
<td class="nump">$ 46,191<span></span>
</td>
<td class="nump">$ 64,248<span></span>
</td>
<td class="nump">$ 66,285<span></span>
</td>
<td class="nump">$ 56,511<span></span>
</td>
<td class="nump">$ 53,475<span></span>
</td>
<td class="nump">$ 40,553<span></span>
</td>
<td class="nump">$ 279,598<span></span>
</td>
<td class="nump">$ 216,824<span></span>
</td>
<td class="nump">$ 147,699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Geographic information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255,680<span></span>
</td>
<td class="nump">202,550<span></span>
</td>
<td class="nump">138,239<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Geographic information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,529<span></span>
</td>
<td class="nump">4,356<span></span>
</td>
<td class="nump">4,206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=nvta_RestOfWorldMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Geographic information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,389<span></span>
</td>
<td class="nump">$ 9,918<span></span>
</td>
<td class="nump">$ 5,254<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=nvta_RestOfWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=nvta_RestOfWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238328354328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected quarterly data (unaudited) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 100,431<span></span>
</td>
<td class="nump">$ 68,728<span></span>
</td>
<td class="nump">$ 46,191<span></span>
</td>
<td class="nump">$ 64,248<span></span>
</td>
<td class="nump">$ 66,285<span></span>
</td>
<td class="nump">$ 56,511<span></span>
</td>
<td class="nump">$ 53,475<span></span>
</td>
<td class="nump">$ 40,553<span></span>
</td>
<td class="nump">$ 279,598<span></span>
</td>
<td class="nump">$ 216,824<span></span>
</td>
<td class="nump">$ 147,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">68,258<span></span>
</td>
<td class="nump">46,643<span></span>
</td>
<td class="nump">42,952<span></span>
</td>
<td class="nump">40,422<span></span>
</td>
<td class="nump">36,723<span></span>
</td>
<td class="nump">32,120<span></span>
</td>
<td class="nump">28,006<span></span>
</td>
<td class="nump">21,254<span></span>
</td>
<td class="nump">198,275<span></span>
</td>
<td class="nump">118,103<span></span>
</td>
<td class="nump">80,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(331,483)<span></span>
</td>
<td class="num">(80,823)<span></span>
</td>
<td class="num">(142,082)<span></span>
</td>
<td class="num">(97,784)<span></span>
</td>
<td class="num">(79,036)<span></span>
</td>
<td class="num">(76,983)<span></span>
</td>
<td class="num">(51,886)<span></span>
</td>
<td class="num">(36,207)<span></span>
</td>
<td class="num">(652,172)<span></span>
</td>
<td class="num">(244,112)<span></span>
</td>
<td class="num">(122,557)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (234,338)<span></span>
</td>
<td class="num">$ (102,902)<span></span>
</td>
<td class="num">$ (166,403)<span></span>
</td>
<td class="num">$ (98,527)<span></span>
</td>
<td class="num">$ (76,905)<span></span>
</td>
<td class="num">$ (78,707)<span></span>
</td>
<td class="num">$ (48,676)<span></span>
</td>
<td class="num">$ (37,677)<span></span>
</td>
<td class="num">$ (602,170)<span></span>
</td>
<td class="num">$ (241,965)<span></span>
</td>
<td class="num">$ (129,355)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare', window );">Net loss per share, basic and diluted (in dollars per share)</a></td>
<td class="num">$ (1.30)<span></span>
</td>
<td class="num">$ (0.78)<span></span>
</td>
<td class="num">$ (1.29)<span></span>
</td>
<td class="num">$ (0.99)<span></span>
</td>
<td class="num">$ (0.79)<span></span>
</td>
<td class="num">$ (0.82)<span></span>
</td>
<td class="num">$ (0.54)<span></span>
</td>
<td class="num">$ (0.47)<span></span>
</td>
<td class="num">$ (4.47)<span></span>
</td>
<td class="num">$ (2.66)<span></span>
</td>
<td class="num">$ (1.94)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140238324095624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent events (Details) - USD ($)<br> $ in Thousands, shares in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 26, 2021</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCash', window );">Hold-back consideration - cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned', window );">Hold-back consideration - common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=nvta_OneCodexMember', window );">OneCodex | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition common stock issued (in shares)</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash transferred</a></td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCash', window );">Hold-back consideration - cash</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned', window );">Hold-back consideration - common stock</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationHoldbackConsiderationCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Hold-back Consideration, Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationHoldbackConsiderationCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Hold-back Consideration, Common Stock, Value Assigned</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=nvta_OneCodexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=nvta_OneCodexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>113
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M)9OML^UV@X2IL2K)@X%!(N3V/WO)$W$0T/>.!/AY@/\F@!Y[0Y '!'4#VGE
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MX@RXN0?@_D(INSMQ+]A_(+K^%U!+ P04    " #\@%I2N;2Z\[@&  "J&P
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MW22J^YO0M'F!1.*^\0R7>/K*/68IPF4@N.4@LGPFN :?4C_T0;6+?&V IH]
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M#9EAVG3P'C@D&(7&/M(!QO%@),J-R1 '8_>J=/,^R9/,F4*NF0$O#" ,CGB
M<3Y,<ZZX:?B2VG+%*];-_*0@3MIUK5)2!+(N&O& XGCXR+M^J_\2H<C-_# O
MI_/>9T6R0$Y#(QY0' ]/-P;/O'_D(@ B6#@9V&-G$G4>BNI!71%G17@"]-
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MD+L/0[L;+=;]MY4;H;5H^\L5HT:]-3"_WPH#R_V-_5PS?)Y;_ ]02P,$%
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M.I(WC,B#%";7Y)/((-LG\%%$K23:*AE%)QDGD%Z1=GA)HB *&C8T_C \[#7
M)Q^'7Y]0TZ[KTG9\[2-\=2G>5^).I+( \NMVIHW"_^;WB71QG2YVZ>(CZ;YB
M@^%8X:9"ELB.0]HNLAZVDB *NVCR>M??AK@H#GM)9S]NTA 71KUVYRUN3T*G
MEM YZ=@WDX,BZ9Y5K+3JW$J[N#GA4U(G24[Z]"RPMW+V#W^6/6YB6]B:,DYG
M'%K8C5N:<L ?5;V L6M$0[I2S##0ET2 *ZNAKTU^ESM(=OP)#ZU^']**#UQN
M8$F29H>[M?CN2?'[Q_#8<>DV'Y?D4$-#G#LNO0,A#7%X7,+KWH$8?Z<)%J 6
M[C+1>"!6PI1=I%ZM[ZM;UZ8/UD=XCY77SAM->0D^4+5@0A,.<Z0,KKJX*U5>
M+.7$R*5KM3-IL'&[88YW,2@;@-_G4IKMQ":H;_?A?U!+ P04    " #\@%I2
M)O3.=\X&  !8(   &    'AL+W=O<FMS:&5E=',O<VAE970V+GAM;+V:VV[;
M.!! ?X4P"FP#Q+5(ZEHD 5KGUH==%$F[?68DVN9&$E61MI-^_9*T:MD2J8V3
M;%YB76:&P^$,STC*R9K7]V)!J00/15Z*T]%"RNKC9"+2!2V(^, K6JH[,UX7
M1*K3>CX154U)9I2*?((\+YP4A)6CLQ-S[6M]=L*7,F<E_5H#L2P*4C]^ICE?
MGX[@Z/>%&S9?2'UA<G92D3F]I?)[];569Y.ME8P5M!2,EZ"FL]/1)_CQ&B=:
MP4C\S>A:[!P#/94[SN_UR9?L=.1ICVA.4ZE-$/6SHE.:Y]J2\N-G8W2T'5,K
M[A[_MGYI)J\F<T<$G?+\!\ODXG04CT!&9V29RQN^OJ;-A )M+^6Y,'_!NI'U
M1B!="LF+1EEY4+!R\TL>FD#L*$#L4$"- NHJ^ X%W"C@CH(?.13\1L'O**#8
MH1 T"D%'(72Y%#8*87<$Z%"(&H6HHQ D#H6X48C-ZFZ6PZSE.9'D[*3F:U!K
M:65-'YB$,-IJ"5FI<_=6UNHN4WKR;,I+P7.6$4DS<"O5CTI,*0"?J3.>WB]X
MGM%:_ $N?BZ9? 1C\/WV'+Q_=P3> 5:";PN^%*3,Q,E$*F^TS4G:C/QY,S)R
MC/R-2Y);U*;#:E->%"KGA7;NHT7]?%C]4YHNBV5NILOE@M8@Y86J^H4NQQ55
M<U+G%+S/N1!'-OL7_V$_RY@N2I*#BK!LK&*4DHJIJ=J,73[;V U=,;-_J(6J
M:L9K4%'UDQT#DOVCTD:OHF7 JZ='1VT +&72YO;UX5:FFRLZQ'0V4QN7=IRD
M*5^6DI5SD"Y(.:?[8TU4+F\3&FT3&IG!?<?@GTE.RI0>@SLZ9V6I;>L0F>
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M*)EP9PQ03\#9HDH K2HV)QKZP^CJ'9E@"R9Q1B 3GG&Q2LW!@45Q;4<*3%$
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M;EQWXH#)@V6(^8Q)L$1\KU:3R+BAL:B&Y3.,1)14H8R!MEL$-*>94<PBAP)
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M]-VT!'[67S!8 ,WY)/'/&,=3=?RRJV !=_7.4E"+L.-EUOF(UJ Q^GDI+^V
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M\JAM+E&)<'LR'>AI!D\6"6$S66J1 T"8)_H2%D779O*C)\[V=I0K=3X+\J*
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M&$%Z"V^(<4;A C:!-2F#,+CCR'#A,@_^<O/Q5ER/KA-Q-OFXX^SC!%!H#AC
M +EV<@,A-NR JWT "S'@U<8 4)*J7>Z:%4-*4A(*)4HQ?)^\MC"-PU)W\4R\
M#R$E7CUTMVB LY[V3R5MR.L"65E5*RQL,[-XVX7F:P[<HPAZ)FY[@?!$C!?C
M9)1>XRJ=),MY2A?729HN<#%)D_F$7UWCW77*O [$?_S#(AVG/W;_B\E<S)/9
M>"P6R62Z$)\,8CNX;@M)RRWR2N?)Z'HFIJ,DG<YQER:3\>B!XSWD,DVFBX5(
MD\5H!&[IHN73KC^K$K"9S2:XF$Z2$5CAU7R9S):+[PW_>/F-\,\FR2(E@<:
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M&8Z &*GG1E!6;2F7\P'Z>'I HXCS$Z&OG^MPON9114=Q.A\(/MIUB \:NVZ
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M^B*YX?>BA!BF=14-RJZ=LU7Z 08G,D,!WO.L%@$^4 G680DQY,XM/DOY(LW
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M=\LVHYS((2F<.B=XRY>#,UA))U3M<75O'OUX6ICGC/\SSZ^T=30OR[[I:^$
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MQ^? -QE&D_'_"GRUPT^#;\QF?0-["-.0[FS<JWRYEH<^WK4M>8VSJ 4:*=6
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MUA\HN[-@>GQ=$(-35_HBA=B @16HD6SI.=&VA3#HGWL(!FC*C/6RZ=F8[VB
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ME/!UB]CE_:RP%4',0NVLDQCWC@N=?$22<8WP%R,HL#4/^/D%>8(5 U_AF.\
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MQPK;BB3T7DTV915/N#$=^O%U91T,M][A6<['SW)+QF[( ,R GD&NP(U;H%X
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M%&3A2EC!H@]F(!L%T L<ERDR?[HL:XD8IBWC<(9*.,N85ZN:4+R[^5 ^ZHE
M,,3(;W!%IKKO9N.C;J8D6!_PL&XZ97="Y%;PI:9D(L(VMDDY6U.T"K?D]6:C
M4J"+@FQ\%).TB;+..907G"5]T+Q'Y^3BEH7 83!3[GJAQJ?W['X##=097.65
M-LX2WM6L[JS#'3I:5\O1W'JDQ:!K/KX115B>&K=;:W5O"W#L! UN,\G0X-;B
ME2T'T ZHS2U.HG:@)^DQ\0!K5%=5/1GW9-H95T22&^)<Z9J!-EUTD9HK;0)A
MZ#SCRF319<1):I@8RK=ES10\4E,AM4/W27]M7)=;9(R5IO2B<@UWRZ"+K -P
M/5W9AU0S]I4F.W28I0(/<Q2K=T9F0.M<751 LM0[XRB<-^'C$,A&-M4E"#J]
ML6[&OMFIW'3)\ONP3FNNA(@B@XNBOJ\UD^_<V =:].0(LX=R:F=+^,+B>PE\
MH%UQU['WS#T*QPW[5N/[#%H;$[Y\@?[ ,:4\<5L7N=,@@^3>)B)X<EO08]2+
M?$3%I".47DZYI"--W5P<^> RN=.RC3*N>X"C5OZU!(4.QM@BOVE8GB1AW##2
M:(3ZG](RDO;0=8!M8D]]@K25]$!!\A^+UM>?YQF!>!*'47,6)1+4+L8JI.QU
MEKT@)$[RDAPJDU5;%/KJY ?CU,+*]E[S6=X:S9%UJ>:F$FVH7/6^W!9.\#F"
M&.BAHK8B,SMQSF!IZA*K49Y1<[.M2%DNZ<F-J7-7'7(J>O:5;QVNFIJ<>LKO
MV**VR_$UUX^=U/LS3YQ4>G$%)P%RB3>^9;SFAO8:1S+APY7OFF#\!DA-4P^"
M];_IE1+GEB=Q=7=7P"7A3F^Q HB/=N(G]JE7,F.; S/V%;@0DR!)$C$.)DDL
MGHA%F"S$%%9^(N(D6$RGG2K4>Q?^J>(>UE@$1("KL/CK@RKS/ E&H\DSP7]
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MZOKHM-"6CF_\N,X6=]<^PKFD_*S9]TD*W1GXFYOKZR\:?]/7M]<_ALU1);L
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M,_0@U;,1)I?4XV1 [F2SS)25-848=&!XA?I#R[!'*2:C%[W5YA:+W%IO3SB
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M0Z@?1%=/(UB"<CLHB$T!K;,UU/K"H)P'265O%%O!A9K%_<@T"4\1&M)'ESE
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M:7YT '1?/<[,,06WWTS!(:J4_T?<];#ZF^Y#,!+HAM:&0*T^V=MJT9#Y15Y
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MAEX_U]W2[P8J:T#K:TDQ. SL!J<?F/D_4$L#!!0    ( /R 6E)971NW$P,
M '@&   9    >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;*552V_;, S^*X2Q
MPP:XL>/8:5PD =)VCQX*%,VZ81AV4&S:%BI+F20WS7[]*#E)4VSM8;O($D5^
M_/@0/=TH?6\:1 N/K9!F%C36KL^BR!0-MLP,U!HEW51*M\S24=>166MDI3=J
M193$\3AJ&9?!?.IE-WH^59T57.*-!M.U+=/;<Q1J,PN&P5YPR^O&.D$TGZY9
MC4NT=^L;3:?H@%+R%J7A2H+&:A8LAF?GJ=/W"E\X;LS1'EPD*Z7NW>&JG 6Q
M(X0""^L0&'T>\ *%<$!$X^<.,SBX=(;'^SWZ!Q\[Q;)B!B^4^,I+V\R"20 E
M5JP3]E9M/N$NGLSA%4H8O\*FUTWC (K.6-7NC(E!RV7_98^[/!P93%XR2'8&
MB>?=._(L+YEE\ZE6&]!.F]#<QH?JK8D<EZXH2ZOIEI.=G7]$56NV;G@!7/8U
MIF1-(TO83B,J=CCG/4[R LXP@6LE;6/@O2RQ? X0$:D#LV3/[#QY%?$2BP&,
MAB$D<1*_@C<Z1#KR>*,7\)984S-9$\)3S$S @EK9P/?%REA-+?+C%4_IP5/J
M/:7_G=-_P8%;?$#9(:RV4*A.6KT%;J@3+6IJ$"Q]EY9 FK8A+2X(MP96EAJ-
M 55Y<=]:J(')TIGWCY+_(D-*1Z4$O58#;[D#49TA+?/N#+XATWV!@<J#[8H
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MT Y9TFX?AF&@I;-%5")=DJK3_?H=*5E5VB3#T.5#?#S>\]SQ.;YH=53Z@VD
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MDR9BI@E:7G["98U&O"1G0A+;J-Z@QU "#Q4<+#D 'OJ&HW2\4[VTYOP"TVN
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M07JQ(4U5"H=H'7086)R(NZ2/Z9F.7LB%Q#L2U;JG@6CDYIB?>PAE61"]2=J
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M?WJT9/J[41Z28U:RL9E6+*/L(TKU'D6&",'$7RODZ@7^6*!JN+U2BS/EW@T
M4T""#EY$T!>A^P1H^A]G1]B=7G;::@]0^TWR8]\0[NL;IP;A$_[=)E]QVPEY
M2CTY#/42037_V2]IU:/,6O ;9^2DQ &.:)CI2WW\E7"EB;YZJE_=6CV)?<#'
M9<.=HELXM!ICX-Y<R1%'!J-NII:_<N?D,UP\<'W^<H"?QQ=X3$KE9X[QP0K
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MGK)@D4 <,!ZG],59% 9#W"/D<Y:8Q5D&G&5!0&P\&WE&_:,A46Z2)"(ACEA
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MRM)MX9=K^C1"[0CH_5(I^[AQ L:/K?F_4$L#!!0    ( /R 6E+0= XLQ00
M +,,   9    >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;*U7;6_;-A#^*P=O
M&!) K?7^DB4&DG3!"K1HD&3KAV$?:.ED$Z5(EZ3B9+]^1\I6DLYV"JR 85/4
MW7-WS[V0/ETK_<4L$2T\=$*:L\G2VM7)=&KJ)7;,O%4KE/2F5;ICEA[U8FI6
M&EGCE3HQC<,PGW:,R\GLU.]=Z]FIZJW@$J\UF+[KF'Z\0*'69Y-HLMVXX8NE
M=1O3V>F*+? 6[1^K:TU/TQ&EX1U*PY4$C>W9Y#PZN2B<O!?XD^/:/%N#BV2N
MU!?W\+XYFX3.(1186X? Z.<>+U$(!T1N?-U@3D:33O'Y>HM^Y6.G6.;,X*42
MGWECEV>3<@(-MJP7]D:M?\=-/)G#JY4P_AO6@VR:3:#NC57=1ID\Z+@<?MG#
MAH=G"F6X1R'>*,3>[\&0]_(=LVQVJM4:M),F-+?PH7IM<HY+EY1;J^DM)ST[
MNV""R1IAJ(!:=2LE45H#1W=L+M <GTXMF7'"TWH#>3% QGL@HQ@^*FF7!GZ3
M#38O :;DW^ADO'7R(CZ(^ [KMY!$ <1A'![ 2\:@$X^7O!+TK0_Z!@6SV, [
M;FJA3*_1P%_G<V,UE<S?!\REH[G4FTOWF+NE3FIZ@:!:X/*>Z%7Z<1>O!V%<
M>YZ8%:OQ;$+]9U#?XV3V?HM'N:-.,2X0,F.7"*T2U')<+N"(2]I1O6&R,<<G
M0'QB-T<]<DI?404W;$VE95%S)@S\#'$4)'%*BSS(\@H^4WN1_[#2:D'V#91!
MF1905'#%):<":F"A5&,@"LJL@E]^*N,H_A7NE&7B*6Z"2^(@3$*/FZ<E'& X
M&QG.OIMA<F^%VCX"!0OXM><KFB$V (EV%^<'@7=S?D?DHK&\\V73&VQ[ 8*&
MB]EO'YA&8&:3%',"5[V6W/9NE^1:_F!]X17PB$P;..^I\]6<BV=['YGL6ZK)
M7KND.K4/;*XT\[0^6<HVXI?4S#UE\]FK9//J5K5V[3S:;GQ FFQ+)1K@'05P
MCYT? K=+I1T"A26<!-!#!TKO"K]%N-X=^O^OS#WN48E2:48Y+:(R2+)X-R%I
M%B1I#'$:E$6RBY8H#*JD@BRHJNR)FRS/(0[R*-J7JRBH\H*^HZI\D:^L=)]+
MBMKJWA\^;[A\,[9-1.6?1\YH0>:&]MA7M NM2*,J@C2M($^"LHSAO*[[KA]F
M5H-4EC5GPPE'NJRCC/%_AHTC8C%)BV,X(IZB)#M^Q1JUB.M*D@UCUZ=%4%"#
M'^C/?.S/_+O[D]6U[LEUP1G1Q2U'LZLO#P+N[LOS_R+_@-K;HKJSD2XC3U3K
MS;F!#VX??3EF01Q'KAQSREA(D"UJC4Z6QE^/-/&2HJ222>/*%^(+0$7^Z1?>
M,V.4RRXAK+E=PKPW1(1Q875S+KVJ<5;S,(0DI#$=PB>/$I=^"),?2;DMLAW,
MDZME'H14KI1WZH\H/93N8DQW\=WIW@2EY.*-'QZOI/T@\.ZT?]IOX0>D_]L4
M4I=0/]<][;G)0?2&XU'WHS+ZTD9)^:V*G([;,-RF-TJ"*@R_.6,/4.WRG$9!
MG+E9.0#MRO/TV46R0[WPUV7G6R_M<*<<=\<;^?EP$7T2'Z[S'YE><"I.@2VI
MAF\+.FCU<$4>'JQ:^6OI7%D:G7ZYI'\5J)T O6^5LML'9V#\GS+[%U!+ P04
M    " #\@%I2A1\"HH4$  !0#   &0   'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6RM5]MNXS80_96!&A0)H,82)<N6:QO(9;-;8!<-<MD^%'V@)<HF(HE>
MDHK7_?H.*5E6G,C9HGT1R>',X=P.34\W0CZI%6,:OA=YJ6;.2NOU9#!0R8H5
M5)V+-2MQ)Q.RH!J7<CE0:\EH:HV*?$ \+QH4E)?.?&IEMW(^%97.><EN):BJ
M**C<7K)<;&:.[^P$=WRYTD8PF$_7=,GNF7Y<WTI<#5J4E!>L5%R4(%DV<R[\
MR65H]*W"5\XVJC,'$\E"B">S^"V=.9YQB.4LT0:!XO#,KEB>&R!TXUN#Z;1'
M&L/N?(=^8V/'6!94L2N1_\%3O9HY8P=2EM$JUW=B\XDU\0P-7B)R9;^PJ76C
MV(&D4EH4C3%Z4/"R'NGW)@\=@['78T : V+]K@^R7EY33>=3*38@C3:BF8D-
MU5JC<[PT1;G7$G<YVNGY#>42GFE>,2@8595DF'&MX/2!+G*FSJ8#C:<8W4'2
M(%[6B*0'T2?P191ZI>!#F;+T)<  W6M])#L?+\E1Q&N6G$/@NT \XAW!"]J8
M XL7'(OYJXWYFJLD%R9L!7]>+)26V"9_'3DC;,\([1EASQGWR)ZTRAF(##)>
MTC+A- =>X@E5G6&J(=LGWS0H-GE22<G+I6DTKM[*_=%3#8,G:DT3-G.0HHK)
M9^;,'U8,,I$C_0RRMG4%A7Q'2NL5:+/=<20#44E(1*E$SE.J6=H3@%YA"!LF
MV\Y)?R F..4E6HI*T3)59Q/ XK)BP61;8+@HT"_^-\)=":7AHQ1*P6.)5TYN
MI1_QJE&OQ9]QC8%]4)H7UNM.F3^S9Y:#WXRD&0.X:0.C:*S5Q+0NVR+!Y)-)
M4(4^P@F, ]?W8IS\_-.8^.37%[-V\XC6X_G].3Q(FZ8ME$*CHWX4NN,XA!&<
M^L.S>CF.VG%G^@)B*9Z9+$WZ 6_,,MEB'3&]7',$1$,2^Q"W)B@(/*]O^2 T
MQIT=9 "=#GR"0"'._ @_UKN==(@S$H[<V,X:Q'V<^WSFG"YX;AV;P+T6R1.L
MZ=;T7KNU-:BQ2X)13V:;S2N\3;!_3-"F*WG*)+4W^BB.W"B(7Z5J)S^,L..3
M+=?0'8^BWJK6NZ_;\XZML3]-LV-D5U2M@'VK.':\)<4)C"(W) &J(5-X8A03
MHX0N856_V,:R:>A4CI#8]7&W=C@YP'210R^P7$#N-#UZ"+4OU$62R HM7D;M
M>^XP)O [LEY"+LKE+YK)XC U9.B2<7@8O!]WN%GSK_[N.?<?B885#^*^DK2;
M1[2N&+J7\80:AN%5EF*Q%-?0;?S=V)5UYV^2=>BY$1FU.C5EC1!_[G;COZ>L
M'P?(( )[NM>2<>^ZG[5X_43$LK)#6B.T+/9CS_40Y\0B1G;V#FM[>8<8_@'Q
MN[-F\SC[?@3A=?N]QST_B/!J&KU!/G\<])$O]-PP^+_(UR3\;?(%-JQWN(=E
M\N"M%\B@\\HKF%S:MZS"VE2EKA]\K;1]+E_4K\2]>OW6QDPLS8]HSC(T]<Y'
M0P=D_7ZM%UJL[9MQ(32^0.UTA4]^)HT"[F<":=$LS 'MGXCY/U!+ P04
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M5W#:?B(_D+<_&MYS ^FQI!)S8(6)#(=RTWZ\MP].K_P'\TP[^/SVRZ7@< 9
M G@_UU#TW0,JZ/^@G/P+4$L#!!0    ( /R 6E*P,9J+[P,  *@)   9
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MY(;/ITKN0%EK0K,#EZKS)G)58YNR-(IF*_(S\\_4=R&UAA:I55NN$-[?\I5
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MG)*":<*]PA9MY'0(AX,^&N+-_'W&>##LQY[6> /W88*'V^M=TWJX0X=JI!V
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M=!/L\T((O>NX!;H+W?P_4$L#!!0    ( /R 6E+?G5W52 <  !(O   9
M>&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;+5:6V^;2!C]*\C:AU9J:^8.41*I
MB7N)XVJCIMU]6.T#L2<VJ@U>P$FSVA^_ \;^N P#+N(E 7S.7+X#YYL/YOPY
MC'[$*RD3Z^=F'<07HU62;,_&XWB^DALO?A=N9:!^>0RCC9>HTV@YCK>1]!89
M:;,>8]OFXXWG!Z/+\^S:771Y'NZ2M1_(N\B*=YN-%[U<R77X?#%"H\.%K_YR
ME:07QI?G6V\I[V7R?7L7J;/QL96%OY%![(>!%<G'B]%[=#83/"5DB#]\^1P7
MCJUT*@]A^",]N5E<C.QT1'(MYTG:A*?^/<EKN5ZG+:EQ_),W.CKVF1*+QX?6
M/V:35Y-Y\&)Y':[_]!?)ZF+DC*R%?/1VZ^1K^/Q9YA-B:7OS<!UG?ZWG'&N/
MK/DN3L)-3E8CV/C!_K_W,P]$@:#:T1-P3L!5 FT@D)Q NA)H3J!="2PGL*X$
MGA-X5X+(":(KP<D)3E>"FQ/<*H$W"6<?E+.[]H&.8M?4;J0<Y$:9WN/]C97=
ME1,O\2[/H_#9BE*\:B\]R&[MC*]N1C](G\+[)%*_^HJ77'Z53S+8R3?J<9B'
MNR")U:,UE_Z3]["6EA<LTCM:1I%<J.L9TGIKW2LK6.S4[^&CM?!C;[F,Y-)+
M"IB'%VOKO<C(FJO+RS!ZL5Y-9.+YZ_BUXG^_GUBO?GMM_6;Y@?5M%>YBU5%\
M/D[4?-)1C>?YV*_V8\<-8R?6ES!(5K'U(5C(A88_-?,1-C0P5H$\1A,?HGF%
MC2U.Y/R=1= ;"]O8U@SHVDR_EUM%MQOI$S-]N@N,] ]F^A<O,@[^8^>Y(U=#
M_]1Y[EKZY\YSU])O.L]=2Y_VT_VV7^AFW>F.X2XF1T\@67NDJ3UXIM-$J9[R
MW"6LOV8*:MTD<A/_;>B('CNB64>TH:-O8>*M#Z:A>_[W=);1T_7$TR6R;4K0
M^?BI^%358=P1V"FC)G44Y<BMM/5!TQ;%M-+61PV*8X>549_J*,89JO3X68,B
M5%3:NM&,WF:,E%'3.@H+E[F5X=]J8(@[F)9A,TWXJ>"N>X255&='U9E1]3MU
M6\D@L6Z">!=YP5P:[B1^;),/>\N*8T>BURT[W=-Y,68.LC&O**"!,>)@45&@
M#G,Y85@O@'.<@]-)@(FO<GUB"(I[;- =-OK(AN6*W2_^.;\8,DQ<@2OQU\"0
M8&XU_CH884[#$X *JRYDG,:5'VY7GJHBU#HI2@(9F8*#H54\L Z0(A#IJ0.I
M18Z@FF'=:F (NU783 ,3PN4-,D#^0>8$]'NR4HO4AUVLKL?QVR1\>S@V!0F,
M#K&!]0#_0[RG'KP604IL*JIZU&$$TRILIH%AU^4-QH3 75&+O<HXT<^BW"!8
M'7(&E@!,$+D])7#K01.8(+NJ@0:',!6UAZ*.0Y0R;NM5P&"RN,5D"RI8_UFG
M)&P,%HC1L,I@\$6,^RF3\UNSM@ZG2]L:G"%O8W!=W.*Z>F%:$SD&1\1T8%7
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M +C0]P-C;NX!F!]BVS,D ,&\T,SA$8"Y) @,:V-H2CR*?4,% ,QS*?&-5)\
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M<VAE971S+W-H965T-#0N>&ULO5?;;N,V$/T5PFB!72 ;W7P-' ..[6Q2--W
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MS03\OA)"/[\8 ]55?/0/4$L#!!0    ( /R 6E*XIG7M7 8  !4D   9
M>&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;+6:6V_;-A3'OPIA;$ +M+%X\R5P
M#,1QDG58@:!)NX=A#XQ%VT)U<4DJ:8%]^)&2(LJ11-E&U(=&DLD_#\\Y_/'H
M,GM.Q'>YY5R!GU$8RXO!5JG=^7 H5UL>,7F6['BL?UDG(F)*GXK-4.X$9W[6
M*0J'R/-&PX@%\6 ^RZ[=B?DL2548Q/Q. )E&$1._%CQ,GB\&</!RX4NPV2IS
M83B?[=B&WW/U=7<G]-FP5/&#B,<R2&(@^/IB< G/;T>>Z9"U^!;P9UDY!F8J
MCTGRW9Q\\B\&GK&(AWREC 33?Y[X%0]#HZ3M^%&(#LHQ3<?J\8OZ339Y/9E'
M)OE5$OX=^&I[,9@,@,_7+ W5E^3Y#UY,B!J]51+*['_PG+<=T0%8I5(E4=%9
M6Q %<?Z7_2P<4>F 84L'5'1 KSJ@M@ZXZ(!?CS!NZ4"*#N3U"&T=:-&!'FK2
MJ.@P.G2$<=%AG 4K]VX6FB53;#X3R3,0IK56,P=9?+/>.B)!;%+Q7@G]:Z#[
MJ?DBE?J*E&"51(]!S$Q^2/ 1W ?Q)@V9 (L@ >^67+$@E._!;R"(P<,V226+
M?3D;*FV"$1JNBN$6^7"H93@(/B>QVDIP'?O<;^A_W=$?.02&>NZE ]"+ Q;(
MJ;CDJS. X0> /.1]O5^"=[^]5X+Y>OY+]JO!PBNWWN5.:#UO3Z]!9>E6^3.-
M7U3@M&:5W#+!F[Q_??Q<6[5N#M8J+6Q0N3U<9>*P:"^TN,QMG(GCKMR^7/U(
M QED[/OG+WT-?%(\DO\ZQB#E&"0;@QRQ?CX E2@6@ETJ5EN-2?V;1K?/1?9K
M4TKE8]!L#+-Y/,U'= KQ;/C48!HM3:-.T^Y5LOK^T7#:-];IS4MF!@#^TQSS
MIORA-4,@G8S)N+0D3XUZLS&=DLE^J]MZ*^1-J-<\JU$YJY%[5A4P.>(W+N7&
MO>7(I!QCXC3YCHL5CY7>V4&RU@!57.>WTKNP'E$T4G#I%H2>=^9YOSM,FY:F
M3?M/W^6T%F@ZQEY+H*%GMR;/:=Q5$D4Z&M+D,=#TB^6:BQ:'%5)[-N!IJPV5
M[1$>YB!6R8]5U;! RE2OL'=Z8\S)]1[\!UJINBS&&U57!?7,OQ93D345=:]W
MG5XFUW1Y!W:A]IBVY< 5 RU687]<A1:LT$W6+_=?)=CHJ*O#O7M=:%:]BYW>
MM3"%;IK>L$" )Q:FC=R$341L']7"#KII9YS@\J;%'.R/<]""#KK!=%K,)K68
M$;WGM'O/P@VZZ?9-8U8;DJ_3- Z47L;/3/C'&#>M&4>QUQY:9.F&W'3+?*57
M9].J==6U%ET(]A9R9*F#W-3Y9I:$V==R_Q;!;[HS*(3VJAQ4\6-1P7:TVC?3
M,@MAIYD/6QW@;1+ZH"BC@:_K:.U_9ZV_*%3W:-UFBR4;<I/ME,(,U4O$=J]8
MJ"$WU$Y:KX5FU2?0@5AD88>Z8=>V(@[?QY!E(NJ/B<@R$;F9>/ "619"U1A/
M'7ZU&$1N#)Z6^TM41Q]NL05;ZF$W]1Z"B!>I_S;AQI:'N#\>8LM#_%8\Q'72
MD;V2-0]#4[.]_2=?E9UJ^_.IW$.[P7D*K K)/5A-X6N3;W =KI",6TVV?,5N
MOK[!MH_K=23R')##%KG8C=P[G?:N1+.TQ*/^TMDR$H_??H<H-/>\YRCHL&4I
M[KB3UN:<4#-ABTH\[>^1D84@.:#T.]*IMX5FU:DM_B06B<1]=^ORY^$()A:.
M!/7G7HLLXD;6X0@F=5 1/*DAN*E9 X([U?;G4WG$^/;U(JG7BW!*:@AN:(8(
M:3794HZX*?<&""8-929R()A8<A)WG7D3"//X+8YUK@O)Q"]MQXEW8\2"E/17
M;!(+2-)1;&J_FP)/,,5!NC/O^LII!HU^7G0HTJY'C<3"E;CKT&/]?CB!J$4O
M]7H+ [5<I6ZN'A^&98<BQF<8N\) +81IQW-"ODIB_VWRGUHHT_X>&E*+2MI=
M^AV9_QV*G?E/*^]C.E[('.OX(Q: A1_MKVRDEG;473:>L@#<BMT+P$*2NI'V
ML U$3V&P+*3]%9HC2[N1N] \(0P=BNUA&%8^0HBXV&3?EY@72VFL\G>VY=7R
M&Y;+[,N-5]<7\'P)&ZY?P_/;_ L5*Y]_,/.9B4V@XQ3RM1[*.QOK=2CR;U#R
M$Y7LLD\@'A.EDB@[W'+F<V$:Z-_72:)>3LP Y9= \_\!4$L#!!0    ( /R
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M1@-9&LX$3!7195%0]6L,7*Z'7NAM!%=LD1LK\$>#)5W -9B;Y53AS&]0,E:
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M_>=R\GHRRTC2>Y[\P59J>SL8#\"*KJ-=HK[R_1=:3R@H_,4\D>7_8%^_ZP]
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M=?&"_GW-N3K<% ,T;?_9?U!+ P04    " #\@%I2$N!))4X'   R*0  &0
M 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6RUFMMNVS@0AE]%,/:B!9I:/-M%
M$J"5VMT"VVW0M'O 8B\4F[:)RJ(KT3F\_5*R8JJ@AE:<Y":Q#L,9DL/O'THZ
MO='E]VHEI8ENUWE1G8U6QFS>C,?5;"776?5:;V1AKRQTN<Z,/2R7XVI3RFS>
M&*WS,8YC/EYGJAB=GS;G+LKS4[TUN2KD11E5V_4Z*^_>R5S?G(W0Z/[$%[5<
MF?K$^/QTDRWEI33?-A>E/1KO6YFKM2PJI8NHE(NST5OTYH/@M4%SQY]*WE2=
MWU'=E2NMO]<''^=GH[B.2.9R9NHF,OOO6B8RS^N6;!P_VD9'>Y^U8??W?>L?
MFL[;SEQEE4QT_I>:F]79:#**YG*1;7/S1=_\)ML.L;J]F<ZKYF]TT]X;CZ+9
MMC)ZW1K;"-:JV/W/;MN!Z!@@"AC@U@ /-2"M 1EJ0%L#.M2 M09LJ %O#9K)
M'.\&JQGI-#/9^6FI;Z*ROMNV5O]HIJNQM@.LBCJS+DUIKRIK9\[?;2M[IJJB
MF5Y?J2*KI[N*3J++7:9%>A$M,E5&UUF^E55]F%65-)5-B1];5<IYE!7S*%?9
ME<J54?86>WV[MN=?I-)D*J]>VM:^7:;1BU]>1K]$JHB^KO2VLE;5Z=C8'M1Q
MC&=MM.]VT6(@VE3.7D<$O8IPC.,>\R1L_GEF@N9IV/SMIK3F,6C^/FS^*2N#
MWC\,[CN:_FP^MI.^GWF\GWG<M$<.S?S;>B8KU2ST?W^WYZ*/1JZK_P(^R-X'
M:7Q0P,>O6L]O5)[WS?3.DC66-?^NS]&$$X[)Z?BZ.RH]]V$NA-C?]E-D=!\9
M#4:6JDVNU3S01[9OB3W;./*]#QZ,-LFJ55_"\9ZQH?T#(_:N1-#5V]E,;PN[
MP$LYD^HZN\IEG^==([SC&?-^QY.]XTG0\<?"9,5267\M8OK<3CRW%(G)M-_S
M=.]Y&O3\59LLC]1<%D8M5.8BV$.N+Y1I3RA3 H2"8L?C>-CX;[([:/#;)KJ^
M3T@,>.XH 0HO";F094UTD]WNB7[7ZQ_Y_E&,&12"0Q+"P1#^L*740^>A;;(;
M#$&<01/AT(6.9M?[UK3KD\6<,<"G@Q(*4VF7B9MM.5O9:BG:E&K6GP#46_@3
M3!"P])%#&6+A/LO"UGRW 6(AARS$GXV+R-$*A7$%D#%MS;HC1 @P/(Y0*(RH
M86Q,D4\IC!'@W$$*A2EU4<I-IN:1O+6[BJHNM&SAI<U*EK9.M.NV,# W4^33
M"EBLV)$*ATGU>2-+6R\6RRB7=;;"WK'/*\B[HQ4.TVJ(7*38!]44QP :<*=R
M"F/J*,%(L0^J*>5 4F+'*1SF5-).?J<&[_7N(^N$8&@:'+'P@3IJJ&BD;4-#
MDL#Q"H=Y];E)_UP7RQ,CR_7!,6"#0W"8P^'2[ C)2MLF?\H$1*%,<"S$818&
M%"O%?L%&8PX4T=@1$8>).%"P4NPC$1&,H-%W4,1A*/ZCMY>S4FU,:+/BB$;B
MY]L2.7*1,+D@R2(^K*!BGCA4D3"J!DH6\=G$@'J>=#9_83(]2K&(SRL!I MQ
MM")A6@V7+.+3BD#U'7&\(F%>#1(MXE,*,X&@Z7"D(F%2':=:Q&<5YF Y0QRL
MR('";9AL$9];)W0">7?<(F%N#9<MXI/K!/,82D5'+A(FUP.EB_@%W F"B@?J
MB$?#-=PQZD7]:@[C*?A QG&1AKD8DB_:P\:I@!XY4(='.J22.ZQ?M(>/6,30
M^#M$T@.;S-V&JR'C$"VCG>=;]-FTC#J@T3#0("VC/L,8E" .8#0,L(%:1GN(
M!6:GXQ4-\^I18D9]BD%B1AW#:)AAP\6,^@P#Q8PZ@M$PP0:)&?6Y1>@4 \Z9
M Q<+@^LX,6,^N@CC$Z#*8@Y=[$!)-TS,6,]SLTD,B!ES$&-AB T7,^9C+"!F
MS&&,A3'V0#%C/7M14,R80QX+5W?'B!GKJ?,P@O;%K/-2X,"3M("8,1^.A(@I
MU'_'1S:DP#LL9LQ_;<#9%$'^'2+9@5<'UK$LT[]#+U4<W=CDV?2+.8:Q,,,
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MVFUWTNE>N,1)T !GV#2==!_^;* X"<9AM[4O&C!^_OBQ_7L>PWC#\J]\1:D
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M<FMS:&5E=',O<VAE970U,RYX;6RU5UUOVS84_2N$T8<6:"R1\E<*VT#L=%B
M!0N:=ALP[(&6:(LH1;HD'3? ?OPN*5ER$IGV@OC%EBB=<S^.><P[WBK]W>2,
M6?2S$-),.KFUZT]19-*<%=1TU9I)>+)4NJ 6;O4J,FO-:.9!A8A(' ^B@G+9
MF8[]VIV>CM7&"B[9G49F4Q14/\Z84-M)!W=V"U_X*K=N(9J.UW3%[IG]MK[3
M<!?5+!DOF#1<2:39<M*YPI_F9.@ _HT_.-N:O6OD2EDH]=W=W&233NPR8H*E
MUE%0^'I@<R:$8X(\?E2DG3JF ^Y?[]A_\<5#,0MJV%R)/WEF\TEGU$$96]*-
ML%_4]E=6%=1W?*D2QG^B;?5NW$'IQEA55&#(H."R_*8_JT;L 8"G'4 J 'D.
MZ!T )!4@\866F?FRKJFET[%66Z3=V\#F+GQO/!JJX=+)>&\U/.6 L]/9QL"*
M,2A5Q8)+ZGIKT 6Z+V5%:HFXM%2N^$(P1(UAUD#O?VRX9AEZ?\TLY<)\ ,2W
M^VOT_MT'] X Z)8+X9C&D84D7:@HK1*:E0F1 PEA=*NDS0WZ+#.6/<5'4%Q=
M(=E5."-!PFN6=E&"/R(2D[@EGWD8_GMJ#\&?I)/4#4\\7^]@.@^P=];0/,O2
M7"JA5H\!VEY-V_.TR3$=KYPVAOL]\O=OL(9N+"O,/X$8_3I&/YCZ9V,Y;!Q(
M?6/8<B.0X$O6IG"89H0>&=4FD-"@3F@09+K2X&KZ^J\ U;"F&IZM?Z,ZQBB8
M[E=EJ6C[!98P''N<,]Z'Z2A.NJ-Q]- 2[K(.=WE2=]"_:.Z-A&DP7E%N\9RO
M0PK@N/&/^&R-PWLNA8.UW#SWH(]HR26W[$+ OT#6UM2*\4E7\;";M#<5DR85
M\B:[8'Z$!Y.C^P WIH+#KK*G]5=-,R9IP4+$C:W@\_D*;HP%ARWA-?+V7\I+
M<!<?D+>Q%!SVE-/E#?.<(F]C3GAXJKS_\_\#-^:$1^=3NO$D'#:EURA]V:)T
MDG0'[5*3QKI(_#92'^$Y06K2.!T).]V>U/Y,C:R"8ZG7'$DX%9^D.FG<C)"S
MJ4X:>R)A>WJ%ZA7C4_N^[/8.B-X8&NF]D>AA'MP_+GKC?R3L?WNBW\B+M5:I
MDT0S Q'2'%&9[7X#,$'94,C&Y\C@?,(WQD7"QM4B/(=S_5'QAR_%[V/R0OUH
M;_"!X\W*SX-NEME(6TX(]6H]<U[Y2>O9^@QFT7)R;&C*0?:6ZA6'D4BP)5#&
MW2$HJ<O9L+RQ:NW'JX6R<,;RESG,TTR[%^#Y4BF[NW$!Z@E]^A]02P,$%
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MI Q&ERA*M;.CW1A9N^>WD08?LUN6.&Y!60<\+Z0TAXT-T _P] ]02P,$%
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MK!GDE-7_^*41HI< @PL)J$E PP3O0H+;)+C7)GA-@E<I4Y=2Z;#!"J\6@I^
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MBDEJ2 '4%+B&[%].$K8\9,*/K-U#+KN "J]C]X8 ;@J<F\,7E(1-S[#MY6#
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M51P:OX#F5UJ[AXX':.O"V4]02P,$%     @ _(!:4K(^Z.F4 @  % <  !D
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MY0Y.PTP: WB^$4(?%\9!<[Z>_P]02P,$%     @ _(!:4K= T]CK P  :P\
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MT,]G7*.FOC &FD/DBW\!4$L#!!0    ( /R 6E('%%BB!P0  /D-   9
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;(U544_;,!#^*U;$ TA
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M)[M?S-GQT0D[8D*Q;QM=67JE'8=(A3@Y8=:(OJQ%QP=$SR$[9TGOE,51''7
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M;"WL@]I\AEU!I<!$"5/^DDTU=Q![)%D;J_)=,"K(N:S^V>O.B(. D+8$A+N
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M[^>0543SA:(9*%[6[^P;KA3/Z\N4$F@2-0#N;SE7QX%^0/>=:/DW4$L#!!0
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MY\E_A%G%@(E]\( ZVGBNX[15OK40M30.#AH'1HUOA+N77&BX)2RA,> 4'$P
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MK+YZ7G_A=%O=2WZDG-.L^K@A."9,$HC?5Y3R_1>YP.$_ %S\#U!+ P04
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MY]\_M]7/E""VMFN3*.%[IJK6IAZM.\/KJA]JIE=MY4<J]!=<H@(VVM0;19I
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M)T$8@'Z^YEP=!N8%=8,Z_0M02P,$%     @ _(!:4O#V"_!O P  FPP  !D
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MQLA=<_Y<2H.GV>9RBW\X0%D!_KZ6F+WMC3W2=G]A9O\!4$L#!!0    ( /R
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M30"C$L6Y3_&@^-Z<A"RY4CPUMSM&8>W0 OA_PV'.E ^Z@^KT;?HO4$L#!!0
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M<.]\@,,^B7UG"G.(LTN$V_'7 !?SD#@57@"8M=5WEWT(XY'KURV 4<XBUWT
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MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
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MY;OE]OCK\OLBOB]65YSK^XKAZ2]02P,$%     @ _(!:4L* #&LZ @  :#,
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M>,G/EC_8W/X$4$L! A0#%     @ _(!:4@=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #\@%I2-OL!
MT^X    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    " #\@%I2F5R<(Q &  "<)P  $P              @ ', 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( /R 6E*'JJ+4E 8  "P:
M   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    " #\@%I2N;2Z\[@&  "J&P  &               @('7#@
M>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ _(!:4IF<"2[1
M @  K0D  !@              ("!Q14  'AL+W=O<FMS:&5E=',O<VAE970S
M+GAM;%!+ 0(4 Q0    ( /R 6E*&0;S_N@0  'L1   8              "
M@<P8  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " #\@%I2
M/%)YOM\"  #I!P  &               @(&\'0  >&PO=V]R:W-H965T<R]S
M:&5E=#4N>&UL4$L! A0#%     @ _(!:4B;TSG?.!@  6"   !@
M     ("!T2   'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (
M /R 6E)"A9CMU@D   ,L   8              " @=4G  !X;"]W;W)K<VAE
M971S+W-H965T-RYX;6Q02P$"% ,4    " #\@%I2CVE;H:H$   L"@  &
M            @('A,0  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#
M%     @ _(!:4HOS)_())P  #'P  !@              ("!P38  'AL+W=O
M<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( /R 6E(;K-Y/90L  )0=
M   9              " @0!>  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL
M4$L! A0#%     @ _(!:4BPMT18"&0  "F<  !D              ("!G&D
M 'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " #\@%I28<G:
M8JD%   :#0  &0              @('5@@  >&PO=V]R:W-H965T<R]S:&5E
M=#$R+GAM;%!+ 0(4 Q0    ( /R 6E+CMOH(;@0  ((*   9
M  " @;6(  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @
M_(!:4H<KKJ'=!P  BA4  !D              ("!6HT  'AL+W=O<FMS:&5E
M=',O<VAE970Q-"YX;6Q02P$"% ,4    " #\@%I2X!B038D:  #14   &0
M            @(%NE0  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4
M Q0    ( /R 6E([B#_W&P@  "H8   9              " @2ZP  !X;"]W
M;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ _(!:4KL^XH%;#P
MA"X  !D              ("!@+@  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6Q02P$"% ,4    " #\@%I2 :>I6B4-  !#(P  &0              @($2
MR   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( /R 6E+0
MT<S*MP,  ,P(   9              " @6[5  !X;"]W;W)K<VAE971S+W-H
M965T,3DN>&UL4$L! A0#%     @ _(!:4EE=&[<3 P  > 8  !D
M     ("!7-D  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /R 6E+SD%V]IP0  * +   9              "
M@=0. 0!X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ _(!:
M4J"'-B&)!P  DQ0  !D              ("!LA,! 'AL+W=O<FMS:&5E=',O
M<VAE970R-BYX;6Q02P$"% ,4    " #\@%I2>1I&THH$  !X#0  &0
M        @(%R&P$ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0
M   ( /R 6E+0= XLQ00  +,,   9              " @3,@ 0!X;"]W;W)K
M<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ _(!:4H4? J*%!   4 P
M !D              ("!+R4! 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q0
M2P$"% ,4    " #\@%I2W^XE6+H%  #3$   &0              @('K*0$
M>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( /R 6E)13"CC
M$P0  #H*   9              " @=PO 0!X;"]W;W)K<VAE971S+W-H965T
M,S$N>&UL4$L! A0#%     @ _(!:4D@,(.5.!@  ] \  !D
M ("!)C0! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " #\
M@%I2>>G:,50&  !-$0  &0              @(&K.@$ >&PO=V]R:W-H965T
M<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( /R 6E*P,9J+[P,  *@)   9
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M970S."YX;6Q02P$"% ,4    " #\@%I2LIN04'L"  "&!@  &0
M    @('C5 $ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (
M /R 6E),Z_2OEP(  $@'   9              " @957 0!X;"]W;W)K<VAE
M971S+W-H965T-# N>&UL4$L! A0#%     @ _(!:4GW"-5&\ @  W D  !D
M             ("!8UH! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"
M% ,4    " #\@%I2WYU=U4@'   2+P  &0              @(%670$ >&PO
M=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( /R 6E('5/Y+D00
M *(2   9              " @=5D 0!X;"]W;W)K<VAE971S+W-H965T-#,N
M>&UL4$L! A0#%     @ _(!:4N6L^)4(!   E@\  !D              ("!
MG6D! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " #\@%I2
MN*9U[5P&   5)   &0              @('<;0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0U+GAM;%!+ 0(4 Q0    ( /R 6E)W)UD%CP,  )X+   9
M      " @6]T 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%
M  @ _(!:4@NB\E4C P  G D  !D              ("!-7@! 'AL+W=O<FMS
M:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " #\@%I2\'1]R$H%  #+&0
M&0              @(&/>P$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+
M 0(4 Q0    ( /R 6E+*.?(5!04   (8   9              " @1"! 0!X
M;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ _(!:4A+@225.
M!P  ,BD  !D              ("!3(8! 'AL+W=O<FMS:&5E=',O<VAE970U
M,"YX;6Q02P$"% ,4    " #\@%I2701V^Q %  !^%P  &0
M@('1C0$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( /R
M6E*^"T?O308  .H<   9              " @1B3 0!X;"]W;W)K<VAE971S
M+W-H965T-3(N>&UL4$L! A0#%     @ _(!:4@Y>Y^K# P  K0\  !D
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M=#4W+GAM;%!+ 0(4 Q0    ( /R 6E+J19Q@F0(  .X&   9
M  " @6JN 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @
M_(!:4FNB-N)R @  0P8  !D              ("!.K$! 'AL+W=O<FMS:&5E
M=',O<VAE970U.2YX;6Q02P$"% ,4    " #\@%I2G\0 \1($  !B$0  &0
M            @('CLP$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4
M Q0    ( /R 6E)\O"GCO@(  %4'   9              " @2RX 0!X;"]W
M;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ _(!:4BGYG@>= @
MP 8  !D              ("!(;L! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX
M;6Q02P$"% ,4    " #\@%I2(U\[ZS4)  #02   &0              @('U
MO0$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( /R 6E+[
M.C1_0P,  ",*   9              " @6'' 0!X;"]W;W)K<VAE971S+W-H
M965T-C0N>&UL4$L! A0#%     @ _(!:4K(^Z.F4 @  % <  !D
M     ("!V\H! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4
M" #\@%I2ZF_<+@D$  !K#P  &0              @(&FS0$ >&PO=V]R:W-H
M965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( /R 6E*W0-/8ZP,  &L/   9
M              " @>;1 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L!
M A0#%     @ _(!:4B4+LKE;!@  4!X  !D              ("!"-8! 'AL
M+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " #\@%I2!Q18H@<$
M  #Y#0  &0              @(&:W $ >&PO=V]R:W-H965T<R]S:&5E=#8Y
M+GAM;%!+ 0(4 Q0    ( /R 6E(X$;_RE@(  "L&   9              "
M@=C@ 0!X;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ _(!:
M4CT%7F(! P  7@D  !D              ("!I>,! 'AL+W=O<FMS:&5E=',O
M<VAE970W,2YX;6Q02P$"% ,4    " #\@%I2H&_+C(\$   S$@  &0
M        @('=Y@$ >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0
M   ( /R 6E)P"FQ(=P<  )4I   9              " @:/K 0!X;"]W;W)K
M<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @ _(!:4H6DKT!> @  ! 4
M !D              ("!4?,! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q0
M2P$"% ,4    " #\@%I2GN&LT*T(   ,,   &0              @('F]0$
M>&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( /R 6E)X,Z<X
M1@4  ' 6   9              " @<K^ 0!X;"]W;W)K<VAE971S+W-H965T
M-S8N>&UL4$L! A0#%     @ _(!:4F1N](7' P  .P\  !D
M ("!1P0" 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"% ,4    " #\
M@%I2W$49P6$#  "B#   &0              @(%%" ( >&PO=V]R:W-H965T
M<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( /R 6E(5Q*MF3 ,  !\,   9
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M970X,RYX;6Q02P$"% ,4    " #\@%I2A+=,#E $  "$$0  &0
M    @(%<'0( >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    (
M /R 6E(VE^?^& ,  &\)   9              " @>,A @!X;"]W;W)K<VAE
M971S+W-H965T.#4N>&UL4$L! A0#%     @ _(!:4HHNK-N; P  ]@P  !D
M             ("!,B4" 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q02P$"
M% ,4    " #\@%I2X4?Q[B8$  ")$P  &0              @($$*0( >&PO
M=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4 Q0    ( /R 6E*VQGUME0,
M .\.   9              " @6$M @!X;"]W;W)K<VAE971S+W-H965T.#@N
M>&UL4$L! A0#%     @ _(!:4H7Z?_+.!   !A,  !D              ("!
M+3$" 'AL+W=O<FMS:&5E=',O<VAE970X.2YX;6Q02P$"% ,4    " #\@%I2
M4R$YBR0#  "2"0  &0              @($R-@( >&PO=V]R:W-H965T<R]S
M:&5E=#DP+GAM;%!+ 0(4 Q0    ( /R 6E*[DVOD80(  $@-   -
M      "  8TY @!X;"]S='EL97,N>&UL4$L! A0#%     @ _(!:4I>*NQS
M    $P(   L              ( !&3P" %]R96QS+RYR96QS4$L! A0#%
M  @ _(!:4O,:%ED]!@  HSL   \              ( ! CT" 'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( /R 6E+FXJ30H (   4U   :
M  "  6Q# @!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M /R 6E+"@ QK.@(  &@S   3              "  41& @!;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@    !B &( Y1H  *]( @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>441</ContextCount>
  <ElementCount>557</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>122</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Organization and description of business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/Organizationanddescriptionofbusiness</Role>
      <ShortName>Organization and description of business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Summary of significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/Summaryofsignificantaccountingpolicies</Role>
      <ShortName>Summary of significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2110103 - Disclosure - Revenue, accounts receivable and deferred revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/Revenueaccountsreceivableanddeferredrevenue</Role>
      <ShortName>Revenue, accounts receivable and deferred revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2115104 - Disclosure - Business combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/Businesscombinations</Role>
      <ShortName>Business combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2127105 - Disclosure - Goodwill and intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/Goodwillandintangibleassets</Role>
      <ShortName>Goodwill and intangible assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2133106 - Disclosure - Balance sheet components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/Balancesheetcomponents</Role>
      <ShortName>Balance sheet components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2139107 - Disclosure - Fair value measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/Fairvaluemeasurements</Role>
      <ShortName>Fair value measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2143108 - Disclosure - Commitments and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/Commitmentsandcontingencies</Role>
      <ShortName>Commitments and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2152109 - Disclosure - Stockholders' equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/Stockholdersequity</Role>
      <ShortName>Stockholders' equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2157110 - Disclosure - Stock incentive plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/Stockincentiveplans</Role>
      <ShortName>Stock incentive plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2164111 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/Incometaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2172112 - Disclosure - Net loss per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/Netlosspershare</Role>
      <ShortName>Net loss per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2176113 - Disclosure - Geographic information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/Geographicinformation</Role>
      <ShortName>Geographic information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2179114 - Disclosure - Selected quarterly data (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/Selectedquarterlydataunaudited</Role>
      <ShortName>Selected quarterly data (unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2182115 - Disclosure - Subsequent event</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/Subsequentevent</Role>
      <ShortName>Subsequent event</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Summary of significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies</Role>
      <ShortName>Summary of significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Summary of significant accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesTables</Role>
      <ShortName>Summary of significant accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.invitae.com/role/Summaryofsignificantaccountingpolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - Revenue, accounts receivable and deferred revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueTables</Role>
      <ShortName>Revenue, accounts receivable and deferred revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.invitae.com/role/Revenueaccountsreceivableanddeferredrevenue</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - Business combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BusinesscombinationsTables</Role>
      <ShortName>Business combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.invitae.com/role/Businesscombinations</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2328304 - Disclosure - Goodwill and intangible assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/GoodwillandintangibleassetsTables</Role>
      <ShortName>Goodwill and intangible assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.invitae.com/role/Goodwillandintangibleassets</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2334305 - Disclosure - Balance sheet components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BalancesheetcomponentsTables</Role>
      <ShortName>Balance sheet components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.invitae.com/role/Balancesheetcomponents</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2340306 - Disclosure - Fair value measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/FairvaluemeasurementsTables</Role>
      <ShortName>Fair value measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.invitae.com/role/Fairvaluemeasurements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2344307 - Disclosure - Commitments and contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/CommitmentsandcontingenciesTables</Role>
      <ShortName>Commitments and contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.invitae.com/role/Commitmentsandcontingencies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2353308 - Disclosure - Stockholders' equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/StockholdersequityTables</Role>
      <ShortName>Stockholders' equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.invitae.com/role/Stockholdersequity</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2358309 - Disclosure - Stock incentive plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/StockincentiveplansTables</Role>
      <ShortName>Stock incentive plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.invitae.com/role/Stockincentiveplans</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2365310 - Disclosure - Income taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/IncometaxesTables</Role>
      <ShortName>Income taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.invitae.com/role/Incometaxes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2373311 - Disclosure - Net loss per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/NetlosspershareTables</Role>
      <ShortName>Net loss per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.invitae.com/role/Netlosspershare</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2377312 - Disclosure - Geographic information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/GeographicinformationTables</Role>
      <ShortName>Geographic information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.invitae.com/role/Geographicinformation</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2380313 - Disclosure - Selected quarterly data (unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/SelectedquarterlydataunauditedTables</Role>
      <ShortName>Selected quarterly data (unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.invitae.com/role/Selectedquarterlydataunaudited</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Organization and description of business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/OrganizationanddescriptionofbusinessDetails</Role>
      <ShortName>Organization and description of business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.invitae.com/role/Organizationanddescriptionofbusiness</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Summary of significant accounting policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails</Role>
      <ShortName>Summary of significant accounting policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Summary of significant accounting policies - Schedule of significant customers, revenue as a percentage (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails</Role>
      <ShortName>Summary of significant accounting policies - Schedule of significant customers, revenue as a percentage (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Summary of significant accounting policies - Schedule of cash, cash equivalents and restricted cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails</Role>
      <ShortName>Summary of significant accounting policies - Schedule of cash, cash equivalents and restricted cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - Summary of significant accounting policies - Schedule of useful lives of property and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails</Role>
      <ShortName>Summary of significant accounting policies - Schedule of useful lives of property and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Revenue, accounts receivable and deferred revenue - Schedule of disaggregated revenue by payer category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails</Role>
      <ShortName>Revenue, accounts receivable and deferred revenue - Schedule of disaggregated revenue by payer category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Revenue, accounts receivable and deferred revenue - Schedule of change in estimate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails</Role>
      <ShortName>Revenue, accounts receivable and deferred revenue - Schedule of change in estimate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - Revenue, accounts receivable and deferred revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails</Role>
      <ShortName>Revenue, accounts receivable and deferred revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - Business combinations - Singular Bio (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BusinesscombinationsSingularBioDetails</Role>
      <ShortName>Business combinations - Singular Bio (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - Business combinations - Jungla (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BusinesscombinationsJunglaDetails</Role>
      <ShortName>Business combinations - Jungla (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - Business combinations - Clear Genetics (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails</Role>
      <ShortName>Business combinations - Clear Genetics (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - Business combinations - Diploid (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BusinesscombinationsDiploidDetails</Role>
      <ShortName>Business combinations - Diploid (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2421413 - Disclosure - Business combinations - Summary of the purchase price and post-combination expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails</Role>
      <ShortName>Business combinations - Summary of the purchase price and post-combination expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2422414 - Disclosure - Business combinations - Summary of fair values of assets acquired and liabilities assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails</Role>
      <ShortName>Business combinations - Summary of fair values of assets acquired and liabilities assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2423415 - Disclosure - Business combinations - Genelex and YouScript (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails</Role>
      <ShortName>Business combinations - Genelex and YouScript (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2424416 - Disclosure - Business combinations - ArcherDX (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BusinesscombinationsArcherDXDetails</Role>
      <ShortName>Business combinations - ArcherDX (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2425417 - Disclosure - Business combinations - Summary of intangible assets acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails</Role>
      <ShortName>Business combinations - Summary of intangible assets acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2426418 - Disclosure - Business combinations - Schedule of pro forma financial information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BusinesscombinationsScheduleofproformafinancialinformationDetails</Role>
      <ShortName>Business combinations - Schedule of pro forma financial information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2429419 - Disclosure - Goodwill and intangible assets - Summary of goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails</Role>
      <ShortName>Goodwill and intangible assets - Summary of goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2430420 - Disclosure - Goodwill and intangible assets - Schedule of intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails</Role>
      <ShortName>Goodwill and intangible assets - Schedule of intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2431421 - Disclosure - Goodwill and intangible assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails</Role>
      <ShortName>Goodwill and intangible assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2432422 - Disclosure - Goodwill and intangible assets - Summary of estimated future amortization expense of intangible assets with finite lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails</Role>
      <ShortName>Goodwill and intangible assets - Summary of estimated future amortization expense of intangible assets with finite lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2435423 - Disclosure - Balance sheet components - Schedule of inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails</Role>
      <ShortName>Balance sheet components - Schedule of inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2436424 - Disclosure - Balance sheet components - Property and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails</Role>
      <ShortName>Balance sheet components - Property and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2437425 - Disclosure - Balance sheet components - Accrued liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails</Role>
      <ShortName>Balance sheet components - Accrued liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2438426 - Disclosure - Balance sheet components - Other long-term liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails</Role>
      <ShortName>Balance sheet components - Other long-term liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2441427 - Disclosure - Fair value measurements - Financial instruments at fair value on a recurring basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails</Role>
      <ShortName>Fair value measurements - Financial instruments at fair value on a recurring basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2442428 - Disclosure - Fair value measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails</Role>
      <ShortName>Fair value measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2445429 - Disclosure - Commitments and contingencies - Lease additional information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails</Role>
      <ShortName>Commitments and contingencies - Lease additional information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2446430 - Disclosure - Commitments and contingencies - Supplemental information regarding our operating and finance leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails</Role>
      <ShortName>Commitments and contingencies - Supplemental information regarding our operating and finance leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2447431 - Disclosure - Commitments and contingencies - Schedule of future payments under operating and finance leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails</Role>
      <ShortName>Commitments and contingencies - Schedule of future payments under operating and finance leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2448432 - Disclosure - Commitments and contingencies - Debt financing (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails</Role>
      <ShortName>Commitments and contingencies - Debt financing (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2449433 - Disclosure - Commitments and contingencies - Convertible senior notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails</Role>
      <ShortName>Commitments and contingencies - Convertible senior notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2450434 - Disclosure - Commitments and contingencies - Components of debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails</Role>
      <ShortName>Commitments and contingencies - Components of debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2451435 - Disclosure - Commitments and contingencies - Other commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails</Role>
      <ShortName>Commitments and contingencies - Other commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2454436 - Disclosure - Stockholders' equity - Schedule of convertible preferred and common stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails</Role>
      <ShortName>Stockholders' equity - Schedule of convertible preferred and common stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2455437 - Disclosure - Stockholders' equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/StockholdersequityNarrativeDetails</Role>
      <ShortName>Stockholders' equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2456438 - Disclosure - Stockholders' equity - Schedule of outstanding warrants to purchase common stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails</Role>
      <ShortName>Stockholders' equity - Schedule of outstanding warrants to purchase common stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2459439 - Disclosure - Stock incentive plans - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails</Role>
      <ShortName>Stock incentive plans - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2460440 - Disclosure - Stock incentive plans - Schedule of activity under stock incentive plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails</Role>
      <ShortName>Stock incentive plans - Schedule of activity under stock incentive plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2461441 - Disclosure - Stock incentive plans - Summary of RSU activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails</Role>
      <ShortName>Stock incentive plans - Summary of RSU activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2462442 - Disclosure - Stock incentive plans - Schedule of assumptions used in determination of fair value of options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails</Role>
      <ShortName>Stock incentive plans - Schedule of assumptions used in determination of fair value of options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2463443 - Disclosure - Stock incentive plans - Stock-based compensation expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails</Role>
      <ShortName>Stock incentive plans - Stock-based compensation expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2466444 - Disclosure - Income taxes - Schedule of components of loss before income taxes by U.S. and foreign jurisdictions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails</Role>
      <ShortName>Income taxes - Schedule of components of loss before income taxes by U.S. and foreign jurisdictions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2467445 - Disclosure - Income taxes - Schedule of components of the provision for income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails</Role>
      <ShortName>Income taxes - Schedule of components of the provision for income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2468446 - Disclosure - Income taxes - Schedule of reconciliation of the tax expense computed at the statutory federal rate and Company's tax expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails</Role>
      <ShortName>Income taxes - Schedule of reconciliation of the tax expense computed at the statutory federal rate and Company's tax expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2469447 - Disclosure - Income taxes - Schedule of net deferred tax assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails</Role>
      <ShortName>Income taxes - Schedule of net deferred tax assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2470448 - Disclosure - Income taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/IncometaxesNarrativeDetails</Role>
      <ShortName>Income taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2471449 - Disclosure - Income taxes - Schedule of reconciliation of unrecognized tax benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails</Role>
      <ShortName>Income taxes - Schedule of reconciliation of unrecognized tax benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2474450 - Disclosure - Net loss per share - Schedule of earnings per share, basic and diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/NetlosspershareScheduleofearningspersharebasicanddilutedDetails</Role>
      <ShortName>Net loss per share - Schedule of earnings per share, basic and diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2475451 - Disclosure - Net loss per share - Schedule of antidilutive securities excluded from computation of earnings per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails</Role>
      <ShortName>Net loss per share - Schedule of antidilutive securities excluded from computation of earnings per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2478452 - Disclosure - Geographic information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/GeographicinformationDetails</Role>
      <ShortName>Geographic information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.invitae.com/role/GeographicinformationTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2481453 - Disclosure - Selected quarterly data (unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/SelectedquarterlydataunauditedDetails</Role>
      <ShortName>Selected quarterly data (unaudited) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.invitae.com/role/SelectedquarterlydataunauditedTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="nvta-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>2483454 - Disclosure - Subsequent events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.invitae.com/role/SubsequenteventsDetails</Role>
      <ShortName>Subsequent events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.invitae.com/role/Subsequentevent</ParentRole>
      <Position>90</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="nvta-20201231.htm">nvta-20201231.htm</File>
    <File>exhibit1021toxarcherdxinc2.htm</File>
    <File>exhibit105-invitae2015stoc.htm</File>
    <File>exhibit211-listofsubsidiar.htm</File>
    <File>exhibit231-sx8consentx1231.htm</File>
    <File>exhibit311-q42020.htm</File>
    <File>exhibit312-q42020.htm</File>
    <File>exhibit321-q42020.htm</File>
    <File>exhibit322-q42020.htm</File>
    <File>exhibit41-invitaecorporati.htm</File>
    <File>exhibit414-invitaexintelli.htm</File>
    <File>nvta-20201231.xsd</File>
    <File>nvta-20201231_cal.xml</File>
    <File>nvta-20201231_def.xml</File>
    <File>nvta-20201231_lab.xml</File>
    <File>nvta-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>nvta-20201231_g1.jpg</File>
    <File>nvta-20201231_g2.jpg</File>
    <File>nvta-20201231_g3.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>119
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "nvta-20201231.htm": {
   "axisCustom": 0,
   "axisStandard": 44,
   "contextCount": 441,
   "dts": {
    "calculationLink": {
     "local": [
      "nvta-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "nvta-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "nvta-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "nvta-20201231_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nvta-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "nvta-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 802,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 13,
    "http://www.invitae.com/20201231": 3,
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 20
   },
   "keyCustom": 53,
   "keyStandard": 504,
   "memberCustom": 57,
   "memberStandard": 60,
   "nsprefix": "nvta",
   "nsuri": "http://www.invitae.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.invitae.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - Revenue, accounts receivable and deferred revenue",
     "role": "http://www.invitae.com/role/Revenueaccountsreceivableanddeferredrevenue",
     "shortName": "Revenue, accounts receivable and deferred revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115104 - Disclosure - Business combinations",
     "role": "http://www.invitae.com/role/Businesscombinations",
     "shortName": "Business combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127105 - Disclosure - Goodwill and intangible assets",
     "role": "http://www.invitae.com/role/Goodwillandintangibleassets",
     "shortName": "Goodwill and intangible assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133106 - Disclosure - Balance sheet components",
     "role": "http://www.invitae.com/role/Balancesheetcomponents",
     "shortName": "Balance sheet components",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139107 - Disclosure - Fair value measurements",
     "role": "http://www.invitae.com/role/Fairvaluemeasurements",
     "shortName": "Fair value measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143108 - Disclosure - Commitments and contingencies",
     "role": "http://www.invitae.com/role/Commitmentsandcontingencies",
     "shortName": "Commitments and contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152109 - Disclosure - Stockholders' equity",
     "role": "http://www.invitae.com/role/Stockholdersequity",
     "shortName": "Stockholders' equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157110 - Disclosure - Stock incentive plans",
     "role": "http://www.invitae.com/role/Stockincentiveplans",
     "shortName": "Stock incentive plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2164111 - Disclosure - Income taxes",
     "role": "http://www.invitae.com/role/Incometaxes",
     "shortName": "Income taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2172112 - Disclosure - Net loss per share",
     "role": "http://www.invitae.com/role/Netlosspershare",
     "shortName": "Net loss per share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Balance Sheets",
     "role": "http://www.invitae.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2176113 - Disclosure - Geographic information",
     "role": "http://www.invitae.com/role/Geographicinformation",
     "shortName": "Geographic information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2179114 - Disclosure - Selected quarterly data (unaudited)",
     "role": "http://www.invitae.com/role/Selectedquarterlydataunaudited",
     "shortName": "Selected quarterly data (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2182115 - Disclosure - Subsequent event",
     "role": "http://www.invitae.com/role/Subsequentevent",
     "shortName": "Subsequent event",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Summary of significant accounting policies (Policies)",
     "role": "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies",
     "shortName": "Summary of significant accounting policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Summary of significant accounting policies (Tables)",
     "role": "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesTables",
     "shortName": "Summary of significant accounting policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Revenue, accounts receivable and deferred revenue (Tables)",
     "role": "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueTables",
     "shortName": "Revenue, accounts receivable and deferred revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - Business combinations (Tables)",
     "role": "http://www.invitae.com/role/BusinesscombinationsTables",
     "shortName": "Business combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328304 - Disclosure - Goodwill and intangible assets (Tables)",
     "role": "http://www.invitae.com/role/GoodwillandintangibleassetsTables",
     "shortName": "Goodwill and intangible assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334305 - Disclosure - Balance sheet components (Tables)",
     "role": "http://www.invitae.com/role/BalancesheetcomponentsTables",
     "shortName": "Balance sheet components (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340306 - Disclosure - Fair value measurements (Tables)",
     "role": "http://www.invitae.com/role/FairvaluemeasurementsTables",
     "shortName": "Fair value measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344307 - Disclosure - Commitments and contingencies (Tables)",
     "role": "http://www.invitae.com/role/CommitmentsandcontingenciesTables",
     "shortName": "Commitments and contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353308 - Disclosure - Stockholders' equity (Tables)",
     "role": "http://www.invitae.com/role/StockholdersequityTables",
     "shortName": "Stockholders' equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2358309 - Disclosure - Stock incentive plans (Tables)",
     "role": "http://www.invitae.com/role/StockincentiveplansTables",
     "shortName": "Stock incentive plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2365310 - Disclosure - Income taxes (Tables)",
     "role": "http://www.invitae.com/role/IncometaxesTables",
     "shortName": "Income taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2373311 - Disclosure - Net loss per share (Tables)",
     "role": "http://www.invitae.com/role/NetlosspershareTables",
     "shortName": "Net loss per share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2377312 - Disclosure - Geographic information (Tables)",
     "role": "http://www.invitae.com/role/GeographicinformationTables",
     "shortName": "Geographic information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2380313 - Disclosure - Selected quarterly data (unaudited) (Tables)",
     "role": "http://www.invitae.com/role/SelectedquarterlydataunauditedTables",
     "shortName": "Selected quarterly data (unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "business",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Organization and description of business (Details)",
     "role": "http://www.invitae.com/role/OrganizationanddescriptionofbusinessDetails",
     "shortName": "Organization and description of business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "business",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Summary of significant accounting policies - Narrative (Details)",
     "role": "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails",
     "shortName": "Summary of significant accounting policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i7e1175abf83148d8836d04d1ecf72a47_D20200101-20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Summary of significant accounting policies - Schedule of significant customers, revenue as a percentage (Details)",
     "role": "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails",
     "shortName": "Summary of significant accounting policies - Schedule of significant customers, revenue as a percentage (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i7e1175abf83148d8836d04d1ecf72a47_D20200101-20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Statements of Operations",
     "role": "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Summary of significant accounting policies - Schedule of cash, cash equivalents and restricted cash (Details)",
     "role": "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails",
     "shortName": "Summary of significant accounting policies - Schedule of cash, cash equivalents and restricted cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ife1d8cfb66ed44aebe09b9526f251933_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - Summary of significant accounting policies - Schedule of useful lives of property and equipment (Details)",
     "role": "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails",
     "shortName": "Summary of significant accounting policies - Schedule of useful lives of property and equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ife1d8cfb66ed44aebe09b9526f251933_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Revenue, accounts receivable and deferred revenue - Schedule of disaggregated revenue by payer category (Details)",
     "role": "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails",
     "shortName": "Revenue, accounts receivable and deferred revenue - Schedule of disaggregated revenue by payer category (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i0865c1b494ba451ab270138139c94f26_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Revenue, accounts receivable and deferred revenue - Schedule of change in estimate (Details)",
     "role": "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails",
     "shortName": "Revenue, accounts receivable and deferred revenue - Schedule of change in estimate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if46861699db14e22b253710d388c79d1_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - Revenue, accounts receivable and deferred revenue - Narrative (Details)",
     "role": "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails",
     "shortName": "Revenue, accounts receivable and deferred revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i604983240be1439382d7e6de61b44b46_D20200401-20200430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - Business combinations - Singular Bio (Details)",
     "role": "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
     "shortName": "Business combinations - Singular Bio (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i175aab7c76c643de95548d9a1cb45a8e_I20190630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i604983240be1439382d7e6de61b44b46_D20200401-20200430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - Business combinations - Jungla (Details)",
     "role": "http://www.invitae.com/role/BusinesscombinationsJunglaDetails",
     "shortName": "Business combinations - Jungla (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "iabffd0b7435a46ab8001e51bc9e0f884_I20190731",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i604983240be1439382d7e6de61b44b46_D20200401-20200430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - Business combinations - Clear Genetics (Details)",
     "role": "http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails",
     "shortName": "Business combinations - Clear Genetics (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "icad31fda692c44d6b3ebd405fc1f5bfb_I20191130",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i604983240be1439382d7e6de61b44b46_D20200401-20200430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - Business combinations - Diploid (Details)",
     "role": "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
     "shortName": "Business combinations - Diploid (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "id28b9a63ced0431fa69e448208ef5a4b_I20200331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i604983240be1439382d7e6de61b44b46_D20200401-20200430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421413 - Disclosure - Business combinations - Summary of the purchase price and post-combination expense (Details)",
     "role": "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails",
     "shortName": "Business combinations - Summary of the purchase price and post-combination expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i604983240be1439382d7e6de61b44b46_D20200401-20200430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Statements of Comprehensive Loss",
     "role": "http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422414 - Disclosure - Business combinations - Summary of fair values of assets acquired and liabilities assumed (Details)",
     "role": "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails",
     "shortName": "Business combinations - Summary of fair values of assets acquired and liabilities assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "id28b9a63ced0431fa69e448208ef5a4b_I20200331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i604983240be1439382d7e6de61b44b46_D20200401-20200430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423415 - Disclosure - Business combinations - Genelex and YouScript (Details)",
     "role": "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
     "shortName": "Business combinations - Genelex and YouScript (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ib16a2d94d1ea453e8429a668b6ea9dbb_I20200430",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i604983240be1439382d7e6de61b44b46_D20200401-20200430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424416 - Disclosure - Business combinations - ArcherDX (Details)",
     "role": "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
     "shortName": "Business combinations - ArcherDX (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i098aab9e153f4c929328dfcb7cfaab20_I20200630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i8bfd608ebc2f4679bbacfd7c6509b051_D20201201-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425417 - Disclosure - Business combinations - Summary of intangible assets acquired (Details)",
     "role": "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
     "shortName": "Business combinations - Summary of intangible assets acquired (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i0c4c49beaa8748e88bf241eeb61857e2_I20201031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426418 - Disclosure - Business combinations - Schedule of pro forma financial information (Details)",
     "role": "http://www.invitae.com/role/BusinesscombinationsScheduleofproformafinancialinformationDetails",
     "shortName": "Business combinations - Schedule of pro forma financial information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i7fe154ccb77e426d92286dae5aeff26e_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429419 - Disclosure - Goodwill and intangible assets - Summary of goodwill (Details)",
     "role": "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails",
     "shortName": "Goodwill and intangible assets - Summary of goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ic716b0d977014b47953f608abb21ee07_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430420 - Disclosure - Goodwill and intangible assets - Schedule of intangible assets (Details)",
     "role": "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails",
     "shortName": "Goodwill and intangible assets - Schedule of intangible assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431421 - Disclosure - Goodwill and intangible assets - Narrative (Details)",
     "role": "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
     "shortName": "Goodwill and intangible assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432422 - Disclosure - Goodwill and intangible assets - Summary of estimated future amortization expense of intangible assets with finite lives (Details)",
     "role": "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails",
     "shortName": "Goodwill and intangible assets - Summary of estimated future amortization expense of intangible assets with finite lives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435423 - Disclosure - Balance sheet components - Schedule of inventory (Details)",
     "role": "http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails",
     "shortName": "Balance sheet components - Schedule of inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ie554d3df8b1f425f9be76437e8b27488_I20171231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ie554d3df8b1f425f9be76437e8b27488_I20171231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436424 - Disclosure - Balance sheet components - Property and equipment (Details)",
     "role": "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails",
     "shortName": "Balance sheet components - Property and equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437425 - Disclosure - Balance sheet components - Accrued liabilities (Details)",
     "role": "http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails",
     "shortName": "Balance sheet components - Accrued liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438426 - Disclosure - Balance sheet components - Other long-term liabilities (Details)",
     "role": "http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails",
     "shortName": "Balance sheet components - Other long-term liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441427 - Disclosure - Fair value measurements - Financial instruments at fair value on a recurring basis (Details)",
     "role": "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails",
     "shortName": "Fair value measurements - Financial instruments at fair value on a recurring basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "nvta:CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "nvta:FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "nvta:FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442428 - Disclosure - Fair value measurements - Narrative (Details)",
     "role": "http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails",
     "shortName": "Fair value measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "nvta:FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "nvta:FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeaseTermOfContract1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445429 - Disclosure - Commitments and contingencies - Lease additional information (Details)",
     "role": "http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails",
     "shortName": "Commitments and contingencies - Lease additional information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeaseTermOfContract1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446430 - Disclosure - Commitments and contingencies - Supplemental information regarding our operating and finance leases (Details)",
     "role": "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails",
     "shortName": "Commitments and contingencies - Supplemental information regarding our operating and finance leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447431 - Disclosure - Commitments and contingencies - Schedule of future payments under operating and finance leases (Details)",
     "role": "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails",
     "shortName": "Commitments and contingencies - Schedule of future payments under operating and finance leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfDebtExtinguishmentCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448432 - Disclosure - Commitments and contingencies - Debt financing (Details)",
     "role": "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails",
     "shortName": "Commitments and contingencies - Debt financing (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i8beb7cf99ebe46ce83c4c7ac46d96be8_D20201001-20201031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i70c89bb06a7246a1bb3d4f7eec32e812_I20190930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449433 - Disclosure - Commitments and contingencies - Convertible senior notes (Details)",
     "role": "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails",
     "shortName": "Commitments and contingencies - Convertible senior notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i70c89bb06a7246a1bb3d4f7eec32e812_I20190930",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i74cd37df131042188edd2e1114ee7668_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450434 - Disclosure - Commitments and contingencies - Components of debt (Details)",
     "role": "http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails",
     "shortName": "Commitments and contingencies - Components of debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i74cd37df131042188edd2e1114ee7668_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451435 - Disclosure - Commitments and contingencies - Other commitments (Details)",
     "role": "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails",
     "shortName": "Commitments and contingencies - Other commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i36aab3b4c6bf4533beccf6b9244c271d_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i468f27e028dd4eabbd6a49ffcfef1827_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454436 - Disclosure - Stockholders' equity - Schedule of convertible preferred and common stock (Details)",
     "role": "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails",
     "shortName": "Stockholders' equity - Schedule of convertible preferred and common stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i226038a1ff7c4ae9a815cea5810f19b6_I20171231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455437 - Disclosure - Stockholders' equity - Narrative (Details)",
     "role": "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
     "shortName": "Stockholders' equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ib58041aa8f654c0bbf3e16262383a5bd_D20190101-20191231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ConversionOfStockSharesConverted1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "id2406ee2925e4cdfa9b0c5c418c48d97_I20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456438 - Disclosure - Stockholders' equity - Schedule of outstanding warrants to purchase common stock (Details)",
     "role": "http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails",
     "shortName": "Stockholders' equity - Schedule of outstanding warrants to purchase common stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "id2406ee2925e4cdfa9b0c5c418c48d97_I20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459439 - Disclosure - Stock incentive plans - Additional Information (Details)",
     "role": "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
     "shortName": "Stock incentive plans - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i2a15e9739bdb4dd3ba91eff47a68dee8_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460440 - Disclosure - Stock incentive plans - Schedule of activity under stock incentive plans (Details)",
     "role": "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails",
     "shortName": "Stock incentive plans - Schedule of activity under stock incentive plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i5ea15f8c81a24316bacab4ca0ba6bd4a_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i8df5ce0c23374e0f96f0da2ab94af033_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461441 - Disclosure - Stock incentive plans - Summary of RSU activity (Details)",
     "role": "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails",
     "shortName": "Stock incentive plans - Summary of RSU activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i8df5ce0c23374e0f96f0da2ab94af033_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i9687cb514ee64df88920c8e6d2c79f5b_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462442 - Disclosure - Stock incentive plans - Schedule of assumptions used in determination of fair value of options (Details)",
     "role": "http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails",
     "shortName": "Stock incentive plans - Schedule of assumptions used in determination of fair value of options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i9687cb514ee64df88920c8e6d2c79f5b_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463443 - Disclosure - Stock incentive plans - Stock-based compensation expense (Details)",
     "role": "http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails",
     "shortName": "Stock incentive plans - Stock-based compensation expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ie3381401fa094fc08b04b11cc3984e08_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Organization and description of business",
     "role": "http://www.invitae.com/role/Organizationanddescriptionofbusiness",
     "shortName": "Organization and description of business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466444 - Disclosure - Income taxes - Schedule of components of loss before income taxes by U.S. and foreign jurisdictions (Details)",
     "role": "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails",
     "shortName": "Income taxes - Schedule of components of loss before income taxes by U.S. and foreign jurisdictions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentForeignTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467445 - Disclosure - Income taxes - Schedule of components of the provision for income taxes (Details)",
     "role": "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails",
     "shortName": "Income taxes - Schedule of components of the provision for income taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentForeignTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468446 - Disclosure - Income taxes - Schedule of reconciliation of the tax expense computed at the statutory federal rate and Company's tax expense (Details)",
     "role": "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails",
     "shortName": "Income taxes - Schedule of reconciliation of the tax expense computed at the statutory federal rate and Company's tax expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469447 - Disclosure - Income taxes - Schedule of net deferred tax assets (Details)",
     "role": "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails",
     "shortName": "Income taxes - Schedule of net deferred tax assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ica8df88fbc13471181f2a555e9880399_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ief55ba984c4f4d3db6d80102c5abb216_D20170101-20171231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470448 - Disclosure - Income taxes - Narrative (Details)",
     "role": "http://www.invitae.com/role/IncometaxesNarrativeDetails",
     "shortName": "Income taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ief55ba984c4f4d3db6d80102c5abb216_D20170101-20171231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i7fe154ccb77e426d92286dae5aeff26e_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471449 - Disclosure - Income taxes - Schedule of reconciliation of unrecognized tax benefits (Details)",
     "role": "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails",
     "shortName": "Income taxes - Schedule of reconciliation of unrecognized tax benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2474450 - Disclosure - Net loss per share - Schedule of earnings per share, basic and diluted (Details)",
     "role": "http://www.invitae.com/role/NetlosspershareScheduleofearningspersharebasicanddilutedDetails",
     "shortName": "Net loss per share - Schedule of earnings per share, basic and diluted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareBasicAndDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2475451 - Disclosure - Net loss per share - Schedule of antidilutive securities excluded from computation of earnings per share (Details)",
     "role": "http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails",
     "shortName": "Net loss per share - Schedule of antidilutive securities excluded from computation of earnings per share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2478452 - Disclosure - Geographic information (Details)",
     "role": "http://www.invitae.com/role/GeographicinformationDetails",
     "shortName": "Geographic information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "ifdb77ef12cba40759cb6e357bad02f51_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2481453 - Disclosure - Selected quarterly data (unaudited) (Details)",
     "role": "http://www.invitae.com/role/SelectedquarterlydataunauditedDetails",
     "shortName": "Selected quarterly data (unaudited) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i25e6185a78214b90bdc6c375fbe4695d_D20201001-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Summary of significant accounting policies",
     "role": "http://www.invitae.com/role/Summaryofsignificantaccountingpolicies",
     "shortName": "Summary of significant accounting policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "if1e6abaa78064375b6c085064a2fc36c_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i604983240be1439382d7e6de61b44b46_D20200401-20200430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2483454 - Disclosure - Subsequent events (Details)",
     "role": "http://www.invitae.com/role/SubsequenteventsDetails",
     "shortName": "Subsequent events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvta-20201231.htm",
      "contextRef": "i2c5ed2de4b2b4acc8e01d44e041365bc_I20210226",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 122,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GeographicinformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GeographicinformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r665",
      "r666",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r665",
      "r666",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "nvta_A2019IncentiveCompensationPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Incentive Compensation Plan [Member]",
        "label": "2019 Incentive Compensation Plan [Member]",
        "terseLabel": "2019 Incentive Compensation Plan"
       }
      }
     },
     "localname": "A2019IncentiveCompensationPlanMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_AccelerationofVestedEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acceleration of Vested Equity [Member]",
        "label": "Acceleration of Vested Equity [Member]",
        "terseLabel": "Post-combination Expense"
       }
      }
     },
     "localname": "AccelerationofVestedEquityMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_ArcherDXInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ArcherDX, Inc. [Member]",
        "label": "ArcherDX, Inc. [Member]",
        "terseLabel": "ArcherDX"
       }
      }
     },
     "localname": "ArcherDXInc.Member",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails",
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_BusinessCombinationAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination accrued liabilities current.",
        "label": "Business Combination Accrued Liabilities Current",
        "terseLabel": "Compensation and other liabilities associated with business combinations"
       }
      }
     },
     "localname": "BusinessCombinationAccruedLiabilitiesCurrent",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_BusinessCombinationAccruedLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination accrued liabilities noncurrent.",
        "label": "Business Combination Accrued Liabilities Noncurrent",
        "terseLabel": "Compensation and other liabilities associated with business combinations, non-current"
       }
      }
     },
     "localname": "BusinessCombinationAccruedLiabilitiesNoncurrent",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable and Liabilities Incurred",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable and Liabilities Incurred",
        "terseLabel": "Contingent consideration and liabilities incurred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableAndLiabilitiesIncurred",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Expected Milestone Duration",
        "label": "Business Combination, Contingent Consideration Arrangements, Expected Milestone Duration",
        "terseLabel": "Business acquisition, expected milestone duration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsExpectedMilestoneDuration",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsJunglaDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nvta_BusinessCombinationHoldbackConsiderationCash": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Hold-back Consideration, Cash",
        "label": "Business Combination, Hold-back Consideration, Cash",
        "terseLabel": "Hold-back consideration - cash"
       }
      }
     },
     "localname": "BusinessCombinationHoldbackConsiderationCash",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails",
      "http://www.invitae.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_BusinessCombinationHoldbackConsiderationCommonStockValueAssigned": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Hold-back Consideration, Common Stock, Value Assigned",
        "label": "Business Combination, Hold-back Consideration, Common Stock, Value Assigned",
        "terseLabel": "Hold-back consideration - common stock"
       }
      }
     },
     "localname": "BusinessCombinationHoldbackConsiderationCommonStockValueAssigned",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails",
      "http://www.invitae.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Post-Combination Expense for Acceleration of Unvested Equity",
        "label": "Business Combination, Post-Combination Expense for Acceleration of Unvested Equity",
        "terseLabel": "Post-combination expense for acceleration of unvested equity"
       }
      }
     },
     "localname": "BusinessCombinationPostCombinationExpenseForAccelerationOfUnvestedEquity",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Operating Lease",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Operating Lease",
        "negatedTerseLabel": "Operating lease obligations"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLease",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Operating Lease",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Operating Lease",
        "negatedTerseLabel": "Operating lease obligations, net of current portion"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLease",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Operating Lease, Right-of-Use Asset",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOperatingLeaseRightofUseAsset",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_BusinessCombinationRemeasurementOfLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination remeasurement of liabilities.",
        "label": "Business Combination Remeasurement Of Liabilities",
        "terseLabel": "Remeasurements of liabilities associated with business combinations"
       }
      }
     },
     "localname": "BusinessCombinationRemeasurementOfLiabilities",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Separately Recognized Transactions, Cash Transferred",
        "label": "Business Combination, Separately Recognized Transactions, Cash Transferred",
        "terseLabel": "Cash transferred"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsCashTransferred",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Separately Recognized Transactions, Common Stock Transferred",
        "label": "Business Combination, Separately Recognized Transactions, Common Stock Transferred",
        "terseLabel": "Common stock transferred"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsCommonStockTransferred",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Separately Recognized Transactions, Contingent Consideration",
        "label": "Business Combination, Separately Recognized Transactions, Contingent Consideration",
        "terseLabel": "Contingent consideration and liabilities incurred"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsContingentConsideration",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_CARESActMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES Act [Member]",
        "label": "CARES Act [Member]",
        "terseLabel": "CARES Act"
       }
      }
     },
     "localname": "CARESActMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash equivalents restricted cash and marketable securities amortized cost.",
        "label": "Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost Gross Unrealized Gain Before Tax",
        "label": "Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost Gross Unrealized Gain Before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash equivalents restricted cash and marketable securities amortized cost gross unrealized loss before tax.",
        "label": "Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost Gross Unrealized Loss Before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash equivalents restricted cash and marketable securities fair value.",
        "label": "Cash Equivalents Restricted Cash And Marketable Securities Fair Value",
        "totalLabel": "Financial assets"
       }
      }
     },
     "localname": "CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_ChangeInEstimateOfRevenueRecognitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in estimate of revenue recognition.",
        "label": "Change In Estimate Of Revenue Recognition [Member]",
        "terseLabel": "Change in estimate of revenue recognition"
       }
      }
     },
     "localname": "ChangeInEstimateOfRevenueRecognitionMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_ClearGeneticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clear Genetics [Member]",
        "label": "Clear Genetics [Member]",
        "terseLabel": "Clear Genetics"
       }
      }
     },
     "localname": "ClearGeneticsMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_CollaborationAndGenomeNetworkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration and genome network.",
        "label": "Collaboration And Genome Network [Member]",
        "terseLabel": "Other revenue"
       }
      }
     },
     "localname": "CollaborationAndGenomeNetworkMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_CombiMatrixCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CombiMatrix Corporation.",
        "label": "Combi Matrix Corporation [Member]",
        "terseLabel": "CombiMatrix"
       }
      }
     },
     "localname": "CombiMatrixCorporationMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_CommonStockSalesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock sales agreement.",
        "label": "Common Stock Sales Agreement [Member]",
        "terseLabel": "2018 Sales Agreement"
       }
      }
     },
     "localname": "CommonStockSalesAgreementMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration.",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Ongoing Development Post-close Milestones [Member]",
        "label": "Contingent Consideration, Ongoing Development Post-close Milestones [Member]",
        "terseLabel": "Ongoing development post-close milestones"
       }
      }
     },
     "localname": "ContingentConsiderationOngoingDevelopmentPostcloseMilestonesMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsJunglaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_ConvertibleSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes",
        "label": "Convertible Senior Notes [Member]",
        "terseLabel": "Convertible Senior Notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_CostOfTestRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of test revenue.",
        "label": "Cost Of Test Revenue [Member]",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfTestRevenueMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_CowenAndCompanyLimitedLiabilityCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cowen and company limited liability company.",
        "label": "Cowen And Company Limited Liability Company [Member]",
        "terseLabel": "Cowen and Company, LLC"
       }
      }
     },
     "localname": "CowenAndCompanyLimitedLiabilityCompanyMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_CustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to Customer A.",
        "label": "Customer [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "CustomerMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_DebtFinancingContingencyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Financing Contingency [Member]",
        "label": "Debt Financing Contingency [Member]",
        "terseLabel": "Debt financing contingency"
       }
      }
     },
     "localname": "DebtFinancingContingencyMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger, Maximum",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger, Maximum",
        "terseLabel": "Maximum threshold percentage of stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageofStockPriceTriggerMaximum",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nvta_DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Threshold Trading Days Immediately after Five Consecutive Trading Days",
        "label": "Debt Instrument, Convertible, Threshold Trading Days Immediately after Five Consecutive Trading Days",
        "terseLabel": "Threshold trading days immediately after five consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDaysImmediatelyafterFiveConsecutiveTradingDays",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "nvta_DebtInstrumentInterestRateFloorRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Interest Rate, Floor Rate",
        "label": "Debt Instrument, Interest Rate, Floor Rate",
        "terseLabel": "Floor rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateFloorRate",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nvta_DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Maturity Terms, Days Prior to Convertible Debt Extended Maturity Date",
        "label": "Debt Instrument, Maturity Terms, Days Prior to Convertible Debt Extended Maturity Date",
        "terseLabel": "Days prior to convertible debt extended maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityTermsDaysPriorToConvertibleDebtExtendedMaturityDate",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nvta_DebtInstrumentMaturityTermsPercentOfDebtExtended": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Maturity Terms, Percent of Debt Extended",
        "label": "Debt Instrument, Maturity Terms, Percent of Debt Extended",
        "terseLabel": "Percent of debt extended"
       }
      }
     },
     "localname": "DebtInstrumentMaturityTermsPercentOfDebtExtended",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nvta_DebtInstrumentPrepaymentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment Fee, Percentage",
        "label": "Debt Instrument, Prepayment Fee, Percentage",
        "terseLabel": "Prepayment fee"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentFeePercentage",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nvta_DebtInstrumentRedemptionPeriodThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redemption Period, Threshold Trading Days",
        "label": "Debt Instrument, Redemption Period, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThresholdTradingDays",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "nvta_DebtSecuritiesAvailableForSaleMaturityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Maturity Period",
        "label": "Debt Securities, Available-for-sale, Maturity Period",
        "terseLabel": "Maturities period of available-for-sale securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityPeriod",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nvta_DeferredTaxAssetsLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Lease, Liability",
        "label": "Deferred Tax Assets, Lease, Liability",
        "terseLabel": "Leasing Liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseLiability",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_DeferredTaxAssetsRevenueRecognitionReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets revenue recognition reserves.",
        "label": "Deferred Tax Assets Revenue Recognition Reserves",
        "terseLabel": "Revenue recognition differences"
       }
      }
     },
     "localname": "DeferredTaxAssetsRevenueRecognitionReserves",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_DeferredTaxAssetsTaxAccruedLiabilitiesAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accruals and not separately disclosed.",
        "label": "Deferred Tax Assets Tax Accrued Liabilities And Other",
        "terseLabel": "Accruals and other"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxAccruedLiabilitiesAndOther",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_DeferredTaxLiabilitiesLeaseRightofUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Lease, Right-of-Use Asset",
        "label": "Deferred Tax Liabilities, Lease, Right-of-Use Asset",
        "negatedTerseLabel": "Leasing Assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeaseRightofUseAsset",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_DiagnosticTestsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostic tests.",
        "label": "Diagnostic Tests [Member]",
        "terseLabel": "Test revenue"
       }
      }
     },
     "localname": "DiagnosticTestsMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_DiploidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diploid [Member]",
        "label": "Diploid [Member]",
        "terseLabel": "Diploid"
       }
      }
     },
     "localname": "DiploidMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_EarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings per share.",
        "label": "Earnings Per Share [Line Items]",
        "terseLabel": "Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareLineItems",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nvta_EarningsPerShareTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings per share.",
        "label": "Earnings Per Share [Table]",
        "terseLabel": "Earnings Per Share [Table]"
       }
      }
     },
     "localname": "EarningsPerShareTable",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nvta_EmployeeStockPurchasePlan2015Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to the 2015 employee stock purchase plan.",
        "label": "Employee Stock Purchase Plan2015 [Member]",
        "terseLabel": "2015 Employee Stock Purchase Plan",
        "verboseLabel": "Shares of common stock pursuant to ESPP"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlan2015Member",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_ExpirationTaxYearUnknownMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration, Tax Year Unknown [Member]",
        "label": "Expiration, Tax Year Unknown [Member]",
        "terseLabel": "No expiration date"
       }
      }
     },
     "localname": "ExpirationTaxYearUnknownMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value assets and liabilities level1 level2 and level3 transfers\u2019 amount.",
        "label": "Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount",
        "terseLabel": "Transfers of assets and liabilities between Level 1, Level 2 and Level 3"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_FinanceLeasePrincipalPaymentsandOtherAncillaryPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Principal Payments and Other Ancillary Payments",
        "label": "Finance Lease, Principal Payments and Other Ancillary Payments",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPaymentsandOtherAncillaryPayments",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_GenelexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genelex [Member]",
        "label": "Genelex [Member]",
        "terseLabel": "Genelex"
       }
      }
     },
     "localname": "GenelexMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_GenelexandYouScriptMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genelex and YouScript [Member]",
        "label": "Genelex and YouScript [Member]",
        "terseLabel": "Genelex and YouScript"
       }
      }
     },
     "localname": "GenelexandYouScriptMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Immaterial Error Related to Classification of Indemnification from Acquisition [Member]",
        "label": "Immaterial Error Related to Classification of Indemnification from Acquisition [Member]",
        "terseLabel": "Reclassification of stock payable liabilities"
       }
      }
     },
     "localname": "ImmaterialErrorRelatedtoClassificationofIndemnificationfromAcquisitionMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_IncomeTaxExaminationNumberOfPeriodUnderExamination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax examination number of period under examination.",
        "label": "Income Tax Examination Number Of Period Under Examination",
        "terseLabel": "Number of tax years open for examination"
       }
      }
     },
     "localname": "IncomeTaxExaminationNumberOfPeriodUnderExamination",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nvta_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods and also includes other current operating assets not separately disclosed in the statement of cash flows.",
        "label": "Increase Decrease In Prepaid Expense And Other Current Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_IndemnificationObligationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indemnification Obligations [Member]",
        "label": "Indemnification Obligations [Member]",
        "terseLabel": "Indemnification obligations"
       }
      }
     },
     "localname": "IndemnificationObligationsMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails",
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsJunglaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_JunglaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Jungla [Member]",
        "label": "Jungla [Member]",
        "terseLabel": "Jungla"
       }
      }
     },
     "localname": "JunglaMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsJunglaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_LeasesCashPaymentsIncludedInMeasurementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases, Cash Payments Included in Measurement",
        "label": "Leases, Cash Payments Included in Measurement [Abstract]",
        "terseLabel": "Cash payments included in the measurement of lease liabilities (in millions):"
       }
      }
     },
     "localname": "LeasesCashPaymentsIncludedInMeasurementAbstract",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nvta_LeasesExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases, Expense",
        "label": "Leases, Expense",
        "totalLabel": "Total lease costs"
       }
      }
     },
     "localname": "LeasesExpense",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_LeasesWeightedAverageDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases, Weighted-Average Discount Rate",
        "label": "Leases, Weighted-Average Discount Rate [Abstract]",
        "terseLabel": "Weighted-average discount rate:"
       }
      }
     },
     "localname": "LeasesWeightedAverageDiscountRateAbstract",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nvta_LeasesWeightedAverageRemainingLeaseTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases, Weighted-Average Remaining Lease Term",
        "label": "Leases, Weighted-Average Remaining Lease Term [Abstract]",
        "terseLabel": "Weighted-average remaining lease term:"
       }
      }
     },
     "localname": "LeasesWeightedAverageRemainingLeaseTermAbstract",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nvta_LoanAndSecurityAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to loan and security agreement.",
        "label": "Loan And Security Agreement [Member]",
        "terseLabel": "Loan and Security Agreement"
       }
      }
     },
     "localname": "LoanAndSecurityAgreementMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_MilestoneAchievementAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Achievement Agreement [Member]",
        "label": "Milestone Achievement Agreement [Member]",
        "terseLabel": "Milestone achievement agreement"
       }
      }
     },
     "localname": "MilestoneAchievementAgreementMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_NetProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net proceeds from issuance of common stock.",
        "label": "Net Proceeds From Issuance Of Common Stock",
        "terseLabel": "Net proceeds from issuance of common stock"
       }
      }
     },
     "localname": "NetProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_NetProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net proceeds from issuance of private placement.",
        "label": "Net Proceeds From Issuance Of Private Placement",
        "terseLabel": "Net proceeds from private placement"
       }
      }
     },
     "localname": "NetProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_NewLeasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to new lease arrangements.",
        "label": "New Leases [Member]",
        "terseLabel": "New Leases"
       }
      }
     },
     "localname": "NewLeasesMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_NotePurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note purchase agreement.",
        "label": "Note Purchase Agreement [Member]",
        "terseLabel": "Note Purchase Agreement"
       }
      }
     },
     "localname": "NotePurchaseAgreementMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_OfficeFacilityInSanFranciscoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to office facility in San Francisco.",
        "label": "Office Facility In San Francisco [Member]",
        "terseLabel": "Office Facility In San Francisco"
       }
      }
     },
     "localname": "OfficeFacilityInSanFranciscoMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_OfficeFacilityInSanFranciscoTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office Facility In San Francisco, Two",
        "label": "Office Facility In San Francisco, Two [Member]",
        "terseLabel": "Additional office facility in San Francisco"
       }
      }
     },
     "localname": "OfficeFacilityInSanFranciscoTwoMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_OneCodexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OneCodex",
        "label": "OneCodex [Member]",
        "terseLabel": "OneCodex"
       }
      }
     },
     "localname": "OneCodexMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_OtherBusinessToBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Business-to-Business",
        "label": "Other Business-to-Business [Member]",
        "terseLabel": "Other business-to-business"
       }
      }
     },
     "localname": "OtherBusinessToBusinessMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_PartnerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Partner",
        "label": "Partner [Member]",
        "terseLabel": "Biopharma partner"
       }
      }
     },
     "localname": "PartnerMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_PatentLicensingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent licensing agreement.",
        "label": "Patent Licensing Agreement [Member]",
        "terseLabel": "Patent licensing agreement"
       }
      }
     },
     "localname": "PatentLicensingAgreementMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_PatientDirectMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient direct.",
        "label": "Patient Direct [Member]",
        "terseLabel": "Patient Direct"
       }
      }
     },
     "localname": "PatientDirectMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_PatientInsuranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient insurance.",
        "label": "Patient Insurance [Member]",
        "terseLabel": "Patient Insurance"
       }
      }
     },
     "localname": "PatientInsuranceMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_PercentageOfCommissionPayableOnGrossProceeds": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of commission payable on gross proceeds.",
        "label": "Percentage Of Commission Payable On Gross Proceeds",
        "terseLabel": "Percentage of commission payable on gross proceeds"
       }
      }
     },
     "localname": "PercentageOfCommissionPayableOnGrossProceeds",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nvta_PerformanceRestrictedStockUnitsRsusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, when specified performance conditions are met.",
        "label": "Performance Restricted Stock Units Rsus [Member]",
        "terseLabel": "Shares of common stock subject to outstanding PRSUs"
       }
      }
     },
     "localname": "PerformanceRestrictedStockUnitsRsusMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_PreferredStockToCommonStockConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock to common stock conversion ratio.",
        "label": "Preferred Stock To Common Stock Conversion Ratio",
        "terseLabel": "Conversion basis"
       }
      }
     },
     "localname": "PreferredStockToCommonStockConversionRatio",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nvta_ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of public offerings of common stock net of issuance costs.",
        "label": "Proceeds From Issuance Of Public Offerings Of Common Stock Net Of Issuance Costs",
        "terseLabel": "Proceeds from public offerings of common stock, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of underwritten public offering of common stock net of issuance costs.",
        "label": "Proceeds From Issuance Of Underwritten Public Offering Of Common Stock Net Of Issuance Costs",
        "terseLabel": "Net proceeds from issuance of underwritten public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfUnderwrittenPublicOfferingOfCommonStockNetOfIssuanceCosts",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_RSUsAndPRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RSUs and PRSUs",
        "label": "RSUs and PRSUs [Member]",
        "terseLabel": "RSUs and PRSUs"
       }
      }
     },
     "localname": "RSUsAndPRSUsMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_RepaymentsofLinesofCreditAccruedInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments of Lines of Credit, Accrued Interest",
        "label": "Repayments of Lines of Credit, Accrued Interest",
        "terseLabel": "Repayment of accrued interest"
       }
      }
     },
     "localname": "RepaymentsofLinesofCreditAccruedInterest",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_RepaymentsofLinesofCreditPrincipal": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments of Lines of Credit, Principal",
        "label": "Repayments of Lines of Credit, Principal",
        "terseLabel": "Repayment of principal"
       }
      }
     },
     "localname": "RepaymentsofLinesofCreditPrincipal",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_ResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to research and development expenses included in the income statement.",
        "label": "Research And Development [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_RestOfWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to rest of the world.",
        "label": "Rest Of World [Member]",
        "terseLabel": "Rest of world"
       }
      }
     },
     "localname": "RestOfWorldMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/GeographicinformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_RestrictedStockUnitsPeriodofTimeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units, Period of Time [Member]",
        "label": "Restricted Stock Units, Period of Time [Member]",
        "terseLabel": "Time-based RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsPeriodofTimeMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_RestructuringandRelatedCostNumberofPositionsEliminatedPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Cost, Number of Positions Eliminated, Percent",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated, Percent",
        "terseLabel": "Positions eliminated, percent of total workforce"
       }
      }
     },
     "localname": "RestructuringandRelatedCostNumberofPositionsEliminatedPercent",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nvta_RestructuringandRelatedCostReductioninOfficerSalaryPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Cost, Reduction in Officer Salary, Percent",
        "label": "Restructuring and Related Cost, Reduction in Officer Salary, Percent",
        "terseLabel": "Reduction in officer salary"
       }
      }
     },
     "localname": "RestructuringandRelatedCostReductioninOfficerSalaryPercent",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nvta_SeniorSecuredTermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Term Loan Facility [Member]",
        "label": "Senior Secured Term Loan Facility [Member]",
        "terseLabel": "2020 Term Loan"
       }
      }
     },
     "localname": "SeniorSecuredTermLoanFacilityMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_SeriesAConvertiblePreferredStockConvertedtoCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A Convertible Preferred Stock Converted to Common Stock [Member]",
        "label": "Series A Convertible Preferred Stock Converted to Common Stock [Member]",
        "terseLabel": "Series A convertible preferred stock converted to common stock"
       }
      }
     },
     "localname": "SeriesAConvertiblePreferredStockConvertedtoCommonStockMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_SeriesAConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A convertible preferred stock.",
        "label": "Series A Convertible Preferred Stock [Member]",
        "terseLabel": "Shares of common stock underlying Series A convertible preferred stock"
       }
      }
     },
     "localname": "SeriesAConvertiblePreferredStockMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_SeriesFWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series F warrants.",
        "label": "Series F Warrants [Member]",
        "terseLabel": "Series F Warrants"
       }
      }
     },
     "localname": "SeriesFWarrantsMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_ServiceAgreementsAndLaboratorySuppliesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service agreements and laboratory supplies.",
        "label": "Service Agreements And Laboratory Supplies [Member]",
        "terseLabel": "Service agreements and laboratory supplies"
       }
      }
     },
     "localname": "ServiceAgreementsAndLaboratorySuppliesMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted, Threshold Trading Days",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedThresholdTradingDays",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the monthly percentage of vesting of share-based compensation awards.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Vesting Rights Equal Monthly Vesting Percentage",
        "terseLabel": "Monthly vesting percentage"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsEqualMonthlyVestingPercentage",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nvta_ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of voting rights of all classes of stock held by the employees.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Voting Rights Of Common Stock Holding Percentage",
        "terseLabel": "Employees holding voting rights of all classes of stock (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVotingRightsOfCommonStockHoldingPercentage",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nvta_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants and Adjustments in Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants and Adjustments in Period",
        "terseLabel": "Granted and adjustments (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantsandAdjustmentsinPeriod",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nvta_SingularBioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Singular Bio [Member]",
        "label": "Singular Bio [Member]",
        "terseLabel": "Singular Bio"
       }
      }
     },
     "localname": "SingularBioMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_StockIncentivePlan2010Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to the 2010 stock incentive plan, which provides for the granting of stock based awards to employees, directors, and consultants under terms and provisions established by the board of directors.",
        "label": "Stock Incentive Plan2010 [Member]",
        "terseLabel": "2010 Plan"
       }
      }
     },
     "localname": "StockIncentivePlan2010Member",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_StockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the stock incentive plans of the entity, which includes the 2010 plan, the 2015 plan, employee stock purchase plan.",
        "label": "Stock Incentive Plan [Member]",
        "terseLabel": "Stock incentive plans"
       }
      }
     },
     "localname": "StockIncentivePlanMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares in connection with private placement, net of offering costs.",
        "label": "Stock Issued During Period, Shares, Connection With Private Placement, Net Of Offering Costs",
        "terseLabel": "Common stock issued in private placement (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConnectionWithPrivatePlacementNetOfOfferingCosts",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nvta_StockIssuedDuringPeriodSharesWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares warrants exercised.",
        "label": "Stock Issued During Period Shares Warrants Exercised",
        "terseLabel": "Common stock issued pursuant to exercises of warrants (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesWarrantsExercised",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nvta_StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value in connection with private placement, net of offering costs.",
        "label": "Stock Issued During Period Value In Connection With Private Placement Net Of Offering Costs",
        "terseLabel": "Common stock issued in private placement, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueInConnectionWithPrivatePlacementNetOfOfferingCosts",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_StockIssuedDuringPeriodValueWarrantsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value warrants exercised.",
        "label": "Stock Issued During Period Value Warrants Exercised",
        "terseLabel": "Common stock issued pursuant to exercises of warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueWarrantsExercised",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvta_SubjectToExpirationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration, Tax Year 2019 [Member]",
        "label": "Subject To Expiration [Member]",
        "terseLabel": "Begins to expire 2030"
       }
      }
     },
     "localname": "SubjectToExpirationMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nvta_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nvta_TestRevenueCentralizedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Test Revenue, Centralized",
        "label": "Test Revenue, Centralized [Member]",
        "terseLabel": "Centralized"
       }
      }
     },
     "localname": "TestRevenueCentralizedMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_TestRevenueDecentralizedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Test Revenue, Decentralized",
        "label": "Test Revenue, Decentralized [Member]",
        "terseLabel": "Decentralized"
       }
      }
     },
     "localname": "TestRevenueDecentralizedMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_TimebasedRSUsandPRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time-based RSUs and PRSUs [Member]",
        "label": "Time-based RSUs and PRSUs [Member]",
        "terseLabel": "Time-based RSUs and PRSUs"
       }
      }
     },
     "localname": "TimebasedRSUsandPRSUsMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_TrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche one.",
        "label": "Tranche One [Member]",
        "terseLabel": "Initial sale of notes"
       }
      }
     },
     "localname": "TrancheOneMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_UnderwrittenPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwritten public offering.",
        "label": "Underwritten Public Offering [Member]",
        "terseLabel": "Underwritten public offering"
       }
      }
     },
     "localname": "UnderwrittenPublicOfferingMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nvta_YouScriptMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "YouScript [Member]",
        "label": "YouScript [Member]",
        "terseLabel": "YouScript"
       }
      }
     },
     "localname": "YouScriptMember",
     "nsuri": "http://www.invitae.com/20201231",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r132",
      "r139",
      "r225",
      "r399",
      "r400",
      "r401",
      "r442",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative effect of accounting change"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r132",
      "r139",
      "r225",
      "r399",
      "r400",
      "r401",
      "r442",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r132",
      "r139",
      "r225",
      "r399",
      "r400",
      "r401",
      "r442",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r208",
      "r339",
      "r345",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r362",
      "r364",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r580",
      "r632",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r362",
      "r364",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r580",
      "r632",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r208",
      "r339",
      "r345",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r204",
      "r339",
      "r343",
      "r581",
      "r631",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r204",
      "r339",
      "r343",
      "r581",
      "r631",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r351",
      "r362",
      "r364",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r580",
      "r632",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r351",
      "r362",
      "r364",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r580",
      "r632",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r137",
      "r138",
      "r139",
      "r141",
      "r142",
      "r144",
      "r145",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Adjustment [Member]",
        "terseLabel": "Revision of prior period, adjustment"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r137",
      "r138",
      "r139",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r157",
      "r226",
      "r227",
      "r402",
      "r443",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r137",
      "r138",
      "r139",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r157",
      "r226",
      "r227",
      "r402",
      "r443",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r205",
      "r206",
      "r339",
      "r344",
      "r634",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GeographicinformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r205",
      "r206",
      "r339",
      "r344",
      "r634",
      "r648",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GeographicinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.",
        "label": "Accounts Payable and Accrued Liabilities [Member]",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r22",
      "r210",
      "r211"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails",
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Stock payable liability"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r40",
      "r272"
     ],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r25",
      "r63",
      "r64",
      "r65",
      "r622",
      "r642",
      "r646"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r62",
      "r65",
      "r66",
      "r128",
      "r129",
      "r131",
      "r490",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss):"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r23",
      "r402"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r128",
      "r129",
      "r131",
      "r399",
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital:"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of change in accounting principle. Excludes change from amendment to accounting standards.",
        "label": "Change in Accounting Principle, Type [Axis]",
        "terseLabel": "Adjustments for Change in Accounting Principle [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForChangeInAccountingPrincipleAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsForErrorCorrectionDomain": {
     "auth_ref": [
      "r130",
      "r137",
      "r138",
      "r141",
      "r142",
      "r144",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of error correction.",
        "label": "Error Correction, Type [Domain]",
        "terseLabel": "Error Correction, Type [Domain]"
       }
      }
     },
     "localname": "AdjustmentsForErrorCorrectionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Equity component of convertible senior notes, net"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r365",
      "r367",
      "r405",
      "r406"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts": {
     "auth_ref": [
      "r294"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from issuance costs from a share-lending arrangement entered into, in contemplation of a convertible debt offering or other financing.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs",
        "terseLabel": "Warrants issued pursuant to loan agreement"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r409"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising expense"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r367",
      "r396",
      "r404"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r105",
      "r524"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r105",
      "r251",
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Arrangements and Non-arrangement Transactions"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r105",
      "r269"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment losses"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r119",
      "r190",
      "r194",
      "r200",
      "r224",
      "r487",
      "r491",
      "r509",
      "r599",
      "r619"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r58",
      "r119",
      "r224",
      "r487",
      "r491",
      "r509"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total financial assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AutomobilesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vehicles that are used primarily for transporting people.",
        "label": "Automobiles [Member]",
        "terseLabel": "Automobiles"
       }
      }
     },
     "localname": "AutomobilesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss": {
     "auth_ref": [
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss",
        "terseLabel": "Total fair value of investments with unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesGrossUnrealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r217",
      "r220",
      "r233",
      "r604"
     ],
     "calculation": {
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails": {
       "order": 2.0,
       "parentTag": "nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r219",
      "r233"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r368",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails",
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r494",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r361",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails",
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsJunglaDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails",
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r361",
      "r363",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails",
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsJunglaDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails",
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Common stock transferred"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsJunglaDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Business acquisition common stock issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails",
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsJunglaDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails",
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsJunglaDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of interest acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails",
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsJunglaDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r461",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Schedule of pro forma financial information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r461",
      "r462"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "negatedTerseLabel": "Net loss"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsScheduleofproformafinancialinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r461",
      "r462"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsScheduleofproformafinancialinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r475",
      "r476",
      "r478"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business combination, total purchase consideration",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails",
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsJunglaDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Consideration Transferred [Abstract]",
        "terseLabel": "Purchase Price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r475",
      "r476"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Common stock transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r473",
      "r475",
      "r476",
      "r480"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Contingent consideration",
        "verboseLabel": "Liabilities incurred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r104",
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Increase in amount of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r474",
      "r477",
      "r482"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsJunglaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/Businesscombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total identifiable assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "negatedTerseLabel": "Current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedTerseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "negatedTerseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Intangible assets, indefinite-lived"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      },
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r465",
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets, finite-lived"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r465",
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r465",
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Net identifiable assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r465",
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total purchase price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Separately Recognized Transactions [Abstract]",
        "terseLabel": "Post-combination Expense"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Axis]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Axis]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of transaction that is recognized separately from the acquisition of assets and assumptions of liabilities in a business combination by transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Domain]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Domain]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized": {
     "auth_ref": [
      "r460"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expenses and losses recorded for each transaction with the acquiree that was recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.",
        "label": "Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized",
        "terseLabel": "Post-combination expense",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.",
        "label": "Business Combination, Separately Recognized Transactions [Table Text Block]",
        "terseLabel": "Summary of purchase price and post-combination expense"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r115",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business combinations and License agreements"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r110",
      "r111",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchases of property and equipment in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeaseObligationsIncurred": {
     "auth_ref": [
      "r110",
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in lease obligation from new lease.",
        "label": "Lease Obligation Incurred",
        "terseLabel": "Equipment acquired through finance leases"
       }
      }
     },
     "localname": "CapitalLeaseObligationsIncurred",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeasesIncomeStatementInterestExpense": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails": {
       "order": 3.0,
       "parentTag": "nvta_LeasesExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The financing charge for leasing arrangements meeting the criteria for capitalization.",
        "label": "Capital Leases, Income Statement, Interest Expense",
        "terseLabel": "Finance lease costs"
       }
      }
     },
     "localname": "CapitalLeasesIncomeStatementInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r37",
      "r107"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r11",
      "r108",
      "r115",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r101",
      "r107",
      "r113"
     ],
     "calculation": {
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r101",
      "r513"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails": {
       "order": 1.0,
       "parentTag": "nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental cash flow information of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInAccountingEstimateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Change in Accounting Estimate [Line Items]",
        "terseLabel": "Change in Accounting Estimate [Line Items]"
       }
      }
     },
     "localname": "ChangeInAccountingEstimateLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleMember": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in accounting principle. Excludes change from amendment to accounting standards.",
        "label": "Change in Accounting Principle, Type [Domain]",
        "terseLabel": "Adjustments for Change in Accounting Principle [Domain]"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r117",
      "r119",
      "r147",
      "r148",
      "r149",
      "r151",
      "r153",
      "r164",
      "r165",
      "r166",
      "r224",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price (in dollars per share)",
        "verboseLabel": "Exercise price per share (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails",
      "http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class of Warrant or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Warrants issued (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Common stock underlying warrants (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r316",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r51",
      "r289",
      "r605",
      "r626"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 8)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r283",
      "r285",
      "r288",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/Commitmentsandcontingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r128",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock:",
        "verboseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails",
      "http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r21",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value: 400,000 shares authorized; 185,886 and 98,796 shares issued and outstanding as of December\u00a031, 2020 and 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r114",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r68",
      "r70",
      "r71",
      "r77",
      "r608",
      "r628"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r173",
      "r174",
      "r208",
      "r507",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r173",
      "r174",
      "r208",
      "r507",
      "r508",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r173",
      "r174",
      "r208",
      "r507",
      "r508",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r169",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of credit risk and other risks and uncertainties"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r173",
      "r174",
      "r208",
      "r507",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r173",
      "r174",
      "r208",
      "r507",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r115",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction-in-progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails",
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsJunglaDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails",
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsJunglaDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r318",
      "r320",
      "r340"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Unbilled revenue"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r318",
      "r319",
      "r340"
     ],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination": {
     "auth_ref": [
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination.",
        "label": "Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination",
        "terseLabel": "Increase in deferred revenue upon acquisition"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r318",
      "r319",
      "r340"
     ],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue, non-current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Deferred revenue, revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockByUniqueDescriptionAxis": {
     "auth_ref": [
      "r110",
      "r111",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by description of stock conversions.",
        "label": "Stock Conversion Description [Axis]",
        "terseLabel": "Stock Conversion Description [Axis]"
       }
      }
     },
     "localname": "ConversionOfStockByUniqueDescriptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConversionOfStockNameDomain": {
     "auth_ref": [
      "r110",
      "r111",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The unique name of a noncash or part noncash stock conversion.",
        "label": "Conversion of Stock, Name [Domain]",
        "terseLabel": "Conversion of Stock, Name [Domain]"
       }
      }
     },
     "localname": "ConversionOfStockNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r110",
      "r111",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Common stock issued upon conversion of preferred stock (in shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.",
        "label": "Convertible Debt Securities [Member]",
        "terseLabel": "Shares of common stock subject to Convertible Senior Notes conversion"
       }
      }
     },
     "localname": "ConvertibleDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r19",
      "r20",
      "r308",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Shares issued upon conversion"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r80",
      "r119",
      "r224",
      "r509"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
      "http://www.invitae.com/role/SelectedquarterlydataunauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r125",
      "r438"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r438",
      "r446",
      "r448"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current benefit for income taxes"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r172",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer concentration risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r110",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Warrants issued pursuant to debt agreement"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r600",
      "r602",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r16",
      "r296",
      "r602",
      "r618"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Outstanding principal"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r48",
      "r308",
      "r311",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Conversion ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Number of consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Threshold percentage of stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Number of threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r523",
      "r525"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Prior to third anniversary of closing date"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "After the third anniversary of closing date"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r49",
      "r122",
      "r308",
      "r312",
      "r313",
      "r314",
      "r522",
      "r523",
      "r525",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Maturity term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r297",
      "r524"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedLabel": "Unamortized debt discount and issuance costs",
        "terseLabel": "Debt discounts and issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r439",
      "r446"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r439",
      "r446"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r105",
      "r121",
      "r439",
      "r446",
      "r447",
      "r448"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred benefit for income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r17",
      "r18",
      "r428",
      "r601",
      "r617"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r414",
      "r415"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r439",
      "r446"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r429"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r431"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetOfValuationAllowanceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r436",
      "r437"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r434",
      "r436",
      "r437"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r430"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r415",
      "r431"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesFinancingArrangements": {
     "auth_ref": [
      "r436",
      "r437"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from financing arrangements.",
        "label": "Deferred Tax Liabilities, Financing Arrangements",
        "negatedTerseLabel": "Convertible Senior Notes"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesFinancingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r436",
      "r437"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Amortization and depreciation"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofnetdeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets": {
     "auth_ref": [
      "r484"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the valuation allowance recorded in a business combination against deductible temporary differences for which related tax benefits will be recorded as a reduction of the acquired entity's other noncurrent intangible assets if those tax benefits subsequently become realizable.",
        "label": "Deferred Taxes, Business Combination, Valuation Allowance, Available to Reduce Intangible Assets",
        "terseLabel": "Valuation allowance available to reduce intangible assets"
       }
      }
     },
     "localname": "DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r105",
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r105",
      "r187"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Right to develop new technology",
        "verboseLabel": "Right to develop new technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r339",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of disaggregated revenue by payer category"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock incentive plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/Stockincentiveplans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Net loss per share, basic and diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/NetlosspershareScheduleofearningspersharebasicanddilutedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r115",
      "r154",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net loss per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net loss per share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/Netlosspershare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r417"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Reconciliation of the tax expense computed at the statutory federal rate and Company's tax expense"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r417",
      "r450"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. federal taxes at statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r417",
      "r450"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r417",
      "r450"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "terseLabel": "Non-deductible expenses"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r417",
      "r450"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r417",
      "r450"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State taxes (net of federal benefit)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r417",
      "r450"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedLabel": "Research and development credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofthetaxexpensecomputedatthestatutoryfederalrateandCompanystaxexpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails",
      "http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Expected period to recognize on a straight-line basis"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized stock-based compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Shares of common stock subject to outstanding options",
        "verboseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Laboratory equipment",
        "verboseLabel": "Manufacturing and Laboratory equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r128",
      "r129",
      "r131",
      "r134",
      "r142",
      "r145",
      "r163",
      "r225",
      "r307",
      "r315",
      "r399",
      "r400",
      "r401",
      "r442",
      "r443",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r637",
      "r638",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails",
      "http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": {
     "auth_ref": [
      "r130",
      "r137",
      "r138",
      "r141",
      "r142",
      "r144",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of error correction.",
        "label": "Error Correction, Type [Axis]",
        "terseLabel": "Error Correction, Type [Axis]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r496",
      "r497",
      "r498",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r497",
      "r553",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value, Hierarchy"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails",
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r496",
      "r497",
      "r499",
      "r500",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair value measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/Fairvaluemeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r352",
      "r353",
      "r358",
      "r360",
      "r497",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r352",
      "r353",
      "r358",
      "r360",
      "r497",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails",
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r497",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedTerseLabel": "Change in fair value, expense"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r553",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails",
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r502",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r115",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair value of financial instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueOptionQuantitativeDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Option, Quantitative Disclosures [Line Items]",
        "terseLabel": "Fair Value, Option, Quantitative Disclosures [Line Items]"
       }
      }
     },
     "localname": "FairValueOptionQuantitativeDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOptionQuantitativeDisclosuresTable": {
     "auth_ref": [
      "r510",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value under fair value option.",
        "label": "Fair Value Option, Disclosures [Table]",
        "terseLabel": "Fair Value Option, Disclosures [Table]"
       }
      }
     },
     "localname": "FairValueOptionQuantitativeDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r530",
      "r534",
      "r543"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Finance lease costs"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r529",
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r529"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      },
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "negatedNetLabel": "Less: current portion",
        "verboseLabel": "Finance lease obligation"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails",
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Schedule of future lease payments under finance leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r529"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      },
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "netLabel": "Lease obligations, net of current portion",
        "verboseLabel": "Finance lease obligation, net of current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails",
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Future non-cancelable minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r540",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r539",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r222",
      "r223",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r234",
      "r235",
      "r236",
      "r237",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.",
        "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Summary of intangible assets acquired"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated useful life, intangible assets",
        "verboseLabel": "Weighted-Average Useful Life (in Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r260"
     ],
     "calculation": {
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r262"
     ],
     "calculation": {
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r262"
     ],
     "calculation": {
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r262"
     ],
     "calculation": {
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r262"
     ],
     "calculation": {
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r262"
     ],
     "calculation": {
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r252",
      "r256",
      "r260",
      "r264",
      "r582",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r260",
      "r583"
     ],
     "calculation": {
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Cost, finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r252",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r260",
      "r582"
     ],
     "calculation": {
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      },
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net, finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofestimatedfutureamortizationexpenseofintangibleassetswithfinitelivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted-Average Estimated Remaining Useful Life (in Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "terseLabel": "Intangible assets acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r105",
      "r301",
      "r302"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Debt extinguishment costs"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r242",
      "r244",
      "r598"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails",
      "http://www.invitae.com/role/ConsolidatedBalanceSheets",
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r245"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and intangible assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/Goodwillandintangibleassets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r115",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r115",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible assets and in-process research and development"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r105",
      "r243",
      "r246",
      "r248"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r105",
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Long-lived asset impairment losses"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r115",
      "r267",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-process research and development",
        "verboseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r124",
      "r449"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "negatedLabel": "United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r75",
      "r190",
      "r193",
      "r196",
      "r199",
      "r202",
      "r596",
      "r606",
      "r610",
      "r629"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "negatedTotalLabel": "Total",
        "totalLabel": "Net loss before taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r124",
      "r449"
     ],
     "calculation": {
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "negatedLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoflossbeforeincometaxesbyUSandforeignjurisdictionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.",
        "label": "Income (Loss) from Continuing Operations, Per Basic and Diluted Share",
        "terseLabel": "Net loss per share, basic and diluted (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicAndDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails",
      "http://www.invitae.com/role/SelectedquarterlydataunauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r421",
      "r425",
      "r427",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r418",
      "r426",
      "r433",
      "r444",
      "r451",
      "r454",
      "r455",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/Incometaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r144",
      "r145",
      "r189",
      "r416",
      "r445",
      "r452",
      "r630"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax benefit",
        "terseLabel": "Income tax benefit",
        "totalLabel": "Total income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
      "http://www.invitae.com/role/IncometaxesScheduleofcomponentsoftheprovisionforincometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r72",
      "r115",
      "r412",
      "r413",
      "r426",
      "r427",
      "r432",
      "r440",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Accrued expenses and other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of businesses acquired:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Deficit"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r255",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r263"
     ],
     "calculation": {
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      },
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r255",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Cost"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r250",
      "r258"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets",
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r73",
      "r186",
      "r521",
      "r524",
      "r609"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r83",
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r100",
      "r102",
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r29",
      "r240"
     ],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r55"
     ],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails",
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r10",
      "r56",
      "r115",
      "r160",
      "r238",
      "r239",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r31",
      "r240"
     ],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r30",
      "r240"
     ],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in progress"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsScheduleofinventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r82",
      "r185"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Investments, interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails": {
       "order": 1.0,
       "parentTag": "nvta_LeasesExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r541",
      "r543"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease costs"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Lease Cost"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of lease cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesOperatingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases, Operating [Abstract]",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "LeasesOperatingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Finance Lease, Description [Abstract]",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "LesseeFinanceLeaseDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseTermOfContract1": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Finance Lease, Term of Contract",
        "terseLabel": "Finance lease, term of contract"
       }
      }
     },
     "localname": "LesseeFinanceLeaseTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of future payments under operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Future non-cancelable minimum operating lease payments",
        "totalLabel": "Future non-cancelable minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating lease, renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r44",
      "r119",
      "r195",
      "r224",
      "r488",
      "r491",
      "r492",
      "r509"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r28",
      "r119",
      "r224",
      "r509",
      "r603",
      "r624"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r46",
      "r119",
      "r224",
      "r488",
      "r491",
      "r492",
      "r509"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Total financial liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r16",
      "r298",
      "r602",
      "r620"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Net carrying amount, liability component"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Long-term Purchase Commitment [Line Items]",
        "terseLabel": "Long-term Purchase Commitment [Line Items]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r49",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesComponentsofdebtDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesConvertibleseniornotesDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "verboseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r101",
      "r103",
      "r106"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r67",
      "r69",
      "r76",
      "r106",
      "r119",
      "r133",
      "r137",
      "r138",
      "r139",
      "r140",
      "r144",
      "r145",
      "r150",
      "r190",
      "r193",
      "r196",
      "r199",
      "r202",
      "r224",
      "r509",
      "r607",
      "r627"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.invitae.com/role/NetlosspershareScheduleofearningspersharebasicanddilutedDetails",
      "http://www.invitae.com/role/SelectedquarterlydataunauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent accounting pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1": {
     "auth_ref": [
      "r110",
      "r111",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of payables that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Payables Assumed",
        "terseLabel": "Consideration payable for acquisitions"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionPayablesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreement"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoteWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A note that entitles the holder to buy stock of the company at a specified price, which is much higher than the stock price at the time of issue.",
        "label": "Note Warrant [Member]",
        "terseLabel": "Warrant"
       }
      }
     },
     "localname": "NoteWarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of businesses acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/OrganizationanddescriptionofbusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/OrganizationanddescriptionofbusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OffsettingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offsetting [Abstract]"
       }
      }
     },
     "localname": "OffsettingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OneTimeTerminationBenefitsMember": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A lump sum payment to an involuntarily terminated employee in conjunction with exit or disposal activities.",
        "label": "One-time Termination Benefits [Member]",
        "terseLabel": "One-time termination costs"
       }
      }
     },
     "localname": "OneTimeTerminationBenefitsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r190",
      "r193",
      "r196",
      "r199",
      "r202"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Loss from operations",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails",
      "http://www.invitae.com/role/SelectedquarterlydataunauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r535",
      "r543"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r529"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r529"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "negatedLabel": "Less: current portion",
        "verboseLabel": "Operating lease obligation"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails",
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r529"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "netLabel": "Lease obligations, net of current portion",
        "verboseLabel": "Operating lease obligation, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesScheduleoffuturepaymentsunderoperatingandfinanceleasesDetails",
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r531",
      "r537"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r528"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r540",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r539",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseSubleaseRentals1": {
     "auth_ref": [
      "r526"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails": {
       "order": 2.0,
       "parentTag": "nvta_LeasesExpense",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of sublease rental income recognized during the period that reduces the entity's rent expense incurred under operating leases.",
        "label": "Operating Leases, Rent Expense, Sublease Rentals",
        "negatedTerseLabel": "Sublease income"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseSubleaseRentals1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r434"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r127",
      "r146",
      "r178",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Organization and description of business"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/Organizationanddescriptionofbusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r45"
     ],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsAccruedliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "auth_ref": [
      "r60",
      "r61",
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "terseLabel": "Unrealized income (loss) on available-for-sale marketable securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r60",
      "r61",
      "r63"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized income (loss) on available-for-sale marketable securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities",
        "totalLabel": "Total other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsOtherlongtermliabilitiesDetails",
      "http://www.invitae.com/role/ConsolidatedBalanceSheets",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebtNoncurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer.",
        "label": "Other Long-term Debt, Noncurrent",
        "verboseLabel": "Debt"
       }
      }
     },
     "localname": "OtherLongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Schedule of other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherTaxExpenseBenefit": {
     "auth_ref": [
      "r120",
      "r416",
      "r440"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other income tax expense (benefit).",
        "label": "Other Tax Expense (Benefit)",
        "terseLabel": "Benefit from income taxes"
       }
      }
     },
     "localname": "OtherTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r89",
      "r93",
      "r126"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedTerseLabel": "Payments of debt extinguishment costs",
        "terseLabel": "Debt extinguishment costs"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails",
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfLoanCosts": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan origination associated cost which is usually collected through escrow.",
        "label": "Payments of Loan Costs",
        "negatedLabel": "Loan payments"
       }
      }
     },
     "localname": "PaymentsOfLoanCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r87",
      "r90",
      "r218"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedTerseLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r91",
      "r479"
     ],
     "calculation": {
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash transferred"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails",
      "http://www.invitae.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisition of businesses, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "PRSUs",
        "verboseLabel": "PRSU"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r368",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.0001 par value: 20,000 shares authorized; 125 shares issued and outstanding as of December\u00a031, 2020 and 2019"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r35",
      "r36"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Prior period reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]",
        "terseLabel": "Private placement"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of convertible senior notes, net"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from issuance of debt, net"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock, net"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Proceeds from Issuance of Private Placement",
        "terseLabel": "Gross proceeds from private placement"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r87",
      "r88",
      "r218"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Notes Payable",
        "terseLabel": "Proceeds from notes sold"
       }
      }
     },
     "localname": "ProceedsFromNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r96",
      "r99",
      "r126"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r87",
      "r88",
      "r218"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "verboseLabel": "Proceeds from stock plans"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]",
        "terseLabel": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r40",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r39",
      "r271"
     ],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r12",
      "r13",
      "r273",
      "r625"
     ],
     "calculation": {
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails",
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r38",
      "r115",
      "r273",
      "r650",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r12",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsTables",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r12",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails",
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful lives",
        "verboseLabel": "Estimated useful life, property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]",
        "terseLabel": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "Selected quarterly data (unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/Selectedquarterlydataunaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r115",
      "r212",
      "r214",
      "r215",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligation": {
     "auth_ref": [
      "r287"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the recorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).",
        "label": "Recorded Unconditional Purchase Obligation",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertinent information about recorded unconditional purchase arrangements to acquire goods or services, by category of goods or services.",
        "label": "Recorded Unconditional Purchase Obligation by Category of Item Purchased [Axis]",
        "terseLabel": "Recorded Unconditional Purchase Obligation by Category of Item Purchased [Axis]"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear": {
     "auth_ref": [
      "r287"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RecordedUnconditionalPurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueAfterFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear": {
     "auth_ref": [
      "r287"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_RecordedUnconditionalPurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueInFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear": {
     "auth_ref": [
      "r287"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_RecordedUnconditionalPurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear": {
     "auth_ref": [
      "r287"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RecordedUnconditionalPurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear": {
     "auth_ref": [
      "r287"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RecordedUnconditionalPurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear": {
     "auth_ref": [
      "r287"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_RecordedUnconditionalPurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueWithinOneYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock": {
     "auth_ref": [
      "r287",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unconditional purchase obligation recognized as liability.",
        "label": "Recorded Unconditional Purchase Obligations [Table Text Block]",
        "terseLabel": "Schedule of future payments under noncancelable unconditional purchase commitments"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r359",
      "r544",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r359",
      "r544",
      "r546",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r97",
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "terseLabel": "Repayment of debt"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "terseLabel": "Repayment of term loan"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r410",
      "r661"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r11",
      "r107",
      "r113",
      "r597",
      "r621"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails": {
       "order": 3.0,
       "parentTag": "nvta_CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue",
       "weight": 1.0
      },
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets",
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofcashcashequivalentsandrestrictedcashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Shares of common stock subject to outstanding RSUs",
        "verboseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r105",
      "r277",
      "r280",
      "r282"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r24",
      "r315",
      "r402",
      "r623",
      "r641",
      "r646"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r128",
      "r129",
      "r131",
      "r134",
      "r142",
      "r145",
      "r225",
      "r399",
      "r400",
      "r401",
      "r442",
      "r443",
      "r637",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated deficit:"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r183",
      "r184",
      "r192",
      "r197",
      "r198",
      "r204",
      "r205",
      "r208",
      "r338",
      "r339",
      "r581"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
      "http://www.invitae.com/role/GeographicinformationDetails",
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails",
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofdisaggregatedrevenuebypayercategoryDetails",
      "http://www.invitae.com/role/SelectedquarterlydataunauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r116",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Deferred revenue, revenue recognition and cost of revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r342",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue, accounts receivable and deferred revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/Revenueaccountsreceivableanddeferredrevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Geographic information"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GeographicinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r538",
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating lease assets obtained in exchange for lease obligations, net"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares issued in transaction"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Shares issued price per share (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r173",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of accrued liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of antidilutive securities excluded from computation of earnings per share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/NetlosspershareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsClearGeneticsDetails",
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsGenelexandYouScriptDetails",
      "http://www.invitae.com/role/BusinesscombinationsJunglaDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryoffairvaluesofassetsacquiredandliabilitiesassumedDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
      "http://www.invitae.com/role/BusinesscombinationsSummaryofthepurchasepriceandpostcombinationexpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangeInAccountingEstimateTable": {
     "auth_ref": [
      "r140",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summarization of the nature of changes in accounting estimates, including changes that occur in interim periods. Changes in accounting estimate have the effect of adjusting the carrying amounts of existing assets or liabilities or altering the subsequent accounting for existing or future assets or liabilities. Changes in accounting estimates are a necessary consequence of assessments, in conjunction with the periodic presentation of financial statements, of the present status and expected future benefits and obligations associated with assets and liabilities. Changes in accounting estimates result from new or better information. Examples of items for which estimates are necessary are uncollectible receivables, inventory obsolescence, service lives and salvage values of depreciable assets, warranty obligations, and regulatory reviews.",
        "label": "Schedule of Change in Accounting Estimate [Table]",
        "terseLabel": "Schedule of Change in Accounting Estimate [Table]"
       }
      }
     },
     "localname": "ScheduleOfChangeInAccountingEstimateTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueScheduleofchangeinestimateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfChangeInAccountingEstimateTextBlock": {
     "auth_ref": [
      "r140",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in an accounting estimate, including a change that occurs in an interim period. If a change in accounting estimate affects several future periods (for example, a change in the service life of a depreciable asset) disclose the effect on income from continuing operations, net income (or other appropriate captions of changes in the applicable net assets or performance indicator), and any related per-share amounts of the current period. Disclosure of the effects of a change in an accounting estimate that occurs in the ordinary course of business (such as uncollectible accounts or inventory obsolescence) is not required, unless the effect is material.",
        "label": "Schedule of Change in Accounting Estimate [Table Text Block]",
        "terseLabel": "Schedule of change in estimate"
       }
      }
     },
     "localname": "ScheduleOfChangeInAccountingEstimateTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Summary of stock based compensation expense related to stock options included in consolidated statements of operations"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of components of the provision for income taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r49",
      "r122",
      "r308",
      "r312",
      "r313",
      "r314",
      "r522",
      "r523",
      "r525",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Components of debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of net deferred tax assets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of earnings per share, basic and diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/NetlosspershareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of the tax expense computed at the statutory federal rate and Company's tax expense"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r367",
      "r395",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails",
      "http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r496",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of financial instruments at fair value on a recurring basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r252",
      "r259",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r252",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r247",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsSummaryofgoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r247",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Summary of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of components of loss before income taxes by U.S. and foreign jurisdictions"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r263",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of intangible assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r10",
      "r32",
      "r33",
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]",
        "terseLabel": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofsignificantcustomersrevenueasapercentageDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r40",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information [Table Text Block]",
        "terseLabel": "Schedule of selected quarterly data"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SelectedquarterlydataunauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Summary of fair values of assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r11",
      "r113",
      "r597",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of restrictions on cash and cash equivalents"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r278",
      "r279",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
        "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]",
        "terseLabel": "Schedule significant customer, revenue as a percentage"
       }
      }
     },
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r79",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Schedule of revenue by geographic region"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GeographicinformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r74",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GeographicinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r380",
      "r385",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Schedule of activity under stock incentive plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r368",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails",
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of RSU activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of assumptions used in determination of fair value of options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r52",
      "r117",
      "r164",
      "r165",
      "r303",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r314",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTextBlock": {
     "auth_ref": [
      "r19",
      "r20",
      "r21",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r314",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information.  Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.",
        "label": "Schedule of Stock by Class [Table Text Block]",
        "terseLabel": "Schedule of convertible preferred and common stock"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r316",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Schedule of outstanding warrants to purchase common stock"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Summary of estimated future amortization expense of intangible assets with finite lives"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecurityDeposit": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.",
        "label": "Security Deposit",
        "terseLabel": "Security deposit"
       }
      }
     },
     "localname": "SecurityDeposit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r179",
      "r181",
      "r182",
      "r190",
      "r191",
      "r196",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r207",
      "r208",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Geographic information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/Geographicinformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentsGeographicalAreasAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments, Geographical Areas [Abstract]",
        "terseLabel": "Segments, Geographical Areas [Abstract]"
       }
      }
     },
     "localname": "SegmentsGeographicalAreasAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansStockbasedcompensationexpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.",
        "label": "Share-based Payment Arrangement, Accelerated Cost",
        "terseLabel": "Stock-based compensation expense, accelerated cost"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on purchase date that participants pay for shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date",
        "terseLabel": "Purchase price, percent of fair market value of common stock"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Cancelled (in shares)",
        "terseLabel": "Units cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails",
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Canceled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "negatedLabel": "Units granted (in shares)",
        "terseLabel": "RSUs granted (in shares)",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails",
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Balance at the end of the period (in shares)",
        "periodStartLabel": "Balance at the beginning of the period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Balance at the end of the period (in dollars per share)",
        "periodStartLabel": "Balance at the beginning of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)",
        "terseLabel": "Vested stock units awarded (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Stock incentive plan"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails",
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Additional shares reserved (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "periodEndLabel": "Shares available for grant, ending balance (in shares)",
        "periodStartLabel": "Shares available for grant, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Additional information"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable, weighted-average exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Exercised, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Option cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value (in dollars per share)",
        "verboseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r376",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Stock options outstanding, ending balance (in shares)",
        "periodStartLabel": "Stock options outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Activity under the plan"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at the end of the period (in dollars per share)",
        "periodStartLabel": "Balance at the beginning of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r388"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Number of options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r366",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails",
      "http://www.invitae.com/role/StockincentiveplansSummaryofRSUactivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Options cancelled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "First anniversary"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Three [Member]",
        "terseLabel": "Third anniversary"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Second anniversary"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting rate upon anniversaries"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding",
        "terseLabel": "Value of units granted"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsArcherDXDetails",
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Term of options granted"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r391",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofassumptionsusedindeterminationoffairvalueofoptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable, aggregate intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable, weighted-average remaining contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r373"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Total grant date fair value of options to purchase common stock vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options vested.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares",
        "terseLabel": "Number of options vested (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Exercise price of options on common stock (as a percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockincentiveplansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Shares issued price per share (in dollars per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Shares outstanding, end of period",
        "periodStartLabel": "Shares outstanding, beginning of period"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of significant accounting policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/Summaryofsignificantaccountingpolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BalancesheetcomponentsPropertyandequipmentDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesScheduleofusefullivesofpropertyandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r19",
      "r20",
      "r21",
      "r117",
      "r119",
      "r147",
      "r148",
      "r149",
      "r151",
      "r153",
      "r164",
      "r165",
      "r166",
      "r224",
      "r307",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r54",
      "r128",
      "r129",
      "r131",
      "r134",
      "r142",
      "r145",
      "r163",
      "r225",
      "r307",
      "r315",
      "r399",
      "r400",
      "r401",
      "r442",
      "r443",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r637",
      "r638",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails",
      "http://www.invitae.com/role/StockholdersequityScheduleofoutstandingwarrantstopurchasecommonstockDetails",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r128",
      "r129",
      "r131",
      "r163",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r110",
      "r111",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "terseLabel": "Common stock issued for acquisitions"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r20",
      "r21",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Common stock issued pursuant to acquisitions (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r20",
      "r21",
      "r307",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued pursuant to employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r20",
      "r21",
      "r307",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Common stock issued in connection with initial public offering, net of offering costs (in shares)",
        "verboseLabel": "Common stock issued during period (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r307",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "terseLabel": "Common stock issued pursuant to vesting of restricted stock units (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r20",
      "r21",
      "r307",
      "r315",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised (in shares)",
        "terseLabel": "Options exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityScheduleofconvertiblepreferredandcommonstockDetails",
      "http://www.invitae.com/role/StockincentiveplansScheduleofactivityunderstockincentiveplansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r54",
      "r307",
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Common stock issued or issuable pursuant to acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r20",
      "r21",
      "r307",
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Common stock issued pursuant to employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r20",
      "r21",
      "r307",
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Common stock issued in connection with public offering, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r54",
      "r307",
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Common stock issued on exercise of stock options, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r21",
      "r26",
      "r27",
      "r119",
      "r213",
      "r224",
      "r509"
     ],
     "calculation": {
      "http://www.invitae.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "negatedTerseLabel": "Decrease to additional paid-in-capital",
        "periodEndLabel": "Balance, end of period",
        "periodStartLabel": "Balance, beginning of period",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets",
      "http://www.invitae.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r118",
      "r315",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/Stockholdersequity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r536",
      "r543"
     ],
     "calculation": {
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedTerseLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesSupplementalinformationregardingouroperatingandfinanceleasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r520",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r520",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r520",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r520",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails",
      "http://www.invitae.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r547",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/Subsequentevent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails",
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r419",
      "r425",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of gross unrecognized tax benefits"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance sheet components"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/Balancesheetcomponents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r434"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense for remeasurement of deferred tax asset from change in tax rate pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Change in Tax Rate, Deferred Tax Asset, Income Tax Expense",
        "terseLabel": "Tax Cuts and Jobs Act, deferred tax asset, income tax expense"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Tradename"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsSummaryofintangibleassetsacquiredDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction [Domain]",
        "terseLabel": "Transaction [Domain]"
       }
      }
     },
     "localname": "TransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction Type [Axis]",
        "terseLabel": "Transaction Type [Axis]"
       }
      }
     },
     "localname": "TransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/StockholdersequityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r222",
      "r223",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Type of Arrangement and Non-arrangement Transactions"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesLeaseadditionalinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r352",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government agency securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r352",
      "r360",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. Treasury notes"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/FairvaluemeasurementsFinancialinstrumentsatfairvalueonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain": {
     "auth_ref": [
      "r283",
      "r284",
      "r286",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General description of the goods or services to be purchased from the counterparty to the unconditional purchase arrangement.",
        "label": "Unconditional Purchase Obligation, Category of Goods or Services Acquired [Domain]",
        "terseLabel": "Unconditional Purchase Obligation, Category of Goods or Services Acquired [Domain]"
       }
      }
     },
     "localname": "UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesOthercommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r411",
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits, end of period",
        "periodStartLabel": "Unrecognized tax benefits, beginning of period",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails",
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r423"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Gross decreases\u2014prior period tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Gross increases\u2014current period tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Gross increases\u2014prior period tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesScheduleofreconciliationofunrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnusualOrInfrequentItemNetGainLoss": {
     "auth_ref": [
      "r85",
      "r86",
      "r188",
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (gain) loss for an event or transaction that is unusual in nature or occurs infrequently, or both.",
        "label": "Unusual or Infrequent Item, or Both, Net (Gain) Loss",
        "negatedTerseLabel": "Income received under the CARES Act"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemNetGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/RevenueaccountsreceivableanddeferredrevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r167",
      "r168",
      "r170",
      "r171",
      "r175",
      "r176",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increase in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/IncometaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/CommitmentsandcontingenciesDebtfinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/BusinesscombinationsDiploidDetails",
      "http://www.invitae.com/role/BusinesscombinationsSingularBioDetails",
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Shares of common stock subject to outstanding warrants",
        "verboseLabel": "Warrant"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/GoodwillandintangibleassetsNarrativeDetails",
      "http://www.invitae.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Shares used in computing net loss per share, basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.invitae.com/role/ConsolidatedStatementsofOperations",
      "http://www.invitae.com/role/NetlosspershareScheduleofearningspersharebasicanddilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e777-108305"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2611-110228"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25383-109308"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=SL6757427-112606"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=51819886&loc=SL6014347-161799"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121554379&loc=d3e9901-128506"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14172-108612"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14210-108612"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14217-108612"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121569800&loc=d3e45031-112735"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8,17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62652-112803"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r662": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r663": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r664": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r665": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r666": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r667": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r668": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r669": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r670": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868879&loc=SL114871939-224231"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>120
<FILENAME>0001501134-21-000012-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001501134-21-000012-xbrl.zip
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MT?]3._# WCW6&YS]IXJO,!PS'-Y>+!H[IVNZ!4&%.JYT]%]K1< Y]853DIM
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MY]_M<IR1%_8AU4W*^BEO5JB'H$W(:OA3,!\'^['>IW<M83VCYM6V'!@\!GI
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M7;ONEM_D= W@Z5)7$D>S2DK/@/[I?#QWK\)1S[.$1HY?F-1VG[.)F:LK^(S
M3CQ3]"7?;%C.C3=]?7+J,ZID+=?;49/DEV%%&6)Q;J$CNA" "@)\$2.7IBOJ
M_/H;[BOZ[^]9#'KRYK6:-++08'%ZH2[W-LUG(-?N]DJAUD!(U3!89E&\H+O>
M)KB3;[I.B.<*SEE5DJ9*-4Y(YH4.+P7?[I3 ;G+6/#<7Z5M$5 ;OIK!\J1AH
MR#55Y^YS53!%O:=4(8ZD(4B>D4,=N!#&$+Q#A@=]=;A?L_+?YHW2R8WZ%E"(
M9!,_-,JS4@5''I>%HPR:JY9;"#5=$-,YJT+?+/RY1(Y^SG A+.'CG)'&1'\5
M4:TG_$M1IG4,H>'\TK4_#?&&=@<VF8I,WGK_3_M <;SVM(>&<H+T.<[\5(8'
M19.64G&J-<Y]5_E89 E00'[AX +K9:0XR[D($E".%7B+5,Y+F>X$C(LOUQ;1
MHH/7Z!6?64>:)45VVR"9BKPQ2L$<#)HO (X&GK?V43-I"WW'D &'B\?(O!06
M4"'D:G,V1\I +=[:I."MS(KX>C#+E;CKG+=[SS9G+2G*=IZ:_JN1%\/AOTM&
MKY-N\=K8^HLA;;<WZ\?"V_-\->@ R\RX0UU_6$U<U#E;].5/F,0E2",_'X><
M-:JI52ZOXJPJDAN->[94Q\W;@#&LQ&K%%*%MN$YV*,XP4V@I2U;GEN3Y,MF(
M?MZ7ESU$"HL*6F:K.&T^X^AM%2AN"6<<L0+*@<4E.K3RHHT0E3*A$.N.L5(4
MLY%S-MR*6'80)K7(U8V'L*(.*TYWGWI<<4O5^GQJ6R=].!'7C!_,#;]<T<:&
MRTX[M]0)?[)D7VI>);+13JCI^)19X'J9+T6A8/,R<L^&/;D&"J\R-4WXGA'X
M-E?0U 9P@RV:HX25-5!+R&OGAUX\YUFVJ \9IR94(R/!8@;6?_WE<M!?-G>#
M.9S@@[+2@\5J^)78D4'A-+_V!'SJXZ\I+NQRH;G)2"V!JQ 4%,E&8:9LIWI&
M,=?14LI'6 \+Z[(-[8TKP41DN(SH[$W*\/2)I0S_/2[0A!2IS*HA,?A;DK_O
MLN C/AB<9\&9!QW49;D''&I/EI$62V67LLAE0 >B-A(1+TE/HK5D<CKM\C+8
MA-E-<!7G964\0R+*5JYMQD!X#?YDMY@+L? 2(XEA.:^8UE#5^_#!#*3FZ0YA
MTDR<XN,^0M4"YTV*)^)[C VG$^H\1(_\@AHIVK*HF.97TN4[=6\L-*OC8AD7
M-4B1P_Y;%BUO]@="UQ09TUQ)T"22YFKF?>O9C=K;GIJHO;)YZ_6O^J_7#BF#
M=Y>K17!:L/.&_=>#).W!PKWX^9-/7+RR5"A-[GL5+DV]NDO=:/6Z;%81.\K:
M=@,9==:\-6X_EN>FLKQLUH\W(IH==Z2+Z\"$*MVN7NM[O_HO=(8<Q,V%SAG%
MCC%<_IKC_E& :46XYG@O#;*G!^NG\-CH9/<K$IJUT\P5!)=(%:-@3%%74MAJ
MP+])\$Y3-EDD0T>0EXNS,0YV%5NRD>EN<"-%7EAX)_R5Q"PN- K"[Y!I$ZD-
MV_KE@1(B1:OL_*2&DFV0-EI1"88_(E34&)U AAXEIP<AH!G&?I.1_@I:(+ZT
M_P)N2)*\)VAN$&D]6;$.*%I1@7J21CX6S8U:NB6*2UT+T!IO?4:'/W:WUG9"
M5QKP#%W660D:T\F#ZXA4O$T,W$T5D,;H#<(',0='<]2; ^=#R [V]MR"0'HU
M+=.NT:@;JFH'UU.]!#8ASAD+1_IJ=\\,2H@@?6H.)L&OC.&S-K^EV-<6N&Z"
MR=-LBVYT75]MK06S7+*@*4ARS62I2(/9EX*T27&J$X>P8<O4[Y7Y<U%,]8M;
M(?O-4IN^6JT@=)A!.T&+/$EVX(\"7+0TX37F G=,_;^9A[3/.]S,*E/=$AA4
MLQU<YL(E!_Q+3AL!]EJ:I3N_3CY-E--9RN*1)GNXR[_J+F>#0+E2Z7\-NV.@
MB%&6&9>/W%G1<M<DUZ)6/$MA ,A;W :*"#G]2"?"$$0":T6+')7^X-_P6!&I
M\*"+&F7):SNGTGQTKS ?CKS=F--FDG\*3]0K7B=\!&T>:H$@\1KWD%K!:BY5
MF\O7D-D^N[Q<@@"51/7 R7B1+.*<B1J5I<3"V>:<MA),H1"VEQKF+%&!''T3
M=KQ?$U?(I=^) =YDX$W3 =YT'WEAMO$D.$T2[W"UN@5:^!2QX"DFLGIA*#3Y
MN?"::=%3KXC=M,Q\%<.I_\KZ"+S %1EU$O-NKD^-=9AGJU@:A)+3E_JK*0OX
MQG^;\MVH//!+FQMHO+"FO?ZK0T-VWUU@V:#6Q-94Z*JD.N@\/5A(ER7.C=*B
MT09_8!(]!U<<U&-GH0A%Q6"0E(I;B0L$6W^'DB>*G2#T.""L]J,+V[@E'_S0
M="LBO 4.C:8J4D! HRYKA\-&Y59,5K6%04E')@@VFB.I.*'=KJZON]VUZ_U*
MT>YP8HJ2&4-=*N,@\$FGW79'@FJP_C)6I8'U.X@&F>X/ H!1 Z9ZG^]S;K/M
MJ?YPGLUE5.6HE,YT:1^OC%_1&,#(4(?,<4OI&!SMGS%O(&6)7S*0EV#JS*NL
MZK@Z6X1BDYMM$>\B6XDX<EDW(J(/X<RM(OX"*GM:7L( $V0%2_E[&QO0B9IJ
M%Q02+F=^*R<4R/PJGDN]]"-_:FM^HMK*CW&"I&YY6[Z]HW9T#32L.4TP?K9-
M@:0F=^Q"23I/TY+)85*5\,E6D;B O7:A5M(1-6KW60OB.JL2-Y6#]HZ6)L[.
M=FCH%2V<+A/C[IF.S6+TKOHD.R7O.]X;4_&Z:KF"T[$DZAT\)/5V0H.;S^52
M&7%FQ)1RHU_!5ER,F8'Q18QF5C&_A&.."JR+,5J*S^3R:H._PVE&3\:-+2C&
M$PA/6W10RU@\O)."<L5J>3P( AK-JO>W'/R&P8V9?WZA4BO9@]LENDM?T;GC
M4#>/,LUNY,+ZZZE"Z'+D5OJOX YYAYLKN'_S_2)_T[M^4&A[L' (/RM1C;%)
MT5;J-*!.;&Z#Z'+T773[X\\*2F?.Y9RH.K/% F0Y_J.TBJ24(6<$.2Q;7J[C
M3))09/8=_-0C#T4N8VC+KV:RRBJDRYFY'*!MLG.A/B049A@D60'BTDC@D&LL
MHF@C1UE%PJXC5U#/0LZ=IDO&F9"9+NQ".K\:3SVT963P3,Y%59BKERNTS1U&
M5J=&F]4#54H6N1(<?7TN5F*.%\I7KH9_O3$!&QSH98J$(92(GI$BD"\I<$:Z
M\U>LO2Z 0SQJ%:-E5Y3'SEY$U"4R!4-&+BB8$'/#41VC%9*.U>')E+M&>HI>
M*?(D):3J8'VB"X%SJZ:]*-TMX 0B1 F#2N5-H?RXP0(C$/BPO;_=Q\GULV0%
M HD"O'KE0J& S5[R/<0Z) GJ?PXG#TVCJC0I;VI7($194YO 1[!C8+)3K7"I
MG%Q:EUHCNK1,P<88O3&[1NU+5!1[GXDH6 CH6O\OX"%Q[@Y5_)![@C;(W\3U
M<.OV8+4X=-9^O[)U8D/]5%H (2^LO%O<'JTJ>RCP)T80=B$0I(F0X;\_E<H,
M>PTB%MXDR7Y40FQ^F8$$W\D6._ =DH6D<-\FTOP8/S5^:2;:0_6=[4/E&G>Q
MT:YHUIT0OO_;*?'5VKU;1-*C1H4V6]+_OTLJ=/WWW7]PYSEHB0$]Z\#=W@,'
M[K"!./KSB_AH+D^FT?[^5.X='AS.=H^/H\5,[)V(V72^>[(W^]?!BWYPI&]W
M%;B"Y<=7?SW[^/J?8?#VW:MMGNO-NMO!+'=J:B#W? 1K50,%B_Z5[I:]W>FA
M&J0=M(N=?;3X\69JU^^="_T@LXN7F&(;W)Y6O=E./T=3TM;VUC72"B?'$Y2-
MTWP.5_7K+R%ND@G24NL[&FR1?*7FP?/>._!2=E4K? RW20[A2!;S/)Y9R.4K
M,/.%SDC*Y0)9TMG(@4[R#]U7\%RC?U>_Q61LN9[IN[\E)+HU'5VJ6:YN#VH<
MC&J@E!.;&3)*2_#;2D2@YH71/":4A]I?G"HMKQ6OVWER_1["![9K0K$_-YCG
M*$KS=:O!M,AF):#M.6>I%<P:_H?=R>X4Q\S,WY:)+FS,L-U")LO-M$NPYCJK
MW=?V_4PW]R&WL:NQ00GK=!=;:S[DEM0B*W09)LU([.#A]]\='O^TNQNL)DLX
M+6>B@%^F!) +O02>K^WW&XI0F-Z[1Z'WDN<MQ1O1A$D9E*Q0S&I.;;5&"L=Z
M4LH81!3-UGN?68_4SSM"PA:8_A8O9YR]C_)*II5&JB^"Z<GQ2RZCNZ2>N;$C
MR\,$!W59)8J=S9IJO@2,G*W45FH./8A<-7IFXB-<SE9+A&Y!0UTD#G)=F)9'
M'K9!J'1=7 HEL7,4!!$8C&2VN>GQ3M%P;XO#F8VCY$:%DS"P1 +K\3E3-MM,
M>T],3?B'HG3_I(*+V_22]%Y2G#O[4#EU.2G2(1#2=P9RY=N[XEZWVN^S%NTH
M@R>P%EI2N%S=1N3,JV7%OH2@R)1,]Y!.CH17P$?=2*0QD@H_H'ZW%%^H$(3Z
M/8$8BB(F7B=]$VCV$(46=?9%A\[52)"'1E19!ZJ,XR35XH:2.G.^]'-?\<^6
M*UB7O"O]HHVN./5Q,/N!RF_+UB7 ;&?!]Y^89#4K\71LL&=%2?6UZ_LF8\H"
MO<Y;O3F;DT;%P*F\E[+^6K4IJ\#.YV3TQ,JI3V";A!SZ[[(231O-U:Q]4&9_
MJ_N,:IB+LA2H29 <07E6/%(*ZM>?SLMX!H+U=)O+!BIR?.$ /3UT 1.ESF7<
M9!] TXZ1GQ0<H51:#'N']67TS15N4U<:@V6CTFP:#RO25.,N'/HGN@'JE2H(
MRF?*DJER9"IXTK#HB7U>[8C9C9?]*;">!_M(1.(4W/"O*%7F6H,H%CDG>R(B
MCOGC<U6 R9+/2WW7;IT^9D/!^YPXJ[[VZ+YB)0O3[#ZNXV*#;SE/IF^2>5VM
M-&U#&XTL;)P%!9ZVZJI3$="7($XVM@??H=\5OK$>*RIF UQ!_Q96*:/9*-"[
M0:U97V?-.9EK[ WEBS,C:E$EI0:41E=Q01SPH;=(FF!!Y(II#ZM;Q!%15-7<
M<5VNE(.1)$S,:.%!ZX,1]$_[U9+X@E3U%D=I_Z7#<R*7^EKI4"M0OU9"]$PP
MJ-JL[D4[QWJBA3(G83NW[6-S,^;PL"K-ZI$[NL(%8>\7N5A=%@$205"&"YR>
MF4RRZW #]QLKC"Y1"I).JD0-SLT@9(:M%3]"%#:\&6YZ='"63@9'B\DZ#GNJ
M,'IJRS8W3KO^[KJ@=,JIY^T0C6)=Q&^%+NLR8>=LZX)GM<0);W&1U,M'\"I+
M0%YD\!<EF>$G PK$H$"&[.W[;'I/KP&S)S,5H5MD2!A<Q5E"E5G)(LG2'4H=
M*6,-W 759(%1';0[$$/KH^&(NM=F'VI8=-CX&4K/%#-)BGF2%5CIV8:&#(;:
M?N0F(KGGL);L?1\Q[-+95RN=?<33\"0\3\^)7N[!/(L?V$']ZXIJ:@E0;I#N
M%6^!1TQR>4CU)HJY;@K'48BE!&\PK(NW-E-W;P^4EM&^I^Z/;Y4+Z$Y/I)_1
MVJ53U0D8T"RB/#(3>==%9QS]$A4Q97!08H7./87?>JQ>1@GS=:_UUWKH9B^K
MT 1ZZE-)I)CP\@3:J5<QC?2VB,RV,(!?5Z8V/5#!B ,5% X6A=,:@7X#H:B4
M4'< F[# 6H*#^O:HZIL3?>322.8W+<M74]R<3)V6/<&V_Z+*;?*5@X6H=]CW
M0% 'UBKU_;]^GA.'VD-:V"CQ7J&HZ]U=LXF:6#LR!M'F*']QX8K\FAO>C%ZQ
M"[!OBN3Y^$&T.!(!AG'9L\%J,5W;Y4EPK\'C2"_@+6BH4[RG-E9U:=1>V\[7
MT35-MFA'QZ Z.#^0#J*:%?(_E4-[:6^X6L%$[O_F\S^3F@,6%L\P2Y/75 VZ
MXQ7ML7C#R48MP+[@\+V3Z^Z5^"#SP$&=W;(?/0'L[$R[%6L.'[>_+M7U7;<5
MYADJ/ )I QO.;MB@?EEA4(M\!4A6@,BZT#D"]][V8]SW;9L:PTLWJOB 7].E
MD+"H7'C3V&B-( (MC*+<H\16/.6Q?G^;MK=PF(0;W0P-*,_]B</-X&J\0D.&
M="5X0N+I136=GG 1)-Q.ZYK'5@FVM*C@#[!9P7*MYF6K[I";!Q<B3M"R;7FJ
MI#H_%/=UY "B69#KCQ2+6!KN0@.J-?FJMG*VI2\$332GE-ZV7M4H*)JV>JB#
M#M2Z"CG<A+Z1'K9Y!-A6+Z ?B;B'S3X.UU+WA&VL/ Y8*<,I*6"S-T*MW3)
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M100P'!@?Q=%N-+D5R4XMW5B(+C*%1:JK,(]7K^G;B5+%"^?N@?G54WW;-13
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M-I[^G^AX.-$;G^B_R0O<)3T\K6Y2@I>LX>W6&;)JB2"A8=34 ,-YKRUNRJ5
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MFD>A_T)R4#8W<Y*S/_325 4B:45.:GTQ.QRR][.V?-J.S4DL&N3IOQ^+A2E
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M->GGA;'VENC9Y?!V49?CP1PK&9CT+E"\6S:3T8ZP[!:*<TR<"$'6ZZO&O6!
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M&I,*MCLUY#NJY9R*]OMOGG!&U=28Q"ZXYF'=:/VW&Q?#W;;Q3C\E.)R.=WL
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M>7MY-$ZC.4A)M'HC7<Z)?[AA--,Y,<=TU;(.^6'SG;])(XVOATE5N<'0JO+
M#)+=MS1D)W\8AI]BNU:@4*9KM0 <XE![4)>>8]6#1%R".5>AGY5,%^H.,G=T
M.3.2IVG:>TIP<,^QWA?$4XNXA"/.*SXP#"/RRI&8?;]%H4(V1!-DRK. E[)E
M]BY6;63C6\>_VK'6\3F# \M?E6:SW 0*+4OG [OV[[5K_]6;\"T$30&3BHML
M<8N-BK$[["/P]JX-X^1.01[]*2)=5L1SOB1TL]_;@+/1:=).Z!R(0R9Q>ZDQ
M ]-UW.)&HR((PA1'I/!13-"<UVEVV>8!GNU>/78-B82N;05*].C_V5[E%C\<
M$\H^9-)>[259WF%Z)9&8DM0<R?I4>TFFD6&1\RBB2"ORCI$*\=C<!XW GXFQ
MM1-H[/82IS*>U^).;3J(494<U<,#K5"=CNPI;!H%JI[J$74/!&HD17_"Z0O&
M,NN\O/KBV+F"4%9\+;K7HYCELSA%YM01YLRP<MSC_$'(=Z2VP5&+[7$K" 2^
M<1!.P>_!=(O\=RH#EVG/J9&)FJU.AK>7@(\3R?QF0CPZ"^+)V(W4D.-N!AR.
M'@_SKC(-[F.9)#KI;WH2K\$<9.R='ZSVDE[IGLZVSFHO-;PT,JTQ=;_,H1RK
M(*  !N="J#>P 0\I7X<V* *Y(H"1Q4FL^ 6F4J^UI";N5#&&CG6*E3(T@W,S
MS<=4^Q=O'0@?8\[4P2;%41 8E<:'9S1Q%G@YF/GP=CK3^!GA,0 8OGURRC?0
MWY"?T7>D(+J,DQQ# U058[Q2%M_!)&_6"SZ[D4)S64^W@+M$F,O_[>;V[M*)
M4I_CNJ1B%&R<H"^#;(S#*(^<MWB*%FX\C;7GKD9NFK ?DJO@2(XH#8>))2T*
ME:Z3P5 ZMA_7*9#"[IE$B:ZXK]Y,W=V$6FD9;C;[RF,+[2[G:DI6;)R$LY\R
M\Y:QZKJXI-Q=B> R&TOC\LQ+8#4Y#GD&1%;! @M(<)P!,B[03A^+EM>\^D#1
MG]*9+G8ULWN:GNMXO6.YCFNP2EY@^O"WSEY09JQG(6%)S&2]G^TL97OEL)&]
M_P7R)G%XIYT;6[9I3 2-N,E'_RR5XX%(KH^*:[FWF8?J\T0-5>)<UKGYK.I6
M;WU69+74/Q),NT@F(EJ4P&_M/4C _Y))*,9ZJE\D:;^9RLNST:QR.!Y49W]=
M=V]TN&2#3ECU$*_>RQS0.M6+/@J_MIAYP*)#?ADN,KLRWK#_WM;A?_46TX=K
MCTE[.88PLR!&1A6]Q-I+E=+\R(/XT)$$J7)-F,,4M\5Q*OG,:1E]C[QE)C=;
MJF\B??(MET5TL:N\-6V,/KI2J]:Y.UW)\\24/)_M8\ESC4[M^8XYM7<FM#*7
MSCLY1M1EXSW<2Q!)J^?A+@-"Q6BD/N>#6AV?U\G@;+L IE@9BI9D>W6(RF/&
M!H;+ 3M#/<H-6N%'0F S:F\D/:PDH HCC(?;03Y?/#Y1;3O#^P;CGWPYTE+!
MYKN?M@*,WYE0WT,AI,K.4<;^)OP+#H\])A<G(5BQU97]@-#\%D'5J+\"LEW0
MQ;$KD1$>6"U/3Y*[64.9/"(.FTP1JR B:RY$21/RI3,T.+P>9ZL[" MSQF&%
M(, X<: " KSA.@Y;#*S/>BU9(.S8$7.A_ P% &[4S,+M8G<HV-%H+$WLGT>.
M9X41Y7B&M75]'5[NSNU7GMNGCBOI+"YM@0-D'92OZ8&ZYT<AZX':8AJ .$!U
MK(NBL/JEO<2PB[<*N#R-Q:/,H8X8BK7S/;9-IW6.\/;3'@'+_DT:;)@AH*AP
MW(33^F KJ$"GDG"<3RQ])X8OQB.!Q:(+$Q.P+0 #.Z#[65W-"K=5/"[3V)5/
MZIZ&>'\7.^;]?2CUTI'.!U\$S2]0%0TM4"UD&M02HJ'<NHC)W5XIC?TA9V1K
M<BDN4&R41@'/C*@8&Z8A5;LU2&_82%Z]C)ULE*[6@^WFQ0P?$;I@6T>99@0G
M-XS&(E#_CS73]9RZ[H+%Z<F1"HKD:S&2C9UZJYC&T_&B?!1?82"V23GH0)T*
MTGP6=FD^3 .2ZG4WE,E1D^3U$\G$;.;G%I:()^UE/BN^F $+<: Z>-4+:T*H
MZ?N _8OR;BEY104#<SV*G!3'?L(%*N6 /OLQ>)^(L0QT%,U@'_%EC:\5E,E>
MT*XI"T'"CV3UD<Q5FW-3;\%0G3OJ5!2=5\CB.NE3ZY2D-J>WA0/.9(Y@9.'7
MLY,,3TP1VS9YFC!%K"0$(^E*A7/J,CN'!6"LRUV-\"NUR,EJ;6:^<(VLU.E_
M*HQU46VCE3T-.'ZIKV?@_N'05V-1>\:_?MMHJCX7DB)U4F.=V-Q^S(G*%%!+
MIL" ](=UG$G5=L9,)\=6R#$>*Q-7R:,,JY297FQS+1V]^=>SX,D0?SH6;#,+
M8H#:"O#)ERD/V78\:G"T8S'J&SJB%%&],YG3)PV*[=<,-!TD50;;9UGG%MMA
MNEV)F8D#'CS_%6O4US/& '39CZ<8#I4T1P-+H.-1$=D3/@:.<#%[F&C(2G;>
MP\!?]&BS4-;J&,!<2?0]VLO%>A@Y=0-?CI+T"*KG82I5#5/;2\X'FA1ZF78M
M]@JD1>IAX3JR9R3'J2;4*NQ-EW]Z&6D!8@+^U8"V<(;F>!HHL+8$0GDEO>]A
M7!3L=D_^.T6@%(9MAP1$I%X)D64=S.52QH&NK )$]6HH(H4W D(5"L8JS+"I
M=D)B"2VZN?#Y1NA$P#JUYHA4_(DN;TDQ2VKIF/ &68MMCQII/G.Z.\.<<8I(
M284;+#]CA3UE"+'\4 ^PJ'.CZY6:V)0DH$D0>#JLDP 'C?I,< B10*GE8\5G
M";X3^O,\EYJE$8NJ2Z=6IN(3)ACU89:%6X(/00B+I5X4=/PW:%*W=<^^^8?2
MVXE#Z6)7FQ%P@$=S1J<S7P)/^6$^2@;YK(J%$"6M>7$H153LX(4,2;(]]'EB
M@M5D?,2@-]RB$78_EL]JM5'GELJ=V%(RLFA6A2XOP58WUN8]'QE-)0U1ZQO$
M1'FA1A[:,^UB4%)JN3N5(M"MK>[0!AZ<GG8SU*I/E"JRIHO]F#<"7N^W+; 1
M\#H-?.P2QG@(+D[BKHG8(-0ZUEV9KBG3?;7K9;HU@?I65LR0(I>?Y92+W;0#
M642@P_<"JYZJ]0(/))Z>ADM#4ULLY+B-UDK>8;;+-.BCRF<5%<OSP,3QI8@3
MFA>\0%N4.D'..5$9K/BF%I_"#-N8BNB33/@;\C,\!ENJY;D;[=VO+&)DAW_
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MP?)6+F!,T*1G/#YH'P3NB 0/+&Z7]NJ!-\$6GJ'&FE#, 01GL 3)IRHVD_^
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MIT1UW((P31Q?357"BG%3:&GQWH><D+>Y2NH\?HMW,L8XESE!!&>T"=1>PI@
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M"3XI=2Q9!81QQ$!ARZ/)I!*M@HG8$7.A_"P?#N;?S$)J8Y<G%\@[EB8:'((
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MCR]%G-"LDP7*&JK<FS.J(5CQ3;T3PC0_FXKHDTSX&_(SD"#.9JMN6AB\WW.
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M@8@=6]T.%!_ML>%;:0KW<!P1CBF*%L_0R!LJR@']LYU]X"F2GR=JJ!+GUVX
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M$==X$WH%PH+B"6(6'P>F0#Q)BN%W,_A<"[LK(:6:%G>4,G:/L5("V+W/@-,
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M1#!"1P?I<H=TVPA-[/9$G@G1$NH%S7XS;BHLF/T"@;S5^CL?!^GOQ$6)*>B
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MU\$/%Y?/C#M?/1(SH);,UY3)Q&Q[!PQ9!N_%!K/PR)8)N*!DPX'Z9=']I,G
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MW-+8B%,QHC>))13M^]58Y0KY-Z.2H0WFSY3:I%%TR@0J)77?'FQOJB)1%=C
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M!A+Z=*L6L3Q8>A_*T)IX&HJ;RBLV%K'@@"A_-'LM%W-VA]1IF(9CS)%<"',
MN7N^V;+8HOCP!6+^S]FXKISI-IH+)$WBINK3Q"W7V"40#)2\-E]3+HQ1O=P9
M7R*Z_YS.6[D,/*Q]6D)"T;&A*"7-D*9'M:!%9*F(S3\VY!Z]="A,8"' 9C_2
M3]0A-=(AM1?$ANB7KLMS?9:-P+_:X C\<(W[M4!X_BC%\)=-MO(VV$=/T&J:
M],.-"1X8U@V/GM%P\9AH!!8!<:@FQ]0G5ZM2\Y)'4%X=>8H4M>O];3$US2[U
M8-/*&^_GY2=H/4LW+?L7F J<;N%=8.$C60NB#O=[][#LD+^?B=*GE>>(&1^
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M?SY[[N SVW/?(L0=_G-;3[.__W]02P,$%     @ _(!:4ADQDE($!0  \SL
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M]=(Q=4\EN@M2/E00F[(21U5%&F _Q!M(!7$S#AX'J8>BQ3$OZR^P)0(.\(6
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MOMD2GU^O[[/*S6^HRCS%7K8L.R&V4$VX:2"\[#\;"A"ND .98KFI=MV(B1"
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MMV!9E=909&O)%HD&W_4]^"CD+;LCI5PSS>GY9IZ^4[[WG6*1_EQ$Z_-^Q.Z
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M?MGDI;]3+]XH5,_R?J.X:3G_"U!+ P04    " #\@%I2]R;"@"P"  #+!0
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M\4!#QVJLYX%*$O"/@RS]H#/X(=(*_?U<[R!C;F55(=^SGT1 $=D<M?8A5UL
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MA!E%JXA-. ]FZ11+)64I-Z6&DQ=.2<T S<R$"'C44$8VRN4A@K_4WU7M&D>
MS 1&F%G8(D*H@(>*^N4L#7:.=K%'T )(6'OPT&1@[\NJ597>QD-*"F(2G"8)
M=JB]U* 'E4K+X<'>?Q F'?SG5&5P._"8Q4O^$]3(JVHLSQJ:^G0U)N:Z;;8B
MU6&L*&:E5 -AF5.N7#7!"%=!=G@=B)IDF413=[&BWC,(3Y'+",=)@P]:3Y:-
MI-3+83*5T0 -C2<84^R-*%X66](0J3/-:1)#*K=S1[@]61>H8Z*&.9B7:%$D
M&\\U?.!B&(:N= 7!"D$Q V@*V )#4WBFRMOM4:J<R]H(OF"),W=NEKW_*Q<[
M"W9LBTU@-KVNJ/,=[?>RN]4/MOK!??4#D"]6R/J"1F2+C3^I^07&RK#K%3^W
M<1UD39[_\>YBD-]S#M%.V([E>=H9@581!Y9,T(=AB\?A0J<#F)GPT9I&A5>H
M#YH!HW"A@)\',;&+US5N64A3:9$3U/)7?# .X)////KA-$M,/JI[F8C?FP21
M01NN>:,RTOSH)WF&RNNNIG*0)_?I0/!-0?9';314.:/OLA0(9YK9^K]V*]Z6
M]+/9H/A@T5Q?4<EUSLH:)BO'H85X&]2I"NCJ%$P7V$L*(5W(PW/*=6E;>*=Q
MW3[VWY&CXJ*"D- *DOWEPR.>X=4B:P8@9G&\3@5OLI,6O1C\N@3;?V<I<;AI
M7N:Z%@(K+WH%CDZ$1IN'4RF BJ9SIE'%310G!ML7 :-=>+F$-'EOEX F#^4G
MEXH'\N.%1=JS'G.T@N:B?[OH57QN!9U:RU'/C@47AF7CKLA=GA395/MP/0H"
MZQH(AK8Y.Q7M2VT$?>V"FA^$+G(K0%F7<.Z &%0FVL<'/FSNK7EY,8PKMODT
M%+=ALG ZYM#=O )?S(,9W$/^H![-:VSR6*MUJR<_]+.Y)(RVA"2JK=S6]Q>2
M*%_NJ5IRO DWH/:G[J!,I2MS/=EBV5.<-5NAIKO0" ^ :$,/EHB6.H* M2QA
MM0K:0H'7\/8F$_,^@C!4TYS5O3;7WAUKSK%/'.33C.;0846^^PF($4QM#<ZO
M/G42+7)AZ\VRI__)UIO5E0#I3]%5TLS_5#+4%968K;V]FJ^P!7E&S@;L$6;E
M6;M.A:)RQ=2Z8AT&Q?J>Q^ JVIX-?/0V'54\4C2I<<9=;A[,WB<TF6)-]AOD
M2\U,ETF508_A2&58AH+>$J6@6W&82*GRANG$(@*?JOR:I8NVNDJ,XL@#$3BA
MS(6^VMA.1O5QNW#2^%_2NR/.-P,-%406Z:T$W5<+:ZP@^J6M0O-DONLS&*UQ
M!E?4>VR^-I+$_TQAVL-Y3RP@KF[BL57OP-YG"]O4T"H 88=C0H=(+/.[N&*O
MK"JCHEFF_55]GRV]+S ?&=]"#6'+S&4.N?H;[L\C=L58,GZ/G4<CGE=.0706
MGI/CLWAT\DI<-)648@9E8\1L@!?\7@EK+S5P/,S1K<EM!#JIXXLQ8POKY[J3
M;)T@6R?(_9P@B\9L0[*9,)/@AFN)Q&0[ K4/K+DB@$CE9,U0$ 7&&5(4YIK;
MAQEN E<'YAF@X* )6^&#T9-"?72G0<8!O""[-9R5/$%<MQP)':*5AB-O^9Y0
M#[V&Z'&ZGRA[.[Q#^ D6OO3-A"'=9FS_'HR'*;*I(,:XS#EV%2)ZF^8..2@U
MH-V*6"+=4?D*$ENBC!B@@E-)7V;L+ )MZW9YN1)Y[4A-8#02&H23Y8Z!%#R=
MZ7P:%V6F>TWG],H!]KAMD1U7VELB*'L2H>LQ;ZLW4D'"=<#$_ &AB<&.E0,N
MHRQ)9;F9>NBH"CWYZ*J=&#XQV9-6)IZS;)>$;L\O!%1'ZASQWA707[4R6(&)
M:>FJ:GL%>UEF:U12<=VF6),!^0ZNAB4*4 X(ZRD)N&Z!U!! JE!3A:,_$8WV
M%OIK4Q ?TL\-27]SAL+P\QL*<!QN&>?4W(952GM($]:)&(!EX7MBWKGHR]58
MKYH=6.=Z4DRU^@3\9L$B\ I$++$+R!IH4C>(%Q@Q+%123L%[M;']9ZD,23J@
MHX,O1'8096J&::+RB*;[/837T^<K8"]'^;4C(_YR>^^Q*#\('P1/G9L5KL)D
M]B+GI,T)GVK@ 2JV/-,^F"+QK(94C&" 18E#@'*D72,-#C.;9AA2]UT?K9O/
M?[38]W!?9$28+X9,QFC24\T5O!QG_E>:?=C"^&X7GVYA_([ ^%=4YMLU,I :
M 9CJ-Y1*5,)NN1XXU2#,7#S=0A-6%Y7N"H?#NG[GJ.%H23!)@5+,E5B&!6P+
M;Q3EDFLW9X@1>DT&UX\WJ6 ("#-3!R8+&(=QFD\S$E-W:?0XHE!G22T[P2G3
M''*.Q<A,9%1&T4LL_'Y-54;!X2^IU':ZF%8Q(MON%G8U*F$+9N$D$R/-11;X
MW; @U:$O1.H)BB $/> R"5@K,R\6WLT.?W09E,^4^\NL@3+W1'4A[/LW4&KT
M-MQ[BW1^PTBG@P>HZ*B45K3%3T2[KAKB]F3[I^,+(AS.+*CFS"R,@."  ;#K
MQ);G0:^"KHR\=%:0FDH!Z6A,Y1Y8UL+QO72>)&I: EN^:D4=V2MG4YU'W=><
MYCD6/^B)*G&[YB[=L6HPF7S+5AXF6QE.,Y2<'6 K<-8K5&4SK-'@1L4K*X"_
M'!]@M8XDM\F?E(I)+L,RR;28Z1A^VCD\DHIN-NV4V(?_#K\LH+P(PR9N;C!]
M@'/S<O,1W_OT@-,^MV2^)?-[D'F3B] %&]#759 .U?1TQHD%4T;#Z:Q8E(]!
M130"1^Q=EV.P0.D2!4HDDMO<'A_EU[M5KZ47VNT=K=HCWV,@I_XX,66"A*K)
ML\4YJQL4V_"* 5:+M:;JTI$U=;GQ;8@;<XLCS$14DU=KFL1HF=!*W&DOD1%!
M]7PKY><V;B%W(A_HN,U2/IMF&:HU[WA!S\L%W=_D00N"E\M#HN^1_XX*[IA=
M[1%'F310D^LJ(&XI;#'%J?CH.HOTT(:GE17+63.DH.XEB.>=R8^LX'FEJ5TZ
M'7"1O))H6;_1"]GSPW4H5MO&N)45#4OG6!5JDI01@A=L\7+/5Q$*Q30L6CV!
MQ.6&._1KT=^(ZC^!+?'<UH?E?-,)[5<9J>1"#)NK9=7FL+1'!Q&51>:6UDO_
M,O$.G6 ))VTLX>UB]JC8$MOZ?IU+F^NK\IQ7XW:K-FZ%6ZZ4:=M;QL9L"Z)*
M9JZ<+(3^$D0 QAKX)MG(J\?*-CXX]ZO25$(/+1M8DNZY++BR3&?C6C2:?+22
M/\?.*V(Q\FLDT<YE]=Z2*37$?BX&+ZIJ2=[F,&10RLZ;<TQ[S,H)?.#:.78]
MJZ5A] )14#*@QOG)5-C@XA"+A0X:KNVIJ+)ST4P%8,!;::3P^D1A50!!?CG+
ML"C@]; MHL3!G+MI3_2YCF'PZX9SG$^+( 8BP%)#:/(NE 2K5#/BU"@%JD9H
M)A2-(DE8MA#-LOB#1N,%??,^P8A=@OTC\'X55UB%_P@Y@#G'S5=8AT/YY:%;
M#ZW=\&=;#VU'/+0.]R80=4$HUIFB/:4830+']/A+'=.-&ZS=S$'V%9VRGT]#
M,H=GQ2S*UD5#H25G@X,DE8VF\HKG;7=NS32Z]VQ^NHBMFKMBH?!^)0I9%OR#
M(76EL84*P4O58C4[0_JF]B9Y<!7<6M25J!@_$0)UB:<2= OI7BT*)6, ON0;
MJ=SV&(C\C#@OS):C_RF<=B'(=O&!H.JQ1ROR5?P:53LG7V-XN4U_Q^CNL>0>
MV!LJ^#T.GD:%.ND000ENW[UPC'J5(99P#(((*R5K%6"UU%GN3M51^<_<-EK8
M#5BGM8M9FYTK!;Y,];<PAKR#PCW@41Z=^IY*KSXU\!LX+7@K@1DR"AO-[BV#
M"]E!UQV("1]3^QXY1'N2WT6Z2#E<_E-K1^'>!N\ 6=8AN),#4)Q;F/D=Q1UM
M1BN3D?$8![FI2BXDA+C?KLYV>/G;$UU\T5HV@J7,/1&TY,HOV+4N=64\2>GV
M1>S)^0(0V(3#Y;Y_@O!&27DNV[B2X4ORH<FZ)G]]^ZY6VWBU5:<#QK;I,]D)
M-/!)*W$PRZVL--ZS6:/YU&O$0#-PPS0)<?;&FC!LM)9W]>J!]YE?.]8U)"O1
MIT&:);HF^G@P5X*8?-(X[GQ5+9:CA>+S,NN9WPM'$U%T:[>W5>R;2;BI)[O6
M*L'XS1R"IZT1\%[7Y@K97>)SNM(YOE8XP:_E*.D3E9A\KR2D\U^WDTG/X;N2
MQ\5O++M7N=!:(+@PUE*R\OR\9[5-!2K03<+J9AGJ"4.^U?-*8UYAV#;26=]5
M6DGB7MTFS3!<"L.JBL*E/]9&Y2;CO42$W8(A6072JTYO'W==/#(/LCO7'RW3
M^-H#.K]XV?_]XOS5^5G9A>OL[<7UY?FO[_&+E?IP?4,R^J2]#]<Y#'*<.#FV
M83S[7#P4G$7<ZJXF1[J70+P$6-F6S5PC-\L(,7"H/7INP(S/QA1)4\/YEWG%
M&NQ8VZ6A)RA BG^"KAZG<XT" NL.)?3[6(\'] <EJ>1^B]Q!EGZ GW9[E9Z7
MM_):U]^5/])XN3$MY3,2TH =:BE=(XWSK6/!$<F/6\="5QP+'A2&VH3PMK%6
MB8<AUXLQ9 MA*<$.TC\<HB[DP,A\1-046G<A$:;'D8BY=)T@G*T7A+$R8^12
M:@P4"'\ 1QE@Z2ZIDZ2MC0;JG)=QSVHJU;&T913:HHAZBWOE\L.'.J)Z+!A(
M0&4%8C7#[/\\':K,%2)K'2O<Y@\7.P<J:91ADC* DA7Z71"BJ$0C>L79T2A4
M!PK!8>Y?6^:1EP6IR^H$/:R D$O(9A;<FC2V[3=@*V..NHOG'2'!/^SPND!Z
MI)-0+&%CN0F*8M,W9'_<78IBQ8)W&ZDG;2_T0UV\+H_V<7ZW1]<7VY&7OR#N
M.U=XPSZC\P5<;/(-S:X\+O[LRB]K+AD)!1>-2'Q1&4+75#CG9BJW8=+/-+Y1
MI>VZHK2HPJGMK\8I>(5Z;+4IO"B1O]W"UY(WUZJS7"(&90MR=+@KVBRN1N=)
MRE*R4,BM"L.,BE,09^>FY9;%.@;N.7@=W@;+/L*RE"/-\VX:M$EN,7SIAM>
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MVV-Z-C\?9I!/5/*O1\>/2H%,3/_YT>1C4-/=4 [4)\'C?]1-[G0JT5D(<'"
M8[,LV) &!U\'AT\1_2E @A?=Y_:M'H+@IY/#@YI"^B6);2/$5!0)LZ??=$*>
ME3,ND.2F_8U-^)4+N;I(]Z5#[<GAD]W@Z-G3O9/#IR>+$W],K.^.Y*=[V7M;
MY;S" 3:S2"U88/_-F_[E@]&VKV&XYYCH$[SNG[ZY?AV<7[QZ>_D[*-YG5[W@
MS9NS[D_BP6O?IV-3!/\QC3\HD")?6.WN$C\I5?+*"G1D=(V:^ -5J4$Q/GCV
M=*M2?VV5^C/!2M^:3N64R.]':5Q#2UQ@%TW@[%?F'T?[AR?//H5_'/ZX_^SH
MZ4K\8YW?CO;AR'S2G4L'>[(RL_LZ@WU(3UVVL$^.]X^/?UQ'BM0\6H=/F.J7
M<H:#@"6"?<=W?NDZ7&:I#[9[/L<U''./!VDTA_^,BG'\R_\!4$L#!!0    (
M /R 6E(IWMNT_=@$ /]-+0 1    ;G9T82TR,#(P,3(S,2YH=&WL?6UW$\?2
M[??G5^3F\W72+]5O6>?D+H.!ZUQL$S#AV%^RJKJK;1E9XD@R8'[]K98MP(0$
M [*ED96$8$NCF='4KNJ]NZNK_O5_WI[V?WC-HW%O./CWC_HG]>,/_^?7?_VO
MC8W_W'OZ^(>M83X[Y<'DA_LCQ@F7'][T)L<_O"@\?OE#'0U/?W@Q'+WLO<:-
MC>EG[@]?G8]Z1\>3'XPR^I,W1[]H=!X,U@W0&38@>+T14\4-'X*FE *S4?_[
MZ!=5K%,VE U;(,MASLIA@3>T84]96V43_^_R"\M/)N520O&0'6%.05?%T7.L
M.DTO>SR1;R??<##^9?!Z@O_^\7@R>?7+SS^_>?/FI][@=6^"_%,>GOXLMZNT
ML?K'RX-[;R<;8\Y7CI???SH:OOZY-^CW!MP>S\^3$0[&=3@ZQ8D\/CF+=ALJ
M;GQ\GBNG>$NC_D_#T5$[TGYTHMGA;^6%EU<^\<9.C]<II9^G[[X_=-S[W(%&
M*?WS?W8>/\O'?(H;O<%X@H/,LT_EX=E@,CI__\GI#<V^V.6;TX>QH?1'7Z,=
MUON[;Z+:-[EZF;/QQA'BJ_>?J#BFZ=&7;WSF$O+$/W^!+SUNLV'\["2%>Y__
M:O+&9ZXY'DW^>HORXM\\@?+)R2^_OO_YXLWWWV0\!*/#/SVNBR-F'_B+T:\>
MW=XF',\>[M_#HX%]>M O?1P<_?M''FP\?_:C. %C^?5?ISS!']I'-_B_9[W7
M__[Q_G P$=?>V#]_)>?.%[_]^\<)OYW\/#W5S[_^S__\S[\FO4F??VW>LS'S
MDG_]?/'BOWZ^.#4-R_FO_RJ]US^,)^=]_O>/I3=^U<?S7P;# <L-]-[^T@[D
MT<6/O5)X,/U1WM^5^#+JY8OKOYT\Y?KO'WM5LT="#%%YL,&1SRHZ^1E-S=;G
M/[?:K2@M)OK@N0,\;9?FWB\/!G)_Y_?EZXRPOSTH_/;_\?F//_2*G+K8/\YI
M:_CZL7GZ^L#NG)63!Z\/'Z63O=/G;W?>;9[OO=A]>;A57NZ>/#W9??';\<&[
MEW;GQ<&;P_TC<[A_?+JSWS]^;'?[!^]>]7?V=][LG/1/#A_];@^W#M3!NS]Z
M!R]VW.Z[AZ<[CY[#[NES.#QYX [^B.JQ.3P_>)'][HL=LW/RQ\G>UM/^WOYS
MM_OH:6]GJ_]R[\5A?W?_2.UN_=;;???<'KPX>%T>/>S1H^=^YW3;[NZ7_L')
MO9.#DX?'NUL/8/?D)>R<;+N#DP-[L/_\[<&+!V9G/U]^Y@^YEAL<[@_/#TZR
MWC5_]'8>[?9V7CQ0._(]]O:/SN6^>[LGY7AW_^'QP?[!VUT=WSW>?S#9>:;>
M/M[?_+/$ZHR"NI&1) AK6S:H5KVA"Z-A9W7$_..O2HS@E-86_O7S%7O>I'DW
M940J;51ZV,>CM5F_9%;UL5F-K]D88S=T-7$#D)*,K: W,,:@54)OR/_X:\7^
MF&_1HC.:\; WSM@_8!P]E%?&:]M^R;;F8]MZ6P,:2QO!.2>\B7D#E1B8$MK*
M(5FEZX^_MN>_,-,^D?,/R]JXUS*N_=BXKE"1(52LB57B,8+$XRCTF T85M8H
M<O''7Q\>?(UI+53'V?FJJH=*&KT*GAV9@L"1Z!],>TGD?GG8&_0F_+CWFLOV
M0#C@48_ZO#D>\^3YF.M9_W&O\F(M;7=[Z32?/ASLG?QN=K=>GN\\^J._L_6[
MD3]6+ 1[6SMO=QX=O)%KV<.3H[>[C[;/']NG??Z_3\\/7Y179,#ORC7V]K??
M'+YX_D9^EC_Y[>Z[(]AY]^#-X<GFV\.3<KJW]4 =G/Q6=]\=P.[O?Q8C&B;*
MHZOB/1L@*F4C86I6BRJS*5DY&4"?N*^SF XH\L@'445B(B%5U6BE*&IC4/31
MVF+?9K&C=WN__PG92% +=4,5-!M@M=U BWHCBYHL%B)P!K&8N6V+/1D-7_%H
M<OY$:/UD<U >"']_U6+JG378SKX$UY.C/[6HJ)(8-X)F"8K>L/B8D!MC7)!8
M1D5I83-/[-]9[.$(<Y.2/YR)3TSM-3@[)1[]>-6&C&B,1JLD!D-0,>H4$(NR
M\I?RI30;ZJ3\U(;M!ZM^_*%P[IT*C_KWC_"I09\=XXB;I"OWAZ>O>#">ZMG-
MD<C;(VZ&O7?^X9 G>-Y>VGR#HS+]WQ\\GO0&1T_;/,M8!M0L[^*10* -L'(5
MM5@PP-[]&1@.WN[MRW'O'IC=4P' N]_E' ^/#_>SG'_W>/?=YKL=^?SAH\,3
M </QP>G;_M[)T_[AR8$Y,+^+P9\>RY_3W4>'QWO[\OF3?O]P7ZXGYSO<VH39
M9^1:9X?FN=]]],?I[LGAR>'60_E,^W.@#D\?.#E>OJL \L7!NYW]PY<[6\=U
MI]=&U>GH^N9/AD 8-(G :7-3SGGA335NJ&RCHR+#84XB=7ZR\L\,2#/D?"62
MM,DZ9S#10H9</7I=06$V-7"UF==(ZAR2SC]"$A@3T)6P86,L&V)B&>Y!F8U,
MZ,D;;3.5.2%)"6@)2ZJ@#<02(I1:K 9K(B3'9HVDKB%I]_Y'2'(N0721-T*V
M:0-(Q0T*"C=LK=FC0R<6G1.2,((*QGBOY9J)*B5GO%Q,Q&0HU<X8BK]D*)\B
M:7OWX1I+U\;2J=S3R6_]W7?W3@0_Y[M;OZN==SNB'G?>[3W:<8?[!["WWS]I
MU_L42P?FZ>G.Z7.[(\?MO-L69?J[G/_(M,\?O.OW=T^.W)ZH6?EN]4(U3K&D
M=_:WW_T99' 1IN0WA,O&#8D9=2-9)037VZ U.6<L-CRY[P03151:A&F!&*$6
M'Q/'XHOV;)5<2*_!U$$P]3X!4]$RQJ"'#8LRN %XM9%2T1LJH65E,05;YP&F
MH@I[C^BT)4BJHL%HO7-8"PC*[ 68M+FBG>XNF-Z*T>QL7NO@73OO'R]W3NZ=
M'IR\% ,?GQR<B,[=^JV_8W;ENK_+O;RT(K<^S&N9P],]>7WOQ?.W,DJ)!-N5
MSQX?[YB=-WM;F^ZPW>/)\W.YCT_GM=X=GAZXPZT'KHV&!_N;2L[5VWOTX-W!
MNTW8V9)14NYC=_^WE[O]^/;#O-:!VCW9_--'K#4)8PH1)3B1MQL17-DHP,4F
M7V-*9AYXB@8;_XXRQF4 '66@ RM\S:JD";5;XZF3>#K_%$]9E^2J2QM,0>*3
MTF%##*Z%E7MEG$AWJO\<G^8]D]-63W_98IH\XWPVZDUZ/-Y\C;T^4I\?#D?/
MQ-H[.&GOG%_,D"_6\&[W_')4.GTH1M[6>]//[ISO;?U^?KA?>KOFP.WM/Y<1
MZ[?CW9.#\P.SV_]T/N?@Q6YOY^2Y:_<I(PSL"E!VS;8]/'GI=O>% I_*2'?R
MFQ#K/]J4J=L]>0X[^P*BK0?O=G[_LP#)HR:_P2KE#4@E;22E\H:UJB!I752*
M/_[Z1.]\W]2.=2%6P[4J46LA*J14JRXRO@F!<14O952:R:CT1;[2S+P]&$]&
MTV6/^\/!:QY-VASKQ8\MS^9IBQ)ZB=S\I9NY^<Z[<GSXJ%GT-Q$VXF*/GJO#
M1P_43A,MCQ[HW=.V9''\<L=LOW?SO2UQSJTLYQ97%LXA0D=XR['<QXZX]H[>
M%6&T]VC;'9S^_JF;P\Z[PY>[\CW$E1OG4 <O'O;W'OTA#.:WESOOGJN=K2,X
M..GW#A_&-X_WM]^[^=[^T9\A:RN# V_XXNP&F,1"0U@&$%."A/5 H4%$_:2L
M]2;]K4SZK+,[$(AIJHI# ,8<*]NLJHNFL9"J/SM4?&9LN/?EL>'>/XT-%^%
M+Q@APOI>'PY^.SY\]ZI95@+OCC#+EV\.]H5Q[F^^/=C?/C_8/SX^V!>I_&CW
M=+<MGCU+ZO _QRJ?_C' %^E,8HE8]D +RY38<>]8&*?X^L/CG9/?CO<$,2*5
M7XK(UH>GS_5_WFV?RS7DN#;_>R1QXNC\3ULM:!#UDFJP+7O,;Q")X9,8)[CL
M0_'VGZ;GKQD1' L3J#%'C<(.M"?,2)!1M3F< OC9,+] DK!A%@Z.YY?@&*J]
M%]MP8)H$>7@BP%![(E<.3L60CWX[%6DA8/G]S=Y^UCN])*[^V_AP_U7O<.NW
MEP*F\QUA!+OF=R4AQNZ].!##[QXWMB$A24#UL'_X[/(S__GMF$Z+R!\)$:>_
MN[9HL+,ES&/K=W.PG]VAL)(=\^!\Y]'!NUTCH'KQ1_\_[YY/WFOBS3]C4*60
M4QL:M0PNE<-&C$0;"*%JCIE:=M:OYGOYYOR@-"40WQQ0KD#HP7_/L+\CMWG<
M/_\09-:H^B94'7R,*FN=T$NO-Y)K>:L5<"-J83!%8A/&A,2>!%4_J?A50Y%)
MQ51F42PI 5C"5"PR>Z>]H>K+EWCG]B /3WD?WSYXBZ>]P10TNU.X[M6+X>7Y
MH/#HHW<7;OJCV6ASLOM(),36CCS^W%8-U:YY;D4.P,&IR(']Y^\.3]J<B?S>
M^W2TV5$B(<3<_=/==VW54*Z[7XYWMHY[AZ?;PD#;*/7;2?O]/^]^E]]__U,[
M12D)VRPA"HMP5@("BHJPT;!+'(JP_\^O)OY\-:UQQ)5'/,@\_DPV9DOG_&4\
M3<\5^_XP3>K]97+^2LPU[IV^ZK<\S^EKQZ-I8/DX\?*GM^,BI_CYZCDNKO_A
MHI?W,!Z>C::_3;-W?[G$U(5IOR6I9W8BGF97SG[KE?9[[?'HA^D-\6=SIN]O
M_[^KR8*??OC7V4M7S_YJBL_9;^,)CB9;..%?9PFZ2L\^]^&]][=9/ARJS8;5
M'RYQ\<[L]]E%?K[RH&;G:2%^^M#.IL_^XL53QO'9B'^]S.3]Y?FSK=G'9V_-
M?F^?_[P-IA,1+FD6OW8Z)U0U9P6VIIQ4X3^WW\^0+O[17V1X3RX?O-^PZOV)
M+M_YRJ<Y;B/5^"\/]-*8TS>_^HE:%U4-3-Z"!QUU=+:*#(@IH^AUIND3U?)?
M6JXGJEL6NT[?]D2O/(&,L=08:]LF 4'+,Z@&G7.<8E0VI0M,+8D[7\'4%0_]
MCB<0*FL9?C.%P&!\2<9$7Y =BL@W?NI5.BW=$]#I>Y[ QS%*AO0I"WS_]4KO
MM=S6QX=.QRV<#$??&,[^\OGVXA8/AE,"\=?37M>IKYSBYZMW_R7?+XFBB'-#
M04(H!Y,">@:EG!#N7$I:P(AV^;7YJ!'QBU^+7.SMJWXO]R8[W"C8#Z4G[UYL
MOAJ/)BW7JYSER=[H&8]>]S)OONU)D+R8/^SAT6 HA#WO"VT?7WS^7S]_]K3O
MG]?[JR_K\'K%B$)%4*?J*QFA(M&28L=.5\[&,8&^G(W3E[-Q:R/^LQ$EJ%S7
MB)_&G^\PHHL9BV+0VB$H&8M,,@@6$Q0FM!=&C#,CQK41OV#$>'TCQKD9L<02
M4RHEQVB!VS*^T-50V"9O8JJQ^^'T_K#?1QJ.+B91!N51&WQXER=OAJ.7JQA<
M&:IA+ FS=S(P^HB>4HC!5E$<P9GN!]<%FG0QH=9KKV*R$4IP8%U"K):\_.Q0
M5 6J[H?:19IT(8$WI<P%"CE1<H!6I:*])<-)>Q0'#@OPTDZX@C".HDLF@T(T
M<BHI"0WQ'D*T206"!;A")_ 6J@TABCPVJ0KE%A7EO*^05$M/EY'^]O3RUT:.
M]\MK$_GJ[3-M7\SDO*V-# ?RZ_@BC,P.D]=/AX-GDV&^@;@Q+R%_Q30FJB1(
MMCE(1$AM,4FYTA(?5+)67IV:9BF#^I*:)L[--.P<%%MJ)%W!N)J(0YM(YT@F
M0(Q3TX2U::YMFC WT^2JQ64\DF@5P!R3252L0PK& Y'O@')9)ALM7K<XB8/L
MJ&83"E24D<K:@F"L#UK5X#N@6Y;5H(NA:I5<SLEH4J5%44 VJ;05"JHN@\4.
MJ):E->A".&0T&JKU&I)7X!.CC<7$7-L.DVJTOKU5IR[;\4:6PTIP5CM?4"@*
M6/%BQ\J(3D*3G0E$*T/O-W,^.SWKMR)U>Y-C'K7C1GS<SO::+U)@ND+[+5)A
M&=P,($B(3,H&(#9.HR[,>F5H_Z)--C\Y8$,IKNT-T$U$URKJ.<94#&E7G-9A
M9>3 HDTV/YE T"KG: ]:6:C0<FY B>$TZRKN5U=/)BS$=HN7#R%;#.1LK:I.
MRX0J2C5KI8*R11QW]>3#P@V]&%D13?0IJ^0-BZ&KIE)RTK4&FY+/GE=/5BS>
MT(N9LN;<*@%3AL"0K,4:0C;BYD;GMF*R,G)CP:/M'&6(I8HN>.*B $)R%!W;
M'&IR*9GB<75D2"F]ME2)_2?8*]N#^_BJ-\%^1Z1'):[6...=9BC5$0,[L,QD
M1#Y>FFDE(N<"S#0_N>&=&$H9!Y@0P"B4@<\G%D>2Z">V6QVYL0 SS4]B!">"
M$%EB'%E@&R-;TEIYLMFYD#^[<6=MKX[("BC(* )"07% V4?+.L7B9' #4?U^
M!=GF(HR[H GMFL!K7U3T%I)2B:%2)B?_65]T7$'-N!#C+D0GML5A&RM$T@9
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M\L4C;X>^S \W%DAYZWR)0! 1B1Q"0&,2565"6+TYE9MW\,5/IAC4*J(&[2)
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MO?,+\+;D@<_#:)I@T'(8CGNO5G)JLQ17B@DF.(@ C@A%@Z1HF!QK__D:\!V
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M-?>'TT_<'ZYH/7]5O351R2!+"*75XHM%%5(V."]^7I<_5V#EMUHLSR:'>>9
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MZ.Q!>9!?DG-L/5>VP7>@9.Y2;46=8_T9UW8Y&G"I5(1L<_2L;&X26^6J-7?
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M6J.W6QLYYAE[C2+0$%EE"X1MKZ46/>"\01FQ:[?F8=9*X(XQ!Z-<CJ0DXOH
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MYSBN;GK,]@-OA!V;8H!]Y/*1-XIW N)OVU_(, +3##P_B,S(#D)WY,6Z;?J
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M^MPR_6%@(<.Q63P<N7!Q3A#'<:@'D>F!:6/8NJX9;C71SJN"\VHY(O54\#J
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MLIUJPJ-?Y[ V+W@6\@MXT:\I4-'?C%3.#H_G?]F<ASH'*@E #QC:W(J&+'3
MT/98H(_LD!D&J!$<N,D,S<*BYD]JJE5\*DTG0R>[J\JU*"EX6.5%2>ZR?L6=
MBS[$7WD&UAGYM\YN,EZ4DV2F-:5A* 5FH&$!Y%\,-,. _YCP'XM6,VP4!.]8
M48D%CX^/M7;( YF,A<(;^$)P:Q0(.-+R+K&#^MI<H\[DY+#KU@R2)W6A*! W
MT@CJSKQ'L#6!+C+IHFN>Q(8]82(]AM0M&=1#WA;EK=@1R;7]+*OABDXXIVN!
M)TF63/(T@CN[1^TW8MOWHL>&=<MR%^V?Q^.4/XP%?V'AG\#3A"\A]H@SBTP_
MC"(O<NW0"5CH>T:L\Y'+1['AL[^\9]O@G7IZ.?OE:4E"I]W_]>T13@P^.#N]
M0('[5>CZ%/N^RVQ_R%C=5F_Z0:44OK_GN-_4A]?0]W3C6PL0[E[6<_>LT;<5
M:'QAM];C=F7ZOAZHCY:R^%TMF1:0<-T)0M]UEG? ,W&RTJKDD 7!X@MR^O;V
M?H_5)O"'K+,2?]UO1<II$D4I%P)E-31'(S ;'Y,_"CIE3_$><?J(AW(HF<A_
MT"8%6E+_\67A;7B&0:/;;U@1#?_G'VRK]OUVVS:<YU>H>V_;ML^W;</*]BII
MXX]0*?(ESK)"52WP3'<(D!W+,>Z S([Y/RDD7"#N>@K*^AP= EM%YK#U]]NV
MX:2\VKI+?KUM&V;D+=QQ_@T%CWD_YU\P=0SS'EOG&TS9;_WIMLFE53;F$OPH
M"11_]2,PZ"MW\!5HI(.QO/_^0CM^+!HG@KT31D]'QBO<&8_;8GNG#]V+6)8(
M0<G@TMY3B9 =)%9!0M61[@3Y1H+'^AH#;D<F/P8.;H]A[>\XUEI!\1[-N]<[
M\V.#061Z.[:U?D#X/;;UZXYMK144'[*"EWEZS2/MO&)Q3#E(.^?YQL++\7<\
M;.V ,,TN#S-W+&RMD'A7Y#.\,[[C69L)H!W/V@1 .%V>9>UXUEHA\9:/6:H!
MYPHYS2#8L:[-A-..=6T"($9=UF7O6-=:(7$":VKG+.;57#M,2JQ4K7$J^XY_
M;2"POL2_=@'W7<#]?BRR#!5PWT7<-P_QMID_6797K#L[L;Y62)R(IB582/K^
MSFX*1_^NDVH^@%^DU/Z\4T2JG6 S.UFH*^9C:^_J(IRP4G5$RF/QOV*53A7L
M3GG82)1P]9WQLWY >%TNZ>ZXY%HA<:ZZJ;YNVFKB@,4= ]M(:+E?56BR(YL?
M @A;[S(P;\? U@J)D^7VPNC$J477$=3=]C.6SLM$=,EJN-Q!GD6B233^YCTO
MZ[2BGYS-N-C-3HO;3(B[NV3-#0!$+[O<VR5KKA<4O]=P4Q5UY"%^]CLVJ%<?
MM$[M4ML/\KK2I&V,*9X[)K>1 /5VJ9T; (A>1OIHQ^/6"@G0V*C?"NN;J^=-
M>P314J^>S5+Z-Y:![VS9C06G-]IQN+4#PK!Z+,[?L;CU@N* ^F;BZ!MB9J"Y
ML7'!)7NCIIG[8AX-PP_ >-UOQ]/@ QTOWBZ38<-A;9@[;]XF@*)7O^/O+-DU
MPP+4/!SV);0Y2BB-T'+=<;'-!->.BVT$*.Q>!8^_JT)<,RS.:!S7<=MD?<>_
M-A-0AFGO,DIW&:7?U<+)=IJ4TEU.Z>:AWG;SJ%ZMB*'O!/MZ87&H!K@,M*-;
M'M8483N+XR14N:('S<"5-SBP&!TR.Q_,AD+3P/%9.^MEW:!PC!Z3VS6K6S,L
M6LZ&\Z9X5NY,F V&UHZ);08H>N4_QJZ+RIIA(<MQYITY>GFL'< ]LB1;GK-'
MNEN;32K30I?*@@1T96W0CB-N)NAW''$S0-$K]3%V/5K6# O%^XBM888[\,2R
MQ^@N"MBA&",,!JY(01#VKG:<11Q4P8COS-F-!?".[VT$*-Q>A9"Q:_"R9EB\
M*Y(L3&:@ZK794]IKSM40YN(Z"7<9!IL*/<-T=Q&Z783NNR)TKJ4B=']\$YE_
M&; [_OV#.$!_*L"NJ\J:87%T.TF"I +K8$4)AG8>3GA4ISMANJG@,W8S S8"
M%#+I6#-V#5#6#(;7>0%@T(?_TN3LT!WKVDQ P8]V=L":[("U:?M?/933?/;+
M^?&;T_V+#^^/SA])U_]'Q8*4JR4623=!GVCUTC+VG)DBWE_^)RC^L?#JSG/R
MQ)8+5S++2^I#\K(@K^PU?W631-5$77OGJ2"OJGSZ4F\?84&9IW5U]R/ S\9)
M-JSRV4NWCULA[)D7K[[J!-W_QI<DT?\^>^B(;/G8I&BO>\R'0<'9U9#%L)67
M++UA\_+9/_H'@-UW;^NN@RZ=[(O'6'U+DFFLHBOZO\?$=Q,/ >+GAA71\&V>
M7V$57UO.O'<G^JR"ZBH8/O8)EE@[G>!BDI1:P6=Y40%991AA*+'M(ATKE<<J
MVRIM+&-,,JV:<&W*68;?YC']\UV17&/>7-M(47L+_S,F5J"]YYA,K^V'%?[>
M\'UG3]M/T^[2M&R[FYR2\*L)W43S(W@8?E/E!7)5+69A-8 'P[2.%C::X(TF
M<<(C+9AK-WD1E5I9AQ.-E1HV&S+U5P%/$W[-!_1/XY7Z>,KFBQ_=)&FZ^!DO
MJV0*KUO\'&\QR>JES[&G!_HQEY]( .6S:&G]VQD/*_4A^CK+!,#."@V^*3BU
M2,(P3\'O@=>>]OIN6(I[XP,MJ"M:)\LK+8678#"IR@?=WS)L/?+R(4AM(5L4
MW'B(,O"E;>YYS@*F#XW1$R,Z7:3;Y$(_U8O[5V'8@L#SNM"N$WZ#R#X&Z"!@
MD(;BNJH!#H#D8YYQP!>M0C23]<%@N&M%GG*DE"D2:@4,> IT&!$QS J,_87\
MU0Y*CP,EA$@RG3'!LP[._C@^'!H^%FXC_ (Y%)9 @S^5D5?M!E@CFVL5NR)(
M :G.X&..OREXE>_ \XA$-$W:5G'8)+CBXSEU#>Y": "DD4=U*)N,5#R<9+#;
M\;PK.O !%B0IYAQ5.?)8_"U^B@Q=Y11%("_2?*9E_*;Y_&:2I)P($J4G$6M5
M$2U><W@S,/UL/ #2+DB@\6R".>6T\B*1ER*8U6!4(0/[=<F)Z\/=80 ?&7:2
M C] 50D>50T'(C[%_U''QU7%B>5^M%F.&T:GWXP5%>9-[9#Q<7F%;%Y#*@_P
MC!Z?F.813W<7_H@7+E0DU/ H'Q"P/2[RJ:8(MT/.2"IC*NN@+\)_UXFPPG84
M\)@ H1L6K @[GR )3$6W.A:&?%8)SA<OL*=%-HC_+EB:SG>P>411V:&&$M1%
M00E)%A<,!"<(1U0\B7*:%JHD5T#,E=60QS$7 @U$#$!G!YE'I!JP(Z4=O9IS
MD?)"XJ7(KZ4]!M^LTB!FH#"0H4TJ1$^-867)YJ58DNP^#?>#@ 9] -?9L<(?
M %2\_:+M3UQ6H&URV0T*+0.@*@5+8H@[&#P2#*2FWO86!.*YY-)$$]Y:-+IS
MJ>)/9T!'6!G:T"!<8PV<<2>$'E,(J8M&28+NBVQ<378X_YA\1VI>@-A@EX83
M1./D.HEJEB+708_K!%U]2G D;9.35N\:H)/TAL./X7_%[UDV;\S1UHSD8 /G
M4U@FGZ'/MLZ$WY>X6[V#ZR-3SI07E+$#0AX]OWW?10DJG6!>0N/&SX5]))6Y
M#DA7^SK(G9 QH1'LE.\?I7SG 95Q"$@)GQ%H8OS?-=I.!4^F05V4(B&KY\G9
MP>.1X%'P<0V,+"_F6D])D&&M#UDBJ@8!'H*@  RP9J91]GF1[!3E'T4:RD\I
ME&:BC"L^!W,U$;$\D#,%&J"JRA,LU3('<W3G57M,@/2D1AN?>@ ;0PF2XDBJ
MFL)1Z$F '\,?E5"\Z=<89$2W ZS),99"?B/<%AE(%/7=$=B/E3UQG1%(E7SI
MN'Q4Z&%<Y#>@Q"WXL+M*1ZL%[MRI/PAR<9.D#0 B/3W;A7=_4'B7M;VX@6%E
M\'?8&4Q &CAFM82$[^U/\S0!Z02$<5E'8_K]0%.9(3+X5I;U=":H2X:.6[A*
MU] .ID\COV1^10%J'V;HD&\;@=]\(#FAM)VR4L(P9+.D0GL7/XP27$166'=6
M53\J0)=/"H$\E+BS ^Z/(-B*W6HINRD7\S&V)?/NGL0L=+B4=7 IG<-,R^II
MP O"U*2\$CB)#(HZ I#+I9HP3."K4T36NJ1LE+IE,+A,E,0Q1_T9S/P$+7P1
M+:TF>=F&4O>TBPDO^9WO^6+.F%A./!Z)67X<?0M:IPYL7^0,-KE^F H(S]7C
M"2;/R+0\<:0VS-M14+HLM>"Q'((J[;=[DA<9T3X#FP%3@@?XLI!E>()QS7#"
M-.<MBZ![&V@IFHA"0%3)-<V;[@AC-$A8.,']RGR[XZR)JPRTC">4]'&#]U20
M$TVD-0K+11R$ERI'*)&:&NIE(J,HK,$@F@L>E&-Z0<4IEX!B17.9>EG>GP&X
MG\WONY2%M,MRQMD5T!2@!RM5;F=$D?,%F/W)528B_!9!G;)D*K85I"KO$TY"
M-9\5NY+^]GH6B2CQ?;O:%B)>F3Z+QTA*H2O 61F!KU4*"*\!(X0R#HA+9*C"
M#=JLAML+.]@NEB\59?:^K^8S? T  /V\(5ZL(INY-F'7G;? 1TG1\_?2>TO@
MG2'M"IYH2"^'/]'?FPA"06*/<JU/*5_$T*4W[FGG^92+.Y&WI>BVO4;XBZ4E
M;( AXY#,7?HFT_8:^SR#CBHL2]7HI()+N4:H)N+P^!+ -<Q\FM,6!EUFDU3-
MH15_V!8</.[='Z@E*;)]8/68*T:<7V84'V? O]A2^O'-TB=UN?@)P*#Y"$A:
M?HJWBCT&@9;5EY@4KLD7-<U4$?1;<YEBZ\H.5O].\W%.\J,J&.;9%5>$XJM.
MBHR1,)B @/???T9(@)#N+9$*9EZ,X1^?V[R++J?=YDJ4IX&:\4BE+NZNU.6N
M4A=97XD(C)-'M=>,&BEO"UV?=3,QD[*K7H-RS8N\+A^B6S/*@UKTA99U")RV
MC&L2Q"H+M)_]V60GDP+;+K/D"]C3/N:U5DZD+@],A)8-43\$18K8NU3+NL)\
M08K"6]!91XF^25BGK!A([3A-\QOAY5!]==IS=]867 H35,CQ'@MP:Q$OPR()
M6I5>,_;W%E3#@9(/741IQ$> E4 8IPX3LLMO)EQ4^F!BTK5,9U:Y B!9]K2'
MHEC??M;W=N9SSWP&L0105+:9"N;#M4\X U5*XS/ KVD2]KR\(@T=655; ('1
M8OSA0*88"-(@%8PUYB580:!]H64I<7U%U40G,:IU0>_@_7CP%I8SPEA5I2%H
MZZ(@:PN$$-(V]M-*<S#3I4M+UJ^@-MUC;)SZ2HN\44Q!(->$L'U1)RS!?,'@
MPJS(8]")!'?< ?.1@'E&1E!'YA0L*7LIG,K]B&X%D6P--HP&Q#AM0MO2MX'0
M)9?-HAQ3U2W2F)/Y)K!SJG=I$[8[6:4[NOT1="MX:4A^Y$C&6.<M#1/AT9<-
M/P4U):<<7XY.*TH!OLQ!?P$3."-WM0B=4TD:"MG&][-HC:#K215(+2@_$P:K
M=H ./*1QDT5)JGA#V?9;+O%B#0]L1M7%>8 O$![*6B4CPS,1#RIB(AV>)#WP
M.[QZ)+PZCGLND!F;\Z(GZT5FA5 Z^Q8I5M")ZFZI*R09#J>5V;)CFI1"*J_\
MFC+4E,<(L]832C?_<I(3X@#(']Q G0D&E@N_TEQD%0J?4C?$0@OTEAPH]5$E
MS$DQ)M$X0'8V)AL9G9RDGJ#C>X=FCZIF4E4[D'F3\HL.<9F36H+\N<+;EZ59
M8-K$\Z9$DI5 ^XDH:.AF9H-XRJN>S /VH]R7N5!>4% )FP=,&\0.,K*%[2,2
M(_<T((36\R]>P'NJSD#I0$$7#8%0T#DHF)R,&';\_Z(&=:<$_5C44IHI0$;!
M1;"M;B16)J\T14L$T8ZI(N1@11$Q-(XKD07;JK=+5OL.A(\$PF:N WK4P@G:
M'&A[H G8A$J$2A(E95'+()\,;.98 35%O;=$ED%5!%T?2,>F[4$1B'1&!%NA
MTB%J1(G:B<.HM([N2E++S1LU!2,A1,Q]3))&;B-'EFU<P2QF=26=PSL\>A0\
MZK260?U!!%5QWC3'WPHUMJ/L4&R2L&QUCJ)*2!1^.^HKP&;X+>Q>2*Y.MGTV
MSO%_TW8+B^5<#-XPYM%#7L;&U,E#VR^ &HK#_SO0CK-PC]3D]B,JW)!*CT3(
M$J-</7VY2J9""$WSC,\' D,'?=MOL$0(@+PID8$<+]"MSAU(2_#KW3N#CE\3
MS!8AL&67!K .J"W"3K-_1+E8( ^"*Y[ 3^&O\@HP!DMU5(:TJ.4-BIP!TRH*
M1HY\#-HG,WQ'*1W&\;+V#50$:"/3L9$T\DJ8 B+SH%-?-! VIDP&%CJXFJ:(
M4I;P[^8.&2Z?0E0%*X$\$A(595<,HFF4[%VYOD.AQT.AC O1>6=U.!6J7*L:
M_E7=1CHY<2Q)\1E83Y25D8J-ZA;F\J]N57+3933*1&LROE;XCY?+!W:Z]P_T
M'DC6@*3;FN:M2ZH#YZ#$*0W(_"6@^U+E#O.<I-S..O_18%1JA?3-E?WN2 VW
M5=X;D>PFC'*1(]ACXJ#&DX=X=3\6"7<90>H4"N W:B,[X#X2<"]:'W^_?@,$
M?54D04W5NPK:W7 XN4PHCZQ)G]+J&9E43;$<*<37J/HU1:8KVKH  [Y.J@+3
M3=DXRS$-CO2"XS\.FU=WM>GSB_?[%_NOCP^/:-UWI+ 02D7: 2Y<:"=YA@X@
M:J,%*[T[.-EAS".&E7KL5X!?2=N.<$6/?<%F282Y"!.6C56G'JPB)]-=^O(*
ML# JXO1-?%=D"5;$T,F@ ..]K"A%;Z7& *RGS'OJ0':'O;$4B:#E6BND"5FT
M)GC'IA'/(,IV198R]9OH![]%LU(N(QV.]V#@+BM+8KKY*%E9^F/D9*EJBA^=
MEK5F.*Q.W1*S<Y;Q]8$ L)YM6"K:\<71B6;LB6*"Y?_6M%\E_3]$2#SY[L^N
M4</B-UN2.*<R7),FBZ!UJZ(1F":89-V1!0O-+"4/+>N9R$L#]AIS<E7!XS/@
MB:AJ4,21]%'CE4J'!]60BDI =Z&HB]0GT&,,(D*<D *-&2D&\!FH%[+KI@Q#
MEF'!>2;K#F9=S4(NEN!BP$:J9FCPM-$U<'\A*2"8>8^>8)D 0<EK=&Q8Z#IA
M<*8Z2_Z-Y6-*0(H$B5Y#+G$+<">\5,=&^40;I>/+,"F&9(,DGZ'D8HM9PL+-
M*7MW#D1'V6".J1^@]*ET+>'D:<MSVV["8I4)3V?R3E3G#SB6J!DJT!>/BW0V
M)FV\>KK7I#N#*ICBIH2'E%>,>BF@,W(@O+!HH-<@SZ3SM,A!O*GWP^D:5SM\
M5.9Q=4,53RCM1%5#FUC$I<L@%,5'6LDPO5*]1'78$I4'M]HU X3/JE8/D>]G
M*NE1]4KN_T!#T*#7@VHL&K6@)#?$C>J]#4>F6@)U0')>!$W/5TP;%1N*X9M(
M%$Z@.VZH_%FK>NZ0TD0(TL0A.E>/29*E2*ZY0/P140NQ(?+24)XY%[XZ6)YZ
M\2PL7\ZX+(! =Q^&ZN?=5K;"XQV+P&F71-15(9(!6G/1-MTP7U&6J&IZ2W4[
M(; -^NU2U^IK4.J4KP"4JE14P0+A\WR6?H4#>,U,\%?@-+!U+C@=7A6J&]30
M#>B4^ ]5.:$.&2EL0"*9=SEC!S #K<-7*YS;BU\I"@8T2Z,>W8J8%?(/RM$!
M4PNVB%QT0']%\%=6BI@X,"+Z$14.(K--\RZ(@/.E^;CF(F:A>@B6$G<5(3%8
M::ZJ7[L(U>F^@:@K6A(VN-+@J^PDB4WP/G>21BKD?YE(%UN7<*9U7F*J7!(^
M0%R?K.@PO258*U&L\?.H9MD)(4=0*( 7?(+8<[VZ*QA +;^OW7P7#Q:\]QU.
MALQR%0-  W2<(T<6&#L>8\5V)4)-EWDA5\*%;_(BC9K#W+E5MG F^!D\>25-
M.6*5I2+;-NP\S8FPQ4]["22=XW7.0U)'T51>5_!._F6<ED8>XL9FH<J?<+V<
MP(1\C.S_6 9PN*H4@'O[Q@$0_L[MTG>[O),*H"KSR&^46P*[O:8RRPT_78'F
MW]@L8@>$!2#\LZ=[QV*B"K9))'X%=,"HESN%3D&A$[*_:92'RN,=PGT'H,<!
MT&&17.,51T@(* $H:Z [':7+_,E]V>3HH4G3\&=J_RIU6PUL#)1/W]&98P>H
M!4"]626+<> !$-(U2VNR &Y ((MFHM$W%0V:-KGPGKQJL#=6!'7I(=94J "+
M\/!1$Y(8M0WL5Q<5Z!QH@E^M-UIDCG6JSDG;2+"S8'999Z$RV1"'206*TSE<
M&T^5UQNN@V=--YN4LTADU6O*::Q\-&BBR!"-C-K2R!!X\D$B_,MNS!8:R72L
ME47XO\^RZXH-3=W4#=,R_AJ;>Y>S\3,P%JN[ONK[RTU7G]V^ZBM*2&<+(Q1I
M$^)KZ<VUW-'L%EV_CW6BNQR_#XPRN?K?I'//*H-I-8,X:OQAW8$Z.?:C@0_W
MGIJ+X>VT_N(_9:YZU$MH*"N@+G0QBO-TL\Z[,[F$H9R4S:&PW+_3-T#Y_P9:
MG8K.%; D$J[TP+7.(F$RR]Q"Z>B1BTWSE%,-;]^WTS5HEETW<&;ASL(X"=")
M=/K,VJBPNG_AZ2)5GY10.$8A\O9$T%AR)8"--(26)A))7_R70F(J"O.WCHI9
M=T?%MB3 M>-V]W.[ Q3?1,4R,+!$+NME>/NBT=(PCX? 78:LD YS-;),A2Q(
MH^[.*U/SR13C$-VQ"JR^0#8E#HOAC^DLOQ&L)02%#]:%?Y3DR"37)6ZOZX)9
MI<Y3/FJK*@V4EYMA* F6 V6L[3ZO&!DR\#01;:]6LW41]*#4Z4[(GR,7KDKE
M$Z>CB0K+QN9371WH-<T$N2'I>MG*V2QA70+OZA1!=A  =]?K<P9X(&]ZB;EV
MQL%A7 (WT.17J4J'0LBBJ)OG0.##8 \HI.RFW8[(YM P$B!$6("^+9$F5)"6
M*6]#96(\6%W?,8:'&;37(,&FZ^8"/?KHU;8);,)J@TJ$BJZ3IC5=-2FHYQ9Y
M6:=)I2(!LT*Z_AOMJ"D-QO29-,7?=><;,@K6<>'>;4<6R$DMF&0N=2T@-60K
MO:2Q3D?PI79IV)%.S>"#AV@NPJ!]PT ^(6? B-_DE(>*:A.3+1""#I%KUQP,
MMY27RV2K K[R_E0 I^W7V%*="+#(Y@F"P2)QEK*>HYG1**.[7U*I=J3W5:2W
M+T=R8DA>W?":I3!-BH6]"C])CSUWL:37IJZ7 A]PBCIT>OR@N=+.'D6R7)KX
M*0OZX<0D&LBMIKS1LFI#A4%4/:Z4-JI=*+JF5TEL*KEB;;UW77;,&!J8VASQ
M9I)3 O%-4D[P6VQ5T'WU J'A[4QK82HT"8"J!9)@7)%DJIC] /RIPJ'?HD!%
M^F]@LQ@7RC,NQICC)!3,"E#U?:BPB%?)GL!=A:?3]$*EK,BCC=,\P+S9G8Q\
M)$)]JS3'!A:"J=_M^5TS'2]$,!7V=Y = ^VJ]@KD9=T]1S-<&%.CVMZ3\L"D
MT:&(T:JZR$!3Q_ <%?J5352"2B^P+$H2@.K\A4\,FCR:,;D4&YU9)!'(G)?]
MLJ^O-BFY'4[3X0"*+1!P2H8:34E,2G4;$@U(\Y+W?K),<S*+"D"&WP@NV O=
M]NP!+!IJA"Q=CYS.(K?3C4&KH_2&)C=)0.+ML-1LD;<LS)%MNZ$IE3BOJY2:
MEI+2O"W-[_[D E5+SJ_:3M D&*J^92?=Q])U##P4E#G 1V#30CDC96XF=;..
MB:(*N1H<VM,N<N6AZAER\D,P'.4$OHFH/&MZ#3>P(P-%X)%R6(F>=#A97?:7
M0:+#[C="QDG)*1/:T?M5D]HHC!NIH YETI),X^("=[$^0HI,M"V3"JYWT-#8
M@YWF/9;FF0N@MY\<\AL1)C)'JCBE 70/5[XM7KJ[W>[MGHBJ7&5B\.DLS>=<
MI(%1UNG"E7]S]'-W[=UK1^'?Q@0[G:\H[KE% H)BA*H' +'H. ^ER9IU50.A
M*\"^%:.<X]1O:N YP>U.0$Z*VV@[ *!Z1*R:TI.Q,NB&45$1!24[4Z>ITJ?;
M>8H$RY3=)M-ZVKEHNEP1)GUH;^D-2"7\M4F<WZX2 (D=A! B-TSE_7:UM0<D
M.Y.*)SNOH)(+^D6ZI.YWE&/I2AK@#REMX[/PJBL7DU0@YPM9]DG9?0F*=&7@
M2N\5:''2CL7G2UJ?W,MB>=2FDTXZ(!4J*.NYXRLCG[?()KG3BWU_1OU :.MM
M:)"V0CFVXDY8U3>Q,R"?"4OC)1DZ: _0!.EDVJUR'\O:?97PW0855;A04_8%
MSO\"NW9KV)<T8*36*@?< A"7S9*>54,&"9E.Q/-P;"[HEN,'ICDNJ7N.O79+
MWGBQ7B/>WS.,3D+0TQOFVE.?_]DODAF]7,-A)1M>K+H0;+:?6+#(>LDI$3/@
MM^@GZ#@6EGW<5&4D<@2Z[88DM;63GT6&% D!X8K UEXW0V+JBUL4,2\TR)7_
M6RBI3 .&-%[I0*>-I:S.PHDLQHV3HJRZC23:A(9,.\5P'*YAZH8E?3!9^PL<
MH(/U[+<J)\/4=5$),6CX/PT-06U%.&W(',7"-2$#< R2N%92?$Q]H*LE1%-M
M#+S)FC55Q#90Q3Y+Y6NJ]8*2$_-N8QV:*H3I4\3/E.$:44(]05BZ?I8.Y3H^
M[0K!(WMURB8=4=O!,-;^T_3\/5>;BOQ\-5))6OR=%37;^"]:Q?3_JQ,RNA:W
M["_M1P0DY6@UV1Y+M.W998H\@+[MGRM39 /DH[DY\A%XVM]"/$HE>AWB4668
MK Q683LT$;R1I908@Y7=K2B\+-WO;2Y=UPQJ_"S*+YPI$P&_(6G3%OE*9C\E
M>;14]-L6'@PZ/9G5,+#^]QC:9M0U1_7F4RGN%37EHRERN3!3U&&H\K-?ZRFK
M_G 65Q-P6PACJ&P;ZJ9!1GJGD$JD ,A>OJV86C')"..,0NL8M+5=<NLDV+$\
M<'4I5QO=:,JQ*G)0JTL8+)R^5\O=2M:F/:3J#CJK"VSL*2.AHLVO"&^(@*(Z
M#^[R'V(2'UB*XET)RU 8MT>F V(1KK Z>D>(Q5"U&!.X8779WJIYU92:7>.'
M3::E5"@H5"2Z(\OH!F+559;?I#P:8]>\UH)MNBL^?!3/_5QY/1/,5'IM.P9&
MZG']4G%5(2[+4KO=Z6@.CV@RH#"U@_:#9DI<P'G6*="G4+NT[B?)K,G2A\M6
M6FBKY(&T[%4C_I^RR>5M:O9#7HLZ[K9V7^ZK9YRK.'*G$\$",1<\+.JD;4V@
ML%A@_U"A,SR#<1QT9 @J7MY)RTXZ!Q4>OUSEM:$ZN? #8F/J?*JEPKRL^)2R
M>K!=<J?9 IQK7+"I@(UZ2NT6&\97257+A)LVDP>C @<3S [4_IF78H*%*,S2
M3@441>_N YK#B4L?T"V)3]_P!%DQ7(M\YIRV)[X\8?.\^?4)!RCBK9ZG.0#R
M7[RJ!%7)'E,'LD_X"8_@$\&ASBN&R!>IQ0\8-K 4I:)B3OTW]J':!)J[D%S\
MR^W9A-$A$$/@A)2;]Z,\ )V5VCZF7WP"IA<R;?]7[?F[.DA?#+3C% R$)!/9
M5B=@OEUI_WK#]@?:(:Q75BP"@GW#<<9JFW(&]P'6A9RR!]*DX&V^9= 4YK<B
M()?-H]$J;3V N3)<T?C%Y):.ZZ\AP 9MR7=&PN61N.O3Z[S63N=]:IVW;9*P
M#K5757I1OXBPEE4=("=+9/)2[^OT<>C+T3WMU[GR$JB$S%)VQ!&^&6" =5;)
M9MI*$Z*ZDU6*'%(?%TYZ*?%D"Q?*J5*41_YI54I#$A:3U-K$#"K2IQX"E$4C
M14Y+IMB/)E3IG-T".YKSH KJ1-@(E\'4#A%Q$'*)9VVS2N6C:H(*(NU+\+]&
M7_Y5M%)N$MQDU0S>PT"C/B X=_ZSNG'5) ]WHW3 ABE)#WU2"%,!^2?QV:5J
M'U'CVB:Z%&PVE]DZH@/!0#9F2=HYNDU33K0)DF9,MHC=B(80V 6AJ,<],P$]
M74UG:!$2D"E$G<O&)W$RX% ,ZUW5N:8;<\%N)-L2K#MHQY9L213D3,Y,5.-2
ME(^R%<HB!"*FP#?1GZ6>/;)#HRPU4&V\>NG7.!420#V7'CXY:UB3XCDO%EZ&
M\V]5\1SJ:RD?"ML:WS'$#72&B]VC5>QI[YJAE?>?M%$_I@%P'AF.0!N4RCX2
M4+K%*--_Y2CPM9,DRU.@3FR]_TK;!VP'U>2P:6 J-O8K, ]LA5%UUFM6DQEU
MO]?H+^X^"4NJ)NC1*^U7-@<4&)XD!8/7JG6TMYV+>X5Z)A#O6R 6[5QX(LJ!
MW!JJJ3E=V/X;^!?BD_9&\)?V-]CP760 7R1E67-ZCW:!.WO[]F#Y$OKZ=F\S
M ^WMWCM:$P/TVGD-" \@4:\ZFN:=ZVV?G"^_Y*C&MMS #\Z;W/U7VFL,.PA.
M<B+]+,M/OL]!#P7K0 @U//?K.AWS'AS$=O#?A[?+*YR]^]>9/&7STQK8,X8Q
M^A\?@Q4P%O[Q=O%S_N\:[UA.9CC("[2]8 ==0*NY#:30GKY9N,5%/&EOJCLZ
MFK3N*5 _X(8\+Z##R1QX0[1TV%-DQDS]ZQTOKH"S'Z53M&+D9V+4 RS</@L(
M@%\@#M$P$_%+LG;XE-D-,KU"ZKGAF+%9MC/B5*"%"CA"1E- D>J_PA#:'%>#
M[)]'=O!RW EM"1+I(C%>5>)*VR%?G0)?R+ZXLH5AZ[GHE0K/DAF)5B5O95Z!
MS*\84%F.1,*F*6 O+2+/TX5FW11Y:\/]"#C1<J!EVLKD$C!O)W&1DI!G39(E
M.BM !2E$U*GKEU%J0T>8X"Q1ZN.[@M/?V1!2CGX5JIMLH#"02-;DF\JYAZ"B
M%N/6_Q"2"=[3B]HRG<Z-=/8I)B=VAUDV$\FN>=L-N[VH#MP&#=!Z4/EZ0.P"
M7@\A3F=K UX2&-8F-O;JUM',EO0G) (UW%MF2JO>[@7_MD08>[&DQ?\[)HBJ
M@I:5[1=DV<<W=HK:W6_G?F7"X>XJO_\J0>:H,7>[Z_S^ZU3I5DV&J"R)WMWM
M]]_M0M8:^0S[A>>[6_[^6VZK$#M=7<E5L[O=[[]=:L:-S5.$0=0=BHTC^N2$
MR%(-OEX<W;T#P6. (+OFF<CV:5G([F8?0^T56!WFXZP)*5,VK?)I[&[Y$52,
MMBL=!;>&\ &/^JZ6KA^*/!:[BW\$QI$FG8XVW]%,=G>KR[8<LHH;'I1)Q96E
MO"VE2(O%$S?2%8F)H^PZ+UB0SMO1"]T@5BZGZ[ F!([=2Z1K9D_[9WZ#8?1!
M4Z39?98BU$VKE^XWE/*&A9.\.RQMDI0J,D%^[[:0#-\O:B!$L'>9C7>F_\W0
M#UK(@1:=?FIP1/5\4P0Z:#VU34_F7II--_C<C%F3SE4QHKI],R7KL%DSIVW0
MUKATFA)$.)I2I>,NZT_4^())<V$@<C5%-F@SWA1K%G*U\K_K)+P269DT $_T
MX&@N3H[GGHJ<7S@-P*.YAO9 TH_>2TUL&EZ)X]+XW5AF!*B1J05=0_=#C7KM
MB%F=-'M'Q/AO<$I.ITZ'$N?*MLN6R%2E=.85@Y@%[O#NC.5F1+G R%Z"[]JB
M^??&[M^+H94/#-UO0++!^Z[ROR6<[CC3]@']4BS]L3$JFHTQGP2(BVJ3$,G?
M%4 #HI!HOTF4H4 O\L-]T<5)/(YS/?=/]@=-5CE%]/M=&A7521+"&G+ =?%
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M>,P A:,PBJE.]G"?;HRP+J+>\R1YY2 I4=)*F?/-G%QD#'= 1C0&D+BO:$-
MIER\-8HY408DN2W@Z;.PRK&#KS60A<5J@]0).Z*84E2PN-+&=1+1K41Y6$MQ
M@_H*&&N1*OU\7; IIZ;8"++W;=CGK,O4.A[ PX;:+X@C/,>-OY#5H70TM3)L
MZ31OO? =!WJ*JR"@WS>%(OCV+[YEH%[3)?F!=$TTM7@,^1<Z6"+*@)$P%_D9
MG;A6W)Q<M+$@)4@D]UZ#T"/;IFDL@(=IV3P 73"XBPYNR.0=+HN%$\P;XX+(
M6C5-:,,+Z'('FM0 *C'#X2YPBFEM&"!!_HC.O39]EG"E*9@2R.*UR-)-^Y4
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MFBJ#<LGV%'Q=L,HN:]\6G5A>L!*A90.XQO^5YC?(*.F.)1]3C3=(H:/" N3
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M(QR#$-WC.[^2'=&(\MAR1#!:P)5H)VR#G%'KL=)^<1>F-<]- ] ,Z6WBS3>
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M%K+1'@W[VGU#O \7%V;&1P 06$-#.XDR]U:RSGA/2RL_$%H%LLF/I:A',0J
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M2FZ7L%'W2_\I,AA-N2VELH%@@5&B>235@=^\>G-^+AW^S!I97@'. ?C&RNI
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MM7?1E23>'&6[@C5+03:[9P=HTI'JV&[0U_*J9S4%F]%'4RW+A12\$;BJE#8
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M@3)E!+Y@\%1+B_<@J,GA\ C*1WC-K0#:7-#/=F&.P6^VK7!^"S]ZL0Z_;/B
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MO>#PYC3JC,F7Q>+AUJ@JC,-YOAKM-U*U"+RKOC(RP>H;9L'<:PM.3,M<?ZC
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M$$=Z.;F=-!LPFX>_?)W:(UH5(8KJ@#D[$!B]]+5J]>O@*M*!+U=D(T@2<O3
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MZEJ:GN>PYH:ZMJG7G.H1"BI94UWD.H#,_DG./OMG//&I1)I[N<#)#R+SHYO
M[]%H@GZ;@JKN8^XTZ(6VC$5\6%]]5,9QS'\K;$<#1'*/LMNPXZ)+?-O;,][6
M<D7[2+'56&-_Z,ZDB'%^53?Q[M08B=V('+67GYJ[U1#?$UD,:[_#H"&(U7=[
MDHO1&]@XPZ[C?F&+JW UR7R]J?&A;@&CKCNO@$(ZQ>:JX)TA.XIX!_2PU3NJ
M=^DKWL%5;1&R&--.%NYZ7518*P2VR- 0&T/#P]N:.*:&J\7W.E<J=/8;R$YR
M:M22P6NJ8*FZLD-.Z]9<')EI_122XXMP&" WP5ZF U<A/ECA7&% !RUWP:P$
M'/V4_>YX'+!^;ED24S Y-8,!H[2;XP!:I0I5X,:7:Q#2V]>H;,3!F!ZQ;S#>
MU-?B[\2.T'S32R\360OV3'V VDP*^74D3O:/4TT#HS8DT:NNV8",783F@&&]
M%<Q24B+<%-.PL1_Y!5K?*JG!U&%8SZE;0E(;Y,XLS P[M3B8DZFO*\8-AHRQ
M7NS;>.'H+>,M/O%ZC\6C/V\-!V@RSAF3#NPC+UU*;)AS5B_:G4 !Q'0!U>FM
M=]6C+DYXR,?ZL7"> ;\TQEN#WU3F< H@!)M"HH=\IN@62 .12LWG<Z,6V]2.
M+'8,40-.P./EO.\4;N46XGDZ>X>2!<85'+77:!3$1:M].M,E#'CCM41+<'03
M6*C8]<E%\!W\?P1;Z1:6EI)(1X@(1%T%";S*6[*]@E<5U'08#=6_4BI60P_I
M;Z;>;2NI <J>?:\<D'\(V[ 51324C,O'YD?R9($^K/4-FB2/W[+FXFK!VZ@?
M'4WQU8]TZTC1@>K[B40YU_95^_1(R34F<I<4UKN*(6<#Q) 6AY&3IPV#_W4:
MWHIA8JN$@PW;4NET,(\8C '6#;K]2=I<MGW06E^:O1$[K.+HSH,E4#3/_\]_
M>240_/RBWFT*2=#)X2N6QNTY3'+=- <-M=,"!5=%,B=%3/'/@]"M2K[Q.2,4
MUXIC%<GBP;1F731TAOR=<!TL\>(DG*3H8"7>&.X1Z="<6,1L)J5Q*73)H6LM
MK#DW*I()D\6HJA6&B-!0TR4?.>W%<-T\G$O)8OM.W;@.G[351B##M>!C>I$&
MHXZ.S06*1Z'>HO)2TA  A"#<*> -C9;/D,UL_^7,02G3H9QHD12/Q;H0=T34
M(MYK%SHG>.,ZQ"84)*6&K33B.DY4/AY*I22U'*\&M3)5U )B_B'N9$E1O?34
MH8F)7*NE9=X4SMG((D*0APY*$HQ$U+?BM@9OU&H7ZO D68P5(R*' !X P:%V
M4@P2&YQZR0&L>M;;;5HC- C%\Q<H9Q+UX.GL!RE?EBH(W4%_AGU<VQ_C@3QF
M8P.#NM]'YD.66J(()M@EK]XT6E#E5=8FC-::AGM)='AY%4OUBN6Q&(>OQGVH
MYJ!:-$#8 OR1=S8..>(0CATB"YPK^7,M]K:59; H0%"Y\435(&I8N#D2CJR*
M9<N=5!2814D(>X*Q6\K)L/N\*2ZI^I*[]N8"FI?^/=]1K%EA-S37$K1#'?3Y
MSRB+-! J70R]BL(-T6I5R5+P9S%VTIN" .@E\9H?W% !_X3J!UPAN<A5IZJ6
M;*$M7K\BPC/G2Q;^">FR)D6B81] W)@[5,1Y,/U:&0Y9Y%8!,HC<97IU<) '
MJD$&I(/X!</BKH'6+4-AF 3L':0EBNG3\Y;5\;]ZH9VC6W^8>[P9[>L6#0"Z
MHQ-9O&O K#;D$OWQRZ=/3I\P2)R6F@H>UM3,,R8)LPO=252,8X3G$!IC5<2.
M5UT$<I.GHG$3;>-F6 J_-WA.V,H:!$?XFQS=U!>22J.:J**Q1=LX]NU\2U51
M$_ML OP)UO](5.7[F-8<&4#)U1&K7T=Y2636TB6;C!7;=9RDU=1;=18[<-B"
M,=,ZHX_L'-A,5$PR8^ $! +YTT.1WJ"5J3*&JO$8T>R@MV&Q\T&(9J5*?T+P
MDHG0,YTO[FTXRRL.ZH[=(KK MXR/<P# ^4EB@]\'%:&1/$NC^[>Q?$_F##4K
M2-%2/W8)=_",K\W']RF/)71Z&^>MQN @<]Q.YXWI.D0@V@K67%2WUDB_Y(_O
M\XNWR2\^/>K\XAV(_4)[#'$<?!"+_90E&!UFH*@M?];J'<K;DP'A@0!4GSG$
M%/F8JE%:[3+4JH!\&?PAKN/SU8%)$S:=BE'L >;KWJAIRV9<#),\,C-%(&5(
M$CV1\SV?!)8\%FO_^U%.E4NV$"+LE6^-NI0DA:3^M.]4&N"L,.83KU$L[;EI
MF\2Z&$K3Z>SML/(SYX_82K$WYFZL?+NE?)C\(W.7%8O).2 YEXP2*#[Y D$^
M<\*\%O8R=)_3?'(*15)0X<3J<05KJHW!!*YK$B"BGZ7+Y#W'3(8R)-?,5(S+
MS^#=^[?G[\]?OGK^(N.^WY.@?ZG.M=_"T)@%9[JI'5\++H17_WP>R0G> )8,
MONE261!?<U>K5%[16_&[-Q>ON=@%;A'2?ND.^R92A?%)D&$,WR^IXSUT9*=W
M?\!H>EB=#+4&_WSVH#B]/,V$,4]*QOD_RN5G1V-C<A*A".?())\[,5K*5)&W
M)*RU+6]%P97Z-3EIX<A2NCL(3!"6!<)*+D'/[F>3:TZ'BC0=?(7/SD2[GWH7
M2^"^RPX*EB+]*$,"/%8N1Z\:+$ 4I#IA_ W-[=)) EI^O9BN=TA/JCO_-F+-
M"]PXOD&=Y*;\0+IZ3J;B$M95CD2&,)JASLW]%SG*Z)180B=HF(/+UX%L0JM[
MPE LJ6CK$FBPO!%O:ZP, 4 ;W]I.:4CU(!&^!3."TRCC W0 OD-7[ *RP"^R
M0\)T2WI,9N\L.$M<C:_?97K]M@?T.0BK3RB-HP.O"5T -8O(!-+UPG'OFDB0
MP\(#\K QA)^@"@7,UDD@G3']9E*6"^5MH@ZYND')V#1!?H+:O08L5'QIT((1
M>"<_IF800\9O= T'O "-]$PM-GFYG; :#FDUK6P)^H0"60AUQ;!4[ &G%J8@
M/05VMI#7\#7"?V[UV,R4.#L]6QP-T0LJ!D\U5R$./P[= O$6PW51/+_.Z0@*
M@N7"-SLPC^P7W7XGMV4^NR38,OB"$>4)AT +Q)S1%:,+DKOT_;!QQ K%B*(3
M'RI:\HDNUW4M;(R:]#P6,VRP!];9JX)=#)M@&F!(BPT[OCFO!4+?%T"OP\X4
MFG5A(QCE/=$.AD 1<MWF(R:QM:7Y;]7!0P*S^5ZQNT11XQ]IRS*7$_GA3:4P
M1K;Z]C"PVS1P=/Q"%H'<6'0JL*Q 6L1$X42EN!FJ1J1]SPUB,&]6 Q,'/0X3
M385MIX,<-Y?(%ZBI:FF)R,)B$3M2Q?#SX_R!L.3+XYH"T78%:Y&?ZO*/ -\X
M:H[7#=*\TQP ,8L[?BE'?>0]L = ZLN@!198E!;S3;[X8!4BR+JDKIB7<MRL
M7(P^J.D:-K[_DNU/WZ%5=$'+51(P!1$"Z]'P_9.JZ% VIIH_UH^%"1^+AIG&
M(Z$,'<,9<#!6,[!6UYM<A82(F (:W-"F%^0@2_J"H^](P5*1?JNE9(?.ZB8E
MAJ;5BM3UY@IT>*^E:W#>U/\_>^^V'<>19 O^2JXUIV>DM0(X(B55J0Z?4* H
ML4H4V215FO,8R/0$HA@9@8X+H*RO/V[;+FX>$0F"$KJ;.8.7*A&9&1>_F-ME
MV][4D#]]R/L\FKBZ$RSN)<01X4%P?&O[@BK9@H9R#<RI\7B:CI5?4E/./5?*
M9Y#84?D5JM<21-;:&['U<"Y38IA]:,%RQ)VS36(!T=2D5BGY=0S):7[;O,?4
M&WN>-BH"&]<UF0UXJ86#)NN:D,Y*OD'(,"T>0NQ!)ZYM6><6:^TC; I'L\?%
MCD[+^6B[DU7->#%J<F=^8G8NJR87:9<,>042\';'4 @U"'(D2LNKG1Y&GU+U
M?LWD2V1"'JUKS7\?SD-)CD05!*_.:\0E!/[7?6?DFA9;<QF#LVV<DND<G3SY
M[K]XBB@']?1/S_ZKU2SS<7CR#2_-3?NOT C>QJ@E4&27-)'?O#@GH#R9E@EJ
MW%Z;B2*D5)$_VUU$9_ '^78!9ESBKZW(1XQW_3NT\%:OJJ:MAQ+ZP\]69W%]
M-.7JN9,>I@7VUWH,)%0ZN.O9U83!_M_)B<I^^=*IQ#Y;_;7<QR$^>57%@*:T
MZZQ^<F2\ST@/.2[@GZIM4"WAOI!'HX@9$,75V0_/2&>YD13@>RXWT157[^D9
M?OKI?/ZZ+ "]^EG<"7_;8O73Z1NZ0TMET-6[,2[B-;5"\(V_W[5N(-,O]_.;
M?#^2Y8JSBH<'!O/9Z@4UP?/>?R5JT_-?OFW7<6?^V-8XV>D-7XPU2KMIQ%DB
MFOY-@M'3*[Q^\_?7F<SUL]4/8]EM*,+._ZP8J+AVTL7?P2S%S<]W.6\[6I;Q
M"?R4FDPU9?-^_F$RBM,5D48J4^FEBO@N[J.X"N1]X\2_VL==MIF\[+/5SQ3&
MEOJO-X&8>E;?USLZE.1O.$OHPNFW<0'0![1:4!+G;])#OPN[\ANZ"S4&],\>
M#=D#&+)RM8UN U)B118T7XK.M9%NI3HM:*"01--R\)5FB3V,DP KI.5Q34T=
MR;3=?V'ABA^Q3(^+X$$6 4]G*@697Y/1K0NF<UV*'%VWE-V+/M*01%Z$47GF
M*-FZHC1QN"KKK83N,9*-D7-T'H5&.7YK&%.Q@E,E/9*;UN+$W4>(9NH];,5C
M)?\>:_#KKXZZDO^XK3]Y6U.(&"@KS?@XH2V4343IIZ4^%6HE,ED!^V"M"8FR
MWO?1[;NNK@.8\"6"$@T+\7V+U+>P274 T&FI/6C;.E=BDP((/#\.E$3O,A4W
M7]8UI>U+=6TLQD;R$*V)VR2D1%C\8PE(?U0YNR+96RFIK]92?D)""8!K5 Y8
M\(KJ0BK'15QEX[6J5\5WK3940F-;7!$RQ$#IVH"K]KH<Q!A3J30&FDH'"5*-
M/?>I3DWYK8+E$WA>+R<4*#OI>ZZH"'89_=O"$FJ;:>CMI$&B\;ED+&!J'$]R
MWZ[818U;%Z6V D$>ZIHXO+)>+T;,<6X#9P:T#SJ*P&=28=-7]$O^6);2&Y\3
MJHQZVW"T4_8\.ZH'P$Y;0R7&(4DP"><8BA#!35#%>6L S%CBE.A+<]:VCBR3
M*:N%%@EDH*RJDW"^/JYFL?1XCB@WZ8>P=UTWE)_BJMR.6\?=9_S0B;",, *+
M]\!UO5=;;FY*TNT-1S/_,VC 1=5.FCJGRWQ;A7K3B]X:<IEYYFH5O:$K)L(5
M&AC97,*-6:V#II)3NGPDE9'+G(J2"J\$QQ&@]S5!%MA[Q-'5+3BB>[M7.D=\
MBI*0$43>!BZGM?;)Z&]8Q'32J 3W<2%I>RPSK V^LX3@I'*5F+*T-C?M19DA
MWA,;9V$?:.)8=H<)%D^)/DGODV@-.!5D[ 5%FM3-)%6UZ<:\HRJ.89Z^S&@U
MXP>:8_CWEV<_?/_SZN?3?U"692EU4D!O;]>N7E" V^D?%Q,\!S-9\2)A=TVH
MX8^&L<4\=-5K_!Q:S6+HG_Y:M6^5GVF2F:$O8'1R;^=XUF9"G  RW]!95&?F
M1)"'2K N#FDT/X_9ZH<(!"AZVPQ*&W)-C2[<;A/'YC&#\A C_!_1KZZ&_>-@
M/L1@$M^0U \?!_1!$@&H[SH:*VD>>QS=AQC="5FR1C2.8N!QG!]BG+G;CLXP
ML;86.SZ.[T.,[QVPGYP\;1DZ^3@)#S,))"U?*=6)&)+'L7T8-YA7-K@)-%I#
M\Y)F$A['^4'<C812 _G 2?Q#<'E]SLVF.@)2_X]#_R#FHP:!F==;>!S7AXOO
M0$(1+OIJ"!H_/S:-WZO4_.3H2\W_S2/X2DC-E$;(BB"9<IO_!$!_85>:JETA
ML:@I=B]#%/^L_4?SX](A+JZI8J#\+"1XBY(<#5@O;:Z5@<0=242]M\L;XY>C
MF$)26%I9EIEN#?9\B.HV%P>LVXL+].J$;3QOM(*(?'^F[<=RA <\6[#:9/K
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MLX=/[CKL;;>W)S5T)4=K(+81\9LFR7YO[)J^M\E!C7Z7 2AL4E839V$3'7%
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M=H1 H]KK\]$HOK5Q.I1= RZVJZHW!VEL9"SAT?1C!^9-S="Y^1&Y- /WQ ?
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M_%0*8]Q G '#51&#UX9NL7I30D_75@>-!)8CJ5^];)KX^DB8O)=>B3C+9[M
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M"RUQ_LB*<4O&P*:+G=.9Q-"L$=QQ_3J*4=R:VY9)-[-KJ7#O:; ?!<D>8DV
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M#*)'!?ZY_IJ@<;J3SU__X^7SDR=_61'!;-A5ZWM9^\\ ,,4R*H0%O2K_%9T
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MF)!_32JL$D!SFMR2K:F4GZ>I6VU11UE2MDZ<^W8(F@,RAK CL?0)U6'&8T]
M8(PVQ[S(P;;C0&5MOU"@5F2\*D[(2% 4P))1(ZA]1_+YW!#<+U&8]=F1[,PI
M ):5489E#ES<HK9:,J*U0ZM,%LC'<S%TC53!W.:^S7"5U#=HC5#>?2WI0*J+
M,$J7>UA18%M.IA1_**_SF-Z^SRK_]JO']/8?RP__E"RM05( U VT)1.:2X0\
M)*82ZLA9(G<2%L8HM.I+3]S#J,_<@O=4?<^.,6+G8-M-G!J^LI47$+6N.0H&
M0MTZUTC<&52>JE)#N_[ ],''8L>%>%7KO^)I\C R;L'4?*6B5]ZT%5/W3T)T
M"<4T7W]-+*!($+ \-W=M)P?/'PGD9X3?2DH?6ZYY/OGI0BZ[&5VR7MAGV4-G
MC)1Y2R'#5TC)7]"-HJBI[;K$QQ)]@W)LHJ^\J=#>(3$K,/(;[2H1'!4"># ^
MP%=#J395/7;P75DF;\($9-',= 4'!\ Y^/YE+_.Q36<,J#D#'&+/\AO79MCP
M"+@8P@]/:<=$?!W@! G$D]Z)J7D=,'1.5:.,Z^+R^)=+C@\7M"U>3\;@[JF^
M;;CEAV:W(ZRS=#2X=<0-$;)Z<"B2--$(LK)*=8S"&O;&]V$9QC!!72$_PS^;
M>HBEF]O\1-<,H]\.'O4Z!2],Z%^Y&159>>O&R:R02R&&WZI>]<;51*G_^ZMQ
MP(X-YS[=EN2@P(W;_M#NR]Y3GD,[P[3WC9=&(2N\A)/DRW$\23GO[7M0D'A>
M9WXV1;NF1!#B \U"]?H*18I02O7*$G,P7=_'C@)6FV3HA&'XHV<(.X$?VX9H
MGJ F;H2)' <34KCA5DM;X'06#7#Z-5,JS'8,!-;>3.KD(]TDMK'B$G/02'8I
M60^/Y&<5Q$'HI-);42J, Z YRW(.^.7 %<=D/)& E8Y^'L^>1*<Z3@RA$T<Y
M=>!PK3,9" M $:\K?E?RXIRC>QY8",^P,*H$D7?C[8C=X0[69A>297S-M$:R
M3Q'#:8<3",$%39XB-J&F%D^^&Q4Y'H=?A1[QYM.O0!":LIOB%T07X29\+%!(
MW74S"F'O0LR0Z65FQ7&R3&,:M]9) 2G?\@X[3L/XQ9,ON3KMATH#>^D/V?^.
M"%^957P2XF!L+_O[V>J+IU_J-O)X+<GO9 IQDA8K*9C'SOIH0NL+VBK(:'T9
M[_0UOS?G>:#=*;7Z+[[Y,J76:)D[@,'!%>^?C)L M;4&F"9V1?T89^XG7"0L
MWQBRC5(O386U3UE(:#G3X(MW@E]:"_'AL7BI+[>V#AC-G"*&NUTEEG05:+WE
M@K=H6N B#)WXM(MG<@;I-,USG7'V12?$K3(J?K$]GJ1-?=Z5G\=6K3/$<X/&
MU30'%-*D9$9X9Q?F9Z-7XV:8S,_V*VD9[W])E&\KGO/>-\O9$X:&U1[E?#"T
M:D5^F72=)I7(>,>:6YD'ZN\?)-_U?]A[]^:VC6Q?]*N@<F;V26Y!#)\B%9\]
M58J<S'C?2>)K>7;._+4+))LB8A#@ *!DSJ>_O5[] $&*E/4@9:1J/+9$ OU8
MO7H]?NNWX#8A2&9*E;/>58!U,M$=WEV95_/@Q+$M?-),/=4?O<URY[33D*O>
M6S6&RJ:\NSIN.:A='><VAD83',19%1L5!IOJ_*%G[@@\][?V]B_(!T0[ W#^
MGE(2B=IRJYV*BKF4JM([<%: OI1]Q)I25O(G%"4\X2)*R.,B>@GL[@&6'IE"
M"'!&D<HF\$P0O;>_7@:VN0!EADO+9L9?082^],;3SRSO($.8C3E)"6Z,OMFD
MN9)01(BU#K2IWTG2'2%+H%PD$,ILI4X9,12O&T/</#7:X-B0NCWM96$.HQJ-
M%;(M&0>R$N!3OY/VWWQ_DT21*JPK2K7L83YQ62%5[35;8^YGTQ$:&Y>PR&)U
M1BBH\-R&F&%W]%D&-E*S\5K2755(FA6N;N9WW3*$L'8 H?VT*4!FX(J;N(?M
M^IA'4P4^5O ;%,Y0 ]-_7+__^!NQ\7.U-9K7L*/:8BZLL\?*RI8>$JT=(]<Y
MP[%*R:..L+@R]%UUS!=!&AL:)NHQP:Z&SRW6#Y3;[0+FJGF+7_=3CJFZ2S@&
M:3!#GDIWZT#8)Q<7>YI'=]S29 *A&"(%=GQP4\9AXPVH9R1#A_ ,"E_D)A^P
M2NT<C#.U@%LUK\0]K# J++']+VVS Z/:&A /6NI+I3]TO1I/Y%^@J-^YQM-[
M,9X0R#5748X16N8,<'IV1I:V %G3A-P1 T"4\*J>I9U*%+N?V\+,8J+'X0IT
MS=0A*/5>;R-6#J.P7,U!-'_ZK"8K'!:='7UNKY66H[\JP/R'S":&(%;H]$(U
MJ(6S*MBA1R!<-"_THVF7P!-G@EG4C5"*S\$S:;&@/Z@5!R>[G:!%:HOX1>[\
MF#?1R& :D8-?MPB.JSDK=:K>8 HJ=2CH5,)\RDJ$9"V1F[W$O  #&L]?ADS)
M4@KL#;E)*NV55.HT2:4O+#K H@G'+'>C:$MJ3B&,+R8-X:)&JB5T6@/-B"S7
MT(]@O UN8B@_S96-0)K63Q(H127(TGDJUN[ORF-X0'96R%L[$Y:%%"6BM?(:
MC[F7> :(#\3;DPRCW!%4IMJ>O-"0FGJC.=U:G<\8@]G0.X0(H-/*)9)G5)Q9
MIG:-G#)<U$"LB.R@"7+C"(.[R1M)*H>-OQ487\#=9JIDT7NM[Q?"ZJ.-DOL)
M?).&HD_%V$B-*CZ)%]RE'[JY@4NUO.]1,%WYJ'D:Z'P@.D,;HQJA=V83NMD?
M+Z^'.U[Q;\5)=Y?&';=]*^^#=-FCX"F58A?@#@/L:<J=.,=LA=8_2>X @<)X
MR3TB:6'&3G<WZ^,^6GS_M4*\3R491\$<">6LF!QGQ]08JZ;R;$JH0_>X.U-U
M^3A.Y_ ;[G]>D&U*DTT1-&M7J4--#BM8S<01K3:S#?"Q-,;%-E7,!<*W0NO(
M9C#:5)B<H.Z%-FV(Q\31]U+V3C:9I[(Y@AX7;+R&IH8?LTY('TA5ZU3<Y)TZ
M) 9'*!Y32#("2(\43S4YR(90FO(S[KP*8F517BFY TTRT!]:) MW8E56I7SA
M*)C)$F(6%JD5.!(A 2\_CLA2"WJM9C6$%I#][SP;1\;_1I>0=8;#8H"]-4E-
MB#)"F+,)Z_GK@"DE"J@3Q[^T<7$^ RML_"-GKAM*O0)?1"A931[Q3B$ 7(Z]
M]GZUJF HX=2D$*P;R.E&1\HDF$]N&>IH($F/\AR[2@/G"KHIU)^DA*;5U L-
M'M0*_K\5:&+D@N.,%>R,UD3S&)-LD-BF?YB4J':W"D5I* &LV</CB+\[3WCE
M*G4/2L5&<1.)+!V\J]1\DPQ],8-,N-DI@"3^4G]$] 0\2-LGQJJ#E;H+#O&F
M4(>YY-V72))]DC@FFR.-[\\05:+$7KB>KAGF=%02ABX\U9B+1G(GA+$3!@LH
MDWW;=.]\/K>QXHPEXJ*1^H!R9MJ,4B;[ /\PCM?V.X]]+TD+0]8L=#@&<![P
M.$:RPD;;GK7\9 ?$BK<?+"N1*@I%R@E=;J)5,[)LM>+50XSK;-Q-L-*G-+L[
M V9.Q_H5&LI]#4ASJU"B%8GS"ND+)_P"KFBA4O8L4"+0D,^&EJQ+A)O9@8W!
M4S?>BOMBIN9R0]D)^19P30V8-!NKF N;Z[GML7"]H^=))BI=MI[?574-+.L;
M/U<\ P&43**4"@T(9H/D'01 0(MMZ],%K,1IZ:H74GT=W8&RYGI;(%@%2?C[
M5GWW>@CF9V,SB8W"<N$8!,"&#48%:^)^"<S"W\O)!-NWWX!13&$I*E[8MG:;
MLS VAQLEQIPJ"!7Q-ZMZ&X&L.L^F_PG5*$42'7Q<%'!&%RO#L(4WS8SN7A\H
M!Y>2YZWR; "V%T^0/\9H6%)I\4*=X98N;.T5].HF@#HQB3+M+UP2%4O#7P]C
M'6R=,-^1FRR27FJ2Z%5R-4'D"+6OQLN(4YT;6B?+MRL=2=G4''TGA+EK3?$R
MBV<V;> **W22W3%A%S@6;HV/./10$3",G4HRE-%U8E:PU^3: SMQ" SGSZ@_
M$5',G<J%BN6.R',T(V,$ N=@SB,@ +,<%?>\QH%DIQ#+M]@SY*[%\N@:YC6N
MKED[I%.HKPT604VK77_)S,=S9UCII89*&;5#Z+XZC#+3P-6-1RYEYRVL<Q":
M9JBVHW&AD"!XALT-Z0J00(,4JYO!&9.+94G U+MAL3N'Z>NMN6(MP\V/S3::
M[0N9&FZE/3E[JHE2V'R$MQAM:)J!/U[7OM\%['7C<]@<EY*ODE9(B'72]&VF
M=KX?;6-FK-N+2ZOG'3 /(A@)E.(CTSU[/9X9M$PH*=@Z""CB=.^%*%>R<"BN
MFP<$Q1:D>*4O7N![DV)#$G_BJ&,F!7%HT9.BWK]8@[V)@+((:&_+^<C(NS%.
MZFZ9J;=R=LWU6^H ^@Z;(]#E3=BQ=WY,^>0)1^V$(,T3,GH7Z%$Q>"2&"ZYU
M)D51)AGN&%>X#$XQ'\0^"-@*L65^S?ILO#[COQ)'K&D[C6UO=QD$5)0B='ZK
M5'Q/-@^*BAG%'MIDGH'<PLF0EDX;(8O \62=Y6 7P>_ X)2&V>VI/(O;U/&#
M6I"V-=4TE3O)SR?&J9%,GV-PHY/Z!@Z-2''1?40[&<*[ENR!74EB!29PI!\7
MLS!P;Q'=1U6<BIWJ;V,1K#TF%G3E2%0:V .&";F"43$*8WQA:G;-!WWB$01T
M;9QMISM#)>(BL+5=+IJMVQ:#=)^+H$FT[I5H[3:)UB\S>ZM5%9N8 8^7W?68
MR;/.,_23(?;"+H?U/W:YQ55GSP_KGXCE#*$H7)[ (8;%OH/HCSD]G'@5L6O,
M*J5JA5+N6#^W%[H]($TDQVF^8HQE]_ZN)C)=[%NEFL[!09;,O9]B<*%FSZMA
M$K82A:UABZL*;[?!J)GC*Y-AKMVC3VS6N4CL[25GK$QWRR)<#G"#D>_J(=XV
M97,+C:!;"^'& ]S2UGKG'*LWX-_*C#.W7ZL6M$F!3^WD;8@=>.I7I;W7N"8,
M,@DF<65,4\9 I[,DIH8AF79 '-Y9=\%D8"2M3!\$U+%3*G@Q'L+6N[H5.)6_
M/(=4@85%F$.3.#:6IZT#DG \T@M[!386S\A!]=C>\MR?&PO4-F@JW(CZ;92L
MN+O"+A\K=V+?!LYOVA*XA"S.^'@VWAB=4L+]+"VL7W*(>XFOQ O0<VF9"/R+
MA5$.(SL=*PKZ89/B"6NJ4V$Z_5UQF8;@^*:N<:R@YQ(6([@[9>FLZQI"U+:"
M<+I_@$"[*[51S&'2? _KUW $5^1EL2$.(67BL"#&">Z@K1Y"MQBPO"6FP^>@
MAKF:]Z8"3O=?Y326YP0DL_QLA%"NHWP<:1?F[+?/B7(XU=M=$T/8_(@'E*)8
MD-LACN-%US]=&=O_5W47_!-NOVLL _R).VL19^<_KW\*;3\JVV# '3JVI=J0
M&;LJN @Y!E[H(LUR:"9O6KRA<!KX)W&=R0"%*)N[(9JH!N$E")4%S>JQ?-R&
MOCSA9EIYM]^4TQC.U#>[W^$.HI0?%CN&CE'-1KW-IM.SG_,H_13\#H5TUV4.
M;7X_*"RB1: PNOP*\,/&'</-$AY)^P3\L87V,H<^K:8>L4^C7K.0Q!S B.0S
M-+/2 J=U)EH1(R$%=T/83,2R56'Z5*1*31WR(+_,E;KH8510RA0X"&/T#CGR
M-E]D30"\=.GSGD =D#6VP[P_%""@;RJ,6!N%=A^SSKT]^790WCC%'#S1>B'=
MJ8'=%:?J6-MKK5Y'N8,T&X'J*72::W$^$O[A' Z[I.;H8/#6)61 ''N\H#9Z
M%,PBN[S0AB[VT';+[O'C-A)FHZ<<K:#J R3&F%+G%I4[)$VF(]6I9&[>&:/-
M5G(*9,SBR )NO9((TP2A[^W6F9L"NRBHPJ *T:045W9B6F)&4!033=;"WH;$
MV$('1:S9\$#EBH?K(EGN6>!:H()PFQ%<+*!?(=X1QK:NU'7NF5L[ AN &Z6X
M3(UF@_;>%L&C<E=IN-R-%KE3T2=8>F5#A]7G%E W0W=!O]V7Q$K-K6]Z\<B)
M5>A.</,Q*5,C]]=(E[OOA\W(( -\FCF<(VO#O1\H;E55R<KR2!7T 4?ASJ9%
MJ=(K4'F.\06(RH-22C@23^K$8RG#GFT+DQ,8VRYK@.J,"_S]%)E-3/X$65TQ
MDXC9+%DCC-Q/L\D*VU;B-GK.II!H$)8"-XP^HZ:"M<:N:F@>[24(."RYC8VX
M4B)OSE *N&)X<#96@M+&X%!332R[(F= <I]K#P3.OPVW7Q . 6$&P9@B.Q4E
M\)8Z?%4VB+!H9!/R2@I2CB*'L[5'%K'ER-=)=1%631C!1-M[ FP4,/5LZ&O_
MTZM%WIQ_,NW<1F Y%-!1!IL-#,=HF,5:5!&F:S4B DN1?Z2$!:'EL8K@$=0-
MX,L >EH [&^MHMQ&/2H+)<M2?.FZA/S=0]:%#X6S+PQIVK+]58^G5A;$]L?F
MW!"$Y:[GM9^%-XFN@:,JA%NAY]TA]P<4>)[.15QG*CW6$1!H$:;(M"^*]I/
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ML#0(;(LF'QAO$)6<4HBZ\"Y;T^\N=$IW87Y.V1(H07U&*9N,8<&W>@XXZ<Y
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M%>'7Z^ NAYH,5,Y0L-=LYV-L)U%%K&D[*XMOS#YO(R=1RD4?L'/(KL7[O7G
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M)?&/E1;B:<QW!:3EX<XN5F"(RV6!78[T-3VAIG^DLG*'*G3"])&\FMZK&;1
MQ,64LKUAJC:T/G.%^?T*>H(XV7Q#P1XK@0OLLH 038%XH^4R(9*S1YT4ZFI4
MQB1=8'R278L8#5Y>P">4W.S&SL===,<?ZAI3RH((W=W3MIL4B7C;ACQI_$)$
M#*(EQJ]^I#VM#.FU[.KFM/;;UXUEQAW>LD&GHD0 UD5) .I9AH3!W 6#81XV
M/(;,*(:SW:UBKE!I>3 WXQ( =(J*U @OQQT]9LPZE3*':VU0XEXIT8[/)(_'
MV!LH(Y:X6!^?><;OJ$H>>*WDAT:N#651[M8+'>?NE8+^:,4+E2ZWLQAP<-99
M_7+O5!QGA)X9[), A._H)#BWG$![ZIYNP6[6^0TNK<N7K FL1O)MNK/ I!@I
M?>">Q*G#:%]F:,RN4CZL$;$D.NV@0@^PRWK1-D+8B$9X;H[M!!/#@739E[G
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M0!)L[PE1ZGHG4#""W3I.92]_5Z;=<J$JR]OKM>N6UYDN+RTLD;/HN-+:I%V
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M_ M][J*+?P?I1+T(VKBHROWO-EBB@MLL66F=3/S.U>_9'@'F-W"\2[XDV.E
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M.5YP?J=.F3D;C"_5QW6%MZDINZ/4))FK!FQ>%08I"2BB!1:,D>!CI9_5(V$
M_#-LD4+XC8&@#EW5W3PCTBJT#GEN%%^$0/^TI.CU+%&?8Y92OM8-XX^4-T86
M-6LM[XI[H6>4@S\/ DQ(/,]\K2B=L#:Z:$?Y8T;X?73MPJTL;;+\4RMXFV6
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M> !W9MB0='=(RD(PZ,-G0-(=L2IQQ!JK<LJJ+$9AP0W<LTEG-0?I]NG)8,#
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M85+G7/@ZR[YWO\W"&"HK<-D6N9MK7!76H!Q;62\H#Z9NV1=4BI('I@T^IP8
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MYVFA  D'_M59[<7UA?4U6Y/W^Y1T)'D!XE@O<)0I/M(>/R.OW@-E!N !_@<
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MF],,L\R6@]:R3>(VM^$7#]I8'?GVWYWOKLO<;X,L-[ UZG6&[UV[N5%J]GR
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M$QIQT/HMCSC(L%1(<1D@++3@RD0,+'=0(&0[B.K4'*41X:U3_QL17JL(ES8
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MYI#CF;"T6$B%>!#9/! MTLIZY)(B24NAM<P!B5UL"I@?&YCO,UN^@/FNE0,
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MLN\W)J25QH[>>)N4LRCA7#P9-@>!<!A1M!38B0F!<=A8-D,Q2K8,NP^E'!0
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M"0PP/[;ZPTEOG!/KNGD1C^WGN&AA,9]98\=>3.A*L\(,69NU?[[>_WW%N #
M\=G < 9; _Q[R0\W/7%Q=)!FC!S'N\V4YL8#_,3(=__K>['_\6^^=_C7EX.7
M?]']W0].:.(9=DC@H!"GG""GB$6.61]X),$RH-($1^22+6!.H'%<XXD"1,^.
M>_ZX$[\ #X0&A^-IKP8W0&<(D#RQ Q!SZR/9',?ZZ *B &*]\3%\T';<:&@#
M !/>!X@!%68X/_Z9,T;V]+PSCOWHY_R^ I4:8IV3(1S*8?Z.9]4$EAESNYG^
M.LS=.?"3(:!@MCFQ(K9^G%2M:>)RB&C>H-V1AX5]^?\UG/I30^VSEZM_DE]_
M?C9_8Z<'.U?O*Y!5I]$_ ;,G0Y^9]FNF"2!2WQM77S';/W>^Q$2+ W(Z&H:I
MG]2G 1;K<\]GL?C83FI-UOMIOC86I-CMU&=Q7N076.\\<_X4U%LXDR!@9>TV
M3C)5 YGF<Q/AR^/)Z?"L_OJ:KWNP/?ES>9F!A:O%&=N\5-T.R'H6OA*FDX^L
MKW5J^"IX;S7MQ7)41@SUZQ@68'X_=4Y!0\ZLM7P5]')MXM'P=-2+U7VP._#'
MPTRV>PW9?NF\>?&V"_?L[MZ;G9_AHCB.P- 9"+ 6>7!PA\+08/ECGOQB(C#=
M?#.M7<)^[FJ5/8[KX7,),7D%84M/,J^?5VM97S/-(SJI-QK#:'J :7A\Q:G/
MYK?ML#+<UM1PY44QCM75U(I[8FYI?E</:OQDKXF]P]=T_^5?7P]>[K&]KT=?
M]@]??R D\012),I)XHA+BI&#>P,E9K&)V!G%U,[SX2!>OB::35[#OYT?5D-E
MV]10>O=JZ+O>T:"7 .*#27OUR?W>[*R">/'RT_G>'__)YY1F?\C>H>=PIK[L
M_?'^#+Z+_?L1SM8?K\\OGM5]^(Z#P]=G_U;G]#W\SW_9_WK$][Z^.OOWX^Z7
M?S^&DX.7K_#[C_^3]C["N#_^_<$RS;RQ&-DD!.+:<00*CT-*RI"2CA*#''-!
M]S$N&:6)CHH+SI734M HHK&.JF""N:A0OIN>G&2VAIMJO-B+6;7YZJIK=N/;
M*N7:Z_S[@UD=? !USF ?G4F,\\"=C3!A[GV45#N:YEZ_NSJ.*Y:0ZAB>/^%#
M2 ]>OO_ -(%]D 19#C\X)1II' QBVF+LG,_+>_%0W2.!5<_Y)5=K[?EK4-H;
MD %\%D:J;@M^>;NW1' ^ .W#+UM4UWD\&K&L5H/GG2.R0#1IG"K5"[ $^0UG
MQ\-^_QP-SW(DUWCJQCU0U4&,RU)@OU]Y6D8S,=C9?A:IFH>-8"+UE3BN-6R
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M7I)Z"<"@8R$M*[6F=?ZB2;XV4>=V5NH57FO?SW1C/Y/:V'ZF&_N35APTS5C
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MDVS;QJTZT#Z;UP@4UTG!?*^3R8<&K/TRY'O^?@YFI1:_7+&3[+YDM:7BEVR
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M;;>LO7@@\\EYBG: 0S4$G[3&4[O:V]BJ,VKI*I#/8/:.3\^R>P/O)_U4@-?
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ME.3F;*MU#;,(JX.&YC3;@HT*21^EM3@'7M^T07/.,JL)&6PU;[".SV>AWW!
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M.RPJ&<Q5-P/.OTN8\"O!(>\4+^QL_GE9[H,-]^T>/Z7[.R\.73I1Y2M$J'7
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M43OCIYZ$6E31J#A9[=CSSISG^L.")_@A^3%+.$LY_MI,ZVYZ>IN#;_MAP>>
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MW,$MET9[)#Q6B(-OAXSA##G'B''$&L(H^(Y;6/Z$O6</G;,M-XQ8J1B7#N@
MP_^8UXIY2JJJHGU;Q&9Q]G*8&%LE544PDCIPQ!6W8(Q'GU2W$VDH.95I),L6
ME;SG[)^-LP.\WV"\-FD:),9"&6&U5))%%K6L[FJ*]YS]8SE[->)+TG ECAT*
M46K$*QR0QH8C$W$5)(X"K+5'3_@6J\C:\_;Z138?\I4/HZ:Y5#-_PT+F6Z9/
M^AF)]WH@&ZZT)=4B2.)X4)@[ZA1Q/D3KJAB5<F76;*^T-T1IK\)0>2ZJR(A#
ME#&,0'W'9(E7R$7G?!388A.^48WW&DU([ 5I+TB_P]!NH357D5'# B<Z*"8L
MY8H9Y1CUI(]K;)8@78'+4L)C0RBRPE2(*_C)<,:R(,646<.\_C;%\;T<[>7H
M@Y*CP3/'*JVHII83Z116A@BCHM*X$KZ'I=@L.;J2^9$N.(P-(K*RB$NBD:(X
M(.(M2$Y+*BL2K!?=TM4]%PWV<K27HP]*CD:,546"5T%([G&E/9BESBDC*).8
MAEZ.;I0<7<ZS*<TM5LPC44EP['6R1R/F2(&F-(KQ2'1JQZ!;G/?V:"]'>SGZ
M%7Z]=L%SL$^,\MPPK#T1S-*@@=5XI+*7HQLE1U>SFL:::"(A(#]U ,^^<LAX
M@Y'142C/..8NPZ2)+46_NF9A;47I^N4$'_*5/;Q:?V5_9<]Z_97]E0_GRC5A
MO;R,?\T-V&/PMQ]^>/+?\$?SC1,S?3<<9^-,-#[><.S#>/Z8D>TR/;D8@W;Z
MKR>M87C-;6H+,-WIJAMW9^'"??.:6N.R6(FPJ9$YG87'S0^_-'L:CK/;D[^T
M:A+"4WXY'_KYT6.MMSFMDD=4GWQ]^_(IV<[.THI=6SZC>EL+?>W'>)M\X6<5
MI5_TS<\MEN!M3.4W6"R3JE]LO]AOL5B*MZFZ-8-MA(A_R%?6ZJVYI E'%95Q
M]6W6'[7@ZOC'9[9R;<^$OLVNUV4L_!]F/H2EW--<^.GD?+5O9 /.X-?AY/3(
M3$_,X-1,Y^,P?="G4> [[-D,/IG-P(Q#S<\/^EC>!#,=/ ?[V ]V@@LG%@Z)
MD:T!Q43=XF#63XH_Y"LW58/E^SP>SN$9[KOJM$ZJ\K8Q_75DXA?CV=G4C-VM
MFE9NW.C/?EH[PVEP]V4:?--+UT_"_("PTFV;R];0^#[H#,9X_$TG8]SB'O?#
M^/T*^Q6NP0K73XH]Y"OO"?0QETO(;;F>W<'/0JKW&<$W_+= ?[S+6?T<)6P_
MX<1.%3/$G1:*2NZ-T=YJ201SVD9IZHG"JBE%4WTIVI>4HAW[X[<[?^+=XS^K
M5$KVYM/+B[WCH^'NP7OZ]K<W'V&]1_NPUK<'NQ>KI6A[=._]W@%<?_ >[_[V
M^_'>S@NZ_]N+C_L';]^_/?[W^ST*ZSOY]VCWT^]I8F>W5Y<<4J>I-98AHUE$
M7 >)M/,4L6 ,]S)JIOVC)UILL8JN/;Y&+Y\>HGSRWGGK";7*22XK8TTEO"+>
M&Z:#$%4OGS9*/N$E^10#QL12AH(T!/% '5+48H1)5!Y'+*BCCYX0ME4IW<NG
M7CZMH7Q2GD>IN#64,(ZC,\1J*RLA*RP8\:Z73QLEG^B2?!+44@ER"%D;&.(4
M<V0K39$@,L2@X4]G'ST16_!2>_'4BZ<U%$^"^8H*Y:OH'"<J*DHT5E$[+61T
M0O3B::/$$U\23Q4W$AL>$(Y&(5Y9$$_@O*-HTR0]5GF1QNU2M<64ZN53+Y_6
M4#XY9BMAC->8>%YQ:D'=ALBEU0%S8F4OGS9*/BUU0NZ]/*P<C432B!Q+$S\)
M9TC'()"J<J#11B<3QA'G6Y7 :R^BUB^-\9"O7)/>CO[*_LJ'=N7# %<NZJ=
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MG/VS<3:+!/B8,9-RR$)JJ['!#ON :1I[U!<=;Q9G+X>)@_;*QL"14M@C+G%
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MN:;Y@%XH;9)0^DH_L1=*:R.4SD$@@2\I.$WJPR'.K47&T%23X:0G-H*][K)
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MEFV-U@M,AL)93@49_R'K@-I0 Q<S,V#Z54=53<8A?>=D C?I7C*QHV$Q*.K
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M_M9W.'BYLQ-[ZIZ==:^*QUNLXO[E>>[#^2U6A[DS5L?H$*ND8N1>Y_.R%">
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M&*+3;0OWI&LR#EZU.VO4@]Y0' V+$N/@>-*P]Q@G07&M-MRI&+X'F#8G@:N
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M6#.7@,\^;+3L-T;;GBS&O%E)4DI/R[8Z'!6LW%G9!>YGC=VG?.1[(IOE5I#
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M?*>S>_?I2FT+@H#F('4KP6.ZO8GJA/;YA?6#!=G)BR*\(]NS%T'.JM+!4<'
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MIF&ZTU2:U/BDZOLE2JWI3EBE)%:GO&7?@(GJ^.RD5.9N?RJY+)>/%B>@4^C
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M_[1_=0C^X,'NVV_[NQ^^'1R]/58"1\.81=8D<.",]<@J2A!1A!'K>#16WH!
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MG[XSJ&F)*D.NICN:89KL@J#.8>O,G^1^EV.>HDZXA4ZIXEY;1%0*@P'#LB*
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M,H^D-EE+H19IR2-BS@LB@DTN 5/ELFG(5;(ZK[?UM4!VK^.JWX#H4F EO4/
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MK38VCOM59-0X;O$W88LG<1H_>"/]K 9AO,?Z&2R8C:6:9^^S41I0_JDA'/.
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M*;)]XJ4<H//M;W__:'_[^FM[_VVWM?'Y!+[OM+<^P;WKO[:WX"]X#]Q_<O4
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MA35[9-XS.+-![%Z*RDQXM9H*O-$-,XS\1_P<.RS_R_$3_$'L]6$;4NP/-DZ
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MPSTW1O Z<%^;+]@:]&WL5 [++Z>UWRKK%I5F@7*Z7F\=9&BG\\IC-?,J@.?
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M]F##>AH?4L/S=_8A-1R_-,=?TD'40> E4[JPA/M2$)E*3EP4D21ID]"Q+&,
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MY3?CZ,S;O9JL.D>*GW-<^#W=W=PX"%+)8(,GI<;>A"E(XI(WI!0%TYRJY%,
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M^1W2)I;2H &@D4.JS/@Q2XX%1TZ).J_JJRZEEF(":9;";C3 EA2#<:K4Y/<
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M:P"=/PQ89DWY7SG;9;;?S\SHT]7--KJY-"MG&-EVW4#YJR5XR\Y#8(8Z9FT
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M[5X>?;/LC A-"Q6HY=&F0OJ8C&)%$8RQA7=1\;(9"_)H> <$\!H;A KF.",
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M'YXC8& = Q98X@. FP\Q);3?\S&/<KFA2F&M58VFF@Y[J1&A&HB& S?B:37
M"FX_Q)*83C7PP,5.[VRF5G0F]WD#*"/V-_^9CHVQ_C^C=@6OK5T_[(VA-\.B
MM]T\#BF7U RK&32A[>M)CZ,A$-A,W4=%I(.J;&;F4]R!:O[-]+T73<7$%%8L
M5\WU+NAAR(\<=>LJG_765AYWFC=Y5%6PP"O!DC[;=J>J1%WTH&ID9#<+VJKB
M=E(E.R[+R"5CH\XP+Z57P1E\HQK/4Z?\YLF)*2?A8@F-BY-3[>"<'A E>5@F
MB+"QP,G2R\Z4W:1^[Z0:LXJ5;_A?P&3<I';W<Z_SN3J$<4+[ E*!V_B.;9_
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MU3WM=?_,M]W;AR__O5WHR6O3COSW(7/.J:@=DMP9Q'&D>5*T1]YF55"Y[3?
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M3WO%TOV9>QG%4!3!%_[<[[87PT=[D9,25N>8>_]#Q:O.CO-U=O=W>.9.!_O
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MW"H/$,=B+'?T2*-6)B@>N:6&*^#DX')Z'IA)TDN<R"WGU8M[I/<A$&4WF ^
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M2M'SJW2J=K_WNQ86I=FVW8N]?CSM-3KM_";=3M7]82\G(,1>OT#^3)!_K;&
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MH#?=O4W:EBU_N5G=L/$<0&)MV"_NK!M[5>LZ6^M>VQ'C7G8Y+AF'NK/J= <
M%&JV7WW6Z]O^H-_I7M32L(RYUH6=5;/M4.L,NM=NS6D;56L\&'HG],;?.\UJ
M5'K>O9 V<FLUV,7WO'OVAD^EX5UI>#<%@&O<DJPTO"L-[TK#N[F1_N/FA\TK
MDVS4=[@_9:UU'\O!\72\MDN8I7M#5^U!5B>+/4+=:_Q^TT-[B%^VW1\1!'T8
M+]ZUBZ_"6(BNJ<\VC&.='3?>'I&C0_#+:./D\Z<C_'EG^_O!VWT&SSD_.MV[
M.+K< _]M]WNC>2..=;J+X7G'^R??V!%MM#Z?O/^VO[/+CRX]^'Z_-8].P,<[
M"? NN_2_EWO3O!R$N<"C94@X9A'7U"$+GCF*.%@:DU1")( -,"!7EP-W"6+S
M?_.TT5Q15NV51Y\Y3Q\+^JP(^DSH0S@SL(XV(DE\RKVW.')Y^40BTG-!-,&A
MH$]!GU5 GSE/[@KZK ;Z7.LI1KV1N8;9$4 ?KP32,@JD, _<2:.EC05]?H(^
M+[?E0$4Z-/(<_]&._7P8,/8G1TG*MPYRGYX7:N5Q<DX?\5;WDX>@Y-W\4+%7
MX'$V>-R?=@V=Y-I0$I#2SB&>HD0Z]TDE).&0%QE'LK'%-F\SNSTG(=32 7!M
M&.56'CGF].\*<BP7.29NG?6)8ZLB(F!'(1X205;"#S"I;*1&<;"@,W*H@AP%
M.5; -RO(L53DF'+)@@<=0,$1XS$W9 N!(!.M1LXKZSF+6&BWL24VE]OG>>G(
M\7)/[3[T._X;<K870Y5I%=N]2MJ>G_UR"2]_?R+Y$WE:]_!?/@3^&IV<=S*
MRUPKCO+*/QS;;OPMK]V;J:5[T^GU"RC.!HKOIATQT&&6FT"1$,DC[G5"#C..
M&.?.)>F=#'9CBVS*97%E+AT/UX;5;^4MJ67X8 5*GAA*)IX9\5Y0J20*7EB
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MHB59#UE_/#G0BM@>UXA16I/CN8>PH\Q  3+OI8NT E<VAK-]FKGE+D=AG'8
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M#05WL?I@&#.NUYJ 'NV+>N7/IABRHUEMH5X_AWJG(LMG@RXHN]B[H6IK!\/
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MH]S7G%\TNLZVVP/XOEN7_%+K#+,HAID*53+$-3]P>&KI869<G$ID^ZE&KD*
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M:S6U+'%>-1@1\KY\X)7#LYD=Z%3];[T:F+WMYCR.,95#;T2$.<[B&5/[31_
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M95R@@3LOM4J84P,BCX,0CI6#E;47]HEGX@SUGGB&,!,"<1P#T@$KA(VT"8
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MPIS0/DAIL 80%*(N]:)(Q5?F\.,GZ6@%]5XUZAF<@DD*6Y,"M\EJ+*W%6E!
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M\7;63!@GWHYGF?V *.04<8@'ZI#)*0>*4A,45T%F0B->9V+&YC)%&)](&&/
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M67S^-UZ(6K!]6_O'H&U!8<$GOSR"^.:GHW@^XIL?;["5XK1Y_EV&,W.]B$S
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M.HJX8P(91@P"!!+"149$(!M;7 /ZS&/J%?0IZ/-B0EX%?>9#GTFP*PHFH\4
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M&B)=AB, ]&P#&);JB!_BT7(!UY@29R^ !_^<0DU)/4L7XY<3GWT0W1 @?LR
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M_)O?@E!%(8*9&UD!P8=U*MQ;R;#QHN'@QF&"V(,R*H04\HF,?I,^,O7(3DP
MT369P$W(?:7'S!XB4V*:0)BGT9.4O=A-J@-291B9\DJG:4=1C*](',MIV9Q\
M60[$K(SD/'Y'@4"2(BX0"9$+*C@@@&-/=+W@;C+,2%ZI-%]7EEKT\ <@3@(%
MH^2AOTU&#L#F$'*2]PK#(4KO28E2[HI2&/*U9/(U:51P4L)<3,T?TCH]*<)%
M$[*.ZFITQ60!';@^&,;R\'D6\DQ7LC*9MRX%(V!DA 'A'OKA[&"84MA"4IZB
M@NY8ZI@VS6%&=EN)=>)8Q@?>SC]^90!P,:/Q[/TZXOX&7[DB&L->P(K')78%
M;_R X12@Z2#O3F-MRZC6*@Q](0GW)5H0EJ,C319#2ZJ.3-P/@]%-OS2!4B"_
MJ.I+HG@F9_3#!::'E'';(M9 HY"51N*'2J.$KJ2TS$*J#L(IHB;PH "G(\TV
M5<A1^<H)K67L#ZXF]70H6A8EGO?U7HC?) -.:JC@+Z(46"GYZX&],17'FY12
M6+HBCH=O#PZFY%5R7+Y'4)T,3EIN$Q5#J5QF,IYTUME@MX5.SF=J^U+]&0X#
MUY<UR5B'0#,]<:%R:%U*8>FQCP+6/00-Y H,1N W#%T>]D.J5R_8IPK[&(3?
M@)EE4/<WE])ACRKL%($7&%&J"7/&04&- 1GJ4A;E<F\'9":G9#4U2I8DL5*R
MS,-9Y-#V^![#^#G-V<DR2L#0].CU2@=9[@*@0R-)9=O2O!'CG\M&_":?'IC0
M\YN\AB_KS*J\/O74,W''ON"!&1)MV0AQN&M5K\OE"#Z^&F;=V%XOGC'7BY?I
MZYBA*?QHJT()JWGI-N"+BQ8ZX\K)IXE%S/MODKMGKO9,5]XL-];C:=?:7MHU
MY]*NPH Q.[_S 8Q4[;W$U?>>:O-))92NTT9\FLR1N51'%W+*,_R$U/17Q /*
MHLQY;.21=%03,E;H"X[DD;+"SRW_+.Z0!U7RK,$N,!LYYS%]!EYI;B^OU.97
M/5;;<IFK5!E-L,!U+G6NI(IF*U3+CG9OCT?L^47#FDN<4/*;66&R-WF^F+D/
M/\$(.M(^'6FO;R32WJAN5Z2]F!AFS<6PB[1B:5:[GWT02LF_4HW+-$#-"9M<
M\CC75$09;M(Z3L[.K57#0R/0!A&HL1D$VJ[&LD7-]?GST<IC8V8O%1B-78:)
M8>^@M[)J__C=9.)D>RJ!M;CX7%_@2^B[75>=<,B<4EG0]<KN"P>],H],ZVU,
M+TIM&L?+M>=..=WC^\\=8)A< [-6:5*Z\U%@C]11)$KVX3/# X_J'5^WIM?Y
MV3.LC<J3+#,]YZT; PC9:RY\N])HXB+,H/3H[0L$G;(NL6XDCPXINQZE^CW^
M,6ND\TI6Y,_!3Q6CRR4]G5! *>BMI'05D:S,;2*K#$!?@KXZV.TA&4 N%I?4
MHDU.AP#)C=.^;HE6J^I3IR'\-%4O57NGNLE,UV&871DH5$5'*#X8!X^4*T4D
MS%IA"3,1\\]/@F_!R!,Y-#+J>]U]/ T>W%78,8:G)NN-DL(E@[&)2Q&/,WI4
M1AQ(-,20D>K,,U'-0@I0#-L1A6?]"58EL/86*"[=HB@NTP3UF#-&,>4%I19B
M"#9P&0L1\6$DWB8?L,D8[/[XK>O3T.BF=[<"2PQS3QDB\,S,^*E4I0$4A_!_
M)WF^NERA2P>Q\_!:NV)4C;E7JY7'7JL;K4?=N6BLK6:EW5IM0 >T#G(M,&T*
MMNM?;VIOIM9=[9,QC"FIVV$)-:GM?VL.[YDQ:?XA14SOA'S.:N;GAG.)'AA
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M5NS95FC1OA?M>WERV=706O&NB@?E5&]7ZZT6:,5.T[#,-CG55:)T!X]GD%#
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M/B,;4/(^G5BC&4!C[#H8>W7XJ\;8HI!8'M*N^7W@!X,Q.[Z/A1^AMGEE]\6
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M"Y'#4SZ%9[YEAWU7]'*'Y=7I^-+L1A,&3(YE79V?@\1H]>+^!E^YXHZQJQB
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MJ=D&NHZ=6>PJLH%8B$9X+N: :]Q E^!8J;SZ?7,P5SF9$70<.Y.5+D(PX7P
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MYR?*Q81^H<&+D-_*.F,%TL8K>,6FOF">N2HKA1I7.O( OU$V&L.@=@D^#[H
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M?"%POI[AEG3^,JK&^]$#,-=MKD+,ZM/2S2JYI1NOAF&DB3-X]\/TX++.D%7
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MX]F,+_0E6B(H.9*[6JQQ\RF\L"/E5^O?]K%$O*LIX_BH.TQF_A!AWY5L6N(
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M4YI<U*+WO\YF^8_Q9#+B %[;Z!D")\JX),HP)H8ZRR0+8C)=?.)MB!M2#-T
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M%!;1<!:U%1&0!TQ=:GBO*#@XKWMKAOB*)Z^\32 ,@U7L8[(@Y\0!4RD%R!K
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M.I\M:*%I<EEML2R7H)DF)-2AJ)YE2W]10):D[M0]^"%RAI3M.1@1CR7F#]!
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M?SKY*P_:*!$**)X4*&LX.%\"&&MY]-XB"O;_7OR59:F9M!ED5HE^34OZ-8O
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M4\:=UN",B\ CHW4:I0NNR8;#7FC/4VK]$=@@&?PQT"\2V6<Z9V@Z<%I%Y!B
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M\O+5U<<PG,Q+4&NI,_>&G"[)(%D105GCP)%'!B%AR:$D3V%]"\6LAW/&&NG
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M6A1O>7'26T+=Y)QM/9YS=R&ZH*%!ZLH:6(M78!M@+5V'C<B.XS)TPM_3FCC
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M@.?(@9P("Z[V]%<B84Y:"1W:;,D?<=!G] 8\&^UT>(XP/_2:C^KETP-_N?/
M?Z9'S#"_)[5//XPO,[E/=;0_A,_306**2"D1C&,,E \)/#E-P%5063@71-FN
MT\-1X)^![I\)]PU*<_=^T^=__+/V[1]=O!U>?)A-;^/-@7+,^F(0M$F>7N'
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MO&/UG%RSH=-25!=$-4C\V<%8R]8V0YR^&J7K^JU!E"(G7004'W)-XA<0DG;
MF?!)Q%PRZ[$=T;:PSU>31Z"UP^/L36_4)NAK6PZ^&.5EST'Z<MWH;';"JN1
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M"CEP-,!0P"&OUQF+XK(T,L:^JH^Z'=E7R3=203_]%/8>X&)$S*6<BR9[*^5
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ML!\3.]RC'%WCQXF).&!8"PVO[?Y)XC?1E5R[)R6!M0R98MY&S2PZKJ*WF?;
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MF7. DB0ONN3DLQ6!%DVOI01N[0;=[3#4G318<\.^U=RPZT=9:/MH:/V##M=
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M>Q8\YPQU25!*SL8W\6\W0WK!%.I)3PVR-/_Z]*_Q-YR,YKOZ9Z2QKQ[Y+/,
M>2)BE\@DQER[H)$@DE4LB9)$T,H*V8A/W0"^:'8UT&&+R_6[7)'O_/)%PQA2
M/H3 HM*2MF)B0? ZLQ@".A&L3="JX-]:0"^82[WHJ,>+];N0DO&HMKN>9R:3
MST)/G-<97"!SP8'">A"-BE90"S7/G5MF;;:^%F(Q?J75ZJ9XG^=>\P(YT;/L
M&]R/=^DJZVT..B3.2M1DYWO"&2TZ5DN=AY2CQ%5Z7'Q+\#,Y*^U9>0VLHR[]
M9[M _-DQO _][M'R>1_E-/#3ND#57*4H/3!N4X7J)*,U&\D;*":%E#)"VSRA
M'[!C>&OZ[**3(]'F27OJX%,6@)D% ,(8?60@P3+NE/;)EY#<T3K-_Q@=PW?2
MZCX=PW=128.CQ8YM8U6Q13E5F!$2F$8,9-';S% %CQG1%&A2F.N\.X:?G6W4
MEPI;%&?:K=UL![ _&XKWKO;#&C[OH;-C;80;0?L4$'PP+#F7ZLU.9MXD<DJ#
M@ 0A*B.;A$6? <'Z:2A^/'[MHJJ6O'K4Q5HL#TN+R%RGPKC/)(2L'2W?G(1@
MR'S@.;FH>5,6/<5T'N943]KLT%!\'U6TM*<>09/+"T"TP6GI6?$%F287A#R0
MD)D@:"*)8!RV76N>8GII+-E'%4=:2]32(<!2JS$E1OAJB#XYJP&<8P5CC9.Q
M)(,FL4?/8'II+-E'%0U.%!>5N#[52ESOZK>KR.N>"P2+O )5>R&9FKA(/J,J
MB=@KM8S*IB*;A MM O2R_:]>U-0@OW0=KL6$Z8*LI7NU&=II?*E^5-B!%P?(
MO\$V] S"G,E\KV5W=+2\=E^KU5N]80*!RQ)E+KI)P>1C,V.+$W1L8NPB]@:$
M>)72^*9V1H7;NBS67GV;[OC)@LH<T3/K:O$%M(;%4I/GG;#)1I*%;U(XMSO$
MXULM?2GV:9Q%"ZTT\'[F54)IBZT;+-;>;JOX5"I<A"29$)'P^9Q82#$SKKDW
M**/TL<DY\C9@%\.57C6P<87IL]KRVF*.?\"DQHY\P[[+9SYY<*.ZF,\/8*7@
M98["):S52++05OJ0=)3@1#%9<0AA?<'+)Z_HR2=]_[6*X/^]@=&,!CI_P7V1
MBT?9F4DF,HRE8MS$2E4@(I'#Q;PT2CA+SA%O>Y?8#>=!P63/.AAWQTYWQPKU
M+W//\2$0Z[JNV8-@4HB:7--HD5S(J#6+,0%-:)0ZEV!CD=N(W ^4$SKQ#1CU
M7=S9<=748-]<3:G_/B)W3>VU =!*H:R4S/K:+%6&Q* 8Q00)S($S-@G1Q/S:
M%>EETNXXBNN[!.3WZ%:Q_PZS^I?;#S@9CO- EV*LCIR%8)#I!)'Y1&Y. F]\
M,-G8U1BC#2O7+F^]3+:T%7Z#D\>WHV\XG54KX^V([!Q\.YHA26$VT%Q&KQUG
MCM9(LAZC9+'6Y049,2;CLVQ30& 3H,OD2Z]J.%(LQW^&LR]_C<9QBF2I$J_O
MCM,_8B)?A';BN7_S<:70Q]T>?5MKY-:UD09Y=4-6\=O1;S 9T=>F \M##. D
M2XGK>D]C68BN#A1!A8!&E29]FHXVPLLF\'D2I<%9>S>AWMTU)$ 5C ':\I5@
M6LT;Y)$O+D+Q!<@BD*%M-:'M&(]>+^B87.Q91:>N^3.=S 8?8?3YKIDTDH2T
M*9&Y2@*MP-=P4DD;A=;69)Y*Z.*5TT,?$8O^M4JJ[]YZ\ON_OE4Z/E2T/5KN
M]R"6 2X=8.QP=]==T_V?E&Z_H#M  ZLZ/$!\#;7IR5DJTM;0<N*\%M97=Y S
M[X*4427-=9?-X#RTN.$RK7\E[B*UGI7W.TGJ^N9Z&2&BM-72!*8+]W<EZD+V
MF7G$)%0@8Z1T"=;II+[OWGP\N_$@V8_[$%R/!VYS(/#/8R"F*)Z\9Q(K$.$\
MBT)$5HIS5G.R*W67H+QN&GS\YA]0@WL+[B@72;^,KZ^'L[N^7Z.<EKG(M<+!
M/M='SSWN\$NCSF!7KXJ4],8E61MO:C)X8\P*BO4!:E>\[ <=8?<EV?T;#6Y_
M:%,I=V@ZR#'X4C*W.0H="GB'SB6E(_W:*Q^?D_6!K0>?>?([<J41<IY+HW:[
M*^/)]=WU\?YWI0>]KZF>=ASNB@I3UCD%2-86K55!\&!"$=(!?1;</:?"[6\^
M,%CBZ[P^PNCS_$7Y[N[JP=<5M#&6I )#(3/3&>8E\Y"!$I;'6CZJDR>W>ZC$
ML[ .;GJ!]#S\_AT?<81_P]6?.+D>1%Z@2$S,U@U%<V&9%R&S%%6,M#]EY9H<
M^&W!=?QCNA[9\:2/18\Z:' 9N@Y>Q?6^U/HB$TBS@8A>6)$X R. S!A)HX\F
MLAA*XIDK[T23_/?MT"Z>* =HHD' XN)"[791:6^ 4'*0Y$PXA>1;@-;,ZVQ9
M4E$&8Y+*HDDUQ!4<%\6"0V3<X&[RCI1WY8MP#27%P!1C,VK'M*LY^R$58F>0
MS)><2RDI>-N$!%N1710M^M5#@UO*3^D+YILK?%_62N'N6%AE&;@2DJ&L/<"\
M$;376<ZD05-TM$KG)E96%W#'NH5IN7;TK8-3W[8L!U:KJ+TOKR:3>J[R4.8Z
M!QVS0Q:M(<M)R?F5O&7119H'.>NHVM0-7X?F5+<R_>M\M2#XP;)OD3KQ &=Z
MEV<&#[^9AQO2FDAR6\9A=X';,@5K1[RGR<OJ0=.K 7M'4-,9L*OXH"QWE@4#
MB>E"6Z_WGF:;P8 \FM2HV]]9L&I+3M?I2;6+=OJ. ?T#_YZOQO>E[=$*G;1A
M+MK(M$Z2QNV1<2-E2KY SBL7D!O"/%<>?'Q;MZD6QCV)L,%YR8?)F/;9V>V'
M*R NCW+M]_>UCOGU;:7Z7?$[GB&9Z)A423,M:WZSC)+9P$6,N6 P3<S<#M@N
MUDSI6R\-?.F-$"O 97&%#A!;&BH=,)[&..E=OUWY<Z!R&I@G7:!RF;D013-C
M:6_5W-(J"4(QYPQX9VWQI4G&RLGXL\4,.0?Z[**3O@V1]Z4,$[Z!- _M?3OZ
M!*,WDUJ2?)K&BXV5*TBT+2>F2JV-6;AFWM:V.Y*K %9SPT,GVV3[NXYOKO2N
MGW$[X6ZT6HX4O_'IYNO7NP.<[^YA)_@9)IF^-;Z9"W.^B=-_6^X.):_F1EJ;
M6_$^$#6]-^]=9"LWZUH;GF5TV0>N'7$('"214(@8'-?/!D?T++S>6+:P",>E
MW,QN)O@5;N??NZ%A'YU?!V%IRZS^Q+0:W%2<#%$F3#X2O4PHP05G45@IBE+A
M64[U);"^V%3S_>[>1;]J0Y*UKVBJ^^V#6E&I\SE[@29R*30O.8B(J(.+7.G@
MR[/+Q-J7'7AY.!Y]KM=4'VXFZ0L1X.'M#_<=8((PN2CF'9]ONO0IFEHWOH!1
M12'/ILGUX79L!]^=TH/>EU\FF(>SI7&PB.I\/9Y,QG^3H'^!K_27V>W 69=4
MT)EE(WWM-I;)^$B2Y: =9N5BL:Z)''8 >7RSK6\&/;E6;:6B!B=/=8(^M ^:
MQPYE9;/*&I@P0C*=,Q(B[YBVW@A.QBS')G?O3Z%<'C4.%'<;OS\AYND;DL4?
MXQDN2U0-HDX2"0GSIC;; $((.27&8Y).$%MY:%+G:1.@RR-#+Z)O<*3X\=[R
M>E^6,JC$'83H>52U@Z"M@S7D>?H4J@8Q)U>$ M=D9=@$Z/(HT8OH&P3B?(>+
M1CI=[F\#59)24GB6@J1%2Z)ET9O:;@Z"43%H8WUS3CQ&=.&DV%OX?7=I?$ U
MOD,U7J#Z,!F2N?\5K@82:/NR,C#A2F!:>,O :L>JCP@<HU:\V\7D]G==CM9;
M"+?'7HS/PUM4M;RO<I*C2M;$P(+6AFD=$@LD% 8Q8I$@8M);O>>=WOA2>'"(
MH)^RP1YL1=XO4'6W^NV?>@)P,YQ^J;_\93R=30>H,Q?&A1IH7/V<8AB4K!DD
M=,*"31Z;Q/MO178YC&FCC*=L<?TZG>0BXZ*&7XZ!"T^XR*RQ-=PX,M"),R%C
M-!:1S-\FM:DV ;H\;O0B^J>4\ <7M7L M5S3/L(,WUR-QY/Z8< C#RYG3F9O
M#?4Q3K* 7#.41EFTZ-"E3CM)AY==CMJ;B/>I^D._*\*\9-2GKQ.$_'[T;Y@,
MJU=<80H2@@JZ""376$2F2S5V@ZPE86Q.40B'I8F[T17@Y5"GJ6K6'&3M?92Y
MAN/+4HQ5+M,/.$GTN_O=<'ZW,1".'&HRF9B72")1VI+!I#)+WDM5:S-ZK?=8
M3[:_^7(8TE[P:VAR>/G4#6A_A=LI>5?CR9_C7\:C;SB9#>-=-=@E].77?ZT+
MIC9@)7)@!: 6H[*% =KJ?TOCDN".5LQ#^;,;I)=#K(:J6L.XO<]3UPSCP_VM
M]AO$Q?R SS@PY,3S'#V32M/VRPTP\MLT*X8+%( 17+<:XYU>=]%,Z4/$:UAP
M\!'J9BOLTXQ^Y$=0N1<%,WGOV9-'KS69(\$DVEAI$S56<P^I27G)[A OAT&-
MU;.&20=7*OWE"J;DW/]GGALQ>S_Y./S\9?;'397?^_)0G_H7N+K"_/IV\;WI
MXHO3@=!&D3&660AD\.O@J]5/@W#9YZR%!*N:9!(<B/OR.'=,1:XAXMYGP,_B
M_^T?FBG#*=(&G?#^C_>@Q8!G\!$T+<2^D)^ 0C'0,3)EE J!EP"Z27V8O="^
M$-+UJK0U5#OX@+D6V*<Y,1NG_[Z?(%^ ENBWT^G\'/Q1=A@9?)YSK6EM-CF3
M)^H<\SY[YL%F!.>+D6TJ NP \O*(U4Q%:_C4\Q'T7R.X'I,7\;^8:]7A>B!*
M9N3U\.;ZU2C/OTI#J"&G\^/S/W!&7BQPK)Z$2;D0?@06E+<,G>%*(M@GQP<M
M3+2=<5\>ZXZIR#5$W/O@>XE_:6G^]L]7'$WG3NS )ZE=,))AB(8<5I59%*JP
M&#5HJ4+]_Q;D6H/E\@ASJ,#7D*#GX^^[O%570.9((XL^.Z8]I\4Q1\$D:N=\
MYE'H)MTYUV Y5A6;(T=?[BSF<ZE<\_TX[DIRNZ "YZD*@S95249:-(8\ ^5D
M21Q%ED<X,CAE,OC!RGV6+#L+N4&H[O>(_H#K98YA%UPM\[LW 3M-4O>ABGN6
M!P=*_9BL\#(1!#!,):%K.'FNM=MJT7X3N"\NQ]0DXN:X;-B2HGTL,NPB[+[3
ML*M?E;[@^]&R.GPMX2A"2,SJ>M0=LF$0@F(FQLQ+[5.;>:?;A-4G']\:[$?@
MX[ZDU6,&SAS,NS&,R#-9UN=\]7F"<U-A <V5&,BJH5EFR"71M&.Q("W6>_6(
MY+9X7,UCVZ#(Y]]S"6KM49)]S\]/.!J.)W-DF*M]6['>)X8M>GICY()KRV(1
M9-;F8%G@5C/P(JHB/'_B\FW0=(>778*Z^Y9ICVDT<WR/[J7OH,X3?!; @$>%
M/BD&N1ZF^I@82&-80O3*2/J_CD4QGGO+)6BY-RDV2(GY/K]S;ED$\B=4(*,B
M2<0:0QE8J*=*D:<2#1HK3)N;C2=0+L4).U#(#9+COD>T('@73"T=L'6@3N-\
M':JP9_5_@+0;.%YKL3GKHS,I,E%*/4GTG(%5P'(LD$.2WL@F1[?'8\ 6A^L8
M!-A%R+T7WZ0=:'D^N6ID<M3<(F3FYGF[/I-3R9-E9%MF<B:L1MMM7W_F)<??
MU@]7P;B!_!K40EA8DW4/6P BO[#H+"4K3I.)(1,0::L%B5F'$A*/LDDQ\"=(
M?F"M]R/=!NMWO6V8+?*K[\OU.=3&9Q6923(Q[90E8\4C$S%R+T(E9I,2A^O
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MCAACPXSJ(Y)EBS%R<J[LHHB^;[L6.^;&=._[J@&S\5.WVR0E<D;)-*VPM;T
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M(\94JUEI+<*Y*0HZ0.D(=<IC/4P=BSGFFIM#'H^G;2&.:ZWT"OZ/(KZ< V(
M9#8G0G@$,E<*<B9"="'(().(HY)PM_CRZ46[L@"KME>B=2 4SUZQDKAEFJ=,
MFX>5-=V<"VVST6E<HR^W<7)!V_DXKFB/P\(([Z7N)JB\F>0Z9*LF4OXZK=]Z
MNIUHY87-L39Z(K=<UP)',$&P@M):- @XSF$C71E\70IC0,Z8+K*>GD<;H[;6
MH8'EH(EJ7):5<1FS$%*0ST,6#3D^: 0+@1OFDC6R>%L\C,N#/IC5UU4S+C2-
M\.:K(\=7*5FK0%C&LTZU[:>B#2/72V^>C.(2@3>9@G(B_BYHI9P(JN=96;UP
M-JKBN"[3'Q^SZ@T4L,$QA3XP+0QQF>CDI940HA1<NC,MJ>%X?%U6QRZK,^'M
M');>/E:?N8G<O944R-+6$5'(.=,2/=D0,;"B-8] 'F#$-G=^)V;T=9&U7F0M
MD7<.FW ?OT^F5>[D-AMAA$<RT\$IIK7@S,<2F'5"6Y3%>7\>?VI0-E]76>M5
MU@YU(TR]ZFH/RV"B48[.:Q=JYR-'A[;E2%]<Y Y",EF]&+_KK+<'NVTG5:*,
M(C #M7]L\H)Y5R3#H'/2IG;('^5U34?^+FAS&T>@J 5N1KA+[8\B[^2>O V,
MC@P?$3TP'0NRJ.ATB0%<*DFCS!=Z*_&ZF"X392VR48_D_KZJH@[)OIG.JYOQ
M)LX7,TB+*Y$CM]QS1AL);2"!S!PP9)$I;31Y[:"L&N42VLG5ZPHY&T9:I;[&
M_<S%WJ;B>ZS*I>^_G4Z6K-["S:\X^RRO<K+9>_*PZW0BIH40#+A%AF0O>_ %
MK6QGCYV6UPM:+,.C];EU-&*HM;J1.(+E[9;J-I;%%?AH"I**I$5DFNO:64DI
MEK/047EE(3=I)G\&7E]7U^5 K=6EQ!$L]S9=MTM"D\8R:8AQ2(9I62\]HT'F
M,!GA8_2EM+L.'(4(7M?BQ0-SW!DN/Q%GUY/Y=?H;W-SBE8@\>Z,C*U9ELN@#
M6?1"!*8B..4<Z@QCSVEYS-'K AH;;%K%](8YI1\S1BO=.J>X(MM6+)-O8F8^
M6LM2!*^S!Q5,NV!#$Y9>5\3H@#/"$-S^P_+-IT\S_ 2+#<ZON#!)>>)49"&9
MMH',5^&P-C\1L3@?09PGQZ05QZ\+ZM)@UR+B-]AH$)6TSUYH)B!9.DLMV9:.
M'$&3D@VDE@2\S?7V4!P,N![@YF:\ >RS:/RY<-I_K_++B_]55S+F?_^WQ>P6
M[[])O@O^L?CQ9DG)O__;'#_5#X,.7N5%H<C@6?+)$0.HF:]=J(66BB3I7&PS
M%.AE#5[M!8-=@U?[J*/]&,XNU'Q7@U=[J6?W/,Y#9-M>X\+JG+-P+"L!=!2K
MPD)6FG95ZSF64*QONAV,9?#J@(KN(]+V@U?7@T,U%&M#8B4#UBP#,A0]:2:&
MF"$FF47<Z(MV:3,Z>XF]TXS./C)KT!O[\4REDH361GCFLPY,ZQK&+#(R$<DN
MBJ$$6YI<:CVBXOL^N ]7R*CJ47:-*.G T^LPO_[#_'IAY20#T0Y0]*CJ%7?P
MIH2O"70U:977G/,(+"00C/S#&#"E)#;'47]OX.TUS&]TV.VCW],.SHK10<Z1
M<9)+/5L4@X# LC5&82T_P29MIU[ZX*Q>"N\^.*N'M@:T[I8FY_L/'^>5S_K_
M%3GHG=+1(>.<K!,=ZK4<6:TL@PQD@PL!FY4R6PSTI\_^CF$PA+2W[B&MIZ;=
M?OX,LZ_30G2OQW8-/!]MQQO:3$+KRM+&S#,;E9 Q (#E6MLZU@Y+EMDG2,(I
M_^S,LQWO.OMT,Y6#U)@-RQYJ"VIP!&/,+(D21%):<1C7D(J?SS[=;&]_R[].
M)U^65U*/6G&2:)6P@3E>R-]+*)D/R,F;#Q$U<O<D[C'VMJG/L3G"'7[8-7"Z
M+JE'HVA,4]*Z<[ONZVEIA\U!,V7KS6Q4R*+1P$PI0699<K;CRBGKR^$%K903
M0/7TJ^H G(VIL67?!N4YEN(MD"DF1&':Y\R"$Y:EDL E,#;J<=6_O=QV]R]I
M.1V!L@%#T7>W)_O2\N*6M+SGF5QL,@F3_";_XW:^6/[.]3>6G34Y),F<%,AT
MEI9!49)!CLE9YXSWOI.[?![Z7]?-,^OF4O TIBJ!O=JYR]+[ME7(:*0B)3"7
MI&&Z2-HJ8LT?3%PD';SF95RM\7LR^+JPSG(@'8&R,?4-.6"&!M<B:LL-2Y(<
M6,U]9E$DQU3T=8JJ\IY?V(*ZY+DL+VE-'8>U,=4I]'</R3_TVA9BU @R:$--
MXQ' !%?21M !1S;#][@PQ"A5L5%@N;2>?H %_AFN9\LT_H<K* B(9#E)EB D
M0J:(#+BA+SHK:SCY)G!AN^!!<KB@G?)BXK#-<'A1<:7NXKCB5@-F2 PM[9O:
M<4^G!'URD6,N3O-8QC5 :$#F+V@!CF$%C' U]X+OF)9PEX[FS["KM1/.H5I.
M'R;;TTERE3 R3WLRQR!CTC"JU7H8GZ\+\RP+\P2@'--4I9YQBOV",* A62F9
MRW6\5.:!!;2:*9ZES<4#&4>C6IU#2^!UW8[S0&T)Y(N*;S\8;K!?"N@<"$#)
MT!4D5X>^>)F!N5!G'B2AH[ZP](8^[+^NY7&NY680OJC0>@\7(3HMLM26&>F
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MHFGQ&_X^FWZYK@X@$?" JI:XV?_6$R"D)^L;6#!<B5)RS$8&C: ]][GF.)1
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M5'2'4I/*RH?"^5H&17)Y= 0=9]):KH5E#7U\?&9WE./7-;G5"$MRH$N8,K;
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M#.7N.@SG6=5]QP*6Y8%>69ZM)&5GG;TZA15"REL;.)B^\9=3H4UV*-9:\R4
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MZLEG;=C">WP,.?3NJXF:^$J2M=Z.>U0QX/&/R %0)9H'1V7.J/S>SSV;=O+
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MH!^(#\A>Q#WP;9FLUHG$B[X%T>!Q HSIQXOQCP-X1C#TXX,E2X9;8?WA-.6
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M'N1SM)&3P[T/%?X7I,:')?+KARQIK=I<BLG)J4JB;*EN,6PC99%-&K>_Q_I
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MA'*F%MFHDO.EH.<B71DCI6_G*ACC-,!%](-0X17M&B2:6^=39AQ4T>)(VB(
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MF++<$"2,V7XX/&^\GK)%(+3&S(,:]"L4_&K[J)2[\L-#3:;P$Z@ [0_--FC
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M@KVKR\<2OYTHE,IKUTWRT/LE&;Z^OQ:OU_6(^ICTR,LFQ?.<24TE>6*D4:
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M(^@$7 %QM>RP&)%G%%%ZENQ]49NP?AUFOR5%)EN).$BG3OUF:JP5Z9?N9KI
MP)GV>+PP)T@ WKZ4:[28%BL&O>7/.^[/3IBH/+6#/K*._QE (&M2306>U<I^
M]<GG23'KMNUXE.A1V^L;O]V(_A^V8,#*82Y+=SL1 AR1?5X$2JI'A3 ?:SHT
M9?AJMTGRF=/;-=;-Q.T-I<X^!#Q*S'1X5#H08/'5 LF<O="\4^;4G88S)NF5
MGQ*@.$='%;BS#E J!L3D5_N<_HI-;[I+MVS!WS/5N+7-VX8%8I$J=F^$9M"*
M*+UBM/1O;OZ44KYHUJ:H0+-LLF49T^J.Y&.IE(A*)9C>IVV5=KM!'*$_:#%4
M:1%:HO&Z(R!?/;92Z%OXNG1N4/WB&IRF^X>Z$T/7/,6KG&V55Z2#(#>4 (P>
M'%V5T#RV24D:)S<GJ1Y3WX'>J-U=.B1&U>H@K$N9LW/G?K";-3;I*V!V25>:
MJU!F2+>7J!B;<L_IG=$RZTKK-2Q0E;Y@MFZ:*]YX*35<U6KMW!5XD!>/ON$V
M,#\%*K#L0>@_JIO^;H#C_?50O^OI4P64DL6<[H.$K<0HSE87ZG;A8<R,Q];4
MQ1UDI#X5FYV'$308IMJX#O7XP8G9=:XFUE,Q:!J4]_$$3\[OW[&YR?)UJ=$J
M0E1P2N.!H[Y]MFC7(1A;LH,_,R^U#K6TK<,HB.YSE\8]GILC4D-#A]?C>XY"
M:CDUU:&;24/4Y)9P_)11QK[#%_P<,S:Z"CQ[SM2**D)[Z7<Q)(V1R=$-E)^&
M+*H=W0[LLU .B&AXQQEBT<Z%ZS(>:&/$99%>.-WV.#4@*>34Z^15P-B,F1]=
M&>9:'6$!OE_MB<@2EZPLCO:B2$#JR8F6F;;?\C\\+/G/N$6;Z&PG7#%K(A<_
MV]=@*D;[M/6,I=D%57HE,YQ],0,-R_8K?O@]KM.-3;Y.XY#,L?JDE#I!U:6@
M6K3<0-7@]]&@_6AZ.G?"6\*V@R>?X!.+M-)XL]ZYCR?=V=34C>\.$ZY(Q""<
M?"_\M'_5C3E95S:&J-D7&.3$*C_K4_ YREO:&_[0_>;I,GN_5+WTNJ==BOHD
MSXG]EM-[1^:I'9JYN&YGV:*NPDB[E1(?N.T\R C-B%IW6/V\.G9JK:;NH4A@
M60?S.''2N@"7PC<MO2B-!N(Z]ZEN+(^[Z%,EN;L!4@BEU17O8-D,%,0J0A=X
MU#3+R W+<%+">,S>$<F6AG$/)JAI=DKY2F.:;>I'%:@+3]_\_Z!+_C90K[7<
MEWX*RS92S]Z.[L9HQ+W675*46+J$2_DB.MJ&;/YY]]ZI"QHAKW!<%? HX9#.
MLU_8E77XS6',IIE,8Q3K=]?77WH?QZFDV=*MO3V <0VXJN1 PSI7;"#I@LW*
MJ$C%Q]Y)Q_U./7]9'WMO^X[O:4\G'Y97/K?\NE09,,G46Z9 R]Z7,/U))UY5
M(G;KDGNCR3>Q1K/JF ^/2"#R7.@$VK$8YFE*7$M9+D+_L8PMH9Y,DV"JS)N@
MU3.-<%SRQUF_!SO_8&WBV258S\PLN-\B7#57W>H"9!+26L0YHSME]O6&+!RD
MM?ZM'M*_%\ X2+5ETA0D2T_OT?0N1=G#1CUT LP%7=R2%:]2+$!?]<:4-%7!
M?3@8K;Z<JM9.7U7O6/Q^"JYU)EE,.I#_NT3?<?+<K%,F7-RLTX&ZY'!U6CS$
MO/ZY2.="]H1O]"DR/T:2H @M-96N,;&RA!Z9>W ]U[]#=K)O?)#.*2,]X'JQ
MM,@_10:]^+DJ/&/NJ4^24XSW579-FV90* 5D.,4GR9#^$GT'A>)M'EX>IIS#
M<>OT_#X&.DT-$<.<9QXN-(=!!RO^;$\U)Z'PD>?[Z38(^!?'H#%1-8D+HVN;
M',>  ++ L.I*Z?XG@X?OI1]>RHQB@:03$RHMY:MG__CLVW\)RX$<_LKAK9?V
M2G=>"XE]O>#0F-__'7,\5E&H+9BU*9+%7ZQ/97ZS%PCD]M>.:4]LF;[T+[K,
MR4YMO+"8N((/QANKN D,"E15]*@)E/>RG1?R5A-':>^HI10:VJZ)6=M!S2@@
MG?W4TC:U+_QI>&DE=2_2YLDOG0LFIFK#&L7\5E*U)3@Y^ALHZGXIR_ZTA%-&
MQ*\;_1QYI<Y1JH+F7#8ZI+7[8F5!X3:YB-(*4($6^%,L^8'PMUUF9[OS7 6X
M8(G6A\.Y["'^9&^62H4>U*B/)S"_'SS_"5<SL_C06B*^F5:!CJEJ7=)G<AM>
M0?^5U6%^V@[AR,#].T#*"Y.YW_@(L8!9Z.\4SS:8FU/85 R9>>U:QRJF\,#U
MKIL98A)$TK+UU@D-U&&!58]U4+5>B0@6H)>\X^!"W^_$+\\86ZNHXRI+L'/7
M+QS- 0I//WFRC07.;U@4/="-!<(*4%980/Y>T!+^,!9@@*J/GMJ;^*E43.Q9
M'I= 'ZI]9IL!N_*'Z83@T-URMH_  J%XB&-,J)0,!B6S:G*[O.P=B*11X%;M
M6%E"UG2)YVC"EWD68P>%"]D'SK<U?AT^9\*G_KX,O;<=^&QT>=+=_L_AWF,N
MRG='. ^^RM[")562XV3O3*?RYUUFLH,K3WJ\VZ^6R,AC4(A:BST7GERF.I4D
M,P1V"LJ".DVE1R39BVQ]'4L+<E,/"MD3;(A9RQ-JGRZ1$S)61+M,U:G[G46C
M?)8']=7%#SOYJ@<<*C0JV[AZ/GG@QRH/CR0#)_6<O!V!'&/^9KFP@JWZ3_0)
M\3_O9+P/]@L1_[CGD]UI>G.*-:\:4UDPNUUCYWE12TIU;TM*X]=&L! 'E"/^
M+ =ERS02CJ&DG(^,L!*31>U!%1%8X'/5,+6MBYVXP@E]5&2ZI[T721V3[ GK
M;TD(,)I5-WOX69IYW!_LM%R<^DK4H^%SY*@AO_!KP)J[@>%Y.]_:69GJU=EW
ME%/^CKH5[Q=6'^J:JJ^S_5S/L4!SD>QEB +@&T"=GH'ZJ(Y4_$Z:G;,H7V#0
M?\Y>Z]P7H%3.U+:FQTOKO2N+8$[C];C6OLL_'TW>IV+#6J '5((R!'$J79P3
M:XZ&.1T@0CR#D4LX<?9I")%.)S*T<OGO1L0ILJ6V-KXW=H!?H?H7Z;.=.TN0
M]:K%: P!<KTL.V^;?D8M<&ILKS;YR4/;9^$'AYKWKT@#BH=;WLI<4*!EL< ;
M"BR0E1@L'?.OT01E0=T+=\;0 9G]>79?PZ/JHO7P_-6GOYW)#-43<; X1RG_
M5C<16%K\8G;W5":L?K2BR4QX1DZ]>B8F40\3/@%F'#3+6.!'.":MEI(&\.H&
MJY%\?+K8Q>!I)?49^B60W5]HHIEN=]#*.\](Y8Z]?:OT:_#ELX,G7:"?&TF6
MOYQF=*;($*=BN+8IGQ]\_ AG";.+2JYGO;<Q*UUPG8:1"G(@E.1;X8Q!_>"8
MM?5YB 6,"5Y87!_*+^Z:R<$W?'M&E<LB>W;D.9^TW7)_ (=C@<I%F" R-\?W
M=BU_7@,N9D=_=5^9 !,F<7E:F"IA%U/7ZQ9D^U[XX>[H^='IGE\4E98!Z-V_
MB;<+A@2.F=$+#7^B0'EOU9P)I#Z?NQ,XR] L[./GN>\!6Q0;\@-793LJL/\>
M!,3_3CWTO\;3L+K2&>^@5XEG9WIAA#"V\S.J%"WPVV_?]!:ZP3&2M@Y+J;?]
MIG\=6[S7LL'_<8+F7#LDWSV7?CS%X\%0,U I[!(G%]VJ'QXCZ>"QZN!J7Y<:
M^OOM@T\G"ONP4K<$Y.\YH\Y7HR@MA$^8V$K^.S2GTS&;CIH6I"[/]IR^^D38
M,S;)\9%#4;&I S1+LMIS[\N)%,UN)_TW&F&7BWC5-J6,<Z%3C0XL ,R@:-6.
M6%F,DJ1MK6=#-'(U42:(C<4VWY>N@_3-A1SS7$VJFRC9LIWF2IP/NK15A4B9
MUBOC!N 7\BQ!FAUUX_V8]A[\:WPG$"L&KFTJC[1OJ[!%?G&:6A"NC:H7#''[
MQ:RD ]D*6A:\S@K:TOUU,_%9;]3XY/<K#2S0ZX;RPP*.6.!2STQOA&"0<U5F
MAM5Y.)2++RU0&0N@3@/NE;Z;"F09<SP9E,.O*Z^/RDIFW^I3)!NY.BNNZLV+
M7J![E##%D:T]=.!<!/2RG5'A'-&&H_4* GN;1>'^4D4*TKG+_3UIAQI6JW[!
M_C7#SU\)RV0")WA2X7N[B&--I&>3!U*CJW_33F1H.%_AP3(5<B/8%Y#690H>
MSBP3Z1RQ6ZS.[U278V+6LEDNO;WPHOIWPBOXUYAOZ3YT2J.T>=[2,5=\:)VZ
MB9)-!/OG6B-4Q(O;]Q,=Z0V^[C\->,T7X]&V>6N$X.&5]<R<F7=Q:^)9I/:!
MD[BH 26A&YOL*Z57+G\E8P1C2! M86_&0,_'3Q\?M<^9F!JQQ0W]68]XQN8V
M0DI@=T0V<ZAK0@8S(ZUFOY7[$^K<2H*(ZX1=@,<]1:8N<Z.:UG.*I4H[[;FT
M,_OJ8[\J36@2])L253M]6*R:1>EW@[' )R]CV?792IKI.C4E>"%8.PFSO9E\
M8O9E$<^#[,OB/<$ ,'BB=+%=F!!ONR'54A0_)0,V,"LK1O .*C-Y<&^%=C\B
MM^SGXKO:40I]G_@$LR>O9]//Y]BG,E'Q'D7H=]<9*<M[]567&N'O4=YO)%[.
MOJ64H!ZB^[)D\P#GIT</01$J10'%E[^M;;#SR_M5'U.*)S26<75>%7UQS@C_
M$=CMU;[8R2PTQLV3O*D2%6?O.L] N@/*US>INR0ZX98Y,T?9+$N\YG4J86N$
M3)-4&-N!W^OI*:H]TRZ.](T$)P?"O/3AIC+(SBF7$N&XC+C[DYZA\IS4@&<K
M2S!'X"@]23/'=4ZC3+:\RZ/,"6[N?=-WT7067K&66 !&[+*8Z[=\G8X!!9FG
MLGF;=KWAV[M2^I[RH5O$)W]S.+!Z+8BR90W1R'"C&A]@W,#C)S@W7O3>QT?=
MX2O#3"BS(=OW)9LD'UJ:XR2MFG/PAZ^R*M!BV1U7LH&CI@]_P]5,WHG3>2]7
M<LGQ9^\IK%:2#P5H,'&"SRRP0-PH4@33T(\%<GGU6FRN/B%X]W%68TAVN,_\
M(J;9KH0QDNT5M)HR"U']9+F KTV74W @#9+VHU-+1941$P.X*C2OLO[7!_,W
M++AR-:W\I'Q#+C^C[2.O/V.!-24DP?4G)0S$\%R#'@6!MP?>FZSVFZ;A]%.S
M^9IXX')4<,JVA+-CWXX%_@5#=P3];$91[70'5;EW5LJ8V*S-!WDQS"ZV6>JR
M4JZ+<+\N-8%:B"=0"PVR3MZ,$\1AMPE(?YIIRT'<[</W#?[ IA;Z@_VRS,9/
M:DY/U1G<W_VAN-33[-+JA"5'QA-.1$ZN]+[+@NP(_LUIFFW(_)"38>9W MN&
M)=*6_"39T<R/]_K\*(PF-%\LT\<Z)]?;;)YW0L-]TSMDR%7RS0J]C;@=W+/7
MDJ24?A](@)D'S3*#R!OQ\OP5$7LS^KGW-S?"/$"2_!9A.A@WLSO>FVWBZ3=:
ME%PC9R?6(5'@Q[K6T<O4)(W\H[)Z5^T1=(=P_Z,/Z9)"'V?[>S'A,FJV!<:V
MM2/S,R_/SI^)QCVQ$+5\T\.2Z34_GLM?OWIOTZ>T2'H#=0^9M;CB">%VHGN(
MQ,\*RI$3I2QH/:;R95XMA^I!!S7NHE(T$8EUML6V;M5-ZY6.BDQD1;%S%!/@
M11!1X&,#?RU$HV%"&4O]2R4/^Y\_<F"L6[X?C3T*COSZ+4X:OPM?K@6$VAQ"
MNX+2@QKWMK(@Z](Y_]HPSH79V286T%MJ.8?*G(4&J-%>5ET27=C_3RJ! .<@
MVL!GMB!"=U$H[^C!(8_:H]S(%[>_?>AENYZDHY,\9:0_Y%QW@DSUKPS/C+<G
M*V9DJ1&R?GS/']"-YY\??<'*C.H"' W]M5#;):]Y*BV6I,3<:\SX'GQGL9'O
MD7C9U@O+BMS,+-M=:H'9\T):[,;+WJ<K(9D@&QO=KS[A5578I)'BW+*D%#^%
MZD 3_=U( N]=ETL*>;QMUK'[0CS'Y7_;5K+'(/9$4V-S*EB*85FFV\&H&T0A
MJ;/,Y-DWU'>NPO7&7G-U0#?>XEY=3!%%=.<D=.;>ZJ/AMFN"E[_']TNA0L2[
M\?1='@U.B45JM7VR/8\(5DU]D+@R*'TL4&T3)OF\I>$7$I>[<7]4+7:M)B#L
MC=WW%?T4VJZ8&0ME1-5BX[B@@]AZO6F#R4A-D'!(L%3VLEE4R_);;SPE)!Z;
MB[H7W7%VA(2VPMN2VS[=NJ?[D#5),62X+E()IF[3-B6L'Y6YS5>IX2U_,?OM
M:0*!Y^A5-^P5Q#[D^KN_N23K$HAQV[=PECW,\5%]'+^SW+YYG\R2ELC*I-^9
M^MA&#2(((ND0&&8T;[BC(F+Q:$QJH#/ Y&=0JP+@B%:^SN05;*'% NU,2ZDD
MJ.^=GV>MY],?LT8F+$7&IJD\X'6#,YYB@>Y%2 NI?PH68$0]'=AR>$ Y9UM&
M_(+L_1=&,H<_PR^/DX^"IK' BG#MTNPP^<Z9Z>V)1IN  N4L^UV=QV_6D[XE
M?+EXVYJF-$^]$\B*0JX,WWM''QWO@; P%3ZO.72\BH3A?(M<W9NO3&\/EKIY
M%\RC<?2;Y2LF&[64X?+&2!6&58*1$ ERV5N>#^!#XX&3ESL[:6RC#OXR3@6[
M7\VN(U2KJZ/!_$55F?.M;#6X[,0QC7Y$VS*63#+&(VBR8EO?J:0"VS"&0^%;
M+;7>7\ */9JM+@GLT?N'QF9[PSE='LA5V/D12V,BU#7V@.ZIZ=I:C'PHZY8Z
MX#O<>B.Q]VXW:)8"-=S1FR64HOBKYT'<O2?OXW#KQ "<8[QH!=_<OV^E#(\M
M]DU4CB<AA/]U-$!]3-#-^R7.NU97F,9U5:U6\KVD\D(^^KQL?!7666D-7=[%
ME>QE'>RLN\I(KY?!N80/GQXGA7$F7=UWF$"A9T$#&*CZ5BT6>'BR-TXU!A^N
M\A^S+,]67M92XQ,ERF:#CYD1!-(J+3>(GIK(L<S\["'*^7BM+(D\A&P$WD;S
M'?^QGTGV+W)QNL,4-"-TJ'?RVI-TJE3+-RCIM,[T=N_;IU"-XQNEV_SI,OAO
M<7(*IKSG(260@7Q\>9*/V]K@4+3Y>-X(6K-V:JR1T[O9VN)MCNC2"5I&_+@<
M51N2N__-)^'T6:G66(Q0F5\N]3%I^FJ4UTO6GHD#8,AYR""PKBRD?U7ILX/G
M'4/B!*WA).8[E[$0Y#:2AMZ,T1#]ZMVJ;=-D3&!6HV_'Z@ DP]36;A/D2\<7
M?R*S:E0#8JA2"VZQ#5N96$W_)GHMT]Y$[]-,E#?)O9O9Z"*8>Q;S(JNN0>9S
M,U.SIHYN**G(6^/,:WO'6>VJ1LT1XXYGW4&>2TC3;YS:A0@5&44G.D4C_D$J
M+2.J_^*)>&]V0Z?WFWEO_-7)>YU*"GZ<00^UWJ-77AW-?O2)B&[)=3%#P"Z'
MKZEF#]&X01AE:!Y'!ED2%EB..4V_?%*[B+J%!="QIA%%_DR3T&:*URAZ,IJF
MFA&+AHGD@=Y' U9)-1:##+(]!!MB>$QW?5.I<'K0/#>^,YH+$543;K[@]X3?
MV(1J!DZ95J;X2ARX_0K 8R]UN;%:,C;(%>AG^J#(*BF?1H%2(P=;2S4-*1NK
M98.HW9COZU*NSZ3<=O_BA3+5Z\EFWOW+\Z4CK[5MXI[(A61^B'OP9Y-5\KPL
M;/7,&BD<5[&-H47%%MI*@Q+^1! L^">PLST! Z<GQN>#'HOWFXGGT)I(4.BI
MJ)!R":W2UP88F\) DOM[7$+8W+7]Y!;>,(8"33LJ3;X]KF0^9FHG(GKU*E,4
M9PVF #@7[U_$=[FU4+?8V <QH^) ][9F!C#T2$8_+Q.YW$2Y;*(Y:BOS9R)X
M(Z2<?PHRR ACSCR0H"^?-%&+*X]S2[?M6IM3WN>Q?2=@=7/<S#]WVU(R7$0Y
M(4C)PF3(A0+\5"=#M@T_.9"/8OJ>?Z+1-U:U9%OZB):ZZ]M%A;/!S(9BQP)W
M:+N9&&!!LS(VF*%H0<SP%<^A@&V@_^ JW>+U^%B3-(0#;T#Z/OH>%@AU6]6X
M9X\%9F5F9&:U!:[3]YK!\?5RJ/FF6@^8[$M4$X)8%97OXE0(\^+YLL)@?LLP
MJG[S 6.!1\\0F1PAZPE4.RM8.K#\.NETWO-LPGL3]GV!;:S46-(WT.Q]I#@M
M%PRYRD8I0G303(@&W7R;2.8.O==9RUG+S$'@Z$9 2L_L46BW2(VOQZ"OU/]K
MS3<8_1X+Q/9@ 3@A%BCU._4FZ+[A+=0W@PSJ?5/AOQ%01K81S6B#B,;SY-1X
M@;0N7*YK[">N>[CY2"#!J6#+GBW9@AY%Y)H@]D1V.HTH/J)>"MH!8C+_;?G1
ML/:(\6= %BD8:=J2:#]>-:\_;%!M%,'Y^>"-8Q2##1:8-'M87EPO\T4(1#I_
M9X]GK2;P2H/@3W18<_Z=5+W\=W#C_A:=^C1QK3'?[-TBSAXT"+FP@,RN@;^E
M&?M)5JTH+7_04>W;5#HA,L(V=92#^-77RW"; $E]>L(G6,ZWD7?@1[4K5]%(
MQTVE9:+8]K>H56.1KN'0&A!5H\BCGVUO)ECP]WF0 TY; ;HG+ W)3_+&Z_E*
M5:F7MB? +]&32-IP*)JS9-[6,+7!R'16&J9X32C5MF?_)$7H'+2/@S"5^6((
MFJW:FI24M\YIGY<\/60 K1^>0L/+2M<K?R<2?YZARWH;PQ#)_VLI1,I^*ON1
MED]ZG+6/_]'E'-2@*?UT(B;78Y$(\]@.1(P&WRY\-W!6^OE@W^UH$.02HS4!
M,NO^O?%^XOV?E08QJH2D-9UB<0&])PV"@<G>-IV)S#PC>Z<!_"XN-NX?1L.U
M=@CW9)<@$] P+&"-!:+N(@X[\50F-F40,3N40%<,S5C:K8\CS#CH*_"<5D]%
M=UDDTWVKUZ]DF;,:52=,Z(PRKVZ#?W3P90Y5Q<T'F=S?X<BJ&S;_MZ.%7GP8
M^"*9'A5=-=>'&-2-VC6M+D/=C#2EKT*I#!J3G0R-T%K#G 53E]2&#]W. C&R
MKV40A6@R+"#G%(X%$& "+$#QG-'FYMC.#,_[N_'X2<H3I\'YDVTGPCBXW:$U
M$;];:V\9[]E/1#-T>?$^RFW%.L(1GC[MQ]H0JOD5$CU4]@=#2?<M;9&WU,_A
MANT3;,.=YPV]=>2KZT,[8]5)4XG$GXF1E- ^^#@'5NZC4_W5(TG^#J]7<'$F
M>WGR %)[;,]K)3S0%#EU1)=0?AZH]^!:%O8;^@QE<3L;.;XZET[.5IXXWI'\
M>O:]]?TY/=7NX&ABR^_O*0E>K31M["XM?G#BZ1IHIAB=>;\6:QT,<LTPQ[#4
M]QLI<W&OUM:$2?AY=T] V(B*I !&(@#).W/<05:$%OIH6(/O)"A1]9N2=X&B
MCO /%OAP?QA]^U>0U>,Z9/Z71I?5653[G-E03?EJ5DSSCE3PD=*RV8M% \.=
M1#=#TUEY+UO^O;@[(^+B:9G?$$I3&:/N=P4Z/*W'5<8=!!NT-^3QOQ$3T8CB
MUQ3@29(&%."MQ,S@>) !:'UD8GI^H9$9U>R+=5W&7SX4?V*T+:,5+OF@OYJ9
M4%J2M$M2]^1FZBJKE-=/; D'PI%O8<CBF?Q/[MRN&.)]-87Q4^)9?T)'QU*+
M1&6$JW EKB*9I%>I'7!QKU7\)+UBN+/)Z3F2D1:O0SREV,CN"<6;4';+CTR*
M4P];>V^1P<::60,GF2E'_7E=%Q@GX."IC<C<'.?V*PO79TS]'/>9/$]%84U^
M-.49VVDLE5<\Q?DS.YYU\VL+<A5Y <ZMD5/,$8C\MAM3;30HT2%NDCM3LY;*
M_=T7I,?FWQ(*6/F3UR/#<I<,>-'VPM?:VP/E+\R5DT6=A</T\#8DT\V?[R8?
M@::#,&H$G<.7J'@LH,H&S2_F54/41&0NF)ALSRB$I7NYNTF>U?0R#+C];.#
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MUTBW'& !\;-3+?I03>KGK8 YT15C-L=98N<*32IMD,CZ15H:P]W!P^$WSXD
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M !K_3M2!5GH.&U@I$YQZ;W-$S1D3O0B,:L'C25AZ4E+=R?OZU8-KV/W0H%-
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M3!MWV3EQ=EUH-8]X],\^)5^RWJ 65U+<=#%;O1'N.GEUKEM:.,W4RHO#ZX/
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M4\<HY<447GNH(W/ +JTN[7"90&N4U^$QJNR&!2&57X$TGH38,WL&T=#[XUM
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M@0:;3S!%A(&]0X&$(QM!O#7EE*)9D8(UQZ+B&ZFJE?$WV?OC-8/,WBZIFQY
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M,9'B/;KGB8I@R&/ZR+;*YIAKGF.A)=[7SD-TJ"Q85LZHRBB QX;C/=V[D*)
MM';TC=>)5VM)PTMI*N]J,S]C#6)5_YENM.INN6%@'BHQ94/]QY[GOM:F_@:7
M2:%G=?B+B]GCD'IJ)8PFC!T=? =?Y]?XP_[DMU-Z.J)K?T/N#4*B0&.A4DE2
M6KO97O+G'EN)_A][?UF"Q$GF"01-">\"F*[]>>(6^#I&]W$'\ OV)J6=%+__
MN_+._0%G@ZF.4Q]L)P!V7*^5H^CZ%_=F3O>.=%6WEJ-FN5<4542JW!0PA0FJ
MQKU^?,]:WNR5>'P_>%[<DXYW.-78WO\=>WE?<4>[H!58-KC]69ZN]OS2PW?;
M1%>[S5QU8 38@#3IWV*%CU30VH \_E4?,,\)6X#M0[[0C[L@U BP\%KW/V15
MI-EG=;5DL"3L[>HT\11\0DN:IOY*6/V^]YL7PZ[ZEWGMW@/W==KI#[4+PI)/
M1PQM4,2XLC^]S-C%U"Q]I55C5!S'S#9+W"_^*,WX9RJJW,:<@UL;UY87;/30
M.VO\XKF<IN'LD&7[@(T%J(=X ,.Q^663"AWZ%0)D@0^6OS7TW01UZ4$%9B,G
M3T):-_T&7W,]'BX;W^TE\JB1+9\?=1*["-B/'1L'4W;4=HM#1\@OB,T7A;#>
MFJ%;M$$S^CN'/>S](2W(U^7/PJ%%]B^;*"]_F;FUI8THO2'A&U0E"^!P6=[>
M)@EFI@=UN![/9^P?N.0V^',"W/JU#G90J@1V,.:XLBAR2 3]YED ':-DL@<Q
M('C!<+EN>(ZNDYU,CB9Z.2PDD8WW77KVQ%,P96'O!6=2Y_?A*.(-U,^#LRP
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M8<WG^:JI':?;C"$P@EO;4QK:;Z:-5#3-"5F@9LG)PPY\)? !;P@OB9APAS)
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MD<8"9'6V79_T;*#KR4[4GW*:'K,]^4[*I=]*\Y;GRG[R[E,P%VE;N#C1D;#
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MJ^XP[3%B \JTD<?Y"FB? /HSCQF]=LK^*_.N\R'@:()UHM+D56SMMH<0"_!
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M%OTN2URQOQ@=W,">%+EG7"1>7A[ZYUCHE.!,"&C=XXJ9*.5(]M?(HT__9[>
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M' RF03LC0HX'T_#YI030:4@Z=2TD!DPVP)#[:P5PQQ:BTP*S'E6&^\]Y_I/
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M^1<AI8[=.RW*K(P.:[4+'F5;18UI4>WJ1YK H:I WMVZO(JE)Y_UQQ1/S+,
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M;A++A[,T)Z8G''T&K(VDI]X(7WXI39+"R3T6UG_RR/+3#-O$R)IJ6$Z,M.[
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MDLC]JNCO&5I1OIH3J J&<>_30/C[H?*H2?]'*;1'5?&;FZ;)27?B ^O"?LQ
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MR!AJ0<#)=\I)[ D".7,V_I!J$L_$\_NU><G[DM$;+[V?=VJFO1V)W67;S48
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M#21E<!A5K,,',NS: 'W5H\GQ1M"/=RJ'5!QY8RXTITN>FI'$QV,LVU1=CE3
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M<PTU9R]'FA=S9Y#;TC8<BF=TN('"J<L4+FQFC]3,SB@UE&M<@+U^Q3"-D"%
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ME2^OUK&35SNX"."N_)DN>U(_6CS4( 1#5ZW-4_<C]25S"S8ZR.TR\SWQ63W
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M!%GLVZ:%#3%3LIZX]\$6YU-3VWEWX).2*+;4#'*7.G0&X)11/ ,DVZ168\X
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MS-5GK4DJMU=2M+MS ]+0QXHMIYDU$X[1=@8*\Q<?T_ >K3!?,5@VH?_,M=P
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M_.BV5,L0?0!B#XS2069M3J\]:#C5^0UCV_OC+,MUR>,GQYVW<EOF"&[JF)
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M^)@R<'\L;H!U[-_^LZA'^5-EUMXG>24&DG"9F@6)T!G,OI'BX63ZP)#"ODJ
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M=M>1K#6ZSD]Y ?._<09HO@>G1I\!,H-0[6W,[OGL?D.#S1(:*.\S  !X^PR
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M5M+=-R%O@34")^^S%H4)"RVV,\D&](G'[(;SO,AFY+:_!F'T%-*Q._.Q\PS
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M*O<3N-*13-L9($-S@%1Z:DO2;I=0_)IYA_31R@Z>X8S]E8*<RTXC28.K)+#
MA'P>=3#!\3&WZB$A4.3YT^JXV]X,IQ5;U+'^HRI;@['=0]P_$H+WAD-.^XU%
M&NJ3?^$.:'-/0M# ;7!(F;IJ=NK:Z<4&9H6/EO0NQ/3[G:Q._4=F$&U&98&O
MZOOA1WEG@)N4X/R;9APY!#K*9\67 38ZP0CD5!H:RH1@(\$PBS62M8;:1#\1
M'/?^!>$&($[)=[THXP2UM,1 O;P.8E" _'2MII0^SM&;/;S]/N@G\#YE<D0'
MF I6_!,([6IVB5'XH# DU"NHVDD3O]Q@]$T#W*31OX*Z2,C G@'B-%FM:NSU
M%5E\)F1=393WKP0KQ)&XY_=":"%JB7T8^=NG?(8+N"7423611Z#B<OI$8/*#
MC/1%L-,*LN)G!2F"P/3@7)'.''X.V+:=T^O4;>V7QT;K[/0=;+ZB43Q>('S$
MWJLF9'3'GI ^>JI>L!@$ZPYHE38=^O;:'@,N.IW'DB]PL@6!UJT9A\KMDKA8
M&\0V]X7*Z;"X5MXGBH*>:E"'^>)Z*M8/C8R<)LBWF:A[6'Z']:C?/B$!4J-^
MO!H:V[<84RV-,'*LB^36[)R]#^3!JWD65H]$(6)K?T]EMGR6?GIO'_D27*SL
MS<Q3]=5ONXCM0C*5O%3VWIU @^+NMZ\03BZZNM)_=F&IJS6=F].*5,:D_%,H
MS@.@&:4Q>=DL!8OSJ[!7,JI+'>B<HGO5<:FS,'6)$GZXKX1S/]663G+W789>
ML5LSS0EP>Y.F=!*M\>PQ*"5N\8!!$ S4L"@)Q;)_$>0&WUS(M_\GE3_NE5?Q
MPNK4H7<-M75$FO)-4QW4S<JE5[C^QJ.9'G;O\4M;H&NC .]]P>QWI9LAR2'<
MVS!"2P_HZK7]?U!2D,=)QM'*T_NQO,I6J]1]H5==^>_7--RQ8$82Y#&A--[#
MS^C6_/PF=_HE[/V)A83M@A<9?V@A)<C+X3P;2Y=#N5V__*$1K3@=;*EL=$^(
MY_]TZO-6#2"!&A*)[7SF&&O:VOS&?FGDY,\Q.=5JODM0_47Q9# QK&B/K.GB
MHL-IV9-?_+\U!.-B65U%Y'O>[)DDS-GVWMW[C;ZJ5RX68:7ZIAMV>8M[R;&:
M<"_MC7_+RUC^]9P_>>WT:_B"*^F)J2'QN&?IKL56SU(,6]-ES<UI1=.# 7?R
M,C"",A!KVT>3WP^YXB.NUWZ^>3DO9]98/NK8A#Z&R\QLZKN?+:1VD[N>>.V8
M:<W^8?57\/TL8><OWNRN<ALB3SP?]_OU;@1[L?T3U+<TK$I 50)>CEG9(%-;
M50IFYA8V57<^.WF^;EG."BDVSPQ>O0R2/3$?8NVVL4RH-!I.*[=QRUK&W9T9
MKBG3C"Y7UIRD*=+ABJD*W.T*Y_DX,'5(47KT$;9@;U_L/0)^_VF4'L=E^'"Z
MEA* PJEZ'M87>7X*FOXI69[_J/Q&A@5*88&>,]ML4LIO_7/]]VQ?R8=#R<O7
M1&Z]E;$P0B4I& JZL0BM659'67RBY4K.OO13_\HK\\O]PZSW_TSRE<+4E0K=
M3#=.8I%?_RP9I-2CN'V*XS0T'_N.>-M@U0WPNYW-?3TX[FY4GO"I4KR48XIG
M[9@O>\(3[CL!5QO7?/TTRF@GQ0N;%BPQ2C%^:B,U;IJBXQY>#9ZR\PZ]J:R-
M4FFD408='<OJ22E_PR=-/YMB=V:-'[\44%4:3671#JO::+8?JJO;^>+NZO-Z
M[FELT)20V3O9@D_5_;0P4RWNLJH0&U(,&LJRF*1AV6WC\#G YS3I8R/6)R\Z
M\C7#=+V'(I.]Q92T1]6SUGIHBV)KQ!@B6H /4*USUSK]TJR!H&.*[M\ 94!P
MAETWB"N4UR>$J-]J7=C_VGB,;ZG;0$-6TPM<!_!_\MC<WM"B>LS3:/I+D/<S
MCU)Z]QP+!6 2F_B%!:Z(0M*Y.M<4;3S5S#QW&-/&?B&CRI77*GVGPG\;UO_;
MAPU]FS[Q+/D^(GGO1Y<$94,D64)I,F+(^G\E]=P+?Y58:]]>KF".,BY\R\MY
MF^Z9B$X*@XYI!/A_Y3 B-P<63T#2?R]5B0P'#$3$K;CI8_0=+_-)OFSCT@60
M;Q_\SYN%3R;T?J2NX2X[>34 ]V>>FYP!\N0M_XN3XE/"91?X1Q+RA-]]PC7N
MG0%V_VU;.P=R-H2(M3=,7-TW"B>?7AIE12DN0Z^*[H>&873/ &4I[>3B9Q#=
M\.'J;9([#?7P=]]AWP&<@V7W.?^A)K?$T3[O(!E,X#_5A81EH&NK78!NS8G
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MI0^%AG&W-R(G02X=,\>19X6^^0N%1_7>2DQP?H6ZWZ1V+JS@C*)C8NX/:Q8
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MR=97RA-(]VGT%+K.J&LP@Q>F:H;G.$O,=L@%I;#W+9GM&=N893-QR(N*CO\
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M<L'!^?6;(>X/C>743RV>N(+^]A)YAG&AN,$^P,5;)E>6'2\<T>T0GCSF!L_
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MZHL]">4W\-"O'73:%'TL&53@8[M]NGCCZ6^7:CHD+/;U3IA#MT@@(K!UD8H
M=C)  Z0@P3<],OL;G;)%T,^I,_>N@]KX_+[G3+B,%+D%N9Y;J@]>=1<^'[Y^
MZC?B]2M-L6&ZK"\Y7=BX;M!IFUQ6YDY65D?9V=3.HR<VV@/ELP(3_2P6'[P;
MU%G29P&"1=F7<VH=0K]:SVT'.W+%WO)-EI$Y#^PV82)#-=\3V3=["(-MCWO
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ME&-MJ%4_%1QP\%R@6Q9OI= Z$K6\P8,MA*Y76D-PT$L4B"G!IE0FI7!<SRX
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M#8ZFZ4#/XB(&'I8I1$@OH#R439MO /^:C7!WZA,*6JLSKM:->!2R !4>[J
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MJ&$J+\;]HDB%1\9IW@B0O "J(T]P;:A%6S_U*)@+2U5'RSUW+I2Q->C:"K*
M*HX2$+EC:$Y- $4??S,>OXRCJ3US1\S:O??3+):K9 $XT5Y01<H&V?0H#5GH
M570.MOE)=KK*5;W0P*LG,-=<:"X7-LZ<-K>YF^DM_DM,X*.:\494QO5L#:XZ
MS<E;\U,G'0)Z!<J#[3(/]Y$CN<O<TU^IP6U)!T_UW-2=@)<Z31*I%P*XZ^<Q
M$3-B!$1_IFOU""?F^I5E4=G?YY\Q3:CG\) 3JS:W0KM&*J(-].ZVI$6$RK,
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MYUUO-_HU*.LR_P32&.[29#*U;4O)$.&[VJN9I%\+N=W%7BWL:O[-2NJ"=PC
M[5]'&FST1!G1GS^_7XFK"'SXW/XMC9E9VWO!QHT09-V&#]P>.?&<$*9^]3DX
M4%;T/;J@H\81S2/%_!LRK4W>.X8[+!KRVG$EC]64=)Y- \>C)0%-'Q"[6=/
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M%-7.LV_0)'O@[\Z4?ZM$#*(])Z08+,,#V0PL&=84Y$( >.!G:&EV(,SR;LT
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MP*&LSZCV(BB$FQE'%UXW4U4P.:'@7/-#]T_D@^.\'[P1D)L6"8 -VR*AAE,
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MTB("HM(L%*E1D29B%!2D1J2#@$B+&A**@'0%!0$A*B(J0J2K(*&C(D9Z4Y*
MBI3(1"2,I.WX[K?EVFM_?+L_]M<.U\R0,N<YYSGG/N<^STQX4SPJ3.J$G:,=
MC&\;'^P"] ?C_8))' V(NA@("X1!&Q]O%F8#V\;W;_MWW/9O$^#_=Q04$. 7
M$!(4$OIOAPMOAW:XD-!VT>W"(O\VZ#\Q41&Q?R_^"?E?+]TFR,\O* (7@HO\
M/]YXG3#I[?Q!@@'\?+M@VZ3Y^*7Y>+TP!*2CX'_J\<'^Q\:WC5] 4 @.J2$*
M?:%9"E*?GQ]26A#2&/HT$?H<)B M**-QX*B0[!D_^*YHN8/)MQ]NUSQ6WR7O
M,@QH';IX)4581$%1:8>R]FZ=/7OW&1F;F!XV,[<Y;FMG[^!XPO7L.3?W\QZ>
M_@&!0<$AH6$QL7'Q"9BKUU)OI*5GW,S,*BB\<[>H^%Y)Z:/*QU5/JI\^>][0
MV-3<TOKJ]9ONGMZ^_H%W[S^,C(Z-3TQ.3<_0YA>^??^Q^'-IF?%[_<\&<Q/\
MN_7/+CX8/]__MOW?VB4-V;7MGP_@_^SBVY;P[PO2 H(:!X1DCIZ!^T7+[CJ8
MO%WNV.V']5W"FH=< /F+5X9%%+2,:-J,?Z;]9]G_G&$I_Z\L^]\-^S_LFH&)
M\?-!SN.7AB%A'/:CK#VP_W___VS?)HYR'8UU-EGPF(C;KJ]'WWFU[M>OJO/S
MZ5HN'W]]/'(.)N-X&!;4(<# LU6+6; 9L/KLYPXXVQHD,PJ=/_\JI7@R@KN1
MZ8K*=;>#5C8WO=MZU8XL8OV&,_:=ET(A>3#X2:PKF$KEP<#==86 /XUR<_?(
M$W"4$7,,$*I^>F0J9+5N8OG'N7<[Z=%!FI>M?SLL8_S1&"Z9!^.SEN,.4H0L
MS0!^:L8-?2-#48R[4U:/PVCM+A$%(R6#;WP=]I?:WN&"XX,N.LD>40U>M6<E
M<C_@@3.2-X88Q<S38%74O+[!W,KJF]K*3N;DS+EW._;[>)T0N-5AMD/%6ZQR
M_X^W!1W18#0/)L#A%.,#\#.3\Y-LN>"NTHEFVE>G><6,VQT[?S)\^]13NL>$
MT2ZL@\>4O&E:07=>PX?NT,4U"W^C5M^S;'FPKG DM18O$2<Y:\,\!4X#HU3#
M[C*.)U,RS7H'PS19Q7N,[1@>;M$9V;RW](B^]/?<L:LBYR]=D$_RT()QCC\B
M&5G*\V""=SF/V.Z0+A\XU1T[01Z,]BF9)CECRD3[V)Q@M&1?RH^K',*+U+>2
M6NT3?TQ<+J#;7<'']AYP>=).FC>DET,2UGBPC'A/?->%6'0F6HAM2E-!P,^#
MSPU3&L%C7J\W(L1'=INZFR??,HH9E%5)%K.0]X_S876]@Z]PY/_J,!:8(SQ8
MRH\AE@B)K:!#(^9PI4 +VJJZ<@LCOAA N !?WN1^I61H2[\K]%F^49E818TV
M+1;I?:AD0*>F_D0"9TB@KCT]$QCH(=43,_%^^+0YM?$-]$PTJIB&EZ]I"M>>
M*_>W*GC;&WCR3(_VC[_W)?PS7[JNP21'WNBN(Q:JZ9#Q@GZ0"B<Q1-K: &*V
M;8'<0\PA";*#%W0-Q<$MM#@H]=-T#E[QYV[Z\M<B=\7XFQ]F2\^\?>6]]W+/
M+ ]V*?\F 3A'R:0T]Y>S='#=OLH #]:#%_3"V+#"^_ (RQA:\?@#TPB3WI$_
M*V=VV6MUG6@K.;7=,+<"O0:S?O^(9(8,1,T:<D44 7ZN2.,3R+&&^$@>+)L+
M YL#%Y 9";XZ0$8^6Y/658F>=KJTJM7\MLE1V5CL]KN>$)T?.1EF@>@]8#0+
MNJ3K"@\6M39#8&9S[I,N\F!*; W ^C:@L["[YG&^$D@^5AI%US5^5:"BMM?_
M>+&>8--O5'325(%4V]4O?%L'@ SF&*C&(#'+P&<L+8P,#^92V(^$(QN0-..4
MQ5,A]'GN2$MX=M1NEV@#?]<VI1D,T9.8S!6#QK7O,)[BSB!:#7M06<I"A768
M&&88$)QA3)*<P238LXRY3]9##E&^]O[R&2PN4*M/+4].&HPC"G!*>+ P/&B
MI/>QM/ ]W<A _*PI$S_9;-;T=\,+/=UZ$G!XY5!@AH@LB7Y:]C!&?&%7Q Q+
MZATUZIQ&)WRE7![(IW^'W&?)><KEPRJ"@@"!9KA*>S*-&T4V17PQ1V>PQ>??
M.J">@)[+AS4*75^U%8V39S2:#^U4]Q+_ /DNJ7_N'.L$;@P/G">"6A+)#W#C
M/%A+<3\Y ZUN+3I(G ZER%T )I,^I3X'[71?N\BU-X9\"VS+U(YST5;Y\L9
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M/+\V"V>^Y[S$4^M*HY+C<N&TC-XHD2F,%\UHZT>Y]GVN1OWHJD#,<KA<$K*
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M<R>NY?>V@N4+7U4QU?TC2TCI9C5CY65.[@?=+H&L1V?3'?QOW:^/O8CRV]J
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M"F?>//B:P:^R3[I?$VM=_C ;T+*A![)U<&&,X&LDRDO(^6@0DPIV .F55H4
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MXWVR+?&PCB!^D,S3#"_KI<%WX,086=D$Z8VR.9W.V/I?:D,+&?]PEBL*TV#
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MDV^=8DIM).L_6IS:JN+QX-/ %']6TU$/,>K6JS97.7<P+WGYILR>@@(??8U
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M3WVAQZ[ )6$(H^VX!(HZ41W]%6I*&O)G.W;N%Q&]=LCF^DR[D15,H'?E,*7
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MG;U6W%/6WAG5-!AD3K&W[*O.-<5>1*1FYJ08_"9+G.NQI([NPM1VQPM@*&O
MJU+P!2,+U1I'#LW_NL!F+B5'1%@L2:G9>A1J8;C?NR>>I.T/O]#S^JO-:&0E
M3QN09ODP&LBXAWZ;^?=-5EMLN_ 3HFJK6&QET#M6GJCKP>A)X_%,]!#S>V?M
MH>A#K?(WJ<6<$H$3NGI9M;I+H?"Q_CF_:+VS_,_/E 2G^TSYCV'4!I$_(85
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M_<N9Q?LO%]\?N'>X*(7'[R=1&S<JRQZB++FNO+_?R\;QG%BNBQ2&NOO(X#&
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MX[O3Z,$6P?=* %_ !J=$4=,$A]"AC*0SANZ<?3=N30(>91="PRO]WKZK'=E
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M<?XW998X";<R16%8"1:&VXW:S:(LJO^]I=GA7">IUC5AR5@>Z0[!9HX#./B
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MII+=)&JPO:?2[/A0LTN9H!>J#SAK5=CX/L_U( Q%.U7Y-R7^/KG7N%/KA&>
M\I$S?9> -2%HLQ:[+ E#3=W ,"=9<B=M)'%0/:29?3T06WI).]8U@'XX(BQ.
M[81'IM2EV];6>X]^D&H\YJR[S1O$O9 "E-.O05B>F P,H:N6"^-) 1]*4:I
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MI)>L80JL.*ZZQ3ILKSOO.7)YHS#>OKQT>8VQH?RF-J8!,=U MRYX]6 O50S
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M"052=CBV^Y!81QKP\NX>7YX1^79/JHU-@YO4]\)@=VTZ5A)(TD0S G*X58\
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M\.V/;+_\5].3 \HOK(^.Y=;4@8UO=3_^VEPF=EA3X8],)SJ>M)5OA)<Y#;T
M<WK6G.,19F]<#<93WGS/^A",#1/_SNI3T>W<F2PCO"UL"WDOTBN% F?'"[9(
MA_])$?EV@EF\$8Y9[ :ZC-31925 J54T ,1GG68),/#C@B.Y5D2[7C]9X=/7
M!LF_\E?UOI,FE7KAH-U*%!RTKWB 5@'\D!1+-I4=,6K2#[A.5-2&C\<WPPV^
M'PLN=&O;F8P])F<;I>:5LB_L<^EIW^-M&NW@(%^"M]%N!^KE'+/F&!(.\<JX
MR%+\P"(_?(?Y@!JVL'KT>OXZS V'(8*)%@W.ZKU2 [-1+7+L<I[ EOT,)T/I
M LJ?0NF<VY(CB V+JJ-WK3-+7]OHV1@LI_8;'1>V7;B9/.OWX^&IL!_H.!+H
MP QG*/4BU8@#9/!,!27;P8SNWXF<XG2E<_VA"XP5!7S@W*F)UCT!C1%CHVOA
M)^1)C=56Z:B;MZ8_51U_?9&0?IKX46"3#S;>I4;=K5]^P='FC^2IL/KCXKDB
MHLS'M*1@3FCG5I/#./V==6,^CVF*'/[G.SUS7M>].J\+_#-"$^3P)5L$CWP/
MRI^3A&^"+-@<4#T[K_C&V\N=$:$FZ?9ZVQ00TT_F'A[4@DE*9=Q#NSE_->/*
M]_(E<!QQH/T$V8N\@_@>+7CZY1(6G%'?!:A]7RG":UK?IQ6]P/)(KSY:Q3EB
M<YKPPU,&U&M%#E_$P!N%#WBFO#3B#JX5=(*SEW  0K&\/52+$YH-P=_6PPC[
MDOB'42N.=6]CU>+KX2VM%^\,$N8C#Z,VIM@\%=SJ'UYRJZ9A!Y(2S*X$2?<1
MI]=N.R^]P"J=K8[(/A5B=^#5#>47<V2%*8(LKPKP)5$L:.5_F6K@A;F*N)"5
MS9B4VXU9B3M;92<I$4^%!GPS/0I,DFS]_-J$TK&_ZQ;:2."Y6H$)%A/'D'"^
M@L#D#R(L6#)GQM\@C%_@3WA"]8S+->'P9:;Q69_,HR8^=4]_NC+F7=3[?IW,
MV:;HU;75GKW(:V@6YP0#[;JKN.A91<@L%,QQ9"DQW>@5T63U5M7K"4=6+5Z\
MTLH:SPMJ+!A4CU*.?'H\7KXJ]4"?%3P?66W(57#FBU,Y/@2;!L$"'2*.>RJP
MT/'EY5^?!61F?)#Z>R#?XEN]RY#E:&*4?6>+E8J.^G@]$RN(3FJ\N'785?M<
M/12OC(R1D8&,_KHG?1N^/3V?B6UZDDHO<L-OMSMI]55%(EI8-D^:(-AXD:]@
M5C1?G*#,RP,"5F+S5"J'",? %'8L&&VIT#!<-KRE=F2_OZFSJT\X; JKO__5
MD-0^V5>]F\N!=F/]VRN))-")/'U_;AV65.;=RMH2,^<AV=8HTO]1?.O3%ZZ8
M_/X:X758J5U1L'[" 94V'2U'T2]P<>)^[GY!E%DZ#36 ;HPM:0R2%#9SEIA1
M$> LP(40C=/IZ;MVIK8_2G[]\6+D,86AB06!0I M&ABA&S)#.=?X'SREJ^T-
M1?'&<S%Y#?3</;,',M<PXS6CC>_J[]G(GM1*N1%OY31[P](;_?R_*>URX:NQ
M_&,(OE?6BJ,1#L6+=95?$-O=?]27(+"ZZ@C?U%05E,C=^^,ITE!U1ZO1VX@+
M'1I[1OZX7?ZI(;[_]O1HGLGCK1I&[VVEBJ-:CBU9J<I? F*Y+G2TRF7+$KJ,
M'&:MO"Q41CC+/&@1I?HQ3D;%1VO+A7;/YW\J2$A:$5"?',]1!=H/\_6)4X!T
M;9*.1Q-XYP$8,.SFT1M\K;'YK^SE::U"<6'ML2ZWD9TTV9X (6]V\\:<%8$%
M(I%7IB</ 91!]FN0'&UB\>3DY^\9@]KC!4,:Z1')8]K/=BULO8!I;V>\W$A)
M%P-OX<QO1WM( BP8G55B)>=C9+/GK.O>A0<=/QRWY83_K;3!MQJ2RQ1Q]=_H
MKL%NPP2T+-&4>W*<:,!U9^7E,PRW0[%\^QFLZ]AUJ7JEX(8^BTINI#I,\"-B
M!R8R5KH&(TERAU /25NX0:_PP=T:ZJ.:+4,AY?N#U=G5^>]]-5\AHHIU/YY^
MNS/5"MF2K=>V#J-ED>M.(NM7EF7 /G9%IH5MK:$\=-V4)5V><7]':XGD(:4'
M+XXX_9Y+?9UWW&AAO*6ZDZ@/5CPL@U\$X^)K>)?&+>*B['--_^@D^9Z(>UBU
M76@?K<+Q[N<M,0HD.ED1[]QS2>8U_D270&MC=W2V:P_DW,WHJ<KO['$1W_0(
M='YU- "D)B+TYO1$QQ"[&$%(I]ID.BU]P:'%;L[%D3ZG'QWY$:\WJE&S*=\3
MP[G GZ1NP)D=2.4K4IENK.H3X*G(B<VSLW]=WNUZ4T1Q^QBE):W_*TBD[E39
MI/ <+'NU$1+E2PQRS(AC0_R)==BF__A4MSINF5[$O54+F6#+IY;0XH:U3ZZ]
M80'JIQO?//LKX65V,(Q0(C+POF.?5A4L/&XY4>"+-S>J2ODSK<;OH"". 7%T
M3><!URY(Z.RL>D-5\XB)^.YSF>D66.AJIM.Y*!>%2&&YR&"/>J8OYQ;_(_KM
M1,SJH!)QE*J\W&R *Y^M+8H+O/83APLY\OB$N9L+Q<:@N]WQ8GV6FLB7ILIW
M_O1]P'44I(/CRLNQ!Z =]!3*;YI_#VF*/+<0R0U2+ $'X _RY%2U&K^]%X';
M)4,O2T+\;[8<>_#D3)G"N2H..DUPJU_Y8XU9RQS!C<M#-IQ3Q)X\V5:HFI5(
M,[S_9WH=%H^6+#N$^5FV.BA&I=S7YHU]">QT>*>VR4K(;O?IF"R_L4="JPOL
M&[PBXF;^!"!>LPY+!JK]NZ6-NV?EQU2&1YR'9^KB9>N:SVO&I*O(@T/O7R_U
M6/7C=;I2H/V#W.TGZ#)=#N%T9!=I^GY'(^I!LV&Y!T:5__AF$-ZGJJ7N:7Z>
MHMXFD?23OH>U?&XXA"UPMPW_IBEUHJ9^33OFL,M G03B;OY(Z[YQ_H&9[[.J
M38J9_29+7?5W*$'//ND<<%565#$S?*)EAVA[1R%O%#Z;DFFOD)4VR\=8@X(5
MPW!.=S+NC(<@IU&]=W/3ABS5%ET_H7VQ3QAJ1;7U:;+UW3KO;:\<N!DK'$E\
M0^PCU<4M%W.PD.52+ZDJI9<L#:V<>?ONLHE*C;25+?O\6^WS^&2MF">;K4+<
M(VT']"J@0I8-_6\[,LY\HGLP4<.@^C/!A-YO[L;#N9 SKIG>&7JSD#:(@%D$
MHY\A0?L6@W48!@[IPWL,H;T5RTR.!3Z'3FYC^M/WD.@7W[%T8N#'+4U9$IZ]
M1\;R:]*<GNZN3Z(953W,@G>Y&]8)GJTM3QQ:87GSQ3%S@U'HZJR.%%E\;U>K
MV>CM(#6.3@>[-6AXJK40I_WER6$GU.Y]CDW;2N<W=TG EEOE@?8 @):)5N=K
M!9#%+&7YTT2)B68'AMYJU= AK&3)F8DLF8Z>R.?"I/(04FT65[Z"+<>+-<DU
M[$37AC(/TJFB@=G]3>X8BM-2W]$OF;3'QD]VVFG9WE(.*\LW*C,C%,/W!B#K
M@&[RY,A<5J>,!'$6 $^3!&%.@B#)DNM6S%,";;H,-T%5(V[KL.A0EZ>V556C
M5C4Q+XR"=/=K:LOG(QZFU0M(PZ/A&E(BN;Z"^8%C"\V=%7#MKB$N3@-6T]ST
MP'8\>\]C[\TGL++7_MULLO48NK'CL4O]-C$8YWX[H&HI2S@%7<"P)MI(<K=W
MN+6'4MP"+[7J5HYY9:#2^R]6HQ9B)V6/U\WK2-96/U1EK<.F^O@2[8)+?N.5
M\_?U@?;LV[PW7$U&BH+6K0];DOQ#M&YYO@QO[JDU*C"@O+JDU>8N<K[W7C;W
M,;3R9A$M+@C@@],6;#%0>G7-YAZ5/3&,./AR"C.LG&4[9++49U':8CFY'_'*
M*+TB\X#I%UOS@Q7U (T\NQE$M>$$]#.E=QT68[EM9/4HEH;L@8NB\5L<=#_L
M#C+_LKC-Q<Y7\?-!G)91-/Z6;,<>VIT$&$_NC28-Q=P%GF!G@_P*1D7DQ@3T
M9OOB[Y9:39]-PDOE4PWJ"@,ONKN9_KG0(+GW\/N%*&Q]13<*TJSGRNLQ!I?)
MX/2<?R=.!&@W)1[A7J[.8#]EY?Y@V726JPY$'-WQT^O"=5?L@^E^Q\BWTP_-
M?UO!WZ01A^'".KR";[ST BC>ARJ;#X9RM<]#CEJD  \UYO$)YM/I:O^\#L3U
MF8P1]0D<.AU9N<)TJB!^!L!;2@FM1MQSO.SF,/ &!EDI!;I_AV]?SJ]O,06A
M@N$+>$5Q+;16G*_HD4^H7J&#W(,"F"HG4N!UZ(YR9X';&@K :@LORW+;]V%/
M] >02D-V[<+>+%FZ8SIB)X^>-ALL.;&?=+3]P=O+7KKQ6CYY+R.)#>?0HM_1
MX#E#RF_VQG0R@+N=5TRFD<A;$3KT":CD4"E+J%<#.;J;=!K"X0+]HM;\ZHVG
M^X@"F1ME^UPRYK#T7JN.=^0I 7M5$=B>$E_B/AT)Z?3VX*;#:0M,A0*N%7BG
MO&0*_X(^&[<EZS4>Z_CVV,&ZEKK:EL9XK_1=>SJZ+!1T=NZ3VL0>C%J'70.F
M@AFB'>1MW!O@8*^A3/U]KG:Y)\92FZ7-7)C27YV>=A%VWM:G3U<X;:&;\3D=
MIF-2ST"EK,-$";M8.9W(ZHEX0A@&,X=2_O%W8E8%Y";P[^3C_&3?^!R7?R4;
M=_S6L7_O^HG27,QGOMXB %XG,75*\'*]%+_'!9?Y$ZHC^ K[EL])HY0R%(.W
MSR!=//H#^\*.]H1+7NFXDP%@4WU*.?EZA!+[+[C"54"Q#X#(2$M-2*8+J8RS
MW 'Q^\ZQ9LOIF.4:^\/NKLWUU*DA]^:'0].1\3*DN)RK?D[Z,-'%/PJ@V7(?
M)Y X"513F;]9,NQ-@F6/)5P @12#9B2HR5><B"-JXYT[@@KZ>&D*G,LSTS-3
M\84/S=]+[CHU,*J5N7_S#?(6@29"0OMQS,<<W11HG^$RDT&-7MN:5C;]90DN
MO0[S]W!N/S_S98ER\M:[6(O^@-E35UKR#G] [3^XU2?EYD-%B4UK_M8$#XX#
MUU=P]2<0N;M5!J1V-JW ^)_X(LU0*.X-?H%1T357O/1[$CN<UM0Y7H=Y=4P-
M(11L%Z*I3((WZ> &YY!5$UP%-/OQ!%]-8(72S?ZL>CJZ&Y#E]R-E /INT+E[
M,);]JM'Y@75/"A"VW7W:^N8AS"&YJ7^WM&X%:57=N! >2<P90F>2I)"TE^LP
M\+Q,%!H\.X/B2ZIQ;@I OH7::2_ O4NN%3&6<GBWX]G2=G_"&ZXQ5Z<*R7Z[
MO!O#LNT<]?[I&8E(5Y8^@5+^[SI=I/=@=".:6<RJYDO(<O9S+P\7-(]\@U)
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M.!'I":$OW'HADEZ5MFIO^V!Y;_=\]L%-B<#QW89B8Z#C".YGSJ=\XB#%0WR
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MVB)#FHC(JM>6-N:&56*7BZXBZ<I0__H!N+C3Y1M !RG&^Y 9$1))G'M 'EP
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M_+GO.(#?M5EUJ(_+V!YW),]B]V"+ZOO8)-ACT=E>P/Z3AZGRP?-]TB,1(Y1
MQD()$=$5HAB2,$E9X!'E,H:Q513F]W""\J+#DA><DISY\<CQ3T5.=1SR]<]!
MVAR '.'DXS7_KW79))#XNMKN(=Z2C'_(WY#'K"++QN/36K3*U84WLG>>^*V@
MU0(%D?1BJ@BF^OP0#@(UFE$.TT!@BA+"16"52]0%J+E)23O[81U@O>'$>N>R
M2Y'K]-_YJA+E%<B%95X()_UH)DY3]\[(8M8S1^^[]B([M$6Z<D5KTZ;FQ9M^
M'_;/UFO+W&F@2YY=:J837)-JK$LF7VJRTV?;:3@7V>*+8.M"/?S=-W:OW<-/
MZDU?,"I$*,-82;%4KII,4ICRD,(01RR@88P%-HKP.]; W+2UPP@ZD$"C-!/0
MHR2>%D,7U(P]_;1CQ5B?SIF^U9JR$YM2L#_?K9Y^4K<V.J/^\E)>CCYV$JDX
M9U3WV9^];L">_\%3? _;/94;V3^_&S%.62!3Z&/E8B&$,"3,9Y#+P!->_?_0
M.!K JNFY??8[2.N\NOV<GZ0L5RS;EE"FW2%?MK75)KC KI=.J\>XW(^L*X=.
M2X,=Y.!&&IUWOI1DBR"&T<B>*+SAYP-O+RAV2-]]_UV=]!A$W,F8"+LG3A<M
M,<C2G3B*84\8FO-LJ7Y[=YWS7TGQ=Z'S/K[[IA<+N\ "SE+&8B*@KT-P42(C
M2$CLJSDZ3B0-DI0D=OLB9QJ<V^C0XJVW'A\ZQ+;ISLYP;+BIX9"YT7W&+6D;
ML*!%.TKV,S-JW*9 .]/FQ'G0S!C83X9F>-_%<21OUD6AQ&L1< ]SYA&(,?+4
MK)*HOWG4@Q&6./%BR9(H652;6N(V(0UM$U82<J0VNM.:#;H-P!IP_<%U<"A(
MQZ69<%S&T,A2T0-W!5IXHT1TO#!]I-B-KI77BM)X8>6)>(R75P[<XQ.%7!4/
M1.%L#@QUVWR1AP6C 0Q#O7:$"((DB$+H$2GC@ D6!=RN4O:1EFQ>Y6D*6]]^
M_O*;Y1;?$1(Q1;%'6 01]0.(4B_1==4\B*-0D(#&D6\7D^* PDFV2Q6!EMIX
MC$'#?=++>1E[JW2+L#LI.L)NZ6D:G&Z8'FEJVCW3T_;N;9N>N7QPD,0CR7CK
M="D_K"X:W23:ZH9Y%L6>C"F%2+ 8(D_'3(0AAB2*$^5+(>['5H4^#-J<G28T
MD(%H,#>AH*NZ4GSG6#5%>ZR#*\ZR;Z@A;CD=6T]:.KLIF6:S!MRF)1S!%;,@
MR'%HQMEFIX[4,.7A0."&\:T3!](V>Y,?\K(JZG7,LH;V]9[D;;7!3WJOLJP$
M_YO0QQP%OU;>&+D3O^C#CV]))3;%EQ9Q(O3F1 13/T!*\Z2 -*%*[KS(%]+#
MC 3>XK$N</ZE(D5EN/ T ]-L%."E@2,N"I-E[5B0JBXI0L5=EN=ZP68EZQ\T
M2.K4)'RU7)*BU#]JTI1,E:7$Y?OEQ0*%OB=AE(0<HI"FZDTC*52C:)0F""./
MD/;]>I<;9BJ>@V'V;U=GWF3OEM"C]O^9;Y7A(NX,H,[(#W&03:>-INHQTWHR
ME>)F6WAY0\\5Z @"+4.@I@AHCL"V=N<, N5'Z/-9A-J[M.O["-8?H2>=A?N/
M@6V8]_E74M1IIC^K9S;G?Q?43[DD,H*1" A$+ X@94$,&9<"![XG(KLEL/TF
MYC;3[1 "#?'\.6A3(LV&I\OH&7FPL&3&6J>/&^]2-0^T,JF&';?RI:*<N'+8
M]_U.2L'TV<&FGN%7\DT_6F<?SEFVS&K!>E/'PGW(>WGDFPFN%IA&TI;+U1_:
MJ5RD'A:84PZ]2!=E"U($2<0HC*@,)8T\$OJ^C3@XQC<W96F@ZU#TIPXK(!U8
M.X%QW9-FZO2*_3.RM&TL VVI3UWKHY:Y7>NNP+83=^J"M-5$-D:"C957X%84
MS.E2WDC]X%)E74.<5*)'XO>EOH_5S+#!X7V6ZZ=\%,H_[;:IGUL_M7RKEVT"
MFL@(^1#[5$"D4P]37R#H^SS122!1Y*4V@2/G&IQ;&,G[=:6K;.>K'#(-?%G[
M0@]9GCVL'\!2FP$>6_AV:GZ6>C-Y=DGHR'K;0@4UUJM-E/'S5;>Z< 7>NEP"
M,*7&I02>;7-233-EX*5(&=\W\.!J4]&HRZ(3IMA+DE1"SU/_0[%/81H%2F/2
MA E,O,075A[E[N/GYA!>#]@Q?4&8F3(,IV%D'6C=IC&2"1VVV>D)RMT6ICT+
M>="ZO5.-AZ^Z-(/T;;%Z%(62 =67U75>KV ]:D&H<^DNXL@+4DH32#R60D13
M"FG" _41LRA.48P#81>R;MCPW#[O#JT:U#3>3?:LQR;#7HW9<F')N \,=T-&
M8';TR(E+2+T@A;,90^-D;#[3]BLE:#9CY'@^9L/[!SH6C*W6N8ZGOUTM,Z83
MH'5C)O)BSR>*;RJ9#Y&?J"E-$"N?(R Q3?U8S67LG(RC3<U-D;9(00?59.RU
M)=C0*7%"V]@.RC#&[+V5LV0X]5R.MS:M%W/6ZCV/YOP=P_3B#2GOE0;I/[0.
M/9&EGN!\%NKA&:L$/_S[&L3S(O;"Q&,A@RF**$11$D 2B@2&TO/] *<A\J6-
MHEP"9FZ:HT%> :;^7R=@;;%>U0-WL;&HOL!.@"[J,3.)FJH?1A8QC:_FN_[+
MNWXO;&T!)ZYJ+ *_MW^.4BS#!=<N-?(B/).JJ OF7NJLDV<.C<A?,2%X^5X9
M6F=(T_YAN4C35%"/,2@]B74.>JEFE4BJOS$6<HZ51R<M3S0=;,CFNYWH0%.+
M$^BN;PM"ZN2OUK'V!WDU4\++N1I_7M@CJ4EH>'N2I $1]*<X<!LT?["EB>/D
M3UF['QI_\NIA2G"CIH=$^WKUZG.WZ+P((HI)3##$:11!A/T0$NPG, Z")$Q2
M[JLIG8VW=;B9N?E1&Y3-5I/EQW^$2K./_W*"1O[XM]RT&TJWY_;AK#_^TQRX
M_/B/M#3IQW_:VI<?_YFKAR[@*+^B$/Q]EF>5^)@]"?XAKU2OZW1[S<+VBWC(
MWTHAU\N/F10+[B<Q"=4T+(V%FI 1H9R%6 908AR'41@SGR"[)9[A8.8F)._*
M*GNH$VJM:XQ@J4#:KOU<T#>FJT/3,#[Z^E%C!FCL@$MM"-A:LCGOMQ<4WY@#
M/I[JG '+3)>SZG8AZ@(\$R]57<[<_F*6@V<.J4ZXJE?0E$BKOY49K]5[E=_D
M=ROUX[?B22Q7]4+\[:JLV%+-<'[-EFKJM\JWJ1'2A$=IRO1I: )1%&!(B"\@
M"@G!0DKFAT9'HAWAF9O&MM !WV('CPH\K-&#APU\F_I_E_?::>E]A;X8>^%K
M8PS8L>8*=!W4,PC<;CMH:].@2HV7]Y1-8<=)>VRJ.I!3])QE\4AG/)^N-7EY
M,Q.6IG3&R6XE2W>/'9@W3:C15^S.:PY%OWT2WZJO?XCED_A50;XO%P'CPI,4
MJ9E&FD*$&(=41A2J5DB >!Q@DEK5XQL(9&X#HGK/?<MT:T.[P&Q^,06Q(X]N
MC0E*$5^N?O3"::L5H*(N@7 %_E.7UKW)'4XG+B71:1*XH5BF315W(6-[">4N
M?=[ E=DZ\0ECQ5KP7DZ[3XJ$-FN/P!'F+ ZAAWT*$=?I1(CZ&\-A[ <)9IP:
ME0PV;G%NBE<#MERD/<NJX7JM2Z[&7KIMLAXU8/OIQNN4 <QU%B1C:IRNZ)YM
M=-K%75,.]M9YC6\<L"BQ\>"NV7VF/+SZ?/Q=(>J_;%8=4DPIBZ$(20)1)"A4
M_PRAE C[D21(>-AXU<&@P;EIR@8R(%O,@'2@+::H)FP;K!8XYG!DK=G2UX,+
M-GB'3/5->+28RSOF<Z+)^L6\VDW$+4@Z.=,V><YT4VD+JW;FRC;W39R4KLU?
M<K.NRHKD7/FGG];U%Q$&*2>*(34M#G3B $Z4CJ<Q]&(/H]@+0S_"$V:8.X;3
MYE.;+EU<$]NR:C"#U1;T52]U'&WS?NGT7G5*KW*JG%Y'.SW"'DTDYU @DJH9
M@7*5<,"I7B1!Q"=$'^^;+.V;NRX?/X?;B0X7]9]S[&VSF<JK]M_(WH:#W&J;
M[&DW_4YO+)U!?K1SG3"+9&='07X?F<O.<>PL#=G9AL9=2=>+D^_5M[>($]]3
M4SD!0QD)G7E?#1,\PC"0)&$,^0DC5J=';0',;<ZGO@<TSLKYAG*W*^9#B)SC
M2KFV8?JE\I?LO<82^0;#+)?&7S(T=$E\[SF7'HO?I&%LC]WG_46R7YOZ<?PF
M_ZSKCA8*F9+@K*S/NNH#-?5YF@7'7BI3O6&8J.D1\G24<T)\B*,XY#[R?!;1
M86?G':";FS1VQNF4QK+.4Y(1U4&]3+2D E)GE-4)U]1E.2"@Z Q47K.R<.CY
M>Q>=;>@COU87CNT?]WIOF_;WJDNEID^B]<P#G7V@+E/:]6%M8GOL?YQS::/0
M/TZ: !< 7RF7@$-NCR<<<-F(W6!1'UHNGA=OKA<D]#P_4)+N$UV9*PH1Q(%/
M89A(/\1,$IX*$X7?/G)NLOR&Y(03,V'M$7-:#8>9.[*$O;G^=/WV^G*MV3?N
M1/7U]N)&(-I_O-2&W@,G^:#W#>B^P@._&; Y^"'GXB'/9,::0#"ZS.Z:TM_M
M'DL2A41Z?JR(2#!$@B)(),*0HI1AD7@I-2N3:]3:W#ZX%WC!:@O88BOK+,<&
M^X$NF1OYVWU)6@_KD(W L^Q9[ *Z9'&B+<"+V+3;_C-EY^3>W]F'3+?Q9VK/
MSJZ?\4W#)K5?R;<WRA?*JC>D*)[EJM KA-</6LL7022"A.BB/9XN#^4G,22(
M!3 B$?-I*D),K)*=G&AK;D*K,SVS&BM@/;"6D\A3Y)I-"1U1-K+":K8:F*"/
M4\WP:J3NIF@&=+B<<)UJ;M+IDX'=+R=#)K=<$"70WSY8D"3FGD@X3*FO9CH)
MB2'F*(%<>E0@3T;,XP-W^?OMS'27OJD2>V1[?B7;^EL#MFEW./8X1WXJ*/1"
MKOQ>QJ62Y3B"02JEI%X8)9X8M*E^&<,3;(H?X+>M;N:&68L-[*%<3;$!O;MY
M['C3^)#ASC=]=QJ9?M/VD(T'-UT/7CBX*'&3[K\._6CJVPF.U0?-.0PX(Q#A
MD$+* P9E&/B,<412[ED6(7[9QMS<K0W$)NG1%?B_O3][GN>#1](NZ?\%!-Z5
M^E$;]0+(NKI?%=E_"_XOP ^B[L=96>KH\KIF\;:3 "FU7+P5K':9_\<_^['W
M+Z%_!?3;6%^L9@W8NJ#Q7L^9*<F%_3&REFR[XDO3%>UB_8>:6:=5BH^QX+@J
M\5XS4U<A/F;G@:K#1R\=L)3V9?WP0(KG&_DENVLFD'FUGU6SR2*=T"# /E(3
MZ$!7?_-\#BD32/W/$RDEE 6AT6E&VX;G)D0M=' C00\\.)@<UB:MMW6'&"S!
MC43SV+[*7!BV6*8;B>F)5NPZQM4(6/88)UO&'UL+_NQHX6X 7R?7\&R>-]UR
MW@ K=U;VAMP_9!C0@\F'7!<FRYZ$SM:GZ/7:M>HTHH'OJVDD]G$$42S5WR3W
M8((#1&,J0\*,TF>=;6EN0J^1U6DC;=3E%),F@NV(G[$5NHY"W^ $'= AFR4G
M*;-18$?4322YG\6C>EP=F*0KL&>Y7!4/S7Z)+H1 LGIMJ%K5OZVY;9*]9AO2
M==K7*_#'?<;NP6.Q>LJX&A#54^H[[G0]X'9UJ;FQ"2HG]1JU?JYX>%RNGH5>
M%.!9(9@2ZS83MU*V<KU4$R.%;9US7;Y;% ]-%$[=4%EOY0@U=Z++K+Q7CZ7/
M=:MTI9ZNF]P\T=EX8="[IP>(4P^8<$0PL&-W"#"Y88#F[Q41W(V-7,2>G\0Q
MCR%/0Q\B*4-(A8B@Q"25<8*%D.:;Z&<:FYOR:W1U8/ V(LA"T,XQ:S ,..1K
MY)'@0.'3J[V :H?D60P(#DF<:$RXC$P[035DYZ2FGGO&=+)J:,V.LIK>,T!<
M/W_Y34<4WNH_6T_&Y[Z@*4MA$.FC+"2,=))$#B/J^5+X1$:Q4:C?D>?/34(U
MLMIAJ#%:", !Z@P$\S)"1M;(72Z&^,@'2+$0PLO(F<H?-GMA[$3NN.4G=>W
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M\F/1]MQD:.MZM [*%>A!M@NN'](59B(U$L$CB]6%W%KKU "67.J53?.3ZM8
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MIKH7Q35CA9HL?LP(S9;U:=PW;4XDD:9!++T(AH@0B$*40!P1!$,A, H$]H+
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MC:S?\P?-[AHJ(X]919;OOCWJ -=JK3.7-E7*^,_KZM.J^D]1W9*,+Y#@4J
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M$@><I4BIEM 9IJD/<1I[D##FQW[@H8C8E6 S;'ANTM5DZ]BB!SV\YT;HRWK
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M-']^R#_D.DG5JM QYU&,L$^1FI7Y6,W*"$I@*J6 49!@%$81$HQT>UM?K<*
MCS<Z8"/KZR31P U"RVB)T_R:B<?E=$T6\UOC W_JD/X(LASTP#H-^3W/B>.0
MWQ,-3AWR>][V R&_!C?-MN#%Y]5R^7Y5Z)L6) F8]+$/>8Q3B#A+=/5XKJ0)
M)2F.*:8LG"0*;!#\N<WQFL3=]4))7;A@=G4+^ET_<F#8Z!TZ_QV9H14,MB\0
M^%V3 UIV7*ZNO4JWSB*>;)@%WT=HV46]\PJ5#@ZA&#9N:I>^P;=<KO[0E65>
MAFN_N=>X/^1M@%-*6"H9Q3 ,1 )1% :0IEX(,1%"2#^-"6,V(Y\M@+F-71N/
M4[F93YTM@'3&V UEUKUA-AB-R?'(P\D&.MA@UQ537YZOT8L%>Y[_E?-XLZ%$
MNA1P:PR32O!0AEZ*Z.#G#,QDS7E]$(4L;TG&/^1OR&-6D66[P!8'D<>X)V'$
M: 01D1)B%B7ZK&#,HC 446+E[9]L;6X"MP4+'A5:J'2.-7C_8IE1^B3'9DKF
MC+F19:M'VFU+6@MUA%5,(U*<)F<^V>"TZ95-;-]+D&QTT\#2T-IGVP3&7K,J
M>ZJ3).AT)N^5E'VI2%5[@8N8BR!!/($Q23V(!.&0B)A#(7":I C'Q+<K\VS:
M\MP4I@9N68_9F&4S71F%NY$UIID3;T/PMZC;U$X:.-@@=UCIV)8LIU6+C1N?
MM@*Q+2=[U82M'S!P8S;+M3?UL5F ;0[&Z,B\O!0+/_)E3%D"DR3 $(4!@BE1
M$[PX"!F5(B!^BFT4Z41;<].@%BI8UG,(MBI/I$*SYM5P@]8-6V-OT+9$M0=^
M.J"@1>IP;_8\'4[W9D\T-^W>['F[]_9F#6X9."]J*I27M^2Y3MM6URPOUJ*?
MKZUUX%' (L_S4NAY@9HDQ1&%RH^)88S\,$IQK/.K64V2C)N>FY:T.(?G7+-@
MW7#:- J78\^A6M"@15U'I'7<]A-:CC"CLN;+Z?3*O/5IYUK6K.Q-O.R?<&'X
MV8ULQ#$CR][">I-N>H'2-$Q"&4 _B!%$J1=#$B*FNB2B!(5(!-QJ+=NHU;FI
M51UQ]51G9%A)(#O<(-L"'QBJ=I)[0Y_(-:-C>T?;]!:*S WD_E[F-$G/K8@;
M)<;M9,.O$^UFPL71N#>CFX<?#UCE]<&#9O^Z=SAJ0;"//1%+2-(PA@BG%!+/
M)Q GB9<(@@1-$]O3 ,<:FYLVO>F=-KH"JRU0\*=,_;B&_Z-]N/]1KLU$R16#
M(VM12]Z7AKP&Z<Y!5K>A^^<8<1VI?[2]R0/SSUE^* [_[#T7YM(]<'0%,<E]
MGD0P3@6%2 ;*V_%0!#%!G.%8"I98G6\\T=;<=*27"M;!B:%3))LIB"/J1A:0
MP:P-SYX[S4&?4\V]3N9<\T,\)K=<>C[ZE]6*_Y$ME_4QU85(I"?22!=W]U.(
M!..01'X(<9C&01@E:2C(L'/1.^W,33/ZYW<[H.W)7=L*[T>(-=,*!W2-K!.#
MF+K@8/-!'L8YT+S;U"L=9#YH[_$#S(<OO\2?^+@JRZ9LL#XRN%9N2KM1M<K+
MGX5<%6*C2KK.L!(CU8::+!7/=3;O3\I@G<IAM50MW74+U L>^X%/$P)3@G0,
M/?=@2AF":<(](84,H\BJ!L>(6*VT:8*:'I]$!93VEX#6%NF\Q[9KS&/VK$QC
MWP^"%/IA(O69+;\YL\4])G$<XX '='-FZ_OIX!<GOJ:JW3*??K5Q;E_].YS&
M.?Z3MO-'H.4;;$T%6UN[3W3K3(OF[$+/O,TNJFN/>M1.<.^1CP/W%3SZ47D_
M/",8M\D!=3C>/3PN5\]"U.L<M^JSNR>EN%7?4.#Y4;M[21-/^"A*H)=&R@7
MOH0$A1X43,TITB0BH?2,ZV\8-#BW.89&!CK<;9:@#CG0T"TJ0YCPS95?%;.$
MPP!Y>BJG_*XTBBA$ON14#=HLPL@L\\(8C$^3?J$](59GN=JN+H/'=5&N25[I
ME'_OOMS>.F;^]- Y!ILCCW^GWMKZM3Z[*S_P%38O:N*8T(F*F7P6C[I.B0Y\
MJ.[UL2*EW0_-$9C'IMZT]AC46ZI_6S,MNJ[8O,E-5SRJY[HJ=6+!Y<D2)R;/
MF:ZTB855.R5-;.X;,'2JZ=UML6)"\'I(_U!J96)J:G];9$]J[J%:8DUT<QA'
M >&A@$0P!I&:=L$48P1#'OJ<JL$UC;CQ &K<[-R&43T=?FR1-Z[X8X-8?P+L
M=/3S)>P;B/HHG(XL[9K.#C30J$$'&]Q(T ('MZ-2:R'SHU \D=COO[E91[5R
M4/;>8E=J;DW924TW?]ITRFYMX8Z^V]\]<=:2]D#X\22Z[[Z)@F5J4"HR)A8X
M8))%H533[@2I>1:*()4B@F'*D.<1]9L4+Y1WD:WXEXH4E>%&SC3H;3[;ES:,
M]^7^3);U9TJJVA&CXB[+:\],?;?Z!PV2.DZ%JTDU*4K]HR9FQ3)D9:JW)&!I
M*!,60$QC-2>,$(($<P2II_Z=8!_)E+=OR;O<L)#,;-^1SH+)WA"1\^_XW3#<
MJYQ?;X^]]^FP ,'I&@,= Z"F8 8I;8;UV2QRV5A"_SZ2V SK#V?9:P8V/SAB
M]K$0]PI>]M0N;#>1N,W_MUGEN9\0S%"B_!V]XAD&"4PC&D#E]""9J%ER$$:6
MT;-&#<]MBKR#N]X[M@Z;-2/<;* 8@\:1E7Z7P0;S-+'\MF0YCK0U:WOJJ%LK
M1@Y$X-K=/TRE6GDLOZZNV3_6F1+-=9GENG1:J6:8-U*?[6Y_PQ<19K%2IE"Y
MVS* *"42IM)'4#*4JOE;DF*/#TAT:X-A2!3$).<I%;RR*>&M/&BZ,> *Y**J
M=W)TN@/26F$G;%9]9"9NSBF?1N ZV'IOH84'?NYQ_:GANDXM<7V.:VN1&T*:
M2Z&S:G]2L1O"S$O!&_0,1X>9KM?5_:K(_EM]/ZGRO8B0".K\N<H;8PRF)-(A
M8CXAR/-E0(SV^PW:FJ$#UCO*1#8X'9YDZA%M[(6YH&]\QVOO'!/8(AWQ%-,^
M':,>8NHU][IGF/;M/GN$Z< M%U=I.S@3_2S*2DT@E>M1M_Y;GE5E/?]L4^8\
MUV'/V_F('T2!'Z82QK[$$(DX@!@3!DD0>SSF$?&'GEYP@F]N,O5E_?! BF<]
MT'_^\IORJ1K0@TN].>E#P\7'U^N9"1<9-XN'VQ69*[ UK0W'T<9==1G!GJ<J
M..>2]I$*U#F!^%H%[5SR>Z( GM-FAHT"G7O:F_K="O4UY16Y4Q#_NJIZ4:KE
M9GX6L$C(0 @U:>8^1!+I&E,DA"B1H:"!2*2P2F V#,;<-'T+6<MZUF7L&C9?
M'M@S9A(^/M\C*W5G .A9< 5V.Z"Q8A/S7XXPF;Z,1Y?2.Q#)I I[&5LOA?3"
MIUVVTG@C/ZY(_D:G+UPHO9,\H@GD7DHA8IZ$J< )]"@+_(1*ZA'9+2C:K27V
M6AFP9#BRVFEHX+%%.FPML,^BW9*?+3,3K^PI]:GI>7,RO^7@M;L#UH^Q1-=O
MYE56X@[8>6S![="E S_Q8J7COY]UF'&ERZDKX7C4;?Q2K,IRD88I"5)*(8T%
MU\$['!*,0\AI2B,28Y_CU,;U.=W<[%R<%FV=(U!T4*_ 76&]TWF&9T,]<,;>
MV-+0 KVJ#VY4-7_OMOS]<I(_>Z$PHL6I9IQN<5KY,+)^3TG,[AHF*EU1C?="
MW:,3F[5'!-OLL3^+7,BL6B0LH#SU&62,*%>"!SY,4Z;C*7# XYA(SJSF56;-
MSDUD6K1V<F+(L)FLN.=M9'G95.II$?>.07<9H\&?6MC'MS^L=<:.)Y=Z8]CR
MI+ICQ\9+_;&\>Y@.=3E+E+ZIJ9%Z@S*='E:7^2F[7[5Y0Q-/!@0Q#@6-E0"E
M,H6$!Q&,A-!N#J6>+VRDR+CEN:E1A\Y.CLR)-E.D4>@;690V.8JTL[-%W502
M*Z\V.8RFB>ZR9M"E7)DW/JEB67/R4K3L'W!)?J1-;8Y-&L (I8&7Z(H^*8LA
M"M3_TC!4DS,L$R83Z0?8RF$ZTL[<-*D=W3<X+TRQN,^KF2@Y8&MD"1I"U, <
M,$=I<)^_9;^I5\B]<M3>PWE3CE\^N&+&^F&]U N==4F? Z&F;28#AE,9Q3B
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MK]9:S6V;VN*O:G[_8 R56V,9LGOU%_/PS5MCN6Q3JV8)2XG.J0"YS 5 B$A
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MSC!TN^V*R+BB\L.600%?U+K\W8PGD"K!)*",*8!B' ..6 (0Q!Q1@LP?L7<
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MG+^8<<WVN#SS7*P*NT9*MO$L"^8Z#ZZT$AS=P9F&;Z*=R+83<B/TMIN7D7N
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MU=4-;%L#3FV)WFLD69:.6?RTSN?^/2.=H7<CXI" #KVO.=?,=J]1^<#-;$]
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M,1##5;!KC?6*)>N.->ZN47?B^AY^-*/>@UJ__?\^+,6?ZP,MI3@B FJ0(*(
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M[;)=DL#\V_.CL;TK#U+K'\H*^[,LU21-,PVP3,NX @@HI C 5*5,0BTP@DU
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MGT^40YG%*#.OCT  D5A;[P\T&REEH_:R&!GS)X,$SS:V8)MCH(WST%Y;JZT
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M$Y)&+@TY*ITXZG](*ZZW]<UZ?GQ<+<M,R+(7P$PB#)E6"L1Q1@#*$ 4TSRB
M.N%QGDN(N5._VG,#3(U *OFBHDK0_7_B/\=QG$1/;!V]6''_,T)Q?&-^5Z=\
M1.QY\[!:6X[_KR@AV0TA>;GUI>0&T[RYRD;7U6<ZJ^=-L3$_E'[7H@H6$V7-
MKG__MR2/_RM-;B+[^I87PSBA-Y%YPI.R_B:U^.F;77TPG6ZD=<TD#<Q2]?S4
M"=2E=#=EI)T*F$IQ3O^P6=,'8XR<*GU:P^/\Z#/7]:.7CAI%.Q^:RA/*4J@
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M(,0RP!(I@"0I53B!6&KFT]?ES#A>+#Y"$Y?O=HRZJ]QBUUW'SZ \AZF;"1D
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M&&U4KKBL]2%;.-QQ127;9[%YMMWN[PP1W:MBEJ7([/6QV0-PF &D\Q@0'L<
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M/?;%3AA]];98^YDC[XJ=,.=X4^S41=?U4_RX?&::)*H^:DO]\+<90CSD)(X
MPR$'"/,4Z.]7@8R2E$<$F<2Q/FT4CT5-[?/=-@3D+57KXDJ\;#>Z+1;KN#G6
M ;?=&M4/B -_\5O\VEH&E9K!'_5_'^2/=?!!O_S_\K@U=AF>(1HJGI#V+GT4
MSUM]KGUBQQWND_ZGVC%]T+?.L&209B0$+(0)0"31*T=($2",R@Q")E42VL[W
M[0=/C2L:W0*CG/TDOX?5Y?F]+P(#?^AVQCM-ZJ<LO6(^WWO<:%/Y*2/:L_C)
MO[M_<%^Y6MUN1*[1O%VO95$M";_,Z>,LCD*6<1D"2@DVS74BD\8D 4:2<XQY
M#+E578UN,5/[&+]^_/(MJ%4-6KH&1EG[C[,#U\N?JA^T!OYP^P'E]"%?QN&*
MS[KCX:-]Y)<-;'_R%E?W3'LT:_??EHME%>VR>*S"7.JNZ[,$X4C), &8FJ:>
M,J2 0L1 E)$X34F*4^R6S]@I;FJ$4&U/R4JYFV A'<-T+X!KY[/[@VQ@5JC0
M:FO:A-#]5"M[OA^9>\:?%2I>4_FZ)8Z;HV=E_5'RG=U=/2MY72KA=ZZ"W]U+
MN7[XN>RO\G5Q+U?Y4OR\6A;%3$84B4R:SGZ9<4-D!K!4T#3>#!.H.,L(<RKO
MY5_'R5%6I6GP:%2]IAG@$.-I1WCO/$H#LZ1-]=3.XJDW06WG3?!SW9-H$52V
MFG_1UGJL S;<4'@M#C: FN-6#!L.YZ,R8@.*ZEM;;"DV?/UUUW?NEVV-?JKB
ME&NJ!Y"'$4 "Q]H3#060F8PCE1+$N-,N<H>LJ3%YK6K0TO6*U@E=(-O1LB?H
M!J;7WJCU*$)V$0^_E<C.BQNY'-E%NX]KDEV^I7>,9-,0_G8AOBZ$5%TMXO^]
MR5>F+.(]7:WOU(EM[+)6HCE;*(\69@P1B!..0)S$>OF+8F7"N2G 7*%,,1HF
MDCJ&5@ZH[M08[/OF^=E$=2R5=E$:VP):-QNIK7,.V1QRO.V8<#JC.#"95H;6
MM6;- >;.UOH?=]8VM6@;>_4X!\9B,_JG3O3JHK7#'.2-,T*> U.'U'CL>-81
MT#\1!CN&U)%W1TS:]OKMZZ)8K\HSGZ+<Q'EXHHO:'_^;+-;&OLH?/RB,43KK
MG^A:;M,59B%7BL0< @8C#!##&+ D8H SE<4292F">)0]%=^636WVJ]0O-V#$
MTD3&%::==K49,]9>C/>W9^ =G/=\)Z:_[U.A$[3@J0-HUQJ@W:Y0_>*U=H4:
MG(*FI%&)5&"@"G9I9Q/8-AIJ_">QV>3=N/^.+:JAQM3;QM9@"O8MK:*7RUS[
M(M]D(?7=3]J;^21?Y7S9KOA#H5YZ(D6!(E$*4!SI"5V&$L1IC&@J:8BA58"4
MD]2I3;%?%^"ETCI8U6J7RQ2Q4]RUD(H-]D1JZ'&$ $2FZTR:I8#PF&FNB!3"
M,4DDI&Y5P+RC/TYML'?"W\X)\8[IT$$U>KZNP?S6!K.E\P#9X$XH^2TX8R-X
MY-HR#E@<EY%QN;E'#N8W^5)GUBR5V3[5__FH5[#Y^I;SU:9<XDK]/JYG.&%I
M'*5,K_ 2I>D)$X!3;.IM,4'B#$D86>6#.TF=VM2PU=OL/]%*5[,+62KKD/)G
MC7HW*0V&Y<"DM%/9X%@J;7ZHU+X):L6#KP,"ZY ].03 (^5+^@+:+4'2%;#.
ME$CKAXV7!.EJWU[:H_/-5]85^KIXV:R+7\R<$=>>#E)AR)C43B:'VLOG,36M
M#2E(!8E"%2981$X!4!VRID;@I6Y!W+-ZT DL+<]V_" T],%,JU90I>A-4 ,V
M9,6@\Y@,4BCHA+CWJ0]TWNZS98$Z;KF^4ZK9J:@K,FLO\YN<F\*D'Y=%TT$3
ML0QA"A.@F*"F+:J)WTY-!8XH"V&*:"2=HK8=9$^-1O:[:[:4+]=6M?I!J?_U
MS4XOC8OE[ODP: ^]O^T1Z*OZE5I"-E1STDOBWZT3J24N76U';1_1C^%^T8MG
M6569J+-)=X$9>OTJ"20")$F8 90E C"4A$!%&*<(\IB%3C7..F1-C<%^<:@4
M9 .E'0EY FA@TJFTO*FJS!3#)H=;(.*34[K$C<HA%G8?<H;-+3UVP#[3E6GR
M4=S+57F2\\LV@A6'"5.4(! A%@*4*@282B&(XH2%1""<A;'UEM=9,5-CAD91
M<\Y;G1OW"!"^@*S%MI87O 8FBC&@<MBH\@+92#M36^BVT2N^VI5>1*%SN^G\
MW>/M+UVT8&]#Z?+5?1TG0[1W35;?MGT7DYP3JF<7*;E)G\LR@%7, $YIJMVH
M3*\%A9O3=%+.U&AQJZ!3D<5+8-JZ35=#-+C+5+4YVZ$T1$/."SCX=91.BQK9
M2>JT]]A!ZKZ\AW/TC^7F.U_E+\TA><(((:G^Y&%F@A0H2@ AI@ KYP@AJD22
MIM8NT<'#I_;%;]5SF,</\;)P=*Y 8>"/>JM9G\[KAT@X^#%7(#*2]^* C)OS
M<L;T3I?E\)[Q')4SVNZY)^>NZ>>4[.T6F3VB<L>HD*O7ELN<4D:PY*:B)XPT
M25$$,(,<1#RA4H8X9=0I&-U&Z-3(:W^SU"A=[YB6:E^1\FDU G9NC6]<!Z9#
M'Y ZNSPN&/GT?ZSDCNH,N2!QZ!DYW=O#37K(GV497/_M^^^F=O&]^6]SVBXB
MD: 4 @X1 0C)!-!0"A!B&0HN8@BY5;;G)4%38R"C:IUQ8)0LOY5270<GH@M7
M"]?*$UH#\\I9H/JX75V(.;A@GI ;R1V[ D$W]\P"EDY7K>O^\=PV"ROV7#B;
MZ_NY<Y^DDJN5"7JJNR VG49R6?PFUS,2I2F., <T24. (CU5$:H0(#(+60BE
MS)A3H8X+\J9&H8VZP9K^".9-$Q8W?^T2Q':NFD?@!F;3+6:[1JM!2]F;X+>.
M>GO.[IDE+CX]LTLB1W7*+.T_],=L;^N;Z[2?EJV?^/D'GV^$=OY^7B[%G_E\
M/H,,"1HC#@B+]$H1Z_4A)DD*6!A)0E+)+&M!NPB=&K]\/:R?T:,:I178$2(,
M*M-C@] 4(&8"+4(-NXH0I*%(0X7TBGRYIO-W GLK>CBPNWBG/[)V].T;KX$Y
M_*C^1\G:IN!GK7/0*.VQ]J<+1GY3EBSDCIRQ9(_$<<*2P[V]*[MQ*4736/M5
MKM9&WB?)UK,8$:Q"I$ <F=J>"8_T8IND(,VT)ZY?NS3*K#KZ6,B:&IDWJE8]
MZ/.BV)2MLI8JX#O%@T(N\N4J6"S7L@_;=V%O1T6>$!V8@?;!;.D9&$6]EGN[
MA(;G<F]GQ8U=[NV2W2?*O5V\9>0R.I_R@B\WB[51Z5>Z^I=<WZ]R+N_U6_BD
MKS7Y^S/*6<HH)( I$T3&0@8PIR%(:88)$2CEL5.QMR&5G1REU;H%+T;3&Q,K
MQ.OD2V5R59Y+,X)7DQI1$=WS\W(1%.LE_]=(M7!L7@$[8IS*P [,K!XJUC0&
M5^1<F1S<5Z_(]I4Q9D^@]HS#X$RBG(R-OO\=%6(<D/=6],5%9L_.&OM5]G\Q
M!=!5RIA,4@D441"@#&* TPP"*$*..(-)R+G+ZOJ$C*DMIHU.U>=?MQU8+APC
M\DX!B6/((B4(2#G/ (JQ!#A,,B!51%E"4"IBISVA:X$<(P]D$"#M9KPKX1EX
MHMJ%,C;]1HR"/IN-G#??:X>1$V+&;2MRWLZC7B(=EU[1B>B7Y>+Q0:Z>S5KA
M-ZWT9K72C#W#'"H41Q)0%NG/G7 (*,RT:YXJ%2<IQ2B%;A67.J2YO-GCU%GJ
M7,DZ@VGYR?L!:.A/OZQ_:-0$FH.?RS7_3;!3U7/#H6X\O'<;.B-N_%9#W7:?
M[#-TX1:?!9"V/<EG"54B"PD$(94)0 I'@(58 2PC2;6G$$>I?1[897E3<Q'V
MBAZ]-%KZ*,JS@[B;/08 ;F &N5!XYWX8%'T4->J%YC3*&5U&U5,=HR.,^E4P
MVCUF K6+CFRRJUIT?%L/#OZ^8?^4?/VP_/SC):\6(77(6I2$&=5H L+B""!(
M%:""14!)"<V1LM1_M:;>LV*FQK@?Y&.^*(+UTG2)S%<RB,(X=*"*\WA:\*P7
ME(;>1*QT#!Z6P4[+/N&2YY%RX%(OB(V5=[M5\:8,C?J'I"O]>D'B.U3R(BB=
MG'G^[O&H\J(%>PQY^>I^"]B_T55NRJ!\HVMY^R,O9EQ2AN(0@Q 338DXC  1
M- 18LR/':2RCU*J+]CD!4R/#1K_ *!C\851T3%DY@M!NK7H-, /SGQ,FSHO2
M<X;[7(D>R1AU^7G.PL,UY]GKKJVVUG2&*3O&%'FY[?KAK?5;5=J+8D9C[>(
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MW*N8V^L!/6:!^U4]XWPWJ3L/2Q,4L5R4OV@YI@BL%O+-B)I%L1()HPI$,&0
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M.VHXC]60'3;<E7&;>X7,9Y^U0NNWORWGF\6:KMZ^Y',]0\P4T9\\S2!0L20
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M'H!='+$:KGO5>='OV+OJ(A[=G:LNW]Z/M7Y>+L6?^7S>WL(7+&:1P)E&.Y,
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M VQ9MKI1VZ2O_?1[A?)?@JWRP>UEF)TYS1TQGXSF('U4/G-'Y9#->CRA1P7
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MLNZXE-W)J_I6'WA929Z7VQGZY[DL]S46HEU:9I8@A04A*2 L@J9\+@=$LA#
MB"9A2E02,Z>&1S9"IT8 ;9U+$J M95TK!UA@;L<-OI$<F#':ZMX$6X5+/&]M
M\.R1XF\/D-\\?@NY(R?KVR-QG)'O<.^U\<YFAW6Y,/MMIJ:5J1BNYY?:A?D@
M%U+EZX.-,D(YATRO'Q03>KF?2 Q8R!1@B*:*42IY%O8+@';696JTU=[3Y%MC
MS&_K)VD"NE[SPGR!IBYG7M7,7],?_4.EW0?/\KQMG"$9^NRL-1H?]T:C[E=@
M/*G:EN"GVIJ_C!1CW1O888*NW=5YIRCLWKB=#\ON_\@^C7GEZC7G\O9Q)<NC
MK$(3NV:EY<J\.6_?-R\O\UP632HOCZA0Y59-E@&4)B&@VCD$*<$)9B1%(;*J
M?.(L>7+$6ND>T*WRI1<SWZH?%+7^+KUM78:BFS@'!7AHFJRQW>D=:,6#G>9!
MHWJO!L(N(+OT%AX([+':#EN_T+X"O/L UMVGV.6!([8P[F'G?G?C/@]PFPE,
MV_?[U5)L^/INU<@S3:%@AA"*< 0R: @_D1"0.,Q $BD21SQ-<939$/XY 5/C
M]5K'\MUO/HD++:/L@.RF:Q_P#,S*/9"QYH-+YG>XF/K6EGNI?SMT+<\^>Q0&
MN&19\Z%?O*Z'9]?4FO]<K/-GNM:.Y3?Y*A<;^4WRY>.B["%:SW,)3A7,E-+@
MD0@@R"/ 9)P H92 ,LI4HI"U7V<O=VI?_ZZC@JQU-XNS5:6]:7G3J._@;SB,
M@H5+-PRV U-'#>O71="H;1+R:L6#EN9]_#D'?!V\N6%P'LF7LWZ-?;ER[FAU
M.G(.CQO/C7.W<<^)ZW%[OYW4S\\O\^6;E/4D<CIT]3=35;4P,:CFI*YX,.ES
M[;^;3JZ_+=?_D.M:O?](406O?EFN6AK#&1949CQ#@#!, 6*9!#327J+(DA@G
MG!#AUE%D7/6G-@&939ZR%M-+57YIO6P^U__H;W@1T*!8KZ@)'P9: QDP6N2.
MF[4COQ]V^[O3'?6A]SI.I4GLXLIO@JW13?:$L5+_ZSIXD^M@9^BV8I?9RO]F
MX:DX;Q6_SQCYW%T>V8)1-Z3?9W0.][#?28L>BZ/]*N/;H&2Y>BX^T;?B7HM;
M/2Q;U<?-#9]_K.5"2-%<;K(V9@GG/.,\!)"K%""A!,",4*#TQ$C2*$E)8A4)
MY5>MJ<UL1GO3;T&SDY[4^,Z 0)C. +(V(7AN8OY-;JG#,L#?>%JLPMYEE :>
MB8X:-&RS+TJ[;H)R!.^;$6P9%Y2W-N;M[OOT7B/HL,Y[EY$<:1DX\HBZ+1F]
M ]^YHO0G;;P%IW>$]M:C_I_>;[G:+FFC)WU9:"_8G&W/TC12,)(AX-1$';*0
M THA!R%-(R8)QREUBNHY)VAJ$^7]7I6EA=$T*)9SX;;*.PNKW7K,!UC#GT>T
M<"J5#&HM_:UY+N'@<W5R5M:HZXA+%A]Z_!>O]YC#7"^0BT\;:?)#O^2O<I9E
M3" ,335YADP:D00X1AI?+%$:HB12H5-[;5O!4Z,-_5(E'G*13T%L1QE# #<P
MA9S/0M;N$).:3G)Q4Z4B&\T'SCGNP&KPA.-3LM\_V[@#$:M4XZ[[^]&2]H?6
M*\K7?\_73Q\WQ7KY+%=;<?L;^O^18B8P2DG,)>"(8(!(S #!DH%4B)@A2(3B
M5L>J_<1/C:(^2257*[V>J$^B;@Z/I+3.;A3F.!QV1#8<R$,?L]:*5[V/&M7W
M>.W@S+4+<&=2ZX>;3VISU&!4@NN'SB'-]7Q*G[#@OB5OZISQ;^:0JOC\[PV=
M_ZJ5?IJ_U7_8-6^<)5"DF"KMNXDPT[Y;B('^E0*:A3(CDD >.T03#Z_PU BU
MUC-XK2L@[%K<NL3#CC#0%ENJ$QN^,8[]@@_=5=0^U%74ZNOVJJ@%3=6+RNZ@
M-#QH7HCFC_=3?2%<XJJG]6*,UI;I13^N#,,VF5K/]<#N-[%NOGO3S[IUCLS;
M+Q0MS]B\Q6R/-QC=H=XCZ#%BA/AXJ.X'EH\HM^<V4%,2KZI#; +?=[TJ?M6+
MO8U>3]PMOIGF.Z;#H;[@M^5BU?SZP83'E*E2,XR3F*0J 214,4 QT4LQD@F0
M18E*0B%DG%&G?2)?FDW-J=B5V33+A5K=,NJ[K7^=E&@9J.E_."WWI-YCD(;>
MM/(S/NY[5KZQ]+JIY4VY<7>]?&-ZM"WF74#?XE]\9;;F/LGJOU\7MYPO-]J]
M:<ZE]!(04;,WQLI&A"GD &?,%"(-(X94E"4(NO#S18E3X]U&/5-NM/,0JR?
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M8\@QD'&2 RBP,OE2"B"*@F:(XY0)I_*0UBU/3AAW@/_;_\!I4OQ'(X&K%]<
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MXZ95=>'B*,NJT\T#IW1-+IE:2UQ7$K(-..]2S$B1S%*.LY3$V/@4QGKFA@M
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M$XX3 DT23 $@Y@7 '") $Y%(G##%B72,4[)J>&JC@_XTH'-4DAW%=DH>@KC
MNMQ![N,K-ZCOS,$DDUJ#2RV]!GADD'N-4G+BRG.DDEW;8T<K.3%R(F+)[7XO
M=0>^&N&;B32%:6X<A5AAMFRS E"5)$"DC,B8IAR16VH.-(U,36Z.4^@W,&\K
M-=#2:3EQO)&DT%,^5WYNK2ZP1T# R@)M.Z]956#/TBL5!?:O'?K-/SW1ZN5!
M;<I8MH[KCW+!2UE_E3]6;S3</_32MLAP(3E(,(T!S"@T4Y$4X"R7'/,DP\PM
MZY=EPY/3!OY-BO5<FMS:E32=K-6X7?#HWSQ6R[J.UHMJNP6]HC_T<-O4!'7,
M&F'=-[:BXI_QX$+30#;,[E3?W8/=:4]DX$<-?J\RY$:97VFR;'MDN7)CY%C"
M'._WD;^UF\FH5""*,*!I8>)A< HH1P+P(I%IS"&+<Z>4S2?:F+)8;8.##Q**
MUL.F-Z<HMA.B&XD+K3E^.+LQW6JP&<^I9EXQA>K%^<ZE2P=&1AR?'VY/#3\*
MW4JI2GJ4#^)^(?IUEQ:I)GV>%+_(U2S7RR .90)8DN4 0F&V:@H&9*8DXKDB
M+->S(A,#9:<IGO$YZ=$&9;AORT3BECM6W)9YQG=GVJG7*W918.4[[5BQXTVQ
M:]UAEIO&NW#'PJ@S\2[21GJ,&@G#OM=@$\\0QXU1"</O46A+H&8&+H*[(?]!
M?:Z68LWUH*.6U5,#JYW8D"0C1:+GCB0VT2]$<4"+I #Z]XBE<4X$=3O8O=;B
ME&>2'>1H!_/ ';*KO%NN;'VR.>+T<@B1[FM86W*\+EZO-CKNJM66@Z/EJO6-
MPY1'KX(KLZO_3K;__;BXYWRYU@L,+8>R_-Y\!'FNH!)22X[2:U989!(PHT!Q
MG"C&!8\YQ[-%XS A[.3'IEFK;X:TW\QNX^$^G1ZCV7?K0+KIC17;=I+CC<%Q
M5*>'&_W4 _XY*A?1AM%?KS/J+#PN%/G4'JMV1Y4?%R8.%<CIWJ$!P?KC-2OL
M?E=.3[.,QT0EO\E%77Z7W6\W:< 0PI0H#%(:9P F(@-$I1)P%"<HR5DA4.86
M"NS4_N2F1CU\,Z3OX>XWK8=&L;EVC.5L*1S=H>=./I@>$-4[B"^_\;QN$$:.
MY!W$SW$,[[#'#"SJ:&Q;K-K$7+^6]1]?]7/ZVHXI4PPA!6ALO'@S10$E^J<X
M2UB:YUQ"['34>:&MJ6G9'M3(8(T,V*&E'B^0;*=5GJ@+K$N#67,O 'F=#Z]U
M("\T-VXYR.MV'U6%M+AE8';GG2VHA6CR"GQ;SO7]]?O_7I>KEUDJ.($H54#&
M0@(H. <8*P*25"@:4YHQZG0J<*W!J6WSMTG?YCN;P69SN-[!_6__ Z=)\1^1
M;/ [9G>^1K^=M/@D-;"^?#I@\OUEUMQS.%M2X36!\[4VQ\W>;,G 4>IFV_L&
MYFUN:O\\J'Z[7&YVPF=,<BQ)BD&,3!5JFB0 HX*!E&<%RW.!,^:4RNU\4U.;
MH[1(S1* ;; ./$&\P*^=B/AA+;!\; G;P@Q0G>(Z%UYS$Y]O;=Q\PU>M/LHA
M?/V.@7F!.5\_K>=F)_9A]4U6)U9/GY9U_8O42ZRO],<,(J90G$L0LSP#,"<$
MT PG(%$JXUP2'.=.Z=P=VY^:KNS CY8&?Y.J=KO%4+9;##_-M0V.)5M=>\9.
M? +R'5B1=JENH)_>S?G)P/^Y\2 PZJ5M\)C4=AAY7K/;.D(8-\WM,'Z.\MT.
M?,S@X[36J72;^6CK)9T1$>>092"3,0*PT*LR4D *D"Q(S"05V*VDX:7&IJ9M
MW0>UHC]<2Q=>I-3ZK,P+4>'/R'H/\]V<:$$<RVTH\7PF=KZ]L<_"KEI^X@SL
M^CVW*(:1H \:ZJFB#9]E]8;6)=?KNW?E?-VG[I[%'!4P510( 06 3"!3!T<
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M'&(6YPJ"C)CRE+! @##% 6:I2B"BN8J=(B%'13^UJ>+'VW(HC=OS7##"I>1
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MF$P"$IL>"IN<Y"*"OU#B$ALF_28UL6IQV$K+/)4O'Q?FN?II75[H^IWDE8E
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MNQE^&XJC^PZO_<IOV)H$+I./H>R5B6+H[25&W=$3[T+. 7UEKX<[9]E-PWY
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MGU[ Q*!T0J"<X):*7IM,&<5DT'7S5G"K0">SXTSN> #M15T+@#H*!?/:*FD
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M_+GU8O/!67IQ/K_8K#VCL]?,!-P[M<&MU$0TP<80%ACS*<O(7=P#:D\_'JG
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M#=C _C;6W4'< 2BCR@?T/""@L*0A+D=:+O++J%*TCM6;1W?8\/-JA<K-H'%
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MX.G>\7*W^?(T9 O,$&",E1ZWR)='YD0 I5C67.<J9[#[$K@?TI[;24$5]30
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MU%#+H-NJH9*.2T&=).@TXV)E_82WB&$;#<@D3=*Z*G'-'K2-GH(<%@_[XNU
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M&E0-^%.=^YMIWPN+2?&@:D+0"71[RIN:XNEP#.]AW,D/X90H=KPL^UF6^H2
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M! OO:\KE$#Q:"4)8K7WDF&R3./'DJ0X&(6$PU<$0LTQ]3-Z4 KPBI>*W39W
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MQ^Y\\>FGL)X_) #-1GHT4=%*$J\'/&T02?EK0<V4I3U9<I/KE5%7T;-K&X#
M[30JQ[;T*;G"WRAK7J1YH(^[&?,>SLOUKRX79,0KM<2JE@.N;4?]_F;.=A2%
M',,[%^\Q:9'!N5S?(2KE8BD11$"9HPJ8<Y.JFJ,$ACON5/H%RHM6/V[<6>%2
MJAQJ-VMMU0^RTI*0YRA,"NEXME&WU<ZA*^C8*P]!WM: \Z@6[N!VY<:OO+[Q
M*QO^'!Y*+KZ6E+J4:1EU6%I!5YDNM?*%#C_79.; %GDZ@=UQT?'CC+N#3=4!
MXCZNPF)-WUS5^ %7W^:)5$31T(^K6]<FS/7C?W75FRF<=90$*G#>*THRLX4@
MK0;4&IFLDZA=DY$L8RYB8FR/@:IE)R;N -Y_+!?X_8^P^B>>_W:QR->]ODHJ
M'S06,,%)4%9(J->E4'3@/*%1+C?QIX^+,RWDIH/'<G1;[8VX;[B*R['*CW%U
M/B]S^K6JK%_PZW(]/[_A+S"Q<*?K$5.'%2H'#C5"S+0:1<I3L4F;UQ,R3?OV
MVPWZQK):!T[OKP\?5YLPZ/N'&O1<Q457Y&2L**%99<TPH#3%/L'5PGY54JC7
M$]HUR7BVBS3M$W W\!O)9EV@[_<EN=/%)G;YA*2K6N06SW]8%[)$FZBFA%@+
M>9PAQ24C(?&2N%?2<-$(B[L)..WK<4?(;&#/#G#Z8U7&U3J<)> $[R%*)2C@
M( 1YIW*=\XN6>V-2:$4?\*A TQ8\=X/#4>PU=4%@+7(D_6$EV5NLYV2ZC2&O
M5F*]#1(+Y78HR=.;4.D>F0%CLG&50UD_+,3=4O[WY-=,RQDV.9Y&MD,'GNSF
M0NRG[W_</E+\ML+_OB!W_7US@>!,]LHG!B4JRJ(<K2L:M. ,US[E*!K5>.\@
MV[0)2">WB2.;L"=4/K:@J_VKF$Q1N #,I+HD6VM''%)\6W3R*64,;8L'MLO6
MR1WW6'C8AK>1C-,IWM8WV_;*LWN7,@^8P8= :XHN0A#! +-2N>2*3[:M&WQ"
MN$X0-Q8B=D#<0>;I"7(_?;_Y\3_F%$NLTN?O;RJA\F:CRF**M+* YB* 0O04
MH)H,*+W#C*A+:-)9M)MXTU[ ='?\CF7(GN!Y=\O]N+YK8M7D,3BO(5F;ZCU[
M!J<3!;V>AQ1\E%HT*=\?)&4G/G)$F.SB)D>Q64^ ?+WX>G&^WFB,7]\>%9Z9
M2@68RZ2TK"B5BXR4ING083G9V&:2ZA,R=0*V\9&P#7,'FJ6+U[?'%B.NWW'0
M>*N$@^(*7A)_1.,S<%H,3]QKBVU=W(\R=9+\3H*Q?<S2J1>3UP$LEHA.):#U
M*'+]E)CY8"T4K$0-UI#.FE3 /"%3)_'=) C;QRP=(.QNY^";^MO56#6R"+0,
MBF5E);FME)61\B-9$NT4H424)A71I&YEFT#3/I'UD3N,8JQ.07>U+7.FP-53
MWJ^B895JN<[?<!HX!B9*%+FH)OWCVT7JAPUC?Y/O@*,]]-\!DEZEM+RH([S#
M][J[*J/WMK<[.OHS0W1@K*&-AT9#+-J!M-PD$TEWKLD,E-U%[ ]I^X#BQ[?4
M%A;J 'N;COC;-O@?UR-38=PG 9Q'6H_+"7R*&9AB3J.(PK6A^7E.L'XH6$;$
MV:C6Z !=8T0<;V[HZQ%S%'6HC(B<\IX0Z+3(E/?0ORK*:8$IM7W]&F,5TU:G
M]!$"3@>+R>M9POISG9SP+9Q=ON>LSU?S=(ZY_@4M\[*<NRKXMESL:KP'_<YR
M?3X3/)E<BRMTK?%6U=&XD"5E:JGRZM/W,7U_$VRK>3E4E$ZN^XZ/H>5D!CUY
M^&X&+?U%9@AG]5_]3@?F3UB6*_P8_IYI%I,N,@,/Y(=5R0*",O3'G(P-G.?B
MC@3MI\3LY ;RQ&$_&A!>VI9X0W^ZU82TKA@,!A2OFD R5?#1@>:819'&H9&3
M;(E[8G9R9?JRML3^0#AT>M?'Z7;&C2UGTJFDBLA0?,VC#8N5=-Z#-=+HZ+#(
MAQ//1T3^C1BG?V$[$;+W,V0'L\$N5?T(5<-,,EZL10LYUJDN,0:(6&]VG'!*
M)Z4\-J%0VRK1Z:>2AX%S7)-U<%UR1X&/K:8@4PJ5AI@<Z4@J#]YP0WEWB5X;
M+CAO\AS_M%C3MD?T@\(1C=<!%!_X_%?G/X?5ZCMI[-*I<V--\(6!5D52TFHE
MT%8*8!)EK):TEQ\2;X_4E_VD6--.8^\'BB,:KP,H_A!O/%C>+!44O*0 EK85
MQ<8R0$B%@]*^N*Q](HVU .-S@NT$1_?RX3BJ 3L Y*MO87Y6P]W?EJL/X6[4
M>[_/=Y93Y%'7>PS:676HD8)@7(:8)4O<JL)3FXAQ1P%W JA_^0!M8M!3(JS\
MD\X'^N!O.#83Y0\?W(QB\NDE'(,[,MK"BQ,2+/V'=3YR@A 8 DO,RNB*<5RW
MV.U'X8Y\^[6:Z?^["(OS^?FEGN^06V]>!%- Z;4.P(TDWRU]?1N,!3@Y\1*4
M\,*W98=\7L9.GJP.1<_6]]21K33A6;M>G<_>A\4GW-2)H4B4KY<(MD) R>!J
MGYN@>$$IHS-+Q>_2AD@?>@=6]*>'D+KWK9V 96R;+@]5< ^HN*:RH..G"%-[
M*^NFX8;$+IJ!LUZ(*)-B:A>7LSLNIJQQ.\!B#VV^A_HFMOH?\\7\R\67Z_IT
MJ8P2VH,JS%T&>SY3'.80$Y<^)59V:1O8R>[WOGEBR^]CM^482IS:^N'ONX+K
M0N&V<R"P"LZM@\AYA%*L-8H9YM4NET^[6?_N-T_S]#^:]?=68@<Y]V['X6TZ
MF,@]\DSA%-.QEF*&!-YX#DYHR:TQ5K"VQ 6[R=E),4FC&.,8QINZ_N/)6XS+
MUM#+YKWZ-YL>JUM&IR^UJ)QV8O)1>5W92!2M5BF(,04(%H7*Q9M8'M3T;WGI
M/EB44XAX]T3)<C*3=> \']YOW;_5>J3N9!8R5](( 68STE/X5,\829O?<QNL
M-HFWF6(^5-)3<*"'0?8X1IS:C=Y?S<.U_A'.Z]]\?X>K^3+/5"G:J,C >TT1
M4*+(U:48(06GG==9FX<T6%L\YI!O[:3(K;5S;&:(#OS@Z\4W7)_7Z^+7B[3\
M@J\7]-GT;V:*B>B4990]1U7C:@&QUF '$3$F[;)H,R]DFT"=E)T=P:N-8I(.
MH/58WWZ=S/[78AG7N/I6]]!EH_U[3,M%HFAC8\_W#YZSKN:WUWKHZL-)*6<7
M&?/KQ:]AM:!?6\\H,XL^6 &4H*O*_F# 1UL5@T%ZCUJ6TC2S:;W"3LK:C@#^
M/D$S=OGPN.^7/R^_?)F?7TZ06^1TS4M;6;;W>;5\ZN/&>*O<6=R17BCO?%\M
MM+C[?;?PO7ET$E*Z$%D [9# *PD;D2</R$HH+!,ZVA#\#)+RX%*V7;[L=BBE
MH,W@DW%@B]:@B@S@%$4WQFOO.1:#O$F7Z3 QITW5VZ'LAU*V=L;KM$#C"8^Q
M_XCEYS^TL;-K.&YY&!A5"<%X;P%K#XU"9^DDI/-:%Y6=DR:'=/HN[PW%$UA[
MBAX,W&7&4@"@#2B!'E0N% 845<!(5[AB2MDVS*I;Y#DE)S8$-S^4AH]@C@YR
MG#>X7B/%Q1OR_\6GS:IN@L_KFX$'2W162HW(H+A(2W1.4\R9'<7(#I.(]"5M
MJ)#VD'7:J\1CHK&M&3M ZN4(#-QI:<+X(KQTE;ZBID:)LJ)ZH9^52!28E.!T
MF[*]W66<]NKQ>,AL9;8.$/DA?<9\<89U5%X\OSNTY69%AK&$V0>0F=7K>H),
MY4<#%R4M5B3)=RIJ&0S$YT6;]CKR>/@;V4@=P*[>&Y%Y\E\+BL;SO)HLG+V[
M6*7/M,7>QK/YIXT9[RQ0YZR\3QQ$"A94B!:<]KH.TC7"%VV8;'*].%C2::\)
MCP?*MB8\O21X<SJ$?*V)^:(L5U\N"=CV;UXXZ/L:I\X#%SQ)5IU#U-DFRE^J
M1U1!UDDGTH,HE-287+@HKH77.&I6?7L\W ^>\V4=R66=E,S",\D%H*@MYTYS
M<-PP$!IIMT<C56Y2>+:+<*>4;P]!U/9S?"1#=7"2U^%^;\NKU:I6@M[.N<]>
MQ4QG2C3:@9)B\T!J(%K*R"R= U$VB1D?E69:>(UO].78%N@ 1G?$7U\V5(;;
M?[,I<Z/-5\.):SI;YZ5AEK:A#@E4206<<Z0_C1Y9U*E1H_] .:>%W@C(>%CL
MU=!,4Y=Z_8G_VFS,:]D5&JZ2HO@TFE@S>4%Z<@A,"Y&2*Q3ZQ.?BM\<^>%I,
M-+7@<B1U=N"0WJV6Y*[/O[\["[1O%KGR GRM.OKI>]U6EY,;&25(FM(8(9.B
MI+MRS8HHP'C&8\P%O6X24^T@V[27QLW/O+&MTS/@ZH*N.+R9R(SSHD ;\MJ*
M&=I#@4NP5@=GC2FN-"E_WD&V:;W:Z'C8%6][&F?JL^YM*?.$OX6TN<I^O?@0
M%K^MZG3N=5I>^6LF0R)OGT"6.L.S, 7.H(<BF/3!**;9;D2'SW]7I]C9U[;+
M=HKNP$\]ZM'?W-0=\L)<2900(Q?DU7-0$ HB!$F^/2JCW$XM\8-=U--B3?M2
MU?PX'-$F'2#LL8?@][CXO^R]Z7);1[(N^D1Y;\W#3\F6^CC"MA22W'WW+T0-
M61).DX V -K6?OJ;!8+SA&$55H&[HR/4M$@1.7R9E5F5 _X5SK[@XGP2:WV6
MP 2F=H<JQ@U)RF=(4<9HO<C2-GD*>(&N<;W8D!#8XF%^7WUT"J_*QX=2[_[6
MEWP\DNGQ1 &"YH%L49"THHX0?4DL,^ELFUK+ETD;-ZX_,L@.T$H'.-MT*_WX
M&;_/E]/5!$/)7H0(5M:JJJ#HG%?90))1>*V3S+S).,![=(Q[%#9$T"'R[@ N
MEP9PN]3D+OSY1!=M,BH+RJ8Z'S,5L@0OP)6<2RG).],$0"]2-FX=1G.G-)1.
M3N]-^_/%]^]GZYO!.^^["_P:%IE^:GZQSIW6TJ=_6RX%=;:^]FOSZCT$18W?
MQ0<7VB@OYSX%5WP,P+&.QT^HP3M9P$7-I.3>Z]3D!>\H+^?KU/SR=OI?./WZ
M;45NXT]2R5>RFIKOWPY KB6"7.4B9 09#(6Y'A5X(2A+4XS.$K0"PW9K@';\
MX%-Z'=\%-7?N25HJHX/#_>X9]2*;?")-BB$CJY*C<T76YSJO/60M6$A:9(Y'
MN$9YF=!QP-D>,L]>L RLOP[P>3O$V8([M#90MB6 U;1?J;J'/?($GGZS=\BD
MB:QU;?I V!P\5SXZ-AOJ;NQGBD?%6(^=.NWH4UC='#PF(*5ZO-X(6$7!>-8D
M.YN@:,NL=]G&]&+8N=M'GE);SK#'\L$*Z,#A/>O0;S/X$1>)I#S1WA.EG$Q2
M*DUF@P)\KK8CLN8Z,J-%DX:Q70GM[4 ^'"R[',6':JX#9#[CSA_C+H<@K>,(
MCJ_G94H'3HO:R>XTSXX\O6J2I^U&9F]'\>"H;*BU/@[ANAOE8_BQ/G%N!KG<
M&A!S$\L(;;.T'B)1 DHH7]FJKT.9OE&X#'J[N9$[?O I=2,>>""W448'SN^N
M<[]B<<)8)H'D3.92^Y0"!:ZQE R%Z83<Z%!LDS:.Q\D9_8AMI/YG#]J]=#&V
MZ[KME3\NIF2-W\/9%2=AEC^LON'B31U@=186/ZY9E")XS8V *-%5J2%9)WEG
MK@P&SZQ6N-T<Q_T^?_3#LBV^CJ69#MS9]8"-&X%1-)J3H1B#6T$'OT_@/%.
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MU;N^\)V^L_HQL<8F68LYLB:K5#ID""'5^37*8I8VEC9W]+L0.7X1U: (N8_
M5NKJ (KWK)6D.,G29)E5 *XY'0@Y(W'@;&WCTIPQSADV&5KRD)3QRZQ:PNI
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MY?I!YE8S66UK9DPI.D)TSJ"*M>!<=N""R1BL*UHT<:R[$+D=*$_V0:.9OCK
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M7(L(<FB-= "RQWI1I5?,8AUX)W.=?R<,1)8X84%JE,4K%9J :M].X'8CX%J
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M_M;G&+!(!U)R1@[%)'"4#D!@A+-2CSYQNATOZR=R+KF6)A=P]>92N6(@( O
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MYL\P/:MNBL2P[C:@Z,HZQ+KF/9LZZZ^6=YJ0P-,I7()+1?&^2AI?8.A$;65
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MWH$^K&LXO/1B//%E8<2=0^I/6*? T=__-)^M17,1SK[@XEQ,<C+9.1O!1U9
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M!_[C[J0C[5Q"KC5P1O)0B6S=H1-UN24ST8B2=)/B@=V'FQVAG[^7XVE_%76
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M6V*VK1*[PNN[4C#5&Z5K/FM!6,V"9FEZ-ETK]1ZOF7GG@_-@K4N@BM'@$X]
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M7AR"4ADA2 I2'0_*2N=*P"9'8BO7X.>;HNQ:P36QLF3#!0)7BO:T]>0W>^F
M&8W96)YB;E+I]!T5G1[CQVA^U]Z=+N4.#N??L':/Q7SU%1?A ]Y4/VRD\V:]
M6JYH2Y+$=AR2B60VYLP=9*,+14ODC+CB=)TMIZ66+F33Y'W^:>1V>LB> [H+
MZ*T#=#[C%T]$S"D(YH'"?I(@A?\0DP_@L!@9"F>17R26.P5OS>ZOFN!M2$V\
M- \MW'-CE[=N+&[=V*J =.?&/O1L6GAP Y'4U,-K(;;6'F#2=&S;8$!NAI]P
M=!1D<POUC01+O$2KTTOP *\[E>W&4YLGK$X5DZ7P$ /2$9"D@"B8HEA*Z,P3
M%^2G'%1$NO?SG?IWQ^CU^VYO9\NP@V/TS#C\AV_[/[!IRA!=#%$7!XEQ"LV5
M-N!T'3 LR+DP@5LK>(L=TY"G<3 \%-SF?>J^VVUPKT6$U<A3\ :L17)BDG+@
MR&<"E.3>,*ZT]4W<R><(&]>H=H.@@Y!]HCH[@.=K\@CGWQ#?K>;I]S=?[K7/
M0JDC"Z* \6A N63!1<8@1Y83N?3&M7FC]BA%/0+R5,7O!CJ#:*$#./U61SO,
M5EOB*?)3BA/)2;$ZU0\SA&@%!(9">8\839,;D^^H&#</TQ0VITN[ ZC\@N0F
M3Q/%\1O4OY]-5\M?WKW?,A.LC]E(4JU%LM$I%Q(+(Y-MK,M21LU]DQ?73U(U
M;HJE*92&T\;83QS)!2CSQ>?:GV O4\OU<LN5\4E;;A@88@)4+ B>9 7HA%(F
MR7SHR\:#EQRW,+<)@!K*?&PD?7<JOUTOTL>PQ#K1D_2O;W8&9Y9Y<B-C$JG.
MO9/D2^H$VM:AV(;[XN1!&#I@L7'+:]NA9V@YGXR;K[B(\T&&8."B!ANOYC/Z
MY*KVZ'E[0\B&R9L3VYND@V9@14T0"6(J!&U!&A%88>B8/PP\AZTW[L/\=OAI
M(.T._*-[[/R(<74GLIN9#XPI5K.+3,5-^;D""ETE;1"N G+Z99OA]<_0->Z;
M_:8^TI :&?ULVTF8_'37V( S"C6+HFV2/2ADY.L5+: $9!1'6&XM/^Q$>VR)
M<2*R@5.= TJQ V-S9KIMVT\GUIF<K&20I28K:G.FR#6)51?!9>%2YB9!VR#4
M=Y2 /Q%&PR;A3]#I@([7L+?L?\7YAT7X\G&:IK--H++I+G/"W?C^#PUQHWT
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MI6GX]+=[&=:'36"#3^1U<P]>W71;]#Q;\));1.ZT;#,7\T@ZS[6#3RYW=Q>
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M@DLB\C)*[34B7<<E_K&F+U6_8'52[+GSB4&BS*?(&JIX^G:-UW6-NRI6CY)
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M^ZJ#[2_J/V)8XK_^T_\!4$L! A0#%     @ _(!:4@7#0O4]V0  <_0( !X
M             ( !     &5X:&EB:70Q,#(Q=&]X87)C:&5R9'AI;F,R+FAT
M;5!+ 0(4 Q0    ( /R 6E)1!U@\05(  #=B @ >              "  7G9
M  !E>&AI8FET,3 U+6EN=FET864R,#$U<W1O8RYH=&U02P$"% ,4    " #\
M@%I2&3&24@0%  #S.P  '@              @ 'V*P$ 97AH:6)I=#(Q,2UL
M:7-T;V9S=6)S:61I87(N:'1M4$L! A0#%     @ _(!:4GDR+(_:!   4AD
M !X              ( !-C$! &5X:&EB:70R,S$M<W@X8V]N<V5N='@Q,C,Q
M+FAT;5!+ 0(4 Q0    ( /R 6E+$1!M("0@  ),C   5              "
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M4 $ 97AH:6)I=#0Q+6EN=FET865C;W)P;W)A=&DN:'1M4$L! A0#%     @
M_(!:4NA]FKH*,P  W'H! !X              ( !1U,! &5X:&EB:70T,30M
M:6YV:71A97AI;G1E;&QI+FAT;5!+ 0(4 Q0    ( /R 6E(IWMNT_=@$ /]-
M+0 1              "  8V& 0!N=G1A+3(P,C Q,C,Q+FAT;5!+ 0(4 Q0
M   ( /R 6E*W.C]Y!QL  #PK 0 1              "  ;E?!@!N=G1A+3(P
M,C Q,C,Q+GAS9%!+ 0(4 Q0    ( /R 6E)(P^D6@SD  $6# @ 5
M      "  >]Z!@!N=G1A+3(P,C Q,C,Q7V-A;"YX;6Q02P$"% ,4    " #\
M@%I2/A6I"(G!  #7Q0@ %0              @ &EM 8 ;G9T82TR,#(P,3(S
M,5]D968N>&UL4$L! A0#%     @ _(!:4KKBQ K>=   <(T  !0
M     ( !878' &YV=&$M,C R,#$R,S%?9S$N:G!G4$L! A0#%     @ _(!:
M4@EJ+AOH;0$ ?:T! !0              ( !<>L' &YV=&$M,C R,#$R,S%?
M9S(N:G!G4$L! A0#%     @ _(!:4D2V [IG5 $ !LT! !0
M ( !BUD) &YV=&$M,C R,#$R,S%?9S,N:G!G4$L! A0#%     @ _(!:4M0V
M>Z\8@0$   00 !4              ( !)*X* &YV=&$M,C R,#$R,S%?;&%B
M+GAM;%!+ 0(4 Q0    ( /R 6E+14!/%A@0! "4Q#  5              "
M 6\O# !N=G1A+3(P,C Q,C,Q7W!R92YX;6Q02P4&     !, $P D!0  *#0-
#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
